PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Shinoda, M; Ando, N; Kato, K; Ishikura, S; Kato, H; Tsubosa, Y; Minashi, K; Okabe, H; Kimura, Y; Kawano, T; Kosugi, SI; Toh, Y; Nakamura, K; Fukuda, H				Shinoda, Masayuki; Ando, Nobutoshi; Kato, Ken; Ishikura, Satoshi; Kato, Hoichi; Tsubosa, Yasuhiro; Minashi, Keiko; Okabe, Hiroshi; Kimura, Yusuke; Kawano, Tatsuyuki; Kosugi, Shin-Ichi; Toh, Yasushi; Nakamura, Kenichi; Fukuda, Haruhiko		Japan Clinical Oncology Grp	Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)	CANCER SCIENCE			English	Article						Chemoradiotherapy; esophageal squamous cell carcinoma; randomized trial; survival; toxicity	PHASE-II; CONCURRENT CHEMORADIOTHERAPY; DEFINITIVE CHEMORADIOTHERAPY; HYPERFRACTIONATED RADIATION; CONTINUOUS-INFUSION; ONCOLOGY-GROUP; LUNG-CANCER; CISPLATIN; 5-FLUOROURACIL; RADIOTHERAPY	Low-dose cisplatin and 5-fluorouracil (LDPF) chemotherapy with daily radiotherapy (RT) is used as an alternative chemoradiotherapy regimen for locally advanced esophageal carcinoma. We evaluated whether RT plus LDPF chemotherapy had an advantage in terms of survival and/or toxicity over RT plus standard-dose cisplatin and 5-fluorouracil (SDPF) chemotherapy in this study. This multicenter trial included esophageal cancer patients with clinical T4 disease and/or unresectable regional lymph node metastasis. Patients were randomly assigned to receive RT (2Gy/fraction, total dose of 60Gy) with SDPF (arm A) or LDPF (arm B) chemotherapy. The primary endpoint was overall survival (OS). A total of 142 patients (arm A/B, 71/71) from 41 institutions were enrolled between April 2004 and September 2009. The OS hazard ratio in arm B versus arm A was 1.05 (80% confidence interval, 0.78-1.41). There were no differences in toxicities in either arm. Arm B was judged as not promising for further evaluation in the phase III setting. Thus, the Data and Safety Monitoring Committee recommended that the study be terminated. In the updated analyses, median OS and 3-year OS were 13.1months and 25.9%, respectively, for arm A and 14.4months and 25.7%, respectively, for arm B. Daily RT plus LDPF chemotherapy did not qualify for further evaluation as a new treatment option for patients with locally advanced unresectable esophageal cancer. This study was registered at the UMIN Clinical Trials Registry as UMIN000000861.	[Shinoda, Masayuki] Aichi Canc Ctr, Dept Thorac Surg, Nagoya, Aichi 464, Japan; [Ando, Nobutoshi] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Surg, Ichikawa, Japan; [Kato, Ken] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan; [Ishikura, Satoshi] Koshigaya Municipal Hosp, Dept Radiol, Koshigaya, Japan; [Kato, Hoichi] Natl Canc Ctr, Esophageal Surg Div, Tokyo, Japan; [Tsubosa, Yasuhiro] Shizuoka Canc Ctr, Esophageal Surg Div, Shizuoka, Japan; [Minashi, Keiko] Natl Canc Ctr Hosp East, Div Digest Endoscopy & Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Okabe, Hiroshi] Kyoto Univ Hosp, Dept Surg, Kyoto 606, Japan; [Kimura, Yusuke] Iwate Med Univ, Dept Surg, Morioka, Iwate 020, Japan; [Kawano, Tatsuyuki] Tokyo Med & Dent Univ, Dept Esophageal & Gastr Surg, Tokyo, Japan; [Kosugi, Shin-Ichi] Niigata Univ, Dept Digest & Gen Surg, Niigata, Japan; [Toh, Yasushi] Kyushu Natl Canc Ctr, Dept Gastroenterol Surg, Fukuoka, Japan; [Nakamura, Kenichi; Fukuda, Haruhiko] Natl Canc Ctr, JCOG Data Ctr, Operat Off, Tokyo 104, Japan	Shinoda, M (reprint author), Aichi Canc Ctr Hosp, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi, Japan.	mshinoda@aichi-cc.jp			Ministry of Health, Labour, and Welfare of Japan; National Cancer Center Research and Development Fund, Japan	Ministry of Health, Labour, and Welfare of Japan; National Cancer Center Research and Development Fund, Japan.	Ohtsu A, 1999, J CLIN ONCOL, V17, P2915; Nishimura Y, 2012, JPN J CLIN ONCOL, V42, P807, DOI 10.1093/jjco/hys112; Ikeda K, 2001, DIS ESOPHAGUS, V14, P197, DOI 10.1046/j.1442-2050.2001.00184.x; HAZUKA MB, 1994, J CLIN ONCOL, V12, P1814; Kaneko K, 2003, BRIT J CANCER, V88, P18, DOI 10.1038/sj.bjc.6600684; PICUS D, 1983, RADIOLOGY, V146, P433; Jeremic B, 2000, J CLIN ONCOL, V18, P1458; SCANLON KJ, 1986, P NATL ACAD SCI USA, V83, P8923, DOI 10.1073/pnas.83.23.8923; Ishida K, 2004, JPN J CLIN ONCOL, V34, P615, DOI 10.1093/jjco/hyh107; AlSarraf M, 1997, J CLIN ONCOL, V15, P277; Nishimura Y, 2002, INT J RADIAT ONCOL, V53, P134, DOI 10.1016/S0360-3016(01)02813-9; Byfield JE, 1990, CANC CHEMOTHERAPY IN, V2nd, P521; CHOI KN, 1991, CANCER, V67, P2748, DOI 10.1002/1097-0142(19910601)67:11<2748::AID-CNCR2820671106>3.0.CO;2-4; ELLERBROEK NA, 1991, INT J RADIAT ONCOL, V20, P351; Fujita H, 2005, WORLD J SURG, V29, P25, DOI 10.1007/s00268-004-7590-2; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Ishikura S, 2005, ESOPHAGUS, V2, P133, DOI 10.1007/s10388-005-0055-3; Matsubara T, 2001, WORLD J SURG, V25, P279; MILANO G, 1990, CANCER CHEMOTH PHARM, V27, P55, DOI 10.1007/BF00689277; Raoul JL, 1998, INT J RADIAT ONCOL, V42, P29, DOI 10.1016/S0360-3016(98)00192-8; Roussel A, 1995, P AN M AM SOC CLIN, V14, p191a; Sai Heitetsu, 2004, Int J Clin Oncol, V9, P149; Sanuki N, 2012, INT J CLIN ONCOL, V17, P105, DOI 10.1007/s10147-011-0264-9; Sasaki K, 1995, INT J RADIAT ONCOL, V31, P921; Sasamoto R, 2007, INT J CLIN ONCOL, V12, P25, DOI 10.1007/s10147-006-0617-y; SCHAAKEKONING C, 1990, INT J RADIAT ONCOL, V19, P967; Takagawa R, 2009, DIS ESOPHAGUS, V22, P482, DOI 10.1111/j.1442-2050.2008.00935.x; The Japan Society for Esophageal Disease, 2002, COMPR REG ES CANC JA, V3rd; UICC, 1997, TNM CLASSIFICATION M, V5th; VansHarskamp G, 1987, INT J RADIAT ONCOL, V13, P1735	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					407	412		10.1111/cas.12622		6	Oncology	Oncology	CG5MQ	WOS:000353336400011		
J	Mishra, R; Watanabe, T; Kimura, MT; Koshikawa, N; Ikeda, M; Uekusa, S; Kawashima, H; Wang, XF; Igarashi, J; Choudhury, D; Grandori, C; Kemp, CJ; Ohira, M; Verma, NK; Kobayashi, Y; Takeuchi, J; Koshinaga, T; Nemoto, N; Fukuda, N; Soma, M; Kusafuka, T; Fujiwara, K; Nagase, H				Mishra, Rajeev; Watanabe, Takayoshi; Kimura, Makoto T.; Koshikawa, Nobuko; Ikeda, Maki; Uekusa, Shota; Kawashima, Hiroyuki; Wang, Xiaofei; Igarashi, Jun; Choudhury, Diptiman; Grandori, Carla; Kemp, Christopher J.; Ohira, Miki; Verma, Narendra K.; Kobayashi, Yujin; Takeuchi, Jin; Koshinaga, Tsugumichi; Nemoto, Norimichi; Fukuda, Noboru; Soma, Masayoshi; Kusafuka, Takeshi; Fujiwara, Kyoko; Nagase, Hiroki			Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation	CANCER SCIENCE			English	Article						Cell cycle; E-Box; MYC; pyrrole-imidazole polyamide; transcription therapy	C-MYC; CHLORAMBUCIL CONJUGATE; TRANSCRIPTION FACTOR; GENOMIC TARGETS; GENE-EXPRESSION; MAX; TRANSLATION; TRANSFORMATION; SUPPRESSION; PROGRESSION	The MYC transcription factor plays a crucial role in the regulation of cell cycle progression, apoptosis, angiogenesis, and cellular transformation. Due to its oncogenic activities and overexpression in a majority of human cancers, it is an interesting target for novel drug therapies. MYC binding to the E-box (5-CACGTGT-3) sequence at gene promoters contributes to more than 4000 MYC-dependent transcripts. Owing to its importance in MYC regulation, we designed a novel sequence-specific DNA-binding pyrrole-imidazole (PI) polyamide, Myc-5, that recognizes the E-box consensus sequence. Bioinformatics analysis revealed that the Myc-5 binding sequence appeared in 5- MYC binding E-box sequences at the eIF4G1, CCND1, and CDK4 gene promoters. Furthermore, ChIP coupled with detection by quantitative PCR indicated that Myc-5 has the ability to inhibit MYC binding at the target gene promoters and thus cause downregulation at the mRNA level and protein expression of its target genes in human Burkitt's lymphoma model cell line, P493.6, carrying an inducible MYC repression system and the K562 (human chronic myelogenous leukemia) cell line. Single i.v. injection of Myc-5 at 7.5mg/kg dose caused significant tumor growth inhibition in a MYC-dependent tumor xenograft model without evidence of toxicity. We report here a compelling rationale for the identification of a PI polyamide that inhibits a part of E-box-mediated MYC downstream gene expression and is a model for showing that phenotype-associated MYC downstream gene targets consequently inhibit MYC-dependent tumor growth.	[Mishra, Rajeev; Watanabe, Takayoshi; Kimura, Makoto T.; Ikeda, Maki; Uekusa, Shota; Kawashima, Hiroyuki; Wang, Xiaofei; Igarashi, Jun; Nagase, Hiroki] Nihon Univ, Res Inst Med Sci, Dept Adv Med Sci, Div Canc Genet, Tokyo, Japan; [Mishra, Rajeev; Choudhury, Diptiman] Samuel Oschin Comprehens Canc Inst, Dept Med, Cedars Sinai Med Ctr, Los Angeles, CA USA; [Watanabe, Takayoshi; Koshikawa, Nobuko; Ohira, Miki; Nagase, Hiroki] Chiba Canc Ctr, Res Inst, Chiba 2608717, Japan; [Kawashima, Hiroyuki; Koshinaga, Tsugumichi; Kusafuka, Takeshi] Nihon Univ, Res Inst Med Sci, Dept Surg, Div Pediat Surg, Tokyo, Japan; [Grandori, Carla; Kemp, Christopher J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Verma, Narendra K.] Univ Padua, Dept Biol Sci, Padua, Italy; [Kobayashi, Yujin; Takeuchi, Jin] Nihon Univ, Res Inst Med Sci, Dept Internal Med, Div Hematol, Tokyo, Japan; [Nemoto, Norimichi] Nihon Univ, Res Inst Med Sci, Dept Pathol & Microbiol, Tokyo, Japan; [Fukuda, Noboru] Nihon Univ, Adv Res Inst Sci & Human, Life Sci, Tokyo, Japan; [Soma, Masayoshi; Fujiwara, Kyoko] Nihon Univ, Res Inst Med Sci, Innovat Therapy Res Grp, Tokyo, Japan	Nagase, H (reprint author), Chiba Canc Ctr, Res Inst, Chuo Ku, 666-2 Nitona Cho, Chiba 2608717, Japan.	hnagase@chiba-cc.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23300344, 26290060]; Setsuro Fujii Memorial Osaka Foundation for the Promotion of Fundamental Medical Research, Osaka; National Institutes of Health/National Institute of Environmental Health Science North Carolina, USA [R01 ES012249]	Ministry of Education, Culture, Sports, Science and Technology of Japan (#23300344). (#26290060). Setsuro Fujii Memorial Osaka Foundation for the Promotion of Fundamental Medical Research, Osaka. National Institutes of Health/National Institute of Environmental Health Science North Carolina, USA. (R01 ES012249).	BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Yang F, 2013, P NATL ACAD SCI USA, V110, P1863, DOI 10.1073/pnas.1222035110; Nickols NG, 2007, ACS CHEM BIOL, V2, P561, DOI 10.1021/ch700110z; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Kang JS, 2014, J AM CHEM SOC, V136, P3687, DOI 10.1021/ja500211z; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Lin CJ, 2012, CELL REPORTS, V1, P325, DOI 10.1016/j.celrep.2012.02.010; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Wang HB, 2013, ONCOTARGET, V4, P936; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Nickols NG, 2013, MOL CANCER THER, V12, P675, DOI 10.1158/1535-7163.MCT-12-1040; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Synold TW, 2012, CANCER CHEMOTH PHARM, V70, P617, DOI 10.1007/s00280-012-1954-3; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Wang YD, 2003, NUCLEIC ACIDS RES, V31, P1208, DOI 10.1093/nar/gkg215; Yao EH, 2009, CARDIOVASC RES, V81, P797, DOI 10.1093/cvr/cvn355; ARVANITAKIS L, 1995, J IMMUNOL, V155, P1047; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Chen M, 2010, MOL THER, V18, P519, DOI 10.1038/mt.2009.263; Chou CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003593; Chou CJ, 2008, MOL CANCER THER, V7, P769, DOI 10.1158/1535-7163.MCT-08-0130; Dervan Peter B., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P373, DOI 10.2174/1568011054222346; Dickinson LA, 2004, CHEM BIOL, V11, P1583, DOI 10.1016/j.chembiol.2004.09.004; Farkas ME, 2009, BIOORG MED CHEM LETT, V19, P3919, DOI 10.1016/j.bmcl.2009.03.072; Huerta M, 2007, MOL BIOL CELL, V18, P4826, DOI 10.1091/mbc.E07-02-0109; Li SN, 2004, J BIOL CHEM, V279, P21312, DOI 10.1074/jbc.M312467200; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Luscher B, 2001, GENE, V277, P1, DOI 10.1016/S0378-1119(01)00697-7; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P16041, DOI 10.1073/pnas.1214267109; Taniguchi M, 2014, FEBS OPEN BIO, V4, P328, DOI 10.1016/j.fob.2014.03.004; Tu LX, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-78; Wang XF, 2010, CANCER SCI, V101, P759, DOI 10.1111/j.1349-7006.2009.01435.x	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					421	429		10.1111/cas.12610		9	Oncology	Oncology	CG5MQ	WOS:000353336400013		
J	Sagawa, M; Tabayashi, T; Kimura, Y; Tomikawa, T; Nemoto-Anan, T; Watanabe, R; Tokuhira, M; Ri, M; Hashimoto, Y; Iida, S; Kizaki, M				Sagawa, Morihiko; Tabayashi, Takayuki; Kimura, Yuta; Tomikawa, Tatsuki; Nemoto-Anan, Tomoe; Watanabe, Reiko; Tokuhira, Michihide; Ri, Masaki; Hashimoto, Yuichi; Iida, Shinsuke; Kizaki, Masahiro			TM-233, a novel analog of 10-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities	CANCER SCIENCE			English	Article						1-acetoxychavicol acetate; apoptosis; bortezomib; multiple myeloma; NF-B	RELAPSED/REFRACTORY MULTIPLE-MYELOMA; 1'-ACETOXYCHAVICOL ACETATE; BORTEZOMIB RESISTANCE; PRECLINICAL MODELS; DRUG-RESISTANCE; IN-VITRO; APOPTOSIS; ACTIVATION; PHASE-1; GROWTH	Although the introduction of bortezomib and immunomodulatory drugs has led to improved outcomes in patients with multiple myeloma, the disease remains incurable. In an effort to identify more potent and well-tolerated agents for myeloma, we have previously reported that 1-acetoxychavicol acetate (ACA), a natural condiment from South-East Asia, induces apoptotic cell death of myeloma cells in vitro and in vivo through inhibition of NF-B-related functions. Searching for more potent NF-B inhibitors, we developed several ACA analogs based on quantitative structure-activity relationship analysis. TM-233, one of these ACA analogs, inhibited cellular proliferation and induced cell death in various myeloma cell lines with a lower IC50 than ACA. Treatment with TM-233 inhibited constitutive activation of JAK2 and STAT3, and then downregulated the expression of anti-apoptotic Mcl-1 protein, but not Bcl-2 and Bcl-xL proteins. In addition, TM-233 rapidly decreased the nuclear expression of NF-B and also decreased the accumulation of cytosolic NF-B. We also examined the effects of TM-233 on bortezomib-resistant myeloma cells that we recently established, KMS-11/BTZ and OPM-2/BTZ. TM-233, but not bortezomib, inhibited cellular proliferation and induced cell death in KMS-11/BTZ and OPM-2/BTZ cells. Interestingly, the combination of TM-233 and bortezomib significantly induced cell death in these bortezomib-resistant myeloma cells through inhibition of NF-B activity. These results indicate that TM-233 could overcome bortezomib resistance in myeloma cells mediated through different mechanisms, possibly inhibiting the JAK/STAT pathway. In conclusion, TM-233 might be a more potent NF-B inhibitor than ACA, and could overcome bortezomib resistance in myeloma cells.	[Sagawa, Morihiko; Tabayashi, Takayuki; Kimura, Yuta; Tomikawa, Tatsuki; Nemoto-Anan, Tomoe; Watanabe, Reiko; Tokuhira, Michihide; Kizaki, Masahiro] Saitama Med Univ, Dept Hematol, Saitama Med Ctr, Kawagoe, Saitama 3508550, Japan; [Ri, Masaki; Iida, Shinsuke] Nagoya City Univ, Dept Med Oncol & Immunol, Nagoya, Aichi, Japan; [Hashimoto, Yuichi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	Kizaki, M (reprint author), Saitama Med Univ, Dept Hematol, Saitama Med Ctr, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	makizaki@saitama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591409]; National Cancer Research and Development Fund [26-A-4]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (24591409). National Cancer Research and Development Fund (26-A-4).	Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hideshima T, 2001, CANCER RES, V61, P3071; Mark TM, 2014, LEUKEMIA RES, V38, P517, DOI 10.1016/j.leukres.2014.02.008; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Wang J, 2012, ONCOGENE, V31, P4798, DOI 10.1038/onc.2011.635; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20020407; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; O'Connor OA, 2009, CLIN CANCER RES, V15, P7085, DOI 10.1158/1078-0432.CCR-09-0822; Ocio EM, 2014, LEUKEMIA, V28, P525, DOI 10.1038/leu.2013.350; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004; Lauta VM, 2001, CYTOKINE, V16, P79, DOI 10.1006/cyto.2001.0982; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Azuma H, 2006, BIOORGAN MED CHEM, V14, P1811, DOI 10.1016/j.bmc.2005.10.029; dasFonseca PC, 2012, MOL CELL, V46, P54; Ito K, 2005, CANCER RES, V65, P4417, DOI 10.1158/0008-5472.CAN-05-0072; Ito K, 2005, BIOCHEM BIOPH RES CO, V338, P702; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Kumar SK, 2014, BLOOD, V124, P1047, DOI 10.1182/blood-2014-01-548941; Kyle RA, 2014, EXPERT REV HEMATOL, V7, P5, DOI 10.1586/17474086.2014.870030; Liu H, 2014, CANCER CELL, V25, P530, DOI 10.1016/j.ccr.2014.03.008; Misawa T, 2008, CHEM PHARM BULL, V56, P1490, DOI 10.1248/cpb.56.1490; Murakami A, 1994, Asia Pac J Clin Nutr, V3, P185; Ohnishi M, 1996, JPN J CANCER RES, V87, P349; Richardson PG, 2014, BLOOD, V124, P1038, DOI 10.1182/blood-2014-01-548826; Wang JH, 2014, BLOOD, V124, P555, DOI [10.1182/blood-2014-03-562439, 10.1182/blood-2014-03562439]	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					438	446		10.1111/cas.12616		9	Oncology	Oncology	CG5MQ	WOS:000353336400015		
J	Wada, K; Kawachi, T; Hori, A; Takeyama, N; Tanabashi, S; Matsushita, S; Tokimitsu, N; Nagata, C				Wada, Keiko; Kawachi, Toshiaki; Hori, Akihiro; Takeyama, Naoharu; Tanabashi, Shinobu; Matsushita, Shogen; Tokimitsu, Naoki; Nagata, Chisato			Husband's smoking status and breast cancer risk in Japan: From the Takayama study	CANCER SCIENCE			English	Article						Alcohol; breast cancer; cohort studies; epidemiology; second-hand smoke	ENVIRONMENTAL TOBACCO-SMOKE; PASSIVE SMOKING; ACTIVE SMOKING; EPIDEMIOLOGIC EVIDENCE; WOMEN; METAANALYSIS; POPULATION; ASSOCIATION; ALCOHOL; COHORT	The effects of smoking on breast cancer remain unclear. We assessed the associations of subjects' or husbands' smoking status with breast cancer incidence in a population-based prospective study in Japan. The subjects were 15719 women aged 35years or older. The follow up was conducted from September 1992 to March 2008. Cancer incidence was mainly confirmed through regional population-based cancer registries. Breast cancer was defined as code C50 according to the International Classification of Diseases and Health Related Problems, 10th Revision. Lifestyle, including smoking status, was assessed with a self-administered questionnaire. Alcohol consumption was assessed with a validated food-frequency questionnaire. After multivariate adjustments for age, body mass index, alcohol consumption, physical activity, education, age at menarche, age at first delivery, menopausal status, number of children and history of hormone replacement therapy, active smoking was not associated with the risk of breast cancer. Compared with never smokers whose husband had never smoked, the risks of breast cancer were 1.98 (95% CI: 1.03-3.84) among never smokers whose husband was a current smoker of 21 cigarettes per day or more. The increased risk of breast cancer among women having a smoking husband was pronounced among those who did not habitually consume alcohol. These results suggest that exposure to smoke from husbands is a potential risk factor for breast cancer. The impact of alcohol consumption on the increased breast cancer risk from passive smoking needs to be addressed in further studies.	[Wada, Keiko; Kawachi, Toshiaki; Nagata, Chisato] Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu 5011194, Japan; [Hori, Akihiro; Takeyama, Naoharu] Kumiai Kosei Hosp, Dept Internal Med, Takayama, Japan; [Tanabashi, Shinobu; Tokimitsu, Naoki] Takayama Red Cross Hosp, Dept Internal Med, Takayama, Japan; [Matsushita, Shogen] Takayama Red Cross Hosp, Dept Radiol, Takayama, Japan	Wada, K (reprint author), Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, 1-1 Yanagido, Gifu 5011194, Japan.	dr_keiko@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology Ministry of Health, Labor, and Welfare of Japan	Ambrosone CB, 2008, CANCER EPIDEM BIOMAR, V17, P15, DOI 10.1158/1055-9965.EPI-07-0598; Gram IT, 2005, CANCER EPIDEM BIOMAR, V14, P61; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; Khuder SA, 2000, EUR J EPIDEMIOL, V16, P1117, DOI 10.1023/A:1010967513957; Li DH, 1996, CANCER RES, V56, P287; Wong SL, 2012, HEALTH REP, V23, P47; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Lin Y, 2008, J EPIDEMIOL, V18, P77, DOI 10.2188/jea.18.77; Miller MD, 2007, PREV MED, V44, P93, DOI 10.1016/j.ypmed.2006.08.015; Conway K, 2002, CANCER RES, V62, P1987; Gaudet MM, 2013, JNCI-J NATL CANCER I, V105, P515, DOI 10.1093/jnci/djt023; Council for Science and Technology Ministry of Education C Sports Science and Technology Japan, 2005, STAND TABL FOOD COMP; Deroo LA, 2011, AM J EPIDEMIOL, V174, P390, DOI 10.1093/aje/kwr090; Gammon MD, 2004, ENVIRON RES, V96, P176, DOI 10.1016/j.envres.2003.08.009; Goodman MT, 1997, PREV MED, V26, P144, DOI 10.1006/pmed.1996.9979; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Hanaoka T, 2005, INT J CANCER, V114, P317, DOI 10.1002/ijc.20709; Hirayama T, 1990, LIFE STYLE MORTALITY; Inaba S, 1998, J Epidemiol, V8, P42; Lee PN, 2006, INHAL TOXICOL, V18, P1053, DOI 10.1080/08958370600945432; MACNICOLL AD, 1980, BIOCHEM BIOPH RES CO, V95, P1599, DOI 10.1016/S0006-291X(80)80081-7; Nagata C, 2007, JPN J CLIN ONCOL, V37, P568, DOI 10.1093/jjco/hym062; Nagata C, 2006, JPN J CLIN ONCOL, V36, P387, DOI 10.1093/jjco/hyl031; Nishino Y, 2001, CANCER CAUSE CONTROL, V12, P797, DOI 10.1023/A:1012273806199; Pirie K, 2008, INT J EPIDEMIOL, V37, P1069, DOI 10.1093/ije/dyn110; Roddam AW, 2007, BRIT J CANCER, V97, P434, DOI 10.1038/sj.bjc.6603859; Shimizu H, 1999, JPN J CLIN ONCOL, V29, P38, DOI 10.1093/jjco/29.1.38; Shimizu H, 1996, BASIC REPORT TAKAYAM; Suzuki I, 1998, J Epidemiol, V8, P152; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077029	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					455	460		10.1111/cas.12619		6	Oncology	Oncology	CG5MQ	WOS:000353336400017		
J	Takachi, T; Takahashi, M; Takahashi-Yoshita, M; Higuchi, M; Obata, M; Mishima, Y; Okuda, S; Tanaka, Y; Matsuoka, M; Saitoh, A; Green, PL; Fujii, M				Takachi, Takayuki; Takahashi, Masahiko; Takahashi-Yoshita, Manami; Higuchi, Masaya; Obata, Miki; Mishima, Yukio; Okuda, Shujiro; Tanaka, Yuetsu; Matsuoka, Masao; Saitoh, Akihiko; Green, Patrick L.; Fujii, Masahiro			Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells	CANCER SCIENCE			English	Article						Adult T cell leukemia; BCL11B; HBZ; HTLV-1; Tax	HTLV-1 BZIP FACTOR; INTERLEUKIN-2-INDEPENDENT GROWTH; DNA-DAMAGE; PDZ DOMAIN; I TAX; PROTEIN; TRANSFORMATION; TRANSCRIPTION; LYMPHOCYTES; ACTIVATION	Human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent of adult T cell leukemia (ATL), which is an aggressive form of T-cell malignancy. HTLV-1 oncoproteins, Tax and HBZ, play crucial roles in the immortalization of T-cells and/or leukemogenesis by dysregulating the cellular functions in the host. Recent studies show that HTLV-1-infected T-cells have reduced expression of the BCL11B tumor suppressor protein. In the present study, we explored whether Tax and/or HBZ play a role in downregulating BCL11B in HTLV-1-infected T-cells. Lentiviral transduction of Tax in a human T-cell line repressed the expression of BCL11B at both the protein and mRNA levels, whereas the transduction of HBZ had little effect on the expression. Tax mutants with a decreased activity for the NF-B, CREB or PDZ protein pathways still showed a reduced expression of the BCL11B protein, thereby implicating a different function of Tax in BCL11B downregulation. In addition, the HTLV-2 Tax2 protein reduced the BCL11B protein expression in T-cells. Seven HTLV-1-infected T-cell lines, including three ATL-derived cell lines, showed reduced BCL11B mRNA and protein expression relative to an uninfected T-cell line, and the greatest reductions were in the cells expressing Tax. Collectively, these results indicate that Tax is responsible for suppressing BCL11B protein expression in HTLV-1-infected T-cells; Tax-mediated repression of BCL11B is another mechanism that Tax uses to promote oncogenesis of HTLV-1-infected T-cells.	[Takachi, Takayuki; Takahashi, Masahiko; Takahashi-Yoshita, Manami; Higuchi, Masaya; Fujii, Masahiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata, Niigata 9518510, Japan; [Takachi, Takayuki; Saitoh, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Div Pediat, Niigata, Niigata 9518510, Japan; [Takahashi-Yoshita, Manami] Ctr Fostering Innovat Leadership, Niigata, Japan; [Obata, Miki; Mishima, Yukio] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Genet, Niigata, Niigata 9518510, Japan; [Okuda, Shujiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Bioinformat, Niigata, Niigata 9518510, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Grad Sch, Dept Immunol, Okinawa, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Fac Med, Okinawa, Japan; [Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto 606, Japan; [Green, Patrick L.] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA	Fujii, M (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, 1-757 Asahimchi Dori, Niigata, Niigata 9518510, Japan.	fujiimas@med.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Promotion of Niigata University Research Project; National Institutes of Health [CA100730]	Ministry of Education, Culture, Sports, Science and Technology of Japan, Promotion of Niigata University Research Project, National Institutes of Health (CA100730).	Schmitt I, 1998, J VIROL, V72, P633; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Haoudi A, 2003, J BIOL CHEM, V278, P37736, DOI 10.1074/jbc.M301649200; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Matsuoka M, 2013, CURR OPIN VIROL, V3, P684, DOI 10.1016/j.coviro.2013.08.010; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Arnold J, 2006, BLOOD, V107, P3976, DOI 10.1182/blood-2005-11-4551; Borowiak M, 2013, CARCINOGENESIS, V34, P2664, DOI 10.1093/carcin/bgt221; Higuchi M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-117; Iwanaga Y, 1999, J VIROL, V73, P1271; Kurosawa N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055147; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; Lemoine FJ, 2002, ONCOGENE, V21, P7230, DOI 10.1038/sj.onc.1205898; Li L, 2013, BLOOD, V122, P902, DOI 10.1182/blood-2012-08-447839; Matsumoto K, 1997, J VIROL, V71, P4445; Meertens L, 2004, J BIOL CHEM, V279, P43307, DOI 10.1074/jbc.M400497200; Neuveut C, 2000, Prog Cell Cycle Res, V4, P157; Niinuma A, 2005, J VIROL, V79, P11925, DOI 10.1128/JVI.79.18.11925-11934.2005; Ross TM, 1996, J VIROL, V70, P5194; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Satou Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001274; Shoji T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-83; TANAKA Y, 1991, INT J CANCER, V48, P623, DOI 10.1002/ijc.2910480423; Tanaka-Nakanishi A, 2014, CANCER RES, V74, P188, DOI 10.1158/0008-5472.CAN-13-0436; Wu KL, 2004, J BIOL CHEM, V279, P495, DOI 10.1074/jbc.M310069200; Yoshita M, 2012, CANCER SCI, V103, P369, DOI 10.1111/j.1349-7006.2011.02123.x	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					461	465		10.1111/cas.12618		5	Oncology	Oncology	CG5MQ	WOS:000353336400018		
J	Yokota, M; Kojima, M; Higuchi, Y; Nishizawa, Y; Kobayashi, A; Ito, M; Saito, N; Ochiai, A				Yokota, Mitsuru; Kojima, Motohiro; Higuchi, Youichi; Nishizawa, Yuji; Kobayashi, Akihiro; Ito, Masaaki; Saito, Norio; Ochiai, Atsushi			Spread of tumor microenvironment contributes to colonic obstruction through subperitoneal fibroblast activation in colon cancer	CANCER SCIENCE			English	Article						Colon cancer; elastic laminal invasion; fibroblast; obstruction; tumor microenvironment	ELASTIC LAMINAL INVASION; COLORECTAL-CANCER; MYOFIBROBLAST; METASTASIS; STATISTICS; FEATURES; STROMA	We evaluated the influence of the cancer microenvironment formed by peritoneal invasion (CMPI) on clinical findings in colon cancer patients. In addition to the association with poor prognosis, we discovered a relationship with bowel obstruction. Detailed analysis revealed that clinical findings related to bowel obstruction occurred more frequently in patients with an elevated type tumor, which had peritoneal elastic laminal elevation to the tumor surface, compared to those with non-elevated type tumors among those with elastic laminal invasion (ELI). Lateral tumor spread and increase of tumor annularity rate in ELI-positive elevated type cases suggested the morphological progression from ELI-positive non-elevated type to elevated type. In addition, -smooth muscle actin expression was the highest in ELI-positive elevated type, and prominent expressions were found not only in the deep tumor area but also in the shallow tumor area. Furthermore, contraction assays revealed the robust contractile ability of subperitoneal fibroblasts stimulated by cancer cell-conditioned medium. Our findings suggest that CMPI spread into the luminal side of the colonic wall along with tumor progression, which caused bowel obstruction through the activation of subperitoneal fibroblasts. However, although the clinical outcome was not different between the two types, the clinical findings were affected by the spread of CMPI. We are the first to explore how the alteration of the tumor-promoting microenvironment, along with tumor progression, contributes to the development of clinical findings.	[Yokota, Mitsuru; Nishizawa, Yuji; Kobayashi, Akihiro; Ito, Masaaki; Saito, Norio] Natl Canc Ctr Hosp East, Div Colorectal Surg, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan; [Yokota, Mitsuru] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Kojima, Motohiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba 2778577, Japan; [Higuchi, Youichi] Univ Tokyo, Canc Biol Lab, Dept Integrated Biosci, Grad Sch Frontier Sci, Tokyo, Japan	Ochiai, A (reprint author), Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	aochiai@east.ncc.go.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science.	Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Alvarez R, 2013, BRIT J CANCER, V109, P926, DOI 10.1038/bjc.2013.415; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Hinz B, 2013, PERIODONTOL 2000, V63, P14, DOI 10.1111/prd.12030; Majumdar SR, 1999, AM J GASTROENTEROL, V94, P3039; Ferlay J, 2010, Eur J Cancer, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Kojima M, 2010, AM J SURG PATHOL, V34, P1351, DOI 10.1097/PAS.0b013e3181ecfe98; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377; Ngo P, 2006, METH MOL B, V341, P103; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Alphonso A, 2009, NEOPLASIA, V11, P1264, DOI 10.1593/neo.91302; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Kojima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088018; Liang WY, 2013, AM J SURG PATHOL, V37, P1565, DOI 10.1097/PAS.0b013e31828ea2de; MIURA S, 1993, J SURG ONCOL, V53, P36, DOI 10.1002/jso.2930530111; Miyamoto S, 2001, J GASTROENTEROL, V36, P158, DOI 10.1007/s005350170123; Sobin LH, 2009, TNM CLASSIFICATION M; UEYAMA T, 1991, JPN J CLIN ONCOL, V21, P100; Yokota M, 2014, DIS COLON RECTUM, V57, P830, DOI 10.1097/DCR.0000000000000124; Yun JA, 2014, J SURG ONCOL, V110, P839, DOI 10.1002/jso.23725	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					466	474		10.1111/cas.12615		9	Oncology	Oncology	CG5MQ	WOS:000353336400019		
J	Yao, R; Mori, S; Noda, T				Yao, Ryoji; Mori, Seiichi; Noda, Tetsuo			JCA-AACR Joint Symposia in the 73rd Annual Meeting of the Japanese Cancer Association, Yokohama, 25-26 September 2014	CANCER SCIENCE			English	Article						Cancer biology; cancer genomics; clinical sequence; immunogenomics; mouse genetics		To integrate and discuss the cutting-edge science and revolutionized therapeutics of cancer in Japan and the United States, JCA (Japanese Cancer Association)-AACR (American Association for Cancer Research) Joint Symposia were held on 25th (Symposium 2) and 26th (Symposium 1) in September 2014 as a part of the 73rd Annual Meeting of the Japanese Cancer Association at Pacifico Yokohama in Yokohama, Japan. The symposia focused on mouse genetics and human genomics in cancer research. Eight prominent scientists from JCA and AACR discussed their own research in the symposia. They provided substantial fruitful information not only for identification of novel target molecules and pathways in cancer therapeutics but also for direct translation of cancer genomics into clinics	[Yao, Ryoji; Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Div Cell Biol, Tokyo 1358550, Japan; [Mori, Seiichi; Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Div Canc Genom, Tokyo 1358550, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Tokyo 1358550, Japan	Noda, T (reprint author), Japanese Fdn Canc Res, Inst Canc, Koto Ku, Directors Room,8-31 Ariake, Tokyo 1358550, Japan.	tnoda@jfcr.or.jp			Princess Takamatsu Cancer Research Fund	The JCA-AACR Joint symposia in the 73rd Annual Meeting of the Japanese Cancer Association were supported by the Princess Takamatsu Cancer Research Fund.		0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1347-9032	1349-7006		CANCER SCI	Cancer Sci.	APR	2015	106	4					475	479		10.1111/cas.12625		5	Oncology	Oncology	CG5MQ	WOS:000353336400020		
J	Soejima, K; Nogami, A; Sekiguchi, Y; Harada, T; Satomi, K; Hirose, T; Ueda, A; Miwa, Y; Sato, T; Nishio, S; Shirai, Y; Kowase, S; Murakoshi, N; Kunugi, S; Murata, H; Nitta, T; Aonuma, K; Yoshino, H				Soejima, Kyoko; Nogami, Akihiko; Sekiguchi, Yukio; Harada, Tomoo; Satomi, Kazuhiro; Hirose, Takeshi; Ueda, Akiko; Miwa, Yousuke; Sato, Toshiaki; Nishio, Satoru; Shirai, Yasuhiro; Kowase, Shinya; Murakoshi, Nobuyuki; Kunugi, Shinobu; Murata, Hiroshige; Nitta, Takashi; Aonuma, Kazutaka; Yoshino, Hideaki			Epicardial Catheter Ablation of Ventricular Tachycardia in No Entry Left Ventricle Mechanical Aortic and Mitral Valves	Circulation-Arrhythmia and Electrophysiology			English	Article						aortic valve; catheter ablation; mitral valve; tachycardia, ventricular	CARDIAC-SURGERY; ACCESS	Background-In patients with mechanical aortic and mitral valves and left ventricular tachycardia, catheter ablation may be prevented by limited access to the left ventricle. Methods and Results-In our series of 6 patients, 2 patients underwent direct surgical ablation and 4 underwent epicardial catheter ablation via a pericardial window. All patients had abnormal low voltage areas with fractionated or delayed isolated potentials on the apical epicardium. Most of the ventricular tachycardias were targeted by pace mapping. Sites with a good pace match or abnormal electrograms were ablated using an irrigated radiofrequency ablation catheter. A microscopic pathological evaluation of the resected tissue from 2 of the open-heart ablation patients revealed dense fibrosis on the epicardium compared with the endocardium, supporting the feasibility of an epicardial ablation for the ventricular tachycardia. Conclusions-Epicardial catheter ablation of ventricular tachycardia is a potentially useful therapy in patients who have mechanical aortic and mitral valves.	[Soejima, Kyoko; Ueda, Akiko; Miwa, Yousuke; Sato, Toshiaki; Yoshino, Hideaki] Kyorin Univ Hosp, Dept Cardiol, Mitaka, Tokyo 1818611, Japan; [Nogami, Akihiko; Sekiguchi, Yukio; Murakoshi, Nobuyuki; Aonuma, Kazutaka] Univ Tsukuba, Div Cardiovasc, Tsukuba, Ibaraki, Japan; [Hirose, Takeshi; Nishio, Satoru] St Marianna Univ, Sch Med Hosp, Dept Cardiol, Kawasaki, Kanagawa, Japan; [Satomi, Kazuhiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Cardiol, Hachioji, Tokyo, Japan; [Harada, Tomoo] Gifu Prefectural Gen Med Ctr, Dept Cardiol, Gifu, Japan; [Shirai, Yasuhiro] Tokyo Med & Dent Univ Hosp, Tokyo, Japan; [Kowase, Shinya] Yokohama Rosai Hosp, Dept Cardiovasc Med, Yokohama, Kanagawa, Japan; [Kunugi, Shinobu] Nippon Med Coll Hosp, Dept Cardiovasc Med, Tokyo, Japan; [Murata, Hiroshige] Nippon Med Sch, Grad Sch Med, Dept Analyt Human Pathol, Tokyo 113, Japan; [Nitta, Takashi] Nippon Med Sch Med, Dept Cardiovasc Surg, Tokyo, Japan	Soejima, K (reprint author), Kyorin Univ Hosp, Dept Cardiol, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	skyoko@ks.kyorin-u.ac.jp					Narasimhan C, 1997, CIRCULATION, V96, P4307; Cesario DA, 2006, HEART RHYTHM, V3, P1, DOI 10.1016/j.hrthm.2005.10.015; Soejima K, 2004, CIRCULATION, V110, P1197, DOI 10.1161/01.CIR.0000140725.42845.90; Bogun FM, 2009, J AM COLL CARDIOL, V53, P1138, DOI 10.1016/j.jacc.2008.11.052; Eckart RE, 2007, CIRCULATION, V116, P2005, DOI 10.1161/CIRCULATIONAHA.107.703157; Elias Nelson, 2009, Arq Bras Cardiol, V92, P63, DOI 10.1590/S0066-782X2009000100010; Herweg B, 2010, PACE, V33, P900, DOI 10.1111/j.1540-8159.2009.02678.x; Hsieh CHC, 2010, CIRC-ARRHYTHMIA ELEC, V3, P178, DOI 10.1161/CIRCEP.109.906628; Michel P L, 1992, J Heart Valve Dis, V1, P72; Nitta T, 2012, ANN THORAC SURG, V93, P1285, DOI 10.1016/j.athoracsur.2011.12.081; Tschabrunn CM, 2013, HEART RHYTHM, V10, P165, DOI 10.1016/j.hrthm.2012.10.012; Vaseghi M, 2013, HEART RHYTHM, V10, P1069, DOI 10.1016/j.hrthm.2013.04.029; Walters DL, 2003, CATHETER CARDIO INTE, V58, P539, DOI 10.1002/ccd.10473	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3149	1941-3084		CIRC-ARRHYTHMIA ELEC	Circ.-Arrhythmia Electrophysiol.	APR	2015	8	2					381	389		10.1161/CIRCEP.114.002517		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG5CQ	WOS:000353309100020		
J	Ishikawa, T; Jou, CJ; Nogami, A; Kowase, S; Arrington, CB; Barnett, SM; Harrell, DT; Arimura, T; Tsuji, Y; Kimura, A; Makita, N				Ishikawa, Taisuke; Jou, Chuanchau J.; Nogami, Akihiko; Kowase, Shinya; Arrington, Cammon B.; Barnett, Spencer M.; Harrell, Daniel T.; Arimura, Takuro; Tsuji, Yukiomi; Kimura, Akinori; Makita, Naomasa			Novel Mutation in the alpha-Myosin Heavy Chain Gene Is Associated With Sick Sinus Syndrome	Circulation-Arrhythmia and Electrophysiology			English	Article						genetics; MYH6; myosin heavy chain; sick sinus syndrome; sinus node dysfunction	BINDING-PROTEIN-C; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HEART-RATE; DILATED CARDIOMYOPATHY; CHANNEL; EXPRESSION; ZEBRAFISH; S2; CARDIOMYOCYTES; BRADYCARDIA	Background-Recent genome-wide association studies have demonstrated an association between MYH6, the gene encoding alpha-myosin heavy chain (alpha-MHC), and sinus node function in the general population. Moreover, a rare MYH6 variant, R721W, predisposing susceptibility to sick sinus syndrome has been identified. However, the existence of disease-causing MYH6 mutations for familial sick sinus syndrome and their underlying mechanisms remain unknown. Methods and Results-We screened 9 genotype-negative probands with sick sinus syndrome families for mutations in MYH6 and identified an in-frame 3-bp deletion predicted to delete one residue (delE933) at the highly conserved coiled-coil structure within the binding motif to myosin-binding protein C in one patient. Co-immunoprecipitation analysis revealed enhanced binding of delE933 alpha-MHC to myosin-binding protein C. Irregular fluorescent speckles retained in the cytoplasm with substantially disrupted sarcomere striation were observed in neonatal rat cardiomyocytes transfected with alpha-MHC mutants carrying delE933 or R721W. In addition to the sarcomere impairments, delE933 alpha-MHC exhibited electrophysiological abnormalities both in vitro and in vivo. The atrial cardiomyocyte cell line HL-1 stably expressing delE933 alpha-MHC showed a significantly slower conduction velocity on multielectrode array than those of wild-type alpha-MHC or control plasmid transfected cells. Furthermore, targeted morpholino knockdown of MYH6 in zebrafish significantly reduced the heart rate, which was rescued by coexpressed wild-type human alpha-MHC but not by delE933 alpha-MHC. Conclusions-The novel MYH6 mutation delE933 causes both structural damage of the sarcomere and functional impairments on atrial action propagation. This report reinforces the relevance of MYH6 for sinus node function and identifies a novel pathophysiology underlying familial sick sinus syndrome.	[Ishikawa, Taisuke; Harrell, Daniel T.; Tsuji, Yukiomi; Makita, Naomasa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Physiol, Nagasaki 8528523, Japan; [Ishikawa, Taisuke; Arimura, Takuro; Kimura, Akinori] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo 1138510, Japan; [Jou, Chuanchau J.; Arrington, Cammon B.; Barnett, Spencer M.] Univ Utah, Div Pediat Cardiol, Salt Lake City, UT USA; [Nogami, Akihiko] Univ Tsukuba, Div Cardiovasc, Tsukuba, Ibaraki, Japan; [Nogami, Akihiko; Kowase, Shinya] Yokohama Rosai Hosp, Dept Heart Rhythm Management, Yokohama, Kanagawa, Japan; [Arimura, Takuro] Kagoshima Univ, Dept Vet Med, Kagoshima 890, Japan	Makita, N (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Physiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	akitis@mri.tmd.ac.jp; makitan@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [22136007, 26860572, 24390199, 25293181, 25670172]; Research Grant for the Cardiovascular Diseases from the Japanese Ministry of Health, Labour and Welfare [H24-033]; Joint Usage/Research Program of Medical Research Institute Tokyo Medical and Dental University; Fukuda Foundation for Medical Technology; Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences; Fellow-to Faculty Award from American Heart Association	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas (HD Physiology) 22136007 (N. Makita) and Grants-in-Aid for Scientific Research 26860572 (T. Ishikawa), 24390199 (N. Makita), 25293181 and 25670172 (A. Kimura) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Research Grant for the Cardiovascular Diseases (H24-033) from the Japanese Ministry of Health, Labour and Welfare (N. Makita); the Joint Usage/Research Program of Medical Research Institute Tokyo Medical and Dental University (N. Makita, A.K.); a research grant from Fukuda Foundation for Medical Technology (T. Ishikawa); Joint Research Promotion Project of Nagasaki University Graduate School of Biomedical Sciences (T. Ishikawa); and Fellow-to Faculty Award from American Heart Association (C.J. Jou).	Amin AS, 2010, PFLUG ARCH EUR J PHY, V460, P223, DOI 10.1007/s00424-009-0761-0; ANAN R, 1994, J CLIN INVEST, V93, P280, DOI 10.1172/JCI116957; Abe K, 2014, CIRC-ARRHYTHMIA ELEC, V7, P511, DOI 10.1161/CIRCEP.113.001340; den Hoed M, 2013, NAT GENET, V45, P621, DOI 10.1038/ng.2610; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; Arimura T, 2011, HUM MUTAT, V32, P1481, DOI 10.1002/humu.21603; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Arrington CB, 2012, CIRC-CARDIOVASC GENE, V5, P175, DOI 10.1161/CIRCGENETICS.111.961797; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Yamamoto M, 2006, CARDIOVASC RES, V72, P271, DOI 10.1016/j.cardiores.2006.07.026; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Kunst G, 2000, CIRC RES, V86, P51; Palmer BM, 2004, CIRC RES, V94, P1249, DOI 10.1161/01.RES.0000126898.95550.31; Granados-Riveron JT, 2010, HUM MOL GENET, V19, P4007, DOI 10.1093/hmg/ddq315; Bahrudin U, 2011, J MOL BIOL, V413, P857, DOI 10.1016/j.jmb.2011.09.006; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; Hughes SE, 2005, HEART, V91, P257, DOI 10.1136/hrt.2004.040337; KIMMEL CB, 1995, DEV DYNAM, V203, P253; Kimura Akinori, 2008, Circ J, V72 Suppl A, pA38, DOI 10.1253/circj.CJ-08-0050; Lakdawala NK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P228, DOI 10.1161/CIRCEP.111.962050; Nof E, 2007, CIRCULATION, V116, P463, DOI 10.1161/CIRCULATIONAHA.107.706887; Posch MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028872; Reiser PJ, 1998, AM J PHYSIOL-HEART C, V274, pH1048; Singleman C, 2012, DEV DYNAM, V241, P1993, DOI 10.1002/dvdy.23882; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434	35	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-3149	1941-3084		CIRC-ARRHYTHMIA ELEC	Circ.-Arrhythmia Electrophysiol.	APR	2015	8	2					400	U200		10.1161/CIRCEP.114.002534		15	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG5CQ	WOS:000353309100022		
J	Stitziel, NO; Peloso, GM; Abifadel, M; Cefalu, AB; Fouchier, S; Motazacker, MM; Tada, H; Larach, DB; Awan, Z; Haller, JF; Pullinger, CR; Varret, M; Rabes, JP; Noto, D; Tarugi, P; Kawashiri, M; Nohara, A; Yamagishi, M; Risman, M; Deo, R; Ruel, I; Shendure, J; Nickerson, DA; Wilson, JG; Rich, SS; Gupta, N; Farlow, DN; Neale, BM; Daly, MJ; Kane, JP; Freeman, MW; Genest, J; Rader, DJ; Mabuchi, H; Kastelein, JJP; Hovingh, GK; Averna, MR; Gabriel, S; Boileau, C; Kathiresan, S				Stitziel, Nathan O.; Peloso, Gina M.; Abifadel, Marianne; Cefalu, Angelo B.; Fouchier, Sigrid; Motazacker, M. Mahdi; Tada, Hayato; Larach, Daniel B.; Awan, Zuhier; Haller, Jorge F.; Pullinger, Clive R.; Varret, Mathilde; Rabes, Jean-Pierre; Noto, Davide; Tarugi, Patrizia; Kawashiri, Masa-aki; Nohara, Atsushi; Yamagishi, Masakazu; Risman, Marjorie; Deo, Rahul; Ruel, Isabelle; Shendure, Jay; Nickerson, Deborah A.; Wilson, James G.; Rich, Stephen S.; Gupta, Namrata; Farlow, Deborah N.; Neale, Benjamin M.; Daly, Mark J.; Kane, John P.; Freeman, Mason W.; Genest, Jacques; Rader, Daniel J.; Mabuchi, Hiroshi; Kastelein, John J. P.; Hovingh, G. Kees; Averna, Maurizio R.; Gabriel, Stacey; Boileau, Catherine; Kathiresan, Sekar		NHLBI Grand Opportunity Exome	Exome Sequencing in Suspected Monogenic Dyslipidemias	CIRCULATION-CARDIOVASCULAR GENETICS			English	Article						DNA sequencing; exome; genetics; human; lipids	AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; APOE P.LEU167DEL MUTATION; FAMILIAL HYPERCHOLESTEROLEMIA; TANGIER-DISEASE; GENE; DISCOVERY; JAPANESE; COMPLEX; DESIGN; UPDATE	Background-Exome sequencing is a promising tool for gene mapping in Mendelian disorders. We used this technique in an attempt to identify novel genes underlying monogenic dyslipidemias. Methods and Results-We performed exome sequencing on 213 selected family members from 41 kindreds with suspected Mendelian inheritance of extreme levels of low-density lipoprotein cholesterol (after candidate gene sequencing excluded known genetic causes for high low-density lipoprotein cholesterol families) or high-density lipoprotein cholesterol. We used standard analytic approaches to identify candidate variants and also assigned a polygenic score to each individual to account for their burden of common genetic variants known to influence lipid levels. In 9 families, we identified likely pathogenic variants in known lipid genes (ABCA1, APOB, APOE, LDLR, LIPA, and PCSK9); however, we were unable to identify obvious genetic etiologies in the remaining 32 families, despite follow-up analyses. We identified 3 factors that limited novel gene discovery: (1) imperfect sequencing coverage across the exome hid potentially causal variants; (2) large numbers of shared rare alleles within families obfuscated causal variant identification; and (3) individuals from 15% of families carried a significant burden of common lipid-related alleles, suggesting complex inheritance can masquerade as monogenic disease. Conclusions-We identified the genetic basis of disease in 9 of 41 families; however, none of these represented novel gene discoveries. Our results highlight the promise and limitations of exome sequencing as a discovery technique in suspected monogenic dyslipidemias. Considering the confounders identified may inform the design of future exome sequencing studies.	[Stitziel, Nathan O.] Washington Univ, Sch Med, Div Cardiovasc, Dept Med, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [Peloso, Gina M.; Tada, Hayato; Neale, Benjamin M.; Daly, Mark J.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Haller, Jorge F.; Freeman, Mason W.] Massachusetts Gen Hosp, Lipid Metab Unit, Boston, MA 02114 USA; [Haller, Jorge F.; Freeman, Mason W.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Peloso, Gina M.; Tada, Hayato; Gupta, Namrata; Farlow, Deborah N.; Neale, Benjamin M.; Daly, Mark J.; Gabriel, Stacey; Kathiresan, Sekar] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Abifadel, Marianne; Varret, Mathilde; Rabes, Jean-Pierre; Boileau, Catherine] INSERM, U698, Paris, France; [Abifadel, Marianne; Varret, Mathilde; Rabes, Jean-Pierre; Boileau, Catherine] Univ Paris Diderot, Paris, France; [Abifadel, Marianne] Univ St Joseph, Lab Biochim, Fac Pharm & Pole Technol Sante, Beirut, Lebanon; [Cefalu, Angelo B.; Noto, Davide; Averna, Maurizio R.] Univ Palermo, Dipartimento Biomed Med Interna & Specialist, Palermo, Italy; [Fouchier, Sigrid; Motazacker, M. Mahdi] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Kastelein, John J. P.; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Larach, Daniel B.; Risman, Marjorie; Rader, Daniel J.] Univ Penn, Dept Med, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Awan, Zuhier] King Abdulaziz Univ, Dept Clin Biochem, Jeddah 21413, Saudi Arabia; [Ruel, Isabelle; Genest, Jacques] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Haller, Jorge F.; Freeman, Mason W.; Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Pullinger, Clive R.; Deo, Rahul; Kane, John P.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Rabes, Jean-Pierre; Boileau, Catherine] Hop Ambroise Pare, AP HP, Lab Biochim & Genet Mol, Boulogne, France; [Rabes, Jean-Pierre; Boileau, Catherine] Univ Versailles St Quentin en Yvelines, UFR Med Paris Ile de France Ouest, Guyancourt, France; [Tarugi, Patrizia] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Kawashiri, Masa-aki; Yamagishi, Masakazu] Kanazawa Univ, Div Cardiovasc Med, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Nohara, Atsushi; Mabuchi, Hiroshi] Kanazawa Univ, Dept Lipidol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Shendure, Jay; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA	Kathiresan, S (reprint author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN 5-252, Boston, MA 02114 USA.	skathiresan1@partners.org		Cefalu', Angelo Baldassare/0000-0003-1259-8284; Noto, Davide/0000-0002-5346-2829	National Heart Lung and Blood Institute (NHLBI) [K08HL114642]; Foundation for Barnes-Jewish Hospital; NHLBI [T32HL007208]; Massachusetts General Hospital (MGH); Howard Goodman Fellowship from MGH; Donovan Family Foundation [R01 HL107816]; Fondation Leducq; Lung Cohorts Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Heart Cohorts Sequencing Project [HL-103010]; Broad Institute Sequencing Project [HL-102925]; Northwest Genomics Center Sequencing Project [HL-102926]; Family Studies Project Team; PHRC [AOM06024]; ANR [ANR-05-PCOD-017, ANR-06-MRAR-038, ANR-08-GENO-002-01]; Conseil de la Recherche de l'Universite Saint-Joseph (Beirut, Lebanon); Lifetime Achievement Award of the Dutch Heart Foundation [2010T082]; NWO [91612122]; Netherlands CardioVascular Research Initiative [CVON2011-19]; European Union [FP7-305707, FP7-603091-2]	N.O. Stitziel is supported, in part, by a career development award (K08HL114642) from the National Heart Lung and Blood Institute (NHLBI) and also by The Foundation for Barnes-Jewish Hospital. G.M. Peloso is supported by award number T32HL007208 from the NHLBI. S. Kathiresan is supported by a Research Scholar award from the Massachusetts General Hospital (MGH), the Howard Goodman Fellowship from MGH, the Donovan Family Foundation, R01 HL107816, and a grant from Fondation Leducq. We thank the National Heart, Lung, and Blood Institute GO Exome Sequencing Project (ESP) Family Study Project Team for supporting the exome sequencing. We also thank the ESP component studies, including the Lung Cohorts Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Heart Cohorts Sequencing Project (HL-103010), the Broad Institute Sequencing Project (HL-102925), the Northwest Genomics Center Sequencing Project (HL-102926), and the Family Studies Project Team. This work was also supported by grants from PHRC (AOM06024) and ANR (ANR-05-PCOD-017, ANR-06-MRAR-038, ANR-08-GENO-002-01). M. Abifadel is supported by grants from Conseil de la Recherche de l'Universite Saint-Joseph (Beirut, Lebanon). J.J.P. Kastelein is a recipient of the Lifetime Achievement Award of the Dutch Heart Foundation (2010T082). G.K. Hovingh is a recipient of a NWO Veni grant (project number 91612122), a grant from the Netherlands CardioVascular Research Initiative (CVON2011-19; Genius) and the European Union (Resolve: FP7-305707; TransCard: FP7-603091-2). M. M. Motazacker is supported by a grant from Fondation LeDucq (2009-2014).	Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Siest G, 1998, CLIN CHEM LAB MED, V36, P35, DOI 10.1515/CCLM.1998.007; Talmud PJ, 2013, LANCET, V381, P1293, DOI 10.1016/S0140-6736(12)62127-8; Davies RW, 2012, CIRC-CARDIOVASC GENE, V5, P217, DOI 10.1161/CIRCGENETICS.111.961243; BERGLUND G, 1993, J INTERN MED, V233, P45; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Cefalu AB, 2013, ARTERIOSCL THROM VAS, V33, P2021, DOI 10.1161/ATVBAHA.112.301101; Marduel M, 2010, HUM MUTAT, V31, pE1811, DOI 10.1002/humu.21348; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Leigh SEA, 2008, ANN HUM GENET, V72, P485, DOI 10.1111/j.1469-1809.2008.00436.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Bodzioch M, 1999, NAT GENET, V22, P347; Futema M, 2012, J MED GENET, V49, P644, DOI 10.1136/jmedgenet-2012-101189; Awan Z, 2013, ATHEROSCLEROSIS, V231, P218, DOI 10.1016/j.atherosclerosis.2013.09.007; Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Marduel M, 2013, HUM MUTAT, V34, P83, DOI 10.1002/humu.22215; Stitziel NO, 2013, ARTERIOSCL THROM VAS, V33, P2909, DOI 10.1161/ATVBAHA.113.302426; Motazacker MM, 2013, ARTERIOSCL THROM VAS, V33, P1521, DOI 10.1161/ATVBAHA.113.301505; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Fouchier SW, 2005, HUM MUTAT, V26, P550, DOI 10.1002/humu.20256; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Barlera S, 2001, Ital Heart J Suppl, V2, P997; Fairfield H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r86; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Guo ZG, 2002, J HUM GENET, V47, P325, DOI 10.1007/s100380200044; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Mckusick-Nathans Institute of Genetic Medicine, ONLINE MENDELIAN INH; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Yamaguchi T, 2011, J BONE MINER RES, V26, P1655, DOI 10.1002/jbmr.385	38	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1942-325X	1942-3268		CIRC-CARDIOVASC GENE	Circ.-Cardiovasc. Genet.	APR	2015	8	2					343	+		10.1161/CIRCGENETICS.114.000776		31	Cardiac & Cardiovascular Systems; Genetics & Heredity	Cardiovascular System & Cardiology; Genetics & Heredity	CG5CV	WOS:000353309600013		
J	Kereiakes, DJ; Meredith, IT; Windecker, S; Jobe, RL; Mehta, SR; Sarembock, IJ; Feldman, RL; Stein, B; Dubois, C; Grady, T; Saito, S; Kimura, T; Christen, T; Allocco, DJ; Dawkins, KD				Kereiakes, Dean J.; Meredith, Ian T.; Windecker, Stephan; Jobe, R. Lee; Mehta, Shamir R.; Sarembock, Ian J.; Feldman, Robert L.; Stein, Bernardo; Dubois, Christophe; Grady, Timothy; Saito, Shigeru; Kimura, Takeshi; Christen, Thomas; Allocco, Dominic J.; Dawkins, Keith D.			Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent The EVOLVE II Randomized Trial	Circulation-Cardiovascular Interventions			English	Article						drug-eluting stent; percutaneous coronary intervention	BARE-METAL STENTS; COMPREHENSIVE NETWORK METAANALYSIS; DUAL ANTIPLATELET THERAPY; NONINFERIORITY TRIAL; CLINICAL-PRACTICE; XIENCE V; THROMBOSIS; DESIGN; THROMBOGENICITY; OUTCOMES	Background-Drug eluting stents with durable polymers may be associated with hypersensitivity, delayed healing, and incomplete endothelialization, which may contribute to late/very late stent thrombosis and the need for prolonged dual antiplatelet therapy. Bioabsorbable polymers may facilitate stent healing, thus enhancing clinical safety. The SYNERGY stent is a thin-strut, platinum chromium metal alloy platform with an ultrathin bioabsorbable Poly(D,L-lactide-co-glycolide) abluminal everolimus-eluting polymer. We performed a multicenter, randomized controlled trial for regulatory approval to determine noninferiority of the SYNERGY stent to the durable polymer PROMUS Element Plus everolimus-eluting stent. Methods and Results-Patients (n=1684) scheduled to undergo percutaneous coronary intervention for non-ST-segment-elevation acute coronary syndrome or stable coronary artery disease were randomized to receive either the SYNERGY stent or the PROMUS Element Plus stent. The primary end point of 12-month target lesion failure was observed in 6.7% of SYNERGY and 6.5% PROMUS Element Plus treated subjects by intention-to-treat (P=0.83 for difference; P=0.0005 for noninferiority), and 6.4% in both the groups by per-protocol analysis (P=0.0003 for noninferiority). Clinically indicated revascularization of the target lesion or definite/probable stent thrombosis were observed in 2.6% versus 1.7% (P=0.21) and 0.4% versus 0.6% (P=0.50) of SYNERGY versus PROMUS Element Plus-treated subjects, respectively. Conclusions-In this randomized trial, the SYNERGY bioabsorbable polymer everolimus-eluting stent was noninferior to the PROMUS Element Plus everolimus-eluting stent with respect to 1-year target lesion failure. These data support the relative safety and efficacy of SYNERGY in a broad range of patients undergoing percutaneous coronary intervention.	[Kereiakes, Dean J.; Sarembock, Ian J.] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA; [Meredith, Ian T.] Monash Med Ctr, Southern Hlth, MonashHEART, Dept Med, Clayton, Vic 3168, Australia; [Windecker, Stephan] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Jobe, R. Lee] Wake Med Ctr, Dept Invas Cardiol, Raleigh, NC USA; [Mehta, Shamir R.] McMaster Univ, Dept Med, Hamilton Hlth Sci, Hamilton, ON, Canada; [Feldman, Robert L.] Mediquest Res Munroe Reg Med Ctr, Invas Intervent Cardiol, Ocala, FL USA; [Stein, Bernardo] Morton Plant Mease Healthcare Syst, Intervent Cardiol, Clearwater, FL USA; [Dubois, Christophe] Univ Hosp Leuven, Dept Cardiol, Leuven, Belgium; [Grady, Timothy] Aspirus Heart & Vasc Inst, Res & Educ, Wausau, WI USA; [Saito, Shigeru] Shonan Kamakura Gen Hosp, Ctr Heart, Div Cardiol & Catherizat Labs, Kamakura, Kanagawa, Japan; [Kimura, Takeshi] Kyoto Univ Hosp, Dept Cardiovasc Med, Kyoto 606, Japan; [Christen, Thomas; Allocco, Dominic J.; Dawkins, Keith D.] Boston Sci Corp, Clin Sci, Marlborough, MA USA	Kereiakes, DJ (reprint author), Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, 2123 Auburn Ave,Suite 424, Cincinnati, OH 45219 USA.	lindner@thechristhospital.com			Boston Scientific Corporation	The EVOLVE II trial was sponsored and funded by Boston Scientific Corporation.	Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Meredith IT, 2013, EUROINTERVENTION, V9, P308, DOI 10.4244/EIJV9I3A52; Nakazawa G, 2011, CIRC-CARDIOVASC INTE, V4, P38, DOI 10.1161/CIRCINTERVENTIONS.110.957654; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Meredith IT, 2012, J AM COLL CARDIOL, V59, P1362, DOI 10.1016/j.jacc.2011.12.016; Navarese EP, 2011, EUROINTERVENTION, V7, P985, DOI 10.4244/EIJV7I8A155; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Wilson GJ, 2012, EUROINTERVENTION, V8, P250, DOI 10.4244/EIJV8I2A39; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Otsuka F, 2014, CIRC-CARDIOVASC INTE, V7, P330, DOI 10.1161/CIRCINTERVENTIONS.113.000990; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Stone GW, 2011, J AM COLL CARDIOL, V57, P1700, DOI 10.1016/j.jacc.2011.02.016; Kang SH, 2014, EUR HEART J, V35, P1147, DOI 10.1093/eurheartj/eht570; Byrne R A, 2009, Minerva Cardioangiol, V57, P567; Eppihimer M, 2013, EUROINTERVENTION; Eppihimer MJ, 2013, CIRC-CARDIOVASC INTE, V6, P370, DOI 10.1161/CIRCINTERVENTIONS.113.000120; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Menown IBA, 2010, ADV THER, V27, P129, DOI 10.1007/s12325-010-0022-9; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Palmaz JC, 2002, J VASC SURG, V36, P1031, DOI 10.1067/MVA.2002.129113; Sabate M, 2014, JACC-CARDIOVASC INTE, V7, P55, DOI 10.1016/j.jcin.2013.07.012; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Vorpahl Marc, 2009, EuroIntervention, V5 Suppl F, pF28, DOI 10.4244/EIJV5IFA5; Yeh RW, 2015, CIRC-CARDIOVASC QUAL, V8, P96, DOI 10.1161/CIRCOUTCOMES.114.001239	27	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-7640	1941-7632		CIRC-CARDIOVASC INTE	Circ.-Cardiovasc. Interv.	APR	2015	8	4							e002372	10.1161/CIRCINTERVENTIONS.114.002372		14	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG5CZ	WOS:000353310000017		
J	Lee, T; Murai, T; Yonetsu, T; Suzuki, A; Hishikari, K; Kanaji, Y; Matsuda, J; Araki, M; Niida, T; Isobe, M; Kakuta, T				Lee, Tetsumin; Murai, Tadashi; Yonetsu, Taishi; Suzuki, Asami; Hishikari, Keiichi; Kanaji, Yoshihisa; Matsuda, Junji; Araki, Makoto; Niida, Takayuki; Isobe, Mitsuaki; Kakuta, Tsunekazu			Relationship Between Subclinical Cardiac Troponin I Elevation and Culprit Lesion Characteristics Assessed by Optical Coherence Tomography in Patients Undergoing Elective Percutaneous Coronary Intervention	Circulation-Cardiovascular Interventions			English	Article						angioplasty; biomarker; coronary disease; imaging; plaque	HIGHLY SENSITIVE ASSAY; ARTERY-DISEASE; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUES; MYOCARDIAL-INFARCTION; RISK; ANGIOGRAPHY; ACQUISITION; POPULATION; ANGIOSCOPY	Background-The prevalence of subclinical, cardiac troponin I (cTnI) elevation in stable patients undergoing elective percutaneous coronary intervention and its relationship to culprit lesion characteristics assessed by optical coherence tomography (OCT) are unknown. Methods and Results-We studied 206 native de novo culprit coronary lesions from 206 patients with stable angina pectoris who underwent OCT before elective percutaneous coronary intervention. Patients were divided into 2 groups according to the presence (cTnI group; n=47; 22.8%) or absence (non-cTnI group; n=159; 77.2%) of cTnI >= 0.03 ng/mL at admission. The clinical and OCT findings were compared between these 2 groups. No significant difference was found in the clinical presentation between the groups except for the serum C-reactive protein levels and presence of multivessel disease. By OCT, cTnI elevation was associated with the presence of thin-cap fibroatheromas, a greater lipid arc, and a longer lipid length. In a multivariable analysis, the presence of positive C-reactive protein levels (odds ratio, 4.38; 95% confidence interval, 1.90-10.08; P=0.001) and OCT-derived thin-cap fibroatheromas (odds ratio, 2.89; 95% confidence interval, 1.22-6.86; P=0.016) were independent predictors of cTnI elevation. Periprocedural myocardial injury, defined as postpercutaneous coronary intervention peak cTnI levels >1.0 ng/mL (5x the upper reference limit), occurred more often in patients with cTnI elevation at admission (cTnI group: 41% versus non-cTnI group: 18%; P=0.001). Conclusions-The presence of subclinical cTnI elevation at admission was not uncommon and was associated with OCT-derived unstable plaque morphology in patients undergoing elective percutaneous coronary intervention, and may help to identify patients with stable angina pectoris at high risk for periprocedural myocardial injury.	[Lee, Tetsumin; Murai, Tadashi; Yonetsu, Taishi; Suzuki, Asami; Hishikari, Keiichi; Kanaji, Yoshihisa; Matsuda, Junji; Araki, Makoto; Niida, Takayuki; Kakuta, Tsunekazu] Tsuchiura Kyodo Gen Hosp, Dept Cardiol, Tsuchiura, Ibaraki 3000053, Japan; [Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan	Kakuta, T (reprint author), Tsuchiura Kyodo Gen Hosp, Cardiovasc Med, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	kaz@joy.email.ne.jp					Kitabata H, 2010, AM J CARDIOL, V105, P1673, DOI 10.1016/j.amjcard.2010.01.346; MacNeill BD, 2004, J AM COLL CARDIOL, V44, P972, DOI 10.1016/j.jacc.2004.05.066; Kume T, 2006, AM J CARDIOL, V97, P1172, DOI 10.1016/j.amjcard.2005.11.035; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tearney GJ, 2003, CIRCULATION, V107, P113, DOI 10.1161/01.CIR.0000044384.41037.43; Fujii K, 2010, JACC-CARDIOVASC IMAG, V3, P168, DOI 10.1016/j.jcmg.2009.11.004; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; DEFEYTER PJ, 1995, CIRCULATION, V92, P1408; Ellis SG, 2002, CIRCULATION, V106, P1205, DOI 10.1161/01.CIR.0000028146.71416.2E; Prasad A, 2008, CIRC-CARDIOVASC INTE, V1, P10, DOI 10.1161/CIRCINTERVENTIONS.108.765610; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Lee T, 2011, CIRC-CARDIOVASC INTE, V4, P378, DOI 10.1161/CIRCINTERVENTIONS.111.962506; Heusch G, 2004, J MOL CELL CARDIOL, V37, P23, DOI 10.1016/j.yjmcc.2004.04.01; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Kavsak PA, 2011, CLIN CHEM, V57, P1146, DOI 10.1373/clinchem.2011.164574; CAMPEAU L, 1976, CIRCULATION, V54, P522; Yabushita H, 2002, CIRCULATION, V106, P1640, DOI 10.1161/01.CIR.0000029927.92825.F6; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Yonetsu T, 2011, EUR HEART J, V32, P1251, DOI 10.1093/eurheartj/ehq518; Prati F, 2010, EUR HEART J, V31, P401, DOI 10.1093/eurheartj/ehp433; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Jeremias A, 2008, CIRCULATION, V118, P632, DOI 10.1161/CIRCULATIONAHA.107.752428; Seifarth H, 2014, J CARDIOVASC COMPUT, V8, P452, DOI 10.1016/j.jcct.2014.09.005; Yonetsu T, 2011, INT J CARDIOL, V146, P180	27	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1941-7640	1941-7632		CIRC-CARDIOVASC INTE	Circ.-Cardiovasc. Interv.	APR	2015	8	4							e001727	10.1161/CIRCINTERVENTIONS.114.001727		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG5CZ	WOS:000353310000003		
J	Myojo, M; Takahashi, M; Tanaka, T; Higashikuni, Y; Kiyosue, A; Ando, J; Fujita, H; Komuro, I; Hirata, Y				Myojo, Masahiro; Takahashi, Masao; Tanaka, Tomofumi; Higashikuni, Yasutomi; Kiyosue, Arihiro; Ando, Jiro; Fujita, Hideo; Komuro, Issei; Hirata, Yasunobu			Midterm Follow-up After Retrievable Inferior Vena Cava Filter Placement in Venous Thromboembolism Patients With or Without Malignancy	CLINICAL CARDIOLOGY			English	Article							PULMONARY-EMBOLISM; GUNTHER-TULIP; IVC FILTER; PERFORATION; HEMORRHAGE	BackgroundA clear indication and strategy for placement of retrievable inferior vena cava filters (IVCFs) have not been established. This study was designed to evaluate the efficacy and disadvantages of the retrievable IVCF use particularly in venous thromboembolism (VTE) patients with malignancy. HypothesisRetrievable IVCFs might be safe and useful in VTE patients with malignancy. MethodsThe study population consisted of 56 consecutive patients undergoing IVCF placement at our institution from January 1, 2008 to December 31, 2011. Prognostic data were retrospectively reviewed in April 2013. ResultsMean follow-up period was 584.6 (range, 1-1857) days. Twenty-six of the 56 patients had a malignancy. In 16 of the 30 patients without malignancy, the filter was retrieved, whereas the other 14 patients eventually received permanent implantation. There was no significant difference in the survival rate between the retrieval group and the nonretrieval group in the nonmalignancy patients (1-year survival rates, 94% vs 85%). In patients with malignancy, the nonretrieval group showed a significantly lower survival rate (P < 0.01). The 1-year and 2-year survival rates were 100% vs 46% and 100% vs 18%, respectively. There was no medical record of pulmonary thromboembolism occurrence or recurrence. All deaths in the patients with malignancy were malignancy related. In 4 of 5 malignancy patients who could undergo tumor resection surgery, adequate thrombus regression enabled us to retrieve the IVCF after surgery. ConclusionsPermanent use of a retrievable IVCF is relatively safe in short- or midterm follow-up regardless of malignancy status. Retrievable filter use might be reasonable in malignancy patients.	[Myojo, Masahiro; Takahashi, Masao; Tanaka, Tomofumi; Higashikuni, Yasutomi; Kiyosue, Arihiro; Ando, Jiro; Fujita, Hideo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Tokyo, Japan	Takahashi, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	masaotakahashi-gi@umin.org			Ministry of Education, Culture, Sports, Science, and Technology of Japan [17659229]	This study was supported in part by Grants-in-Aid #17659229 (to Y.H.), Core Research for Evolutional Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Torbicki A, 2000, EUR HEART J, V21, P1301; Ota S, 2008, CIRC J, V72, P287, DOI 10.1253/circj.72.287; Durack JC, 2012, CARDIOVASC INTER RAD, V35, P299, DOI 10.1007/s00270-011-0151-9; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Smouse HB, 2009, J VASC INTERV RADIOL, V20, P871, DOI 10.1016/j.jvir.2009.03.033; Binkert CA, 2005, J VASC INTERV RADIOL, V16, P395, DOI 10.1097/01.RVI.0000150029.86869.DE; Chintalapudi UB, 1997, CATHETER CARDIO DIAG, V41, P53, DOI 10.1002/(SICI)1097-0304(199705)41:1<53::AID-CCD13>3.0.CO;2-R; Goldman HB, 1996, J UROLOGY, V156, P1763, DOI 10.1016/S0022-5347(01)65506-X; Parkin E, 2009, J VASC SURG, V50, P417, DOI 10.1016/j.jvs.2009.03.002; Sadaf A, 2007, J VASC INTERV RADIOL, V18, P1447, DOI 10.1016/j.jvir.2007.07.009; Sarkar MR, 1997, VASA-J VASCULAR DIS, V26, P305; Verso M, 2012, THROMB RES, V130, P369, DOI 10.1016/j.thromres.2012.04.003; Woodward EB, 2002, ANN VASC SURG, V16, P193, DOI 10.1007/s10016-001-0150-4	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-9289	1932-8737		CLIN CARDIOL	Clin. Cardiol.	APR	2015	38	4					216	221		10.1002/clc.22377		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG5UO	WOS:000353361600004		
J	Myoe, MA				Myoe, Maung Aung			Comparative Study of Child Soldiering on Myanmar-China Border: Evolutions, Challenges and Countermeasures	CONTEMPORARY SOUTHEAST ASIA			English	Book Review									[Myoe, Maung Aung] Int Univ Japan, Minami Uonuma, Niigata 9497277, Japan	Myoe, MA (reprint author), Int Univ Japan, 777 Kokusai Cho, Minami Uonuma, Niigata 9497277, Japan.	koko@iuj.ac.jp					Chen K, 2014, SPRINGERBRIEF CRIM, P1, DOI 10.1007/978-981-4560-02-3	1	0	0	INST SOUTHEAST ASIAN STUDIES-ISEAS	PASIR PANJANG	30 HENG MUI KING TERACE, PASIR PANJANG, 119614, SINGAPORE	0129-797X	1793-284X		CONTEMP SE ASIA	Contemp. Southeast Asia	APR	2015	37	1					143	145		10.1355/cs37-1i		3	Area Studies; International Relations; Political Science	Area Studies; International Relations; Government & Law	CG0YZ	WOS:000353001500009		
J	Sugawara, K; Hayashi, Y; Fukushima, J; Takizawa, H				Sugawara, Kenta; Hayashi, Yamato; Fukushima, Jun; Takizawa, Hirotsugu			Facile synthesis of silver-nanobeadwire transparent conductive film by organic-precursor paint reduction	CRYSTAL RESEARCH AND TECHNOLOGY			English	Article						silver nanowire; silver carboxylates; ultrasound; microwave; low-dimensional materials	POLYOL SYNTHESIS; THERMAL-DECOMPOSITION; NANOWIRES; NANOPARTICLES; GRAPHENE; ACETATE; NANOSTRUCTURES; CARBOXYLATES; IRRADIATION; PERCOLATION	A new facile process has been developed to synthesize silver nanowire transparent conductive films by reducing high-aspect-ratio, needle-shaped silver carboxylates, prepared as the precursor, while retaining their morphology. Nanowire precursors are simply obtained by ultrasound irradiation when silver (I) oxide and carboxylic acids are used as starting materials. The aspect ratio of the precursors is increased when the ultrasound irradiation is followed by microwave irradiation. Silver nanowires can be easily obtained by reducing these precursors with hydrazine gas or irradiating them with Ar plasma for a short time. The morphology of the resulting nanowires is different from that of typical nanowires that have been reported. The nanowires have porous morphology, where small nanoparticles are connected to form nanobeadwire. The nanobeadwire is considered to increase the transparency of the film because of its rough morphology. This new method can synthesize silver nanobeadwires and fabricate the transparent conductive film simultaneously, in one-step, so that it can significantly simplify manufacturing processes.	[Sugawara, Kenta; Hayashi, Yamato; Fukushima, Jun; Takizawa, Hirotsugu] Tohoku Univ, Grad Sch Engn, Dept Appl Chem, Aoba Ku, Sendai, Miyagi 9808579, Japan	Hayashi, Y (reprint author), Tohoku Univ, Grad Sch Engn, Dept Appl Chem, Aoba Ku, 6-6-07 Aramaki Aoba, Sendai, Miyagi 9808579, Japan.	hayashi@aim.che.tohoku.ac.jp					Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Rathmell AR, 2010, ADV MATER, V22, P3558, DOI 10.1002/adma.201000775; Rathmell AR, 2011, ADV MATER, V23, P4798, DOI 10.1002/adma.201102284; De S, 2010, ACS NANO, V4, P7064, DOI 10.1021/nn1025803; Tsuji M, 2005, CHEM-EUR J, V11, P440, DOI 10.1002/chem.200400417; Behrens S, 2004, CHEM MATER, V16, P3085, DOI 10.1021/cm049462s; Wiley B, 2005, LANGMUIR, V21, P8077, DOI 10.1021/la050887i; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Bang JH, 2010, ADV MATER, V22, P1039, DOI 10.1002/adma.200904093; Yamamoto T, 2004, CHEM LETT, V33, P158, DOI 10.1243/cl.2004.158; Gedanken A, 2004, ULTRASON SONOCHEM, V11, P47, DOI 10.1016/j.ultsonch.2004.01.037; Sun YG, 2003, NANO LETT, V3, P955, DOI 10.1021/nl034312m; Bergin SM, 2012, NANOSCALE, V4, P1996, DOI 10.1039/c2nr30126a; Lee SJ, 2002, J PHYS CHEM B, V106, P2892, DOI 10.1021/jp0132937; Coskun S, 2011, CRYST GROWTH DES, V11, P4963, DOI 10.1021/cg200874g; Shchukin DG, 2011, ADV MATER, V23, P1922, DOI 10.1002/adma.201004494; De S, 2011, MRS BULL, V36, P774, DOI 10.1557/mrs.2011.236; Olson LP, 2006, CHEM MATER, V18, P1667, DOI 10.1021/cm052657v; Zeiger BW, 2011, J AM CHEM SOC, V133, P14530, DOI 10.1021/ja205867f; Aret E, 2006, CRYST GROWTH DES, V6, P1027, DOI 10.1021/cg0600039; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Hammarberg E, 2009, J COLLOID INTERF SCI, V334, P29, DOI 10.1016/j.jcis.2009.03.010; Hayashi Y, 2005, IEEE T ELECTRON PACK, V28, P338, DOI 10.1109/TEPM.2005.858452; Li Y, 2006, NUCL INSTRUM METH B, V251, P425, DOI 10.1016/j.nimb.2006.06.019; Liu XH, 2006, THERMOCHIM ACTA, V440, P1, DOI 10.1016/j.tca.2005.08.030; Logvinenko V, 2007, J THERM ANAL CALORIM, V90, P813, DOI 10.1007/s10973-006-7883-9; Makita Y, 2002, CHEM LETT, P928, DOI 10.1246/cl.2002.928; Malandrino G, 2004, J MATER CHEM, V14, P2726, DOI 10.1039/b408981b; NAGATOMO T, 1990, THIN SOLID FILMS, V192, P17, DOI 10.1016/0040-6090(90)90475-S	29	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0232-1300	1521-4079		CRYST RES TECHNOL	Cryst. Res. Technol.	APR	2015	50	4					319	330		10.1002/crat.201400473		12	Crystallography	Crystallography	CG4DW	WOS:000353234300008		
J	Zhang, L; Hamad, EA; Vausort, M; Funakoshi, H; Feldman, AM; Wagner, DR; Devaux, Y				Zhang, Lu; Hamad, Eman A.; Vausort, Melanie; Funakoshi, Hajime; Feldman, Arthur M.; Wagner, Daniel R.; Devaux, Yvan			Identification of Candidate Long Noncoding RNAs Associated with Left Ventricular Hypertrophy	CTS-CLINICAL AND TRANSLATIONAL SCIENCE			English	Article						cardiac hypertrophy; long noncoding RNAs; microarrays; adenosine; cardioprotective molecules; experimental disease model	CARDIAC-RESTRICTED OVEREXPRESSION; HEART-FAILURE; A(1)-ADENOSINE RECEPTOR; MYOCARDIAL-INFARCTION; HUMAN GENOME; EXPRESSION; DATABASE; TRANSCRIPTION; ANNOTATION; PROTEINS	PurposeLong noncoding RNAs (lncRNAs) constitute an emerging group of noncoding RNAs, which regulate gene expression. Their role in cardiac disease is poorly known. Here, we investigated the association between lncRNAs and left ventricular hypertrophy. MethodsWild-type and adenosine A2A receptor overexpressing mice (A2A-Tg) were subjected to transverse aortic constriction (TAC) and expression of lncRNAs in the heart was investigated using genome-wide microarrays and an analytical pipeline specifically developed for lncRNAs. ResultsMicroarray analysis identified two lncRNAs up-regulated and three down-regulated in the hearts of A2A-Tg mice subjected to TAC. Quantitative PCR showed that lncRNAs 2900055J20Rik and Gm14005 were decreased in A2A-Tg mice (3.5- and 1.8-fold, p < 0.01). We found from public microarray dataset that 2900055J20Rik and Gm14005 were increased in TAC mice compared to sham-operated animals (1.8- and 1.4-fold, after 28 days, p < 0.01). Interestingly, in this public dataset, cardioprotective drug JQ1 decreased 2900055J20Rik and Gm14005 expression by 2.2- and 1.6-fold (p < 0.01). ConclusionsFirst, we have shown that data on lncRNAs can be obtained from gene expression microarrays. Second, expression of lncRNAs 2900055J20Rik and Gm14005 is regulated after TAC and can be modulated by cardioprotective molecules. These observations motivate further investigation of the therapeutic value of lncRNAs in the heart.	[Zhang, Lu; Vausort, Melanie; Wagner, Daniel R.; Devaux, Yvan] Publ Res Ctr Hlth CRP Sante, Lab Cardiovasc Res, Luxembourg, Luxembourg; [Hamad, Eman A.; Feldman, Arthur M.] Temple Univ, Sch Med, Cardiovasc Res Ctr, Dept Physiol, Philadelphia, PA 19122 USA; [Funakoshi, Hajime] Fukuoka Natl Hosp, Dept Cardiol, Fukuoka, Japan; [Wagner, Daniel R.] Ctr Hosp, Div Cardiol, Luxembourg, Luxembourg	Devaux, Y (reprint author), Publ Res Ctr Hlth CRP Sante, Lab Cardiovasc Res, Luxembourg, Luxembourg.	yvan.devaux@crp-sante.lu			Society for Research on Cardiovascular Diseases; Ministry of Culture, Higher Education and Research of Luxembourg	We thank Laurent Vallar, Nathalie Nicot, and Petr Nazarov from the Genomics Research Unit of the Centre de la Recherche Public - Sante for Affymetrix experiments. This work was supported by the Society for Research on Cardiovascular Diseases and the Ministry of Culture, Higher Education and Research of Luxembourg.	Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Chen J, 2013, CIRCULATION, V128, P2577, DOI 10.1161/CIRCULATIONAHA.113.003668; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Funakoshi H, 2006, CIRCULATION, V114, P2240, DOI 10.1161/CIRCULATIONAHA.106.620211; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Anand P, 2013, CELL, V154, P569, DOI 10.1016/j.cell.2013.07.013; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Gellert P, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks877; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Ishii N, 2006, J HUM GENET, V51, P1087, DOI 10.1007/s10038-006-0070-9; Wahlestedt C, 2013, NAT REV DRUG DISCOV, V12, P433, DOI 10.1038/nrd4018; Haas B, 2011, J CARDIOVASC TRANSL, V4, P790, DOI 10.1007/s12265-011-9279-x; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Liao Q, 2011, NUCLEIC ACIDS RES, V39, pW118, DOI 10.1093/nar/gkr432; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Zhang XQ, 2012, NEUROBIOL DIS, V48, P1, DOI 10.1016/j.nbd.2012.06.004; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Michelhaugh SK, 2011, J NEUROCHEM, V116, P459, DOI 10.1111/j.1471-4159.2010.07126.x; Spiltoir JI, 2013, J MOL CELL CARDIOL, V63, P175, DOI 10.1016/j.yjmcc.2013.07.017; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Bousquenaud M, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-65; Chan TO, 2008, CTS-CLIN TRANSL SCI, V1, P126, DOI 10.1111/j.1752-8062.2008.00027.x; Delmore Jake E., 2011, CELL, V146, P904; Gurha P, 2013, CIRC RES, V113, pE115, DOI 10.1161/CIRCRESAHA.113.302988; Hamad EA, 2010, AM J PHYSIOL-HEART C, V298, pH1738, DOI 10.1152/ajpheart.00688.2009; Hamad EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039919; Leonard F, 2011, J LEUKOCYTE BIOL, V90, P199, DOI 10.1189/jlb.0910505; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Podlowski S, 2002, J CELL BIOCHEM, V85, P198, DOI 10.1002/jcb.10116; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999	45	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1752-8054	1752-8062		CTS-CLIN TRANSL SCI	CTS-Clin. Transl. Sci.	APR	2015	8	2					100	106		10.1111/cts.12234		7	Medicine, Research & Experimental	Research & Experimental Medicine	CG4FO	WOS:000353239900004		
J	Nakahara, T; Moroi, Y; Takayama, K; Nakanishi, Y; Furue, M				Nakahara, T.; Moroi, Y.; Takayama, K.; Nakanishi, Y.; Furue, M.			Analysis of sebum lipid composition and the development of acneiform rash before and after administration of EGFR inhibitor	Current Oncology			English	Article						Skin toxicity; EGFR inhibitor; sebum; sebaceous glands; lipids; skin	C-MYC; SEBACEOUS GLAND; STEM-CELLS; EXPRESSION; CETUXIMAB; EFFICACY; CANCER	Treatment with an epidermal growth factor receptor inhibitor (EGFRI) in patients having non-small-cell lung cancer can cause frequent and diverse skin toxicities, an acneiform rash being one of the commonest. Although the exact pathophysiology of this rash and its development mechanisms remain unknown, investigators have noted that EGFRI-induced skin toxicity might be partly associated with sebaceous gland function. Sebum is composed mainly of the lipids squalene (SQ), wax ester (WE), triglyceride, free fatty acid, and cholesterol, which are secreted mostly from the sebaceous glands and by keratinocytes. We therefore investigated the lipid composition of sebum before and after administration of egfri and whether sebum composition was associated with the development of acneiform rash. To investigate any associated changes in sebum gland activity, we focused especially on alterations in the amounts of SQ and WE, which are secreted solely from the sebaceous glands. In contrast to our expectations, we observed no substantial changes in the lipid composition of sebum before and after administration of EGFRI. Composition varies with the individual; however, the proportion of SQ and WE derived from the sebaceous glands was significantly lower in regions that did not develop acneiform rash than in regions that did. Our results suggest that development of an acneiform rash after administration of EGFRI could be related to sebaceous gland activity. Measurement of the lipid composition of sebum before therapy with egfri might predict which patients will be prone to acneiform rash.	[Nakahara, T.; Furue, M.] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Div Skin Surface Sensing, Fukuoka, Japan; [Nakahara, T.; Moroi, Y.; Furue, M.] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka, Japan; [Takayama, K.; Nakanishi, Y.] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan	Nakahara, T (reprint author), Maidashi 3-1-1,Higashi Ku, Fukuoka 8128582, Japan.	nakahara@dermatol.med.kyushu-u.ac.jp					Guttman-Yassky E, 2010, EUR J CANCER, V46, P2010, DOI 10.1016/j.ejca.2010.04.028; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wacker B, 2007, CLIN CANCER RES, V13, P3913, DOI 10.1158/1078-0432.CCR-06-2610; Orditura M, 2009, ONCOL REP, V21, P1023, DOI 10.3892/or_00000319; Cufer T, 2013, EUR J CANCER, V49, P1216, DOI 10.1016/j.ejca.2012.11.021; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Bull JJ, 2005, BRIT J DERMATOL, V152, P1125, DOI 10.1111/j.1365-2133.2005.06458.x; Dahlhoff M, 2013, EXP DERMATOL, V22, P667, DOI 10.1111/exd.12219; Picardo Mauro, 2009, Dermatoendocrinol, V1, P68; Takata T, 2012, J DERMATOL SCI, V66, P165, DOI 10.1016/j.jdermsci.2012.02.012; Zouboulis CC, 2013, EXP DERMATOL, V22, P695, DOI 10.1111/exd.12220	12	0	0	MULTIMED INC	TORONTO	66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA	1198-0052			CURR ONCOL	Curr. Oncol.	APR	2015	22	2					E124	E127		10.3747/co.22.2283		4	Oncology	Oncology	CG4XJ	WOS:000353292200009		
J	Fukuzumi, S				Fukuzumi, Shunichi			Artificial photosynthetic systems for production of hydrogen	CURRENT OPINION IN CHEMICAL BIOLOGY			English	Review							ELECTRON-TRANSFER STATE; DONOR-ACCEPTOR DYAD; 2-PHENYL-4-(1-NAPHTHYL)QUINOLINIUM ION; PHOTOSYSTEM-I; VISIBLE-LIGHT; EVOLUTION; WATER; NANOPARTICLES; REDUCTION; CATALYST	The rapid consumption of fossil fuels has caused unacceptable environmental problems such as the greenhouse effect, which may lead to disastrous climatic consequences. Because fossil fuels are the products of long-term photosynthesis, it is highly desirable to develop artificial photosynthetic systems for the production of renewable and clean energy such as hydrogen. This article summarizes recent advances on studies of artificial photosynthetic systems for photocatalytic production of hydrogen with hydrogenases and their functional mimics including hybrids of natural and artificial components. Because it is highly desired to convert gaseous H-2 to an easily storable form, recent progress on storage of hydrogen as liquid or solid form has also been described in this article.	Osaka Univ, Japan Sci & Technol Agcy JST, ALCA, Grad Sch Engn,Dept Mat & Life Sci, Suita, Osaka 5650871, Japan	Fukuzumi, S (reprint author), Osaka Univ, Japan Sci & Technol Agcy JST, ALCA, Grad Sch Engn,Dept Mat & Life Sci, Suita, Osaka 5650871, Japan.	fukuzumi@chem.eng.osaka-u.ac.jp	Fukuzumi, Shunichi /E-4728-2010		MEXT; ALCA project from JST, Japan	The authors are most grateful to the collaborators and coworkers who performed the researches reported in this article and support by a Grant-in-Aid from MEXT and an ALCA project from, JST, Japan.	Fukuzumi S, 2013, DALTON T, V42, P18, DOI 10.1039/c2dt31823g; Fukuzumi S, 2012, J MATER CHEM, V22, P4575, DOI 10.1039/c2jm15585k; BROWN GM, 1979, J AM CHEM SOC, V101, P1298, DOI 10.1021/ja00499a051; Wilker MB, 2014, J AM CHEM SOC, V136, P4316, DOI 10.1021/ja413001p; Hull JF, 2012, NAT CHEM, V4, P383, DOI [10.1038/nchem.1295, 10.1038/NCHEM.1295]; Gorka M, 2014, BIOCHEMISTRY-US, V53, P2295, DOI 10.1021/bi500104r; Yamada Y, 2012, ENERG ENVIRON SCI, V5, P6111, DOI 10.1039/c2ee03106j; Lubner CE, 2010, BIOCHEMISTRY-US, V49, P404, DOI 10.1021/bi901704v; Magnuson A, 2009, ACCOUNTS CHEM RES, V42, P1899, DOI 10.1021/ar900127h; Fukuzumi S, 2011, ENERG ENVIRON SCI, V4, P2754, DOI 10.1039/c1ee01551f; Nelson N, 2011, BBA-BIOENERGETICS, V1807, P856, DOI 10.1016/j.bbabio.2010.10.011; Grimme RA, 2009, DALTON T, P10106, DOI 10.1039/b909137h; Bullock RM, 2014, CHEM COMMUN, V50, P3125, DOI 10.1039/c3cc46135a; Yamada Y, 2013, RSC ADV, V3, P25677, DOI 10.1039/c3ra44534h; Kotani H, 2011, CHEM-EUR J, V17, P2777, DOI 10.1002/chem.201002399; Simmons TR, 2014, COORDIN CHEM REV, V270, P127, DOI 10.1016/j.ccr.2013.12.018; Ogo S, 2013, SCIENCE, V339, P682, DOI 10.1126/science.1231345; Wu LZ, 2014, ACCOUNTS CHEM RES, V47, P2177, DOI 10.1021/ar500140r; DARWENT JR, 1982, COORDIN CHEM REV, V44, P83, DOI 10.1016/S0010-8545(00)80518-4; Fukuzumi S, 2012, J MATER CHEM, V22, P24284, DOI 10.1039/c2jm32926c; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Fukuzumi S, 2012, P NATL ACAD SCI USA, V109, P15572, DOI 10.1073/pnas.1119994109; Maenaka Y, 2012, ENERG ENVIRON SCI, V5, P7360, DOI 10.1039/c2ee03315a; Utschig LM, 2011, J PHYS CHEM LETT, V2, P236, DOI 10.1021/jz101728v; Brown KA, 2012, J AM CHEM SOC, V134, P5627, DOI 10.1021/ja2116348; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Fukuzumi S, 2004, J AM CHEM SOC, V126, P1600, DOI 10.1021/ja038656q; Yamada Y, 2013, CHEM COMMUN, V49, P5132, DOI 10.1039/c3cc41575a; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; Stiebritz MT, 2012, CHEM SCI, V3, P1739, DOI 10.1039/c2sc01112c; Fukuzumi S, 2014, ACCOUNTS CHEM RES, V47, P1455, DOI 10.1021/ar400200u; Simmons TR, 2013, ANGEW CHEM INT EDIT, V52, P6143, DOI 10.1002/anie.201302908; Kotani H, 2012, FARADAY DISCUSS, V155, P89, DOI 10.1039/c1fd00084e; Fukuzumi S, 2013, J PHYS CHEM LETT, V4, P3458, DOI 10.1021/jz401560x; DuBois DL, 2014, INORG CHEM, V53, P3935, DOI 10.1021/ic4026969; Fukuzumi S, 2011, ANGEW CHEM INT EDIT, V50, P728, DOI 10.1002/anie.201004876; Kaur-Ghumaan S, 2014, DALTON T, V43, P9392, DOI 10.1039/c4dt00539b; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P1677, DOI 10.1562/2006-05-07-RA-893; Nielsen M, 2013, NATURE, V495, P85, DOI 10.1038/nature11891; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Yamada Y, 2011, J AM CHEM SOC, V133, P16136, DOI 10.1021/ja206079e; Lv HJ, 2014, J AM CHEM SOC, V136, P14015, DOI 10.1021/ja5084078; GREENBAUM E, 1985, SCIENCE, V230, P1373, DOI 10.1126/science.230.4732.1373; Kotani H, 2006, J PHYS CHEM B, V110, P24047, DOI 10.1021/jp065215v; Deponti E, 2014, DALTON T, V43, P16345, DOI 10.1039/c4dt02269f; Fukuzumi S, 2008, EUR J INORG CHEM, P1351, DOI 10.1002/ejic.200701369; GRATZEL M, 1981, ACCOUNTS CHEM RES, V14, P376; King PW, 2013, BBA-BIOENERGETICS, V1827, P949, DOI 10.1016/j.bbabio.2013.03.006; Kotani H, 2007, PHYS CHEM CHEM PHYS, V9, P1487, DOI [10.1039/b612794k, 10.1039/b61279k]; Kufryk G., 2013, ADV MICROBIOL, V3, P60; Maenaka Y, 2011, J AM CHEM SOC, V134, P367; Photosystem I, 2006, LIGHT DRIVEN PLASTOC; SBtif P, 2001, BIOCHIM BIOPHYS ACTA, V1507, P161; Suenobu T, 2015, CHEM COMMUN, V51; Wasielewski MR, 2009, ACCOUNTS CHEM RES, V42, P1910, DOI 10.1021/ar9001735; Yamada Y, 2015, CATAL SCI TECHNOL, V5, P428, DOI 10.1039/c4cy01005a; Yamada Y, 2012, PHYS CHEM CHEM PHYS, V14, P10564, DOI 10.1039/c2cp41906h	58	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1367-5931	1879-0402		CURR OPIN CHEM BIOL	Curr. Opin. Chem. Biol.	APR	2015	25						18	26		10.1016/j.cbpa.2014.12.008		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CG2HO	WOS:000353095700005		
J	Maity, B; Fujita, K; Ueno, T				Maity, Basudev; Fujita, Kenta; Ueno, Takafumi			Use of the confined spaces of apo-ferritin and virus capsids as nanoreactors for catalytic reactions	CURRENT OPINION IN CHEMICAL BIOLOGY			English	Review							PROTEIN NANOMATERIALS; BACTERIOPHAGE P22; NANOPARTICLES; ENCAPSULATION; APOFERRITIN; ENZYME; CAGE; COMPLEXES; CASCADE; DESIGN	Self-assembled protein cages providing nanosized internal spaces which are capable of encapsulating metal ions/complexes, enzymes/proteins have great potential for use as catalytic nanoreactors in efforts to mimic confined cellular environments for synthetic applications. Despite many uses in biomineralization, drug delivery, bio-imaging and so on, applications in catalysis are relatively rare. Because of their restricted size, protein cages are excellent candidates for use as vessels to exert control over reaction kinetics and product selectivity. Virus capsids with larger internal spaces can encapsulate multiple enzymes and can mimic natural enzymatic reactions. The apo-ferritin cage is known to accommodate various metal ions/complexes and suitable for organic transformation reactions in an aqueous medium. This review highlights the importance, prospects and recent significant research on catalytic reactions using the apo-ferritin cage and virus capsids.	[Maity, Basudev; Fujita, Kenta; Ueno, Takafumi] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Ueno, T (reprint author), Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan.	tueno@bio.titech.ac.jp			Japan Society for the Promotion of Science	Parts of this work were supported by the Funding Program for Next Generation World-Leading Researchers (for TU), and research fellowship for young scientists for BM from the Japan Society for the Promotion of Science.	Kim KT, 2010, NANOSCALE, V2, P844, DOI 10.1039/b9nr00409b; Yokoi N, 2010, SMALL, V6, P1873, DOI 10.1002/smll.201000772; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; Xing RM, 2009, J INORG BIOCHEM, V103, P1039, DOI 10.1016/j.jinorgbio.2009.05.001; Fan J, 2011, BIOMATERIALS, V32, P1611, DOI 10.1016/j.biomaterials.2010.11.004; Cutrin JC, 2013, MOL PHARMACEUT, V10, P2079, DOI 10.1021/mp3006177; Ueno T, 2004, ANGEW CHEM INT EDIT, V43, P2527, DOI 10.1002/anie.200353436; Flenniken ML, 2009, CURR TOP MICROBIOL, V327, P71; Abe S, 2008, J AM CHEM SOC, V130, P10512, DOI 10.1021/ja802463a; Ueno T, 2009, J AM CHEM SOC, V131, P5094, DOI 10.1021/ja806688s; Brasch M, 2011, J AM CHEM SOC, V133, P6878, DOI 10.1021/ja110752u; Zhen ZP, 2013, ACS NANO, V7, P6988, DOI 10.1021/nn402199g; Min J, 2013, BIOMACROMOLECULES, V14, P2332, DOI 10.1021/bm400461j; van Dongen SFM, 2009, CHEM-EUR J, V15, P1107, DOI 10.1002/chem.200802114; Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t; Sun CJ, 2011, J AM CHEM SOC, V133, P8617, DOI 10.1021/ja200746p; Abe S, 2010, INORG CHEM, V49, P6967, DOI 10.1021/ic1003758; Zhang LB, 2010, NANO LETT, V10, P219, DOI 10.1021/nl903313r; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Kuiper SM, 2008, ORG BIOMOL CHEM, V6, P4315, DOI 10.1039/b811196k; Sanghamitra NJM, 2013, CHEM COMMUN, V49, P4114, DOI 10.1039/c2cc36935d; Kanbak-Aksu S, 2012, CHEM COMMUN, V48, P5745, DOI 10.1039/c2cc31401k; Li F, 2014, SMALL, V10, P230, DOI 10.1002/smll.201301393; de la Escosura A, 2009, J MATER CHEM, V19, P2274, DOI 10.1039/b815274h; Ueno T, 2013, CHEM-ASIAN J, V8, P1646, DOI 10.1002/asia.201300347; Suzuki M, 2009, CHEM COMMUN, P4871, DOI 10.1039/b908742g; Patterson DP, 2012, ACS NANO, V6, P5000, DOI 10.1021/nn300545z; Liang MM, 2014, P NATL ACAD SCI USA, V111, P14900, DOI 10.1073/pnas.1407808111; Minten IJ, 2011, CHEM SCI, V2, P358, DOI 10.1039/c0sc00407c; Abe S, 2009, J AM CHEM SOC, V131, P6958, DOI 10.1021/ja901234j; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Inaba H, 2012, DALTON T, V41, P11424, DOI 10.1039/c2dt31030a; Zhang W, 2012, SMALL, V8, P2948, DOI 10.1002/smll.201102480; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; Minten IJ, 2009, J AM CHEM SOC, V131, P17771, DOI 10.1021/ja907843s; Patterson DP, 2012, SOFT MATTER, V8, P10158, DOI 10.1039/c2sm26485d; Yokoi N, 2011, CHEM COMMUN, V47, P2074, DOI 10.1039/c0cc03015e; Luque D, 2014, CHEM SCI, V5, P575, DOI 10.1039/c3sc52276h; Fan KL, 2012, NAT NANOTECHNOL, V7, P459, DOI [10.1038/nnano.2012.90, 10.1038/NNANO.2012.90]; Liu XY, 2012, CHEM COMMUN, V48, P3155, DOI 10.1039/c1cc15815e; Takezawa Y, 2011, DALTON T, V40, P2190, DOI 10.1039/c0dt00955e; Bode SA, 2011, NANOSCALE, V3, P2376, DOI 10.1039/c0nr01013h; Comellas-Aragones M, 2007, NAT NANOTECHNOL, V2, P635, DOI 10.1038/nnano.2007.299; de la Escosura A, 2008, CHEM COMMUN, P1542; Fan RL, 2010, SMALL, V6, P1483, DOI 10.1002/smll.201000457; Inaba H, 2014, ISR J CHEM IN PRESS; Koshiyama T, 2008, SMALL, V4, P50, DOI 10.1002/smll.200700855; Niemeyer J, 2008, CHEM COMMUN, P6519, DOI 10.1039/b813181c; Patterson D, 2014, ISR J CHEM IN PRESS; Patterson DP, 2014, J MATER CHEM B, V2, P5948, DOI 10.1039/c4tb00983e; Patterson DP, 2014, ACS CHEM BIOL, V9, P359, DOI 10.1021/cb4006529; Renggli K, 2014, ANGEW CHEM INT EDIT, V53, P1443, DOI 10.1002/anie.201306798; Ueno T, 2013, COORDINATION CHEMISTRY IN PROTEIN CAGES: PRINCIPLES, DESIGN, AND APPLICATIONS, P1, DOI 10.1002/9781118571811; Wang ZY, 2011, CHEM COMMUN, V47, P170, DOI 10.1039/c0cc02221g; Yang Z, 2007, CHEM COMMUN, P3453, DOI 10.1039/b705326f	56	4	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1367-5931	1879-0402		CURR OPIN CHEM BIOL	Curr. Opin. Chem. Biol.	APR	2015	25						88	97		10.1016/j.cbpa.2014.12.026		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CG2HO	WOS:000353095700013		
J	Onoda, A; Hayashi, T				Onoda, Akira; Hayashi, Takashi			Artificial hydrogenase: biomimetic approaches controlling active molecular catalysts	CURRENT OPINION IN CHEMICAL BIOLOGY			English	Review							OUTER-COORDINATION SPHERE; NICKEL ELECTROCATALYST; DIIRON HYDROGENASE; IRON HYDROGENASE; PHOTOSYSTEM-I; H-2 OXIDATION; PROTEIN; METALLOENZYMES; DESIGN; SITE	Hydrogenase catalyses reversible transformation of H-2 to H+ using an active site which includes an iron or nickel atom. Synthetic model complexes and molecular catalysts inspired by nature have unveiled the structural and functional basis of the active site with remarkable accuracy and this has led to the discovery of active synthetic catalysts. To further improve the activity of such molecular catalysts, both the first and outer coordination spheres should be well-organized and harmonized for an efficient shuttling of H+, electrons, and H-2. This article reviews recent advances in the design and catalytic properties of artificial enzymes that mimic the hydrogenase active site and the outer coordination sphere in combination with a peptide or protein scaffold.	[Onoda, Akira; Hayashi, Takashi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Onoda, A (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	onoda@chem.eng.osaka-u.ac.jp; thayashi@chem.eng.osaka-u.ac.jp			MEXT, Japan [2204]	The authors appreciate the financial support provide by Grants-in-Aid for Scientific Research (Innovative Areas "Molecular Activation", area 2204) from MEXT, Japan.	Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; Esselborn J, 2013, NAT CHEM BIOL, V9, P607, DOI [10.1038/nchembio.1311, 10.1038/NCHEMBIO.1311]; Lu Y, 2009, NATURE, V460, P855, DOI 10.1038/nature08304; Rosati F, 2010, CHEMCATCHEM, V2, P916, DOI 10.1002/cctc.201000011; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; Yu TJ, 2013, ANGEW CHEM INT EDIT, V52, P5631, DOI 10.1002/anie.201301289; Sano Y, 2012, J INORG BIOCHEM, V108, P159, DOI 10.1016/j.jinorgbio.2011.07.010; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Camara JM, 2012, NAT CHEM, V4, P26, DOI 10.1038/nchem.1180; Ueno T, 2007, COORDIN CHEM REV, V251, P2717, DOI 10.1016/j.ccr.2007.04.007; Dutta A, 2013, J AM CHEM SOC, V135, P18490, DOI 10.1021/ja407826d; Reback ML, 2014, CHEM-EUR J, V20, P1510, DOI 10.1002/chem.201303976; Onoda A, 2014, ACS CATAL, V4, P2645, DOI 10.1021/cs500392e; Roy A, 2012, CHEM COMMUN, V48, P9816, DOI 10.1039/c2cc34470j; Onoda A, 2012, CHEM COMMUN, V48, P9756, DOI 10.1039/c2cc35165j; Simmons TR, 2014, COORDIN CHEM REV, V270, P127, DOI 10.1016/j.ccr.2013.12.018; Bacchi M, 2014, INORG CHEM, V53, P8071, DOI 10.1021/ic501014c; Ogo S, 2013, SCIENCE, V339, P682, DOI 10.1126/science.1231345; Wu LZ, 2014, ACCOUNTS CHEM RES, V47, P2177, DOI 10.1021/ar500140r; Helm ML, 2011, SCIENCE, V333, P863, DOI 10.1126/science.1205864; Yu FT, 2014, CHEM REV, V114, P3495, DOI 10.1021/cr400458x; Sun LC, 2005, COORDIN CHEM REV, V249, P1653, DOI 10.1016/j.ccr.2005.01.013; Utschig LM, 2011, J AM CHEM SOC, V133, P16334, DOI 10.1021/ja206012r; Silver SC, 2013, J AM CHEM SOC, V135, P13246, DOI 10.1021/ja405277g; Fukumoto K, 2014, CHEMCATCHEM, V6, P1229, DOI 10.1002/cctc.201301055; Eckenhoff WT, 2012, DALTON T, V41, P13004, DOI 10.1039/c2dt30823a; Capon JF, 2009, COORDIN CHEM REV, V253, P1476, DOI 10.1016/j.ccr.2008.10.020; Wen FY, 2013, ACCOUNTS CHEM RES, V46, P2355, DOI 10.1021/ar300224u; Singleton ML, 2010, J AM CHEM SOC, V132, P8870, DOI 10.1021/ja103774j; Nicolet Y, 1999, STRUCT FOLD DES, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Jones AK, 2007, J AM CHEM SOC, V129, P14844, DOI 10.1021/ja075116a; Lewis JC, 2013, ACS CATAL, V3, P2954, DOI 10.1021/cs400806a; Deuss PJ, 2011, CHEM-EUR J, V17, P4680, DOI 10.1002/chem.201003646; Sano Y, 2011, CHEM COMMUN, V47, P8229, DOI 10.1039/c1cc11157d; Armstrong F, 2007, ENERGY BEYOND OIL; Cammack R, 2002, HYDROGEN FUEL LEARNI; Dutta A, 2014, ANGEW CHEM INT EDIT, V53, P6487, DOI 10.1002/anie.201402304; Dutta A, 2012, INORG CHEM, V51, P9580, DOI 10.1021/ic2026818; Ginovska-Pangovska B, 2014, ACCOUNTS CHEM RES, V47, P2621, DOI 10.1021/ar5001742; Jain A, 2012, INORG CHEM, V51, P6592, DOI 10.1021/ic300149x; Jain A, 2011, INORG CHEM, V50, P4073, DOI 10.1021/ic1025872; Jian J. X., 2013, NAT COMMUN, P4; Kleingardner J. G., 2013, J AM CHEM SOC, V136, P4; Onoda A, 2014, BIOORGANOMETALLIC CH; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Roy S, 2011, EUR J INORG CHEM, P1050, DOI 10.1002/ejic.201000979; Sommer DJ, 2014, CHEM COMMUN, V50, P15852, DOI 10.1039/c4cc06700b; Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u	49	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1367-5931	1879-0402		CURR OPIN CHEM BIOL	Curr. Opin. Chem. Biol.	APR	2015	25						133	140		10.1016/j.cbpa.2014.12.041		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CG2HO	WOS:000353095700019		
J	Takahashi, S; Ishiki, M; Kondo, N; Ishiki, A; Toriyama, T; Takahashi, S; Moriyama, H; Ueno, M; Shimanuki, M; Kanno, T; Oki, T; Tabata, K				Takahashi, Sho; Ishiki, Mikihito; Kondo, Naoki; Ishiki, Aiko; Toriyama, Takeshi; Takahashi, Shuko; Moriyama, Hidenori; Ueno, Masahiro; Shimanuki, Masaaki; Kanno, Toshio; Oki, Tomoharu; Tabata, Kiyoshi			Health Effects of a Farming Program to Foster Community Social Capital of a Temporary Housing Complex of the 2011 Great East Japan Earthquake	DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS			English	Article						preventive health services; public health practice; earthquakes	BONE-MINERAL DENSITY; SELF-RATED HEALTH; OLDER JAPANESE; MORTALITY; SUPPORT; ADULTS; WOMEN	Objective: We launched a health promotion program called the Hamarassen ("let's get together") Farm, which provided farming opportunities for the victims of the Great East Japan Earthquake who resided in temporary housing. The aim of this study was to evaluate the effects of this program on physical and mental health in terms of bone mineral density (BMD) and a sense of purpose in life. Methods: Among 39 female participants in whom BMD was evaluated, there were 12 Hamarassen participants, 8 self-farming control subjects, and 19 non-farming control subjects. BMD was measured by calcaneal quantitative ultrasound immediately after the project launch and 5 months later. A sense of purpose in life prior to and 2 months after the project's commencement was measured in 21 additional Hamarassen participants by use of the K-I Scale. Interviews were also conducted to qualitatively evaluate the effects of the Hamarassen program. Results: The mean BMD T-score improved by 0.43 in the Hamarassen group, by 0.33 in the self-farming group, and by 0.06 in the controls (p = 0.02). Among the 21 Hamarassen participants in whom mental health was evaluated, the average score for a sense of purpose in life improved from 20.5 to 24.9 (p = 0.001). Conclusions: The Hamarassen Farm provided disaster victims with opportunities for social participation, interpersonal interaction, and physical exercise; such opportunities may improve physical and psychosocial well-being.	[Takahashi, Sho; Ishiki, Mikihito; Ishiki, Aiko; Toriyama, Takeshi; Takahashi, Shuko; Ueno, Masahiro; Shimanuki, Masaaki; Tabata, Kiyoshi] Iwate Prefectural Takata Hosp, Dept Internal Med, Rikuzentakata, Japan; [Kondo, Naoki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Tokyo, Japan; [Moriyama, Hidenori; Oki, Tomoharu] Iwate Prefectural Takata Hosp, Dept Pediat, Rikuzentakata, Japan; [Kanno, Toshio] Iwate Prefectural Takata Hosp, Dept Ophthalmol, Rikuzentakata, Japan	Takahashi, S (reprint author), Iwate Prefectural Takata Hosp, Dept Internal Med, Internal Med, Rikuzentakata, Japan.	sho1973@gmail.com			Ministry of Health, Labour, and Welfare [H26-ryoshitei-003, H25-kenki-wakate-015]	The authors thank the landowners who supported this project with the gratuitous use of their fallow farmland and the hospital employees who participated in this project. The authors also thank Tsuyoshi Komori and members of the "Let's Talk Foundation" for technical assistance and Fumiko Osaka, Erika Nakajima, and Ayumi Sato for supporting the fieldwork. NK was funded by the Ministry of Health, Labour, and Welfare (No. H26-ryoshitei-003, fukkou; and H25-kenki-wakate-015).	Aida J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-499; Aldrich D. P., 2012, BUILDING RESILIENCE; [Anonymous], WORLD POP AG 1950 20; Kim D, 2006, J EPIDEMIOL COMMUN H, V60, P116, DOI 10.1136/jech.2005.038281; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293; Nakamura K, 2006, OSTEOPOROSIS INT, V17, P1202, DOI 10.1007/s00198-006-0132-z; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Haines VA, 1996, J HEALTH SOC BEHAV, V37, P252, DOI 10.2307/2137295; [Anonymous], 2010, POP CENS JAP BAS COM; Marques EA, 2012, AGE, V34, P1493, DOI 10.1007/s11357-011-9311-8; [Anonymous], 2013, SYST SOC DEM STAT JA; [Anonymous], 2014, ENCOURAGEMENT COMMUN; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, P137; Fair Society Healthy Lives (The Marmot Review), 2014, FAIR SOC HLTH LIVES; Fukudo S., 2012, JPN J PSYCHOSOM MED, V52, P388; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Ichida Y, 2013, SOC SCI MED, V94, P83, DOI 10.1016/j.socscimed.2013.05.006; Kage R, 2011, CIVIC ENGAGEMENT POS; Kawachi I., 2008, SOCIAL CAPITAL HLTH; Kawachi Ichiro, 2013, GLOBAL PERSPECTIVES; Kondo N, 2012, J EPIDEMIOL, V22, P543, DOI 10.2188/jea.JE20120025; Kondo T, 2003, JPN J SOC WELFARE, V43, P93; Leavell H, 1953, TXB PREVENTIVE MED; Ogawa S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000830; Okamoto N, 2014, J HUMANITARIAN STUD, V3, P86; Okawa Y., 2005, IRYO, V59, P205; Saito M, 2012, SOC SCI MED, V75, P940, DOI 10.1016/j.socscimed.2012.04.006; Sanada K, 1997, JPN J PHYS FIT SPORT, V46, P69; Shiga H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002294	32	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1935-7893	1938-744X		DISASTER MED PUBLIC	Dis. Med. Public Health Prep.	APR	2015	9	2					103	110		10.1017/dmp.2015.6		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG3XO	WOS:000353213100003		
J	Nishiyama, Y; Matsukuma, S; Matsumura, T; Kanatani, Y; Saito, T				Nishiyama, Yasumasa; Matsukuma, Susumu; Matsumura, Takuya; Kanatani, Yasuhiro; Saito, Tomoya			Preparedness for a Smallpox Pandemic in Japan: Public Health Perspectives	DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS			English	Article						smallpox; bioterrorism; public health; pandemics; biological warfare agents		Smallpox is an acute, febrile, contagious disease caused by the Variola virus, which is a member of the Poxviridae family. Until the 1970s, smallpox had been a pandemic disease for more than 3000 years, endemic in tropical and developing areas and periodically epidemic worldwide. The World Health Organization declared smallpox to be completely eradicated in 1980 as the result of global vaccination efforts. At that time, all routine vaccination programs were terminated, given the success of this monumental eradication. Although smallpox remains fully eradicated, uncertainty exists regarding the possibility of recurrent smallpox outbreaks. At the end of the Cold War, concerns regarding unstable international security and the feasibility of terrorism with weapons of mass destruction have been highlighted. The potential threat of intentional release of smallpox has forced regional health authorities to reconsider their political landscape and create preparedness plans to protect the community in the event of biological attacks. Here we present current countermeasures to this biological threat in Japan and discuss methods for strengthening public health preparedness both domestically and internationally. These methods include infection control, vaccination policy, and international partnerships to help deter or contain a contagious smallpox pandemic.	[Nishiyama, Yasumasa; Matsukuma, Susumu; Matsumura, Takuya] Japan Ground Self Def Force Cent Hosp, Hlth Serv Sect, Setagaya Ku, Tokyo, Japan; [Kanatani, Yasuhiro; Saito, Tomoya] Natl Inst Publ Hlth, Dept Hlth Crisis Management, Wako, Saitama 3510197, Japan	Nishiyama, Y (reprint author), Japan Self Def Forces Cent Hosp, Hlth Care Ctr, Setagaya Ku, 1-2-24 Ikejiri, Tokyo, Japan.	nishiyamajpn@gmail.com			Japan Ministry of Health, Labour, and Welfare	This study was supported by research funding from the Japan Ministry of Health, Labour, and Welfare in fiscal year 2013.	Saito T, 2009, JAMA-J AM MED ASSOC, V301, P1025, DOI 10.1001/jama.2009.289; Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412; Broad WJ, 1998, NY TIMES; Burkle FM, 2007, DISASTER MED PUBLIC, V1, P135, DOI 10.1097/DMP.0b013e3181583d66; Graham B, 2011, DISASTER MED PUBLIC, V5, P170; Hashizume S., 2004, MODERN MEDIA, V50, P4; Henderson DA, 2014, BIOSECUR BIOTERROR, V12, P1; Ohkusa Yasushi, 2009, Kansenshogaku Zasshi, V83, P236; Okabe Nobuhiko, 2004, Uirusu, V54, P249, DOI 10.2222/jsv.54.249; O'Toole T, 2002, CLIN INFECT DIS, V34, P972, DOI 10.1086/339909; Saijo H, 2006, J VIROL, V80, P5179; Sugishima Masaaki, 2003, Prehosp Disaster Med, V18, P179; Tanihata T., 2012, Journal of the National Institute of Public Health, V61, P344; WEHRLE PF, 1970, B WORLD HEALTH ORGAN, V43, P669; World Health Organization, 1980, WKLY EPIDEMIOL REC, V55, P145; Zenihana Tomohiro, 2010, Environmental Health and Preventive Medicine, V15, P84, DOI 10.1007/s12199-009-0111-z	16	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1935-7893	1938-744X		DISASTER MED PUBLIC	Dis. Med. Public Health Prep.	APR	2015	9	2					220	223		10.1017/dmp.2014.157		4	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG3XO	WOS:000353213100017		
J	Takaki, Y				Takaki, Yasuhiro			Super multi-view and holographic displays using MEMS devices	DISPLAYS			English	Review						3D display; Holography; Super multi-view display; MEMS spatial light modulator; MEMS scanner; Visual fatigue	3-DIMENSIONAL DISPLAY; DIRECTIONAL IMAGES; SPECKLE-FREE; REPRESENTATION; IMPROVEMENT	Holographic displays and super multi-view (SMV) displays have been developed to solve the accommodation-vergence conflict that is responsible for visual fatigue caused by the 3D images that are generated by conventional three-dimensional (3D) displays upon which the eye cannot focus. However, holographic and SMV displays provide 3D images upon which the eye can readily focus so that the accommodation-vergence conflict does not occur. Because these two display techniques require the generation of a very large amount of image data, the high data bandwidth of microelectromechanical (MEMS) devices is effectively utilized. The present article describes the holographic display system that employs a MEMS spatial light modulator (SLM), which increases the screen size and viewing zone angle. Two SMV displays are also described, where one employs MEMS SLMs and the other an array of MEMS projectors. The resolution and the number of viewpoints of the SMV displays have increased. Moreover, the technique using a MEMS SLM to eliminate speckles from holographic reconstructed images is also described. (C) 2014 Elsevier B.V. All rights reserved.	Tokyo Univ Agr & Technol, Inst Engn, Koganei, Tokyo 1848588, Japan	Takaki, Y (reprint author), Tokyo Univ Agr & Technol, Inst Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	ytakaki@cc.tuat.ac.jp			JSPS KAKENHI [18360165, 23656234]; Samsung R&D Institute Japan	Some of the work presented in this article was partly supported by JSPS KAKENHI Grant Number 18360165, 23656234, and Samsung R&D Institute Japan.	Takaki Y, 2011, OPT EXPRESS, V19, P7567, DOI 10.1364/OE.19.007567; Kurihara T, 2013, OPT EXPRESS, V21, P4044, DOI 10.1364/OE.21.004044; Takaki Y, 2012, OPT EXPRESS, V20, P3918, DOI 10.1364/OE.20.003918; Nakanuma H, 2005, P SOC PHOTO-OPT INS, V5664, P28, DOI 10.1117/12.589596; Takaki Y, 2010, OPT EXPRESS, V18, P8824, DOI 10.1364/OE.18.008824; Takaki Y, 2012, OPT EXPRESS, V20, P28257, DOI 10.1364/OE.20.028257; Takaki Y, 2009, APPL OPTICS, V48, P3255, DOI [10.1364/AO.48.003256, 10.1364/AO.48.003255]; Matsumoto Y, 2014, OPT LETT, V39, P3433, DOI 10.1364/OL.39.003433; Takaki Y, 2010, OPT EXPRESS, V18, P11327, DOI 10.1364/OE.18.011327; Takaki Y, 2009, APPL OPTICS, V48, pH64, DOI 10.1364/AO.48.000H64; Takaki Y, 2005, P SOC PHOTO-OPT INS, V5664, P56, DOI 10.1117/12.589613; Geng JS, 2013, ADV OPT PHOTONICS, V5, P456, DOI 10.1364/AOP.5.000456; Yaras F, 2010, J DISP TECHNOL, V6, P443, DOI 10.1109/JDT.2010.2045734; Takaki Y, 2010, OPT EXPRESS, V18, P24926, DOI 10.1364/OE.18.024926; Hoffman D. M., 2008, J VISION, V8, P1, DOI DOI 10.1167/8.3.33; Honda T., 2002, 3 DIMENSIONAL TELEVI, P461; Kanebako T., 2008, P SOC PHOTO-OPT INS, V6803; Kikuta K., 2007, P SOC PHOTO-OPT INS, V6490; Nakajima T., 2013, DIGITAL HOLOGRAPHY 3; Takaki Y., 2006, P SOC PHOTO-OPT INS, V6055	20	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-9382	1872-7387		DISPLAYS	Displays	APR	2015	37				SI		19	24		10.1016/j.displa.2014.09.002		6	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic; Instruments & Instrumentation; Optics	Computer Science; Engineering; Instruments & Instrumentation; Optics	CG2FM	WOS:000353090300004		
J	Ishizuka, H; Miki, N				Ishizuka, Hiroki; Miki, Norihisa			MEMS-based tactile displays	DISPLAYS			English	Review						Tactile display; MEMS; Actuators; Smart materials; Mechanoreceptors	ULTRASONIC VIBRATION; SURFACE-TEXTURE; ACTUATORS; SENSATION; ARRAY; DISCRIMINATION; STIMULATION; RECOGNITION; FABRICATION; PERCEPTION	This paper discusses state-of-the-art tactile displays fabricated by a micro-electronic-mechanical-system (MEMS). A tactile display conveys tactile sensations to users by using actuators. Traditional tactile displays consist of large size actuators, such as a motor or an ultrasound vibrator, to convey tactile feedback by vibration. In addition, the tactile sensation of traditional displays has poor resolution. Microelectromechanical system (MEMS) technology, which is a miniature fabrication process, enables etching, sputtering and assembling of miniature structures. Recently, the technology was applied to tactile displays. For example, shape memory alloy (SMA) actuators are widely used in tactile displays to convey roughness or vibration. The actuators are fabricated by a sputtering process and then thinned. The displays convey various tactile sensations, including feedback and tactile sensations of objects such as paper or wood. This paper is a review of tactile displays fabricated by MEMS technology. We also describe the fabrication processes and stimulation methods to present the potential and applications of the displays. (C) 2014 Elsevier B.V. All rights reserved.	[Ishizuka, Hiroki; Miki, Norihisa] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Ishizuka, H (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	Ishizuka1314@a3.keio.jp	Miki, Norihisa/F-7659-2014				Hollins M, 2000, PERCEPT PSYCHOPHYS, V62, P695, DOI 10.3758/BF03206916; Schweizer R, 2008, NEUROIMAGE, V42, P28, DOI 10.1016/j.neuroimage.2008.04.184; Yang TH, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P13, DOI 10.1109/WHC.2009.4810818; Kwon HJ, 2009, SENSOR ACTUAT A-PHYS, V154, P238, DOI 10.1016/j.sna.2008.10.002; Kato Y, 2007, IEEE T ELECTRON DEV, V54, P202, DOI 10.1109/TED.2006.888678; Kajimoto H, 2012, IEEE T HAPTICS, V5, P184, DOI [10.1109/TOH.2011.39, 10.1109/ToH.2011.39]; Miyaoka T, 1999, J ACOUST SOC AM, V105, P2485, DOI 10.1121/1.426852; Streque J, 2010, IEEE T HAPTICS, V3, P88, DOI [10.1109/TOH.2009.61, 10.1109/ToH.2009.61]; Yun GY, 2010, SENSOR ACTUAT A-PHYS, V164, P68, DOI 10.1016/j.sna.2010.09.005; Ninomiya T, 2011, SENSOR ACTUAT A-PHYS, V166, P277, DOI 10.1016/j.sna.2009.07.002; WATANABE T, 1995, IEEE INT CONF ROBOT, P1134, DOI 10.1109/ROBOT.1995.525433; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177; Kaczmarek KA, 2003, IEEE T NEUR SYS REH, V11, P9, DOI 10.1109/TNSRE.2003.810421; Wu XS, 2012, J MICROELECTROMECH S, V21, P908, DOI 10.1109/JMEMS.2012.2190043; Matysek M, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P290, DOI 10.1109/WHC.2009.4810822; Lee HS, 2014, SENSOR ACTUAT A-PHYS, V205, P191, DOI 10.1016/j.sna.2013.11.009; Arai M., 2012, P IEEE 25 INT C MEMS, P148; Asano S., 2012, P 2012 IEEE INT S RO, P1001; Campanella C.J., 2012, J MICROMECH MICROENG, V22, P1; Casset F., 2013, P TRANSDUCERS, V2013, P2733; Choi H.R., 2009, ELECTROACT POLYM ACT; Doh E, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.017302; Goto M, 2013, IEEE INT C INT ROBOT, P4478, DOI 10.1109/IROS.2013.6697000; Green S.C., 2006, IEEE SENSORS, P307; Hachisu T., 2014, P CHI 2014, P411; Higashiya6a A., 2009, TACTILE SENSATION PA; Ikei Y, 1997, P IEEE VIRT REAL ANN, P199, DOI 10.1109/VRAIS.1997.583071; Ikei Y, 1997, IEEE COMPUT GRAPH, V17, P53, DOI 10.1109/38.626970; Ishizuka H., 2014, MECH ENG J, V1, P1; Johansson R.S., 1983, J PHYSL, V286, P633; Jun L.S., 2005, J MICROELECTROMECH S, V14, P673; Kajimoto H., 2001, P WORLD MULT SYST CY; Kameyama T., 2014, P IEEE HAPT S 2014, P283; Kim J., 2014, P 2014 JSME C ROB ME; Kim S.Y., 2013, HAPTIC AUDIO INTERAC, V7989, P109; Kim Y., 2006, P SICE ICASE INT JOI, V2006, P1933; King CH, 2008, IEEE T BIO-MED ENG, V55, P2593, DOI 10.1109/TBME.2008.2001137; King C.H., 2008, J MED DEVICES, V2, P1; Kitamura K., P MEMS 2014, P1183; Kitamura K., 2014, P EUR 2014; Kitazawa T., 2014, P EUR 2014; Konyo M., 2000, P IEEE INT C ROB AUT, V4, P3416, DOI 10.1109/ROBOT.2000.845250; Koo I, 2006, IEEE INT CONF ROBOT, P2220; Kosemura Y., 2014, P MEMS 2014, P931; Kyung K.U., 2005, P 1 JOINT EUR C S HA; Kyung K.U., 2008, J BIOMED BIOTECHNOL, P1; Lee CH, 2011, SENSORS-BASEL, V11, P2845, DOI 10.3390/s110302845; Lee H.S., 2012, ELECTROACT POLYM ACT, V2012; Levent Y., 2001, J MICROELECTROMECHAN, V10, P187; Levent Y., 2003, J MICROELECTROMECH S, V12, P252; Maeno T, 2006, ULTRASON, P62, DOI 10.1109/ULTSYM.2006.29; Mizoguchi S., 2008, DICT SKIN ASAKURA SY; Na K., 2012, P IEEE 25 INT C MEMS, P1149; Nakamura T., 2014, P EUR 2014; Okayama Y., 2010, J MICROMECH MICROENG, V20, P1; Ostrom N.P., 1999, P 1 JOINT BMES EMBS, P838; Ozawa M, 2014, SENSOR ACTUAT A-PHYS, V205, P208, DOI 10.1016/j.sna.2013.11.028; Paschew G., 2010, P SOC PHOTO-OPT INS, V7642, P1; Paul B.R., 1998, J REHABIL RES DEV, V35, P427; Pyo D., 2014, P EUR 2014; Saga S., 2010, P HAPT S, P309; Santos-Carreras L., 2010, P IEEE RSJ INT C INT, P5060; Sasaki H, 2006, J MICROMECH MICROENG, V16, P2673, DOI 10.1088/0960-1317/16/12/021; Scilingo E.P., 2003, P IEEE INT C ROB AUT, P2412; Shikida M., 2008, J MICROMECH MICROENG, V18, P1; Shimojo M., 2010, SCI TECHNOL; Simon G., 2012, P 12 IEEE INT WORKSH; Smithmaitrie Pruittikorn, 2008, Disabil Rehabil Assist Technol, V3, P360, DOI 10.1080/17483100802281442; Soulimane S., 2014, P 15 INT C THERM MEC; Stanley AA, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P25, DOI 10.1109/WHC.2013.6548379; Streque J, 2008, LECT NOTES COMPUT SC, V5024, P437, DOI 10.1007/978-3-540-69057-3_57; Takagi S, 2007, TRANSDUCERS '07 & Eurosensors XXI. 2007 14th International Conference on Solid-State Sensors, Actuators and Microsystems, DOI 10.1109/SENSOR.2007.4300338; Takayama H., 2008, P 2008 JSME C ROB ME; Talbi A, 2006, J PHYS CONF SER, V34, P637, DOI 10.1088/1742-6596/34/1/105; Taylor PM, 1998, DISPLAYS, V18, P135, DOI 10.1016/S0141-9382(98)00014-6; Tsujita T., 2010, ELECTRORHEOLOGICAL F; Tsujita T, 2010, INT J APPL ELECTROM, V33, P1661, DOI 10.3233/JAE-2010-1298; Uchiyama K., 2008, SENSES TOUCH HEARING; Vitushinsky R, 2009, J MICROELECTROMECH S, V18, P186, DOI 10.1109/JMEMS.2008.2009816; Watanabe J., 2012, P IEEE I5 INT C MEMS, P1129; Watanabe J, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FL11; Winfield L., 2007, P EUR 2007; Wu X., 2007, P 14 INT C SOL STAT, P1409; Yamamoto A, 2004, IEEE INT CONF ROBOT, P1536, DOI 10.1109/ROBOT.2004.1308042; Yamaoka M, 2008, LECT NOTES COMPUT SC, V5024, P427, DOI 10.1007/978-3-540-69057-3_56; Yang GH, 2006, IEEE INT CONF ROBOT, P3917; Yang TH, 2010, SENSOR ACTUAT A-PHYS, V163, P180, DOI 10.1016/j.sna.2010.07.004; Yoshikawa W., 2008, IEE J T SM, V128, P151, DOI 10.1541/ieejsmas.128.151; Youn S, 2013, SENSOR ACTUAT A-PHYS, V195, P105, DOI 10.1016/j.sna.2013.03.002; Zhao F., 2009, P 18 IEEE INT S ROB, P28	90	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-9382	1872-7387		DISPLAYS	Displays	APR	2015	37				SI		25	32		10.1016/j.displa.2014.10.007		8	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic; Instruments & Instrumentation; Optics	Computer Science; Engineering; Instruments & Instrumentation; Optics	CG2FM	WOS:000353090300005		
J	Osakabe, A; Tachiwana, H; Horikoshi, N; Kagawa, W; Yamamoto, J; Yasuda, T; Hanaoka, F; Sugasawa, K; Iwai, S; Kurumizaka, H				Osakabe, Akihisa; Tachiwana, Hiroaki; Horikoshi, Naoki; Kagawa, Wataru; Yamamoto, Junpei; Yasuda, Takeshi; Hanaoka, Fumio; Sugasawa, Kaoru; Iwai, Shigenori; Kurumizaka, Hitoshi			Structures of the nucleosomes containing UV-damaged DNA bases and the damaged base recognition mechanism by DNA repair proteins	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Osakabe, Akihisa; Tachiwana, Hiroaki; Horikoshi, Naoki; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Kagawa, Wataru] Meisei Univ, Sch Sci & Engn, Tokyo, Japan; [Yamamoto, Junpei; Iwai, Shigenori] Osaka Univ, Grad Sch Engn Sci, Osaka, Japan; [Yasuda, Takeshi] Natl Inst Radiol Sci, Chiba 260, Japan; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Tokyo 171, Japan; [Sugasawa, Kaoru] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					2.1	139	140				2	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700019		
J	Sekiguchi, M; Ishii, T; Ito, R; Hayakawa, H				Sekiguchi, Mutsuo; Ishii, Takashi; Ito, Riyoko; Hayakawa, Hiroshi			Roles of MutT, MTH1 and AUF1 in defense against oxidative stress	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Sekiguchi, Mutsuo; Ishii, Takashi; Ito, Riyoko; Hayakawa, Hiroshi] Fukuoka Dent Coll, Fukuoka, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					1.3	139	139				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700018		
J	Yasui, A; Watanabe, R				Yasui, Akira; Watanabe, Reiko			Cooperation of SWI/SNF chromatin remodeling factors with DNA repair, and their frequent loss in cancer cells	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Yasui, Akira; Watanabe, Reiko] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome, Aoba Ku, Sendai, Miyagi 9808575, Japan							Watanabe R, 2014, CANCER RES, V74, P2465, DOI 10.1158/0008-5472.CAN-13-3608	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					1.1	139	139				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700016		
J	Ikura, T; Shima, H; Sun, JY; Matsuda, R; Ikura, M; Tashiro, S				Ikura, Tsuyoshi; Shima, Hiroki; Sun Jiying; Matsuda, Ryo; Ikura, Masae; Tashiro, Satoshi			Activation of the SUMO modification system is required for the accumulation of RAD51 at sites containing DNA damage	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Ikura, Tsuyoshi; Matsuda, Ryo; Ikura, Masae] Kyoto Univ, Ctr Radiat Biol, Dept Mutagenesis, Lab Chromatin Regulatory Network, Kyoto 6068501, Japan; [Shima, Hiroki] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 980, Japan; [Sun Jiying; Tashiro, Satoshi] Hiroshima Univ, RIRBM, Dept Cellular Biol, Hiroshima 730, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					3.1	140	140				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700022		
J	Ogiwara, H; Kohno, T				Ogiwara, Hideaki; Kohno, Takashi			Personalized medicine of lung cancer using RET oncogene fusion and SWI/SNF chromatin remodeling deficiency	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Ogiwara, Hideaki; Kohno, Takashi] Natl Canc Ctr, Div Genome Biol, Tokyo, Japan							D'Antonio M, 2013, CELL REP; Helming KC, 2014, NAT MED; Hoffman GR, 2014, PNAS; Kohno T, 2012, NAT MED; Mizukami T, 2014, JTO; Oike T, 2013, CANC RES; Wilson BG, 2014, MCB	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					2.2	140	140				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700020		
J	Takata, M; Hira, A; Yoshida, K; Sato, K; Shimamoto, A; Tahara, H; Kurumizaka, H; Ogawa, S; Yabe, H; Yabe, M				Takata, Minoru; Hira, Asuka; Yoshida, Kenichi; Sato, Koichi; Shimamoto, Akira; Tahara, Hidetoshi; Kurumizaka, Hitoshi; Ogawa, Seishi; Yabe, Hiromasa; Yabe, Miharu			Comprehensive analysis of Japanese Fanconi anemia (FA) patients has led to the identification of an E2 enzyme UBE2T as a novel FA gene	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Takata, Minoru; Hira, Asuka] Kyoto Univ, Ctr Radiat Biol, Dept Late Effects Studies, Lab DNA Damage Signaling, Kyoto, Japan; [Yoshida, Kenichi; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan; [Sato, Koichi; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Lab Struct Biol, Tokyo, Japan; [Shimamoto, Akira; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Minami Ku, Hiroshima, Japan; [Yabe, Hiromasa; Yabe, Miharu] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					3.2	140	141				2	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700023		
J	Hosono, Y; Abe, T; Kajii, K; Tada, S; Enomoto, T; Seki, M				Hosono, Yoshifumi; Abe, Takuya; Kajii, Kosa; Tada, Shusuke; Enomoto, Takemi; Seki, Masayuki			Tipin Functions in the Protection against Topoisomerase Inhibitors	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Hosono, Yoshifumi; Abe, Takuya; Kajii, Kosa; Tada, Shusuke; Enomoto, Takemi; Seki, Masayuki] Tohoku Pharmaceut Univ, Sendai, Miyagi, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					4.4	141	142				2	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700028		
J	Oka, S; Sheng, ZJ; Ohno, M; Sakumi, K; Nakabeppu, Y				Oka, Sugako; Sheng, Zijing; Ohno, Mizuki; Sakumi, Kunihiko; Nakabeppu, Yusaku			MUTYH-dependent programed cell death induced by 8-oxoguanine accumulated in cellular DNAs and its implication in tumorigenesis and neruodegeneration	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Oka, Sugako; Sheng, Zijing; Sakumi, Kunihiko; Nakabeppu, Yusaku] Kyushu Univ, Fac Med Sci, Med Inst Bioregulat, Div Neurofunct Genom,Higashi Ku, Fukuoka 8128582, Japan; [Sheng, Zijing; Sakumi, Kunihiko; Nakabeppu, Yusaku] Kyushu Univ, Fac Med Sci, Res Ctr Nucleotide Pool, Higashi Ku, Fukuoka 8128582, Japan; [Ohno, Mizuki] Kyushu Univ, Fac Med Sci, Dept Med Biophys, Higashi Ku, Fukuoka 8128582, Japan; [Ohno, Mizuki] Kyushu Univ, Fac Med Sci, Dept Radiat Oncol, Higashi Ku, Fukuoka 8128582, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					4.3	141	141				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700027		
J	Shibutani, T; Iwai, S; Kuraoka, I				Shibutani, Toshihiro; Iwai, Shigenori; Kuraoka, Isao			5-carboxylcytosine G base pairs are mismatch mimicking-base pairs	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Shibutani, Toshihiro; Iwai, Shigenori; Kuraoka, Isao] Osaka Univ, Osaka, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					4.1	141	141				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700025		
J	Tsuzuki, T; Ohno, M; Takano, N; Taguchi, K; Nakabeppu, Y; Aoki, Y; Nohmi, T; Nakatsu, Y				Tsuzuki, Teruhisa; Ohno, Mizuki; Takano, Noriko; Taguchi, Kenichi; Nakabeppu, Yusaku; Aoki, Yasunobu; Nohmi, Takehiko; Nakatsu, Yoshimichi			Oxidative stress-induced intestinal tumors in Mutyh-deficient mice treated with low doses of potassium bromate	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Tsuzuki, Teruhisa; Ohno, Mizuki; Takano, Noriko; Nakatsu, Yoshimichi] Kyushu Univ, Fac Med Sci, Dept Med Biophys & Radiat Biol, Fukuoka 812, Japan; [Taguchi, Kenichi] Natl Hosp Org, Kyushu Canc Ctr, Dept Canc Biol, Canc Pathol Lab, Fukuoka, Japan; [Nakabeppu, Yusaku] Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Fukuoka 812, Japan; [Aoki, Yasunobu] Natl Inst Environm Studies, Ctr Environm Risk Res, Ibaraki, Japan; [Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					4.2	141	141				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700026		
J	Kajio, M; Yokota, T; Iwama, A; Ura, K				Kajio, Makiko; Yokota, Takafumi; Iwama, Atsushi; Ura, Kiyoe			Histone H3 lysine 36 methyltransferase controls the programmed DNA-damage response	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Kajio, Makiko; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Chiba, Japan; [Yokota, Takafumi] Osaka Univ, Grad Sch Med, Osaka, Japan; [Ura, Kiyoe] JST, PRESTO, Saitama, Japan; [Ura, Kiyoe] Chiba Univ, Grad Sch Sci, Chiba, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					5.2	142	142				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700031		
J	Kato, A; Yanagihara, H; Saito, Y; Hui, Z; Kobayashi, J; Komatsu, K				Kato, Akihiro; Yanagihara, Hiromi; Saito, Yuichiro; Hui, Zhou; Kobayashi, Junya; Komatsu, Kenshi			Roles of NBS1 in radiation responses and the initiation of translesional DNA synthesis	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Kato, Akihiro; Yanagihara, Hiromi; Saito, Yuichiro; Hui, Zhou; Kobayashi, Junya; Komatsu, Kenshi] Kyoto Univ, Kyoto, Japan			Kobayashi, Junjiro/J-8547-2015					0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					6.1	142	142				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700032		
J	Narita, T; Tanaka, K				Narita, Takashi; Tanaka, Kiyoji			Regulation of transcription elongation by XPG-TFIIH complex is implicated in Cockayne syndrome	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Narita, Takashi; Tanaka, Kiyoji] Osaka Univ, Osaka, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					5.1	142	142				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700030		
J	Natsume, T; Nishimura, K; Kanehara, Y; Kanemaki, M				Natsume, Toyoaki; Nishimura, Kohei; Kanehara, Yoshiki; Kanemaki, Masato			A hidden DNA synthesis that contributes integrity of genomic DNA	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Natsume, Toyoaki; Nishimura, Kohei; Kanehara, Yoshiki; Kanemaki, Masato] SOKENDAI, Natl Inst Genet, Ctr Frontier Res, Mishima, Shizuoka 4118540, Japan; [Kanehara, Yoshiki; Kanemaki, Masato] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					4.5	142	142				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700029		
J	Kanemaru, Y; Takeiri, A; Suzuki, T; Wada, NA; Niimi, N; Gruz, P; Motoyama, S; Matsuzaki, K; Tateishi, H; Matsumoto, K; Sassa, A; Masumura, K; Yamada, M; Mishima, M; Jishage, K; Matsumoto, K; Adachi, N; Honma, M; Nohmi, T				Kanemaru, Yuki; Takeiri, Akira; Suzuki, Tetsuya; Wada, Naoko A.; Niimi, Naoko; Gruz, Petr; Motoyama, Shigeki; Matsuzaki, Kaori; Tateishi, Hiromi; Matsumoto, Kaoru; Sassa, Akira; Masumura, Kenichi; Yamada, Masami; Mishima, Masayuki; Jishage, Kou-ichi; Matsumoto, Kyomu; Adachi, Noritaka; Honma, Masamitsu; Nohmi, Takehiko			In vivo protective roles of DNA polymerase kappa against genotoxic insults	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Kanemaru, Yuki; Suzuki, Tetsuya; Niimi, Naoko; Gruz, Petr; Sassa, Akira; Masumura, Kenichi; Yamada, Masami; Honma, Masamitsu; Nohmi, Takehiko] Natl Inst Hlth Sci, Tokyo, Japan; [Kanemaru, Yuki] Showa Univ, Sch Pharm, Tokyo, Japan; [Takeiri, Akira; Wada, Naoko A.; Motoyama, Shigeki; Matsuzaki, Kaori; Mishima, Masayuki; Jishage, Kou-ichi] Chugai Pharmaceut Co Ltd, Shizuoka, Japan; [Tateishi, Hiromi; Matsumoto, Kaoru] Chugai Res Inst Med Sci, Shizuoka, Japan; [Matsumoto, Kyomu] Inst Environm Toxicol, Ibaraki, Japan; [Adachi, Noritaka] Yokohama City Univ, Kanagawa, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					6.3	143	143				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700034		
J	Masutani, C; Kanao, R; Masuda, Y; Hanaoka, F				Masutani, C.; Kanao, R.; Masuda, Y.; Hanaoka, F.			Relevance of simultaneous mono-ubiquitinations of multiple units of PCNA homo-trimers in DNA damage tolerance	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Masutani, C.; Kanao, R.; Masuda, Y.] Nagoya Univ, Environm Med Res Inst, Dept Genome Dynam, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Hanaoka, F.] Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Toshima Ku, Tokyo 1718588, Japan		masutani@riem.nagoya-u.ac.jp						0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					7	143	144				2	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700037		
J	Sakurai, Y; Yokoi, M; Hanaoka, F				Sakurai, Yasutaka; Yokoi, Masayuki; Hanaoka, Fumio			Roles of DNA polymerases eta and iota in UV-induced mutagenesis	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Sakurai, Yasutaka; Yokoi, Masayuki; Hanaoka, Fumio] Gakushuin Univ, Tokyo 171, Japan; [Sakurai, Yasutaka] Kitasato Univ, Sch Med, Kanagawa, Japan		fumio.hanaoka@gakushuin.ac.jp						0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					6.5	143	143				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700036		
J	Yang, W; Lee, YS; Zhao, Y; Gregory, M; Nakamura, T; Biertuempfel, C; Hanaoka, F				Yang, Wei; Lee, Young-Sam; Zhao, Ye; Gregory, Mark; Nakamura, Teruya; Biertuempfel, Christian; Hanaoka, Fumio			Mechanisms for Translesion DNA Synthesis	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Yang, Wei; Lee, Young-Sam; Zhao, Ye; Gregory, Mark; Nakamura, Teruya; Biertuempfel, Christian] NIDDK, LMB, NIH, Bethesda, MD 20892 USA; [Zhao, Ye] Zhejiang Univ, Hangzhou, Zhejiang, Peoples R China; [Nakamura, Teruya] Kumamoto Univ, Kumamoto 860, Japan; [Biertuempfel, Christian] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Hanaoka, Fumio] Gakushuin Univ, Tokyo 171, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					6.2	143	143				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700033		
J	Ide, H; Nakano, T; Shoulkamy, MI; Salem, AMH				Ide, Hiroshi; Nakano, Toshiaki; Shoulkamy, Mahmoud I.; Salem, Amir M. H.			Repair mechanism of DNA-protein cross-link damage	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Ide, Hiroshi; Nakano, Toshiaki; Shoulkamy, Mahmoud I.; Salem, Amir M. H.] Hiroshima Univ, Higashihiroshima 724, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28						144	145				2	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700041		
J	Matsumoto, S; Akita, M; Sakai, W; Sugasawa, K				Matsumoto, Syota; Akita, Masaki; Sakai, Wataru; Sugasawa, Kaoru			Post-translational modifications coordinating recognition and repair of UV-induced DNA damage	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Matsumoto, Syota; Akita, Masaki; Sakai, Wataru; Sugasawa, Kaoru] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					8.2	144	144				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700040		
J	Sekimoto, T; Oda, T; Kurashima, K; Hanaoka, F; Yamashita, T				Sekimoto, Takayuki; Oda, Tsukasa; Kurashima, Kiminori; Hanaoka, Fumio; Yamashita, Takayuki			Y-family polymerases are involved in oncogene-induced aberrant replication	DNA REPAIR			English	Meeting Abstract	5th Japan-US DNA Repair Meeting	OCT 28-31, 2014	Naruto, JAPAN						[Sekimoto, Takayuki; Oda, Tsukasa; Kurashima, Kiminori; Hanaoka, Fumio; Yamashita, Takayuki] Gunma Univ, Gunma, Japan								0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	APR	2015	28					7.1	144	144				1	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	CG6QJ	WOS:000353426700038		
J	Shao, CW; Niu, YC; Rastas, P; Liu, Y; Xie, ZY; Li, HD; Wang, L; Jiang, Y; Tai, SS; Tian, YS; Sakamoto, T; Chen, SL				Shao, Changwei; Niu, Yongchao; Rastas, Pasi; Liu, Yang; Xie, Zhiyuan; Li, Hengde; Wang, Lei; Jiang, Yong; Tai, Shuaishuai; Tian, Yongsheng; Sakamoto, Takashi; Chen, Songlin			Genome-wide SNP identification for the construction of a high-resolution genetic map of Japanese flounder (Paralichthys olivaceus): applications to QTL mapping of Vibrio anguillarum disease resistance and comparative genomic analysis	DNA RESEARCH			English	Article						Japanese flounder; RAD-seq-based SNP; high-resolution linkage map; QTL mapping; genome synteny	LINKAGE MAP; VERTEBRATE CHROMOSOMES; LYMPHOCYSTIS DISEASE; TELEOST FISHES; OLIVE FLOUNDER; ALPHA GENE; DE-NOVO; DNA; ZEBRAFISH; RECOMBINATION	High-resolution genetic maps are essential for fine mapping of complex traits, genome assembly, and comparative genomic analysis. Single-nucleotide polymorphisms (SNPs) are the primary molecular markers used for genetic map construction. In this study, we identified 13,362 SNPs evenly distributed across the Japanese flounder (Paralichthys olivaceus) genome. Of these SNPs, 12,712 high-confidence SNPs were subjected to high-throughput genotyping and assigned to 24 consensus linkage groups (LGs). The total length of the genetic linkage map was 3,497.29 cM with an average distance of 0.47 cM between loci, thereby representing the densest genetic map currently reported for Japanese flounder. Nine positive quantitative trait loci (QTLs) forming two main clusters for Vibrio anguillarum disease resistance were detected. All QTLs could explain 5.1-8.38% of the total phenotypic variation. Synteny analysis of the QTL regions on the genome assembly revealed 12 immune-related genes, among them 4 genes strongly associated with V. anguillarum disease resistance. In addition, 246 genome assembly scaffolds with an average size of 21.79 Mb were anchored onto the LGs; these scaffolds, comprising 522.99 Mb, represented 95.78% of assembled genomic sequences. The mapped assembly scaffolds in Japanese flounder were used for genome synteny analyses against zebrafish (Danio rerio) and medaka (Oryzias latipes). Flounder and medaka were found to possess almost one-to-one synteny, whereas flounder and zebrafish exhibited a multi-syntenic correspondence. The newly developed high-resolution genetic map, which will facilitate QTL mapping, scaffold assembly, and genome synteny analysis of Japanese flounder, marks a milestone in the ongoing genome project for this species.	[Shao, Changwei; Liu, Yang; Wang, Lei; Tian, Yongsheng; Chen, Songlin] CAFS, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Dev Marine Fisheries, Minist Agr, Qingdao 266071, Peoples R China; [Shao, Changwei; Liu, Yang; Wang, Lei; Tian, Yongsheng; Chen, Songlin] Natl Lab Ocean Sci & Technol, Funct Lab Marine Fisheries Sci & Food Prod Proc, Qingdao 266071, Peoples R China; [Shao, Changwei; Sakamoto, Takashi] Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Minato Ku, Tokyo 1088477, Japan; [Niu, Yongchao; Xie, Zhiyuan; Tai, Shuaishuai] BGI Shenzhen, Shenzhen 518000, Peoples R China; [Rastas, Pasi] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, FI-00014 Helsinki, Finland; [Li, Hengde] Chinese Acad Fisheries Sci, Beijing 100039, Peoples R China; [Jiang, Yong] Natl Oceanog Ctr, Qingdao 266071, Peoples R China	Sakamoto, T (reprint author), Tokyo Univ Marine Sci & Technol, Fac Marine Sci, Minato Ku, Tokyo 1088477, Japan.	takashis@kaiyodai.ac.jp; chensl@ysfri.ac.cn	SAKAMOTO, Takashi/O-1949-2014		State 863 High-Technology RD Project [2012AA10A408]; National Nature Science Foundation of China [31461163005]; JSPS RONPAKU (Dissertation PhD) Program; Taishan Scholar Project Fund of Shandong of China; State 863 HIgh Technology RD Project [2012AA10A408]	The work was supported by grants from State 863 High-Technology R&D Project (2012AA10A408), National Nature Science Foundation of China (31461163005), JSPS RONPAKU (Dissertation PhD) Program for C.S., and Taishan Scholar Project Fund of Shandong of China. Funding to pay the Open Access publication charges for this article was provided by the State 863 HIgh Technology R&D Project (2012AA10A408).	Ahola V., 2006, NATURE COMMUN, V5, P4737; Andriantahina F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075206; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Bergero R, 2009, TRENDS ECOL EVOL, V24, P94, DOI 10.1016/j.tree.2008.09.010; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/mls049; Rowe HC, 2011, MOL ECOL, V20, P3499, DOI 10.1111/j.1365-294X.2011.05197.x; Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Amish SJ, 2012, MOL ECOL RESOUR, V12, P653, DOI 10.1111/j.1755-0998.2012.03157.x; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Hinz A, 2014, J BIOL CHEM, V289, P33109, DOI 10.1074/jbc.M114.609263; Kang JH, 2008, INT J BIOL SCI, V4, P143; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Coimbra MRM, 2003, AQUACULTURE, V220, P203, DOI 10.1016/S0044-8486(02)00353-8; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Willing EM, 2011, BIOINFORMATICS, V27, P2187, DOI 10.1093/bioinformatics/btr346; Kluver N, 2007, DEV DYNAM, V236, P271, DOI 10.1002/dvdy.20997; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Fuji K, 2007, AQUACULTURE, V272, P291, DOI 10.1016/j.aquaculture.2007.07.210; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Berthier-Schaad Y, 2007, ELECTROPHORESIS, V28, P2812, DOI 10.1002/elps.200600674; Buermans H.P., 2014, BIOCHIM BIOPHYS ACTA, V10, P1932; Castano-Sanchez C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-554; Dai ZM, 2014, MOL BIOL EVOL, V31, P1166, DOI 10.1093/molbev/msu065; Du M., 2011, EVID-BASED COMPL ALT, V20; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fujiwara A, 2007, GENETICA, V131, P267, DOI 10.1007/s10709-006-9136-z; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hwang SD, 2011, MAR BIOTECHNOL, V13, P1086, DOI 10.1007/s10126-011-9371-x; Jiang YL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-780; Le Bras Y, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-46; Liu F., 2013, J FISH SCI CHINA, V3, P521; Moorthie Sowmiya, 2011, Hugo J, V5, P1, DOI 10.1007/s11568-011-9156-3; Natri HM, 2013, MOL BIOL EVOL, V30, P1131, DOI 10.1093/molbev/mst035; Nystoyl R., 2013, FISH PRODUCTION ESTI; Schaack S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r46; Seikai T, 2002, REV FISH SCI, V10, P421, DOI 10.1080/20026491051721; Silva Lda C, 2012, METHOD MOL BIOL, V871, P75; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050404; Van Ooijen JW, 2006, JOINMAP 4 SOFTWARE C; Wang L, 2014, MAR BIOTECHNOL, V16, P513, DOI 10.1007/s10126-014-9569-9; Xu TJ, 2008, FISH SHELLFISH IMMUN, V25, P213, DOI 10.1016/j.fsi.2008.05.007; Xu TJ, 2010, GENETICA, V138, P1251, DOI 10.1007/s10709-010-9524-2; Xu TJ, 2010, DEV COMP IMMUNOL, V34, P1042, DOI 10.1016/j.dci.2010.05.008; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Yu YongTao, 2006, Journal of Maize Sciences, V14, P88; Yue GH, 2013, FISH FISH, V15, P376; Zhang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-387	57	4	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	APR	2015	22	2					161	170		10.1093/dnares/dsv001		10	Genetics & Heredity	Genetics & Heredity	CG9OE	WOS:000353644600004		
J	Hirakawa, H; Okada, Y; Tabuchi, H; Shirasawa, K; Watanabe, A; Tsuruoka, H; Minami, C; Nakayama, S; Sasamoto, S; Kohara, M; Kishida, Y; Fujishiro, T; Kato, M; Nanri, K; Komaki, A; Yoshinaga, M; Takahata, Y; Tanaka, M; Tabata, S; Isobe, SN				Hirakawa, Hideki; Okada, Yoshihiro; Tabuchi, Hiroaki; Shirasawa, Kenta; Watanabe, Akiko; Tsuruoka, Hisano; Minami, Chiharu; Nakayama, Shinobu; Sasamoto, Shigemi; Kohara, Mitsuyo; Kishida, Yoshie; Fujishiro, Tsunakazu; Kato, Midori; Nanri, Keiko; Komaki, Akiko; Yoshinaga, Masaru; Takahata, Yasuhiro; Tanaka, Masaru; Tabata, Satoshi; Isobe, Sachiko N.			Survey of genome sequences in a wild sweet potato, Ipomoea trifida (H. B. K.) G. Don	DNA RESEARCH			English	Article						Ipomoea trifida; genome sequence assembly; core- and line-specific sequences; SNPs; CNVs	S-LOCUS REGION; SELF-INCOMPATIBILITY; PAN-GENOME; EVOLUTION; GENES; DNA; CONVOLVULACEAE; RELATIVES; ALIGNMENT; TOOL	Ipomoea trifida (H. B. K.) G. Don. is the most likely diploid ancestor of the hexaploid sweet potato, I. batatas (L.) Lam. To assist in analysis of the sweet potato genome, de novo whole-genome sequencing was performed with two lines of I. trifida, namely the selfed line Mx23Hm and the highly heterozygous line 0431-1, using the Illumina HiSeq platform. We classified the sequences thus obtained as either 'core candidates' (common to the two lines) or 'line specific'. The total lengths of the assembled sequences of Mx23Hm (ITR_r1.0) was 513 Mb, while that of 0431-1 (ITRk_r1.0) was 712 Mb. Of the assembled sequences, 240 Mb (Mx23Hm) and 353 Mb (0431-1) were classified into core candidate sequences. A total of 62,407 (62.4 Mb) and 109,449 (87.2 Mb) putative genes were identified, respectively, in the genomes of Mx23Hm and 0431-1, of which 11,823 were derived from core sequences of Mx23Hm, while 28,831 were from the core candidate sequence of 0431-1. There were a total of 1,464,173 single-nucleotide polymorphisms and 16,682 copy number variations (CNVs) in the two assembled genomic sequences (under the condition of log(2) ratio of > 1 and CNV size > 1,000 bases). The results presented here are expected to contribute to the progress of genomic and genetic studies of I. trifida, as well as studies of the sweet potato and the genus Ipomoea in general.	[Hirakawa, Hideki; Shirasawa, Kenta; Watanabe, Akiko; Tsuruoka, Hisano; Minami, Chiharu; Nakayama, Shinobu; Sasamoto, Shigemi; Kohara, Mitsuyo; Kishida, Yoshie; Fujishiro, Tsunakazu; Kato, Midori; Nanri, Keiko; Komaki, Akiko; Tabata, Satoshi; Isobe, Sachiko N.] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [Okada, Yoshihiro] NARO KARC, Kyushu Okinawa Agr Res Ctr, Crop & Agribusiness Res Div, Itoman, Okinawa 9010336, Japan; [Tabuchi, Hiroaki; Yoshinaga, Masaru; Takahata, Yasuhiro; Tanaka, Masaru] NARO KARC, Kyushu Okinawa Agr Res Ctr, Upland Farming Res Div, Miyakonojo, Miyazaki 8850091, Japan	Isobe, SN (reprint author), Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan.	sisobe@kazusa.or.jp			Kazusa DNA Research Institute Foundation; National Agriculture and Food Research Organization; Kazusa DNA Research Institute	The work was supported by the Kazusa DNA Research Institute Foundation and National Agriculture and Food Research Organization. Funding to pay the Open Access publication charges for this article was provided by the Kazusa DNA Research Institute.	C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Saxena RK, 2014, BRIEF FUNCT GENOMICS, V13, P296, DOI 10.1093/bfgp/elu016; SHIOTANI I, 1989, JPN J BREED, V39, P57; Austin DF, 1996, TAXON, V45, P3, DOI 10.2307/1222581; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Ashburner M, 2000, NAT GENET, V25, P25; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Takahata Y, 2010, PLANT CELL REP, V29, P535, DOI 10.1007/s00299-010-0842-8; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Hirakawa H, 2014, DNA RES, V21, P649, DOI 10.1093/dnares/dsu027; Li Ruiqiang, 2010, Genome Res, V20, P265, DOI 10.1101/gr.097261.109; Sato S, 2005, DNA RES, V12, P301, DOI 10.1093/dnares/dsi018; Boetzer M, 2010, BIOINFORMATICS, V27, P578; Eddy Sean R, 2009, Genome Inform, V23, P205; Guigo R, 1998, J COMPUT BIOL, V5, P681, DOI 10.1089/cmb.1998.5.681; Hirakawa H, 2014, DNA RES, V21, P169, DOI 10.1093/dnares/dst049; Huang JC, 2000, THEOR APPL GENET, V100, P1050, DOI 10.1007/s001220051386; Jarret R. L., 1994, Genetic Resources and Crop Evolution, V41, P165, DOI 10.1007/BF00051633; Kobayashi M., 1983, P 6 S INT SOC TROP R, P561; Komaki K, 1999, BREEDING SCI, V49, P123; Komaki K, 1998, BREEDING SCI, V48, P281; Kowyama Y, 2000, ANN BOT-LONDON, V85, P191, DOI 10.1006/anbo.1999.1036; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; MARTIN F. W., 1965, ECON BOT, V19, P406, DOI 10.1007/BF02904812; Michael TP, 2013, PLANT GENOME, V6, P2, DOI DOI 10.3835/PLANTGEN0ME2013.03.0001IN; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nakayama H., 2010, I BATATAS L LAM TROP, V54, P9; Nieuwerburgh F.V., 2012, NUCLEIC ACIDS RES, V40, pe24; ORJEDA G, 1991, THEOR APPL GENET, V83, P159, DOI 10.1007/BF00226245; OZIASAKINS P, 1994, J AM SOC HORTIC SCI, V119, P110; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Rahman MH, 2007, SEX PLANT REPROD, V20, P63, DOI 10.1007/s00497-007-0044-x; Rahman MH, 2007, SEX PLANT REPROD, V20, P73, DOI 10.1007/s00497-007-0045-9; Roullier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062707; Srisuwan S, 2006, PLANT SCI, V171, P424, DOI 10.1016/j.plantsci.2006.05.007; Stanke M, 2003, BIOINFORMATICS S2, V19, pii215, DOI DOI 10.1093/BI0; Suzuki G, 2004, CHROMOSOME RES, V12, P475, DOI 10.1023/B:CHRO.0000034749.58877.b7; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tomita RN, 2004, BREEDING SCI, V54, P165, DOI 10.1270/jsbbs.54.165; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xie C., 2009, BMC BIOINFORMATICS, V12, P80	65	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	APR	2015	22	2					171	179		10.1093/dnares/dsv002		9	Genetics & Heredity	Genetics & Heredity	CG9OE	WOS:000353644600005		
J	Fujita, K; Ikeda, A; Shirono, M; Takewaki, I				Fujita, Kohei; Ikeda, Ayumi; Shirono, Minami; Takewaki, Izuru			System identification of high-rise buildings using shear-bending model and ARX model: Experimental investigation	EARTHQUAKES AND STRUCTURES			English	Article						system identification; high-rise building; shear-bending model; ARX model; experiment	DAMPING SIMULTANEOUS IDENTIFICATION; STRUCTURAL SYSTEMS	System identification is regarded as the most basic technique for structural health monitoring to evaluate structural integrity. Although many system identification techniques extracting mode information (e.g., mode frequency and mode shape) have been proposed so far, it is also desired to identify physical parameters (e.g., stiffness and damping). As for high-rise buildings subjected to long-period ground motions, system identification for evaluating only the shear stiffness based on a shear model does not seem to be an appropriate solution to the system identification problem due to the influence of overall bending response. In this paper, a system identification algorithm using a shear-bending model developed in the previous paper is revised to identify both shear and bending stiffnesses. In this algorithm, an ARX (Auto-Regressive eXogenous) model corresponding to the transfer function for interstory accelerations is applied for identifying physical parameters. For the experimental verification of the proposed system identification framework, vibration tests for a 3-story steel mini-structure are conducted. The test structure is specifically designed to measure horizontal accelerations including both shear and bending responses. In order to obtain reliable results, system identification theories for two different inputs are investigated; (a) base input motion by a modal shaker, (b) unknown forced input on the top floor.	[Fujita, Kohei; Ikeda, Ayumi; Shirono, Minami; Takewaki, Izuru] Kyoto Univ, Dept Architecture & Architectural Engn, Nishikyo Ku, Kyoto 6158540, Japan	Fujita, K (reprint author), Kyoto Univ, Dept Architecture & Architectural Engn, Nishikyo Ku, Kyoto 6158540, Japan.	fm.fujita@archi.kyoto-u.ac.jp			Japan Society for the Promotion of Science [24246095]	The authors would like to thank Mr. Y. Minami for his help in the computation. Part of the present work is supported by the Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (No. 24246095). This support is greatly appreciated.	Zhang DY, 2013, STRUCT CONTROL HLTH, V20, P804, DOI 10.1002/stc.1497; UDWADIA FE, 1978, J APPL MECH-T ASME, V45, P181; Takewaki I, 2000, EARTHQUAKE ENG STRUC, V29, P1219, DOI 10.1002/1096-9845(200008)29:8<1219::AID-EQE968>3.0.CO;2-X; Kuwabara M, 2013, STRUCT CONTROL HLTH, V20, P703, DOI 10.1002/stc.1486; Housner GW, 1997, J ENG MECH-ASCE, V123, P897, DOI 10.1061/(ASCE)0733-9399(1997)123:9(897); Minami Y, 2013, STRUCT CONTROL HLTH, V20, P1317, DOI 10.1002/stc.1537; HART GC, 1977, J ENG MECH DIV-ASCE, V103, P1089; Takewaki I, 2005, J ENG MECH-ASCE, V131, P1027, DOI 10.1061/(ASCE)0733-9399(2005)131:10(1027); Bendat J., 1998, NONLINEAR SYSTEMS TE; Bendat J. S., 1992, PROBALISTIC ENG MECH, V7, P43, DOI 10.1016/0266-8920(92)90008-6; Bernal D, 2004, J ENG MECH-ASCE, V130, P1, DOI 10.1061/(ASCE)0733-9399(2004)130:1(1); Casciati F., 2002, P 3 WORLD C STRUCT C; Doebling S.W., 1996, LA13070MS LOS AL NAT; Fujino Y., 2010, P 5 WORLD C STRUCT C; Housner G. W., 1994, P 1 WORLD C STRUCT C; Johnson E., 2006, P 4 WORLD C STRUCT C; Kobori T., 1998, P 2 WORLD C STRUCT C; Kougioumtzoglou IA, 2013, MECH SYST SIGNAL PR, V37, P338, DOI 10.1016/j.ymssp.2013.01.011; KOZIN F, 1986, STRUCT SAF, V3, P269, DOI 10.1016/0167-4730(86)90006-8; Minami Y., 2013, J STRUCT CONSTRUCT E, V690; Nayeri R., 2008, SMART MATER STRUCT, V17, P1; SPANOS PD, 1995, J OFFSHORE MECH ARCT, V117, P171, DOI 10.1115/1.2827086; Takewaki I., 2011, SYSTEM IDENTIFICATIO; Yoshitomi S., 2009, J STRUCT CONSTRUCT E, V74, P1983	24	1	1	TECHNO-PRESS	DAEJEON	PO BOX 33, YUSEONG, DAEJEON 305-600, SOUTH KOREA	2092-7614	2092-7622		EARTHQ STRUCT	Earthq. Struct.	APR	2015	8	4			SI		843	857				15	Engineering, Civil; Engineering, Geological	Engineering	CG3TL	WOS:000353202400003		
J	Dan, M; Ishizawa, Y; Tanaka, S; Nakahara, S; Wakayama, S; Kohiyama, M				Dan, Maki; Ishizawa, Yuji; Tanaka, Sho; Nakahara, Shuchi; Wakayama, Shizuka; Kohiyama, Masayuki			Vibration characteristics change of a base-isolated building with semi-active dampers before, during, and after the 2011 Great East Japan earthquake	EARTHQUAKES AND STRUCTURES			English	Article						base isolation system; semi-active damper; system identification; 2011 Great East Japan earthquake; structural response	IDENTIFICATION	Structural vibration characteristics of a semi-active base-isolated building were investigated using seismic observation records including those of the 2011 Great East Japan earthquake (Tohoku earthquake). Three different types of analyses were conducted. First, we investigated the long-term changes in the natural frequencies and damping factors by using an ARX model and confirmed that the natural frequency of the superstructure decreased slightly after the main shock of the Tohoku earthquake. Second, we investigated short-term changes in the natural frequencies and damping factors during the main shock by using the N4SID method and observed different transition characteristics between the first and second modes. In the second mode, in which the superstructure response is most significant, the natural frequency changed depending on the response amplitude. In addition, at the beginning of the ground motion, the identified first natural frequency was high possibly as a result of sliding friction. Third, we compared the natural frequencies and damping factors between the conditions of a properly functional semi-active control system and a nonfunctional system, by using the records of the aftershocks of the Tohoku earthquake. However, we could not detect major differences because the response was probably influenced by sliding friction, which had a more significant effect on damping characteristics than did the semi-active dampers.	[Dan, Maki; Ishizawa, Yuji; Tanaka, Sho; Nakahara, Shuchi; Wakayama, Shizuka; Kohiyama, Masayuki] Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 223, Japan	Dan, M (reprint author), Keio Univ, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 223, Japan.	dan13.f.raven@gmail.com; kohiyama@sd.keio.ac.jp			JSPS KAKENHI [24360230]	This research was supported by a JSPS KAKENHI Grant-in-Aid for Scientific Research (B), Grant Number 24360230.	Adachi S., 2014, J SOC INSTRUMENT CON, V47, P915; Adachi S., 2004, MATLAB NI YORU SEIGY; Furukawa T, 2005, J ENG MECH-ASCE, V131, P268, DOI 10.1061/(ASCE)0733-9399(2005)131:3(268); VANOVERSCHEE P, 1994, AUTOMATICA, V30, P75, DOI 10.1016/0005-1098(94)90230-5; Association for Development of Earthquake Prediction, 2014, JISH KAS JOH; Dan M., 2013, P 11 INT C STRUCT SA; Ljung L, 1999, SYSTEM IDENTIFICATIO; Mita A., 2003, STRUCTURAL DYNAMICS, P114; Nagashima I., 2011, P INT S DIS SIM STRU; Nakajima K., 2012, P INT S ENG LESS LEA; Yoshida K., 2001, J JAPAN SOC MECH ENG, V104, P698	11	0	0	TECHNO-PRESS	DAEJEON	PO BOX 33, YUSEONG, DAEJEON 305-600, SOUTH KOREA	2092-7614	2092-7622		EARTHQ STRUCT	Earthq. Struct.	APR	2015	8	4			SI		889	913				25	Engineering, Civil; Engineering, Geological	Engineering	CG3TL	WOS:000353202400005		
J	Richardson, JS; Sato, T				Richardson, John S.; Sato, Takuya			Resource subsidy flows across freshwater-terrestrial boundaries and influence on processes linking adjacent ecosystems	Ecohydrology			English	Article						consumer-resource dynamics; pulse; resource subsidies; stability; streams	AQUATIC FOOD WEBS; SOUTHWESTERN BRITISH-COLUMBIA; TEMPERATE RAIN-FOREST; ORGANIC-MATTER; SOUTHEASTERN ALASKA; HEADWATER STREAMS; TROPHIC CASCADES; DYNAMICS; COMMUNITIES; INPUTS	Freshwaters receive more than water from their catchments, including a large amount of materials and biologically available energy, referred to as cross-ecosystem resource subsidies. The passive flows of energy such as leaf litter and terrestrial invertebrate inputs, as well as dissolved organic carbon, are donor-controlled, whereas other flows, such as between fish and fish-eating birds, have more directly coupled feedbacks. There are also flows upstream or to the terrestrial environment in the form of adult aquatic insects, salmon carcasses and particulate carbon through overbank flooding, as well as directed foraging activities. Hypotheses about the effects of flux rates, timing, quality and physical structure of such resource subsidies on the responses of consumers have been experimentally tested at many trophic levels. Many freshwater and terrestrial consumers depend on these subsidies for at least part of their life cycle, and timing of inputs can affect growth. Developing more quantitative relations between the population and community responses across gradients of cross-ecosystem resource subsidy input rates will require exploring the shape of the relations, as well as the effects of quality and timing on responses. The stage is now set to consider how resource subsidies might affect the stability of communities and processes such as the strength of trophic cascades. The high degree of connectivity between the land and water are essential to biodiversity conservation and to ensuring that critical aquatic ecosystem services are sustained. The management of riparian areas is a key to the security of these values. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Richardson, John S.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada; [Sato, Takuya] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan	Richardson, JS (reprint author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V6T 1Z4, Canada.	john.richardson@ubc.ca					Richardson JS, 2005, J AM WATER RESOUR AS, V41, P921, DOI 10.1111/j.1752-1688.2005.tb04470.x; WEBSTER JR, 1990, J N AM BENTHOL SOC, V9, P120, DOI 10.2307/1467446; Pace ML, 2004, NATURE, V427, P240, DOI 10.1038/nature02227; Nowlin WH, 2007, ECOLOGY, V88, P2174, DOI 10.1890/06-0570.1; Baxter CV, 2005, FRESHWATER BIOL, V50, P201; COLWELL RK, 1974, ECOLOGY, V55, P1148, DOI 10.2307/1940366; Marcarelli AM, 2011, ECOLOGY, V92, P1215, DOI 10.1890/10-2240.1; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Hoekman D, 2011, ECOLOGY, V92, P2063, DOI 10.1890/11-0160.1; Wallace JB, 1999, ECOL MONOGR, V69, P409, DOI 10.1890/0012-9615(1999)069[0409:EORLOA]2.0.CO;2; Wipfli MS, 2010, FISHERIES, V35, P373, DOI 10.1577/1548-8446-35.8.373; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Kawaguchi Y, 2001, FRESHWATER BIOL, V46, P303, DOI 10.1046/j.1365-2427.2001.00667.x; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Kominoski JS, 2011, ECOLOGY, V92, P151, DOI 10.1890/10-0028.1; Iwata T, 2003, ECOGRAPHY, V26, P325, DOI 10.1034/j.1600-0587.2003.03355.x; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Sabo JL, 2002, ECOLOGY, V83, P3023, DOI 10.2307/3071839; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Murakami M, 2002, ECOL LETT, V5, P333, DOI 10.1046/j.1461-0248.2002.00321.x; RICHARDSON JS, 1991, ECOLOGY, V72, P873, DOI 10.2307/1940589; Schreiber S, 2008, ECOL LETT, V11, P576, DOI 10.1111/j.1461-0248.2008.01171.x; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Christensen JR, 2005, ENVIRON SCI TECHNOL, V39, P6952, DOI 10.1021/es050749f; Sato T, 2011, ECOLOGY, V92, P201, DOI 10.1890/09-1565.1; Wipfli MS, 2002, FRESHWATER BIOL, V47, P957, DOI 10.1046/j.1365-2427.2002.00826.x; Gratton C, 2009, ECOLOGY, V90, P2689, DOI 10.1890/08-1546.1; Negishi JN, 2003, CAN J FISH AQUAT SCI, V60, P247, DOI 10.1139/F03-013; Kominoski JS, 2013, FRONT ECOL ENVIRON, V11, P423, DOI 10.1890/120056; Leroux SJ, 2012, ECOSYSTEMS, V15, P48, DOI 10.1007/s10021-011-9492-0; Davis JM, 2011, OECOLOGIA, V167, P821, DOI 10.1007/s00442-011-2026-9; Richardson JS, 2010, RIVER RES APPL, V26, P55, DOI 10.1002/rra.1283; Wipfli MS, 2007, J AM WATER RESOUR AS, V43, P72, DOI 10.1111/j.1752-1688.2007.00007.x; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Hernandez O, 2005, HYDROBIOLOGIA, V533, P45, DOI 10.1007/s10750-004-2105-6; Piovia-Scott J, 2011, SCIENCE, V331, P461, DOI 10.1126/science.1200282; Walters DM, 2008, ECOL APPL, V18, P1835, DOI 10.1890/08-0354.1; Kawaguchi Y, 2003, ECOLOGY, V84, P701, DOI 10.1890/0012-9658(2003)084[0701:TIIDTL]2.0.CO;2; Dreyer J, 2012, OIKOS, V121, P252, DOI 10.1111/j.1600-0706.2011.19588.x; Sato T, 2012, ECOL LETT, V15, P786, DOI 10.1111/j.1461-0248.2012.01798.x; Bartrons M, 2013, ECOSYSTEMS, V16, P1353, DOI 10.1007/s10021-013-9688-6; Epanchin PN, 2010, ECOLOGY, V91, P2406, DOI 10.1890/09-1974.1; Marczak LB, 2007, J ANIM ECOL, V76, P687, DOI 10.1111/j.1365-2656.2007.01240.x; Paetzold A, 2006, FRESHWATER BIOL, V51, P1103, DOI 10.1111/j.1365-2427.2006.01559.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Beechie T, 2013, STREAM WATERSHED RES, P11; Boss SM, 2002, CAN J FISH AQUAT SCI, V59, P1044, DOI 10.1139/F02-079; Davis JM, 2010, LIMNOL OCEANOGR, V55, P2305, DOI 10.4319/lo.2010.55.6.2305; Eggert SL, 2012, ECOSPHERE, V3; Forbes SA., 1887, REPRINTED ILLINOIS N, V15, P537; Fretwell S. D., 1972, POPULATIONS SEASONAL; Garcia L, 2014, AQUAT SCI, V76, P29, DOI 10.1007/s00027-013-0308-5; Helmus MR, 2013, OECOLOGIA, V173, P997, DOI 10.1007/s00442-013-2661-4; Hoover TM, 2006, FRESHWATER BIOL, V51, P435, DOI 10.1111/1365-2427.2005.01499; Hoover TM, 2010, FRESHWATER BIOL, V55, P436, DOI 10.1111/j.1365-2427.2009.02292.x; Huxel GR, 1998, AM NAT, V152, P460, DOI 10.1086/286182; Hynes H, 1975, VERH INT VEREIN LIMN, V19, P1; Hynes H. B. N., 1941, TRANS ROY ENT SOC LONDON, V91, P459; Kiffney PM, 2010, FOREST ECOL MANAG, V260, P1931, DOI 10.1016/j.foreco.2010.08.016; Klemmer AJ, 2013, ECOLOGY, V94, P1920, DOI 10.1890/12-1444.1; Marczak LB, 2007, OIKOS, V116, P1651, DOI 10.1111/j.2007.0030-1299.15982.x; Masclaux H, 2013, LIMNOL OCEANOGR, V58, P1185, DOI 10.4319/lo.2013.58.4.1185; McCoy MW, 2009, OIKOS, V118, P87, DOI 10.1111/j.1600-0706.2008.16878.x; Nakao S, 1999, ECOLOGY, V80, P2435; Paetzold A, 2007, HYDROECOLOGY ECOHYDR, P57; Polis GA, 2004, FOOD WEBS LANDSCAPE, P548; Richardson JS, 2004, ARCH HYDROBIOL, V159, P309, DOI 10.1127/0003-9136/2004/0159-0309; Richardson John S., 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V118, P9; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Sato T, 2014, J ANIM ECOL, V83, P907, DOI 10.1111/1365-2656.12192; Swain NR, 2014, CAN J FISH AQUAT SCI, V71, P521, DOI 10.1139/cjfas-2013-0159; Takimoto G, 2009, AM NAT, V173, P200, DOI 10.1086/595759; WARREN CHARLES E., 1964, J WILDLIFE MANAGE, V28, P617, DOI 10.2307/3798780; Wipfli MS, 1997, CAN J FISH AQUAT SCI, V54, P1259, DOI 10.1139/cjfas-54-6-1259; Zhang YX, 2011, AQUAT SCI, V73, P53, DOI 10.1007/s00027-010-0159-2	82	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1936-0584	1936-0592		ECOHYDROLOGY	Ecohydrology	APR	2015	8	3					406	415		10.1002/eco.1488		10	Ecology; Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	CG4FE	WOS:000353238400007		
J	Asaeda, T; Rashid, MH; Sanjaya, HLK				Asaeda, Takashi; Rashid, Md H.; Sanjaya, Henegama Liyanage Kelum			Flushing sediment from reservoirs triggers forestation in the downstream reaches	Ecohydrology			English	Article						edaphic factors; Elaeagnus umbellata; forestation; Kurobe River; Salix gilgiana	RIPARIAN VEGETATION; RIVER REGULATION; REGULATED RIVER; DAM REMOVAL; FLUVIAL GEOMORPHOLOGY; PHRAGMITES-JAPONICA; FLOW REGULATION; DOLORES RIVER; WATER; GROWTH	It was assumed that sediment release from a reservoir would trigger forestation and change the spatial pattern of tree recruitment in the downstream. This study tested these hypotheses by observation on a downstream sandbar of the Kurobe River. Prior to sediment release, Elaeagnus umbellata and Salix gilgiana were the most abundant tree species (33% and 64% of the total tree population) on the bar. The former colonized on elevated areas, whereas the latter mostly grew along the edges of river channels. After 2008 and 2009 sediment releases, a thick layer of fine sediment accumulated in active river channels and on low-elevated areas of the bar. The particle size of the accumulated sediment was significantly lower (p<001) and the moisture content was higher (p<001) than in the underlying substrate. Total nitrogen, carbon and phosphorus concentrations of the accumulated sediment were higher than in the covered portions. After sediment release, a seedling flushing of both species occurred on the bar where 87% was composed of S.gilgiana and the remaining 13% was of E.umbellata. Although most of the S.gilgiana seedlings recruited on low-lying areas, numerous individuals also grew on elevated margins of the channels and on areas dominated by E.umbellata. The accumulated sediment made changes in the substrate, which were favourable for the recruitment and spread of S.gilgiana. This study suggests that an alternative to sediment flushing for reservoir maintenance should be sought or the impacts on downstream environment should carefully be considered before an extensive sediment flushing operation. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Asaeda, Takashi] Saitama Univ, Inst Environm Sci & Technol, Sakura, Saitama 3388570, Japan; [Asaeda, Takashi; Rashid, Md H.; Sanjaya, Henegama Liyanage Kelum] Saitama Univ, Dept Environm Sci, Sakura, Saitama 3388570, Japan; [Rashid, Md H.] Bangladesh Agr Univ, Mymensingh 2202, Bangladesh	Asaeda, T (reprint author), Saitama Univ, Dept Environm Sci & Technol, 255 Shimo Okubo, Sakura, Saitama 3388570, Japan.	asaeda@mail.saitama-u.ac.jp			Kurobe River Management Office; Japanese Ministry of Land, Infrastructure, Transport and Tourism; Water Resources Environment Technology Center (WEC); Japan Society for the Promotion of Science; Sumitomo Foundation; River Basin Environment Foundation	The authors would like to thank Dr Kentaro Sakamoto, Hideaki Sekine, Takayuki Kawashima and Souichiro Kotagiri for their help with sampling. The authors also thank the Kurobe River Management Office, the Japanese Ministry of Land, Infrastructure, Transport and Tourism and the Water Resources Environment Technology Center (WEC) for their support. This study was financially supported by a Grant-in-Aid for Scientific Research, the Japan Society for the Promotion of Science, the Sumitomo Foundation and the River Basin Environment Foundation.	Poff NL, 2002, BIOSCIENCE, V52, P659, DOI 10.1641/0006-3568(2002)052[0659:HDVAWI]2.0.CO;2; Bombino G, 2008, ECOL ENG, V32, P166, DOI 10.1016/j.ecoleng.2007.10.011; Jansson R, 2005, J ECOL, V93, P1094, DOI 10.1111/j.1365-2745.2005.01057.x; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Morita K, 2009, ECOL RES, V24, P711, DOI 10.1007/s11284-008-0579-9; Wintle BC, 2007, AUSTRAL ECOL, V32, P592, DOI 10.1111/j.1442-9993.2007.01753.x; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Tiessen KHD, 2011, J SOIL WATER CONSERV, V66, P158, DOI 10.2489/jswc.66.3.158; Tealdi S, 2011, J HYDROL, V396, P302, DOI 10.1016/j.jhydrol.2010.11.016; Mallik AU, 2009, ECOL ENG, V35, P810, DOI 10.1016/j.ecoleng.2008.12.005; Gomes PIA, 2009, ANN LIMNOL-INT J LIM, V45, P181, DOI 10.1051/limn/2009015; Surian N, 2003, GEOMORPHOLOGY, V50, P307, DOI 10.1016/S0169-555X(02)00219-2; Rood SB, 2003, TREE PHYSIOL, V23, P1113; Kondolf GM, 1997, ENVIRON MANAGE, V21, P533, DOI 10.1007/s002679900048; DeWine JM, 2007, WETLANDS, V27, P278, DOI 10.1672/0277-5212(2007)27[278:EORROR]2.0.CO;2; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; King J, 2003, RIVER RES APPL, V19, P619, DOI 10.1002/rra.709; Shafroth PB, 2002, BIOSCIENCE, V52, P703, DOI 10.1641/0006-3568(2002)052[0703:PRORVT]2.0.CO;2; Stromberg JC, 2007, FRESHWATER BIOL, V52, P651, DOI 10.1111/j.1365-2427.2006.01713.x; Rood SB, 2005, FRONT ECOL ENVIRON, V3, P193, DOI 10.1890/1540-9295(2005)003[0193:MRFTRF]2.0.CO;2; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Asaeda T, 2012, J HYDROL, V430, P25, DOI 10.1016/j.jhydrol.2012.01.040; Gurnell AM, 2004, WATER SCI APPL, V8, P209; Oguchi T, 2001, GEOMORPHOLOGY, V39, P3, DOI 10.1016/S0169-555X(01)00048-4; Coble AP, 2012, WEST J APPL FOR, V27, P205, DOI 10.5849/wjaf.12-001; Uowolo AL, 2005, FOREST ECOL MANAG, V218, P107, DOI 10.1016/j.foreco.2005.07.003; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; Dickson NE, 2012, J HYDROL, V464, P505, DOI 10.1016/j.jhydrol.2012.07.044; Wentworth CK, 1922, J GEOL, V30, P377; Amlin NM, 2002, WETLANDS, V22, P338, DOI 10.1672/0277-5212(2002)022[0338:CTORWA]2.0.CO;2; Wohl EE, 2000, WATER RESOUR RES, V36, P319, DOI 10.1029/1999WR900272; Gurnell AM, 2002, FRESHWATER BIOL, V47, P581, DOI 10.1046/j.1365-2427.2002.00923.x; Klaver G, 2007, ENVIRON POLLUT, V148, P718, DOI 10.1016/j.envpol.2007.01.037; APHA, 1998, STANDARD METHODS EXA; Asaeda T, 2011, RIVER RES APPL, V27, P976, DOI 10.1002/rra.1372; Asaeda T, 2010, RIVER RES APPL, V26, P960, DOI 10.1002/rra.1313; Asaeda T, 2009, RIVER RES APPL, V25, P874, DOI 10.1002/rra.1191; Asaeda T, 2008, RIVER RES APPL, V24, P1310, DOI 10.1002/rra.1128; ASTM, 2002, C9295 ASTM; Azami K, 2004, RIVER RES APPL, V20, P549, DOI 10.1002/rra.763; Azami K, 2013, LANDSC ECOL ENG, V9, P227, DOI 10.1007/s11355-012-0200-9; Beauchamp VB, 2007, WETLANDS, V27, P381, DOI 10.1672/0277-5212(2007)27[381:FROTVR]2.0.CO;2; Blacks CA, 1965, METHOD SOIL ANAL 2; BOWMAN WD, 1994, OECOLOGIA, V97, P93, DOI 10.1007/BF00317912; Coble AP, 2013, WEST N AM NATURALIST, V73, P41, DOI 10.3398/064.073.0104; Duttine A, 2007, SOLID MECH APPL, V146, P367, DOI 10.1007/978-1-4020-6146-2_20; Edwardss PJ, 1999, WETLANDS ECOLOGY MAN, V7, P141, DOI DOI 10.1023/A:1008411311774; Fonsecas RMF, 2003, WATER SOIL ENV BIOL, P55; Geist DR, 2008, N AM J FISH MANAGE, V28, P30, DOI 10.1577/M07-009.1; Grants GE, 2003, PECULIAR RIVER GEOLO, P203; JOHNSON WC, 1994, ECOL MONOGR, V64, P45, DOI 10.2307/2937055; Johnson RK, 2004, CAN J FISH AQUAT SCI, V61, P1493, DOI 10.1139/F04-081; Kantoush S. A., 2011, INT WATER POWER DAM, P38; Kikuchis T., 1996, INT J ROCK MECH MIN, V33, p189A, DOI [10.1016/0148-9062(96)85298-3, DOI 10.1016/0148-9062(96)85298-3]; KOHLS SJ, 1989, PLANT SOIL, V118, P171, DOI 10.1007/BF02232804; Kohri Mari, 2008, P205, DOI 10.1007/978-4-431-76737-4_14; Kohri Mari, 2002, Plant Species Biology, V17, P25, DOI 10.1046/j.1442-1984.2002.00071.x; Mostollers EL, 2008, SITE CHARACTERISTICS; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI DOI 10.1016/S0003-2670(00)88444-5; Naimans R, 2005, RIPARIA ECOLOGY CONS; Nakai A, 2007, J FOREST RES-JPN, V12, P365, DOI 10.1007/s10310-007-0027-7; News T, 2008, BIODIVERS CONSERV, V17, P3149, DOI [10.1007/s10531-008-9416-2, DOI 10.1007/S10531-008-9416-2]; NIIYAMA K, 1990, Ecological Research, V5, P317, DOI 10.1007/BF02347007; Niiyama Kaoru, 2008, P165, DOI 10.1007/978-4-431-76737-4_11; Ogden RW, 2002, HYDROBIOLOGIA, V489, P277, DOI 10.1023/A:1023293925854; Sakamoto K, 2010, LANDSC ECOL ENG, V6, P317, DOI 10.1007/s11355-010-0109-0; Sakio Hitoshi, 2008, P313, DOI 10.1007/978-4-431-76737-4_21; Sasaki Akiko, 2008, P191, DOI 10.1007/978-4-431-76737-4_13; Sasaki A, 2001, ECOL RES, V16, P165, DOI 10.1046/j.1440-1703.2001.00382.x; Sato Y, 2005, RIVER RES APPL, V21, P939, DOI 10.1002/rra.859; Shin N, 2005, PLANT ECOL, V178, P15, DOI 10.1007/s11258-004-2484-9; Steiger J, 2001, REGUL RIVER, V17, P443, DOI 10.1002/rrr.644.abs; Steiger J, 2003, GEOMORPHOLOGY, V49, P1, DOI 10.1016/S0169-555X(02)00144-7; Tardif J, 1999, ECOL MONOGR, V69, P107, DOI 10.1890/0012-9615(1999)069[0107:PDOFNI]2.0.CO;2; Tazaki K, 2003, CLAY MINER, V38, P243, DOI 10.1180/0009855033820093; Tebakaris T., 2011, FALL M 2011 AM GEOPH; Williamss GP, 1984, 1286 US GEOL SURV, P1; Wus J, 2003, SCIENCE, V300, P1239, DOI [10.1126/science.1083312, DOI 10.1126/SCIENCE.1083312]; Yin Y, 1998, REGUL RIVER, V14, P217, DOI 10.1002/(SICI)1099-1646(199803/04)14:2<217::AID-RRR499>3.0.CO;2-S	79	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1936-0584	1936-0592		ECOHYDROLOGY	Ecohydrology	APR	2015	8	3					426	437		10.1002/eco.1513		12	Ecology; Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	CG4FE	WOS:000353238400009		
J	Ichihashi, R; Komatsu, H; Kume, T; Onozawa, Y; Shinohara, Y; Tsuruta, K; Otsuki, K				Ichihashi, Ryuji; Komatsu, Hikaru; Kume, Tomonori; Onozawa, Yuka; Shinohara, Yoshinori; Tsuruta, Kenji; Otsuki, Kyoichi			Stand-scale transpiration of two Moso bamboo stands with different culm densities	Ecohydrology			English	Article						bamboo dominance; Granier's method; microtopography; Moso bamboo; sap flow; stand density; stand-scale transpiration; water cycle	PHYLLOSTACHYS-PUBESCENS FOREST; JAPANESE CEDAR FOREST; SAP FLOW; CANOPY CONDUCTANCE; SPATIAL VARIATION; DECIDUOUS FOREST; WATER; FLUX; INTERCEPTION; CATCHMENT	The large-scale expansion of Moso bamboo forests in Japan raises concerns about how vegetation will affect the hydrological cycle and local water resources. However, information on transpiration (E) is limited to study on a single bamboo stand with low culm density (4000ha(-1)). The present study conducted a year-round measurement of E in a high-density (11000ha(-1)) stand using sap-flow measurements, and additional measurements were made during summer in the previously studied low-density stand and a neighbouring Japanese cedar stand for comparison. Annual E of the high-density stand was estimated at 455mm. Although the value was greater than those reported for neighbouring coniferous forests (250-370mm), it was lower than previous measurements made in the low-density stand (567mm). The daytime sap flux density of the high-density stand was generally less than half that in the low-density stand, resulting in similar daily maximum E values in those stands. In addition, E typically peaked before midday in the high-density stand followed by a rapid decline; the midday suppression of E led to decreased total E in the stand. Based on present and previous measurements of E, combined with the lower rainfall interception (I) reported for bamboo stands, water loss through evapotranspiration would be comparable between bamboo and coniferous forests. Present results also suggest that the E of bamboo stands does not have strong positive relationships with stand structural parameters (e.g., culm density and sapwood area) but possibly depends more on the sites' microenvironments (e.g., solar radiation). Copyright (c) 2014 John Wiley & Sons, Ltd.	[Ichihashi, Ryuji; Otsuki, Kyoichi] Kyushu Univ, Kasuya Res Forest, Fukuoka 8112415, Japan; [Komatsu, Hikaru] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Kume, Tomonori] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10617, Taiwan; [Shinohara, Yoshinori] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Tsuruta, Kenji] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan	Ichihashi, R (reprint author), Kyushu Univ, Kasuya Res Forest, Fukuoka 8112415, Japan.	ichihashiryuji184@gmail.com			Japanese Ministry of Education, Culture, Sports, Science and Technology [21380098]	We appreciate the discussion with, and advice on data analysis from, Y. Miyazawa and M. Tateishi, and the valuable comments from two anonymous reviewers. This research was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology through a Grant-in-Aid for Scientific Research (#21380098).	Alsheimer M, 1998, ANN SCI FOREST, V55, P103, DOI 10.1051/forest:19980107; HAMILTON NRS, 1995, ANN BOT-LONDON, V76, P569, DOI 10.1006/anbo.1995.1134; Vertessy RA, 2001, FOREST ECOL MANAG, V143, P13, DOI 10.1016/S0378-1127(00)00501-6; Kumagai T, 2005, FOREST ECOL MANAG, V206, P191, DOI 10.1016/j.foreco.2004.10.066; Kunert N, 2010, AGR FOREST METEOROL, V150, P411, DOI 10.1016/j.agrformet.2010.01.006; Dierick D, 2010, AGR FOREST METEOROL, V150, P1568, DOI 10.1016/j.agrformet.2010.08.006; Kume T, 2010, FOREST ECOL MANAG, V260, P1287, DOI 10.1016/j.foreco.2010.07.012; Wullschleger SD, 2001, FOREST ECOL MANAG, V143, P205, DOI 10.1016/S0378-1127(00)00518-1; Kume T, 2010, TREE PHYSIOL, V30, P129, DOI 10.1093/treephys/tpp074; Komatsu H, 2010, FOREST ECOL MANAG, V260, P1295, DOI 10.1016/j.foreco.2010.06.040; Pataki DE, 2003, ADV WATER RESOUR, V26, P1267, DOI 10.1016/j.advwatres.2003.08.001; Saha S, 2009, PLANT PHYSIOL, V149, P1992, DOI 10.1104/pp.108.129015; Shinohara Y, 2013, HYDROL PROCESS, V27, P2041, DOI 10.1002/hyp.9359; James SA, 2002, TREE PHYSIOL, V22, P277; GRANIER A, 1987, TREE PHYSIOL, V3, P309; Yang SJ, 2012, TREE PHYSIOL, V32, P414, DOI 10.1093/treephys/tps028; Shinohara Y, 2013, TREE PHYSIOL, V33, P550, DOI 10.1093/treephys/tpt029; Isagi Y, 1997, PLANT ECOL, V130, P41, DOI 10.1023/A:1009711814070; Onozawa Y, 2009, J FOREST RES-JPN, V14, P111, DOI 10.1007/s10310-008-0108-2; Kume T, 2012, HYDROL PROCESS, V26, P1161, DOI 10.1002/hyp.8205; KELLIHER FM, 1995, AGR FOREST METEOROL, V73, P1, DOI 10.1016/0168-1923(94)02178-M; Luizao RCC, 2004, GLOBAL CHANGE BIOL, V10, P592, DOI 10.1111/j.1529-8817.2003.00757.x; Komatsu H, 2007, J HYDROL, V336, P361, DOI 10.1016/j.jhydrol.2007.01.009; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Granier A, 2000, ANN FOR SCI, V57, P755, DOI 10.1051/forest:2000158; Bullied WJ, 2012, CAN J PLANT SCI, V92, P627, DOI [10.4141/CJPS2011-281, 10.4141/cjps2011-281]; Caos KF, 2012, ECOL LETT, V15, P666, DOI [10.1111/j.1461-0248.2012.01783.x, DOI 10.1111/J.1461-0248.2012.01783.X]; Dhillions SS, 2003, ENV NA HAEO THAILAND, P47; Hattoris S, 1989, SUIRIKAGAKU, V186, P34; Hayashi K., 2008, Japanese Journal of Conservation Ecology, V13, P55; Haydon S.R., 1996, J HYDROL, V187, P351; Joness HG, 1992, PLANT MICROCLIMATE Q; Kais S, 2004, B FACULTY AGR U MIYA, V50, P73; Komatsu H., 2007, B TOKYO U FORESTS, V117, P11; Kumagai T, 2008, AGR FOREST METEOROL, V148, P1444, DOI 10.1016/j.agrformet.2008.04.010; Kumars P, 2008, J AGR PHYS, V8, P11; Kumemuras A, 2009, RES B KAGOSHIMA U FO, V36, P1; O'Connor PJ, 2000, J TROP ECOL, V16, P499, DOI 10.1017/S0266467400001541; Ohnos T, 2003, LANDSCAPE RES JAPAN, V66, P547; Shuttleworths WJ., 1993, HDB HYDROLOGY; Soderstroms AN, 1979, BIOTROPICA, V11, P161, DOI [10.2307/2388036, DOI 10.2307/2388036]; Suzukis S, 1978, INDEX JAPANESE BAMBU; Suzukis S, 2010, SHINRIN KAGAKU, V53, P11; Tadaki Y., 1959, Nihon Ringaku Kai Shi = Journal of the Japanese Forestry Society, V41, P341; Torii Atsushi, 1997, Japanese Journal of Ecology (Tokyo), V47, P31; Tsuruta K, 2010, J FOREST RES-JPN, V15, P398, DOI 10.1007/s10310-010-0202-0; WANG YH, 1995, HYDROL PROCESS, V9, P797, DOI 10.1002/hyp.3360090706; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107; Yokoos K, 2005, KYUSHU J FOREST RES, V58, P195; Zimmermann R, 2000, GLOB CHANGE BIOL, V6, P25, DOI 10.1046/j.1365-2486.2000.00289.x	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1936-0584	1936-0592		ECOHYDROLOGY	Ecohydrology	APR	2015	8	3					450	459		10.1002/eco.1515		10	Ecology; Environmental Sciences; Water Resources	Environmental Sciences & Ecology; Water Resources	CG4FE	WOS:000353238400011		
J	Noguchi, M; Miura, S; Morioka, E; Ohno, Y; Yokoi-Noguchi, M; Nakano, Y; Kosaka, T				Noguchi, M.; Miura, S.; Morioka, E.; Ohno, Y.; Yokoi-Noguchi, M.; Nakano, Y.; Kosaka, T.			Is axillary reverse mapping feasible in breast cancer patients?	EJSO			English	Review						Axillary reverse mapping; Fluorescence imaging system; Breast carcinoma	NIPPLE-SPARING MASTECTOMY; COMPARING RADICAL-MASTECTOMY; RANDOMIZED CLINICAL-TRIAL; LYMPH-NODE DISSECTION; PREVENTING LYMPHEDEMA; ARM; DRAINAGE; BIOPSY; SAFETY; RECONSTRUCTION	In the surgical treatment of breast cancer, axillary lymph node dissection (ALND) can be avoided not only in sentinel lymph node (SLN)-negative patients but also in SLN-positive patients who undergo breast-conserving surgery with whole-breast irradiation and systemic therapy. However, it should be performed not only in clinically node-positive patients but also in other SLN-positive patients who do not meet the Z-0011 criteria. The axillary reverse mapping (ARM) technique has been developing for identifying and preserving lymphatic drainage from the arm during ALND, thereby expected to minimize arm lymphedema. Nevertheless, ARM nodes could be involved not only in clinically node-positive patients but also in clinically node-negative patients. Previously, it was considered that preservation of the ARM lymphatics or lymph nodes is not oncologically safe in patients with axillary lymph node metastases. However, recent studies have demonstrated that the ARM procedure is oncologically feasible in clinically node-negative, SLN-positive patients when ARM nodes do not coincide with SLNs. When ARM nodes do not coincide with SLNs, they are not involved even in SLN-positive patients. On the other hand, ARM lymphatics/nodes within the boundaries of a standard ALND should be resected in SLN-positive patients, when ARM nodes are SLN-ARM nodes. Therefore, surgical treatment of the axilla can be individualized on the basis of the axillary nodal status. (C) 2015 Elsevier Ltd. All rights reserved.	[Noguchi, M.; Miura, S.; Morioka, E.; Ohno, Y.; Yokoi-Noguchi, M.; Nakano, Y.] Kanazawa Med Univ Hosp, Dept Breast & Endocrine Surg, Uchinada, Ishikawa 9200293, Japan; [Kosaka, T.] Kanazawa Med Univ Hosp, Dept Surg Oncol, Uchinada, Ishikawa 9200293, Japan	Noguchi, M (reprint author), Kanazawa Med Univ Hosp, Dept Breast & Endocrine Surg, Uchinada Daigaku 1-1, Kahoku, Ishikawa 9200293, Japan.	nogumasa@kanazawa-med.ac.jp					Boccardo F, 2009, ANN SURG ONCOL, V16, P703, DOI 10.1245/s10434-008-0270-y; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Casabona F, 2009, ANN SURG ONCOL, V16, P2459, DOI 10.1245/s10434-009-0554-x; Tausch C, 2013, EJSO-EUR J SURG ONC, V39, P880, DOI 10.1016/j.ejso.2013.05.009; Thompson M, 2007, ANN SURG ONCOL, V14, P1890, DOI 10.1245/s10434-007-9412-x; Han JW, 2012, J BREAST CANCER, V15, P91, DOI 10.4048/jbc.2012.15.1.91; Gobardhan PD, 2012, EJSO-EUR J SURG ONC, V38, P657, DOI 10.1016/j.ejso.2012.04.012; Sakorafas GH, 2006, SURG ONCOL, V15, P153, DOI 10.1016/j.suronc.2006.11.003; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; Fisher B, 2002, NEW ENGL J MED, V347, P567, DOI 10.1056/NEJMoa020128; Nos C, 2008, ANN SURG ONCOL, V15, P2550, DOI 10.1245/s10434-008-0030-z; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Jagsi R, 2014, J CLIN ONCOL, V32, P3600, DOI 10.1200/JCO.2014.56.5838; Boneti C, 2009, AM J SURG, V198, P482, DOI 10.1016/j.amjsurg.2009.06.008; Petit JY, 2009, BREAST CANCER RES TR, V117, P333, DOI 10.1007/s10549-008-0304-y; Ikeda K, 2014, EJSO-EUR J SURG ONC, V40, P818, DOI 10.1016/j.ejso.2014.03.023; Wilke LG, 2006, ANN SURG ONCOL, V13, P491, DOI 10.1245/ASO.2006.05.013; BERG JW, 1955, CANCER, V8, P776, DOI 10.1002/1097-0142(1955)8:4<776::AID-CNCR2820080421>3.0.CO;2-B; Bedrosian I, 2010, CANCER-AM CANCER SOC, V116, P2543, DOI 10.1002/cncr.25096; Boneti C, 2008, J AM COLL SURGEONS, V206, P1038, DOI 10.1016/j.jamcollsurg.2007.12.022; Britton TB, 2009, NUCL MED COMMUN, V30, P427, DOI 10.1097/MNM.0b013e328315a6c6; Casabona F, 2008, ANN SURG ONCOL, V15, P3318, DOI 10.1245/s10434-008-0118-5; Chen CM, 2009, PLAST RECONSTR SURG, V124, P1772, DOI 10.1097/PRS.0b013e3181bd05fd; Clough KB, 2010, BRIT J SURG, V97, P1659, DOI 10.1002/bjs.7217; Connor C, 2013, ANN SURG ONCOL, V20, P3303, DOI 10.1245/s10434-013-3113-4; Deng HR, 2011, J CANCER RES CLIN, V137, P1869, DOI 10.1007/s00432-011-1064-3; Gennaro M, 2013, EJSO-EUR J SURG ONC, V39, P1341, DOI 10.1016/j.ejso.2013.09.022; Ikeda K, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-233; Kang SH, 2009, CANCER RES, V69, p87S; Klimberg VS, 2008, J SURG ONCOL, V97, P563, DOI 10.1002/jso.20905; Klompenhouwer EG, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-111; Kodama H, 2012, J INT MED RES, V40, P2336; Noguchi M, 2010, J SURG ONCOL, V101, P217, DOI 10.1002/jso.21473; Noguchi M, 2009, BREAST CANC RES TREA, p[119, 529]; Noguchi M, 2012, J SURG ONCOL, V105, P229, DOI 10.1002/jso.22094; Noguchi M, 2013, BREAST CANCER-TOKYO, V20, P41, DOI 10.1007/s12282-012-0416-4; Nos C, 2007, ANN SURG ONCOL, V14, P2490, DOI 10.1245/s10434-007-9450-4; Ochoa D, 2014, SURGERY, V156, P1261, DOI 10.1016/j.surg.2014.05.011; Ohno Y, 2013, BREAST CANCER-TOKYO, V20, P54, DOI 10.1007/s12282-011-0302-5; Palvlista D, 2012, ANN SURG ONCOL, V19, P3410; Ponzone R, 2008, ANN SURG ONCOL, V15, P390, DOI 10.1245/s10434-007-9663-6; Ponzone R, 2009, J CLIN ONCOL, V27, P5547, DOI 10.1200/JCO.2009.22.1846; Rubio IT, 2012, J SURG ONCOL, V106, P89, DOI 10.1002/jso.23048; Sakurai T, 2014, J SURG ONCOL, V109, P612, DOI 10.1002/jso.23528; Schunemann E, 2014, ANN SURG ONCOL, V21, P2197, DOI 10.1245/s10434-014-3626-5; Spear SL, 2014, PLAST RECONSTR SURG, V133, p605E, DOI 10.1097/PRS.0000000000000098; Suami H, 2008, PLAST RECONSTR SURG, V121, P1231, DOI 10.1097/01.prs.0000302511.21140.36	48	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	APR	2015	41	4					442	449		10.1016/j.ejso.2015.01.029		8	Oncology; Surgery	Oncology; Surgery	CG2II	WOS:000353097700003		
J	Kawai, K; Ishihara, S; Yamaguchi, H; Sunami, E; Kitayama, J; Miyata, H; Sugihara, K; Watanabe, T				Kawai, K.; Ishihara, S.; Yamaguchi, H.; Sunami, E.; Kitayama, J.; Miyata, H.; Sugihara, K.; Watanabe, T.			Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: A multicenter retrospective study	EJSO			English	Article						Colorectal cancer; Stage IV; Curative resection; Nomogram; Prognosis	DISEASE-SPECIFIC SURVIVAL; LIVER METASTASES; CARCINOMA METASTASES; INITIAL HEPATECTOMY; SCORING SYSTEM; CHEMOTHERAPY; VALIDATION; EFFICACY; IMPROVE; SURGERY	Purpose: Although stage IV colorectal cancer (CRC) encompasses a wide variety of clinical conditions with diverse prognoses, no statistical model for predicting the postoperative prognosis of stage IV CRC has been established. Thus, we here aimed to construct a predictive model for disease-free survival (DFS) and overall survival (OS) after curative surgery for stage IV CRC using nomograms. Methods: The study included 1133 stage IV CRC patients who underwent curative surgical resection in 19 institutions. Patients were divided into derivation (n = 586) and validation (n = 547) groups. Nomograms to predict the 1- and 3-year DFS rates and the 3- and 5-year OS rates were constructed using the derivation set. Calibration plots were constructed, and concordance indices (c-indices) were calculated. The predictive utility of the nomogram was validated in the validation set. Results: The postoperative carcinoembryonic antigen (CEA) level, depth of tumor invasion (T factor), lymph node metastasis (N factor), and number of metastatic organs were adopted as variables for the DFS-predicting nomogram, whereas the postoperative CEA level, T factor, N factor, and peritoneal dissemination were adopted for the nomogram to predict OS. The nomograms showed moderate calibration, with c-indices of 0.629 and 0.640 in the derivation set and 0.604 and 0.637 in the validation set for DFS and OS, respectively. Conclusions: The nomograms developed were capable of estimating the probability of DFS and OS on the basis of only 4 variables, and may represent useful tools for postoperative surveillance of stage IV CRC patients in routine practice. (C) 2015 Elsevier Ltd. All rights reserved.	[Kawai, K.; Ishihara, S.; Yamaguchi, H.; Sunami, E.; Kitayama, J.; Watanabe, T.] Univ Tokyo, Dept Surg Oncol, Tokyo 1130033, Japan; [Miyata, H.] Tokyo Univ Hosp, Dept Healthcare Assessment, Tokyo 1130033, Japan; [Sugihara, K.] Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan	Kawai, K (reprint author), Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kz-kawai@mvd.biglobe.ne.jp					Gronchi A, 2013, J CLIN ONCOL, V31, P1649, DOI 10.1200/JCO.2012.44.3747; Yun HR, 2007, INT J COLORECTAL DIS, V22, P1301, DOI 10.1007/s00384-007-0315-x; Kattan MW, 2008, ANN SURG, V247, P282, DOI 10.1097/SLA.0b013e31815ed67b; Lin BR, 2009, ANN SURG ONCOL, V16, P1026, DOI 10.1245/s10434-008-0286-3; Kattan MW, 2003, J CLIN ONCOL, V21, P4568, DOI 10.1200/LCO.2003.05.046; Kobayashi H, 2013, INT J CLIN ONCOL, V18, P696, DOI 10.1007/s10147-012-0433-5; Kanemitsu Y, 2010, WORLD J SURG, V34, P2973, DOI 10.1007/s00268-010-0745-4; Hyodo I, 2010, JPN J CLIN ONCOL, V40, pi38, DOI 10.1093/jjco/hyq125; Akiyoshi T, 2012, ANN SURG, V255, P1129, DOI 10.1097/SLA.0b013e3182565d9d; Minagawa M, 2007, ARCH SURG-CHICAGO, V142, P269, DOI 10.1001/archsurg.142.3.269; Kanemitsu Y, 2008, WORLD J SURG, V32, P1097, DOI 10.1007/s00268-007-9348-0; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R; Song KY, 2014, GASTRIC CANCER, V17, P287, DOI 10.1007/s10120-013-0270-x; Onaitis MW, 2009, ANN THORAC SURG, V87, P1684, DOI 10.1016/j.athoracsur.2009.03.034; Kattan MW, 2003, J CLIN ONCOL, V21, P3647, DOI 10.1200/JCO.2003.01.240; Beppu T, 2012, J HEPATO-BIL-PAN SCI, V19, P72, DOI 10.1007/s00534-011-0460-z; Chew MH, 2012, J GASTROINTEST SURG, V16, P603, DOI 10.1007/s11605-011-1725-1; Dexiang Zhu, 2012, Ann Surg Oncol, V19, P2860, DOI 10.1245/s10434-012-2356-9; Edge SB, 2010, AJCC CANC STAGING MA; Harrell FE, 2001, REGRESSION MODELING; Hirokawa F, 2014, ANN SURG ONCOL, V21, P139, DOI 10.1245/s10434-013-3310-1; Hsu HC, 2013, ANTICANCER RES, V33, P3317; Huh JW, 2014, J CANCER RES CLIN, V140, P435, DOI 10.1007/s00432-013-1580-4; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Kim HR, 2011, ONCOLOGY-BASEL, V81, P175, DOI 10.1159/000333440; Link KH, 2005, LANGENBECK ARCH SURG, V390, P83, DOI 10.1007/s00423-004-0508-5; Morise Z, 2006, J GASTROINTEST SURG, V10, P6, DOI 10.1016/j.gassur.2005.09.006; Nagakura S, 2002, WORLD J SURG, V26, P141; Sakamoto Y, 2013, J HEPATO-BIL-PAN SCI, V20, P307, DOI 10.1007/s00534-012-0523-9; Yi JH, 2013, ONCOLOGY-BASEL, V85, P283, DOI 10.1159/000355475	31	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	APR	2015	41	4					457	465		10.1016/j.ejso.2015.01.026		9	Oncology; Surgery	Oncology; Surgery	CG2II	WOS:000353097700005		
J	Tanaka, K; Matsuo, K; Murakami, T; Kawaguchi, D; Hiroshima, Y; Koda, K; Endo, I; Ichikawa, Y; Taguri, M; Tanabe, M				Tanaka, K.; Matsuo, K.; Murakami, T.; Kawaguchi, D.; Hiroshima, Y.; Koda, K.; Endo, I.; Ichikawa, Y.; Taguri, M.; Tanabe, M.			Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): Short-term outcome, functional changes in the future liver remnant, and tumor growth activity	EJSO			English	Article						ALPPS; Staged hepatectomy; Liver metastases; Colorectal cancer	2-STAGE HEPATECTOMY; EMBOLIZATION; METASTASES; FAILURE; REGENERATION; RESECTION; MULTIPLE; CANCER	Background: We compared clinical outcomes of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) against those of classical 2-stage hepaectomy in treating metastatic liver disease. Methods: Short-term outcomes, serial changes in volume of the future liver remnant (FLR), functional FLR volume, and tumor growth activity during the treatment period, were compared between our first 11 consecutive patients treated with ALPPS and 54 patients treated with classical 2-stage hepatectomy. Results: Mortality in the ALPPS group (9%) tended to be higher than in the classical 2-stage group (2%, P = 0.341). The FLR hypertrophy ratio (FLR volume after vs. before the procedure) 1 week after the first operation in the ALPPS group (1.54 +/- 0.18) exceeded that in the classical 2-stage group (1.19 +/- 0.29, P = 0.005), being similar to the ratio at 3 weeks after the first procedure in the classical 2-stage group (1.40 +/- 0.43). However, functional volume of the FLR in the ALPPS group 1 week after the first procedure (52.1%) tended to be smaller than that in the classical group 3 weeks after the first procedure (59.2%). Conclusions: ALPPS should be used with extreme caution, giving special attention to postoperative complications and grade of functional liver regeneration. (C) 2015 Elsevier Ltd. All rights reserved.	[Tanaka, K.; Matsuo, K.; Murakami, T.; Kawaguchi, D.; Hiroshima, Y.; Koda, K.] Teikyo Univ, Chiba Med Ctr, Dept Surg, Ichihara, Chiba 2990111, Japan; [Endo, I.] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan; [Ichikawa, Y.] Yokohama City Univ, Grad Sch Med, Dept Clin Oncol, Yokohama, Kanagawa 232, Japan; [Taguri, M.] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan; [Tanabe, M.] Yokohama City Univ, Med Ctr, Div Diagnost Pathol, Yokohama, Kanagawa 232, Japan	Tanaka, K (reprint author), Teikyo Univ, Chiba Med Ctr, Dept Surg, 3426-3 Anesaki, Ichihara, Chiba 2990111, Japan.	U17-92TS@med.teikyo-u.ac.jp					Alvarez FA, 2013, J GASTROINTEST SURG, V17, P814, DOI 10.1007/s11605-012-2092-2; Alvarez FA, 2011, CIR ESPAN, V89, P645, DOI 10.1016/j.ciresp.2011.08.001; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; Wicherts DA, 2008, ANN SURG, V248, P994, DOI 10.1097/SLA.0b013e3181907fd9; Tanaka K, 2007, EJSO-EUR J SURG ONC, V33, P329, DOI 10.1016/j.ejso.2006.10.038; Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; de Santibanes E, 2012, ANN SURG, V255, P415, DOI 10.1097/SLA.0b013e318248577d; Li J, 2013, J GASTROINTEST SURG, V17, P956, DOI 10.1007/s11605-012-2132-y; Jaeck D, 2003, AM J SURG, V185, P221, DOI 10.1016/S0002-9610(02)01373-9; Jaeck D, 2004, ANN SURG, V240, P1037, DOI 10.1097/01.sla.0000145965.86383.89; YAMANAKA N, 1994, ANN SURG, V219, P342, DOI 10.1097/00000658-199404000-00003; Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Ko GY, 2003, RADIOLOGY, V227, P407, DOI 10.1148/radiol.2272011702; Adam R, 2000, ANN SURG, V232, P777, DOI 10.1097/00000658-200012000-00006; de Santibanes E, 2012, WORLD J SURG, V36, P125, DOI 10.1007/s00268-011-1331-0; Sala Sofía, 2012, Updates Surg, V64, P167, DOI 10.1007/s13304-012-0175-y; The Terminology Committee of the IHPBA, 2000, HPB, V2, P333	19	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	APR	2015	41	4					506	512		10.1016/j.ejso.2015.01.031		7	Oncology; Surgery	Oncology; Surgery	CG2II	WOS:000353097700012		
J	Okumura, Y; Nishimura, R; Nakatsukasa, K; Yoshida, A; Masuda, N; Tanabe, M; Shien, T; Tanaka, S; Arima, N; Komoike, Y; Taguchi, T; Iwase, T; Inaji, H; Ishitobi, M				Okumura, Y.; Nishimura, R.; Nakatsukasa, K.; Yoshida, A.; Masuda, N.; Tanabe, M.; Shien, T.; Tanaka, S.; Arima, N.; Komoike, Y.; Taguchi, T.; Iwase, T.; Inaji, H.; Ishitobi, M.		Japanese Breast Canc Soc	Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence	EJSO			English	Article						Breast cancer; Ipsilateral breast tumor recurrence; Ki-67	PROGNOSTIC IMPACT; LOCAL RECURRENCE; DISCORDANCE; RELAPSE; METASTASES; THERAPY; SUBTYPE; MARKERS; TRIAL; KI67	Introduction: Changes in the biological marker status between primary and recurrent tumors are observed in breast cancer. However, their clinical significance is still uncertain, especially for patients with ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery. Patients and methods: A total of 117 patients with IBTR without distant metastases were enrolled in this study. All patients were examined for estrogen receptor (ER), HER2, and Ki-67 in both the primary tumors and paired IBTR. We evaluated the impact of changes in these biomarkers between primary tumors and IBTR on the prognosis after IBTR. Results: There were no associations of changes in the ER, HER2 status with distant disease-free survival (DDFS) after surgical resection of IBTR, whereas the change in the Ki-67 status between the primary tumors and IBTR was significantly correlated with DDFS (unadjusted: p = 0.0094; adjusted: p = 0.013). Patients in the "increased or remained high" Ki-67 group had a significantly shorter DDFS than those in the "decreased or remained low" Ki-67 group (5-year DDFS: 55.5 vs. 79.3%, respectively, p = 0.0084 by log-rank test). Conclusion: An increased or persistently high Ki-67 status in the IBTR was significantly correlated with a poorer prognosis after IBTR. (C) 2015 Elsevier Ltd. All rights reserved.	[Okumura, Y.; Nishimura, R.] Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, Japan; [Nakatsukasa, K.; Taguchi, T.] Kyoto Prefectural Univ Med, Dept Endocrine & Breast Surg, Kyoto, Japan; [Yoshida, A.] St Lukes Int Hosp, Dept Breast Surg, Tokyo, Japan; [Masuda, N.] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Breast Oncol, Osaka, Japan; [Tanabe, M.; Iwase, T.] Japanese Fdn Canc Res, Canc Inst Hosp, Div Breast Oncol, Tokyo, Japan; [Shien, T.] Okayama Univ Hosp, Dept Breast & Endocrine Surg, Okayama, Japan; [Tanaka, S.] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Sect Breast & Endocrine Surg, Osaka, Japan; [Arima, N.] Kumamoto City Hosp, Dept Pathol, Kumamoto, Japan; [Komoike, Y.; Inaji, H.; Ishitobi, M.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan	Ishitobi, M (reprint author), 1-3-3 Nakamichi,Higashinari Ku, Osaka 5378511, Japan.	isitobi-ma@mc.pref.osaka.jp			Japanese Breast Cancer Society	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Breast Cancer Society. The authors declare that the study sponsor had no role in the study design, collection, analysis, and interpretation of data, writing of the manuscript, nor decision to submit the manuscript for publication.	Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; Cardoso F, 2012, BREAST, V21, P242, DOI 10.1016/j.breast.2012.03.003; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Ishitobi M, 2013, ANN SURG ONCOL, V20, P1886, DOI 10.1245/s10434-012-2825-1; Smith TE, 2000, INT J RADIAT ONCOL, V48, P1281, DOI 10.1016/S0360-3016(00)01378-X; Aurilio G, 2014, EUR J CANCER, V50, P277, DOI 10.1016/j.ejca.2013.10.004; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Dieci MV, 2013, ANN ONCOL, V24, P101, DOI 10.1093/annonc/mds248; Amir E, 2012, J CLIN ONCOL, V30, P587, DOI 10.1200/JCO.2010.33.5232; Freedman GM, 2005, INT J RADIAT ONCOL, V61, P1328, DOI 10.1016/j.ijrobp.2004.08.026; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; HAFFTY BG, 1993, INT J RADIAT ONCOL, V27, P575; Veronesi U, 2013, LANCET ONCOL, V14, P1269, DOI 10.1016/S1470-2045(13)70497-2; Waeber M, 2003, ANN ONCOL, V14, P1215, DOI 10.1093/annonc/mdg347; Spyratos F, 2002, CANCER, V94, P2151, DOI 10.1002/cncr.10458; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974; Ibrahim T, 2013, ONCOLOGY-BASEL, V84, P150, DOI 10.1159/000345795; Komoike Yoshifumi, 2005, Breast Cancer, V12, P104, DOI 10.2325/jbcs.12.104; Montagna E, 2012, ANN ONCOL, V23, P324, DOI 10.1093/annonc/mdr129; National Comprehensive Cancer Network, 2013, CLIN PRACT GUID ONC; Nishimura R, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-131; SPATARO V, 1992, ANN ONCOL, V3, P733; Yi M, 2011, ANN SURG, V253, P572, DOI 10.1097/SLA.0b013e318208fc2a	25	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	APR	2015	41	4					548	552		10.1016/j.ejso.2015.01.030		5	Oncology; Surgery	Oncology; Surgery	CG2II	WOS:000353097700018		
J	Kida, K; Ishikawa, T; Yamada, A; Shimizu, D; Tanabe, M; Sasaki, T; Ichikawa, Y; Endo, I				Kida, K.; Ishikawa, T.; Yamada, A.; Shimizu, D.; Tanabe, M.; Sasaki, T.; Ichikawa, Y.; Endo, I.			A prospective feasibility study of sentinel node biopsy by Modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer	EJSO			English	Article						Breast cancer; Sentinel lymph node biopsy; Blue dye; Neoadjuvant chemotherapy	LYMPH-NODES; AXILLARY DISSECTION; TRIAL	Background: Although sentinel lymph node biopsy (SLNB) is a standard staging method for assessing nodal status of breast cancer patients, SLNB after neoadjuvant chemotherapy (NAC) remains controversial. The aim of this study was to validate the practicality and accuracy of SLNB by our modified Indigocarmine blue dye methods following NAC. Methods: One hundred consecutive cases with breast cancers treated by NAC were enrolled in this study. After NAC, all patients underwent SLNB performed by our modified Indigocarmine blue dye methods without radioisotope, followed by back-up axillary lymph node dissection (ALND). Results: Sentinel nodes (SNs) were identified in 94 cases (identification rate, 94%); the accuracy was 94.7% (89/94 cases); and the false negative rate (FNR) 13.5% (5/37 cases). For cases with vs. without clinically evident metastatic nodes before NAC, the identification rate was 92.4% (61/66 cases) vs. 97.1% (33/34 cases); the accuracy 91.8% (56/61 cases) vs. 97.0% (32/33 cases) and the FNR 16.1% (5/31 cases) vs. 0% (0/6 case), respectively. There were six patients without identified SNs, three of them had metastatic nodes. False negatives occurred in five cases; in four, fewer than two sentinel nodes had been removed. Conclusion: Following NAC, the accuracy of SLNB by modified Indigocarmine blue dye methods is adequate compared with other tracers. In patients in whom no SNs have been identified, lymphatic metastasis is likely and therefore ALND is recommended. For patients with cNO prior to NAC, SLNB by modified Indigocarmine blue dye methods is clinically feasible, though controversial for patients with positive nodes. (C) 2015 Elsevier Ltd. All rights reserved.	[Kida, K.; Ichikawa, Y.; Endo, I.] Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Yokohama, Kanagawa 232, Japan; [Ishikawa, T.; Yamada, A.; Shimizu, D.] Yokohama City Univ, Med Ctr, Dept Breast & Thyroid Surg, Yokohama, Kanagawa 232, Japan; [Tanabe, M.; Sasaki, T.] Yokohama City Univ, Med Ctr, Dept Pathol, Yokohama, Kanagawa 232, Japan	Kida, K (reprint author), Yokohama City Univ, Grad Sch Med, Dept Surg Gastroenterol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 232, Japan.	kidakumiko117@yahoo.co.jp					Ahlgren J, 2002, EUR J SURG ONCOL, V28, P97, DOI 10.1053/ejso.2001.1228; Rouzier R, 2002, J CLIN ONCOL, V20, P1304, DOI 10.1200/JCO.20.5.1304; van Deurzen CHM, 2009, EUR J CANCER, V45, P3124, DOI 10.1016/j.ejca.2009.08.001; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Classe JM, 2009, J CLIN ONCOL, V27, P726, DOI 10.1200/JCO.2008.18.3228; Narui K, 2010, EJSO-EUR J SURG ONC, V36, P731, DOI 10.1016/j.ejso.2010.06.011; Kuerer HM, 1998, AM J SURG, V176, P502, DOI 10.1016/S0002-9610(98)00253-0; Mamounas EP, 2005, J CLIN ONCOL, V23, P2694, DOI 10.1200/JCO.2005.05.188; Kuehn T, 2013, LANCET ONCOL, V14, P609, DOI 10.1016/S1470-2045(13)70166-9; Kim T, 2006, CANCER, V106, P4, DOI 10.1002/cncr.21568; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; FORREST APM, 1995, BRIT J SURG, V82, P1504, DOI 10.1002/bjs.1800821118; Chetty U, 2000, BRIT J SURG, V87, P163, DOI 10.1046/j.1365-2168.2000.01345.x; Cure H, 2002, BREAST CANCER RES TR, V76, P37, DOI 10.1023/A:1020274709327; Gimbergues P, 2008, ANN SURG ONCOL, V15, P1316, DOI 10.1245/s10434-007-9759-z; Ishikawa T, 2005, EJSO, V31, P1119, DOI 10.1016/j.ejso.2005.04.013; Kinoshita Takayuki, 2007, Breast Cancer, V14, P10, DOI 10.2325/jbcs.14.10; Lee S, 2007, BREAST CANC RES TREA, V102, P203; Tan VKM, 2011, J SURG ONCOL, V104, P97, DOI 10.1002/jso.21911; Tausch C, 2008, ANN SURG ONCOL, V15, P3378, DOI 10.1245/ASO.2006.08.010; Yu JC, 2007, ANN SURG ONCOL, V14, P174, DOI 10.1245/s10434-006-9132-7	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0748-7983	1532-2157		EJSO-EUR J SURG ONC	EJSO	APR	2015	41	4					566	570		10.1016/j.ejso.2014.10.066		5	Oncology; Surgery	Oncology; Surgery	CG2II	WOS:000353097700021		
J	Egashira, M; Tsubouchi, Y; Yoshimoto, N; Morita, M				Egashira, Minato; Tsubouchi, Yohei; Yoshimoto, Nobuko; Morita, Masayuki			Electrode Behavior of Iron Oxide/Carbon Nanotube Composite in Ionic Liquid Electrolyte	ELECTROCHEMISTRY			English	Article						Lithium Batteries; Ionic Liquid; Iron Oxide; Carbon Nanotube	NEGATIVE-ELECTRODE; LITHIUM; BATTERIES; ALPHA-FE2O3; BIS(FLUOROSULFONYL)IMIDE; CARBON	Composite electrode of iron oxide Fe2O3 and carbon nanotube has been prepared for the negative electrode of lithium batteries with ionic liquid electrolyte. The composite containing 29 wt% of Fe2O3 exhibits as large as 300 mAh g(-1) of specific capacity in the electrolyte based on 1-ethyl-3-methyl imidazolium bis(fluorosulfonyl)amide (EMIFSA) as well as in a conventional alkylcarbonate electrolyte. When the loading of Fe2O3 is at as low extent as 29 wt%, cross-linking morphology created by carbon nanotube substrate provides nano-spaces in the composite and assures mass transfer beneath electrode and thus rate capability even in viscous ionic liquid electrolyte. (C) The Electrochemical Society of Japan, All rights reserved.	[Egashira, Minato; Tsubouchi, Yohei; Yoshimoto, Nobuko; Morita, Masayuki] Yamaguchi Univ, Grad Sch Sci & Engn, Ube, Yamaguchi 7558611, Japan	Egashira, M (reprint author), Yamaguchi Univ, Grad Sch Sci & Engn, 2-16-1 Tokiwadai, Ube, Yamaguchi 7558611, Japan.	egashira.minato@nihon-u.ac.jp					Fang S, 2011, ELECTROCHIM ACTA, V56, P4663, DOI 10.1016/j.electacta.2011.02.107; THACKERAY MM, 1982, MATER RES BULL, V17, P785, DOI 10.1016/0025-5408(82)90029-0; Stefan CS, 2009, J POWER SOURCES, V189, P1174, DOI 10.1016/j.jpowsour.2008.12.114; Larcher D, 2003, J ELECTROCHEM SOC, V150, pA1643, DOI 10.1149/1.1622959; Tachikawa N, 2010, ELECTROCHEMISTRY, V78, P349; Matsumoto H, 2006, J POWER SOURCES, V160, P1308, DOI 10.1016/j.jpowsour.2006.02.018; Reddy MV, 2007, ADV FUNCT MATER, V17, P2792, DOI 10.1002/adfm.200601186; Hang BT, 2007, J POWER SOURCES, V174, P493, DOI 10.1016/j.jpowsour.2007.06.031; Poizot P, 2000, NATURE, V407, P496; Nakagawa H, 2007, J POWER SOURCES, V174, P1021, DOI 10.1016/j.jpowsour.2007.06.133; Zhao L, 2011, ADV MATER, V23, P1385, DOI 10.1002/adma.201003294; Wu CZ, 2006, J PHYS CHEM B, V110, P17806, DOI 10.1021/jp0633906; Ishikawa M, 2006, J POWER SOURCES, V162, P658, DOI 10.1016/j.jpowsour.2006.02.077; Cheng YY, 2012, ELECTROCHIM ACTA, V66, P332, DOI 10.1016/j.electacta.2012.02.003; DIPIETRO B, 1982, J POWER SOURCES, V8, P289, DOI 10.1016/0378-7753(82)80062-1; Egashira M., 2014, ELECTROCHEMISTRY, V81, P473; Egashira M, 2011, J POWER SOURCES, V196, P6419, DOI 10.1016/j.jpowsour.2011.03.075; Femicola A., 2006, IONICS, V12, P95; Lcwandowski A., 2009, J POWER SOURCES, V194, P601; Sugimoto T, 2009, J POWER SOURCES, V189, P802, DOI 10.1016/j.jpowsour.2008.07.053	20	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	APR	2015	83	4					244	248		10.5796/electrochemistry.83.244		5	Electrochemistry	Electrochemistry	CG0BB	WOS:000352930500002		
J	Naoi, K; Kisu, K; Okita, N; Shinoda, M; Muramatsu, M; Iwama, E; Naoi, W				Naoi, Katsuhiko; Kisu, Kazuaki; Okita, Naohisa; Shinoda, Mariko; Muramatsu, Masanori; Iwama, Etsuro; Naoi, Wako			Cathode Properties of Nanocrystalline Li3V1.8Al0.2(PO4)(3)/Multi-Walled Carbon Nanotube Composites for Hybrid Capacitor Prepared via Ultra-Centrifugation Treatment	ELECTROCHEMISTRY			Japanese	Article						Lithium-ion Battery; Hybrid Capacitor; Lithium Vanadium Phosphate	LITHIUM-ION BATTERIES; POSITIVE-ELECTRODE MATERIALS; STATE SYNTHESIS ROUTINE; ELECTROCHEMICAL PROPERTIES; VANADIUM PHOSPHATE; LI3V2(PO4)(3)/C CATHODE; DOPED LI3V2(PO4)(3); PERFORMANCE; TEMPERATURE; OXIDE	Highly-dispersed Li3V1.8Al0.2(PO4)(3) nanoparticles which are directly impregnated onto the surface of multi-walled carbon nanotubes (MWCNT) were successfully synthesized via a unique two-step process using an ultracentrifugation at 75,000g. The synthetic procedure of the Li3V1.8Al0.2(PO4)(3)/MWCNT composite involves the following two steps: i) precipitation of V1.8Al0.2O3 (10-100 nm) nanoparticles on the surface of MWCNT, and ii) the subsequent transformation of the V1.8Al0.2O3 into the Li3V1.8Al0.2(PO4)(3) nanoparticles without any change of their shape and dimensions. The 10% of Al-doping brought out an increase in the discharge capacity from 119 to 124 mAh g(-1) per Li3V2-xAlx(PO4)(3), which corresponds to a 14% increase of the Li3V2-xAlx(PO4)(3) utilization ratio. The Al-doping also reduced its electric resistance by 26%. The Li3V1.8Al0.2(PO4)(3)/MWCNT with such an efficient electron transport can deliver excellent electrochemical performances ever attained to date; capacity density of 85 mAh g(-1) at a high discharge rate of 480C and stable cycle performance over 10,000 cycles at 10C rate with 85% retention of the initial capacity.	[Naoi, Katsuhiko; Kisu, Kazuaki; Okita, Naohisa; Shinoda, Mariko; Muramatsu, Masanori; Iwama, Etsuro] Tokyo Univ Agr & Technol, Dept Appl Chem, Koganei, Tokyo 1848558, Japan; [Naoi, Katsuhiko; Naoi, Wako] K&W Inc, Div Arts & Sci, Kunitachi, Tokyo 1860002, Japan; [Naoi, Katsuhiko] Tokyo Univ Agr & Technol, Adv Capacitor Res Ctr, Koganei, Tokyo 1848558, Japan	Naoi, K (reprint author), Tokyo Univ Agr & Technol, Dept Appl Chem, 2-24-16 Naka Cho, Koganei, Tokyo 1848558, Japan.	k-naoi@cc.tuat.ac.jp	Naoi, Katsuhiko/G-1092-2013; Kisu, Kazuaki/A-2154-2015	Kisu, Kazuaki/0000-0002-1693-4225			Gao B, 2008, APPL CATAL B-ENVIRON, V85, P17, DOI 10.1016/j.apcatb.2008.06.027; Son JN, 2013, ELECTROCHIM ACTA, V97, P210, DOI 10.1016/j.electacta.2013.02.118; Pan AQ, 2010, ELECTROCHEM COMMUN, V12, P1674, DOI 10.1016/j.elecom.2010.09.014; Han DW, 2014, CHEM MATER, V26, P3644, DOI 10.1021/cm500509q; Kuang Q, 2010, ELECTROCHIM ACTA, V55, P1575, DOI 10.1016/j.electacta.2009.10.028; Chen QQ, 2012, J POWER SOURCES, V201, P267, DOI 10.1016/j.jpowsour.2011.10.133; Xia A, 2014, CERAM INT, V40, P14845, DOI 10.1016/j.ceramint.2014.06.078; Barker J, 2007, J ELECTROCHEM SOC, V154, pA307, DOI 10.1149/1.2437072; Saidi MY, 2003, J POWER SOURCES, V119, P266, DOI 10.1016/S0378-7753(03)00245-3; Wang YL, 2014, SOLID STATE IONICS, V261, P11, DOI 10.1016/j.ssi.2014.03.027; Yonekura D, 2014, PHYS CHEM CHEM PHYS, V16, P6027, DOI 10.1039/c4cp00334a; Rui XH, 2012, J POWER SOURCES, V214, P171, DOI 10.1016/j.jpowsour.2012.03.113; Wang C, 2014, NEW J CHEM, V38, P430, DOI 10.1039/c3nj01021j; Yang YX, 2014, J POWER SOURCES, V269, P15, DOI 10.1016/j.jpowsour.2014.07.005; Kobayashi G, 2009, ADV FUNCT MATER, V19, P395, DOI 10.1002/adfm.200801522; Fu P, 2006, J POWER SOURCES, V162, P651, DOI 10.1016/j.jpowsour.2006.07.029; Naoi K, 2010, J POWER SOURCES, V195, P6250, DOI 10.1016/j.jpowsour.2009.12.104; Zhong SK, 2009, J RARE EARTH, V27, P134, DOI 10.1016/S1002-0721(08)60207-0; Fu P, 2006, ELECTROCHIM ACTA, V52, P1003, DOI 10.1016/j.electacta.2006.06.039; Naoi K, 2013, ACCOUNTS CHEM RES, V46, P1075, DOI 10.1021/ar200308h; Ellis BL, 2010, CHEM MATER, V22, P691, DOI 10.1021/cm902696j; Morgan D, 2002, CHEM MATER, V14, P4684, DOI 10.1021/cm020348o; Cho AR, 2012, J MATER CHEM, V22, P6556, DOI 10.1039/c2jm00022a; Ai DJ, 2011, ELECTROCHIM ACTA, V56, P2823, DOI 10.1016/j.electacta.2010.12.063; Whittingham MS, 2004, CHEM REV, V104, P4271, DOI 10.1021/cr020731c; Deng C, 2011, J PHYS CHEM C, V115, P15048, DOI 10.1021/jp201686g; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Yin SC, 2003, J AM CHEM SOC, V125, P10402, DOI 10.1021/ja034565h; Chen YH, 2009, ELECTROCHIM ACTA, V54, P5844, DOI 10.1016/j.electacta.2009.05.041; Dai CS, 2010, J POWER SOURCES, V195, P5775, DOI 10.1016/j.jpowsour.2010.02.081; Kisu K., 2014, J MATER CHEM A, V2, P13058; Mani V, 2014, RSC ADV, V4, P17091, DOI 10.1039/c4ra00963k; Masquelier C, 2000, CHEM MATER, V12, P525, DOI 10.1021/cm991138n; Membreno N, 2013, J PHYS CHEM C, V117, P11994, DOI 10.1021/jp403282a; Naoi K, 2009, J ELECTROCHEM SOC, V156, pA52, DOI 10.1149/1.3021026; Ogihara N, 2012, J ELECTROCHEM SOC, V159, pA1034, DOI 10.1149/2.057207jes; Saidi MY, 2002, ELECTROCHEM SOLID ST, V5, pA149, DOI 10.1149/1.1479295; Zhang L, 2012, J POWER SOURCES, V203, P121, DOI 10.1016/j.jpowsour.2011.11.082	38	1	1	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	APR	2015	83	4					249	255		10.5796/electrochemistry.83.249		7	Electrochemistry	Electrochemistry	CG0BB	WOS:000352930500003		
J	Kawaguchi, K; Morimitsu, M				Kawaguchi, Kenji; Morimitsu, Masatsugu			Effects of Oxide Composition on Structure, Surface Morphology, and Oxygen Evolution Behaviors of IrO2-Ta2O5/Ti Anodes Prepared at a High Temperature	ELECTROCHEMISTRY			English	Article						Ordered Nano IrO2 Particles; IrO2-Ta2O5/Ti Anodes; Oxygen Evolution; Surface Morphology	LONG SERVICE LIFE; COATED TITANIUM ELECTRODES; ELECTROCATALYTIC PROPERTIES; EVOLVING ELECTRODES; ELECTROCHEMICAL PROPERTIES; TI/IRO2-TA2O5 ANODES; IRO2-BASED ANODES; COATING THICKNESS; MICROSTRUCTURE; OXIDATION	Catalytic coatings comprising a mixture of IrO2 and Ta2O5 were prepared at 50-80 mol% Ir by thermal decomposition at 470 degrees C, and the crystallographic structures and surface morphologies were investigated. XRD analysis and high-resolution SEM observation using low accelerated incident beam revealed that decreasing Ir ratio made a phase transition of IrO2 from crystalline to partly amorphous, and nano IrO2 particles of 10 nm or less and nano chains made of them, which were uniformly dispersed on the flat area of the coating, were generated at 50-60 mol% Ir. The relationship between nano-scale surface morphology of the coating and electrocatalysis for oxygen evolution in H2SO4 solutions was also investigated. The active surface area and oxygen evolution current increased with reducing Jr ratio. The electrocatalysis of the IrO2-Ta2O5 coatings for oxygen evolution is possible to be attributed to nano IrO2 particles. (C) The Electrochemical Society of Japan, All rights reserved.	[Kawaguchi, Kenji] Doshisha Univ, Org Res Initiat & Dev, Kyoto 6100394, Japan; [Morimitsu, Masatsugu] Doshisha Univ, Dept Environm Syst Sci, Kyoto 6100394, Japan	Kawaguchi, K (reprint author), Doshisha Univ, Org Res Initiat & Dev, 1-3 Tatara Miyakodani, Kyoto 6100394, Japan.	kkawaguc@mail.doshisha.ac.jp					MURAKAMI Y, 1994, ELECTROCHIM ACTA, V39, P651, DOI 10.1016/0013-4686(94)80006-5; Xu LK, 2009, ELECTROCHIM ACTA, V54, P1820, DOI 10.1016/j.electacta.2008.10.004; COMNINELLIS C, 1991, J APPL ELECTROCHEM, V21, P136, DOI 10.1007/BF01464294; Cardarelli F, 1998, J APPL ELECTROCHEM, V28, P245, DOI 10.1023/A:1003251329958; Otogawa R, 1998, ELECTROCHIM ACTA, V44, P1509, DOI 10.1016/S0013-4686(98)00274-6; MARTELLI GN, 1994, ELECTROCHIM ACTA, V39, P1551, DOI 10.1016/0013-4686(94)85134-4; Chen AC, 2004, J PHYS CHEM B, V108, P2245, DOI 10.1021/jp036639h; Hu JM, 2004, INT J HYDROGEN ENERG, V29, P791, DOI 10.1016/j.ijhydene.2003.09.007; Hu JM, 2003, J MATER SCI, V38, P705, DOI 10.1023/A:1021840426997; Xu LK, 2003, CORROS SCI, V45, P2729, DOI 10.1016/S0010-938X(03)00108-2; Hu JM, 2002, CORROS SCI, V44, P1655, DOI 10.1016/S0010-938X(01)00165-2; Morimitsu M, 2000, ELECTROCHIM ACTA, V46, P401, DOI 10.1016/S0013-4686(00)00598-3; TRASATTI S, 1984, ELECTROCHIM ACTA, V29, P1503, DOI 10.1016/0013-4686(84)85004-5; ARDIZZONE S, 1981, J ELECTROANAL CHEM, V126, P287, DOI 10.1016/S0022-0728(81)80437-8; Tolba R, 2010, J ELECTROANAL CHEM, V649, P9, DOI 10.1016/j.jelechem.2009.12.013; COMNINELLIS C, 1991, J APPL ELECTROCHEM, V21, P335, DOI 10.1007/BF01020219; Bakambo G. E., 2014, INT J MAT SCI APPL, V3, P1; Beer H., 1972, U.S. Patent, Patent No. 362498; Da Silva LM, 2004, ELECTROCHIM ACTA, V49, P3977, DOI 10.1016/j.electacta.2003.11.039; Hu JM, 2003, THERMOCHIM ACTA, V403, P257, DOI 10.1016/S0040-6031(03)00061-3; Hu JM, 2001, J MATER SCI LETT, V20, P1353, DOI 10.1023/A:1010975223405; Kawaguchi K, 2013, ECS TRANSACTIONS, V50, P75, DOI 10.1149/05019.0075ecst; Kawaguchi K, 2009, ELECTROCHEMISTRY, V77, P879; Kawaguchi K., 2009, ECS T, V16, P41; Krysa J, 1996, J APPL ELECTROCHEM, V26, P999, DOI 10.1007/BF00242194; Krysa J, 1998, J APPL ELECTROCHEM, V28, P369, DOI 10.1023/A:1003284204458; Kunihiro T, 2000, J APPL ELECTROCHEM, V30, P359, DOI 10.1023/A:1003997303650; Lee J.-Y, 2011, MAT SCI APPL, V2, P237; Li BS, 2006, T NONFERR METAL SOC, V16, P1193, DOI 10.1016/S1003-6326(06)60400-7; Liu JY, 2000, MATER CHARACT, V44, P353, DOI 10.1016/S1044-5803(99)00076-5; Meng HM, 1998, DENKI KAGAKU, V66, P1148; Morimitsu M, 2000, J APPL ELECTROCHEM, V30, P511, DOI 10.1023/A:1003977928651; Morimitsu M, 2009, CHEM LETT, V38, P822, DOI 10.1246/cl.2009.822; Morimitsu M., 2009, P HYDR NICK COB 2009, P571; Morimitsu M., 2014, J MMIJ, V130, P415; Morimitsu M, 2009, ECS TRANSACTIONS, V19, P211, DOI 10.1149/1.3118554; Morimitsu M, 2004, J NEW MAT ELECTR SYS, V7, P323; Morimitsu M., 2009, ELECTROCHEMISTRY, V77, P1011; MRAZ R, 1994, J APPL ELECTROCHEM, V24, P1262, DOI 10.1007/BF00249891; Msindo ZS, 2010, J APPL ELECTROCHEM, V40, P691, DOI 10.1007/s10800-009-0044-7; Murakami C., 2001, 199 M EL SOC; Otogawa R, 1997, DENKI KAGAKU, V65, P987; Otogawa R, 2000, NIPPON KAGAKU KAISHI, P299, DOI 10.1246/nikkashi.2000.299; Otogawa R, 1998, TETSU TO HAGANE, V84, P785; Otogawa R., 1999, P 9 CONT STEEL STRIP, P11; ROGINSKAYA YE, 1993, J CHEM SOC FARADAY T, V89, P1707, DOI 10.1039/ft9938901707; ROGINSKAYA YE, 1995, ELECTROCHIM ACTA, V40, P817, DOI 10.1016/0013-4686(95)00002-V; ROLEWICZ J, 1988, ELECTROCHIM ACTA, V33, P573, DOI 10.1016/0013-4686(88)80180-4; Trasatti S., 1980, ELECT CONDUCTIVE MET; VERCESI GP, 1991, THERMOCHIM ACTA, V176, P31, DOI 10.1016/0040-6031(91)80257-J; VERCESI GP, 1991, ELECTROCHIM ACTA, V36, P991, DOI 10.1016/0013-4686(91)85306-R; Xin YL, 2010, RARE METAL MAT ENG, V39, P1903; Xu LK, 2003, J ELECTROCHEM SOC, V150, pB254, DOI 10.1149/1.1569479; Xu LK, 2003, J ELECTROCHEM SOC, V150, pB288, DOI 10.1149/1.1574033; Yan ZW, 2012, RARE METAL MAT ENG, V41, P772	55	0	0	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	APR	2015	83	4					256	261		10.5796/electrochemistry.83.256		6	Electrochemistry	Electrochemistry	CG0BB	WOS:000352930500004		
J	Kozuka, C; Sunagawa, S; Ueda, R; Higa, M; Tanaka, H; Shimizu-Okabe, C; Ishiuchi, S; Takayama, C; Matsushita, M; Tsutsui, M; Miyazaki, J; Oyadomari, S; Shimabukuro, M; Masuzaki, H				Kozuka, Chisayo; Sunagawa, Sumito; Ueda, Rei; Higa, Moritake; Tanaka, Hideaki; Shimizu-Okabe, Chigusa; Ishiuchi, Shogo; Takayama, Chitoshi; Matsushita, Masayuki; Tsutsui, Masato; Miyazaki, Jun-ichi; Oyadomari, Seiichi; Shimabukuro, Michio; Masuzaki, Hiroaki			gamma-Oryzanol Protects Pancreatic beta-Cells Against Endoplasmic Reticulum Stress in Male Mice	ENDOCRINOLOGY			English	Article							THIOREDOXIN-INTERACTING PROTEIN; HIGH-FAT DIET; BROWN RICE; NLRP3 INFLAMMASOME; INSULIN-SECRETION; INDUCED APOPTOSIS; ER STRESS; OBESITY; DEATH; IRE1-ALPHA	Endoplasmic reticulum (ER) stress is profoundly involved in dysfunction of beta-cells under high-fat diet and hyperglycemia. Our recent study in mice showed that gamma-oryzanol, a unique component of brown rice, acts as a chemical chaperone in the hypothalamus and improves feeding behavior and diet-induced dysmetabolism. However, the entire mechanism whereby gamma-oryzanol improves glucose metabolism throughout the body still remains unclear. In this context, we tested whether gamma-oryzanol reduces ER stress and improves function and survival of pancreatic beta-cells using murine beta-cell line MIN6. In MIN6 cells with augmented ER stress by tunicamycin, gamma-oryzanol decreased exaggerated expression of ER stress-related genes and phosphorylation of eukaryotic initiation factor-2 alpha, resulting in restoration of glucose-stimulated insulin secretion and prevention of apoptosis. In islets from high-fat diet-fed diabetic mice, oral administration of gamma-oryzanol improved glucose-stimulated insulin secretion on following reduction of exaggerated ER stress and apoptosis. Furthermore, we examined the impact of gamma-oryzanol on low-dose streptozotocin-induced diabetic mice, where exaggerated ER stress and resultant apoptosis in beta-cells were observed. Also in this model, gamma-oryzanol attenuated mRNA level of genes involved in ER stress and apoptotic signaling in islets, leading to amelioration of glucose dysmetabolism. Taken together, our findings demonstrate that gamma-oryzanol directly ameliorates ER stress-induced beta-cell dysfunction and subsequent apoptosis, highlighting usefulness of gamma-oryzanol for the treatment of diabetes mellitus.	[Kozuka, Chisayo; Sunagawa, Sumito; Ueda, Rei; Higa, Moritake; Tanaka, Hideaki; Shimabukuro, Michio; Masuzaki, Hiroaki] Univ Ryukyus, Grad Sch Med, Dept Internal Med 2, Div Endocrinol Diabet & Metab,Hematol,Rheumatol, Nishihara, Okinawa 9030215, Japan; [Higa, Moritake] Tomishiro Cent Hosp, Diabet & Life Style Related Dis Ctr, Okinawa 9010243, Japan; [Tanaka, Hideaki] Tanaka Clin, Okinawa 9010244, Japan; [Shimizu-Okabe, Chigusa; Takayama, Chitoshi] Univ Ryukyus, Grad Sch Med, Dept Mol Anat, Okinawa 9030215, Japan; [Ishiuchi, Shogo] Univ Ryukyus, Grad Sch Med, Dept Neurosurg, Okinawa 9030215, Japan; [Matsushita, Masayuki] Univ Ryukyus, Grad Sch Med, Dept Cellular & Mol Physiol, Okinawa 9030215, Japan; [Tsutsui, Masato] Univ Ryukyus, Grad Sch Med, Dept Pharmacol, Okinawa 9030215, Japan; [Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, Suita, Osaka 5650871, Japan; [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 7708506, Japan; [Shimabukuro, Michio] Univ Tokushima, Grad Sch Hlth Biosci, Dept Cardiodiabet Med, Tokushima 7708503, Japan	Masuzaki, H (reprint author), Univ Ryukyus, Grad Sch Med, Dept Internal Med 2, Div Endocrinol Diabet & Metab,Hematol,Rheumatol, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	hiroaki@med.u-ryukyu.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X	Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [24591338, 25.9668]; Takeda Science Foundation; Society for Woman's Health Science Research [13-A1-001]; Leave a Nest grants; Metabolic Syndrome Foundation; Council for Science Technology and Innovation	This work was supported in part by Grants-in-Aid from Japan Society for the Promotion of Science (JSPSKAKENHI Grant Numbers 24591338 and 25.9668), Takeda Science Foundation (Specified Research Grant), Society for Woman's Health Science Research (13-A1-001), Leave a Nest grants, Metabolic Syndrome Foundation, Specified Project "Establishing a research hub toward the development of an intellectual cluster in Okinawa Prefecture" (2011-2014), and Council for Science Technology and Innovation, Cross-ministerial Strategic Innovation Promotion Program, "Technologies for creating next-generation agriculture, forestry and fisheries."	Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Lerma-Garcia MJ, 2009, FOOD CHEM, V115, P389, DOI 10.1016/j.foodchem.2009.01.063; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JC1200214550; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Kozuka C, 2012, DIABETES, V61, P3084, DOI 10.2337/db11-1767; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Kusakabe T, 2009, DIABETOLOGIA, V52, P675, DOI 10.1007/s00125-009-1258-2; Bergman RN, 2002, EUR J CLIN INVEST, V32, P35, DOI 10.1046/j.1365-2362.32.s3.5.x; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Kozuka C, 2013, OBES RES CLIN PRACT, V7, pE165, DOI 10.1016/j.orcp.2013.02.003; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Chakravarthy MV, 2008, DIABETES, V57, P2698, DOI 10.2337/db08-0404; LEBARON FN, 1956, J NEUROCHEM, V1, P101, DOI 10.1111/j.1471-4159.1956.tb12060.x; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Radl DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018097; Shimabukuro M, 2014, BRIT J NUTR, V111, P310, DOI 10.1017/S0007114513002432; Tanaka T, 2007, CELL METAB, V5, P395, DOI 10.1016/j.cmet.2007.04.004; Zhang R, 2011, EVID-BASED COMPL ALT, V2011; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	28	3	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	APR	2015	156	4					1242	1250		10.1210/en.2014-1748		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QX	WOS:000353272700006		
J	Nio-Kobayashi, J; Trendell, J; Giakoumelou, S; Boswell, L; Nicol, L; Kudo, M; Sakuragi, N; Iwanaga, T; Duncan, WC				Nio-Kobayashi, Junko; Trendell, Jennifer; Giakoumelou, Sevasti; Boswell, Lyndsey; Nicol, Linda; Kudo, Masataka; Sakuragi, Noriaki; Iwanaga, Toshihiko; Duncan, William Colin			Bone Morphogenetic Proteins Are Mediators of Luteolysis in the Human Corpus Luteum	ENDOCRINOLOGY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; HUMAN GRANULOSA-CELLS; RECEPTOR-IB; IN-VITRO; PROGESTERONE-RECEPTORS; MATERNAL RECOGNITION; GENE-EXPRESSION; ACTIVIN-A; PREGNANCY; MONKEY	Bone morphogenetic proteins (BMPs), members of the transforming growth factor beta (TGF beta) superfamily, play important roles in folliculogenesis in various species; however, little is known about their role in luteal function. In this study, we investigated the expression, regulation, and effects of BMP2, BMP4, and BMP6 in carefully dated human corpora lutea and cultured human luteinized granulosa cells. The mRNA abundance of BMPs was increased in the regressing corpus luteum in vivo (P<.01-.001). Human chorionic gonadotropin (hCG) down-regulated BMP2, BMP4, and BMP6 transcripts both in vivo (P=.05-.001) and in vitro (P<.001), and decreased the mRNA abundance of BMP receptors (BMPR1A, BMPR1B, BMPR2; P<.05-.01) in vitro. Three BMPs were regulated by differential signaling pathways. H89, a protein kinase A inhibitor, increased the expression of both BMP2 (P<.05) and BMP4 (P<.05) while decreasing BMP6 (P<.01). PMA, a protein kinase C activator, decreased both BMP4 and BMP6 expression (P<.0001) while enhancing the mRNA abundance of BMP2 (P<.01). BMPs significantly down-regulated transcripts for LH/choriogonadotropin receptor (LHCGR; P<.001) and steroidogenic acute regulatory protein (STAR; P<.001), whereas up-regulating those of follicular stimulating hormone receptor (FSHR; P<.01) and aromatase (CYP19A1; P<.05-.01) in vitro, possessing an effect opposite to hCG but similar to Activin A. Like Activin A, BMP4 and BMP6 stimulated the expression of Inhibin/Activin subunits with a marked effect on INHBB expression (P<.05-.01). These data confirm that BMPs are increased during luteal regression and negatively regulated by hCG via differential mechanisms, suggesting that BMPs are one of the mediators of luteolysis in women.	[Nio-Kobayashi, Junko; Trendell, Jennifer; Giakoumelou, Sevasti; Boswell, Lyndsey; Nicol, Linda; Duncan, William Colin] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Nio-Kobayashi, Junko; Iwanaga, Toshihiko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido 0608638, Japan; [Kudo, Masataka; Sakuragi, Noriaki] Hokkaido Univ, Grad Sch Med, Dept Reprod Endocrinol & Oncol, Sapporo, Hokkaido 0608638, Japan	Nio-Kobayashi, J (reprint author), Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	niojun@med.hokudai.ac.jp			Cunningham Trust; Japan Society for the Promotion of Science; Suntory Foundation for Life Sciences	This work was supported by the Cunningham Trust to W.C.D., a Postdoctoral Fellowship for Research Abroad from Japan Society for the Promotion of Science and the Suntory Foundation for Life Sciences to J.N.-K.	Duncan WC, 1998, J CLIN ENDOCR METAB, V83, P2470, DOI 10.1210/jc.83.7.2470; Shi J, 2009, FERTIL STERIL, V92, P1794, DOI 10.1016/j.fertnstert.2009.05.004; Knight PG, 2012, MOL CELL ENDOCRINOL, V359, P53, DOI 10.1016/j.mce.2011.04.024; Kayani AR, 2009, REPRODUCTION, V137, P67, DOI 10.1530/REP-08-0198; Souza CJH, 2002, REPRODUCTION, V123, P363, DOI 10.1530/rep.0.1230363; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Miyoshi T, 2006, BIOL REPROD, V74, P1073, DOI 10.1095/biolreprod.105.047969; Abir R, 2008, FERTIL STERIL, V89, P1430, DOI 10.1016/j.fertnstert.2007.04.064; Wulff C, 2001, HUM REPROD, V16, P2515, DOI 10.1093/humrep/16.12.2515; Dickinson RE, 2008, ENDOCRINOLOGY, V149, P5024, DOI 10.1210/en.2008-0204; Fabre S, 2003, J ENDOCRINOL, V177, P435, DOI 10.1677/joe.0.1770435; Shi J, 2011, AM J REPROD IMMUNOL, V65, P421, DOI 10.1111/j.1600-0897.2010.00917.x; Trombly DJ, 2009, SEMIN REPROD MED, V27, P14, DOI 10.1055/s-0028-1108006; Duncan WC, 1998, HUM REPROD, V13, P2435, DOI 10.1093/humrep/13.9.2435; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; Shi J, 2010, FERTIL STERIL, V93, P1273, DOI 10.1016/j.fertnstert.2008.11.014; Mulsant P, 2001, P NATL ACAD SCI USA, V98, P5104, DOI 10.1073/pnas.091577598; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Duncan WC, 2000, REV REPROD, V5, P12, DOI 10.1530/ror.0.0050012; Duncan WC, 2005, REPRODUCTION, V130, P83, DOI 10.1530/rep.1.00216; COLE FE, 1976, FERTIL STERIL, V27, P921; Duffy DM, 1997, BIOL REPROD, V57, P693, DOI 10.1095/biolreprod57.4.693; Duncan W. C., 2009, Animal Reproduction, V6, P34; Erickson Gregory F, 2003, Reprod Biol Endocrinol, V1, P9, DOI 10.1186/1477-7827-1-9; FRASER HM, 1987, ENDOCRINOLOGY, V121, P612; Jaatinen R, 2002, J CLIN ENDOCR METAB, V87, P1254, DOI 10.1210/jc.87.3.1254; Jaatinen R, 1996, J CLIN ENDOCR METAB, V81, P3877, DOI 10.1210/jc.81.11.3877; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Maybin JA, 2004, REPRODUCTION, V128, P423, DOI 10.1530/rep.1.00051; Myers M, 2007, ENDOCRINOLOGY, V148, P3730, DOI 10.1210/en.2007-0244; Myers M, 2008, J ENDOCRINOL, V199, P201, DOI 10.1677/JOE-08-0302; Priyanka S, 2009, ENDOCRINOLOGY, V150, P1473, DOI 10.1210/en.2008-0840; Senturk LM, 1999, MOL HUM REPROD, V5, P697, DOI 10.1093/molehr/5.8.697; Yamashita H, 2011, MOL CELL BIOCHEM, V348, P183, DOI 10.1007/s11010-010-0653-9	35	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	APR	2015	156	4					1494	1503		10.1210/en.2014-1704		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QX	WOS:000353272700028		
J	Sagata, D; Minagawa, I; Kohriki, H; Pitia, AM; Uera, N; Katakura, Y; Sukigara, H; Terada, K; Shibata, M; Park, EY; Hasegawa, Y; Sasada, H; Kohsaka, T				Sagata, Dai; Minagawa, Itaru; Kohriki, Hiroshi; Pitia, Ali Mohammed; Uera, Naoto; Katakura, Yuta; Sukigara, Hiroyuki; Terada, Kei; Shibata, Masatoshi; Park, Enoch Y.; Hasegawa, Yoshihisa; Sasada, Hiroshi; Kohsaka, Tetsuya			The Insulin-Like Factor 3 (INSL3)-Receptor (RXFP2) Network Functions as a Germ Cell Survival/Anti-Apoptotic Factor in Boar Testes	ENDOCRINOLOGY			English	Article							TESTICULAR LEYDIG-CELLS; HORMONE-RECEPTOR LGR8; GENE-EXPRESSION; SPLICE VARIANTS; FACTOR RLF; 3 INSL3; RELAXIN; PEPTIDE; CRYPTORCHIDISM; MATURATION	Relaxin-like factor, commonly known as insulin-like factor (INSL3), is essential for testis descent during fetal development; however, its function in the adult testis is still being elucidated. The study aimed to identify a relaxin family peptide receptor 2 (RXFP2)-specific antibody suitable for immunological approaches, analyze which testicular germ cell types express RXFP2, and clarify its expression dynamics in the boar testis. In addition, the function of INSL3-RXFP2 signaling on the germ cells was explored by neutralizing INSL3 using long-term active immunization. Samples were collected from Duroc boars, and a commercially available RXFP2-specific antibody directed against the human RXFP2 endodomain was identified by characterizing its specificity in HEK-293 cells expressing mouse RXFP2, and by demonstrating the suitability for analyzing RXFP2 expression in porcine tissues. RXFP2 mRNA and protein were both localized mainly in meiotic and post-meiotic germ cells, but not in Leydig cells. Functional RXFP2, which enables INSL3 to bind, was detected as an similar to 85-kDa band, which increased in intensity from the pubertal stage onward. Interestingly, INSL3 immunization significantly reduced testis weight and induced a 4-fold increase in the frequency of apoptotic germ cells, which was associated with the up-regulation of pro-apoptotic caspase-3 (CASP3) and BAX, and the down-regulation of anti-apoptotic XIAP and BCL2, and a substantial reduction in sperm concentration. These results revealed that RXFP2 was expressed in boar meiotic and post-meiotic germ cells, where INSL3 neutralization led to increased germ cell apoptosis and reduced sperm output, suggesting that INSL3 acts as a survival/ anti-apoptotic factor in maintaining sperm production.	[Sagata, Dai; Minagawa, Itaru; Kohriki, Hiroshi; Pitia, Ali Mohammed; Uera, Naoto; Katakura, Yuta; Sukigara, Hiroyuki; Kohsaka, Tetsuya] Shizuoka Univ, Fac Agr, Lab Anim Reprod & Physiol, Shizuoka 4228529, Japan; [Minagawa, Itaru; Pitia, Ali Mohammed; Kohsaka, Tetsuya] Gifu Univ, United Grad Sch Agr Sci, Div Anim Resource Prod, Gifu 5011193, Japan; Shizuoka Swine & Poultry Expt Stn, Kikugawa 4390037, Japan; [Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Biotechnol Lab, Shizuoka 4228529, Japan; [Hasegawa, Yoshihisa] Kitasato Univ, Sch Vet Sci, Anim Sci High Tech Res Ctr, Towada, Aomori 0348628, Japan; [Sasada, Hiroshi] Kitasato Univ, Sch Vet Sci, Lab Anim Reprod, Towada, Aomori 0348628, Japan	Kohsaka, T (reprint author), Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Lab Anim Reprod & Physiol,Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	t-kohsaka@agr.shizuoka.ac.jp			Japan Society for the Promotion of Science (JSPS) [24580408]	This work was supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS Grant No. 24580408 to T.K.).	Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; Bullesbach EE, 2002, BIOCHEMISTRY-US, V41, P274, DOI 10.1021/bi0117302; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Siqin, 2013, BIOL CHEM, V394, P1181, DOI 10.1515/hsz-2012-0357; Del Borgo MP, 2006, J BIOL CHEM, V281, P13068, DOI 10.1074/jbc.M600472200; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Kato S, 2010, J ENDOCRINOL, V207, P135, DOI 10.1677/JOE-10-0149; Muda M, 2005, MOL HUM REPROD, V11, P591, DOI 10.1093/molehr/gah205; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Scott DJ, 2006, J BIOL CHEM, V281, P34942, DOI 10.1074/jbc.M602728200; Wikstrom AM, 2006, J CLIN ENDOCR METAB, V91, P4705, DOI 10.1210/jc.2006-0669; Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011; PURSEL VG, 1975, J ANIM SCI, V40, P99; Anand-Ivell R, 2009, BIOL REPROD, V81, P480, DOI 10.1095/biolreprod.109.077552; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Okwun OE, 1996, J REPROD FERTIL, V107, P137; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Ivell R, 2002, BIOL REPROD, V67, P699, DOI 10.1095/biolreprod.102.005199; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681; Gorlov IP, 2002, HUM MOL GENET, V11, P2309, DOI 10.1093/hmg/11.19.2309; ADHAM IM, 1993, J BIOL CHEM, V268, P26668; Sasaki Y, 2001, INT J ANDROL, V24, P24, DOI 10.1046/j.1365-2605.2001.00259.x; Anand-Ivell RJK, 2006, BIOL REPROD, V74, P945, DOI 10.1095/biolreprod.105.048165; Minagawa I, 2012, BIOCHEM J, V441, P265, DOI 10.1042/BJ20111107; Ferlin A, 2006, J CLIN ENDOCR METAB, V91, P3426, DOI 10.1210/jc.2006-0821; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Bogatcheva NV, 2007, AM J PHYSIOL-ENDOC M, V292, pE138, DOI 10.1152/ajpendo.00228.2006; Boockfor FR, 2001, REPRODUCTION, V122, P899, DOI 10.1530/rep.0.1220899; De Miguel MP, 2001, J ANDROL, V22, P212; Filonzi M, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-29; Franca LR, 1998, TISSUE CELL, V30, P573, DOI 10.1016/S0040-8166(98)80038-4; Hadziselimovic Faruk, 2007, Int Braz J Urol, V33, P407, DOI 10.1590/S1677-55382007000300015; Hanna CB, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-150; Hartley BJ, 2009, ANN NY ACAD SCI, V1160, P67, DOI 10.1111/j.1749-6632.2009.03949.x; Hay FC, 2002, PRACTICAL IMMUNOLOGY, P1; HESS HH, 1978, ANAL BIOCHEM, V85, P295, DOI 10.1016/0003-2697(78)90304-4; HOSSENLOPP P, 1986, ANAL BIOCHEM, V154, P138, DOI 10.1016/0003-2697(86)90507-5; Huang Z, 2013, BIOL REPROD, V87, P143; Ivell Richard, 2014, Front Endocrinol (Lausanne), V5, P6, DOI 10.3389/fendo.2014.00006; Koeva Yvetta A, 2008, Folia Med (Plovdiv), V50, P37; Minagawa I, 2014, J ENDOCRINOL, V220, P247, DOI 10.1530/JOE-13-0430; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Tan K, 2013, J CANCER RES CLIN, V139, P1795, DOI 10.1007/s00432-013-1482-5; Yan Y, 2008, BIOCHEMISTRY-US, V47, P6953, DOI 10.1021/bi800535b	47	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	APR	2015	156	4					1523	1539		10.1210/en.2014-1473		17	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QX	WOS:000353272700031		
J	Yu, L; Iwasaki, T; Xu, M; Lesmana, R; Xiong, Y; Shimokawa, N; Chin, WW; Koibuchi, N				Yu, Lu; Iwasaki, Toshiharu; Xu, Ming; Lesmana, Ronny; Xiong, Yu; Shimokawa, Noriaki; Chin, William W.; Koibuchi, Noriyuki			Aberrant Cerebellar Development of Transgenic Mice Expressing Dominant-Negative Thyroid Hormone Receptor in Cerebellar Purkinje Cells	ENDOCRINOLOGY			English	Article							SONIC-HEDGEHOG; RAT-BRAIN; POSTNATAL-DEVELOPMENT; EARLY HYPOTHYROIDISM; MOUSE CEREBELLUM; GENE-EXPRESSION; NERVOUS-SYSTEM; CONGENITAL HYPOTHYROIDISM; DIFFERENTIAL EXPRESSION; CURRENT PERSPECTIVES	To study the role of the thyroid hormone (TH) in cerebellar development, we generated transgenic mice expressing a dominant-negative TH receptor (TR) in cerebellar Purkinje cells. A mutant human TR beta 1 (G345R), which binds to the TH-response element but cannot bind to T3, was subcloned into exon 4 of the full-length L7/Pcp-2 gene, which is specifically expressed in Purkinje and retinal rod bipolar cells. The transgene was specifically expressed in Purkinje cells in the postnatal cerebellum. Purkinje cell dendrite arborization was significantly delayed in the transgenic mice. Surprisingly, granule cell migration was also significantly delayed. In the primary cerebellar culture, TH-induced Purkinje cell dendrite arborization was also suppressed. In quantitative real-time RT-PCR analysis, the expression levels of several TH-responsive genes were altered. The expression levels of inositol trisphosphate receptor type 1 and retinoic acid receptor-related orphan receptor alpha mRNAs, which are mainly expressed in Purkinje cells, and brain-derived neurotrophic factor mRNA, which is expressed in both Purkinje and granule cells, were significantly decreased. The expression levels of neurotrophin-3 and hairless mRNAs, which are mainly expressed in granule cells, and myelin basic protein mRNA, which is mainly expressed in oligodendrocytes, were also decreased. The motor coordination of transgenic mice was significantly disrupted. These results indicate that TH action through its binding to TR in Purkinje cells is required for the normal cerebellar development. TH action through TR in Purkinje cells is also important for the development of other subsets of cerebellar cells such as granule cells and oligodendrocytes.	[Yu, Lu; Iwasaki, Toshiharu; Xu, Ming; Lesmana, Ronny; Shimokawa, Noriaki; Koibuchi, Noriyuki] Gunma Univ, Grad Sch Med, Dept Integrat Physiol, Maebashi, Gunma 3718511, Japan; [Xiong, Yu] Gunma Univ, Grad Sch Med, Dept Lab Sci, Maebashi, Gunma 3718511, Japan; [Xu, Ming] Keio Univ, Sch Med, Dept Neuropsychiat, Shinjuku Ku, Tokyo 1608582, Japan; [Lesmana, Ronny] Padjadjaran State Univ, Dept Physiol, Bandung 45363, Indonesia; [Chin, William W.; Koibuchi, Noriyuki] Harvard Univ, Sch Med, Boston, MA 02115 USA	Koibuchi, N (reprint author), Gunma Univ, Grad Sch Med, Dept Integrat Physiol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	nkoibuch@gunma-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [21390065, 25281024, 20510061, 23510072]; Cosmic Research Award from the Japan Thyroid Association	This work was supported by Grants-in-Aid for Scientific Research 21390065 and 25281024 (to N.K., T.I., and N.S.) and 20510061 and 23510072 (to T.I. and N.K.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by a Cosmic Research Award (T.I.) from the Japan Thyroid Association.	ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Traiffort E, 1998, J NEUROCHEM, V70, P1327; LAUDER JM, 1974, BRAIN RES, V76, P33, DOI 10.1016/0006-8993(74)90511-3; Morte B, 2002, P NATL ACAD SCI USA, V99, P3985, DOI 10.1073/pnas.062413299; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; Jensen AM, 1997, DEVELOPMENT, V124, P363; FIELD J, 1988, MOL CELL BIOL, V8, P2159; SAKURAI A, 1989, P NATL ACAD SCI USA, V86, P8977, DOI 10.1073/pnas.86.22.8977; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; O'Halloran CJ, 2012, J CLIN EXP NEUROPSYC, V34, P35, DOI 10.1080/13803395.2011.614599; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; FORREST D, 1991, EMBO J, V10, P269; Rovet JF, 2002, CHILD NEUROPSYCHOL, V8, P150, DOI 10.1076/chin.8.3.150.13501; MONGE M, 1986, DEV NEUROSCI-BASEL, V8, P222, DOI 10.1159/000112255; Koibuchi N, 1999, ENDOCRINOLOGY, V140, P3955, DOI 10.1210/en.140.9.3955; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Ramos HE, 2006, THYROID, V16, P211, DOI 10.1089/thy.2006.16.211; Fauquier T, 2014, DEVELOPMENT, V141, P166, DOI 10.1242/dev.103226; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; MELLSTROM B, 1991, MOL ENDOCRINOL, V5, P1339; Portella AC, 2010, MOL CELL NEUROSCI, V44, P68, DOI 10.1016/j.mcn.2010.02.004; CALVO R, 1990, J CLIN INVEST, V86, P889, DOI 10.1172/JCI114790; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Potter GB, 2002, MOL ENDOCRINOL, V16, P2547, DOI 10.1210/me.2002-0115; Kimura-Kuroda J, 2002, DEV BRAIN RES, V137, P55, DOI 10.1016/S0165-3806(02)00408-X; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Heuer H, 2003, J NEUROSCI, V23, P10604; Avci HX, 2012, P NATL ACAD SCI USA, V109, P14206, DOI 10.1073/pnas.1119853109; BIGLER J, 1995, EMBO J, V14, P5710; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Fauquier T, 2011, DEV BIOL, V356, P350, DOI 10.1016/j.ydbio.2011.05.657; Hasebe M, 2008, J TOXICOL SCI, V33, P473, DOI 10.2131/jts.33.473; Hasebe M, 2008, INT J DEV NEUROSCI, V26, P409, DOI 10.1016/j.ijdevneu.2008.03.007; Ino H, 2004, J HISTOCHEM CYTOCHEM, V52, P311; KANFER J, 1989, J MOL NEUROSCI, V1, P39, DOI 10.1007/BF02918889; Koenig RJ, 1998, THYROID, V8, P703, DOI 10.1089/thy.1998.8.703; Koibuchi N, 2001, THYROID, V11, P205, DOI 10.1089/105072501750159534; Koibuchi N, 1998, ENDOCRINOLOGY, V139, P2335, DOI 10.1210/en.139.5.2335; Koibuchi N, 2003, CEREBELLUM, V2, P279, DOI 10.1080/14734220310011920; LAUDER JM, 1977, BRAIN RES, V126, P31, DOI 10.1016/0006-8993(77)90213-X; LAUDER JM, 1978, BRAIN RES, V142, P25, DOI 10.1016/0006-8993(78)90174-9; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Liu Y, 1998, ENDOCRINOLOGY, V139, P4197, DOI 10.1210/en.139.10.4197; NICHOLSO.JL, 1972, BRAIN RES, V44, P13, DOI 10.1016/0006-8993(72)90362-9; NICHOLSO.JL, 1972, BRAIN RES, V44, P25, DOI 10.1016/0006-8993(72)90363-0; O'Shea PJ, 2002, J ENDOCRINOL, V175, P553, DOI 10.1677/joe.0.1750553; Peeters RP, 2013, ENDOCRINOLOGY, V154, P550, DOI 10.1210/en.2012-1738; Picou F, 2012, MOL ENDOCRINOL, V26, P608, DOI 10.1210/me.2011-1316; Qiu CH, 2007, ENDOCRINOLOGY, V148, P1745, DOI 10.1210/en.2006-1131; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; Roots B., 1995, NEURON GLIA INTERREL, P223; SAMUELS HH, 1988, J CLIN INVEST, V81, P957, DOI 10.1172/JCI113449; STRAIT KA, 1992, MOL ENDOCRINOL, V6, P1874, DOI 10.1210/me.6.11.1874; STRAIT KA, 1991, P NATL ACAD SCI USA, V88, P3887, DOI 10.1073/pnas.88.9.3887; Tagami T, 1998, MOL ENDOCRINOL, V12, P1888, DOI 10.1210/me.12.12.1888; WIEBEL J, 1976, ACTA PAEDIATR SCAND, V65, P201, DOI 10.1111/j.1651-2227.1976.tb16537.x; ZOU LL, 1994, J BIOL CHEM, V269, P13346	62	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	APR	2015	156	4					1565	1576		10.1210/en.2014-1079		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CG4QX	WOS:000353272700034		
J	Uchimiya, M; Hiradate, S; Antal, MJ				Uchimiya, Minori; Hiradate, Syuntaro; Antal, Michael Jerry, Jr.			Influence of Carbonization Methods on the Aromaticity of Pyrogenic Dissolved Organic Carbon	ENERGY & FUELS			English	Article							PARALLEL FACTOR-ANALYSIS; RESONANCE MASS-SPECTROMETRY; PYROLYSIS TEMPERATURE; BLACK CARBON; FLUORESCENCE SPECTROSCOPY; FUNCTIONAL-GROUPS; BIOCHAR; BIOMASS; CHARCOAL; MATTER	Dissolved organic carbon (DOC) components of soil amendments, such as biochar, will influence the fundamental soil chemistry, including the metal speciation, nutrient availability, and microbial activity. Quantitative correlation is necessary between (i) pyrogenic DOC components of varying aromaticity and ionizable (carboxyl and hydroxyl) substituents and (ii) bulk and solution properties of biochars. This study employed fluorescence excitationemission (EEM) spectrophotometry with parallel factor analysis (PARAFAC) to understand the influence of the pyrolysis platform (flash and high-yield carbonization, slow pyrolysis, and fast pyrolysis) and solution pH on the DOC structure of carbonaceous materials. The PARAFAC fingerprint representative of conjugated, polyaromatic DOC correlated (Pearsons r >= 0.6; p < 0.005) with (i) volatile matter content and (ii) total organic carbon and nitrogen concentrations in water and base (50100 mM NaOH) extracts. Electric conductivity of the extracts correlated with S (indicative of labile sulfate species) and Na + K concentrations (r > 0.9; p < 0.0005). The pH-dependent changes in fluorescence peak position and intensity suggested (i) protonation of carboxylate/phenolic functionalities and (ii) acid-induced aggregation of colloidal particles for <= 350 degrees C slow-pyrolysis biochars; DOC of high-yield/flash carbonization charcoals and >= 500 degrees C slow-pyrolysis biochars were less sensitive to pH. Solid-state 13C cross-polarization and magic angle spinning nuclear magnetic resonance analysis of bulk aromaticity (-C-C peak at 110-160 ppm) suggested that both recalcitrant and labile fluorescence DOC fingerprints are composed of polyaromatic structures that begin to form near 350 degrees C. These biochar-borne DOC components of varying aromaticity and carboxyl substituents will participate in hydrophobic and hydrogen-bonding interactions with soil components that will ultimately impact the biogeochemical cycles.	[Uchimiya, Minori] ARS, Southern Reg Res Ctr, USDA, New Orleans, LA 70124 USA; [Hiradate, Syuntaro] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Antal, Michael Jerry, Jr.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Hawaii Nat Energy Inst, Honolulu, HI 96822 USA	Uchimiya, M (reprint author), ARS, Southern Reg Res Ctr, USDA, 1100 Robert E Lee Blvd, New Orleans, LA 70124 USA.	sophie.uchimiya@ars.usda.gov			National Science Foundation [CBET11-58965]; Coral Industries Endowment of the University of Hawaii Foundation	This work was partly supported by the National Science Foundation (Award CBET11-58965) and the Coral Industries Endowment of the University of Hawaii Foundation. The authors acknowledge Drs. Isabel Lima and Keri Cantrell for providing manure feedstocks and biochars.	Uchimiya M, 2014, J AGR FOOD CHEM, V62, P1802, DOI 10.1021/jf4053385; Lima IM, 2009, IND ENG CHEM RES, V48, P1292, DOI 10.1021/ie800989s; Uchimiya M, 2013, J ANAL APPL PYROL, V104, P84, DOI 10.1016/j.jaap.2013.09.003; Antal MJ, 1996, ENERG FUEL, V10, P652; Ishii SKL, 2012, ENVIRON SCI TECHNOL, V46, P2006, DOI 10.1021/es2043504; Hockaday WC, 2006, ORG GEOCHEM, V37, P501, DOI 10.1016/j.orggeochem.2005.11.003; Wang L, 2008, BIOMASS BIOENERG, V32, P573, DOI 10.1016/j.biombioe.2007.12.007; Uchimiya M, 2012, J AGR FOOD CHEM, V60, P1798, DOI 10.1021/jf2047898; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Christensen JH, 2005, ANAL CHEM, V77, P2210, DOI 10.1021/ac048213k; Zhu DQ, 2005, ENVIRON SCI TECHNOL, V39, P2033, DOI 10.1021/es0491376; Hunt JF, 2007, J AGR FOOD CHEM, V55, P2121, DOI 10.1021/jf063336m; Schnitzer MI, 2007, J ENVIRON SCI HEAL B, V42, P71, DOI 10.1080/03601230601020894; Ono K, 2013, BIOGEOCHEMISTRY, V112, P7, DOI 10.1007/s10533-011-9682-z; Wang DJ, 2013, ENVIRON SCI TECHNOL, V47, P821, DOI 10.1021/es303794d; Gao XP, 2014, ENERG FUEL, V28, P4642, DOI 10.1021/ef501114v; Ferretto N, 2014, CHEMOSPHERE, V107, P344, DOI 10.1016/j.chemosphere.2013.12.087; Cheah S, 2014, ENVIRON SCI TECHNOL, V48, P8474, DOI 10.1021/es500073r; Andersen CM, 2008, J AGR FOOD CHEM, V56, P720, DOI 10.1021/jf072025o; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572; Antal MJ, 2000, IND ENG CHEM RES, V39, P4024; Uchimiya M, 2012, J ENVIRON QUAL, V41, P1138, DOI 10.2134/jeq2011.0115; Shinogi Y, 2003, BIORESOURCE TECHNOL, V90, P241, DOI 10.1016/S0960-8524(03)00147-0; Smith CR, 2013, ENVIRON SCI TECHNOL, V47, P13294, DOI 10.1021/es4034777; Uchimiya M, 2011, J AGR FOOD CHEM, V59, P2501, DOI 10.1021/jf104206c; Hiradate S, 2004, GEODERMA, V119, P133, DOI 10.1016/S0016-7061(03)00257-X; Erich MS, 2012, SOIL SCI SOC AM J, V76, P408, DOI 10.2136/sssaj2011.0273; Uchimiya M, 2013, J ANAL APPL PYROL, V102, P53, DOI 10.1016/j.jaap.2013.03.014; Antal MJ, 2003, IND ENG CHEM RES, V42, P1619, DOI 10.1021/ie0207919; Wang L, 2011, ENERG FUEL, V25, P3251, DOI 10.1021/ef200450h; Brewer CE, 2009, ENVIRON PROG SUSTAIN, V28, P386, DOI 10.1002/ep.10378; Kramer RW, 2004, ENVIRON SCI TECHNOL, V38, P3387, DOI 10.1021/es030124m; Wu HW, 2011, IND ENG CHEM RES, V50, P12143, DOI 10.1021/ie200679n; Ni JZ, 2011, ENVIRON SCI TECHNOL, V45, P9240, DOI 10.1021/es201859j; McBeath AV, 2014, BIOMASS BIOENERG, V60, P121, DOI 10.1016/j.biombioe.2013.11.002; Antal MJ, 2003, IND ENG CHEM RES, V42, P3690, DOI 10.1021/ie0301839; PRESTON CM, 1992, J AGR FOOD CHEM, V40, P206, DOI 10.1021/jf00014a008; Uchimiya M, 2014, ACS SUSTAIN CHEM ENG, V2, P2019, DOI 10.1021/sc5002269; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38; Mao JD, 2012, ENVIRON SCI TECHNOL, V46, P9571, DOI 10.1021/es301107c; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Stubbins A, 2014, ENVIRON SCI TECHNOL, V48, P10598, DOI 10.1021/es502086e; Skjemstad JO, 2002, SOIL SCI SOC AM J, V66, P1249; Davis CC, 2014, CRIT REV ENV SCI TEC, V44, P303, DOI 10.1080/10643389.2012.718947; ASTM International, 2010, D7582 ASTM; Branca C, 2006, IND ENG CHEM RES, V45, P5891, DOI 10.1021/ie060161x; Bruice P, 1998, ORGANIC CHEM, V2nd; International Humic Substance Society (IHSS), 2014, 13C NMR EST CARB DIS; Uchimiya M, 2013, J AGR FOOD CHEM, V61, P7679, DOI 10.1021/jf401481x; United States Environmental Protection Agency (U.S. EPA), 1994, 1311 US EPA; U.S. EPA, 2001, EPA821R01010 OFF RES; Verwey E. J. W., 1948, THEORY STABILITY LYO	53	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0887-0624	1520-5029		ENERG FUEL	Energy Fuels	APR	2015	29	4					2503	2513		10.1021/acs.energyfuels.5b00146		11	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	CG4JQ	WOS:000353251800050		
J	Ohki, M; Baba, Y; Kikuchi, S; Ohata, A; Tsutsumi, T; Tanaka, S; Tahara, A; Urata, S; Ishikawa, J				Ohki, Masafumi; Baba, Yuka; Kikuchi, Shigeru; Ohata, Atsushi; Tsutsumi, Takeshi; Tanaka, Sunao; Tahara, Atsushi; Urata, Shinji; Ishikawa, Junichi			Potentially lethal pharyngolaryngeal edema with dyspnea in adult patients with mumps: A series of 5 cases	ENT-EAR NOSE & THROAT JOURNAL			English	Article							VIRUS INFECTION	In this article we describe 5 rare cases of mumps-associated pharyngolaryngeal edema. To the best of our knowledge, this report includes the first case of mumps-associated pharyngolaryngeal edema in a patient who had previously received mumps vaccination, and these cases represent the sixth report of mumps-associated pharyngolaryngeal edema in the English literature. All 5 of our patients with mumps infection were adults and manifested airway stenosis duet pharyngolaryngeal edema. This edema responded favorably to steroid treatment without tracheotomy. We conclude that a pharyngolaryngeal examination is recommended for patients with mumps infection. Steroid treatment is usually effective against pharyngolaryngeal edema; however, in certain cases tracheotomy may be inevitable.	[Ohki, Masafumi; Baba, Yuka; Kikuchi, Shigeru; Ohata, Atsushi; Tsutsumi, Takeshi; Tanaka, Sunao; Tahara, Atsushi; Urata, Shinji; Ishikawa, Junichi] Saitama Med Ctr, Dept Otolaryngol, Saitama, Japan	Ohki, M (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Otolaryngol, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	masaohki@saitama-med.ac.jp					Yoshida N, 2008, J MED VIROL, V80, P517, DOI 10.1002/jmv.21106; Hanna-Wakim R, 2008, J INFECT DIS, V197, P1669, DOI 10.1086/588195; Hattori Y, 2013, PEDIATR EMERG CARE, V29, P1104, DOI 10.1097/PEC.0b013e3182a60049; Ishida M, 2006, LARYNGOSCOPE, V116, P2221, DOI 10.1097/01.mlg.0000246189.38777.2c; lizuka T, 2013, BMJ CASE REP, V2013, DOI [10.1136/bcr-2012-007829, DOI 10.1136/BCR-2012-007829]; Mason WH, 2007, NELSON TXB PEDIAT, V18th, P1341; Nakao Y, 2012, INTERNAL MED, V51, P3311, DOI 10.2169/internalmedicine.51.8770; Sasaki T, 2009, LANCET, V374, P1722, DOI 10.1016/S0140-6736(09)61341-6; WELLER TH, 1949, AM J PATHOL, V25, P1105; Wharton M, 1990, MMWR Recomm Rep, V39, P1; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P49	11	0	0	VENDOME GROUP LLC	NEW YORK	6 EAST 32 ST, 8 FLOOR, NEW YORK, NY 10016 USA	0145-5613	1942-7522		ENT-EAR NOSE THROAT	ENT-Ear Nose Throat J.	APR-MAY	2015	94	4-5					184	186				3	Otorhinolaryngology	Otorhinolaryngology	CG3KW	WOS:000353180100013		
J	Tashima, D; Asano, Y; Tomomatsu, S; Sugimoto, Y				Tashima, Daisuke; Asano, Yoki; Tomomatsu, Shigeki; Sugimoto, Yasuhiro			THERMAL EFFICIENCY OF SMALL SCALE BIOGAS PLANT FOR BIO-METHANE PRODUCTION	Environmental Engineering and Management Journal			English	Article						biogas plant; methane fermentation; thermal efficiency	FERMENTATION PROCESS; ANAEROBIC-DIGESTION; HYDROGEN-PRODUCTION; CHICKEN MANURE; CATTLE DUNG; CULTURE; WASTE; WATER; EFFLUENT; NICKEL	In this research, a small-scale biogas plant using methane fermentation was developed. The electrical energy consumed by the heater/pump and the outside temperature of the small-scale biogas plant were logged from 1 July 2007 until 31 July 2009. The thermal efficiency of the small-scale biogas plant was calculated based on the electrical energy consumed by the heater/pump and the generated gas quantity. The results showed that a total thermal efficiency of 17.5% was obtained in the system. To improve thermal efficiency in the small-scale biogas plant at the University of Miyazaki, Japan, it is necessary to reduce the power consumption of the heater/pump during spring and summer.	[Tashima, Daisuke] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki 8892192, Japan; [Asano, Yoki] Kagoshima Univ, Fac Educ, Dept Technol, Kagoshima 8900065, Japan; [Tomomatsu, Shigeki] Miyazaki Univ, Fac Engn, Dept Mech Design Syst Engn, Miyazaki 8892192, Japan; [Sugimoto, Yasuhiro] Miyazaki Univ, Fac Agr, Dept Agr & Environm Sci, Miyazaki 8892192, Japan	Tashima, D (reprint author), Miyazaki Univ, Interdisciplinary Res Org, 1-1 Gakuenkibanadai Nishi, Miyazaki 8892192, Japan.	tashima@cc.miyazaki-u.ac.jp					ABURAS R, 1995, BIORESOURCE TECHNOL, V53, P101, DOI 10.1016/0960-8524(95)00052-G; Abouelenien F, 2010, BIORESOURCE TECHNOL, V101, P6368, DOI 10.1016/j.biortech.2010.03.071; Cozma P, 2013, ENVIRON ENG MANAG J, V12, P147; MAWSON AJ, 1991, WATER RES, V25, P1549, DOI 10.1016/0043-1354(91)90187-U; Ohkubo T, 2010, INT J HYDROGEN ENERG, V35, P13021, DOI 10.1016/j.ijhydene.2010.04.063; Sasaki K, 2011, BIORESOURCE TECHNOL, V102, P6837, DOI 10.1016/j.biortech.2011.04.022; Cheng XY, 2012, BIORESOURCE TECHNOL, V104, P373, DOI 10.1016/j.biortech.2011.10.082; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; PAUSS A, 1993, BIOMASS BIOENERG, V4, P263, DOI 10.1016/0961-9534(93)90084-H; Coskun C, 2012, INT J HYDROGEN ENERG, V37, P16498, DOI 10.1016/j.ijhydene.2012.02.174; Gilroyed BH, 2010, BIORESOURCE TECHNOL, V101, P5780, DOI 10.1016/j.biortech.2010.02.077; Matsui T, 2010, J BIOSCI BIOENG, V110, P558, DOI 10.1016/j.jbiosc.2010.06.011; Grieder C, 2012, BIOMASS BIOENERG, V37, P132, DOI 10.1016/j.biombioe.2011.12.020; KOUTINAS AA, 1991, J FERMENT BIOENG, V72, P64, DOI 10.1016/0922-338X(91)90149-B; Amirta R, 2006, J BIOTECHNOL, V123, P71, DOI 10.1016/j.biotec.2005.10.004; RICHARDS BK, 1991, BIOMASS BIOENERG, V1, P65, DOI 10.1016/0961-9534(91)90028-B; Abouelenien F, 2009, J BIOSCI BIOENG, V107, P293, DOI 10.1016/j.jbiosc.2008.10.009; Kobayashi T, 2012, INT J HYDROGEN ENERG, V37, P5602, DOI 10.1016/j.ijhydene.2011.12.123; Zhou ZM, 2012, BIORESOURCE TECHNOL, V103, P173, DOI 10.1016/j.biortech.2011.10.013; Hu QH, 2008, CHEM ENG J, V143, P111, DOI 10.1016/j.cej.2007.12.021; BALASUBRAMANIAN PR, 1992, BIORESOURCE TECHNOL, V41, P213, DOI 10.1016/0960-8524(92)90004-H; Balasubramanian PR, 1996, BIORESOURCE TECHNOL, V55, P119, DOI 10.1016/0960-8524(95)00185-9; BAYKOV B, 1995, RESOUR CONSERV RECY, V13, P251, DOI 10.1016/0921-3449(94)00047-9; Coskun C, 2011, INT J HYDROGEN ENERG, V36, P11418, DOI 10.1016/j.ijhydene.2010.12.125; DAR GH, 1987, BIOL WASTE, V22, P261; Khoiyangbam RS, 2004, BIORESOURCE TECHNOL, V95, P35, DOI 10.1016/j.biortech.2004.02.009; KIDA K, 1994, J FERMENT BIOENG, V77, P335, DOI 10.1016/0922-338X(94)90247-X; MATSUYAMA H, 1988, J FERMENT BIOENG, V66, P229, DOI 10.1016/0385-6380(88)90053-2; RICHARDS BK, 1991, BIOMASS BIOENERG, V1, P47, DOI 10.1016/0961-9534(91)90051-D; Singh SP, 1997, BIORESOURCE TECHNOL, V59, P69, DOI 10.1016/S0960-8524(96)00123-X; VERRIER D, 1982, BIOMASS, V2, P17, DOI 10.1016/0144-4565(82)90004-X; Yeole TY, 1996, BIORESOURCE TECHNOL, V58, P323, DOI 10.1016/S0960-8524(96)00119-8	32	0	0	GH ASACHI TECHNICAL UNIV IASI	IASI	71 MANGERON BLVD, IASI, 700050, ROMANIA	1582-9596	1843-3707		ENVIRON ENG MANAG J	Environ. Eng. Manag. J.	APR	2015	14	4					745	749				5	Environmental Sciences	Environmental Sciences & Ecology	CG7LA	WOS:000353483700004		
J	Fujii, H; Fukuda, S; Narumi, D; Ihara, T; Watanabe, Y				Fujii, Hisako; Fukuda, Sanae; Narumi, Daisuke; Ihara, Tomohiko; Watanabe, Yasuyoshi			Fatigue and sleep under large summer temperature differences	ENVIRONMENTAL RESEARCH			English	Article						Fatigue; Sleep; Temperature differences	QUALITY-OF-LIFE; URBAN HEAT-ISLAND; BODY-TEMPERATURE; HEALTH; POPULATION; INSOMNIA; INDEX; ONSET	Background: It has been recognized that an increase in outdoor ambient temperatures has a negative impact on health, particularly fatigue and sleep quality; however, the relationship among fatigue, sleep quality, and air temperature has yet to be sufficiently elucidated. Objectives: To examine whether fatigue and sleep quality in a healthy Japanese population were affected by rising air temperature at three time points in summer and to investigate the confounding factors for fatigue. Methods: A total of 602 healthy volunteers in Osaka, Japan, participated in a survey that was conducted at the end of July, August, and September in 2010. The questionnaire consisted of four sections; demographic variables, accommodation status, fatigue, and sleep quality. We used the Chalder fatigue scale for assessment of fatigue, and the Japanese version of the Pittsburgh Sleep Quality Index (PSQI) for assessment of sleep quality. Results: The fatigue score was positively correlated with the sleep quality score in the total cohort. All the questionnaires at the three time points were completed by 162 participants. There were significant differences in fatigue scores among the surveys. We stratified the subjects into two groups of good and poor sleepers using a cutoff value of the PSQI. The good sleepers did not show differences in fatigue score regardless of the change in air temperature. However, the fatigue score of poor sleepers was greater at higher air temperatures. The use of air conditioners, accommodation type, and subject's age were confounding factors for fatigue. Conclusions: High air temperatures in summer increased fatigue in healthy volunteers, especially those with poor sleep patterns, depending on the use of air conditioners, accommodation status, and subject's age. (C) 2015 Elsevier Inc. All rights reserved.	[Fujii, Hisako; Fukuda, Sanae; Watanabe, Yasuyoshi] Osaka City Univ, Grad Sch Med, Osaka 5400051, Japan; [Narumi, Daisuke] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 2408501, Japan; [Ihara, Tomohiko] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan; [Fukuda, Sanae; Watanabe, Yasuyoshi] RIKEN, Ctr Life Sci Technol, Kobe, Hyogo 6500047, Japan; [Fukuda, Sanae] Kansai Univ Walf Sci, Dept Hlth Sci, Kashihara, Nara 5820026, Japan	Fukuda, S (reprint author), Kansai Univ Walf Sci, Dept Hlth Sci, 3-11-1 Asahigaoka, Kashihara, Nara 5820026, Japan.	hfujii@med.osaka-cu.ac.jp; sfukuda@fuksi-kagk-u.ac.jp; narumi@ynu.ac.jp; ihara-t@k.u-tokyo.ac.jp; yywata@riken.jp			KAKENHI-B [23360437]	This study was conducted by a Research Project for Creation of Housing that Promotes Health and Well-being and was funded by a Grant-in-Aid for Scientific Research (KAKENHI-B 23360437).	Kim K, 2000, SLEEP, V23, P41; Okamoto-Mizuno K, 1999, SLEEP, V22, P767; Murphy PJ, 1997, SLEEP, V20, P505; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Yang EH, 2000, SLEEP, V23, P535; Epstein Y, 2006, IND HEALTH, V44, P388, DOI 10.2486/indhealth.44.388; Ohayon MM, 2004, SLEEP, V27, P1255; Hajat S, 2010, LANCET, V375, P856, DOI 10.1016/S0140-6736(09)61711-6; Tan JG, 2010, INT J BIOMETEOROL, V54, P75, DOI 10.1007/s00484-009-0256-x; Tomlinson CJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-42; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Patterson PD, 2010, PREHOSP EMERG CARE, V14, P187, DOI 10.3109/10903120903524971; Hatoum HT, 1998, PHARMACOECONOMICS, V14, P629, DOI 10.2165/00019053-199814060-00004; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Council N.R., 2000, RECONSILING OBSERVAT, P86; Dapi LN, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5610; Doi Y, 1998, JAPANESE J PSYCHIAT, V13, P755; Doi Y, 2000, J Epidemiol, V10, P79; González-Hidalgo Germán, 2011, Rev Med Inst Mex Seguro Soc, V49, P487; HASKELL EH, 1981, ELECTROEN CLIN NEURO, V51, P494, DOI 10.1016/0013-4694(81)90226-1; IPCC, 2007, CLIM CHANG 2007 IMP; IPCC-WG1, 2013, CLIM CHANG 2013 PHYS; Japan Meteorological Agency, 2013, HEAT ISL PHEN EACH C; Japan Meteorological Agency, 2008, HEAT ISL MON REP KIN; Krauchi K, 2001, NEUROPSYCHOPHARMACOL, V25, pS92, DOI 10.1016/S0893-133X(01)00315-3; KUMASHIRO M, 1984, Journal of UOEH, V6, P273; Matsumoto K., 1985, EFFECT SLEEPING ENV, P375; Naoshi K., 2010, NIHON SEIRI JINRUIGA, V15, P1; Sohar E., 1962, BIOMETEOROLOGY, P395; Taylor RR, 2000, PSYCHOL MED, V30, P849, DOI 10.1017/S0033291799002500; Watanabe Y., 2008, FATIGUE SCI HUMAN HL, pV; Zeitlhofer J, 2000, ACTA NEUROL SCAND, V102, P249, DOI 10.1034/j.1600-0404.2000.102004249.x	33	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	APR	2015	138						17	21		10.1016/j.envres.2015.02.006		5	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CG1CT	WOS:000353011300003		
J	Mizukawa, H; Nomiyama, K; Kunisue, T; Watanabe, MX; Subramanian, A; Iwata, H; Ishizuka, M; Tanabe, S				Mizukawa, Hazuki; Nomiyama, Kei; Kunisue, Tatsuya; Watanabe, Michio X.; Subramanian, Annamalai; Iwata, Hisato; Ishizuka, Mayumi; Tanabe, Shinsuke			Organohalogens and their hydroxylated metabolites in the blood of pigs from an open waste dumping site in south India: Association with hepatic cytochrome P450	ENVIRONMENTAL RESEARCH			English	Article						Dumping site; Hydroxylated metabolite; Pig; Polychlorinated biphenyl (PCB); Thyroid hormone	POLYBROMINATED DIPHENYL ETHERS; ASIAN DEVELOPING-COUNTRIES; PERSISTENT ORGANIC POLLUTANTS; DIBENZO-P-DIOXINS; CONSTITUTIVE ANDROSTANE RECEPTOR; POLYCHLORINATED-BIPHENYLS PCBS; BROMINATED FLAME RETARDANTS; THYROID-HORMONE METABOLISM; LIVER-MICROSOMES; DISRUPTING CHEMICALS	The concentrations of polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and their hydroxylated metabolites (OH-PCBs and OH-PBDEs) were measured in the blood of Eurasian wild pigs (Sus scrofa) from a municipal waste open dumping site (DS) and a reference site (RS) in South India. We showed that contamination with OH-PCBs was higher in female pigs from the DS than in all other adult pigs. The highest OH-PCB concentrations were found in piglets from the DS. Moreover, the hepatic expression levels of CYP1A and CYP2B were higher in piglets than in their dam, implying metabolism of PCBs by cytochrome P450 (CYP) enzymes. The OH-PCB congener profiles differed according to sex and collection sites, possibly because of variations in the expression levels of phase I and phase II enzymes among individual pigs, differences in the exposure sources, and maternal transfer of parent PCBs. The hepatic CYP1A expression levels were positively correlated with the blood concentrations of 4OH-CB107, 4OH-CB162, and 4OH-CB187, implying CYP1A-dependent formation of these OH-PCBs in the pig liver. We found no significant correlations between the blood concentrations of OH-PCBs and thyroid hormones (THs); however, the thyroxin (T-4) levels were lower in pigs from the DS than in pigs from the RS. Our limited dataset suggest that induced CYP enzymes accelerate the metabolism of xenobiotics and endogenous molecules in pigs. Thus, besides parental compounds, the risk of hydroxylated metabolites entering wildlife and humans living in and around municipal open waste dumping sites should be considered. (C) 2015 Elsevier Inc. All rights reserved.	[Mizukawa, Hazuki; Nomiyama, Kei; Kunisue, Tatsuya; Watanabe, Michio X.; Subramanian, Annamalai; Iwata, Hisato; Tanabe, Shinsuke] Ehime Univ, CMES, Matsuyama, Ehime 7908577, Japan; [Ishizuka, Mayumi] Hokkaido Univ, Grad Sch Vet Med, Toxicol Lab, Kita Ku, Sapporo, Hokkaido 0600818, Japan	Mizukawa, H (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Kita Ku, Kita 18,Nishi 9, Sapporo, Hokkaido 0600818, Japan.	hazuki.mizukawa@vetmed.hokudai.ac.jp	Tanabe, Shinsuke/G-6950-2013; Kunisue, Tatsuya/G-4171-2014	Kunisue, Tatsuya/0000-0002-8167-1564	Japan Society for the Promotion of Science (JSPS) [2589200104, 26220103, 25701014, 25241013]	This study was supported by Grants-in-Aid (KAKENHI) for Young Scientists (Start-up) (No. 2589200104), Scientific Research (S) (No. 26220103), Young Scientists (A) (No. 25701014), and Scientific Research (A) (No. 25241013) from the Japan Society for the Promotion of Science (JSPS).	Yamazaki K, 2011, J BIOCHEM, V149, P487, DOI 10.1093/jb/mvr009; Tanabe S, 2002, MAR POLLUT BULL, V45, P69, DOI 10.1016/S0025-326X(02)00175-3; Braathen M, 2004, ENVIRON HEALTH PERSP, V112, P826, DOI 10.1289/ehp.6809; Stapleton HM, 2009, ENVIRON HEALTH PERSP, V117, P197, DOI 10.1289/ehp.11807; Hale RC, 2003, ENVIRON INT, V29, P771, DOI 10.1016/S0160-4120(03)00113-2; Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200; Meerts IATM, 2002, TOXICOL SCI, V68, P361, DOI 10.1093/toxsci/68.2.361; Minh NH, 2003, ENVIRON SCI TECHNOL, V37, P1493, DOI 10.1021/es026078s; ISHIDA C, 1991, J PHARMACOBIO-DYNAM, V14, P276; Mizukawa H, 2013, ENVIRON POLLUT, V174, P28, DOI 10.1016/j.envpol.2012.11.004; Miyazaki W, 2004, J BIOL CHEM, V279, P18195, DOI 10.1074/jbc.M310531200; Malmberg T, 2005, ENVIRON SCI TECHNOL, V39, P5342, DOI 10.1021/es050574+; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; Koga N, 1996, BIOCHEM BIOPH RES CO, V225, P685, DOI 10.1006/bbrc.1996.1230; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Weber R, 2011, WASTE MANAGE RES, V29, P107, DOI 10.1177/0734242X10390730; Qatanani M, 2005, ENDOCRINOLOGY, V146, P995, DOI 10.1210/en.2004-1350; Malmvarn A, 2008, CHEMOSPHERE, V72, P910, DOI 10.1016/j.chemosphere.2008.03.036; McGraw JE, 2006, BIOCHEM BIOPH RES CO, V344, P129, DOI 10.1016/j.bbrc.2006.03.122; Ucan-Marin F, 2010, ENVIRON SCI TECHNOL, V44, P497, DOI 10.1021/es902691u; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Marchesini GR, 2008, TOXICOL APPL PHARM, V232, P150, DOI [10.1016/j.taap.2008.06.014, 10.1016/j.tiap.2008.06.014]; Marchesini GR, 2006, ANAL CHEM, V78, P1107, DOI 10.1021/ac051399i; Eguchi A, 2013, CHEMOSPHERE, V90, P2365, DOI 10.1016/j.chemosphere.2012.10.027; Nomiyama K, 2011, ENVIRON POLLUT, V159, P3364, DOI 10.1016/j.envpol.2011.08.035; Ucan-Marin F, 2009, TOXICOL SCI, V107, P440, DOI 10.1093/toxsci/kfn240; Park KJ, 2009, CHEMOSPHERE, V77, P1459, DOI 10.1016/j.chemosphere.2009.08.063; Qiu XH, 2007, ENVIRON HEALTH PERSP, V115, P1052, DOI 10.1289/ehp.10011; Wan Y, 2010, ENVIRON SCI TECHNOL, V44, P8729, DOI 10.1021/es102287q; Houde M, 2006, ENVIRON SCI TECHNOL, V40, P5860, DOI 10.1021/es060629n; Malmvarn A, 2005, ENVIRON SCI TECHNOL, V39, P2990, DOI 10.1021/es0482886; Montie EW, 2008, ANAT REC, V291, P263, DOI 10.1002/ar.20654; Nomiyama K, 2010, ENVIRON SCI TECHNOL, V44, P3732, DOI 10.1021/es1003928; LANS MC, 1993, CHEM-BIOL INTERACT, V88, P7, DOI 10.1016/0009-2797(93)90081-9; Kunisue T, 2009, CHEMOSPHERE, V74, P950, DOI 10.1016/j.chemosphere.2008.10.038; Hamers T, 2008, MOL NUTR FOOD RES, V52, P284, DOI 10.1002/mnfr.200700104; Anzenbacher P, 1998, DRUG METAB DISPOS, V26, P56; Cheek AO, 1998, ENVIRON HEALTH PERSP, V106, P5, DOI 10.2307/3433910; Chen H, 2000, DRUG METAB DISPOS, V28, P315; Chen S., 2005, J BIOL CHEM, V280, P3757; Cooper DA, 1997, J NUTR, V127, pS1555; Eguchi A, 2011, INT J ENVIRON AN CH, V91, P348, DOI 10.1080/03067319.2010.496040; Gebbink WA, 2008, ENVIRON POLLUT, V152, P621, DOI 10.1016/j.envpol.2007.07.001; Hites RA, 2004, ENVIRON SCI TECHNOL, V38, P4945, DOI [10.1021/es049548m, 10.1021/es049548n]; Hoekstra PF, 2003, ENVIRON TOXICOL CHEM, V22, P2650, DOI 10.1897/02-641; Hoogenboom LAP, 2004, CHEMOSPHERE, V57, P35, DOI 10.1016/j.chemosphere.2004.04.057; Jaspers VLB, 2008, ENVIRON SCI TECHNOL, V42, P3465, DOI 10.1021/es7030455; Kitamura S, 2005, TOXICOLOGY, V208, P377, DOI 10.1016/j.tox.2004.11.037; Kunisue T, 2007, MAR POLLUT BULL, V54, P963, DOI 10.1016/j.marpolbul.2007.02.017; Kunisue T, 2004, ARCH ENVIRON CON TOX, V47, P414, DOI 10.1007/s00244-004-3172-4; Malmberg T, 2004, XENOBIOTICA, V34, P581, DOI 10.1080/00498250410001713078; Minh NH, 2006, ARCH ENVIRON CON TOX, V50, P474, DOI 10.1007/s00244-005-1087-3; Nomiyama K, 2010, ENVIRON SCI TECHNOL, V44, P2890, DOI 10.1021/es9012432; Richardson KL, 2011, CHEM RES TOXICOL, V24, P718, DOI 10.1021/tx1004562; Sakai H, 2006, TOXICOL SCI, V94, P57, DOI 10.1093/toxsci/kfl088; Tanabe S, 2006, J ENVIRON MONITOR, V8, P782, DOI 10.1039/b602677j; Tien ES, 2007, J PHARMACOL EXP THER, V320, P307, DOI 10.1124/jpet.106.112706; Watanabe MX, 2005, ENVIRON SCI TECHNOL, V39, P4421, DOI 10.1021/es050057r; Watanabe MX, 2010, ENVIRON TOXICOL CHEM, V29, P1551, DOI 10.1002/etc.189; Weijs L, 2009, ENVIRON INT, V35, P842, DOI 10.1016/j.envint.2009.02.001; ZILE MH, 1992, P SOC EXP BIOL MED, V201, P141	61	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0013-9351	1096-0953		ENVIRON RES	Environ. Res.	APR	2015	138						255	263		10.1016/j.envres.2015.02.012		9	Environmental Sciences; Public, Environmental & Occupational Health	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CG1CT	WOS:000353011300028		
J	Kinoshita, E; Arashiba, K; Kuriyama, S; Eizawa, A; Nakajima, K; Nishibayashi, Y				Kinoshita, Eriko; Arashiba, Kazuya; Kuriyama, Shogo; Eizawa, Aya; Nakajima, Kazunari; Nishibayashi, Yoshiaki			Synthesis and Catalytic Activity of Molybdenum-Nitride Complexes Bearing Pincer Ligands	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Nitrogen fixation; Nitrides; Ammonia; Molybdenum; Ligand design	TUNGSTEN-DINITROGEN COMPLEXES; NUCLEAR MAGNETIC RESONANCE; MOLECULAR DINITROGEN; NITROGEN-FIXATION; N-2 CLEAVAGE; AMMONIA; REDUCTION; IRON; CONVERSION; FERROCENYLDIPHOSPHINE	Molybdenum-nitride complexes bearing pincer ligands have been designed, prepared, and characterized spectroscopically. The synthetic method described in this paper provides a convenient and useful approach to the preparation of cationic molybdenum(V)-nitride complexes that may act as catalysts for the formation of ammonia from molecular dinitrogen under ambient reaction conditions..	[Kinoshita, Eriko; Arashiba, Kazuya; Kuriyama, Shogo; Eizawa, Aya; Nakajima, Kazunari; Nishibayashi, Yoshiaki] Univ Tokyo, Sch Engn, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan	Nishibayashi, Y (reprint author), Univ Tokyo, Sch Engn, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan.	ynishiba@sogo.t.u-tokyo.ac.jp	Nishibayashi, Yoshiaki/E-9230-2010		Japan Society for the Promotion of Science (JSPS) [26288044, 26620075, 26105708]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	The authors thank the Japan Society for the Promotion of Science (JSPS) for a Grant-in-Aid for Scientific Research (grant numbers 26288044, 26620075, and 26105708) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). S. K. is a recipient of a JSPS Predoctoral Fellowship for Young Scientists. The authors also thank the Research Hub for Advanced Nano Characterization at The University of Tokyo for X-ray analysis.	ADACHI T, 1995, J CHEM SOC CHEM COMM, P1081, DOI 10.1039/c39950001081; Miyazaki T, 2013, CHEM-EUR J, V19, P11874, DOI 10.1002/chem.201302700; van der Ham CJM, 2014, CHEM SOC REV, V43, P5183, DOI 10.1039/c4cs00085d; Semproni SP, 2013, J AM CHEM SOC, V135, P11373, DOI 10.1021/ja405477m; Nishibayashi Y, 2012, DALTON T, V41, P7447, DOI 10.1039/c2dt30105a; Chavez I, 2000, J ORGANOMET CHEM, V601, P126, DOI 10.1016/S0022-328X(00)00044-9; MacLeod KC, 2014, J AM CHEM SOC, V136, P10226, DOI 10.1021/ja505193z; Anderson JS, 2013, NATURE, V501, P84, DOI 10.1038/nature12435; Zhang J, 2006, INORG CHIM ACTA, V359, P1955, DOI 10.1016/j.ica.2005.11.039; Benito-Garagorri D, 2006, ORGANOMETALLICS, V25, P1900, DOI 10.1021/om0600644; Ishida Y, 2014, J AM CHEM SOC, V136, P16990, DOI 10.1021/ja510317h; Schrock RR, 2008, ANGEW CHEM INT EDIT, V47, P5512, DOI 10.1002/anie.200705246; SHIINA K, 1972, J AM CHEM SOC, V94, P9266, DOI 10.1021/ja00781a068; Hinrichsen S, 2012, ANNU REP PROG CHEM A, V108, P17, DOI 10.1039/c2ic90033e; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326; Jia HP, 2014, CHEM SOC REV, V43, P547, DOI 10.1039/c3cs60206k; MacLeod KC, 2013, NAT CHEM, V5, P559, DOI [10.1038/nchem.1620, 10.1038/NCHEM.1620]; Suess DLM, 2013, J AM CHEM SOC, V135, P4938, DOI 10.1021/ja400836u; Fryzuk MD, 2013, CHEM COMMUN, V49, P4866, DOI 10.1039/c3cc42001a; Tanaka H, 2011, J AM CHEM SOC, V133, P3498, DOI 10.1021/ja109181n; Creutz SE, 2014, J AM CHEM SOC, V136, P1105, DOI 10.1021/ja4114962; Mori M, 2004, J ORGANOMET CHEM, V689, P4210, DOI 10.1016/j.jorganchem.2004.05.053; Weare WW, 2006, P NATL ACAD SCI USA, V103, P17099, DOI 10.1073/pnas.0602778103; Arashiba K, 2012, ORGANOMETALLICS, V31, P2035, DOI 10.1021/om300011z; Mock MT, 2013, J AM CHEM SOC, V135, P11493, DOI 10.1021/ja405668u; Kinoshita E, 2012, ORGANOMETALLICS, V31, P8437, DOI 10.1021/om301046t; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Broda H, 2013, COORDIN CHEM REV, V257, P587, DOI 10.1016/j.ccr.2012.05.010; Miyazaki T, 2014, ANGEW CHEM INT EDIT, V53, P11488, DOI 10.1002/anie.201405673; Arashiba K, 2011, NAT CHEM, V3, P120, DOI [10.1038/nchem.906, 10.1038/NCHEM.906]; KOMORI K, 1989, J AM CHEM SOC, V111, P1939, DOI 10.1021/ja00187a092; Bain GA, 2008, J CHEM EDUC, V85, P532; Gradert C, 2015, CHEM-EUR J, V21, P1130, DOI 10.1002/chem.201405737; Tanabe Y, 2013, COORDIN CHEM REV, V257, P2551, DOI 10.1016/j.ccr.2013.02.010; Hebden TJ, 2012, CHEM COMMUN, V48, P1851, DOI 10.1039/c2cc17634c; Kuriyama S, 2014, J AM CHEM SOC, V136, P9719, DOI 10.1021/ja5044243; [Anonymous], 2014, DALTON TRANS; Oztopcu O, 2013, ORGANOMETALLICS, V32, P3042, DOI 10.1021/om400254k; [Anonymous], 2000, CRYSTALSTRUCTURE VER, P2000; Arashiba K, 2015, Z ANORG ALLG CHEM, V641, P100, DOI 10.1002/zaac.201400117; Beurskens P. T., 1999, THE DIRDIF 99 PROGRA; Burla M.C., 2003, J APPL CRYSTALLOGR, V36, P1103, DOI 10.1107/S0021889803012585; EVANS DF, 1959, J CHEM SOC, P2003, DOI 10.1039/jr9590002003; Khoenkhoen Y. N., 2015, EUR J INORG CHEM, P567; Kthe C., 2015, Z ANORG ALLG CHEM, V641, P18; Liao Q., 2014, ANGEW CHEM, V126, P14430; Liao Q, 2014, ANGEW CHEM INT EDIT, V53, P14206, DOI 10.1002/anie.201408664; LIVE DH, 1970, ANAL CHEM, V42, P791, DOI 10.1021/ac60289a028; Margulieux GW, 2014, ANGEW CHEM INT EDIT, V53, P14211, DOI 10.1002/anie.201408725; Margulieux G. W., 2014, ANGEW CHEM, V126, P14435; Neumann H, 2008, ANGEW CHEM INT EDIT, V47, P4887, DOI 10.1002/anie.200800994; Schrock RR, 2005, ACCOUNTS CHEM RES, V38, P955, DOI 10.1021/ar0501121; Schrock R.R., 2008, ANGEW CHEM, V120, P5594, DOI 10.1002/ange.200705246; Stoffelbach F, 2001, EUR J INORG CHEM, P2699; Tanaka H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4737; Ung G, 2015, ANGEW CHEM INT EDIT, V54, P532, DOI 10.1002/anie.201409454; Ung G., 2015, ANGEW CHEM, V127, P542; WEATHERB.MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Yuki M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2264	59	5	5	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	APR	2015		10					1789	1794		10.1002/ejic.201500017		6	Chemistry, Inorganic & Nuclear	Chemistry	CF4DR	WOS:000352499400017		
J	Martin, L; Akutsu, H; Horton, PN; Hursthouse, MB; Harrington, RW; Clegg, W				Martin, Lee; Akutsu, Hiroki; Horton, Peter N.; Hursthouse, Michael B.; Harrington, Ross W.; Clegg, William			Chiral Radical-Cation Salts of BEDT-TTF Containing a Single Enantiomer of Tris(oxalato)aluminate(III) and -chromate(III)	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						BEDT-TTF; Semiconductors; Chirality; Conductivity; Magnetic properties	CHARGE-TRANSFER SALTS; PHYSICAL-PROPERTIES; MOLECULAR CONDUCTORS; GUEST MOLECULES; MAGNETIC METAL; BIS(ETHYLENEDITHIO)TETRATHIAFULVALENE; SUPERCONDUCTORS; ANION; NH4; CR	Radical-cation salts of BEDT-TTF with chiral anions provide the opportunity to combine chirality with conductivity in the same molecular material. We report here two salts, (BEDT-TTF)(3)NaAl(C2O4)(3<bold>)nitromethane and </bold>(BEDT-TTF)(3)(NH4)(0.83)Cr-1.17(C2O4)(3<bold>)nitromethane</bold>. The former crystallises in space group P2(1) and the latter in P2(1)2(1)2(1). The use of nitromethane alone as the electrolyte for electrocrystallisation produces no crystals, but the addition of chiral (R)-(-)-carvone yields crystals of these two new chiral radical-cation salts of BEDT-TTF through chiral induction from racemic tris(oxalato)aluminate(III) and tris(oxalato)chromate starting materials. The honeycomb anion layers in these salts contain a single enantiomer of tris(oxalato)metallate and creates hexagonal cavities that are smaller than those found in the superconducting salts in this tris(oxalate)metallate family, which gives preference for smaller solvents to be included, such as nitromethane. The chromium salt has a non-stoichiometric composition of the anion layer, which provides an electron doping effect to the donor layer.	[Martin, Lee] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Akutsu, Hiroki] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka 5600043, Japan; [Akutsu, Hiroki] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan; [Horton, Peter N.; Hursthouse, Michael B.] Univ Southampton, Sch Chem, Fac Nat & Environm Sci, Southampton SO17 1BJ, Hants, England; [Harrington, Ross W.; Clegg, William] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Martin, L (reprint author), Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.	lee.martin@ntu.ac.uk			Royal Society of Chemistry; Royal Society [RG100853, RG081209, IE130367, JP0869972]; EPSRC	L. M. thanks the Royal Society of Chemistry for a Journals Grant for International Authors. This work has been supported by the Royal Society [Research Grants (RG100853 and RG081209), International Exchange Scheme (IE130367), and International Joint Project (JP0869972)]. We thank EPSRC for funding the National Crystallography Service, and STFC for access to diffraction facilities at SRS station 9.8.	Akutsu H, 2004, CHEM COMMUN, P18, DOI 10.1039/b310683g; Avarvari N, 2009, J MATER CHEM, V19, P4061, DOI 10.1039/b820598a; Rikken GLJA, 1997, NATURE, V390, P493, DOI 10.1038/37323; Prokhorova TG, 2011, CRYSTENGCOMM, V13, P537, DOI 10.1039/c0ce00095g; Prokhorova TG, 2003, ADV FUNCT MATER, V13, P403, DOI 10.1002/adfm.200304283; KURMOO M, 1995, J AM CHEM SOC, V117, P12209, DOI 10.1021/ja00154a022; Rashid S, 2001, J MATER CHEM, V11, P2095, DOI 10.1039/b101134k; Martin L, 2001, INORG CHEM, V40, P1363, DOI 10.1021/ic001193u; Martin L, 2010, CRYSTENGCOMM, V12, P1369, DOI 10.1039/b916136h; Zorina LV, 2011, CRYSTENGCOMM, V13, P2430, DOI 10.1039/c0ce00804d; Coronado E, 2012, INORG CHEM, V51, P1111, DOI 10.1021/ic202269x; Rikken GLJA, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.236602; Turner SS, 1999, INORG CHEM, V38, P3543, DOI 10.1021/ic990102u; Coronado E, 2005, J MATER CHEM, V15, P1429, DOI 10.1039/b500107m; Martin L, 2010, J MATER CHEM, V20, P2738, DOI 10.1039/b920224b; Coronado E, 2004, INORG CHEM, V43, P8072, DOI 10.1021/ic049257e; Guionneau P, 1997, SYNTHETIC MET, V86, P1973, DOI 10.1016/S0379-6779(97)80983-6; Martin L, 1999, SYNTHETIC MET, V102, P1638, DOI 10.1016/S0379-6779(98)00240-9; Martin L, 2007, CRYSTENGCOMM, V9, P865, DOI 10.1039/b709558a; Martin L, 2014, CRYSTENGCOMM, V16, P5424, DOI 10.1039/c4ce00116h; Atzori M, 2014, INORG CHEM, V53, P7028, DOI 10.1021/ic501001r; Bailar J. C., 1939, INORG SYNTH, V1, P35, DOI 10.1002/9780470132326.ch13; Benmansour S, 2014, EUR J INORG CHEM, P3949, DOI 10.1002/ejic.201402023; Clemente-Leon M, 2007, INORG CHIM ACTA, V360, P955, DOI 10.1016/j.ica.2006.07.025; Coronado E, 2005, SYNTHETIC MET, V154, P245, DOI 10.1016/j.synthmet.2005.07.061; WALLIS JD, 1986, HELV CHIM ACTA, V69, P69, DOI 10.1002/hlca.19860690110; Gomez-Garcia CJ, 2006, CHEM COMMUN, P4931, DOI 10.1039/b610408h; Krstic V, 2002, CHEM PHYS LETT, V364, P51, DOI 10.1016/S0009-2614(02)01243-5; Madalan AM, 2008, NEW J CHEM, V32, P333, DOI 10.1039/b713030a; Pop F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4757; Rashid S, 2000, INORG CHEM, V39, P2426, DOI 10.1021/ic991409w	31	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	APR	2015		11					1865	1870		10.1002/ejic.201500092		6	Chemistry, Inorganic & Nuclear	Chemistry	CF8JI	WOS:000352803900003		
J	Chung, G; Saito, M; Kawasaki, Y; Kawano, T; Yin, DX; Lee, S; Kogo, M; Takada, M; Bae, YC; Kim, JS; Oh, SB; Kang, Y				Chung, Gehoon; Saito, Mitsuru; Kawasaki, Yasuhiro; Kawano, Tsutomu; Yin, Dongxu; Lee, Soojung; Kogo, Mikihiko; Takada, Masahiko; Bae, Yong Chul; Kim, Joong Soo; Oh, Seog Bae; Kang, Youngnam			Generation of resonance-dependent oscillation by mGluR-I activation switches single spiking to bursting in mesencephalic trigeminal sensory neurons	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						burst firing; mesencephalic trigeminal nucleus; metabotropic glutamate receptor; persistent sodium current; primary sensory neurons	PROTEIN-KINASE-C; ROOT GANGLION NEURONS; METABOTROPIC GLUTAMATE-RECEPTOR; NEOCORTICAL PYRAMIDAL NEURONS; PERSISTENT SODIUM CURRENT; MUSCLE-SPINDLE AFFERENTS; V NEURONS; MEMBRANE EXCITABILITY; HIPPOCAMPAL-NEURONS; POTASSIUM CURRENTS	The primary sensory neurons supplying muscle spindles of jaw-closing muscles are unique in that they have their somata in the mesencephalic trigeminal nucleus (MTN) in the brainstem, thereby receiving various synaptic inputs. MTN neurons display bursting upon activation of glutamatergic synaptic inputs while they faithfully relay respective impulses arising from peripheral sensory organs. The persistent sodium current (I-NaP) is reported to be responsible for both the generation of bursts and the relay of impulses. We addressed how I-NaP is controlled either to trigger bursts or to relay respective impulses as single spikes in MTN neurons. Protein kinase C (PKC) activation enhanced I-NaP only at low voltages. Spike generation was facilitated by PKC activation at membrane potentials more depolarized than the resting potential. By injection of a ramp current pulse, a burst of spikes was triggered from a depolarized membrane potential whereas its instantaneous spike frequency remained almost constant despite the ramp increases in the current intensity beyond the threshold. A puff application of glutamate preceding the ramp pulse lowered the threshold for evoking bursts by ramp pulses while chelerythrine abolished such effects of glutamate. Dihydroxyphenylglycine, an agonist of mGluR1/5, also caused similar effects, and increased both the frequency and impedance of membrane resonance. Immunohistochemistry revealed that glutamatergic synapses are made onto the stem axons, and that mGluR1/5 and Nav1.6 are co-localized in the stem axon. Taken together, glutamatergic synaptic inputs onto the stem axon may be able to switch the relaying to the bursting mode.	[Chung, Gehoon; Saito, Mitsuru; Kawasaki, Yasuhiro; Kawano, Tsutomu; Yin, Dongxu; Kogo, Mikihiko; Kang, Youngnam] Osaka Univ, Grad Sch Dent, Dept Neurosci & Oral Physiol, Suita, Osaka 5650871, Japan; [Chung, Gehoon; Kim, Joong Soo; Oh, Seog Bae] Seoul Natl Univ, Pain Cognit Funct Res Ctr, Dent Res Inst, Seoul 151742, South Korea; [Chung, Gehoon; Kim, Joong Soo; Oh, Seog Bae] Seoul Natl Univ, Dept Neurobiol & Physiol, Sch Dent, Seoul 151742, South Korea; [Lee, Soojung] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Tissue Regenerat, Seoul, South Korea; [Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan; [Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat, Daegu, South Korea; [Oh, Seog Bae] Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul 151742, South Korea	Kang, Y (reprint author), Osaka Univ, Grad Sch Dent, Dept Neurosci & Oral Physiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	odolbae@snu.ac.kr; kang@dent.osaka-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [22300127]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2012R1A3A2048834, NRF-2014S1A2A2028387, MEST 2008-0062282]	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (No. 22300127 to Y. Kang), and also supported by the National Research Foundation of Korea (NRF) grant (NRF-2012R1A3A2048834 to S.B.O.; NRF-2014S1A2A2028387 to G.C.; MEST 2008-0062282 to Y.C.B.) funded by the Korea government (MSIP).	Westberg KG, 2000, EUR J NEUROSCI, V12, P1145, DOI 10.1046/j.1460-9568.2000.00001.x; Pelkey KA, 1998, CAN J PHYSIOL PHARM, V76, P900, DOI 10.1139/cjpp-76-9-900; Verdier D, 2004, J NEUROPHYSIOL, V92, P2444, DOI 10.1152/jn.00279.2004; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683; Kole MHP, 2011, NEURON, V71, P671, DOI 10.1016/j.neuron.2011.06.024; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Gorelova NA, 2000, J NEUROPHYSIOL, V84, P75; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; PUIL E, 1994, J NEUROPHYSIOL, V71, P575; Turman JE, 2001, DEV NEUROSCI-BASEL, V23, P41; Astman N, 1998, J NEUROPHYSIOL, V80, P1547; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; PUIL E, 1986, J NEUROPHYSIOL, V55, P995; Astman N, 2006, J NEUROSCI, V26, P3465, DOI 10.1523/JNEUROSCI.4907-05.2006; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; Carlier E, 2006, J PHYSIOL-LONDON, V577, P141, DOI 10.1113/jphysiol.2006.118026; DelsNegro C. A., 1997, J NEUROPHYSIOL, V77, P537; Enomoto A, 2007, J NEUROPHYSIOL, V98, P710, DOI 10.1152/jn.00292.2007; Everill B, 1998, J NEUROPHYSIOL, V79, P1814; Franceschetti S, 2000, J PHYSIOL-LONDON, V528, P291, DOI 10.1111/j.1469-7793.2000.00291.x; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621; Hidaka O, 1999, J NEUROPHYSIOL, V82, P2633; HINRICHS.CF, 1970, AM J ANAT, V127, P303, DOI 10.1002/aja.1001270306; Hsiao CF, 2009, J NEUROPHYSIOL, V101, P1407, DOI 10.1152/jn.91053.2008; Kang YN, 2007, J NEUROPHYSIOL, V97, P2385, DOI 10.1152/jn.01191.2006; Kang YN, 2004, J NEUROSCI, V24, P3694, DOI 10.1523/JNEUROSCI.5641-03.2004; Leao RM, 2005, J NEUROSCI, V25, P3724, DOI 10.1523/JNEUROSCI.3983-04.2005; Levin SI, 2004, GENESIS, V39, P234, DOI 10.1002/gene.20050; Levy M, 1998, J BIOL CHEM, V273, P6495, DOI 10.1074/jbc.273.11.6495; LIEM RSB, 1992, ACTA ANAT, V143, P74; Pedroarena CM, 1999, J NEUROPHYSIOL, V82, P1465; PUIL E, 1988, NEUROSCIENCE, V24, P635, DOI 10.1016/0306-4522(88)90357-0; PUIL E, 1987, J NEUROPHYSIOL, V58, P66; Saito M, 2006, J NEUROPHYSIOL, V96, P1887, DOI 10.1152/jn.00176.2006; Wu NP, 2001, J NEUROSCI, V21, P3729; Wu NP, 2005, J NEUROPHYSIOL, V93, P2710, DOI 10.1152/jn.00636.2004; WU RL, 1992, J NEUROSCI, V12, P2235	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2015	41	8					998	1012		10.1111/ejn.12858		15	Neurosciences	Neurosciences & Neurology	CG4BT	WOS:000353226700001		
J	Saito, Y; Zhang, Y; Yanagawa, Y				Saito, Yasuhiko; Zhang, Yue; Yanagawa, Yuchio			Electrophysiological and morphological properties of neurons in the prepositus hypoglossi nucleus that express both ChAT and VGAT in a double-transgenic rat model	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						afterhyperpolarization; cholinergic; firing pattern; GABAergic; whole-cell recording	MEDIAL VESTIBULAR NUCLEUS; GAMMA-AMINOBUTYRIC-ACID; INTRINSIC MEMBRANE-PROPERTIES; CHOLINERGIC AMACRINE CELLS; NEURAL-NETWORK MODEL; GABAERGIC NEURONS; OCULOMOTOR SYSTEM; INFERIOR OLIVE; INHIBITORY NEURONS; RABBIT RETINA	Although it has been proposed that neurons that contain both acetylcholine (ACh) and -aminobutyric acid (GABA) are present in the prepositus hypoglossi nucleus (PHN), these neurons have not been characterized because of the difficulty in identifying them. In the present study, PHN neurons that express both choline acetyltransferase and the vesicular GABA transporter (VGAT) were identified using double-transgenic rats, in which the cholinergic and inhibitory neurons express the fluorescent proteins tdTomato and Venus, respectively. To characterize the neurons that express both tdTomato and Venus (D+ neurons), the afterhyperpolarization (AHP) profiles and firing patterns of these neurons were investigated via whole-cell recordings of brainstem slice preparations. Regarding the three AHP profiles and four firing patterns that the D+ neurons exhibited, an AHP with an afterdepolarization and a firing pattern that exhibited a delay in the generation of the first spike were the preferential properties of these neurons. In the three morphological types classified, the multipolar type that exhibited radiating dendrites was predominant among the D+ neurons. Immunocytochemical analysis revealed that the VGAT-immunopositive axonal boutons that expressed tdTomato were primarily located in the dorsal cap of inferior olive (IO) and the PHN. Although the PHN receives cholinergic inputs from the pedunculopontine tegmental nucleus and laterodorsal tegmental nucleus, D+ neurons were absent from these brain areas. Together, these results suggest that PHN neurons that co-express ACh and GABA exhibit specific electrophysiological and morphological properties, and innervate the dorsal cap of the IO and the PHN.	[Saito, Yasuhiko; Zhang, Yue; Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gumma 371, Japan; [Saito, Yasuhiko] Nara Med Univ, Dept Neurophysiol, Kashihara, Nara 6348521, Japan; [Zhang, Yue] Gunma Univ, HRCC, Kiryu, Gumma 376, Japan; [Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Saito, Y (reprint author), Nara Med Univ, Dept Neurophysiol, Kashihara, Nara 6348521, Japan.	syasu@naramed-u.ac.jp			Takeda Science Foundation; MEXT; JSPS; Co-operative Program of the National Institute for Physiological Sciences, Japan	The authors thank Prof. Chitoshi Takayama for providing the anti-VGAT antibody, Ryosuke Kaneko, Keiko Harada and Ayako Morita for technical assistance, and the members of our lab for helpful comments. The authors also thank the staff of the Institute of Experimental Animal Research, Gunma University Graduate School of Medicine for technical support. This work was supported by funding from the Takeda Science Foundation, a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from MEXT, a Grant-in-Aid for Scientific Research from JSPS, and a grant from the Co-operative Program of the National Institute for Physiological Sciences, Japan.	Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Ito T, 2007, J COMP NEUROL, V502, P113, DOI 10.1002/cne.21309; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Santos PF, 1998, EUR J NEUROSCI, V10, P2723, DOI 10.1046/j.1460-9568.1998.00281.x; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Navarro-Lopez JD, 2004, J NEUROSCI, V24, P5109, DOI 10.1523/JNEUROSCI.0235-04.2004; Burnstock G, 2004, CURR OPIN PHARMACOL, V4, P47, DOI 10.1016/j.coph.2003.08.001; McCrea RA, 2006, PROG BRAIN RES, V151, P205, DOI 10.1016/S0079-6123(05)51007-0; BURNSTOCK G, 1976, NEUROSCIENCE, V1, P239, DOI 10.1016/0306-4522(76)90054-3; Uematsu M, 2008, CEREB CORTEX, V18, P315, DOI 10.1093/cercor/bhm056; Smith MR, 2002, J NEUROPHYSIOL, V87, P2031, DOI 10.1152/jn.00821.2001; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; OJIMA H, 1989, J COMP NEUROL, V290, P41, DOI 10.1002/cne.902900104; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; FUKUSHIMA K, 1992, PROG NEUROBIOL, V39, P609, DOI 10.1016/0301-0082(92)90016-8; KOSAKA T, 1988, EXP BRAIN RES, V70, P605; BARMACK NH, 1992, J COMP NEUROL, V317, P233, DOI 10.1002/cne.903170303; Saito Y, 2008, EUR J NEUROSCI, V28, P288, DOI 10.1111/j.1460-9568.2008.06338.x; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Takayama C, 2004, NEUROSCI RES, V50, P447, DOI 10.1016/j.neures.2004.08.012; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; HajDahmane S, 1997, J NEUROPHYSIOL, V78, P1983; Czubayko U, 2001, J NEUROPHYSIOL, V85, P2017; Eugene D, 2011, EXP BRAIN RES, V210, P423, DOI 10.1007/s00221-011-2569-3; Arts MP, 2000, J NEUROPHYSIOL, V84, P2552; OMALLEY DM, 1989, P NATL ACAD SCI USA, V86, P3414, DOI 10.1073/pnas.86.9.3414; Bayraktar T, 1997, BRAIN RES, V757, P209, DOI 10.1016/S0006-8993(97)00218-7; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Jaarsma D, 1997, PROG BRAIN RES, V114, P67; Arima J, 2001, J PHYSIOL-LONDON, V534, P99, DOI 10.1111/j.1469-7793.2001.00099.x; BARMACK NH, 1993, J COMP NEUROL, V328, P263, DOI 10.1002/cne.903280208; Barmack NH, 2006, PROG BRAIN RES, V151, P269, DOI 10.1016/S0079-6123(05)51009-4; Beraneck Mathieu, 2012, Front Neurol, V3, P25, DOI 10.3389/fneur.2012.00025; Boehmer G, 2000, J PHYSIOL-LONDON, V526, P115, DOI 10.1111/j.1469-7793.2000.t01-1-00115.x; BROWN DA, 1990, PROG BRAIN RES, V83, P141; Caffe AR, 1996, BRAIN RES, V724, P136, DOI 10.1016/0006-8993(96)00286-7; CAMPBELL G, 1987, ANNU REV PHARMACOL, V27, P51; CANNON SC, 1985, BIOL CYBERN, V53, P93, DOI 10.1007/BF00337026; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; Cui GH, 2004, J NEUROSCI, V24, P11079, DOI 10.1523/JNEUROSCI.2713-04.2004; Delgado-Garcia JM, 2006, PROG BRAIN RES, V154, P211, DOI 10.1016/S0079-6123(06)54011-7; Draye JP, 1997, BIOL CYBERN, V76, P365, DOI 10.1007/s004220050350; FORD B, 1995, J COMP NEUROL, V363, P177, DOI 10.1002/cne.903630203; FUKUSHIMA K, 1995, NEUROSCI RES, V22, P249, DOI 10.1016/0168-0102(95)00904-8; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P210; HIGO S, 1990, BRAIN RES, V536, P79, DOI 10.1016/0006-8993(90)90011-Y; Idoux E, 2008, J NEUROPHYSIOL, V100, P1278, DOI 10.1152/jn.90559.2008; Idoux E, 2006, J NEUROPHYSIOL, V96, P175, DOI 10.1152/jn.01355.2005; Ito T, 2005, BRAIN RES, V1046, P234, DOI 10.1016/j.brainres.2005.04.018; Iwasaki H, 1999, NEUROSCIENCE, V93, P195, DOI 10.1016/S0306-4522(99)00151-7; JOHNSTON AR, 1994, J PHYSIOL-LONDON, V481, P61; Klement G, 2010, J NEUROPHYSIOL, V103, P2900, DOI 10.1152/jn.00566.2009; KLINK R, 1993, J NEUROPHYSIOL, V70, P144; Lefler Y, 2014, NEURON, V81, P1389, DOI 10.1016/j.neuron.2014.02.032; MCCREA RA, 1985, J COMP NEUROL, V237, P360, DOI 10.1002/cne.902370307; Moschovakis A K, 1997, Front Biosci, V2, pd552; Navarro-Lopez JD, 2005, J NEUROSCI, V25, P9902, DOI 10.1523/JNEUROSCI.2061-05.2005; NEAL MJ, 1992, NEUROCHEM INT, V20, P43, DOI 10.1016/0197-0186(92)90124-A; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; Robinson DA, 1975, BASIC MECH OCULAR MO, P337; Rossert C, 2011, EXP BRAIN RES, V210, P437, DOI 10.1007/s00221-011-2585-3; Saito Y, 2013, J NEUROPHYSIOL, V109, P389, DOI 10.1152/jn.00617.2012; Saito Y, 1999, J NEUROPHYSIOL, V82, P754; Saito Y, 2012, NEUROSCI RES, V73, P32, DOI 10.1016/j.neures.2012.02.011; Saito Y, 2000, J PHYSIOL-LONDON, V528, P91, DOI 10.1111/j.1469-7793.2000.00091.x; SERAFIN M, 1991, EXP BRAIN RES, V84, P426, DOI 10.1007/BF00231465; Shino M, 2011, NEUROSCIENCE, V197, P89, DOI 10.1016/j.neuroscience.2011.09.017; Shino M, 2008, EUR J NEUROSCI, V27, P2413, DOI 10.1111/j.1460-9568.2008.06204.x; Takazawa T, 2004, J NEUROPHYSIOL, V92, P3106, DOI 10.1152/jn.00494.2004; Uusisaari M, 2007, J NEUROPHYSIOL, V97, P901, DOI 10.1152/jn.00974.2006; vonsEngelhardt J., 2007, J NEUROSCI, V27, P5633; Zhang Y, 2014, EUR J NEUROSCI, V39, P1294, DOI 10.1111/ejn.12509	77	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	APR	2015	41	8					1036	1048		10.1111/ejn.12878		13	Neurosciences	Neurosciences & Neurology	CG4BT	WOS:000353226700004		
J	Khan, KN; Kitajima, M; Hiraki, K; Fujishita, A; Nakashima, M; Masuzaki, H				Khan, Khaleque N.; Kitajima, Michio; Hiraki, Koichi; Fujishita, Akira; Nakashima, Masahiro; Masuzaki, Hideaki			Decreased expression of human heat shock protein 70 in the endometria and pathological lesions of women with adenomyosis and uterine myoma after GnRH agonist therapy	EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY			English	Article						Adenomyosis; Uterine myoma; HSP70; Inflammation; GnRHa	HEAT-SHOCK PROTEINS; HEPATOCYTE GROWTH-FACTOR; RECEPTOR 4-MEDIATED GROWTH; ECTOPIC ENDOMETRIUM; PERITONEAL-FLUID; MENSTRUAL-CYCLE; STROMAL CELLS; HSP90; HSP70; INFILTRATION	Objective: A prominent stress reaction in the pelvis of women with endometriosis and the role of human heat shock protein 70 (HSP70) in inflammation and the growth of endometriosis has been recently demonstrated. We report here expression of HSP70 in tissues derived from GnRH agonist (GnRHa)untreated and -treated women with adenomyosis and uterine myoma. Study design: This is a case-controlled biological study. Biopsy specimens were collected from pathological lesions and eutopic endometria/autologous myometria of 30 women with adenomyosis, 35 women with uterine myoma and 15 control women during laparoscopy, laparotomy and hysteroscopy. Fourteen women with adenomyosis and 20 women with uterine myoma were treated with GnRHa for a variable period of 3-6 months before surgery. The immunoexpressions of HSP70 and CD68-positive M phi in endometria, lesions/myometria were examined by immunohistochemistry. The immunoreactivity of HSP70 in tissues was analyzed by quantitative-histogram (Q-H) scores. Results: Comparing to control women, HSP70 immunoexpression was significantly higher in endometria/myometria and pathological lesions of women with adenomyosis and myoma. A significant positive correlation between Q-H scores of HSP70 and CD68-positive M phi numbers was found in the endometria derived from women with adenomyosis (r = 0388). Treatment with GnRHa significantly decreased Q-H scores of HSP70 in pathological lesions and endometria/myometria of women with adenomyosis and uterine myoma comparing to similar tissues derived from GnRHa-untreated women. Conclusion: A variable amount of tissue stress reaction occurred in endometria and pathological lesions of women adenomyosis and uterine myoma that can be effectively suppressed after GnRHa treatment. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Khan, Khaleque N.; Kitajima, Michio; Hiraki, Koichi; Masuzaki, Hideaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, Nagasaki 8528501, Japan; [Fujishita, Akira] Saiseikai Nagasaki Hosp, Nagasaki, Japan; [Nakashima, Masahiro] Atom Bomb Dis Inst, Dept Tumor & Diagnost Pathol, Nagasaki, Japan	Khan, KN (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Obstet & Gynecol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	nemokhan@nagasaki-u.ac.jp			Japan Society of the Promotion of Science [21592101, 24592474]	This work was supported in part by Grants-in-aid for Scientific Research (Grant nos. 21592101 and 24592474) from the Japan Society of the Promotion of Science (to KN Khan).	Khan KN, 2008, HUM REPROD, V23, P2210, DOI 10.1093/humrep/den195; Zugel U, 1999, IMMUNOBIOLOGY, V201, P22; Khan KN, 2004, ACTA OBSTET GYN SCAN, V83, P375, DOI 10.1111/j.0001-6349.2004.00229.x; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Khan KN, 2004, FERTIL STERIL, V81, P652, DOI 10.1016/j.fertnstert.2003.07.037; Khan KN, 2010, HUM REPROD, V25, P642, DOI 10.1093/humrep/dep437; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Imamura T, 2014, EUR J OBSTET GYN R B, V180, P16, DOI 10.1016/j.ejogrb.2014.06.002; Beere HM, 2000, NAT CELL BIOL, V2, P469; Benitez MJ, 2014, BBA-MOL CELL RES, V1843, P245, DOI 10.1016/j.bbamcr.2013.11.013; Chehna-Patel N, 2011, FERTIL STERIL, V95, P1560, DOI 10.1016/j.fertnstert.2011.01.122; Ishimaru T, 2004, FERTIL STERIL, V81, P810, DOI 10.1016/j.fertnstert.2003.09.037; Khan KN, 2005, HUM REPROD, V20, P2715, DOI 10.1093/humrep/dei156; Khan KN, 2006, ACTA OBSTET GYN SCAN, V85, P458, DOI 10.1080/00016340500432556; Khan KN, 2003, FERTIL STERIL, V79, P173, DOI 10.1016/S0015-0282(02)04535-1; Khan KN, 2014, REPROD SCI IN PRESS; Khan KN, 2002, ACTA OBSTET GYN SCAN, V81, P764, DOI 10.1034/j.1600-0412.2002.810814.x; Khan KN, 2013, HUM REPROD, V28, P2794, DOI 10.1093/humrep/det280; Komatsu T, 1997, J CLIN ENDOCR METAB, V82, P1385, DOI 10.1210/jc.82.5.1385; KOSHIYAMA M, 1995, J CLIN ENDOCR METAB, V80, P1106, DOI 10.1210/jc.80.4.1106; Miura S, 2006, HUM REPROD, V21, P2545, DOI 10.1093/humrep/del205; Ota H, 1997, FERTIL STERIL, V68, P23, DOI 10.1016/S0015-0282(97)81470-7; Tabibzadeh S, 1996, HUM REPROD, V11, P633	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-2115	1872-7654		EUR J OBSTET GYN R B	Eur. J. Obstet. Gynecol. Reprod. Biol.	APR	2015	187						6	13		10.1016/j.ejogrb.2015.01.012		8	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CG2GB	WOS:000353091800002		
J	Tanimura, K; Yamasaki, Y; Ebina, Y; Deguchi, M; Ueno, Y; Kitajima, K; Yamada, H				Tanimura, Kenji; Yamasaki, Yui; Ebina, Yasuhiko; Deguchi, Masashi; Ueno, Yoshiko; Kitajima, Kazuhiro; Yamada, Hideto			Prediction of adherent placenta in pregnancy with placenta previa using ultrasonography and magnetic resonance imaging	EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY			English	Article						Adherent placenta; Magnetic resonance imaging; Placenta previa; Prenatal diagnosis; Ultrasonography	PRIOR CESAREAN-SECTION; PRENATAL-DIAGNOSIS; ABNORMAL PLACENTATION; COLOR DOPPLER; ACCRETA; MRI; DELIVERIES; PERCRETA; WOMEN	Objective: Adherent placenta is a life-threatening condition in pregnancy, and is often complicated by placenta previa. The aim of this prospective study was to determine prenatal imaging findings that predict the presence of adherent placenta in pregnancies with placenta previa. Study design: The study included 58 consecutive pregnant women with placenta previa who underwent both ultrasonography and magnetic resonance imaging prenatally. Ultrasonographic findings of anterior placental location, grade 2 or higher placental lacunae (PL >= G2), loss of retroplacental hypoechoic clear zone (LCZ) and the presence of turbulent blood flow in the arteries were evaluated, in addition to MRI findings. Forty-three women underwent cesarean section alone; 15 women with adherent placenta underwent cesarean section followed by hysterectomy with pathological examination. To determine imaging findings that predict adherent placenta, univariate and multivariate logistic regression analyses were performed. Results: Univariate logistic regression analyses demonstrated that anterior placental location, PL >= G2, LCZ, and MRI were associated with the presence of adherent placenta. Multivariate analyses revealed that LCZ (p < 0.01, odds ratio 15.6, 95%Cl 2.1-114.6) was a single significant predictor of adherent placenta in women with placenta previa. Conclusion: This prospective study demonstrated for the first time that US findings, especially LCZ, might be useful for identifying patients at high risk for adherent placenta among pregnant women with placenta previa. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Tanimura, Kenji; Yamasaki, Yui; Ebina, Yasuhiko; Deguchi, Masashi; Yamada, Hideto] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Ueno, Yoshiko; Kitajima, Kazuhiro] Kobe Univ, Grad Sch Med, Dept Radiol, Kobe, Hyogo 6500017, Japan	Yamada, H (reprint author), Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yhideto@med.kobe-u.ac.jp					FINBERG HJ, 1992, J ULTRAS MED, V11, P333; Comstock CH, 2005, ULTRASOUND OBST GYN, V26, P89, DOI 10.1002/uog.1926; Grobman WA, 2007, OBSTET GYNECOL, V110, P1249, DOI 10.1097/01.AOG.0000292082.80566.cd; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Comstock CH, 2004, AM J OBSTET GYNECOL, V190, P1135, DOI 10.1016/j.ajog.2003.11.024; Yang JI, 2006, ULTRASOUND OBST GYN, V28, P178, DOI 10.1002/uog.2797; Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0; Taipale P, 2004, OBSTET GYNECOL, V104, P537, DOI 10.1097/01.AOG.0000136482.69152.7d; Chou MM, 2000, ULTRASOUND OBST GYN, V15, P28, DOI 10.1046/j.1469-0705.2000.00018.x; Wu S, 2005, AM J OBSTET GYNECOL, V192, P1458, DOI 10.1016/j.ajog.2004.12.074; Eller AG, 2009, BJOG-INT J OBSTET GY, V116, P648, DOI 10.1111/j.1471-0528.2008.02037.x; Bauer ST, 2009, SEMIN PERINATOL, V33, P88, DOI 10.1053/j.semperi.2008.12.003; Young BC, 2014, J PERINATOL, V34, P264, DOI 10.1038/jp.2013.185; Lax A, 2007, MAGN RESON IMAGING, V25, P87, DOI 10.1016/j.mri.2006.10.007; Derman AY, 2011, AM J ROENTGENOL, V197, P1514, DOI 10.2214/AJR.10.5443; Berkley EM, 2013, J ULTRAS MED, V32, P1345, DOI 10.7863/ultra.32.8.1345; Bowman ZS, 2014, AM J OBSTET GYNECOL, V211, pe1, DOI DOI 10.1016/J.AJ0G.2014.03.029.EPUB; Hudon L, 1998, Obstet Gynecol Surv, V53, P509, DOI 10.1097/00006254-199808000-00024; MCGAHAN JP, 1980, RADIOLOGY, V134, P475; PASTO ME, 1983, J ULTRAS MED, V2, P155; Rac MW, 2014, AM J OBSTET GYNECOL; THORP JM, 1992, OBSTET GYNECOL, V80, P506; Twickler D M, 2000, J Matern Fetal Med, V9, P330; Ueno Y, 2014, EUR RADIOL, V24, P881, DOI 10.1007/s00330-013-3076-7	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-2115	1872-7654		EUR J OBSTET GYN R B	Eur. J. Obstet. Gynecol. Reprod. Biol.	APR	2015	187						41	44		10.1016/j.ejogrb.2015.02.017		4	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	CG2GB	WOS:000353091800008		
J	Weerapol, Y; Limmatvapirat, S; Jansakul, C; Takeuchi, H; Sriamornsak, P				Weerapol, Yotsanan; Limmatvapirat, Sontaya; Jansakul, Chaweewan; Takeuchi, Hirofumi; Sriamornsak, Pornsak			Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: Effect of solid carriers and dietary state	EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS			English	Article						Poorly water-soluble drug; Nifedipine; Spontaneous emulsifying formulation; Spontaneous emulsifying powder; Silica derivatives; Porous calcium silicate	DRUG-DELIVERY SYSTEM; IN-VIVO EVALUATION; MESOPOROUS SILICA NANOPARTICLES; LIPID-BASED FORMULATIONS; WATER-SOLUBLE DRUGS; PORE SIZES; VITRO; ABSORPTION; RELEASE; OPTIMIZATION	The objective of this study was to prepare spontaneous emulsifying powder (SEP) for improving dissolution and enhancing oral bioavailability of a poorly water-soluble drug, nifedipine (NDP). In order to investigate the effects of solid carrier properties, such as surface area and pore size, and a concurrent food intake on absorption of NDP in rats, different SEP formulations were prepared by adsorbing liquid spontaneous emulsifying formulation (SEF), composing of polyoxyl 35 castor oil, caprylic/capric glyceride and diethylene glycol monoethyl ether at a ratio of 1:1:8, onto various solid carriers (i.e., silica (FS), porous calcium silicate (PCS) and porous silicon dioxide). The solid characterization by scanning electron microscopy, differential scanning calorimetry and powder X-ray diffraction revealed the absence of crystalline NDP in the formulations. SEP also demonstrated excellent spontaneous emulsification properties similar to SEF. The droplet size of emulsions formed after dilution was less than 200 nm. The solid carriers (particularly PCS) had significant and positive effect in drug dissolution; the mean dissolution time of SEP containing PCS was considerably improved. SEP also provided a good stability after storage in accelerated and long-term conditions for 6 months. The bioavailability study resulted in enhanced values of C-max and AUC for SEP formulations, when tested in both fasted and fed rats. Furthermore, comparing the AUC in fasted and fed rats, NDP powder exhibited a significant food effect. The difference in bioavailability of NDP in fed compared to fasted state can be avoided by using SEP. (C) 2015 Elsevier B.V. All rights reserved.	[Weerapol, Yotsanan; Limmatvapirat, Sontaya; Sriamornsak, Pornsak] Silpakorn Univ, Fac Pharm, Dept Pharmaceut Technol, Nakhon Pathom 73000, Thailand; [Weerapol, Yotsanan; Limmatvapirat, Sontaya; Sriamornsak, Pornsak] Silpakorn Univ, Fac Pharm, Pharmaceut Biopolymer Grp PBiG, Nakhon Pathom 73000, Thailand; [Jansakul, Chaweewan] Prince Songkla Univ, Fac Tradit Thai Med, Dept Thai Med, Hat Yai, Thailand; [Takeuchi, Hirofumi] Gifu Pharmaceut Univ, Lab Pharmaceut Engn, Gifu, Japan	Sriamornsak, P (reprint author), Silpakorn Univ, Fac Pharm, Dept Pharmaceut Technol, Nakhon Pathom 73000, Thailand.	sriamornsak_p@su.ac.th			Thailand Research Fund [BRG5480013]; Royal Golden Jubilee Ph.D. Program [PHD/0346/2550]	The authors wish to acknowledge The Thailand Research Fund for the financial support (Grant Number BRG5480013). YW is financially supported by the Royal Golden Jubilee Ph.D. Program (Grant Number PHD/0346/2550). Thanks to BASF (Thai) Co., Ltd. (Thailand), Gattefosse (France), Evonik Industries (Germany), Grace Davison (Germany), Eisai R&D Management Co., Ltd. (Japan), Freund Industrial Co., Ltd. (Japan) and Fuji Silysia Chemical, Ltd. (Japan) who kindly supported samples.	Albertini B, 2004, J CONTROL RELEASE, V100, P233, DOI 10.1016/j.jconrel.2004.08.013; Weerapol Y, 2014, AAPS PHARMSCITECH, V15, P456, DOI 10.1208/s12249-014-0078-y; Hauss DJ, 2007, ADV DRUG DELIVER REV, V59, P667, DOI 10.1016/j.addr.2007.05.006; Burapapadh K, 2012, EUR J PHARM BIOPHARM, V82, P250, DOI 10.1016/j.ejpb.2012.07.010; Wang LJ, 2009, J COLLOID INTERF SCI, V330, P443, DOI 10.1016/j.jcis.2008.10.077; Pouton CW, 2006, EUR J PHARM SCI, V29, P278, DOI 10.1016/j.ejps.2006.04.016; Jannin V, 2008, ADV DRUG DELIVER REV, V60, P734, DOI 10.1016/j.addr.2007.09.006; Patel AR, 2007, AAPS J, V9, pE344, DOI 10.1208/aapsj0903041; Woo JS, 2008, EUR J PHARM SCI, V33, P159, DOI 10.1016/j.ejps.2007.11.001; Hauss DJ, 1998, J PHARM SCI, V87, P164, DOI 10.1021/js970300n; Jia LJ, 2013, INT J PHARMACEUT, V445, P12, DOI 10.1016/j.ijpharm.2013.01.058; Gao Y, 2011, ACS NANO, V5, P9788, DOI 10.1021/nn2033105; Kawakami K, 2002, J CONTROL RELEASE, V81, P75, DOI 10.1016/S0168-3659(02)00050-0; Ito Y, 2005, J CONTROL RELEASE, V105, P23, DOI 10.1016/j.jconrel.2005.03.017; Agarwal V, 2009, INT J PHARM, V366, P44, DOI 10.1016/j.ijpharm.2008.08.046; Balakrishnan P, 2009, EUR J PHARM BIOPHARM, V72, P539, DOI 10.1016/j.ejpb.2009.03.001; Costa FO, 2003, J CONTROL RELEASE, V89, P199, DOI 10.1016/S0168-3659(03)00033-6; Pouton CW, 2000, EUR J PHARM SCI, V11, pS93, DOI 10.1016/S0928-0987(00)00167-6; AUNGST BJ, 1993, J PHARM SCI, V82, P979, DOI 10.1002/jps.2600821002; Apparaju S.K., 2007, INFORM HEALTHCARE, P29; Atef E, 2008, EUR J PHARM SCI, V35, P257, DOI 10.1016/j.ejps.2008.07.004; Barakat NS, 2010, DRUG DEVELOP RES, V71, P149, DOI 10.1002/ddr.20356; Chen ML, 2008, ADV DRUG DELIVER REV, V60, P768, DOI 10.1016/j.addr.2007.09.010; Jansakul C, 2012, EUR J PHARMACOL, V691, P235, DOI 10.1016/j.ejphar.2012.07.019; Kumpugdee-Vollrath M, 2014, ADV MAT RES, V970, P272, DOI 10.4028/www.scientific.net/AMR.970.272; Liu Y, 2009, INT J PHARM, V365, P136, DOI 10.1016/j.ijpharm.2008.08.009; Mendyk A, 2007, EXPERT SYST APPL, V32, P1124, DOI 10.1016/j.eswa.2006.02.019; Nepal PR, 2010, EUR J PHARM SCI, V39, P224, DOI 10.1016/j.ejps.2009.12.004; Nielsen FS, 2008, EUR J PHARM BIOPHARM, V69, P553, DOI 10.1016/j.ejpb.2007.12.020; UENO K, 1989, DICP ANN PHARMAC, V23, P662; Venkatesan N, 2005, BIOMATERIALS, V26, P7154, DOI 10.1016/j.biiomaterials.2005.05.012; Venkatesan N, 2006, INT J PHARM, V310, P46, DOI 10.1016/j.ijpharm.2005.11.014; Weerapol Y, 2015, POWDER TECHNOL, V271, P100, DOI 10.1016/j.powtec.2014.10.037; Weerapol Y, 2015, AAPS PHARMSCITECH; Yalkowsky S. H., 2010, HDB AQUEOUS SOLUBILI; Zhang QY, 2007, DRUG METAB DISPOS, V35, P1617, DOI 10.1124/dmd.107.016543	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0939-6411	1873-3441		EUR J PHARM BIOPHARM	Eur. J. Pharm. Biopharm.	APR	2015	91						25	34		10.1016/j.ejpb.2015.01.011		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG1YM	WOS:000353072100004		
J	Hamaguchi, E; Tanaka, K; Tsutsumi, R; Sakai, Y; Fukuta, K; Kasai, A; Tsutsumi, YM				Hamaguchi, E.; Tanaka, K.; Tsutsumi, R.; Sakai, Y.; Fukuta, K.; Kasai, A.; Tsutsumi, Y. M.			Exendin-4, glucagon-like peptide-1 receptor agonist, enhances isoflurane-induced preconditioning against myocardial infarction via caveolin-3 expression	European Review for Medical and Pharmacological Sciences			English	Article						Volatile anesthetic; Isoflurane; Exendin-4; Glucagon-like peptide-1; Preconditioning	ISCHEMIA-REPERFUSION INJURY; INDUCED CARDIAC PROTECTION; HEART; GLP-1; MICE	OBJECTIVE: To investigate the cardioprotective effects of isoflurane and exendin-4 against myocardial ischemia/reperfusion injury and the signaling pathways through which these effects are mediated. MATERIALS AND METHODS: For infarct size measurements, anesthetized mice were subjected to 30 min of coronary artery occlusion followed by 2 h of reperfusion. Wild-type or caveolin-3 knockout mice received isoflurane, exendin-4, or isoflurane with exendin-4 before ischemia index determination. Caveolin-3 expression in the heart was measured by immunoblotting. RESULTS: Myocardial infarct size was smaller in the isoflurane-[1.0 minimum alveolar concentration (MAC)] or exendin-4-(30 ng/kg i.v.) treated groups than the controls. Infarct size was not affected by isoflurane at 0.5 MAC or 3 ng/kg i.v. exendin-4, but the combination of these treatments reduced infarct size. Pharmacological preconditioning (isoflurane at 1.0 MAC, 30 ng/kg i.v. exendin-4, or isoflurane at 0.5 MAC with 3 ng/kg i.v. exendin-4) increased caveolin-3 protein expression in the heart after infarct induction. The cardioprotective effects of isoflurane, exendin-4, and isoflurane with exendin-4 were abolished in caveolin-3 knockout mice. CONCLUSIONS: The combination of isoflurane and exendin-4 reduced infarct size, but it was not more effective than either agent alone, and the cardioprotective effects of these agents are mediated by caveolin-3 expression.	[Hamaguchi, E.; Tanaka, K.; Sakai, Y.; Fukuta, K.; Kasai, A.; Tsutsumi, Y. M.] Univ Tokushima, Dept Anesthesiol, Tokushima 770, Japan; [Tsutsumi, R.] Univ Tokushima, Dept Nutr, Tokushima 770, Japan	Tsutsumi, R (reprint author), Univ Tokushima, Dept Nutr, Tokushima 770, Japan.	tsutsumi@tokushima-u.ac.jp			JSPS KAKENHI from Japan Society for the Promotion of Science, Tokyo [24592300, 25462404, 25462405, 26463071]	This study was funded in part by JSPS KAKENHI Numbers 24592300, 25462404, 25462405, and 26463071 from Japan Society for the Promotion of Science, Tokyo.	Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Ban K, 2010, ENDOCRINOLOGY, V151, P1520, DOI 10.1210/en.2009-1197; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Tanaka K, 2002, AM J PHYSIOL-HEART C, V282, pH2018, DOI 10.1152/ajpheart.01130.2001; Yamamoto H, 2002, J CLIN INVEST, V110, P43, DOI 10.1172/JCI200215595; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Nikolaidis LA, 2005, AM J PHYSIOL-HEART C, V289, pH2401, DOI 10.1152/ajpheart.00347.2005; Hirose K, 2011, ANESTHESIOLOGY, V115, P955, DOI 10.1097/ALN.0b013e31822fcede; Horikawa YT, 2014, CURR PHARM DESIGN, V20, P5681; Kawano T, 2012, ANESTH ANALG, V115, P62, DOI 10.1213/ANE.0b013e318253cbf0; Tsutsumi YM, 2010, ANESTHESIOLOGY, V112, P1136, DOI 10.1097/ALN.0b013e3181d3d624; Tsutsumi YM, 2006, ANESTHESIOLOGY, V104, P495, DOI 10.1097/00000542-200603000-00017; Tsutsumi YM, 2014, J ANESTH, V28, P733, DOI 10.1007/s00540-014-1816-8	15	0	0	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	APR	2015	19	7					1285	1290				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CG8TX	WOS:000353587000026		
J	Yokoyama, K; Kawanishi, M; Yamada, M; Tanaka, H; Ito, Y; Kawabata, S; Kuroiwa, T				Yokoyama, Kunio; Kawanishi, Masahiro; Yamada, Makoto; Tanaka, Hidekazu; Ito, Yutaka; Kawabata, Shinji; Kuroiwa, Toshihiko			Postoperative change in sagittal balance after Kyphoplasty for the treatment of osteoporotic vertebral compression fracture	EUROPEAN SPINE JOURNAL			English	Article						Kyphoplasty; Sagittal balance; Vertebral compression fracture	BALLOON KYPHOPLASTY; DEFORMITY CORRECTION; VERTEBROPLASTY; RESTORATION; ALIGNMENT; SPINE	The influence of vertebral cement augmentation on spinal sagittal balance is unknown. The present study aimed to analyze the changes in total spinal alignment after Kyphoplasty in VCF patients. The study involved 21 VCF patients who underwent Kyphoplasty. In all patients, lateral radiographs of the entire spine were taken preoperatively and 1 month after surgery, to measure the pelvic incidence (PI), sacral slope (SS), pelvic tilt (PT), lumbar lordosis (LL), sagittal vertical axis (SVA), and spinosacral angle (SSA). These parameters were compared between VCF patients and 30 healthy volunteers. In VCF patients, the parameters were compared before and after Kyphoplasty. In VCF patients, preoperative SVA was 7.00 +/- A 3.9 cm, showing a significant shift to anterior sagittal balance as compared to the healthy group (1.45 +/- A 2.7 cm) (P < 0.0001). Preoperative SS was smaller and PT was larger in VCF group than in the healthy group (P < 0.05). After Kyphoplasty, SVA decreased to 5.02 +/- A 2.91 (P = 0.0007) and LL and SSA increased (LL P = 0.028; SSA P = 0.0031). Postoperative decrease of SVA was correlated with the kyphotic change of treated vertebra (r = 0.792, P < 0.01). VAS score decreased from 7.98 +/- A 1.8 before Kyphoplasty to 2.38 +/- A 2.3 postoperatively (P < 0.0001). Total spinal alignment is shifted to anterior sagittal balance in VCF patients. Kyphoplasty plays a role not only in reducing pain associated with fractures but also in improving sagittal imbalance in the treatment of painful vertebral compression fracture.	[Yokoyama, Kunio; Kawanishi, Masahiro; Yamada, Makoto; Tanaka, Hidekazu; Ito, Yutaka] Takeda Gen Hosp, Dept Neurosurg, Fushimi Ku, Kyoto, Kyoto 6011495, Japan; [Kawabata, Shinji; Kuroiwa, Toshihiko] Osaka Med Coll Takatsuki, Dept Neurosurg, Osaka, Japan; [Kawabata, Shinji; Kuroiwa, Toshihiko] Osaka Med Coll Takatsuki, Dept Surg Pathol, Osaka, Japan	Yokoyama, K (reprint author), Takeda Gen Hosp, Dept Neurosurg, Fushimi Ku, 28-1 Ishidamoriminami Machi, Kyoto, Kyoto 6011495, Japan.	neu100@poh.osaka-med.ac.jp					Hiwatashi A, 2009, AM J NEURORADIOL, V30, P669, DOI 10.3174/ajnr.A1442; Voggenreiter G, 2005, SPINE, V30, P2806, DOI 10.1097/01.brs.0000190885.85675.a0; Zhu ZZ, 2014, SPINE, V39, pE1, DOI 10.1097/BRS.0000000000000022; Park SJ, 2011, NEUROSURGERY, V68, P355, DOI 10.1227/NEU.0b013e3182117249; Endo K, 2010, EUR SPINE J, V19, P435, DOI 10.1007/s00586-009-1240-1; JACKSON RP, 1994, SPINE, V19, P1611, DOI 10.1097/00007632-199407001-00010; Berven SH, 2003, SPINE, V28, P1710, DOI 10.1097/00007632-200308010-00015; Liu JT, 2010, OSTEOPOROSIS INT, V21, P359, DOI 10.1007/s00198-009-0952-8; Barrey C, 2013, EUR SPINE J, V22, pS834, DOI 10.1007/s00586-013-3030-z; Booth KC, 1999, SPINE, V24, P1712, DOI 10.1097/00007632-199908150-00013; Bozkurt Melih, 2014, Asian Spine J, V8, P27, DOI 10.4184/asj.2014.8.1.27; Cawley DT, 2011, J CLIN NEUROSCI, V18, P834, DOI 10.1016/j.jocn.2010.10.009; Gill J Brian, 2007, Pain Physician, V10, P583; Jang JS, 2007, J NEUROSURG-SPINE, V7, P387, DOI 10.3171/SPI-07/10/387; Kim KH, 2012, J SPINAL DISORD TECH, V25, P338, DOI 10.1097/BSD.0b013e318224a6e6; Kumar K, 2010, NEUROSURGERY, V67, P171, DOI 10.1227/01.NEU.0000380936.00143.11; Xu C, 2014, AM J NEURORADIOL, V35, P202, DOI 10.3174/ajnr.A3617; Yokoyama K, 2013, AM J NEURORADIOL, V34, P1474, DOI 10.3174/ajnr.A3424	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	APR	2015	24	4					744	749		10.1007/s00586-014-3678-z		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CF9AL	WOS:000352853800011		
J	Tofuku, K; Koga, H; Komiya, S				Tofuku, Katsuhiro; Koga, Hiroaki; Komiya, Setsuro			The diagnostic value of single-photon emission computed tomography/computed tomography for severe sacroiliac joint dysfunction	EUROPEAN SPINE JOURNAL			English	Article						Diagnosis; Imaging fusion; Sacroiliac joint dysfunction; SPECT/CT	PROVOCATION TESTS; BACK-PAIN; SPECT; OSTEOARTHRITIS; INJECTION; LESIONS; FUSION; SPINE	We aimed to evaluate the value of single-photon emission computed tomography (SPECT)/computed tomography (CT) for the diagnosis of sacroiliac joint (SIJ) dysfunction. SPECT/CT was performed in 32 patients with severe SIJ dysfunction, who did not respond to 1-year conservative treatment and had a score of > 4 points on a 10-cm visual analog scale. We investigated the relationship between the presence of severe SIJ dysfunction and tracer accumulation, as confirmed by SPECT/CT. In cases of bilateral SIJ dysfunction, we also compared the intensity of tracer accumulation on each side. Moreover, we examined the relationship between the intensity of tracer accumulation and the different treatments the patients subsequently received. All 32 patients with severe SIJ dysfunction had tracer accumulation with a standardized uptake value (SUV) of > 2.2 (mean SUV 4.7). In the 19 patients with lateralized symptom intensity, mean SUVs of the dominant side were significantly higher than those of the nondominant side. In 10 patients with no lateralization, the difference in the SUVs between sides was < 0.6. Patients exhibiting higher levels of tracer accumulation required more advanced treatment. Patients with higher levels of tracer accumulation had greater symptom severity and also required more advanced treatment. Thus, we believe that SPECT/CT may be a suitable supplementary diagnostic modality for SIJ dysfunction as well as a useful technique for predicting the prognosis of this condition.	[Tofuku, Katsuhiro; Koga, Hiroaki] Imakiire Gen Hosp, Dept Orthoped Surg, Kagoshima 8928502, Japan; [Komiya, Setsuro] Kagoshima Grad Sch Med & Dent Sci, Dept Orthoped Surg, Kagoshima, Japan	Tofuku, K (reprint author), Imakiire Gen Hosp, Dept Orthoped Surg, 4-16 Shimotatsuo, Kagoshima 8928502, Japan.	tofuku@m2.kufm.kagoshima-u.ac.jp					Horger M, 2004, AM J ROENTGENOL, V183, P655; Dieppe PA, 1997, OSTEOARTHR CARTILAGE, V5, P87, DOI 10.1016/S1063-4584(97)80002-7; Dolan AL, 1996, BRIT J RHEUMATOL, V35, P1269; van der Wurff P, 2006, ARCH PHYS MED REHAB, V87, P10, DOI 10.1016/j.apmr.2005.09.023; Pneumaticos SG, 2006, RADIOLOGY, V238, P693, DOI 10.1148/radiol.2382041930; Albert HB, 2002, SPINE, V27, P2831, DOI 10.1097/00007632-200212150-00020; Katz V, 2003, J SPINAL DISORD TECH, V16, P96; Bastian L, 2001, EUR SPINE J, V10, P295, DOI 10.1007/s005860100278; Chen CS, 2002, J SPINAL DISORD TECH, V15, P53; Albert H, 2001, ACTA OBSTET GYN SCAN, V80, P505, DOI 10.1034/j.1600-0412.2001.080006505.x; Beauregard JM, 2011, CANCER IMAGING, V11, P56, DOI 10.1102/1470-7330.2011.0012; Szadek KM, 2009, J PAIN, V10, P354, DOI 10.1016/j.jpain.2008.09.014; Slipman CW, 1996, SPINE, V21, P2251, DOI 10.1097/00007632-199610010-00013; Atlihan D, 2000, CLIN ORTHOP RELAT R, P236; Cachovan M, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-45; Cusi M, 2013, EUR SPINE J, V22, P1674, DOI 10.1007/s00586-013-2725-5; Galm R, 1998, Eur Spine J, V7, P450, DOI 10.1007/s005860050107; Gates GF, 1998, SEMIN NUCL MED, V28, P78, DOI 10.1016/S0001-2998(98)80020-2; Hansen Hans C, 2007, Pain Physician, V10, P165; Kim HR, 2008, OSTEOARTHR CARTILAGE, V16, P212, DOI 10.1016/j.joca.2007.05.025; Laslett M, 2005, MANUAL THER, V10, P207, DOI 10.1016/j.math.2005.01.003; Maigne J Y, 1998, Eur Spine J, V7, P328, DOI 10.1007/s005860050083; Reinartz P, 2000, EUR J NUCL MED, V27, P721, DOI 10.1007/s002590050568	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	APR	2015	24	4					859	863		10.1007/s00586-014-3375-y		5	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CF9AL	WOS:000352853800024		
J	Ishigaki, Y; Nakamura, Y; Tatsuno, T; Ma, SF; Tomosugi, N				Ishigaki, Yasuhito; Nakamura, Yuka; Tatsuno, Takanori; Ma, Shaofu; Tomosugi, Naohisa			Phosphorylation status of human RNA-binding protein 8A in cells and its inhibitory regulation by Magoh	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						mRNA; RBM8A(Y14); Magoh; phosphorylation; Phos-tag gel	EXON-JUNCTION COMPLEX; TAG SDS-PAGE; MESSENGER-RNA; Y14; RBM8A; ACTIVATION; KNOCKDOWN; APOPTOSIS; COMPONENT; PROVIDES	The RNA-binding protein 8A (RBM8A)-mago-nashi homolog, proliferation-associated (Magoh) complex is a component of the exon junction complex (EJC) required for mRNA metabolism involving nonsense-mediated mRNA decay (NMD). RBM8A is a phosphorylated protein that plays some roles in NMD. However, the detailed status and mechanism of the phosphorylation of RBM8A is not completely understood. Therefore, in this study, we analyzed in detail RBM8A phosphorylation in human cells. Accordingly, analysis of the phosphorylation status of RBM8A protein in whole-cell lysates by using Phos-tag gels revealed that the majority of endogenous RBM8A was phosphorylated throughout the cell-cycle progression. Nuclear and cytoplasmic RBM8A and RBM8A in the EJC were also found to be mostly phosphorylated. We also screened the phosphorylated serine by mutational analysis using Phos-tag gels to reveal modifications of serine residues 166 and 168. A single substitution at position 168 that concomitantly abolished the phosphorylation of serine 166 suggested the priority of kinase reaction between these sites. Furthermore, analysis of the role of the binding protein Magoh in RBM8A phosphorylation revealed its inhibitory effect in vitro and in vivo. Thus, we conclude that almost all synthesized RBM8A proteins are rapidly phosphorylated in cells and that phosphorylation occurs before the complex formation with Magoh.	[Ishigaki, Yasuhito; Nakamura, Yuka; Tatsuno, Takanori; Ma, Shaofu; Tomosugi, Naohisa] Kanazawa Med Univ, Med Res Inst, Kahoku, Ishikawa 9200293, Japan; [Tomosugi, Naohisa] Med Care Prote Biotechnol Co Ltd, Kahoku, Ishikawa 9200293, Japan	Ishigaki, Y (reprint author), Kanazawa Med Univ, Med Res Inst, Kahoku, Ishikawa 9200293, Japan.	ishigaki@kanazawa-med.ac.jp			Kanazawa Medical University [S2013-2, SR2012-02, C2014-3]; Kanazawa Medical University, Ministry of Education, Culture, Sports, Science and Technology, Japan [H2012-16 (S1201022)]; KAKENHI [25460376]	The present study was supported by grants from the Kanazawa Medical University (S2013-2, SR2012-02, C2014-3); Grants of Strategic Research Project [H2012-16 (S1201022)] from the Kanazawa Medical University, Ministry of Education, Culture, Sports, Science and Technology, Japan; and a Grant-in-Aid for Scientific Research in Japan (KAKENHI # 25460376).	Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Ma HT, 2011, BIOCHEM J, V435, P17, DOI 10.1042/BJ20100284; Inaki M, 2011, GENES CELLS, V16, P166, DOI 10.1111/j.1365-2443.2010.01479.x; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Le Hir H, 2008, CELL, V133, P213, DOI 10.1016/j.cell.2008.04.002; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Bono F, 2011, RNA BIOL, V8, P24, DOI 10.4161/rna.8.1.13618; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Mahen R, 2012, CURR OPIN CELL BIOL, V24, P14, DOI 10.1016/j.ceb.2011.12.012; Sudo H, 2010, GENOMICS, V95, P210, DOI 10.1016/j.ygeno.2010.02.002; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Albers CA, 2012, NAT GENET, V44, P435, DOI 10.1038/ng.1083; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Lau CK, 2003, CURR BIOL, V13, P933, DOI 10.1016/S0960-9822(03)00328-2; Le Hir H, 2001, EMBO REP, V2, P1119, DOI 10.1093/embo-reports/kve245; Chaung TW, 2013, MOL BIOL CELL, V24, P1; Chaung TW, 2011, J BIOL CHEM, V286, P8722; Hsu IW, 2005, J BIOL CHEM, V280, P34507, DOI 10.1074/jbc.M507658200; Ishigaki Y, 2013, EXP BIOL MED, V238, P889, DOI 10.1177/1535370213494646; Ishigaki Y, 2013, HISTOCHEM CELL BIOL, V141, P101; Kataoka N, 2011, SCI REP-UK, V1, DOI 10.1038/srep00092; Maru S, 2013, J UROLOGY, V189, P1921, DOI 10.1016/j.juro.2012.11.010; Muromoto R, 2009, BIOCHEM BIOPH RES CO, V382, P63, DOI 10.1016/j.bbrc.2009.02.127; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V372, P475, DOI 10.1016/j.bbrc.2008.05.073; Salicioni AM, 2000, GENOMICS, V69, P54, DOI 10.1006/geno.2000.6315; Togi S, 2013, J IMMUNOL, V191, P1436, DOI 10.4049/jimmunol.1300501; Zhao X, 2014, INT J ONCOL, V44, P222, DOI 10.3892/ijo.2013.2149; Zhao XF, 1998, GENOMICS, V47, P319, DOI 10.1006/geno.1997.5126	32	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1535-3702	1535-3699		EXP BIOL MED	Exp. Biol. Med.	APR	2015	240	4					438	445		10.1177/1535370214556945		8	Medicine, Research & Experimental	Research & Experimental Medicine	CG1SP	WOS:000353054600004		
J	Koshiba, Y; Agata, S; Takahashi, T; Ohtani, H				Koshiba, Yusuke; Agata, Saori; Takahashi, Tomohide; Ohtani, Hideo			Direct comparison of the flame inhibition efficiency of transition metals using metallocenes	FIRE SAFETY JOURNAL			English	Article						Flame inhibition; Metallocene; Transition metal; Flame spread rate; Kissinger method	IRON PENTACARBONYL; FERROCENE; PRESSURE; KINETICS	This study aimed to directly and systematically compare the flame inhibition abilities of various transition metals, including vanadium, ruthenium, osmium, chromium, manganese, iron, cobalt, and nickel, by using the corresponding metallocenes: vanadocene, ruthenocene, osmocene, chromocene, manganocene, ferrocene, cobaltocene, and nickelocene. The downward flame spread rates over filter paper samples on which each metallocene was adsorbed were measured. In addition, thermogravimetric measurements were carried out to finally determine the phase in which each metallocene produced its flame inhibition effect. The results indicated that all these metallocenes, with the exception of vanadocene, exhibit a flame inhibition effect solely in the gas phase, whereas vanadocene shows fire suppression ability in the solid phase. This work also found that, in terms of their fire suppression abilities, the transition metals can be ranked in the following order: Cr > Mn > Fe > Co > Ni > (V>)Os > Ru. (C) 2015 Elsevier Ltd. All rights reserved.	[Koshiba, Yusuke] Yokohama Natl Univ, Fac Engn, Dept Mat Sci & Chem Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Agata, Saori; Takahashi, Tomohide] Yokohama Natl Univ, Coll Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Ohtani, Hideo] Yokohama Natl Univ, Fac Environm & Informat Sci, Dept Safety Management, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan	Koshiba, Y (reprint author), Yokohama Natl Univ, Fac Engn, Dept Mat Sci & Chem Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	ykoshiba@ynu.ac.jp			JSPS KAKENHI [25750135]	XRD measurements were conducted at the Instrumental Analysis Center of Yokohama National University. This work was financially supported by JSPS KAKENHI Grant number 25750135.	Agrawal MR, 1996, J APPL TOXICOL, V16, P407; ALCOCK CB, 1984, CAN METALL QUART, V23, P309; Cheng K, 2012, POLYM DEGRAD STABIL, V97, P1606, DOI 10.1016/j.polymdegradstab.2012.06.027; Amutio M, 2012, FUEL, V95, P305, DOI 10.1016/j.fuel.2011.10.008; Brnardic I, 2008, J APPL POLYM SCI, V107, P1932, DOI 10.1002/app.27230; Rumminger MD, 1999, COMBUST FLAME, V116, P207, DOI 10.1016/S0010-2180(98)00033-9; Joseph P, 2013, FIRE SAFETY J, V58, P221, DOI 10.1016/j.firesaf.2013.03.003; Shen DK, 2013, CARBOHYD POLYM, V98, P514, DOI 10.1016/j.carbpol.2013.06.031; Linteris GT, 2002, COMBUST FLAME, V129, P221, DOI 10.1016/S0010-2180(02)00346-2; Mayor-Lopez MJ, 1997, CHEM PHYS LETT, V281, P226, DOI 10.1016/S0009-2614(97)01214-1; Babushok V, 1998, COMBUST FLAME, V115, P551, DOI 10.1016/S0010-2180(98)00019-4; Blasi C.D., 1994, COMBUST FLAME, V97, P225; BULEWICZ EM, 1971, CHEM PHYS LETT, V9, P467, DOI 10.1016/0009-2614(71)80271-3; Gerasimov IE, 2011, P COMBUST INST, V33, P2523, DOI 10.1016/j.proci.2010.06.026; HIRANO T, 1974, COMBUST FLAME, V23, P83, DOI 10.1016/S0010-2180(74)80029-5; Koshiba Y, 2012, FIRE SAFETY J, V51, P10, DOI 10.1016/j.firesaf.2012.02.008; Linteris GT, 2000, P COMBUST INST, V28, P2965; Linteris GT, 2004, COMBUST FLAME, V138, P78, DOI 10.1016/j.combustflame.2004.04.003; Linteris GT, 2008, PROG ENERG COMBUST, V34, P288, DOI 10.1016/j.pecs.2007.08.002; Ohtani H., 2011, P ASIA PAC S SAF, V7, P81; Rumminger M.D., 2000, COMBUST FLAME, V123, P1932	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0379-7112	1873-7226		FIRE SAFETY J	Fire Saf. J.	APR	2015	73						48	54		10.1016/j.firesaf.2015.03.003		7	Engineering, Civil; Materials Science, Multidisciplinary	Engineering; Materials Science	CG2DY	WOS:000353086300005		
J	Ling, Y; Zhao, L; Liu, X; Lin, B				Ling, Y.; Zhao, L.; Liu, X.; Lin, B.			Tailoring Electrochemical Property of Layered Perovskite Cathode by Cu-doping for Proton-Conducting IT-SOFCs	Fuel Cells			English	Article						Defect Chemistry Analysis; Intermediate Temperature Solid Oxide Fuel Cells; Layered Perovskite Oxide; Polarization Resistance	OXIDE FUEL-CELLS; ELECTRICAL-PROPERTIES; ELECTROLYTE; POLARIZATION; GDBACO2O5+X; PERFORMANCE; DIFFUSION; EXCHANGE; SYSTEM; FE	Layered perovskite oxide YBaCuCoO5+x (YBCC) was synthesized by an EDTA-citrate complexation process and was investigated as a novel cathode for proton-conducting intermediate temperature solid oxide fuel cells (IT-SOFCs). The thermal expansion coefficient (TEC) of YBCC was 15.3 x 10(-6) K-1 and the electrical conductivity presented a semiconductor-like behavior with the maximum value of 93.03 Scm(-1) at 800 degrees C. Based on the defect chemistry analysis, the electrical conductivity gradually decreases by the introduction of Cu into Co sites of YBaCo2O5+x and the conductor mechanism can transform from the metallic-like behavior to the semiconductor-like behavior. Thin proton-conducting (BaZr0.1Ce0.7Y0.1Yb0.1O3-delta) BZCYYb electrolyte and NiO-BZCYYb anode functional layer were prepared over porous anode substrates composed of NiO-BZCYYb by a one-step dry-pressing/co-firing process. Laboratory-sized quad-layer cells of NiO-BZCYYb /NiOBZCYYb /BZCYYb /YBCC with a 20 mu m-thick BZCYYb electrolyte membrane exhibited the maximum power density as high as 435 mWcm(-2) with an open-circuit potential (OCV) of 0.99V and a low interfacial polarization resistance of 0.151 Omega cm(2) at 700 degrees C. The experimental results have indicated that the layered perovskite oxide YBCC can be a cathode candidate for utilization as proton-conducting IT-SOFCs.	[Ling, Y.; Liu, X.] Univ Sci & Technol China, Dept Mat Sci & Engn, CAS Key Lab Mat Energy Convers, Hefei 230026, Anhui, Peoples R China; [Ling, Y.] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan; [Zhao, L.] China Univ Geosci, Dept Mat Sci & Chem, Wuhan 430074, Peoples R China; [Lin, B.] Huainan Normal Univ HNNU, Dept Chem & Engn, Anhui Key Lab Low Temp Cofired Mat, Huainan 232001, Peoples R China	Ling, Y (reprint author), Univ Sci & Technol China, Dept Mat Sci & Engn, CAS Key Lab Mat Energy Convers, Hefei 230026, Anhui, Peoples R China.	lyhyy@mail.ustc.edu.cn	Lin, Bin/C-5933-2011; Zhao, Ling/L-6001-2015	Zhao, Ling/0000-0002-9500-3110	Japan Society for the Promotion of Science; Chinese Natural Science Foundation [51102107, 51402266]	The authors would like to thank Japan Society for the Promotion of Science for the JSPS Postdoctoral Fellowship and the financial support from Chinese Natural Science Foundation on contract No. 51102107, No. 51402266.	Kim G, 2007, J MATER CHEM, V17, P2500, DOI 10.1039/b618345j; Taskin AA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1864244; Zhou QJ, 2008, J POWER SOURCES, V185, P754, DOI 10.1016/j.jpowsour.2008.07.064; Zhao L, 2010, J POWER SOURCES, V195, P453, DOI 10.1016/j.jpowsour.2009.08.009; Yang L, 2009, SCIENCE, V326, P126, DOI 10.1126/science.1174811; Zhu CJ, 2008, J POWER SOURCES, V185, P193, DOI 10.1016/j.jpowsour.2008.06.075; Fabbri E, 2008, ENERG ENVIRON SCI, V1, P355, DOI 10.1039/b806655h; Ling YH, 2013, INT J HYDROGEN ENERG, V38, P7430, DOI 10.1016/j.ijhydene.2013.04.051; Taskin AA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.176603; Kim JH, 2008, J ELECTROCHEM SOC, V155, pB385, DOI 10.1149/1.2839028; Ralph JM, 2001, J MATER SCI, V36, P1161, DOI 10.1023/A:1004881825710; Mukundan R, 2001, J ELECTROCHEM SOC, V148, pA82, DOI 10.1149/1.1344520; Hilpert K, 2003, J EUR CERAM SOC, V23, P3009, DOI 10.1016/S0955-2219(03)00097-9; Kim JH, 2010, CHEM MATER, V22, P883, DOI 10.1021/cm901720w; Xue JF, 2011, J POWER SOURCES, V196, P3729, DOI 10.1016/j.jpowsour.2010.12.071; Gu HT, 2009, INT J HYDROGEN ENERG, V34, P2416, DOI 10.1016/j.ijhydene.2009.01.003; Lin B, 2008, J POWER SOURCES, V177, P330, DOI 10.1016/j.jpowsour.2007.11.109; Kim YN, 2011, J ELECTROCHEM SOC, V158, pB276, DOI 10.1149/1.3527006; TAI LW, 1995, SOLID STATE IONICS, V76, P259, DOI 10.1016/0167-2738(94)00244-M; Bishop SR, 2011, J EUR CERAM SOC, V31, P2351, DOI 10.1016/j.jeurceramsoc.2011.05.034; Pena-Martinez J, 2008, FUEL CELLS, V8, P351, DOI 10.1002/fuce.200800026; Imanishi N, 2004, SOLID STATE IONICS, V174, P245, DOI 10.1016/j.ssi.2004.06.019; Lin B, 2009, J POWER SOURCES, V186, P446, DOI 10.1016/j.jpowsour.2008.09.120; Adler SB, 2007, J CATAL, V245, P91, DOI 10.1016/j.jcat.2006.09.019; Zhang YJ, 2014, ELECTROCHIM ACTA, V134, P107, DOI 10.1016/j.electacta.2014.04.126; Zhao L, 2009, J POWER SOURCES, V194, P835, DOI 10.1016/j.jpowsour.2009.06.010; Marrocchelli D, 2012, ADV FUNCT MATER, V22, P1958, DOI 10.1002/adfm.201102648; Tarancon A, 2007, J MATER CHEM, V17, P3175, DOI [10.1039/b704320a, 10.1039/B704320A]; Atkinson A, 2000, SOLID STATE IONICS, V129, P259, DOI 10.1016/S0167-2738(99)00331-8; Kreuer KD, 2003, ANNU REV MATER RES, V33, P333, DOI 10.1146/annurev.matsci.33.022802.091825; Maignan A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.026401; Fabbri E, 2011, ADV FUNCT MATER, V21, P158, DOI 10.1002/adfm.201001540; Chang AM, 2006, SOLID STATE IONICS, V177, P2009, DOI 10.1016/j.ssi.2006.05.047; Zhou XL, 2011, J POWER SOURCES, V196, P5000, DOI 10.1016/j.jpowsour.2011.01.092; Grimaud A, 2012, J ELECTROCHEM SOC, V159, pB683, DOI 10.1149/2.101205jes; Baek SW, 2008, SOLID STATE IONICS, V179, P1570, DOI 10.1016/j.ssi.2007.12.010; Hirabayashi D, 2005, SOLID STATE IONICS, V176, P881, DOI 10.1016/j.ssi.2004.12.007; Kim J, 2014, CHEMSUSCHEM, V7, P2811, DOI 10.1002/cssc.201402351; Lin B, 2010, J POWER SOURCES, V195, P1624, DOI 10.1016/j.jpowsour.2009.09.039; Ling YH, 2010, J POWER SOURCES, V195, P7042, DOI 10.1016/j.jpowsour.2010.05.015; Ling YH, 2013, INT J HYDROGEN ENERG, V38, P14323, DOI 10.1016/j.ijhydene.2013.08.089; Ling YH, 2010, J ALLOY COMPD, V493, P252, DOI 10.1016/j.jallcom.2009.12.072; Yamaura H, 2005, SOLID STATE IONICS, V176, P269, DOI 10.1016/j.ssi.2004.08.008; ZHOU WZ, 1994, CHEM MATER, V6, P441, DOI 10.1021/cm00040a018; Zou C. D., 2006, ADV MATER, V18, P3318	45	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-6846	1615-6854		FUEL CELLS	Fuel Cells	APR	2015	15	2					384	389		10.1002/fuce.201400141		6	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CG6EE	WOS:000353388000015		
J	Yang, J; Akagi, T; Okanishi, T; Muroyama, H; Matsui, T; Eguchi, K				Yang, J.; Akagi, T.; Okanishi, T.; Muroyama, H.; Matsui, T.; Eguchi, K.			Catalytic Influence of Oxide Component in Ni-Based Cermet Anodes for Ammonia-Fueled Solid Oxide Fuel Cells	Fuel Cells			English	Article						Ammonia Decomposition; Ammonia-fueled Solid Oxide Fuel Cells; Doped Barium Cerate; Proton-conducting Solid Oxide Fuel Cells	PERFORMANCE; PROTON; ELECTROLYTE; CATHODE; HYDROGEN; SOFCS	Recently, the promising prospect of ammonia as a hydrogen carrier for solid oxide fuel cells (SOFCs) has attracted significant interests. In this work, the effects of temperature, fuel content, and total flow rate of anode gas on the performance of Ni/yttria-stabilized zirconia (Ni/YSZ) anode for ammonia-fueled SOFCs were investigated. Based on obtained results, the utilization route of ammonia on Ni/YSZ anode was discussed; the results of electrochemical experiments were related with the catalytic decomposition bahavior of ammonia over Ni/YSZ. Moreover, the catalytic activity for ammonia decomposition and anode performance of Ni/samarium-doped ceria (Ni/SDC) and Ni/yttrium-doped barium cerate (Ni/BCY) were also investigated. Among these anode materials, Ni/BCY exhibited the highest ammonia decomposition activity and anode performance for ammonia-fueled SOFCs at intermediate temperatures.	[Yang, J.; Akagi, T.; Okanishi, T.; Muroyama, H.; Matsui, T.; Eguchi, K.] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Kyoto 6158510, Japan	Eguchi, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Kyoto 6158510, Japan.	eguchi@scl.kyoto-u.ac.jp			Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST)	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST).	Akimoto W., 2012, 38 S SOL STAT ION JA, P208; Ma QL, 2007, J POWER SOURCES, V164, P86, DOI 10.1016/j.jpowsour.2006.09.093; Yang L, 2010, J POWER SOURCES, V195, P471, DOI 10.1016/j.jpowsour.2009.07.057; Uribe FA, 2002, J ELECTROCHEM SOC, V149, pA293, DOI 10.1149/1.1447221; Christensen CH, 2006, CATAL TODAY, V111, P140, DOI 10.1016/j.cattod.2005.10.011; Chen XB, 2009, INT J HYDROGEN ENERG, V34, P5737, DOI 10.1016/j.ijhydene.2009.05.085; Singhal SC, 2002, SOLID STATE IONICS, V152, P405, DOI 10.1016/S0167-2738(02)00349-1; Iwahara H, 1996, SOLID STATE IONICS, V86-8, P9, DOI 10.1016/0167-2738(96)00087-2; Wojcik A, 2003, J POWER SOURCES, V118, P342, DOI 10.1016/S0378-7753(03)00083-1; Muroyama H, 2012, APPL CATAL A-GEN, V443, P119, DOI 10.1016/j.apcata.2012.07.031; Halseid R, 2006, J POWER SOURCES, V154, P343, DOI 10.1016/j.jpowsour.2005.10.011; Fournier GGM, 2006, J POWER SOURCES, V162, P198, DOI 10.1016/j.jpowsour.2006.06.047; Gupta GK, 2006, J POWER SOURCES, V158, P497, DOI 10.1016/j.jpowsour.2005.09.036; Liang FL, 2008, ELECTROCHEM SOLID ST, V11, pB213, DOI 10.1149/1.2987693; Zhang LM, 2008, J POWER SOURCES, V179, P92, DOI 10.1016/j.jpowsour.2007.12.061; Meng GY, 2007, J POWER SOURCES, V173, P189, DOI 10.1016/j.jpowsour.2007.05.002; Ni M, 2009, INT J ENERG RES, V33, P943, DOI 10.1002/er.1588; Puengjinda P, 2012, J POWER SOURCES, V216, P409, DOI 10.1016/j.jpowsour.2012.05.089; Puengjinda P, 2012, J POWER SOURCES, V204, P67, DOI 10.1016/j.jpowsour.2011.12.036; Tsai CL, 2011, J ELECTROCHEM SOC, V158, pB885, DOI 10.1149/1.3596361; Yamaura H, 2005, SOLID STATE IONICS, V176, P269, DOI 10.1016/j.ssi.2004.08.008; Yang J, 2012, J POWER SOURCES, V204, P25, DOI 10.1016/j.jpowsour.2011.12.049	22	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-6846	1615-6854		FUEL CELLS	Fuel Cells	APR	2015	15	2					390	397		10.1002/fuce.201400135		8	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CG6EE	WOS:000353388000016		
J	Yamada, M				Yamada, Masaya			New Middleware as a Driver of Innovation	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Looking to the future, all manner of things will come to be connected to the Internet, resulting in the exchange of massive amounts of information. In that world, innovative approaches to converting constant streams of information into real value will play a major role in growing a company's business and promoting social development. Believing that the three management resources of people, information, and infrastructure are the key elements driving innovation, Fujitsu has announced a Mobile Initiative, Big Data Initiative, Cloud Initiative, and Security Initiative as a system for providing information and communications technology (ICT) products that integrate and use those elements. In this system, middleware the foundation of solutions and systems will be given the role of coordinating and integrating a wide variety of services, networks, and mobile devices and of achieving safe and easy-to-manage operations. It will also have the role of supporting innovation in the field for corporate business. Fujitsu is leveraging the know-how it has accumulated in implementing systems both inside and outside the company to promote the further evolution of middleware. This paper describes Fujitsu middleware that supports these four initiatives.	Fujitsu Ltd, Kawasaki, Kanagawa, Japan	Yamada, M (reprint author), Fujitsu Ltd, Kawasaki, Kanagawa, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					3	11				9	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600002		
J	Hara, H; Kuwabara, H				Hara, Hideki; Kuwabara, Hiroshi			Innovation in On-site Work Using Smart Devices and Augmented Reality Technology	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								There is a growing need in the corporate world for improving operations in the field and raising the quality of work through the use of smart devices. To meet this need, Fujitsu provides the FUJITSU Software Interstage AR Processing Server (Interstage AR), which uses augmented reality (AR) technology to overlay digital information obtained via information and communications technology (ICT) on real-world information displayed on a smart device. This product has a variety of features that foster innovation in on-site work. It can improve the accuracy and quality of fieldwork by overlaying information such as operating instructions and manuals needed for on-site operations on screens displaying actual facilities and by providing an intuitive and visually appealing navigation system. In addition, it enables users to input messages while in the field, which improves the accuracy of information passed on to others and facilitates preventive maintenance. Furthermore, it makes work more efficient by incorporating a terminal data cache for offline environments or sites with poor signal reception. These features can produce valuable results for customers, such as shortening work-training periods. This paper introduces Fujitsu's approach to putting this product into actual practice and fostering innovation in customers' on-site work.	[Hara, Hideki; Kuwabara, Hiroshi] Fujitsu Ltd, Kawasaki, Kanagawa, Japan	Hara, H (reprint author), Fujitsu Ltd, Kawasaki, Kanagawa, Japan.						[Anonymous], BRIEF SOFTW LEV SMAR; [Anonymous], MIDDL CHANN HAND EXP; [Anonymous], FUJ TECHN SERV VIS 2; Ministry of Economy Trade and Industry (METI), 2003, INT REP RES IND ACC	4	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					12	19				8	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600003		
J	Imai, J; Okano, K				Imai, Jutaro; Okano, Kensuke			Mobile Platform Products Supporting Use of Smart Devices	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Smart devices such as smartphones and tablets are coming to be applied in a wide variety of business scenarios both inside and outside the company thanks to their mobile and portable features. This revolution in work style centered about the use of smart devices was perhaps inevitable, but there are still many needs in system management and development such as enhanced security measures and efficient software development methods under multiple OSs. To meet these needs, Fujitsu provides a middleware product called FUJITSU Software Interstage Mobile Application Server (IMAPS) and a service platform called FUJITSU Cloud PaaS MobileSUITE (MobileSUITE). IMAPS enables the efficient development and operation of applications for smart devices by providing a multi-platform development environment, a secure application execution infrastructure, and a business operation environment for improving on-site productivity. MobileSUITE provides services that enable functions for content delivery and digital catalogs to be used immediately and also provides mobile device management (MDM) Functions. Using these MobileSUITE services and functions in combination enables prompt support of situations requiring security measures. This paper introduces the features of these two products and presents examples of their application.	[Imai, Jutaro; Okano, Kensuke] Fujitsu Ltd, Tokyo, Japan	Imai, J (reprint author), Fujitsu Ltd, Tokyo, Japan.						Gartner, GARTN SAYS 2016 MOR; Ogawa T., 2013, WORK STYLE RENAISSAN, P26	2	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					20	26				7	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600004		
J	Fujitake, M; Hirao, Y; Miura, A				Fujitake, Mitsuo; Hirao, Yukio; Miura, Akihiko			WSMGR for Web Supporting Mission-critical Applications on Smart Devices -Mainframe in Your Pocket-	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Mainframes are widely used for running mission-critical enterprise systems as they provide a high level of reliability while enabling the use of existing assets. An enterprise that combines the use of open systems and mainframes is generally more concerned about the effective use of information and communications technology (ICT) assets and in particular the use of existing mainframes than a full migration to open systems. At the same time, the surge in using smart devices for business applications in the open-system world is now bearing down on the mainframe world. The FUJITSU Software WSMGR for Web open server software provides an environment in which mainframe business applications can be used on smart devices anytime and anywhere with optimal operability without having to rewrite those applications. Introducing smart devices into business operations, however, brings up difficult issues related to security, operations know-how, etc., so Fujitsu also provides a service called Mainframe Connect as an all-in-one solution that includes network security from the terminal to the mainframe. This paper introduces WSMGR for Web technologies supporting smart devices, mainframe technologies supporting mobile use, and key services that make use of those technologies.	[Fujitake, Mitsuo; Hirao, Yukio; Miura, Akihiko] Fujitsu Ltd, Tokyo, Japan	Fujitake, M (reprint author), Fujitsu Ltd, Tokyo, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					27	32				6	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600005		
J	Shibata, T; Kurachi, T				Shibata, Tooru; Kurachi, Thichi			Big Data Analysis Solutions for Driving Innovation in On-site Decision Making	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Information systems have traditionally been constructed and used for increasing corporate value, developing competitive products, improving employee productivity, and accelerating the decision-making process. Today, however, dramatic improvements in hardware performance, advances in various types of sensors, and changes in the social environment such as consumer-driven dissemination of information via social networking services (SNSs) are generating a great need for "big data" analysis. In its early stages, the use of big data depended on information and communications technology (ICT) specialists and expert analysts located at support sites. Now, to speed up decision-making at sites directly involved in increasing sales and lowering costs, analysis based on big data is being performed at these frontline sites, and some marketing and planning departments have already begun to base their actions on big data. Moreover, high-function middleware that facilitates such big data usage has been appearing. However, issues arising in actual implementations of systems with such middleware have hindered advanced decision-making in the field. This paper introduces Fujitsu's approach to resolving these issues by providing integrated solutions that optimally combine big-data middleware and analysis scenarios and describes the effects of introducing these solutions.	[Shibata, Tooru; Kurachi, Thichi] Fujitsu Ltd, Tokyo, Japan	Shibata, T (reprint author), Fujitsu Ltd, Tokyo, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					33	41				9	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600006		
J	Nakamura, K; Echigo, S; Aoyagi, T				Nakamura, Kazushige; Echigo, Shinya; Aoyagi, Takehiko			Technologies for Real-time Use of Information through Integration of Diverse Forms of Internal and External Data	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								As markets continue to diversify, the amount of internal and external data and the amount of processing required are growing explosively, and the quality of the target data is changing as well. This situation is creating a demand for systems that can quickly and easily analyze and use massive amounts of data so that market needs can be accurately assessed and sound business decisions can be made. FUJITSU Integrated System Analytics Ready is a hardware appliance product integrating a series of functions that can extract the data deemed necessary from a huge amount of stored data and analyze and use that information. These functions include "easy-to-implement system," "high-speed database as a platform for analyzing and using data," "operational data storage for storing huge amounts of data by using simple settings," "data linking for collecting data from diverse data sources," "data processing by using an intuitive graphical user interface (GUI)," and "safe sharing of consolidated data." The last one is the most needed function because it protects stored data from a variety of threats without a loss in customer convenience. This paper introduces technologies for high-speed and safe use of data in response to market needs.	[Nakamura, Kazushige; Echigo, Shinya; Aoyagi, Takehiko] Fujitsu Ltd, Tokyo, Japan	Nakamura, K (reprint author), Fujitsu Ltd, Tokyo, Japan.						Nagakura H., 2006, FUJITSU, V57, P134	1	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					42	47				6	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600007		
J	Yamamoto, S; Yamada, T; Shimabayashi, D; Sarashina, H				Yamamoto, Shoji; Yamada, Toshiaki; Shimabayashi, Daisuke; Sarashina, Hideo			High-speed Data Processing through Ultra-high-speed Data Management Using InfiniBand	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Today, many enterprises seek to link core business operations with the processing of big data on computers, so the need is growing for accurate processing of data that can be instantaneously generated in huge amounts. Fujitsu is responding to this need by applying its extensive experience in mission-critical systems and advanced technologies and by offering ultra-high-speed in-memory data management software. This software uses InfiniBand, which is widely used in the supercomputer field, as the network communications medium. Incorporation of InfiniBand's remote direct memory access (RDMA) function in the network management layer enables this software to achieve response times less than half those of conventional systems and eliminates the need for modifying interfaces to existing applications, thereby resolving compatibility issues. This paper introduces Fujitsu's approach toward providing a highly reliable system that can provide stable system response times and reduce the risk of accumulating or losing large volumes of data at the time of a system fault.	[Yamamoto, Shoji; Yamada, Toshiaki; Shimabayashi, Daisuke; Sarashina, Hideo] Fujitsu Ltd, Tokyo, Japan	Yamamoto, S (reprint author), Fujitsu Ltd, Tokyo, Japan.						ALTIMA, GRAPH EXPL WHAT IS I; [Anonymous], STRUCT ISS FAIL; Fujitsu, CAS STUD INTR FUJ MI; Imamura N., 2001, Fujitsu, V52; Kimura Y., 1999, FUJITSU, V50, P202	5	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					48	54				7	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600008		
J	Miyauchi, Y; Takahashi, R; Kinomura, M				Miyauchi, Yosuke; Takahashi, Ryohei; Kinomura, Mitsuhiro			Vertically Integrated Database System Combining Advanced Hardware with Database Technologies	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								To survive in a highly competitive, rapidly changing business world, an enterprise needs information and communications technology (ICT) systems that can respond flexibly and quickly to the market. However, as ICT systems become increasingly complex, the need to reduce their management and operating costs increases. Databases, moreover, are ICT systems having high-reliability and high-performance requirements. The FUJITSU Integrated System HA Database Ready product integrates database technologies cultivated by Fujitsu over many years with advanced hardware. Providing "high-reliability and high-performance," "open-standards," and "ready-to-use" features, HA Database Ready can significantly reduce the costs of deploying, designing, and operating a database infrastructure. This paper introduces a fully redundant system that uses advanced hardware to support high-reliability and high-performance operation and Fujitsu's Smart Software Technology for performing a full range of tasks from system deployment to system operation, monitoring, and troubleshooting using a simple graphical user interface (GUI).	[Miyauchi, Yosuke; Takahashi, Ryohei; Kinomura, Mitsuhiro] Fujitsu Ltd, Tokyo, Japan	Miyauchi, Y (reprint author), Fujitsu Ltd, Tokyo, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					55	61				7	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600009		
J	Yanagawa, T				Yanagawa, Toshihide			Open Stack-based Next-generation Cloud Resource Management	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								FUJITSU Software Server View Resource Orchestrator (ROR) is a middleware product for more efficiently operating and managing private clouds. In recent years, many companies have moved to aggregate their internal hardware resources, creating private clouds, while actively utilizing public clouds to reduce system deployment costs. These have produced a greater need for flexible operations of private clouds, demand for the ability to use the diverse application programming interfaces (APIs) that are available on public clouds on private clouds as well, and demand for the ability to centrally manage both public and private clouds. Fujitsu offers ROR to respond to this need. This paper introduces ROR, which uses Open Stack open source software to centrally and easily manage the resources of both public and private clouds.	Fujitsu Ltd, Tokyo, Japan	Yanagawa, T (reprint author), Fujitsu Ltd, Tokyo, Japan.						Matsumoto H, 2011, FUJITSU SCI TECH J, V47, P270	1	1	1	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					62	65				4	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600010		
J	Aki, Y; Nakajima, M; Kizuka, YT				Aki, Yuko; Nakajima, Masaki; Kizuka, Yoshi Taka			Realization of Construction and Simple Operation of Flexible Cloud System by SDN	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								FUJITSU Software Server View Resource Orchestrator (ROR) is a middleware product which realizes centralized management and effective utilization of information and communications technology (ICT) resources such as servers, storage and networks and ICT cost optimization by improving the operation and management efficiency. Applying this middleware makes it possible to construct a flexible cloud system according to the customer's cloud requirements and needs and to simply operate it. One technology to support this functionality is software-defined networking (SDN), which is a control technology that uses software to allow network configurations and settings to be dynamically changed in a centralized manner. ROR is a core product that realizes SDN in the datacenter domain, in particular. Fujitsu's SDN, which features close coordination between ROR and network virtualization-enabled hardware equipment, is in the practical application phase in the Numazu Software Development Cloud center. This paper describes product features with the focus on the network functions of ROR from the viewpoint of SDN and future outlook in terms of network operation and management of a cloud system.	[Aki, Yuko; Nakajima, Masaki; Kizuka, Yoshi Taka] Fujitsu Ltd, Tokyo, Japan	Aki, Y (reprint author), Fujitsu Ltd, Tokyo, Japan.						Yanagawa T, 2015, FUJITSU SCI TECH J, V51, P62	1	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					66	72				7	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600011		
J	Shimizu, H; Suzuki, S; Sakamoto, N				Shimizu, Hideo; Suzuki, Shingo; Sakamoto, Norihiko			Next-generation Cloud Operation Management Technologies	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								The difficult business climate in which companies find themselves today is forcing them to make their business and technology processes more flexible and less costly in accordance with their business policies. Many companies are doing this by making greater use of cloud computing systems, and there is a growing number of companies that use hybrid clouds, which combine a private cloud with a public cloud. These trends are increasing the number and variety of resources that must be managed. Moreover, the resources themselves are changing, making it difficult to gain the bird's eye view of the entire information and communications technology (ICT) system that is needed to manage it. Furthermore, new issues are arising, such as the inability of information systems departments (ISDs) to control all the clouds used within companies or to optimize ICT resources on a company-wide basis. This paper introduces FUJITSU Software Systemwalker Software Configuration Manager, developed by Fujitsu to help companies meet the operation and management challenges presented by cloud environments and the technologies it uses for centrally managing and automatically acquiring configuration information for everything from hardware to virtual environments, operating systems, and software. It also introduces FUJITSU Software Systemwalker Service Catalog Manager and the technologies it uses for controlling cloud usage and automatically deploying services.	[Shimizu, Hideo; Suzuki, Shingo; Sakamoto, Norihiko] Fujitsu Ltd, Tokyo, Japan	Shimizu, H (reprint author), Fujitsu Ltd, Tokyo, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					73	80				8	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600012		
J	Yoshii, J; Hanawa, D				Yoshii, Jun; Hanawa, Daiki			Technology to Automate System Operations for Flexibly Responding to Dynamically Changing Cloud Environments	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Cloud services (hereafter referred to as "the cloud") and virtualization technologies are rapidly growing in popularity. There is increasing demand for corporate information systems to be efficient, optimized ones which do not consist solely of on-premises systems, but also employ private and public clouds where appropriate. Virtual environments and private clouds are often composed of large numbers of physical servers and devices in order to enable them to accept all the execution environments of widely distributed operational systems. This shift of corporate information systems to large-scale environments composed of diverse server devices has made it difficult to manage these environments manually. This problem has been addressed by automating system operation work, which involves creating scripts that perform sequences of commands, reducing management workload. However, simple automation scripts have difficulty handling operations which span multiple servers. This has required operation procedure documentation to be created and much work based on the documentation to be performed. This paper introduces Fujitsu's development and operation of FUJITSU Software Systemwalker Runbook Automation, which dramatically improves operation efficiency by standardizing, creating workflows, and automating the operation of corporate information systems, which has until now been done manually.	[Yoshii, Jun; Hanawa, Daiki] Fujitsu Ltd, Tokyo, Japan	Yoshii, J (reprint author), Fujitsu Ltd, Tokyo, Japan.						Fujitsu, FUJ SOFTW SERVERVIEW; Fujitsu: FUJITSU Software Systemwalker Runbook Automation, FUJITSU SOFTW SYST R; IDC Japan, JAP SYST NETW MAN SO; Ito H, 2011, FUJITSU SCI TECH J, V47, P300	4	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					81	85				5	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600013		
J	Hamanaka, S; Takahashi, K				Hamanaka, Seishiro; Takahashi, Kunikazu			High-reliability, High-availability Cluster System Supporting Cloud Environment	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Fujitsu is offering FUJITSU Software PRIMECLUSTER, a high-reliability software platform that supports the continuous operation of entire systems. With its highly reliable technology linked to Fujitsu servers (SPARC M10, FUJITSU Server PRIMEQUEST 2000/1000 series, and FUJITSU Server PRIMERGY), PRIMECLUSTER ensures fast detection of malfunctions and secure operational continuity not only in a physical environment but also in a cloud environment, unlike other companies' cluster software. Also, due to a link to the live migration function of the server provided by virtualization software, PRIMECLUSTER enables the server unit to undergo maintenance without changing redundant configurations, or active-standby configurations. This realizes even greater availability for platform systems in a cloud environment. In these ways, PRIMECLUSTER supports continuous operation on a 24/7 basis, even in a cloud environment that integrates a customer's business systems. This paper introduces the technology of PRIMECLUSTER, cluster software that supports platform systems in a cloud environment and business systems running in a cloud environment.	[Hamanaka, Seishiro; Takahashi, Kunikazu] Fujitsu Ltd, Tokyo, Japan	Hamanaka, S (reprint author), Fujitsu Ltd, Tokyo, Japan.						Abe T., 2002, FUJITSU, V53, P456; Sakai M, 2005, FUJITSU SCI TECH J, V41, P328	2	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					86	91				6	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600014		
J	Kurita, T; Masuno, M; Wataki, A				Kurita, Takayoshi; Masuno, Michio; Wataki, Atsushi			Fujitsu's Security Technology Based on Practical Knowledge	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Information and communications technology (ICT) is leveraged in wider applications today, and enterprises are faced with an ever-growing need to protect themselves against cyber-attacks, which continue each day to become technically more sophisticated. Measures against these attacks should aim to not only prevent malicious intrusions, but also implement possible countermeasures in case such intrusions take place. It is crucial to respond to a security breach quickly, and the response time significantly impacts security risks such as those relating to data leakage and network contamination. Fujitsu has developed a software suite, FUJITSU Software Systemwalker Security Control (SSC), which follows a preprogrammed operation process and navigates through automated responses against cyber-attacks. This product has already been launched on the market. It helps enterprises to reduce the costs of process programming and actual security operation, and it can automate operation process to enhance flawless security operations by eliminating human error. Fujitsu has integrated its operation management technology with response scenarios developed through the company's practical knowledge. This paper describes a software product with built-in operational processes against standard cyber-attacks based on this technology. It also outlines its features that significantly reduce the response time by automating a series of actions upon detecting malware (network shut-down, identification of infected terminals, response alert to operators, etc.).	[Kurita, Takayoshi; Masuno, Michio; Wataki, Atsushi] Fujitsu Ltd, Tokyo, Japan	Kurita, T (reprint author), Fujitsu Ltd, Tokyo, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					92	98				7	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600015		
J	Sugii, J; Nojiri, K				Sugii, Jun; Nojiri, Keita			Device Management Technology for Preventing Data Leakage	FUJITSU SCIENTIFIC & TECHNICAL JOURNAL			English	Article								Security countermeasures against targeted attacks are important elements in preventing the leakage of data such as critical internal company data and customer data. Targeted attacks often focus on known vulnerabilities, making it essential to apply security patches in a timely fashion. However, making sure that security patches are applied to all devices is no easy feat. Even if security patches are applied in a thorough manner, this will not guard against zero-day attacks that target unknown vulnerabilities. That makes it vital to implement security countermeasures which prevent data from being leaked even in the event of malware infection. Fujitsu provides FUJITSU Software Systemwalker Desktop Patrol (DTP) and FUJITSU Software Systemwalker Desktop Keeper (DTK) to solve this problem. DTP is used to centrally manage information and communications technology (ICT) assets and control security. DTK almost completely eliminates the risk of data leaks by applying operation restrictions to ICT assets and logging ICT asset usage. This paper introduces DTP and DTK, which prevent data leakage from endpoint devices (computers, virtual terminals, and smart devices).	[Sugii, Jun; Nojiri, Keita] Fujitsu Ltd, Dev ICT Asset Management Software, Tokyo, Japan	Sugii, J (reprint author), Fujitsu Ltd, Dev ICT Asset Management Software, Tokyo, Japan.							0	0	0	FUJITSU LTD	KAWASAKI	1015 KAMIKODANAKU NAKAHARA-KU, KAWASAKI, 211, JAPAN	0016-2523			FUJITSU SCI TECH J	Fujitsu Sci. Tech. J.	APR	2015	51	2					99	104				6	Engineering, Electrical & Electronic	Engineering	CG1AY	WOS:000353006600016		
J	Matsuyama, M; Kondo, M; Noda, N; Tanaka, M; Nishimura, K				Matsuyama, Masao; Kondo, Masamitsu; Noda, Nobuaki; Tanaka, Masahiro; Nishimura, Kiyohiko			ISOTOPE EFFECTS ON DESORPTION KINETICS OF HYDROGEN ISOTOPES IMPLANTED INTO STAINLESS STEEL BY GLOW DISCHARGE	FUSION SCIENCE AND TECHNOLOGY			English	Article								Desorption kinetics of hydrogen isotopes implanted into type 316L stainless steel by glow discharge have been studied by the experiment and numerical calculation. The temperature of a maximum desorption rate depended on glow discharge time and heating rate. Desorption spectra observed under various experimental conditions were successfully reproduced by numerical calculation which is based on a diffusion-limited process. It is suggested, therefore, that desorption rate of a hydrogen isotope implanted into the stainless steel is limited by a diffusion process of hydrogen isotope atoms in bulk. Furthermore, small isotope effects were observed for the diffusion process of hydrogen isotope atoms.	[Matsuyama, Masao; Kondo, Masamitsu; Noda, Nobuaki] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Tanaka, Masahiro; Nishimura, Kiyohiko] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Matsuyama, M (reprint author), Toyama Univ, Hydrogen Isotope Res Ctr, Gofuku 3190, Toyama 9308555, Japan.	matsu3h@ctg.u-toyama.ac.jp			NIFS Collaboration Research program [NIFS13KUHR019]; Japan Society for the Promotion of Science [KAKENHI 25289335]	This work is partly supported by a NIFS Collaboration Research program (NIFS13KUHR019), and by a Grant-in-Aid for Research (B) from the Japan Society for the Promotion of Science (KAKENHI 25289335).	CLAUSING R. E., 1976, P INT C PWI JUL GERM, V573; WATANABE K, 1987, J VAC SCI TECHNOL A, V5, P237, DOI 10.1116/1.574111; WILSON KL, 1978, J NUCL MATER, V74, P179, DOI 10.1016/0022-3115(78)90550-0	3	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					471	474				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300002		
J	Munakata, K; Nakamura, A; Kawamura, Y				Munakata, Kenzo; Nakamura, Ayano; Kawamura, Yoshinori			CORRELATION OF ADSORPTION ISOTHERMS OF HYDROGEN ISOTOPES ON MORDENITE ADSORBENTS USING REACTIVE VACANCY SOLUTION THEORY	FUSION SCIENCE AND TECHNOLOGY			English	Article								The authors applied the isotherm equations derived from the reactive vacancy solution theory to correlation of experimental and highly non-ideal adsorption isotherms of hydrogen and deuterium on a mordenite adsorbent, and examined the correlativity of the isotherm equations. The results reveal that the isotherm equations derived from the theory can better correlate the experimental isotherms.	[Munakata, Kenzo; Nakamura, Ayano] Akita Univ, Fac Engn & Resource Sci, Akita, Akita 0108502, Japan; [Kawamura, Yoshinori] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Munakata, K (reprint author), Akita Univ, Fac Engn & Resource Sci, Tegata Gakuen Machi 1-1, Akita, Akita 0108502, Japan.	kenzo@gipc.akita-u.ac.jp					Munakata K, 2013, SURF SCI, V616, P1, DOI 10.1016/j.susc.2013.03.007; SUWANAYUEN S, 1980, AICHE J, V26, P68, DOI 10.1002/aic.690260112; KAWAMURA Y., 2013, J NUCL MATER, V442, P455; Munakata K, 2013, FUSION ENG DES, V88, P2408, DOI 10.1016/j.fusengdes.2013.04.032	4	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					495	498				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300008		
J	Nakamura, A; Munakata, K; Hara, K; Narita, S; Sugiyama, T; Kotoh, K; Tanaka, M; Uda, T				Nakamura, Ayano; Munakata, Kenzo; Hara, Keisuke; Narita, Syodai; Sugiyama, Takahiko; Kotoh, Kenji; Tanaka, Masahiro; Uda, Tatsuhiko			ADSORPTION CHARACTERISTICS OF WATER VAPOR ON GEAR-PELLET AND HONEYCOMB-PELLET TYPES OF ADSORBENTS CONTAINING A-TYPE ZEOLITE	FUSION SCIENCE AND TECHNOLOGY			English	Article								It is necessary to recover or process tritiated species that are extensively coexistent in nuclear fusion installations. A conventional way to recover tritium release to atmosphere is catalytic oxidation of tritiated species and adsorption of tritated water vapor on adsorbents with high surface areas. However, pressure loss would become more serious with increase in the size of adsorbent beds, which could lead to greater power needs for ventilation systems. Therefore, new adsorbents with low pressure loss and high surface areas need to be developed and utilized for such large-scale adsorption systems. Thus, the authors tested new types of adsorbents, which are gear-type and honeycomb-type pellet adsorbents. The experimental results reveal that the gear-type pellet adsorbents have larger adsorption capacity than the honeycomb-type pellet adsorbent. It was also found that the gear-type MS4A adsorbent possesses larger adsorption capacity than other adsorbents tested in this work. Furthermore, it was found that new types of adsorbents are lower pressure than conventional-type of adsorbents. Among the new adsorbents studied in this work, the gear-type MS4A adsorbent appears to be most promising for the application to the adsorption systems in terms of adsorption capacity and adsorption rate.	[Nakamura, Ayano; Munakata, Kenzo; Hara, Keisuke; Narita, Syodai] Akita Univ, Akita 0108502, Japan; [Sugiyama, Takahiko] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kotoh, Kenji] Kyushu Univ, Nishi Ku, Fukuoka 8190395, Japan; [Tanaka, Masahiro; Uda, Tatsuhiko] Natl Inst Fus Sci, Tokai, Gifu 5095292, Japan	Nakamura, A (reprint author), Akita Univ, Tegata Gakuen Machi 1-1, Akita 0108502, Japan.	iam3gozira.mush@gmail.com			NIFS Collaboration Research programs [NIFS 10KOBA023, NIFS13KOBA029]	This work was performed with the support and under the auspices of the NIFS Collaboration Research programs (NIFS 10KOBA023, NIFS13KOBA029).	Wajima T, 2011, J NUCL MATER, V417, P1166, DOI 10.1016/j.jnucmat.2010.12.292; Wajima T, 2010, FUSION ENG DES, V85, P1064, DOI 10.1016/j.fusengdes.2010.01.012	2	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					499	502				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300009		
J	Nakayama, M; Torikai, Y; Saito, M; Penzhorn, RD; Isobe, K; Yamanishi, T; Kurishita, H				Nakayama, M.; Torikai, Y.; Saito, M.; Penzhorn, R-D.; Isobe, K.; Yamanishi, T.; Kurishita, H.			MEASUREMENT OF UPTAKE AND RELEASE OF TRITIUM BY TUNGSTEN	FUSION SCIENCE AND TECHNOLOGY			English	Article							DEUTERIUM RETENTION; PLASMA; TRANSPORT; HYDROGEN	The uptake of tritium by tungsten and its release behavior have been investigated Specimens annealed at 773 K, 873 K, 973 K, 1,073 K and 1,173 K for 3 hours and loaded with tritium at 773 K for 3 hours accumulated 0.125 ppm, 0.068 ppm, 0.067 ppm, 0.038 ppm and 0.033 ppm, respectively (tritium solubilities were 3.6x 10(-9) at.fr.Pa-1/2, 2.0x 10(-9) at.fr.Pa-1/2, 1.9x 10(-9) at.fr.Pa-1/2, 1.1x 10(-9) at.fr.Pa-1/2 and 9.7x 10(-10) at.fr.Pa-1/2, respectively). The difference is attributed to the existence of trapping sites or oxide films.	[Nakayama, M.; Torikai, Y.; Saito, M.; Penzhorn, R-D.] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama, Toyama 9308555, Japan; [Isobe, K.; Yamanishi, T.] Japan Atom Energy Agcy, Tritium Technol Grp, Tokai, Ibaraki 3191195, Japan; [Kurishita, H.] Tohoku Univ, Inst Mat Res, Oarai, Ibaraki 3111313, Japan	Nakayama, M (reprint author), Toyama Univ, Hydrogen Isotope Res Ctr, 3190 Gofuku, Toyama, Toyama 9308555, Japan.	dmknre51@ctg.u-toyanta.ac.jp			KAKENHI [24360380]	This work has been supported by a KAKENHI Grant-in-Aid for Scientific Research (B) 24360380.	Skinner CH, 2008, FUSION SCI TECHNOL, V54, P891; Nagata S, 2000, J NUCL MATER, V283, P1038, DOI 10.1016/S0022-3115(00)00215-4; Causey R, 1999, J NUCL MATER, V266, P467, DOI 10.1016/S0022-3115(98)00538-8; ANDERL RA, 1992, FUSION TECHNOL, V21, P745; Nygren RE, 2011, J NUCL MATER, V417, P451, DOI 10.1016/j.jnucmat.2010.12.289; Naoe S, 2008, FUSION SCI TECHNOL, V54, P515; Alimov VK, 2012, J NUCL MATER, V420, P519, DOI 10.1016/j.jnucmat.2011.11.003; Haasz AA, 1998, J NUCL MATER, V258, P889, DOI 10.1016/S0022-3115(98)00072-5; Tanabe T, 2000, J NUCL MATER, V283, P1128, DOI 10.1016/S0022-3115(00)00119-7; FRAUENFE.R, 1969, J VAC SCI TECHNOL, V6, P388, DOI 10.1116/1.1492699; Saito M, 2011, FUSION SCI TECHNOL, V60, P1459; Tyburska B, 2011, J NUCL MATER, V415, pS680, DOI 10.1016/j.jnucmat.2010.11.044	12	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					503	506				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300010		
J	Otsuka, T; Hashizume, K				Otsuka, Teppei; Hashizume, Kenichi			BEHAVIOR OF TRITIUM PERMEATION INDUCED BY WATER CORROSION OF ALPHA IRON AROUND ROOM TEMPERATURE	FUSION SCIENCE AND TECHNOLOGY			English	Article								In order to understand behaviors of hydrogen uptake and permeation in pure alpha-iron (alpha Fe) during water corrosion around room temperature, hydrogen permeation experiments for a alpha Fe membrane have been conducted by means of tritium tracer techniques. Hydrogen produced by water corrosion of alpha Fe is trapped and/or blocked in/by product oxide layers to delay hydrogen uptake in alpha Fe for a moment. However, the oxide layers do not work as a sufficient barrier for hydrogen uptake. Some of hydrogen dissolved in alpha Fe could normally diffuse and permeate through the alpha Fe bulk. Assuming hydrogen dissolution at the water/Fe interface proportional to the square root of the hydrogen pressure (Sieverts' law), the partial hydrogen pressure were estimated to be 0.7, 5.0 and 9.5 kPa at 303, 323 and 348 K, respectively.	[Otsuka, Teppei; Hashizume, Kenichi] Kyushu Univ, Fukuoka 8168580, Japan	Otsuka, T (reprint author), Kyushu Univ, 6-1 Kasuga Kouen, Fukuoka 8168580, Japan.	t-otsuka@nucl.kyushu-u.ac.jp					BOCKRIS JO, 1965, J ELECTROCHEM SOC, V112, P1025, DOI 10.1149/1.2423335; Addach H, 2005, MATER LETT, V59, P1347, DOI 10.1016/j.matlet.2004.12.037; REARDON EJ, 1995, ENVIRON SCI TECHNOL, V29, P2936, DOI 10.1021/es00012a008; Hayashi T, 2009, FUSION SCI TECHNOL, V56, P836; Ikeda T, 2011, J NUCL MATER, V417, P568, DOI 10.1016/j.jnucmat.2010.12.116; LONGHURST G. R., 1992, EGGFSP10315 ID NAT E; Otsuka T, 2011, J NUCL MATER, V415, pS769, DOI 10.1016/j.jnucmat.2010.11.046; Otsuka T, 2010, FUSION ENG DES, V85, P1437, DOI 10.1016/j.fusengdes.2010.03.063; TANABE T., 1984, J JPN I MET, V25, P1; Volkl J, 1978, HYDROGEN METALS, P321	10	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					511	514				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300012		
J	Oya, Y; Sato, M; Uchimura, H; Ashikawa, N; Sagara, A; Yoshida, N; Hatano, Y; Okuno, K				Oya, Yasuhisa; Sato, Misaki; Uchimura, Hiromichi; Ashikawa, Naoko; Sagara, Akio; Yoshida, Naoaki; Hatano, Yuji; Okuno, Kenji			IN-SITU OBSERVATION OF SPUTTERED PARTICLES FOR CARBON IMPLANTED TUNGSTEN DURING ENERGETIC HYDROGEN ISOTOPE ION IMPLANTATION	FUSION SCIENCE AND TECHNOLOGY			English	Article								The effect of carbon implantation for the dynamic recycling of deuterium, which demonstrates tritium recycling, including retention and sputtering, was investigated using in-situ sputtered particle measurements. The C+ implanted W, WC and HOPG were prepared and dynamic sputtered particles were measured during H-2(+) irradiation. It was found that the major hydrocarbon species for C+ implanted tungsten was found to be CH3, although those for WC and HOPG were CH4. The chemical state of hydrocarbon is controlled by the H concentration in a W-C mixed layer. The amount of C-H bond and the retention of H trapped by carbon atom should control the chemical form of hydrocarbon sputtered by H-2(+) irradiation and the desorption of CH3 and CH2 was due to chemical sputtering, although that for CH was physical sputtering. The activation energy for CH3 desorption was estimated to be 0.4 eV, corresponding to the trapping process of hydrogen by carbon through the diffusion in W It was concluded that the chemical states of hydrocarbon sputtered by H-2(+) irradiation for W was determined by the amount of C-H bond on the W surface.	[Oya, Yasuhisa; Sato, Misaki; Uchimura, Hiromichi; Okuno, Kenji] Shizuoka Univ, Grad Sch Sci, Shizuoka 4228529, Japan; [Ashikawa, Naoko; Sagara, Akio] Natl Inst Fus Sci, Gifu, Japan; [Yoshida, Naoaki] Kyushu Univ, Inst Appl Mech, Fukuoka 812, Japan; [Hatano, Yuji] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 930, Japan	Oya, Y (reprint author), Shizuoka Univ, Grad Sch Sci, Shizuoka 4228529, Japan.	syoya@ipc.shizuoka.ac.jp	Kyushu, RIAM/F-4018-2015		NIFS collaboration program; University of Toyama collaboration program; JSPS Kakenhi from MEXT, Japan [22360389]; Center for Instrumental Analysis at Shizuoka University	This study has been supported by NIFS collaboration program, University of Toyama collaboration program, JSPS Kakenhi No. 22360389 from MEXT, Japan, and the Center for Instrumental Analysis at Shizuoka University.	Loarer T, 2009, J NUCL MATER, V390-91, P20, DOI 10.1016/j.jnucmat.2009.01.039; Sharma SK, 2012, FUSION ENG DES, V87, P77, DOI 10.1016/j.fusengdes.2011.10.001; Roth J, 2008, PLASMA PHYS CONTR F, V50, DOI 10.1088/0741-3335/50/10/103001; Roth J, 2009, J NUCL MATER, V390-91, P1, DOI 10.1016/j.jnucmat.2009.01.037; FRAUENFE.R, 1969, J VAC SCI TECHNOL, V6, P388, DOI 10.1116/1.1492699; Huber A, 2001, J NUCL MATER, V290, P276, DOI 10.1016/S0022-3115(00)00629-2; VIETZKE E., 1966, CHEM EROSION PHYS PR	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					515	518				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300013		
J	Oyaidzu, M; Isobe, K; Hayashi, T				Oyaidzu, M.; Isobe, K.; Hayashi, T.			EFFECT OF TRITIUM ON CORROSION BEHAVIOR OF CHROMIUM IN 0.01 N SULFURIC ACID SOLUTION	FUSION SCIENCE AND TECHNOLOGY			English	Article							316L STAINLESS-STEEL; TRITIATED-WATER; SUS304	The effects of tritium on the corrosion behavior of chromium were investigated in the present study, since it was suggested in the previous studies that the elution of chromium, which is one of the main constituent elements of passive layer of SUS 304 stainless steel, during passivation through further oxidation induced by oxidative radiolysis products would be the key reaction for the enhancement of the corrosion of SUS304 stainless steel induced by tritium. As the experimental results of the dependence of both dissolved oxygen and tritium concentration on the anodic behavior of chromium, it was found that the self-passivation of chromium induced by dissolved oxygen was inhibited in the tritiated solution, as found in the previous studies for SUS304 stainless steel. Therefore, it was considered that the elution of chromium by highly oxidative radiolysis products would induce a passivation inhibitory effect onto SUS304 stainless steel in a tritiated solution, resulting in an enhancement of the corrosion.	[Oyaidzu, M.; Isobe, K.; Hayashi, T.] Japan Atom Energy Agcy, Tritium Technol Grp, Rokkasho, Aomori 0393212, Japan	Oyaidzu, M (reprint author), Japan Atom Energy Agcy, Tritium Technol Grp, 2-166 Omotedate, Rokkasho, Aomori 0393212, Japan.	oyaizu.makoto@jaea.go.jp			MEXT [24360380]	This work was performed with the support and under the auspices of MEXT (24360380).	Oyaidzu M, 2013, ECS TRANSACTIONS, V50, P63, DOI 10.1149/05050.0063ecst; BELLANGER B., 2009, J NUCL MATER, V389, P365; Bellanger G, 2008, J NUCL MATER, V374, P20, DOI [10.1016/j.jnucmat.2007.07.005, 10.1016/j.jnuemat.2007.07.005]; BELLANGER G, 1994, CORROS SCI, V36, P545, DOI 10.1016/0010-938X(94)90043-4; BJORNKVIST L, 1991, CORROS SCI, V32, P231, DOI 10.1016/0010-938X(91)90045-Q; Hayashi T, 2006, FUSION ENG DES, V81, P1365, DOI 10.1016/j.fusengdes.2005.09.062; Hayashi T, 2009, FUSION SCI TECHNOL, V56, P836; Oyaidzu M, 2011, FUSION SCI TECHNOL, V60, P1515; Oyaidzu M, 2011, J NUCL SCI TECHNOL, V48, P880, DOI 10.3327/jnst.48.880	9	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					519	522				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300014		
J	Sato, M; Uchimura, H; Toda, K; Tokunaga, T; Watanabe, H; Yoshida, N; Hatano, Y; Kasada, R; Nagasaka, T; Kimura, A; Oya, Y; Okuno, K				Sato, Misaki; Uchimura, Hiromichi; Toda, Kensuke; Tokunaga, Tomonori; Watanabe, Hideo; Yoshida, Naoaki; Hatano, Yuji; Kasada, Ryuta; Nagasaka, Takuya; Kimura, Akihiko; Oya, Yasuhisa; Okuno, Kenji			PREHEATING TEMPERATURE EFFECT ON TRITIUM RETENTION IN VPS-W	FUSION SCIENCE AND TECHNOLOGY			English	Article							GRAPHITE; TUNGSTEN	The deuterium retention behavior for the Vacuum Plasma Spraying (VPS) tungsten (W) coating was studied to demonstrate the tritium retention as a function of heating temperature. It was found that two major deuterium desorption stages were observed at the temperature regions of 400 - 700 K (Stage 1) and 900 - 1100 K (Stage 2), considering that Stage I was linked to the desorption of deuterium trapped by near surface and intrinsic defects, and Stage 2 was related to the desorption of deuterium bound to impurities as C-D bonds. By heating the sample above 673 K, the major peak of C-1s was shifted from C-O bond to C-C bond, where the retention of deuterium as Stage 2 was increased. Therefore it was indicating that the hydrogen isotope retention was controlled by the amount of C-C bond in VPS, most of which was contaminated during the VPS coating process. The comparison of several samples (VPS-W with shading, VPS-W without shading and Polycrystalline W (PCW)) shows that the carbon impurity has a large affinity with deuterium and make stable trapping states compared to that with intrinsic defects and grain boundaries. However, most of them was reduced by heating at 1173 K Therefore, heating treatment is quite important to get rid of carbon impurities and refrain higher tritium retention in VPS.	[Sato, Misaki; Uchimura, Hiromichi; Toda, Kensuke; Oya, Yasuhisa; Okuno, Kenji] Shizuoka Univ, Grad Sch Sci, Suruga Ku, Shizuoka 4228529, Japan; [Tokunaga, Tomonori; Watanabe, Hideo; Yoshida, Naoaki] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan; [Hatano, Yuji] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama, Toyama 9308555, Japan; [Kasada, Ryuta; Kimura, Akihiko] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Nagasaka, Takuya] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Sato, M (reprint author), Shizuoka Univ, Grad Sch Sci, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	r0332013@ipc.shizuoka.ac.jp	Kyushu, RIAM/F-4018-2015		NIFS collaboration program [NIFS09KOBF017]; JSPS; Kakenhi from MEXT, Japan [22360389]; Research Foundation for the Electrotechnology of Chubu	This study was supported by NIFS collaboration program, NIFS09KOBF017, JSPS, Kakenhi No. 22360389 from MEXT, Japan, and Research Foundation for the Electrotechnology of Chubu. The TEM observation was performed under the collaboration program at the Institute of Applied Mechanics, Kyushu University.	Ueda Y, 2009, J NUCL MATER, V390-91, P44, DOI 10.1016/j.jnucmat.2009.01.042; Philipps V, 2011, J NUCL MATER, V415, pS2, DOI 10.1016/j.jnucmat.2011.01.110; Ogorodnikova OV, 2003, J NUCL MATER, V313, P469, DOI 10.1016/S0022-3115(02)01375-2; Atsumi H, 2003, J ALLOY COMPD, V356, P705, DOI 10.1016/S0925-8388(03)00290-1; ELEVELD H, 1992, J NUCL MATER, V191, P433; HINNEN C, 1994, APPL SURF SCI, V78, P219, DOI 10.1016/0169-4332(94)90009-4; Oya Y, 2013, J NUCL MATER, V442, pS242, DOI 10.1016/j.jnucmat.2013.01.321; TOKUNAGA T., 2013, PLASMA FUSION RES, V8; UEDA Y., 2010, J PLASMA FUSION RES, V5, pS1009	9	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					551	554				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300022		
J	Sugiyama, T; Sugiura, K; Enokida, Y; Yamamoto, I				Sugiyama, Takahiko; Sugiura, Kei; Enokida, Youichi; Yamamoto, Ichiro			SEPARATIVE ANALYSES OF A CHROMATOGRAPHIC COLUMN PACKED WITH A CORE-SHELL ADSORBENT FOR LITHIUM ISOTOPE SEPARATION	FUSION SCIENCE AND TECHNOLOGY			English	Article							DISPLACEMENT CHROMATOGRAPHY; RESIN	A core-shell type adsorbent was proposed for lithium isotope separation by chromatography. Concentration profiles and its time variation in the column were numerically simulated. It became clear that core-shell type adsorbents with thin porous shell were saturated rapidly relative to filly porous one and established a sharp edge of adsorption band. This is very important feature because lithium isotope separation requires long-distance development of adsorption band The values of HETP for core-shell adsorbent packed column were estimated by statistical moments of the step response curve. The value of HETP decreased with the thickness of the porous shell. A core-shell type adsorbent is, then, useful for lithium isotope separation.	[Sugiyama, Takahiko; Sugiura, Kei; Enokida, Youichi; Yamamoto, Ichiro] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Sugiyama, T (reprint author), Nagoya Univ, Chikusa Ku, Fro Cho, Nagoya, Aichi 4648603, Japan.	t-sugiyama@nucl.nagoya-u.ac.jp			KAKENHI [B-24760697]	This work was supported financially in part by KAKENHI (Grant-in-Aid for Young Scientists B-24760697).	Ban Y, 2002, J NUCL SCI TECHNOL, V39, P279, DOI 10.3327/jnst.39.279; Kirkland JJ, 2000, J CHROMATOGR A, V890, P3, DOI 10.1016/S0021-9673(00)00392-7; Araki H, 2000, J NUCL SCI TECHNOL, V37, P267; Araki H, 1998, J NUCL SCI TECHNOL, V35, P692, DOI 10.3327/jnst.35.692; BISCHOFF KB, 1962, CHEM ENG SCI, V17, P245, DOI 10.1016/0009-2509(62)85003-9; Kataoka T, 1972, J CHEM ENGNG JAPAN, V5, P132, DOI 10.1252/jcej.5.132; Sugiyama T, 2012, FUSION ENG DES, V87, P1186, DOI 10.1016/j.fusengdes.2012.02.092	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					584	587				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300030		
J	Taguchi, A; Kato, Y; Akai, R; Torikai, Y; Matsuyama, M				Taguchi, Akira; Kato, Yuki; Akai, Rie; Torikai, Yuji; Matsuyama, Masao			TRITIUM REMOVAL FROM TRITIATED WATER BY ORGANIC FUNCTIONALIZED SBA-15	FUSION SCIENCE AND TECHNOLOGY			English	Article							MESOPOROUS SILICA; HYDROGEN	Mesoporous silicas (SBA-15) were modified by -COOH, -SO3H and -NH2 groups and their tritium adsorption ability from tritiated water under solid-liquid sorption was investigated. The adsorption abilities and separation factor of organic functionalized SBAs were comparable to those of bare SBA. The desorption of water from bare SBA and -COOH functionalized SBA were studied by Fourier transform infra-red spectroscopy using D2O as a probe molecule. An interaction was observed for D2O with -COOH group where the hydrogen bonds became weaker than D2O with bare SBA.	[Taguchi, Akira; Kato, Yuki; Akai, Rie; Torikai, Yuji; Matsuyama, Masao] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan	Taguchi, A (reprint author), Toyama Univ, Hydrogen Isotope Res Ctr, 3190 Gofuku, Toyama 9308555, Japan.	atagu@ctg.u-toyama.ac.jp					Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; KOTAKA M, 1992, J AM CHEM SOC, V114, P6436, DOI 10.1021/ja00042a022; Lebed PJ, 2012, CHEM MATER, V24, P4166, DOI 10.1021/cm3023709; Ng EP, 2008, MICROPOR MESOPOR MAT, V114, P1, DOI 10.1016/j.micromeso.2007.12.022; Zhang Z, 2013, MICROPOR MESOPOR MAT, V176, P103, DOI 10.1016/j.micromeso.2013.03.048; BIGELEISEN J, 1981, P NATL ACAD SCI USA, V78, P5271, DOI 10.1073/pnas.78.9.5271; Iwai Y, 2009, J PHYS CHEM SOLIDS, V70, P881, DOI 10.1016/j.jpcs.2009.04.010; Nishi M, 2006, FUSION ENG DES, V81, P745, DOI 10.1016/j.fusengdes.2005.08.052; ONO F, 1980, J NUCL SCI TECHNOL, V17, P721, DOI 10.3327/jnst.17.721; Rosanvallon S, 2011, FUSION SCI TECHNOL, V60, P855; Sugiyama T, 2006, FUSION ENG DES, V81, P833, DOI 10.1016/j.fusengdes.2005.06.373; Taguchi A, 2005, MICROPOR MESOPOR MAT, V77, P1, DOI 10.1016/j.micromeso.2004.06.030; Taguchi A, 2011, FUSION SCI TECHNOL, V60, P1395; Taguchi A, 2013, MICROPOR MESOPOR MAT, V179, P217, DOI 10.1016/j.micromeso.2013.05.031; VASARU G., 1993, TRITIUM ISOTOPE SEPA; Wang XH, 2013, ANN NUCL ENERGY, V56, P151, DOI 10.1016/j.anucene.2013.01.041	16	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					592	595				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300032		
J	Takeishi, T; Kotoh, K; Kawabata, Y; Tanaka, J; Kawamura, S; Iwata, M				Takeishi, Toshiharu; Kotoh, Kenji; Kawabata, Yoshiya; Tanaka, Jun-ichi; Kawamura, Shingo; Iwata, Masayuki			TRITIUM CONTAMINATION AND DECONTAMINATION OF SEALING OIL FOR VACUUM PUMP	FUSION SCIENCE AND TECHNOLOGY			English	Article							RELEASE; JT-60U; WASTE	In the decommissioning project of tritium handling laboratories or/and facilities, oils such as used in the vacuum pumps have been left conventionally in their comprehensive facilities. Existence of oils, especially highly-contaminated with tritium, is becoming one of the serious problems in projects for decommissioning tritium handling laboratories because of no disposal way of the tritiated waste oils. Experiments using bubblers were carried out to examine the tritium contamination and decontamination of a volume of rotary-vacuum-pump-oil. Contamination of pump oil was observed by bubbling with tritiated water vapor and tritiated hydrogen gas. And then, subsequent decontamination of tritiated oil was processed by bubbling with pure water vapor and dry argon gas. The bubbling with water vapor was more effective than with the dry gas. Experimental results show that the water vapor bubbling in an oil bottle can remove tritium efficiently from the contaminated oil into another water-bubbling bottle.	[Takeishi, Toshiharu; Kotoh, Kenji; Kawabata, Yoshiya; Tanaka, Jun-ichi] Kyushu Univ, Fac Engn, Nishi Ku, Fukuoka 8190395, Japan; [Kawamura, Shingo; Iwata, Masayuki] ATOX Co Ltd, Technol Dev Ctr, Kashiwa, Chiba 2770861, Japan	Takeishi, T (reprint author), Kyushu Univ, Fac Engn, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.	take@nucl.kyushu-u.ac.jp					Munakata K, 2003, FUSION ENG DES, V69, P27, DOI 10.1016/S0920-3796(03)00228-X; Dianu M, 2012, FUSION ENG DES, V87, P1443, DOI 10.1016/j.fusengdes.2012.03.030; Katayama K, 2005, J NUCL MATER, V340, P83, DOI 10.1016/j.jnucmat.2004.11.005; Sazonov AB, 2005, ATOM ENERGY+, V98, P127, DOI 10.1007/s10512-005-0181-y; Sazonov AB, 2008, FUSION SCI TECHNOL, V54, P584; Takeishi T, 2006, J NUCL MATER, V349, P327, DOI 10.1016/j.jnucmat.2005.10.018	6	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					596	599				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300033		
J	Tanaka, M; Sugiyama, T				Tanaka, Masahiro; Sugiyama, Takahiko			DEVELOPMENT OF A TRITIUM MONITOR COMBINED WITH AN ELECTROCHEMICAL TRITIUM PUMP USING A PROTON CONDUCTING OXIDE	FUSION SCIENCE AND TECHNOLOGY			English	Article							HYDROGEN PUMP; EXTRACTION; HTO	To fabricate a tritium monitoring system with electrochemical hydrogen pumping attached, a tritium monitor system was constructed and assembled with a commercial tritium monitor and an electrochemical hydrogen pump using a proton conducting oxide. The hydrogen pump with CaZr0.9In0.1O3-alpha,, as the proton conducting oxide was operated at 973 K under electrolysis conditions using tritiated water vapor (HTO). The tritium molecules (HT) were extracted and controlled by the applied current over a range of two orders of magnitude. The tritium molecules have an advantage with respect to the tritium memory effect in the monitor because the tritium contamination is reduced. Next, a system feasibility test was conducted under various water vapor partial pressure conditions. Thus, the measurement of the tritium concentration via this proposed system was successfully demonstrated	[Tanaka, Masahiro; Sugiyama, Takahiko] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Sugiyama, Takahiko] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Tanaka, M (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	tanaka.masahiro@nifs.ac.jp			NIFS [NIFS12ULAA022]; MEXT of Japan [24561032]	This study was supported by NIFS funding (NIFS12ULAA022), and in part by a Grant-in-Aid for Scientific Research (C) (No. 24561032) from the MEXT of Japan.	Iwahara H, 2004, SOLID STATE IONICS, V168, P299, DOI 10.1016/j.ssi.2003.03.001; UCHIDA H, 1983, SOLID STATE IONICS, V11, P117, DOI 10.1016/0167-2738(83)90048-6; [Anonymous], 2009, TRIT MON LB 110 MAN; [Anonymous], 1991, IAEA TECHN REP SER, V324; HOWELL RH, 1975, NUCL INSTRUM METHODS, V124, P579, DOI 10.1016/0029-554X(75)90613-8; MCELROY RGC, 1982, IEEE T NUCL SCI, V29, P816, DOI 10.1109/TNS.1982.4335966; SASAKI S., 2003, RADIOANAL NUCL CHEM, V255, P91; Tanaka M, 2012, FUSION ENG DES, V87, P1065, DOI 10.1016/j.fusengdes.2012.02.082; Tanaka M, 2008, FUSION ENG DES, V83, P1414, DOI 10.1016/j.fusengdes.2008.06.038; Tanaka M, 2011, FUSION SCI TECHNOL, V60, P1391; YAMAMOTO I, 1988, J NUCL SCI TECHNOL, V25, P289	11	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					600	603				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300034		
J	Tanaka, M; Takayama, S; Sano, S				Tanaka, Masahiro; Takayama, Sadatsugu; Sano, Saburo			MICROWAVE-ASSISTED REGENERATION OF SYNTHETIC ZEOLITE USED IN TRITIUM REMOVAL SYSTEMS	FUSION SCIENCE AND TECHNOLOGY			English	Article								Microwave irradiation was conducted for the effective regeneration process of a synthetic honeycomb type 5A zeolite adsorbent in a single-mode microwave cavity at 2.46 GHz. To investigate the effect of electromagnetic fields, inductive heating by a magnetic field was applied to synthetic zeolite containing water. Because the microwave energy absorbed in the sample was less than 15 W, the zeolite sample was only heated to a temperature of 71 degrees C. Water desorption was observed based on the increased temperature of the zeolite sample and the thermogravimetric curve that indicated a single step phenomenon. As a result, the regeneration process of zeolite was not complete over a period of 6000 s. A comparison of dielectric heating by an electric field with inductive heating by a magnetic field showed that the regeneration process by microwave irradiation was particularly beneficial in dielectric heating.	[Tanaka, Masahiro; Takayama, Sadatsugu] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Sano, Saburo] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Tanaka, M (reprint author), Natl Inst Nat Sci, Natl Inst Fus Sci, 322-6 Oroshi Cho, Toki, Gifu 5095292, Japan.	tanaka.masahiro@nifs.ac.jp			NIFS [NIFS13UFAA021]; Ministry of Education, Culture, Sports, Science and Technology of Japan [24561032]	This study was supported by the NIFS funding (NIFS13UFAA021) and a Grant-in-Aid for Scientific Research (C) (No. 24561032) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bathen D, 2003, SEP PURIF TECHNOL, V33, P163, DOI 10.1016/S1383-5866(03)00004-2; [Anonymous], 1991, IAEA TECHNICAL REPOR, V324; Price DW, 1997, J MICROWAVE POWER EE, V32, P145; ROUSSY G, 1981, J PHYS CHEM-US, V85, P2199, DOI 10.1021/j150615a013; SINGH V. P., 1984, CFFTPF84023; Tanaka M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.11NJ11; Tanaka Masahiro, 2011, Plasma and Fusion Research, V6, DOI 10.1585/pfr.6.2405038	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					604	607				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300035		
J	Torikai, Y; Penzhorn, RD				Torikai, Y.; Penzhorn, R-D			TRITIUM RELEASE FROM SS316 UNDER VACUUM CONDITION	FUSION SCIENCE AND TECHNOLOGY			English	Article							316 STAINLESS-STEEL; AMBIENT-TEMPERATURE; SURFACE	Type 316 stainless steel specimens loaded with tritium either by exposure to 1.2 kPa HT at 573 K or submersion into liquid HTO at 298 K showed characteristic thin surface layers trapping tritium in concentrations far higher than those determined in the bulk. The evolution of the tritium depth profile in the bulk during heating under vacuum was non-discernable from that of tritium liberated into a stream of argon. Only the relative amount of the two released tritium-species, i.e. HT or HTO, was dfferent. Temperature-dependent depth profiles could be predicted with a one-dimensional diffusion model. Diffusion coefficients derived from fitting of the tritium release into an evacuated vessel or a stream of argon were found to be (1.4 +/- 1.0)x10(-7) and (1.3 +/- 0.9) x 10(-9) cm(2)/s at 573 and 423 K, respectively. Polished surfaces on type SS316 stainless steel inhibit considerably the thermal release rate of tritium.	[Torikai, Y.; Penzhorn, R-D] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan	Torikai, Y (reprint author), Toyama Univ, Hydrogen Isotope Res Ctr, Gofuku 3190, Toyama 9308555, Japan.	y2torik@ctg.u-toyama.ac.jp			IEA-TEXTOR [NIFS13KETE001]; KAKENHI [24360380]; Japan Atomic Energy Agency [25K293]; University of Toyama	This work has been partly supported by the IEA-TEXTOR agreement (NIFS13KETE001), a KAKENHI Grant-in-Aid for Scientific Research (B) 24360380 and the Japan Atomic Energy Agency under the Joint Work Contract # 25K293, as part of Broader Approach activities.; RDP gratefully acknowledges continuing support from the University of Toyama.	ADAMS R. O., 1983, VAC SCI TECHNOL, VA1, P12; CALDER R, 1967, BRIT J APPL PHYS, V18, P1459, DOI 10.1088/0508-3443/18/10/313; Naoe S, 2008, FUSION SCI TECHNOL, V54, P515; Torikai Y, 2005, FUSION SCI TECHNOL, V48, P177; Penzhorn RD, 2006, J NUCL MATER, V353, P66, DOI 10.1016/j.jnucmat.2006.03.004; HIRABAYASHI T, 1984, J NUCL MATER, V120, P309, DOI 10.1016/0022-3115(84)90069-2; Oya Y, 2012, FUSION ENG DES, V87, P580, DOI 10.1016/j.fusengdes.2012.01.025; Penzhorn RD, 2012, J NUCL MATER, V429, P346, DOI 10.1016/j.jnucmat.2012.03.012; Penzhorn RD, 2010, FUSION SCI TECHNOL, V57, P185; REITER F., 1993, 15217 EUR EN; SURETTE RA, 1988, FUSION TECHNOL, V14, P1141; Torikai Y, 2007, J NUCL MATER, V363, P462, DOI 10.1016/j.jnucmat.2007.01.043; Zajec B, 2001, VACUUM, V61, P447, DOI 10.1016/S0042-207X(01)00142-7	13	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					615	618				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300038		
J	Torikai, Y; Alimov, VK; Isobe, K; Oyaidzu, M; Yamanishi, T; Penzhorn, RD; Ueda, Y; Kurishita, H; Philipps, V; Kreter, A; Zlobinski, M				Torikai, Y.; Alimov, V. Kh; Isobe, K.; Oyaidzu, M.; Yamanishi, T.; Penzhorn, R-D.; Ueda, Y.; Kurishita, H.; Philipps, V.; Kreter, A.; Zlobinski, M.		TEXTOR Team	TRITIUM TRAPPING ON THE PLASMA IRRADIATED TUNGSTEN SURFACE	FUSION SCIENCE AND TECHNOLOGY			English	Article							RETENTION	Tungsten (W) specimens previously exposed to deuterium (D) plasmas both in the TEXTOR tokamak and high flux linear plasma generator (LPG) were subsequently loaded with tritium at 573 K for 3 h. Retention of tritium in the near-surface W layer was examined by imaging plate technique. On the TEXTOR-plasma-exposed W surface, tritium was mainly trapped in carbon deposits. For LPG-plasma-exposed W specimens, tritium was trapped in defects created in the near-surface layer during the course of D plasma exposure.	[Torikai, Y.; Alimov, V. Kh; Penzhorn, R-D.] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Isobe, K.; Oyaidzu, M.; Yamanishi, T.] Japan Atom Energy Agcy, Tritium Technol Grp, Tokai, Ibaraki 3191195, Japan; [Ueda, Y.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Kurishita, H.] Tohoku Univ, Inst Mat Res, Int Res Ctr Nucl Mat Sci, Oarai, Ibaraki 3111313, Japan; [Philipps, V.; Kreter, A.; Zlobinski, M.] Assoc EURATOM FZJ, Forschungszentrum Julich, Inst Energy & Climate Res Plasma Phys, D-52425 Julich, Germany	Torikai, Y (reprint author), Toyama Univ, Hydrogen Isotope Res Ctr, Gofuku 3190, Toyama 9308555, Japan.	y2torik@ctg.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology through the IEA-TEXTOR [NIFS13KETE001]; KAKENHI [24360380]	This work has been partly supported by the Ministry of Education, Culture, Sports, Science, and Technology through the IEA-TEXTOR agreement (NIFS13KETE001) and by KAKENHI Grant-in Aid for Scientific Research (B) 24360380.	ALIMOV V. Kh., 2008, J NUCL MATER, V375, P192; ALIMOV V. Kh., 2011, J NUCL MATER, V417, P572; ALIMOV V. Kh., 2009, PHYS SCRIPTA, VT138; Causey RA, 2002, J NUCL MATER, V300, P91, DOI 10.1016/S0022-3115(01)00732-2; Lindig S, 2009, PHYS SCRIPTA, VT138, DOI 10.1088/0031-8949/2009/T138/014040; Ogorodnikova OV, 2003, J NUCL MATER, V313, P469, DOI 10.1016/S0022-3115(02)01375-2; Causey RA, 2001, PHYS SCRIPTA, VT94, P9, DOI 10.1238/Physica.Topical.094a00009; Hatano Y, 2013, J NUCL MATER, V438, pS114, DOI 10.1016/j.jnucmat.2013.01.018; Isobe K., 2013, J PLASMA FUSION RES, V10, P81; Tanabe T, 2013, J NUCL MATER, V438, pS19, DOI 10.1016/j.jnucmat.2013.01.284; Torikai Y, 2013, J NUCL MATER, V438, pS1121, DOI 10.1016/j.jnucmat.2013.01.247	11	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					619	622				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300039		
J	Yoshida, T; Ezumi, N; Sawada, K; Tanaka, Y; Tanaka, M; Nishimura, K				Yoshida, T.; Ezumi, N.; Sawada, K.; Tanaka, Y.; Tanaka, M.; Nishimura, K.			ENERGY DENSITY DEPENDENCE OF HYDROGEN COMBUSTION EFFICIENCY IN ATMOSPHERIC PRESSURE MICROWAVE PLASMA	FUSION SCIENCE AND TECHNOLOGY			English	Article							OXIDATION	Recovery of tritium in nuclear fusion plants is a key issue for safety. So far, the oxidation procedure using atmospheric pressure plasma is expected to the recovery method. In this study, to clarify the mechanism of hydrogen oxidation by plasma chemistry, we investigated the dependence of hydrogen combustion efficiency on gas flow rate and input power in the atmospheric pressure microwave plasma. It is found that the combustion efficiency depended on energy density of absorbed microwave power. Hence, the energy density is considered as a key parameter for combustion processes. Also neutral gas temperatures in and outside of the plasma were measured by an optical emission spectroscopy method and thermocouple. The result shows that the neutral gas temperature in the plasma is much higher than the outside temperature of plasma. The high neutral gas temperature would affect to the combustion reaction.	[Yoshida, T.; Ezumi, N.] Nagano Natl Coll Technol, Nagano, Nagano 3818550, Japan; [Sawada, K.] Shinshu Univ, Nagano, Nagano 3808553, Japan; [Tanaka, Y.] Kanazawa Univ, Kanazawa, Ishikawa 9201192, Japan; [Tanaka, M.; Nishimura, K.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan	Yoshida, T (reprint author), Nagano Natl Coll Technol, Tokuma 716, Nagano, Nagano 3818550, Japan.	hns08340@gmail.com			NIFS Collaborative Research Program [NIFS11KE, SA005, NIFS13KESA014]	This work was supported by NIFS Collaborative Research Program (NIFS11KE, SA005 and NIFS13KESA014).	Akahane K, 2011, FUSION SCI TECHNOL, V60, P1343; [Anonymous], 1999, DOEHDBK112999; EZUMI N., 2012, PLASMA FUSION RES, V7; Kambara S, 2008, INT J HYDROGEN ENERG, V33, P6792, DOI 10.1016/j.ijhydene.2008.07.024; Luque J, 1999, 99009 MP SRI INT; OSAKABE T., 2008, J COMB SOC JAPAN, V50, P136; Yamada M, 2002, FUSION SCI TECHNOL, V41, P593	7	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					650	653				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300047		
J	Yoshihara, Y; Furuta, E; Ohyama, R; Yokota, S; Kato, Y; Yoshimura, T; Ogiwara, K				Yoshihara, Yuri; Furuta, Etsuko; Ohyama, Ryu-ichiro; Yokota, Shigeaki; Kato, Yuka; Yoshimura, Tomoyuki; Ogiwara, Kiyoshi			MEASUREMENT OF TRITIUM WITH PLASTIC SCINTILLATOR SURFACE IMPROVEMENT WITH PLASMA TREATMENT	FUSION SCIENCE AND TECHNOLOGY			English	Article								Tritium is usually measured by using a liquid scintillation counter. However, liquid scintillator used for measurement will be radioactive waste fluid. To solve this issue, we have developed the method of measuring tritium samples with plasma-treated plastic scintillator sheets instead of liquid scintillator (Plasma method). With the Plasma method of 2-min plasma treatment, we had obtained measurement efficiency of 48 +/- 2 % for 2 min measurement of tritium except for tritiated water. On the other hand, it needed almost 6 hours to obtain constant measurement efficiency. We tried putting silica gel beads into vials to remove H2O molecules from PS sheet surface quickly. The silica gel beads worked well and we got constant measurement efficiency within 1-3 hours. Also, we tried using other kinds of PS treated with plasma to obtain higher measurement efficiencies of tritium samples.	[Yoshihara, Yuri; Furuta, Etsuko] Ochanomizu Univ, Tokyo, Japan; [Ohyama, Ryu-ichiro; Yokota, Shigeaki] Tokai Univ, Hiratsuka, Kanagawa 25912, Japan; [Kato, Yuka; Yoshimura, Tomoyuki; Ogiwara, Kiyoshi] Hitachi Aloka Med Ltd, Mitaka, Tokyo, Japan	Yoshihara, Y (reprint author), Ochanomizu Univ, 2-1-1 Otsuka, Tokyo, Japan.	furuta.etsuko@ocha.ac.jp					FURUTA E., 2013, RADIOANAL NUCL CHEM, V299, P471; Furuta E, 2009, RADIOCARBON, V2008, P19; Nakamura H, 2010, P ROY SOC A-MATH PHY, V466, P2847, DOI 10.1098/rspa.2010.0118; Ogata Y, 2007, J RADIOANAL NUCL CH, V273, P253, DOI 10.1007/s10967-007-0744-6; OHYAMA R, 2009, APPL PHYS, V42; Takamatsu T, 2013, IEEE T PLASMA SCI, V41, P119, DOI 10.1109/TPS.2012.2227459; Tarancon A, 2004, NUCL INSTRUM METH A, V516, P602, DOI 10.1016/j.nima.2003.08.172	7	1	1	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					654	657				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300048		
J	Yoshimura, S; Yoshimura, R; Okada, M; Fukada, S; Edao, Y				Yoshimura, Shunsuke; Yoshimura, Ryosuke; Okada, Makoto; Fukada, Satoshi; Edao, Yuki			STUDY ON HYDROGEN ISOTOPES PERMEATION IN FLUIDIZED STATE OF LIQUID LITHIUM-LEAD	FUSION SCIENCE AND TECHNOLOGY			English	Article							DIFFUSION; NICKEL	Hydrogen transfer under a fluidized condition of Li-Pb is investigated experimentally to design a Li-Pb blanket system. Li-Pb eutectic alloy flows through inside of a Ni tube in the experimental system, where H-2 permeates into and out of the forced Li-Pb flow. The overall H-2 permeation rate is analyzed using a mass balance model. Hydrogen atoms diffuse in Ni and Li-Pb. The steady-state H-2 permeation rate obtained by this experiment is smaller than the result of the calculation model. A resistance factor is introduced to the present analysis in order to evaluate the influence of other H-2 transfer mechanisms, such as diffusion in Li-Pb and dissolution reaction between Ni and Li-Pb. The contribution of the resistance to the overall H-2 permeation rate becomes large when the flow rate of Li-Pb is low. This is because the boundary layer thickness between Ni and Li-Pb affects the overall H-2 permeation rate. When the flow velocity of Li-Pb is large, the thickness of the boundary layer becomes thin, and the driving force of H-2 permeation through Ni wall becomes large.	[Yoshimura, Shunsuke; Yoshimura, Ryosuke; Okada, Makoto; Fukada, Satoshi; Edao, Yuki] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Yoshimura, S (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, 6-1 Kasugakoen, Kasuga, Fukuoka 8168580, Japan.	s.yoshimura@aees.kyushu-u.ac.jp					Ikeda T, 2011, J NUCL MATER, V415, pS684, DOI 10.1016/j.jnucmat.2010.12.007; Shiraishi T, 1998, J NUCL MATER, V254, P205, DOI 10.1016/S0022-3115(97)00362-0; Okitsu H, 2012, FUSION ENG DES, V87, P1324, DOI 10.1016/j.fusengdes.2012.03.004; Mas de les Valls E., 2008, J NUC MAT, V376, P353; Post CB, 1938, J CHEM PHYS, V6, P598, DOI 10.1063/1.1750131	5	0	0	AMER NUCLEAR SOC	LA GRANGE PK	555 N KENSINGTON AVE, LA GRANGE PK, IL 60526 USA	1536-1055	1943-7641		FUSION SCI TECHNOL	Fusion Sci. Technol.	APR	2015	67	3					658	661				4	Nuclear Science & Technology	Nuclear Science & Technology	CG5EG	WOS:000353313300049		
J	Iwanami, H; Moriya-Tanaka, Y; Honda, C; Wada, M				Iwanami, Hiroshi; Moriya-Tanaka, Yuki; Honda, Chikako; Wada, Masato			Efficiency of Hand-thinning in Apple Cultivars with Varying Degrees of Fruit Abscission	Horticulture Journal			English	Article						abscission; fruit; June drop; labor cost; Malus x domestica	EFFICACY	The thinning of flowers or fruit is an essential part of the commercial production of quality apples. Although chemical thinners are generally used in apple orchards throughout the world, hand-thinning remains essential for controlling crop load to improve fruit quality and return bloom. The objectives of this study were to investigate factors that determine the time required for hand-thinning and to elucidate cultivar-related efficiency of hand-thinning. In all cultivars, the time taken for hand-thinning per cluster became shorter after petal fall, but the degree of this decrease differed among cultivars. The time taken for hand-thinning depended on both how much and when natural abscission of fruitlets occurred. The times required for hand-thinning were very similar among clusters with four, five, or six flowers/fruitlets, which was twice as long as that required for clusters with two or three flowers/fruitlets. This means that the time required for hand-thinning clusters is critically reduced when the number of flowers/fruitlets within a cluster is three or fewer. The time required for hand-thinning clusters of axillary buds became significantly longer from bloom to 7 days after bloom, and then decreased gradually from 7 to 25 days after bloom. When the proportion of clusters with three or fewer fruitlets is 50% at 15 days after bloom, the planting area of the cultivar that a person is able to hand-thin (six hours per day) from 10 to 30 days after bloom was 24.3 a, which was 40% larger than that of a cultivar in which the proportion of clusters with three or fewer fruitlets is 50% at 30 days after bloom (17.4 a). Therefore, the introduction of cultivars in which fruit abscission occurs at an early stage and on a large scale is a solution for reducing the labor costs of hand-thinning.	[Iwanami, Hiroshi; Moriya-Tanaka, Yuki; Honda, Chikako; Wada, Masato] NARO Inst Fruit Tree Sci, Apple Res Stn, Morioka, Iwate 0200123, Japan	Iwanami, H (reprint author), NARO Inst Fruit Tree Sci, Apple Res Stn, Morioka, Iwate 0200123, Japan.	hiwanami@affrc.go.jp					Lakso AN, 2006, ACTA HORTIC, P321; Wertheim SJ, 2000, PLANT GROWTH REGUL, V31, P85, DOI 10.1023/A:1006383504133; Dennis FG, 2000, PLANT GROWTH REGUL, V31, P1; Koike H, 2003, J AMER POMOLOG SOC, V57, P169; Hampson C, 2011, CAN J PLANT SCI, V91, P983, DOI [10.4141/CJPS2011-070, 10.4141/cjps2011-070]; Byers Ross E., 2003, P409, DOI 10.1079/9780851995922.0409; Dennis Frank Jr., 2003, P153, DOI 10.1079/9780851995922.0153; Fukuda H., 1994, P23; Glover J., 2002, COST PRODUCTION ANAL; Greene DW, 2002, HORTSCIENCE, V37, P477; Iwanami H, 2012, SCI HORTIC-AMSTERDAM, V146, P39, DOI 10.1016/j.scienta.2012.08.017; Koike H., 1998, Compact Fruit Tree, V31, P13; Lind K., 2003, ORGANIC FRUIT GROWIN; Weibel Franco, 2003, P551, DOI 10.1079/9780851995922.022; Wertheim S. J., 2005, FUNDAMENTALS TEMPERA, P267	15	0	0	JAPAN SOC HORTICULTURAL SCI	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	2189-0102	2189-0110		HORTICULT J	Horticult. J.	APR	2015	84	2					99	105		10.2503/hortj.CH-112		7	Horticulture	Agriculture	CG5XB	WOS:000353368100001		
J	Matsumoto, T; Yamamoto, S; Fukui, K; Rafique, T; Engelmann, F; Niino, T				Matsumoto, Toshikazu; Yamamoto, Shin-ichi; Fukui, Kuniaki; Rafique, Tariq; Engelmann, Florent; Niino, Takao			Cryopreservation of Persimmon Shoot Tips from Dormant Buds Using the D Cryo-plate Technique	Horticulture Journal			English	Article						dormant shoot tips; genebank; kaki; osmoprotection	DIOSPYROS-KAKI THUNB.; DROPLET-VITRIFICATION; L.	Cryopreservation has become a very important tool for the long-term storage of plant germplasm. A new cryopreservation protocol based on air dehydration of explants placed on aluminum cryo-plates, termed the D cryo-plate technique, was developed. In this study, the most suitable conditions of cryopreservation for dormant shoot tips of Japanese persimmon (Diospyros kaki Thunb. 'Saijo') using the D cryo-plate technique were investigated. Dormant one-year-old shoots of persimmon were collected from the experimental farm of Shimane University in January 2013 and stored at 2 degrees C until use. After surface sterilization, shoot tips of about 1 mm in size were dissected from the dormant buds and precultured overnight at 25 degrees C on solidified 1/2MS medium containing 0.3 M sucrose. Precultured shoot tips were placed on aluminum cryo-plates and embedded in calcium alginate gel. Osmoprotection of shoot tips was performed by immersing the cryo-plates for 30 min at 25 degrees C in an LS solution containing 2 M glycerol + 1.0 M sucrose in 1/2MS solution. For the D cryo-plate technique, encapsulated shoot tips were dehydrated by placing the cryo-plates in the air current of a laminar flow cabinet for 30-90 min. Cooling was performed by placing the cryo-plates in uncapped cryotubes, which were immersed in liquid nitrogen. For rewarming, the cryo-plates were immersed in 1/2MS medium containing 1.0 M sucrose for 20 min at 25 degrees C. In this study, the preculture did not improve the regrowth after cryopreservation; however, we consider that it should be performed in the D cryo-plate procedure for application of other cultivars and utilization in genebanks. A high regrowth rate of cryopreserved shoot tips (84%) was achieved after dehydration for 30 min. This optimized procedure was applied to 10 additional persimmon cultivars, resulting in regrowth rates ranging between 67 and 97%, with an average of 87%. As shoot tips derived from dormant buds proved to be highly tolerant to liquid nitrogen exposure, the D cryoplate technique may facilitate long-term conservation of persimmon germplasm.	[Matsumoto, Toshikazu] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6901102, Japan; [Yamamoto, Shin-ichi; Fukui, Kuniaki; Rafique, Tariq] NIAS, Tsukuba, Ibaraki 3058602, Japan; [Engelmann, Florent] IRD, UMR DIADE, F-34394 Montpellier 5, France; [Niino, Takao] Univ Tsukuba, Gene Res Ctr, Tsukuba, Ibaraki 3058572, Japan	Matsumoto, T (reprint author), Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6901102, Japan.	tmatsumoto@life.shimane-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [CRS-1001]	This study was mainly supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, CRS-1001).	Matsumoto T., 2014, Advances in Horticultural Science, V28, P79; Kaviani B, 2011, AUST J CROP SCI, V5, P778; Yamamoto S, 2011, CRYOLETTERS, V32, P256; Salma M, 2014, SCI HORTIC-AMSTERDAM, V179, P91, DOI 10.1016/j.scienta.2014.09.017; Sakai A, 2007, CRYOLETTERS, V28, P151; Sekizawa K, 2011, PLANT BIOTECHNOL-NAR, V28, P401, DOI 10.5511/plantbiotechnology.11.0531a; Matsumoto T, 2013, CRYOLETTERS, V34, P128; Yamamoto S, 2012, CRYOLETTERS, V33, P12; Engelmann F, 2004, IN VITRO CELL DEV-PL, V40, P427, DOI 10.1079/IVP2004541; Niino T, 2013, CRYOLETTERS, V34, P549; Engelmann Florent, 2008, P59, DOI 10.1007/978-0-387-72276-4_4; Matsumoto T., 2014, AM SOC HORT SCI 2014, P337; Matsumoto T., 2004, PLANT BIOTECHNOL, V21, P229, DOI 10.5511/plantbiotechnology.21.229; Matsumoto T, 2001, PLANT CELL REP, V20, P398, DOI 10.1007/s002990100350; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Niino T., 2006, EFFECTIVE GENEBANK M, P197; Niino T, 2014, PLANT BIOTECHNOL-NAR, V31, P281, DOI 10.5511/plantbiotechnology.14.0624a; Niu Y, 2012, CRYOLETTERS, V33, P69; SAKAI A., 1997, CONSERVATION PLANT G, P53; Sakai Akira, 2008, P33, DOI 10.1007/978-0-387-72276-4_3; Yamamoto S, 2011, PLANT GENET RESOUR-C, V10, P14; Yamamoto S., 2012, Sanshi Konchu Biotec (Journal of Insect Biotechnology and Sericology), V81, P57; Yonemori K., 2000, Plant Breeding Reviews, V19, P191	23	1	1	JAPAN SOC HORTICULTURAL SCI	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	2189-0102	2189-0110		HORTICULT J	Horticult. J.	APR	2015	84	2					106	110		10.2503/hortj.MI-043		5	Horticulture	Agriculture	CG5XB	WOS:000353368100002		
J	Higashide, T; Yasuba, K; Kuroyanagi, T; Nakano, A				Higashide, Tadahisa; Yasuba, Ken-ichiro; Kuroyanagi, Takeshi; Nakano, Akimasa			Decreasing or Non-decreasing Allocation of Dry Matter to Fruit in Japanese Tomato Cultivars in Spite of the Increase in Total Dry Matter of Plants by CO2 Elevation and Fogging	Horticulture Journal			English	Article						dry matter allocation; humidity; inflorescence appearance; number of immature fruit; tomato yield	CARBON-DIOXIDE; GAS-EXCHANGE; YIELD; GREENHOUSE; ENRICHMENT; GROWTH; LIGHT; ACCLIMATION; PHOTOSYNTHESIS; TEMPERATURE	To investigate the mechanism of yield increase by elevated carbon dioxide (CO2) and fogging in Japanese tomato cultivars (Solanum lycoperskum), total above-ground dry matter (TDM), fraction of dry matter distribution to fruit (FDF), and photosynthetic characteristics were measured in 3 Japanese cultivars grown in elevated CO2 with fogging and ambient CO2 without fogging. Fresh fruit yield and TDM were improved by the elevated CO2 and fogging in the 3 Japanese cultivars. Light use efficiency (LUE) was also increased by the elevated CO2 and fogging. No significant decrease in FDF was observed by the elevated CO2 and fogging in 2 Japanese cultivars, 'Asabiyori 10' and 'Junkei Aichi Fast'. Thus, the increase in TDM by higher LUE contributed directly to the yield increase in these 2 cultivars. However, FDF in 'Momotaro York' was decreased significantly by the elevated CO2 and fogging. Thereby, the yield increase by the elevated CO2 and fogging was diminished in 'Momotaro York' in spite of the increase in TDM. The number of trusses having immature fruit in 'Momotaro York' under elevated CO2 and fogging was significantly higher than those of the others, although no increase in the number of trusses having immature fruit was observed in the other 2 cultivars. Although vegetative growth characteristics such as leaf area, LAI, and fresh and dry weights of leaves and stem were increased by the elevated CO2 and fogging, no negative effects such as a change in light-extinction coefficient and a decrease in maximum photosynthetic rate were observed. The elevated CO2 and fogging increased the number of harvested fruit but decreased weight per fruit, namely, fruit size, in the 3 cultivars.	[Higashide, Tadahisa; Yasuba, Ken-ichiro; Nakano, Akimasa] NARO Inst Vegetable & Tea Sci, Tsukuba, Ibaraki 3058666, Japan; [Kuroyanagi, Takeshi] NARO Western Reg Agr Res Ctr, Zentsuji 7650053, Japan	Higashide, T (reprint author), NARO Inst Vegetable & Tea Sci, Tsukuba, Ibaraki 3058666, Japan.	ton@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Japan	This work was partly supported by a research project entitled "Development of mitigation and adaptation techniques for global warming in the sectors of agriculture, forestry, and fisheries" by the Ministry of Agriculture, Forestry and Fisheries, Japan.	Adams SR, 2002, J HORTIC SCI BIOTECH, V77, P461; Adams SR, 2002, ACTA HORTIC, P19; POORTER H, 1993, VEGETATIO, V104, P77, DOI 10.1007/BF00048146; Monsi M, 2005, ANN BOT-LONDON, V95, P549, DOI 10.1093/aob/mci052; De Gelder A, 2012, J HORTIC SCI BIOTECH, V87, P193; Heuvelink E, 1996, ANN BOT-LONDON, V77, P71, DOI 10.1006/anbo.1996.0009; Bakker J. C., 1991, THESIS WAGENINGEN AG; BAKKER JC, 1990, J HORTIC SCI, V65, P323; Barrios-Masias FH, 2014, EUR J AGRON, V53, P45, DOI 10.1016/j.eja.2013.11.007; BESFORD RT, 1990, J EXP BOT, V41, P925, DOI 10.1093/jxb/41.8.925; BESFORD RT, 1993, VEGETATIO, V104, P441, DOI 10.1007/BF00048173; de Koning A. N. M., 1992, ACTA HORTIC, V305, P51; de Koning A. N. M, 1994, THESIS WAGENINGEN AG; de Gelder A, 2005, ACTA HORTIC, P549; de Koning JCM, 1997, ACTA HORTIC, P65; FIERRO A, 1994, HORTSCIENCE, V29, P152; Harel D., 2014, AGRONOMY, V4, P167; Heuvelink E., 1989, ACTA HORTIC, V260, P149; HICKLENTON PR, 1978, CAN J PLANT SCI, V58, P801; Higashide T, 2012, HORTSCIENCE, V47, P1408; Higashide T, 2014, J JPN SOC HORTIC SCI, V83, P235, DOI 10.2503/jjshs1.CH-048; Higashide T, 2009, J AM SOC HORTIC SCI, V134, P460; Jolliet O., 1993, ACTA HORTIC, V328, P115; JOLLIET O, 1992, AGR FOREST METEOROL, V58, P43, DOI 10.1016/0168-1923(92)90110-P; Kinomoto M., 2013, B TOCHIGI AGR EXP ST, V71, P27; Kurata K., 1994, GREENHOUSE HORTICULT, P233; Kuroyanagi T, 2014, BIOSYST ENG, V119, P58, DOI 10.1016/j.biosystemseng.2014.01.007; Li X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03433; Matsuda R, 2011, SCI HORTIC-AMSTERDAM, V127, P528, DOI 10.1016/j.scienta.2010.12.009; Matsuda R, 2013, SCI HORTIC-AMSTERDAM, V156, P19, DOI 10.1016/j.scienta.2013.03.031; Monsi M., 1953, JAPANESE J BOTANY, V14, P22; Nederhoff E. M., 1994, THESIS WAGENINGEN AG; Ohtani Y., 1997, AGR METEOROLOGY GLOS, P106; ROGERS HH, 1993, VEGETATIO, V104, P117, DOI 10.1007/BF00048148; Romero-Aranda R, 2002, J AM SOC HORTIC SCI, V127, P644; Saito T, 2011, PLANT BIOTECHNOL-NAR, V28, P455, DOI 10.5511/plantbiotechnology.11.0928a; STANGHELLINI C, 1993, PHOTOSYNTHETICA, V29, P487; Takada M, 1976, B FACULTY ED CHIBA 2, V25; Takahashi T., 2012, Journal of Science and High Technology in Agriculture, V24, P110, DOI 10.2525/shita.24.110; Tremblay N., 1998, HortTechnology, V8, P524; TRIPP KE, 1991, PLANT PHYSIOL, V96, P713, DOI 10.1104/pp.96.3.713; VANOOSTEN JJ, 1995, NEW PHYTOL, V130, P357; Yasuba K., 2011, B NATL I VEG TEA SCI, V10, P85; Yasuba K., 2013, AGR INFORM RES, V22, P247; YELLE S, 1990, J AM SOC HORTIC SCI, V115, P52	45	0	0	JAPAN SOC HORTICULTURAL SCI	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	2189-0102	2189-0110		HORTICULT J	Horticult. J.	APR	2015	84	2					111	121		10.2503/hortj.MI-010		11	Horticulture	Agriculture	CG5XB	WOS:000353368100003		
J	Takatori, Y; Shimizu, K; Ogata, J; Endo, H; Ishimaru, K; Okamoto, S; Hashimoto, F				Takatori, Yuka; Shimizu, Keiichi; Ogata, Jun; Endo, Hiroki; Ishimaru, Kanji; Okamoto, Shigehisa; Hashimoto, Fumio			Cloning of the Flavonoid 3 '-Hydroxylase Gene of Eustoma grandiflorum (Raf.) Shinn. (EgF3 ' H) and Complementation of an F3 ' H-deficient Mutant of Ipomoea nil (L.) Roth. by Heterologous Expression of EgF3 ' H	Horticulture Journal			English	Article						anthocyanin; flower color; Japanese morning glory; lisianthus; transformation	JAPANESE MORNING GLORY; FLOWER COLOR; ANTHOCYANIN BIOSYNTHESIS; TRANSPOSABLE ELEMENTS; LISIANTHUS CULTIVARS; ARABIDOPSIS-THALIANA; PLANT-REGENERATION; PETUNIA-HYBRIDA; PHARBITIS-NIL; IN-VITRO	A full-length cDNA of a putative flavonoid 3'-hydroxylase (F3'H) gene encoding a key enzyme in the production of cyanidin was cloned from a lisianthus (Eustoma grandiflorum) petal. Lisianthus F3'H (EgF3'H) shares 75.1, 73.8, and 68.2% amino acid identity with Arabidopsis thaliana, Ipomoea nil, and Petunia hybrida, respectively. RT-PCR revealed that wild-type lisianthus flowers accumulated higher levels of F3'H mRNA during the early stages of development than in the late stages. The accumulated F3'H transcript levels in leaves were similar to those in flowers in the early stages of development. Overexpression of lisianthus F3'H cDNA altered flower color from red to blue in the I. nil cultivar 'Violet', which lacks a functional F3'H gene. In addition, the transgenic 'Violet' plants accumulated cyanidin and peonidin at similar levels to wild-type I. nil. Taking these findings together, this study demonstrates that EgF3'H functions as a flavonoid 3'-hydroxylase with a role in the synthesis of cyanidin and peonidin pigments.	[Takatori, Yuka; Shimizu, Keiichi; Endo, Hiroki; Okamoto, Shigehisa; Hashimoto, Fumio] Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan; [Takatori, Yuka] Saga Prefectural Agr Res Ctr, Saga 8408502, Japan; [Ogata, Jun] Japan Sci & Technol Agcy JST Innovat Satellite Mi, Miyazaki 8800805, Japan; [Ishimaru, Kanji] Saga Univ, Fac Agr, Saga 8408502, Japan	Shimizu, K (reprint author), Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan.	shimk-1@agri.kagoshima-u.ac.jp					Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Nakatsuka T, 2005, PLANT SCI, V168, P1309, DOI 10.1016/j.plantsci.2005.01.009; Ueyama Y, 2002, PLANT SCI, V163, P253, DOI 10.1016/S0168-9452(02)00098-5; Kitada C, 2001, PLANT CELL PHYSIOL, V42, P1338, DOI 10.1093/pcp/pce169; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Morita Y, 2006, PLANT CELL PHYSIOL, V47, P457, DOI 10.1093/pcp/pcj012; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Schwinn KE, 2004, ANNU PLANT REV, V14, P92; Brugliera F, 1999, PLANT J, V19, P441, DOI 10.1046/j.1365-313X.1999.00539.x; YAMAZAKI S, 1993, J BIOCHEM-TOKYO, V114, P652; Iida S, 2004, ADV BIOPHYS, V38, P141, DOI 10.1016/S0065-227X(04)80136-9; Xu BB, 2007, J PLANT PHYSIOL, V164, P350, DOI 10.1016/j.jplph.2006.03.001; Schoenbohm C, 2000, BIOL CHEM, V381, P749, DOI 10.1515/BC.2000.095; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Noda N, 2004, PHYSIOL PLANTARUM, V122, P305, DOI 10.1111/j.1399-3054.2004.00407.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; MURAKAMI K, 1994, J BIOCHEM, V116, P164; BAPAT VA, 1977, PLANT SCI LETT, V10, P327, DOI 10.1016/0304-4211(77)90057-8; Chopra S, 2006, SCI FLAVONOIDS, P147; DAVIES KM, 1993, PLANT SCI, V95, P67, DOI 10.1016/0168-9452(93)90080-J; Hashimoto F, 2002, BIOSCI BIOTECH BIOCH, V66, P1652, DOI 10.1271/bbb.66.1652; Hashimoto F, 2004, J JPN SOC HORTIC SCI, V73, P235; HOLTON TA, 1993, NATURE, V366, P276, DOI 10.1038/366276a0; Hoshino A, 2003, PLANT CELL PHYSIOL, V44, P990, DOI 10.1093/pcp/pcg143; Iida S, 1999, ANN NY ACAD SCI, V870, P265, DOI 10.1111/j.1749-6632.1999.tb08887.x; IMAI YOSHITAKA, 1927, JOUR COLL AGRIC IMP UNIV TOKYO, V9, P223; Ishikawa N., 2002, SEIBUTSU NO KAGAKU S, V15, P32; JIA SR, 1992, PLANT SCI, V87, P215, DOI 10.1016/0168-9452(92)90153-D; Kikuchi R., 2005, PLANT BIOTECHNOL, V22, P295, DOI 10.5511/plantbiotechnology.22.295; Ledger SE, 1997, PLANT CELL REP, V16, P853, DOI 10.1007/s002990050333; Mori S, 2004, PLANT CELL REP, V22, P415, DOI 10.1007/s00299-003-0709-3; Nielsen KM, 1997, PLANT SCI, V129, P167, DOI 10.1016/S0168-9452(97)00175-1; Oka M, 2001, PLANT SCI, V160, P1237, DOI 10.1016/S0168-9452(01)00388-0; Ono M, 2000, PLANT BIOTECHNOL, V17, P211; Otani M, 1998, PLANT BIOTECH, V15, P127; SANGWAN RS, 1975, NATURE, V257, P222, DOI 10.1038/257222a0; Shimada Y, 1999, FEBS LETT, V461, P241, DOI 10.1016/S0014-5793(99)01425-8; Shimizu K, 2011, J JPN SOC HORTIC SCI, V80, P434, DOI 10.2503/jjshs1.80.434; Shimizu K, 2003, J JPN SOC HORTIC SCI, V72, P409; SHINNERS LLOYD H., 1957, SOUTHWESTERN NAT, V2, P38, DOI 10.2307/3669563; Uddin AFMJ, 2001, SCI HORTIC-AMSTERDAM, V89, P73, DOI 10.1016/S0304-4238(01)00224-2; Uddin AFMJ, 2002, J JPN SOC HORTIC SCI, V71, P40; Werck-Reichhart D., 2002, ARABIDOPSIS BOOK; Yoneda Y, 1987, REP FAC LIBERAL ARTS, V23, P11; Zabala G, 2003, GENETICS, V163, P295; Zufall RA, 2004, NATURE, V428, P847, DOI 10.1038/nature02489	46	0	0	JAPAN SOC HORTICULTURAL SCI	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	2189-0102	2189-0110		HORTICULT J	Horticult. J.	APR	2015	84	2					131	139		10.2503/hortj.M1-029		9	Horticulture	Agriculture	CG5XB	WOS:000353368100005		
J	Mizunoe, Y; Kubota, S; Kanno, A; Ozaki, Y				Mizunoe, Yuki; Kubota, Shosei; Kanno, Akira; Ozaki, Yukio			Morphological Variation and AGAMOUS-like Gene Expression in Double Flowers of Cyclamen persicum Mill	Horticulture Journal			English	Article						ABC-model; Cyclamen; floral morphogenesis; MADS-box gene; petaloidy	FLORAL HOMEOTIC GENES; STEM-CELL MAINTENANCE; MODIFIED ABC MODEL; CHIMERIC REPRESSOR; TRANSCRIPTION FACTOR; ARABIDOPSIS; MERISTEM; WUSCHEL; SHOOT; PATTERNS	Several kinds of double-flowered cultivars have been produced from spontaneous mutants in Cyclamen persicum Mill. The morphology and number of organs in double flowers were investigated, and were categorized into three types: "petaloid-stamen type", "petaloid-sepal type", and "extra petals in whorl 2 type". Morphological observations showed that petaloid mutations of stamen and sepal did not appear together within an individual. In addition, three types of AG-like gene were isolated from single and petaloid-stamentype double-flower buds, and expressions in each whorl were compared. All AG-like genes were expressed in whorl 3 of single flowers, but not in that of petaloid-stamen-type double flowers. In whorl 4, although expressions of the three types of AG-like gene were observed in both single and double flowers, the expression of double flowers was lower than that of single flowers. These results suggest that naturally occurring double flowers of cyclamen can be explained by the ABC-model, and it is suspected that petaloidy of the stamen is caused by the repression of AG-like gene expression in whorl 3.	[Mizunoe, Yuki] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan; [Kubota, Shosei; Kanno, Akira] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan; [Ozaki, Yukio] Kyushu Univ, Fac Agr, Kasuya, Fukuoka 8112307, Japan	Mizunoe, Y (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 8128581, Japan.	y.mizunoe@gmail.com					Akita Y, 2011, SCI HORTIC-AMSTERDAM, V128, P48, DOI 10.1016/j.scienta.2010.12.012; Sun B, 2009, GENE DEV, V23, P1791, DOI 10.1101/gad.1800409; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Kramer EM, 2003, INT J PLANT SCI, V164, P1, DOI 10.1086/344694; Nakamura T, 2005, PLANT MOL BIOL, V58, P435, DOI 10.1007/s11103-005-5218-z; SCHWARZSOMMER Z, 1992, EMBO J, V11, P251; Laux T, 1996, DEVELOPMENT, V122, P87; Running MP, 1996, DEVELOPMENT, V122, P1261; Tsaftaris AS, 2006, PLANT SCI, V170, P238, DOI 10.1016/j.plantsci.2005.08.008; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Lohmann JU, 2001, CELL, V105, P793, DOI 10.1016/S0092-8674(01)00384-1; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Grey-Wilson C., 1988, GENUS CYCLAMEN; Hirai M, 2007, PLANT CELL PHYSIOL, V48, P310, DOI 10.1093/pcp/pcm004; Matsuhashi S, 2012, INT J PLANT SCI, V173, P391, DOI 10.1086/663966; Mibus H, 2011, J PLANT GROWTH REGUL, V30, P272, DOI 10.1007/s00344-010-9190-8; Mitsuda N, 2006, PLANT BIOTECHNOL J, V4, P325, DOI 10.1111/j.1467-7652.2006.00184.x; Narumi T, 2008, PLANT BIOTECHNOL, V25, P45, DOI 10.5511/plantbiotechnology.25.45; Sablowski RWM, 1998, PLANT CELL, V10, P1453; Sage-Ono K, 2011, PLANT BIOTECHNOL-NAR, V28, P153, DOI 10.5511/plantbiotechnology.11.0119a; Shitaka M., 2008, PLANT BIOTECHNOL, V25, P31; Tanaka Y, 2011, PLANT BIOTECHNOL-NAR, V28, P167, DOI 10.5511/plantbiotechnology.11.0201a; Tanaka Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02641; van Tunen AJ, 1993, FLOWERING NEWSL, V16, P33	32	1	1	JAPAN SOC HORTICULTURAL SCI	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	2189-0102	2189-0110		HORTICULT J	Horticult. J.	APR	2015	84	2					140	147		10.2503/hortj.MI-024		8	Horticulture	Agriculture	CG5XB	WOS:000353368100006		
J	Bai, JF; Kawabata, S				Bai, Jianfang; Kawabata, Saneyuki			Regulation of Diurnal Rhythms of Flower Opening and Closure by Light Cycles, Wavelength, and Intensity in Eustoma grandiflorum	Horticulture Journal			English	Article						blue light; circadian clock; lisianthus; oscillation; red light	DISRUPTS CIRCADIAN-RHYTHMS; PHARBITIS-NIL; CONSTITUTIVE EXPRESSION; ARABIDOPSIS; GENE; TIME; POLLINATION; SUPPRESSES; CLOCK; PLANT	Flowers of Eustoma grandiflorum open in the morning and close in the evening, showing diurnal rhythms. In this study, the process of flower opening and closure of E. grandiflorum 'Azuma-no-Murasaki' was examined under different light cycles by capturing corolla images using interval photography. At 24-hour light cycles, the flower opening rhythm synchronized with the light cycles, and the process was composed of dual steps. The first one was immediate opening and closure at the times of initiation and cessation of the light period, respectively. The second one was gradual opening and closure, which occurred 12 hours after the end of the former light period and 2-3 hours after the initiation of the current light period, respectively. The first response appeared to be a direct effect of light, while the second one appeared to be under the regulation of circadian clocks. Under constant dark, blue, or red conditions, flowers showed circadian oscillations of 25.5 +/- 0.6, 25.6 +/- 0.6, or 24.3 +/- 0.4 hours, respectively. Under constant white light or co-irradiation of blue and red light, flowers opened and closed once, but the oscillations did not continue thereafter. The synchronization of flower opening and closure rhythms to 24- and 20-hour day cycles was observed for both blue light and red light cycles. The synchronization was not complete for 16-hour light cycles and the flower oscillation period became 24 hours under 12-hour light cycles. The direct effect of light was found to be dependent on light intensity. When blue light intensity was adjusted at 25, 40, or 100 W.m(-2), flowers opened more rapidly after illumination at a stronger light intensity, but such intensity-dependent effect was not observed for red light.	[Bai, Jianfang; Kawabata, Saneyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Kawabata, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.	ayuki@mail.ecc.u-tokyo.ac.jp			JSPS KAKENHI Grant [25660020]	This work was supported by JSPS KAKENHI Grant Number 25660020.	Bieleski R, 2000, ANN BOT-LONDON, V86, P1175, DOI 10.1006/anbo.2000.1291; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; van Doorn WG, 2003, J EXP BOT, V54, P1801, DOI 10.1093/jxb/erg213; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; BALL N. G., 1933, NEW PHYTOLOGIST, V32, P13, DOI 10.1111/j.1469-8137.1933.tb06997.x; Bieleski R, 2000, ANN BOT-LONDON, V86, P1169, DOI 10.1006/anbo.2000.1289; BUNNING E, 1962, PLANTA, V59, P1; EWUSIE JY, 1977, NEW PHYTOL, V78, P479, DOI 10.1111/j.1469-8137.1977.tb04854.x; Higuchi Y, 2011, PLANT CELL PHYSIOL, V52, P638, DOI 10.1093/pcp/pcr023; Horibe T, 2014, J JPN SOC HORTIC SCI, V83, P302, DOI 10.2503/jjshs1.CH-101; Ichimura K, 1998, ANN BOT-LONDON, V82, P67, DOI 10.1006/anbo.1998.0642; KAIHARA S, 1979, PLANT CELL PHYSIOL, V20, P1659; KAIHARA S, 1980, PLANT CELL PHYSIOL, V21, P21; KARVE A, 1961, PLANTA, V56, P700, DOI 10.1007/BF01928213; Mas P, 2009, CURR OPIN PLANT BIOL, V12, P574, DOI 10.1016/j.pbi.2009.07.010; Nakanishi F, 2005, J BIOL EDUC, V39, P87, DOI 10.1080/00219266.2005.9655968; Niu Y, 2011, ANN BOT-LONDON, V108, P1257, DOI 10.1093/aob/mcr224; Primack RB, 1985, POPULATION STRUCTURE, P571; Sigmond H., 1930, BEIHEFTE BOT ZENTRAL, V47, P69; Sigmond H., 1929, BEIHEFTE BOT ZENTRAL, V46, P68; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; TANAKA O, 1989, BOT MAG TOKYO, V102, P245, DOI 10.1007/BF02488567; vanDoorn WG, 1997, J EXP BOT, V48, P1615, DOI 10.1093/jexbot/48.314.1615; Yanovsky MJ, 2001, CURR OPIN PLANT BIOL, V4, P429, DOI 10.1016/S1369-5266(00)00196-5	28	0	0	JAPAN SOC HORTICULTURAL SCI	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	2189-0102	2189-0110		HORTICULT J	Horticult. J.	APR	2015	84	2					148	155		10.2503/hortj.MI-019		8	Horticulture	Agriculture	CG5XB	WOS:000353368100007		
J	Kitamura, Y; Ueno, S				Kitamura, Yoshikuni; Ueno, Sachiyo			Inhibition of Transpiration from the Inflorescence Extends the Vase Life of Cut Hydrangea Flowers	Horticulture Journal			English	Article						decorative sepal; hortensia; Japanese hydrangea market; stomatal conductance	ROSE FLOWERS; SENESCENCE; BACTERIA; BLOCKAGE; PETALS	The relationship between transpiration from the inflorescence and the vase life of cut hydrangea 'Endless Summer' flowers was studied. In the defoliated cut flowers, the vase life increased with a decreasing number of decorative florets. Cut flowers having small inflorescences with 189 decorative florets exhibited a lower level of transpiration (7 g.day(-1)) and longer vase life (15 days) than those having large inflorescences with 422 decorative florets. The stomatal conductivity of the decorative sepals was very low, ranging from 2.7 mmol.m(-2).s(-1) to 3.3 mmol.m(-2).s(-1), and approximately 6% of the stomata were observed to be open microscopically. In addition, diurnal change of transpiration from a defoliated cut flower was not observed. These observations indicate that most of the transpiration from the sepals is through cuticular transpiration. The use of defoliated cut flowers that do not bear too many decorative florets and treatments that suppress transpiration from the surface of the decorative sepals would be effective for the vase life extension of cut hydrangea flowers.	[Kitamura, Yoshikuni; Ueno, Sachiyo] Shinshu Univ, Fac Agr, Minamiminowa, Nagano 3994598, Japan	Kitamura, Y (reprint author), Shinshu Univ, Fac Agr, Minamiminowa, Nagano 3994598, Japan.	hyphy281@shinshu-u.ac.jp			Hokuto Biological Science Foundation	This work was supported by a grant from the Hokuto Biological Science Foundation.	Elibox W, 2010, SCI HORTIC-AMSTERDAM, V124, P102, DOI 10.1016/j.scienta.2009.12.005; WILLIAMSON B, 1995, MYCOL RES, V99, P1303, DOI 10.1016/S0953-7562(09)81212-4; Azad AK, 2007, ANN APPL BIOL, V150, P81, DOI 10.1111/j.1744-7348.2006.00111.x; CARPENTER W J, 1974, Scientia Horticulturae (Amsterdam), V2, P293, DOI 10.1016/0304-4238(74)90038-7; Doi M, 1999, J JPN SOC HORTIC SCI, V68, P861; HALEVY AH, 1974, PLANT CELL PHYSIOL, V15, P813; HEW CS, 1980, ANN BOT-LONDON, V46, P195; Ichimura K., 2010, B NATL I FLOR SCI, V10, P11; Loubaud M, 2004, POSTHARVEST BIOL TEC, V32, P281, DOI 10.1016/j.postharvbio.2003.12.004; MEGA K., 1957, Bulletin of the University of Osaka Prefecture. Series B. Agriculture and Biology, V7, P15; Mujaffar S., 2003, International Agrophysics, V17, P77; PAULL RE, 1985, J AM SOC HORTIC SCI, V110, P84; Uemachi T., 2005, SER H SERRATA THUNB, V4, P435; Uemachi T, 2006, J JPN SOC HORTIC SCI, V75, P154, DOI 10.2503/jjshs.75.154; VANDOORN WG, 1989, J PLANT PHYSIOL, V134, P375; van Doorn WG, 2000, POSTHARVEST BIOL TEC, V19, P73, DOI 10.1016/S0925-5214(00)00069-7	16	0	0	JAPAN SOC HORTICULTURAL SCI	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	2189-0102	2189-0110		HORTICULT J	Horticult. J.	APR	2015	84	2					156	160		10.2503/hortj.MI-016		5	Horticulture	Agriculture	CG5XB	WOS:000353368100008		
J	Sugiyama, S; Satoh, S				Sugiyama, So; Satoh, Shigeru			Pyridinedicarboxylic Acids Prolong the Vase Life of Cut Flowers of Spray-type 'Light Pink Barbara' Carnation by Accelerating Flower Opening in Addition to an Already-known Action of Retarding Senescence	Horticulture Journal			English	Article						flower opening; pyridinedicarboxylic acid (PDCA); senescence; spray-type carnation; vase life	GIBBERELLIN BIOSYNTHESIS; ETHYLENE; PURIFICATION; EXPRESSION; SUCROSE; CLONING; GENES	2,4-Pyridinedicarboxylic acid (2,4-PDCA) was shown to prolong the vase life of cut flowers of spray-type 'Light Pink Barbara' (LPB) carnation, mainly due to the reduced ethylene production caused by inhibition of 1-aminocyclopropane-1-carboxylate oxidase in the flowers. In addition, 2,4-PDCA has been suggested to accelerate flower opening in the flowers (Satoh et al., 2014). In the present study, we successfully developed a procedure to evaluate the activity of chemicals to accelerate flower (bud) opening by determining the shortened time (in days) to flower opening. Using this procedure, we could show the activities of several PDCA analogs to accelerate flower opening, in addition to their already-known activity to extend the vase life in cut flowers of 'LPB' carnation. Judging from their effectiveness in the acceleration of flower opening and extension of vase life, 2,3-PDCA and 2,4-PDCA were thought to be suitable agents for treatment of the flowers. The present study confirmed that PDCAs accelerate flower opening and retard senescence, which increase the number of open flowers, resulting in extension of the vase life of cut flowers of 'LPB' carnation.	[Sugiyama, So; Satoh, Shigeru] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan; [Satoh, Shigeru] Kyoto Prefectural Inst Agr Biotechnol, Seika, Kyoto 6190224, Japan	Satoh, S (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto 6068522, Japan.	ssatoh@kpu.ac.jp			Japan Society for the Promotion of Science [24580050]	This study was supported financially by a Grant-in-Aid (24580050 to S. Satoh) for Scientific Research from the Japan Society for the Promotion of Science.	Harada T, 2010, J EXP BOT, V61, P2345, DOI 10.1093/jxb/erq064; LANGE T, 1994, P NATL ACAD SCI USA, V91, P8552, DOI 10.1073/pnas.91.18.8552; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; LANGE T, 1994, PLANTA, V195, P98; MAYAK S, 1976, J AM SOC HORTIC SCI, V101, P503; BOROCHOV A, 1984, SCI HORTIC-AMSTERDAM, V22, P173, DOI 10.1016/0304-4238(84)90098-0; Fragkostefanakis S, 2013, J PLANT GROWTH REGUL, V32, P140, DOI 10.1007/s00344-012-9286-4; MAYAK S, 1976, J AM SOC HORTIC SCI, V101, P583; Morita S, 2011, J JPN SOC HORTIC SCI, V80, P358; SAKS Y, 1992, PLANT GROWTH REGUL, V11, P45, DOI 10.1007/BF00024432; Satoh S, 2011, J JPN SOC HORTIC SCI, V80, P127, DOI 10.2503/jjshs1.80.127; Satoh S, 2013, J JPN SOC HORTIC SCI, V82, P337; Satoh S, 2014, J JPN SOC HORTIC SCI, V83, P72, DOI 10.2503/jjshs1.CH-082; Satoh S., 2005, Journal of Applied Horticulture (Lucknow), V7, P8; SMITH VA, 1984, J PLANT GROWTH REGUL, V2, P251; SMITH VA, 1986, PLANTA, V167, P9, DOI 10.1007/BF00446362; Vlad F, 2010, PHYSIOL PLANTARUM, V140, P199, DOI 10.1111/j.1399-3054.2010.01390.x	17	0	0	JAPAN SOC HORTICULTURAL SCI	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	2189-0102	2189-0110		HORTICULT J	Horticult. J.	APR	2015	84	2					172	177		10.2503/hortj.MI-025		6	Horticulture	Agriculture	CG5XB	WOS:000353368100010		
J	Kumar, R; Corbett, MA; Smith, NJC; Jolly, LA; Tan, C; Keating, DJ; Duffield, MD; Utsumi, T; Moriya, K; Smith, KR; Hoischen, A; Abbott, K; Harbord, MG; Compton, AG; Woenig, JA; Arts, P; Kwint, M; Wieskamp, N; Gijsen, S; Veltman, JA; Bahlo, M; Gleeson, JG; Haan, E; Gecz, J				Kumar, Raman; Corbett, Mark A.; Smith, Nicholas J. C.; Jolly, Lachlan A.; Tan, Chuan; Keating, Damien J.; Duffield, Michael D.; Utsumi, Toshihiko; Moriya, Koko; Smith, Katherine R.; Hoischen, Alexander; Abbott, Kim; Harbord, Michael G.; Compton, Alison G.; Woenig, Joshua A.; Arts, Peer; Kwint, Michael; Wieskamp, Nienke; Gijsen, Sabine; Veltman, Joris A.; Bahlo, Melanie; Gleeson, Joseph G.; Haan, Eric; Gecz, Jozef			Homozygous mutation of STXBP5L explains an autosomal recessive infantile-onset neurodegenerative disorder	HUMAN MOLECULAR GENETICS			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NEUROTRANSMITTER RELEASE; INBREEDING COEFFICIENT; GENETIC-VARIANTS; TOMOSYN; EXOCYTOSIS; DISEASE; COMPLEXES; FRAMEWORK; PROTEINS	We report siblings of consanguineous parents with an infantile-onset neurodegenerative disorder manifesting a predominant sensorimotor axonal neuropathy, optic atrophy and cognitive deficit. We used homozygosity mapping to identify an similar to 12-Mbp interval identical by descent (IBD) between the affected individuals on chromosome 3q13.13-21.1 with an LOD score of 2.31. We combined family-based whole-exome and whole-genome sequencing of parents and affected siblings and, after filtering of likely non-pathogenic variants, identified a unique missense variant in syntaxin-binding protein 5-like (STXBP5L c.3127G>A, p.Val1043Ile [CCDS43137.1]) in the IBD interval. Considering other modes of inheritance, we also found compound heterozygous variants in FMNL3 (c.114G>C, p.Phe38Leu and c.1372T>G, p.Ile458Leu [CCDS44874.1]) located on chromosome 12. STXBP5L (or Tomosyn-2) is expressed in the central and peripheral nervous system and is known to inhibit neurotransmitter release through inhibition of the formation of the SNARE complexes between synaptic vesicles and the plasma membrane. FMNL3 is expressed more widely and is a formin family protein that is involved in the regulation of cell morphology and cytoskeletal organization. The STXBP5L p. Val1043Ile variant enhanced inhibition of exocytosis in comparison with wild-type (WT) STXBP5L. Furthermore, WT STXBP5L, but not variant STXBP5L, promoted axonal outgrowth in manipulated mouse primary hippocampal neurons. However, the FMNL3 p.Phe38Leu and p.Ile458Leu variants showed minimal effects in these cells. Collectively, our clinical, genetic and molecular data suggest that the IBD variant in STXBP5L is the likely cause of the disorder.	[Kumar, Raman; Woenig, Joshua A.; Gecz, Jozef] Womens & Childrens Hlth Res Inst, Adelaide, SA, Australia; [Kumar, Raman; Woenig, Joshua A.; Gecz, Jozef] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Kumar, Raman; Corbett, Mark A.; Smith, Nicholas J. C.; Jolly, Lachlan A.; Tan, Chuan; Woenig, Joshua A.; Haan, Eric; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA, Australia; [Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Smith, Nicholas J. C.; Abbott, Kim] Womens & Childrens Hlth Network, Dept Neurol, Adelaide, SA, Australia; [Keating, Damien J.; Duffield, Michael D.] Flinders Univ South Australia, Dept Human Physiol, Adelaide, SA, Australia; [Keating, Damien J.; Duffield, Michael D.] Flinders Univ South Australia, Ctr Neurosci, Adelaide, SA, Australia; [Utsumi, Toshihiko; Moriya, Koko] Yamaguchi Univ, Appl Mol Biosci, Yamaguchi, Japan; [Smith, Katherine R.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Smith, Katherine R.; Bahlo, Melanie] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Compton, Alison G.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Bahlo, Melanie] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia; [Hoischen, Alexander; Arts, Peer; Kwint, Michael; Wieskamp, Nienke; Gijsen, Sabine; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Harbord, Michael G.] Modbury Hosp, Ctr Disabil Hlth, Adelaide, SA, Australia; [Compton, Alison G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Gleeson, Joseph G.] Univ Calif San Diego, Inst Genom Med, Neurogenet Lab, San Diego, CA 92103 USA; [Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Gleeson, Joseph G.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Haan, Eric] SA Pathol, South Australian Clin Genet Serv, Adelaide, SA, Australia	Gecz, J (reprint author), Univ Adelaide, Womens & Childrens Hosp, Fac Hlth Sci, Sch Paediat & Reprod Hlth, 72 King William Rd, Adelaide, SA 5006, Australia.	jozef.gecz@adelaide.edu.au	Veltman, Joris/F-5128-2010; Hoischen, Alexander/D-1282-2013; 	Hoischen, Alexander/0000-0002-8072-4476; Compton, Alison/0000-0002-2725-7055	philanthropic funds; Channel 7 Children's Research Foundation of SA; Netherlands Organization for Health Research and Development; Australian Research Council; National Health and Medical Research Council; MS McLeod Fellowship of the Women's and Children's Hospital Foundation	This work was supported by philanthropic funds, The Channel 7 Children's Research Foundation of SA (R.K., E.H., M.A.C. and J.G.), the Netherlands Organization for Health Research and Development (A.H. and J.A.V.), an Australian Research Council Future Fellowship (M.B.), National Health and Medical Research Council Research Fellowship (J.G.) and Program Grants (M.B. and J.G.) and MS McLeod Fellowship of the Women's and Children's Hospital Foundation (M.A.C.).	Moriya K, 2012, BIOSCI BIOTECH BIOCH, V76, P1201, DOI 10.1271/bbb.120069; Nguyen LS, 2012, MOL PSYCHIATR, V17, P1103, DOI 10.1038/mp.2011.163; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Zhu XL, 2008, INT J COLORECTAL DIS, V23, P1041, DOI 10.1007/s00384-008-0520-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; Stolk P, 2006, B WORLD HEALTH ORGAN, V84, P745, DOI 10.2471/BLT.06.031518; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Lybaek H, 2009, EUR J HUM GENET, V17, P904, DOI 10.1038/ejhg.2008.261; Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; [Anonymous], 2014, RAR DIS COLL; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Cukier HN, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-1; Davis LK, 2009, J NEURODEV DISORD, V1, P292, DOI 10.1007/s11689-009-9013-z; Geerts C. J., 2014, BRAIN STRUCT FUNCT, DOI [10.1007/s00429-014-0766-0, DOI 10.1007/S00429-014-0766-0]; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar R, 2008, J BIOL CHEM, V283, P19026, DOI 10.1074/jbc.M709136200; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Randall T. S., 2013, EUR J CELL BIOL, V93, P205; Schoenmakers T. J., 1992, BIOTECHNIQUES, V12, P876; Stegeman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068287; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x	53	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906	1460-2083		HUM MOL GENET	Hum. Mol. Genet.	APR 1	2015	24	7					2000	2010		10.1093/hmg/ddu614		11	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CG1WE	WOS:000353065300016		
J	Yuen, C; Elkashlan, M; Qian, Y; Duong, TQ; Shu, L; Schmidt, F				Yuen, Chau; Elkashlan, Maged; Qian, Yi; Duong, Trung Q.; Shu, Lei; Schmidt, Frank			ENERGY HARVESTING COMMUNICATIONS: PART 1	IEEE COMMUNICATIONS MAGAZINE			English	Editorial Material									[Yuen, Chau] Lucent Technol Bell Labs, Murray Hill, NJ USA; [Yuen, Chau] Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China; [Yuen, Chau] Inst Infocomm Res, Singapore, Singapore; [Yuen, Chau] Singapore Univ Technol & Design, Singapore, Singapore; [Elkashlan, Maged] Univ British Columbia, Lab Adv Networking, Vancouver, BC V5Z 1M9, Canada; [Elkashlan, Maged] CSIRO, Wireless & Networking Technol Lab, Clayton, Vic, Australia; [Elkashlan, Maged] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Elkashlan, Maged] Univ London, Sch Elect Engn & Comp Sci, London WC1E 7HU, England; [Qian, Yi] UNL, Dept Elect & Comp Engn, Lincoln, NE USA; [Qian, Yi] UNL, Telecommun Ind Acad & Govt, Lincoln, NE USA; [Qian, Yi] Nortel Networks, Res Triangle Pk, NC USA; [Qian, Yi] Univ Puerto Rico, Mayaguez, PR USA; [Qian, Yi] Natl Inst Stand & Technol, Gaithersburg, MD USA; [Duong, Trung Q.] BTH, Cochin, Kerala, India; [Duong, Trung Q.] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; [Shu, Lei] Osaka Univ, Dept Multimedia Engn, Grad Sch Informat Sci & Technol, Suita, Osaka 565, Japan; [Shu, Lei] Guangdong Univ Petrochem Technol, Maoming, Guangdong, Peoples R China; [Shu, Lei] Dalian Univ Technol, Dalian, Liaoning Provin, Peoples R China; [Shu, Lei] Beijing Univ Posts & Telecommun, Coll Software, Informat & Commun Engn, Beijing, Peoples R China; [Shu, Lei] Wuhan Univ, Coll Comp Sci, Wuhan, Hubei, Peoples R China; [Shu, Lei] Tianjin Univ Sci & Technol, Tianjin, Peoples R China; [Shu, Lei] Chinese Acad Sci, Guangzhou Inst Adv Technol, Beijing 100864, Peoples R China; [Shu, Lei] Guangdong Prov Key Lab Petrochem Equipment Fault, Maoming, Guangdong, Peoples R China; [Schmidt, Frank] EnOcean, Energy Harvesting & Visionary Management Team, Oberhaching, Germany; [Schmidt, Frank] Siemens AG, Cent Res Dept, Selfpowered Wireless Sensor Technol, Munich, Germany		yuenchau@sutd.edu.sg	Duong, Trung Q./I-1291-2013	Duong, Trung Q./0000-0002-4703-4836				0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0163-6804	1558-1896		IEEE COMMUN MAG	IEEE Commun. Mag.	APR	2015	53	4					68	69				2	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CF6ZB	WOS:000352704400010		
J	Mitran, P; Ochiai, H				Mitran, Patrick; Ochiai, Hideki			Parallel Concatenated Convolutional Lattice Codes With Constrained States	IEEE TRANSACTIONS ON COMMUNICATIONS			English	Article						Lattice codes; structured codes; parallel concatenation	AWGN CHANNEL; TURBO-CODES; CONSTRUCTION; CAPACITY	Convolutional lattice codes, also known as signal codes, have been proposed as a technique to generate structured codes that have good performance. While in principle optimal decoding can be achieved using the Viterbi Algorithm, in practice due to Tomlinson-Harashima precoding, the size of the state space is too large, and one must resort to suboptimal techniques such as sequential decoding. In this paper, we take an alternate approach. By employing a judicious selection of tap coefficients and in combination with precoding, we show that the state space can be constrained to a relatively small set such that Viterbi decoding is practical. The performance of such codes still exhibits a large gap to capacity, and we further propose a parallel concatenation similar to that of turbo codes, resulting in a "turbo signal code." Due to the relatively small state space, iterative decoding based on the BCJR algorithm is now possible. The gaps between the SNR for a frame error rate of 1% and the optimal performance theoretically achievable for a code of the same rate over an AWGN channel are found by simulation to be within 0.75-0.85 dB with a block length of 8192.	[Mitran, Patrick] Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada; [Ochiai, Hideki] Yokohama Natl Univ, Dept Elect & Comp Engn, Yokohama, Kanagawa 2408501, Japan	Mitran, P (reprint author), Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada.	pmitran@ecemail.uwaterloo.ca; hideki@ynu.ac.jp			JSPS; Compute/Calcul Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)	Manuscript received June 4, 2014; revised November 4, 2014 and February 13, 2015; accepted February 21, 2015. Date of publication March 2, 2015; date of current version April 14, 2015. This work was supported in part by the JSPS Invitation Fellowships for Research in Japan program, by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET:www.sharcnet.ca) and Compute/Calcul Canada, and by the Natural Sciences and Engineering Research Council of Canada (NSERC). The associate editor coordinating the review of this paper and approving it for publication was A. Graell i Amat.	Abediseid W, 2013, IEEE T COMMUN, V61, P2446, DOI 10.1109/TCOMM.2013.042313.120746; Nam W, 2010, IEEE T INFORM THEORY, V56, P5488, DOI 10.1109/TIT.2010.2069150; LINDER T, 1993, IEEE T INFORM THEORY, V39, P1735, DOI 10.1109/18.259668; Sadeghi MR, 2006, IEEE T INFORM THEORY, V52, P4481, DOI 10.1109/TIT.2006.881720; DIVSALAR D, 1995, ICC '95 - 1995 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CONFERENCE RECORD, VOLS 1-3, P54, DOI 10.1109/ICC.1995.525138; Urbanke R, 1998, IEEE T INFORM THEORY, V44, P273, DOI 10.1109/18.651040; Zamir R, 2002, IEEE T INFORM THEORY, V48, P1250, DOI 10.1109/TIT.2002.1003821; Nazer B, 2011, IEEE T INFORM THEORY, V57, P6463, DOI 10.1109/TIT.2011.2165816; Polyanskiy Y, 2010, IEEE T INFORM THEORY, V56, P2307, DOI 10.1109/TIT.2010.2043769; Benedetto S, 1996, IEEE T INFORM THEORY, V42, P409, DOI 10.1109/18.485713; Benedetto S, 1996, IEEE T COMMUN, V44, P591, DOI 10.1109/26.494303; Benedetto S, 1998, IEEE T COMMUN, V46, P1101, DOI 10.1109/26.718548; Berrou C, 1996, IEEE T COMMUN, V44, P1261, DOI 10.1109/26.539767; CALDERBANK AR, 1987, IEEE T INFORM THEORY, V33, P177, DOI 10.1109/TIT.1987.1057291; Conway J., 1988, SPHERE PACKINGS LATT; DEBUDA R, 1989, IEEE J SEL AREA COMM, V7, P893, DOI 10.1109/49.29612; De Buda R., 1975, IEEE Transactions on Information Theory, VIT-21, DOI 10.1109/TIT.1975.1055409; di Pietro N., 2013, P IEEE INT S INF THE, P1675; Erez U, 2004, IEEE T INFORM THEORY, V50, P2293, DOI 10.1109/TIT.2004.834787; Feng C, 2013, IEEE T INFORM THEORY, V59, P7576, DOI 10.1109/TIT.2013.2274264; Harshan J, 2013, IEEE T COMMUN, V61, P4417, DOI 10.1109/TCOMM.2013.100213.130018; Kurkoski BM, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY, VOLS 1- 4, P734, DOI 10.1109/ISIT.2009.5205680; Li Y., 2012, P IEEE INT C ICT CON, P426; Ling C., 2013, P IEEE INT S INF THE, P1416; Narayanan K., 2007, P 45 ANN ALL C COMM, P254; Ordentlich O, 2012, IEEE T INFORM THEORY, V58, P5804, DOI 10.1109/TIT.2012.2202633; Ordentlich Or, 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6284113; Sakzad A., 2010, P 48 ANN ALL C COMM, P14; Sakzad A., 2011, ARXIV11081873; Shalvi O, 2011, IEEE T INFORM THEORY, V57, P5203, DOI 10.1109/TIT.2011.2158876; Sommer N, 2008, IEEE T INFORM THEORY, V54, P1561, DOI 10.1109/TIT.2008.917684; Uchikawa H., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, DOI 10.1109/ISIT.2012.6283575; Uchikawa H., 2012, P INT C COMP NETW CO, P1036; Wang Y., 2014, P ACM SIGCHI C SIGN, P1; Yan Y., 2013, P IEEE INT S INF THE, P1292; Yona Y., 2008, P IEEE 25 IEEEI DEC, P484; Yona Yair, 2010, Proceedings of the 2010 IEEE International Symposium on Information Theory. ISIT 2010, DOI 10.1109/ISIT.2010.5513735; Zhan JN, 2010, IEEE INT SYMP INFO, P1022, DOI 10.1109/ISIT.2010.5513734	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0090-6778	1558-0857		IEEE T COMMUN	IEEE Trans. Commun.	APR	2015	63	4					1081	1090		10.1109/TCOMM.2015.2408317		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CG2NY	WOS:000353112700005		
J	Han, Y; Horiuchi, O; Hayashi, S; Nogita, K; Katoh, Y; Tomokage, H				Han, Younggun; Horiuchi, Osamu; Hayashi, Shigehiro; Nogita, Kanta; Katoh, Yoshihisa; Tomokage, Hajime			Process Feasibility and Reliability Performance of Fine Pitch Si Bare Chip Embedded in Through Cavity of Substrate Core	IEEE Transactions on Components Packaging and Manufacturing Technology			English	Article						Chip alignment; fine-pitch Si bare chip; production yield and reliability; through cavity core device-embedded substrate		We demonstrate the concept and fabrication of through cavity core device-embedded substrate for fine-pitch Si bare chips with pad pitches down to 60 mu m. Instead of using a real active Si chip, we embedded a Si test element group inside a through cavity of the core. To adjust to the thickness of the passive device with a maximum thickness of 150 mu m, the Si chip was thinned to 120 mu m, not including bump height. After placing a chip, the cavity is filled by laminating a two-layer structure Ajinomoto build-up film from both sides of the substrate core. To accurately place the chip in the cavity, we strictly controlled the lamination conditions and curing temperature of the epoxy resin. Laser via drilling produced the best alignment for fine-pitch small pads using the local alignment marks of each test frame kit with overhead epoxy resin of the Cu mark pattern removed. To produce a high-quality microvia interconnection to the Al pad of the Si chip, we used a new, combined desmearing technique that included a plasma treatment with CF4 + O-2 mixed gas. Finally, we discussed the production yield and reliability of the fine-pitch Si bare chip-embedded substrate using the daisy-chain structure consisted of Si chip pattern, microvia on Si pad, and substrate tracks.	[Han, Younggun; Horiuchi, Osamu; Katoh, Yoshihisa; Tomokage, Hajime] Fukuoka Univ, Dept Elect Engn & Comp Sci, Fukuoka 8140180, Japan; [Hayashi, Shigehiro; Nogita, Kanta] Fukuoka Ind Sci & Technol Fdn, Res Ctr Dimens Semicond 3, Itoshima 8191122, Japan	Han, Y (reprint author), Fukuoka Univ, Dept Elect Engn & Comp Sci, Fukuoka 8140180, Japan.	han@fukuoka-u.ac.jp; horiuchi@fukuoka-u.ac.jp; s-hayashi@ist.or.jp; nogita@ist.or.jp; ykatoh@fukuoka-u.ac.jp; tomokage@fukuoka-u.ac.jp					Liu FH, 2010, ELEC COMP C, P758, DOI 10.1109/ECTC.2010.5490757; Che FX, 2009, MICROELECTRON RELIAB, V49, P754, DOI 10.1016/j.microrel.2009.03.022; Braunisch H, 2002, ELEC COMP C, P353, DOI 10.1109/ECTC.2002.1008120; Ko CT, 2006, ELEC COMP C, P322; Lee D, 2008, EL PACKAG TECH CONF, P224; Manessis D, 2010, ELEC COMP C, P803, DOI 10.1109/ECTC.2010.5490733; Ostamann A., 2005, ADV MICROELECTRON, V32, P13; OSTMANN A, 2008, P 2 EL SYST INT TECH, P315; Tanaka K, 2011, ELEC COMP C, P1377, DOI 10.1109/ECTC.2011.5898691; Towle S. N., 2001, P ASME INT MECH ENG, P11; Waris TF, 2001, POLYTRONIC 2001, PROCEEDINGS, P218	11	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2156-3950	2156-3985		IEEE T COMP PACK MAN	IEEE Trans. Compon. Pack. Manuf. Technol.	APR	2015	5	4					551	561		10.1109/TCPMT.2015.2406880		11	Engineering, Manufacturing; Engineering, Electrical & Electronic; Materials Science, Multidisciplinary	Engineering; Materials Science	CG7WY	WOS:000353519000012		
J	Hirokawa, S; Harada, R; Hashimoto, M; Onoye, T				Hirokawa, Soichi; Harada, Ryo; Hashimoto, Masanori; Onoye, Takao			Characterizing Alpha- and Neutron-Induced SEU and MCU on SOTB and Bulk 0.4-V SRAMs	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Alpha particle; body bias; bulk; multiple cell upset; neutron; silicon on insulator (SOI); single event upset; soft error; thin buried oxide	10T SUBTHRESHOLD SRAM; HEAVY-ION IRRADIATION; MULTIPLE-CELL UPSETS; SOFT ERROR RATES; SOI; RADIATION; DEVICES; MOSFETS	We experimentally characterized and compared the soft error rates of 65-nm bulk and silicon on thin buried oxide (SOTB) SRAMs by conducting accelerated alpha and neutron irradiation tests. Measurement results show that an SOTB SRAM has better soft error immunity than a bulk SRAM. In particular, the number of 2-bit multiple cell upsets (MCUs) of SOTB SRAM was smaller by two orders of magnitude than that of bulk SRAM, and the number of 3-bit or larger MCUs decreased further. In addition, the reverse body bias (RBB) reduced the soft error rate of SOTB SRAM to two-thirds of zero body bias (ZBB). To investigate this dependence on body bias, we evaluated the sensitive cross sectional area for ZBB and RBB with 3D technology computer aided design device simulations. The simulation results show that the RBB decreases the sensitive cross-sectional area of an SOTB device for small linear energy transfer (LET) ions, which is consistent with the measured dependence on body bias.	[Hirokawa, Soichi; Harada, Ryo; Hashimoto, Masanori; Onoye, Takao] Osaka Univ, Dept Informat Syst Engn, Osaka 5600034, Japan	Hirokawa, S (reprint author), Osaka Univ, Dept Informat Syst Engn, Osaka 5600034, Japan.	hirokawa.soichi@ist.osaka-u.ac.jp; hasimoto@ist.osaka-u.ac.jp			METI; NEDO	This work was done in the "Ultra-Low Voltage Device Project" of LEAP funded and supported by METI and NEDO.	Ziegler JF, 1996, IBM J RES DEV, V40, P3; Seifert N, 2006, INT REL PHY, P217, DOI 10.1109/RELPHY.2006.251220; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Schwank JR, 2003, IEEE T NUCL SCI, V50, P522, DOI 10.1109/TNS.2003.812930; Abe S, 2012, IEEE T NUCL SCI, V59, P965, DOI 10.1109/TNS.2012.2187215; Ferlet-Cavrois V, 2005, IEEE T NUCL SCI, V52, P2104, DOI 10.1109/TNS.2005.860682; Black JD, 2013, IEEE T NUCL SCI, V60, P1836, DOI 10.1109/TNS.2013.2260357; Munteanu D, 2006, IEEE T NUCL SCI, V53, P3363, DOI 10.1109/TNS.2006.886206; Simoen E, 2013, IEEE T NUCL SCI, V60, P1970, DOI 10.1109/TNS.2013.2255313; LIM HK, 1983, IEEE T ELECTRON DEV, V30, P1244; Raine M, 2011, IEEE T NUCL SCI, V58, P2607, DOI 10.1109/TNS.2011.2168238; Baggio J, 2005, IEEE T NUCL SCI, V52, P2319, DOI 10.1109/TNS.2005.860722; Esqueda IS, 2009, IEEE T NUCL SCI, V56, P2247, DOI 10.1109/TNS.2009.2012709; Fuketa H, 2014, IEEE T DEVICE MAT RE, V14, P463, DOI 10.1109/TDMR.2013.2252430; Gouker PM, 2009, IEEE T NUCL SCI, V56, P3477, DOI 10.1109/TNS.2009.2034153; Harada R, 2012, IEEE T NUCL SCI, V59, P2791, DOI 10.1109/TNS.2012.2224373; Ibe E., 2007, P CICC, P437; Ibe E, 2010, IEEE T ELECTRON DEV, V57, P1527, DOI 10.1109/TED.2010.2047907; Ishibashi K., 2014, P COOL CHIPS; Kobayashi K., IEEE T NUCL IN PRESS; Magarshack P., 2013, P C DES AUT TEST EUR, P952; Morita Y, 2008, 2008 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P166, DOI 10.1109/VLSIT.2008.4588604; Niita K., 2010, PHITS PARTICLE HEAVY; Roche P, 2003, IEEE T NUCL SCI, V50, P2046, DOI 10.1109/TNS.2003.821588; Tipton AD, 2008, IEEE T DEVICE MAT RE, V8, P565, DOI 10.1109/TDMR.2008.2002356; Tosaka Y, 1999, IEEE ELECTR DEVICE L, V20, P89, DOI 10.1109/55.740661; Tsuchiya R, 2004, IEEE INTERNATIONAL ELECTRON DEVICES MEETING 2004, TECHNICAL DIGEST, P631, DOI 10.1109/IEDM.2004.1419245; Yamamoto Y., 2013, P S VLSI TECHN, pT212; Ziegler J. F., 1985, STOPPING RANGE IONS	29	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	APR	2015	62	2					420	427		10.1109/TNS.2015.2403265		8	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CF9LZ	WOS:000352887500003		
J	Gnatyuk, DV; Poperenko, LV; Yurgelevych, IV; Dacenko, OI; Aoki, T				Gnatyuk, Dmytro V.; Poperenko, Leonid V.; Yurgelevych, Iryna V.; Dacenko, Oleksandr I.; Aoki, Toru			Characterization of Functional Layers of CdTe Crystals Subjected to Different Surface Treatments	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Chemical processes; ellipsometry; photoluminescence; semiconductor detectors; thin films	LASER IRRADIATION; RADIATION; PHOTOLUMINESCENCE; DETECTORS; DEVICES	The surface functional layers of commercial detector-grade CdTe crystals are characterized after different surface treatments such as chemical polishing etching in bromine-containing solutions and laser annealing with nanosecond pulses of the second harmonic of a YAG:Nd laser. The effects of etching and laser irradiation with energy density near the melting threshold of CdTe on the optical properties of the CdTe crystal surface are studied using ellipsometry and photoluminescence (PL). The samples after storage in air are also investigated. The intrinsic emission band at 1.58 eV and broad dopant band peaked at 1.45 eV are observed in the PL spectra excited by a semiconductor laser with wavelength of 405 nm at 80 K. The low energy band is associated with carrier recombination at structural defects in the surface layer. The redistribution of the PL band intensities after chemical polishing is found and it is attributed to transformation of the point defect structure and defect formation in the surface region of CdTe. The laser treatment essentially changes the surface state and structure of the surface layer that can be used for effective modification of characteristics of the functional layers of CdTe crystals particularly band bending before formation of electrical contacts.	[Gnatyuk, Dmytro V.; Poperenko, Leonid V.; Yurgelevych, Iryna V.; Dacenko, Oleksandr I.] Taras Shevchenko Natl Univ Kyiv, Fac Phys, UA-03127 Kiev, Ukraine; [Aoki, Toru] Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka 4328011, Japan; [Aoki, Toru] Univ Kyiv, UA-03127 Kiev, Ukraine	Gnatyuk, DV (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, Hamamatsu, Shizuoka 4328011, Japan.	dimamid@i.ua; plv@univ.kiev.ua; vladira_19@ukr.net; lesoto@ukr.net; rtaoki@ipc.shizuoka.ac.jp					Shiraki H, 2009, IEEE T NUCL SCI, V56, P1717, DOI 10.1109/TNS.2009.2016843; Takahashi T, 2001, IEEE T NUCL SCI, V48, P287, DOI 10.1109/23.940067; Aoki T, 2011, THIN SOLID FILMS, V519, P2834, DOI 10.1016/j.tsf.2010.12.049; BELL RO, 1977, REV PHYS APPL, V12, P391, DOI 10.1051/rphysap:01977001202039100; Del Sordo S, 2009, SENSORS-BASEL, V9, P3491, DOI 10.3390/s90503491; Drozd P. I., 1985, IND LAB+, V51, P35; Fernandez P, 2003, J OPTOELECTRON ADV M, V5, P369; Gavrilenko V. I., 1987, HANDBOOK, P606; Gnatyuk D. V., 2011, P SOC PHOTO-OPT INS, V8142; Gnatyuk V. A., P SPIE IN PRESS; Gnatyuk V. A., 2011, P SOC PHOTO-OPT INS, V8142; Gnatyuk VA, 2011, IEEE NUCL SCI CONF R, P4506, DOI 10.1109/NSSMIC.2011.6154699; Gnatyuk VA, 2003, SEMICOND SCI TECH, V18, P560, DOI 10.1088/0268-1242/18/6/329; Gnatyuk VA, 2003, APPL PHYS LETT, V83, P3704, DOI 10.1063/1.1625777; Higa A, 2007, JPN J APPL PHYS 1, V46, P2869, DOI 10.1143/JJAP.46.2869; Medvid A., 2008, PHYS STAT SOL C, V6, P209; Medvid A, 2010, OPT MATER, V32, P836, DOI 10.1016/j.optmat.2010.03.006; MYERS TH, 1983, J APPL PHYS, V54, P4232, DOI 10.1063/1.332527; Poperenko L. V., 2007, MONOGRAPHY KYIV U, P336; Popovych V. D., 2002, SEMICONDUCTORS, V36, P674; Rouse AA, 2002, IEEE T NUCL SCI, V49, P2005, DOI 10.1109/TNS.2002.801705; Schlesinger T. E., 1995, SEMICONDUCT SEMIMET, V43, P606; Tanaka T, 2004, NEW ASTRON REV, V48, P309, DOI 10.1016/j.newar.2003.11.036; Zakharenko NI, 1998, FIZ MET METALLOVED+, V85, P28; Zanio K., 1978, SEMICONDUCT SEMIMET, V13, P235	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	APR	2015	62	2					428	432		10.1109/TNS.2015.2394329		5	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CF9LZ	WOS:000352887500004		
J	Suzuki, K; Shorohov, M; Sawada, T; Seto, S				Suzuki, K.; Shorohov, M.; Sawada, T.; Seto, S.			Time-of-Flight Measurements on TlBr Detectors	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Gamma-ray detector; mobility; time-of-flight; TlBr	TRANSPORT-PROPERTIES; FINITE TEMPERATURE; POLARON MOBILITY; ELECTRONS; CRYSTALS; BROMIDE; CDTE	Carrier transport properties of TlBr crystals grown using the Bridgman method were investigated by the time-of-flight technique. The electron and hole mobilities were measured as 20 - 27 cm(2)/Vs and 1.0 - 2.0 cm(2)/Vs respectively at room temperature. The temperature dependence of the electron mobility increases with decreasing temperature as approximated by a well-known empirical formula reflecting the reciprocal of the LO-phonon density.	[Suzuki, K.; Sawada, T.] Hokkaido Univ Sci, Sapporo, Hokkaido 0068585, Japan; [Shorohov, M.] Balt Sci Instruments Ltd, LV-1005 Riga, Latvia; [Seto, S.] Ishikawa Natl Coll Technol, Tsubata, Ishikawa 9290342, Japan	Suzuki, K (reprint author), Hokkaido Univ Sci, Sapporo, Hokkaido 0068585, Japan.	suzukik@hus.ac.jp; m.shorohov@bsi.lv; sawada@hus.ac.jp; seto@ishikawanct.ac.jp					Suzuki K, 2011, IEEE T NUCL SCI, V58, P1958, DOI 10.1109/TNS.2011.2138719; Vaitkus J, 2004, NUCL INSTRUM METH A, V531, P192, DOI 10.1016/j.nima.2004.06.004; BELL RO, 1974, IEEE T NUCL SCI, VNS21, P331, DOI 10.1109/TNS.1974.4327479; Du MH, 2012, J APPL PHYS, V111, DOI 10.1063/1.3702574; Du MH, 2010, J APPL PHYS, V108, DOI 10.1063/1.3476564; KAWAI T, 1971, J PHYS SOC JPN, V30, P1101, DOI 10.1143/JPSJ.30.1101; Kazukauskas V, 2009, PHYS STATUS SOLIDI C, V6, P2795, DOI 10.1002/pssc.200982551; KOBAYASH.K, 1967, J PHYS SOC JPN, V23, P305, DOI 10.1143/JPSJ.23.305; OKAMOTO K, 1974, J PHYS SOC JPN, V37, P333, DOI 10.1143/JPSJ.37.333; OLSCHNER F, 1990, IEEE T NUCL SCI, V37, P1162, DOI 10.1109/23.57359; OSAKA Y, 1966, J PHYS SOC JPN, V21, P423, DOI 10.1143/JPSJ.21.423; OTTAVIAN.G, 1973, J APPL PHYS, V44, P360, DOI 10.1063/1.1661888; Ruzin A, 1997, J APPL PHYS, V82, P4166, DOI 10.1063/1.366218; Sato G, 2002, IEEE T NUCL SCI, V49, P1258, DOI 10.1109/TNS.2002.1039648; Tada T., 2009, CYRIC ANN REP, P55	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	APR	2015	62	2					433	436		10.1109/TNS.2015.2403279		4	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CF9LZ	WOS:000352887500005		
J	Tran, LT; Chartier, L; Prokopovich, DA; Reinhard, MI; Petasecca, M; Guatelli, S; Lerch, MLF; Perevertaylo, VL; Zaider, M; Matsufuji, N; Jackson, M; Nancarrow, M; Rosenfeld, AB				Tran, Linh T.; Chartier, Lachlan; Prokopovich, Dale A.; Reinhard, Mark I.; Petasecca, Marco; Guatelli, Susanna; Lerch, Michael L. F.; Perevertaylo, Vladimir L.; Zaider, Marco; Matsufuji, Naruhiro; Jackson, Michael; Nancarrow, Mitchell; Rosenfeld, Anatoly B.			3D-Mesa "Bridge" Silicon Microdosimeter: Charge Collection Study and Application to RBE Studies in C-12 Radiation Therapy	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						3D mesa; charge collection; heavy ion therapy; IBIC; microdosimetry; silicon microdosimeter	DETECTORS	Microdosimetry is an extremely useful technique, used for dosimetry in unknown mixed radiation fields typical of space and aviation, as well as in hadron therapy. A new silicon microdosimeter with 3D sensitive volumes has been proposed to overcome the shortcomings of the conventional Tissue Equivalent Proportional Counter. In this article, the charge collection characteristics of a new 3D mesa microdosimeter were investigated using the ANSTO heavy ion microprobe utilizing 5.5 MeV He2+ and 2 MeV H+ ions. Measurement of the microdosimetric characteristics allowed for the determination of the Relative Biological Effectiveness of the C-12 heavy ion therapy beam at the Heavy Ion Medical Accelerator in Chiba (HIMAC), Japan. Well-defined sensitive volumes of the 3D mesa microdosimeter have been observed and the microdosimetric RBE obtained showed good agreement with the TEPC. The new 3D mesa "bridge" microdosimeter is a step forward towards a microdosimeter with fully free-standing 3D sensitive volumes.	[Tran, Linh T.; Chartier, Lachlan; Petasecca, Marco; Guatelli, Susanna; Lerch, Michael L. F.; Rosenfeld, Anatoly B.] Univ Wollongong, Ctr Med Radiat Phys, Wollongong, NSW 2522, Australia; [Prokopovich, Dale A.; Reinhard, Mark I.] Australian Nucl Sci & Technol Org, Inst Mat Engn, Lucas Heights, NSW 2234, Australia; [Perevertaylo, Vladimir L.] SPA BIT, UA-01001 Kiev, Ukraine; [Zaider, Marco] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA; [Matsufuji, Naruhiro] Natl Inst Radiol Sci, Res Ctr Charge Particle Therapy, Chiba 2638555, Japan; [Jackson, Michael] Univ New S Wales, Sydney, NSW 2052, Australia; [Nancarrow, Mitchell] Univ Wollongong, Electron Microscopy Ctr, Wollongong, NSW 2500, Australia	Tran, LT (reprint author), Univ Wollongong, Ctr Med Radiat Phys, Wollongong, NSW 2522, Australia.	tlt822@uowmail.edu.au; lc52@uowmail.edu.au; dpr@ansto.gov.au; mrz@ansto.gov.au; marcop@uow.edu.au; susanna@uow.edu.au; mlerch@uow.edu.au; zaiderm@mskcc.org; matu-fuji@nirs.go.jp; michael.jackson@sesiahs.health.nsw.gov.au; nancarro@uow.edu.au; anatoly@uow.edu.au					Kase Y, 2006, RADIAT RES, V166, P629, DOI 10.1667/RR0536.1; Siegele R, 1999, NUCL INSTRUM METH B, V158, P31, DOI 10.1016/S0168-583X(99)00393-6; Cornelius IM, 2003, IEEE T NUCL SCI, V50, P2373, DOI 10.1109/TNS.2003.820740; Tran LT, 2014, IEEE T NUCL SCI, V61, P1537, DOI 10.1109/TNS.2014.2301729; Kase Y, 2011, J RADIAT RES, V52, P59, DOI 10.1269/jrr.10062; Hawkins RB, 1996, INT J RADIAT BIOL, V69, P739, DOI 10.1080/095530096145481; Tran LT, 2014, IEEE T NUCL SCI, V61, P1552, DOI 10.1109/TNS.2014.2298461; Bradley PD, 1998, MED PHYS, V25, P2220, DOI 10.1118/1.598421; Bradley P. D., 2000, THESIS U WOLLONGONG; Bradley PD, 1998, IEEE T NUCL SCI, V45, P2700, DOI 10.1109/23.736518; ICRU, 1983, 36 ICRU; Lim WH, 2009, IEEE T NUCL SCI, V56, P424, DOI 10.1109/TNS.2009.2013467; Livingstone J, 2012, IEEE T NUCL SCI, V59, P3126, DOI 10.1109/TNS.2012.2219069; Zaider M., 1996, MICRODOSIMETRY ITS A; Ziebell AL, 2008, IEEE T NUCL SCI, V55, P3414, DOI 10.1109/TNS.2008.2004464; Ziegler J., 2008, SRIM STOPPING RANGE	16	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	APR	2015	62	2					504	511		10.1109/TNS.2015.2391102		8	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	CF9LZ	WOS:000352887500012		
J	Ishizawa, H; Hosseini, H; Yoshida, D; Sugimoto, K; Nejad, SM; Katsuki, S; Akiyama, H				Ishizawa, Hidetoshi; Hosseini, Hamid; Yoshida, Daiki; Sugimoto, Kenjiro; Nejad, Seyedehfatemeh Moosavi; Katsuki, Sunao; Akiyama, Hidenori			Effects of Burst Electromagnetic Wave Focusing and Their Combination With Nanosecond Pulsed Electric Fields on HeLa S3 Cells	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Burst electromagnetic wave; cancer treatment; cell death; focusing system; medical application	ANTENNA	Burst electromagnetic waves focusing, nanosecond pulsed electric fields (nsPEF), and their combinations were applied to HeLa S3 cells to investigate their respective biological effects. The research was motivated by its application for cancer therapy. Burst electromagnetic waves, characterized by high-frequency (800 MHz) and narrow-band signals, were applied through a focusing system consisting of an ellipsoidal reflector and a radiating antenna. Burst widths of electromagnetic waves were adjusted to 1 and 5 ms. For nsPEF exposure, a magnetic pulse power modulator with an 80-ns pulsewidth and repetition frequencies of 0.5 and 1 pulse per second was employed. Cervical cancer cells (HeLa S3) subjected to electric fields were cultured in an incubator for 24 h and stained using propidium iodide to monitor the cell death rate. Sole application of burst electromagnetic waves was found not to change the cancer cell survival, while sole application of nsPEF suppressed the cells growth. The combination of nsPEF and focused burst electromagnetic wave was found to be very effective in producing maximum cell death rate. The results show the importance of the exposure combination component, as a first step, to design a more efficient and less-invasive cancer therapy system.	[Ishizawa, Hidetoshi; Hosseini, Hamid; Yoshida, Daiki; Sugimoto, Kenjiro; Nejad, Seyedehfatemeh Moosavi; Katsuki, Sunao; Akiyama, Hidenori] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8600862, Japan; [Hosseini, Hamid; Katsuki, Sunao; Akiyama, Hidenori] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8600862, Japan	Ishizawa, H (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8600862, Japan.	h.ishizawa@st.cs.kumamoto-u.ac.jp; hosseini@kumamoto-u.ac.jp; d.yoshida@st.cs.kumamoto-u.ac.jp; k.sugimoto@st.cs.kumamoto-u.ac.jp; moosavi@kumamoto-u.ac.jp; katsuki@st.cs.kumamoto-u.ac.jp; akiyama@st.cs.kumamoto-u.ac.jp			Global Center of Excellence Program on Global Initiative Center for Pulsed Power Engineering through Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Global Center of Excellence Program on Global Initiative Center for Pulsed Power Engineering through the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Schoenbach KH, 2002, IEEE T PLASMA SCI, V30, P293, DOI 10.1109/TPS.2002.1003873; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; Xiao S, 2010, IEEE ANTENN WIREL PR, V9, P12, DOI 10.1109/LAWP.2010.2041027; Chen NY, 2004, BIOCHEM BIOPH RES CO, V317, P421, DOI 10.1016/j.bbrc.2004.03.063; Chichel A., 2007, REP PRACT ONCOL RADI, V12, P267, DOI DOI 10.1016/S1507-1367(10)60065-X; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Hosoya Y., 1999, RADIOWAVE PROPAGATIO, P70; Ishizawa H, 2013, IEEE T DIELECT EL IN, V20, P1321, DOI 10.1109/TDEI.2013.6571451; Kang DK, 2012, IEEE T PLASMA SCI, V40, P2379, DOI 10.1109/TPS.2012.2192506; Kumar P, 2011, IEEE T MICROW THEORY, V59, P1090, DOI 10.1109/TMTT.2011.2114110; Minamitani Y, 2010, IEEE T DIELECT EL IN, V17, P1895, DOI 10.1109/TDEI.2010.5658244; Mitsutake K, 2012, IEEE T DIELECT EL IN, V19, P337, DOI 10.1109/TDEI.2012.6148536; Nomura N, 2009, IEEE T DIELECT EL IN, V16, P1288, DOI 10.1109/TDEI.2009.5293940; Seebass M, 2001, INT J HYPERTHER, V17, P321, DOI 10.1080/02656730110049529; Vernier PT, 2004, FEBS LETT, V572, P103, DOI 10.1016/j.febslet.2004.07.021; Xiao S., 2007, PULS POW C 2007 16 I, V1, P744	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	APR	2015	43	4	1		SI		1093	1099		10.1109/TPS.2015.2407052		7	Physics, Fluids & Plasmas	Physics	CG2OI	WOS:000353113700025		
J	Hong, J; Ohtsuki, T				Hong, Jihoon; Ohtsuki, Tomoaki			Signal Eigenvector-Based Device-Free Passive Localization Using Array Sensor	IEEE TRANSACTIONS ON VEHICULAR TECHNOLOGY			English	Article						Antenna array; device-free localization; machine learning; support vector machine (SVM)	RECOGNITION; NETWORKS; SYSTEMS	Device-free passive (DFP) localization techniques have received increasing attention for location-based services due to their ability to realize localization without holding any wireless device. Most of the existing DFP localization systems are based on the measurement of received signal strength (RSS) only. However, the localization accuracy is easily affected by the spatial and temporal variance of RSS due to multipath fading and noise, even in a static environment. In this paper, we propose a novel localization system for DFP localization using an array sensor, which uses an antenna array at a receiver and is mainly based on the signal eigenvector. We use a fingerprinting technique with multiclass support vector machines (SVMs) based on a combination of array signal features with spatial and temporal averaging. We evaluate the localization performance of our proposed system in different propagation environments, i.e., line-of-sight (LOS) and non-line-of-sight (NLOS). In addition, we analyze two types of receive antenna placement, i.e., centralized and distributed antennas. The experimental results show that the localization accuracy can be improved by the proposed system, particularly in the centralized antenna case. Moreover, they show that the proposed system can improve localization accuracy compared with the conventional RSS-only-based system.	[Hong, Jihoon; Ohtsuki, Tomoaki] Keio Univ, Dept Informat & Comp Sci, Yokohama, Kanagawa 2238522, Japan	Hong, J (reprint author), Keio Univ, Dept Informat & Comp Sci, Yokohama, Kanagawa 2238522, Japan.	hong@ohtsuki.ics.keio.ac.jp; ohtsuki@ics.keio.ac.jp			Japan Society for the Promotion of Science (JSPS) [26.6267]	This work was supported by the Japan Society for the Promotion of Science (JSPS) under Grant-in-Aid for JSPS Fellows (26.6267). The review of this paper was coordinated by Prof. D. Dardari.	Seifeldin M, 2013, IEEE T MOBILE COMPUT, V12, P1321, DOI 10.1109/TMC.2012.106; Youssef M, 2007, MOBICOM'07: PROCEEDINGS OF THE THIRTEENTH ACM INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P222; Song B, 2010, IEEE T IMAGE PROCESS, V19, P2564, DOI 10.1109/TIP.2010.2052823; Patwari N, 2010, P IEEE, V98, P1961, DOI 10.1109/JPROC.2010.2052010; Liu H, 2007, IEEE T SYST MAN CY C, V37, P1067, DOI 10.1109/TSMCC.2007.905750; Krim H, 1996, IEEE SIGNAL PROC MAG, V13, P67, DOI 10.1109/79.526899; Wilson J, 2010, IEEE T MOBILE COMPUT, V9, P621, DOI 10.1109/TMC.2009.174; Ni LM, 2004, WIREL NETW, V10, P701, DOI 10.1023/B:WINE.0000044029.06344.dd; Gu YY, 2009, IEEE COMMUN SURV TUT, V11, P13, DOI 10.1109/SURV.2009.090103; Youssef M, 2008, WIREL NETW, V14, P357, DOI 10.1007/s11276-006-0725-7; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Haimovich AM, 2008, IEEE SIGNAL PROC MAG, V25, P116, DOI [10.1109/MSP.2008.4408448, 10.1109/MSP.2007.909532]; Bahl P., 2000, Proceedings IEEE INFOCOM 2000. Conference on Computer Communications. Nineteenth Annual Joint Conference of the IEEE Computer and Communications Societies (Cat. No.00CH37064), DOI 10.1109/INFCOM.2000.832252; Chandran S., 2006, ADV DIRECTION OF ARR; Chang C-C, 2011, ACM T INTEL SYST TEC, V2, P3, DOI DOI 10.1145/1961189.1961199; Diggelen F.V., 2002, P IEEE POS LOC NAV S, P240; Hnat T. W., 2012, P 10 ACM C EMB NETW, P309; Hong J., 2013, P ACM UBICOMP ADJ SE, P509; Ikeda S., 2008, P IEEE VEH TECHN C V, P1; Ikeda S, 2009, 2009 IEEE 20TH INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR AND MOBILE RADIO COMMUNICATIONS, P2792, DOI 10.1109/PIMRC.2009.5449774; Kemper Jurgen, 2010, Proceedings of the 2010 7th Workshop on Positioning, Navigation and Communication (WPNC 2010), DOI 10.1109/WPNC.2010.5653529; Shi S., 2013, P ACM UBICOMP ADJ SE, P521; Sigg S, 2014, IEEE T MOBILE COMPUT, V13, P907, DOI 10.1109/TMC.2013.28; Song H, 2012, IEEE T IND ELECTRON, V59, P4349, DOI 10.1109/TIE.2011.2151821; Vapnik V. N., 1995, NATURE STAT LEARNING	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9545	1939-9359		IEEE T VEH TECHNOL	IEEE Trans. Veh. Technol.	APR	2015	64	4					1354	1363		10.1109/TVT.2015.2397436		10	Engineering, Electrical & Electronic; Telecommunications; Transportation Science & Technology	Engineering; Telecommunications; Transportation	CG2NR	WOS:000353111900009		
J	Aung, TT; Thumchirdchupong, H; Tangsangiumvisai, N; Nishihara, A				Aung, Thiri Thandar; Thumchirdchupong, Hathaichanok; Tangsangiumvisai, Nisachon; Nishihara, Akinori			Two-microphone subband noise reduction scheme with a new noise subtraction parameter for speech quality enhancement	IET SIGNAL PROCESSING			English	Article						speech enhancement; signal denoising; correlation methods; microphones; microphone subband noise reduction; speech quality enhancement; subband noise reduction technique; two-microphone voice communication system; signal correlation; spectral subtraction method; variable noise subtraction parameter; noise attenuation; speech distortion; speech spectrum; modified cross-spectral subtraction technique	FILTERING TECHNIQUE; HEARING-AIDS; SUPPRESSION; MICROPHONES	An improved subband noise reduction technique is proposed for two-microphone voice communication systems. The technique aims to enhance the speech quality by utilising a subband structure with different noise reduction schemes for different frequency bands. In the low-frequency band where dominant cues of speech spectral components are usually located and the noise signals from the two channels are mainly correlated, the spectral subtraction method, together with a new variable noise subtraction parameter, is employed so that the noise attenuation performance and speech distortion are controllable. In the high-frequency band where less-dominant frequency information of speech spectrum is located, the modified cross-spectral subtraction technique is utilised to remove the high-frequency decorrelated noise spectral components. Extensive comparisons among various noise reduction techniques based on computer simulations demonstrate that the proposed two-microphone subband noise reduction scheme achieves excellent noise attenuation performance while preserving the speech quality.	[Aung, Thiri Thandar; Thumchirdchupong, Hathaichanok; Tangsangiumvisai, Nisachon] Chulalongkorn Univ, Fac Engn, Dept Elect Engn, Bangkok 10330, Thailand; [Nishihara, Akinori] Tokyo Inst Technol, Ctr Res & Dev Educ Technol, Meguro Ku, Tokyo 1528552, Japan	Aung, TT (reprint author), Chulalongkorn Univ, Fac Engn, Dept Elect Engn, Bangkok 10330, Thailand.	Nisachon.T@chula.ac.th			AUN/SEED-Net project, JICA	This research work was financially supported by AUN/SEED-Net project, JICA.	Maj JB, 2004, EAR HEARING, V25, P215, DOI 10.1097/01.AUD.0000130794.28068.96; EPHRAIM Y, 1984, IEEE T ACOUST SPEECH, V32, P1109, DOI 10.1109/TASSP.1984.1164453; Plapous C, 2006, IEEE T AUDIO SPEECH, V14, P2098, DOI 10.1109/TASL.2006.872621; Chen JD, 2006, IEEE T AUDIO SPEECH, V14, P1218, DOI 10.1109/TSA.2005.860851; BOLL SF, 1979, IEEE T ACOUST SPEECH, V27, P113, DOI 10.1109/TASSP.1979.1163209; Guerin A., 2003, EURASIP Journal on Applied Signal Processing, V2003, DOI 10.1155/S1110865703305098; Azirani A. A., 1997, IEEE T SPEECH AUDIO, V5, P484, DOI [10.1109/89.622576, DOI 10.1109/89.622576]; Chung K, 2004, INT CONGR SER, V1273, P89, DOI 10.1016/j.ics.2004.08.005; Hayashi S, 2009, IEICE T FUND ELECTR, VE92A, P226, DOI 10.1587/transfun.E92.A.226; Li JF, 2008, IEICE T FUND ELECTR, VE91A, P1337, DOI 10.1093/ietfec/e91-a.6.1337; Maj JB, 2002, EURASIP J APPL SIG P, V2002, P432, DOI 10.1155/S1110865702000690; Rahmani M, 2009, SIGNAL PROCESS, V89, P703, DOI 10.1016/j.sigpro.2008.10.020; Thoonsaengngam R, 2009, IEICE T COMMUN, VE92B, P3022, DOI 10.1587/transcom.E92.B.3022; Vaseghi S. V., 2000, ADV DIGITAL SIGNAL P, V2nd; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445	15	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1751-9675	1751-9683		IET SIGNAL PROCESS	IET Signal Process.	APR	2015	9	2					130	142		10.1049/iet-spr.2013.0182		13	Engineering, Electrical & Electronic	Engineering	CG3WJ	WOS:000353210000003		
J	Kamil, MSM; Manikandan, K; Elangovan, SP; Ogura, M; Cheralathan, KK				Kamil, M. S. M.; Manikandan, K.; Elangovan, S. P.; Ogura, Masaru; Cheralathan, K. K.			Crystallization of amorphous silica to silicalite-1: Effect of nature of silica sources and tetrapropylammonium hydroxide concentration	INDIAN JOURNAL OF CHEMISTRY SECTION A-INORGANIC BIO-INORGANIC PHYSICAL THEORETICAL & ANALYTICAL CHEMISTRY			English	Article						Zeolites; Mesoporous materials; Macroporous materials; Silicalite-1; Silica	HIERARCHICAL ZEOLITE-BETA; CATALYTIC-PROPERTIES; MASS-TRANSPORT; ZSM-5 ZEOLITE; DRY-GEL; NANOCRYSTALS; ZEOLITIZATION; ARCHITECTURES; CONVERSION; MESOPORES	Dry gels obtained from different sources of silica such as SBA-15, SBA-16, fumed silica and tetraethyl orthosilicate have been crystallized into silicalite-1 by steam assisted conversion and characterized by powder X-ray diffraction, Fourier transform infrared spectroscopy, nitrogen adsorption, and high resolution scanning electron microscopy. The results show that the nature of source and concentration of tetrapropylammonium hydroxide have a significant effect on shape, size and pore structure of silicalite-1. Si-29 MAS NMR spectra of the dry gels obtained from different sources show that Si environment in these gels is similar. However, the morphology of silicalite-1 prepared under same experimental conditions is found to differ for different sources. Further, it is observed that silicalite-1 particles obtained from same source but under different TPAOH concentrations, exhibit different shapes and sizes. N-2 adsorption results reveal that the prepared silicalite-1 samples possess a wide pore size distribution and comprise pores in meso- and macro-pore regions, apart from zeolitic micropores.	[Kamil, M. S. M.; Manikandan, K.; Cheralathan, K. K.] VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India; [Elangovan, S. P.] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1538505, Japan; [Ogura, Masaru] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Cheralathan, KK (reprint author), VIT Univ, Sch Adv Sci, Mat Chem Div, Vellore 632014, Tamil Nadu, India.	cheralathan.k@vit.ac.in	Ogura, Masaru/M-5971-2014	Ogura, Masaru/0000-0002-7323-3070	Department of Science and Technology, Science and Engineering Research Board (DST-SERB), New Delhi, India [SR/FT/CS-65/2011]; VIT University, Vellore, India	Thanks are due to Department of Science and Technology, Science and Engineering Research Board (DST-SERB), New Delhi, India for the financial support vide sanction letter No. SR/FT/CS-65/2011, dated 16.05.2012. One of the authors (MSMK) sincerely thanks VIT University, Vellore, India, for research associate fellowship. The authors also thank Sophisticated Analytical Instruments Facility (SAIF), Indian Institute of Technology Madras, Chennai, India, for HRSEM analysis and NMR Research Centre, Indian Institute of Science, Bangalore, India, for <SUP>29</SUP>Si MAS NMR analysis.	Alfaro S, 2009, J POROUS MAT, V16, P337, DOI 10.1007/s10934-008-9205-z; Serrano DP, 2013, CHEM SOC REV, V42, P4004, DOI 10.1039/c2cs35330j; Abello S, 2009, APPL CATAL A-GEN, V364, P191, DOI 10.1016/j.apcata.2009.05.055; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Dong AG, 2002, ADV MATER, V14, P926, DOI 10.1002/1521-4095(20020618)14:12<926::AID-ADMA926>3.0.CO;2-1; Lee YJ, 2001, ADV MATER, V13, P1259, DOI 10.1002/1521-4095(200108)13:16<1259::AID-ADMA1259>3.0.CO;2-U; Moller K, 2011, CHEM MATER, V23, P4301, DOI 10.1021/cm103533e; Hua ZL, 2011, CHEM COMMUN, V47, P10536, DOI 10.1039/c1cc10261c; Chen LH, 2012, J MATER CHEM, V22, P17381, DOI 10.1039/c2jm31957h; Zhu H, 2008, CHEM MATER, V20, P1134, DOI 10.1021/cm071385o; Srivastava R, 2008, CHEM-EUR J, V14, P9507, DOI 10.1002/chem.200801113; Valtchev VP, 2005, LANGMUIR, V21, P10724, DOI 10.1021/la050323e; Xin HC, 2010, J PHYS CHEM C, V114, P6553, DOI 10.1021/jp912112h; Xiao FS, 2006, ANGEW CHEM INT EDIT, V45, P3090, DOI 10.1002/anie.200600241; Serrano DP, 2006, CHEM MATER, V18, P2462, DOI 10.1021/cm060080r; Hartmann M, 2004, ANGEW CHEM INT EDIT, V43, P5880, DOI 10.1002/anie.200460644; Koo JB, 2010, J CATAL, V276, P327, DOI 10.1016/j.jcat.2010.09.024; Holm MS, 2011, CATAL TODAY, V168, P3, DOI 10.1016/j.cattod.2011.01.007; Valtchev V, 2003, ANGEW CHEM INT EDIT, V42, P2782, DOI 10.1002/anie.200351175; Wang YJ, 2002, J MATER CHEM, V12, P1812, DOI 10.1039/b201113a; Parlett CMA, 2013, CHEM SOC REV, V42, P3876, DOI 10.1039/c2cs35378d; Xue ZT, 2012, MICROPOR MESOPOR MAT, V151, P271, DOI 10.1016/j.micromeso.2011.10.026; Lopez-Orozco S, 2011, ADV MATER, V23, P2602, DOI 10.1002/adma.201100462; Matsukata M, 1999, TOP CATAL, V9, P77, DOI 10.1023/A:1019106421183; Lesthaeghe D, 2008, J PHYS CHEM C, V112, P9186, DOI 10.1021/jp711550s; Li CL, 2009, MICROPOR MESOPOR MAT, V117, P104, DOI 10.1016/j.micromeso.2008.06.017; Na K, 2011, SCIENCE, V333, P328, DOI 10.1126/science.1204452; Meynen V, 2009, MICROPOR MESOPOR MAT, V125, P170, DOI 10.1016/j.micromeso.2009.03.046; Epping JD, 2006, CURR OPIN COLLOID IN, V11, P81, DOI 10.1016/j.cocis.2005.12.002; Zhou JA, 2010, CHEM COMMUN, V46, P4994, DOI 10.1039/c0cc00499e; Cundy CS, 2005, MICROPOR MESOPOR MAT, V82, P1, DOI 10.1016/j.micromeso.2005.02.016; FRANKLIN KR, 1987, ZEOLITES, V7, P135, DOI 10.1016/0144-2449(87)90075-3; Holland BT, 1999, J AM CHEM SOC, V121, P4308, DOI 10.1021/ja990425p; Li C, 2003, HAND BOOK ZEOLITE SC, P435; Madsen C, 1999, CHEM COMMUN, P673; Ogura M, 2000, CHEM LETT, P882, DOI 10.1246/cl.2000.882; Moller K, 2011, J AM CHEM SOC, V133, P5284, DOI 10.1021/ja108698s; Patel A K, 1997, MOL SIEVES, VII, P207; Schmidt I, 2000, CHEM COMMUN, P2157, DOI 10.1039/b006460m; Treacy M. M., 2001, COLLECTION SIMULATED; Wang YJ, 2002, ADV MATER, V14, P994, DOI 10.1002/1521-4095(20020705)14:13/14<994::AID-ADMA994>3.0.CO;2-9; Xue CF, 2012, MICROPOR MESOPOR MAT, V151, P495, DOI 10.1016/j.micromeso.2011,09.001; Zhang BJ, 2000, CHEM COMMUN, P781, DOI 10.1039/b001528h	43	0	0	NATL INST SCIENCE COMMUNICATION-NISCAIR	NEW DELHI	DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA	0376-4710	0975-0975		INDIAN J CHEM A	Indian J. Chem. Sect A-Inorg. Bio-Inorg. Phys. Theor. Anal. Chem.	APR	2015	54	4					469	477				9	Chemistry, Multidisciplinary	Chemistry	CG6SG	WOS:000353432100003		
J	Nowak, D; Zhang, Y				Nowak, David; Zhang, Yu			Formal security proofs with minimal fuss: Implicit computational complexity at work	INFORMATION AND COMPUTATION			English	Article						Lambda-calculus; Safe recursion; Probabilistic computation; Cryptography	PROBABILISTIC POLYNOMIAL-TIME; CALCULUS; MONADS	We show how implicit computational complexity can be used in order to increase confidence in game-based security proofs in cryptography. For this purpose we extend CSLR, a probabilistic lambda-calculus with a type system that guarantees the existence of a probabilistic polynomial-time bound on computations. This allows us to define cryptographic constructions, feasible adversaries, security notions, computational assumptions, game transformations, and game-based security proofs in a unified framework. We also show that the standard practice of cryptographers, ignoring that polynomial-time Turing machines cannot generate all uniform distributions, is actually sound. We illustrate our calculus on cryptographic constructions for public-key encryption and pseudorandom bit generation. (C) 2014 Elsevier Inc. All rights reserved.	[Nowak, David] Univ Tokyo, Tokyo 1138654, Japan							Affeldt R, 2012, SCI COMPUT PROGRAM, V77, P1058, DOI 10.1016/j.scico.2011.07.003; MOGGI E, 1991, INFORM COMPUT, V93, P55, DOI 10.1016/0890-5401(91)90052-4; ELGAMAL T, 1985, IEEE T INFORM THEORY, V31, P469, DOI 10.1109/TIT.1985.1057074; BLUM L, 1986, SIAM J COMPUT, V15, P364, DOI 10.1137/0215025; Barthe G, 2009, ACM SIGPLAN NOTICES, V44, P90; Backes M, 2008, LECT NOTES ARTIF INT, V5330, P353, DOI 10.1007/978-3-540-89439-1_26; GOLDWASSER S, 1984, J COMPUT SYST SCI, V28, P270, DOI 10.1016/0022-0000(84)90070-9; Ramsey N, 2002, ACM SIGPLAN NOTICES, V37, P154, DOI 10.1145/565816.503288; Barthe G., 2010, P 17 ACM C COMP COMM, P375, DOI 10.1145/1866307.1866350; Barthe G., 2011, LNCS, V6841, P71; Bellantoni S., 1992, COMPUT COMPLEX, V2, P97, DOI 10.1007/BF01201998; Bellare M., 2004, 2004331 CRYPT EPRINT; Blanchet B, 2006, LECT NOTES COMPUT SC, V4117, P537; Boneh D., 1998, ALGORITHMIC NUMBER T, V1423, P48, DOI 10.1007/BFb0054851; COBHAM A., 1964, P 1964 INT C LOG MET, P24; Corin R., 2006, LNCS, V4052, P252; Courant J, 2008, CCS'08: PROCEEDINGS OF THE 15TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P371; DIFFIE W, 1976, IEEE T INFORM THEORY, V22, P644, DOI 10.1109/TIT.1976.1055638; Goldreich O., 2001, FDN CRYPTOGRAPHY BAS; Halevi S., 2005, 2005181 CRYPT EPRINT; Heraud S., 2011, LECT NOTES COMPUTER, V6898, P119; Hofmann M, 2000, ANN PURE APPL LOGIC, V104, P113, DOI 10.1016/S0168-0072(00)00010-5; Hofmann M, 1998, LECT NOTES COMPUT SC, V1414, P275; Hurd J., 2002, LNCS, V2410, P230; Impagliazzo R, 2006, J COMPUT SYST SCI, V72, P286, DOI 10.1016/j.jcss.2005.06.008; Lago U. Dal, 2011, P 2 INT WOR IN PRESS, P1; Marion JY, 2011, IEEE S LOG, P123, DOI 10.1109/LICS.2011.41; Menezes Alfred J., 1996, HDB APPL CRYPTOGRAPH; Mitchell J, 1998, ANN IEEE SYMP FOUND, P725; Mitchell JC, 2006, THEOR COMPUT SCI, V353, P118, DOI 10.1016/j.tcs.2005.10.044; Nowak D, 2007, LECT NOTES COMPUT SC, V4681, P319; Nowak D., 2008, LNCS, V5461, P368; Nowak D, 2010, LECT NOTES COMPUT SC, V6402, P35, DOI 10.1007/978-3-642-16280-0_3; Shoup V., 2004, 2004332 CRYPT EPRINT; Yao AC, 1982, P 23 IEEE S FDN COMP, P80; Zhang Y, 2010, MATH STRUCT COMP SCI, V20, P951, DOI 10.1017/S0960129510000265	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0890-5401	1090-2651		INFORM COMPUT	Inf. Comput.	APR	2015	241						96	113		10.1016/j.ic.2014.10.008		18	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	CG5RX	WOS:000353352800005		
J	Sugi, T; Kawazu, S; Horimoto, T; Kato, K				Sugi, Tatsuki; Kawazu, Shin-ichiro; Horimoto, Taisuke; Kato, Kentaro			A single mutation in the gatekeeper residue in TgMAPKL-1 restores the inhibitory effect of a bumped kinase inhibitor on the cell cycle	International Journal for Parasitology-Drugs and Drug Resistance			English	Article						Cytokinesis; BKI; MAPK; Toxoplastria gondii	DEPENDENT PROTEIN-KINASE; TOXOPLASMA-GONDII; PLASMODIUM-FALCIPARUM; DIVISION; IDENTIFICATION; 1NM-PP1; INFECTION; PATHWAYS; INVASION; GENES	Toxoplasma gondii is the causative pathogen for Toxoplasmosis. Bumped kinase inhibitor 1NM-PP1 inhibits the growth of T. gondii by targeting TgCDPK1. However, we recently reported that resistance to 1NM-PP1 can be acquired via a mutation in T gouda mitogen-activated protein kinase like 1 (TgMAPKL-1). Further characterization of how this TgMAPKL-1 mutation restores the inhibitory effect of 1NM-PP1 would shed further light on the function of TgMAPKL-1 in the parasite life cycle. Therefore, we made parasite clones with TgMAPKL-1 mutated at the gatekeeper residue Ser 191, which is critical for 1NM-PP1 susceptibility. Host cell lysis of RH/ku80(-)/HA-TgMAPKL-1(S191A) was completely inhibited at 250 nM 1NM-PP1, whereas that of RH/ku80(-)/HA-TgMAPKL-1(S191Y) was not. By comparing 1NM-PP1-sensitive (RH/ku80(-)/HA-TgMAPKL-1(S191A)) and -resistant (RH/ku80(-)/HA-TgMAPKL-1(S191Y)) clones, we observed that inhibition of TgMAPKL-1 blocked cell cycle progression after DNA duplication. Morphological analysis revealed that TgMAPKL-1 inhibition caused enlarged parasite cells with many daughter cell scaffolds and imcomplete cytokinesis. We conclude that the mutation in TgMAPKL-1 restored the cell cycle-arresting effect of 1NM-PP1 on T. gondii endodyogeny. Given that endodyogeny is the primary mechanism of cell division for both the tachyzoite and bradyzoite stages of this parasite, TgMAPKL-1 may be a promising target for drug development. Exploration of the signals that regulate TgMAPKL-1 will provide further insights into the unique mode of T. gondii cell division. (C) 2014 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.	[Sugi, Tatsuki; Kawazu, Shin-ichiro; Kato, Kentaro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Horimoto, Taisuke; Kato, Kentaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan	Kato, K (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Nishi 2-13,Inada Cho, Obihiro, Hokkaido 0808555, Japan.	kkato@obihiro.ac.jp			JSPS Research Fellowship for Young Scientists; Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan; Program for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry; Program to Disseminate Tenure Tracking System from the Japan Science and Technology Agency (JST)	ALPHA;-TgIMC3 antibody was a kind gift from Dr, Marc-Jan Gubbels. alpha-TgGAP45 antibody was a kind gift from Dr. Dominique Soldati. TS is supported by a JSPS Research Fellowship for Young Scientists. KK is supported by grants-in-aid for Young Scientists, Exploratory Research, Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan, the Program for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN), the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry, and the Program to Disseminate Tenure Tracking System from the Japan Science and Technology Agency (JST). TS and KK designed the study, TS performed the experiments, TS, SK, TH, and KK analyzed the data, and TS and KK wrote the paper.	Chen CT, 2013, J CELL SCI, V126, P3344, DOI 10.1242/jcs.123364; Dzierszinski F, 2004, EUKARYOT CELL, V3, P992, DOI 10.1128/EC.3.4.992-1003.2004; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Morlon-Guyot J, 2014, CELL MICROBIOL, V16, P95, DOI 10.1111/cmi.12186; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Ojo KK, 2010, NAT STRUCT MOL BIOL, V17, P602, DOI 10.1038/nsmb.1818; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Arnot DE, 2011, INT J PARASITOL, V41, P71, DOI 10.1016/j.ijpara.2010.07.012; Bishop AC, 2000, NATURE, V407, P395; Lourido S, 2013, J MED CHEM, V56, P3068, DOI 10.1021/jm4001314; Miranda-Saavedra D, 2012, MICROBES INFECT, V14, P796, DOI 10.1016/j.micinf.2012.04.007; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Murphy RC, 2010, ACS MED CHEM LETT, V1, P331, DOI 10.1021/ml1000961; Brown KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004180; Brumlik MJ, 2013, EXP PARASITOL, V134, P389, DOI 10.1016/j.exppara.2013.03.016; Conde de Felipe M. M, 2008, MOL BIOCHEM PARASIT, V157, P22; Doggett JS, 2014, ANTIMICROB AGENTS CH, V58, P3547, DOI 10.1128/AAC.01823-13; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Hu K, 2004, J CELL SCI, V117, P5697, DOI 10.1242/jcs.01494; Lacey MR, 2007, J MOL EVOL, V64, P4, DOI 10.1007/s00239-005-0197-x; Lorestani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012302; Ojo KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092929; Ojo KK, 2014, J INFECT DIS, V209, P275, DOI 10.1093/infdis/jit522; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Sugi T, 2011, J VET MED SCI, V73, P1377, DOI 10.1292/jvms.11-0085; Sugi T, 2013, INT J PARASITOL-DRUG, V3, P93, DOI 10.1016/j.ijpddr.2013.04.001; Sugi T., 2014, ANAL BIOCH IN PRESS; Tomita T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003823; Wei S, 2002, INT J PARASITOL, V32, P969, DOI 10.1016/S0020-7519(02)00061-9	35	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2211-3207			INT J PARASITOL-DRUG	Int. J. Parasitol.-Drugs Drug Resist.	APR	2015	5	1					1	8		10.1016/j.ijpddr.2014.12.001		8	Parasitology; Pharmacology & Pharmacy	Parasitology; Pharmacology & Pharmacy	CG4QO	WOS:000353271600001		
J	Motoji, Y; Tanaka, H; Fukuda, Y; Sano, H; Ryo, K; Imanishi, J; Miyoshi, T; Sawa, T; Mochizuki, Y; Matsumoto, K; Emoto, N; Hirata, K				Motoji, Yoshiki; Tanaka, Hidekazu; Fukuda, Yuko; Sano, Hiroyuki; Ryo, Keiko; Imanishi, Junichi; Miyoshi, Tatsuya; Sawa, Takuma; Mochizuki, Yasuhide; Matsumoto, Kensuke; Emoto, Noriaki; Hirata, Ken-ichi			Interdependence of right ventricular systolic function and left ventricular filling and its association with outcome for patients with pulmonary hypertension	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Pulmonary hypertension; Bi-ventricular function; Echocardiography	INTERVENTRICULAR MECHANICAL ASYNCHRONY; SPECKLE-TRACKING STRAIN; ARTERIAL-HYPERTENSION; PROGNOSTIC VALUE; DIASTOLIC DYSFUNCTION; EUROPEAN-ASSOCIATION; PRESSURE-OVERLOAD; AMERICAN-SOCIETY; ECHOCARDIOGRAPHY; PERFORMANCE	Although impaired right ventricular (RV) performance has been associated with adverse outcomes for pulmonary hypertension (PH) patients, the relationship between bi-ventricular interdependence and outcomes is not yet fully understood. We studied 96 PH patients. RV systolic function was assessed by means of RV free-wall longitudinal speckle-tracking strain (RV-free), and left ventricular (LV) filling as early diastolic transmitral flow velocity (TMF-E). RV-free a parts per thousand currency sign19 % and TMF-E < 60 cm/s were adopted as pre-defined cut-offs for RV systolic dysfunction and LV under-filling, respectively, associated with worse outcomes. Long-term outcome was tracked over 2.2 years. RV-free correlated significantly with TMF-E (r = 0.57, p < 0.001).TMF-E and RV-free were significantly lower in patients with than in those without cardiac events. RV systolic dysfunction and LV under-filling was observed in 35 patients. These features were associated with worse long-term survival compared to other sub-groups (log-rank p = 0.012). A sequential Cox model based on clinical variables including world health organization functional class IV and brain natriuretic peptide > 150 pg/dl (chi(2) = 1.2) was improved by the addition of RV-free (chi(2) = 5.5, p = 0.04) as well as of TMF-E (chi(2) = 11.5, p = 0.01). In conclusions, RV systolic function was shown to correlate significantly with LV filling in PH patients. In addition, not only assessment of RV systolic function, but also of a combined bi-ventricular parameter comprising RV systolic function and LV filling may well have clinical implications for more successful management of PH patients.	[Motoji, Yoshiki; Tanaka, Hidekazu; Fukuda, Yuko; Sano, Hiroyuki; Ryo, Keiko; Imanishi, Junichi; Miyoshi, Tatsuya; Sawa, Takuma; Mochizuki, Yasuhide; Matsumoto, Kensuke; Emoto, Noriaki; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chuo Ku, Kobe, Hyogo 6500017, Japan	Tanaka, H (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	tanakah@med.kobe-u.ac.jp					Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Gan CTJ, 2006, AM J PHYSIOL-HEART C, V290, pH1528, DOI 10.1152/ajpheart.01031.2005; Motoji Y, 2013, CIRC J, V77, P756, DOI 10.1253/circj.CJ-12-1083; Nagaya N, 2000, CIRCULATION, V102, P865; Haeck MLA, 2012, CIRC-CARDIOVASC IMAG, V5, P628, DOI 10.1161/CIRCIMAGING.111.971465; RYAN T, 1985, J AM COLL CARDIOL, V5, P918; Galie N, 2003, J AM COLL CARDIOL, V41, P1380, DOI 10.1016/S0735-1087(03)00121-9; Fukuda Y, 2011, J AM SOC ECHOCARDIOG, V24, P1101, DOI 10.1016/j.echo.2011.06.005; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Gurudevan SV, 2007, J AM COLL CARDIOL, V49, P1334, DOI 10.1016/j.jacc.2007.01.028; Mahmud E, 2002, J AM COLL CARDIOL, V40, P318, DOI 10.1016/S0735-1097(02)01959-9; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709; Fine NM, 2013, CIRC-CARDIOVASC IMAG, V6, P711, DOI 10.1161/CIRCIMAGING.113.000640; Galie N, 2010, EUR HEART J, V31, P2080, DOI 10.1093/eurheartj/ehq152; Yilmaz R, 2005, J AM SOC ECHOCARDIOG, V18, P873, DOI 10.1016/j.echo.2005.01.016; Ghio S, 2010, INT J CARDIOL, V140, P272, DOI 10.1016/j.ijcard.2008.11.051; Marcus JT, 2008, J AM COLL CARDIOL, V51, P750, DOI 10.1016/j.jacc.2007.10.041; Mathai SC, 2009, ARTHRITIS RHEUM, V60, P569, DOI 10.1002/art.24267; Chang SM, 2007, ECHOCARDIOGR-J CARD, V24, P366, DOI 10.1111/j.1540-8175.2007.00405.x; Fukuda Y, 2014, INT J CARDIOVAS IMAG, V30, P1269, DOI 10.1007/s10554-014-0460-6; López-Candales Angel, 2005, Cardiovasc Ultrasound, V3, P23, DOI 10.1186/1476-7120-3-23; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, p:, DOI DOI 10.1016/J.ECH0.2010.05.010; Tonelli AR, 2012, CHEST, V141, P1457, DOI 10.1378/chest.11-1903; Vonk-Noordegraaf A, 2005, CHEST, V128, p628S, DOI 10.1378/chest.128.6_suppl.628S	29	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	APR	2015	31	4					691	698		10.1007/s10554-015-0598-x		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CG4AO	WOS:000353222400003		
J	Kato, K; Sakai, Y; Ishibashi, I; Kobayashi, Y				Kato, Ken; Sakai, Yoshiaki; Ishibashi, Iwao; Kobayashi, Yoshio			Mid-ventricular takotsubo cardiomyopathy preceding acute myocardial infarction	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Editorial Material									[Kato, Ken; Kobayashi, Yoshio] Chiba Univ, Chiba, Japan; [Sakai, Yoshiaki; Ishibashi, Iwao] Chiba Emergency Med Ctr, Chiba, Japan	Kato, K (reprint author), Chiba Univ, Chiba, Japan.	kkatou0424@yahoo.co.jp					Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Koeth O, 2010, CASE REP MED, V2010, DOI [10.1155/2010/467867, DOI 10.1155/2010/467867]	2	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	APR	2015	31	4					821	822		10.1007/s10554-015-0602-5		2	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CG4AO	WOS:000353222400019		
J	Bolen, MA; Rajiah, P; Kusunose, K; Collier, P; Klein, A; Popovic, ZB; Flamm, SD				Bolen, Michael A.; Rajiah, Prabhakar; Kusunose, Kenya; Collier, Patrick; Klein, Allan; Popovic, Zoran B.; Flamm, Scott D.			Cardiac MR imaging in constrictive pericarditis: multiparametric assessment in patients with surgically proven constriction	INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING			English	Article						Constrictive pericarditis; Magnetic resonance; Pericardium	VENTRICULAR SEPTAL MOTION; TIME CINE MRI; REAL-TIME; MODERN-ERA; DISEASES; INDEX	To assess the utility of cardiac magnetic resonance (MR) imaging in the diagnosis of constrictive pericarditis (CP). This study was approved by the institutional review board, with a waiver of informed consent. A total of 42 consecutive patients (mean age, 55 +/- A 16 years; 3 women, 39 men) with CP treated with pericardiectomy who had undergone cardiac MR before surgery were evaluated retrospectively. An additional 21 patients were evaluated as a control group; of these, 10 consecutive patients received cardiac MR for reasons other than suspected pericardial disease, and 11 consecutive patients had a history of pericarditis but no clinical suspicion of pericardial constriction. MR imaging parameters were analyzed independently and with a decision tree algorithm for usefulness in the prediction of CP. Catheterization data were also reviewed when available. A model combining pericardial thickness and relative interventricular septal (IVS) excursion provided the best overall performance in prediction of CP (C statistic, 0.98, 100 % sensitivity, 90 % specificity). Several individual parameters also showed strong predictive value in the assessment of constriction, including relative IVS excursion (sensitivity, 93 %; specificity, 95 %), pericardial thickness (sensitivity, 83 %; specificity, 100 %), qualitative assessment of pathologic coupling (sensitivity, 88 %; specificity, 100 %), diastolic IVS bounce (sensitivity, 90 %; specificity, 85 %), left ventricle area change (sensitivity, 86 %; specificity, 100 %), and eccentricity index (sensitivity, 86 %; specificity, 90 %; all P < 0.001). Strong agreement was observed between catheterization and surgical findings of constriction (97 %). Cardiac MR provides robust quantitative and qualitative analysis for the diagnosis of CP.	[Bolen, Michael A.; Popovic, Zoran B.; Flamm, Scott D.] Cleveland Clin, Cardiovasc Sect, Imaging Inst, Cleveland, OH 44195 USA; [Bolen, Michael A.; Collier, Patrick; Klein, Allan; Popovic, Zoran B.; Flamm, Scott D.] Cleveland Clin, Inst Heart & Vasc, Cardiovasc Med, Cleveland, OH 44195 USA; [Rajiah, Prabhakar] Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland Case Med Ctr, Dept Cardiothorac Imaging, Cleveland, OH 44106 USA; [Kusunose, Kenya] Tokushima Univ Hosp, Dept Cardiovasc Med, Tokushima, Japan	Bolen, MA (reprint author), Cleveland Clin, Cardiovasc Sect, Imaging Inst, 9500 Euclid Ave,J1-4, Cleveland, OH 44195 USA.	bolenm@ccf.org					Anavekar NS, 2013, INT J CARDIOVAS IMAG, V29, P363, DOI 10.1007/s10554-012-0101-x; Ling LH, 1999, CIRCULATION, V100, P1380; Francone M, 2006, EUR RADIOL, V16, P944, DOI 10.1007/s00330-005-0009-0; RYAN T, 1985, J AM COLL CARDIOL, V5, P918; Talreja DR, 2003, CIRCULATION, V108, P1852, DOI 10.1161/01.CIR.0000087606.18453.FD; Zurick AO, 2011, JACC-CARDIOVASC IMAG, V4, P1180, DOI 10.1016/j.jcmg.2011.08.011; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Little WC, 2006, CIRCULATION, V113, P1622, DOI 10.1161/CIRCULATIONAHA.105.561514; Francone M, 2005, J MAGN RESON IMAGING, V21, P305, DOI 10.1002/jmri.20259; Bauner K, 2010, EUR RADIOL, V20, P1831, DOI 10.1007/s00330-010-1741-7; Giorgi B, 2003, RADIOLOGY, V228, P417, DOI 10.1148/radiol.2282020345; Lachhab Amal, 2011, Int Arch Med, V4, P36, DOI 10.1186/1755-7682-4-36; Nishimura RA, 2001, HEART, V86, P619, DOI 10.1136/heart.86.6.619; Rajiah P, 2011, AM J ROENTGENOL, V197, pW621, DOI 10.2214/AJR.10.7265; Thavendiranathan P, 2012, JACC-CARDIOVASC IMAG, V5, P15, DOI 10.1016/j.jcmg.2011.07.010	15	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1569-5794	1573-0743		INT J CARDIOVAS IMAG	Int. J. Cardiovasc. Imaging	APR	2015	31	4					859	866		10.1007/s10554-015-0616-z		8	Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical Imaging	Cardiovascular System & Cardiology; Radiology, Nuclear Medicine & Medical Imaging	CG4AO	WOS:000353222400024		
J	Li, FJ; Yamaki, K; Cheng, YQ; Fang, YY				Li, Fengjuan; Yamaki, Kohji; Cheng, Yongqiang; Fang, Yuanyuan			Assessment and Separation of Angiotensin I-Converting Enzyme Inhibitory Peptides in Chinese Soypaste	INTERNATIONAL JOURNAL OF FOOD ENGINEERING			English	Article						angiotensin I-converting enzyme (ACE) inhibition; Chinese soypaste; peptide; separation	FERMENTED SOYBEAN PRODUCT; SOY-PROTEIN; FOOD; IDENTIFICATION; SUBSTANCES; DOUCHI; SAUCE	A Chinese soypaste-derived fraction with potent angiotensin I-converting enzyme (ACE) inhibitory activity (IC50 = 25.9 mu g/mL) was obtained by treating soypaste extract with 80% ethanol. The result of gradient reversed-phase high-performance liquid chromatography (RP-HPLC) suggested that bioactive peptides bearing some polarity groups made a substantial contribution to the ACE inhibitory activity. By mass spectrometric analysis, a component was separated as Glu-Ser-Gly-Asp which was then found to act in a dose-dependent manner against ACE activity as a non-competitive inhibitor, with an IC50 value of 2.297 mM.	[Li, Fengjuan; Fang, Yuanyuan] Tianjin Univ Sci & Technol, Key Lab Food Nutr & Safety, Minist Educ, Tianjin 300457, Peoples R China; [Li, Fengjuan; Yamaki, Kohji] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Cheng, Yongqiang] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China	Li, FJ (reprint author), Tianjin Univ Sci & Technol, Key Lab Food Nutr & Safety, Minist Educ, 29,13th Ave, Tianjin 300457, Peoples R China.	lifengjuansh@163.com; kyamaki@affrc.go.jp			Kirin Holdings Co., Ltd. (former Kirin Brewery Co., Ltd.), Tokyo; National Natural Science Foundation of China (NSFC) [31101329]	This work was supported by Kirin Holdings Co., Ltd. (former Kirin Brewery Co., Ltd.), Tokyo, during UNU-Kirin Fellowship Programme at National Food Research Institute (NFRI), Tsukuba, Japan, in 2012-13, and its Follow-Up Project in 2013-15. This work was also within the framework of the fund project (Grant No. 31101329) entitled "Generation mechanism of angiotensin-converting enzyme inhibitors in traditional soypaste" from National Natural Science Foundation of China (NSFC).	Wu JP, 2006, J AGR FOOD CHEM, V54, P732, DOI 10.1021/jf051263l; Chen ZY, 2009, J AGR FOOD CHEM, V57, P4485, DOI 10.1021/jf900803r; Kuba M, 2005, PROCESS BIOCHEM, V40, P2191, DOI 10.1016/j.procbio.2004.08.010; Wu JP, 2002, FOOD RES INT, V35, P367, DOI 10.1016/S0963-9969(01)00131-4; Mahmoudpour SH, 2013, PHARMACOGENOMICS, V14, P249, DOI [10.2217/pgs.12.206, 10.2217/PGS.12.206]; Lo WMY, 2005, J AGR FOOD CHEM, V53, P3369, DOI 10.1021/jf048174d; Rho SJ, 2009, PROCESS BIOCHEM, V44, P490, DOI 10.1016/j.procbio.2008.12.017; Li GH, 2004, NUTR RES, V24, P469, DOI 10.1016/j.nutres.2003.10.014; ERDOS EG, 1975, CIRC RES, V36, P247; Wang HK, 2013, INT J FOOD ENG, V9, P1, DOI 10.1515/ijfe-2012-0207; Kuba M, 2003, BIOSCI BIOTECH BIOCH, V67, P1278, DOI 10.1271/bbb.67.1278; Zhang JH, 2006, FOOD CHEM, V98, P551, DOI 10.1016/j.foodchem.2005.06.024; Fan JF, 2009, BIOSCI BIOTECH BIOCH, V73, P2749, DOI 10.1271/bbb.90361; Gouda KGM, 2006, J AGR FOOD CHEM, V54, P4568, DOI 10.1021/jf060264q; Kwon DY, 2011, NUTRITION, V27, P244, DOI 10.1016/j.nut.2010.02.004; Lee HK, 2004, J MICROBIOL BIOTECHN, V14, P628; Li FJ, 2009, INT J FOOD ENG, V5, DOI 10.2202/1556-3758.1661; Li FJ, 2013, J FUNCT FOODS, V5, P1991, DOI 10.1016/j.jff.2013.07.007; Ma YL, 2013, INT J FOOD ENG, V9, P45, DOI 10.1515/ijfe-2012-0204; Nakahara T, 2010, J AGR FOOD CHEM, V58, P821, DOI 10.1021/jf903261h; Zhu YP, 2011, INT J FOOD ENG, V7, DOI 10.2202/1556-3758.2029; Zhuang YL, 2012, FOOD BIOPROCESS TECH, V5, P1622, DOI 10.1007/s11947-010-0439-9	22	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	2194-5764	1556-3758		INT J FOOD ENG	Int. J. Food Eng.	APR	2015	11	2								10.1515/ijfe-2014-0221		5	Food Science & Technology	Food Science & Technology	CG2XL	WOS:000353138900014		
J	Tokairin, Y; Nagai, K; Fujiwara, H; Ogo, T; Okuda, M; Nakajima, Y; Kawada, K; Miyawaki, Y; Nasu, H; Akita, K; Kawano, T				Tokairin, Yutaka; Nagai, Kagami; Fujiwara, Hisashi; Ogo, Taichi; Okuda, Masafumi; Nakajima, Yasuaki; Kawada, Kenro; Miyawaki, Yutaka; Nasu, Hisayo; Akita, Keiichi; Kawano, Tatsuyuki			Mediastinoscopic Subaortic and Tracheobronchial Lymph Node Dissection With a New Cervico-Hiatal Crossover Approach in Thiel-Embalmed Cadavers	INTERNATIONAL SURGERY			English	Article						Mediastinoscopic esophagectomy; Esophagectomy; Minimally invasive esophagectomy; MELD; Cross-over technique; Thiel	TRANSHIATAL ESOPHAGECTOMY; THORACOSCOPIC ESOPHAGECTOMY; CANCER; ENDODISSECTION; PRESERVATION; NECK	The use of mediastinal surgery for minimally invasive esophagectomy (MIE) has been proposed; however, this method is not performed as radical surgery because it has been thought to be impossible to perform complete upper mediastinal dissection, including the left tracheobronchial lymph nodes (106tbL). We herein describe a new method for performing complete dissection of the upper mediastinum. We developed a method for performing complete mediastinoscopic esophagectomy as radical surgery via the bilateral transcervical and transhiatal approach in 6 Thiel-embalmed human cadavers. The lower and middle mediastinal lymph nodes are dissected via the transhiatal approach. The dorsal side of the left recurrent nerve is dissected up to the aortic arch and left recurrent nerve lymph nodes (106recL) are dissected under pneumomediastinum. Next, the right recurrent nerve lymph nodes (106recR) are dissected. The cartilage of the left main bronchus is dissected and pushed downward, thereby obtaining a good view between the aortic arch and left main bronchus via the transhiatal approach. The 106tbL lymph nodes are dissected until the aortic arch is reached. Simultaneously, the lymph nodes are dissected via a right cervical incision. This method is termed the "cross-over technique.'' We herein demonstrated that the upper mediastinal lymph nodes, including the 106tbL nodes, can be dissected using the bilateral transcervical and transhiatal approach under pneumomediastinum and named this method "mediastinoscopic esophagectomy with lymph node dissection'' (MELD). MELD is therefore considered to be a useful modality based on our experience with Thiel-embalmed human cadavers.	[Tokairin, Yutaka; Nagai, Kagami; Fujiwara, Hisashi; Ogo, Taichi; Okuda, Masafumi; Nakajima, Yasuaki; Kawada, Kenro; Miyawaki, Yutaka; Kawano, Tatsuyuki] Tokyo Med & Dent Univ, Dept Esophageal & Gen Surg, Tokyo 1138510, Japan; [Nasu, Hisayo; Akita, Keiichi] Tokyo Med & Dent Univ, Dept Clin Anat, Tokyo 1138510, Japan	Tokairin, Y (reprint author), Tokyo Med & Dent Univ, Dept Esophageal & Gen Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tokairin.srg1@tmd.ac.jp					THIEL W, 1992, ANN ANAT, V174, P185; Thiel W, 2002, ANN ANAT, V184, P267, DOI 10.1016/S0940-9602(02)80121-2; Galvani CA, 2008, SURG ENDOSC, V22, P188, DOI 10.1007/s00464-007-9441-3; Boone J, 2009, BRIT J SURG, V96, P878, DOI 10.1002/bjs.6647; ORRINGER MB, 1978, J THORAC CARDIOV SUR, V76, P643; Bumm R, 1997, WORLD J SURG, V21, P822; BUMM R, 1993, ANN SURG, V218, P97, DOI 10.1097/00000658-199307000-00015; Ikeda Y, 2002, ANN THORAC SURG, V73, P1329, DOI 10.1016/S0003-4975(01)03593-7; Ikeda Y, 2001, SURGERY, V129, P504, DOI 10.1016/S0039-6060(01)54694-2; MORI K, 2013, J ROBOT SURG, V7, P385; Parker M, 2011, SURG ENDOSC, V25, P3865, DOI 10.1007/s00464-011-1811-1; Pop D, 2007, J THORAC CARDIOV SUR, V133, P267, DOI 10.1016/j.jtcvs.2006.08.066; Shiozaki A, 2013, ANTICANCER RES, V33, P2577; Tandon S, 2001, BRIT J ANAESTH, V86, P633, DOI 10.1093/bja/86.5.633; Tangoku A, 2004, SURG ENDOSC, V18, P383, DOI 10.1007/s00464-003-8181-2	15	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					580	588		10.9738/INTSURG-D-14.00305.1		9	Surgery	Surgery	CG1JM	WOS:000353028900002		
J	Ishizuka, M; Nagata, H; Takagi, K; Iwasaki, Y; Yamagishi, H; Tanaka, G; Kubota, K				Ishizuka, Mitsuru; Nagata, Hitoshi; Takagi, Kazutoshi; Iwasaki, Yoshimi; Yamagishi, Hidetsugu; Tanaka, Genki; Kubota, Keiichi			Usefulness of Intraoperative Observation Using a Fluorescence Imaging Instrument for Patients With Nonocclusive Mesenteric Ischemia	INTERNATIONAL SURGERY			English	Article						Dark spot; Fluorescence; Indocyanine green; Nonocclusive mesenteric ischemia; Photodynamic eye	INTESTINAL VIABILITY; INDOCYANINE GREEN; BREAST-CANCER; RISK-FACTORS; IDENTIFICATION; FAILURE; BOWEL	The authors evaluated the usefulness of intraoperative photodynamic eye (PDE) observation in patients with nonocclusive mesenteric ischemia (NOMI). Between February 2012 and July 2013, 6 patients who had undergone emergency surgery for NOMI were enrolled. Intraoperative PDE observation was performed to decide the adequate length of bowel resection including all skipped dark spots, which could not be detected as ongoing mucosal ischemic changes under visible light observation. All ongoing mucosal ischemic changes were easily detected as dark spots using PDE observation in all 6 patients. The mean length of adequate ileal resection (92 +/- 48 cm) was significantly longer than that of ischemic ileum (85 +/- 50 cm) (mean +/- SD) (P = 0.043). After resection of an adequate length of bowel, all the patients had a good course until discharge without incidents due to residual bowel ischemia, except for 1patient who died. PDE observation is useful for deciding the adequate length of bowel to resect, including ongoing mucosal ischemic changes that cannot be detected under visible light observation. In patients with NOMI, resection of an adequate length of bowel is necessary to prevent postoperative incidents due to residual bowel ischemia.	[Ishizuka, Mitsuru; Nagata, Hitoshi; Takagi, Kazutoshi; Iwasaki, Yoshimi; Tanaka, Genki; Kubota, Keiichi] Dokkyo Med Univ, Dept Surg Gastroenterol, Mibu, Tochigi 3210293, Japan; [Yamagishi, Hidetsugu] Dokkyo Med Univ, Anat & Diagnost Pathol, Mibu, Tochigi 3210293, Japan	Ishizuka, M (reprint author), Dokkyo Med Univ, Dept Surg Gastroenterol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	mm-ishizuka@umin.ac.jp					Tagaya N, 2010, J HEPATO-BIL-PAN SCI, V17, P595, DOI 10.1007/s00534-009-0195-2; Unno N, 2008, EUR J VASC ENDOVASC, V35, P205, DOI 10.1016/j.ejvs.2007.09.001; Nitori N, 2014, SURG TODAY, V44, P359, DOI 10.1007/s00595-013-0503-y; Tagaya N, 2008, AM J SURG, V195, P850, DOI 10.1016/j.amjsurg.2007.02.032; STONEY RJ, 1993, SURGERY, V114, P489; Kubota K, 2006, J HEPATO-BILIARY-PAN, V13, P100, DOI 10.1007/s00534-005-1014-z; Acosta S, 2006, J INTERN MED, V259, P305, DOI 10.1111/j.1365-2796.2006.01613.x; CARTER MS, 1984, AM J SURG, V147, P117, DOI 10.1016/0002-9610(84)90044-8; Kamiya K, 2009, SURG TODAY, V39, P421, DOI 10.1007/s00595-008-3852-1; Trompeter M, 2002, EUR RADIOL, V12, P1179, DOI 10.1007/00330-001-1220-2; Tagaya N, 2011, WORLD J SURG, V35, P154, DOI 10.1007/s00268-010-0811-y; Archodovassilis F, 2007, PERITON DIALYSIS INT, V27, P136; Bassilios N, 2003, NEPHROL DIAL TRANSPL, V18, P911, DOI 10.1093/ndt/gfg004; BOLEY SJ, 1977, SURGERY, V82, P848; ENDE N, 1958, NEW ENGL J MED, V258, P879, DOI 10.1056/NEJM195805012581804; HAGLUND U, 1979, BRIT J SURG, V66, P155, DOI 10.1002/bjs.1800660305; MANN A, 1982, SURG GYNECOL OBSTET, V154, P53; Ori Y, 2005, NEPHRON CLIN PRACT, V101, pC87, DOI 10.1159/000086346; Sawada Tokihiko, 2010, Am J Surg, V199, pe69, DOI 10.1016/j.amjsurg.2009.08.049; WRIGHT CB, 1975, AM J SURG, V129, P642, DOI 10.1016/0002-9610(75)90337-2	20	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					593	599		10.9738/INTSURG-D-14-00038.1		7	Surgery	Surgery	CG1JM	WOS:000353028900004		
J	Kawai, K; Sunami, E; Tanaka, J; Tanaka, T; Kiyomatsu, T; Nozawa, H; Kazama, S; Kanazawa, T; Hosaka, A; Ishihara, S; Yamaguchi, H; Shigematsu, K; Watanabe, T				Kawai, Kazushige; Sunami, Eiji; Tanaka, Junichiro; Tanaka, Toshiaki; Kiyomatsu, Tomomichi; Nozawa, Hiroaki; Kazama, Shinsuke; Kanazawa, Takamitsu; Hosaka, Akihiro; Ishihara, Soichiro; Yamaguchi, Hironori; Shigematsu, Kunihiro; Watanabe, Toshiaki			Synchronous Colorectal Malignancy and Abdominal Aortic Aneurysm Treated With Endovascular Aneurysm Repair Followed by Laparoscopic Colectomy	INTERNATIONAL SURGERY			English	Article						Abdominal aortic aneurysm; Endovascular aneurysm repair; Colorectal cancer; Laparoscopic surgery	CANCER	Although the incidence of synchronous abdominal aortic aneurysm (AAA) and malignancies is increasing, there has been no clear consensus in the surgical treatment of such patients. The focus on surgical treatments with minimal invasiveness, such as endovascular aneurysm repair (EVAR) for AAA and laparoscopic colectomy for colorectal cancer, has increased; however, the clinical applicability of combination treatment with EVAR and laparoscopic colectomy has not been established. A 61-year-old man was diagnosed with AAA, advanced sigmoid colon cancer, and coronary artery stenosis. Because the patient also had chronic renal failure with nephrotic syndrome, among several other comorbidities, surgery was considered to be associated with high risks in this patent. Sequential treatments with percutaneous coronary intervention, EVAR, and laparoscopic colectomy were successfully performed. Staged treatment of EVAR followed by laparoscopic colectomy may be a promising strategy for high-risk patients with AAA associated with malignancy.	[Kawai, Kazushige; Sunami, Eiji; Tanaka, Junichiro; Tanaka, Toshiaki; Kiyomatsu, Tomomichi; Nozawa, Hiroaki; Kazama, Shinsuke; Kanazawa, Takamitsu; Ishihara, Soichiro; Yamaguchi, Hironori; Watanabe, Toshiaki] Univ Tokyo, Fac Med, Dept Surg Oncol, Bunkyo Ku, Tokyo 1130033, Japan; [Hosaka, Akihiro; Shigematsu, Kunihiro] Univ Tokyo, Fac Med, Vasc Surg, Bunkyo Ku, Tokyo 1130033, Japan	Kawai, K (reprint author), Univ Tokyo, Fac Med, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kz-kawai@mvd.biglobe.ne.jp					Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Porcellini M, 2007, J VASC SURG, V46, P16, DOI 10.1016/j.jvs.2006.09.070; Dangas G, 2012, JACC-CARDIOVASC INTE, V5, P1071, DOI 10.1016/j.jcin.2012.06.015; Baxter NN, 2002, DIS COLON RECTUM, V45, P165, DOI 10.1007/s10350-004-6138-8; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Kawaguchi Masahiko, 2013, Int J Surg Case Rep, V4, P1117, DOI 10.1016/j.ijscr.2013.07.038; Mohandas S, 2013, INT J SURG, V11, P112, DOI 10.1016/j.ijsu.2012.11.022; Orcutt ST, 2011, AM J SURG, V202, P528, DOI 10.1016/j.amjsurg.2011.06.024; Pattaras JG, 2009, CAN J UROL, V16, P4596; Shalhoub J, 2009, EUR J VASC ENDOVASC, V37, P544, DOI 10.1016/j.ejvs.2009.01.004; Tanaka Hiroki, 2009, Ann Vasc Dis, V2, P47, DOI 10.3400/avd.AVDcr08016	11	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					600	603		10.9738/INTSURG-D-14-00111.1		4	Surgery	Surgery	CG1JM	WOS:000353028900005		
J	Takeshita, N; Tohma, T; Miyauchi, H; Suzuki, K; Nishimori, T; Ohira, G; Narushima, K; Imanishi, S; Toyozumi, T; Matsubara, H				Takeshita, Nobuyoshi; Tohma, Takayuki; Miyauchi, Hideaki; Suzuki, Kazufumi; Nishimori, Takanori; Ohira, Gaku; Narushima, Kazuo; Imanishi, Shunsuke; Toyozumi, Takeshi; Matsubara, Hisahiro			Suture Granuloma With False-Positive Findings on FDG-PET/CT Resected via Laparoscopic Surgery	INTERNATIONAL SURGERY			English	Article						Suture granuloma; Laparoscopy; Positron emission tomography (PET)	FOREIGN-BODY GRANULOMA	A 61-year-old woman who had undergone total hysterectomy 16 years previously exhibited a pelvic tumor on computed tomography (CT). F-18 fluorodeoxyglucose (FDG) combined positron emission tomography (PET)/CT imaging revealed a solitary small focus of increased FDG activity in the pelvis. A gastrointestinal stromal tumor originating in the small intestine or another type of tumor originating in the mesentery (desmoid, schwannoma, or foreign body granuloma) was suspected; therefore, laparoscopic resection was conducted. A white, hard tumor was found to originate from the mesentery of the sigmoid colon and adhered slightly to the small intestine. The tumor was resected with a negative margin, and the pathologic diagnosis was suture granuloma. The possibility of suture granuloma should be kept in mind in cases of tumors with positive PET findings and a history of surgery close to the lesion. However, it is difficult to preoperatively diagnose pelvic tumors using a biopsy. Therefore, considering the possibility of malignancy, it is necessary to achieve complete resection without exposing the tumor.	[Takeshita, Nobuyoshi; Tohma, Takayuki; Miyauchi, Hideaki; Suzuki, Kazufumi; Nishimori, Takanori; Ohira, Gaku; Narushima, Kazuo; Imanishi, Shunsuke; Toyozumi, Takeshi; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba 2608670, Japan	Takeshita, N (reprint author), Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.	ntakeshita1225@gmail.com					Chung YE, 2006, YONSEI MED J, V47, P748; Ghersin E, 2004, J COMPUT ASSIST TOMO, V28, P839, DOI 10.1097/00004728-200411000-00019; Iwase K, 1999, SURG TODAY, V29, P874; Kikuchi M, 2012, AURIS NASUS LARYNX, V39, P94, DOI 10.1016/j.anl.2011.04.012; Kim YK, 2008, ABDOM IMAGING, V33, P94, DOI 10.1007/s00261-007-9180-x; Lim JWM, 2005, ANN ACAD MED SINGAP, V34, P457; NAGAR H, 1993, J PEDIATR SURG, V28, P1505, DOI 10.1016/0022-3468(93)90442-N; POSTLETHWAIT RW, 1975, ANN SURG, V181, P144; Poyanli A, 2005, BRIT J RADIOL, V78, P752, DOI 10.1259/bjr/65834078; Strauss LG, 1997, ONCOLOGIST, V2, P381; Takahara K, 2013, CASE REP UROL, V2013; Yeretsian RA, 2003, AM J NEURORADIOL, V24, P1164; Yuksel M, 2007, EUR J CARDIO-THORAC, V31, P563, DOI 10.1016/j.ejcts.2006.11.056	13	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					604	607		10.9738/INTSURG-D-14-00140.1		4	Surgery	Surgery	CG1JM	WOS:000353028900006		
J	Yaegashi, M; Kimura, T; Sakamoto, T; Sato, T; Kawasaki, Y; Otsuka, K; Wakabayashi, G				Yaegashi, Mizunori; Kimura, Toshimoto; Sakamoto, Takashi; Sato, Tadao; Kawasaki, Yuichiro; Otsuka, Koki; Wakabayashi, Go			Laparoscopic Sigmoidectomy for a Patient With Situs Inversus Totalis: Effect of Changing Operator Position	INTERNATIONAL SURGERY			English	Article						Laparoscopic sigmoidectomy; Laparoscopic surgery; Situs inversus totalis; Colon cancer	RECTAL-CANCER; CHOLECYSTECTOMY; HEMICOLECTOMY; RESECTION	Situs inversus totalis (SIT) is a rare congenital condition in which the abdominal and thoracic organs are on the opposite sides to their normal anatomic positions. Reports of laparoscopic surgery for colorectal cancer with SIT are very few. Due to the mirror-image transposition of organs and vascular abnormalities, laparoscopic surgery for patients with SIT is technically complicated. Therefore, it has been reported as easier for left-handed surgeons. This report presents that operative procedures can be conducted as usual by changing the positions of the operator and assistants, even if the operator is right-handed. A 71-year-old woman visited our hospital with a 2-month history of hematochezia. Colonoscopy revealed an ulcerative tumor in the sigmoid colon and biopsy confirmed well-differentiated adenocarcinoma. Laparoscopic sigmoidectomy radical lymphadenectomy was performed. The operating time was 189 minutes and blood loss was 13 mL. The patient was discharged on postoperative day 7, without any complications. We report that complicated surgical procedures for patients with SIT can be simplified by changing viewpoints. Due to the altered anatomy in SIT, the positions of the operator and assistants are very important. Location of the pelvis is almost the same as in orthotopic patients, by moving the operator from the left side to the right side of the patient. Changing the position of the operator to the right side seems to be effective for patients with SIT during pelvic procedures.	[Yaegashi, Mizunori; Kimura, Toshimoto; Otsuka, Koki; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 0208505, Japan; [Sakamoto, Takashi; Sato, Tadao; Kawasaki, Yuichiro] Iwate Prefectural Ninohe Hosp, Dept Surg, Ninohe, Iwate, Japan	Yaegashi, M (reprint author), Iwate Med Univ, Sch Med, Dept Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.						Iwamura T, 2001, J CLIN GASTROENTEROL, V33, P148, DOI 10.1097/00004836-200108000-00012; Fujiwara Y, 2007, WORLD J GASTROENTERO, V13, P5035; Kobus C, 2004, LANGENBECK ARCH SURG, V389, P396, DOI 10.1007/s00423-004-0500-0; Choi SI, 2011, SURG LAPARO ENDO PER, V21, pE87, DOI 10.1097/SLE.0b013e31820b0258; Davies H, 2003, Surg Endosc, V17, P160; Huh JW, 2010, J KOREAN MED SCI, V25, P790, DOI 10.3346/jkms.2010.25.5.790; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Jobanputra S, 2007, SURG INNOV, V14, P284, DOI 10.1177/1553350607311089; Kim HJ, 2011, SURG TODAY, V41, P1538, DOI 10.1007/s00595-010-4530-7; Machado Norman Oneil, 2006, JSLS, V10, P386; Nursal TZ, 2001, J LAPAROENDOSC ADV A, V11, P239, DOI 10.1089/109264201750539772; Oms LM, 2003, SURG ENDOSC, V17, P1859, DOI 10.1007/s00464-003-9051-7; Sumi Yasuo, 2013, World J Gastrointest Surg, V5, P22, DOI 10.4240/wjgs.v5.i2.22	13	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					638	642		10.9738/INTSURG-D-14-00217.1		5	Surgery	Surgery	CG1JM	WOS:000353028900011		
J	Takebayashi, K; Matsumura, M; Kawai, Y; Hoashi, T; Katsura, N; Fukuda, S; Shimizu, K; Inada, T; Sato, M				Takebayashi, Katsushi; Matsumura, Masakata; Kawai, Yasuhiro; Hoashi, Takahiko; Katsura, Nagato; Fukuda, Seijun; Shimizu, Kenji; Inada, Takuji; Sato, Masugi			Efficacy of Transversus Abdominis Plane Block and Rectus Sheath Block in Laparoscopic Inguinal Hernia Surgery	INTERNATIONAL SURGERY			English	Article						TAP block; RS block; Inguinal hernia; Laparoscopic surgery	CHRONIC PAIN; REPAIR; LICHTENSTEIN; ANESTHESIA; TRIAL	We aimed to assess the efficacy of transversus abdominis plane (TAP) block and rectus sheath (RS) block in patients undergoing laparoscopic inguinal hernia surgery. Few studies have addressed the efficacy and safety associated with TAP block and RS block for laparoscopic surgery. Thirty-two patients underwent laparoscopic inguinal hernia surgery, either with TAP and RS block (Block(+) group, n = 18) or without peripheral nerve block (Block(-) group, n = 14). Preoperatively, TAP and RS block were performed through ultrasound guidance. We evaluated postoperative pain control and patient outcomes. The mean postoperative hospital stays were 1.56 days (Block(+) group) and 2.07 days (Block(-) group; range, 1-3 days in both groups; P = 0.0038). A total of 11 patients and 1 patient underwent day surgery in the Block(+) and Block(-) groups, respectively (P = 0.0012). Good postoperative pain control was more commonly observed in the Block(+) group than in the Block(-) group (P = 0.011). TAP and RS block was effective in reducing postoperative pain and was associated with a fast recovery in patients undergoing laparoscopic inguinal hernia surgery.	[Takebayashi, Katsushi; Matsumura, Masakata; Kawai, Yasuhiro; Hoashi, Takahiko; Sato, Masugi] Misugikai Sato Hosp, Dept Surg, Osaka, Japan; [Takebayashi, Katsushi] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga 5202192, Japan; [Katsura, Nagato; Fukuda, Seijun; Shimizu, Kenji] Misugikai Otokoyama Hosp, Dept Surg, Kyoto, Japan; [Inada, Takuji] Soryukai Inoue Hosp, Dept Anesthesiol, Osaka, Japan	Takebayashi, K (reprint author), Shiga Univ Med Sci, Dept Surg, Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	katsushi@belle.shiga-med.ac.jp					AMID PK, 1994, CHIRURG, V65, P54; McDermott G, 2012, BRIT J ANAESTH, V108, P499, DOI 10.1093/bja/aer422; Farooq M, 2008, REGION ANESTH PAIN M, V33, P274, DOI 10.1016/j.rapm.2007.11.009; De Oliveira GS, 2014, ANESTH ANALG, V118, P454, DOI 10.1213/ANE.0000000000000066; Hindmarsh AC, 2003, BRIT J SURG, V90, P1152, DOI 10.1002/bjs.4213; Carter J, 2011, WORLD J SURG, V35, P1519, DOI 10.1007/s00268-011-1030-x; Eklund A, 2010, BRIT J SURG, V97, P600, DOI 10.1002/bjs.6904; Isaac LA, 2006, PEDIATR ANESTH, V16, P406, DOI 10.1111/j.1460-9592.2005.01785.x; LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6; Milone M, 2013, HERNIA, V17, P749, DOI 10.1007/s10029-012-1022-2; Koninger J, 2004, LANGENBECK ARCH SURG, V389, P361, DOI 10.1007/s00423-004-0496-5; Charlton S, 2010, COCHRANE DB SYST REV, V8; Ferguson S, 1996, PAEDIATR ANAESTH, V6, P463, DOI 10.1046/j.1460-9592.1996.d01-24.x; GER R, 1990, AM J SURG, V159, P370, DOI 10.1016/S0002-9610(05)81273-5; Gurnaney HG, 2011, BRIT J ANAESTH, V107, P790, DOI 10.1093/bja/aer263; Jankovic Z, 2008, ANESTH ANALG, V107, P1758, DOI 10.1213/ane.0b013e3181853619; Nicholson T, 1999, JSLS, V3, P39; Schrenk P, 1997, BRIT J SURG, V83, P728; Singh AN, 2012, SURG ENDOSC, V26, P1304, DOI 10.1007/s00464-011-2029-y; Young MJ, 2012, ANESTHESIOL RES PRAC, V2012, DOI DOI 10.1155/2012/731645	20	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					666	671		10.9738/INTSURG-D-14-00193.1		6	Surgery	Surgery	CG1JM	WOS:000353028900016		
J	Matsumoto, T; Tanaka, N; Nagai, M; Koike, D; Sakuraoka, Y; Kubota, K				Matsumoto, Takatsugu; Tanaka, Nobutaka; Nagai, Motoki; Koike, Daisuke; Sakuraoka, Yuki; Kubota, Keiichi			A Case of Gastric Heterotopic Pancreatitis Resected by Laparoscopic Surgery	INTERNATIONAL SURGERY			English	Article						Stomach; Pancreatitis; Laparoscopic surgery	OF-THE-LITERATURE; ECTOPIC PANCREAS; TUMOR; DIAGNOSIS; WALL	Heterotopic pancreas (HP) is a rare entity which is defined as the presence of pancreatic tissue lacking anatomical and vascular continuity with the pancreas. It is most commonly found along foregut derivatives, such as the stomach, duodenum, and jejunum. It is frequently encountered incidentally in asymptomatic patients, and symptomatic patients are rare and do not exhibit any specific symptoms. Accordingly, HP is difficult to diagnose before surgery. Here we report an unusual case of gastric heterotopic pancreatitis causing gastric outlet obstruction diagnosed preoperatively using endoscopic ultrasonography guided fine needle aspiration cytology. A 21-year-old woman was referred to our hospital because of abdominal pain, nausea, and vomiting. Gastroduodenal endoscopic examination revealed an oval-shaped submucosal tumor in the gastric body. Contrast-enhanced computed tomography (CT) revealed that the tumor had a cystic component and marked perigastric inflammation. Endoscopic ultrasonography (EUS) demonstrated a hypoechoic mass arising from the third to fourth layer of the gastric wall. Pancreatic exocrine glands were detected by EUS-guided fine needle aspiration biopsy. The lesion was diagnosed as gastric heterotopic pancreas with inflammation of the pancreatic tissue. Laparoscopic partial gastrectomy was performed, and the diagnosis was also histologically confirmed. The patient was discharged 5 days after the operation. She has remained healthy and symptom-free during 10 months of follow-up. We experienced a first case of gastric heterotopic pancreatitis which was correctly diagnosed preoperatively and resected by laparoscopic surgery. Partial resection of the heterotopic pancreatic tissue could lead to a good outcome.	[Matsumoto, Takatsugu; Kubota, Keiichi] Dokkyo Med Univ, Dept Gastroenterol Surg, Mibu, Tochigi, Japan; [Tanaka, Nobutaka; Nagai, Motoki; Koike, Daisuke; Sakuraoka, Yuki] Asahi Gen Hosp, Dept Gen Surg, Chiba, Japan	Matsumoto, T (reprint author), 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	takatsugu_m_475@yahoo.co.jp					Ormarsson OT, 2006, WORLD J SURG, V30, P1682, DOI 10.1007/s00268-005-0669-6; Hsu SD, 2008, AM J SURG, V195, P498, DOI 10.1016/j.amjsurg.2007.01.043; ARMSTRONG CP, 1981, BRIT J SURG, V68, P384, DOI 10.1002/bjs.1800680606; BARBOSA JJD, 1946, SURG GYNECOL OBSTET, V82, P527; Hiki N, 2008, SURG ENDOSC, V22, P1729, DOI 10.1007/s00464-007-9696-8; Cárdenas Carmen M Hernández, 2009, JOP, V10, P321; Eisenberger CF, 2004, HEPATO-GASTROENTEROL, V51, P854; Hirasaki S, 2005, INTERNAL MED, V44, P1169, DOI 10.2169/internalmedicine.44.1169; Hsu SD, 2005, WORLD J GASTROENTERO, V11, P7694; Hyung WJ, 2005, J SURG ONCOL, V89, P95, DOI 10.1002/jso.20195; MARTINEZ NS, 1958, ANN SURG, V147, P1, DOI 10.1097/00000658-195801000-00001; Matissek C, 2012, EUR J PEDIATR SURG, V22, P165, DOI 10.1055/s-0031-1285921; Matsushita M, 1997, AM J GASTROENTEROL, V92, P2121; TANAKA K, 1993, INT SURG, V78, P32; UENO S, 1993, SURG TODAY, V23, P269	15	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					678	682		10.9738/INTSURG-D-14-00182.1		5	Surgery	Surgery	CG1JM	WOS:000353028900018		
J	Nakayama, H; Takayama, T; Higaki, T; Okubo, T; Moriguchi, M; Yoshida, N; Kuronuma, A				Nakayama, Hisashi; Takayama, Tadatoshi; Higaki, Tokio; Okubo, Takao; Moriguchi, Masamichi; Yoshida, Nao; Kuronuma, Akiko			Verification of Inferior Right Hepatic Vein-Conserving Segments 7 to 8 Resection of the Liver	INTERNATIONAL SURGERY			English	Article						Inferior right hepatic vein; Liver resection; Segmentectomy; 3D-CT	HEPATOCELLULAR-CARCINOMA; RECONSTRUCTION; HEPATECTOMY; SURGERY	This study aims to investigate the safety of inferior right hepatic vein (IRHV)-conserving surgery by comparing the surgical data and postoperative complications between IRHV-conserving segments 7 to 8 (S7 to S8) resection and conventional right hemihepatectomy (RH). Five patients who underwent IRHV-conserving S7 to S8 segmentectomy between 2007 and 2011 (IRHV group) and 25 liver cancer patients who underwent RH without biliary tract reconstruction during the same period (RH group) were investigated. The surgical data, postoperative complications, and duration of hospital stay were compared. The IRHV and RH groups included 2 (40%) and 13 (52%) hepatocellular carcinoma patients, respectively. There were no significant differences in liver function before surgery between the groups. The presence of the IRHV did not adversely affect the processing of the short hepatic vein or frontal dissection of the inferior vena cava. The operative time was shorter (median, 366 minutes versus 501 minutes; P = 0.0001), the postoperative bilirubin level was lower (12 mg/dL versus 1.8 mg/dL; P = 0.037), and the duration of hospital stay was shorter (10 days versus 14 days; P = 0.002) in the IRHV group. No significant differences were noted in the intraoperative blood loss, postoperative transaminase levels, or the incidence of severe complications (Clavien grade IIIb or higher) between the groups. IRHV-conserving resection of the liver is a safe surgical procedure that is useful in preventing postoperative elevation of bilirubin level and in shortening the duration of hospital stay.	[Nakayama, Hisashi; Takayama, Tadatoshi; Higaki, Tokio; Okubo, Takao; Moriguchi, Masamichi; Yoshida, Nao; Kuronuma, Akiko] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo 1738610, Japan	Nakayama, H (reprint author), Nihon Univ, Sch Med, Dept Digest Surg, 30-1 Oyaguchikami Machi, Tokyo 1738610, Japan.	nakayama.hisashi@nihon-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25350856]	This work was supported by Grant-in-Aid for Scientific Research (C) 25350856 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Beppu T, 2014, J HEPATO-BIL-PAN SCI, V21, P169, DOI 10.1002/jhbp.58; Agrawal S, 2011, ANN SURG, V253, P656, DOI 10.1097/SLA.0b013e3181fc08ca; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Abulkhir A, 2008, ANN SURG, V247, P49, DOI 10.1097/SLA.0b013e31815f6e5b; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Sano K, 2002, ANN SURG, V236, P241, DOI 10.1097/01.SLA.0000021845.89475.00; Fan ST, 2010, J HEPATO-BIL-PAN SCI, V17, P380, DOI [10.1007/s00534-009-0229-9, 10.1007/s00534-009-0228-x]; Mise Y, 2013, J HEPATO-BIL-PAN SCI, V20, P157, DOI 10.1007/s00534-012-0574-y; BAER HU, 1991, BRIT J SURG, V78, P1221, DOI 10.1002/bjs.1800781024; Choi SH, 2013, J GASTROINTEST SURG, V17, P1153, DOI 10.1007/s11605-012-2130-0; Jiang CP, 2014, WORLD J SURG, V38, P159, DOI 10.1007/s00268-013-2240-1; Kokudo N, 2005, ANN SURG, V242, P651, DOI 10.1097/01.sla.0000186129.46123.81; Machado MA, 2008, EJSO-EUR J SURG ONC, V34, P247, DOI 10.1016/j.ejso.2007.01.004; MAKUUCHI M, 1983, RADIOLOGY, V148, P213; Makuuchi M, 1987, Surg Gynecol Obstet, V164, P68; NAKAMURA S, 1981, SURG GYNECOL OBSTET, V152, P43; Sato H, 2000, HEPATO-GASTROENTEROL, V47, P504; Sato M, 2012, J GASTROENTEROL, V47, P1125, DOI 10.1007/s00535-012-0569-0; Sugimoto M, 2013, J ENDOUROL, V27, P804, DOI 10.1089/end.2012.0708; Takayama T, 1996, BRIT J SURG, V83, P762, DOI 10.1002/bjs.1800830611	21	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					683	688		10.9738/INTSURG-D-14-00183.1		6	Surgery	Surgery	CG1JM	WOS:000353028900019		
J	Aosasa, S; Maejima, T; Kimura, A; Nishiyama, K; Edo, H; Shinmoto, H; Kaji, T; Ogata, S; Hatsuse, K; Hase, K; Yamamoto, J				Aosasa, Suefumi; Maejima, Tadashi; Kimura, Akifumi; Nishiyama, Kiyoshi; Edo, Hiromi; Shinmoto, Hiroshi; Kaji, Tatsumi; Ogata, Sho; Hatsuse, Kazuo; Hase, Kazuo; Yamamoto, Junji			Intrahepatic Cholangiocarcinoma With Lymphoepithelioma-like Carcinoma Components Not Associated With Epstein-Barr Virus: Report of a Case	INTERNATIONAL SURGERY			English	Article						Lymphoepithelioma-like carcinoma; Cholangiocarcinoma; Epstein-Barr virus; Liver	HEPATOCELLULAR-CARCINOMA; LYMPHOID STROMA; INFECTION; TUMOR; HEPATOBILIARY; INFILTRATION; PROGNOSIS; ABSENCE; GENOMES; ENTITY	A carcinoma displaying undifferentiated features with dense lymphoplasmacytic infiltration is defined as lymphoepithelioma-like carcinoma (LELC). Intrahepatic cholangiocarcinoma (ICC) with LELC components is rare, and most LELCs are associated with Epstein-Barr virus (EBV). We report here on a case of ICC with LELC components not associated with EBV. A 65-year-old woman was incidentally found to have a hepatic tumor in the caudate lobe. An extended right hepatectomy with lymphadenectomy was performed. Histologically, the tumor was mainly composed of large undifferentiated epithelial cells with vesicular nuclei, prominent nucleoli, indistinct cell borders, and heavy small lymphocytic infiltration, which are the characteristic features of LELC. Immunohistochemical studies revealed that the tumor cells were positive for cytokeratin 19 but were negative for glypican 3. In situ hybridization using EBV-encoded RNA was negative. Therefore, a diagnosis of ICC with LELC components not associated with EBV was made. Because there is limited information available regarding the prognosis and treatment of ICC with LELC components because of the limited number of reported cases, additional studies will be needed to clarify the clinicopathologic features of this disease.	[Aosasa, Suefumi; Maejima, Tadashi; Kimura, Akifumi; Nishiyama, Kiyoshi; Hatsuse, Kazuo; Hase, Kazuo; Yamamoto, Junji] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 3598513, Japan; [Edo, Hiromi; Shinmoto, Hiroshi; Kaji, Tatsumi] Natl Def Med Coll, Dept Radiol, Tokorozawa, Saitama 3598513, Japan; [Ogata, Sho] Natl Def Med Coll, Dept Pathol, Tokorozawa, Saitama 3598513, Japan	Aosasa, S (reprint author), Natl Def Med Coll, Dept Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	suaosasa@ndmc.ac.jp					Adachi S, 2008, PATHOL INT, V58, P69, DOI 10.1111/j.1440-1827.2007.02192.x; Lee TY, 2008, AM J GASTROENTEROL, V103, P1716, DOI 10.1111/j.1572-0241.2008.01796.x; Emile JF, 2000, HISTOPATHOLOGY, V37, P523, DOI 10.1046/j.1365-2559.2000.00952.x; Szekely E, 2001, AM J SURG PATHOL, V25, P1464, DOI 10.1097/00000478-200111000-00023; WEISS LM, 1989, AM J SURG PATHOL, V13, P625, DOI 10.1097/00000478-198908000-00001; Yamamoto S, 2004, CANCER SCI, V95, P592, DOI 10.1111/j.1349-7006.2004.tb02492.x; El-Serag HB, 2009, HEPATOLOGY, V49, P116, DOI 10.1002/hep.22606; Jeng YM, 2001, AM J SURG PATHOL, V25, P516, DOI 10.1097/00000478-200104000-00012; Si MW, 2004, DIAGN MOL PATHOL, V13, P183, DOI 10.1097/01.pas.0000124336.90615.8d; Tsai CC, 1996, HUM PATHOL, V27, P258, DOI 10.1016/S0046-8177(96)90066-0; Nemolato S, 2008, WORLD J GASTROENTERO, V14, P4694, DOI 10.3748/wjg.14.4694; Chen FF, 1998, CANCER, V82, P2334; WEINBERG E, 1993, AM J CLIN PATHOL, V99, P195; SHIBATA D, 1991, AM J PATHOL, V139, P469; IEZZONI JC, 1995, AM J CLIN PATHOL, V103, P308; Castro CY, 2001, HUM PATHOL, V32, P863, DOI 10.1053/hupa.2001.26457; El Rassi Z, 1999, EUR J SURG ONCOL, V25, P375; Matsunou H, 1996, CANCER, V77, P1998, DOI 10.1002/(SICI)1097-0142(19960515)77:10<1998::AID-CNCR6>3.0.CO;2-D; LEYVRAZ S, 1985, NEW ENGL J MED, V312, P1296, DOI 10.1056/NEJM198505163122006; Chen Chih-Jung, 2007, Chang Gung Med J, V30, P172; Chen PCH, 2003, HUM PATHOL, V34, P407, DOI 10.1053/hupa.2003.71; Chen TC, 2001, MODERN PATHOL, V14, P527, DOI 10.1038/modpathol.3880342; DIETL J, 1994, INT J GYNECOL PATHOL, V13, P186, DOI 10.1097/00004347-199404000-00013; DINNEY CPN, 1993, J UROLOGY, V149, P840; Henderson-Jackson E, 2010, INT J CLIN EXP PATHO, V3, P736; Hsu HC, 1996, HUM PATHOL, V27, P848, DOI 10.1016/S0046-8177(96)90460-8; Huang YL, 2004, ANN CLIN LAB SCI, V34, P476; Hur YH, 2011, ANZ J SURG, V81, P652, DOI 10.1111/j.1445-2197.2011.05840.x; Ishida Mitsuaki, 2011, World J Gastrointest Oncol, V3, P111, DOI 10.4251/wjgo.v3.i7.111; Kim YB, 1999, ARCH PATHOL LAB MED, V123, P441; Kohrenhagen N, 2008, ARCH GYNECOL OBSTET, V277, P175, DOI 10.1007/s00404-007-0427-0; Lee Wonae, 2011, Case Rep Oncol, V4, P68, DOI 10.1159/000324485; ONIZUKA M, 1990, CHEST, V98, P236, DOI 10.1378/chest.98.1.236; Ortiz MR, 2000, INT J SURG PATHOL, V8, P347, DOI 10.1177/106689690000800418; Vortmeyer AO, 1998, AM J CLIN PATHOL, V109, P90	35	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					689	695		10.9738/INTSURG-D-14-00117.1		7	Surgery	Surgery	CG1JM	WOS:000353028900020		
J	Furihata, T; Furihata, M; Satoh, N; Kosaka, M; Ishikawa, K; Kubota, K				Furihata, Tadashi; Furihata, Makoto; Satoh, Naoki; Kosaka, Masato; Ishikawa, Kunibumi; Kubota, Keiichi			Repeated Duodenal Stump Perforation Using a Stapling Device Following Subtotal Gastrectomy With Roux-en-Y Reconstruction for Advanced Gastric Cancer: Lessons From a Rare Case	INTERNATIONAL SURGERY			English	Article						Duodenal stump perforation; Roux-en-Y; Gastrectomy; Gastric cancer; Stapling device	RISK-FACTORS; DISTAL GASTRECTOMY; MANAGEMENT; EXPERIENCE; FISTULA; LEAKAGE; COMPLICATIONS; MORBIDITY; MORTALITY; BYPASS	Closure of the duodenal stump using a stapling device is commonly applied in Roux-en-Y reconstruction after gastrectomy. However, serious and possibly fatal duodenal stump perforation can develop in extremely rare cases. We describe a case of subtotal gastrectomy with Roux-en-Y reconstruction followed by repeated duodenal stump perforations. A 79-year-old man with a long history of diabetes and hypertension was admitted to our institution with epigastralgia and right hypochondralgia. Computed tomography and an upper gastrointestinal imaging series revealed remarkable wall thickening of the gastric antrum and corpus. Upper endoscopy also showed a giant ulcerative lesion in the same area. The lesion was confirmed by histology to be poorly differentiated adenocarcinoma. The patient underwent open subtotal gastrectomy with Roux-en-Y reconstruction. However, duodenal stump perforation occurred repeatedly on postoperative days 1, 3, and 19, which caused peritonitis. The patient was kept alive through duodenal stump repair, an additional resection using a stapling device, and repeated drainage treatments; but he suffered considerable morbidity due to these complications. We report a case of a life-threatening duodenal stump perforation after subtotal gastrectomy, highlighting lessons learned from the profile and clinical course. Abdominal surgeons should be aware of the possibility of this serious complication of duodenal stump perforation, and be able to perform immediate interventions, including life-saving reoperation.	[Furihata, Tadashi; Satoh, Naoki; Kosaka, Masato; Ishikawa, Kunibumi] Kyouwa Chuo Hosp, Dept Gen Surg, Chikusei, Ibaraki 3091195, Japan; [Furihata, Tadashi; Kubota, Keiichi] Dokkyo Med Univ, Dept Gastroenterol Surg, Mibumachi, Tochigi, Japan; [Furihata, Makoto] Mutual Aid Assoc Teachers, Dept Surg, Chiyoda Ku, Tokyo, Japan; [Furihata, Makoto] Officials Sanraku Hosp, Chiyoda Ku, Tokyo, Japan	Furihata, T (reprint author), Kyouwa Chuo Hosp, Dept Gen Surg, 1676-1 Kadoi, Chikusei, Ibaraki 3091195, Japan.	furihata@kokikai.com					Oh SJ, 2009, J GASTROINTEST SURG, V13, P239, DOI 10.1007/s11605-008-0716-3; Oh JS, 2013, CARDIOVASC INTER RAD, V36, P1344, DOI 10.1007/s00270-012-0518-6; Baker RS, 2004, OBES SURG, V14, P1290, DOI 10.1381/0960892042583888; Hoya Y, 2009, SURG TODAY, V39, P647, DOI 10.1007/s00595-009-3964-2; Kumagai K, 2011, J GASTROINTEST SURG, V15, P2145, DOI 10.1007/s11605-011-1683-7; Carrasquilla C, 2004, OBES SURG, V14, P613, DOI 10.1381/096089204323093372; Cozzaglio L, 2010, J GASTROINTEST SURG, V14, P805, DOI 10.1007/s11605-010-1166-2; Cozzaglio L, 2011, J GASTROINTEST SURG, V15, P1977, DOI 10.1007/s11605-011-1668-6; Gong DJ, 2008, WORLD J GASTROENTERO, V14, P6560, DOI 10.3748/wjg.14.6560; Gonzalez R, 2006, SURG ENDOSC, V20, P1687, DOI 10.1007/s00464-004-8253-y; Kim KH, 2014, HEPATO-GASTROENTEROL, V61, P1446, DOI 10.5754/hge.14355; Koksoy FN, 2010, INT J SURG, V8, P633, DOI 10.1016/j.ijsu.2010.07.296; Lee JY, 2009, J SURG ONCOL, V100, P80, DOI 10.1002/jso.21285; Orsenigo E, 2014, GASTRIC CANCER, V17, P733, DOI 10.1007/s10120-013-0327-x; Shao QS, 2011, CHINESE MED J-PEKING, V124, P1018, DOI 10.3760/cma.j.issn.0366-6999.2011.07.013; Sobin LH, 2010, TNM CLASSIFICATION M, V7th, P70; Vasiliadis K, 2014, Int J Surg Case Rep, V5, P1229, DOI 10.1016/j.ijscr.2014.11.026	17	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					726	732		10.9738/INTSURG-D-14-00266.1		7	Surgery	Surgery	CG1JM	WOS:000353028900026		
J	Kumagai, Y; Sobajima, J; Higashi, M; Ishiguro, T; Fukuchi, M; Ishibashi, K; Mochiki, E; Yakabi, K; Kawano, T; Tamaru, J; Ishida, H				Kumagai, Youichi; Sobajima, Jun; Higashi, Morihiro; Ishiguro, Toru; Fukuchi, Minoru; Ishibashi, Keiichiro; Mochiki, Erito; Yakabi, Koji; Kawano, Tatsuyuki; Tamaru, Jun-ichi; Ishida, Hideyuki			Coexpression of COX-2 and iNOS in Angiogenesis of Superficial Esophageal Squamous Cell Carcinoma	INTERNATIONAL SURGERY			English	Article						COX-2; iNOS; CD34; CD105; Esophageal cancer; Angiogenesis	NITRIC-OXIDE SYNTHASE; CANCER-CELLS; MICROVESSEL DENSITY; TUMOR PROGRESSION; BLACK-RASPBERRIES; C-JUN; CYCLOOXYGENASE-2; EXPRESSION; GROWTH; VEGF	Using immunohistochemical staining, the present study was conducted to examine whether cyclooxygenase (COX)-2 and inducible nitric oxide synthase (iNOS) affect angiogenesis in early-stage esophageal squamous cell carcinoma (ESCC). We also analyzed the correlation between these two factors. Cyclooxygenase 2, iNOS, and angiogenesis in early-stage ESCC are unclear. Using 10 samples of normal squamous epithelium, 7 samples of low-grade intraepithelial neoplasia (LGIN), and 45 samples of superficial esophageal cancer, we observed the expression of COX-2 and iNOS. We then investigated the COX-2 and iNOS immunoreactivity scores and the correlation between COX-2 or iNOS scores and microvessel density (MVD) using CD34 or CD105. The intensity of COX-2 or iNOS expression differed significantly according to histological type (P < 0.001). The scores of COX-2 and iNOS were lowest for normal squamous epithelium, followed in ascending order by LGIN, carcinoma in situ and tumor invading the lamina propria mucosae (M1-M2 cancer); and tumor invading the muscularis mucosa (M3) or deeper cancer. The differences were significant (P < 0.001). Cancers classified M1-M2 (P < 0.01 and P < 0.05, respectively); M3; or deeper cancer (P < 0.01) had significantly higher COX-2 and iNOS scores than normal squamous epithelium. There was a significant correlation between COX-2 and iNOS scores (P < 0.001, r(s) = 0.51). Correlations between COX-2 score and CD34-positive MVD or CD105-positive MVD were significant (r(s) = 0.53, P < 0.001; r(s) = 0.62, P < 0.001, respectively). Inducible nitric oxide synthase score was also significantly correlated with CD34 MVD and CD105 MVD (rs = 0.45, P < 0.001; r(s) = 0.60, P < 0.001, respectively). Chemoprevention of COX-2 or iNOS activity may blunt the development of ESCC from precancerous lesions.	[Kumagai, Youichi; Sobajima, Jun; Ishiguro, Toru; Fukuchi, Minoru; Ishibashi, Keiichiro; Mochiki, Erito; Ishida, Hideyuki] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Kawagoe, Saitama 3508550, Japan; [Higashi, Morihiro; Tamaru, Jun-ichi] Saitama Med Univ, Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama 3508550, Japan; [Yakabi, Koji] Saitama Med Univ, Saitama Med Ctr, Dept Internal Med, Kawagoe, Saitama 3508550, Japan; [Kawano, Tatsuyuki] Tokyo Med & Dent Univ, Dept Surg, Tokyo, Japan	Kumagai, Y (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	kuma7srg1@gmail.com			Saitama Medical University	We thank Tomoyuki Kawada for his advice and confirmation of statistical analysis. This work was supported by a grant from Saitama Medical University.	Mukherjee R, 2005, BJU INT, V96, P62, DOI 10.1111/j.1464-410X.2005.05568.x; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Chen T, 2006, CANCER RES, V66, P2853, DOI 10.1158/0008-5472.CAN-05-3279; Dubois RN, 1998, FASEB J, V12, P1063; Kalgutkar AS, 1998, SCIENCE, V280, P1268, DOI 10.1126/science.280.5367.1268; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Shamma A, 2000, CLIN CANCER RES, V6, P1229; Taketo MM, 1998, J NATL CANCER I, V90, P1529, DOI 10.1093/jnci/90.20.1529; Ambs S, 1998, NAT MED, V4, P1371, DOI 10.1038/3957; Urabe Y, 2009, ENDOSCOPY, V41, P304, DOI 10.1055/s-0029-1214477; Kumagai Y, 2002, LANCET ONCOL, V3, P604, DOI 10.1016/S1470-2045(02)00874-4; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kumagai Y, 2014, JPN J CLIN ONCOL, V44, P526, DOI 10.1093/jjco/hyu039; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; BRAUGHLER JM, 1979, J BIOL CHEM, V254, P2450; Chen LC, 2004, BBA-MOL CELL BIOL L, V1683, P38, DOI 10.1016/j.bbalip.2004.04.003; Chen T, 2006, CARCINOGENESIS, V27, P2301, DOI 10.1093/carcin/bg1109; Eibl G, 2003, BIOCHEM BIOPH RES CO, V306, P887, DOI 10.1016/S0006-291X(03)01079-9; Garavito RM, 2003, ANNU REV BIOPH BIOM, V32, P183, DOI 10.1146/annurev.biophys.32.110601.141906; Ichinoe M, 2004, HISTOPATHOLOGY, V45, P612, DOI 10.1111/j.1365-2559.2004.02031.x; Inoue H, 1997, DIGEST ENDOSC, V9/1, P16, DOI 10.1111/j.1443-1661.1997.tb00453.x; Inoue H, 1996, DIGEST ENDOSC, V8, P134, DOI 10.1111/j.1443-1661.1996.tb00429.x; Japan Esophageal Society, 2009, ESOPHAGUS, V6, P71, DOI DOI 10.1007/S10388-009-0193-0]; Japanese Esophageal Society, 2009, ESOPHAGUS, V6, P1, DOI DOI 10.1007/S10388-009-0169-0; KENNEDY TA, 1994, J BIOL CHEM, V269, P27357; Kumagai Y, 2010, DIGEST ENDOSC, V22, P259, DOI 10.1111/j.1443-1661.2010.01010.x; Kumagai Y, 2002, ENDOSCOPY, V34, P369, DOI 10.1055/s-2002-25285; Kuwano H, 2008, ESOPHAGUS, V5, P61, DOI [10.1007/s10388-008-0151-2, DOI 10.1007/S10388-008-0151-2]; Lala PK, 1998, CANCER METAST REV, V17, P1, DOI 10.1023/A:1005963400984; Lala PK, 1998, CANCER METAST REV, V17, P91, DOI 10.1023/A:1005960822365; Li M, 2001, INT J CANCER, V93, P218, DOI 10.1002/ijc.1322; Li SL, 2007, WORLD J GASTROENTERO, V13, P6076, DOI 10.3748/wjg.13.6076; Marrogi A, 2000, CANCER RES, V60, P3696; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Nogawa S, 1998, P NATL ACAD SCI USA, V95, P10966, DOI 10.1073/pnas.95.18.10966; Ohashi K, 2000, CANCER, V88, P2201, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.3.CO;2-E; Ratnasinghe D, 1999, ANTICANCER RES, V19, P171; Shi Q, 1999, CANCER RES, V59, P2072; Tanaka H, 1999, INT J ONCOL, V14, P1069; Teoh AYB, 2010, ANN SURG, V251, P186, DOI 10.1097/SLA.0b013e3181c76a66; Tomisaki S, 1996, CANCER, V77, P1722, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1722::AID-CNCR22>3.0.CO;2-Z; Vartanian RK, 1995, LAB INVEST, V73, P844; Yuan A, 2005, INT J CANCER, V115, P545, DOI 10.1002/ijc.20898	43	1	1	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					733	743		10.9738/INTSURG-D-14-00234.1		11	Surgery	Surgery	CG1JM	WOS:000353028900027		
J	Matsumoto, T; Ishizuka, M; Iso, Y; Kita, J; Kubota, K				Matsumoto, Takatsugu; Ishizuka, Mitsuru; Iso, Yukihiro; Kita, Junji; Kubota, Keiichi			Mini-Laparotomy for Superior Mesenteric Artery Aneurysm Due to Takayasu's Arteritis	INTERNATIONAL SURGERY			English	Article						Superior mesenteric artery aneurysm; Takayasu's arteritis; Mini-laparotomy	MANAGEMENT; CLASSIFICATION; EXPERIENCE	Superior mesenteric artery aneurysm (SMAA) is reported to be the third-most common type of visceral aneurysm (VA), accounting for 5% of all VAs. The etiology of SMAA is commonly thought to be infection, and it usually exists in the proximal part of the superior mesenteric artery, which is suitable for endovascular treatment. We herein report an extremely rare case of the distal part of SMAA caused by Takayasu's arteritis (TA), which was successfully resected using a mini-laparotomy method without impairing the intestinal blood supply. A 51-year-old woman was admitted to our hospital with sustained fever and lower back pain. Physical examination showed that she had a discrepancies in blood pressure between both arms. Contrast-enhanced whole-body computed tomography showed stenosis of the thoracic aorta and an aneurysm located in the distal part of the superior mesenteric artery. The diameter of the aneurysm was 4.5 cm. The aneurysm was resected via 4-cm mini-laparotomy, and the vascularity of the intestine was successfully preserved. The postoperative course was uneventful, and the patient was diagnosed as having TA based on both clinical and pathologic findings. Additional corticosteroid therapy was started to treat the arteritis, and at 3-month followup she was without critical incidents. Mini-laparotomy is a safe and less-invasive approach to treat SMAA, especially when the lesion is located in the distal part of the artery.	[Matsumoto, Takatsugu; Ishizuka, Mitsuru; Iso, Yukihiro; Kita, Junji; Kubota, Keiichi] Dokkyo Med Univ, Dept Gastroenterol Surg, Mibu, Tochigi 3210293, Japan	Matsumoto, T (reprint author), Dokkyo Med Univ, Dept Gastroenterol Surg, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	takatsugu_m_475@yahoo.co.jp					Reardon PR, 2005, SURG ENDOSC, V19, P488, DOI 10.1007/s00464-004-8916-8; Carr SC, 2001, J VASC SURG, V33, P806, DOI 10.1067/mva.2001.112320; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Stone WM, 2002, J VASC SURG, V36, P234, DOI 10.1067/mva.2002.125027; Pulli R, 2008, J VASC SURG, V48, P334, DOI 10.1016/j.jvs.2008.03.043; Ferrero E, 2011, ANN VASC SURG, V25, P923, DOI 10.1016/j.avsg.2011.04.006; Marone EM, 2011, ANN VASC SURG, V25, P936, DOI 10.1016/j.avsg.2011.03.006; Carmeci C, 2000, AM J SURG, V179, P486, DOI 10.1016/S0002-9610(00)00380-9; Hata A, 1996, INT J CARDIOL, V54, pS155; KERR GS, 1994, ANN INTERN MED, V120, P919; Numano F, 2000, LANCET, V356, P1023, DOI 10.1016/S0140-6736(00)02701-X; de Leeuw K, 2012, AM J MED GENET A, V158A, P626, DOI 10.1002/ajmg.a.34420; Ferrero E, 2011, ANN VASC SURG, V25; FRIEDMAN SG, 1987, J VASC SURG, V6, P87, DOI 10.1067/mva.1987.avs0060087; Gehlen JMLG, 2011, VASC ENDOVASC SURG, V45, P681, DOI 10.1177/1538574411418129; Huang YK, 2007, EUR J VASC ENDOVASC, V33, P293, DOI 10.1016/j.ejvs.2006.09.016; Mendonca CT, 2010, J VASC SURG, V51, P461, DOI 10.1016/j.jvs.2009.08.039; Numano F, 1992, Heart Vessels Suppl, V7, P3, DOI 10.1007/BF01744536; Panayiotopoulos YP, 1996, ANN ROY COLL SURG, V78, P412; Sachdev U, 2006, J VASC SURG, V44, P718, DOI 10.1016/j.jvs.2006.06.027; Van Petersen AS, 2011, J CARDIOVASC SURG, V52, P333	21	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					765	769		10.9738/INTSURG-D-14-00127.1		5	Surgery	Surgery	CG1JM	WOS:000353028900032		
J	Fujita, F; Torashima, Y; Takatsuki, M; Kuroki, T; Eguchi, S				Fujita, Fumihko; Torashima, Yasuhiro; Takatsuki, Mitsuhisa; Kuroki, Tamotsu; Eguchi, Susumu			To the Editor: Is the Serum Level of Reactive Oxygen Metabolites Appropriate for Evaluating Short-Term Surgical Stress of Patients Undergoing Colectomy?	INTERNATIONAL SURGERY			English	Article						Reactive oxygen metabolites; Surgical stress; Colectomy; Laparoscopy	OXIDATIVE STRESS	To demonstrate whether reactive oxygen and free radical measuring are appropriate to evaluate short-term surgical stress after laparoscopic colectomy. The subjects consisted of 22 cases (laparoscopic surgery, 16; and laparotomy, 6) that underwent surgery for colon cancer. The reactive oxygen metabolites (ROM) value in the blood were measured perioperatively. The average ROM values immediately prior to surgery, immediately following surgery, and 1 day following surgery were 360.1, 316.0, and 346.7 U.CARR, respectively, meaning that ROM declined immediately following surgery compared with immediately prior to surgery (P < 0.05), while a tendency was observed for these values to increase again 1 day following surgery. In the comparison of pain control 1 day following surgery, a significantly lower value was indicated in the epidural anesthesia group (n = 12) compared with the fentanyl intravenous injection group (n = 10). Moreover, no significant change was observed in the surgical stress level in a comparison of patient background items such as age, sex, and so forth, laparoscopic surgery, and laparotomy. The low-invasiveness of laparoscopic surgery was not indicated in the ROM value 1 day following surgery, probably because pain control offsets the level of surgical stress using this method.	[Fujita, Fumihko; Torashima, Yasuhiro; Takatsuki, Mitsuhisa; Kuroki, Tamotsu; Eguchi, Susumu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan	Eguchi, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueguchi@nagasaki-u.ac.jp					Kanaoka Y, 2010, ACTA MED OKAYAMA, V64, P323; Kaneda T, 2006, JPN J REANIMATOLOGY, V25, P12; Pappas-Gogos G, 2013, SURG ENDOSC, V27, P2357, DOI 10.1007/s00464-013-2788-8; Sato Y, 2013, FREE RADICAL RES, V47, P181, DOI 10.3109/10715762.2012.759218; Sista Federico, 2013, World J Gastrointest Surg, V5, P73, DOI 10.4240/wjgs.v5.i4.73	5	0	0	INT COLLEGE OF SURGEONS	CHICAGO	1516 N LAKE SHORE DR, CHICAGO, IL 60610 USA	0020-8868			INT SURG	Int. Surg.	APR	2015	100	4					770	772		10.9738/INTSURG-D-14-00171.1		3	Surgery	Surgery	CG1JM	WOS:000353028900033		
J	Nokami, T; Itoh, T; Mong, KKT				Nokami, Toshiki; Itoh, Toshiyuki; Mong, Kwok-Kong Tony			Chemical Glycosylation by Single Electron Transfer	ISRAEL JOURNAL OF CHEMISTRY			English	Review						electrochemistry; electron transfer; glycosylation; oligosaccharides; synthetic methods	AUTOMATED OLIGOSACCHARIDE SYNTHESIS; ALKOXYCARBENIUM ION POOLS; SOLID-PHASE SYNTHESIS; PHENYL S-GLYCOSIDES; ELECTROCHEMICAL GLYCOSYLATION; 2,3-DICHLORO-5,6-DICYANO-P-BENZOQUINONE DDQ; ITERATIVE GLYCOSYLATION; EFFICIENT SYNTHESIS; O-GLYCOSYLATION; OXIDATION POTENTIALS	Oligosaccharides play important roles in nature; however, chemical synthesis of oligosaccharides is still difficult and not carried out in a fully automated manner. Among various methods, the activation of glycosyl donors by single electron transfer using electrochemical and photochemical methods has several benefits. In particular, electrochemical oxidation is a powerful method to activate glycosyl donors, including thioglycosides, which are one of the most popular class of glycosyl donors in modern chemical glycosylations. This review article covers the pioneering works of electrochemical glycosylations, other chemical glycosylations achieved by single electron transfer, and our recent approach to the automated solution-phase synthesis of oligosaccharides based on the electrochemical method.	[Nokami, Toshiki; Itoh, Toshiyuki] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori, Tottori 6808552, Japan; [Mong, Kwok-Kong Tony] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu 300, Taiwan	Nokami, T (reprint author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, 4-101 Koyamachominami, Tottori, Tottori 6808552, Japan.	tnokami@chem.tottori-u.ac.jp; tmong@mail.nctu.edu.tw			JSPS [25410115]; Ube Foundation; Electric Technology Research Foundation of Chugoku	T. N. thanks a Grant-in-Aid for Scientific Research (no. 25410115) from the JSPS, the Ube Foundation, and the Electric Technology Research Foundation of Chugoku for financial support.	AMATORE C, 1990, J CHEM SOC CHEM COMM, P718, DOI 10.1039/c39900000718; AMATORE C, 1994, J APPL ELECTROCHEM, V24, P725, DOI 10.1007/BF00578086; Nokami T, 2013, ORG LETT, V15, P4520, DOI 10.1021/ol402034g; Huang XF, 2004, ANGEW CHEM INT EDIT, V43, P5221, DOI 10.1002/anie.200460176; Zhu XM, 2009, ANGEW CHEM INT EDIT, V48, P1900, DOI 10.1002/anie.200802036; Nokami T, 2011, ORG LETT, V13, P1544, DOI 10.1021/ol200242u; Walvoort MTC, 2012, ANGEW CHEM INT EDIT, V51, P4393, DOI 10.1002/anie.201108744; Danishefsky SJ, 1996, ANGEW CHEM INT EDIT, V35, P1380, DOI 10.1002/anie.199613801; Hsu CH, 2011, ANGEW CHEM INT EDIT, V50, P11872, DOI 10.1002/anie.201100125; Codee JDC, 2005, CHEM SOC REV, V34, P769, DOI 10.1039/b417138c; Nokami T, 2007, J AM CHEM SOC, V129, P10922, DOI 10.1021/ja072440x; Sperry JB, 2006, CHEM SOC REV, V35, P605, DOI 10.1039/b512308a; Moeller KD, 2000, TETRAHEDRON, V56, P9527, DOI 10.1016/S0040-4020(00)00840-1; Werz DB, 2007, J AM CHEM SOC, V129, P2770, DOI 10.1021/ja069218x; Ganesh NV, 2012, ORG LETT, V14, P3036, DOI 10.1021/ol301105y; Waldvogel SR, 2012, ELECTROCHIM ACTA, V82, P434, DOI 10.1016/j.electacta.2012.03.173; Yoshida J, 2008, CHEM REV, V108, P2265, DOI 10.1021/cr0680843; Krock L, 2012, CHEM SCI, V3, P1617, DOI 10.1039/c2sc00940d; Galonic DP, 2007, NATURE, V446, P1000, DOI 10.1038/nature05813; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/nchem.399, 10.1038/NCHEM.399]; Mitsudo K, 2005, ORG LETT, V7, P4649, DOI 10.1021/ol0521776d; Seeberger PH, 2007, NATURE, V446, P1046, DOI 10.1038/nature05819; Seeberger PH, 2000, CHEM REV, V100, P4349, DOI 10.1021/cr9903104; Yamago S, 2004, ANGEW CHEM INT EDIT, V43, P2145, DOI 10.1002/anie.200353552; BALAVOINE G, 1995, J CARBOHYD CHEM, V14, P1217, DOI 10.1080/07328309508005406; Zhang N, 2014, CHEM REV, V114, P5848, DOI 10.1021/cr400689s; Wever WJ, 2013, ORG LETT, V15, P30, DOI 10.1021/ol302941q; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; BALAVOINE G, 1995, J CARBOHYD CHEM, V14, P1237, DOI 10.1080/07328309508005407; BALAVOINE G, 1990, TETRAHEDRON LETT, V31, P5761, DOI 10.1016/S0040-4039(00)97951-6; Calin O., 2013, ANGEW CHEM INT EDIT, V52, P5162; Crich D, 2002, J CARBOHYD CHEM, V21, P667, DOI 10.1081/CAR-120016486; Drouin L, 2007, SYNLETT, P2711, DOI 10.1055/s-2007-986644; Drouin L, 2008, J PHYS ORG CHEM, V21, P516, DOI 10.1002/poc.1388; Eller S., 2013, ANGEW CHEM INT EDIT, V52, P5158; France RR, 2004, ORG BIOMOL CHEM, V2, P2195, DOI 10.1039/b316728c; France RR, 2004, ORG BIOMOL CHEM, V2, P2188, DOI 10.1039/b316720h; INANAGA J, 1993, CHEM LETT, P85, DOI 10.1246/cl.1993.85; Kawa K, 2013, ORG LETT, V15, P5484, DOI 10.1021/ol4026342; MALLET JM, 1993, CARBOHYD RES, V244, P237; MARRA A, 1990, SYNLETT, P572; Mehta S, 1998, CARBOHYD RES, V310, P43, DOI 10.1016/S0008-6215(98)00163-3; MEHTA S, 1991, TETRAHEDRON LETT, V32, P4435, DOI 10.1016/0040-4039(91)80005-Q; Nokami J, 1999, CHEM LETT, P1053, DOI 10.1246/cl.1999.1053; Nokami T, 2012, BEILSTEIN J ORG CHEM, V8, P456, DOI 10.3762/bjoc.8.52; Nokami T, 2012, CARBOHYD RES, V363, P1, DOI 10.1016/j.carres.2012.09.023; Nokami T, 2008, CHEM LETT, V37, P942, DOI 10.1246/cl.2008.942; Nokami T, 2009, CHEM-EUR J, V15, P2252, DOI 10.1002/chem.200802293; Noyori R., 1986, J ORG CHEM, V51, P4322; Saito K, 2011, CHEM LETT, V40, P678, DOI 10.1246/cl.2011.678; Saito K, 2011, ANGEW CHEM INT EDIT, V50, P5153, DOI 10.1002/anie.201100854; Seeberger PH, 2008, CHEM SOC REV, V37, P19, DOI 10.1039/b511197h; Steckhan E., 1987, ELECTROCHEMISTRY, V1; Suga S, 2006, J AM CHEM SOC, V128, P7710, DOI 10.1021/ja0625778; Suzuki S, 2004, ORG LETT, V6, P3755, DOI 10.1021/ol048524h; Tanaka N, 2007, TETRAHEDRON LETT, V48, P7383, DOI 10.1016/j.tetlet.2007.08.004; Thomas HG, 2008, TETRAHEDRON, V64, P5124, DOI 10.1016/j.tet.2008.03.056; TIMPA JD, 1984, CARBOHYD RES, V131, P185, DOI 10.1016/0008-6215(84)85240-4; TOSHIMA K, 1993, J CHEM SOC CHEM COMM, P704, DOI 10.1039/c39930000704; TOSHIMA K, 1993, CHEM LETT, P2013, DOI 10.1246/cl.1993.2013; TOSHIMA K, 1993, CHEM REV, V93, P1503, DOI 10.1021/cr00020a006; Wain AJ, 2006, J PHYS CHEM B, V110, P2681, DOI 10.1021/jp0535137; Yamada T, 2005, CHEM LETT, V34, P1556, DOI 10.1246/cl.2005.1556; Yamada T, 2006, ANGEW CHEM INT EDIT, V45, P7575, DOI 10.1002/anie.200602699; Yamago S, 2002, J ORG CHEM, V67, P8584, DOI 10.1021/jo0261350; Yamago S, 1997, CHEM LETT, P111, DOI 10.1246/cl.1997.111; ZHANG YM, 1992, CARBOHYD RES, V236, P73, DOI 10.1016/0008-6215(92)85007-M	68	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0021-2148	1869-5868		ISR J CHEM	Isr. J. Chem.	APR	2015	55	3-4			SI		297	305		10.1002/ijch.201400144		9	Chemistry, Multidisciplinary	Chemistry	CF8IS	WOS:000352801400006		
J	Izumi, M; Dedola, S; Ito, Y; Kajihara, Y				Izumi, Masayuki; Dedola, Simone; Ito, Yukishige; Kajihara, Yasuhiro			Chemical Synthesis of Homogeneous Glycoproteins for the Study of Glycoprotein Quality Control System	ISRAEL JOURNAL OF CHEMISTRY			English	Review						glycoproteins; oligosaccharides; protein folding; synthesis design; transferases	UDP-GLUCOSE-GLYCOPROTEIN; PROTEIN-FOLDING SENSOR; PHASE PEPTIDE-SYNTHESIS; ENDOPLASMIC-RETICULUM; GLUCOSYLTRANSFERASE RECOGNIZES; ER; ENZYME; GLC; OLIGOSACCHARIDES; GLUCOSYLATION	The glycoprotein quality control system exists in the endoplasmic reticulum to maintain protein homeostasis and prevent accumulation of aberrant glycoproteins. Folding sensor enzyme uridine diphosphate ( UDP)-glucose : glycoprotein glucosyltransferase ( UGGT) plays an important role in this system through its ability to discriminate immature or misfolded glycoproteins from native ones. UGGT transfers a glucose residue to a glycoprotein containing Man(9)GlcNAc(2) (M9; Man=mannose, GlcNAc=N-acetyl-D-glucosamine) N-glycan only when the glycoprotein has not attained a native form. We chemically prepared homogeneous glycoproteins containing M9 N-glycan in the native form as well as in misfolded forms and examined them as substrates of UGGT. Glucose transfer to misfolded glycoproteins was clearly observed by LC-MS, but glycoproteins in the native form were barely glucosylated. Furthermore, we constructed an in vitro glycoprotein folding system in the presence of UGGT and found out that all folding intermediates which appeared during folding were also glucosylated. Through these experiments, we demonstrated the usefulness of chemically synthesized homogeneous glycoproteins as probes to gain insights into the molecular basis of the glycoprotein quality control system.	[Izumi, Masayuki; Kajihara, Yasuhiro] Osaka Univ, Dept Chem, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Dedola, Simone; Ito, Yukishige; Kajihara, Yasuhiro] Japan Sci & Technol Agcy, ERATO Ito Glycotril Project, Wako, Saitama 3510198, Japan; [Ito, Yukishige] RIKEN, Synthet Cellular Chem Lab, Wako, Saitama 3510198, Japan	Izumi, M (reprint author), Osaka Univ, Dept Chem, Grad Sch Sci, 1-1 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	mizumi@chem.sci.osaka-u.ac.jp	Ito, Yukishige/M-5119-2014; Izumi, Masayuki/C-6230-2008	Ito, Yukishige/0000-0001-6251-7249; Izumi, Masayuki/0000-0001-6486-9678			Unverzagt C, 2013, CHEM SOC REV, V42, P4408, DOI 10.1039/c3cs35485g; Takeda Y, 2014, GLYCOBIOLOGY, V24, P344, DOI 10.1093/glycob/cwt163; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Arnold SM, 2000, BIOCHEMISTRY-US, V39, P2149, DOI 10.1021/bi9916473; Arnold SM, 2003, J BIOL CHEM, V278, P43320, DOI 10.1074/jbc.M305800200; Murakami M, 2012, ANGEW CHEM INT EDIT, V51, P3567, DOI 10.1002/anie.201109034; Taylor SC, 2003, EMBO REP, V4, P405, DOI 10.1038/sj.embor.embor797; SOUSA M, 1995, EMBO J, V14, P4196; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Tessier DC, 2000, GLYCOBIOLOGY, V10, P403, DOI 10.1093/glycob/10.4.403; Johnson ECB, 2006, J AM CHEM SOC, V128, P6640, DOI 10.1021/ja058344i; Izumi M, 2012, J AM CHEM SOC, V134, P7238, DOI 10.1021/ja3013177; Dedola S, 2014, ANGEW CHEM INT EDIT, V53, P2883, DOI 10.1002/anie.201309665; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Schnolzer M, 2007, INT J PEPT RES THER, V13, P31, DOI 10.1007/s10989-006-9059-7; Guerin M, 2003, J BIOL CHEM, V278, P20540, DOI 10.1074/jbc.M300891200; Caramelo JJ, 2004, J BIOL CHEM, V279, P46280, DOI 10.1074/jbc.M408404200; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Takeda Y, 2009, CURR OPIN CHEM BIOL, V13, P582, DOI 10.1016/j.cbpa.2009.09.011; Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Taylor SC, 2004, NAT STRUCT MOL BIOL, V11, P128, DOI 10.1038/nsmb715; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Totani K, 2005, ANGEW CHEM INT EDIT, V44, P7950, DOI 10.1002/anie.200502723; Totani K, 2009, BIOCHEMISTRY-US, V48, P2933, DOI 10.1021/bi8020586; Dobson CM, 2001, PHILOS T ROY SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Keith N, 2005, J BIOL CHEM, V280, P18138, DOI 10.1074/jbc.M501710200; Makimura Y, 2012, CARBOHYD RES, V364, P41, DOI 10.1016/j.carres.2012.10.011; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Deras IL, 1998, CARBOHYD RES, V306, P469; Franco-Fraguas L, 2003, J CHROMATOGR B, V790, P365, DOI 10.1016/S1570-0232(03)00086-2; Ito Y, 2012, P JPN ACAD B-PHYS, V88, P31, DOI 10.2183/pjab.88.31; Izumi M, 2013, TRENDS GLYCOSCI GLYC, V25, P1, DOI 10.4052/tigg.25.1; Okamoto R, 2014, ANGEW CHEM INT EDIT, V53, P5188, DOI 10.1002/anie.201310574; Okamoto R, 2014, CURR OPIN CHEM BIOL, V22, P92, DOI 10.1016/j.cbpa.2014.09.029; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Sumiyoshi W, 2009, BIOSCI BIOTECH BIOCH, V73, P543, DOI 10.1271/bbb.80598; Yamamoto N, 2007, CHEM-EUR J, V13, P613, DOI 10.1002/chem.200600179	51	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0021-2148	1869-5868		ISR J CHEM	Isr. J. Chem.	APR	2015	55	3-4			SI		306	314		10.1002/ijch.201400154		9	Chemistry, Multidisciplinary	Chemistry	CF8IS	WOS:000352801400007		
J	Yamaki, K				Yamaki, Kazushige			Network governance of endangered species conservation: A case study of Rebun Lady's-Slipper	JOURNAL FOR NATURE CONSERVATION			English	Article						Conservation; Endangered species; Governance; Performance; Rebun Lady's-Slipper (Cypripedium macranthos var. rebunense); Social networks	NATURAL-RESOURCE MANAGEMENT; SOCIAL-ECOLOGICAL SYSTEMS; ADAPTIVE COMANAGEMENT; LEADERSHIP; COMMUNITY; POLICY	Since networks among stakeholders significantly affect the performance of natural resource governance, including endangered species conservation, effective co-management by diverse stakeholders is a crucial challenge. Using social network analysis, this study analyzes how stakeholders' networks influence the performance of collaborative endangered species conservation. Conservation activities regarding the Rebun Lady's-Slipper (Cypripedium macranthos var. rebunense) are used as a case study, in which conservation activities are implemented under two formal institutions: the Rebun Lady's-Slipper Program and the Alpine Flowers Council. The former is responsible for overall policy-making, and the latter conducts monitoring and educational activities. I asked 38 actors involved in Rebun Lady's-Slipper conservation to assess the network activities. Most respondents evaluated "monitoring and patrol" and "educational activities" as good, while less than half of the respondents evaluated "policy-making arena" as good. The social network of the Alpine Flowers Council that conducts "monitoring and patrol" and "educational activities" was highly closed and heterogeneous; the network is dense, having a high proportion of ties between actors in different subgroups. This indicates that bonding and bridging social capital are developed, thus fostering the collaborative relationship necessary for monitoring and educational activities. Conversely, the network of the Rebun Lady's-Slipper Program is less closed, but is also heterogeneous. Furthermore, the network is separated into subnetworks, indicating the lower performance of the policy-making arena. Finally, these results indicate that the performance of Rebun Lady's-Slipper conservation activities is closely related to the social network structures. (C) 2014 Elsevier GmbH. All rights reserved.	Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Sapporo, Hokkaido 0628516, Japan	Yamaki, K (reprint author), Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, 7 Hitsujigaoka, Sapporo, Hokkaido 0628516, Japan.	yamaki@ffpri.affrc.go.jp			Japanese Ministry of Environment	The author would like to thank all the respondents who took time to participate in the interviews. This research was funded by the Japanese Ministry of Environment.	Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dougill AJ, 2006, J AGR ECON, V57, P259, DOI 10.1111/j.1477-9552.2006.00051.x; Sandstrom A, 2008, POLICY STUD J, V36, P497, DOI 10.1111/j.1541-0072.2008.00281.x; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Schneider M, 2003, AM J POLIT SCI, V47, P143, DOI 10.2307/3186098; Berkes F, 2009, J ENVIRON MANAGE, V90, P1692, DOI 10.1016/j.jenvman.2008.12.001; Carlsson L, 2005, J ENVIRON MANAGE, V75, P65, DOI 10.1016/j.jenvman.2004.11.008; Schliep R, 2010, LAND USE POLICY, V27, P917, DOI 10.1016/j.landusepol.2009.12.005; Prell C, 2009, SOC NATUR RESOUR, V22, P501, DOI 10.1080/08941920802199202; Woolcock M, 2000, WORLD BANK RES OBSER, V15, P225; Lauber TB, 2008, ENVIRON MANAGE, V42, P677, DOI 10.1007/s00267-008-9181-8; Hoppe B, 2010, LEADERSHIP QUART, V21, P600, DOI 10.1016/j.leaqua.2010.06.004; Olsson P, 2004, ENVIRON MANAGE, V34, P75, DOI 10.1007/s00267-003-0101-7; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Armitage DR, 2009, FRONT ECOL ENVIRON, V7, P95, DOI 10.1890/070089; Pretty J, 2004, CONSERV BIOL, V18, P631, DOI 10.1111/j.1523-1739.2004.00126.x; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Bodin O, 2009, GLOBAL ENVIRON CHANG, V19, P366, DOI 10.1016/j.gloenvcha.2009.05.002; Armitage D., 2007, ADAPTIVE COMANAGEMEN; Ballet J., 2007, Journal of Environment & Development, V16, P355, DOI 10.1177/1070496507310740; Bodin O, 2006, ECOL SOC, V11; Bodin O, 2008, WORLD DEV, V36, P2763, DOI 10.1016/j.worlddev.2007.12.002; Bodin O., 2011, SOCIAL NETWORKS NATU; Burt RS, 2000, RES ORGAN BEHAV, V22, P345, DOI 10.1016/S0191-3085(00)22009-1; Burt Ronald S., 2005, BROKERAGE CLOSURE IN; Carlsson L., 2008, INT J COMMONS, V2, P33; Coleman J. S., 1988, AM J SOCIOL, V94, P95, DOI DOI 10.1086/228943; Coleman J. S., 1990, FDN SOCIAL THEORY; Crona B, 2006, ECOL SOC, V11; Cundill G., 2010, ECOLOGY SOC, V15; Garcia-Amado LR, 2012, ECOL SOC, V17, DOI 10.5751/ES-04855-170303; GRANOVET.MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hahn T, 2006, BALLETTANZ, P34; Holt AR, 2012, ECOL SOC, V17, DOI 10.5751/ES-05200-170425; Crona B, 2010, ECOL SOC, V15; Luo J-D., 2005, INT J BUSINESS PERFO, V7, P208, DOI 10.1504/IJBPM.2005.006491; Newig J, 2010, ECOL SOC, V15; Newman L., 2005, ECOLOGY SOC, V10, pr2; Ostrom E., 1990, GOVERNING COMMONS EV; Plummer R, 2009, ECOL SOC, V14; Prell C., 2012, SOCIAL NETWORK ANAL; Putnam R., 2000, BOWLING ALONE COLLAP; Putnam R. D, 2002, DEMOCRACIES FLUX EVO; Rhodes R.A.W., 1997, UNDERSTANDING GOVERN; Rova C., 2010, INT J COMMONS, V4, P528; Sandstrom A., 2010, ECOL SOC, V15, P14; Sandstrom A., 2011, SOCIAL NETWORKS NATU, P288; Scott J., 2000, SOCIAL NETWORK ANAL; Svendsen GT, 2009, ELGAR ORIG REF, P1; Wasserman S., 1994, SOCIAL NETWORK ANAL; Yamaki K., 2011, J FOREST ECON, V57, P2	51	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1617-1381	1618-1093		J NAT CONSERV	J. Nat. Conserv.	APR	2015	24						83	92		10.1016/j.jnc.2014.10.004		10	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CG2GL	WOS:000353092800012		
J	Naoe, S; Katayama, N; Amano, T; Akasaka, M; Yamakita, T; Ueta, M; Matsuba, M; Miyashita, T				Naoe, Shoji; Katayama, Naoki; Amano, Tatsuya; Akasaka, Munemitsu; Yamakita, Takehisa; Ueta, Mutsuyuki; Matsuba, Misako; Miyashita, Tadashi			Identifying priority areas for national-level conservation to achieve Aichi Target 11: A case study of using terrestrial birds breeding in Japan	JOURNAL FOR NATURE CONSERVATION			English	Article						Aichi target; Complementarity analysis; Conservation planning; Niche modeling; Openlands; Terrestrial birds	LAND-USE CHANGE; SPECIES DISTRIBUTIONS; CLIMATE-CHANGE; PROTECTED AREAS; SAMPLE-SIZE; BIODIVERSITY; DIVERSITY; LANDSCAPE; HABITAT; UNCERTAINTY	Target II of the Aichi Biodiversity Targets established in 2010 by the Convention on Biological Diversity aims to conserve at least 17% of terrestrial areas by 2020. Although global-scale conservation planning to achieve this target has already been attempted, conservation effectiveness strongly depends on region-specific natural and social factors, necessitating planning at the national and regional levels. We conducted complementarity analysis to achieve the target with regard to species distributions of 172 terrestrial birds in Japan, using in part the results of niche modeling, and identified candidate protected areas not currently included in existing protected areas. There was a large difference in landscape structure between existing and candidate protected areas due to the spatial bias of the existing protected areas; these areas were characterized by a high proportion of forest areas and low landscape heterogeneity, while candidate protected areas had a low proportion of forest areas and high landscape heterogeneity. As candidate areas were represented by mainly open lands, including agricultural fields, and were mixed to some degree with secondary forests, threatened species preferring agricultural fields or grasslands were well covered by candidate protected areas. Considering the extremely high cost of land in Japan and the infeasibility of strictly limiting human activities, we propose that facilitating the sustainable use of open lands is a promising approach to achieving Aichi Target 11 in Japan. (C) 2014 Elsevier GmbH. All rights reserved.	[Naoe, Shoji; Matsuba, Misako; Miyashita, Tadashi] Univ Tokyo, Sch Agr & Life Sci, Lab Biodivers Sci, Bunkyo Ku, Tokyo 1138656, Japan; [Katayama, Naoki] Natl Inst Agroenvironm Sci, Biodivers Div, Tsukuba, Ibaraki 3058604, Japan; [Amano, Tatsuya] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Akasaka, Munemitsu] Tokyo Univ Agr & Technol, Inst Agr, Fuchu, Tokyo 1838538, Japan; [Yamakita, Takehisa] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa 2370061, Japan; [Ueta, Mutsuyuki] Japan Bird Res Assoc, Fuchu, Tokyo 1830034, Japan	Naoe, S (reprint author), Univ Tokyo, Sch Agr & Life Sci, Lab Biodivers Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138656, Japan.	naoeshoji@affrc.go.jp		Naoe, Shoji/0000-0002-0605-4187	Environment Research and Technology Development Fund of the Ministry of the Environment [S9, 1-1401]; JSPS KAKENHI [23241077]	We thank over 1000 volunteers who contributed to the National Survey on the Natural Environment. We also thank F. Ishihama, Y. Osada, S. Nishijima and Y. Yamaura for statistical help, T. Osawa and A. Yoshioka for their help and comments. This work was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment (S9, 1-1401), and by JSPS KAKENHI (Grant no. 23241077).	Akasaka M, 2014, BIODIVERSITY OBSERVA, P209; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Loyola RD, 2013, BIODIVERS CONSERV, V22, P483, DOI 10.1007/s10531-012-0424-x; Fuller T, 2008, BIOL CONSERV, V141, P1547, DOI 10.1016/j.biocon.2008.03.021; [Anonymous], 2013, HOZEN SEITAIGAKU KEN; Uematsu Y, 2013, ECOL APPL, V23, P1357, DOI 10.1890/12-1939.1; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Smith RJ, 2008, BIOL CONSERV, V141, P2127, DOI 10.1016/j.biocon.2008.06.010; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; DOBSON M, 1994, MAMMAL REV, V24, P91, DOI 10.1111/j.1365-2907.1994.tb00137.x; Nhancale BA, 2011, BIODIVERS CONSERV, V20, P1821, DOI 10.1007/s10531-011-0063-7; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Rosenzweig ML, 2003, ORYX, V37, P194, DOI 10.1017/S0030605303000371; Katoh K, 2009, BIOL CONSERV, V142, P1930, DOI 10.1016/j.biocon.2009.02.030; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Hamel MA, 2013, CONSERV LETT, V6, P46, DOI 10.1111/j.1755-263X.2012.00285.x; Katayama N, 2011, AQUAT CONSERV, V21, P146, DOI 10.1002/aqc.1169; Polasky S, 2000, BIOL CONSERV, V94, P1, DOI 10.1016/S0006-3207(99)00171-8; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.2307/3061007; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Yamaura Y, 2009, ANIM CONSERV, V12, P110, DOI 10.1111/j.1469-1795.2008.00227.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Fujioka M, 1997, ECOL RES, V12, P101, DOI 10.1007/BF02523615; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Yamaura Y, 2011, OIKOS, V120, P427, DOI 10.1111/j.1600-0706.2010.18764.x; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Ball I.R., 2009, SPATIAL CONSERVATION, P185; Biodiversity Center of Japan, 2004, NAT SURV NAT ENV REP; BirdLife International, 2004, STAT WORLDS BIRDS 20; Drummond SP, 2010, CONSERV BIOL, V24, P441, DOI 10.1111/j.1523-1739.2009.01346.x; Faria N, 2012, J NAT CONSERV, V20, P211, DOI 10.1016/j.jnc.2012.03.003; Gill F. B., 2007, ORNITHOLOGY; Hasegawa M, 1998, CONSERVATION BIOL CO, P53; Higuchi H., 1996, ENCY ANIMALS JAPAN, V4; Itoga R, 1985, J JAPANESE I LANDSCA, V48, P240; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kadoya T, 2009, BIOL CONSERV, V142, P1899, DOI 10.1016/j.biocon.2009.02.033; Kiritani Keizi, 2000, Integrated Pest Management Reviews, V5, P175, DOI 10.1023/A:1011315214598; Langhammer P. F., 2007, IUCN BEST PRACTICE P, V15; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Ministry of Environment Government of Japan, 2014, NAT REST NETW JAP; Ministry of Environment Government of Japan, 2014, DOC C IB REINTR PROJ; Ministry of Environment Government of Japan, 2014, JAP RAMS SIT; Ministry of Internal Affairs and Communications Government of Japan, 2014, AG SOC FEW CHILDR; Mittermeier R.A., 2004, HOTSPOTS REVISITED; Miyashita T., SOCIAL ECOLOGICAL RE; Mizuno T, 2013, J WATER ENV ISSUES, V26, P7; Naito K., 2011, Japanese Journal of Conservation Ecology, V16, P181; Natori Yoji, 2012, Journal of Threatened Taxa, V4, P2797; Ogura J, 2012, HIST FORESTS GRASSLA; Osawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079978; PAOLETTI MG, 1992, AGR ECOSYST ENVIRON, V40, P3, DOI 10.1016/0167-8809(92)90080-U; Quinn GP, 2002, EXPT DESIGN DATA ANA, P537; R Development Core Team, 2013, R LANG ENV STAT COMP; Ramsar Convention on Wetlands, 2014, RAMS CONV ITS MISS; Sekercioglu C. H., 2006, TRENDS ECOL EVOL, V21, P456; Takagawa Shin-ichi, 2011, Bird Research, V7, pR9; Wilson K, 2010, MEANJIN, V69, P20; Yoshioka A, 2014, RESTOR ECOL, V22, P185, DOI 10.1111/rec.12075	71	1	1	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	1617-1381	1618-1093		J NAT CONSERV	J. Nat. Conserv.	APR	2015	24						101	108		10.1016/j.jnc.2014.10.002		8	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CG2GL	WOS:000353092800014		
J	Ogawara, H				Ogawara, Hiroshi			Penicillin-binding proteins in Actinobacteria	JOURNAL OF ANTIBIOTICS			English	Review							BETA-LACTAM ANTIBIOTICS; STREPTOMYCES-CLAVULIGERUS; GENE-CLUSTER; KEY PLAYERS; RESISTANCE; PEPTIDOGLYCAN; BACTERIA; PHOSPHORYLATION; BIOSYNTHESIS; EXPRESSION	Because some Actinobacteria, especially Streptomyces species, are beta-lactam-producing bacteria, they have to have some self-resistant mechanism. The beta-lactam biosynthetic gene clusters include genes for beta-lactamases and penicillin-binding proteins (PBPs), suggesting that these are involved in self-resistance. However, direct evidence for the involvement of beta-lactamases does not exist at the present time. Instead, phylogenetic analysis revealed that PBPs in Streptomyces are distinct in that Streptomyces species have much more PBPs than other Actinobacteria, and that two to three pairs of similar PBPs are present in most Streptomyces species examined. Some of these PBPs bind benzylpenicillin with very low affinity and are highly similar in their amino-acid sequences. Furthermore, other low-affinity PBPs such as SCLAV_4179 in Streptomyces clavuligerus, a beta-lactam-producing Actinobacterium, may strengthen further the self-resistance against beta-lactams. This review discusses the role of PBPs in resistance to benzylpenicillin in Streptomyces belonging to Actinobacteria.	[Ogawara, Hiroshi] HO Bio Inst, Tokyo 1130034, Japan; [Ogawara, Hiroshi] Meiji Pharmaceut Univ, Tokyo, Japan	Ogawara, H (reprint author), HO Bio Inst, Bunkyo Ku, 33-9,Yushima 2, Tokyo 1130034, Japan.	hogawara@sc5.so-net.ne.jp					Gao BL, 2012, MICROBIOL MOL BIOL R, V76, P66, DOI 10.1128/MMBR.05011-11; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079; Morlot C, 2013, MOL MICROBIOL, V90, P88, DOI 10.1111/mmi.12348; OGAWARA H, 1978, ANTIMICROB AGENTS CH, V13, P865; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Thaker MN, 2013, NAT BIOTECHNOL, V31, P922, DOI 10.1038/nbt.2685; Ochi K, 2013, APPL MICROBIOL BIOT, V97, P87, DOI 10.1007/s00253-012-4551-9; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Nunez LE, 2003, CHEM BIOL, V10, P301, DOI 10.1016/S1074-5521(03)00069-3; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Hoch JA, 2001, J BACTERIOL, V183, P4941, DOI 10.1128/JB.183.17.4941-4949.2001; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; Goffin C, 2002, MICROBIOL MOL BIOL R, V66, P702, DOI 10.1128/MMBR.66.4.702-738.2002; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Zhi XY, 2009, INT J SYST EVOL MICR, V59, P589, DOI 10.1099/ijs.0.65780-0; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Cundliffe E, 2010, J IND MICROBIOL BIOT, V37, P643, DOI 10.1007/s10295-010-0721-x; Fiuza M, 2010, J BIOL CHEM, V285, P29387, DOI 10.1074/jbc.M110.154427; Hempel AM, 2012, P NATL ACAD SCI USA, V109, pE2371, DOI 10.1073/pnas.1207409109; Ishida K, 2006, BIOTECHNOL LETT, V28, P409, DOI 10.1007/s10529-005-6071-5; Liras P, 2006, INT MICROBIOL, V9, P9; Munshi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060143; National Institutes of Health, PCLA 902386; Ogawara H., 2014, B MEIJI PHARM U, V43, P1; OGAWARA H, 1975, ANTIMICROB AGENTS CH, V8, P402; OGAWARA H, 1980, ANTIMICROB AGENTS CH, V17, P1; OGAWARA H, 1981, MICROBIOL REV, V45, P591; Paradkar AS, 1996, J BACTERIOL, V178, P6266; Pratt RF, 2008, CELL MOL LIFE SCI, V65, P2138, DOI 10.1007/s00018-008-7591-7; Spratt BG, 2012, J ANTIMICROB CHEMOTH, V67, P1578, DOI 10.1093/jac/dks109; SUGINAKA H, 1972, J BIOL CHEM, V247, P5279; URABE H, 1995, GENE, V153, P99, DOI 10.1016/0378-1119(94)00789-U	41	1	1	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	APR	2015	68	4					223	245		10.1038/ja.2014.148		23	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CG8NH	WOS:000353564400001		
J	Yamazaki, Y; Someno, T; Igarashi, M; Kinoshita, N; Hatano, M; Kawada, M; Momose, I; Nomoto, A				Yamazaki, Yohko; Someno, Tetsuya; Igarashi, Masayuki; Kinoshita, Naoko; Hatano, Masaki; Kawada, Manabu; Momose, Isao; Nomoto, Akio			Androprostamines A and B, the new anti-prostate cancer agents produced by Streptomyces sp MK932-CF8	JOURNAL OF ANTIBIOTICS			English	Article							CONSTITUENT AMINO-ACIDS; ANDROGEN RECEPTOR; ABSOLUTE-CONFIGURATION; MARFEYS METHOD; THERAPY; CHROMATOGRAPHY; ELUCIDATION; PROGRESSION; STATISTICS; RESORMYCIN	Androgen receptor (AR) is a validated target in all clinical states of prostate cancer. Androprostamines A and B, the new inhibitors of androgen receptor, were isolated from Streptomyces sp. MK932-CF8. Their structures were determined by the spectroscopic analysis, degradation studies and synthesis. Androprostamines showed potent inhibitory effect against androgen-dependent growth of human prostate cancer cells without cytotoxicity and repressed the androgen-induced expression of AR-regulated genes.	[Yamazaki, Yohko; Someno, Tetsuya; Kawada, Manabu; Momose, Isao; Nomoto, Akio] Inst Microbial Chem BIKAKEN, Numazu, Shizuoka 4100301, Japan; [Igarashi, Masayuki; Kinoshita, Naoko; Hatano, Masaki; Nomoto, Akio] Inst Microbial Chem BIKAKEN, Shinagawa Ku, Tokyo, Japan	Momose, I (reprint author), Inst Microbial Chem BIKAKEN, 18-24 Miyamoto, Numazu, Shizuoka 4100301, Japan.	imomose@bikaken.or.jp					American Cancer Society, 2008, CANC FACTS FIG 2008; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Koivisto P, 1997, CANCER RES, V57, P314; Fujii K, 1997, ANAL CHEM, V69, P3346, DOI 10.1021/ac9701795; Henshall SM, 2001, CANCER RES, V61, P423; BECKER B, 1964, APPL MICROBIOL, V12, P421; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Rathkopf D, 2013, CANCER J, V19, P43, DOI 10.1097/PPO.0b013e318282635a; Fujii K, 1997, ANAL CHEM, V69, P5146, DOI 10.1021/ac970289b; STANECK JL, 1974, APPL MICROBIOL, V28, P226; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Lam JS, 2006, J UROLOGY, V175, P27, DOI 10.1016/S0022-5347(05)00034-0; Dorkin TJ, 1997, SEMIN CANCER BIOL, V8, P21, DOI 10.1006/scbi.1997.0049; Hamada M., 1995, ACTINOMYCETOL, V9, P27, DOI 10.3209/saj.9_27; Igarashi M, 1997, J ANTIBIOT, V50, P1020; Igarashi M, 1997, J ANTIBIOT, V50, P1026; Rennie PS, 1998, CANCER METAST REV, V17, P401, DOI 10.1023/A:1006121219097; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Waksman S. A., 1961, THE ACTINOMYCETES, VII, P1	24	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	APR	2015	68	4					279	285		10.1038/ja.2014.135		7	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CG8NH	WOS:000353564400007		
J	Jang, JP; Nogawa, T; Uramoto, M; Okano, A; Futamura, Y; Shimizu, T; Takahashi, S; Jang, JH; Ahn, JS; Osada, H				Jang, Jun-Pil; Nogawa, Toshihiko; Uramoto, Masakazu; Okano, Akiko; Futamura, Yushi; Shimizu, Takeshi; Takahashi, Shunji; Jang, Jae-Hyuk; Ahn, Jong Seog; Osada, Hiroyuki			RK-270A-C, new oxindole derivatives isolated from a microbial metabolites fraction library of Streptomyces sp RK85-270	JOURNAL OF ANTIBIOTICS			English	Article							BIOSYNTHESIS; ELUCIDATION		[Jang, Jun-Pil; Takahashi, Shunji] RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan; [Jang, Jun-Pil; Jang, Jae-Hyuk; Ahn, Jong Seog] KRIBB, Chem Biol Res Ctr, Ochang, South Korea; [Nogawa, Toshihiko; Uramoto, Masakazu; Okano, Akiko; Shimizu, Takeshi; Takahashi, Shunji; Osada, Hiroyuki] RIKEN, Ctr Sustainable Res Sci, Wako, Saitama 3510198, Japan; [Futamura, Yushi] Viral Hepatitis Res Fdn Japan, Tokyo, Japan	Ahn, JS (reprint author), KRIBB, Chem Biol Res Ctr, 30 Yeongudanji Ro, Cheongwon Gun 363883, Chungbuk, South Korea.	jsahn@kribb.re.kr; hisyo@riken.jp			Ministry of Education, Culture, Sports and Technology of Japan; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Health and Labour Sciences Research Grant; KRIBB Research Initiative Program; GRDC Program of NRF from Ministry of Science, ICT and Future Planning of Korea	We thank Dr T Nakamura and Dr Y Hongo in RIKEN for the HRESIMS measurements and Ms H Aono and Ms N Morita in RIKEN for activity tests. We also thank Dr H Kusakabe in RIKEN for the collection of the strain. This work was supported in part by a Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports and Technology of Japan, the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry and Health and Labour Sciences Research Grant. This work was also supported in part by grants of KRIBB Research Initiative Program and GRDC Program of NRF funded from Ministry of Science, ICT and Future Planning of Korea.	Williams RM, 2000, TOP CURR CHEM, V209, P97; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Zheng D, 2013, MAGN RESON CHEM, V51, P188, DOI 10.1002/mrc.3928; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Kato N, 2012, CURR OPIN CHEM BIOL, V16, P101, DOI 10.1016/j.cbpa.2012.02.016; Lim CL, 2014, J ANTIBIOT, V67, P323, DOI 10.1038/ja.2013.144; Nogawa T, 2013, J ANTIBIOT, V66, P621, DOI 10.1038/ja.2013.55; Nogawa T, 2012, J ANTIBIOT, V65, P123, DOI 10.1038/ja.2011.121; Nogawa T, 2010, ORG LETT, V12, P4564, DOI 10.1021/ol1018618; Osada H, 2012, PURE APPL CHEM, V84, P1407, DOI 10.1351/PAC-CON-11-08-11; Osada H., 2009, CHEM BIOL TECHNIQUES, P1; Panthee S, 2011, J ANTIBIOT, V64, P509, DOI 10.1038/ja.2011.41; Satou R, 2014, J ANTIBIOT, V67, P231, DOI 10.1038/ja.2013.116	14	0	0	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	APR	2015	68	4					293	295		10.1038/ja.2014.141		3	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	CG8NH	WOS:000353564400010		
J	Yoshikawa, Y; Endoh, T				Yoshikawa, Yutaka; Endoh, Takahiro			Estimating the Eddy Viscosity Profile from Velocity Spirals in the Ekman Boundary Layer	JOURNAL OF ATMOSPHERIC AND OCEANIC TECHNOLOGY			English	Article							TURBULENCE; MICROSTRUCTURE; DISSIPATION	Turbulent mixing induced by tidal currents near the sea bottom plays a key role in coastal and shallow sea environments. Many attempts have been made to quantify turbulent mixing near the seabed, such as velocity microstructure measurements with microstructure profilers and turbulent Reynolds stress measurements using acoustic Doppler current profilers (ADCPs). This study proposes an alternative method in which the Ekman balance equations are solved with measured velocity spirals to estimate the eddy viscosity profile. Three schemes (schemes 1, 2, and 3) are described in this paper; schemes 1 and 2 were used in previous studies, while scheme 3 is newly proposed in the present study. The performance of the three schemes was tested using velocity spirals simulated with an idealized eddy viscosity profile, showing that scheme 2 is useful if the random measurement errors are small, while scheme 3 is useful when the errors in the Ekman balance are small. The performance was also evaluated using measured velocity spirals. This method utilizes velocity measured with standard ADCPs operated in normal modes, allowing for easier and more frequent quantifications of the mixing averaged over longer periods.	[Yoshikawa, Yutaka] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan; [Endoh, Takahiro] Univ Tokyo, Univ Tokyo Ocean Alliance, Tokyo, Japan	Yoshikawa, Y (reprint author), Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	yosikawa@kugi.kyoto-u.ac.jp			Japan Society for the Promotion of Science [22340140, 25287123]; Research Institute for Applied Mechanics, Kyushu University	The authors express their hearty thanks to Kousuke Aoyama, who helped in the preliminary analysis of this work. This work was partly supported by the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (22340140, 25287123) and by the joint research program of the Research Institute for Applied Mechanics, Kyushu University.	Rippeth TP, 2003, J PHYS OCEANOGR, V33, P1889, DOI 10.1175/1520-0485(2003)033<1889:MOTROP>2.0.CO;2; Lueck RG, 2002, J OCEANOGR, V58, P153, DOI 10.1023/A:1015837020019; LOHRMANN A, 1990, J ATMOS OCEAN TECH, V7, P19, DOI 10.1175/1520-0426(1990)007<0019:HRMOTV>2.0.CO;2; Burchard H, 2008, PROG OCEANOGR, V76, P399, DOI 10.1016/j.pocean.2007.09.005; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Lu YY, 1999, J ATMOS OCEAN TECH, V16, P1568, DOI 10.1175/1520-0426(1999)016<1568:UABAIA>2.0.CO;2; PRICE JF, 1986, J GEOPHYS RES-OCEANS, V91, P8411, DOI 10.1029/JC091iC07p08411; OSBORN TR, 1974, J PHYS OCEANOGR, V4, P109, DOI 10.1175/1520-0485(1974)004<0109:VPOVM>2.0.CO;2; CHERESKIN TK, 1995, J GEOPHYS RES-OCEANS, V100, P18261, DOI 10.1029/95JC02182; Nidzieko NJ, 2006, J ATMOS OCEAN TECH, V23, P854, DOI 10.1175/JTECH1885.1; Sakamoto K, 2008, J FLUID MECH, V615, P1, DOI 10.1017/S0022112008003340; Soulsby R.L, 1990, SEA A, V9, P523; Stacey M. T., 1999, J GEOPHYS RES, V104, p10 993, DOI [10.1029/1998JC900095, DOI 10.1029/1998JC900095]; Thorpe SA, 2007, INTRODUCTION TO OCEAN TURBULENCE, P1, DOI 10.1017/CBO9780511801198; Yoshikawa Y, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003625; Yoshikawa Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044156; Yoshikawa Y, 2012, CONT SHELF RES, V50-51, P41, DOI 10.1016/j.csr.2012.10.007	17	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0739-0572	1520-0426		J ATMOS OCEAN TECH	J. Atmos. Ocean. Technol.	APR	2015	32	4					793	804		10.1175/JTECH-D-14-00090.1		12	Engineering, Ocean; Meteorology & Atmospheric Sciences	Engineering; Meteorology & Atmospheric Sciences	CG0OT	WOS:000352966600011		
J	Iida, Y				Iida, Yoshio			Task-based income inequalities and redistribution preferences: A comparison of China and Japan	JOURNAL OF BEHAVIORAL AND EXPERIMENTAL ECONOMICS			English	Article						Inequity aversion; Redistribution preferences; Experimental economics; Comparative study	DISTRIBUTIVE JUSTICE; SOCIAL-EXCHANGE; PROPERTY-RIGHTS; ALLOCATION; FAIRNESS; DISAPPOINTMENT; PERFORMANCE; DICTATOR; ABILITY; ENTITLEMENTS	To clarify whether a difference exists in the redistribution preferences of Japan and China and to provide insights into the possible causes of this difference, this study conducts an experiment similar to a dictator game but in which both donors and recipients have the chance to redistribute the initial incomes. In the experiment, an initial income gap is caused by one of two kinds of tasks that the subjects performed. One task requires subjects' innate abilities for better performance, and the other requires simple efforts. This study also explores the effect of subjectively recognized reasons for income gaps on these preferences. The experimental results show the following: (1) Chinese donors are more generous than Japanese donors; (2) both Chinese and Japanese recipients are similarly greedy; (3) the causes of the income gap and subjective recognitions regarding this gap do not affect the redistribution preferences; (4) males are less generous than females in Japan but not in China; and, (5) Japanese donors become more generous when they did not expect to win the higher initial income. (C) 2015 Elsevier Inc. All rights reserved.	Kyoto Sangyo Univ, Dept Econ, Kita Ku, Kyoto, Kyoto 6038555, Japan	Iida, Y (reprint author), Kyoto Sangyo Univ, Dept Econ, Kita Ku, Kyoto, Kyoto 6038555, Japan.	iida01@cc.kyoto-su.ac.jp			JSPS [23530388]	This study was supported by JSPS Grant in Aid for Scientific Research (C) no. 23530388. I thank Sobei H. Oda, Zhou Yan, and Professor Rui Cheng Huang for their assistance in conducting the experiments. I am indebted to Sebastian Schafer for coding the intelligence test on z-Tree. I also thank editors and two anonymous referees for their helpful suggestions for this study.	Rutstrom EE, 2000, J ECON BEHAV ORGAN, V43, P75, DOI 10.1016/S0167-2681(00)00109-8; Takahashi C, 2008, INT J INTERCULT REL, V32, P215, DOI 10.1016/j.ijintrel.2007.11.003; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037//0033-2909.128.1.3; Cherry TL, 2002, AM ECON REV, V92, P1218, DOI 10.1257/00028280260344740; Buchan NR, 2006, J ECON BEHAV ORGAN, V60, P373, DOI 10.1016/j.jebo.2004.03.017; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037//0033-295X.92.4.548; Abeler J, 2011, AM ECON REV, V101, P470, DOI 10.1257/aer.101.2.470; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Buchan NR, 2002, AM J SOCIOL, V108, P168, DOI 10.1086/344546; Bailey JR, 1997, J INT BUS STUD, V28, P605, DOI 10.1057/palgrave.jibs.8490113; Gill D, 2012, AM ECON REV, V102, P469, DOI 10.1257/aer.102.1.469; Konow J, 2000, AM ECON REV, V90, P1072, DOI 10.1257/aer.90.4.1072; Durante R, 2014, J EUR ECON ASSOC, V12, P1059, DOI 10.1111/jeea.12082; Burrows P., 1994, EMPIR ECON, V19, P21; CHEN C, 1995, PSYCHOL SCI, V6, P170, DOI 10.1111/j.1467-9280.1995.tb00327.x; HOFFMAN E, 1985, J LEGAL STUD, V14, P259, DOI 10.1086/467773; Hofstede G., 2010, CULTURES ORG SOFTWAR; Huang Li-Li, 2011, ASIAN J SOC PSYCHOL, V14, P246; KAYSER E, 1982, SOC BEHAV PERSONAL, V10, P105, DOI 10.2224/sbp.1982.10.1.105; LAMM H, 1978, EUR J SOC PSYCHOL, V8, P275, DOI 10.1002/ejsp.2420080212; LEVENTHA.GS, 1971, J PERS SOC PSYCHOL, V17, P229, DOI 10.1037/h0030602; LOOMES G, 1986, REV ECON STUD, V53, P271, DOI 10.2307/2297651; Oxoby RJ, 2008, J ECON BEHAV ORGAN, V65, P703, DOI 10.1016/j.jebo.2005.12.006; REST S, 1973, J PERS SOC PSYCHOL, V28, P187, DOI 10.1037/h0035739; Rodrigues Aroldo, 1980, INT J INTERCULTURAL, V4, P379, DOI 10.1016/0147-1767(80)90012-7; Rousu MC, 2011, J SOCIO-ECON, V40, P364, DOI 10.1016/j.socec.2010.09.007; Schmidt Klaus M., 1999, ADV BEHAV EC, P271; Triandis Harry C., 1995, INDIVIDUALISM COLLEC; van Dijk WW, 2003, J ECON PSYCHOL, V24, P505, DOI 10.1016/S0167-4870(02)00211-8; Weiner B., 1972, ATTRIBUTION PERCEIV, P95	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2214-8043	2214-8051		J BEHAV EXP ECON	J. Behav. Exp. Econ.	APR	2015	55						91	102		10.1016/j.socec.2015.02.002		12	Economics	Business & Economics	CG1AR	WOS:000353005900010		
J	Nagashima, S; Kodaka, M; Iwasa, H; Hata, Y				Nagashima, Shunta; Kodaka, Manami; Iwasa, Hiroaki; Hata, Yutaka			MAGI2/S-SCAM outside brain	JOURNAL OF BIOCHEMISTRY			English	Review						cancer; intestine; kidney; scaffold protein; synapse	SYNAPTIC-SCAFFOLDING-MOLECULE; KINASE-INTERACTING PROTEIN; DOMAIN-CONTAINING PROTEIN; TIGHT JUNCTION PROTEIN; D-ASPARTATE RECEPTORS; GUANYLATE KINASE; S-SCAM; BETA-CATENIN; PDZ DOMAIN; MULTIPROTEIN COMPLEX	Membrane-associated guanylate kinase with an inverted arrangement of protein-protein interaction domains (MAGI)2 (also called synaptic scaffolding molecule (S-SCAM), atrophin-l-interacting protein 1, activin receptor-interacting protein 1) is a scaffold protein that binds a wide variety of receptors, cell adhesion molecules and signalling molecules. It also interacts with other scaffold proteins and adaptors, and forms a protein network that supports cell junctions. As it is highly expressed in brain, the study on its roles in synaptic organization initially preceded. However, mounting evidence indicates that MAGI2/S-SCAM functions as a tumour suppressor and plays essential roles to maintain the integrity of cell structures in non-neuronal tissues. We review the articles regarding to MAGI2/S-SCAM outside brain and discuss future perspectives for the research of MAGI family proteins.	[Nagashima, Shunta; Kodaka, Manami; Iwasa, Hiroaki; Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo 1138519, Japan; [Hata, Yutaka] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo 1138519, Japan	Hata, Y (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo 1138519, Japan.	yuhammch@tmd.ac.jp			Japan Society for the Promotion of Science [26460359, 26293061]; Mitsubishi Foundation	H.I. and Y.H. were supported by research grants from Japan Society for the Promotion of Science (26460359, 26293061) and the Mitsubishi Foundation.	Lee SJ, 2011, GASTROENTEROLOGY, V140, P924, DOI 10.1053/j.gastro.2010.11.054; Kitano J, 2003, J BIOL CHEM, V278, P14762, DOI 10.1074/jbc.M300184200; Ikeda M, 2007, EXP CELL RES, V313, P1484, DOI 10.1016/j.yexcr.2007.02.013; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Yao I, 1999, J BIOL CHEM, V274, P11889, DOI 10.1074/jbc.274.17.11889; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Nishimura W, 2002, J NEUROSCI, V22, P757; Marshall CR, 2008, AM J HUM GENET, V83, P106, DOI 10.1016/j.ajhg.2008.06.001; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; Zaric J, 2012, ONCOGENE, V31, P48, DOI 10.1038/onc.2011.218; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Sumita K, 2007, J NEUROCHEM, V100, P154, DOI 10.1111/j.1471-4159.2006.04170.x; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Karlsson R, 2012, BIOL PSYCHIAT, V71, P922, DOI 10.1016/j.biopsych.2012.01.020; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Zhang L, 2014, CELL SIGNAL, V26, P1392, DOI 10.1016/j.cellsig.2014.02.023; Shiratsuchi T, 1998, BIOCHEM BIOPH RES CO, V247, P597, DOI 10.1006/bbrc.1998.8603; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Woo J, 2013, J CELL BIOL, V201, P929, DOI 10.1083/jcb.201209132; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Thomas M, 2002, ONCOGENE, V21, P5088, DOI 10.1038/sj.onc.1205668; Babayeva S, 2011, AM J PHYSIOL-RENAL, V300, pF549, DOI 10.1152/ajprenal.00566.2009; Balbas MD, 2014, P NATL ACAD SCI USA, V111, P14876, DOI 10.1073/pnas.1417297111; Bauss K, 2014, HUM MOL GENET, V23, P3923, DOI 10.1093/hmg/ddu104; Chen YC, 2014, INT J CANCER, V135, P117, DOI 10.1002/ijc.28658; Danielson E, 2012, CHANNELS, V6, P393, DOI 10.4161/chan.21301; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Fukaya M, 2011, J NEUROCHEM, V116, P1122, DOI 10.1111/j.1471-4159.2010.07167.x; Gee HY, 2009, GASTROENTEROLOGY, V137, P607, DOI 10.1053/j.gastro.2009.01.065; Gregorc U, 2007, APOPTOSIS, V12, P343, DOI 10.1007/s10495-006-0579-6; Hirabayashi S, 2004, J NEUROCHEM, V90, P332, DOI 10.1111/j.1471-4159.2004.02497.x; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Hu YL, 2007, ARCH BIOCHEM BIOPHYS, V467, P1, DOI 10.1016/j.abb.2007.07.027; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Ihara K, 2012, GENE EXPR PATTERNS, V12, P95, DOI 10.1016/j.gep.2012.01.006; Ihara KI, 2014, AM J PATHOL, V184, P2699, DOI 10.1016/j.ajpath.2014.06.019; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; Ito H, 2012, J NEUROSCI RES, V90, P1776, DOI 10.1002/jnr.23074; Kaufman L, 2010, J BIOL CHEM, V285, P25677, DOI 10.1074/jbc.M110.133959; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Kawata A, 2006, J BIOCHEM, V139, P931, DOI 10.1093/jb/mvj105; Kitamura K, 2014, MOL CANCER THER, V13, P444, DOI 10.1158/1535-7163.MCT-13-0448; Kohda K, 2007, EUR J NEUROSCI, V25, P1357, DOI 10.1111/j.1460-9568.2007.05412.x; Koide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036836; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Mahdian R, 2014, MOL BIOL REP, V41, P6125, DOI 10.1007/s11033-014-3491-0; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P75, DOI 10.1002/ibd.20611; Mohseni M, 2014, NAT CELL BIOL, V16, P108, DOI 10.1038/ncb2884; Ohno H, 2003, ONCOGENE, V22, P8422, DOI 10.1038/sj.onc.1206996; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Pfister S, 2003, J MOL BIOL, V333, P229, DOI 10.1016/j.jmb.2003.08.043; Rosenberg MM, 2010, J NEUROSCI, V30, P11073, DOI 10.1523/JNEUROSCI.0983-10.2010; Shi SH, 2004, P NATL ACAD SCI USA, V101, P13346, DOI 10.1073/pnas.0405371101; Shoji H, 2000, J BIOL CHEM, V275, P5485, DOI 10.1074/jbc.275.8.5485; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Tolkacheva T, 2001, CANCER RES, V61, P4985; Yamada A, 2003, GENES CELLS, V8, P985, DOI 10.1046/j.1365-2443.2003.00690.x; Yap CC, 2003, BIOCHEM BIOPH RES CO, V301, P1122, DOI 10.1016/S0006-291X(03)00070-6; Zou SW, 2011, J NEUROCHEM, V117, P833, DOI 10.1111/j.1471-4159.2011.07250.x	69	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					177	184		10.1093/jb/mvv009		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100001		
J	Sasaki, K; Yoshida, H				Sasaki, Kanae; Yoshida, Hiderou			Organelle autoregulation-stress responses in the ER, Golgi, mitochondria and lysosome	JOURNAL OF BIOCHEMISTRY			English	Review						ER stress response; Golgi stress response; lysosome stress response; mitochondrial unfolded protein response; organelle autoregulation	UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; XBP1 MESSENGER-RNA; TRANSCRIPTION FACTOR; TRANSMEMBRANE PROTEIN; TRANSLATIONAL CONTROL; MAMMALIAN-CELLS; GENE-EXPRESSION; QUALITY-CONTROL; LUMINAL DOMAIN	Organelle autoregulation is a homeostatic mechanism to regulate the capacity of each organelle according to cellular demands. The endoplasmic reticulum (ER) stress response increases the expression of ER chaperones and ER-associated degradation factors when the capacity of the ER becomes insufficient, e.g. during cellular differentiation or viral propagation, and which can be restored through increased synthesis of secretory or membrane proteins. In the Golgi stress response, insufficient organelle capacity is responded to by augmentation of glycosylation enzyme expression and vesicular transport components. The mitochondrial stress response upregulates mitochondrial chaperone and protease expression in the mitochondrial matrix and intermembrane space when unfolded proteins accumulate in the mitochondria. The lysosome stress response is activated during autophagy to enhance the function of the lysosome by transcriptional induction of lysosome genes including cathepsins. However, many of the molecular mechanisms of organelle autoregulation remain unclear. Here, we review recent discoveries in organelle autoregulation and their molecular mechanisms.	[Sasaki, Kanae; Yoshida, Hiderou] Univ Hyogo, Grad Sch Life Sci, Dept Mol Biochem, Kobe, Hyogo 6781297, Japan	Yoshida, H (reprint author), Univ Hyogo, Grad Sch Life Sci, Dept Mol Biochem, Harima Sci Pk, Kobe, Hyogo 6781297, Japan.	hide@sci.u-hyogo.ac.jp			MEXT; JSPS KAKENHI [22020019, 22370069, 23657136, 25650070, 253584]; MEXT [23110007]	This work was supported by MEXT and JSPS KAKENHI (22020019, 22370069, 23657136, 25650070 and 253584) and a Grant-in-Aid for Scientific Research on Innovative Areas of MEXT (23110007).	Rath E, 2012, GUT, V61, P1269, DOI 10.1136/gutjnl-2011-300767; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Shen HM, 2014, TRENDS BIOCHEM SCI, V39, P61, DOI 10.1016/j.tibs.2013.12.001; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Oku M, 2011, CELL STRUCT FUNCT, V36, P1, DOI 10.1247/csf.10014; Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865; Haze K, 1999, MOL BIOL CELL, V10, P3787; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; MORI K, 1993, CELL, V74, P743; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Harding HP, 1999, NATURE, V397, P271; Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; CAMPADELLI G, 1993, P NATL ACAD SCI USA, V90, P2798, DOI 10.1073/pnas.90.7.2798; DenBoer LM, 2005, BIOCHEM BIOPH RES CO, V331, P113, DOI 10.1016/j.bbrc.2005.03.141; Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Horibe T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000835; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Martinus RD, 1996, EUR J BIOCHEM, V240, P98; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Ishikawa T, 2013, MOL BIOL CELL, V24, P1387, DOI 10.1091/mbc.E12-11-0830; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Berger E.G., 1997, THE GOLGI APPARATUS; BIERRING F, 1962, ACTA PATHOL MIC SC, V54, P241; CLERMONT Y, 1993, ANAT REC, V237, P308, DOI 10.1002/ar.1092370303; FREEMAN JA, 1962, ANAT REC, V144, P341, DOI 10.1002/ar.1091440406; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Helenius A., 2004, ANNU REV BIOCHEM, V73, P1; Miyata S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069732; Nakai W, 2013, MOL BIOL CELL, V24, P2570, DOI 10.1091/mbc.E13-04-0197; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; RAMBOURG A, 1993, ANAT REC, V235, P353, DOI 10.1002/ar.1092350304; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Ron D, 2012, COLD SPRING HARB PER, V4; Shen JS, 2005, MOL CELL BIOL, V25, P921, DOI 10.1128/MCB.25.3.921-932.2005; Shen JS, 2004, J BIOL CHEM, V279, P43046, DOI 10.1074/jbc.M408466200; Taniguchi M, 2015, CELL STRUCT FUNCT, V40, P13, DOI 10.1247/csf.14015; Tsuru A, 2013, P NATL ACAD SCI USA, V110, P2864, DOI 10.1073/pnas.1212484110; Uemura A, 2009, J CELL SCI, V122, P2877, DOI 10.1242/jcs.040584; Wakabayashi S, 2013, COMPUT STRUCT BIOTEC, V6; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	87	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					185	195		10.1093/jb/mvv010		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100002		
J	Hu, D; Huang, H; Tateno, H; Nakakita, S; Sato, T; Narimatsu, H; Yao, XS; Hirabayashi, J				Hu, Dan; Huang, Hang; Tateno, Hiroaki; Nakakita, Shin-ichi; Sato, Takashi; Narimatsu, Hisashi; Yao, Xinsheng; Hirabayashi, Jun			Engineering of a 3 '-sulpho-Gal beta 1-4GlcNAc-specific probe by a single amino acid substitution of a fungal galectin	JOURNAL OF BIOCHEMISTRY			English	Article						frontal affinity chromatography; galectin; glycan microarry; glycoengineering; molecular evolution; sulphated glycan	LEWIS X DETERMINANTS; AGROCYBE-CYLINDRACEA; MOLECULAR-CLONING; BINDING SPECIFICITY; LECTIN MICROARRAY; E-SELECTIN; OLIGOSACCHARIDES; BIOSYNTHESIS; GLYCOPROTEIN; EXPRESSION	Among sulphated glycans, little is known about 3'-sulphation because of the lack of useful probes. In the course of molecular engineering of a fungal galectin from Agrocybe cylindracea, we found that a single substitution of Glu86 with alanine resulted in acquisition of specific binding for the 3'-sulpho-Gal beta 1-4GlcNAc structure. Extensive glyco-technological analysis revealed that this property was obtained in a 'loss-of-function' manner. Though this mutant (E86A) had low total affinity, it showed substantial binding to a naturally occurring N-glycan, of which the terminal galactose is 3-sulphated. Moreover, E86A specifically bound to HeLa cells, in which galactose-3-O-sulfotransferases (Gal3ST2 or Gal3ST3) were over-expressed.	[Hu, Dan; Huang, Hang; Yao, Xinsheng] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China; [Hu, Dan; Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058568, Japan; [Nakakita, Shin-ichi] Kagawa Univ, Inst Res Promot, Life Sci Res Ctr, Div Funct Glyc, Miki, Kagawa 7610793, Japan; [Sato, Takashi; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan	Yao, XS (reprint author), Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Coll Pharm, Guangzhou 510632, Guangdong, Peoples R China.	tyaoxs@jnu.edu.cn; jun-hirabayashi@aist.go.jp			National Natural Science Foundation of China [81302673]; Natural Science Foundation of Guangdong Province [2014A030313389]; 111 Project from the Ministry of P. R. China [B13038];  [22-00218]	This work was supported in part by Grant-in-Aid for JSPS Fellows (J.H., 22-00218), grants from the National Natural Science Foundation of China (D.H., 81302673), Natural Science Foundation of Guangdong Province (D.H., 2014A030313389), and the 111 Project (X.Y., No. B13038) from the Ministry of P. R. China. Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (D.H., 2014).	Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Hu D, 2012, J BIOL CHEM, V287, P20313, DOI 10.1074/jbc.M112.351965; Yagi F, 2001, GLYCOCONJUGATE J, V18, P745, DOI 10.1023/A:1021193432577; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Degroote S, 1999, GLYCOBIOLOGY, V9, P1199, DOI 10.1093/glycob/9.11.1199; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Seko A, 2001, J BIOL CHEM, V276, P25697, DOI 10.1074/jbc.M101558200; Zheng T, 2005, J AM CHEM SOC, V127, P9982, DOI 10.1021/ja0505550; Ban M, 2005, J MOL BIOL, V351, P695, DOI 10.1016/j.jmb.2005.06.045; Capon C, 1997, J BIOL CHEM, V272, P31957, DOI 10.1074/jbc.272.51.31957; CHANDRASEKARAN EV, 1992, J BIOL CHEM, V267, P23806; El-Fasakhany FM, 2001, J BIOL CHEM, V276, P26988, DOI 10.1074/jbc.M100348200; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; Honke K, 2001, J BIOL CHEM, V276, P267; Hu D, 2013, BIOCHEM J, V453, P261, DOI 10.1042/BJ20121901; Ideo H, 2002, GLYCOBIOLOGY, V12, P199, DOI 10.1093/glycob/12.3.199; Imamura K, 2011, J BIOCHEM, V150, P545, DOI 10.1093/jb/mvr094; Iwaki J, 2011, BBA-GEN SUBJECTS, V1810, P643, DOI 10.1016/j.bbagen.2011.04.001; Konno A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-43; Leffler Hakon, 2004, Glycoconjugate Journal, V19, P433; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Shi BZ, 2005, BIOCHEM BIOPH RES CO, V332, P934, DOI 10.1016/j.bbrc.2005.05.040; SPIRO RG, 1988, J BIOL CHEM, V263, P14351; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; YUEN CT, 1992, BIOCHEMISTRY-US, V31, P9126, DOI 10.1021/bi00153a003; YUEN CT, 1994, J BIOL CHEM, V269, P1595; Zhang CY, 2010, BIOCHEMISTRY-US, V49, P7811, DOI 10.1021/bi101040k	31	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					197	200		10.1093/jb/mvv023		4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100003		
J	Tani, Y; Omatsu, K; Saito, S; Miyake, R; Kawabata, H; Ueda, M; Mihara, H				Tani, Yasushi; Omatsu, Koichiro; Saito, Shigeki; Miyake, Ryoma; Kawabata, Hiroshi; Ueda, Makoto; Mihara, Hisaaki			Heterologous expression of L-lysine alpha-oxidase from Scomber japonicus in Pichia pastoris and functional characterization of the recombinant enzyme	JOURNAL OF BIOCHEMISTRY			English	Article						apoptosis-inducing protein; flavoprotein; L-lysine oxidase; Pichia pastoris; Scomber japonicus	AMINO-ACID OXIDASE; PROTEIN DISULFIDE-ISOMERASE; APOPTOSIS-INDUCING FACTOR; VIPER CALLOSELASMA-RHODOSTOMA; HUMAN PLATELET-AGGREGATION; L-PHENYLALANINE OXIDASE; LUMINAL ER PROTEINS; SNAKE-VENOM; ENDOPLASMIC-RETICULUM; SKIN MUCUS	Fish have a complex self-defense mechanism against microbial invasion. Recently, L-lysine alpha-oxidases have been identified from a number of fish species as a novel type of antibacterial protein in the integument. These enzymes exhibit strict substrate specificity for L-lysine, but the underlying mechanisms and details of their catalytic properties remain unknown. In this study, a synthetic gene coding for Sconzber japonicus L-lysine a-oxidase, originally termed AIP (for apoptosis-inducing protein), was expressed in Pichia pastoris, and the recombinant enzyme (rAIP) was purified and characterized. rAIP exhibited essentially the same substrate specificity as the native enzyme, catalyzing the oxidative deamination of L-lysine as an exclusive substrate. rAIP was N-glycosylated and remained active over a wide range of pH, with an optimal pH of 7.5. The enzyme was stable in the pH range from 4.5 to 10.0 and was thermally stable up to 60 degrees C. A molecular modelling of rAIP and a comparative structure/sequence analysis with homologous enzymes indicate that Asp(220) and Asp(320) are the substrate-binding residues that are likely to confer exclusive substrate specificity for L-lysine on the fish enzymes.	[Tani, Yasushi; Omatsu, Koichiro; Saito, Shigeki; Mihara, Hisaaki] Ritsumeikan Univ, Coll Life Sci, Kusatsu, Shiga 5258577, Japan; [Tani, Yasushi; Saito, Shigeki] Ritsumeikan Univ, R GIRO, Kusatsu, Shiga 5258577, Japan; [Miyake, Ryoma; Kawabata, Hiroshi; Ueda, Makoto] Mitsubishi Chem Grp Sci & Technol Res Ctr Inc, Yokohama, Kanagawa 2278502, Japan; [Miyake, Ryoma; Kawabata, Hiroshi] API Corp, Yokohama, Kanagawa 2278502, Japan	Ueda, M (reprint author), Oyama Natl Coll Technol, Dept Mat Chem & Bioengn, Oyama, Tochigi 3230806, Japan.	mihara@fc.ritsumei.ac.jp					Ali SA, 2000, ARCH BIOCHEM BIOPHYS, V384, P216, DOI 10.1006/abbi.2000.2130; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; Gong B, 2013, J MASS SPECTROM, V48, P1308, DOI 10.1002/jms.3291; Arima J, 2009, FEBS J, V276, P4318, DOI 10.1111/j.1742-4658.2009.07103.x; Kitani Y, 2008, COMP BIOCHEM PHYS B, V149, P394, DOI 10.1016/j.cbpb.2007.10.013; Boulland ML, 2007, BLOOD, V110, P220, DOI 10.1182/blood-2006-07-036210; Nagashima Y, 2009, COMP BIOCHEM PHYS B, V154, P55, DOI 10.1016/j.cbpb.2009.05.006; Geueke B, 2003, PROTEIN EXPRES PURIF, V28, P303, DOI 10.1016/S1046-5928(02)00701-5; Helenius J, 2002, SEMIN CELL DEV BIOL, V13, P171, DOI 10.1016/S1084-9521(02)00045-9; Puiffe ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054589; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; BOOTH C, 1989, CELL, V59, P729, DOI 10.1016/0092-8674(89)90019-6; Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x; Hughes AL, 2010, IMMUNOGENETICS, V62, P753, DOI 10.1007/s00251-010-0482-8; Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984; Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Zhang HM, 2004, ACTA CRYSTALLOGR D, V60, P974, DOI 10.1107/S0907444904000046; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ehara T, 2002, FEBS LETT, V531, P509, DOI 10.1016/S0014-5793(02)03608-6; Yang HC, 2005, J EXP BIOL, V208, P3609, DOI 10.1242/jeb.01795; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; VALLON O, 1993, EUR J BIOCHEM, V215, P351, DOI 10.1111/j.1432-1033.1993.tb18041.x; Kommoju PR, 2007, PROTEIN EXPRES PURIF, V52, P89, DOI 10.1016/j.pep.2006.09.016; Davis MA, 2005, APPL ENVIRON MICROB, V71, P3551, DOI 10.1128/AEM.71.7.3551-3555.2005; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUSAKABE H, 1980, J BIOL CHEM, V255, P976; Masuda S, 1997, BIOCHEM BIOPH RES CO, V235, P59, DOI 10.1006/bbrc.1997.6728; Pollegioni L, 2013, APPL MICROBIOL BIOT, V97, P9323, DOI 10.1007/s00253-013-5230-1; Faust A, 2007, J MOL BIOL, V367, P234, DOI 10.1016/j.jmb.2006.11.071; Guo CM, 2012, TOXICON, V60, P302, DOI 10.1016/j.toxicon.2012.05.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Charlwood J, 2001, BIOMOL ENG, V18, P229, DOI 10.1016/S1389-0344(01)00098-3; Cheng CH, 2011, J AGR FOOD CHEM, V59, P9142, DOI 10.1021/jf201598z; Delic M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-6; Huang YD, 2014, BIOTECHNOL APPL BIOC, V61, P175, DOI 10.1002/bab.1146; Ida K, 2008, J BIOL CHEM, V283, P16584, DOI 10.1074/jbc.M800366200; Jung SK, 2000, J IMMUNOL, V165, P1491; Kasai K, 2010, FEBS J, V277, P453, DOI 10.1111/j.1742-4658.2009.07497.x; Kitani Y, 2007, FEBS J, V274, P125, DOI 10.1111/j.1742-4658.2006.05570.x; Komeda H, 2000, EUR J BIOCHEM, V267, P2028, DOI 10.1046/j.1432-1327.2000.01208.x; Li R, 2014, PROTEIN EXPRES PURIF, V96, P1, DOI 10.1016/j.pep.2014.01.005; LI ZY, 1994, TOXICON, V32, P1349, DOI 10.1016/0041-0101(94)90407-3; Macheroux P, 2001, EUR J BIOCHEM, V268, P1679, DOI 10.1046/j.1432-1327.2001.02042.x; Medina-Godoy Sergio, 2006, Biotechnology Journal, V1, P1085, DOI 10.1002/biot.200600126; MORI N, 1980, AGR BIOL CHEM TOKYO, V44, P1391; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Murakawa M, 2001, CELL DEATH DIFFER, V8, P298, DOI 10.1038/sj.cdd.4400811; Patrick S.M., 2005, YEAST, V22, P249; Pawelek PD, 2000, EMBO J, V19, P4204, DOI 10.1093/emboj/19.16.4204; PISTORIUS EK, 1980, BIOCHIM BIOPHYS ACTA, V611, P227, DOI 10.1016/0005-2744(80)90059-5; Sakurai Y, 2001, TOXICON, V39, P1827, DOI 10.1016/S0041-0101(01)00133-7; STILES BG, 1991, TOXICON, V29, P1129, DOI 10.1016/0041-0101(91)90210-I; TERADA K, 1995, J BIOL CHEM, V270, P20410; Torii S, 2000, BIOCHEMISTRY-US, V39, P3197, DOI 10.1021/bi992416z; Torii S, 1997, J BIOL CHEM, V272, P9539; Warsame A, 2001, BIOCHEM BIOPH RES CO, V281, P1176, DOI 10.1006/bbrc.2001.4479; Zhang YJ, 2003, BIOCHEM BIOPH RES CO, V309, P598, DOI 10.1016/j.bbrc.2003.08.044	59	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					201	210		10.1093/jb/mvu064		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100004		
J	Matsumoto, Y; Saito, T; Hoshi, K; Ito, H; Kariya, Y; Nagae, M; Yamaguchi, Y; Hagiwara, Y; Kinoshita, N; Wada, I; Saito, K; Honda, T; Hashimoto, Y				Matsumoto, Yuka; Saito, Toshie; Hoshi, Kyoka; Ito, Hiromi; Kariya, Yoshinobu; Nagae, Masamichi; Yamaguchi, Yoshiki; Hagiwara, Yoshiaki; Kinoshita, Noriaki; Wada, Ikuo; Saito, Kiyoshi; Honda, Takashi; Hashimoto, Yasuhiro			In situ visualization of a glycoform of transferrin: localization of alpha 2,6-sialylated transferrin in the liver	JOURNAL OF BIOCHEMISTRY			English	Article						alpha 2,6-sialic acid; immunohistochemistry; Sambucus sieboldiana agglutinin (SSA) lectin; transferrin	ALPHA-FETOPROTEIN; GLYCOPROTEINS; PROTEINS; ANTIBODY; CLEAVAGE; GLYCAN	We previously found that a lectin, Sambucus sieboldiana agglutinin (SSA), bound to alpha 2,6-sialylated glycan epitopes on transferrin and inhibited anti-transferrin antibody binding to the antigen in ELISA (SSA inhibition). Here we report that SSA inhibition is applicable to immunohistochemistry, localizing alpha 2,6-sialylated transferrin in the liver. Immunohistochemistry using anti-transferrin polyclonal antibody revealed that transferrin was detected in hepatocytes near interlobular veins. Addition of SSA lectin markedly attenuated the staining. Sialidase treatment of a liver section abolished SSA binding and concomitantly cancelled SSA inhibition, suggesting that SSA binding to glycan epitopes on the section was essential for the inhibition. To examine the importance of proximity between antigen epitopes and SSA-binding (glycosylation) sites, we prepared two anti-peptide antibodies against partial amino acid sequences of transferrin. One antibody (Tf-596Ab) is against a peptide sequence, Cys596-Ala614, which is proximal to N-glycosylation sites (Asn-432 and Asn-630). The other (Tf-120Ab) is against a peptide sequence, Val120-Cys137, distal to the sites. The staining signals of Tf-596Ab were reduced by the addition of SSA, whereas those of Tf-120Ab were reduced only a little. This result suggests that proximity of the antigen epitope to SSA binding sites is critical for SSA inhibition in immunohistochemistry.	[Matsumoto, Yuka; Saito, Kiyoshi] Fukushima Med Univ, Dept Neurosurg, Fukushima, Fukushima 9601295, Japan; [Saito, Toshie; Hoshi, Kyoka; Ito, Hiromi; Kariya, Yoshinobu; Hashimoto, Yasuhiro] Fukushima Med Univ, Dept Biochem, Fukushima, Fukushima 9601295, Japan; [Nagae, Masamichi; Yamaguchi, Yoshiki] RIKEN, RIKEN Max Planck Joint Res Ctr Syst Chem Biol, Global Res Cluster, Struct Glycobiol Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Hagiwara, Yoshiaki] Immunobiol Labs Co Ltd, Dept Biol Sci, Fujioka, Gunma 3750005, Japan; [Kinoshita, Noriaki] GeneticLab Co Ltd, Tyuou Ku, Sapporo, Hokkaido 060009, Japan; [Wada, Ikuo] Fukushima Med Univ, Dept Cell Sci, Fukushima, Fukushima 9601295, Japan; [Honda, Takashi] Fukushima Med Univ, Dept Human Life Sci, Fukushima, Fukushima 9601295, Japan; [Honda, Takashi; Hashimoto, Yasuhiro] Fukushima Med Univ, Fukushima Ind Univ Govt Res Ctr, Fukushima, Fukushima 9601295, Japan	Hashimoto, Y (reprint author), Fukushima Med Univ, Dept Biochem, Hikarigaoka 1, Fukushima, Fukushima 9601295, Japan.	ponchan@fmu.ac.jp; yasuc@fmu.ac.jp			Ministry of Health, Labor, and Welfare of Japan [2011-Nanchi-Ippan-018, 2014-Nanchi-Ippan-052]; Japan Science and Technology Agency [AS221Z00232F, AS231Z01053, 241FT0255, 149]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23110002, 23590367]	This work was supported by the Ministry of Health, Labor, and Welfare of Japan [2011-Nanchi-Ippan-018 and 2014-Nanchi-Ippan-052]; Japan Science and Technology Agency [AS221Z00232F, AS231Z01053, 241FT0255, and 149] and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (a Grant-in-Aid for Scientific Research on Innovative Areas, Deciphering sugar chain-based signals regulating integrative neuronal functions [23110002] and a Grant-in-Aid for Scientific Research [23590367]).	Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Futakawa S, 2012, NEUROBIOL AGING, V33, P1807, DOI 10.1016/j.neurobiolaging.2011.02.023; JUNGERMANN K, 1982, HEPATOLOGY, V2, P385; Debruyne EN, 2008, CLIN CHIM ACTA, V395, P19, DOI 10.1016/j.cca.2008.05.010; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; YAMASHITA K, 1995, CANCER RES, V55, P1675; Ashida H., 2007, COMPREHENSIVE GLYCOS, V3, P151; COURTOY PJ, 1981, LAB INVEST, V44, P105; Dam T.K., 2007, COMPREHENSIVE GLYCOS, V3, P397; FUKUSHIMA K, 1995, GLYCOBIOLOGY, V5, P105, DOI 10.1093/glycob/5.1.105; HARADA H, 1987, J CHROMATOGR, V407, P299, DOI 10.1016/S0021-9673(01)92627-5; Hoshi K, 2013, J BIOCHEM, V154, P229, DOI 10.1093/jb/mvt065; Kobata A., 2007, COMPREHENSIVE GLYCOS, V1, P39; Sugimoto I, 2007, J BIOL CHEM, V282, P34896, DOI 10.1074/jbc.M704766200; SUZUKI Y, 1987, BRIT J CANCER, V55, P147, DOI 10.1038/bjc.1987.30; Toyoda H., 2010, ONCOLOGY S1, V81, P5; Yamaji T, 2003, METHOD ENZYMOL, V363, P104	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					211	216		10.1093/jb/mvu071		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100005		
J	Miura, T				Miura, Toshiaki			The peroxidase activity of bleomycin-Fe3+ is associated with damage to biological components	JOURNAL OF BIOCHEMISTRY			English	Article						bleomycin-Fe3+; compound I-like species; hydroxyl radical; lipid hydroperoxide; peroxidase	ENZYMATIC REDUCTION; ACTIVATED BLEOMYCIN; LIPID-PEROXIDATION; IRON COMPLEXES; DNA; OXYGEN; MECHANISM; DEGRADATION; OXIDATION; 3,5,3,5-TETRAMETHYLBENZIDINE	In this study, bleomycin-Fe3+ steadily oxidized tetramethylbenzidine (TMB) in the presence of peroxides. However, the ability of bleomycin-Fe3+ to function as a peroxidase was extremely low compared with that of other peroxidases. A characteristic property of bleomycin-Fe3+ different from that observed for other peroxidases is its ability to oxidize TMB at the similar rate at both a pH 5 and 8 in the presence of lipid hydroperoxide (LOOH). In the present experiments, hydroxyl radicals (HO center dot) were generated only when bleomycin-Fe3+ was incubated with H2O2 at a pH of 5. No generation of HO center dot was observed during the incubation of bleomycin-Fe3+ with LOOH. Meanwhile, bleomycin-Fe3+ induced the formation of LOOH from linoleic acid and alcohol dehydrogenase was inactivated by bleomycin-Fe3+ with peroxides. Thiobarbituric acid reactive substances were formed from DNA by bleomycin-Fe3+ with H2O2, and strand breaks were caused by bleomycin-Fe3+ with LOOH. The oxidative substrates for bleomycin-Fe3+ blocked the damage to biological components induced by bleomycin-Fe3+. These results suggest that compound I-like species contribute to the process of damage to biological components induced by bleomycin-Fe3+.	Hokkaido Pharmaceut Univ, Dept Nat Sci, Sch Pharm, Otaru, Hokkaido 0470264, Japan	Miura, T (reprint author), Hokkaido Pharmaceut Univ, Dept Nat Sci, Sch Pharm, Katsuraoka Cho 7-1, Otaru, Hokkaido 0470264, Japan.	miurat@hokuyakudai.ac.jp			Hokkaido University of Science	This work was supported by the Research Fund of Hokkaido University of Science.	Marquez LA, 1997, BIOCHEMISTRY-US, V36, P9349, DOI 10.1021/bi970595j; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; MINOTTI G, 1989, CHEM-BIOL INTERACT, V71, P1, DOI 10.1016/0009-2797(89)90087-2; STUBBE J, 1987, CHEM REV, V87, P1107, DOI 10.1021/cr00081a011; Sener G, 2007, PULM PHARMACOL THER, V20, P642, DOI 10.1016/j.pupt.2006.07.003; SAUSVILLE EA, 1976, BIOCHEM BIOPH RES CO, V73, P814, DOI 10.1016/0006-291X(76)90882-2; JOSEPHY PD, 1982, J BIOL CHEM, V257, P3669; Chen JY, 2004, CURR OPIN CHEM BIOL, V8, P175, DOI 10.1016/j.cbpa.2004.02.008; Stubbe J, 1996, ACCOUNTS CHEM RES, V29, P322, DOI 10.1021/ar9501333; Claussen CA, 1999, CHEM REV, V99, P2797, DOI 10.1021/cr980449z; BLUM RH, 1973, CANCER, V31, P903, DOI 10.1002/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N; Chakrabarti S, 1996, FREE RADICAL BIO MED, V20, P777, DOI 10.1016/0891-5849(95)02160-4; Neese F, 2000, J AM CHEM SOC, V122, P11703, DOI 10.1021/ja001812y; BUETTNER GR, 1992, BIOCHEMISTRY-US, V31, P9784, DOI 10.1021/bi00155a035; BURGER RM, 1981, J BIOL CHEM, V256, P1636; BURGER RM, 1983, J BIOL CHEM, V258, P1559; CASPARY WJ, 1982, BIOCHEMISTRY-US, V21, P334, DOI 10.1021/bi00531a021; Dunford H.B., 1999, HEME PEROXIDASES, P219; Dunford H.B., 1999, HEME PEROXIDASES, P18; EKIMOTO H, 1985, J ANTIBIOT, V38, P1077; GAJEWSKI E, 1991, BIOCHEMISTRY-US, V30, P2444, DOI 10.1021/bi00223a021; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; KIKUCHI H, 1992, J ANTIBIOT, V45, P548; Kumar D, 2006, J AM CHEM SOC, V128, P16148, DOI 10.1021/ja064611o; LIN PS, 1983, CANCER RES, V43, P1049; MAHMUTOGLU I, 1987, ARCH TOXICOL, V60, P150, DOI 10.1007/BF00296969; PADBURY G, 1985, J BIOL CHEM, V260, P7820; PETERING DH, 1990, CHEM-BIOL INTERACT, V73, P133, DOI 10.1016/0009-2797(90)90001-4; RODRIGUEZ LO, 1982, BIOCHEM BIOPH RES CO, V104, P1470, DOI 10.1016/0006-291X(82)91416-4; SAUSVILLE EA, 1978, BIOCHEMISTRY-US, V17, P2746, DOI 10.1021/bi00607a008; TEROKUBOTA S, 1987, BIOCHEM INT, V14, P879; Uchida K., 2013, REDOX BIOL, V12, P94	32	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					217	224		10.1093/jb/mvu063		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100006		
J	Miyazaki, T; Yashiro, H; Nishikawa, A; Tonozuka, T				Miyazaki, Takatsugu; Yashiro, Hiroyuki; Nishikawa, Atsushi; Tonozuka, Takashi			The side chain of a glycosylated asparagine residue is important for the stability of isopullulanase	JOURNAL OF BIOCHEMISTRY			English	Article						crystal structure; glycoprotein; glycoside hydrolase; N-glycosylation; thermostability	N-LINKED GLYCANS; NIGER ATCC 9642; ASPERGILLUS-NIGER; ESCHERICHIA-COLI; PICHIA-PASTORIS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; DEXTRANASE GENE; PENICILLIUM-MINIOLUTEUM; ENDOPLASMIC-RETICULUM	N-glycosylation has been shown to be important for the stability of some glycoproteins. Isopullulanase (IPU), a polysaccharide-hydrolyzing enzyme, is a highly N-glycosylated protein, and IPU deglycosylation results in a decrease in thermostability. To investigate the function of N-glycan in IPU, we focused on an N-glycosylated residue located in the vicinity of the active site, Asn448. The thermostabilities of three IPU variants, Y440A, N448A and S450A, were 0.5-8.4 degrees C lower than the wild-type enzyme. The crystal structure of endoglycosidase H (Endo H)-treated N448A variant was determined. There are four IPU molecules, Mol-A, B, C and D, in the asymmetric unit. The conformation of a loop composed of amino acid residues 435-455 in Mol-C was identical to wildtype IPU, whereas the conformations of this loop in Mol-A, Mol-B and Mol-D were different from each other. These results suggest that the Asn448 side chain is primarily important for the stability of IPU. Our results indicate that mutation of only N-glycosylated Asn residue may lead to incorrect conclusion for the evaluation of the function of N-glycan. Usually, the structures of N-glycosylation sites form an extended configuration in IPU; however, the Asn448 site had an atypical structure that lacked this configuration.	[Miyazaki, Takatsugu; Yashiro, Hiroyuki; Nishikawa, Atsushi; Tonozuka, Takashi] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan	Tonozuka, T (reprint author), Tokyo Univ Agr & Technol, Dept Appl Biol Sci, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	tonozuka@cc.tuat.ac.jp	Tonozuka, Takashi/D-2268-2013		Japan Society for the Promotion of Science [26660277, 25-7279]; Japan Society for the Promotion of Science	This work was supported in part by a Grant-in-Aid for Scientific Research (T.T., No. 26660277; T.M., No. 25-7279) and a Research Fellowship (T.M.) of the Japan Society for the Promotion of Science.	Akeboshi H, 2004, EUR J BIOCHEM, V271, P4420, DOI 10.1111/j.1432-1033.2004.04378.x; Akeboshi H, 2003, BIOSCI BIOTECH BIOCH, V67, P1149; Price JL, 2011, P NATL ACAD SCI USA, V108, P14127, DOI 10.1073/pnas.1105880108; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Davies GJ, 1997, BIOCHEM J, V321, P557; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; IMPERIALI B, 1992, J AM CHEM SOC, V114, P3182, DOI 10.1021/ja00035a002; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; Lee JH, 2010, FOOD SCI BIOTECHNOL, V19, P757, DOI 10.1007/s10068-010-0106-y; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Aoki H, 1996, BIOSCI BIOTECH BIOCH, V60, P1795; Aoki H, 1997, BIOCHEM J, V323, P757; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clark SE, 2004, PROTEIN ENG DES SEL, V17, P245, DOI 10.1093/protein/gzh028; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Fonseca-Maldonado R, 2013, J BIOL CHEM, V288, P25522, DOI 10.1074/jbc.M113.485953; Garcia B, 1996, FEMS MICROBIOL LETT, V143, P175, DOI 10.1016/0378-1097(96)00303-5; Guerrero-Olazaran M, 2010, APPL ENVIRON MICROB, V76, P5601, DOI 10.1128/AEM.00762-10; IMPERIALI B, 1991, BIOCHEMISTRY-US, V30, P4374, DOI 10.1021/bi00232a002; Jafari-Aghdam J, 2005, BBA-PROTEINS PROTEOM, V1750, P61, DOI 10.1016/j.bbapap.2005.03.011; Kang HK, 2005, YEAST, V22, P1239, DOI 10.1002/yea.1311; Ko CY, 2012, J AGR FOOD CHEM, V60, P5169, DOI 10.1021/jf300945c; Koseki T, 2006, BIOSCI BIOTECH BIOCH, V70, P2476, DOI 10.1271/bbb.60207; Koseki T, 2006, BBA-GEN SUBJECTS, V1760, P1458, DOI 10.1016/j.bbagen.2006.04.009; Larsson AM, 2003, STRUCTURE, V11, P1111, DOI 10.1016/S0969-2126(03)00147-3; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Li XM, 2006, BIOTECHNOL LETT, V28, P1955, DOI 10.1007/S10529-006-9183-7; Lizak C., 2001, NATURE, V474, P350; Miyazaki T, 2011, GLYCOCONJUGATE J, V28, P563, DOI 10.1007/s10719-011-9356-z; Mizuno M, 2008, J MOL BIOL, V376, P210, DOI 10.1016/j.jmb.2007.11.098; Mizuno T, 1999, BIOSCI BIOTECH BIOCH, V63, P1582, DOI 10.1271/bbb.63.1582; Muller-Steffner H, 2010, PROTEIN EXPRES PURIF, V70, P151, DOI 10.1016/j.pep.2009.10.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oguma T, 1999, BIOSCI BIOTECH BIOCH, V63, P2174, DOI 10.1271/bbb.63.2174; OKUSHIMA M, 1991, JPN J GENET, V66, P173, DOI 10.1266/jjg.66.173; Padmajanti A., 2000, Journal of Applied Glycoscience, V47, P287; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; SAKANO Y, 1978, CARBOHYD RES, V61, P175, DOI 10.1016/S0008-6215(00)84478-X; SAKANO Y, 1972, ARCH BIOCHEM BIOPHYS, V153, P180, DOI 10.1016/0003-9861(72)90434-1; Tull D, 2001, PROTEIN EXPRES PURIF, V21, P13, DOI 10.1006/prep.2000.1348; Yanez E, 1998, BIOCHEM J, V329, P65; Zhao XH, 2012, BIORESOURCE TECHNOL, V110, P539, DOI 10.1016/j.biortech.2011.12.086	52	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					225	234		10.1093/jb/mvu065		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100007		
J	Izuta, Y; Taira, T; Asayama, A; Machigashira, M; Kinoshita, T; Fujiwara, M; Suzuki, ST				Izuta, Yusuke; Taira, Tetsuro; Asayama, Ayako; Machigashira, Mika; Kinoshita, Tsutomu; Fujiwara, Miwako; Suzuki, Shintaro T.			Protocadherin-9 involvement in retinal development in Xenopus laevis	JOURNAL OF BIOCHEMISTRY			English	Article						development; morpholino oligonucleotide; protocadherin-9; retina; Xenopus laevis	NON-CLUSTERED PROTOCADHERIN; N-CADHERIN; CELL-ADHESION; NERVOUS-SYSTEM; DELTA-PROTOCADHERINS; GAMMA-PROTOCADHERINS; OL-PROTOCADHERIN; MOUSE-BRAIN; EXPRESSION; ZEBRAFISH	Biological roles of most protocadherins (Pcdhs) are a largely unsolved problem. Therefore, we cloned cDNA for Xenopus laevis protocadherin-9 and characterized its properties to elucidate the role. The deduced amino acid sequence was highly homologous to those of mammalian protocadherin-9 s. X. laevis protocadherin-9 expressed from the cDNA in L cells showed basic properties similar to those of mammalian Pcdhs. Expression of X. laevis protocadherin-9 was first detected in stage-31 embryos and increased as the development proceeded. In the later stage embryos and the adults, the retina strongly expressed protocadherin-9, which was mainly localized at the plexiform layers. Injection of morpholino anti-sense oligonucleotide against protocadherin-9 into the fertilized eggs inhibited eye development; and eye growth and formation of the retinal laminar structure were hindered. Moreover, affected retina showed abnormal extension of neurites into the ganglion cell layer. Co-injection of protocadherin-9 mRNA with the morpholino anti-sense oligonucleotide rescued the embryos from the defects. These results suggest that X. laevis protocadherin-9 was involved in the development of retina structure possibly through survival of neurons, formation of the lamina structure and neurite localization.	[Izuta, Yusuke; Taira, Tetsuro; Asayama, Ayako; Machigashira, Mika; Fujiwara, Miwako; Suzuki, Shintaro T.] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan; [Kinoshita, Tsutomu] Rikkyo Univ, Rikkyo Coll Sci, Toshima Ku, Tokyo 1718501, Japan	Suzuki, ST (reprint author), Kwansei Gakuin Univ, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	stsuzuki@kwansei.ac.jp			Kwansei Gakuin University	This study was supported in part by grants-in-aid from Kwansei Gakuin University to S.T.S. (Kwansei Gakuin University Special Research Fund).	Redies C, 2005, CELL MOL LIFE SCI, V62, P2840, DOI 10.1007/s00018-005-5320-z; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Leung LC, 2013, NAT NEUROSCI, V16, P166, DOI 10.1038/nn.3290; Lele Z, 2002, DEVELOPMENT, V129, P3281; Murata Y, 2004, J BIOL CHEM, V279, P49508, DOI 10.1074/jbc.M408771200; Yoshida K, 1999, FEBS LETT, V460, P93, DOI 10.1016/S0014-5793(99)01309-5; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; Ozaki C, 2010, J BIOCHEM, V147, P415, DOI 10.1093/jb/mvp192; OCHMAN H, 1988, GENETICS, V120, P621; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Vanhalst K, 2005, CELL MOL LIFE SCI, V62, P1247, DOI 10.1007/s00018-005-5021-7; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Kitagawa M, 2000, BIOCHEM BIOPH RES CO, V271, P358, DOI 10.1006/bbrc.2000.2636; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Rattner A, 2001, NEURON, V32, P775, DOI 10.1016/S0896-6273(01)00531-1; SANO K, 1993, EMBO J, V12, P2249; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Tai K, 2010, BRAIN RES, V1344, P13, DOI 10.1016/j.brainres.2010.04.065; Dibbens LM, 2008, NAT GENET, V40, P776, DOI 10.1038/ng.149; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Blevins CJ, 2011, NEUROSCIENCE, V199, P523, DOI 10.1016/j.neuroscience.2011.09.061; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Asahina H, 2012, NEUROSCIENCE, V225, P88, DOI 10.1016/j.neuroscience.2012.09.006; Babb SG, 2005, DEV DYNAM, V233, P930, DOI 10.1002/dvdy.20431; Bolz H, 2005, MOL VIS, V11, P929; Chen XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008411; Chen Y., 2012, DEV NEUROBIOL, V73, P259; Erdmann B, 2003, DEV DYNAM, V226, P570, DOI 10.1002/dvdy.10266; Hirano S, 1999, J NEUROSCI, V19, P995; Hirano S., 2003, FRONT BIOSCI, V8, P306; Hoshina N, 2013, NEURON, V78, P839, DOI 10.1016/j.neuron.2013.03.031; Hynes K, 2010, J MED GENET, V47, P211, DOI 10.1136/jmg.2009.068817; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Malicki J, 2003, DEV BIOL, V259, P95, DOI 10.1016/S0012-1606(03)00181-7; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ostergaard E, 2010, J MED GENET, V47, P665, DOI 10.1136/jmg.2009.069120; Reiners J, 2005, MOL VIS, V11, P347; Ruan G, 2006, MECH DEVELOP, V123, P881, DOI 10.1016/j.mod.2006.08.010; Strehl S, 1998, GENOMICS, V53, P81, DOI 10.1006/geno.1998.5467; Tanabe K, 2004, DEV DYNAM, V229, P899, DOI 10.1002/dvdy.10493; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					235	249		10.1093/jb/mvu070		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100008		
J	Wijayanti, I; Watanabe, D; Oshiro, S; Takagi, H				Wijayanti, Indah; Watanabe, Daisuke; Oshiro, Satoshi; Takagi, Hiroshi			Isolation and functional analysis of yeast ubiquitin ligase Rsp5 variants that alleviate the toxicity of human alpha-synuclein	JOURNAL OF BIOCHEMISTRY			English	Article						alpha-synuclein; Rsp5; Saccharomyces cerevisiae; ubiquitin; WW domain	ACID PERMEASE GAP1; PARKINSONS-DISEASE; SACCHAROMYCES-CEREVISIAE; STRESS CONDITIONS; HEAT-SHOCK; CELLS; PHOSPHORYLATION; DEGRADATION; ENDOCYTOSIS; SYSTEM	The essential ubiquitin ligase Rsp5 is a key enzyme involved in the degradation of abnormal or unfavourable proteins in the yeast Saccharomyces cerevisiae. Overexpression of human alpha-synuclein (alpha-syn), a small lipid-binding protein implicated in several neurodegenerative diseases, in S. cerevisiae leads to growth inhibition due to many intracellular defects, including accumulation of reactive oxygen species (ROS). Here, to understand the mechanism of Rsp5-mediated detoxification of alpha-syn, we isolated novel Rsp5 variants (T255A, D295G, P343S and N427D), which conferred alpha-syn tolerance to yeast cells. Interestingly, these mutants were phenotypically distinguished from our previously identified RSP5(T357A) mutation, which increases ubiquitination of the general amino acid permease Gap1. Among them, the RSP5(P343S) substitution accelerated the degradation of alpha-syn, suppressed the accumulation of intracellular ROS and enhanced the interaction with alpha-syn and its ubiquitination. In contrast, the RSP5(T255A) mutation did not contribute to degradation of alpha-syn, but improved cell growth under acetate stress conditions, possibly leading to alleviation of the alpha-syn toxicity. Thus, these novel mutations might be useful not only in elucidating the molecular basis by which disused proteins are specifically recognized and effectively removed but also in screening drug candidates for neurodegenerative diseases or in improving ethanol production under acidic fermentation conditions.	[Wijayanti, Indah; Watanabe, Daisuke; Oshiro, Satoshi; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Takagi, H (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	hiro@bs.naist.jp			Global COE Program in NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment) from the Ministry of Education, Science, Culture, Sports and Technology of Japan; Nagase Science and Technology Foundation	This work was supported in part by Global COE Program in NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment) from the Ministry of Education, Science, Culture, Sports and Technology of Japan, and Nagase Science and Technology Foundation to D.W.	Westfall PJ, 2004, SCIENCE, V306, P1511, DOI 10.1126/science.1104879; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Sampaio-Marques B, 2012, AUTOPHAGY, V8, P1494, DOI 10.4161/auto.21275; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Fujii K, 2009, GENE DEV, V23, P963, DOI 10.1101/gad.1775609; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Sasaki T, 2013, GENES CELLS, V18, P459, DOI 10.1111/gtc.12049; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Hoshikawa C, 2003, P NATL ACAD SCI USA, V100, P11505, DOI 10.1073/pnas.1933153100; Mollapour M, 2007, MOL CELL BIOL, V27, P6446, DOI 10.1128/MCB.02205-06; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Wang GL, 1999, MOL CELL BIOL, V19, P342; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Griffioen G, 2006, BBA-MOL BASIS DIS, V1762, P312, DOI 10.1016/j.bbadis.2005.11.009; Haitani Y, 2009, FEMS YEAST RES, V9, P73, DOI 10.1111/j.1567-1364.2008.00460.x; Haitani Y, 2008, GENES CELLS, V13, P105, DOI 10.1111/j.1365-2443.2007.01154.x; Hiraishi H, 2009, FEBS J, V276, P5287, DOI 10.1111/j.1742-4658.2009.07226.x; Inaba T, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-74; Junn E, 2002, NEUROSCI LETT, V320, P146, DOI 10.1016/S0304-3940(02)00016-2; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Noda Y, 2010, J BIOL CHEM, V285, P15420, DOI 10.1074/jbc.M109.086272; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Uesugi S, 2014, FEMS YEAST RES, V14, P567, DOI 10.1111/1567-1364.12143	29	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0021-924X	1756-2651		J BIOCHEM	J. Biochem.	APR	2015	157	4					251	260		10.1093/jb/mvu069		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CG7ZT	WOS:000353527100009		
J	Tang, YQ; Shigematsu, T; Morimura, S; Kida, K				Tang, Yue-Qin; Shigematsu, Toru; Morimura, Shigeru; Kida, Kenji			Dynamics of the microbial community during continuous methane fermentation in continuously stirred tank reactors	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Review						Microbial community; Continuous stirred tank reactor; Continuous methane fermentation; Anaerobic digestion; Phylogenetic analysis; Chemostat	DEGRADING METHANOGENIC CONSORTIUM; CHEMOSTAT CULTIVATION; WASTE-WATER; DILUTION RATE; ANAEROBIC-DIGESTION; SOLID-WASTE; SP NOV.; ACETATE; PERFORMANCE; DIVERSITY	Methane fermentation is an attractive technology for the treatment of organic wastes and wastewaters. However, the process is difficult to control, and treatment rates and digestion efficiency require further optimization. Understanding the microbiology mechanisms of methane fermentation is of fundamental importance to improving this process. In this review, we summarize the dynamics of microbial communities in methane fermentation chemostats that are operated using completely stirred tank reactors (CSTRs). Each chemostat was supplied with one substrate as the sole carbon source. The substrates include acetate, propionate, butyrate, long-chain fatty acids, glycerol, protein, glucose, and starch. These carbon sources are general substrates and intermediates of methane fermentation. The factors that affect the structure of the microbial community are discussed. The carbon source, the final product, and the operation conditions appear to be the main factors that affect methane fermentation and determine the structure of the microbial community. Understanding the structure of the microbial community during methane fermentation will guide the design and operation of practical wastewater treatments. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Tang, Yue-Qin; Kida, Kenji] Sichuan Univ, Coll Architecture & Environm, Chengdu 610065, Sichuan, Peoples R China; [Shigematsu, Toru] Niigata Univ Pharm & Appl Life Sci, Fac Appl Life Sci, Dept Food Sci, Akiha Ku, Niigata, Niigata 9568603, Japan; [Morimura, Shigeru] Kumamoto Univ, Grad Sch Sci & Technol, Chuo Ku, Kumamoto 8600862, Japan	Tang, YQ (reprint author), Sichuan Univ, Coll Architecture & Environm, 24,South Sect 1,First Ring Rd, Chengdu 610065, Sichuan, Peoples R China.	tangyq@scu.edu.cn					Hattori S, 2000, INT J SYST EVOL MICR, V50, P1601; Tang YQ, 2008, J BIOSCI BIOENG, V106, P180, DOI 10.1263/jbb.106.180; Tang YQ, 2004, WATER RES, V38, P2537, DOI 10.1016/j.watres.2004.03.012; Fernandez AS, 2000, APPL ENVIRON MICROB, V66, P4058, DOI 10.1128/AEM.66.9.4058-4067.2000; Fang HHP, 2002, J BIOTECHNOL, V93, P99, DOI 10.1016/S0168-1656(01)00397-2; Carballa M, 2011, APPL MICROBIOL BIOT, V89, P303, DOI 10.1007/s00253-010-2858-y; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Shigematsu T, 2004, APPL ENVIRON MICROB, V70, P4048, DOI 10.1128/AEM.70.7.4048-4052.2004; Ito T, 2011, ISME J, V5, P1844, DOI 10.1038/ismej.2011.59; Tang YQ, 2007, APPL MICROBIOL BIOT, V75, P451, DOI 10.1007/s00253-006-0819-2; Shigematsu T, 2006, J BIOSCI BIOENG, V102, P535, DOI 10.1263/jbb.102.535; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Tang YQ, 2005, J BIOSCI BIOENG, V99, P150, DOI 10.1263/jbb.99.150; Kundu K, 2013, J BIOTECHNOL, V168, P616, DOI 10.1016/j.jbiotec.2013.08.023; Hashsham SA, 2000, APPL ENVIRON MICROB, V66, P4050, DOI 10.1128/AEM.66.9.4050-4057.2000; ZEIKUS JG, 1977, BACTERIOL REV, V41, P514; Chong SC, 2002, ANTON LEEUW INT J G, V81, P263, DOI 10.1023/A:1020535222281; Ferry James G., 1993, P304; Kobayashi T, 2014, J ENVIRON SCI-CHINA, V26, P423, DOI 10.1016/S1001-0742(13)60423-4; Krakat N, 2010, APPL ENVIRON MICROB, V76, P6322, DOI 10.1128/AEM.00927-10; Liu K, 2009, J BIOSCI BIOENG, V107, P54, DOI 10.1016/j.jbiosc.2008.09.007; LOVLEY DR, 1982, APPL ENVIRON MICROB, V43, P552; MACKIE RI, 1981, APPL ENVIRON MICROB, V41, P1363; Milcucki J. A., 2003, APPL ENVIRON MICROB, V69, P3311; MOUNTFORT DO, 1978, APPL ENVIRON MICROB, V35, P648; Panichnumsin P, 2012, WATER SCI TECHNOL, V66, P1590, DOI 10.2166/wst.2012.358; POL LH, 1986, WATER SCI TECHNOL, V18, P41; Sasaki D, 2011, J BIOSCI BIOENG, V111, P41, DOI 10.1016/j.jbiosc.2010.08.011; Schink B., 2002, PROKARYOTES EVOLVING; Shigematsu T, 2003, J BIOSCI BIOENG, V96, P547, DOI 10.1016/S1389-1723(04)70148-6; Shigematsu T., 2009, Seibutsu-kogaku Kaishi, V87, P570; Shigematsu T., 2003, YOSUI TO HAISUI, V45, P866; Shigematsu T, 2006, APPL MICROBIOL BIOT, V72, P401, DOI 10.1007/s00253-005-0275-4; Tang YQ, 2007, J BIOSCI BIOENG, V104, P281, DOI 10.1263/jbb.104.281; Zellner G, 1998, INT J SYST BACTERIOL, V48, P1111; Zinder SH, 1993, METHANOGENESIS ECOLO, V1, P128	37	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					375	383		10.1016/j.jbiosc.2014.09.014		9	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900001		
J	Sharmin, D; Sasano, Y; Sugiyama, M; Harashima, S				Sharmin, Dilruba; Sasano, Yu; Sugiyama, Minetaka; Harashima, Satoshi			Type 2C protein phosphatase Ptc6 participates in activation of the Slt2-mediated cell wall integrity pathway in Saccharomyces cerevisiae	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Protein phosphatase 2C; PTC6; Stress response; Slt2 pathway; Functional redundancy; Saccharomyces cerevisiae	YEAST; KINASE; MAINTENANCE; INHERITANCE; RESPONSES; COMPLEX; STRESS; ROLES; SED1P; PCR	The phosphorylation status of cellular proteins results from an equilibrium between the activities of protein kinases and protein phosphatases (PPases). Reversible protein phosphorylation is an important aspect of signal transduction that regulate many biological processes in eukaryotic cells. The Saccharomyces cerevisiae genome encodes 40 PPases, including seven members of the protein phosphatase 2C subfamily (PTO to PTC7). In contrast to other PPases, the cellular roles of Pits have not been investigated in detail. Here, we sought to determine the cellular role of PTC6 in S. cerevisiae with disruption of PTC genes. We found that cells with Delta ptc6 disruption were tolerant to the cell wall-damaging agents Congo red (CR) and calcofluor white (CFW); however, cells with simultaneous disruption of PTC1 and PTC6 were very sensitive to these agents. Thus, simultaneous disruption of PTC1 and PTC6 gave a synergistic response to cell wall damaging agents. The level of phosphorylated Slt2 increased significantly after CR treatment in Delta ptc1 cells and more so in Delta ptc1 Delta ptc6 cells; therefore, deletion of PTC6 enhanced Slt2 phosphorylation in the Delta ptc1 disruptant. The level of transcription of KIWI upon exposure to CR increased to a greater extent in the Delta ptc1 Delta ptc6 double disruptant than the Delta ptcl single disruptant. The Delta ptcl Delta ptc6 double disruptant cells showed normal vacuole formation under standard growth conditions, but fragmented vacuoles were present in the presence of CR or CFW. Our analyses indicate that S. cerevisiae PTC6 participates in the negative regulation of Slt2 phosphorylation and vacuole morphogenesis under cell wall stress conditions. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Sharmin, Dilruba; Sasano, Yu; Sugiyama, Minetaka; Harashima, Satoshi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan	Harashima, S (reprint author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	harashima@bio.eng.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [19380193]	This work was partially supported by a Grant-in-Aid for Scientific Research B, 19380193, 2007 to 2009, to S. H. from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We are also grateful to the National Bio-Resource Project (NBRP) of the MEXT, Japan for providing strain (YEp51B-VPS73).	Markovich S, 2004, ANTIMICROB AGENTS CH, V48, P3871, DOI 10.1128/AAC.48.10.3871-3876.2004; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Garcia R, 2009, J BIOL CHEM, V284, P10901, DOI 10.1074/jbc.M808693200; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Hermansyah, 2009, ARCH MICROBIOL, V191, P721, DOI 10.1007/s00203-009-0498-3; Phadnis N, 2004, J MOL BIOL, V342, P1115, DOI 10.1016/j.jmb.2004.07.096; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; An XX, 2006, GENETICS, V173, P63, DOI 10.1534/genetics.105.055236; ROBINSON MK, 1994, MOL CELL BIOL, V14, P3634; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Li X, 2010, MOL BIOL CELL, V21, P1772, DOI 10.1091/mbc.E09-06-0532; Shirahige K, 1998, NATURE, V395, P618; Zhao YY, 2012, FEMS YEAST RES, V12, P897, DOI 10.1111/j.1567-1364.2012.00840.x; Journo D, 2009, J BIOL CHEM, V284, P35885, DOI 10.1074/jbc.M109.048140; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.213585100; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Jin Y, 2009, MOL BIOL CELL, V20, P1312, DOI 10.1091/mbc.E08-09-0954; Shimoi H, 1998, J BACTERIOL, V180, P3381; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Arifio J., 2011, EUKARYOT CELL, V10, P21; Cabib E, 2009, EUKARYOT CELL, V8, P1626, DOI 10.1128/EC.00228-09; Carrion N. P., 2013, APPL ENVIRON MICROB, V79, P6459; Dalmau J. F., 2010, J BIOL CHEM, V426, P355; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Gonzalez A, 2009, MOL CELL BIOL, V29, P2876, DOI 10.1128/MCB.01740-08; Gonzalez A, 2006, J BIOL CHEM, V281, P35057, DOI 10.1074/jbc.M607919200; Gonzalez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064470; Lavina W. A., 2012, J BIOSCI BIOENG, V115, P138; Lavina W.A., 2013, J BIOSCI BIOENG, V117, P135; Sharmin D., 2014, YEAST, V10, P393; [Anonymous], 1991, METHOD ENZYMOL; Strathern J. N., 2005, METHODS YEAST GENETI; Warmka J, 2001, MOL CELL BIOL, V21, P51, DOI 10.1128/MCB.21.1.51-60.2001; Zhang JZ, 2012, ADV EXP MED BIOL, V751, P279, DOI 10.1007/978-1-4614-3567-9_13	41	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					392	398		10.1016/j.jbiosc.2014.09.013		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900003		
J	Srichaisupakit, A; Ohashi, T; Misaki, R; Fujiyama, K				Srichaisupakit, Akkaraphol; Ohashi, Takao; Misaki, Ryo; Fujiyama, Kazuhito			Production of initial-stage eukaryotic N-glycan and its protein glycosylation in Escherichia coli	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Campylobacter jejuni; Escherichia coli; N-Glycan analysis; Eukaryotic N-glycosylation; Glycosyltransferase; PglB; Saccharomyces cerevisiae	CAMPYLOBACTER-JEJUNI; LINKED GLYCOSYLATION; BACTERIAL OLIGOSACCHARYLTRANSFERASE; ENDOPLASMIC-RETICULUM; CONSENSUS SEQUENCE; HMW1 ADHESIN; RFE-GENE; BIOSYNTHESIS; EXPRESSION; GLYCOPROTEIN	N-Glycosylation is a ubiquitous protein post-translational modification mechanism in eukaryotes. In this work, a synthetic pathway containing glycosyltransferases from Saccharomyces cerevisiae was introduced to Escherichia coli to synthesize lipid-linked mannosyl-chitobiose (Man-GlcNAc(2)) and trimannosyl-chitobiose (Man(3)-GlcNAc(2)). Transfer of Man(3)-GlcNAc(2) onto a model periplasmic protein occurred in the engineered E. con cell using oligosaccharyltransferase PglB. from Campylobacter jejuni. Mass spectrometric analysis of the fluorescently labeled N-glycan indicated a glycan signal composed of 2 HexNAc and 3 Hex residues. The reversed-phase HPLC analysis suggested that the Hex residues were alpha 1,3-, alpha 1,6- and beta 1,4-linked mannoses. These results indicated that the constructed system synthesizes a Man(3)-GlcNAc(2), identical to that observed in an early eukaryotic dolichol pathway. Finally, glycopeptide mass spectrometry confirmed the transfer of the assembled glycan moiety onto an engineered glycosylation motif of recombinant maltose binding protein. Surprisingly, the Man(3)-GlcNAc(2) structure but not Man-GlcNAc(2) was transferred onto maltose binding protein. This work showed that PglB protein might be able to accommodate the transfer of the further engineered glycan with greater complexity. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Srichaisupakit, Akkaraphol; Ohashi, Takao; Misaki, Ryo; Fujiyama, Kazuhito] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan	Fujiyama, K (reprint author), Osaka Univ, Int Ctr Biotechnol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	fujiyama@icb.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25630378]	We thank Dr. Hiroyuki Kajiura for his excellent technical assistance in the nanoLC-MS analysis. This study was supported by a Grant-in-Aid for Challenging Exploratory Research (No. 25630378) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to K. F.	ALEXANDER DC, 1994, J BACTERIOL, V176, P7079; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; Gao XD, 2008, J BIOL CHEM, V283, P32534, DOI 10.1074/jbc.M804060200; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Olivier NB, 2006, BIOCHEMISTRY-US, V45, P13659, DOI 10.1021/bi061456h; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Sturla L, 1997, FEBS LETT, V412, P126, DOI 10.1016/S0014-5793(97)00762-X; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Lu JS, 2012, GLYCOBIOLOGY, V22, P504, DOI 10.1093/glycob/cwr162; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; BOLIVAR F, 1977, GENE, V2, P95; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Voisin S, 2005, J BIOL CHEM, V280, P16586, DOI 10.1074/jbc.M500329200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Gao XD, 2005, J BIOL CHEM, V280, P36254, DOI 10.1074/jbc.M507569200; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Fisher AC, 2011, APPL ENVIRON MICROB, V77, P871, DOI 10.1128/AEM.01901-10; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Wildt S, 2005, NAT REV MICROBIOL, V3, P119, DOI 10.1038/nrmicro1087; STGEME JW, 1994, INFECT IMMUN, V62, P3881; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujiyama K, 2006, J BIOSCI BIOENG, V101, P212, DOI 10.1263/jbb.101.212; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Glover KJ, 2005, CHEM BIOL, V12, P1311, DOI 10.1016/j.chembiol.2005.10.004; Kelleher D. J., 2006, GLYCOBIOLOGY, V16, p47R; Nita-Lazar M, 2005, GLYCOBIOLOGY, V15, P361, DOI 10.1093/glycob/cwi019; REVERS L, 1994, BIOCHEM J, V299, P23; Sambrook J, 2001, MOL CLONING LAB MANU; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Srichaisupakit A, 2014, J BIOSCI BIOENG, V118, P256, DOI 10.1016/j.jbiosc.2014.02.011; Swartz JR, 2001, CURR OPIN BIOTECH, V12, P195, DOI 10.1016/S0958-1669(00)00199-3; Valderrama-Rincon JD, 2012, NAT CHEM BIOL, V8, P434, DOI [10.1038/nchembio.921, 10.1038/NCHEMBIO.921]; Weerapana E, 2005, J AM CHEM SOC, V127, P13766, DOI 10.1021/ja054265v; YAMADA M, 1993, J BACTERIOL, V175, P5539; Yan Qi, 2002, Journal of Biological Chemistry, V277, P47692, DOI 10.1074/jbc.M208136200	53	1	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					399	405		10.1016/j.jbiosc.2014.09.016		7	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900004		
J	David, BG; Okamoto, K; Kakizuka, T; Ichimura, T; Watanabe, TM; Fujita, H				David, Brit G.; Okamoto, Kazuko; Kakizuka, Taishi; Ichimura, Taro; Watanabe, Tomonobu M.; Fujita, Hideaki			Gene dynamics of core transcription factors for pluripotency in embryonic stem cells	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Embryonic stem cell; Nanog; Oct3/4; Sox2; Imaging	SELF-RENEWAL; ES CELLS; NANOG; EXPRESSION; OCT4; SOX2	Embryonic stem cell (ESC) pluripotency is maintained by core transcription factors (TFs). Although the expression of these TFs is well documented, their expression dynamics is poorly evaluated. Here, we visualized the dynamics of Nanog and Oct3/4 expression in ESC using fluorescent reporters and found that expression of these TFs change dramatically during culture. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[David, Brit G.; Kakizuka, Taishi; Watanabe, Tomonobu M.; Fujita, Hideaki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Okamoto, Kazuko; Ichimura, Taro; Watanabe, Tomonobu M.; Fujita, Hideaki] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka 5650874, Japan; [Fujita, Hideaki] Osaka Univ, Immunol Frontier Res Ctr IFReC, WPI, Suita, Osaka 5650871, Japan	Fujita, H (reprint author), RIKEN, QBiC, Comprehens Bioimaging Grp, 6-2-3 Furue Dai, Suita, Osaka 5650874, Japan.	hideaki.fujita@riken.jp	Ichimura, Taro/E-2792-2010; Fujita, Hideaki/B-7633-2008				Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Descalzo SM, 2012, STEM CELLS, V30, P2683, DOI 10.1002/stem.1230; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Ariasi AM, 2011, CURR OPIN CELL BIOL, V23, P650, DOI 10.1016/j.ceb.2011.09.007	19	0	1	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					406	409		10.1016/j.jbiosc.2014.09.011		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900005		
J	Yamada, M; Adachi, K; Ogawa, N; Kishino, S; Ogawa, J; Kataoka, M; Shimizu, S; Isobe, K				Yamada, Miwa; Adachi, Keika; Ogawa, Natsumi; Kishino, Shigenobu; Ogawa, Jun; Kataoka, Michihiko; Shimizu, Sakayu; Isobe, Kimiyasu			A new aldehyde oxidase catalyzing the conversion of glycolaldehyde to glycolate from Burkholderia sp AIU 129	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Aldehyde oxidase; Glycolaldehyde; Glycolic acid; Burkholderia sp.; Xanthine oxidase/dehydrogenase	ALCOHOL OXIDASE; ETHYLENE-GLYCOL; PURIFICATION; MICROORGANISMS; OXIDATION; SEQUENCE	We found a new aldehyde oxidase (ALOD), which catalyzes the conversion of glycolaldehyde to glycolate, from Burkholderia sp. AIU 129. The enzyme further oxidized aliphatic aldehydes, an aromatic aldehyde, and glyoxal, but not glycolate or alcohols. The molecular mass of this enzyme was 130 kDa, and it was composed of three different subunits (alpha beta gamma structure), in which the alpha, beta, and gamma subunits were 76 kDa, 36 kDa, and 14 kDa, respectively. The N-terminal amino acid sequences of each subunit showed high similarity to those of putative subunits of xanthine dehydrogenase. Metals (copper, iron and molybdenum) and chelating reagents (alpha,alpha'-dipyridyl and 8-hydroxyquinoline) inhibited the ALOD activity. The ALOD showed highest activity at pH 6.0 and 50 degrees C. Twenty mM glycolaldehyde was completely converted to glycolate by incubation at 30 degrees C for 3 h, suggesting that the ALOD found in this study would be useful for enzymatic production of glycolate. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Yamada, Miwa; Adachi, Keika; Ogawa, Natsumi; Isobe, Kimiyasu] Iwate Univ, Dept Biol Chem & Food Sci, Morioka, Iwate 0208550, Japan; [Kishino, Shigenobu; Ogawa, Jun; Shimizu, Sakayu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Kataoka, Michihiko] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Naka Ku, Sakai, Osaka 5998531, Japan; [Shimizu, Sakayu] Kyoto Gakuen Univ, Fac Bioenvironm Sci, Kameoka 6218555, Japan	Isobe, K (reprint author), Iwate Univ, Dept Biol Chem & Food Sci, Ueda 3, Morioka, Iwate 0208550, Japan.	kiso@iwate-u.ac.jp	Kataoka, Michihiko/E-5847-2011; 	Kishino, Shigenobu/0000-0002-4587-2422	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [25820395]	The work described here was supported by a Grant-in-Aid for Scientific Research of Japan (no. 25820395) (to M. Yamada), from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Kataoka M, 2001, BIOSCI BIOTECH BIOCH, V65, P2265, DOI 10.1271/bbb.65.2265; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; COUDERC R, 1980, AGR BIOL CHEM TOKYO, V44, P2279; Cunha CD, 2012, J BACTERIOL, V194, P6675, DOI 10.1128/JB.01821-12; DELEY J, 1964, BACTERIOL REV, V28, P164; HARADA T, 1968, AGR BIOL CHEM TOKYO, V32, P1175; Isobe K, 1995, J MOL CATAL B-ENZYM, V1, P37, DOI 10.1016/1381-1177(95)00008-9; Neumann M, 2008, FEBS J, V275, P5678, DOI 10.1111/j.1742-4658.2008.06694.x; Sasaki Y, 2008, J BIOSCI BIOENG, V106, P297, DOI 10.1263/jbb.106.297; Thiwthong R, 2008, MICROB BIOTECHNOL, V1, P395, DOI 10.1111/j.1751-7915.2008.00038.x; Uchida H, 2005, APPL MICROBIOL BIOT, V68, P53, DOI 10.1007/s00253-005-1894-5; Uchida H, 2003, FEMS MICROBIOL LETT, V229, P31, DOI 10.1016/S0378-1097(03)00781-X; Uchida H, 2006, WORLD J MICROB BIOT, V22, P469, DOI 10.1007/s11274-005-9058-4; UWAJIMA T, 1980, AGR BIOL CHEM TOKYO, V44, P399; Yamada M, 2014, J MOL CATAL B-ENZYM, V105, P41, DOI 10.1016/j.molcatb.2014.03.022; Yasuhara A, 2002, J BIOSCI BIOENG, V94, P124, DOI 10.1263/jbb.94.124	19	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					410	415		10.1016/j.jbiosc.2014.09.005		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900006		
J	Kadoya, R; Kodama, Y; Matsumoto, K; Taguchi, S				Kadoya, Ryosuke; Kodama, Yu; Matsumoto, Ken'ichiro; Taguchi, Seiichi			Enhanced cellular content and lactate fraction of the poly(lactate-co-3-hydroxybutyrate) polyester produced in recombinant Escherichia coli by the deletion of sigma factor RpoN	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Polyhydroxyalkanoate; Polyhydroxybutyrate; Poly(lactic acid); Biobased plastic; sigma factor	MICROBIAL-PRODUCTION; GENE DOSAGE; ENZYME; MUTATIONS	A new approach at the transcriptional level was applied to lactate-based polyester production. Four sigma factor disruptants, Delta rpoN, Delta rpoS, Delta fliA and Delta fecl, of Escherichia con were used as hosts for poly(lactate-co-3-hydroxybutyrate) production from glucose. Among them, Delta rpoN caused dual positive effects of polymer production, enhanced cellular content and lactate fraction. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Kadoya, Ryosuke; Kodama, Yu; Matsumoto, Ken'ichiro; Taguchi, Seiichi] Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Kadoya, Ryosuke; Taguchi, Seiichi] JST, CREST, Chiyoda Ku, Tokyo, Japan	Taguchi, S (reprint author), Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, N13-W8, Sapporo, Hokkaido 0608628, Japan.	staguchi@eng.hokudai.ac.jp			CREST, JST	We are grateful to the National BioResource Project, Japan, for providing the Keio collection strains and the rpoN-overexpression plasmid in ASKA clone. This study was partly supported by the CREST, JST.	Aldor Ilana S., 2003, Current Opinion in Biotechnology, V14, P475, DOI 10.1016/j.copbio.2003.09.002; Yamada M, 2010, BIOMACROMOLECULES, V11, P815, DOI 10.1021/bm901437z; Shozui F, 2010, BIOSCI BIOTECH BIOCH, V74, P1710, DOI 10.1271/bbb.100224; Yamada M, 2011, J BIOTECHNOL, V154, P255, DOI 10.1016/j.jbiotec.2011.05.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsumoto K, 2010, APPL MICROBIOL BIOT, V85, P921, DOI 10.1007/s00253-009-2374-0; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Zhao K, 2010, NUCLEIC ACIDS RES, V38, P1273, DOI 10.1093/nar/gkp1123; Jo SJ, 2007, J BIOSCI BIOENG, V104, P457, DOI 10.1263/jbb.104.457; Yamada M, 2009, BIOMACROMOLECULES, V10, P677, DOI 10.1021/bm8013846; Osanai T, 2013, DNA RES, V20, P525, DOI 10.1093/dnares/dst028; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Baba Tomoya, 2006, Mol Syst Biol, V2; Maehara A, 1998, BIOTECHNOL BIOENG, V60, P61, DOI 10.1002/(SICI)1097-0290(19981005)60:1<61::AID-BIT7>3.0.CO;2-Z; Matsumoto K, 2013, APPL ENVIRON MICROB, V79, P6134, DOI 10.1128/AEM.01768-13; Taguchi Seiichi, 2004, Macromol Biosci, V4, P146; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4	17	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					427	429		10.1016/j.jbiosc.2014.09.001		3	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900009		
J	Ayano, H; Kuroda, M; Soda, S; Ike, M				Ayano, Hiroyuki; Kuroda, Masashi; Soda, Satoshi; Ike, Michihiko			Effects of culture conditions of Pseudomonas aeruginosa strain RB on the synthesis of CdSe nanoparticles	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Pseudomonas aeruginosa; Cadmium selenide nanoparticles; Selenite reduction; Cadmium resistance; Optimization	FUSARIUM-OXYSPORUM; QUANTUM DOTS; DIVERSITY; SELENITE; FUNGUS	Cadmium selenide (CdSe) was synthesized by Pseudomonas aeruginosa strain RB in a culture containing lactic add as a carbon source, 1 mM selenite, and 1 mM cadmium under various conditions. High purity (1.02-1.16 of the atomic ratio of Se to Cd) and efficient synthesis of biogenic CdSe nanoparticles were observed at 25-30 degrees C, 0.05-10 g L-1 NaCl, and neutral pH conditions compared with other tested conditions. However, the size and shape of synthesized CdSe nanoparticles were not changed by changing culture conditions. The contents of S and Se in the particles respectively increased under alkaline and weak acidic conditions. Furthermore, high temperature (>37 degrees C), high salinity (>10 g L-1 NaCl), and alkaline pH affected the CdSe synthesizing rate by strain RB. This report is the first optimizing the culture conditions for synthesizing biogenic CdSe nanoparticles in a batch processing. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Ayano, Hiroyuki; Kuroda, Masashi; Soda, Satoshi; Ike, Michihiko] Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Suita, Osaka 5650871, Japan	Ike, M (reprint author), Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	ike@see.eng.osaka-u.ac.jp					Cui R, 2009, ADV FUNCT MATER, V19, P2359, DOI 10.1002/adfm.200801492; Gurunathan S, 2009, COLLOID SURFACE B, V74, P328, DOI 10.1016/j.colsurfb.2009.07.048; De M, 2008, ADV MATER, V20, P4225, DOI 10.1002/adma.200703183; Konishi Y, 2007, ELECTROCHIM ACTA, V53, P186, DOI 10.1016/j.electacta.2007.02.073; Kumar SA, 2007, J BIOMED NANOTECHNOL, V3, P190, DOI 10.1166/jbn.2007.027; Ayano H, 2014, J BIOSCI BIOENG, V117, P576, DOI 10.1016/j.jbiosc.2013.10.010; Masala O, 2004, ANNU REV MATER RES, V34, P41, DOI 10.1146/annurev.matsci.34.052803.090949; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/10399710290038972; Sanghi R, 2009, CHEM ENG J, V155, P886, DOI 10.1016/j.cej.2009.08.006; Ahmad A, 2002, J AM CHEM SOC, V124, P12108, DOI 10.1021/ja0272960o; He SY, 2008, BIOTECHNOL PROGR, V24, P476, DOI 10.1021/bp0703174; Park TJ, 2010, ANGEW CHEM INT EDIT, V49, P7019, DOI 10.1002/anie.201001524; Kuroda M, 2011, J BIOSCI BIOENG, V112, P259, DOI 10.1016/j.jbiosc.2011.05.012; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Ayano H., 2014, GENOME ANNOUNC, V2; Grimont PAD, 1996, SYST APPL MICROBIOL, V19, P510; Mohammed F. A., 2009, COLLOID SURFACE B, V74, P123, DOI DOI 10.1016/J.C0LSURFB2009.07.002; Ogasawara Y, 2001, P NATL ACAD SCI USA, V98, P9494, DOI 10.1073/pnas.171320998; Pearce C. I., 2008, NANOTECHNOLOGY, V19; Yan Z., 2014, MAT RES EXPRESS, V1	20	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					440	445		10.1016/j.jbiosc.2014.09.021		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900012		
J	Ishii, Y; Imamoto, Y; Yamamoto, R; Tsukahara, M; Wakamatsu, K				Ishii, Yoichi; Imamoto, Yasufumi; Yamamoto, Rie; Tsukahara, Masayoshi; Wakamatsu, Kaori			Titer of trastuzumab produced by a Chinese hamster ovary cell line is associated with tricarboxylic acid cycle activity rather than lactate metabolism	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Antibody aggregate; Antibody productivity; Antibody quality; Cell line; Fucosylation; Lactate metabolism shift; Chinese hamster ovary cell; Oxidative stress; Therapeutic antibody; Tricarboxylic acid cycle intermediates	CHO-CELLS; CULTURE; GLYCOSYLATION; AMMONIA; DITYROSINE; OXIDATION; SHIFT; GLUTATHIONE; PERFORMANCE; CONSUMPTION	Achieving high productivity and quality is the final goal of therapeutic antibody development, but the productivity and quality of antibodies are known to be substantially dependent on the nature of the cell lines expressing the antibodies. We characterized two contrasting cell lines that produce trastuzumab, namely cell line A with a high titer and a low aggregate content and cell line B with a low titer and a high aggregate content to identify the causes of the differences. We observed the following differences: cell growth (A > B), proportion of defucosylated oligosaccharides on antibodies (A < B), and proportion of covalent antibody aggregates (A > B). Our results suggest that the high monoclonal antibody (mAb) titers in cell line A is associated with the high proliferation and is not caused by the lactate metabolism shift (switching from lactate production to net lactate consumption). Rather, these differences can be accounted for by the following: levels of tricarboxylic acid cycle intermediates (A > B), ammonium ion levels (A B), and oxidative stress (A > B). (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Ishii, Yoichi; Imamoto, Yasufumi; Yamamoto, Rie] Kyowa Hakko Kirin Co Ltd, Bioproc Res & Dev Labs, Takasaki, Gunma 3700013, Japan; [Tsukahara, Masayoshi] Kyowa Hakko Kirin Co Ltd, Chiyoda Ku, Tokyo 1008185, Japan; [Ishii, Yoichi; Wakamatsu, Kaori] Gunma Univ, Grad Sch Engn, Kiryu, Gunma 3768515, Japan	Ishii, Y (reprint author), Kyowa Hakko Kirin Co Ltd, Bioproc Res & Dev Labs, 100-1 Hagiwara Machi, Takasaki, Gunma 3700013, Japan.	yoichi.ishii@kyowa-kirin.co.jp					BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Gagnon M, 2011, BIOTECHNOL BIOENG, V108, P1328, DOI 10.1002/bit.23072; Mahler HC, 2009, J PHARM SCI-US, V98, P2909, DOI 10.1002/jps.21566; Zagari F, 2013, NEW BIOTECHNOL, V30, P238, DOI 10.1016/j.nbt.2012.05.021; Rivinoja A, 2012, ANN MED, V44, P542, DOI 10.3109/07853890.2011.579150; Mulukutla BC, 2012, METAB ENG, V14, P138, DOI 10.1016/j.ymben.2011.12.006; Elvin JG, 2013, INT J PHARMACEUT, V440, P83, DOI 10.1016/j.ijpharm.2011.12.039; Huhn C, 2009, PROTEOMICS, V9, P882, DOI 10.1002/pmic.200800715; Yang M, 2002, BIOTECHNOL PROGR, V18, P129, DOI 10.1021/bp0101334; Schneider M, 1996, J BIOTECHNOL, V46, P161, DOI 10.1016/0168-1656(95)00196-4; Luo J, 2012, BIOTECHNOL BIOENG, V109, P146, DOI 10.1002/bit.23291; Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0; BORYS MC, 1994, BIOTECHNOL BIOENG, V43, P505, DOI 10.1002/bit.260430611; Gadgil HS, 2006, J AM SOC MASS SPECTR, V17, P867, DOI 10.1016/j.jasms.2006.02.023; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI 10.1089/ARS.2009.2695; Yang M, 2000, BIOTECHNOL BIOENG, V68, P370, DOI 10.1002/(SICI)1097-0290(20000520)68:4<370::AID-BIT2>3.0.CO;2-K; GIULIVI C, 1994, METHOD ENZYMOL, V233, P363; Passarella S, 2008, FEBS LETT, V582, P3569, DOI 10.1016/j.febslet.2008.09.042; Kanda Y, 2007, J BIOTECHNOL, V130, P300, DOI 10.1016/j.jbiotec.2007.04.025; Cromwell MEM, 2006, AAPS J, V8, pE572, DOI 10.1208/aapsj080366; Chen PF, 2006, METAB ENG, V8, P123, DOI 10.1016/j.ymben.2005.10.002; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dean J, 2013, BIOTECHNOL BIOENG, V110, P1735, DOI 10.1002/bit.24826; Dubinina EE, 2002, BIOCHEMISTRY-MOSCOW+, V67, P343, DOI 10.1023/A:1014840617890; Ishii Y, 2015, BIOL PHARM BULL, V38, P306, DOI 10.1248/bpb.b14-00729; Kamoda S, 2006, J CHROMATOGR A, V1133, P332, DOI 10.1016/j.chroma.2006.08.028; Kato Y, 2001, FREE RADICAL BIO MED, V31, P624, DOI 10.1016/S0891-5849(01)00623-2; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; Li JC, 2012, BIOTECHNOL BIOENG, V109, P1173, DOI 10.1002/bit.24389; Milburn M, 2009, BIOPHARM INT, P28; Pace C. N., 1997, PROTEIN STRUCTURE PR, P253; US Dep, 2014, GUID IND IMM ASS THE	33	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					478	485		10.1016/j.jbiosc.2014.09.017		8	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900017		
J	Yamashita, H; Morita, M; Sugiura, H; Fujiwara, K; Onoe, H; Takinoue, M				Yamashita, Hitoyoshi; Morita, Masamune; Sugiura, Haruka; Fujiwara, Kei; Onoe, Hiroaki; Takinoue, Masahiro			Generation of monodisperse cell-sized microdroplets using a centrifuge-based axisymmetric co-flowing microfluidic device	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						Monodisperse microdroplets; Microfluidic device; Centrifuge; Plateau-Rayleigh instability; Biochemical reactions; Cell encapsulation	SINGLE-MOLECULE PCR; HIGH-THROUGHPUT; DROPLETS; MICROREACTORS	We report an easy-to-use generation method of biologically compatible monodisperse water-in-oil microdroplets using a glass-capillary-based microfluidic device in a tabletop mini-centrifuge. This device does not require complicated microfabrication; furthermore, only a small sample volume is required in experiments. Therefore, we believe that this method will assist biochemical and cell-biological experiments. (C) 2014, The Society for Biotechnology, Japan. All rights reserved.	[Yamashita, Hitoyoshi] Tokyo Inst Technol, Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Yamashita, Hitoyoshi; Morita, Masamune; Sugiura, Haruka; Takinoue, Masahiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Fujiwara, Kei] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Onoe, Hiroaki] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Takinoue, Masahiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Takinoue, M (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268502, Japan.	takinoue@dis.titech.ac.jp	FUJIWARA, KEI/G-5467-2010		PRESTO "Design and Control of Cellular Functions" research area of Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24104002]; Japan Society for the Promotion of Science (JSPS) [24680033, 26280097]; Creative Design for Bioscience and Biotechnology course of the School of Bioscience and Biotechnology at Tokyo Tech	We thank Mr. Masayuki Hayakawa (Tokyo Tech.) for their technical support. We also thank Prof. Hiroyuki Ohta as well as Prof. Hisakazu Mihara, Prof. Makio Tokunaga, Prof. Hiroyuki Ohtani, and Prof. Yasunori Aizawa (Tokyo Tech.) for the helpful discussions. This work was supported by the PRESTO "Design and Control of Cellular Functions" research area of Japan Science and Technology Agency (JST), a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (Project No. 24104002) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Grant-in-Aids for Young Scientists (A) (Project No. 24680033) and Scientific Research (B) (Project No. 26280097) from the Japan Society for the Promotion of Science (JSPS), and the Creative Design for Bioscience and Biotechnology course of the School of Bioscience and Biotechnology at Tokyo Tech.	He MY, 2005, ANAL CHEM, V77, P1539, DOI 10.1021/ac0480850; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; Huebner A, 2008, LAB CHIP, V8, P1244, DOI 10.1039/b806405a; Hase M, 2007, LANGMUIR, V23, P348, DOI 10.1021/la0618521; Baroud CN, 2010, LAB CHIP, V10, P2032, DOI 10.1039/c001191f; Song H, 2006, ANGEW CHEM INT EDIT, V45, P7336, DOI 10.1002/anie.200601554; Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g; Cramer C, 2004, CHEM ENG SCI, V59, P3045, DOI 10.1016/j.ces.2004.04.006; Taly V, 2007, CHEMBIOCHEM, V8, P263, DOI 10.1002/cbic.200600425; Maeda K, 2012, ADV MATER, V24, P1340, DOI 10.1002/adma.201102560; Utada AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.094502; Takinoue M, 2011, ANAL BIOANAL CHEM, V400, P1705, DOI 10.1007/s00216-011-4984-5; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Takeuchi S, 2005, ADV MATER, V17, P1067, DOI 10.1002/adma.200401738; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Hasatani K, 2013, CHEM COMMUN, V49, P8090, DOI 10.1039/c3cc44323j; de Gennes P.G., 2003, CAPILLARITY WETTING; Fujiwara K., 2013, NUCLEIC ACIDS RES, V41, P1; Takinoue M, 2010, SMALL, V6, P2374, DOI 10.1002/smll.201000945	20	2	2	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723	1347-4421		J BIOSCI BIOENG	J. Biosci. Bioeng.	APR	2015	119	4					492	495		10.1016/j.jbiosc.2014.09.018		4	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CG9AD	WOS:000353605900019		
J	Takahashi, K; Komatsuzaki, J; Takahata, Y				Takahashi, Koji; Komatsuzaki, Jun; Takahata, Yasuyuki			Prediction of Agglomeration Weight for Emulsion Polymerization Conducted in an Agitated Vessel	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Agglomeration Weight; Emulsion Polymerization; Estimation Method; Co-Axial Cylinders; Maxblend		To estimate the agglomeration weight for emulsion polymerization conducted in an agitated vessel, a simple method of combining a preliminary experiment and a CFD analysis is proposed. To get the relation between agglomeration weight and shear rate, the emulsion polymerization of interest (we adopted the styrene polymerization) was conducted in a vessel consisting of two-axial cylinders, which provides almost constant shear rate throughout vessel. To predict the shear rate experienced by a liquid or polymer, the trajectories of particles were obtained by CFD for the actual agitator adopted for emulsion polymerization. Employing these results, the agglomeration rate in emulsion polymerization in the real agitator equipped with a Maxblend could be estimated. The estimated result of agglomeration weight for emulsion polymerization shows good agreement with the experimental result conducted in the actual agitator.	[Takahashi, Koji; Komatsuzaki, Jun; Takahata, Yasuyuki] Yamagata Univ, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan	Takahashi, K (reprint author), Yamagata Univ, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan.	koji@yz.yamagata-u.ac.jp					Guntzburger Y, 2009, ASIA-PAC J CHEM ENG, V4, P528, DOI 10.1002/apj.275; Yao WG, 2001, CHEM ENG J, V84, P565, DOI 10.1016/S1385-8947(01)00135-8	2	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	APR	2015	48	4					253	256		10.1252/jcej.13we358		4	Engineering, Chemical	Engineering	CG5OB	WOS:000353340300001		
J	Tokanai, H; Kuriyama, M				Tokanai, Hideki; Kuriyama, Masafumi			Sizes of Maximum Stable Drops with Different Flow Behavior in Liquid-Liquid Agitation	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Agitation; Drop Breakup; Drop Size; Herschel-Bulkley Model; Yield Stress	DISPERSED-PHASE VISCOSITY; BREAKUP; VESSEL; TANK	The drop breakup model in liquid-liquid agitation, which has been proposed by the authors, is extended theoretically and experimentally. The extended model provides a new correlation equation for the maximum stable drop size. The equation is shown to be useful in prediction of sizes of the maximum stable drops with various flow behavior.	[Tokanai, Hideki; Kuriyama, Masafumi] Yamagata Univ, Dept Chem & Chem Engn, Yonezawa, Yamagata 9928510, Japan	Tokanai, H (reprint author), Yamagata Univ, Dept Chem & Chem Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	toka@yz.yamagata-u.ac.jp					SPROW FB, 1967, CHEM ENG SCI, V22, P435, DOI 10.1016/0009-2509(67)80130-1; LAGISETTY JS, 1986, CHEM ENG SCI, V41, P65, DOI 10.1016/0009-2509(86)85198-3; CALABRESE RV, 1986, AICHE J, V32, P657, DOI 10.1002/aic.690320416; ARAI K, 1977, J CHEM ENG JPN, V10, P325, DOI 10.1252/jcej.10.325; COLLIAS DI, 1992, CHEM ENG SCI, V47, P1401, DOI 10.1016/0009-2509(92)80285-K; KONNO M, 1977, J CHEM ENG JPN, V10, P474, DOI 10.1252/jcej.10.474; KURIYAMA M, 1995, KAGAKU KOGAKU RONBUN, V21, P508; Kuriyama M, 2000, KAGAKU KOGAKU RONBUN, V26, P745; Ono M, 1997, KAGAKU KOGAKU RONBUN, V23, P157; SHINNAR R, 1960, IND ENG CHEM, V52, P253, DOI 10.1021/ie50603a036	10	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	APR	2015	48	4					257	261		10.1252/jcej.14we251		5	Engineering, Chemical	Engineering	CG5OB	WOS:000353340300002		
J	Kanno, T; Horiuchi, J				Kanno, Toru; Horiuchi, Jun-ichi			Simultaneous Removal Behavior of Phosphate and Fluoride Ions in the Presence of Scallop Shell	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Phosphate; Fluoride; Apatite; Scallop Shell	WASTE-WATER; PHOSPHORUS; CRYSTALLIZATION; RECOVERY; CALCITE	Phosphate and fluoride ions were simultaneously removed from model industrial waste water, with the formation of fluorine-containing apatite. 70% of fluoride and 50% of phosphate ions were removed in the presence of calcium ion from calcium nitrate. Using scallop shell powder (calcite CaCO3) instead of the calcium ion increased removal efficiency (%) of fluoride and phosphate ions to 92% and 97% at 48 h, respectively. This was ascribed to alkaline condition of pH higher than 8 due to the solution of CaCO3, accelerating fluorine-containing apatite formation. With a mixture of calcium ion and scallop shell powder, high removal efficiency at the initial stage was obtained as opposed to the gradual increase with only scallop-shell, suggesting that an induction period of reaching sufficient concentration of calcium ion for apatite formation existed. These results showed that scallop shells were a promising material for simultaneous removal of phosphate and fluoride ions in waste water from e.g. electronic device plants.	[Kanno, Toru; Horiuchi, Jun-ichi] Kitami Inst Technol, Dept Biotechnol & Environm Chem, Kitami, Hokkaido 0908507, Japan	Kanno, T (reprint author), Kitami Inst Technol, Dept Biotechnol & Environm Chem, 165 Koen Cho, Kitami, Hokkaido 0908507, Japan.	kannotr@mail.kitami-it.ac.jp					Yang M, 1999, WATER RES, V33, P3395, DOI 10.1016/S0043-1354(99)00052-4; Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2; Kim EH, 2006, CHEMOSPHERE, V63, P192, DOI 10.1016/j.chemosphere.2005.08.029; Donnert D, 1999, WATER SCI TECHNOL, V40, P195, DOI 10.1016/S0273-1223(99)00501-6; Song YH, 2006, CHEMOSPHERE, V63, P236, DOI 10.1016/j.chemosphere.2005.08.021; Bellier N, 2006, WATER RES, V40, P2965, DOI 10.1016/j.watres.2006.05.016; ICDD (International Centre for Diffraction Data), 1967, 9432 ICDD JCPDS, P542; ICDD (International Centre for Diffraction Data), 1972, 15876 ICDD JCPDS, P1073; ICDD (International Centre for Diffraction Data), 1990, 35816 ICDD JCPDS, P304; Koyama S., 2007, APPL MAT, V55, P81; Kuroda A., 2005, J ENV BIOTECHNOL, V4, P87; Ooki M., 1998, CHEM ENCY, P1368; Park JY, 2008, CHEMOSPHERE, V70, P1429, DOI 10.1016/j.chemosphere.2007.09.012; Shibata E., 1999, B I ADV MAT PROCESSI, V55, P81; Van Kauwenbergh S. J., 2010, WORLD PHOSPHATE ROCK, P33	15	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	APR	2015	48	4					276	280		10.1252/jcej.14we223		5	Engineering, Chemical	Engineering	CG5OB	WOS:000353340300005		
J	Kubo, M; Mantani, Y; Shimada, M				Kubo, Masaru; Mantani, Yuki; Shimada, Manabu			Effects of Annealing on the Morphology and Porosity of Porous TiO2 Films Fabricated by Deposition of Aerosol Nanoparticles	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Phase Transformation; Non-agglomerated Nanoparticles; Plasma-Enhanced CVD; Sintering	SENSITIZED SOLAR-CELLS; CHEMICAL-VAPOR-DEPOSITION; PHASE-TRANSFORMATION; THIN-FILMS; TITANIUM-DIOXIDE; NANOCRYSTALLINE TITANIA; OPTICAL-PROPERTIES; RAMAN; NANOSTRUCTURES; TEMPERATURE	The present study investigates the impact of post annealing of TiO2 nanoparticulate films on their crystallinity, mechanical strength, and morphology. Non-agglomerated and amorphous TiO2 nanoparticles of 46 nm diameter were synthesized in a plasma field, and were subsequently deposited on substrates to form nanoparticulate films. The films were annealed at various temperatures in the range of 100-1,200 degrees C. Phase transformations from amorphous-to-anatase and from anatase-to-rutile were observed at 400 degrees C and at 1,000 degrees C, respectively. The high rutile transformation temperature was considered to be due to a tensile field induced by shrinkage of the film. The as-deposited film and the films annealed at below 400 degrees C had poor mechanical strength. Conversely, the films annealed at over 500 degrees C were strengthened by necking of the nanoparticles. The size of nanoparticles changed with increasing temperature. Annealing at 100-300 degrees C caused the nanoparticles to shrink to approximately 30 nm. The nanoparticle diameters changed only slightly when annealed at 400-600 degrees C because the annealing time was insu efficient for changes to manifest. Annealing at 700-900 degrees C caused the nanoparticle diameter to increase to approximately 50 nm because of sintering and coalescence of the nanoparticles. The diameter of the nanoparticles annealed at over 1,000 degrees C became approximately 200 nm because of densification during the anatase-to-rutile transformation. The porosities of the films annealed at below 900 degrees C were over 80%. However, the porosities of the films annealed at over 1,000 degrees C decreased significantly due to densification.	[Kubo, Masaru; Mantani, Yuki; Shimada, Manabu] Hiroshima Univ, Fac Engn, Dept Chem Engn, Div Chem & Chem Engn, Higashihiroshima, Hiroshima 7398527, Japan	Shimada, M (reprint author), Hiroshima Univ, Fac Engn, Dept Chem Engn, Div Chem & Chem Engn, 1-4-1 Kagamiyama, Higashihiroshima, Hiroshima 7398527, Japan.	smd@hiroshima-u.ac.jp	Kubo, Masaru/D-8460-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was partly supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Yum JH, 2005, J PHOTOCH PHOTOBIO A, V173, P1, DOI 10.1016/j.jphotochem.2004.12.023; Pichot F, 2000, LANGMUIR, V16, P5626, DOI 10.1021/1a000095i; Rubio J, 1997, J MATER SCI, V32, P643, DOI 10.1023/A:1018579500691; Kim DJ, 2002, MATER LETT, V57, P355, DOI 10.1016/S0167-577X(02)00790-5; Madler L, 2006, SENSOR ACTUAT B-CHEM, V114, P283, DOI 10.1016/j.snb.2005.05.014; Zhang HZ, 1998, J MATER CHEM, V8, P2073, DOI 10.1039/a802619j; Zhang QF, 2009, ADV MATER, V21, P4087, DOI 10.1002/adma.200803827; Choy KL, 2003, PROG MATER SCI, V48, P57, DOI 10.1016/S0079-6425(01)00009-3; Zhang J, 2006, J PHYS CHEM B, V110, P927, DOI 10.1021/jp0552473; Won DJ, 2001, APPL PHYS A-MATER, V73, P595, DOI 10.1007/s003390100804; Pratsinis SE, 2010, AICHE J, V56, P3028, DOI 10.1002/aic.12478; KUMAR KNP, 1993, J MATER CHEM, V3, P1141, DOI 10.1039/jm9930301141; Cao Y, 2005, COLLOID SURFACE A, V262, P181, DOI 10.1016/j.colsurfa.2005.04.029; Wiggins MD, 1996, J VAC SCI TECHNOL A, V14, P772, DOI 10.1116/1.580387; Nolan MG, 2006, THIN SOLID FILMS, V515, P1956, DOI 10.1016/j.tsf.2006.07.182; Tricoli A, 2008, ADV MATER, V20, P3005, DOI 10.1002/adma.200701844; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; BUSCA G, 1994, J CHEM SOC FARADAY T, V90, P3181, DOI 10.1039/ft9949003181; Wu CY, 2011, APPL SURF SCI, V257, P1893, DOI 10.1016/j.apsusc.2010.09.022; PARKER JH, 1967, PHYS REV, V155, P712, DOI 10.1103/PhysRev.155.712; Tiemann M, 2007, CHEM-EUR J, V13, P8376, DOI 10.1002/chem.200700927; Tricoli A, 2012, J MATER CHEM, V22, P14254, DOI 10.1039/c2jm15953h; Hanaor DAH, 2011, J MATER SCI, V46, P855, DOI 10.1007/s10853-010-5113-0; EDELSON LH, 1988, J AM CERAM SOC, V71, P225, DOI 10.1111/j.1151-2916.1988.tb05852.x; HAGUE DC, 1993, NANOSTRUCT MATER, V3, P61, DOI 10.1016/0965-9773(93)90063-H; Hayashi Y, 2008, J CHEM ENG JPN, V41, P62, DOI 10.1252/jcej.07WE097; Kubo M, 2013, CHEM ENG J, V232, P221, DOI 10.1016/j.cej.2013.07.097; Merrill MH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/7/075606; Nakaso K, 2001, AEROSOL SCI TECH, V35, P929, DOI 10.1080/02786820126857; Shishiyanu ST, 2005, SENSOR ACTUAT B-CHEM, V107, P379, DOI 10.1016/j.snb.2004.10.030; Wang H, 2013, AICHE J, V59, P1502, DOI 10.1002/aic.13936; Winardi S, 2010, LANGMUIR, V26, P4567, DOI 10.1021/la904619x	32	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	APR	2015	48	4					292	299		10.1252/jcej.14we197		8	Engineering, Chemical	Engineering	CG5OB	WOS:000353340300007		
J	Tamoto, S; Tabelin, CB; Igarashi, T; Ito, M; Hiroyoshi, N				Tamoto, Shuichi; Tabelin, Carlito Baltazar; Igarashi, Toshifumi; Ito, Mayumi; Hiroyoshi, Naoki			Short and long term release mechanisms of arsenic, selenium and boron from a tunnel-excavated sedimentary rock under in situ conditions	JOURNAL OF CONTAMINANT HYDROLOGY			English	Article						Arsenic; Boron; Selenium; Sedimentary rock; Leaching; In situ column experiments	HYDROTHERMALLY ALTERED ROCK; DRINKING-WATER; ENVIRONMENTAL SELENIUM; CLAY-MINERALS; GLUTATHIONE-PEROXIDASE; IONIC-STRENGTH; ADSORPTION; GOETHITE; CALCITE; MONTMORILLONITE	Sedimentary rocks of marine origin excavated from tunnel construction projects usually contain background levels of hazardous trace elements, but when exposed to the environment, they generate leachates with concentrations of arsenic (As), selenium (Se) and boron (B) exceeding the WHO guideline for drinking water. In this study, the leaching of As, Se and B was evaluated under in situ conditions at various flow patterns, particle size distributions and column thicknesses. The results showed that these trace elements were leached out of the rock via short and long term mechanisms. In the short term, all three elements were rapidly and simultaneously released due to the dissolution of soluble evaporite salts formed from entrapped sea water of the Cretaceous. After their rapid release, however, these trace elements behaved differently as a result of their contrasting adsorption affinities onto minerals like clays and Feoxyhydroxides, which were further influenced by the pH, presence of coexisting ions and speciation of the trace elements. Selenium was quickly and easily transported out of the columns because it was mostly present as the very mobile selenate ion (Se[VI]). In comparison, the migration of As and B was hindered by adsorption reactions onto mineral phases of the rock Boron was initially the least mobile among the three because of its preferential adsorption onto clay minerals that was further enhanced by the slightly alkaline pH and high concentrations of Ca2+ and Na+. However, it was gradually re-mobilized in the latter part of the experiments because it was only weakly adsorbed via outer sphere complexation reactions. In the long term, the rock continued to release substantial amounts of As, Se and B via pyrite oxidation and adsorption/desorption reactions, which were regulated by the temperature and rainfall intensity/frequency on site. (C) 2015 Elsevier B.V. All rights reserved.	[Tamoto, Shuichi] Publ Works Res Inst, Civil Engn Res Inst Cold Reg, Sapporo, Hokkaido, Japan; [Tamoto, Shuichi; Tabelin, Carlito Baltazar; Igarashi, Toshifumi; Ito, Mayumi; Hiroyoshi, Naoki] Hokkaido Univ, Fac Engn, Div Sustainable Resources Engn, Sapporo, Hokkaido 060, Japan	Tabelin, CB (reprint author), Hokkaido Univ, Fac Engn, Div Sustainable Resources Engn, North 13,West 8, Sapporo, Hokkaido 060, Japan.	95353@ceri.go.jp; carlito@eng.hokudai.ac.jp; tosifumi@eng.hokudai.ac.jp; itomayu@eng.hokudai.ac.jp; hiroyosi@eng.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) [26289149]	The authors wish to thank Hokkaido Regional Development Bureau of the Ministry of Land, Transport and Tourism for providing us with the sample and test area for the in situ experiments as well as the anonymous reviewers for their valuable inputs to this paper. Part of this research was supported by the Japan Society for the Promotion of Science (JSPS) grant-in-aid for scientific research (grant number: 26289149),	ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Renard F, 2013, CHEM GEOL, V340, P151, DOI 10.1016/j.chemgeo.2012.12.017; Navarro-Alarcon M, 2008, SCI TOTAL ENVIRON, V400, P115, DOI 10.1016/j.scitotenv.2008.06.024; Lin Z, 2000, ENVIRON GEOL, V39, P753; Manning BA, 1998, ENVIRON SCI TECHNOL, V32, P2383, DOI 10.1021/es9802201; LEVANDER OA, 1983, J NUTR, V113, P55; Maraldi T, 2011, NEUROTOXICOLOGY, V32, P180, DOI 10.1016/j.neuro.2010.10.008; FROST RR, 1977, SOIL SCI SOC AM J, V41, P53; BALISTRIERI LS, 1987, SOIL SCI SOC AM J, V51, P1145; NIELSEN FH, 1994, ENVIRON HEALTH PERSP, V102, P59; CEBRIAN ME, 1983, HUM TOXICOL, V2, P121; Tabelin CB, 2014, SCI TOTAL ENVIRON, V472, P620, DOI 10.1016/j.scitotenv.2013.11.006; NEVE J, 1991, EXPERIENTIA, V47, P187; CHEN CJ, 1985, CANCER RES, V45, P5895; Vinceti M, 2013, SCI TOTAL ENVIRON, V443, P633, DOI 10.1016/j.scitotenv.2012.11.025; BARYOSEF B, 1987, SOIL SCI, V144, P11, DOI 10.1097/00010694-198707000-00003; Wilkie JA, 1996, COLLOID SURFACE A, V107, P97, DOI 10.1016/0927-7757(95)03368-8; Meng XG, 2000, WATER RES, V34, P1255, DOI 10.1016/S0043-1354(99)00272-9; Goldberg S, 1996, SOIL SCI, V161, P99, DOI 10.1097/00010694-199602000-00003; ISHIKAWA T, 1993, EARTH PLANET SC LETT, V117, P567, DOI 10.1016/0012-821X(93)90103-G; YANG GQ, 1983, AM J CLIN NUTR, V37, P872; Fendorf S, 1997, ENVIRON SCI TECHNOL, V31, P315, DOI 10.1021/es950653t; Blanc P, 2012, APPL GEOCHEM, V27, P2107, DOI 10.1016/j.apgeochem.2012.06.002; Cornelis G, 2008, APPL GEOCHEM, V23, P955, DOI 10.1016/j.apgeochem.2008.02.001; Peak D, 2002, ENVIRON SCI TECHNOL, V36, P1460, DOI 10.1021/es0156643; Ayaz M, 2008, METHOD FIND EXP CLIN, V30, P271, DOI 10.1358/mf.2008.30.4.1166220; Bethke C., 1992, GEOCHEMISTS WORKBENC; Beyer K.H., 1983, J AM COLL TOXICOL, V2, P87; Bjorlykke K, 2013, SEDIMENT GEOL, V301, P1; BRTKO J, 1994, BIOL TRACE ELEM RES, V41, P191, DOI 10.1007/BF02917228; CHAKRABORTY AK, 1987, INDIAN J MED RES, V85, P326; CHATTERJEE M, 1982, CANCER LETT, V17, P187, DOI 10.1016/0304-3835(82)90031-3; CHEN CJ, 1992, BRIT J CANCER, V66, P888, DOI 10.1038/bjc.1992.380; Dzombak D. A., 1990, SURFACE COMPLEXATION; FISHBEIN L, 1983, FUND APPL TOXICOL, V3, P411, DOI 10.1016/S0272-0590(83)80014-1; Ganther H.E, 1980, ANN NEW YORK ACAD SC; GIRLING CA, 1984, AGR ECOSYST ENVIRON, V11, P37, DOI 10.1016/0167-8809(84)90047-1; GOLDBERG S, 1985, SOIL SCI SOC AM J, V49, P1374; GOLDBERG S, 1993, SOIL SCI SOC AM J, V57, P704; Havercroft J.M., 1991, TRACE ELEMENTS MAN A, V7; Kang Y., 2002, ENV SCI, V15, P173; KEREN R, 1982, CLAY CLAY MINER, V30, P341, DOI 10.1346/CCMN.1982.0300504; Keren R., 1994, Soil Science Society of America Journal, V58, P1095; Majidi A, 2010, CHEMOSPHERE, V80, P733, DOI 10.1016/j.chemosphere.2010.05.025; MATTIGOD SV, 1985, CLAY CLAY MINER, V33, P433, DOI 10.1346/CCMN.1985.0330509; Nielsen E.H., 1987, FASEB J, V1, P394; NIELSEN F H, 1990, Journal of Trace Elements in Experimental Medicine, V3, P45; Parkhurst D., 1999, US GEOL SURV WATER R, V99, P4259; Pirajno F., 2009, HYDROTHERMAL PROCESS; PREZBINDOWSKI DR, 1991, ORG GEOCHEM, V17, P131, DOI 10.1016/0146-6380(91)90071-Q; SHAH S A, 1990, Fitoterapia, V61, P121; SIEGEL E, 1986, PEDIATR CLIN N AM, V33, P363; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Spears A., 1964, GEOCHIM COSMOCHIM AC, V20, P315; Stoica A, 2000, J CELL BIOCHEM, V79, P282, DOI 10.1002/1097-4644(20001101)79:2<282::AID-JCB110>3.0.CO;2-V; Tabelin CB, 2014, GEODERMA, V213, P163, DOI 10.1016/j.geoderma.2013.07.037; Tabelin CB, 2014, SCI TOTAL ENVIRON, V473, P244, DOI 10.1016/j.scitotenv.2013.12.029; Tabelin CB, 2012, J GEOCHEM EXPLOR, V119, P17, DOI 10.1016/j.gexplo.2012.06.003; Tabelin CB, 2009, J HAZARD MATER, V169, P980, DOI 10.1016/j.jhazmat.2009.04.049; Tabelin CB, 2013, ENG GEOL, V156, P58, DOI 10.1016/j.enggeo.2013.02.001; Tabelin CB, 2010, MINER ENG, V23, P238, DOI 10.1016/j.mineng.2009.09.019; Tabelin CB, 2012, APPL GEOCHEM, V27, P2300, DOI 10.1016/j.apgeochem.2012.07.020; Tabelin CB, 2012, APPL GEOCHEM, V27, P326, DOI 10.1016/j.apgeochem.2011.10.007; Tatsuhara T, 2012, ENG GEOL, V139, P76, DOI 10.1016/j.enggeo.2012.04.006; TRAVERS R L, 1990, Journal of Nutritional Medicine, V1, P127, DOI 10.3109/13590849009003147; van Bochove E, 2000, SOIL SCI SOC AM J, V64, P1638; VANRIJ AM, 1979, AM J CLIN NUTR, V32, P2076; VINCETI M, 1995, J CLIN EPIDEMIOL, V48, P1091, DOI 10.1016/0895-4356(95)00014-U; Vinceti M, 1996, EPIDEMIOLOGY, V7, P529, DOI 10.1097/00001648-199609000-00013; Vinceti M, 1998, CANCER EPIDEM BIOMAR, V7, P853; Webster J.G., 1999, ENCY GEOCHEMISTRY	71	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-7722	1873-6009		J CONTAM HYDROL	J. Contam. Hydrol.	APR-MAY	2015	175						60	71		10.1016/j.jconhyd.2015.01.003		12	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CG1CF	WOS:000353009900005		
J	Morita, A				Morita, Akimichi			Greetings from the new Secretary-General of the Japanese Society for Investigative Dermatology (JSID)	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Editorial Material									Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi 4678601, Japan	Morita, A (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Nagoya, Aichi 4678601, Japan.	amorita@med.nagoya-cu.ac.jp						0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	APR	2015	78	1					4	4		10.1016/j.jdermsci.2015.03.005		1	Dermatology	Dermatology	CG6SL	WOS:000353432600002		
J	Ujiie, H				Ujiie, Hideyuki			IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review						Autoantibody; IgE; Eosinophil; Mast cell; Omalizumab	MEMBRANE ZONE ANTIBODIES; FC-EPSILON-RI; BLISTER FLUID; XVII COLLAGEN; AUTOIMMUNE-DISEASE; ELEVATED LEVELS; SERUM-LEVELS; MOUSE MODEL; SEVERE FORM; HUMAN SKIN	Bullous pemphigoid (BP) is a common autoimmune blistering skin disease in which two hemidesmosomal components - the transmembrane collagen XVII (BP180 or BPAG2) and the plakin family protein BP230 (BPAG1) - are targeted by autoimmunity. Of these, collagen XVII (COL17) is thought to be a major autoantigen, and vital roles of IgG autoantibodies in blister formation have been elucidated. However, BP shows distinct features, including pruritic urticarial erythema and eosinophilic infiltration, which may be independent of IgG-mediated autoimmunity. Recently, it has been revealed that sera from certain patients with BP contain IgE autoantibodies to COL17 and that IgE autoantibodies bind to peri-lesional dermal-epidermal junctions. Mouse models have demonstrated that IgE antibodies to COL17 induce erythema and eosinophilic infiltration in skin. In addition, the successful treatment of severe BP with omalizumab, a humanized monoclonal antibody targeting IgE, has been reported. These findings suggest that both IgG and IgE autoantibodies to COL17 may be involved in the BP pathogenesis. This article summarizes IgE-mediated autoimmunity to COL17 in BP. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Ujiie, H (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	h-ujiie@med.hokudai.ac.jp					Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Ameglio F, 1998, BRIT J DERMATOL, V138, P611; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Chen RY, 2001, J CLIN INVEST, V108, P1151; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Liu Z, 2008, J AUTOIMMUN, V31, P331, DOI 10.1016/j.jaut.2008.08.009; Natsuga K, 2012, J IMMUNOL, V188, P5792, DOI [10.4049/jimmunol.1003402, 10.4049/jimmunol.1103402]; Sardy M, 2013, J AM ACAD DERMATOL, V69, P748, DOI 10.1016/j.jaad.2013.07.009; Messingham KN, 2011, J IMMUNOL, V187, P553, DOI 10.4049/jimmunol.1001753; Iwata Y, 2008, ARCH DERMATOL, V144, P41, DOI 10.1001/archdermatol.2007.9; Zillikens D, 1997, J INVEST DERMATOL, V109, P573, DOI 10.1111/1523-1747.ep12337492; ASBRINK E, 1984, ACTA DERM-VENEREOL, V64, P243; DVORAK AM, 1982, J INVEST DERMATOL, V78, P91, DOI 10.1111/1523-1747.ep12505711; Ishiura N, 2008, J DERMATOL SCI, V49, P153, DOI 10.1016/j.jdermsci.2007.08.008; Messingham KAN, 2014, IMMUNOL RES, V59, P273, DOI 10.1007/s12026-014-8547-7; Zone JJ, 2007, J INVEST DERMATOL, V127, P1167, DOI 10.1038/sj.jid.5700681; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Franzke CW, 2003, MATRIX BIOL, V22, P299, DOI 10.1016/S0945-053X(03)00051-9; Iwata H, 2009, J INVEST DERMATOL, V129, P919, DOI 10.1038/jid.2008.305; Schulman ES, 2001, AM J RESP CRIT CARE, V164, pS6; Messingham KAN, 2009, J IMMUNOL METHODS, V346, P18, DOI 10.1016/j.jim.2009.04.013; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Fairley JA, 2007, J INVEST DERMATOL, V127, P2605, DOI 10.1038/sj.jid.5700958; Corren J, 2008, J ALLERGY CLIN IMMUN, V121, P506, DOI 10.1016/j.jaci.2007.11.026; D'Auria L, 1998, ARCH DERMATOL RES, V290, P25, DOI 10.1007/s004030050272; Delaporte E, 1996, J IMMUNOL, V157, P3642; Dimson OG, 2003, J INVEST DERMATOL, V120, P784, DOI 10.1046/j.1523-1747.2003.12146.x; Dopp R, 2000, J AM ACAD DERMATOL, V42, P577, DOI 10.1016/S0190-9622(00)90168-3; Dufour C, 2012, BRIT J DERMATOL, V166, P1140, DOI 10.1111/j.1365-2133.2011.10748.x; Fairley JA, 2009, J ALLERGY CLIN IMMUN, V123, P704, DOI 10.1016/j.jaci.2008.11.035; Friedmann PS, 1999, CLIN EXP ALLERGY, V29, P109, DOI 10.1046/j.1365-2222.1999.0290s3109.x; Gatalica B, 1997, AM J HUM GENET, V60, P352; Hirose M, 2011, J IMMUNOL, V187, P1176, DOI 10.4049/jimmunol.1100596; Hurskainen T, 2014, J INVEST DERMATOL; Ikeda T, 2012, J DERMATOL, V39, P720, DOI 10.1111/j.1346-8138.2011.01388.x; Kamiya K, 2015, J DERMATOL SCI, V78, P77, DOI 10.1016/j.jdermsci.2015.02.009; Kobayashi M, 2002, J DERMATOL SCI, V30, P224, DOI 10.1016/S0923-1811(02)00109-3; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; London VA, 2012, ARCH DERMATOL, V148, P1241, DOI 10.1001/archdermatol.2012.1604; Ma L, 2015, J DERMATOL SCI, V78, P76, DOI 10.1016/j.jdermsci.2015.02.015; Messingham KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107725; Moriuchi R, 2015, J DERMATOL SCI, V78, P21, DOI 10.1016/j.jdermsci.2015.01.013; Nishie W, 2014, J DERMATOL SCI, V73, P179, DOI 10.1016/j.jdermsci.2013.12.001; Nishie W, 2010, J IMMUNOL, V185, P4938, DOI 10.4049/jimmunol.1001524; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; PARODI A, 1992, BRIT J DERMATOL, V126, P526, DOI 10.1111/j.1365-2133.1992.tb11833.x; PROVOST TT, 1974, CLIN EXP IMMUNOL, V18, P193; Schmidt E, 1996, ARCH DERMATOL RES, V288, P353; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; Teraki Y, 2001, J INVEST DERMATOL, V117, P1097, DOI 10.1046/j.0022-202x.2001.01505.x; Ujiie H, 2014, J IMMUNOL, V193, P4415, DOI 10.4049/jimmunol.1400095; Ujiie H, 2010, J IMMUNOL, V184, P2166, DOI 10.4049/jimmunol.0903101; Wakugawa M, 2000, BRIT J DERMATOL, V143, P112, DOI 10.1046/j.1365-2133.2000.03599.x; Wilczek A, 2006, INT J DERMATOL, V45, P1353, DOI 10.1111/j.1365-4632.2006.02861.x; Yalcin AD, 2014, CLIN LAB, V60, P523, DOI 10.7754/Clin.Lab.2013.130642; Yayli S, 2011, BRIT J DERMATOL, V165, P1133, DOI 10.1111/j.1365-2133.2011.10481.x; Yu KK, 2014, J AM ACAD DERMATOL, V71, P468, DOI 10.1016/j.jaad.2014.04.053	58	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	APR	2015	78	1					5	10		10.1016/j.jdermsci.2015.03.002		6	Dermatology	Dermatology	CG6SL	WOS:000353432600003		
J	Moriuchi, R; Nishie, W; Ujiie, H; Natsuga, K; Shimizu, H				Moriuchi, Reine; Nishie, Wataru; Ujiie, Hideyuki; Natsuga, Ken; Shimizu, Hiroshi			In vivo analysis of IgE autoantibodies in bullous pemphigoid: A study of 100 cases	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Autoantibody; Bullous pemphigoid; Type XVII collagen; Direct immunofluorescence study; Immunoglobulin E; In vivo study	SERUM-LEVELS; HUMAN SKIN; BP180; ANTIBODIES; DISEASE; PATHOGENESIS; AUTOANTIGEN; ECTODOMAIN; BLISTERS; ANTIGEN	Background: Bullous pemphigoid (BP) is an acquired autoimmune blistering disease characterized by subepidermal blister formation, in vivo linear deposition of immunoglobulin G (IgG) and complements at the dermal-epidermal junction (DEJ). The circulating IgG autoantibodies are directed against two epidermal hemidesmosomal glycoproteins: BP180, also known as type XVII collagen (COL17), and BP230. In addition, recent studies have shown that IgE autoantibodies may be involved in the pathogenesis of BP, although in vivo IgE deposition in lesional skin has not been fully characterized in large numbers of BP patients. Objective: This study investigated the incidence of in vivo deposition of IgE autoantibodies at the DEJ in lesional skin from a large number of BP patients. Methods: Peri-lesional skin samples from 100 patients who met the clinical and histopathological criteria for BP were investigated by direct immunofluorescence for the deposition of autoantibodies and complement. Patients' sera were also investigated by enzyme-linked immunosorbent assay and indirect immunofluorescence. Results: 18% of BP patients were found to show IgE deposition at the DEJ. Disease severity, clinical course and outcome did not differ between IgE-positive and IgE-negative patients. In 3 IgE-positive cases, IgG was undetectable in vivo, and these cases showed atypical manifestations. Conclusion: The results of in vivo IgE deposition may not be useful in predicting the disease course of BP, although predominant IgE deposition could alter the pattern of clinical manifestations. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Moriuchi, Reine; Nishie, Wataru; Ujiie, Hideyuki; Natsuga, Ken; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Nishie, W (reprint author), Hokkaido Univ, Grad Sch Med, Dept Dermatol, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	parallelridge@yahoo.co.jp; nishie@med.hokudai.ac.jp; h-ujiie@med.hokudai.ac.jp; natsuga@med.hokudai.ac.jp; shimizu@med.hokudai.ac.jp			Challenging Exploratory Research [20443955]; Ministry of Health, Labour and Welfare [H26-069];  [24390274]	This work was supported in part by Grant-in-Aid for Scientific Research (B) (24390274 to W.N.), Challenging Exploratory Research (20443955 to W.N.) and by the "Research on Measures for Intractable Diseases" Project: matching fund subsidy (H26-069 to H.S.) from Ministry of Health, Labour and Welfare.	Alonso-Llamazares J, 1998, J AM ACAD DERMATOL, V39, P827, DOI 10.1016/S0190-9622(98)70358-5; Ghohestani RF, 1998, J CLIN IMMUNOL, V18, P202, DOI 10.1023/A:1020531005776; Li QA, 2010, J IMMUNOL, V185, P7746, DOI 10.4049/jimmunol.1000667; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Marazza G, 2009, BRIT J DERMATOL, V161, P861, DOI 10.1111/j.1365-2133.2009.09300.x; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; Ishiura N, 2008, J DERMATOL SCI, V49, P153, DOI 10.1016/j.jdermsci.2007.08.008; Zone JJ, 2007, J INVEST DERMATOL, V127, P1167, DOI 10.1038/sj.jid.5700681; Wang G, 2010, AM J PATHOL, V176, P914, DOI 10.2353/ajpath.2010.090744; Messingham KAN, 2009, J IMMUNOL METHODS, V346, P18, DOI 10.1016/j.jim.2009.04.013; Murrell DF, 2012, J AM ACAD DERMATOL, V66, P479, DOI 10.1016/j.jaad.2011.06.032; Fairley JA, 2007, J INVEST DERMATOL, V127, P2605, DOI 10.1038/sj.jid.5700958; Christophoridis S, 2000, BRIT J DERMATOL, V143, P349, DOI 10.1046/j.1365-2133.2000.03661.x; Dopp R, 2000, J AM ACAD DERMATOL, V42, P577, DOI 10.1016/S0190-9622(00)90168-3; Kobayashi M, 2002, J DERMATOL SCI, V30, P224, DOI 10.1016/S0923-1811(02)00109-3; Messingham KN, 2012, GIORN ITAL DERMAT V, V147, P251; Natsuga K, 2010, BRIT J DERMATOL, V162, P513, DOI 10.1111/j.1365-2133.2009.09508.x; Nishie W, 2014, J DERMATOL SCI, V73, P179, DOI 10.1016/j.jdermsci.2013.12.001; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; PARODI A, 1992, BRIT J DERMATOL, V126, P526, DOI 10.1111/j.1365-2133.1992.tb11833.x; Provost TT, 1974, CLIN EXP DERMATOL, V18, P1933; Ujiie H, 2011, DERMATOL CLIN, V29, P439, DOI 10.1016/j.det.2011.03.008; Wu Y, 2013, J DERMATOL SCI, V72, P25, DOI 10.1016/j.jdermsci.2013.05.010; Yayli S, 2011, BRIT J DERMATOL, V165, P1133, DOI 10.1111/j.1365-2133.2011.10481.x; Yoshida M, 2006, J DERMATOL SCI, V41, P21, DOI 10.1016/j.jdermsci.2005.11.002	25	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	APR	2015	78	1					21	25		10.1016/j.jdermsci.2015.01.013		5	Dermatology	Dermatology	CG6SL	WOS:000353432600005		
J	Wada, M; Horinaka, M; Yasuda, S; Masuzawa, M; Sakai, T; Katoh, N				Wada, Makoto W; Horinaka, Mano; Yasuda, Shusuke; Masuzawa, Mikio; Sakai, Toshiyuki; Katoh, Norito			PDK1 is a potential therapeutic target against angiosarcoma cells	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						PDK1; Cyclin D; AKT-independent	RICTOR-MTOR COMPLEX; IN-VIVO; OSU-03012; CELECOXIB; PHOSPHORYLATION; ACTIVATION; MUTATIONS; RAPAMYCIN; PATHWAYS; SARCOMAS		[Wada, Makoto W; Katoh, Norito] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto 6028566, Japan; [Wada, Makoto W; Horinaka, Mano; Yasuda, Shusuke; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto 6028566, Japan; [Masuzawa, Mikio] Kitasato Univ, Dept Biochem Regulat, Sch Allied Hlth Sci, Kanagawa, Japan	Wada, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kamigyo Ku, Kyoto 6028566, Japan.	wada-102@koto.kpu-m.ac.jp					Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Zhang S, 2007, CLIN CANCER RES, V13, P4750, DOI 10.1158/1078-0432.CCR-07-0136; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Antonescu CR, 2009, CANCER RES, V69, P7175, DOI 10.1158/0008-5472.CAN-09-2068; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Young RJ, 2010, LANCET ONCOL, V11, P983, DOI 10.1016/S1470-2045(10)70023-1; Du W, 2013, LAB INVEST, V93, P1115, DOI 10.1038/labinvest.2013.98; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Perry B, 2007, ARCH DERMATOL, V143, P504, DOI 10.1001/archderm.143.4.504; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Yacoub A, 2006, MOL PHARMACOL, V70, P589, DOI 10.1124/mol.106.025007; Fayette J, 2007, ANN ONCOL, V18, P2030, DOI 10.1093/annonc/mdm381; Italiano A, 2012, CANCER-AM CANCER SOC, V118, P5878, DOI 10.1002/cncr.27614; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Alessi DR, 1996, EMBO J, V15, P6541; Masuzawa M, 1999, INT J CANCER, V81, P305, DOI 10.1002/(SICI)1097-0215(19990412)81:2<305::AID-IJC22>3.0.CO;2-Z; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Bundscherer A, 2010, ANTICANCER RES, V30, P4017; Garcia JM, 2000, BRIT J CANCER, V82, P1183; LaMontagne KR, 2000, AM J PATHOL, V157, P1937, DOI 10.1016/S0002-9440(10)64832-8; Przygodzki RM, 1997, LAB INVEST, V76, P153; Weihrauch M, 2002, ENVIRON MOL MUTAGEN, V40, P36, DOI 10.1002/em.10084	23	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	APR	2015	78	1					44	50		10.1016/j.jdermsci.2015.01.015		7	Dermatology	Dermatology	CG6SL	WOS:000353432600008		
J	Masunaga, T; Niizeki, H; Yasuda, F; Yoshida, K; Amagai, M; Ishiko, A				Masunaga, Takuji; Niizeki, Hironori; Yasuda, Fumiyo; Yoshida, Kenji; Amagai, Masayuki; Ishiko, Akira			Splicing abnormality of integrin beta 4 gene (ITGB4) due to nucleotide substitutions far from splice site underlies pyloric atresia-junctional epidermolysis bullosa syndrome	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Genodermatosis; Blister; Branch-point mutation; Splice site mutation; RT-PCR	BASEMENT-MEMBRANE; MUTATIONS; ORGANIZATION; PATIENT	Background: Pyloric atresia-junctional epidermolysis bullosa syndrome (PA-JEB) is a rare subgroup of epidermolysis bullosa, which is inherited disorder characterized by skin fragile. PA-JEB is caused by mutation of ITGB4 or ITGA6, which encodes integrin beta 4 or alpha 6, respectively. Objective: To clarify the molecular basis of PA-JEB and to expand the mutational database, we carried out the mutational analysis of a 29-year-old Japanese PA-JEB patient. Methods: Standard methods were used to prepare, PCR-amplify, and sequence DNA or mRNA in peripheral blood or skin samples, respectively. Results: Sequence analysis revealed two novel mutations in ITGB4, c.264+2TtoA and c.1762-25TtoA. The paternal c.264+2TtoA resided within a splice site consensus region and generated two splice variants resulting in a premature termination codon (PTC). The maternal c.1762-25TtoA was a unique mutation because of its location, 25 bp away from the splice site, and resided in branch-point consensus sequence. This c.1762-25TtoA substitution resulted in generation of two abnormal transcripts each with a PTC. Genotype-phenotype correlation in this case was also unique because the proband showed a non-lethal phenotype regardless of both mutations resulted in only abnormal transcripts with a PTC. Conclusion: The present case expands the mutational database and further elucidates the genotype-phenotype correlation for this rare disease, PA-JEB. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Masunaga, Takuji; Yasuda, Fumiyo; Amagai, Masayuki; Ishiko, Akira] Keio Univ, Dept Dermatol, Sch Med, Shinjuku Ku, Tokyo 1628582, Japan; [Masunaga, Takuji] KOSE Corp, Res Labs, Kita Ku, Tokyo 1140005, Japan; [Niizeki, Hironori] Natl Ctr Child Hlth & Dev, Dept Dermatol, Setagaya Ku, Tokyo 1578535, Japan; [Yoshida, Kenji; Ishiko, Akira] Toho Univ, Fac Med, Sch Med, Dept Dermatol,Ota Ku, Tokyo 1438541, Japan	Masunaga, T (reprint author), Keio Univ, Dept Dermatol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1628582, Japan.	masunaga@z3.keio.jp	Amagai, Masayuki/K-5325-2013		Health Labour Sciences Research Grant, "Research on rare and intractable diseases"	This work was supported in part by a Health Labour Sciences Research Grant, "Research on rare and intractable diseases".	Nakano A, 2001, PEDIATR RES, V49, P618, DOI 10.1203/00006450-200105000-00003; Varki R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039685; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Lewandowska MA, 2013, INT J CLIN EXP PATHO, V6, P2675; Chavanas S, 1999, HUM MOL GENET, V8, P2097, DOI 10.1093/hmg/8.11.2097; Nalla VK, 2005, HUM MUTAT, V25, P334, DOI 10.1002/humu.20151; Inoue M, 2000, J INVEST DERMATOL, V114, P1061, DOI 10.1046/j.1523-1747.2000.00960-3.x; Chung HJ, 2010, DERMATOL CLIN, V28, P43, DOI 10.1016/j.det.2009.10.005; Masunaga T, 2004, EXP DERMATOL, V13, P61, DOI 10.1111/j.0906-6705.2004.00107.x; Masunaga T, 2006, CONNECT TISSUE RES, V47, P55, DOI 10.1080/03008200600584157; Nakamura H, 2005, J MOL DIAGN, V7, P28, DOI 10.1016/S1525-1578(10)60005-0; Pfendner E, 2005, EXP DERMATOL, V14, P241, DOI 10.1111/j.0906-6705.2005.00324.x; Pulkkinen L, 1997, LAB INVEST, V76, P823; Pulkkinen L, 1998, AM J PATHOL, V152, P157; Salvestrini C, 2008, J PEDIATR GASTR NUTR, V47, P585, DOI 10.1097/MPG.0b013e31817af98d; Takizawa Y, 1997, J INVEST DERMATOL, V108, P943, DOI 10.1111/1523-1747.ep12296240	17	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	APR	2015	78	1					61	66		10.1016/j.jdermsci.2015.01.016		6	Dermatology	Dermatology	CG6SL	WOS:000353432600010		
J	Usui, K; Ikeda, T; Horibe, Y; Nakao, M; Hoshino, T; Mizushima, T				Usui, Keiko; Ikeda, Tsuyoshi; Horibe, Yuumi; Nakao, Mitsuyoshi; Hoshino, Tatsuya; Mizushima, Tohru			Identification of HSP70-inducing activity in Arnica montana extract and purification and characterization of HSP70-inducers	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Heat shock protein 70; Arnica montana; Photo-aging; Melanogenesis; Hypopigmenting cosmetics	HEAT-SHOCK PROTEINS; NF-KAPPA-B; INDUCED GASTRIC-LESIONS; MELANIN PRODUCTION; SKIN PIGMENTATION; SESQUITERPENE LACTONES; QUANTITATIVE-ANALYSIS; GENETIC-EVIDENCE; INDUCED COLITIS; PROTECTIVE ROLE	Background: The expression of heat shock proteins (HSPs), particularly HSP70, is receiving considerable attention in the field of cosmetics, particularly given our recent report that ultraviolet-induced melanin production, skin damage and wrinkle formation were all suppressed in transgenic mice expressing HSP70. Objective: In the present study, we searched for HSP70-inducers from a library of herbal extracts that have already been approved as quasi-pharmaceutical products in Japan. We selected an ethanol extract of Arnica montana (A. montana), based on its high HSP70-inducing activity and low cytotoxicity. Methods: Cell viability was determined by MIT method and expression of HPS70 was monitored by immunoblotting analysis. Results: From the extract, we purified and identified eight sesquiterpene lactones (AM1-8) as HSP70-inducers, among which AM-2 (helenalin 2-methylbutyrate) was selected due to its good HSP70-inducing properties and low cytotoxicity. Treatment of cultured mouse melanoma cells with AM-2 or A. montana extract up-regulated the expression of HSP70 in a dose-dependent manner. This treatment also activated heat shock factor-1, a transcription factor for hsp genes. Furthermore, pre-treatment of cells with AM-2 or A. montana extract decreased melanin production and expression and activity of tyrosinase. Conclusion: These results suggest that AM-2 and A. montana extract could be beneficial for use in hypopigmenting cosmetics as a consequence of their stimulatory effects on HSP70 expression. (C) 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Usui, Keiko; Horibe, Yuumi; Nakao, Mitsuyoshi; Hoshino, Tatsuya; Mizushima, Tohru] Keio Univ, Dept Drug Discovery & Dev, Fac Pharm, Tokyo 1058512, Japan; [Ikeda, Tsuyoshi] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan	Mizushima, T (reprint author), Keio Univ, Dept Drug Discovery & Dev, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	mizushima-th@pha.keio.ac.jp			Ministry of Health, Labour, and Welfare of Japan; Center of Innovation Program from Japan Science and Technology Agency; Scientific Technique Research Promotion Program for Agriculture, Forestry and Food Industry; Ministry of Education, Culture, Sports, Science and Technology, Japan	We thank to Dr. Akira Nakai (Yamaguchi University) for providing antiserum against HSF-1. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan; as well as Center of Innovation Program from Japan Science and Technology Agency; Scientific Technique Research Promotion Program for Agriculture, Forestry and Food Industry; and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Agar N, 2005, MUTAT RES-FUND MOL M, V571, P121, DOI 10.1016/j.mrfmmm.2004.11.016; Albert A, 2009, OECOLOGIA, V160, P1, DOI 10.1007/s00442-009-1277-1; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Zhu WY, 2008, J INVEST DERM SYMP P, V13, P20, DOI 10.1038/jidsymp.2008.8; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; Svobodova Alena, 2006, Biomedical Papers (Olomouc), V150, P25; Hirakawa T, 1996, GASTROENTEROLOGY, V111, P345, DOI 10.1053/gast.1996.v111.pm8690199; Sawazaki R, 2014, INVEST OPHTH VIS SCI, V55, P2547, DOI 10.1167/iovs.13-13850; Kim KS, 2006, PIGM CELL RES, V19, P90, DOI 10.1111/j.1600-0749.2005.00281.x; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Yang JY, 2006, ACTA PHARMACOL SIN, V27, P1467, DOI 10.1111/j.1745-7254.2006.00435.x; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Ganzera M, 2008, ANAL CHIM ACTA, V614, P196, DOI 10.1016/j.aca.2008.03.023; Klaas CA, 2002, PLANTA MED, V68, P385, DOI 10.1055/s-2002-32067; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; McMillan TJ, 2008, J PHARM PHARMACOL, V60, P969, DOI 10.1211/jpp.60.8.0004; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Tang DL, 2007, J IMMUNOL, V179, P1236; Tanaka KI, 2007, MOL PHARMACOL, V71, P985, DOI 10.1124/mol.106.033282; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Seemann A, 2010, PLANTA MED, V76, P837, DOI 10.1055/s-0029-1240797; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Tanaka KI, 2010, BIOCHEM PHARMACOL, V80, P920, DOI 10.1016/j.bcp.2010.05.025; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; Lei TC, 2002, ANAL BIOCHEM, V305, P260, DOI 10.1006/abio.2002.5665; Morris SD, 2002, CLIN EXP DERMATOL, V27, P220, DOI 10.1046/j.1365-2230.2002.01012.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Craciunescu O, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-97; Enriz R D, 1994, Drug Des Discov, V11, P23; Hofmann U, 2014, SENSORS-BASEL, V14, P11293, DOI 10.3390/s140711293; Hoshino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076306; Hoshino T, 2010, J BIOL CHEM, V285, P13254, DOI 10.1074/jbc.M110.103051; Kos O, 2005, PLANTA MED, V71, P1044, DOI 10.1055/s-2005-871284; Kouzi SA, 2007, AM J HEALTH-SYST PH, V64, P2434, DOI 10.2146/ajhp070155; Maeda K, 2007, BIOL PHARM BULL, V30, P873, DOI 10.1248/bpb.30.873; Matsuda M, 2013, J INVEST DERMATOL, V133, P919, DOI 10.1038/jid.2012.383; Ohkawara T, 2005, SCAND J GASTROENTERO, V40, P1049, DOI 10.1080/00365520510023161; Ohkawara T, 2006, INT J MOL MED, V17, P229; Shorrocks J, 2008, J INVEST DERMATOL, V128, P685, DOI 10.1038/sj.jid.5701037; Staneva J, 2011, J PHARMACEUT BIOMED, V54, P94, DOI 10.1016/j.jpba.2010.08.018; Tsutsumi S, 2002, BBA-MOL CELL RES, V1589, P168, DOI 10.1016/S0167-4889(02)00171-4; WILLUHN G, 1983, PLANTA MED, V49, P226, DOI 10.1055/s-2007-969856; Wilson N, 2000, J CUTAN PATHOL, V27, P176, DOI 10.1034/j.1600-0560.2000.027004176.x; Yamashita Y, 2010, EXP DERMATOL, V19, pE340, DOI 10.1111/j.1600-0625.2009.01061.x; Yamashita Y, 2012, BIOCHEM PHARMACOL, V83, P909, DOI 10.1016/j.bcp.2011.12.040; Yan D, 2004, CELL STRESS CHAPERON, V9, P378, DOI 10.1379/CSC-51R.1; Yoshihisa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047903	59	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	APR	2015	78	1					67	75		10.1016/j.jdermsci.2015.01.014		9	Dermatology	Dermatology	CG6SL	WOS:000353432600011		
J	Kamiya, K; Aoyama, Y; Noda, K; Miyake, T; Yamaguchi, M; Hamada, T; Tokura, Y; Iwatsuki, K				Kamiya, Koji; Aoyama, Yumi; Noda, Kazuyo; Miyake, Tomoko; Yamaguchi, Mari; Hamada, Toshihisa; Tokura, Yoshiki; Iwatsuki, Keiji			Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Bullous pemphigoid; 8P180 antibody; IgE; BPDAI			[Kamiya, Koji; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan; [Kamiya, Koji; Aoyama, Yumi; Noda, Kazuyo; Miyake, Tomoko; Yamaguchi, Mari; Hamada, Toshihisa; Iwatsuki, Keiji] Okayama Univ, Dept Dermatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Kamiya, K (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan.	m01023kk@jichi.ac.jp					Iwata Y, 2008, ARCH DERMATOL, V144, P41, DOI 10.1001/archdermatol.2007.9; Ishiura N, 2008, J DERMATOL SCI, V49, P153, DOI 10.1016/j.jdermsci.2007.08.008; Messingham KAN, 2009, J IMMUNOL METHODS, V346, P18, DOI 10.1016/j.jim.2009.04.013; Fairley JA, 2007, J INVEST DERMATOL, V127, P2605, DOI 10.1038/sj.jid.5700958; Levy-Sitbon C, 2014, DERMATOLOGY, V229, P116, DOI 10.1159/000362717; Nishie W, 2014, J DERMATOL SCI, V73, P179, DOI 10.1016/j.jdermsci.2013.12.001; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Pomponi D, 2013, BRIT J DERMATOL, V168, P1205, DOI 10.1111/bjd.12161; Yu KK, 2014, J AM ACAD DERMATOL, V71, P468, DOI 10.1016/j.jaad.2014.04.053	9	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	APR	2015	78	1					77	79		10.1016/j.jdermsci.2015.02.009		3	Dermatology	Dermatology	CG6SL	WOS:000353432600013		
J	Numata, S; Teye, K; Krol, RP; Karashima, T; Fukuda, S; Matsuda, M; Ishii, N; Furumura, M; Ohata, C; Saminathan, SD; Ariffin, R; Pramono, ZAD; Leong, KF; Hamada, T; Hashimoto, T				Numata, Sanae; Teye, Kwesi; Krol, Rafal P.; Karashima, Tadashi; Fukuda, Shunpei; Matsuda, Mitsuhiro; Ishii, Norito; Furumura, Minao; Ohata, Chika; Saminathan, Sasi D.; Ariffin, Roziana; Pramono, Zacharias A. D.; Leong, Kin Fon; Hamada, Takahiro; Hashimoto, Takashi			Mutation study for 9 genes in 23 unrelated patients with autosomal recessive congenital ichthyosis in Japan and Malaysia	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Autosomal recessive congenital ichthyosis; Malaysia; Mutation analysis	ERYTHRODERMA; ABCA12		[Numata, Sanae; Teye, Kwesi; Krol, Rafal P.; Karashima, Tadashi; Fukuda, Shunpei; Matsuda, Mitsuhiro; Ishii, Norito; Furumura, Minao; Ohata, Chika; Hamada, Takahiro; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan; [Numata, Sanae; Teye, Kwesi; Krol, Rafal P.; Karashima, Tadashi; Fukuda, Shunpei; Matsuda, Mitsuhiro; Ishii, Norito; Furumura, Minao; Ohata, Chika; Hamada, Takahiro; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 830, Japan; [Saminathan, Sasi D.; Ariffin, Roziana] Kuala Lumpur Hosp, Dept Med Genet, Kuala Lumpur, Malaysia; [Pramono, Zacharias A. D.] Natl Skin Ctr, Dept Res, Singapore, Singapore; [Leong, Kin Fon] Gen Hosp, Dept Dermatol, Kuala Lumpur, Malaysia	Hashimoto, T (reprint author), Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan.	hashimot@med.kurume-u.ac.jp	Ohata, Chika/F-3277-2015	Ohata, Chika/0000-0001-8341-7300			Akiyama M, 2010, BRIT J DERMATOL, V163, P201, DOI 10.1111/j.1365-2133.2010.09745.x; Akiyama M, 2001, BRIT J DERMATOL, V144, P401, DOI 10.1046/j.1365-2133.2001.04037.x; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Fukuda S, 2012, BRIT J DERMATOL, V166, P218, DOI 10.1111/j.1365-2133.2011.10516.x; Grall A, 2012, NAT GENET, V44, P140; Radner FPW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003536; Sakai K, 2009, J INVEST DERMATOL, V129, P2306, DOI 10.1038/jid.2009.23; Thomas AC, 2006, J INVEST DERMATOL, V126, P2408, DOI 10.1038/sj.jid.5700455; Zhi Jizu, 2010, BMC Res Notes, V3, P137, DOI 10.1186/1756-0500-3-137	10	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	APR	2015	78	1					82	85		10.1016/j.jdermsci.2015.02.006		4	Dermatology	Dermatology	CG6SL	WOS:000353432600015		
J	Le, T; Maki, H; Takahashi, K; Okazaki, E; Osako, K				Thuy Le; Maki, Hiroki; Takahashi, Kigen; Okazaki, Emiko; Osako, Kazufumi			Properties of Gelatin Film from Horse Mackerel (Trachurus japonicus) Scale	JOURNAL OF FOOD SCIENCE			English	Article						gelatin film; horse mackerel scale; mechanical properties; extraction temperature; extraction time	WATER-VAPOR PERMEABILITY; ACID-SOLUBLE COLLAGEN; LOLIGO-FORMOSANA SKIN; EDIBLE FILMS; FISH GELATIN; EXTRACTION TEMPERATURES; BIGEYE SNAPPER	Optimal conditions for extracting gelatin and preparing gelatin film from horse mackerel scale, such as extraction temperature and time, as well as the protein concentration of film-forming solutions were investigated. Yields of extracted gelatin at 70 degrees C, 80 degrees C, and 90 degrees C for 15 min to 3 h were 1.08% to 3.45%, depending on the extraction conditions. Among the various extraction times and temperatures, the film from gelatin extracted at 70 degrees C for 1 h showed the highest tensile strength and elongation at break. Horse mackerel scale gelatin film showed the greatly low water vapor permeability (WVP) compared with mammalian or fish gelatin films, maybe due to its containing a slightly higher level of hydrophobic amino acids (total 653 residues per 1000 residues) than that of mammalian, cold-water fish and warm-water fish gelatins. Gelatin films from different preparation conditions showed excellent UV barrier properties at wavelength of 200 nm, although the films were transparent at visible wavelength. As a consequence, it can be suggested that gelatin film from horse mackerel scale extracted at 70 degrees C for 1 h can be applied to food packaging material due to its lowest WVP value and excellent UV barrier properties. Practical Application In this study, gelatin film from horse mackerel scale at various preparation conditions could be successfully prepared. Horse mackerel scale gelatin films exhibited lower water vapor permeability values than gelatin films from the skin of other fishes or mammals do. Utilization of horse mackerel scale as a raw material of edible film could be solved the environmental pollution by seafood waste during fish processing.	[Thuy Le; Maki, Hiroki; Takahashi, Kigen; Okazaki, Emiko; Osako, Kazufumi] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Tokyo, Japan	Osako, K (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Tokyo, Japan.	osako@kaiyodai.ac.jp	OSAKO, Kazufumi/O-1978-2014		JSPS KAKENHI [25450302]	This work was supported by JSPS KAKENHI Grant Number 25450302.	Fang Y, 2002, J FOOD SCI, V67, P188, DOI 10.1111/j.1365-2621.2002.tb11381.x; Benjakul S, 2009, FOOD CHEM, V116, P445, DOI 10.1016/j.foodchem.2009.02.063; MCHUGH TH, 1993, J FOOD SCI, V58, P899, DOI 10.1111/j.1365-2621.1993.tb09387.x; Nagarajan M, 2012, INT J BIOL MACROMOL, V51, P489, DOI 10.1016/j.ijbiomac.2012.06.017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Nagarajan M, 2012, FOOD HYDROCOLLOID, V29, P389, DOI 10.1016/j.foodhyd.2012.04.001; Wangtueai S, 2009, LWT-FOOD SCI TECHNOL, V42, P825, DOI 10.1016/j.lwt.2008.11.014; Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007; Avena-Bustillos RJ, 2006, J FOOD SCI, V71, pE202, DOI 10.1111/j.1750-3841.2006.00016.x; Gomez-Guillen MC, 2007, FOOD HYDROCOLLOID, V21, P1133, DOI 10.1016/j.foodhyd.2006.08.006; Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038; Zhang FX, 2011, FOOD BIOPROD PROCESS, V89, P185, DOI 10.1016/j.fbp.2010.05.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Hoque MS, 2011, FOOD HYDROCOLLOID, V25, P82, DOI 10.1016/j.foodhyd.2010.05.008; Carvalho RA, 2008, FOOD HYDROCOLLOID, V22, P1117, DOI 10.1016/j.foodhyd.2007.06.003; AOAC, 2000, OFFICIAL METHODS ANA; ASTM, 1983, ANN BOOK ASTM STAND, P761; ASTM, 1999, ANN BOOK ASTM STAND; Gomez-Guillen MC, 2009, TRENDS FOOD SCI TECH, V20, P3, DOI 10.1016/j.tifs.2008.10.002; GONTARD N, 1992, J FOOD SCI, V57, P190, DOI 10.1111/j.1365-2621.1992.tb05453.x; Irwandi J., 2009, International Food Research Journal, V16, P381; Johnston-Banks FA, 1990, FOOD GEL, P233; Jongjareonrak A, 2006, FOOD HYDROCOLLOID, V20, P492, DOI 10.1016/j.foodhyd.2005.04.007; Kavoosi G, 2013, J FOOD SCI, V78, P244, DOI DOI 10.1111/J.1750-3841.2013.12015; Kim D, 2012, J FOOD SCI, V77, P240, DOI [10.1111/j.1750-3841.2012.02880, DOI 10.1111/J.1750-3841.2012.02880]; Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042; Kittiphattanabawon P, 2012, FOOD BIOPROCESS TECH, V5, P2646, DOI 10.1007/s11947-010-0427-0; Limpisophon K, 2009, FOOD HYDROCOLLOID, V23, P1993, DOI 10.1016/j.foodhyd.2009.03.014; Nikoo Mehdi, 2011, International Aquatic Research, V3, P135; Tongnuanchan P, 2011, INT J BIOL MACROMOL, V48, P758, DOI 10.1016/j.ijbiomac.2011.02.017; Wangtueai S, 2010, J FOOD SCI, V75, pC731, DOI 10.1111/j.1750-3841.2010.01835.x; Ward A. G., 1977, SCI TECHNOLOGY GELAT; Yamanaka H, 2007, SEAFOOD PROCESSING, P18	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	APR	2015	80	4					E734	E741		10.1111/1750-3841.12806		8	Food Science & Technology	Food Science & Technology	CG1VH	WOS:000353062800011		
J	Ochiai, M; Kuroda, T; Gohtani, S; Matsuo, T				Ochiai, Masaru; Kuroda, Takashi; Gohtani, Shoichi; Matsuo, Tatsuhiro			Dietary Protein Derived from Dried Bonito Fish Improves Type-2 Diabetes Mellitus-Induced Bone Frailty in Goto-Kakizaki Rats	JOURNAL OF FOOD SCIENCE			English	Article						apparent calcium absorption; bone; bonito fish protein; polyunsaturated fatty acids; young Goto-Kakizaki rat	POLYUNSATURATED FATTY-ACIDS; PERIPHERAL-BLOOD FLOW; OVARIECTOMIZED RATS; CALCIUM-ABSORPTION; MINERAL DENSITY; OXIDATIVE STRESS; MASS; METABOLISM; STRENGTH; OBESITY	Type-2 diabetes mellitus (T2DM) induces bone frailty. Protein and polyunsaturated fatty acids (PUFA) contained in fish can be effective in enhancing bone quality, but the bone developing effect of fish protein containing less PUFA has not been evaluated in young animals with T2DM. We prepared a bonito fish (BF) and defatted BF (DBF) and hypothesized that protein contained in BF and DBF would be effective for mitigating the effects of T2DM-induced bone frailty. We mainly evaluated the effect of dietary BF and DBF on bone and apparent calcium absorption in young Goto-Kakizaki (GK) rats with T2DM. GK rats were divided into 3 groups based on diets (casein, BF, and DBF) and fed with each diet for 6 wk. Wistar rats were fed with the casein diet as a non-T2DM control. Bone mass, bone strength, apparent calcium absorption, and serum biochemical parameters were determined. The dry weight and strength of the femurs were lower in the GK rats than in the Wistar rats fed with the casein diet. Dietary intake of the BF and DBF diets enhanced the maximum load and dry weight of the femurs and suppressed the serum alkaline phosphatase activity although the apparent calcium absorption was lower in the GK rats fed with the BF and DBF diets than in those fed with the casein diet. These parameters were not different between the rats fed with the BF and DBF diets. Our data suggest that protein contained in the BF and DBF diets improved T2DM-induced bone frailty. Practical Application Bonito fish (BF) is often processed by dried and smoked, and the processed product is used as one of the most traditional fish products in Japan. BF has been known as a nutritionally effective food material for improving hyperlipidemia, peripheral blood flow, oxidative stress, and mental fatigue. Here, we have showed that protein contained in the BF, but not lipids, suppressed the bone frailty induced by insulin resistance and type-2 diabetes mellitus in young rats independent of apparent calcium absorption in small intestines.	[Ochiai, Masaru; Kuroda, Takashi; Gohtani, Shoichi; Matsuo, Tatsuhiro] Kagawa Univ, Fac Agr, Kita, Kagawa 7610795, Japan	Matsuo, T (reprint author), Kagawa Univ, Fac Agr, 2393 Ikenobe, Kita, Kagawa 7610795, Japan.	matsuo@ag.kagawa-u.ac.jp			Kagawa Univ. research fund grant	This study was supported by an internal Kagawa Univ. research fund grant. There are no conflicts of interest to declare.	ABELOW BJ, 1992, CALCIFIED TISSUE INT, V50, P14, DOI 10.1007/BF00297291; Ahmad T, 2008, GROWTH HORM IGF RES, V18, P404, DOI 10.1016/j.ghir.2008.02.003; Bronner F, 1999, J NUTR, V129, P9; Fujii H, 2008, BONE, V42, P372, DOI 10.1016/j.bone.2007.10.007; Hamada Y, 2007, BONE, V40, P1408, DOI 10.1016/j.bone.2006.12.057; Pilon G, 2011, METABOLISM, V60, P1122, DOI 10.1016/j.metabol.2010.12.005; Vestergaard P, 2014, DIABETOLOGIA, V57, P2007, DOI 10.1007/s00125-014-3338-1; Haag M, 2003, PROSTAG LEUKOTR ESS, V68, P423, DOI 10.1016/S0952-3278(03)00067-X; Matsuo T, 2003, BIOSCI BIOTECH BIOCH, V67, P2518, DOI 10.1271/bbb.67.2518; Bronner F, 1998, J NUTR, V128, P917; Hamada Y, 2009, BONE, V45, pS35, DOI 10.1016/j.bone.2009.02.004; Bilezikian JP, 2013, J CLIN ENDOCR METAB, V98, P1519, DOI 10.1210/jc.2012-4018; Agata U, 2013, J NUTR SCI VITAMINOL, V59, P29, DOI 10.3177/jnsv.59.29; Jakubowicz D, 2013, J NUTR BIOCHEM, V24, P1, DOI 10.1016/j.jnutbio.2012.07.008; GACS G, 1977, GUT, V18, P64, DOI 10.1136/gut.18.1.64; Lavigne C, 2001, AM J PHYSIOL-ENDOC M, V281, pE62; Zhang LP, 2009, ACTA DIABETOL, V46, P119, DOI 10.1007/s00592-008-0068-1; Kimura S, 2012, J BONE MINER METAB, V30, P312, DOI 10.1007/s00774-011-0324-2; Ahmad T, 2003, J ENDOCRINOL, V178, P111, DOI 10.1677/joe.0.1780111; Uehara K, 2014, NUTRITION, V30, P719, DOI 10.1016/j.nut.2013.11.005; HU JF, 1993, AM J CLIN NUTR, V58, P398; Musumeci G, 2011, ACTA HISTOCHEM, V113, P619, DOI 10.1016/j.acthis.2010.07.002; Rapuri PB, 2003, AM J CLIN NUTR, V77, P1517; Nakanishi A, 2013, MOL MED REP, V7, P1896, DOI 10.3892/mmr.2013.1446; CALVO MS, 1982, J NUTR, V112, P1401; Chau D.L., 2002, CLIN DIABETES, V20, P153, DOI DOI 10.2337/DIACLIN.20.3.153; FAIRWEATHERTAIT SJ, 1993, BRIT J NUTR, V69, P527, DOI 10.1079/BJN19930052; Fernandes G, 2003, PROSTAG LEUKOTR ESS, V68, P361, DOI 10.1016/S0952-3278(03)00060-7; FOLCH J, 1957, J BIOL CHEM, V226, P497; Honda M, 2009, BIOMED RES-TOKYO, V30, P129, DOI 10.2220/biomedres.30.129; Ishikawa SI, 2007, J FOOD SCI, V72, pS412, DOI 10.1111/j.1750-3841.2007.00417.x; Kelly OJ, 2013, NUTR RES, V33, P521, DOI 10.1016/j.nutres.2013.04.012; Kruger MC, 2005, PROSTAG LEUKOTR ESS, V73, P327, DOI 10.1016/j.plefa.2005.08.001; Lukas R, 2011, BONE, V49, P455, DOI 10.1016/j.bone.2011.05.029; Marotte C, 2013, EUR J NUTR, V52, P297, DOI 10.1007/s00394-012-0336-2; Marotte C, 2014, EUR J NUTR, V53, P769, DOI 10.1007/s00394-013-0581-z; Matsler AL, 2005, CEREAL CHEM, V82, P282, DOI 10.1094/CC-82-0282; Matsumoto J, 2005, J FOOD SCI, V70, pS467, DOI 10.1111/j.1365-2621.2005.tb11494.x; Matsumoto J, 2007, J NUTR SCI VITAMINOL, V53, P225, DOI 10.3177/jnsv.53.225; Nagaya T, 2005, DIABETIC MED, V22, P1107, DOI 10.1111/j.1464-5491.2005.01602.x; Nozawa Y, 2008, PHYSIOL BEHAV, V93, P267, DOI 10.1016/j.physbeh.2007.08.021; Ochiai M, 2013, J OLEO SCI, V62, P745, DOI 10.5650/jos.62.745; Ostenson CG, 1997, J DIABETES COMPLICAT, V11, P319, DOI 10.1016/S1056-8727(96)00079-7; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P35; Saito Mitsuru, 2013, Front Endocrinol (Lausanne), V4, P72, DOI 10.3389/fendo.2013.00072; Starup-Linde Jakob, 2013, Front Endocrinol (Lausanne), V4, P21, DOI 10.3389/fendo.2013.00021; Takeda S, 2012, J NUTR SCI VITAMINOL, V58, P240; TAKESHITA N, 1993, ACTA ENDOCRINOL-COP, V128, P69; World Health Organization, 1994, ASS FRACT RISK ITS A; Xu YJ, 2010, J SCI FOOD AGR, V90, P1485, DOI 10.1002/jsfa.3972; Yoon GA, 2006, NUTRITION, V22, P414, DOI 10.1016/j.nut.2005.07.019	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	APR	2015	80	4					H848	H856		10.1111/1750-3841.12797		9	Food Science & Technology	Food Science & Technology	CG1VH	WOS:000353062800026		
J	Sakuragi, N				Sakuragi, Noriaki			Nerve-sparing radical hysterectomy: time for a new standard of care for cervical cancer?	JOURNAL OF GYNECOLOGIC ONCOLOGY			English	Editorial Material							RANDOMIZED-TRIALS		[Sakuragi, Noriaki] Hokkaido Univ, Grad Sch Med, Dept Gynecol, Div Reprod Endocrinol & Oncol, Sapporo, Hokkaido 0608638, Japan	Sakuragi, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gynecol, Div Reprod Endocrinol & Oncol,Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	sakuragi@med.hokudai.ac.jp					Hockel M, 1998, AM J OBSTET GYNECOL, V178, P971, DOI 10.1016/S0002-9378(98)70533-2; Fujii S, 2007, GYNECOL ONCOL, V107, P4, DOI 10.1016/j.ygyno.2007.08.076; Hockel M, 2005, LANCET ONCOL, V6, P751, DOI 10.1016/S1470-2045(05)70324-7; Yabuki Y, 2000, GYNECOL ONCOL, V77, P155, DOI 10.1006/gyno.1999.5723; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; Aoun F, 2014, INT UROGYNECOL J; Basaran D, 2015, ANN SURG ONCOL; Bonchek LI, 1997, HEART, V78, P535; Fujiwara T, 1984, RADICAL HYSTERECTOMY; Kim HS, 2015, J GYNECOL ONCOL, V26, P100, DOI 10.3802/jgo.2015.26.2.100; Kobayashi T, 1961, ABDOMINAL RADICAL HY; Long Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094116; Maas CP, 2005, ACTA OBSTET GYN SCAN, V84, P868, DOI 10.1111/j.0001-6349.2005.00742.x; Roh JW, 2015, J GYNECOL ONCOL, V26, P90, DOI 10.3802/jgo.2015.26.2.90; SAKAMOTO S, 1988, BAILLIERE CLIN OB GY, V2, P953, DOI 10.1016/S0950-3552(98)80022-9; Sakuragi N, 2005, INT J GYNECOL CANCER, V15, P389, DOI 10.1111/j.1525-1438.2005.15236.x	16	0	0	KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY	SEOUL	102-HO, 55-5, NONHYEON-DONG, GANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2005-0380	2005-0399		J GYNECOL ONCOL	J. Gynecol. Oncol.	APR	2015	26	2					81	82		10.3802/jgo.2015.26.2.81		2	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CG2GN	WOS:000353093000001		
J	Aoyama, A; Chen, F; Tanaka, S; Miyamoto, E; Takahashi, M; Ohata, K; Kondo, T; Motoyama, H; Hijiya, K; Isomi, M; Minakata, K; Yamada, T; Sato, M; Date, H				Aoyama, A.; Chen, F.; Tanaka, S.; Miyamoto, E.; Takahashi, M.; Ohata, K.; Kondo, T.; Motoyama, H.; Hijiya, K.; Isomi, M.; Minakata, K.; Yamada, T.; Sato, M.; Date, H.			Sparing Native Upper Lobe or Segment in Living-Donor Lobar Lung Transplantation Due to Small-for-Size Grafts	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Aoyama, A.; Chen, F.; Tanaka, S.; Miyamoto, E.; Takahashi, M.; Ohata, K.; Kondo, T.; Motoyama, H.; Hijiya, K.; Isomi, M.; Yamada, T.; Sato, M.; Date, H.] Kyoto Univ, Thorac Surg, Kyoto, Japan; [Minakata, K.] Kyoto Univ, Cardiovasc Surg, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		353	S136	S137				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500347		
J	Besa, V; Bonella, F; Ohshimo, S; Weinreich, G; Costabel, U; Kamler, M; Teschler, H; Sommerwerck, U				Besa, V.; Bonella, F.; Ohshimo, S.; Weinreich, G.; Costabel, U.; Kamler, M.; Teschler, H.; Sommerwerck, U.			KL-6 Changes in Serum Can Be Predictive of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Besa, V.; Weinreich, G.; Teschler, H.; Sommerwerck, U.] Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Ruhrlandklin,Pneumol, Essen, Germany; [Bonella, F.; Costabel, U.] Univ Duisburg Essen, Univ Hosp Essen, West German Lung Ctr, Interstitial & Rare Lung Dis Unit,Ruhrlandklin, Essen, Germany; [Ohshimo, S.] Hiroshima Univ, Mol & Internal Med, Grad Sch Biomed Sci, Hiroshima, Japan; [Kamler, M.] Univ Duisburg Essen, Univ Hosp Essen, Thorac Transplantat, Essen, Germany								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		100	S46	S46				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500099		
J	Fujii, Y; Mizuno, T; Takehisa, T; Shirai, M; Tatsumi, E				Fujii, Y.; Mizuno, T.; Takehisa, T.; Shirai, M.; Tatsumi, E.			Development of the New Polymer Coating (MDM-Coating) for Reduce the Inflammatory Response During ECMO -Evaluation Using a Small Animal ECMO Model	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Fujii, Y.; Mizuno, T.; Tatsumi, E.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Artificial Organs, Suita, Osaka, Japan; [Takehisa, T.] DIC Corp, Cent Res Labs, Sakura, Japan; [Shirai, M.] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cardiac Physiol, Suita, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		742	S272	S272				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500727		
J	Fujino, T; Hatano, M; Yao, A; Nitta, D; Muraoka, H; Minatsuki, S; Imamura, T; Inaba, T; Maki, H; Kinugawa, K; Komuro, I				Fujino, T.; Hatano, M.; Yao, A.; Nitta, D.; Muraoka, H.; Minatsuki, S.; Imamura, T.; Inaba, T.; Maki, H.; Kinugawa, K.; Komuro, I.			The Reliability of 6-Minute Walk Test to Predict Exercise Capacity in Patients With Pulmonary Hypertension	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Fujino, T.; Hatano, M.; Nitta, D.; Muraoka, H.; Minatsuki, S.; Inaba, T.; Maki, H.; Komuro, I.] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Yao, A.] Univ Tokyo, Div Hlth Serv Promot, Tokyo, Japan; [Imamura, T.; Kinugawa, K.] Univ Tokyo, Dept Therapeut Strategy Heart Failure, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		946	S339	S339				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500927		
J	Hata, H; Fujita, T; Ishibashi-Ueda, H; Nakatani, T; Kobayashi, J				Hata, H.; Fujita, T.; Ishibashi-Ueda, H.; Nakatani, T.; Kobayashi, J.			Histopathological Analysis of the Mitral Valve After Long-Term Mechanical Circulatory Support	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Hata, H.; Fujita, T.; Kobayashi, J.] Natl Cerebral & Cardiovasc Ctr, Cardiovasc Surg, Suita, Osaka, Japan; [Ishibashi-Ueda, H.] Natl Cerebral & Cardiovasc Ctr, Pathol, Suita, Osaka, Japan; [Nakatani, T.] Natl Cerebral & Cardiovasc Ctr, Transplantat, Suita, Osaka, Japan			Kobayashi, Junjiro/J-8547-2015					0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		580	S217	S217				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500568		
J	Imamura, T; Kinugawa, K; Nitta, D; Inaba, T; Maki, H; Hatano, M; Kinoshita, O; Nawata, K; Ono, M				Imamura, T.; Kinugawa, K.; Nitta, D.; Inaba, T.; Maki, H.; Hatano, M.; Kinoshita, O.; Nawata, K.; Ono, M.			Recipients With Shorter Cardiopulmonary Bypass Time Achieve Improvement of Parasympathetic Reinnervation Within 6 Months After Heart Transplantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Imamura, T.; Kinugawa, K.] Univ Tokyo, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Nitta, D.; Inaba, T.; Maki, H.; Hatano, M.] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan; [Kinoshita, O.; Nawata, K.; Ono, M.] Univ Tokyo, Dept Cardiac Surg, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		803	S293	S293				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500786		
J	Imamura, T; Kinugawa, K; Inaba, T; Maki, H; Hatano, M; Kinoshita, O; Nawata, K; Ono, M				Imamura, T.; Kinugawa, K.; Inaba, T.; Maki, H.; Hatano, M.; Kinoshita, O.; Nawata, K.; Ono, M.			New Scoring System Using Cardiopulmonary Exercise Parameters Can Predict Prognosis in Heart Failure Patients Receiving Guideline-Directed Optimal Medical Therapy Including Beta-Blocker, Angiotensin Converting Enzyme Inhibitor, and Aidosterone Antagosnit	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Imamura, T.; Kinugawa, K.] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Inaba, T.; Maki, H.; Hatano, M.] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kinoshita, O.; Nawata, K.; Ono, M.] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		470	S177	S178				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500460		
J	Imamura, T; Kinugawa, K; Inaba, T; Maki, H; Hatano, M; Kinoshita, O; Nawata, K; Ono, M				Imamura, T.; Kinugawa, K.; Inaba, T.; Maki, H.; Hatano, M.; Kinoshita, O.; Nawata, K.; Ono, M.			Parasympathetic Reinnervation Accompanied By Improved Post-Exercise Heart Rate Recovery and Quality of Life in Heart Transplant Recipients	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Imamura, T.; Kinugawa, K.] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Inaba, T.; Maki, H.; Hatano, M.] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Kinoshita, O.; Nawata, K.; Ono, M.] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		828	S301	S301				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500811		
J	Kato, N; Jaarsma, T; Okada, I; Kagami, Y; Endo, M; Ono, M; Kinugawa, K				Kato, N.; Jaarsma, T.; Okada, I.; Kagami, Y.; Endo, M.; Ono, M.; Kinugawa, K.			Quality of Life and Burden in Caregivers at 3 Months After Left Ventricular Assist Device Implantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Kato, N.; Jaarsma, T.] Linkoping Univ, Social & Welf Studies, Norrkoping, Sweden; [Okada, I.; Kinugawa, K.] Univ Tokyo, Grad Sch Med, Therapeut Strategy Heart Failure, Tokyo, Japan; [Kagami, Y.; Endo, M.] Tokyo Univ Hosp, Organ Transplantat, Tokyo 113, Japan; [Ono, M.] Univ Tokyo, Grad Sch Med, Cardiovasc Surg, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		37	S22	S23				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500038		
J	Kato, N; Jaarsma, T; Okada, I; Imamura, T; Kagami, Y; Endo, M; Ono, M; Kinugawa, K				Kato, N.; Jaarsma, T.; Okada, I.; Imamura, T.; Kagami, Y.; Endo, M.; Ono, M.; Kinugawa, K.			Quality of Life and Associated Factors in Patients 3 Months After Left Ventricular Assist Device Implantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Kato, N.; Jaarsma, T.] Linkoping Univ, Social & Welf Studies, Norrkoping, Sweden; [Okada, I.; Imamura, T.; Kinugawa, K.] Univ Tokyo, Grad Sch Med, Therapeut Strategy Heart Failure, Tokyo, Japan; [Kagami, Y.; Endo, M.] Tokyo Univ Hosp, Organ Transplantat, Tokyo 113, Japan; [Ono, M.] Univ Tokyo, Grad Sch Med, Cardiovasc Surg, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		642	S238	S238				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500628		
J	Kondo, T; Chen, F; Ohsumi, A; Takahashi, M; Ohata, K; Hijiya, K; Motoyama, H; Tanaka, S; Miyamoto, E; Yamada, T; Sato, M; Aoyama, A; Date, H				Kondo, T.; Chen, F.; Ohsumi, A.; Takahashi, M.; Ohata, K.; Hijiya, K.; Motoyama, H.; Tanaka, S.; Miyamoto, E.; Yamada, T.; Sato, M.; Aoyama, A.; Date, H.			Characteristics of De Novo Donor-Specific Anti-HLA Antibodies (DSAs) in Living-Donor Lobar Lung Transplantation Might Be Different From Those in Cadaveric Lung Transplantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Kondo, T.; Chen, F.; Ohsumi, A.; Takahashi, M.; Ohata, K.; Hijiya, K.; Motoyama, H.; Tanaka, S.; Miyamoto, E.; Yamada, T.; Sato, M.; Aoyama, A.; Date, H.] Kyoto Univ, Thorac Surg, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		704	S259	S259				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500690		
J	Kuroda, K; Seguchi, O; Hisamatsu, E; Satoh, T; Nakajima, S; Sunami, H; Sato, T; Muto, S; Nishigori, M; Hata, H; Ohgoh, K; Asakura, M; Yanase, M; Fujita, T; Ishibashi-Ueda, H; Minamino, N; Kobayashi, J; Nakatani, T				Kuroda, K.; Seguchi, O.; Hisamatsu, E.; Satoh, T.; Nakajima, S.; Sunami, H.; Sato, T.; Muto, S.; Nishigori, M.; Hata, H.; Ohgoh, K.; Asakura, M.; Yanase, M.; Fujita, T.; Ishibashi-Ueda, H.; Minamino, N.; Kobayashi, J.; Nakatani, T.			Left Ventricular Assist Device Support Provides Drastic Restoration of Gene Expression Together With Myocardial Recovery in Patients With Advanced Heart Failure	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Kuroda, K.; Seguchi, O.; Hisamatsu, E.; Satoh, T.; Nakajima, S.; Sunami, H.; Sato, T.; Yanase, M.; Nakatani, T.] Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, Osaka, Japan; [Muto, S.; Ohgoh, K.; Ishibashi-Ueda, H.] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka, Japan; [Nishigori, M.; Minamino, N.] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pharmacol, Osaka, Japan; [Hata, H.; Kobayashi, J.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Osaka, Japan; [Asakura, M.] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan			Kobayashi, Junjiro/J-8547-2015					0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		505	S190	S191				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500495		
J	Matsumoto, Y; Fujita, T; Hata, H; Shimahara, Y; Sato, S; Seguchi, O; Nakatani, T; Kobayashi, J				Matsumoto, Y.; Fujita, T.; Hata, H.; Shimahara, Y.; Sato, S.; Seguchi, O.; Nakatani, T.; Kobayashi, J.			Hemodynamic Performance and Early Clinical Result, EVAHEART and HeartMate II	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Matsumoto, Y.; Fujita, T.; Hata, H.; Shimahara, Y.; Sato, S.; Kobayashi, J.] Natl Cerebral & Cardiovasc Ctr, Cardiovasc Surg, Suita, Osaka, Japan; [Seguchi, O.; Nakatani, T.] Natl Cerebral & Cardiovasc Ctr, Transplantat, Suita, Osaka, Japan			Kobayashi, Junjiro/J-8547-2015					0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		610	S227	S227				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500597		
J	Miyoshi, K; Oto, T; Sugimoto, S; Yamane, M; Miyoshi, S				Miyoshi, K.; Oto, T.; Sugimoto, S.; Yamane, M.; Miyoshi, S.			Chronic Lung Allograft Dysfunction After Bilateral Living Donor Lobar Lung Transplantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Miyoshi, K.; Oto, T.; Sugimoto, S.; Yamane, M.; Miyoshi, S.] Okayama Univ Hosp, Dept Thorac Surg, Organ Transplant Ctr, Okayama, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		97	S45	S45				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500096		
J	Murayama, T; Anraku, M; Murakawa, T; Yoshioka, T; Inui, M; Hiyama, N; Kawashima, M; Tsuchiva, T; Ichinose, J; Hino, H; Nagayama, K; Nitadori, J; Kakimi, K; Nakajima, J				Murayama, T.; Anraku, M.; Murakawa, T.; Yoshioka, T.; Inui, M.; Hiyama, N.; Kawashima, M.; Tsuchiya, T.; Ichinose, J.; Hino, H.; Nagayama, K.; Nitadori, J.; Kakimi, K.; Nakajima, J.			Circulating Histone-Induced Lung Injury: A Novel Model of Damaged Lungs From Brain-Dead Donors	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Murayama, T.; Anraku, M.; Murakawa, T.; Yoshioka, T.; Inui, M.; Hiyama, N.; Kawashima, M.; Tsuchiya, T.; Ichinose, J.; Hino, H.; Nagayama, K.; Nitadori, J.; Nakajima, J.] Univ Tokyo, Thorac Surg, Bunkyo Ku, Tokyo 1138654, Japan; [Kakimi, K.] Univ Tokyo, Immunotherapeut, Bunkyo Ku, Tokyo 1138654, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		733	S268	S269				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500718		
J	Nakajima, S; Seguchi, O; Kuroda, K; Hisamatsu, E; Sato, T; Sunami, H; Sato, T; Yanase, M; Hata, H; Fujita, T; Kobayashi, J; Nakatani, T				Nakajima, S.; Seguchi, O.; Kuroda, K.; Hisamatsu, E.; Sato, T.; Sunami, H.; Sato, T.; Yanase, M.; Hata, H.; Fujita, T.; Kobayashi, J.; Nakatani, T.			Low Prevalence of Acquired von Willebrand Syndrome in Japanese Recipients of Continuous-Flow Ventricular Assist Devices	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Nakajima, S.; Seguchi, O.; Kuroda, K.; Hisamatsu, E.; Sato, T.; Sunami, H.; Sato, T.; Yanase, M.; Nakatani, T.] Natl Cerebral & Cardiovasc Ctr, Dept Transplantat, Osaka, Japan; [Hata, H.; Fujita, T.; Kobayashi, J.] Natl Cerebral & Cardiovasc Ctr, Dept Adult Cardiac Surg, Osaka, Japan			Kobayashi, Junjiro/J-8547-2015					0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		159	S67	S67				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500157		
J	Nakano, A; Kuroda, K; Hisamatsu, E; Sato, T; Nakajima, S; Sato, T; Sunami, H; Yanase, M; Kitakaze, M; Nakatani, T				Nakano, A.; Kuroda, K.; Hisamatsu, E.; Sato, T.; Nakajima, S.; Sato, T.; Sunami, H.; Yanase, M.; Kitakaze, M.; Nakatani, T.			Partial Pressure of End-Tidal Carbon Dioxide Predicts the Complication of Secondary Pulmonary Hypertension in Patients With Advanced Heart Failure	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Nakano, A.; Hisamatsu, E.; Sato, T.; Nakajima, S.; Sato, T.; Sunami, H.; Yanase, M.; Nakatani, T.] Natl Cerebral & Cardiovasc Ctr, Transplantat, Osaka, Japan; [Kuroda, K.] Natl Cerebral & Cardiovasc Ctr, Developopment Clin Res, Osaka, Japan; [Kitakaze, M.] Natl Cerebral & Cardiovasc Ctr, Dev Clin Res, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		491	S185	S186				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500481		
J	Nishinaka, T; Ichihara, Y; Komagamine, M; Umehara, N; Katsube, K; Iizuka, K; Saito, S; Nunoda, S; Yamazaki, K				Nishinaka, T.; Ichihara, Y.; Komagamine, M.; Umehara, N.; Katsube, K.; Iizuka, K.; Saito, S.; Nunoda, S.; Yamazaki, K.			Japanese Experience of Long-Term Mechanical Circulatory Support With EVAHEART LVAD	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Nishinaka, T.; Ichihara, Y.; Komagamine, M.; Umehara, N.; Katsube, K.; Iizuka, K.; Saito, S.; Nunoda, S.; Yamazaki, K.] Tokyo Womens Med Univ, Cardiovasc Surg, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		397	S153	S153				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500391		
J	Ohata, K; Chen, F; Takahashi, M; Kondo, T; Motoyama, H; Hijiya, K; Yamada, T; Sato, M; Menju, T; Aoyama, A; Sato, T; Sonobe, M; Omasa, M; Date, H				Ohata, K.; Chen, F.; Takahashi, M.; Kondo, T.; Motoyama, H.; Hijiya, K.; Yamada, T.; Sato, M.; Menju, T.; Aoyama, A.; Sato, T.; Sonobe, M.; Omasa, M.; Date, H.			Protective Effect of Nebulized Rho-Kinase Inhibitor on Ischemia Reperfusion Injury in Isolated Rat Lung Perfusion Model	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Ohata, K.; Chen, F.; Takahashi, M.; Kondo, T.; Motoyama, H.; Hijiya, K.; Yamada, T.; Sato, M.; Menju, T.; Aoyama, A.; Sato, T.; Sonobe, M.; Omasa, M.; Date, H.] Kyoto Univ, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		737	S270	S270				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500722		
J	Oishi, H; Martinu, T; Sato, M; Guan, Z; Saito, T; Sakamoto, J; Hirayama, S; Matsuda, Y; Cypel, M; Hwang, DM; Liu, M; Keshavjee, S				Oishi, H.; Martinu, T.; Sato, M.; Guan, Z.; Saito, T.; Sakamoto, J.; Hirayama, S.; Matsuda, Y.; Cypel, M.; Hwang, D. M.; Liu, M.; Keshavjee, S.			A Novel Ex Vivo Intrabronchial Delivery of Ientivirus IL-10 Gene Therapy Attenuates Both Acute Allograft Rejection and Bronchiolitis Obliterans After Murine Orthotopic Lung Transplantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Oishi, H.; Martinu, T.; Guan, Z.; Saito, T.; Sakamoto, J.; Cypel, M.; Hwang, D. M.; Liu, M.; Keshavjee, S.] Univ Toronto, Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON, Canada; [Sato, M.] Kyoto Univ, Dept Thorac Surg, Kyoto, Japan; [Hirayama, S.] Okayama Rosai Hosp, Dept Surg, Okayama, Japan; [Matsuda, Y.] Tohoku Univ, Dept Thorac Surg, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		119	S52	S53				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500118		
J	Ono, M; Sawa, Y; Nakatani, T; Tominaga, R; Matsui, Y; Yamazaki, K; Saiki, Y; Niinami, H; Matsumiya, G; Arai, H				Ono, M.; Sawa, Y.; Nakatani, T.; Tominaga, R.; Matsui, Y.; Yamazaki, K.; Saiki, Y.; Niinami, H.; Matsumiya, G.; Arai, H.			Japanese Multi-Center Outcomes With the HeartMate II in the Post-Approval Era: Focusing on Results in Patients With Small Body Size	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Ono, M.] Univ Tokyo, Dept Cardiac Surg, Tokyo, Japan; [Sawa, Y.] Osaka Univ, Dept Cardiovasc Surg, Osaka, Japan; [Nakatani, T.] Natl Cardiovasc Res Ctr, Dept Transplantat, Osaka, Japan; [Tominaga, R.] Kyushu Univ, Dept Cardiovasc Surg, Fukuoka 812, Japan; [Matsui, Y.] Hokkaido Univ, Dept Cardiovasc Surg, Sapporo, Hokkaido, Japan; [Yamazaki, K.] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan; [Saiki, Y.] Tohoku Univ, Dept Cardiovasc Surg, Sendai, Miyagi 980, Japan; [Niinami, H.] Saitama Med Univ, Dept Cardiovasc Surg, Hidaka, Japan; [Matsumiya, G.] Chiba Univ, Dept Cardiovasc Surg, Chiba, Japan; [Arai, H.] Tokyo Med & Dent Univ, Dept Cardiovasc Surg, Tokyo, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		547	S205	S205				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500535		
J	Sahara, H; Sekijima, M; Waki, S; Ichinari, Y; Shimizu, A; Yamada, K				Sahara, H.; Sekijima, M.; Waki, S.; Ichinari, Y.; Shimizu, A.; Yamada, K.			Hydrogen Sulfide (H2S) Prevents Ischemia-Reperfusion Injury (IRI) and Prolongs Survival of the Fully MHC-Disparate Lung Graft in CLAM Miniature Swine	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Sahara, H.; Sekijima, M.; Waki, S.; Ichinari, Y.; Shimizu, A.; Yamada, K.] Kagoshima Univ, Ctr Adv Biomed Sci & Swine Res, Kagoshima 890, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		387	S149	S149				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500381		
J	Sahara, H; Nagashima, H; Sekijima, M; Miura, K; Kawai, A; Waki, S; Nakano, K; Matsunari, H; Shimizu, A; Yamada, K				Sahara, H.; Nagashima, H.; Sekijima, M.; Miura, K.; Kawai, A.; Waki, S.; Nakano, K.; Matsunari, H.; Shimizu, A.; Yamada, K.			Carbon Monoxide Attenuates Hyperacute Dysfunction and Microangiopathy in GalT-KO Pulmonary Xenotransplantation	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Sahara, H.; Sekijima, M.; Miura, K.; Kawai, A.; Waki, S.; Shimizu, A.; Yamada, K.] Kagoshima Univ, Ctr Adv Biomed Sci & Swine Res, Kagoshima 890, Japan; [Nagashima, H.; Nakano, K.; Matsunari, H.] Meiji Univ, Sch Agr, Dept Life Sci, Kawasaki, Kanagawa, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		740	S271	S271				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500725		
J	Saito, S; Toda, K; Nakamura, T; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Yoshioka, D; Saito, T; Tsukamoto, Y; Ueno, T; Kuratani, T; Sakata, Y; Sawa, Y				Saito, S.; Toda, K.; Nakamura, T.; Miyagawa, S.; Yoshikawa, Y.; Fukushima, S.; Yoshioka, D.; Saito, T.; Tsukamoto, Y.; Ueno, T.; Kuratani, T.; Sakata, Y.; Sawa, Y.			Multidisciplinary Treatment for Acute Fulminant and Nonfulminant Myocarditis	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Saito, S.; Toda, K.; Nakamura, T.; Miyagawa, S.; Yoshikawa, Y.; Fukushima, S.; Yoshioka, D.; Saito, T.; Ueno, T.; Kuratani, T.; Sawa, Y.] Osaka Univ, Grad Sch Med, Cardiovasc Surg, Suita, Osaka, Japan; [Tsukamoto, Y.; Sakata, Y.] Osaka Univ, Grad Sch Med, Cardiovasc Med, Suita, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		593	S221	S222				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500581		
J	Sugimoto, S; Oto, T; Okada, M; Iga, N; Miyoshi, K; Yamane, M; Miyoshi, S				Sugimoto, S.; Oto, T.; Okada, M.; Iga, N.; Miyoshi, K.; Yamane, M.; Miyoshi, S.			Update on the Outcomes of Lung Transplantation After Hematopoietic Stem Cell Transplantation: A Single-Center Experience	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Sugimoto, S.; Oto, T.; Okada, M.; Iga, N.; Miyoshi, K.; Yamane, M.; Miyoshi, S.] Okayama Univ Hosp, Gen Thorac Surg, Okayama, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		693	S256	S256				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500679		
J	Takahashi, M; Chen, F; Menju, T; Ohata, K; Kondo, T; Motoyama, H; Hijiya, K; Yamada, T; Sato, M; Aoyama, A; Date, H				Takahashi, M.; Chen, F.; Menju, T.; Ohata, K.; Kondo, T.; Motoyama, H.; Hijiya, K.; Yamada, T.; Sato, M.; Aoyama, A.; Date, H.			Hyperglycemia Exacerbates Ischemia-Reperfusion Injury of the Lung By Activating TLR4 Signaling Pathway	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Takahashi, M.; Chen, F.; Menju, T.; Ohata, K.; Kondo, T.; Motoyama, H.; Hijiya, K.; Yamada, T.; Sato, M.; Aoyama, A.; Date, H.] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		734	S269	S269				1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500719		
J	Yoshioka, D; Toda, K; Nakamura, T; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Saito, T; Sawa, Y				Yoshioka, D.; Toda, K.; Nakamura, T.; Miyagawa, S.; Yoshikawa, Y.; Fukushima, S.; Saito, T.; Sawa, Y.			Subclinical Hemorrhagic Cerebral Lesions Are Prevalent in Patients With Long Term Continuous-Flow LVAD Support	JOURNAL OF HEART AND LUNG TRANSPLANTATION			English	Meeting Abstract	35th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation	APR 15-18, 2015	Nice, FRANCE	Int Soc Heart & Lung Transplantat					[Yoshioka, D.; Toda, K.; Nakamura, T.; Miyagawa, S.; Yoshikawa, Y.; Fukushima, S.; Saito, T.; Sawa, Y.] Osaka Univ, Grad Sch Med, Cardiovasc Surg, Suita, Osaka, Japan								0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1053-2498	1557-3117		J HEART LUNG TRANSPL	J. Heart Lung Transplant.	APR	2015	34	4		S		582	S217	S218				2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery; Transplantation	Cardiovascular System & Cardiology; Respiratory System; Surgery; Transplantation	CG4JN	WOS:000353251500570		
J	Miyazaki, M; Yoshitomi, H; Miyakawa, S; Uesaka, K; Unno, M; Endo, I; Ota, T; Ohtsuka, M; Kinoshita, H; Shimada, K; Shimizu, H; Tabata, M; Chijiiwa, K; Nagino, M; Hirano, S; Wakai, T; Wada, K; Iasayama, H; Okusaka, T; Tsuyuguchi, T; Fujita, N; Furuse, J; Yamao, K; Murakami, K; Yamazaki, H; Kijima, H; Nakanuma, Y; Yoshida, M; Takayashiki, T; Takada, T				Miyazaki, Masaru; Yoshitomi, Hideyuki; Miyakawa, Shuichi; Uesaka, Katsuhiko; Unno, Michiaki; Endo, Itaru; Ota, Takehiro; Ohtsuka, Masayuki; Kinoshita, Hisafumi; Shimada, Kazuaki; Shimizu, Hiroaki; Tabata, Masami; Chijiiwa, Kazuo; Nagino, Masato; Hirano, Satoshi; Wakai, Toshifumi; Wada, Keita; Iasayama, Hiroyuki; Okusaka, Takuji; Tsuyuguchi, Toshio; Fujita, Naotaka; Furuse, Junji; Yamao, Kenji; Murakami, Koji; Yamazaki, Hideya; Kijima, Hiroshi; Nakanuma, Yasuni; Yoshida, Masahiro; Takayashiki, Tsukasa; Takada, Tadahiro			Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Ampullary carcinoma; Bile duct carcinoma; Biliary tract cancer; Gallbladder carcinoma	PORTAL-VEIN EMBOLIZATION; BILE-DUCT CANCER; FINE-NEEDLE-ASPIRATION; PRIMARY SCLEROSING CHOLANGITIS; T2 GALLBLADDER CARCINOMA; QUALITY-OF-LIFE; UNRESECTABLE HILAR CHOLANGIOCARCINOMA; ENDOSCOPIC NASOBILIARY DRAINAGE; INTRADUCTAL PAPILLARY NEOPLASM; EXTERNAL-BEAM RADIOTHERAPY	Background The Japanese Society of Hepato-Biliary-Pancreatic Surgery launched the clinical practice guidelines for the management of biliary tract and ampullary carcinomas in 2008. Novel treatment modalities and handling of clinical issues have been proposed after the publication. New approaches for editing clinical guidelines, such as the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system, also have been introduced for better and clearer grading of recommendations. Methods Clinical questions (CQs) were proposed in seven topics. Recommendation, grade of recommendation and statement for each CQ were discussed and finalized by evidence-based approach. Recommendation was graded to grade 1 (strong) and 2 (weak) according to the concept of GRADE system. Results The 29 CQs covered seven topics: (1) prophylactic treatment, (2) diagnosis, (3) biliary drainage, (4) surgical treatment, (5) chemotherapy, (6) radiation therapy, and (7) pathology. In 27 CQs, 19 recommendations were rated strong and 11 recommendations weak. Each CQ included the statement of how the recommendation was graded. Conclusions This guideline provides recommendation for important clinical aspects based on evidence. Future collaboration with cancer registry will be a key for assessment of the guidelines and establishment of new evidence. Free full-text articles and amobile application of this guideline are available via http://www.jshbps.jp/en/guideline/biliary-tract2.html.	[Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, Chiba 2608670, Japan	Miyazaki, M (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	masaru@faculty.chiba-u.jp	Unno, Michiaki/A-8633-2010	Unno, Michiaki/0000-0002-2145-6416	Isayama H, Boston Scientific Japan, Tokyo, Japan; Taiho Pharma, Tokyo, Japan; Yakult Pharmaceutical Industry Co., Ltd., Tokyo, Japan; Piolax Inc., Yokohama, Japan; Unno M, Takeda Pharmaceutical Co., Ltd., Osaka, Japan; Chugai pharmaceutical Co., Ltd., Tokyo, Japan; Janssen Pharmaceutical K., K., Tokyo, Japan; Ousaka T, Taiho Pharma, Tokyo, Japan; Onco Therapy Science, Inc., Kawasaki, Japan; Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan; Bayer Yakuhin, Osaka, Japan; Eisai Co., Ltd., Tokyo, Japan; Bristol-Myers Squibb, Tokyo, Japan; Eli Lily Japan; Kobe, Japan; Novartis Pharma, Tokyo, Japan; Takeda Pharmaceutical Co., Ltd., Osaka, Japan; Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan; Boehringer Inglheim Japan, Inc., Tokyo, Japan; Kowa Pharmaceutical Co., Ltd., Tokyo, Japan; Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan; Merck Serono Japan, Tokyo, Japan; Ono pharmaceutical Co., Ltd., Osaka, Japan; AstraZeneca K. K., Osaka, Japan; Furuse J, Taiho Pharma, Tokyo, Japan; Pfizer Japan Inc., Tokyo, Japan; Glaxo SmithKline K. K., Tokyo, Japan; Zeria Pharmaceutical Co., Ltd., Tokyo, Japan; Miyazaki M, Eli Lily Japan; Sanofi K. K., Tokyo, Japan; Murakami K, FUJIFILM RI Pharma Co., Ltd., Tokyo, Japan	Isayama H, Boston Scientific Japan, Tokyo, Japan, Taiho Pharma, Tokyo, Japan, Yakult Pharmaceutical Industry Co., Ltd., Tokyo, Japan, Piolax Inc., Yokohama, Japan; Unno M, Takeda Pharmaceutical Co., Ltd., Osaka, Japan, Yakult Pharmaceutical Industry Co., Ltd., Tokyo, Japan, Chugai pharmaceutical Co., Ltd., Tokyo, Japan, Janssen Pharmaceutical K., K., Tokyo, Japan; Ousaka T, Taiho Pharma, Tokyo, Japan, Chugai pharmaceutical Co., Ltd., Tokyo, Japan, Yakult Pharmaceutical industry Co., Ltd., Tokyo, Japan, Onco Therapy Science, Inc., Kawasaki, Japan, Sumitomo Dainippon Pharma Co., Ltd., Tokyo, Japan, Bayer Yakuhin, Osaka, Japan, Eisai Co., Ltd., Tokyo, Japan, Bristol-Myers Squibb, Tokyo, Japan, Eli Lily Japan, Kobe, Japan, Novartis Pharma, Tokyo, Japan, Takeda Pharmaceutical Co., Ltd., Osaka, Japan, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan, Boehringer Inglheim Japan, Inc., Tokyo, Japan, Kowa Pharmaceutical Co., Ltd., Tokyo, Japan, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan, Merck Serono Japan, Tokyo, Japan, Ono pharmaceutical Co., Ltd., Osaka, Japan, AstraZeneca K. K., Osaka, Japan; Furuse J, Taiho Pharma, Tokyo, Japan, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan, Pfizer Japan Inc., Tokyo, Japan, Bayer Yakuhin, Osaka, Japan, Novartis Pharma, Tokyo, Japan, Glaxo SmithKline K. K., Tokyo, Japan, Takeda Pharmaceutical Co., Ltd., Osaka, Japan, Eli lily Japan, Kobe, Japan, Yakult Pharmaceutical Industry Co., Ltd., Tokyo, Japan, Ono Pharmaceutical Co., Ltd., Osaka, Japan, Onco Therapy Science, Inc., Kawasaki, Japan, Zeria Pharmaceutical Co., Ltd., Tokyo, Japan, Merck Serono Japan, Tokyo, Japan; Miyazaki M, Eli Lily Japan, Kobe, Japan, Taiho pharma, Tokyo, Japan, Yakult Pharmaceutical industry Co., Ltd., Tokyo, Japan, Sanofi K. K., Tokyo, Japan; Murakami K, FUJIFILM RI Pharma Co., Ltd., Tokyo, Japan.	Abdalla EK, 2002, ARCH SURG-CHICAGO, V137, P680, DOI 10.1001/archsurg.137.6.675; Akatsu T, 2006, DIGEST DIS SCI, V51, P416, DOI 10.1007/s10620-006-3146-7; Albores-Saavedra J, 2011, MACSEWWNS PATHOLOGY, P563; Albu Sergiu, 2005, Rom J Gastroenterol, V14, P33; Ando H, 1995, J PEDIATR SURG, V30, P1658, DOI 10.1016/0022-3468(95)90445-X; Beger HG, 1999, ARCH SURG-CHICAGO, V134, P526, DOI 10.1001/archsurg.134.5.526; Lewis JT, 2010, AM J SURG PATHOL, V34, P27, DOI 10.1097/PAS.0b013e3181bc96f9; Kwon W, 2009, J KOREAN MED SCI, V24, P481, DOI 10.3346/jkms.2009.24.3.481; Kloek JJ, 2010, J GASTROINTEST SURG, V14, P119, DOI 10.1007/s11605-009-1009-1; SHARP KW, 1990, AM SURGEON, V56, P214; Atkins D, 2004, BRIT MED J, V328, P1490; Kondo S, 2000, BRIT J SURG, V87, P418, DOI 10.1046/j.1365-2168.2000.01384.x; Unno M, 2007, J HEPATO-BILIARY-PAN, V14, P434, DOI 10.1007/s00534-006-1191-4; Hirano S, 2010, J HEPATO-BIL-PAN SCI, V17, P455, DOI 10.1007/s00534-009-0208-1; Jin KT, 2011, CLIN TRANSL ONCOL, V13, P25, DOI 10.1007/s12094-011-0613-1; SHIRAI Y, 1992, ANN SURG, V215, P326, DOI 10.1097/00000658-199204000-00004; Chijiiwa K, 2001, J AM COLL SURGEONS, V192, P600, DOI 10.1016/S1072-7515(01)00814-6; Miyazaki M, 2007, SURGERY, V141, P581, DOI 10.1016/j.surg.2006.09.016; Sakamoto E, 1998, ANN SURG, V227, P405, DOI 10.1097/00000658-199803000-00013; Liu CL, 2006, BRIT J SURG, V93, P1488, DOI 10.1002/bjs.5482; Sasaki T, 2013, CANCER CHEMOTH PHARM, V71, P973, DOI 10.1007/s00280-013-2090-4; BACZAKO K, 1985, HUM PATHOL, V16, P305, DOI 10.1016/S0046-8177(85)80018-6; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Mukai T, 2013, J HEPATO-BIL-PAN SCI, V20, P214, DOI 10.1007/s00534-012-0508-8; Iacono C, 2013, ANN SURG, V257, P191, DOI 10.1097/SLA.0b013e31826f4b0e; Sano T, 2006, ANN SURG, V244, P240, DOI 10.1097/01.sla.0000217605.66519.38; Ebata T, 2012, DIGEST SURG, V29, P23, DOI 10.1159/000335718; Kubota K, 1997, HEPATOLOGY, V26, P1176; Aljiffry M, 2009, J AM COLL SURGEONS, V208, P134, DOI 10.1016/j.jamcollsurg.2008.09.007; KUBOTA K, 1995, SURGERY, V117, P481, DOI 10.1016/S0039-6060(05)80245-4; Arakura N, 2009, J HEPATO-BILIARY-PAN, V16, P473, DOI 10.1007/s00534-009-0076-8; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Liu F, 2011, DIGEST DIS SCI, V56, P663, DOI 10.1007/s10620-010-1338-7; Nagino M, 2008, J HEPATO-BILIARY-PAN, V15, P25, DOI 10.1007/s00534-007-1277-7; Howe JR, 1997, CLIN CANCER RES, V3, P129; Suda K, 2009, AM J SURG, V197, P752, DOI 10.1016/j.amjsurg.2008.05.007; Yoon YS, 2005, ANN SURG, V242, P92, DOI 10.1097/01.sla.0000167853.04171.bb; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Neuhaus P, 1999, ANN SURG, V230, P808, DOI 10.1097/00000658-199912000-00010; Parks RW, 1996, BRIT J SURG, V83, P1345, DOI 10.1002/bjs.1800831007; Miyazaki M, 2010, J HEPATO-BIL-PAN SCI, V17, P470, DOI 10.1007/s00534-009-0207-2; Tsukada K, 1996, SURGERY, V120, P816, DOI 10.1016/S0039-6060(96)80089-4; Igami T, 2010, J HEPATO-BIL-PAN SCI, V17, P449, DOI 10.1007/s00534-009-0209-0; Aloia TA, 2007, AM J SURG, V193, P702, DOI 10.1016/j.amjsurg.2006.10.024; Takada T, 2013, J HEPATO-BIL-PAN SCI, V20, P1, DOI 10.1007/s00534-012-0566-y; Patel T, 2011, NAT REV GASTRO HEPAT, V8, P189, DOI 10.1038/nrgastro.2011.20; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; Roggin KK, 2005, ANN SURG ONCOL, V12, P971, DOI 10.1245/ASO.2005.03.009; Krokidis M, 2010, CARDIOVASC INTER RAD, V33, P97, DOI 10.1007/s00270-009-9604-9; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Cortes A, 2006, J AM COLL SURGEONS, V202, P93, DOI 10.1016/j.jamcollsurg.2005.09.006; Rougemont AL, 2010, VIRCHOWS ARCH, V456, P711, DOI 10.1007/s00428-010-0899-3; Varshney S, 2002, EUR J SURG ONCOL, V28, P4, DOI 10.1053/ejso.2001.1175; Hemming AW, 2011, J AM COLL SURGEONS, V212, P604, DOI 10.1016/j.jamcollsurg.2010.12.028; Shinohara ET, 2009, INT J RADIAT ONCOL, V74, P1191, DOI 10.1016/j.ijrobp.2008.09.017; Shimizu H, 2010, ANN SURG, V251, P281, DOI 10.1097/SLA.0b013e3181be0085; Takara D, 2011, WORLD J SURG, V35, P850, DOI 10.1007/s00268-011-0990-1; Valek V, 2007, EUR J RADIOL, V62, P175, DOI 10.1016/j.ejrad.2007.01.037; NAGINO M, 1995, HEPATOLOGY, V21, P434, DOI 10.1016/0270-9139(95)90104-3; Endo I, 2007, SURGERY, V142, P666, DOI 10.1016/j.surg.2007.05.018; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Shinchi H, 2000, J SURG ONCOL, V75, P89, DOI 10.1002/1096-9098(200010)75:2<89::AID-JSO3>3.0.CO;2-V; Sasaki T, 2010, CANCER CHEMOTH PHARM, V65, P1101, DOI 10.1007/s00280-009-1115-5; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7; Ribero D, 2011, ANN SURG, V254, P776, DOI 10.1097/SLA.0b013e3182368f85; Takeshita N, 2011, ANN SURG, V254, P1050, DOI 10.1097/SLA.0b013e3182243550; Mainprize KS, 2000, BRIT J SURG, V87, P414, DOI 10.1046/j.1365-2168.2000.01363.x; Hochwald SN, 1999, ARCH SURG-CHICAGO, V134, P261, DOI 10.1001/archsurg.134.3.261; ALDEN ME, 1994, INT J RADIAT ONCOL, V28, P945; Farges O, 2013, BRIT J SURG, V100, P274, DOI 10.1002/bjs.8950; Hueman MT, 2009, ANN SURG ONCOL, V16, P2101, DOI 10.1245/s10434-009-0538-x; Ebata T, 2003, ANN SURG, V238, P720, DOI 10.1097/01.sla.0000094437.68038.a3; DAVIDS PHP, 1992, LANCET, V340, P1488, DOI 10.1016/0140-6736(92)92752-2; Furuse J, 2008, CANCER CHEMOTH PHARM, V62, P849, DOI 10.1007/s00280-007-0673-7; YAMAGUCHI K, 1990, GASTROINTEST ENDOSC, V36, P588, DOI 10.1016/S0016-5107(90)71170-4; Jagannath P, 2005, BRIT J SURG, V92, P356, DOI 10.1002/bjs.4864; Klein P, 1996, EUR J SURG ONCOL, V22, P366, DOI 10.1016/S0748-7983(96)90286-3; Kalra N, 2006, AM J ROENTGENOL, V186, P758, DOI 10.2214/AJR.04.1342; Hong YK, 2011, EJSO-EUR J SURG ONC, V37, P237, DOI 10.1016/j.ejso.2010.12.010; Suzuki S, 2004, WORLD J SURG, V28, P160, DOI 10.1007/s00268-003-7080-y; Kim JH, 2002, RADIOGRAPHICS, V22, P1335, DOI 10.1148/rg.226025060; Sano T, 2007, J HEPATO-BILIARY-PAN, V14, P455, DOI 10.1007/s00534-006-1194-1; Ito F, 2009, ANN SURG, V250, P210, DOI 10.1097/SLA.0b013e3181afe0ab; Kanai M, 1996, SURGERY, V119, P498, DOI 10.1016/S0039-6060(96)80257-1; Kow AWC, 2012, WORLD J SURG, V36, P1112, DOI 10.1007/s00268-012-1497-0; Watanabe K, 2010, HPB, V12, P664, DOI 10.1111/j.1477-2574.2010.00229.x; Sakata J, 2005, WORLD J GASTROENTERO, V11, P7024; Shin HS, 2003, INT J RADIAT ONCOL, V57, P105, DOI 10.1016/S0360-3016(03)00410-3; Branum GD, 1996, ANN SURG, V224, P621, DOI 10.1097/00000658-199611000-00006; Kondo S, 2008, J HEPATO-BILIARY-PAN, V15, P41, DOI 10.1007/s00534-007-1279-5; Morizane C, 2013, CANCER SCI, V104, P1211, DOI 10.1111/cas.12218; Abraham NS, 2002, GASTROINTEST ENDOSC, V56, P835, DOI 10.1067/mge.2002.129868; Takamura A, 2003, INT J RADIAT ONCOL, V57, P1357, DOI 10.1016/S0360-3016(03)00770-3; SMITH AC, 1994, LANCET, V344, P1655, DOI 10.1016/S0140-6736(94)90455-3; Chen HW, 2009, HEPATO-GASTROENTEROL, V56, P578; Kishi Y, 2009, ANN SURG, V250, P540, DOI 10.1097/SLA.0b013e3181b674df; Lundberg O, 1999, EUR J SURG, V165, P215; DeWitt J, 2006, GASTROINTEST ENDOSC, V64, P325, DOI 10.1016/j.gie.2005.11.064; Lee SG, 2010, J HEPATO-BIL-PAN SCI, V17, P476, DOI 10.1007/s00534-009-0204-5; Abdalla EK, 2002, ARCH SURG-CHICAGO, V137, P675, DOI 10.1001/archsurg.137.6.675; Luman W, 1997, EUR J GASTROEN HEPAT, V9, P481; Kamiya S, 2004, ANN SURG, V239, P510, DOI 10.1097/01.sla.0000118594.23874.89; Garcia P, 2009, MOL CARCINOGEN, V48, P79, DOI 10.1002/mc.20457; Sugawara G, 2013, SURGERY, V153, P200, DOI 10.1016/j.surg.2012.07.032; Zen Y, 2006, J HEPATOL, V44, P350, DOI 10.1016/j.jhep.2005.09.025; Kennedy TJ, 2009, HPB, V11, P445, DOI 10.1111/j.1477-2574.2009.00090.x; Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010; Grandadam S, 2010, ANN SURG ONCOL, V17, P3155, DOI 10.1245/s10434-010-1168-z; Itatsu K, 2007, LIVER INT, V27, P1174, DOI 10.1111/j.1478-3231.2007.01577.x; Neuhaus P, 2012, ANN SURG ONCOL, V19, P1602, DOI 10.1245/s10434-011-2077-5; Unno M, 2010, J HEPATO-BIL-PAN SCI, V17, P463, DOI 10.1007/s00534-009-0206-3; Maguchi H, 2007, J HEPATO-BILIARY-PAN, V14, P441, DOI 10.1007/s00534-006-1192-3; Duffy A, 2008, J SURG ONCOL, V98, P485, DOI 10.1002/jso.21141; BALLINGER AB, 1994, GUT, V35, P467, DOI 10.1136/gut.35.4.467; WAGNER HJ, 1993, ENDOSCOPY, V25, P213, DOI 10.1055/s-2007-1010295; Kosuge T, 1999, ANN SURG, V230, P663, DOI 10.1097/00000658-199911000-00008; Valle JW, 2009, BRIT J CANCER, V101, P621, DOI 10.1038/sj.bjc.6605211; Ito K, 2012, DIGEST ENDOSC, V24, P30, DOI 10.1111/j.1443-1661.2011.01161.x; Kumaran V, 2002, EUR RADIOL, V12, P1993, DOI 10.1007/s00330-002-1440-0; Takikawa H, 1997, J GASTROENTEROL, V32, P134, DOI 10.1007/BF01213311; Paolucci V, 1999, WORLD J SURG, V23, P989; Zen Y, 2004, AM J SURG PATHOL, V28, P1193, DOI 10.1097/01.pas.0000136449.37936.6c; Hirano S, 2014, J HEPATO-BIL-PAN SCI, V21, P533, DOI 10.1002/jhbp.76; Komori K, 2006, BRIT J SURG, V93, P745, DOI 10.1002/bjs.5332; Nakanishi Y, 2010, J HEPATO-BIL-PAN SCI, V17, P166, DOI 10.1007/s00534-009-0127-1; Nishio H, 2007, J HEPATO-BILIARY-PAN, V14, P351, DOI 10.1007/s00534-006-1187-0; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; MAKUUCHI M, 1990, SURGERY, V107, P521; Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9; Takahashi Y, 2010, BRIT J SURG, V97, P1860, DOI 10.1002/bjs.7228; Myers RP, 2002, CAN J GASTROENTEROL, V16, P187; Selvaggi SM, 2004, CYTOPATHOLOGY, V15, P74, DOI 10.1111/j.1365-2303.2004.00133.x; Lee JH, 2004, AM J GASTROENTEROL, V99, P1069, DOI 10.1111/j.1572-0241.2004.30223.x; Takashima M, 2000, MODERN PATHOL, V13, P1300, DOI 10.1038/modpathol.3880238; Seyama Y, 2003, ANN SURG, V238, P73, DOI 10.1097/01.SLA.0000074960.55004.72; Wakai T, 2003, ANN SURG ONCOL, V10, P447, DOI 10.1245/ASO.2003.06.014; Roa I, 2006, J SURG ONCOL, V93, P615, DOI 10.1002/jso.20527; Gleeson FC, 2008, GASTROINTEST ENDOSC, V67, P438, DOI 10.1016/j.gie.2007.07.018; Fritscher-Ravens A, 2004, AM J GASTROENTEROL, V99, P45, DOI 10.1046/j.1572-0241.2003.04006.x; Araida T, 2009, SURG TODAY, V39, P770, DOI 10.1007/s00595-009-3960-6; Benson AB, 2015, NCCN CLIN PRACTICE G; Cha BH, 2011, WORLD J GASTROENTERO, V17, P2216, DOI 10.3748/wjg.v17.i17.2216; CHIJIWA K, 1994, INT SURG, V79, P106; Choi SB, 2009, WORLD J SURG, V33, P2657, DOI 10.1007/s00268-009-0249-2; Choi SB, 2010, J GASTROINTEST SURG, V14, P668, DOI 10.1007/s11605-009-1132-z; Cozzi G, 1999, TUMORI, V85, P153; de Castro SMM, 2004, SURGERY, V136, P994, DOI 10.1016/j.surg.2004.03.010; de Groen PC, 1999, NEW ENGL J MED, V341, P1368, DOI 10.1056/NEJM199910283411807; de Aretxabala XA, 2004, WORLD J SURG, V28, P544, DOI 10.1007/s00268-004-6886-6; Dinant Sander, 2005, HPB (Oxford), V7, P263, DOI 10.1080/13651820500372376; DUARTE I, 1993, CANCER, V72, P1878, DOI 10.1002/1097-0142(19930915)72:6<1878::AID-CNCR2820720615>3.0.CO;2-2; Ebata T, 2002, BRIT J SURG, V89, P1260, DOI 10.1046/j.1365-2168.2002.02211.x; ENGELS JT, 1989, RADIOLOGY, V172, P35; Funabiki T, 2009, LANGENBECK ARCH SURG, V394, P159, DOI 10.1007/s00423-008-0336-0; Furuse J, 2008, J HEPATO-BILIARY-PAN, V15, P55, DOI 10.1007/s00534-007-1280-z; Gazzaniga G M, 2000, J Hepatobiliary Pancreat Surg, V7, P122, DOI 10.1007/s005340050165; Goetze TO, 2013, SURG ENDOSC, V27, P2821, DOI 10.1007/s00464-013-2819-5; GOLDBERG M, 1987, AM J GASTROENTEROL, V82, P1169; Jarnagin W, 2011, J AM COLL SURGEONS, V212, P613; Higuchi R, 2010, SURGERY, V148, P7, DOI 10.1016/j.surg.2009.11.018; Hijioka S, 2012, J HEPATO-BIL-PAN SCI, V19, P650, DOI 10.1007/s00534-011-0482-6; Ishizawa T, 2007, AM J SURG, V193, P149, DOI 10.1016/j.amjsurg.2006.07.015; Jacobson BC, 2002, PANCREATOLOGY, V2, P26, DOI 10.1159/000049444; Jarnagin WR, 2001, ANN SURG, V234, P507, DOI 10.1097/00000658-200110000-00010; Kaiser A, 2002, Z GASTROENTEROL, V40, P913, DOI 10.1055/s-2002-35414; Kamisawa T, 2012, J GASTROENTEROL, V47, P731, DOI 10.1007/s00535-012-0611-2; Kanai M, 2011, CANCER CHEMOTH PHARM, V67, P1429, DOI 10.1007/s00280-010-1443-5; Khan SA, 2002, GUT, V51, P1; Kim SJ, 2008, AM J ROENTGENOL, V190, P74, DOI 10.2214/AJR.07.2348; KNOX RA, 1986, BRIT J SURG, V73, P72, DOI 10.1002/bjs.1800730129; Kokudo N, 2003, ARCH SURG-CHICAGO, V138, P741, DOI 10.1001/archsurg.138.7.741; Kokudo N, 2003, ARCH SURG-CHICAGO, V138, P750; Konishi M, 2010, BRIT J SURG, V97, P1363, DOI 10.1002/bjs.7122; Konstantinidis IT, 2009, ARCH SURG-CHICAGO, V144, P447; Konstantinidis IT, 2009, ARCH SURG-CHICAGO, V144, P441, DOI 10.1001/archsurg.2009.46; Krones E, 2012, LIVER INT, V32, P352, DOI 10.1111/j.1478-3231.2011.02607.x; Kurosaki I, 2008, J GASTROINTEST SURG, V12, P907, DOI 10.1007/s11605-007-0387-5; LAITIO M, 1983, PATHOL RES PRACT, V178, P51; Lammer J, 1996, RADIOLOGY, V201, P167; Lee S G, 2000, J Hepatobiliary Pancreat Surg, V7, P135, DOI 10.1007/s005340050167; Lundberg O, 2001, J Hepatobiliary Pancreat Surg, V8, P525, DOI 10.1007/s005340100020; Matsubara Toshiki, 2002, J Hepatobiliary Pancreat Surg, V9, P312, DOI 10.1007/s005340200035; Miyakawa S, 2008, J HEPATO-BILIARY-PAN, V15, P7, DOI 10.1007/s00534-007-1275-9; Miyazaki M, 2008, J HEPATO-BILIARY-PAN, V15, P15, DOI 10.1007/s00534-007-1276-8; Miyazaki M, 2015, J HEPATO-BIL-PAN SCI, V22, P181, DOI 10.1002/jhbp.211; Miyazaki M, 1998, SURGERY, V123, P131, DOI 10.1067/msy.1998.85440; MIZUMOTO R, 1986, SURG GYNECOL OBSTET, V162, P153; Morine Y, 2013, J HEPATO-BIL-PAN SCI, V20, P472, DOI 10.1007/s00534-013-0606-2; Nakanishi Y, 2008, HUM PATHOL, V39, P1153, DOI 10.1016/j.humpath.2007.11.018; Nakayama A, 1999, SURGERY, V125, P514, DOI 10.1067/msy.1999.97628; NIMURA Y, 1990, WORLD J SURG, V14, P535; Nimura Y, 1995, J HEP BIL PANCR SURG, V2, P239, DOI 10.1007/BF02350905; Nimura Y, 2000, J Hepatobiliary Pancreat Surg, V7, P155, DOI 10.1007/s005340050170; Nishimura A, 2004, J HEPATO-BILIARY-PAN, V11, P342, DOI 10.1007/s00534-004-0911-x; Noie T, 2001, SURGERY, V130, P74, DOI 10.1067/msy.2001.116028; Ohshima Y, 2011, J GASTROENTEROL, V46, P921, DOI 10.1007/s00535-011-0404-z; OHTANI T, 1993, RADIOLOGY, V189, P875; Ohuchida J, 2006, ARCH SURG-CHICAGO, V141, P1066, DOI 10.1001/archsurg.141.11.1066; Ojima H, 2009, CANCER SCI, V100, P62, DOI 10.1111/j.1349-7006.2008.01009.x; Okusaka T, 2006, CANCER CHEMOTH PHARM, V57, P647, DOI 10.1007/s00280-005-0095-3; Ouchi Kiyoaki, 2002, J Hepatobiliary Pancreat Surg, V9, P256, DOI 10.1007/s005340200028; Paolucci V, 1999, WORLD J SURG, V23, P996; Park JK, 2008, GUT LIVER, V2, P88, DOI 10.5009/gnl.2008.2.2.88; Povoski SP, 1999, J GASTROINTEST SURG, V3, P496, DOI 10.1016/S1091-255X(99)80103-6; Reddy YP, 2000, EUR J SURG ONCOL, V26, P95; Regimbeau JM, 2011, EJSO-EUR J SURG ONC, V37, P505, DOI 10.1016/j.ejso.2011.03.135; Ribero D, 2011, ANN SURG, V254, P781; Roa JC, 2005, J GASTROENTEROL, V40, P79, DOI 10.1007/s00535-004-1497-4; Saito H, 2008, J HEPATO-BILIARY-PAN, V15, P63, DOI 10.1007/s00534-007-1281-y; Sakamoto Y, 2006, LANGENBECK ARCH SURG, V391, P203, DOI 10.1007/s00423-006-0026-8; Sakamoto Y, 2006, J SURG ONCOL, V94, P298, DOI 10.1002/jso.20585; Sakata J, 2009, LANGENBECK ARCH SURG, V394, P1065, DOI 10.1007/s00423-009-0464-1; Saleem A, 2011, GASTROINTEST ENDOSC, V74; Sano T, 2004, HEPATO-GASTROENTEROL, V51, P672; Sarli L, 2000, ARCH SURG-CHICAGO, V135, P1340, DOI 10.1001/archsurg.135.11.1340; Sasaki R, 2007, WORLD J SURG, V31, P1788, DOI 10.1007/s00268-007-9102-7; Sawada S, 2007, PATHOL INT, V57, P652, DOI 10.1111/j.1440-1827.2007.02154.x; Schauer RJ, 2001, LANGENBECK ARCH SURG, V386, P110, DOI 10.1007/s004230000189; SHIMADA K, 1991, HEPATOLOGY, V13, P438, DOI 10.1016/0270-9139(91)90296-8; Shimizu Y, 2004, SURGERY, V136, P1012, DOI 10.1016/j.surg.2004.04.032; Shingu Y, 2010, SURGERY, V147, P49, DOI 10.1016/j.surg.2009.06.030; Shinohara ET, 2010, INT J RADIAT ONCOL, V78, P722, DOI 10.1016/j.ijrobp.2009.08.070; Shukla PJ, 2008, HPB, V10, P43, DOI 10.1080/13651820701867794; Silecchia Gianfranco, 2002, JSLS, V6, P339; Sirichindakul B, 2007, HEPATO-GASTROENTEROL, V54, P2297; Slattery JM, 2006, ONCOLOGIST, V11, P913, DOI 10.1634/theoncologist.11-8-913; Stancu Manuela, 2007, Rom J Morphol Embryol, V48, P335; SUGIURA Y, 1994, SURGERY, V115, P445; Sugiyama M, 2000, GUT, V46, P250, DOI 10.1136/gut.46.2.250; Tabata M, 2000, J Hepatobiliary Pancreat Surg, V7, P148, DOI 10.1007/s005340050169; Takada T, 2008, J HEPATO-BILIARY-PAN, V15, P1, DOI 10.1007/s00534-007-1273-y; Takada T, 2008, J HEPATO-BILIARY-PAN, V15, P2, DOI 10.1007/s00534-007-1274-x; Tanaka A, 2008, LIVER INT, V28, P983, DOI 10.1111/j.1478-3231.2008.01726.x; TARAZI RY, 1986, SURGERY, V100, P716; Tsuchida A, 2004, ONCOL REP, V11, P269; Tsukada K, 2008, J HEPATO-BILIARY-PAN, V15, P31, DOI 10.1007/s00534-007-1278-6; Tsuyuguchi T, 2008, J HEPATO-BILIARY-PAN, V15, P69, DOI 10.1007/s00534-007-1282-x; Ueno H, 2004, BRIT J CANCER, V91, P1769, DOI 10.1038/sj.bjc.6602208; Varadarajulu S, 2005, ENDOSCOPY, V37, P751, DOI 10.1055/s-870161; Wahab Mohamed Abdel, 2012, Hepatogastroenterology, V59, P321, DOI 10.5754/hge11999; Wakai T, 2002, WORLD J SURG, V26, P867, DOI 10.1007/s00268-002-6274-z; Wakai T, 2005, CANCER, V103, P1210, DOI 10.1002/cncr.20906; Weiland ST, 2002, J GASTROINTEST SURG, V6, P50, DOI 10.1016/S1091-255X(01)00014-2; Weiland ST, 2002, J GASTROINTEST SURG, V6, P56; Welsh FKS, 1998, ANN SURG, V227, P205, DOI 10.1097/00000658-199802000-00009; Whalen GF, 2001, J AM COLL SURGEONS, V192, P189, DOI 10.1016/S1072-7515(00)00794-8; WIBBENMEYER LA, 1995, J AM COLL SURGEONS, V181, P504; Wittekind C, 2009, TNM CLASSIFICATION M, P122; Working Group IAP/APA Acute Pancreatitis Guidelines, 2013, PANCREATOLOGY, V13, pe1; Wu LM, 2011, EUR J GASTROEN HEPAT, V23, P113, DOI 10.1097/MEG.0b013e3283426313; Wullstein C, 2002, SURG ENDOSC, V16, P828, DOI 10.1007/s00464-001-9085-7; YAMAGIWA H, 1989, JPN J CANCER RES, V80, P238; Yamamoto H, 2005, J HEPATO-BILIARY-PAN, V12, P391, DOI 10.1007/s00534-005-0996-x; Yamanaka N, 2001, LANGENBECK ARCH SURG, V386, P364, DOI 10.1007/s004230100225; Yoshida T, 2000, J AM COLL SURGEONS, V191, P158, DOI 10.1016/S1072-7515(00)00285-4; Yoshitomi H, 2015, J HEPATO-BIL-PAN SCI, V22, P274, DOI 10.1002/jhbp.234; Z'graggen K, 1998, SURGERY, V124, P831, DOI 10.1016/S0039-6060(98)70005-4; Zhang WJ, 2009, WORLD J SURG, V33, P2651, DOI 10.1007/s00268-009-0218-9	260	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					249	273		10.1002/jhbp.233		25	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800002		
J	Yoshitomi, H; Miyakawa, S; Nagino, M; Takada, T; Miyazaki, M				Yoshitomi, Hideyuki; Miyakawa, Shuichi; Nagino, Masato; Takada, Tadahiro; Miyazaki, Masaru			Updated clinical practice guidelines for the management of biliary tract cancers: revision concepts and major revised points	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Ampullary carcinoma; Bile duct carcinoma; Biliary tract cancer; Clinical guidelines; Gallbladder carcinoma	EXTRAHEPATIC BILE-DUCT; ADVANCED GALLBLADDER CANCER; AMPULLARY CARCINOMAS; HILAR CHOLANGIOCARCINOMA; SURGICAL-TREATMENT; RADICAL SURGERY; MARGIN STATUS; RESECTION; DRAINAGE; MULTICENTER	Background In 2008, the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS) launched the clinical practice guideline for the management of biliary tract cancers. JSHBPS decided to revise these guidelines for distribution of updated points concerning the treatment of biliary tract cancers. Methods To make clearer recommendations, we introduced the concepts of Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, in which the strength of recommendations are decided considering not only quality of evidence, but also balance of benefits and harms/burdens, patients' preferences, and cost benefits. Results We emphasize the importance of the dynamic contrast enhanced multiple row detector CT (MDCT) in the diagnosis of biliary tract and gallbladder carcinomas. For biliary drainage, we suggest to perform endoscopic approaches instead of percutaneous approach to avoid complications. Regarding the surgical treatments, we included new clinical questions about the importance of combined vascular resection, intraoperative histological examination of the bile duct resection margin, and the combined extrahepatic bile duct resection for the gallbladder carcinoma. We also discussed details about premalignant lesions and non-neoplastic lesions in pathology section. Conclusion With this major revision, we expect that the Japanese standards of treatments of these diseases are recorded and reported in the universal language.	[Yoshitomi, Hideyuki; Miyazaki, Masaru] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, Chiba 2608670, Japan; [Miyakawa, Shuichi] Toyota Reg Med Ctr, Toyota, Japan; [Nagino, Masato] Nagoya Univ, Grad Sch Med, Dept Surg, Div Surg Oncol, Nagoya, Aichi 4648601, Japan; [Takada, Tadahiro] Teiko Univ, Sch Med, Dept Surg, Tokyo, Japan	Miyazaki, M (reprint author), Chiba Univ, Grad Sch Med, Dept Gen Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	masaru@faculty.chiba-u.jp					Atkins D, 2004, BRIT MED J, V328, P1490; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Nagino M, 2008, J HEPATO-BILIARY-PAN, V15, P25, DOI 10.1007/s00534-007-1277-7; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Tsukada K, 1996, SURGERY, V120, P816, DOI 10.1016/S0039-6060(96)80089-4; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Endo I, 2007, SURGERY, V142, P666, DOI 10.1016/j.surg.2007.05.018; Kalra N, 2006, AM J ROENTGENOL, V186, P758, DOI 10.2214/AJR.04.1342; Suzuki S, 2004, WORLD J SURG, V28, P160, DOI 10.1007/s00268-003-7080-y; Kondo S, 2008, J HEPATO-BILIARY-PAN, V15, P41, DOI 10.1007/s00534-007-1279-5; Chen HW, 2009, HEPATO-GASTROENTEROL, V56, P578; Kumaran V, 2002, EUR RADIOL, V12, P1993, DOI 10.1007/s00330-002-1440-0; Hirano S, 2014, J HEPATO-BIL-PAN SCI, V21, P533, DOI 10.1002/jhbp.76; Nakanishi Y, 2010, J HEPATO-BIL-PAN SCI, V17, P166, DOI 10.1007/s00534-009-0127-1; Takahashi Y, 2010, BRIT J SURG, V97, P1860, DOI 10.1002/bjs.7228; Araida T, 2009, SURG TODAY, V39, P770, DOI 10.1007/s00595-009-3960-6; Furuse J, 2008, J HEPATO-BILIARY-PAN, V15, P55, DOI 10.1007/s00534-007-1280-z; Higuchi R, 2010, SURGERY, V148, P7, DOI 10.1016/j.surg.2009.11.018; Kim SJ, 2008, AM J ROENTGENOL, V190, P74, DOI 10.2214/AJR.07.2348; Kokudo N, 2003, ARCH SURG-CHICAGO, V138, P741, DOI 10.1001/archsurg.138.7.741; Miyakawa S, 2008, J HEPATO-BILIARY-PAN, V15, P7, DOI 10.1007/s00534-007-1275-9; Miyazaki M, 2008, J HEPATO-BILIARY-PAN, V15, P15, DOI 10.1007/s00534-007-1276-8; Ojima H, 2009, CANCER SCI, V100, P62, DOI 10.1111/j.1349-7006.2008.01009.x; Saito H, 2008, J HEPATO-BILIARY-PAN, V15, P63, DOI 10.1007/s00534-007-1281-y; Sakamoto Y, 2006, J SURG ONCOL, V94, P298, DOI 10.1002/jso.20585; Sasaki R, 2007, WORLD J SURG, V31, P1788, DOI 10.1007/s00268-007-9102-7; Shimizu Y, 2004, SURGERY, V136, P1012, DOI 10.1016/j.surg.2004.04.032; Takada T, 2008, J HEPATO-BILIARY-PAN, V15, P1, DOI 10.1007/s00534-007-1273-y; Takada T, 2008, J HEPATO-BILIARY-PAN, V15, P2, DOI 10.1007/s00534-007-1274-x; Tsukada K, 2008, J HEPATO-BILIARY-PAN, V15, P31, DOI 10.1007/s00534-007-1278-6; Tsuyuguchi T, 2008, J HEPATO-BILIARY-PAN, V15, P69, DOI 10.1007/s00534-007-1282-x; Unnno M, 2007, J HEPATOBILIARY PANC, V14, P434; Wakai T, 2005, CANCER, V103, P1210, DOI 10.1002/cncr.20906	34	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					274	278		10.1002/jhbp.234		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800003		
J	Takada, Y; Tohyama, T; Watanabe, J				Takada, Yasutsugu; Tohyama, Taiji; Watanabe, Jota			Biological markers of hepatocellular carcinoma for use as selection criteria in liver transplantation	Journal of Hepato-Biliary-Pancreatic Sciences			English	Review						Biological marker; Hepatocellular carcinoma; Liver transplantation; Selection criteria	GAMMA-CARBOXY PROTHROMBIN; POSITRON-EMISSION-TOMOGRAPHY; TO-TREAT ANALYSIS; NEUTROPHIL-LYMPHOCYTE RATIO; ALPHA-FETOPROTEIN; MILAN CRITERIA; EXPANDED CRITERIA; TRANSARTERIAL CHEMOEMBOLIZATION; RETROSPECTIVE-ANALYSIS; PROGNOSTIC INDICATOR	The Milan criteria (MC) have been widely accepted as an effective way of selecting patients with early-stage hepatocellular carcinoma (HCC) for curative liver transplantation (LT). However, since a substantial subset of HCC patients exists that is beyond the MC but with the potential for good outcomes after LT, several institutions have recently proposed new extended criteria. To explore optimal criteria that can reasonably predict the risk of recurrence, it is considered that new markers of biological behavior are needed in addition to morphological tumor size and number. Several promising candidates for such biological markers have been reported, including serum tumor markers such as alpha-fetoprotein and des-gamma-carboxy prothrombin, inflammatory markers such as C-reactive protein and neutrophil-to-lymphocyte ratio, response to pre-transplant treatments for bridging therapy or down-staging, and fluorine-18-fluorodeoxyglucose positron emission tomography. However, the role of these biological markers in patient selection criteria for LT has yet to be clarified. This review article aims to summarize the results of recent reported studies and to display perspectives for the establishment of optimal criteria that incorporate such biological markers.	[Takada, Yasutsugu; Tohyama, Taiji; Watanabe, Jota] Ehime Univ, Grad Sch Med, Dept HPB & Breast Surg, Toon, Ehime 7910295, Japan	Takada, Y (reprint author), Ehime Univ, Grad Sch Med, Dept HPB & Breast Surg, Toon, Ehime 7910295, Japan.	takaday@m.ehime-u.ac.jp					Cillo U, 2007, AM J TRANSPLANT, V7, P972, DOI 10.1111/j.1600-6143.2006.01719.x; Cillo U, 2004, ANN SURG, V239, P150, DOI 10.1097/01.sla.0000109146.72827.76; Bertuzzo VR, 2011, TRANSPLANTATION, V91, P1279, DOI 10.1097/TP.0b013e3182187cf0; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Kaido T, 2013, SURGERY, V154, P1053, DOI 10.1016/j.surg.2013.04.056; Lai Q, 2013, LIVER TRANSPLANT, V19, P1108, DOI 10.1002/lt.23706; Berry K, 2013, LIVER TRANSPLANT, V19, P634, DOI 10.1002/lt.23652; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Taketomi A, 2009, TRANSPLANTATION, V87, P531, DOI 10.1097/TP.0b013e3181943bee; Yao FY, 2008, HEPATOLOGY, V48, P819, DOI 10.1002/hep.22412; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Koike Y, 2001, CANCER, V91, P561, DOI 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N; Hustinx R, 2002, SEMIN NUCL MED, V32, P35, DOI 10.1053/snuc.2002.29272; Ravaioli M, 2008, AM J TRANSPLANT, V8, P2547, DOI 10.1111/j.1600-6143.2008.02409.x; Mano Y, 2013, ANN SURG, V258, P301, DOI 10.1097/SLA.0b013e318297ad6b; Yang SH, 2007, SURGERY, V141, P598, DOI 10.1016/j.surg.2006.11.006; Yao FY, 2007, AM J TRANSPLANT, V7, P2587, DOI 10.1111/j.1600-6143.2007.01965.x; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Seo S, 2007, CLIN CANCER RES, V13, P427, DOI 10.1158/1078-0432.CCR-06-1357; Duvoux C, 2012, GASTROENTEROLOGY, V143, P986, DOI 10.1053/j.gastro.2012.05.052; Takada Y, 2007, DIGEST DIS, V25, P299, DOI 10.1159/000106908; Ito T, 2007, LIVER TRANSPLANT, V13, P1637, DOI 10.1002/It.21281; Otto G, 2006, LIVER TRANSPLANT, V12, P1260, DOI 10.1002/lt.20837; Graziadei IW, 2003, LIVER TRANSPLANT, V9, P557, DOI 10.1053/jlts.2003.50106; Cescon M, 2013, J HEPATOL, V58, P609, DOI 10.1016/j.jhep.2012.09.021; Khan MA, 2000, J HEPATOL, V32, P792, DOI 10.1016/S0168-8278(00)80248-2; Vibert E, 2010, AM J TRANSPLANT, V10, P129, DOI 10.1111/j.1600-6143.2009.02750.x; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Takada Y, 2010, J HEPATO-BIL-PAN SCI, V17, P527, DOI 10.1007/s00534-009-0162-y; Cheung TT, 2011, LIVER TRANSPLANT, V17, P1218, DOI 10.1002/lt.22362; Shimada M, 1996, CANCER, V78, P2094, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2094::AID-CNCR9>3.0.CO;2-O; Dumitra TC, 2013, TRANSPLANTATION, V95, P228, DOI 10.1097/TP.0b013e31827743d7; Chapman WC, 2008, ANN SURG, V248, P617, DOI 10.1097/SLA.0b013e31818a07d4; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fujiki M, 2009, AM J TRANSPLANT, V9, P2362, DOI 10.1111/j.1600-6143.2009.02783.x; FUJIYAMA S, 1988, CANCER, V61, P1621, DOI 10.1002/1097-0142(19880415)61:8<1621::AID-CNCR2820610820>3.0.CO;2-C; Toso C, 2009, HEPATOLOGY, V49, P832, DOI 10.1002/hep.22693; Todo S, 2007, LIVER TRANSPLANT, V13, pS48, DOI 10.1002/lt.21334; Duffy JP, 2007, ANN SURG, V246, P502, DOI 10.1097/SLA.0b013e318148c704; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; De Luna W, 2009, AM J TRANSPLANT, V9, P1158, DOI 10.1111/j.1600-6143.2009.02576.x; Hatano E, 2006, WORLD J SURG, V30, P1736, DOI 10.1007/s00268-005-0791-5; Majno P, 2006, LIVER TRANSPLANT, V12, P896, DOI 10.1002/lt.20808; An HJ, 2012, LIVER TRANSPLANT, V18, P1406, DOI 10.1002/lt.23512; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; Decaens T, 2006, LIVER TRANSPLANT, V12, P1761, DOI 10.1002/lt.20884; European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer, 2012, J HEPATOL, V56, P908, DOI DOI 10.1016/J.JHEP.2011.12.001; Furukawa H, 2010, J HEPATO-BIL-PAN SCI, V17, P533, DOI 10.1007/s00534-009-0168-5; Guiteau JJ, 2010, AM J TRANSPLANT, V10, P2092, DOI 10.1111/j.1600-6143.2010.03222.x; Hakamada K, 2008, WORLD J GASTROENTERO, V14, P1370, DOI 10.3748/wjg.14.1370; Hemming AW, 2001, ANN SURG, V233, P652, DOI 10.1097/00000658-200105000-00009; IWATSUKI S, 1985, ANN SURG, V202, P401, DOI 10.1097/00000658-198510000-00001; Komberg A, 2012, LIVER TRANSPLANT, V18, P53; Komberg A, 2009, AM J TRANSPLANT, V9, P592; Lee S, 2010, J HEPATO-BIL-PAN SCI, V17, P539, DOI 10.1007/s00534-009-0167-6; Lee SD, 2013, TRANSPL INT, V26, P50, DOI 10.1111/j.1432-2277.2012.01572.x; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mehta N, 2013, LIVER TRANSPLANT, V19, P1055, DOI 10.1002/lt.23730; Nanashima A, 2003, EUR J SURG ONCOL, V29, P735, DOI 10.1016/j.ejso.2003.08.007; Ng KK, 2010, J HEPATO-BIL-PAN SCI, V17, P548, DOI 10.1007/s00534-009-0165-8; Okuda H, 2000, CANCER, V88, P544; Prasad KR, 2011, LIVER TRANSPLANT, V17, pS81, DOI 10.1002/lt.22380; RINGE B, 1989, ANN SURG, V209, P88, DOI 10.1097/00000658-198901000-00013; Shimada M, 2005, TRANSPLANT P, V37, P1177, DOI 10.1016/j.transproceed.2005.12.030; Shindoh J, 2014, TRANSPL INT, V27, P391, DOI 10.1111/tri.12274; SUEHIRO T, 1994, CANCER-AM CANCER SOC, V73, P2464, DOI 10.1002/1097-0142(19940515)73:10<2464::AID-CNCR2820731004>3.0.CO;2-9; SUEHIRO T, 1995, SURGERY, V117, P682, DOI 10.1016/S0039-6060(95)80013-1; Takada Y, 2006, LIVER TRANSPLANT, V12, P912, DOI 10.1002/lt.20642	69	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					279	286		10.1002/jhbp.195		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800004		
J	Mizuno, T; Kanemoto, H; Sugiura, T; Okamura, Y; Uesaka, K				Mizuno, Takashi; Kanemoto, Hideyuki; Sugiura, Teiichi; Okamura, Yukiyasu; Uesaka, Katsuhiko			Central hepatectomy with pancreatoduodenectomy for diffusely spread bile duct cancer	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Bile duct cancer; Central bisectionectomy; Pancreatoduodenectomy	PORTAL-VEIN EMBOLIZATION; BILIARY-TRACT CANCER; MAJOR HEPATECTOMY; EXTENDED HEPATECTOMY; ADVANCED-CARCINOMA; RESECTION; CHOLANGIOCARCINOMA; LIVER; HEPATOPANCREATODUODENECTOMY; MALIGNANCIES	Background Major hepatectomy with concomitant pancreatoduodenectomy (major-HPD) is the only procedure that provides a curative resection for diffusely spread extrahepatic bile duct cancer (DSEBDC). We sometimes encounter patients who cannot undergo major-HPD because of a poor functional hepatic reserve. The aim of the present study was to assess the feasibility of central hepatectomy with pancreatoduodenectomy (central-HPD) for patients with DSEBDC as an alternative to major-HPD. Methods Between 2002 and 2010, six patients with DSEBDC underwent central-HPD. The hepatectomy procedures for central-HPD included central bisectionectomy with S1 resection (S1r) and right anterior sectionectomy with S1r. Results The estimated resection liver volume was decreased from 77.5% to 46.6% by the application of central-HPD. The median operative duration was 929 min, and the median blood loss was 2568 ml. Postoperative complications were observed in five patients. The proximal ductal stump was histologically positive with non-invasive cancer in three patients and positive with invasive cancer in one. The overall survival of the six patients was 62.5% at 5 years after surgery. Conclusions While central-HPD was a technically complicated procedure associated with a high morbidity rate, it offered a favorable overall survival and might be an alternative option for DSEBDC patients with a poor hepatic functional reserve.	[Mizuno, Takashi; Kanemoto, Hideyuki; Sugiura, Teiichi; Okamura, Yukiyasu; Uesaka, Katsuhiko] Shizuoka Canc Ctr Hosp, Div Hepatobiliary Pancreat Surg, Nagaizumi, Shizuoka 4118777, Japan	Mizuno, T (reprint author), Shizuoka Canc Ctr Hosp, Div Hepatobiliary Pancreat Surg, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	takashimzn@gmail.com					Abdalla EK, 2002, ARCH SURG-CHICAGO, V137, P80; Azoulay D, 2000, ANN SURG, V231, P480, DOI 10.1097/00000658-200004000-00005; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Imamura H, 1999, HEPATOLOGY, V29, P1099, DOI 10.1002/hep.510290415; Horgan AM, 2012, J CLIN ONCOL, V30, P1934, DOI 10.1200/JCO.2011.40.5381; Igami T, 2009, ANN SURG, V249, P296, DOI 10.1097/SLA.0b013e318190a647; Kaneoka Y, 2010, WORLD J SURG, V34, P2662, DOI 10.1007/s00268-010-0702-2; NAGINO M, 1995, HEPATOLOGY, V21, P434, DOI 10.1016/0270-9139(95)90104-3; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Sugiura T, 2008, WORLD J SURG, V32, P1478, DOI 10.1007/s00268-008-9547-3; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Kondo S, 2008, J HEPATO-BILIARY-PAN, V15, P41, DOI 10.1007/s00534-007-1279-5; Azoulay D, 2000, ANN SURG, V232, P665, DOI 10.1097/00000658-200011000-00008; Abdalla EK, 2002, ARCH SURG-CHICAGO, V137, P675, DOI 10.1001/archsurg.137.6.675; Ebata T, 2012, ANN SURG, V256, P297, DOI 10.1097/SLA.0b013e31826029ca; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Ikeyama T, 2007, ANN SURG, V246, P1052, DOI 10.1097/SLA.0b013e318142d97e; Chijiiwa K, 1999, HEPATO-GASTROENTEROL, V46, P1634; Fukami Y, 2011, J HEPATOBILIARY PANC, V19, P179; Hemming AW, 2010, J AM COLL SURGEONS, V210, P808; Hirono S, 2006, WORLD J SURG, V30, P74; Hirono S, 2006, WORLD J SURG, V30, P567, DOI 10.1007/s00268-005-0380-7; Kawarada Y, 1999, J GASTROINTEST SURG, V3, P369, DOI 10.1016/S1091-255X(99)80052-3; Kurosaki I, 1999, HEPATO-GASTROENTEROL, V46, P1623; Miwa S, 2007, J HEPATO-BILIARY-PAN, V14, P136, DOI 10.1007/s00534-006-1107-3; Miyagawa S, 1996, WORLD J SURG, V20, P77; Nakamura K, 1992, TAN TO SUI, V13, P1305; NIMURA Y, 1990, WORLD J SURG, V14, P535; NIMURA Y, 1991, HEPATO-GASTROENTEROL, V38, P170; Senda Y, 2009, WORLD J SURG, V33, P1459, DOI 10.1007/s00268-009-0025-3; Shimamura T, 1997, SURGERY, V121, P135, DOI 10.1016/S0039-6060(97)90282-8; Takasaki K, 1980, TAN SUI, V1, P923; TSUKADA K, 1994, BRIT J SURG, V81, P108, DOI 10.1002/bjs.1800810139; Wakai T, 2008, WORLD J SURG, V32, P1067, DOI 10.1007/s00268-007-9393-8	35	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					287	293		10.1002/jhbp.197		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800005		
J	Miura, F; Sano, K; Amano, H; Toyota, N; Wada, K; Yoshida, M; Hayano, K; Matsubara, H; Takada, T				Miura, Fumihiko; Sano, Keiji; Amano, Hodaka; Toyota, Naoyuki; Wada, Keita; Yoshida, Masahiro; Hayano, Koichi; Matsubara, Hisahiro; Takada, Tadahiro			Evaluation of portal vein invasion of distal cholangiocarcinoma as borderline resectability	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Borderline respectability; Distal cholangiocarcinoma; Portal vein invasion; Prognostic factor	BILE-DUCT CANCER; BILIARY-TRACT CANCER; AMERICAN JOINT COMMITTEE; PROGNOSTIC-FACTORS; PANCREATIC-CANCER; HILAR CHOLANGIOCARCINOMA; SURGICAL RESECTION; RADICAL RESECTION; MIDDLE; CARCINOMA	Background The concept of borderline resectability has not yet been introduced for extrahepatic cholangiocarcinoma (ECC). In this study, the surgical results of ECC patients were analyzed to clarify the implications of surgery for distal ECC with portal vein (PV) invasion as a preliminary step for the introduction of the concept of borderline resectability. Methods The clinicopathological data of 129 patients who had undergone pancreatoduodenectomy of distal ECC were reviewed retrospectively. Combined PV resection was performed in 10 patients. The clinicopathological variables were evaluated using univariate and multivariate analyses. Results Pathological PV invasion was observed in eight of the 129 patients. The survival rates of patients with PV invasion were significantly poorer than those of patients without PV invasion: 3 and 5 years after surgery, 17% and 0% versus 50% and 39% (P < 0.001), respectively. Presence of pancreatic or PV invasion, tumor progression, nodal status, and residual tumor were significant prognostic factors on univariate analysis. On multivariate analysis, PV invasion was the only significant independent predictive factor of a poor prognosis. Conclusions PV invasion of distal ECC should be regarded as indicating borderline resectability.	[Miura, Fumihiko; Sano, Keiji; Amano, Hodaka; Toyota, Naoyuki; Wada, Keita; Takada, Tadahiro] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1738605, Japan; [Yoshida, Masahiro] Int Univ Hlth & Welf, Kaken Hosp, Clin Res Ctr, Ohtawara City, Tochigi, Japan; [Hayano, Koichi; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan	Miura, F (reprint author), Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	f-miura@med.teikyo-u.ac.jp					Yoshida T, 2002, ARCH SURG-CHICAGO, V137, P69, DOI 10.1001/archsurg.137.1.69; Miyazaki M, 2007, SURGERY, V141, P581, DOI 10.1016/j.surg.2006.09.016; Nomura T, 2009, HEPATO-GASTROENTEROL, V56, P294; TASHIRO S, 1991, SURGERY, V109, P481; Sakamoto Y, 2005, SURGERY, V137, P396, DOI 10.1016/j.surg.2004.10.008; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Yamaue H, 2002, PANCREAS, V25, P366, DOI 10.1097/00006676-200211000-00008; Bahra M, 2008, J HEPATO-BILIARY-PAN, V15, P501, DOI 10.1007/s00534-007-1308-4; Barugola G, 2012, AM J SURG, V203, P132, DOI 10.1016/j.amjsurg.2011.03.008; Okusaka T, 2010, BRIT J CANCER, V103, P469, DOI 10.1038/sj.bjc.6605779; Nagino M, 2010, ANN SURG, V252, P115, DOI 10.1097/SLA.0b013e3181e463a7; Ebata T, 2007, WORLD J SURG, V31, P2008, DOI 10.1007/s00268-007-9173-5; Shimizu Y, 2008, HEPATO-GASTROENTEROL, V55, P699; Kayahara M, 1999, ANN SURG, V229, P76, DOI 10.1097/00000658-199901000-00010; Cheng QB, 2007, ANN SURG ONCOL, V14, P1212, DOI 10.1245/s10434-006-9260-0; Kondo S, 2008, J HEPATO-BILIARY-PAN, V15, P41, DOI 10.1007/s00534-007-1279-5; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; Neuhaus P, 2012, ANN SURG ONCOL, V19, P1602, DOI 10.1245/s10434-011-2077-5; de Jong MC, 2012, CANCER-AM CANCER SOC, V118, P4737, DOI 10.1002/cncr.27492; Kato A, 2013, ANN SURG ONCOL, V20, P318, DOI 10.1245/s10434-012-2312-8; Qiao QL, 2011, AM SURGEON, V77, P1445; Satoi S, 2009, PANCREAS, V38, P282, DOI 10.1097/MPA.0b013e31819438c3; Varadhachary GR, 2006, ANN SURG ONCOL, V13, P1035, DOI 10.1245/ASO.2006.08.011; Choi SB, 2009, J SURG ONCOL, V99, P335, DOI 10.1002/jso.21238; [Anonymous], TITLE ERROR; Katz MHG, 2008, J AM COLL SURGEONS, V206, P833, DOI 10.1016/j.jamcollsurg.2007.12.020; Bachellier P, 2001, AM J SURG, V182, P120, DOI 10.1016/S0002-9610(01)00686-9; Edge SB, 2010, AJCC CANC STAGING MA, V7th, P227; Fuhrman GM, 1996, ANN SURG, V223, P154, DOI 10.1097/00000658-199602000-00007; Hong SM, 2009, SURGERY, V146, P250, DOI 10.1016/j.surg.2009.02.023; Katz MH, 2008, J AM COLL SURGEONS, V206, P46; Kawai M, 2010, AM J SURG, V199, P447, DOI 10.1016/j.amjsurg.2009.01.019; Kurosaki I, 2008, J GASTROINTEST SURG, V12, P907, DOI 10.1007/s11605-007-0387-5; Lee JL, 2012, SURGERY, V152, P851, DOI 10.1016/j.surg.2012.03.010; Motoi F, 2014, J HEPATO-BIL-PAN SCI, V21, P148, DOI 10.1002/jhbp.15; Nakeeb A, 1996, ANN SURG, V224, P463, DOI 10.1097/00000658-199610000-00005; Nakeeb A, 1996, ANN SURG, V224, P73; Park SW, 2004, HEPATO-GASTROENTEROL, V51, P1612; Satoi S, 2013, J HEPATO-BIL-PAN SCI, V20, P590, DOI 10.1007/s00534-013-0616-0; Takahashi S, 2011, J HEPATO-BIL-PAN SCI, V18, P567, DOI 10.1007/s00534-011-0371-z; Todoroki T, 2001, BRIT J SURG, V88, P364, DOI 10.1046/j.1365-2168.2001.01685.x	41	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					294	300		10.1002/jhbp.198		7	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800006		
J	Koshita, S; Fujita, N; Noda, Y; Kobayashi, G; Ito, K; Horaguchi, J; Kanno, Y; Ogawa, T; Masu, K; Michikawa, Y; Iwashita, Y; Sawai, T; Uzuki, M; Fujishima, F				Koshita, Shinsuke; Fujita, Naotaka; Noda, Yutaka; Kobayashi, Go; Ito, Kei; Horaguchi, Jun; Kanno, Yoshihide; Ogawa, Takahisa; Masu, Kaori; Michikawa, Yousuke; Iwashita, Yuji; Sawai, Takashi; Uzuki, Miwa; Fujishima, Fumiyoshi			Invasive carcinoma derived from "flat type" branch duct intraductal papillary mucinous neoplasms of the pancreas: impact of classification according to the height of mural nodule on endoscopic ultrasonography	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Endoscopic ultrasound; Flat type; Invasive carcinoma; Intraductal papillary mucinous neoplasms; Mural nodule	INTERNATIONAL-CONSENSUS-GUIDELINES; FOLLOW-UP; MALIGNANCY; TUMORS; PREDICTORS; MANAGEMENT; SIZE; IPMN	Background It has been reported that many branch duct intraductal papillary mucinous neoplasms (BD-IPMN) with a mural nodule (MN) reveal adenocarcinomas. On the other hand, invasive cancer derived from BD-IPMN without MN on endoscopic ultrasound (EUS) also exists. The aim of this study was to elucidate the clinicopathological features of invasive cancer derived from BD-IPMN without MN on EUS. Methods Twenty-one patients pathologically diagnosed with invasive cancer derived from BD-IPMN were included in this study. Results Based on the height of MNs on EUS, the subjects could be clearly classified as 12 patients whose background BD-IPMNs had high MNs (nodule-forming type IPMN) and nine whose background BD-IPMNs showed no MNs (flat type IPMN). The background BD-IPMN of the 12 patients with nodule-forming type IPMN were non-gastric type. On the other hand, the background BD-IPMN of the nine patients with flat type IPMN was gastric type. The recurrence rate was higher (33% vs. 67%) and the 5-year survival was worse (76% vs. 33%) in flat type IPMN. Conclusions There may be a pathway for the development of invasive cancer without the formation of an MN in BD-IPMN, and attention should be paid even to the patients with BD-IPMN which does not present an MN.	[Koshita, Shinsuke; Fujita, Naotaka; Noda, Yutaka; Kobayashi, Go; Ito, Kei; Horaguchi, Jun; Kanno, Yoshihide; Ogawa, Takahisa; Masu, Kaori; Michikawa, Yousuke; Iwashita, Yuji] Sendai City Med Ctr, Dept Gastroenterol, Miyagino Ku, Sendai, Miyagi 9830824, Japan; [Noda, Yutaka; Sawai, Takashi] Sendai City Med Ctr, Dept Pathol, Sendai, Miyagi 9830824, Japan; [Uzuki, Miwa] Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, Morioka, Iwate 020, Japan; [Fujishima, Fumiyoshi] Tohoku Univ, Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan	Koshita, S (reprint author), Sendai City Med Ctr, Dept Gastroenterol, Miyagino Ku, 5-22-1 Tsurugaya, Sendai, Miyagi 9830824, Japan.	skoshita@openhp.or.jp					Adsay NV, 2010, WHO CLASSIFICATION T, P304; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Sugiyama M, 2003, BRIT J SURG, V90, P1244, DOI 10.1002/bjs.4265; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Rodriguez JR, 2007, GASTROENTEROLOGY, V133, P72, DOI 10.1053/j.gastro.2007.05.010; Akita H, 2011, AM J SURG, V202, P214, DOI 10.1016/j.amjsurg.2010.06.020; Sahora K, 2013, ANN SURG, V258, P466, DOI 10.1097/SLA.0b013e3182a18f48; Shimizu Y, 2013, PANCREAS, V42, P883, DOI 10.1097/MPA.0b013e31827a7b84; Sawai Y, 2010, ENDOSCOPY, V42, P1077, DOI 10.1055/s-0030-1255971; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Kobayashi G, 2005, J GASTROENTEROL, V40, P744, DOI 10.1007/s00535-005-1619-7; Schmidt CM, 2007, ANN SURG, V246, P644, DOI 10.1097/SLA.0b013e318155a7b6; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Uehara H, 2011, J GASTROENTEROL, V46, P657, DOI 10.1007/s00535-010-0343-0; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Mohri D, 2012, J GASTROENTEROL, V47, P203, DOI 10.1007/s00535-011-0482-y; Bernard P, 2002, ARCH SURG-CHICAGO, V137, P1274, DOI 10.1001/archsurg.137.11.1274; Kobayashi G, 2008, J MED ULTRASON, V35, P85, DOI 10.1007/s10396-008-0188-9; Kubo H, 2001, AM J GASTROENTEROL, V96, P1429; Salvia R, 2007, GASTROENTEROLOGY, V133, P309, DOI [10.1053/ j. gastro. 2007.05.010, DOI 10.1053/J.GASTR0.2007.05.010]; Sugiyama M, 1998, GASTROINTEST ENDOSC, V48, P164, DOI 10.1016/S0016-5107(98)70158-0	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					301	309		10.1002/jhbp.199		9	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800007		
J	Hyodo, R; Suzuki, K; Ebata, T; Komada, T; Mori, Y; Yokoyama, Y; Igami, T; Sugawara, G; Naganawa, S; Nagino, M				Hyodo, Ryota; Suzuki, Kojiro; Ebata, Tomoki; Komada, Tomohiro; Mori, Yoshine; Yokoyama, Yukihiro; Igami, Tsuyoshi; Sugawara, Gen; Naganawa, Shinji; Nagino, Masato			Assessment of percutaneous transhepatic portal vein embolization with portal vein stenting for perihilar cholangiocarcinoma with severe portal vein stenosis	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Percutaneous transhepatic portal vein embolization; Perihilar cholangiocarcinoma; Portal vein stenosis; Stent	HILAR CHOLANGIOCARCINOMA; SURGICAL-TREATMENT; LIVER RESECTION; BILIARY CANCER; PLACEMENT; HEPATECTOMY; VENOPLASTY	Background The aim of the present study was to assess the clinical efficiency of portal vein (PV) stenting when performed with preoperative percutaneous transhepatic portal vein embolization (PTPVE) in patients with severe PV stenosis due to tumor invasion. Methods Between 2007 and 2013, four consecutive patients (one male, three females; mean age, 52 years; age range, 25-73 years) with perihilar cholangiocarcinoma and PV stenosis underwent PTPVE and PV stenting. Patients were analyzed with regard to the procedure, hypertrophy of the future remnant liver (FRL), and plasma clearance rate of indocyanine green by the FRL (ICGK-F). Further, the %FRL volume increase in PTPVE was compared between the stenting group and the usual PTPVE group who have perihilar cholangiocarcinomas without PV stenosis. Results Preoperative PTPVE with PV stenting was successfully performed and portal flow to the FRL improved after stenting in all four patients. The % FRL volume increase was 18-60% (mean, 34%) in the stenting group and was 12-51% (mean, 21%) in the usual PTPVE group. The ICGK-F value after PTPVE exceeded 0.05 in all four patients. All patients achieved R0 resection. Conclusions Preoperative PTPVE with PV stenting appears to be feasible in cases of severe PV tumor invasion and stenosis. This procedure may allow a broader indication for surgery.	[Hyodo, Ryota; Suzuki, Kojiro; Komada, Tomohiro; Mori, Yoshine; Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ebata, Tomoki; Yokoyama, Yukihiro; Igami, Tsuyoshi; Sugawara, Gen; Nagino, Masato] Nagoya Univ, Grad Sch Med, Div Surg Oncol, Dept Surg, Nagoya, Aichi 4648601, Japan	Hyodo, R (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ryouta771@med.nagoya-u.ac.jp	Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X			Anaya Daniel A, 2008, Semin Intervent Radiol, V25, P110, DOI 10.1055/s-2008-1076684; Novellas S, 2009, CARDIOVASC INTER RAD, V32, P462, DOI 10.1007/s00270-008-9455-9; Yokoyama Y, 2010, BRIT J SURG, V97, P1260, DOI 10.1002/bjs.7084; Ebata T, 2012, DIGEST SURG, V29, P23, DOI 10.1159/000335718; Higuchi R, 2014, J HEPATO-BIL-PAN SCI, V21, P542, DOI 10.1002/jhbp.77; Nagino M, 2012, J GASTROENTEROL, V47, P1165, DOI 10.1007/s00535-012-0628-6; Kaneoka Y, 1998, SURG TODAY, V28, P862; Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; Wei BJ, 2009, WORLD J GASTROENTERO, V15, P1880, DOI 10.3748/wjg.15.1880; van Lienden KP, 2013, CARDIOVASC INTER RAD, V36, P25, DOI 10.1007/s00270-012-0440-y; Woodrum DA, 2009, J VASC INTERV RADIOL, V20, P593, DOI 10.1016/j.jvir.2009.02.010; Lee SG, 2010, J HEPATO-BIL-PAN SCI, V17, P476, DOI 10.1007/s00534-009-0204-5; Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010; Nagino M, 1996, RADIOLOGY, V200, P559; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Yamakado K, 2001, J VASC INTERV RADIOL, V12, P1407, DOI 10.1016/S1051-0443(07)61699-6; Uesaka K, 1996, ANN SURG, V223, P77, DOI 10.1097/00000658-199601000-00011; Nagino M, 2013, ANN SURG, V258, P129, DOI 10.1097/SLA.0b013e3182708b57; Yokoyama Y, 2007, J HEPATO-BILIARY-PAN, V14, P447, DOI 10.1007/s00534-006-1193-2	19	1	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					310	315		10.1002/jhbp.200		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800008		
J	Ukai, T; Shikata, S; Inoue, M; Noguchi, Y; Igarashi, H; Isaji, S; Mayumi, T; Yoshida, M; Takemura, YC				Ukai, Tomohiko; Shikata, Satoru; Inoue, Machiko; Noguchi, Yoshinori; Igarashi, Hisato; Isaji, Shuji; Mayumi, Toshihiko; Yoshida, Masahiro; Takemura, Yousuke C.			Early prophylactic antibiotics administration for acute necrotizing pancreatitis: a meta-analysis of randomized controlled trials	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Antibiotics; Meta-analysis; Pancreatitis	CLINICAL-TRIAL; MORTALITY; NECROSIS; IMIPENEM; SURGERY; QUALITY; NEED	Background The effectiveness of prophylactic antibiotics use for acute necrotizing pancreatitis has been explored and a number of systematic reviews have been published with conflicting results. The timing of antibiotics administration can be fundamental to their effectiveness, but thus far no reviews have focused on the timing of administration. Methods A systematic review of randomized controlled trials (RCTs) of prophylactic antibiotics for acute necrotizing pancreatitis was conducted using MEDLINE (PubMed), CINAHL and Japana Centra Revuo Medicina. Trials in which antibiotics were administered within 72 h after onset of symptoms or 48 h after admission were included. Our primary outcomes were the mortality rate and the incidence of infected pancreatic necrosis, and secondary outcomes were the incidence of non-pancreatic infection and the incidence of surgical intervention. Results The search revealed six RCTs with a total of 397 patients. The mortality rates were significantly different for those taking antibiotics (7.4%), and controls (14.4%) (odds ratio [OR], 0.48; 95% confidence interval [CI], 0.25-0.94). Also, early prophylactic antibiotics use was associated with reduced incidence of infected pancreatic necrosis (antibiotics 16.3%, controls 25.1%; OR, 0.55; 95% CI, 0.33-0.92). Conclusion Early use of prophylactic antibiotics for acute necrotizing pancreatitis is associated with reduced mortality and lower incidence of infected pancreatic necrosis.	[Ukai, Tomohiko] Mie Univ, Sch Med, Dept Community Med, Tsu, Mie 514, Japan; [Shikata, Satoru] Mie Prefectural Ichishi Hosp, Dept Family Med, Tsu, Mie 5153133, Japan; [Inoue, Machiko] Hamamatsu Univ, Sch Med, Dept Family & Community Med, Hamamatsu, Shizuoka 4312102, Japan; [Noguchi, Yoshinori] Japanese Red Cross Nagoya Daini Hosp, Gen Internal Med, Nagoya, Aichi, Japan; [Igarashi, Hisato] Kyushu Univ Hosp, Clin Educ Ctr, Fukuoka 812, Japan; [Isaji, Shuji] Mie Univ, Grad Sch Med, Hepatobiliary Pancreat & Transplant Surg, Tsu, Mie 514, Japan; [Mayumi, Toshihiko] Univ Occupat & Environm Hlth, Sch Med, Dept Emergency Med, Kitakyushu, Fukuoka 807, Japan; [Yoshida, Masahiro] Int Univ Hlth & Welf, Dept Hemodialysis & Surg, Chemotherapy Res Inst, Otawara, Tochigi, Japan; [Takemura, Yousuke C.] Mie Univ, Grad Sch Med, Dept Family Med, Tsu, Mie 514, Japan	Shikata, S (reprint author), Mie Prefectural Ichishi Hosp, Dept Family Med, 616 Minami Ieki, Tsu, Mie 5153133, Japan.	shikata-s@umin.org			Department of Community Medicine, Mie University School of Medicine	This research is supported in part by an endowment from the Department of Community Medicine, Mie University School of Medicine.	MANTEL N, 1959, J NATL CANCER I, V22, P719; Swaroop VS, 2004, JAMA-J AM MED ASSOC, V291, P2865, DOI 10.1001/jama.291.23.2865; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; Isenmann R, 2004, GASTROENTEROLOGY, V126, P997, DOI 10.1053/j.gastro.2003.12.050; Baron TH, 1999, NEW ENGL J MED, V340, P1412, DOI 10.1056/NEJM199905063401807; Jiang K, 2012, WORLD J GASTROENTERO, V18, P279, DOI 10.3748/wjg.v18.i3.279; Liberati A, 2009, ANN INTERN MED, V151, pW65; Sharma VK, 2001, PANCREAS, V22, P28, DOI 10.1097/00006676-200101000-00005; Bai Y, 2008, AM J GASTROENTEROL, V103, P104, DOI 10.1111/j.1572-0241.2007.01575.x; Bassis C, 2003, COCHRANE DB SYST REV; de Vries AC, 2007, PANCREATOLOGY, V7, P531, DOI 10.1159/000108971; Golub R, 1998, J Gastrointest Surg, V2, P496, DOI 10.1016/S1091-255X(98)80048-6; Manes G, 2006, AM J GASTROENTEROL, V101, P1348, DOI 10.1111/j.1572-0241.2006.00567.x; Mazaki T, 2006, BRIT J SURG, V93, P674, DOI 10.1002/bjs.5389; Helton S, 2001, J GASTROINTEST SURG, V5, P118; Nordback I, 2001, J GASTROINTEST SURG, V5, P113, DOI 10.1016/S1091-255X(01)80021-4; PEDERZOLI P, 1993, SURG GYNECOL OBSTET, V176, P480; Rokke O, 2007, SCAND J GASTROENTERO, V42, P771, DOI 10.1080/00365520601173855; SAINIO V, 1995, LANCET, V346, P663, DOI 10.1016/S0140-6736(95)92280-6; Villatoro E, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002941.pub2; Villatoro E, 2010, COCHRANE DB SYST REV, V12; Wittau M, 2011, SCAND J GASTROENTERO, V46, P261, DOI 10.3109/00365521.2010.531486; Xu T, 2008, SCAND J GASTROENTERO, V43, P1249, DOI 10.1080/00365520802130175; Xue P, 2009, J GASTROEN HEPATOL, V24, P736, DOI 10.1111/j.1440-1746.2008.05758.x; Yao LH, 2010, DIGEST SURG, V27, P442, DOI 10.1159/000318780	27	3	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					316	321		10.1002/jhbp.221		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800009		
J	Kawakami, H; Itoi, T; Kuwatani, M; Kawakubo, K; Kubota, Y; Sakamoto, N				Kawakami, Hiroshi; Itoi, Takao; Kuwatani, Masaki; Kawakubo, Kazumichi; Kubota, Yoshimasa; Sakamoto, Naoya			Technical tips and troubleshooting of endoscopic biliary drainage for unresectable malignant hilar biliary obstruction	Journal of Hepato-Biliary-Pancreatic Sciences			English	Article						Biliary drainage; Hilar biliary obstruction; Side-by-side; Stenting; Stent-in-stent	SIDE-BY-SIDE; OCCLUDED METALLIC STENTS; DELIVERY-SYSTEM; PANCREATIC-DUCT; PLASTIC STENT; STRICTURES; DEPLOYMENT; CHOLANGIOCARCINOMA; PLACEMENT; MANAGEMENT	Unresectable malignant hilar biliary obstruction (MHBO) occurs in various diseases, such as cholangiocarcinoma, gallbladder carcinoma, hepatocellular carcinoma, pancreatic cancer, and lymph node metastasis of the hilum of the liver. The majority of patients with advanced MHBO are not candidates for surgical resection because of the tumor location in the hepatic hilum and adjacent areas, advanced tumor stage, or comorbidities. Therefore, these patients often have a poor prognosis in terms of survival and quality of life. Most of these patients will require nonsurgical, palliative biliary drainage. To date, various biliary drainage techniques for unresectable MHBO (UMHBO) have been reported. Of these techniques, endoscopic biliary drainage is currently considered to be the most safe and minimally invasive procedure. However, endoscopic biliary drainage for UMHBO is still not standardized regarding the optimal stent, drainage area, stenting method, and reintervention technique. Recently, towards standardization of this technique for UMHBO, clinical research and trials including randomized controlled trials have been performed. In this article, we reviewed the most important issues regarding endoscopic biliary drainage for UMHBO, focusing on prospective studies. We also described in detail the techniques and future perspectives of endoscopic biliary drainage in patients with UMHBO.	[Kawakami, Hiroshi; Kuwatani, Masaki; Kawakubo, Kazumichi; Kubota, Yoshimasa; Sakamoto, Naoya] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Sapporo, Hokkaido 0608648, Japan; [Itoi, Takao] Tokyo Med Univ, Dept Gastroenterol & Hepatol, Tokyo 1608402, Japan	Kawakami, H (reprint author), Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Kita Ku, Kita 14,Nishi 5, Sapporo, Hokkaido 0608648, Japan.	hiropon@med.hokudai.ac.jp	Kawakubo, Kazumichi/F-2937-2011				Kawakami H, 2011, J HEPATO-BIL-PAN SCI, V18, P630, DOI 10.1007/s00534-011-0404-7; Rerknimitr R, 2013, J GASTROEN HEPATOL, V28, P593, DOI 10.1111/jgh.12128; Hirano S, 2010, J HEPATO-BIL-PAN SCI, V17, P455, DOI 10.1007/s00534-009-0208-1; Perdue DG, 2008, J CLIN GASTROENTEROL, V42, P1040, DOI 10.1097/MCG.0b013e31815853e0; Mukai T, 2013, J HEPATO-BIL-PAN SCI, V20, P214, DOI 10.1007/s00534-012-0508-8; Vienne A, 2010, GASTROINTEST ENDOSC, V72, P728, DOI 10.1016/j.gie.2010.06.040; Kawakami H, 2011, J GASTROENTEROL, V46, P242, DOI 10.1007/s00535-010-0298-1; Cotton PB, 2011, GASTROINTEST ENDOSC, V73, P868, DOI 10.1016/j.gie.2010.12.036; Kawakami H, 2009, ENDOSCOPY, V41, P959, DOI 10.1055/s-0029-1215178; De Palma GD, 2003, GASTROINTEST ENDOSC, V58, P50, DOI 10.1067/mge.2003.310; Park SJ, 2013, GASTROINTEST ENDOSC, V78, P374, DOI 10.1016/j.gie.2013.04.183; Kondo S, 2004, ANN SURG, V240, P95, DOI 10.1097/01.sla.0000129491.43855.6b; WAGNER HJ, 1993, ENDOSCOPY, V25, P213, DOI 10.1055/s-2007-1010295; Kawakubo K, 2014, J HEPATO-BIL-PAN SCI, V21, P328, DOI 10.1002/jhbp.27; Vila JJ, 2012, GASTROINTEST ENDOSC, V76, P1133, DOI 10.1016/j.gie.2012.08.001; Chennat J, 2010, GASTROINTEST ENDOSC, V72, P632, DOI 10.1016/j.gie.2010.04.037; Hookey LC, 2005, GASTROINTEST ENDOSC, V62, P605, DOI 10.1016/j.gie.2005.04.051; Kato H, 2011, ENDOSCOPY, V43, pE225, DOI 10.1055/s-0030-1256318; Kawakami H, 2014, GASTROINTEST ENDOSC, V79, P338, DOI 10.1016/j.gie.2013.07.055; Kawakubo K, 2015, J HEPATO-BIL-PAN SCI, V22, P151, DOI 10.1002/jhbp.173; Kawakubo K, 2015, J HEPATO-BIL-PAN SCI, V22, P79, DOI 10.1002/jhbp.170; Kawamoto H, 2008, CLIN GASTROENTEROL H, V6, P401, DOI 10.1016/j.cgh.2007.12.036; Kawamoto H, 2007, GASTROINTEST ENDOSC, V66, P1030, DOI 10.1016/j.gie.2007.06.055; Kim KM, 2012, HEPATO-GASTROENTEROL, V59, P341, DOI 10.5754/hge11533; Law R, 2013, DIGEST DIS SCI, V58, P2667, DOI 10.1007/s10620-013-2671-4; Lee T H, 2014, Minerva Gastroenterol Dietol, V60, P135; Lee Tae Hoon, 2013, Clin Endosc, V46, P260, DOI 10.5946/ce.2013.46.3.260; Mukai T, 2011, J HEPATO-BIL-PAN SCI, V18, P646, DOI 10.1007/s00534-011-0406-5; Naitoh I, 2012, DIGEST DIS SCI, V57, P3279, DOI 10.1007/s10620-012-2270-9; Nguyen-Tang T, 2011, ENDOSCOPY, V43, pE24, DOI 10.1055/s-0030-1255945; Ridtitid W, 2010, SURG ENDOSC, V24, P2216, DOI 10.1007/s00464-010-0931-3	31	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1868-6974	1868-6982		J HEPATO-BIL-PAN SCI	J. Hepato-Biliary-Pancreat. Sci.	APR	2015	22	4					E12	E21		10.1002/jhbp.186		10	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CG7CM	WOS:000353459800001		
J	Tohyama, J; Nakashima, M; Nabatame, S; Gaik-Siew, C; Miyata, R; Rener-Primec, Z; Kato, M; Matsumoto, N; Saitsu, H				Tohyama, Jun; Nakashima, Mitsuko; Nabatame, Shin; Gaik-Siew, Ch'ng; Miyata, Rie; Rener-Primec, Zvonka; Kato, Mitsuhiro; Matsumoto, Naomichi; Saitsu, Hirotomo			SPTAN1 encephalopathy: distinct phenotypes and genotypes	JOURNAL OF HUMAN GENETICS			English	Review							DE-NOVO MUTATIONS; INFANTILE EPILEPTIC ENCEPHALOPATHY; ALPHA-II-SPECTRIN; SEVERE INTELLECTUAL DISABILITY; SUPPRESSION-BURST PATTERN; ONSET WEST-SYNDROME; OHTAHARA-SYNDROME; STXBP1 MUTATIONS; MENTAL-RETARDATION; CEREBRAL HYPOMYELINATION	Recent progress in genetic analysis reveals that a significant proportion of cryptogenic epileptic encephalopathies are single-gene disorders. Mutations in numerous genes for early-onset epileptic encephalopathies have been rapidly identified, including in SPTAN1, which encodes alpha-II spectrin. The aim of this review is to delineate SPTAN1 encephalopathy as a distinct clinical syndrome. To date, a total of seven epileptic patients with four different in-frame SPTAN1 mutations have been identified. The major clinical features of SPTAN1 mutations include epileptic encephalopathy with hypsarrhythmia, no visual attention, acquired microcephaly, spastic quadriplegia and severe intellectual disability. Brainstem and cerebellar atrophy and cerebral hypomyelination, as observed by magnetic resonance imaging, are specific hallmarks of this condition. A milder variant is characterized by generalized epilepsy with pontocerebellar atrophy. Only in-frame SPTAN1 mutations in the last two spectrin repeats in the C-terminal region lead to dominant negative effects and these specific phenotypes. The last two spectrin repeats are required for alpha/beta spectrin heterodimer associations and the mutations can alter heterodimer formation between the two spectrins. From these data we suggest that SPTAN1 encephalopathy is a distinct clinical syndrome owing to specific SPTAN1 mutations. It is important that this syndrome is recognized by pediatric neurologists to enable proper diagnostic work-up for patients.	[Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Dept Child Neurol, Niigata 9502085, Japan; [Tohyama, Jun] Niigata Univ Med & Dent Hosp, Niigata, Japan; [Nakashima, Mitsuko; Matsumoto, Naomichi; Saitsu, Hirotomo] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Nabatame, Shin] Osaka Univ, Grad Sch Med, Dept Pediat, Osaka, Japan; [Gaik-Siew, Ch'ng] Kuala Lumpur Hosp, Dept Genet, Kuala Lumpur, Malaysia; [Miyata, Rie] Tokyo Kita Social Insurance Hosp, Dept Pediat, Tokyo, Japan; [Rener-Primec, Zvonka] Univ Childrens Hosp, Dept Pediat Neurol, Ljubljana, Slovenia; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan	Tohyama, J (reprint author), Nishi Niigata Chuo Natl Hosp, Dept Child Neurol, Nishi Ku, 1-14-1 Masago, Niigata 9502085, Japan.	jtohyama@masa.go.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems; Strategic Research Program for Brain Sciences; Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank the patients and their parents for their valuable contributions. We are grateful to Dr Masumi Inagaki for critical advice; Dr Masayuki Sasaki for his continuous support; and Dr Noriyuki Akasaka, Dr Yutaka Nonoda, Dr Barbara G. Strazisar and Dr Karin Writzl for providing patients' information. This work was supported by the Ministry of Health, Labour and Welfare of Japan; the Japan Society for the Promotion of Science (a Grant-in-Aid for Scientific Research (B), and a Grant-in-Aid for Scientific Research (A)); the Takeda Science Foundation; the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems; the Strategic Research Program for Brain Sciences; and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Hamdan FF, 2009, ANN NEUROL, V65, P748, DOI 10.1002/ana.21625; Hamdan FF, 2011, EUR J HUM GENET, V19, P607, DOI 10.1038/ejhg.2010.183; Paciorkowski AR, 2011, PEDIATR NEUROL, V45, P355, DOI 10.1016/j.pediatrneurol.2011.08.010; Tohyama J, 2008, BRAIN DEV-JPN, V30, P349, DOI 10.1016/j.braindev.2007.10.006; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Guerrini R, 2007, NEUROLOGY, V69, P427, DOI 10.1212/01.wnl.0000266594.16202.c1; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Campbell IM, 2012, GENET MED, V14, P868, DOI 10.1038/gim.2012.65; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Molinari F, 2009, CLIN GENET, V76, P188, DOI 10.1111/j.1399-0004.2009.01236.x; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Mastrangelo M, 2012, PEDIATR NEUROL, V46, P24, DOI 10.1016/j.pediatrneurol.2011.11.003; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Nakamura K, 2013, NEUROLOGY, V81, P992, DOI 10.1212/WNL.0b013e3182a43e57; Machnicka B, 2014, BBA-BIOMEMBRANES, V1838, P620, DOI 10.1016/j.bbamem.2013.05.002; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Stromme P, 2002, BRAIN DEV-JPN, V24, P266, DOI 10.1016/S0387-7604(02)00079-7; Kanazawa K, 2010, MOVEMENT DISORD, V25, P2265, DOI 10.1002/mds.23164; Rankin J, 2010, AM J MED GENET A, V152A, P2079, DOI 10.1002/ajmg.a.33531; Saitsu H, 2012, CLIN GENET, V81, P399, DOI 10.1111/j.1399-0004.2011.01733.x; Writzl K, 2012, EPILEPSIA, V53, pe106, DOI 10.1111/j.1528-1167.2012.03437.x; Nonoda Y, 2013, BRAIN DEV-JPN, V35, P280, DOI 10.1016/j.braindev.2012.05.002; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Vijayakumar K, 2011, PEDIATR NEUROL, V45, P246, DOI 10.1016/j.pediatrneurol.2011.06.006; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Saitsu H, 2012, EPILEPSIA, V53, P1441, DOI 10.1111/j.1528-1167.2012.03548.x; Bennett V, 2001, PHYSIOL REV, V81, P1353; Ng BG, 2013, AM J HUM GENET, V92, P632, DOI 10.1016/j.ajhg.2013.03.012; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Perrotta S, 2008, LANCET, V372, P1411, DOI 10.1016/S0140-6736(08)61588-3; Kodera H, 2013, HUM MUTAT, V34, P1708, DOI 10.1002/humu.22446; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; Dulac O, 2001, EPILEPSIA, V42, P23, DOI 10.1046/j.1528-1157.2001.042suppl.3023.x; Mignot C, 2011, EPILEPSIA, V52, P1820, DOI 10.1111/j.1528-1167.2011.03163.x; Guerrini R, 2012, EPILEPSIA, V53, P2067, DOI 10.1111/j.1528-1167.2012.03656.x; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Deprez L, 2010, NEUROLOGY, V75, P1159, DOI 10.1212/WNL.0b013e3181f4d7bf; Nakamura K, 2013, AM J HUM GENET, V93, P496, DOI 10.1016/j.ajhg.2013.07.014; Kato M, 2007, AM J HUM GENET, V81, P361, DOI 10.1086/518903; Barcia G, 2014, EUR J MED GENET, V57, P15, DOI 10.1016/j.ejmg.2013.10.006; Hamdan FF, 2012, EUR J HUM GENET, V20, P796, DOI 10.1038/ejhg.2011.271; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Jaeken J, 1996, ARCH DIS CHILD, V74, P542; Kamien BA, 2012, J CLIN NEUROSCI, V19, P934, DOI 10.1016/j.jocn.2012.01.017; Kato M, 2003, NEUROLOGY, V61, P267; Lemke J. R., 2012, EPILEPSIA, V53, P1378; Mastrangelo M, 2013, EPILEPTIC DISORD, V15, P55, DOI 10.1684/epd.2013.0558; Meary F, 2007, J BIOL CHEM, V282, P14226, DOI 10.1074/jbc.M700028200; SALONEN R, 1991, CLIN GENET, V39, P287; Sharma S, 2013, CAN J NEUROL SCI, V40, P10; Tzschach A, 2012, AM J MED GENET A, V158A, P1709, DOI 10.1002/ajmg.a.35398	53	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	APR	2015	60	4					167	173		10.1038/jhg.2015.5		7	Genetics & Heredity	Genetics & Heredity	CG8NT	WOS:000353565700001		
J	Miyatake, S; Koshimizu, E; Fujita, A; Fukai, R; Imagawa, E; Ohba, C; Kuki, I; Nukui, M; Araki, A; Makita, Y; Ogata, T; Nakashima, M; Tsurusaki, Y; Miyake, N; Saitsu, H; Matsumoto, N				Miyatake, Satoko; Koshimizu, Eriko; Fujita, Atsushi; Fukai, Ryoko; Imagawa, Eri; Ohba, Chihiro; Kuki, Ichiro; Nukui, Megumi; Araki, Atsushi; Makita, Yoshio; Ogata, Tsutomu; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi			Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: an 'exome-first' approach	JOURNAL OF HUMAN GENETICS			English	Article							DELETIONS; SPECTRUM; TOOLS	Whole-exome sequencing (WES) is becoming a standard tool for detecting nucleotide changes, and determining whether WES data can be used for the detection of copy-number variations (CNVs) is of interest. To date, several algorithms have been developed for such analyses, although verification is needed to establish if they fit well for the appropriate purpose, depending on the characteristics of each algorithm. Here, we performed WES CNV analysis using the eXome Hidden Markov Model (XHMM). We validated its performance using 27 rare CNVs previously identified by microarray as positive controls, finding that the detection rate was 59%, or higher (89%) with three or more targets. XHMM can be effectively used, especially for the detection of 4200 kb CNVs. XHMM may be useful for deletion breakpoint detection. Next, we applied XHMM to genetically unsolved patients, demonstrating successful identification of pathogenic CNVs: 1.5-1.9-Mb deletions involving NSD1 in patients with unknown overgrowth syndrome leading to the diagnosis of Sotos syndrome, and 6.4-Mb duplication involving MECP2 in affected brothers with late-onset spasm and progressive cerebral/cerebellar atrophy confirming the clinical suspect of MECP2 duplication syndrome. The possibility of an 'exome-first' approach for clinical genetic investigation may be considered to save the cost of multiple investigations.	[Miyatake, Satoko; Koshimizu, Eriko; Fujita, Atsushi; Fukai, Ryoko; Imagawa, Eri; Ohba, Chihiro; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 2360004, Japan; [Kuki, Ichiro; Nukui, Megumi] Osaka City Gen Hosp, Dept Pediat Neurol, Pediat Med Care Ctr, Osaka, Japan; [Araki, Atsushi] Kansai Med Univ, Dept Pediat, Hirakata, Osaka, Japan; [Makita, Yoshio] Asahikawa Med Univ, Educ Ctr, Asahikawa, Hokkaido, Japan; [Ogata, Tsutomu] Hamamatsu Univ, Dept Pediat, Hamamatsu, Shizuoka 4312102, Japan	Matsumoto, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp			Ministry of Health, Labour and Welfare of Japan; Japan Society for the Promotion of Science [26461549, 25293085, 25293235, 13313587, 26670505]; Takeda Science Foundation; Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems; Strategic Research Program for Brain Sciences [11105137]; Ministry of Education, Culture, Sports, Science and Technology of Japan [12024421]	We thank all the participants for their cooperation in this research. We also thank Dr K. Nishiyama, Ms K. Takabe, Mr T. Miyama, Ms N. Watanabe, Ms A. Sato and Ms S. Sugimoto from the Department of Human Genetics, Yokohama City University Graduate School of Medicine, and Dr D. Yamaguchi from BITS Co., Ltd., for their technical assistance. This work was supported by the Ministry of Health, Labour and Welfare of Japan (NMi, NMa); the Japan Society for the Promotion of Science (a Grant-in-Aid for Scientific Research (C) (26461549) (SM), a Grant-in-Aid for Scientific Research (B) (25293085, 25293235) (NMi, HS), a Grant-in-Aid for Scientific Research (A) (13313587) (NMa) and a Grant-in-Aid for Challenging Exploratory Research (26670505) (HS)); the Takeda Science Foundation (NMi, NMa, HS); the Fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems (NMa); the Strategic Research Program for Brain Sciences (11105137) (NMa); and a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (12024421) (NMi, NMa).	Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tan RJ, 2014, HUM MUTAT, V35, P899, DOI 10.1002/humu.22537; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Lehalle D, 2014, AM J MED GENET A, V164, P1310, DOI 10.1002/ajmg.a.36452; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Fromer M, 2012, AM J HUM GENET, V91, P597, DOI 10.1016/j.ajhg.2012.08.005; Fromer M., 2014, CURR PROTOC HUM GENE, V81; Kadalayil L, 2014, BRIEF BIOINFORM; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhou WC, 2013, HUM MOL GENET, V22, P2642, DOI 10.1093/hmg/ddt113	15	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	APR	2015	60	4					175	182		10.1038/jhg.2014.124		8	Genetics & Heredity	Genetics & Heredity	CG8NT	WOS:000353565700002		
J	Kunii, M; Doi, H; Higashiyama, Y; Kugimoto, C; Ueda, N; Hirata, J; Tomita-Katsumoto, A; Kashikura-Kojima, M; Kubota, S; Taniguchi, M; Murayama, K; Nakashima, M; Tsurusaki, Y; Miyake, N; Saitsu, H; Matsumoto, N; Tanaka, F				Kunii, Misako; Doi, Hiroshi; Higashiyama, Yuichi; Kugimoto, Chiharu; Ueda, Naohisa; Hirata, Junichi; Tomita-Katsumoto, Atsuko; Kashikura-Kojima, Mari; Kubota, Shun; Taniguchi, Midori; Murayama, Kei; Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi; Tanaka, Fumiaki			A Japanese case of cerebellar ataxia, spastic paraparesis and deep sensory impairment associated with a novel homozygous TTC19 mutation	JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX-III DEFICIENCY; MAGNETIC-RESONANCE-SPECTROSCOPY; LACTIC-ACIDOSIS; LEIGH-SYNDROME; I DEFICIENCY; BCS1L GENE; CHAIN; ENCEPHALOPATHY; PATIENT; DIAGNOSIS	Mitochondrial complex III (CIII) deficiency comprises a group of complex and heterogeneous genetic disorders. TTC19 mutations constitute a rare cause of CIII deficiency and are associated with neurological disorders in childhood and adulthood. Herein, we describe a 27-year-old Japanese man with cerebellar ataxia, spastic paraparesis, loss of deep sensation, mild frontal lobe dysfunction and transient psychiatric symptoms. Brain magnetic resonance imaging showed cerebellar atrophy and bilateral high-intensity signals in the inferior olives and regions adjacent to periaqueductal gray matter, on T2-weighted images. On whole-exome sequencing, we detected a novel homozygous frameshift mutation c.157_158dup [p.Pro54Alafs* 48] in TTC19. Mitochondrial enzyme assays confirmed mild impairment of CIII enzymatic activity in lymphoblasts, which was consistent with TTC19-related CIII deficiency. His symptoms and radiological findings demonstrated an early stage or mild form of this disease, and further clarify the characteristics of patients with rare TTC19 mutations.	[Kunii, Misako; Doi, Hiroshi; Higashiyama, Yuichi; Kugimoto, Chiharu; Ueda, Naohisa; Hirata, Junichi; Tomita-Katsumoto, Atsuko; Kashikura-Kojima, Mari; Kubota, Shun; Tanaka, Fumiaki] Yokohama City Univ, Dept Neurol & Stroke Med, Yokohama, Kanagawa 2360004, Japan; [Taniguchi, Midori; Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan; [Nakashima, Mitsuko; Tsurusaki, Yoshinori; Miyake, Noriko; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Yokohama, Kanagawa 232, Japan	Tanaka, F (reprint author), Yokohama City Univ, Dept Neurol & Stroke Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hdoi@yokohama-cu.ac.jp; ftanaka@yokohama-cu.ac.jp			Japan Society for the Promotion of Science [25293235, 25293085, 26670505, 24249019, 26670445, 25293207]; Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; Strategic Research Program for Brain Sciences; Ministry of Education, Culture, Sports, Science and Technology of Japan [24118007, 22129005]	We thank the patient and his family for their participation in this study. This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (NM (25293235), HS (25293085 and 26670505), NMa (24249019) and FT (26670445 and 25293207)), Research Grants from the Ministry of Health, Labour and Welfare (NM, HS and NMa), the Japan Science and Technology Agency (NMa) and the Strategic Research Program for Brain Sciences (NMa). It was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (NMa (24118007) and FT (22129005)).	Al-Owain M, 2013, J INHERIT METAB DIS, V36, P813, DOI 10.1007/s10545-012-9536-4; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Kirby DM, 1999, NEUROLOGY, V52, P1255; Murayama K, 2009, EUR J PEDIATR, V168, P297, DOI 10.1007/s00431-008-0753-7; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Waragai M, 2007, J NEUROL SCI, V260, P57, DOI 10.1016/j.jns.2007.03.027; Dubois B, 2000, NEUROLOGY, V55, P1621; Benit P, 2009, BBA-MOL CELL RES, V1793, P181, DOI 10.1016/j.bbamcr.2008.06.004; Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761; Hinson JT, 2007, NEW ENGL J MED, V356, P809, DOI 10.1056/NEJMoa055262; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Atwal P S, 2014, JIMD Rep, V14, P43, DOI 10.1007/8904_2013_282; Barel O, 2008, AM J HUM GENET, V82, P1211, DOI 10.1016/j.ajhg.2008.03.020; BAUM H, 1967, P NATL ACAD SCI USA, V57, P798, DOI 10.1073/pnas.57.3.798; Doi H, 2013, INTERNAL MED, V52, P1629, DOI 10.2169/internalmedicine.52.0252; Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072; Gaignard P, 2013, AM J HUM GENET, V93, P384, DOI 10.1016/j.ajhg.2013.06.015; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; Invernizzi F, 2013, HUM MUTAT, V34, P1619, DOI 10.1002/humu.22441; Miyake N, 2013, HUM MUTAT, V34, P446, DOI 10.1002/humu.22257; Morino H, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-5; Nogueira C, 2013, NEUROGENETICS, V14, P153, DOI 10.1007/s10048-013-0361-1; Park JH, 2012, J STROKE CEREBROVASC, V21, P507, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.001; Rossi A, 2013, NEUROIMAG CLIN N AM, V23, P425, DOI 10.1016/j.nic.2012.12.013; Takahashi S, 1999, BRAIN DEV-JPN, V21, P200, DOI 10.1016/S0387-7604(98)00095-3; Tucker EJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004034; Wanschers BFJ, 2014, HUM MOL GENET, V23, P6356, DOI 10.1093/hmg/ddu357	27	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	APR	2015	60	4					187	191		10.1038/jhg.2015.7		5	Genetics & Heredity	Genetics & Heredity	CG8NT	WOS:000353565700004		
J	Hayashi, S; Yagi, M; Morisaki, I; Inazawa, J				Hayashi, Shin; Yagi, Mariko; Morisaki, Ichijiro; Inazawa, Johji			Identical deletion at 14q13.3 including PAX9 and NKX2-1 in siblings from mosaicism of unaffected parent	JOURNAL OF HUMAN GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATIONS; CONGENITAL-ANOMALIES; HAPLOINSUFFICIENCY; MUTATIONS	By screening patients with undiagnosed multiple congenital anomalies and intellectual disability using array-comparative genomic hybridization, we identified an 884 kb heterozygous microdeletion at 14q13.3 in two siblings presenting with oligodontia, hypothyroidism and persistent pulmonary hypertension of the newborn, resulting from their parental gonosomal mosaicism. Among the six genes included in the deletion, haploinsufficiency of PAX9 and NKX2-1 was probably associated with their phenotypes. These results highlighted a possibility of recurrence of pathogenic copy-number variants associated with parental mosaicism, which requires careful genetic counseling.	[Hayashi, Shin; Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Hayashi, Shin; Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Hayashi, Shin; Inazawa, Johji] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Yagi, Mariko] Nikoniko House Med & Welf Ctr, Dept Pediat, Kobe, Hyogo, Japan; [Morisaki, Ichijiro] Osaka Univ, Dent Hosp, Div Special Care Dent, Osaka, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan	Hayashi, S (reprint author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan.	lin-shin.cgen@mri.tmd.ac.jp; johinaz.cgen@mri.tmd.ac.jp			Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Japan Society for the Promotion of Science (JSPS); Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare, Japan	We would like to appreciate Ms Daniela Tiaki Uehara for her technical assistance and review of the manuscript, and Dr Andrea Guala for his manuscript. This work was supported by the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University, and also supported by Grants-in-Aid for Scientific Research on Priority Areas and Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science (JSPS), and a Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare, Japan.	Devriendt K, 1998, NEW ENGL J MED, V338, P1317, DOI 10.1056/NEJM199804303381817; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Vissers LELM, 2010, J MED GENET, V47, P289, DOI 10.1136/jmg.2009.072942; D'Amours G, 2012, CLIN GENET, V81, P128, DOI 10.1111/j.1399-0004.2011.01687.x; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Stockton DW, 2000, NAT GENET, V24, P18; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Carre A, 2009, HUM MOL GENET, V18, P2266, DOI 10.1093/hmg/ddp162; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Das P, 2002, HUM GENET, V110, P371, DOI 10.1007/s00439-002-0699-1; Breedveld GJ, 2002, HUM MOL GENET, V11, P971, DOI 10.1093/hmg/11.8.971; Chiang PW, 2009, AM J MED GENET A, V149A, P1463, DOI 10.1002/ajmg.a.32948; Gamage Thilini H, 2012, Indian J Hum Genet, V18, P130, DOI 10.4103/0971-6866.96684; Gross SJ, 1996, HUM GENET, V98, P291, DOI 10.1007/s004390050209; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hayashi S, 2011, J HUM GENET, V56, P110, DOI 10.1038/jhg.2010.129; Hayashi S, 2005, AM J MED GENET A, V139A, P32, DOI 10.1002/ajmg.a.30982; Inazawa J, 2004, CANCER SCI, V95, P559, DOI 10.1111/j.1349-7006.2004.tb02486.x; Koolen DA, 2012, EUR J HUM GENET, V20, P729, DOI 10.1038/ejhg.2012.1; Santen GWE, 2012, J MED GENET, V49, P366, DOI 10.1136/jmedgenet-2011-100721	21	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	APR	2015	60	4					203	206		10.1038/jhg.2014.123		4	Genetics & Heredity	Genetics & Heredity	CG8NT	WOS:000353565700007		
J	Koh, K; Kobayashi, F; Miwa, M; Shindo, K; Isozaki, E; Ishiura, H; Tsuji, S; Takiyama, Y				Koh, Kishin; Kobayashi, Fumikazu; Miwa, Michiaki; Shindo, Kazumasa; Isozaki, Eiji; Ishiura, Hiroyuki; Tsuji, Shoji; Takiyama, Yoshihisa			Novel mutations in the PNPLA6 gene in Boucher-Neuhauser syndrome	JOURNAL OF HUMAN GENETICS			English	Article							NEUROPATHY TARGET ESTERASE; CEREBELLAR-ATAXIA; HYPOGONADISM; DEGENERATION; BRAIN	On whole-exome sequencing, a novel compound heterozygous mutation (c.2923A>G/c.3523_3524insTGTCCG, p.T975A/p.1175_1176insVS) and a novel homozygous one (c.3534G>C, p.W1178C) in the PNPLA6 gene were identified in sporadic and familial Japanese patients with Boucher-Neuhauser syndrome (BNS), respectively. However, we did not find any mutations in the PNPLA6 gene in 88 patients with autosomal recessive hereditary spastic paraplegia (ARHSP). Our study confirmed the earlier report that a PNPLA6 mutation causes BNS. This is the first report on PNPLA6 mutations in non-Caucasian patients. Meanwhile, PNPLA6 mutations might be extremely rare in Japanese ARHSP patients. Moreover, we first found hypersegmented neutrophils in two BNS patients with PNPLA6 mutations.	[Koh, Kishin; Kobayashi, Fumikazu; Miwa, Michiaki; Shindo, Kazumasa; Takiyama, Yoshihisa] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neurol, Chuo, Yamanashi 4093898, Japan; [Isozaki, Eiji] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo, Japan; [Ishiura, Hiroyuki; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan	Takiyama, Y (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Neurol, 1110-1 Shimokato, Chuo, Yamanashi 4093898, Japan.	ytakiyama@yamanashi.ac.jp			Research Committee for Ataxic Disease, the Ministry of Health, Labour and Welfare of Japan	We thank the Japan Spastic Paraplegia Research Consortium (JASPAC) for sending us the DNA from patients with autosomal recessive spastic paraplegia. This work was supported by Grants-in-Aid from the Research Committee for Ataxic Disease, the Ministry of Health, Labour and Welfare of Japan.	Winrow CJ, 2003, NAT GENET, V33, P477, DOI 10.1038/ng1131; Rainier S, 2008, AM J HUM GENET, V82, P780, DOI 10.1016/j.ajhg.2007.12.018; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Synofzik M, 2014, BRAIN, V137, P69, DOI 10.1093/brain/awt326; Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993; Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024; JOHNSON MK, 1969, BIOCHEM J, V111, P487; Yoon G, 2013, NEUROGENETICS, V14, P181, DOI 10.1007/s10048-013-0366-9; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; BOUCHER BJ, 1969, ACTA NEUROL SCAND, V45, P507; Deik A, 2014, J NEUROL, V261, P2411, DOI 10.1007/s00415-014-7516-3; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; Holmes G, 1907, BRAIN, V30, P466; Hufnagel RB, 2015, J MED GENET, V52, P85, DOI 10.1136/jmedgenet-2014-102856; Jbour A. K., 2003, MED GENET, V40, pe2; Kobayashi Fumikazu, 2010, Rinsho Shinkeigaku, V50, P98; Li H., 2010, BIOINFOMATICS, V38, P1767; NEUHAUSER G, 1975, CLIN GENET, V7, P426; Synofzik M., 2014, GENE REV, P1993; Synofzik M, 2015, J NEUROL NEUROSUR PS, V86, P580, DOI 10.1136/jnnp-2014-307793; Tarnutzer A. A., 2014, J NEUROL, V262, P194; Topaloglu A. K., 2014, J CLIN ENDOCR METAB, V10, pE2067; Umehara T, 2010, J NEUROL SCI, V295, P128, DOI 10.1016/j.jns.2010.05.005; Yoshida T., 2014, AM J MED GENET A, V167, P1830	25	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	APR	2015	60	4					217	220		10.1038/jhg.2015.3		4	Genetics & Heredity	Genetics & Heredity	CG8NT	WOS:000353565700010		
J	Yamamoto, N; Kawashima, M; Fujita, T; Suzuki, M; Kato, K				Yamamoto, Natsuko; Kawashima, Minae; Fujita, Takanori; Suzuki, Masatomo; Kato, Kazuto			How should the legal framework for the protection of human genomic data be formulated?-Implications from the revision processes of the Act on the Protection of Personal Information (PPI Act)	JOURNAL OF HUMAN GENETICS			English	Letter									[Yamamoto, Natsuko; Kato, Kazuto] Osaka Univ, Dept Biomed Eth & Publ Policy, Grad Sch Med, Suita, Osaka, Japan; [Kawashima, Minae] Japan Sci & Technol Agcy, Natl Biosci Database Ctr, Tokyo, Japan; [Fujita, Takanori] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Suzuki, Masatomo] Niigata Univ, Fac Law, Niigata, Japan	Yamamoto, N (reprint author), Osaka Univ, Dept Biomed Eth & Publ Policy, Grad Sch Med, Suita, Osaka, Japan.	kato@eth.med.osaka-u.ac.jp					Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Erlich Y, 2014, NAT REV GENET, V15, P409, DOI 10.1038/nrg3723; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; European Parliament, 2011, EUR PARL RES COMPR A; Greenleaf G., 2014, INT DATA PRIVACY LAW, V4, P139; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; OECD, 2013, REC COUNC CONC GUID; Strategic Headquarters for the Promotion of an Advanced Information and Telecommunications Network Society, 2014, POL OUTL I REV UT PE; White House, 2012, CONS DAT PRIV NETW W	9	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1434-5161	1435-232X		J HUM GENET	J. Hum. Genet.	APR	2015	60	4					225	226		10.1038/jhg.2014.121		2	Genetics & Heredity	Genetics & Heredity	CG8NT	WOS:000353565700012		
J	Parmesan, C; Williams-Anderson, A; Moskwik, M; Mikheyev, AS; Singer, MC				Parmesan, Camille; Williams-Anderson, Alison; Moskwik, Matthew; Mikheyev, Alexander S.; Singer, Michael C.			Endangered Quino checkerspot butterfly and climate change: Short-term success but long-term vulnerability?	JOURNAL OF INSECT CONSERVATION			English	Article						Assisted colonization; Climate change; Global warming; Critical Habitat; Endangered Species Act; Euphydryas editha quino	CHANGE ADAPTATION STRATEGIES; BIODIVERSITY CONSERVATION; OVIPOSITION PREFERENCE; EVOLUTIONARY RESPONSES; ASSISTED COLONIZATION; MANAGED RELOCATION; INSECT POPULATION; EUPHYDRYAS-EDITHA; SHIFTS; RANGE	The butterfly Euphydryas editha is known to be vulnerable to climate events that exacerbate natural phenological asynchrony between insect and hosts. In prior work, populations of E. editha have been more persistent at high latitudes and high elevations than in the south and at low elevations, consistent with response to observed warming climate. However, poleward range shifts by the endangered subspecies E. e. quino are blocked by urbanization and range shifts to higher elevation may require host shifts. Prior studies were inconclusive as to whether elevational and host shifts were already occurring. Here, we re-evaluate this scenario with new evidence from molecular genetics, host-choice behaviour and field recording of butterfly distribution. We found a statistically significant upward shift in population distribution since 2009. Insects in the expanding region were neither genomic outliers within Quino nor specifically adapted to their principal local host genus, Collinsia. These diverse data collectively support the hypothesis that an elevational range expansion is already in progress, accompanied and facilitated by a shift of principal host from Plantago to Collinsia. Quino appears resilient to warming climate. However, projections indicate that most or all of Quino's current range in the USA, including the new high elevation expansion, will become uninhabitable. Our most frequent projected future range (circa 2050) is c. 400 km northward from current populations, hence conservation of Quino may eventually require assisted colonization. For now, Critical Habitat (sensu Endangered Species Act) has been designated at sites around the new upper elevational limit that were not known to be occupied. Designating Critical Habitat outside the historic range is a pioneering response to climate change. This politically challenging, non-traditional, climate change-oriented conservation effort exemplifies flexible thinking needed for species vulnerable to climate change.	[Parmesan, Camille] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Parmesan, Camille] Univ Texas Austin, Dept Geol, Austin, TX 78712 USA; [Parmesan, Camille] Univ Texas Austin, Inst Environm Sci, Austin, TX 78712 USA; [Williams-Anderson, Alison] Carlsbad Fish & Wildlife Off, Carlsbad, CA 92008 USA; [Moskwik, Matthew] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Mikheyev, Alexander S.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan; [Singer, Michael C.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England	Parmesan, C (reprint author), Univ Texas Austin, Dept Geol, Austin, TX 78712 USA.	parmesan@uts.cc.utexas.edu	Mikheyev, Alexander/O-7670-2014	Mikheyev, Alexander/0000-0003-4369-1019	San Diego Foundation; Okinawa Institute for Science and Technology (Japan); NSF Earth Systems Models Grant [1049208]	We thank the United States Fish and Wildlife Service for compiling Quino records. Modeling was performed at Texas Advanced Computing Center (TACC). We are very grateful to John Fonner at TACC for training MM and for his cheerful help throughout. We also give many thanks to Seth McGinnis at NCAR for providing us with downscaled climate projection data and to Emilie Luciani for converting FWS GIS files for making lovely maps. We thank Dr. Richard Lowry for developing and maintaining the VassarStats website http://vassarstats.net that we used to perform the statistics presented in this paper. We also thank the PRISM Climate Group (Oregon State University, http://prism.oregonstate.edu) and the WorldClim Global Climate Data group (http://www.worldclim.org) for making their high resolution interpolated climate data freely available for research purposes. Personal observations by Paul Opler, Gordon Pratt, John Emmel and Ken Osborne were invaluable. We also thank two anonymous reviewers for their very helpful suggestions that have substantially improved the manuscript. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the U.S. Fish and Wildlife Service. Support came from the San Diego Foundation, the Okinawa Institute for Science and Technology (Japan) and from NSF Earth Systems Models Grant, Award Number 1049208.	Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Schwartz MW, 2012, BIOSCIENCE, V62, P732, DOI 10.1525/bio.2012.62.8.6; SINGER MC, 1991, J INSECT BEHAV, V4, P531, DOI 10.1007/BF01049336; Preston K, 2008, GLOBAL CHANGE BIOL, V14, P2501, DOI 10.1111/j.1365-2486.2008.01671.x; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Hanski I, 2001, AM NAT, V158, P341, DOI 10.1086/321985; Thomas CD, 2011, METHODS ECOL EVOL, V2, P125, DOI 10.1111/j.2041-210X.2010.00065.x; Singer MC, 2010, EVOLUTION, V64, P921, DOI 10.1111/j.1558-5646.2009.00866.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; SINGER MC, 1972, SCIENCE, V176, P75, DOI 10.1126/science.176.4030.75; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Willis SG, 2009, CONSERV LETT, V2, P45, DOI 10.1111/j.1755-263X.2008.00043.x; Gomulkiewicz R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0093; Hellmann JJ, 2002, J ANIM ECOL, V71, P925, DOI 10.1046/j.1365-2656.2002.00658.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Buckley J, 2014, ECOL LETT, V17, P1316, DOI 10.1111/ele.12340; McCoy RC, 2014, MOL ECOL, V23, P136, DOI 10.1111/mec.12591; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Forister ML, 2003, GLOBAL CHANGE BIOL, V9, P1130, DOI 10.1046/j.1365-2486.2003.00643.x; Di Luzio M, 2008, J APPL METEOROL CLIM, V47, P475, DOI 10.1175/2007JAMC1356.1; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Singer MC, 2012, ECOLOGY, V93, P2658, DOI 10.1890/11-2078.1; SINGER MC, 1993, NATURE, V361, P251, DOI 10.1038/361251a0; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Boggs CL, 2006, J ANIM ECOL, V75, P466, DOI 10.1111/j.1365-2656.2006.01067.x; Preston KL, 2012, BIOL CONSERV, V152, P280, DOI 10.1016/j.biocon.2012.03.011; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Singer MC, 2010, PHILOS T R SOC B, V365, P3161, DOI 10.1098/rstb.2010.0144; SINGER MC, 1988, EVOLUTION, V42, P977, DOI 10.2307/2408913; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Kirkpatrick M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0082; SINGER MC, 1993, NATURE, V366, P681, DOI 10.1038/366681a0; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Mikheyev AS, 2013, MOL ECOL, V22, P4753, DOI 10.1111/mec.12423; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Bennett NL, 2015, HIGH RESILIENCE CLIM, pEV1, DOI [10.1111/oik.01490, DOI 10.1111/OIK.01490]; Bridle JR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1800; Collins M, 2013, CLIMATE CHANGE 2013, P1029, DOI DOI 10.1017/CBO9781107415324.024; EHRLICH PR, 1980, OECOLOGIA, V46, P101, DOI 10.1007/BF00346973; Evans DM, ISSUES ECOL IN PRESS; Field CB, 2014, GLOBAL SECTORAL AS A, P1; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Glick P, 2011, SCANNING CONSERVATIO; Gonzalez A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0079; Hartmann D. L., 2013, CLIMATE CHANGE 2013, P159, DOI DOI 10.1017/CBO9781107415324.008; HOLDREN CE, 1981, OECOLOGIA, V50, P125, DOI 10.1007/BF00378805; Kirtman B., 2013, CLIMATE CHANGE 2013, P953, DOI DOI 10.1017/CBO9781107415324.023; Mastrandrea MD, 2010, GUIDANCE NOTE LEAD A; McBride CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000529; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Mearns L, 2009, EOS, V90, P311, DOI DOI 10.1029/2009EO360002; Mikheyev AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011212; Miller MP, 2014, P ENTOMOL SOC WASH, V116, P80, DOI 10.4289/0013-8797.116.1.80; Parmesan C, 2003, EVOLUTION ECOLOGY TA, P541; Parmesan C, 2005, CLIMATE CHANGE BIODI; Parmesan C, 2004, OBSERVED ECOLOGICAL; Pratt Gordon F., 2001, Journal of the Lepidopterists' Society, V55, P169; Pratt GF, 2008, J LEPID SOC, V64, P36; Scalercio S, 2014, J INSECT CONSERV, V18, P643, DOI 10.1007/s10841-014-9669-x; SINGER MC, 1971, EVOLUTION, V25, P383, DOI 10.2307/2406930; SINGER MC, 1992, ANIM BEHAV, V44, P463, DOI 10.1016/0003-3472(92)90056-F; [USFWS] United States Fish and Wildlife Service, 2009, QUIN CHECK BUTT EUPH; [USFWS] United States Fish and Wildlife Service, 2009, FED REGISTER, V74, P28776; [USFWS] United States Fish and Wildlife Service, 2008, FED REGISTER, V73, P3328; [USFWS] United States Fish and Wildlife Service, 2003, REC PLAN QUIN CHECK; WEISS S.R., 1988, ECOLOGY, V65, P1486, DOI DOI 10.2307/1941646	84	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1366-638X	1572-9753		J INSECT CONSERV	J. Insect Conserv.	APR	2015	19	2			SI		185	204		10.1007/s10841-014-9743-4		20	Biodiversity Conservation; Entomology	Biodiversity & Conservation; Entomology	CG4CK	WOS:000353229100002		
J	Amano, H; Ikeda, T; Toda, M; Okubo, R; Yabe, T; Koike, M; Saito, D; Yamazaki, J				Amano, Hideo; Ikeda, Takanori; Toda, Mikihito; Okubo, Ryo; Yabe, Takayuki; Koike, Makiko; Saito, Daiga; Yamazaki, Junichi			Assessment of Angiographic Coronary Calcification and Plaque Composition in Virtual Histology Intravascular Ultrasound	JOURNAL OF INTERVENTIONAL CARDIOLOGY			English	Article							RADIOFREQUENCY DATA-ANALYSIS; IN-VIVO; ATHEROSCLEROTIC LESIONS; SPOTTY CALCIFICATION; VULNERABLE PLAQUE; DENSE CALCIUM; ARTERIES; TISSUE; PATHOPHYSIOLOGY; CLASSIFICATION	ObjectivesWe assessed the relation between coronary plaque composition and angiographic calcification by using virtual histology intravascular ultrasound (VH-IVUS). BackgroundThe plaque vulnerability according to angiographic calcification is unclear. MethodsSubjects were 140 consecutive patients (145 lesions) undergoing VH-IVUS before percutaneous coronary intervention. Subjects were divided into 4 groups: no calcification group (n=27), spotty group (n=65) that had calcium deposits under 90 degrees in grayscale IVUS, intermediate group (n=37) had calcium deposits with 90 degrees or more and under 180 degrees, and extensive group (n=16) had calcium deposits with 180 degrees or more. ResultsThe number of VH thin-cap fibroatheromas in spotty group was significantly larger than no calcification group, intermediate group, and extensive group (0.660.71 vs 0.22 +/- 0.42 [P<0.01], 0.32 +/- 0.48 [P<0.05], 0.13 +/- 0.34 [P<0.01], respectively). Spotty group without angiographic calcification had significantly larger %necrotic core than with angiographic calcification (24.5 +/- 6.7% vs 19.9 +/- 7.2%, P<0.05). Intermediate group without angiographic calcification had significantly larger necrotic core area than with angiographic calcification (2.5 +/- 0.9mm(2) vs 1.7 +/- 0.9mm(2), P<0.05). Extensive group with angiographic calcification had significantly larger %dense calcium than without angiographic calcification (18.3 +/- 4.0% vs 13.4 +/- 4.4%, P<0.05). ConclusionsLesions with spotty calcification was highly vulnerable in VH-IVUS. Spotty or intermediate plaque calcification without angiographic calcification was more vulnerable than those with angiographic calcification. Extensive plaque calcification with angiographic calcification had more dense calcium than those without angiographic calcification.	[Amano, Hideo; Ikeda, Takanori; Toda, Mikihito; Okubo, Ryo; Yabe, Takayuki; Koike, Makiko; Saito, Daiga; Yamazaki, Junichi] Toho Univ, Fac Med, Dept Cardiovasc Med, Tokyo 1438541, Japan	Amano, H (reprint author), Toho Univ, Fac Med, Dept Cardiovasc Med, Ota Ku, 6-11-1 Omorinishi, Tokyo 1438541, Japan.	300095ah@med.toho-u.ac.jp					Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Ehara S, 2004, CIRCULATION, V110, P3424, DOI 10.1161/01.CIR.0000148131.41425.E9; FRINK RJ, 1970, AM J CARDIOL, V26, P241, DOI 10.1016/0002-9149(70)90790-3; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Kataoka Y, 2012, J AM COLL CARDIOL, V59, P1592, DOI 10.1016/j.jacc.2012.03.012; Kolodgie FD, 2001, CURR OPIN CARDIOL, V16, P285, DOI 10.1097/00001573-200109000-00006; Garcia-Garcia HM, 2009, EUROINTERVENTION, V5, P177, DOI 10.4244/EIJV5I2A29; Pu J, 2012, EUR HEART J, V33, P372, DOI 10.1093/eurheartj/ehr387; Sales FJR, 2010, EUROINTERVENTION, V6, P394, DOI 10.4244/EIJV6I3A65; HIROTA S, 1993, AM J PATHOL, V143, P1003; Kwon TG, 2013, INT J CARDIOL, V167, P2611, DOI 10.1016/j.ijcard.2012.06.123; MINTZ GS, 1995, CIRCULATION, V91, P1959; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Shin ES, 2011, EUROINTERVENTION, V6, P1017, DOI 10.4244/EIJV6I8A175; Kolodgie FD, 2004, HEART, V90, P1385, DOI 10.1136/hrt.2004.041798; Missel E, 2008, EUR HEART J, V29, P2141, DOI 10.1093/eurheartj/ehn293; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262; FALK E, 1995, CIRCULATION, V92, P657; Beckman JA, 2001, ARTERIOSCL THROM VAS, V21, P1618, DOI 10.1161/hq0901.095554; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Mintz GS, 2014, J AM COLL CARDIOL, V64, P207, DOI 10.1016/j.jacc.2014.01.015; Missel E, 2008, AM J CARDIOL, V101, P573, DOI 10.1016/j.amjcard.2007.10.018; Burke AP, 2001, HERZ, V26, P239, DOI 10.1007/PL00002026; DINSMORE RE, 1985, AM J ROENTGENOL, V144, P895; Fujii K, 2005, AM J CARDIOL, V96, P352, DOI 10.1016/j.amjcard.2005.03.074; GERTZ SD, 1991, AM J CARDIOL, V67, P1228; MEEMA HE, 1976, RADIOLOGY, V121, P315; Popma JJ, 1994, TXB INTERVENTIONAL C, P1052; Santos-Gallego CG, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0401-9; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0896-4327	1540-8183		J INTERV CARDIOL	J. Interv. Cardiol.	APR	2015	28	2					205	214		10.1111/joic.12189		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG3HN	WOS:000353170600011		
J	Hagiwara, K; Kato, T				Hagiwara, Kazuo; Kato, Takuma			Effect of Angiotensin Converting Enzyme Inhibitors on Soluble Tumor Necrosis Factor Related Apoptosis-inducing Ligand Levels - Association with Neointimal Hyperplasia in Drug Eluting Stents	JOURNAL OF INTERVENTIONAL CARDIOLOGY			English	Letter									[Hagiwara, Kazuo; Kato, Takuma] Nagoya Univ, Dept Cardiol, Nagoya, Aichi 4648601, Japan	Hagiwara, K (reprint author), Nagoya Univ, Dept Cardiol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	kazuo.p.hagiwara@outlook.com						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0896-4327	1540-8183		J INTERV CARDIOL	J. Interv. Cardiol.	APR	2015	28	2					220	220		10.1111/joic.12184		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CG3HN	WOS:000353170600014		
J	Kawasaki, H; Mizoguchi, A; Kanamori, H				Kawasaki, Hiroyuki; Mizoguchi, Asao; Kanamori, Hideto			New series of satellite peaks associating with the nu(3) band of CH3F-(ortho-H-2)n clusters in solid para-H-2 studied by high resolution quantum cascade laser spectroscopy	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						Solid para-hydrogen; Quantum crystal; Ortho para conversion; Ortho-H-2 clusters; Methyl fluoride	INFRARED-SPECTROSCOPY; PARAHYDROGEN; TRANSITIONS; HYDROGEN; MATRIX	New satellite series were found to the lower energy side of each main peak of the nu(3) band of CH3F embedded in a para-H-2 crystal. All the peaks showed a common red shouldered line profile, which corresponds to partly resolved transitions of ortho- and para-CH3F. The spectral pattern and time behavior of the peaks may suggest that these satellite series originate from a family of CH3F clusters involving ortho-H-2 in second nearest neighbor sites. A model function assuming this idea is used to resolve the observed spectrum into each Lorentzian component, and then the detailed features of these series are studied. The peak intervals in the series are not as equally spaced as the main series, but there is a strong resemblance among the satellite series. The peak intensity distribution in the series showed an irregular pattern rather than statistically smooth one, but there is a strong resemblance among the satellite series with the common feature in which the third peak is strongest. The linewidths are similar among each series. However, the amount of the peak shift seems too small, considering the distance of ortho-H-2 at a second nearest neighbor site. (C) 2015 Elsevier Inc. All rights reserved.	[Kawasaki, Hiroyuki; Mizoguchi, Asao; Kanamori, Hideto] Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan	Kanamori, H (reprint author), Tokyo Inst Technol, Dept Phys, Ohokayama 2-12-1, Tokyo 1528551, Japan.	kanamori@phys.titech.ac.jp			JSPS KAKENHI [26287089]	This work was supported by JSPS KAKENHI Grant Number 26287089. The authors acknowledge to Dr. A.R.W. McKellar for critical reading of the manuscript.	SILVERA IF, 1980, REV MOD PHYS, V52, P393, DOI 10.1103/RevModPhys.52.393; CHAN MC, 1991, J CHEM PHYS, V95, P9404, DOI 10.1063/1.461169; CONSTABLE JH, 1975, J LOW TEMP PHYS, V21, P599, DOI 10.1007/BF01141613; Du JH, 2011, J PHYS CHEM A, V115, P1040, DOI 10.1021/jp108769n; Futami Y, 2002, CHEM PHYS LETT, V357, P209, DOI 10.1016/S0009-2614(02)00518-3; Lee YP, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2975340; McKellar ARW, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3640888; McKellar ARW, 2011, PHYS CHEM CHEM PHYS, V13, P11587, DOI 10.1039/c1cp20871c; Mengel M, 1997, PHYS REV B, V55, P10420, DOI 10.1103/PhysRevB.55.10420; Miyamoto Y, 2011, J PHYS CHEM A, V115, P14254, DOI 10.1021/jp207419m; Miyamoto Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4765698; NOSANOW LH, 1966, PHYS REV, V146, P120, DOI 10.1103/PhysRev.146.120; OKA T, 1993, ANNU REV PHYS CHEM, V44, P299, DOI 10.1146/annurev.physchem.44.1.299; OKUMURA M, 1989, PHYS REV LETT, V62, P32, DOI 10.1103/PhysRevLett.62.32; SOUERS P. C., 1986, HYDROGEN PROPERTIES; Toda N, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3429252; Tom BA, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3072881; Townes C.H., 1975, MICROWAVE SPECTROSCO; Van Kranendonk J., 1983, SOLID HYDROGEN THEOR; WELIKY DP, 1994, APPL PHYS B-LASERS O, V59, P265, DOI 10.1007/BF01081395; Yoshioka K, 2003, J CHEM PHYS, V119, P4731, DOI 10.1063/1.1595089	21	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	APR	2015	310				SI		39	44		10.1016/j.jms.2015.01.001		6	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CG0AC	WOS:000352928000007		
J	Muller, HSP; Kobayashi, K; Takahashi, K; Tomaru, K; Matsushima, F				Mueller, Holger S. P.; Kobayashi, Kaori; Takahashi, Kazumasa; Tomaru, Kazuko; Matsushima, Fusakazu			Terahertz spectroscopy of (NO)-O-18 and isotopic invariant fit of several nitric oxide isotopologs	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						Nitric oxide; Terahertz spectroscopy; Electric dipole transitions; Magnetic dipole transitions; Fine structure; Hyperfine structure	HETERODYNE FREQUENCY MEASUREMENTS; RADIOFREQUENCY DOUBLE-RESONANCE; BORN-OPPENHEIMER APPROXIMATION; DIATOMIC-MOLECULES; ROTATIONAL SPECTROSCOPY; FUNDAMENTAL-BAND; MICROWAVE SPECTRUM; VIBRATION-ROTATION; COLOGNE DATABASE; SPIN-ORBIT	A tunable far-infrared laser sideband spectrometer was used to investigate a nitric oxide sample enriched in 180 between 0.99 and 4.75 THz. Regular, electric dipole transitions were recorded between 0.99 and 2.52 THz, while magnetic dipole transitions between the (2)Pi(1/2) and (2)Pi(3/2) spin-ladders were recorded between 3.71 and 4.75 THz. These data were combined with lower frequency data of (NO)-O-18 (unlabeled atoms refer to N-14 and O-16, respectively), with rotational data of NO, (NO)-N-15, (NO)-O-17, and (NO)-N-15-O-18, and with heterodyne infrared data of NO to be subjected to one isotopic invariant fit. Rotational, fine and hyperfine structure parameters were determined along with vibrational, rotational, and Born-Oppenheimer breakdown corrections. The resulting spectroscopic parameters permit prediction of rotational spectra suitable for the identification of various nitric oxide isotopologs especially in the interstellar medium by means of rotational spectroscopy. (C) 2014 Elsevier Inc. All rights reserved.	[Mueller, Holger S. P.] Univ Cologne, Inst Phys 1, D-50937 Cologne, Germany; [Kobayashi, Kaori; Takahashi, Kazumasa; Tomaru, Kazuko; Matsushima, Fusakazu] Toyama Univ, Fac Sci, Dept Phys, Toyama 9308555, Japan	Muller, HSP (reprint author), Univ Cologne, Inst Phys 1, Zulpicher Str 77, D-50937 Cologne, Germany.	hspm@ph1.uni-koeln.de; kaori@sci.u-toyama.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26108507]; Collaborative Research Grant [SFB 956]	This study was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant No. 26108507). K.K. is grateful for support of her stay in Cologne by the Collaborative Research Grant SFB 956.	AMANO T, 1969, J MOL SPECTROSC, V32, P97, DOI 10.1016/0022-2852(69)90145-3; AMIOT C, 1979, J MOL SPECTROSC, V76, P86, DOI 10.1016/0022-2852(79)90219-4; AMIOT C, 1982, J MOL SPECTROSC, V94, P150, DOI 10.1016/0022-2852(82)90301-0; AMIOT C, 1980, J MOL SPECTROSC, V81, P424, DOI 10.1016/0022-2852(80)90203-9; Thompson JK, 2004, NATURE, V430, P58, DOI 10.1038/nature02682; PICKETT HM, 1991, J MOL SPECTROSC, V148, P371, DOI 10.1016/0022-2852(91)90393-O; WHITE JB, 1993, J CHEM PHYS, V99, P8371, DOI 10.1063/1.465612; EVENSON KM, 1984, APPL PHYS LETT, V44, P576, DOI 10.1063/1.94845; Velichko TI, 2012, J QUANT SPECTROSC RA, V113, P1643, DOI 10.1016/j.jqsrt.2012.04.014; Pickett HM, 1998, J QUANT SPECTROSC RA, V60, P883, DOI 10.1016/S0022-4073(98)00091-0; BERINGER R, 1950, PHYS REV, V78, P581, DOI 10.1103/PhysRev.78.581; BROWN JM, 1977, J MOL SPECTROSC, V65, P65, DOI 10.1016/0022-2852(77)90358-7; Varberg TD, 1999, J MOL SPECTROSC, V196, P5, DOI 10.1006/jmsp.1999.7850; Muller HSP, 2005, J MOL STRUCT, V742, P215, DOI 10.1016/j.molstruc.2005.01.027; Dunham JL, 1932, PHYS REV, V41, P721, DOI 10.1103/PhysRev.41.721; Wang M, 2012, CHINESE PHYS C, V36, P1603, DOI 10.1088/1674-1137/36/12/003; Drouin BJ, 2001, J MOL SPECTROSC, V207, P4, DOI 10.1006/jmsp.2001.8332; BROWN JM, 1979, J MOL SPECTROSC, V74, P294, DOI 10.1016/0022-2852(79)90059-6; Drouin BJ, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4719169; WATSON JKG, 1980, J MOL SPECTROSC, V80, P411, DOI 10.1016/0022-2852(80)90152-6; Muller HSP, 2001, ASTRON ASTROPHYS, V370, pL49, DOI 10.1051/0004-6361:20010367; BOGEY M, 1982, CHEM PHYS, V66, P99, DOI 10.1016/0301-0104(82)88010-5; BURRUS CA, 1953, PHYS REV, V92, P1437, DOI 10.1103/PhysRev.92.1437; Chen HJ, 2014, J QUANT SPECTROSC RA, V142, P49, DOI 10.1016/j.jqsrt.2014.03.015; CLANCY RT, 1992, GEOPHYS RES LETT, V19, P261, DOI 10.1029/91GL03006; COUDERT LH, 1995, J MOL SPECTROSC, V172, P435, DOI 10.1006/jmsp.1995.1191; Crockett NR, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/112; DALE RM, 1977, J MOL SPECTROSC, V67, P440, DOI 10.1016/0022-2852(77)90051-0; Dousmanis G.C., 1955, Physical Review, V97, DOI 10.1103/PhysRev.97.967; Drouin BJ, 2001, J MOL SPECTROSC, V205, P128, DOI 10.1006/jmsp.2000.8252; FAVERO PG, 1959, PHYS REV, V114, P1534, DOI 10.1103/PhysRev.114.1534; GALLAGHER JJ, 1956, PHYS REV, V103, P1727, DOI 10.1103/PhysRev.103.1727; GERIN M, 1992, ASTRON ASTROPHYS, V266, P463; Hallin K.-E. J., 1979, J MOL SPECTROSC, V72, P26; HINZ A, 1986, J MOL SPECTROSC, V119, P120, DOI 10.1016/0022-2852(86)90206-7; Jaszunski M, 2012, PROG NUCL MAG RES SP, V67, P49, DOI 10.1016/j.pnmrs.2012.03.002; Klisch E, 1999, MOL PHYS, V97, P65; LISZT HS, 1978, ASTROPHYS J, V224, pL73, DOI 10.1086/182762; LOWE RS, 1981, J MOL SPECTROSC, V88, P372, DOI 10.1016/0022-2852(81)90187-9; MANDIN JY, 1994, J MOL SPECTROSC, V167, P262, DOI 10.1006/jmsp.1994.1233; Martin S, 2003, ASTRON ASTROPHYS, V411, pL465, DOI 10.1051/0004-6361:20031442; Matsushima F, 2006, J MOL SPECTROSC, V235, P261, DOI 10.1016/j.jms.2005.11.014; MCGONAGLE D, 1990, ASTROPHYS J, V359, P121, DOI 10.1086/169040; MEERTS WL, 1976, CHEM PHYS, V14, P421, DOI 10.1016/0301-0104(76)80139-5; MEERTS WL, 1972, J MOL SPECTROSC, V44, P320, DOI 10.1016/0022-2852(72)90109-9; Miller CE, 2001, J CHEM PHYS, V115, P6459, DOI 10.1063/1.1398308; Mount BJ, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.064501; Muller HSP, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/201014398; Muller HSP, 2007, PHYS CHEM CHEM PHYS, V9, P1579, DOI 10.1039/b618799d; Muller HSP, 2013, J PHYS CHEM A, V117, P13843, DOI 10.1021/jp408391f; Neill JL, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/8; NEUMANN RM, 1970, ASTROPHYS J, V161, P779, DOI 10.1086/150578; Pickett H. M., 1979, 34 S MOL SPECTR COL; RAGHAVAN P, 1989, ATOM DATA NUCL DATA, V42, P189, DOI 10.1016/0092-640X(89)90008-9; Redshaw M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.012507; SALECK AH, 1994, Z NATURFORSCH A, V49, P1111; SALECK AH, 1995, CHEM PHYS LETT, V244, P199, DOI 10.1016/0009-2614(95)00924-S; SALECK AH, 1992, MOL PHYS, V76, P1443, DOI 10.1080/00268979200102211; SALECK AH, 1991, MOL PHYS, V72, P1135, DOI 10.1080/00268979100100811; Saupe S, 1996, J MOL SPECTROSC, V179, P13, DOI 10.1006/jmsp.1996.0179; Shayesteh A, 2006, J MOL SPECTROSC, V237, P87, DOI 10.1016/j.jms.2006.03.004; SPENCER MN, 1994, J MOL SPECTROSC, V165, P506, DOI 10.1006/jmsp.1994.1154; Spezzano S, 2013, J PHYS CHEM A, V117, P9814, DOI 10.1021/jp312616u; Tamassia F, 2002, MOL PHYS, V100, P3485, DOI 10.1080/00268970210155635; TEFFO JL, 1980, J MOL SPECTROSC, V82, P348, DOI 10.1016/0022-2852(80)90120-4; TIEMANN E, 1982, CHEM PHYS, V67, P133, DOI 10.1016/0301-0104(82)85027-1; VANDENHEUVEL FC, 1980, J MOL SPECTROSC, V84, P162, DOI 10.1016/0022-2852(80)90250-7; Varberg TD, 2004, J MOL SPECTROSC, V223, P1, DOI 10.1016/j.jms.2003.08.010; VESETH L, 1971, J MOL SPECTROSC, V38, P228, DOI 10.1016/0022-2852(71)90108-1; WATSON JKG, 1973, J MOL SPECTROSC, V45, P99, DOI 10.1016/0022-2852(73)90179-3; Yu SS, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4719170	71	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	APR	2015	310				SI		92	98		10.1016/j.jms.2014.12.002		7	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CG0AC	WOS:000352928000014		
J	Hirota, E				Hirota, Eizi			Vibrational assignment and vibronic interaction for NO3 in the ground electronic state	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						Vibrational assignment; Vibronic interaction; Nitrate radical; High-resolution infrared spectroscopy; Vibration-rotation interaction	TRANSFORM INFRARED-SPECTROSCOPY; BAND	Two important problems exist for the NO3 free radical. One is the frequency of the degenerate N-O stretching mode v(3). It has been assigned to a band at 1492 cm(-1) (Assignment I), whereas Stanton calculated it by an ab initio MO method to be around 1000 cm(-1) (Assignment II). The second concerns an anomalous v(4) progression, which appeared in the photoelectron spectra of the NO3 anion and was accounted for by Herzberg-Teller (H-T) mechanism, but the interaction parameter derived was too large. The present study critically examines Assignment II and the H-T vibronic interaction model against the results of high-resolution infrared (IR) spectroscopy supplemented with dispersed fluorescence (DF), and concludes Assignment I to be correct and the H-T mechanism to be complemented by a new vibronic interaction model, based upon the observations: (I) Stanton's ab initio MO v(3) appeared in neither IR nor DF spectra, (2) only one A-E type subband was present in the Z-v(4) hot band (Z denotes the upper state of the 1492 cm(-1) band), at variance with the two predicted by Assignment II, (3) the l-type doubling constant and the first-order Coriolis coupling constant derived for the Z state by assuming Assignment II were not acceptable, and (4) anomalous features expected from the H-T vibronic interaction model for the v(4) fundamental state were not observed at all. Infrared spectroscopic results on a few E-2' degenerate states indicated that the first-order Coriolis coupling constant and the effective spin-orbit interaction constant were closely correlated, suggesting that the unpaired electron azimuthal motion was affected much by that of the degenerate vibrational mode. This sort of vibronic interaction has been well known for linear polyatomic free radicals in (2)Sigma electronic states with a bending mode singly excited. A similar vibronic interaction should be present also in symmetric-top free radicals, where a degenerate vibrational mode is singly excited. However, few examples have been reported and the NO3 radical is perhaps the first case, where the unpaired electron was shown to be strongly coupled with an excited degenerate vibrational mode, as was evidenced in the observed IR and DF spectra. (C) 2014 Elsevier Inc. All rights reserved.	[Hirota, Eizi] Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan	Hirota, E (reprint author), 2-22-16 Noge, Tokyo 1580092, Japan.	ehirota@triton.ocn.ne.jp			JSPS [21550009]	The present author acknowledges the late Dr. Marilyn E. Jacox much. He belongs to more or less the same generation as Dr. Jacox and has received a number of inspiring encouragements from her. He remembers when he met her in NBS Washington in 1961 for the first time. At that time Dr. Jacox already established the status as a top runner in molecular spectroscopy, and in fact she had published a number of excellent papers jointly with Dr. Milligan on IR and UV spectra of transient species trapped in low temperature matrices. Hirota should also mention that he enjoyed a special occasion during a meeting MATRIX2011 held at Vancouver and discussed the NO<INF>3</INF> matter with Dr. Jacox. She understood our results by FTIR and suggested to extend our study to <SUP>18</SUP>O substituted species. Hirota would like to thank three Reviewers for polishing the English. The present study was partially supported by JSPS, Grant-in-Aid for Scientific Research (C), No. 21550009.	Kawaguchi K, 2011, J MOL SPECTROSC, V268, P85, DOI 10.1016/j.jms.2011.04.003; Beckers H, 2009, CHEMPHYSCHEM, V10, P706, DOI 10.1002/cphc.200800860; CROFTON MW, 1988, J CHEM PHYS, V88, P666, DOI 10.1063/1.454194; FRIEDL RR, 1987, J PHYS CHEM-US, V91, P2721, DOI 10.1021/j100295a015; Fujimori R, 2013, J MOL SPECTROSC, V283, P10, DOI 10.1016/j.jms.2012.11.005; Fukushima M., 2013, 68 INT S MOL SPECTR; Herzberg G., 1949, MOL SPECTRA MOL STRU, P405; Hirota E., 2011, COPY IS AVAILA UNPUB; HIROTA E, 1991, J CHEM PHYS, V95, P771, DOI 10.1063/1.461083; ISHIWATA T, 1985, J CHEM PHYS, V82, P2196, DOI 10.1063/1.448362; ISHIWATA T, 1983, J PHYS CHEM-US, V87, P1349, DOI 10.1021/j100231a016; Jacox M.E., 2008, J CHEM PHYS, V129; Kawaguchi K., 2012, RESULTS DESCRIBED RE; Kawaguchi K, 2013, J PHYS CHEM A, V117, P13732, DOI 10.1021/jp407822g; KAWAGUCHI K, 1990, J CHEM PHYS, V93, P951, DOI 10.1063/1.459121; Oka T., 1963, J CHEM PHYS, V38, P1167; Simmons CS, 2012, J PHYS CHEM LETT, V3, P1946, DOI 10.1021/jz300721b; Stanton JF, 2009, MOL PHYS, V107, P1059, DOI 10.1080/00268970902740530; Stanton J.F., 2007, J CHEM PHYS, V126; WEAVER A, 1991, J CHEM PHYS, V94, P1740, DOI 10.1063/1.459947	20	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	APR	2015	310				SI		99	104		10.1016/j.jms.2014.12.010		6	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CG0AC	WOS:000352928000015		
J	Nakajima, M; Yue, Q; Endo, Y				Nakajima, Masakazu; Yue, Qiang; Endo, Yasuki			Fourier-transform microwave spectroscopy of an alkyl substituted Criegee intermediate anti-CH3CHOO	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						Criegee intermediate; FTMW spectroscopy; Methyl internal rotation; Pure rotational transitions	DIRECT KINETIC MEASUREMENTS; VOLATILE ORGANIC-COMPOUNDS; OZONE-ALKENE REACTION; GAS-PHASE; ABSORPTION-SPECTRUM; TORSIONAL STATES; CARBONYL OXIDES; CH2OO REACTIONS; HOX FORMATION; SELF-REACTION	Pure rotational transitions of the anti-form of the simplest alkyl-substituted Criegee intermediate, anti-CH3CHOO, were observed by Fourier-transform microwave spectroscopy. The observed transition frequencies in the A and E levels of the ground vibrational state were analyzed together, and molecular constants including parameters which characterize the internal rotation of the methyl rotor were determined. The experimentally determined barrier height of the three-fold potential for the methyl internal rotation is 399.1 cm(-1), less than a half of that of the other conformer, syn-CH3CHOO (Nakajima and Endo, 2014). (C) 2014 Elsevier Inc. All rights reserved.	[Nakajima, Masakazu; Yue, Qiang; Endo, Yasuki] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Endo, Y (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	endo@bunshi.c.u-tokyo.ac.jp			JSPS KAKENHI Grant [25410004, 19205002]	The authors deeply thank Dr. Isabelle Kleiner (LISA, CNRS) for her advice on the least-squares analysis with the BELGI-Cs code. The present study was supported by JSPS KAKENHI Grant Numbers 25410004 (M.N. & Y.E.), 19205002 (Y.E.).	Welz O, 2012, SCIENCE, V335, P204, DOI 10.1126/science.1213229; HOUGEN JT, 1994, J MOL SPECTROSC, V163, P559, DOI 10.1006/jmsp.1994.1047; Kroll JH, 2001, J PHYS CHEM A, V105, P4446, DOI 10.1021/jp004136v; ENDO Y, 1994, FARADAY DISCUSS, V97, P341, DOI 10.1039/fd9949700341; Liu F, 2014, J PHYS CHEM A, V118, P2298, DOI 10.1021/jp412726z; Atkinson R, 2003, CHEM REV, V103, P4605, DOI 10.1021/cr0206420; Kroll JH, 2001, J PHYS CHEM A, V105, P1554, DOI 10.1021/jp002121r; Nakajima M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4821165; Hartwig H, 1996, Z NATURFORSCH A, V51, P923; Stone D, 2014, PHYS CHEM CHEM PHYS, V16, P1139, DOI 10.1039/c3cp54391a; Ting WL, 2014, PHYS CHEM CHEM PHYS, V16, P10438, DOI 10.1039/c4cp00877d; Smith MC, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4892582; Taatjes CA, 2008, J AM CHEM SOC, V130, P11883, DOI 10.1021/ja804165q; CRIEGEE R, 1975, ANGEW CHEM INT EDIT, V14, P745, DOI 10.1002/anie.197507451; Su YT, 2013, SCIENCE, V340, P174, DOI 10.1126/science.1234369; Beames JM, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4810865; BALLE TJ, 1981, REV SCI INSTRUM, V52, P33, DOI 10.1063/1.1136443; Atkinson R, 1997, J PHYS CHEM REF DATA, V26, P215; Daly AM, 2014, J MOL SPECTROSC, V297, P16, DOI 10.1016/j.jms.2014.01.002; Su YT, 2014, NAT CHEM, V6, P477, DOI [10.1038/nchem.1890, 10.1038/NCHEM.1890]; Sumiyoshi Y, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1943967; Beames JM, 2012, J AM CHEM SOC, V134, P20045, DOI 10.1021/ja310603j; XU LH, 1995, J MOL SPECTROSC, V173, P540, DOI 10.1006/jmsp.1995.1255; Buras ZJ, 2014, J PHYS CHEM A, V118, P1997, DOI 10.1021/jp4118985; Taatjes CA, 2012, PHYS CHEM CHEM PHYS, V14, P10391, DOI 10.1039/c2cp40294g; Xu LH, 2008, J MOL SPECTROSC, V251, P305, DOI 10.1016/j.jms.2008.03.017; GRABOW JU, 1990, Z NATURFORSCH A, V45, P1043; Taatjes CA, 2013, SCIENCE, V340, P177, DOI 10.1126/science.1234689; McCarthy MC, 2013, J PHYS CHEM LETT, V4, P4133, DOI 10.1021/jz4023128; Buras ZJ, 2014, J PHYS CHEM LETT, V5, P2224, DOI 10.1021/jz5008406; Kleiner I, 2010, J MOL SPECTROSC, V260, P1, DOI 10.1016/j.jms.2009.12.011; Sheps L, 2013, J PHYS CHEM LETT, V4, P4201, DOI 10.1021/jz402191w; Nakajima M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869696; Kuwata KT, 2010, J PHYS CHEM A, V114, P9192, DOI 10.1021/jp105358v; Anglada JM, 2011, PHYS CHEM CHEM PHYS, V13, P13034, DOI 10.1039/c1cp20872a; Calvert J. G., 2000, MECH ATMOSPHERIC OXI; CREMER D, 1993, CHEM PHYS LETT, V209, P547, DOI 10.1016/0009-2614(93)80131-8; CRIEGEE R, 1949, LIEBIGS ANN CHEM, V564, P9; Csaszar AG, 2004, J CHEM PHYS, V120, P1203, DOI 10.1063/1.1633260; Kleiner I, 1996, J MOL SPECTROSC, V179, P41, DOI 10.1006/jmsp.1996.0182; Nakajima M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4861494; Welz O, 2014, ANGEW CHEM INT EDIT, V53, P4547, DOI 10.1002/anie.201400964; WOODS RC, 1966, J MOL SPECTROSC, V21, P4, DOI 10.1016/0022-2852(66)90117-2	43	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	APR	2015	310				SI		109	112		10.1016/j.jms.2014.11.004		4	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CG0AC	WOS:000352928000017		
J	Piccolo, L; Kumar, G; Nakashima, I; Misu, T; Kong, Y; Wakerley, B; Ryan, S; Cavey, A; Fujihara, K; Palace, J				Piccolo, L.; Kumar, G.; Nakashima, I.; Misu, T.; Kong, Y.; Wakerley, B.; Ryan, S.; Cavey, A.; Fujihara, K.; Palace, Jacqueline			Multiple sclerosis in Japan appears to be a milder disease compared to the UK	JOURNAL OF NEUROLOGY			English	Article						Multiple sclerosis; Prognosis; Disability; Disease modifying treatments	CLINICAL CHARACTERISTICS; NORTHERN JAPAN; HONG-KONG; SEVERITY; SCORE; EPIDEMIOLOGY; PREVALENCE; DISABILITY; RISK	Multiple sclerosis (MS) is relatively common in the West, but rare in Japan. In the literature, there are few comparative data regarding disease severity throughout the world. The objective of this study was to compare disability in patients from a UK and a Japanese MS cohort. We retrospectively analysed the clinical features of patients with MS from a UK and Japanese MS centre. The Multiple Sclerosis Severity Score (MSSS), which adjusts the Expanded Disability Status Scale score according to disease duration, was used as a marker of disease severity. One thousand one hundred forty-eight UK patients and 104 Japanese patient were identified representing the relative national prevalence. Demographics and disease duration did not differ between the groups. Median MSSS was significantly different between the two groups (Japan 3.34 vs. UK 5.87, p < 0.001). Primary progressive MS was more common in the UK (12.9 %) than in the Japanese cohort (3 %, p = 0.044). The majority of Japanese patients (83.7 % vs. UK 17 %) had been exposed to disease modifying treatments (DMTs). Exposure to DMTs did not show a significant effect on disability. In conclusion, this study suggests that MS in Japan may be associated with less disability than in UK. More Japanese patients were treated with DMTs. Differences in treatments do not seem to explain the disparity in disability severity. This suggests either genetic or environmental influences on disease severity.	[Piccolo, L.; Kumar, G.; Kong, Y.; Wakerley, B.; Ryan, S.; Cavey, A.; Palace, Jacqueline] Univ Oxford, Oxford Univ Hosp NHS Trust, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Piccolo, L.] Univ Pavia, IRCCS C Mondino, Dept Neurol Sci, I-27100 Pavia, Italy; [Nakashima, I.] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Misu, T.; Fujihara, K.] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan	Palace, J (reprint author), Univ Oxford, Oxford Univ Hosp NHS Trust, Nuffield Dept Clin Neurosci, Level 3 West Wing,Headley Way, Oxford OX3 9DU, England.	jacqueline.palace@ndcn.ox.ac.uk			Biogen Idec Japan; Tanabe Mitsubishi; Novartis Pharma; LSI Medience Corporation; Bayer Schering Pharma; Asahi Kasei Kuraray Medical Co.; Chemo-Sero-Therapeutic Research Institute; Mitsubishi Tanabe Pharma Corporation; Teijin Pharma; Ministry of Education, Science and Technology; Ministry of Health, Labor and Welfare of Japan; Novartis; Biogen Idec; Eisai Inc.; Astellas Pharma Inc.; Takeda Pharmaceutical Company Limited; Asahi Kasei Medical Co.; Daiichi Sankyo; Nihon Pharmaceutical; Asahi Kasei Medical; Teva Pharmaceutical; Mitsubishi Tanabe Pharma; Chugai Pharmaceutical; Ono Pharmaceutical; Genzyme Japan; Ministry of Education, Science and Technology of Japan [26293205, 22229008]; Ministry of Health, Welfare and Labor of Japan; Merck Serono; Bayer Schering; MS society; Guthie Jackson Foundation	Dr. Piccolo reports no disclosures. Dr. Kumar reports no disclosures. Dr. Ichiro Nakashima has served on the scientific advisory boards for Biogen Idec Japan and Novartis Pharma, has received funding for a trip and speaks from Biogen Idec Japan, Tanabe Mitsubishi, and Novartis Pharma, has received grant support from LSI Medience Corporation. Dr. Misu has received speaker honoraria from Bayer Schering Pharma, Biogen Idec Japan, Mitsubishi Tanabe Pharma Corporation, Asahi Kasei Medical Co., and Astellas Pharma Inc. and has received research support from Bayer Schering Pharma, Biogen Idec Japan, Asahi Kasei Kuraray Medical Co., The Chemo-Sero-Therapeutic Research Institute, Mitsubishi Tanabe Pharma Corporation, Teijin Pharma, and Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Technology, and the Ministry of Health, Labor and Welfare of Japan. Dr. Kong reports no disclosures. Dr. Wakerley has been sponsored by Novartis in the past. Dr. Ryan reports no disclosures. Ana Cavey is the Coloplast Neurogenic Nurse Advisory Board March 2014. Dr. Fujihara serves on scientific advisory boards for Bayer Schering Pharma, Biogen Idec, Mitsubishi Tanabe Pharma Corporation, Novartis Pharma, Chugai Pharmaceutical, Ono Pharmaceutical, Nihon Pharmaceutical, Merck Serono, Alexion Pharmaceuticals, Medimmune and Medical Review; has received funding for travel and speaker honoraria from Bayer Schering Pharma, Biogen Idec, Eisai Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co., Daiichi Sankyo, and Nihon Pharmaceutical; serves as an editorial board member of Clinical and Experimental Neuroimmunology (2009-present) and a advisory board member of Sri Lanka journal of Neurology; has received research support from Bayer Schering Pharma, Biogen Idec Japan, Asahi Kasei Medical, The Chemo-Sero-Therapeutic Research Institute, Teva Pharmaceutical, Mitsubishi Tanabe Pharma, Teijin Pharma, Chugai Pharmaceutical, Ono Pharmaceutical, Nihon Pharmaceutical, and Genzyme Japan; is funded as the primary investigator (#26293205, 2014-2016) and the secondary investigator (#22229008, 2010-2015) by the Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Technology of Japan and as the secondary investigator by the Grants-in-Aid for Scientific Research from the Ministry of Health, Welfare and Labor of Japan (2010-present). Dr. Palace is partly funded by highly specialised services to run a National congenital myasthenia service and a neuromyelitis service. She has received support for scientific meetings and honorariums for advisory work from Merck Serono, Biogen Idec, Novartis, Teva, Chugai Pharma and Bayer Schering, and unrestricted grants from Merck Serono, Novartis, Biogen Idec and Bayer Schering. Her hospital trust receives funds for her role as clinical lead for the RSS, and she has received grants from the MS society and Guthie Jackson Foundation for unrelated research studies. She is a board member for the charitable European MS foundation 'The Charcot Foundation' and on the steering committee for a European collaborative MS imaging group 'MAGNIMS'.	DETELS R, 1977, AM J EPIDEMIOL, V105, P303; KURTZKE JF, 1983, NEUROLOGY, V33, P1444; Houzen H, 2012, J NEUROL SCI, V323, P117, DOI 10.1016/j.jns.2012.08.032; Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144; Gale CR, 1995, PROG NEUROBIOL, V47, P425, DOI 10.1016/0301-0082(95)00033-X; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Houzen H, 2003, J NEUROL SCI, V211, P49, DOI 10.1016/S0022-510X(03)00033-9; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Osoegawa M, 2009, MULT SCLER, V15, P159, DOI 10.1177/1352458508098372; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Wang H, 2008, NEUROLOGY, V71, P1142, DOI 10.1212/01.wnl.0000316195.52001.e1; Chan KH, 2011, CLIN NEUROL NEUROSUR, V113, P617, DOI 10.1016/j.clineuro.2011.04.013; Chang KH, 2006, MULT SCLER J, V12, P501, DOI 10.1191/1352458506ms1297oa; Chong H T, 2008, Med J Malaysia, V63, P356; Faridar A, 2012, ACTA NEUROL BELG, V112, P327, DOI 10.1007/s13760-012-0108-z; Koutsouraki E, 2010, INT REV PSYCHIATR, V22, P2, DOI 10.3109/09540261003589216; Lau KK, 2008, J NEUROL SCI, V268, P78, DOI 10.1016/j.jns.2007.11.006; Nakashima I, 1999, J NEUROL NEUROSUR PS, V67, P153, DOI 10.1136/jnnp.67.2.153; Pachner AR, 2009, J NEUROL SCI, V278, P66, DOI 10.1016/j.jns.2008.11.020; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Strange RC, 2010, MULT SCLER J, V16, P1109, DOI 10.1177/1352458510373784; Tanaka K, 2005, INTERNAL MED, V44, P560, DOI 10.2169/internalmedicine.44.560; Wasay M, 2006, Int MS J, V13, P58	26	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	APR	2015	262	4					831	836		10.1007/s00415-015-7637-3		6	Clinical Neurology	Neurosciences & Neurology	CG4YL	WOS:000353295400005		
J	Uzawa, A; Kawaguchi, N; Kanai, T; Himuro, K; Oda, F; Yoshida, S; Yoshino, I; Kuwabara, S				Uzawa, Akiyuki; Kawaguchi, Naoki; Kanai, Tetsuya; Himuro, Keiichi; Oda, Fumiko; Yoshida, Shigetoshi; Yoshino, Ichiro; Kuwabara, Satoshi			Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis	JOURNAL OF NEUROLOGY			English	Article						Anti-acetylcholine receptor antibody; Late-onset; Thymectomy; Thymic hyperplasia; Myasthenia gravis; Prognosis	EXTENDED THYMECTOMY; MYOID CELLS; THYMUS	Thymectomy is an effective treatment for myasthenia gravis (MG). However, there is limited data on its effectiveness in non-thymomatous late-onset MG (LOMG). The aim of this study was to analyze the effects of thymectomy in LOMG. We retrospectively reviewed the 2-year post-thymectomy prognosis in 39 consecutive patients with non-thymomatous, anti-acetylcholine receptor antibody positive, and generalized LOMG (age at onset a parts per thousand yen50 years). The MG foundation of America (MGFA) classification, MGFA post-intervention status, dosage of prednisolone and pyridostigmine, and anti-acetylcholine receptor antibody titers were evaluated. Among the 39 LOMG patients, thymic hyperplasia was seen in 5 (12.8 %). MGFA classification and prednisolone dosage before thymectomy were similar between the LOMG with thymic hyperplasia group (n = 5) and the LOMG with involuted thymus group (n = 34). Two years after thymectomy, the LOMG patients with thymic hyperplasia showed higher proportion of remission (60 vs. 26 %) and received lower prednisolone dosage compared to patients with involuted thymus (0.8 vs. 4.0 mg/day). Notably, the proportion of patients with minimal manifestation or better status with receiving a parts per thousand currency sign5 mg/day prednisolone was much higher in the thymic hyperplasia group than in the involuted thymus group (100 vs. 62 %). In conclusion, thymectomy could have beneficial effects in generalized LOMG, particularly in patients with thymic hyperplasia.	[Uzawa, Akiyuki; Kawaguchi, Naoki; Kanai, Tetsuya; Himuro, Keiichi; Oda, Fumiko; Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Kawaguchi, Naoki] Neurol Chiba Clin, Dept Neurol, Chiba, Japan; [Yoshida, Shigetoshi; Yoshino, Ichiro] Chiba Univ, Dept Gen Thorac Surg, Grad Sch Med, Chiba 2608670, Japan	Uzawa, A (reprint author), Chiba Univ, Dept Neurol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	auzawa@chiba-u.jp					Tomulescu V, 2011, ANN SURG, V254, P761, DOI 10.1097/SLA.0b013e31823686f6; Jaretzki A, 2000, NEUROLOGY, V55, P16; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; SCHLUEP M, 1987, ANN NEUROL, V22, P212, DOI 10.1002/ana.410220205; Pompeo E, 2009, EUR J CARDIO-THORAC, V36, P164, DOI 10.1016/j.ejcts.2009.02.021; Kawaguchi N, 2007, CLIN NEUROL NEUROSUR, V109, P858, DOI 10.1016/j.clineuro.2007.08.006; Leite MI, 2007, AM J PATHOL, V171, P893, DOI 10.2353/ajpath.2007.070240; Murai H, 2014, CLIN EXP NEUROIMMUNO, V5, P84; Strobel P, 2008, J NEUROIMMUNOL, V201, P64, DOI 10.1016/j.jneuroim.2008.06.017; Utsugisawa K, 2014, MUSCLE NERVE, V50, P493, DOI 10.1002/mus.24213	10	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	APR	2015	262	4					1019	1023		10.1007/s00415-015-7673-z		5	Clinical Neurology	Neurosciences & Neurology	CG4YL	WOS:000353295400027		
J	Maeshima, S; Koike, H; Noda, S; Noda, T; Nakanishi, H; Iijima, M; Ito, M; Kimura, S; Sobue, G				Maeshima, Shinya; Koike, Haruki; Noda, Seiya; Noda, Tomoko; Nakanishi, Hirotaka; Iijima, Masahiro; Ito, Mizuki; Kimura, Seigo; Sobue, Gen			Clinicopathological features of sarcoidosis manifesting as generalized chronic myopathy	JOURNAL OF NEUROLOGY			English	Article						Muscle biopsy; Myopathy; Prognosis; Sarcoidosis	INCLUSION-BODY MYOSITIS; SPINAL-CORD SARCOIDOSIS; OF-THE-LITERATURE; IMAGING FINDINGS; SKELETAL-MUSCLE; INFLAMMATORY MYOPATHIES; GRANULOMATOUS MYOSITIS; POLYMYOSITIS; DERMATOMYOSITIS; EXPRESSION	Although chronic myopathy has been reported to affect skeletal muscle in sarcoidosis, its clinicopathological features have not been fully elucidated. We characterized the clinical, histopathological, and prognostic features of eleven patients with sarcoidosis manifesting with chronically progressive, generalized myopathy that was confirmed with muscle biopsy. Generalized muscle weakness extending to the four extremities and trunk was the cardinal feature of these cases. Muscle atrophy was evident in nine patients, particularly in the lower limbs, whereas myalgia was reported in only two patients. Myopathy was the first manifestation of sarcoidosis in five patients. Only six patients showed elevated plasma creatine kinase levels. Using skeletal muscle computed tomography, the distribution of muscle atrophy was predominant in the hip adductors, knee flexors and ankle plantarflexors. Radiological assessments, including magnetic resonance imaging, gallium scintigraphy, and fluorodeoxyglucose positron emission tomography-computed tomography imaging, revealed findings suggestive of skeletal muscle inflammation in only half of the patients examined. However, in all patients, muscle biopsy specimens revealed an active inflammatory process, as observed by focal non-caseating epithelioid granuloma with predominant CD4-positive lymphocytic infiltration. Sarcolemmas were diffusely stained with HLA-ABC, HLA-DR and intercellular adhesion molecule-1 antibodies, suggesting diffuse and active antigen presentation. Functional improvement after immunomodulatory treatment was significantly better in patients with short disease durations (p < 0.05). The therapeutic response was poor in patients with long disease durations; thus, early diagnosis and early initiation of treatment are important.	[Maeshima, Shinya; Koike, Haruki; Noda, Seiya; Noda, Tomoko; Nakanishi, Hirotaka; Iijima, Masahiro; Ito, Mizuki; Kimura, Seigo; Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Koike, H (reprint author), Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	koike-haruki@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp			Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by grants from the Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ADAMS EM, 1995, RADIOGRAPHICS, V15, P563; Ammitzboll F, 1956, ACTA RHEUMATOL SCAND, V2, P3; Nakanishi H, 2013, INTERNAL MED, V52, P333, DOI 10.2169/internalmedicine.52.8910; Kim DS, 1999, CHEST, V115, P1059, DOI 10.1378/chest.115.4.1059; Garcia J, 2000, SKELETAL RADIOL, V29, P425; VANSWIETEN JC, 1988, STROKE, V19, P604; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Callen JP, 2000, LANCET, V355, P53, DOI 10.1016/S0140-6736(99)05157-0; Ohyama K, 2014, EUR J NEUROL, V21, P1002, DOI 10.1111/ene.12426; OTAKE S, 1994, AM J ROENTGENOL, V162, P369; Needham M, 2007, LANCET NEUROL, V6, P620, DOI 10.1016/S1474-4422(07)70171-0; HEWLETT RH, 1975, J NEUROL NEUROSUR PS, V38, P1090, DOI 10.1136/jnnp.38.11.1090; JAMAL MM, 1988, J RHEUMATOL, V15, P1868; Dimachkie MM, 2012, SEMIN NEUROL, V32, P237, DOI 10.1055/s-0032-1329197; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885; BRUN ARNE, 1961, ACTA PSYCHIATR ET NEUROL SCAND, V36, P515, DOI 10.1111/j.1600-0447.1961.tb01771.x; CROMPTON MR, 1961, BRAIN, V84, P62, DOI 10.1093/brain/84.1.62; DALAKAS MC, 1991, NEW ENGL J MED, V325, P1487, DOI 10.1056/NEJM199111213252107; DOUGLAS AC, 1973, J NEUROL NEUROSUR PS, V36, P1034, DOI 10.1136/jnnp.36.6.1034; FONSECA GA, 1993, CLIN EXP RHEUMATOL, V11, P553; GARDNERT.C, 1972, NEUROLOGY, V22, P917; HARVEY JC, 1959, AM J MED, V26, P356, DOI 10.1016/0002-9343(59)90244-X; HINTERBUCHNER CN, 1964, BRAIN, V87, P355, DOI 10.1093/brain/87.2.355; Ibi T, 1995, Rinsho Shinkeigaku, V35, P996; Inukai A, 2000, MUSCLE NERVE, V23, P385, DOI 10.1002/(SICI)1097-4598(200003)23:3<385::AID-MUS10>3.0.CO;2-T; Judson MA, 2006, CHEST, V130, P855, DOI 10.1378/chest.130.3.855; Koike H, 2000, J NEUROL, V247, P544, DOI 10.1007/s004150070154; KRYGER J, 1959, Acta Rheumatol Scand, V5, P314; Kumamoto T, 2002, ACTA NEUROPATHOL, V104, P38, DOI 10.1007/s00401-002-0517-9; Kuru S, 2003, ACTA NEUROPATHOL, V105, P217, DOI 10.1007/s00401-002-0632-4; Lampa J, 2001, ANN RHEUM DIS, V60, P423, DOI 10.1136/ard.60.4.423; Le Roux K, 2007, MUSCLE NERVE, V35, P171, DOI 10.1002/mus.20683; Liang YD, 2000, ACTA NEUROPATHOL, V100, P521; Liem IH, 1998, J NUCL MED, V39, P1605; MCCONKEY B, 1958, ARCH INTERN MED, V102, P443; Moore SL, 2005, AM J ROENTGENOL, V185, P154; Needham M, 2008, J NEUROL NEUROSUR PS, V79, P1056, DOI 10.1136/jnnp.2007.138891; OST D, 1995, CHEST, V107, P879, DOI 10.1378/chest.107.3.879; Prayson RA, 1999, AM J CLIN PATHOL, V112, P63; SILVERST.A, 1969, ARCH NEUROL-CHICAGO, V21, P235; STRIZ I, 1992, CHEST, V102, P882, DOI 10.1378/chest.102.3.882; SWASH M, 1995, MUSCLE NERVE, V18, P708, DOI 10.1002/mus.880180706; TALBOT PS, 1967, BRIT MED J, V4, P465; Weber MA, 2006, J NEUROL, V253, P1625, DOI 10.1007/s00415-006-0318-5; WOLFE SM, 1987, SEMIN ARTHRITIS RHEU, V16, P300, DOI 10.1016/0049-0172(87)90008-4; Yasui K, 2000, NEUROPATH APPL NEURO, V26, P481, DOI 10.1046/j.1365-2990.2000.00266-3.x; Zisman DA, 2002, SEM RESP CRIT CARE M, V23, P555, DOI 10.1055/s-2002-36520	47	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	APR	2015	262	4					1035	1045		10.1007/s00415-015-7680-0		11	Clinical Neurology	Neurosciences & Neurology	CG4YL	WOS:000353295400029		
J	El-Dakhly, KM; Goto, M; Noishiki, K; El-Nahass, ES; Sakai, H; Yanai, T; Takashima, Y				El-Dakhly, Khaled Mohamed; Goto, Minami; Noishiki, Kaori; El-Nahass, El-Shaymaa; Sakai, Hiroki; Yanai, Tokuma; Takashima, Yasuhiro			DISTRIBUTION PATTERNS OF BABESIA GIBSONI INFECTION IN HUNTING DOGS FROM NINE JAPANESE ISLANDS	JOURNAL OF PARASITOLOGY			English	Article							MOLECULAR CHARACTERIZATION; CANIS-VOGELI; EPIDEMIOLOGIC SURVEY; UNITED-STATES; PCR-RFLP; PREVALENCE; TICK; DNA; DIFFERENTIATION; PIROPLASMS	Canine babesiosis constitutes a major global veterinary medical problem caused by tick-borne hemoparasites Babesia gibsoni and Babesia canis. Babesia gibsoni induces more severe clinical signs and is mainly transmitted by the ixodid Haemaphysalis longicornis. In Japan, Babesia gibsoni is primarily found in the western districts, with few records in the eastern parts. The aim of the current investigation was to evaluate distribution patterns of Babesia gibsoni infection in 9 Japanese islands and peninsulas using direct microscopy and PCR. Therefore, 196 hunting dogs were randomly sampled during the period from March to September 2011. Ages and sexes of dogs were identified. Direct microscopy of Giemsa-stained blood smear revealed pear-shaped piroplasms of Babesia gibsoni in 3 (1.6%) dogs. PCR was done initially with the universal primer set (B18S-F and B18S-R) amplifying the 1,665-bp portion of the 18S rRNA gene, followed by the specific primer set (Bg18F1 and Bg18R2) amplifying 2,363-bp fragments of the same gene. Accordingly, 84 (42.9%) and 8 (4.1%) dogs were positive, respectively. The current investigation shows that canine babesiosis was recorded in all islands except for Sado Island, Atsumi Peninsula, and Tanegashima Island. The highest infection rate was detected in the main island of Okinawa, while the lowest was on Ishigaki Island. Both sexes were non-significantly infected. However, the diversity of infection in islands was significantly different (P < 0.05). Although Babesia gibsoni has been previously found in western and eastern Japan, the present work highlights the prevalence of infection in many Japanese districts, including islands and peninsulas, giving realistic data that can facilitate treatment and control.	[El-Dakhly, Khaled Mohamed; Goto, Minami; Noishiki, Kaori; El-Nahass, El-Shaymaa; Sakai, Hiroki; Yanai, Tokuma; Takashima, Yasuhiro] Beni Suef Univ, Fac Vet Med, Dept Vet Parasitol, Bani Suwayf 62515, Egypt	Yanai, T (reprint author), Gifu Univ, Fac Appl Biol Sci, Lab Vet Pathol, 1-1 Yanagido, Gifu 5011193, Japan.	yanai@gifu-u.ac.jp			Ministry of Health, Labor and Welfare in Japan; Hokkaido University, Japan	This study was partially supported by a Grant-in-Aid for scientific research from the Ministry of Health, Labor and Welfare in Japan and was also supported by a grant from Hokkaido University, Japan.	Ano H, 2001, J VET MED SCI, V63, P561, DOI 10.1292/jvms.63.561; Criado-Fornelio A, 2003, VET PARASITOL, V117, P123, DOI 10.1016/j.vetpar.2003.08.006; Behnke JM, 1999, J HELMINTHOL, V73, P31; Solano-Gallego L, 2011, VET PARASITOL, V181, P48, DOI 10.1016/j.vetpar.2011.04.023; El-Dakhly KM, 2013, PARASITOL RES, V112, P3267, DOI 10.1007/s00436-013-3505-1; HIGUCHI S, 1991, J VET MED SCI, V53, P129; Caccio SM, 2002, VET PARASITOL, V106, P285, DOI 10.1016/S0304-4017(02)00112-7; Miyama T, 2005, J VET MED SCI, V67, P467, DOI 10.1292/jvms.67.467; Wozniak EJ, 1997, J PARASITOL, V83, P692, DOI 10.2307/3284248; Boozer AL, 2003, VET CLIN N AM-SMALL, V33, P885, DOI 10.1016/S0195-5616(03)00039-1; Casapulla R, 1998, VET REC, V142, P168; Macintire DK, 2002, J AM VET MED ASSOC, V220, P325, DOI 10.2460/javma.2002.220.325; Inokuma H, 2004, VET PARASITOL, V121, P341, DOI 10.1016/j.vetpar.2004.03.012; Cardoso L, 2008, VET PARASITOL, V156, P199, DOI 10.1016/j.vetpar.2008.05.027; BOSE R, 1995, VET PARASITOL, V57, P61, DOI 10.1016/0304-4017(94)03111-9; Sobczyk AS, 2005, B VET I PULAWY, V49, P407; Trapp SM, 2006, VET PARASITOL, V141, P177, DOI 10.1016/j.vetpar.2006.04.036; Inokuma H, 2003, J CLIN MICROBIOL, V41, P3494, DOI 10.1128/JCM.41.8.3494-3498.2003; Ikadai H, 2004, J CLIN MICROBIOL, V42, P2465, DOI 10.1128/JCM.42.6.2465-2469.2004; Shaw SE, 2001, TRENDS PARASITOL, V17, P74, DOI 10.1016/S1471-4922(00)01856-0; Kjemtrup AM, 2006, VET PARASITOL, V138, P112, DOI 10.1016/j.vetpar.2006.01.045; Brandao LP, 2003, VET PARASITOL, V114, P253, DOI 10.1016/S0304-4017(03)00130-4; Jefferies R, 2007, VET PARASITOL, V144, P20, DOI 10.1016/j.vetpar.2006.09.022; Kjemtrup AM, 2006, VET PARASITOL, V138, P103, DOI 10.1016/j.vetpar.2006.01.044; Birkenheuer AJ, 2004, VET PARASITOL, V124, P151, DOI 10.1016/j.vetpar.2004.07.008; Bourdoiseau G, 2006, VET PARASITOL, V138, P118, DOI 10.1016/j.vetpar.2006.01.046; Rene-Martellet M, 2013, VET PARASITOL, V197, P50, DOI 10.1016/j.vetpar.2013.04.034; Solano-Gallego L, 2008, VET PARASITOL, V157, P211, DOI 10.1016/j.vetpar.2008.07.024; Schetters TPM, 1997, PARASITOLOGY, V115, P485, DOI 10.1017/S0031182097001686; Schetters T, 2005, TRENDS PARASITOL, V21, P179, DOI 10.1016/j.pt.2005.02.006; Birkenheuer AJ, 2005, JAVMA-J AM VET MED A, V227, P942, DOI 10.2460/javma.2005.227.942; Aysul N., TURKISH J VET ANIMAL, V37, P226; Birkenheuer AJ, 2003, J AM ANIM HOSP ASSOC, V39, P551; Camacho García A. T., 2006, Veterinary Parasitology, V138, P97; Carrat C, 1999, J EUKARYOT MICROBIOL, V46, P298, DOI 10.1111/j.1550-7408.1999.tb05128.x; HAUSCHILD S, 1995, PARASITOL RES, V81, P638, DOI 10.1007/BF00931839; Imre M, 2013, J PARASITOL, V99, P161, DOI 10.1645/GE-3129.1; Itoh N., 1987, Journal of the Japan Veterinary Medical Association, V40, P167; Jefferies R, 2003, J PARASITOL, V89, P409, DOI 10.1645/0022-3395(2003)089[0409:TSOCBI]2.0.CO;2; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1501, DOI 10.1016/S0020-7519(00)00120-X; Kubelova M., VET PARASITOLOGY, V191, P353; Lee CC, 2010, J VET MED SCI, V72, P1329, DOI 10.1292/jvms.10-0093; Lee MJ, 2009, VECTOR-BORNE ZOONOT, V9, P681, DOI 10.1089/vbz.2008.0116; Lee Seung-Ok, 2005, Journal of Veterinary Science, V6, P151; Matjila PT, 2007, J S AFR VET ASSOC, V78, P2; Matsuu A, 2004, J VET MED SCI, V66, P893, DOI 10.1292/jvms.66.893; M'ghirbi Y, 2008, VET PARASITOL, V152, P1, DOI 10.1016/j.vetpar.2007.12.018; Muhlnickel CJ, 2002, AUST VET J, V80, P606, DOI 10.1111/j.1751-0813.2002.tb10961.x; Nayel Kh. M., 2012, PARASITOL RES, V111, P1019; O'Dwyer LH, 2009, REV BRAS PARASITOL V, V18, P23, DOI 10.4322/rbpv.01802005; Shen Y., TROPICAL ANIMAL HLTH, V29, p19S; Tamboura HH, 2006, ONDERSTEPOORT J VET, V73, P53; Zahler M, 2000, VET PARASITOL, V89, P241, DOI 10.1016/S0304-4017(00)00202-8; Zahler M, 2000, PARASITOLOGY, V120, P365, DOI 10.1017/S0031182099005557	54	0	0	AMER SOC PARASITOLOGISTS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	0022-3395	1937-2345		J PARASITOL	J. Parasitol.	APR	2015	101	2					160	166		10.1645/14-564.1		7	Parasitology	Parasitology	CG2XG	WOS:000353138400007		
J	Gu, YH; Yokoyama, K; Mizuta, K; Tsuchioka, T; Kudo, T; Sasaki, H; Nio, M; Tang, JL; Ohkubo, T; Matsui, A				Gu, Yan-Hong; Yokoyama, Koji; Mizuta, Koichi; Tsuchioka, Takashi; Kudo, Toyoichiro; Sasaki, Hideyuki; Nio, Masaki; Tang, Julian; Ohkubo, Takayoshi; Matsui, Akira			Stool Color Card Screening for Early Detection of Biliary Atresia and Long-Term Native Liver Survival: A 19-Year Cohort Study in Japan	JOURNAL OF PEDIATRICS			English	Article							KASAI OPERATION; OUTCOMES; REGISTRY; EPIDEMIOLOGY; EXPERIENCE; ENGLAND; IMPACT; AGE	Objective To evaluate the sensitivity and specificity of a stool color card used for a mass screening of biliary atresia conducted over 19 years. In addition, the age at Kasai procedure and the long-term probabilities of native liver survival were investigated. Study design From 1994 to 2011, the stool color card was distributed to all pregnant women in Tochigi Prefecture, Japan. Before or during the postnatal 1-month health checkup, the mothers returned the completed stool color card to the attending pediatrician or obstetrician. All suspected cases of biliary atresia were referred for further examination. Diagnosis was confirmed by laparotomy or operative cholangiography for high-risk cases before the Kasai procedure. Patients with biliary atresia were followed from the date of their Kasai procedure until liver transplantation, death, or October 31, 2013, whichever comes sooner. Results A total of 313 230 live born infants were screened; 34 patients with biliary atresia were diagnosed. The sensitivity and specificity of stool color card screening at the 1-month check-up was 76.5% (95% CI 62.2-90.7) and 99.9% (95% CI 99.9-100.0), respectively. Mean age at the time of Kasai procedure was 59.7 days. According to Kaplan-Meier analysis, the native liver survival probability at 5, 10, and 15 years was 87.6%, 76.9%, and 48.5%, respectively. Conclusions The sensitivity and specificity of the stool color card have been demonstrated by our 19-year cohort study. We found that the timing of Kasai procedure and long-term native liver survival probabilities were improved, suggesting the beneficial effect of stool color card screening.	[Gu, Yan-Hong; Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Gu, Yan-Hong] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan; [Yokoyama, Koji] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan; [Mizuta, Koichi] Jichi Med Univ, Dept Transplant Surg, Shimotsuke, Tochigi, Japan; [Tsuchioka, Takashi] Dokkyo Med Univ, Dept Surg, Mibu, Tochigi, Japan; [Kudo, Toyoichiro; Matsui, Akira] Natl Ctr Child Hlth & Dev, Natl Med Ctr Children & Mothers, Dept Hepatol, Tokyo, Japan; [Sasaki, Hideyuki; Nio, Masaki] Tohoku Univ, Sch Med, Dept Pediat Surg, Sendai, Miyagi, Japan; [Tang, Julian] Natl Ctr Child Hlth & Dev, Dept Educ Clin Res, Tokyo, Japan	Gu, YH (reprint author), Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan.				National Center for Child Health and Development of Japan [25-5, 26-31]	Supported by the National Center for Child Health and Development of Japan (25-5 and 26-31). The authors declare no conflicts of interest.	Altman RP, 1997, ANN SURG, V226, P348, DOI 10.1097/00000658-199709000-00014; McKiernan PJ, 2000, LANCET, V355, P25, DOI 10.1016/S0140-6736(99)03492-3; Lien TH, 2011, HEPATOLOGY, V53, P202, DOI 10.1002/hep.24023; Hsiao CH, 2008, HEPATOLOGY, V47, P1233, DOI 10.1002/hep.22182; Wildhaber BE, 2011, HEPATOLOGY, V54, P367, DOI 10.1002/hep.24346; Chardot C, 2013, J HEPATOL, V58, P1209, DOI 10.1016/j.jhep.2013.01.040; Nio M, 2003, J PEDIATR SURG, V38, P997, DOI 10.1016/S0022-3468(03)00178-7; Superina R, 2011, ANN SURG, V254, P577, DOI 10.1097/SLA.0b013e3182300950; Yoon PW, 1997, PEDIATRICS, V99, P376, DOI 10.1542/peds.99.3.376; Chardot C, 1999, J HEPATOL, V31, P1006, DOI 10.1016/S0168-8278(99)80312-2; Serinet MO, 2009, PEDIATRICS, V123, P1280, DOI 10.1542/peds.2008-1949; Shinkai M, 2009, J PEDIATR GASTR NUTR, V48, P443; Kasahara M, 2013, AM J TRANSPLANT, V13, P1830, DOI 10.1111/ajt.12276; Davenport M, 2011, J PEDIATR SURG, V46, P1689, DOI 10.1016/j.jpedsurg.2011.04.013; Nio M, 2010, J PEDIATR SURG, V45, P2361, DOI 10.1016/j.jpedsurg.2010.08.032; Gu YH, 2014, J PEDIAT, V55, P1191; Gu YH, 2008, PEDIATR INT, V50, P376, DOI 10.1111/j.1442-200X.2008.02595.x; Howard ER, 2001, J PEDIATR SURG, V36, P892, DOI 10.1053/jpsu.2001.23965; Ibrahim M, 1997, TOHOKU J EXP MED, V181, P85, DOI 10.1620/tjem.181.85; Kasai M, 1974, Prog Pediatr Surg, V6, P5; Kasai M, 1959, SHUJUTSU OPERATION, V13, P733; MATSUI A, 1995, LANCET, V345, P1181, DOI 10.1016/S0140-6736(95)91013-1; MATSUI A, 1994, LANCET, V343, P925, DOI 10.1016/S0140-6736(94)90052-3; MATSUI A, 1993, SCREENING, V2, P201, DOI 10.1016/0925-6164(93)90003-2; Nio M, 2006, J PEDIATR SURG, V41, P1973, DOI 10.1016/j.jpedsrug.2006.08.019; Ohi R, 1998, PEDIAT SURG, P1465; Ramonet M., 2006, HEALTH; Takakura M, 2012, PUBLIC HLTH, V39, P41; Yang MC, 2010, PEDIATR INT, V52, P569, DOI 10.1111/j.1442-200X.2009.03014.x	29	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	APR	2015	166	4					897	U431		10.1016/j.jpeds.2014.12.063		7	Pediatrics	Pediatrics	CG6DL	WOS:000353385700025		
J	Nakano, Y; Fujisaki, H; Ishiguro, T; Manabe, T; Inoue, T; Park, YD; Nakamura, T; Hara, J				Nakano, Yoshiko; Fujisaki, Hiroyuki; Ishiguro, Tomoya; Manabe, Takao; Inoue, Takeshi; Park, Young-Dong; Nakamura, Tetsuro; Hara, Junichi			Isolated Diffuse Hemangiomatosis of the Spleen with Disseminated Intravascular Coagulation: Successful Treatment with Embolization and Splenectomy	JOURNAL OF PEDIATRICS			English	Editorial Material									[Nakano, Yoshiko; Fujisaki, Hiroyuki; Hara, Junichi] Osaka City Gen Hosp, Dept Pediat Hematol & Oncol, Osaka, Japan; [Ishiguro, Tomoya] Osaka City Gen Hosp, Dept Neurosurg, Osaka, Japan; [Manabe, Takao] Osaka City Gen Hosp, Dept Radiol, Osaka, Japan; [Inoue, Takeshi] Osaka City Gen Hosp, Dept Pathol, Osaka, Japan; [Park, Young-Dong] Osaka Red Cross Hosp, Dept Pediat, Osaka, Japan; [Nakamura, Tetsuro] Osaka City Gen Hosp, Dept Pediat Surg, Osaka, Japan	Nakano, Y (reprint author), Osaka City Gen Hosp, Dept Pediat Hematol & Oncol, Osaka, Japan.						D'Antonio Antonio, 2002, Adv Clin Path, V6, P119; Dufau JP, 1999, HISTOPATHOLOGY, V35, P337; Steininger H, 2004, PATHOL RES PRACT, V200, P479, DOI 10.1016/j.prp.2004.04.004	3	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	APR	2015	166	4					1093	U420		10.1016/j.jpeds.2014.12.033		2	Pediatrics	Pediatrics	CG6DL	WOS:000353385700061		
J	Shimizu, Y; Nakazato, M; Sato, S; Koyamatsu, J; Yamanashi, H; Nagayoshi, M; Kadota, K; Hayashida, N; Yamasaki, H; Kusano, Y; Takamura, N; Aoyagi, K; Maeda, T				Shimizu, Yuji; Nakazato, Mio; Sato, Shimpei; Koyamatsu, Jun; Yamanashi, Hirotomo; Nagayoshi, Mako; Kadota, Koichiro; Hayashida, Naomi; Yamasaki, Hironori; Kusano, Yosuke; Takamura, Noboru; Aoyagi, Kiyoshi; Maeda, Takahiro			Association between hemoglobin A1c and carotid atherosclerosis in rural community-dwelling elderly Japanese men	Journal of Physiological Anthropology			English	Article							INTIMA-MEDIA THICKNESS; CHRONIC KIDNEY-DISEASE; HDL-CHOLESTEROL RATIO; DIABETES REGISTER NDR; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; NAGASAKI ISLANDS; ENDOTHELIAL DYSFUNCTION; GLYCATED HEMOGLOBIN; GLYCEMIC CONTROL	Background: Recent studies have reported an association between both higher and lower levels of hemoglobin A1c (HbA1c) and higher mortality of diabetes patients. Like diabetes, carotid atherosclerosis is a well known lifestyle-related disease. However, no studies have yet reported an association between HbA1c levels and carotid atherosclerosis. Methods: We conducted a cross-sectional study of 1,150 Japanese elderly men aged >= 60 years who were undergoing general health checkups. Carotid atherosclerosis was defined as a carotid intima-media thickness (CIMT) >= 1.1 mm. Since body mass index (BMI) is regarded as a cardiovascular risk factor that exerts a strong influence on both HbA1c levels and carotid atherosclerosis, we performed a stratified analysis of this risk based on BMI. Results: Using the intermediate HbA1c quintile as a reference group, the groups in the lowest HbA1c quintiles showed a significantly higher risk of carotid atherosclerosis in patients with low BMI (<= 23 kg/m(2)) vs. no increased risk in those with high BMI (>23 kg/m(2)). The association of HbA1c with carotid atherosclerosis became slightly stronger when these analyses were limited to subjects who were not taking glucose-lowering medications or medications for hyperlipidemia and cardiovascular disease. After adjusting for classical cardiovascular risk factors, adjusted odds ratios (ORs) for carotid atherosclerosis were 1.36 (0.84 to 2.20) for total subjects, 2.29 (1.12 to 4.66) for low-BMI groups, and 0.68 (0.33 to 1.41) for high-BMI groups. Conclusions: Lower HbA1c level is a significant risk factor for carotid atherosclerosis in rural community-dwelling elderly Japanese men with low, but not high BMI, particularly in those not taking glucose-lowering medication.	[Shimizu, Yuji; Sato, Shimpei; Nagayoshi, Mako; Kadota, Koichiro; Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Med, Nagasaki 852, Japan; [Nakazato, Mio; Koyamatsu, Jun; Yamanashi, Hirotomo; Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Isl & Community Med, Nagasaki 852, Japan; [Hayashida, Naomi; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Yamasaki, Hironori] Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki 852, Japan; [Kusano, Yosuke] Nagasaki Natl Hosp, Dept Internal Med, Nagasaki, Japan; [Aoyagi, Kiyoshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Publ Hlth, Nagasaki 852, Japan	Shimizu, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Med, Nagasaki 852, Japan.	simizicyuu@yahoo.co.jp			Japan Society for the Promotion of Science [22370090]	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 22370090).	Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Kitamura A, 2004, STROKE, V35, P2788, DOI 10.1161/01.STR.0000147723.52033.9e; Eeg-Olofsson K, 2010, J INTERN MED, V268, P471, DOI 10.1111/j.1365-2796.2010.02265.x; Mannami T, 1997, STROKE, V28, P518; Kiechl S, 1998, STROKE, V29, P900; KAWAMORI R, 1992, DIABETES CARE, V15, P1290, DOI 10.2337/diacare.15.10.1290; Eeg-Olofsson K, 2010, DIABETES CARE, V33, P1640, DOI 10.2337/dc10-0398; Gimenez M, 2011, DIABETES CARE, V34, P198, DOI 10.2337/dc10-1371; Huang ES, 2001, AM J MED, V111, P633, DOI 10.1016/S0002-9343(01)00978-0; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Wang JL, 2012, ARTERIOSCL THROM VAS, V32, P712, DOI 10.1161/ATVBAHA.111.227389; Myint PK, 2007, STROKE, V38, P271, DOI 10.1161/01.STR.0000254549.75763.5f; Shimizu Y, 2013, ATHEROSCLEROSIS, V228, P491, DOI 10.1016/j.atherosclerosis.2013.03.021; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Barr ELM, 2009, DIABETOLOGIA, V52, P415, DOI 10.1007/s00125-008-1246-y; Yanase T, 2006, AM J HYPERTENS, V19, P1206, DOI 10.1016/j.amjhyper.2006.05.010; Moen MF, 2009, CLIN J AM SOC NEPHRO, V4, P1121, DOI 10.2215/CJN.00800209; Barba C, 2004, LANCET, V363, P157; Hara T, 2006, CLIN CHEM LAB MED, V44, P824, DOI 10.1515/CCLM.2006.149; Imai Enyu, 2008, Nihon Rinsho, V66, P1725; SCHNEDL WJ, 1995, AM J CLIN PATHOL, V104, P444; Shimizu Y, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-19; Shimizu Yuji, 2013, Acta Medica Nagasakiensia, V58, P85	24	1	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1880-6805			J PHYSIOL ANTHROPOL	J. Physiol. Anthropol.	APR 1	2015	34								16	10.1186/s40101-015-0054-6		8	Physiology	Physiology	CH0CR	WOS:000353687100001		
J	Goto, T; Shiraishi, J; Bungo, T; Tsudzuki, M				Goto, Tatsuhiko; Shiraishi, Jun-ichi; Bungo, Takashi; Tsudzuki, Masaoki			Characteristics of Egg-related Traits in the Onagadori (Japanese Extremely Long Tail) Breed of Chickens	JOURNAL OF POULTRY SCIENCE			English	Article						egg; native Japanese chickens; Onagadori; principal component analysis; repeatability	F-2 INTERCROSS CHICKENS; LOCI AFFECTING GROWTH; BODY-WEIGHT; BROILER-CHICKENS; CARCASS TRAITS; OH-SHAMO; HATCHABILITY; IDENTIFICATION; REPEATABILITY; INHERITANCE	The Tosa-no-Onagadori (briefly Onagadori) is one of the native Japanese chickens that is characterized by extremely long tail feathers in males, and thus designated as a "Special National Natural Treasure" of Japan. We investigated the timing of sexual maturity of the Onagadori and White Leghorn hens and the quality of the first 10 eggs laid by these young hens to obtain basic information for reproducing the Onagadori efficiently and also to assess their usefulness as research material for quantitative trait loci (QTL) analysis of egg-related traits. Onagadori and White Leghorn hens reached sexual maturity at around 237 and 192 days of age, respectively. The repeatability, a genetic parameter, of 22 egg quality traits including weight, size, and color of the eggshell, albumen, and yolk was estimated to be 0.14-0.61 and 0.15-0.83 for the Onagadori and White Leghorn, respectively, which indicated the stability of Onagadori eggs as well as the White Leghorn and further suggested that young Onagadori hens lay eggs with suitable quality to produce more offspring from their earliest egg laying stage. Principal component analysis with the 22 egg quality traits revealed five principal components explaining 79.70% of the total phenotypic variance. One-way ANOVA revealed differences between the two breeds in PC2 (heights of the albumen and yolk, size of the whole egg, and weights of the whole egg and albumen), PC3 (eggshell color), and PC4 (weight, thickness, and strength of the eggshell), which means that besides cultural assets the Onagadori is also valuable for QTL analysis of egg-related traits, for which phenotypic differences are quite useful for detecting corresponding loci.	[Goto, Tatsuhiko; Bungo, Takashi; Tsudzuki, Masaoki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398528, Japan; [Goto, Tatsuhiko; Shiraishi, Jun-ichi; Bungo, Takashi; Tsudzuki, Masaoki] Hiroshima Univ, Japanese Avian Bioresource Project Res Ctr, Higashihiroshima, Hiroshima 7398528, Japan; [Shiraishi, Jun-ichi] Nippon Vet & Life Sci Univ, Dept Anim Sci, Div Anim Biochem, Musashino, Tokyo 1808602, Japan	Tsudzuki, M (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Lab Anim Breeding & Genet, Higashihiroshima, Hiroshima 7398528, Japan.	tsudzuki@hiroshima-u.ac.jp					Uemoto Y, 2011, POULTRY SCI, V90, P35, DOI 10.3382/ps.2010-01119; Yoshida M, 2013, J POULT SCI, V50, P198, DOI 10.2141/jpsa.0120189; COLE RK, 1968, AVIAN DIS, V12, P9, DOI 10.2307/1588081; LESSELLS CM, 1987, AUK, V104, P116; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Uemoto Y, 2009, POULTRY SCI, V88, P477, DOI 10.3382/ps.2008-00296; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Le Rouzic A, 2008, GENETICS, V179, P1591, DOI 10.1534/genetics.108.089300; Narushin VG, 2002, WORLD POULTRY SCI J, V58, P297, DOI 10.1079/WPS20020023; Liao B, 2013, POULTRY SCI, V92, P2236, DOI 10.3382/ps.2012-02728; BRILES WE, 1982, IMMUNOGENETICS, V15, P449, DOI 10.1007/BF00345904; Cucco M, 2006, CAN J ZOOL, V84, P72, DOI 10.1139/Z05-179; Fulton JE, 2004, POULTRY SCI, V83, P658; Goto T, 2014, J POULT SCI, V51, P375, DOI 10.2141/jpsa.0140030; Goto T, 2014, J POULT SCI, V51, P118, DOI 10.2141/jpsa.0130100; Goto T, 2011, ANIM GENET, V42, P634, DOI 10.1111/j.1365-2052.2011.02190.x; Hocking PM, 2003, BRIT POULTRY SCI, V44, P365, DOI [NO_DOI, 10.1080/00071660301988]; Ishikawa A, 2004, GENES GENET SYST, V79, P27, DOI 10.1266/ggs.79.27; Mackay T. F. C., 1996, INTRO QUANTITATIVE G; Ohara K., 2013, International Journal of Poultry Science, V12, P517; Oka T, 2014, J POULT SCI, V51, P262, DOI 10.2141/jpsa.0130199; Osman SAM, 2006, ASIAN AUSTRAL J ANIM, V19, P1369; Rikimaru K, 2011, ASIAN AUSTRAL J ANIM, V24, P1329, DOI 10.5713/ajas.2011.11004; Roberts Juliet R., 2004, Journal of Poultry Science, V41, P161, DOI 10.2141/jpsa.41.161; Tadano R, 2009, ANIM GENET, V40, P989, DOI 10.1111/j.1365-2052.2009.01955.x; Tatsuda Ken, 2001, Journal of Poultry Science, V38, P266; Tatsuda K, 2001, BRIT POULTRY SCI, V42, P333, DOI 10.1080/00071660120055296; The Cultural Properties Protection Committee of Japan, 1953, JAPANESE OFFICIAL G, V7937, P435; Tsudzuki M, 2007, CYTOGENET GENOME RES, V117, P288, DOI 10.1159/000103190; Tsudzuki M., 2003, RELATIONSHIP INDIGEN, P91; Udeh I, 2010, INT J POULTRY SCI, V9, P675; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-5; Wolc A, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-47; Wolc A, 2010, POULTRY SCI, V89, P2334, DOI 10.3382/ps.2009-00614	34	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	APR	2015	52	2					81	87		10.2141/jpsa.0140109		7	Agriculture, Dairy & Animal Science	Agriculture	CG9AY	WOS:000353608000001		
J	Oka, T; Ito, N; Sekiya, M; Kinoshita, K; Kawakami, SI; Bungo, T; Tsudzuki, M				Oka, Takao; Ito, Naoya; Sekiya, Masao; Kinoshita, Keiji; Kawakami, Shin-Ichi; Bungo, Takashi; Tsudzuki, Masaoki			Genetic Differentiation among Populations of the Kurokashiwa Breed of Indigenous Japanese Chickens Assessed by Microsatellite DNA Polymorphisms	JOURNAL OF POULTRY SCIENCE			English	Article						conservation genetics; genetic differentiation; genetic diversity; Kurokashiwa breed; microsatellite; native Japanese chickens	PHYLOGENETIC TREES; DIVERSITY	The Kurokashiwa breed of native Japanese chickens is primarily reared in Shimane and Yamaguchi Prefectures, Japan. To reveal the genetic diversity and differentiation among the Kurokashiwa populations in both prefectures, 29 microsatellites were analyzed. To prepare the microsatellites, 54, 55, and 24 blood samples were collected from the Kurokashiwa populations of five fancy breeders in Shimane Prefecture, three fancy breeders in Yamaguchi Prefecture, and the Livestock Technology Research Department, Yamaguchi Prefectural Agriculture and Forestry General Technology Center (LTRDY), respectively. The corrected number of alleles (allelic richness: AR) was considerably low (1.63-2.48) through all Shimane and Yamaguchi populations. However, inbreeding coefficient (F-IS) values were not significant in the entire Shimane and Yamaguchi ornamental populations as well as the LTRDY population. In addition, there was no statistically significant difference in expected heterozygosity (H-E) through all populations in Shimane and Yamaguchi Prefectures, although the H-E varied from 0.237 to 0.445 depending on populations. The topology of the phylogenetic tree, pairwise F-ST values, and STRUCTURE analysis indicated that Kurokashiwa populations were genetically separated between Shimane and Yamaguchi Prefectures. On the other hand, there was no genetic differentiation among ornamental populations within each prefecture, which seemed to have resulted from adequate random matings by exchanging individuals among fancy breeders within each conservation community, along with a proper random mating within LTRDY. The present study proposes a conservation strategy suggesting that the Kurokashiwa populations of Shimane and Yamaguchi Prefectures should be maintained separately with continuous exchange of birds within each conservation community to preserve genetic diversity. Also, the LTRDY population should be independently kept by avoiding matings with ornamental bird populations because it is a well established closed colony with a uniform genetic constitution.	[Oka, Takao; Kawakami, Shin-Ichi; Bungo, Takashi; Tsudzuki, Masaoki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398528, Japan; [Oka, Takao; Kawakami, Shin-Ichi; Bungo, Takashi; Tsudzuki, Masaoki] Hiroshima Univ, Japanese Avian Bioresource Project Res Ctr, Higashihiroshima, Hiroshima 7398528, Japan; [Ito, Naoya; Sekiya, Masao] Yamaguchi Prefectural Agr & Forestry Gen Technol, Livestock Technol Res Dept, Mine, Yamaguchi 7592221, Japan; [Kinoshita, Keiji] Nagoya Univ, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan	Tsudzuki, M (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398528, Japan.	tsudzulci@hiroshima-u.ac.jp					Pritchard JK, 2000, GENETICS, V155, P945; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Goudet J, 1995, J HERED, V86, P485; FAO, 2004, GUID DEV NAT MAN FAR; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Oana H, 1951, HIST JAPANESE NATIVE; Oka Takao, 2011, Journal of Agricultural Science Tokyo Nogyo Daigaku, V56, P44; Oka Takao, 2010, Journal of Agricultural Science Tokyo Nogyo Daigaku, V55, P211; Oka Takao, 2011, Journal of Agricultural Science Tokyo Nogyo Daigaku, V55, P275; Oka Takao, 2011, Journal of Agricultural Science Tokyo Nogyo Daigaku, V56, P199; Osman SAM, 2006, ASIAN AUSTRAL J ANIM, V19, P1369; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sambrook J, 2001, MOL CLONING LAB MANU; Tadano R, 2009, ANIM GENET, V40, P989, DOI 10.1111/j.1365-2052.2009.01955.x; Tsudzuki M., 2003, RELATIONSHIP INDIGEN, P91	17	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	APR	2015	52	2					88	93		10.2141/jpsa.0140063		6	Agriculture, Dairy & Animal Science	Agriculture	CG9AY	WOS:000353608000002		
J	Nanto, F; Ito, C; Kikusato, M; Toyomizu, M				Nanto, Fumika; Ito, Chiaki; Kikusato, Motoi; Toyomizu, Masaaki			Effects of Whole-Grain Paddy Rice on Growth Performance, Oxidative Stress and Morphological Alterations of the Intestine in Broiler Chickens Exposed to Acute and Chronic Heat Stress	JOURNAL OF POULTRY SCIENCE			English	Article						broiler chicken; heat stress; intestinal morphology; oxidative stress; whole-grain paddy rice	SKELETAL-MUSCLE; MODIFIED PROTEINS; INJURY; DAMAGE; HULLS; FEED	We have previously shown that, under thermoneutral conditions, the growth performance of chicks fed a rice-based diet containing 6% soybean oil [metabolizable energy (ME): 2,800 kcal/kg] for 28 days was comparable to that obtained with a corn-based diet containing 6% soybean oil (ME: 3,100 kcal/kg). However, there is no information available concerning how such diets compare with respect to growth performance under heat stress conditions. The present study was therefore conducted to clarify differences in dietary effectiveness between corn-based and whole-grain paddy rice-based diets [formulated to be equivalent in terms of fat (6%), but not iso-caloric] under the two conditions of acute and chronic heat stress (Experiment 1 and Experiment 2, respectively). In Experiment 1, the body weight gain of a corn- and rice-fed group of chickens exposed to acute heat (33 degrees C-12 h) were significantly decreased compared with that of a corn-fed control group (24 degrees C), with similar results obtained for the two heat-treated groups. Malondialdehyde (MDA) levels in the M. pectoralis superficialis were significantly increased in corn-fed birds exposed to acute heat stress, but not in the rice-fed group (33 degrees C-12 h). In Experiment 2, body weight gains in the corn- and rice-fed groups exposed to chronic heat (33 degrees C-6 d) were significantly decreased, and to a similar extent, compared with the corn-fed control group (24 degrees C). Muscle MDA levels in the corn- and rice-fed groups were similarly increased by the chronic heat exposure compared with the control group. These results suggest that, in response to acute heat stress (but not chronic heat stress) conditions, the feeding of whole-grain paddy rice diet to chickens may attenuate skeletal muscle oxidative damage compared with that in corn-fed chickens. The possible involvement of intestinal morphology (such as the villus height: crypt depth ratio observed here) on growth performance is also discussed.	[Nanto, Fumika; Ito, Chiaki; Kikusato, Motoi; Toyomizu, Masaaki] Tohoku Univ, Grad Sch Agr, Appl Life Sci, Anim Nutr,Aoba Ku, Sendai, Miyagi 9818555, Japan	Toyomizu, M (reprint author), Tohoku Univ, Grad Sch Agr, Div Life Sci, Anim Nutr,Aoba Ku, 1-1 Tsustsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	toyomizu@bios.tohoku.ac.jp			Ministry of Agriculture, Forestry and Fisheries; Japan Society for the Promotion of Science (JSPS) [13J06451]; Japan Poultry Science Association	This study was supported by a Grant-in-Aid for "Research for Production of Valuable Livestock by Feeding Self-Sufficient Forage Crops" from the Ministry of Agriculture, Forestry and Fisheries, and a Research Fellowship from the Japan Society for the Promotion of Science (JSPS) for Young Scientists (No. 13J06451; F.N.). Acknowledgment is also made to the Japan Poultry Science Association for providing a travel grant to F.N. to allow presentation of some of the findings at the 24th WPC in Salvador, Brazil.	AKIBA Y, 1978, J NUTR, V108, P739; Pluske JR, 1996, ANIM SCI, V62, P131; HAMPSON DJ, 1986, RES VET SCI, V40, P32; Engberg RM, 1996, POULTRY SCI, V75, P1003; Mujahid A, 2005, POULTRY SCI, V84, P307; Xu ZR, 2003, POULTRY SCI, V82, P1030; Hetland H, 2003, BRIT POULTRY SCI, V44, P275, DOI [10.1080/0007166031000124595, 10.1080/00071660301954]; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Cabrini L, 2001, J AGR FOOD CHEM, V49, P6026, DOI 10.1021/jf010837t; YAHAV S, 1995, J THERM BIOL, V20, P245, DOI 10.1016/0306-4565(94)00046-L; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Mujahid Ahmad, 2007, Journal of Poultry Science, V44, P439, DOI 10.2141/jpsa.44.439; Jimenez-Moreno E, 2011, ANIM FEED SCI TECH, V168, P100, DOI 10.1016/j.anifeedsci.2011.03.013; Singh PK, 2012, RADIAT RES, V177, P133, DOI 10.1667/RR2627.1; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Azad MAK, 2010, COMP BIOCHEM PHYS A, V155, P401, DOI 10.1016/j.cbpa.2009.12.011; Azad MAK, 2010, COMP BIOCHEM PHYS A, V157, P266, DOI 10.1016/j.cbpa.2010.07.011; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Fan YK, 1997, POULTRY SCI, V76, P1738; BOTTJE WG, 1985, POULTRY SCI, V64, P1285; CABEL MC, 1988, POULTRY SCI, V67, P1725; Daghir NJ, 1995, POULTRY PRODUCTION H, P103; Honda K, 2011, J POULT SCI, V48, P85, DOI 10.2141/jpsa.010097; MIYAZAWA T, 1991, J AM OIL CHEM SOC, V68, P39, DOI 10.1007/BF02660307; Mujahid A, 2009, AM J PHYSIOL-REG I, V297, P690; Nanto F, 2012, J POULT SCI, V49, P291, DOI 10.2141/jpsa.0120049; Obembe AO, 2011, ISRN GASTROENTEROLOG, V2011; Quinteiro WM, 2010, POULTRY SCI, V89, P1905, DOI 10.3382/ps.2010-00812; Shermer W.D, 1985, FEEDSTUFFS, V4, P19; Sittiya J, 2011, J POULT SCI, V48, P259, DOI 10.2141/jpsa.011033; Standard Tables of Feed Composition in Japan, 2009, STAND TABL FEED COMP	31	0	0	JAPAN POULTRY SCIENCE ASSOC	TSUKUBA	C/O NATL INST LIVESTOCK & GLASSLAND SCIENCE, 2 IKENODAI, TSUKUBA, IBARAKI 305-0901, JAPAN	1346-7395			J POULT SCI	J. Poult. Sci.	APR	2015	52	2					109	118		10.2141/jpsa.0140009		10	Agriculture, Dairy & Animal Science	Agriculture	CG9AY	WOS:000353608000005		
J	Kang, SS; Koyama, K; Huang, WP; Yang, YH; Yanagawa, Y; Takahashi, Y; Nagano, M				Kang, Sung-Sik; Koyama, Keisuke; Huang, Weiping; Yang, Yinghua; Yanagawa, Yojiro; Takahashi, Yoshiyuki; Nagano, Masashi			Addition of D-penicillamine, hypotaurine, and epinephrine (PHE) mixture to IVF medium maintains motility and longevity of bovine sperm and enhances stable production of blastocysts in vitro	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						computer-assisted sperm analysis (CASA); In vitro fertilization (IVF); Oocyte; PHE; Theophylline	CATECHOLAMINE AGONISTS; NUCLEAR MATURATION; SORTED SPERM; HEPARIN; OOCYTES; FERTILIZATION; SPERMATOZOA; CAPACITATION; THEOPHYLLINE; CULTURE	The present study aimed to establish an efficient system for bovine embryo production by in vitro fertilization (IVF) that can achieve stable normal fertilization and blastocyst developmental rates in any bull without optimization of the sperm concentration in IVF medium. We examined the effects of a PHE mixture (20 mu M D-penicillamine, 10 mu M hypotaurine and 1 mu M epinephrine), theophylline (2.5 mM), and sperm concentration (1, 2 or 5 x 10(6) cells/ml) on fertilization and blastocyst developmental rates. High cleavage rates (78.3 to 92.4%) and blastocyst developmental rates (31.9 to 62.0%) at day 7 were obtained in the presence of PHE and theophylline in IVF medium with a sperm concentration of 2 x 10(6) cells/ml using sperm from 9 bulls. In addition, the synergistic effect of PHE and theophylline on normal fertilization (2 pronuclei) was clarified at 12 h after IVF with a sperm concentration of 1 x 10(6) cells/ml. Moreover, high linearity, high flagellar beat cross frequency, and low amplitude of lateral head of motile sperm were found by computer-assisted spell!' analysis. In conclusion, the combination of the PHE mixture and theophylline synergistically accelerates sperm motility and sperm penetration of bovine oocytes. Theophylline activates sperm motility with increasing intracellular cAMP. However, PHE prevents an excessive increase of cAMP and maintains speiln motility without hyperactivation. When the combination of PHE and theophylline is added to IVF medium at a sperm concentration of 2 x 10(6) cells/ml, we can achieve stable normal fertilization and blastocyst development in any bull.	[Kang, Sung-Sik; Huang, Weiping; Yang, Yinghua; Yanagawa, Yojiro; Takahashi, Yoshiyuki; Nagano, Masashi] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Theriogenol, Sapporo, Hokkaido 0600818, Japan; [Koyama, Keisuke] Hokkaido Res Org, Konsen Agr Expt Stn, Dairy Cattle Grp, Nakashibetsu, Hokkaido 0861135, Japan; [Takahashi, Yoshiyuki] Genet Hokkaido Assoc, Sapporo, Hokkaido 0600040, Japan	Nagano, M (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Theriogenol, Sapporo, Hokkaido 0600818, Japan.	mnaga@vetmed.hokudai.ac.jp			Japan Society for the Promotion of Science [25450441]	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to M. Nagano (No. 25450441). We thank the Genetics Hokkaido Association for the donation of frozen bull sperm.	Nagano M, 2013, JPN J VET RES, V61, P149; Lu KH, 2004, THERIOGENOLOGY, V62, P819, DOI 10.1016/j.theriogenology.2003.12.029; Calogero AE, 1998, HUM REPROD, V13, P911, DOI 10.1093/humrep/13.4.911; Parrish JJ, 2014, THERIOGENOLOGY, V81, P67, DOI 10.1016/j.theriogenology.2013.08.005; Koyama K, 2014, J REPROD DEVELOP, V60, P136, DOI 10.1262/jrd.2013-115; HOSKINS DD, 1975, BIOL REPROD, V13, P168, DOI 10.1095/biolreprod13.2.168; Rath D, 2009, THERIOGENOLOGY, V71, P22, DOI 10.1016/j.theriogenology.2008.09.027; BOATMAN DE, 1990, J ANDROL, V11, P66; Chamberland A, 2001, THERIOGENOLOGY, V55, P823, DOI 10.1016/S0093-691X(01)00446-0; Hasler JF, 2013, REPROD FERT DEVELOP, V25, P259; Huang WP, 2014, J REPROD DEVELOP, V60, P9, DOI 10.1262/jrd.2013-082; Kang S-S, 2014, ZYGOTE, V1-4, P1; Kawakami E, 1999, ANIM REPROD SCI, V54, P251, DOI 10.1016/S0378-4320(98)00158-4; LOUGHLIN KR, 1992, ARCH ANDROLOGY, V28, P99; MILLER GF, 1994, THERIOGENOLOGY, V41, P689, DOI 10.1016/0093-691X(94)90178-L; NIWA K, 1988, THERIOGENOLOGY, V30, P733, DOI 10.1016/0093-691X(88)90308-1; PARRISH JJ, 1989, BIOL REPROD, V41, P683, DOI 10.1095/biolreprod41.4.683; Pavlok A, 2000, THERIOGENOLOGY, V53, P1135, DOI 10.1016/S0093-691X(00)00258-2; Person CN, 2007, AAES RES SERIES, V553, P47; Schuh SM, 2007, BIOL REPROD, V77, P960, DOI 10.1095/biolreprod.107.062562; Schuh SM, 2006, BIOL REPROD, V74, P492, DOI 10.1095/biolreprod.105.047837; Selokar NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090755; SUSKO-PARRISH J L, 1990, Theriogenology, V33, P333, DOI 10.1016/0093-691X(90)90757-K; TAKAHASHI Y, 1993, ANIM REPROD SCI, V34, P1, DOI 10.1016/0378-4320(93)90045-S; Takahashi Y, 1998, J VET MED SCI, V60, P433, DOI 10.1292/jvms.60.433; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A	26	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	APR	2015	61	2					99	105				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CG9BP	WOS:000353609700003		
J	Shibutani, M; Lee, J; Miyano, T; Miyake, M				Shibutani, Mihiro; Lee, Jibak; Miyano, Takashi; Miyake, Masashi			Demands for carbohydrates as major energy substrates depend on the preimplantation developmental stage in pig embryos: Differential use of fructose by parthenogenetic diploids before and after the 4-cell stage in the pig	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Fructose; Parthenogenetic diploids; Pig; Preimplantation development	CHEMICALLY-DEFINED MEDIUM; IN-VITRO DEVELOPMENT; FREE CULTURE-MEDIUM; PORCINE-EMBRYOS; BLASTOCYST STAGE; GLUCOSE; INVITRO; HEXOSES; REPLACEMENT; OSMOLARITY	The embryo culture technique has been improving, but the detailed demands for energy substrates such as glucose, fructose, pyruvate and lactate of preimplantation embryos are still unclear. In the present study, the demands of pig preimplantation embryos at each different developmental stage were investigated by use of parthenogenetic diploids as a model of pig preimplantation embryos. Pig parthenogenetic diploids showed different use of glucose and fructose before and after the 4-cell stage. Although glucose supported the development of pig embryos throughout the preimplantation stages and even maintained the expansion and hatching of blastocysts, it suppressed development to the blastocyst stage when glucose coexisted with pyruvate and lactate from 4 h after activation, but not after 48 h (early 4-cell stage). Since ketohexolcinase that metabolizes fructose was not expressed in 2-cell and 4-cell diploids, a medium that included only fructose as a major energy substrate did not support early cleavage of pig diploids beyond the 4-cell stage, and almost no diploids developed to the morula stage just as in a medium without carbohydrates. These results may explain the different suppressive effects on pig preimplantation development between glucose and fructose when pyruvate and lactate were present in a medium. In addition, 4-cell diploids that had been cultured in a medium with pyruvate and lactate developed to the expanded blastocyst stage without any carbohydrates as a major energy substrate. These results show that the demands for carbohydrates are different depending on the developmental stage in pig preimplantation embryos.	[Shibutani, Mihiro; Lee, Jibak; Miyano, Takashi] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Miyake, Masashi] Kobe Univ, Integrated Res Ctr, Kobe, Hyogo 6500047, Japan	Miyake, M (reprint author), Kobe Univ, Integrated Res Ctr, Kobe, Hyogo 6500047, Japan.	miyake@kobe-u.ac.jp			JSPS [25292160]	This study was supported by JSPS Grant-in-Aid for Scientific Research (B), Grant Number 25292160.	Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; FLOOD MR, 1988, J REPROD FERTIL, V84, P7; CHATOT CL, 1989, J REPROD FERTIL, V86, P679; KureBayashi S, 1996, THERIOGENOLOGY, V46, P1027, DOI 10.1016/S0093-691X(96)00267-1; Mito T, 2012, REPROD FERT DEVELOP, V24, P443, DOI 10.1071/RD11197; KIM JH, 1993, THERIOGENOLOGY, V39, P875, DOI 10.1016/0093-691X(93)90425-5; JARRELL VL, 1991, BIOL REPROD, V44, P62, DOI 10.1095/biolreprod44.1.62; BECKMANN LS, 1993, THERIOGENOLOGY, V39, P611, DOI 10.1016/0093-691X(93)90248-4; Bhuiyan MMU, 2007, ZYGOTE, V15, P189, DOI 10.1017/S0967199407004236; Karja NWK, 2004, J REPROD DEVELOP, V50, P587, DOI 10.1262/jrd.50.587; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Kwun J, 2003, MOL REPROD DEV, V65, P167, DOI 10.1002/mrd.10309; Ludwig TE, 2001, BIOL REPROD, V64, P1366, DOI 10.1095/biolreprod64.5.1366; MIYANO T, 1994, THERIOGENOLOGY, V41, P1299, DOI 10.1016/0093-691X(94)90488-5; Nguyen VT, 2003, THERIOGENOLOGY, V59, P719, DOI 10.1016/S0093-691X(02)01085-3; Park Y, 2005, ZYGOTE, V13, P269, DOI 10.1017/S0967199405003369; Petters R M, 1993, J Reprod Fertil Suppl, V48, P61; Wongsrikeao P, 2006, THERIOGENOLOGY, V65, P332, DOI 10.1016/j.theriogenology.2005.03.027; WRIGHT RW, 1977, J ANIM SCI, V44, P854	19	1	1	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	APR	2015	61	2					106	115				10	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CG9BP	WOS:000353609700004		
J	Ogata, K; Sasaki, A; Kato, Y; Takeda, A; Wakabayashi, M; Sarentonglaga, B; Yamaguchi, M; Hara, A; Fukumori, R; Nagao, Y				Ogata, Kazuko; Sasaki, Aiko; Kato, Yuka; Takeda, Arisa; Wakabayashi, Mikio; Sarentonglaga, Borjigin; Yamaguchi, Mio; Hara, Asuka; Fukumori, Rika; Nagao, Yoshikazu			Glutathione supplementation to semen extender improves the quality of frozen-thawed canine spermatozoa for transcervical insemination	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						Canine sperm; Cryopreservation; Glutathione; Transcervical insemination	REDUCED GLUTATHIONE; ANTIOXIDANT SUPPLEMENTATION; SPERM CAPACITATION; ACROSOME REACTION; BOVINE SPERM; BOAR SPERM; DOG SEMEN; CRYOPRESERVATION; FERTILITY; PRESERVATION	The present study was conducted to evaluate whether supplementation of semen extender with glutathione (GSH) can maintain the quality of frozen-thawed canine spermatozoa. Eighteen ejaculates were obtained from 5 dogs and placed in extender (20% egg yolk, Tris, citric acid, lactose, raffinose, antibiotics and 6.5% glycerol) containing 0 (control), 2.5, 5, 7.5 or 10 mM GSH. The samples were cooled to 4 C and then frozen in liquid nitrogen vapor. Motility parameters of the sperm were evaluated at 0, 1, 2, 3, 4, 12 and 24 h after thawing. Sperm motility was higher in the 5 mM GSH group than in the control or 2.5 and 10 mM GSH groups; this effect was observed at 1 to 24 h after thawing (P < 0.05). The 5 mM GSH group had a higher speini viability index at 12 and 24 h after thawing compared with the other groups (P < 0.05). Acrosome integrity, evaluated at 4 h after thawing, was greater in two of the GSH-treated groups (5 and 10 mM) compared with the control. Lipid peroxidation (LP) levels immediately after thawing were lower in the 5 and 10 mM GSH groups compared with the control, while those at 12 h after thawing did not differ significantly. Frozen-thawed semen in the 5 mM GSH group was used for transcervical insemination of 4 bitches, resulting in delivery of 5 puppies from 2 bitches. These results indicate that supplementation of semen extender with 5 mM GSH was effective in improving motility, longevity and acrosomal integrity and inhibiting LP levels in post-thaw canine spermatozoa, without any adverse impacts on full-term development after transcervical insemination.	[Ogata, Kazuko; Yamaguchi, Mio; Hara, Asuka; Nagao, Yoshikazu] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Anim Prod Sci, Fuchu, Tokyo 1838509, Japan; [Ogata, Kazuko; Sasaki, Aiko; Kato, Yuka; Takeda, Arisa; Sarentonglaga, Borjigin; Yamaguchi, Mio; Hara, Asuka; Fukumori, Rika; Nagao, Yoshikazu] Utsunomiya Univ, Fac Agr, Univ Farm, Utsunomiya, Tochigi 3214415, Japan; [Sasaki, Aiko; Wakabayashi, Mikio] East Japan Guide Dog Assoc, Utsunomiya, Tochigi 3210342, Japan; [Sarentonglaga, Borjigin] Utsunomiya Univ, Collaborat Ctr Res & Dev, Utsunomiya, Tochigi 3210904, Japan	Nagao, Y (reprint author), Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, Dept Anim Prod Sci, Fuchu, Tokyo 1838509, Japan.	ynagao@cc.utsunomiya-u.ac.jp			VBL, Utsunomiya University (Tochigi, Japan)	This work was supported by the grant of Young Scholarship, VBL, Utsunomiya University (Tochigi, Japan). We thank Dr Hiroshi Takano (Takano Veterinary Hospital, Tochigi, Japan) for performance of TCI and helpful discussion and Kenji Nishihara, Naoko Sugane, Seigo Suzuki, Yuki Nishihara, Yoshinori Yanagisawa and Ryota Fukui (East Japan Guide Dog Association, Tochigi, Japan) for their technical assistance in semen collection and TCI.	Abe Y, 2011, BIOL REPROD, V84, P363, DOI 10.1095/biolreprod.110.087312; ANDERSEN K, 1975, Zuchthygiene (Berlin), V10, P1; Pena FJ, 2003, ANIM REPROD SCI, V78, P85, DOI 10.1016/S0378-4320(03)00049-6; Michael A, 2007, THERIOGENOLOGY, V68, P204, DOI 10.1016/j.theriogenology.2007.04.053; Salamon S, 2000, ANIM REPROD SCI, V62, P77, DOI 10.1016/S0378-4320(00)00155-X; Rivlin J, 2004, BIOL REPROD, V70, P518, DOI 10.1095/biolreprod.103.020487; Aitken RJ, 2006, MOL CELL ENDOCRINOL, V250, P66, DOI 10.1016/j.mce.2005.12.026; Petrunkina AM, 2007, REPRODUCTION, V134, P3, DOI 10.1530/REP-07-0046; Gadea J, 2005, J ANDROL, V26, P396, DOI 10.2164/jandrol.04155; Nagao Y, 2010, ZYGOTE, V18, P315, DOI 10.1017/S0967199409990384; Silva SV, 2011, REPROD DOMEST ANIM, V46, P874, DOI 10.1111/j.1439-0531.2011.01758.x; Gadea J, 2004, THERIOGENOLOGY, V62, P690, DOI 10.1016/j/theriogenology.2003.11.013; Stradaioli G, 2007, THERIOGENOLOGY, V67, P1249, DOI 10.1016/j.theriogenology.2007.01.009; Rauen U, 2004, J INVEST MED, V52, P299, DOI 10.2310/6650.2004.00025; Gomez E, 1998, INT J ANDROL, V21, P81; Kanthaswamy S, 2009, J FORENSIC SCI, V54, P829, DOI 10.1111/j.1556-4029.2009.01080.x; Estrada E, 2014, ANDROLOGY-US, V2, P88, DOI 10.1111/j.2047-2927.2013.00144.x; Strzezek R, 2009, POL J VET SCI, V12, P55; McCarthy MJ, 2011, THERIOGENOLOGY, V76, P168, DOI 10.1016/j.theriogenology.2011.01.029; Gandini L, 2000, HUM REPROD, V15, P830, DOI 10.1093/humrep/15.4.830; Mellersh CS, 1997, GENOMICS, V46, P326, DOI 10.1006/geno.1997.5098; SOUTHARD JH, 1995, ANNU REV MED, V46, P235; Thomassen R, 2006, THERIOGENOLOGY, V66, P1645, DOI 10.1016/j.theriogenology.2006.01.022; Burruel V, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110981; Rijsselaere T, 2014, REPROD DOMEST ANIM, V49, P2, DOI 10.1111/rda.12299; Batista M, 2012, REPROD DOMEST ANIM, V47, P1049, DOI 10.1111/j.1439-0531.2012.02014.x; BOYD JS, 1993, J REP FER S, P101; Brouwers JFHM, 2003, FREE RADICAL BIO MED, V35, P1382, DOI 10.1016/j.freeradbiomed.2003.08.010; [Department of Reproductive Health and Research World Health Organization], 1999, WHO LAB MAN EX HUM S; Farstad W., 1984, REPROD DOMEST ANIM, V19, P211, DOI 10.1111/j.1439-0531.1984.tb00972.x; FRASER LR, 1995, MOL REPROD DEV, V40, P233, DOI 10.1002/mrd.1080400213; Fukui Y, 2004, J REPROD DEVELOP, V50, P147, DOI 10.1262/jrd.50.147; Hase M, 2000, J VET MED SCI, V62, P243, DOI 10.1292/jvms.62.243; Hewitt DA, 1998, ANIM REPROD SCI, V51, P321, DOI 10.1016/S0378-4320(98)00079-7; Ichikawa Y, 2001, J VET MED SCI, V63, P1209, DOI 10.1292/jvms.63.1209; Ishizuka Y, 2013, THERIOGENOLOGY, V80, P421, DOI 10.1016/j.theriogenology.2013.07.002; Lane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100832; Luvoni GC, 2005, THERIOGENOLOGY, V63, P41, DOI 10.1016/j.theriogenology.2004.03.004; Meyers SA, 2005, ANIM REPROD SCI, V89, P57, DOI 10.1016/j.anireprosci.2005.06.026; Monteiro JC, 2009, REPROD DOMEST ANIM, V44, P359, DOI 10.1111/j.1439-0531.2009.01434.x; Nothling JO, 2005, THERIOGENOLOGY, V63, P1469, DOI 10.1016/j.theriogenology.2004.07.012; Okano T, 2004, J VET MED SCI, V66, P1359, DOI 10.1292/jvms.66.1359; Sanocka Dorota, 2004, Reprod Biol Endocrinol, V2, P12, DOI 10.1186/1477-7827-2-12; Seager SWJ, 1969, AI DIGEST, V17, P6; Selles E, 2003, REPROD DOMEST ANIM, V38, P66, DOI 10.1046/j.1439-0531.2003.00406.x; Silva AR, 2002, VET J, V164, P244, DOI 10.1053/tvjl.2002.0704; Suwa Yoshinori, 2009, Reproductive Medicine and Biology, V8, P125, DOI 10.1007/s12522-009-0019-8; Takeuchi Y, 2009, ANIM GENET, V40, P217, DOI 10.1111/j.1365-2052.2008.01823.x; Tsutsui T, 1989, J Reprod Fertil Suppl, V39, P269; Zakosek Pipan M, 2014, BIOMED RES INT, V2014	50	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	APR	2015	61	2					116	122				7	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CG9BP	WOS:000353609700005		
J	Trisomboon, J; Li, CM; Suzuki, AK; Watanabe, G; Taya, K				Trisomboon, Jiratthiya; Li, ChunMei; Suzuki, Akira K.; Watanabe, Gen; Taya, Kazuyoshi			4-Nitro-3-phenylphenol has both androgenic and anti-androgenic-like effects in rats	JOURNAL OF REPRODUCTION AND DEVELOPMENT			English	Article						4-Nitro-3-phenylphenol; Gonadotropins; Leydig cell; Pituitary; Testosterone	DIESEL EXHAUST PARTICLES; TESTICULAR FUNCTION; IN-VITRO; ESTROGENIC ACTIVITIES; NITROPHENOLS; TESTOSTERONE; PITUITARY; 3-METHYL-4-NITROPHENOL; RECEPTOR; SPERMATOGENESIS	To investigate the effect of endocrine disruption of 4-nitro-3-phenylphenol (PNMPP) on immature male Wistar-Imamichi rats, the rat pituitary was exposed to PNMPP (10(-5)-10(-9) M) for 24 h with or without gonadotropin-releasing hormone (GnRH) in experiment I. In addition, the Leydig cells (10(-5)-10(-9) M) were exposed to PNMPP for 24 h with or without human chronic gonadotropin (hCG) in experiment II. Our results showed that the PNMPP at 10(-5)-10(-7) M suppressed follicle-stimulating hormone (FSH) and luteinizing hormone (LH) productions from GnRH-stimulated pituitary cells. At the same time, PNMPP 10(-5)-10(-7) M induced an increase in testosterone production from the Leydig cells treated with or without hCG. Based on our results, it can be concluded that that PNMPP might have both androgen agonist action by decreasing FSH and LH production in the pituitary and anti-androgenic action by increasing testosterone production in the Leydig cell.	[Trisomboon, Jiratthiya] Srinakharinwirot Univ, Fac Med, Dept Physiol, Bangkok 10110, Thailand; [Trisomboon, Jiratthiya; Watanabe, Gen; Taya, Kazuyoshi] Tokyo Univ Agr & Technol, Fac Agr, Cooperat Dept Vet Med, Vet Physiol Lab, Tokyo 1838509, Japan; [Li, ChunMei] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China; [Suzuki, Akira K.] Natl Inst Environm Studies, Res Ctr Environm Risk, Ibaraki 3058506, Japan; [Watanabe, Gen] Gifu Univ, United Grad Sch Vet Sci, Dept Vet Basic Sci, Gifu 5011193, Japan	Watanabe, G (reprint author), Tokyo Univ Agr & Technol, Fac Agr, Cooperat Dept Vet Med, Vet Physiol Lab, Tokyo 1838509, Japan.	gen@cc.tuat.ac.jp			Japan Society for the Promotion of Sciences [C-26340037, P05480]; Ministry of Education Culture, Sports, Science and Technology of Japan [B18310044]	We are grateful to the Rat Pituitary Hormone Distribution Program, NIDDK, NIH, Bethesda, MD, USA, for providing RIA materials and Dr GD Niswender, Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, CO, USA, for providing antisera to testosterone (GDN 250). This study was supported by a grant in Aid for Scientific Research (C-26340037) from the Japan Society for the Promotion of Sciences.; This work was supported by a Grants-in-Aid for Scientific Research (the 21st Century Center of Excellence Program, E-I) from the Ministry of Education Culture, Sports, Science and Technology of Japan (B18310044) and the Japan Society for the Promotion of Science (P05480).	Yamagishi N, 2012, INHAL TOXICOL, V24, P459, DOI 10.3109/08958378.2012.688225; Ramdhan DH, 2009, TOXICOL LETT, V191, P103, DOI 10.1016/j.toxlet.2009.08.013; Houk CP, 2004, ENDOCRINOLOGY, V145, P1269, DOI 10.1210/en.2003-1046; Taneda S, 2004, BIOL PHARM BULL, V27, P835, DOI 10.1248/bpb.27.835; Komatsu T, 2008, TOXICOL IN VITRO, V22, P1825, DOI 10.1016/j.tiv.2008.08.009; Furuta C, 2008, TOXICOL APPL PHARM, V229, P109, DOI 10.1016/j.taap.2008.01.026; Furuta C, 2004, BIOL REPROD, V70, P1527, DOI 10.1095/biolreprod.103.024810; Furuta C, 2005, ENDOCRINE, V27, P33, DOI 10.1385/ENDO:27:1:033; Furuta C, 2008, TOXICOL APPL PHARM, V230, P320, DOI 10.1016/j.taap.2008.02.027; Hileman SM, 1999, J REPROD FERTIL, P231; Izawa H, 2007, J REPROD DEVELOP, V53, P1069, DOI 10.1262/jrd.19114; Izawa H, 2008, BIOSCI BIOTECH BIOCH, V72, P1235, DOI 10.1271/bbb.70705; Izawa H, 2007, J REPROD DEVELOP, V53, P1191, DOI 10.1262/jrd.19114; KAO L W L, 1975, Endocrinology, V96, P253; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Li CM, 2009, INHAL TOXICOL, V21, P803, DOI 10.1080/08958370802524381; Li CM, 2012, INHAL TOXICOL, V24, P599, DOI 10.3109/08958378.2012.702140; Li CM, 2006, J ENDOCRINOL, V189, P555, DOI 10.1677/joe.1.06628; Li CM, 2007, J ANDROL, V28, P252, DOI 10.2164/jandrol.106.000802; Li XZ, 2009, BIOSCI BIOTECH BIOCH, V73, P2018, DOI 10.1271/bbb.90204; MCGINNIS MY, 1983, BRAIN RES, V275, P75, DOI 10.1016/0006-8993(83)90418-3; Okada Y, 2003, ENDOCRINOLOGY, V144, P267, DOI 10.1210/en.2002-220770; Richardson HN, 2002, J NEUROENDOCRINOL, V14, P375, DOI 10.1046/j.0007-1331.2002.00787.x; SAR M, 1990, ENDOCRINOLOGY, V127, P3180; SHARMA MKG, 1992, J ENDOCRINOL INVEST, V15, P549; Svechnikov K, 2005, J ENDOCRINOL, V187, P117, DOI 10.1677/joe.1.06192; Taneda S, 2004, J HEALTH SCI, V50, P133; Taya K, 1985, JAPANESE J ANIMAL RE, V31, P186; Tsukue N, 2001, J TOXICOL ENV HEAL A, V63, P115, DOI 10.1080/15287390151126441; Watanabe N, 1999, ENVIRON HEALTH PERSP, V107, P539, DOI 10.2307/3434395	30	0	0	SOCIETY REPRODUCTION & DEVELOPMENT-SRD	TSUKUBA	C/O KAZUHIRO KIKUCHI, PHD DVM, NATL INST AGROBIOLOGICAL SCIENCES KANNONDAI 2-1-2, TSUKUBA, IBARAKI 305-8602, JAPAN	0916-8818			J REPROD DEVELOP	J. Reprod. Dev.	APR	2015	61	2					134	137				4	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CG9BP	WOS:000353609700007		
J	Oishi, S; Kimura, R; Hayashi, H; Tatsuki, S; Tamura, K; Ishii, K; Tucker, J				Oishi, Shigehiro; Kimura, Reo; Hayashi, Haruo; Tatsuki, Shigeo; Tamura, Keiko; Ishii, Keiko; Tucker, Jane			Psychological adaptation to the Great Hanshin-Awaji Earthquake of 1995: 16 years later victims still report lower levels of subjective well-being	JOURNAL OF RESEARCH IN PERSONALITY			English	Article						Subjective well-being; Disaster; Adaptation; Life events	SET-POINT MODEL; HURRICANE KATRINA; HAPPINESS	We investigated psychological adaptation to the Great Hanshin-Awaji Earthquake of 1995, using surveys conducted in 2001, 2003, 2005, and 2011. Respondents whose houses were damaged reported lower life satisfaction, more negative affect, and more health problems than those who did not suffer any damage in all surveys, including in 2011, or 16 years after the earthquake. Likewise, residents with at least one immediate family member who died in the earthquake reported lower life satisfaction, more negative affect, and more health problems than those who did not have any immediate family members killed in all surveys, including in 2011. Surprisingly, the effect of housing damage on subjective well-being remained significant, above and beyond human loss. Equally important, the 2011 survey data showed that pre-existing differences in socioeconomic status between the victims of housing damage and human loss did not change our main findings. (C) 2015 Elsevier Inc. All rights reserved.	[Oishi, Shigehiro; Tucker, Jane] Univ Virginia, Charlottesville, VA 22904 USA; [Kimura, Reo] Univ Hyogo, Kobe, Hyogo 6500044, Japan; [Hayashi, Haruo] Kyoto Univ, Kyoto 6068501, Japan; [Tatsuki, Shigeo] Doshisha Univ, Kyoto, Japan; [Tamura, Keiko] Niigata Univ, Niigata 95021, Japan; [Ishii, Keiko] Kobe Univ, Kobe, Hyogo, Japan	Oishi, S (reprint author), Univ Virginia, Dept Psychol, POB 400400, Charlottesville, VA 22904 USA.	soishi@virginia.edu					Lucas RE, 2003, J PERS SOC PSYCHOL, V84, P527, DOI 10.1037/0022-3514.84.3.527; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; LEHMAN DR, 1987, J PERS SOC PSYCHOL, V52, P218, DOI 10.1037/0022-3514.52.1.218; Lowe SR, 2013, J CONSULT CLIN PSYCH, V81, P877, DOI 10.1037/a0033252; BEGGAN JK, 1992, J PERS SOC PSYCHOL, V62, P229, DOI 10.1037/0022-3514.62.2.229; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; Merdjanoff AA, 2013, SOC SCI RES, V42, P1222, DOI 10.1016/j.ssresearch.2013.04.004; BRICKMAN P, 1978, J PERS SOC PSYCHOL, V36, P917, DOI 10.1037/0022-3514.36.8.917; Bryant F. B., 2005, J HAPPINESS STUD, V6, P227, DOI DOI 10.1007/S10902-005-3889-4; James W., 1890, PRINCIPLES PSYCHOL; Kimura R, 2007, J DISASTER RES, V2, P465; Lucas RE, 2007, CURR DIR PSYCHOL SCI, V16, P75, DOI 10.1111/j.1467-8721.2007.00479.x; McFarlane AC, 2009, BRIT J PSYCHIAT, V195, P142, DOI 10.1192/bjp.bp.108.054270; Nussbaum M. C., 1986, FRAGILITY GOODNESS L; Papanikolaou V, 2011, PSYCHOLOGY, V02, P132; Schwarz Norbert, 1999, WELL BEING FDN HEDON, P61; SHERMAN E, 1991, INT J AGING HUM DEV, V33, P89, DOI 10.2190/FJW1-60UF-WW1R-FP2K; Tanami N., 2005, CURRENT SITUATION OU, P241; Tatsuki S., 2007, J DISASTER RES, V2, P484; Wickrama T., 2011, INT J SOC PSYCHIAT, V58, P278	21	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0092-6566	1095-7251		J RES PERS	J. Res. Pers.	APR	2015	55						84	90		10.1016/j.jrp.2015.02.001		7	Psychology, Social	Psychology	CG0ZY	WOS:000353004000010		
J	Rahayu, A; Lim, LW; Takeuchi, T				Rahayu, Aster; Lim, Lee Wah; Takeuchi, Toyohide			Preparation of a hybrid monolithic stationary phase with allylsulfonate for the rapid and simultaneous separation of cations in capillary ion chromatography	JOURNAL OF SEPARATION SCIENCE			English	Article						Ion-exchange chromatography; Silica hybrid monolithic column; Strong cation exchangers; Sulfonate groups	PERFORMANCE LIQUID-CHROMATOGRAPHY; ONE-POT APPROACH; COLUMNS; ELECTROCHROMATOGRAPHY	A hybrid monolithic column with sulfonate functionality was successfully prepared for the simultaneous separation of common inorganic cations in ion-exchange chromatographic mode through a simple and easy single-step preparation method. The strong cation-exchange moieties were provided directly from allylsulfonate, which worked as an organic monomer in the single-step reaction. Inorganic cations (Li+, Na+, K+, NH4+, Cs+, Rb+, Mg2+, Ca2+, and Sr2+) were separated satisfactorily by using CuSO4 as the eluent with indirect UV detection. The allysulfonate hybrid monolith showed a better performance in terms of speed and pressure drop than the capillary packed column. The number of theoretical plates achieved was 19017 plates/m (in the case of NH4+ as the analyte). The relative standard deviations (n = 6) of both retention time and peak height were less than 1.96% for all the analyte cations. The allysulfonate hybrid monolithic column was successfully applied for the rapid and simultaneous separation of inorganic cations in groundwater and the effluent of onsite domestic wastewater treatment system.	[Rahayu, Aster; Lim, Lee Wah; Takeuchi, Toyohide] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan	Takeuchi, T (reprint author), Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, 1-1 Yanagido, Gifu 5011193, Japan.	take-t@gifu-u.ac.jp					Svec F, 2004, J SEP SCI, V27, P1419, DOI 10.1002/jssc.200401825; Zhu T, 2012, J SEP SCI, V35, P1294, DOI 10.1002/jssc.201200084; Xu HR, 2011, J SEP SCI, V34, P2314, DOI 10.1002/jssc.201100177; Tian Y, 2008, ELECTROPHORESIS, V29, P960, DOI 10.1002/elps.200700471; Aguiar VS, 2013, MICROCHEM J, V109, P51, DOI 10.1016/j.microc.2012.04.006; Stanelle RD, 2005, J CHROMATOGR A, V1100, P68, DOI 10.1016/j.chroma.2005.09.014; Rong L, 2012, ANAL SCI, V28, P367; Wu RA, 2002, ELECTROPHORESIS, V23, P1239, DOI 10.1002/1522-2683(200205)23:9<1239::AID-ELPS1239>3.0.CO;2-X; Lin Z, 2013, J CHROMATOGR A, V1271, P115, DOI 10.1016/j.chroma.2012.11.038; Ishizuka N, 2002, J CHROMATOGR A, V960, P85, DOI 10.1016/S0021-9673(01)01580-1; Xie CH, 2005, J SEP SCI, V28, P751, DOI 10.1002/jssc.200400101; Zhang ZB, 2011, ANAL CHEM, V83, P3616, DOI 10.1021/ac200414r; Zhao KL, 2012, TALANTA, V98, P86, DOI 10.1016/j.talanta.2012.06.050; Wu MH, 2010, ANAL CHEM, V82, P5447, DOI 10.1021/ac1003147; Wu MH, 2009, ANAL CHEM, V81, P3529, DOI 10.1021/ac9000749; Ueki Y, 2004, ANAL CHEM, V76, P7007, DOI 10.1021/ac040079g; Guiochon G, 2007, J CHROMATOGR A, V1168, P101, DOI 10.1016/j.chroma.2007.05.090; NEVEJANS F, 1985, J CHROMATOGR, V350, P145, DOI 10.1016/S0021-9673(01)93514-9; Ma J., 2005, ANAL METHODS, V4, P247; Trojer L, 2006, J CHROMATOGR A, V1117, P56, DOI 10.1016/j.chroma.2006.03.051; Yan LJ, 2005, ELECTROPHORESIS, V26, P2935, DOI 10.1002/elps.200500016; Yang HH, 2013, ELECTROPHORESIS, V34, P510, DOI 10.1002/elps.201200354; Zhang ZB, 2012, J CHROMATOGR A, V1256, P136, DOI 10.1016/j.chroma.2012.07.071	23	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	APR	2015	38	7					1109	1116		10.1002/jssc.201401264		8	Chemistry, Analytical	Chemistry	CG1SG	WOS:000353053700007		
J	Obayashi, K; Saeki, K; Kurumatani, N				Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio			Independent Associations Between Nocturia and Nighttime Blood Pressure/Dipping in Elderly Individuals: The HEIJO-KYO Cohort	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						nocturia; nighttime blood pressure; dipping; physical activity; circadian rhythm	URINARY MELATONIN EXCRETION; PLASMA VASOPRESSIN; HYPERTENSION; PATTERN; SLEEP; POPULATION; DIURESIS; POLYURIA; ADULTS; WOMEN	ObjectivesTo evaluate the association between nocturnal void frequency and ambulatory blood pressure (BP). DesignCross-sectional. SettingNara, Japan. ParticipantsCommunity-based elderly individuals (mean age 72.1, N=867). MeasurementsNocturnal void frequency and ambulatory BP. ResultsTwo hundred twenty-four participants had no nocturnal void, 384 had one nocturnal void, and 259 had two or more nocturnal voids. Univariate comparisons showed that more-frequent nocturnal voiding was significantly associated with higher nighttime systolic BP (SBP) and lower dipping (nocturnal voids: 2, nighttime SBP 121.1mmHg, dipping 11.8% vs 0, nighttime SBP 111.5mmHg, dipping 15.8%, P<.001). Multivariate models revealed that two or more nocturnal voids was significantly associated with higher nighttime SBP and lower dipping than no nocturnal voids (adjusted mean difference for nighttime SBP (nocturnal voids 2 minus 0): 6.3mmHg, 95% confidence interval (CI)=2.6 to 10.1mmHg, P<.001; adjusted mean difference for dipping (nocturnal voids 2 minus 0): -2.8%, 95% CI=-4.9% to -0.7%, P=.005) and that the associations were independent of potential confounding factors such as age, sex, body mass index, smoking status, antihypertensive use, diabetes mellitus, renal function, asymmetric dimethylarginine, bedtime, length of time in bed, daytime and nighttime physical activity, endogenous melatonin levels, and bedroom light levels. In contrast, one void per night was not significantly associated with nighttime SBP and dipping. ConclusionNocturia is significantly associated with nighttime SBP and dipping in the general elderly population, independent of several confounding factors such as age, sex, metabolic abnormalities, physical activity, and circadian rhythm parameters.	[Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio] Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, Nara, Japan	Obayashi, K (reprint author), 840 Shijocho, Nara 6348521, Japan.	obayashi@naramed-u.ac.jp			Department of Indoor Environmental Medicine, Nara Medical University; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; Japan Science and Technology Agency; YKK AP, Inc.	This work was supported by grants from the Department of Indoor Environmental Medicine, Nara Medical University; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; the Japan Science and Technology Agency; and YKK AP, Inc.	Agarwal R, 2009, HYPERTENSION, V54, P646, DOI 10.1161/HYPERTENSIONAHA.109.135822; Nakagawa H, 2010, J UROLOGY, V184, P1413, DOI 10.1016/j.juro.2010.05.093; Feldstein CA, 2013, J AM SOC HYPERTENS, V7, P75, DOI 10.1016/j.jash.2012.12.004; KHOURY S, 1992, AM J HYPERTENS, V5, P616; Obayashi K, 2013, HYPERTENS RES, V36, P736, DOI 10.1038/hr.2013.20; Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727; Kupelian V, 2011, J UROLOGY, V185, P571, DOI 10.1016/j.juro.2010.09.108; VALLANCE P, 1992, LANCET, V339, P572; Kamperis K, 2010, AM J PHYSIOL-RENAL, V299, pF404, DOI 10.1152/ajprenal.00126.2010; Yoshimura K, 2012, NEUROUROL URODYNAM, V31, P1266, DOI 10.1002/nau.22250; Tikkinen KAO, 2006, J UROLOGY, V175, P596, DOI 10.1016/S0022-5347(05)00245-4; Helfand BT, 2012, J UROLOGY, V188, P2288, DOI 10.1016/j.juro.2012.07.104; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Aizawa N, 2011, EUR UROL, V59, P264, DOI 10.1016/j.eururo.2010.10.035; Obayashi K, 2012, J CLIN ENDOCR METAB, V97, P4166, DOI 10.1210/jc.2012-1873; Negoro H, 2013, J UROLOGY, V190, P843, DOI 10.1016/j.juro.2013.02.024; van Kerrebroeck P, 2002, NEUROUROL URODYNAM, V21, P179, DOI 10.1002/nau.10053; Asplund R, 2002, NETH J MED, V60, P276; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; GEORGE CPL, 1975, J CLIN ENDOCR METAB, V41, P332; Graugaard-Jensen C, 2006, J UROLOGY, V176, P1034, DOI 10.1016/j.juro.2006.04.046; Kanbay M, 2008, CLIN EXP HYPERTENS, V30, P585, DOI 10.1080/10641960802251974; Kawano Y, 2011, HYPERTENS RES, V34, P281, DOI 10.1038/hr.2010.241; Mehra R, 2008, SLEEP, V31, P1569; Natsume O, 2007, INT J UROL, V14, P822, DOI 10.1111/j.1442-2042.2007.01847.x; Obayashi K, 2014, J UROLOGY, V191, P1816, DOI 10.1016/j.juro.2013.12.043; Parthasarathy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030969; Perk G, 2001, HYPERTENSION, V37, P749; Shea SA, 2011, CIRC RES, V108, P980, DOI 10.1161/CIRCRESAHA.110.233668	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	APR	2015	63	4					733	738		10.1111/jgs.13333		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	CG4EB	WOS:000353234900015		
J	Fukunaga, H				Fukunaga, Hisanori			After the earthquake, tsunami and nuclear crisis	JOURNAL OF THE ROYAL SOCIETY OF MEDICINE			English	Editorial Material										Fukunaga, H (reprint author), 142 Tsubogasaku, Soma, Fukushima 9760011, Japan.	fukunaga@bb.soma.or.jp						0	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0141-0768	1758-1095		J ROY SOC MED	J. R. Soc. Med.	APR	2015	108	4					151	152		10.1177/0141076815572936		2	Medicine, General & Internal	General & Internal Medicine	CG6AG	WOS:000353376700010		
J	Horiguchi, M; Miyata, N; Mizuno, H				Horiguchi, Masatoshi; Miyata, Nariaki; Mizuno, Hiroshi			FOCUSED MULTIPLE LASER BEAMS: THE NEW CONCEPT OF IRRADIATION WITH THE 1064nm Nd:YAG LASER FOR SKIN REJUVENATION - HISTOLOGICAL ANALYSES AND CLINICAL APPLICATION	LASERS IN SURGERY AND MEDICINE			English	Meeting Abstract									Todachuo Gen Hosp, Mitaka, Tokyo, Japan; Miyata Plast Surg & Dermatol Clin, Minato Ku, Tokyo, Japan; Juntendo Univ, Bunkyo Ku, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0196-8092	1096-9101		LASER SURG MED	Lasers Surg. Med.	APR	2015	47	4				LB1	373	373				1	Surgery	Surgery	CG4DN	WOS:000353233100012		
J	Dong, LJ; Wang, D; Wang, KX; Li, SH; Mei, ZG; Wang, SY; Akamatsu, T; Kimura, S				Dong, Lijun; Wang, Ding; Wang, Kexiong; li, Songhai; Mei, Zhigang; Wang, Shiyong; Akamatsu, Tomonari; Kimura, Satoko			Yangtze finless porpoises along the main channel of Poyang Lake, China: Implications for conservation	MARINE MAMMAL SCIENCE			English	Article						cetacean; finless porpoise; Yangtze River; season; passive acoustic survey; population status; distribution	PASSIVE ACOUSTIC DETECTION; NEOPHOCAENA-PHOCAENOIDES; DENSITY-ESTIMATION; INIA-GEOFFRENSIS; RIVER DOLPHIN; ABUNDANCE; EXTINCTION; CETACEAN; WHALES; ASIAEORIENTALIS	Poyang Lake is the largest freshwater lake in China and flows into the Yangtze River. It is a traditional habitat for the endangered Yangtze finless porpoise, which has not been well investigated. To reveal the distribution of the porpoise in Poyang Lake, 12 passive acoustic surveys were conducted along 123 km of the main channel of the lake during different seasons (spring transition season, wet season, autumn transition season, and dry season) from 2008 to 2012. We counted the number of phonating porpoises encountered and calculated the detection rate (encountered individuals detected per kilometer). The median porpoise detection rates ranged from 0 to 0.65 individuals per kilometer during the different surveys. The highest median detection rate of 0.50 was detected in the autumn transition season. The seasonal shrinking of the lake during the dry season may cause a concentration of porpoises in the narrow channels and a high incidence of collisions with cargo ships and fishing boats. Conservation actions should be focused on the main channel of the lake during the dry and transition seasons. In addition, the expansion of the existing reserve to include areas with high porpoise detection rates is necessary.	[Dong, Lijun; Wang, Ding; Wang, Kexiong; Mei, Zhigang; Wang, Shiyong] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Dong, Lijun; Wang, Shiyong] Univ Chinese Acad Sci, Beijing, Peoples R China; [li, Songhai] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, Marine Mammal & Marine Bioacoust Lab, Sanya, Peoples R China; [Akamatsu, Tomonari] Fisheries Res Agcy, Natl Res Inst Fisheries Engn, Kamisu, Ibaraki, Japan; [Akamatsu, Tomonari] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Kimura, Satoko] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Wang, D (reprint author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China.	wangd@ihb.ac.cn			National Natural Science Foundation of China [31170501, 41306169, 41422604]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4, SIDSSE-201210]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Japan Science and Technology Agency, CREST, Japan [19405005, 24-3578]; "Hundred Talents Program" of the Chinese Academy of Sciences [SIDSSE-BR-201201, Y410012]; Ocean Park Conservation Foundation of Hong Kong (OPCFHK)	We are grateful to Liang Fang, Zhitao Wang and other staff and students of the Institute of Hydrobiology of the Chinese Academy of Sciences and Huazhong Agricultural University for their help during the surveys. We thank Dr. Sun Xiulian of the Institute of Virology of the Chinese Academy of Sciences for his help with the statistical analysis. We thank all the reviewers for their hard work in the reviewing process. We thank the captains of the survey boats for their help in conducting the surveys. This research was supported by grants from National Natural Science Foundation of China (31170501), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Japan Science and Technology Agency, CREST, Japan Grants-in-Aid for Scientific Research (B) (19405005) and for JSPS fellows (24-3578). Li S. was supported by National Natural Science Foundation of China (No. 41306169, 41422604), "Hundred Talents Program" of the Chinese Academy of Sciences (SIDSSE-BR-201201, Y410012), Knowledge Innovation Program of the Chinese Academy of Sciences (SIDSSE-201210), and the Ocean Park Conservation Foundation of Hong Kong (OPCFHK).	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2002, ICES J MAR SCI, V59, P438, DOI 10.1006/jmsc.2001.1159; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Bashir T, 2010, AQUAT MAMM, V36, P19, DOI 10.1578/AM.36.1.2010.19; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Mei ZG, 2014, BIOL CONSERV, V172, P117, DOI 10.1016/j.biocon.2014.02.033; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3; Morano JL, 2012, CONSERV BIOL, V26, P698, DOI 10.1111/j.1523-1739.2012.01866.x; Turvey ST, 2013, BIOL CONSERV, V157, P352, DOI 10.1016/j.biocon.2012.07.016; Li SH, 2005, J ACOUST SOC AM, V117, P3288, DOI 10.1121/1.1882945; Akamatsu T, 2005, P ROY SOC B-BIOL SCI, V272, P797, DOI 10.1098/rspb.2004.3024; Akamatsu T, 1998, J ACOUST SOC AM, V104, P2511, DOI 10.1121/1.423757; Whitfield AK, 1999, REV FISH BIOL FISHER, V9, P151, DOI 10.1023/A:1008994405375; Wu GF, 2007, WATER RES, V41, P3271, DOI 10.1016/j.watres.2007.05.018; Kusel ET, 2011, J ACOUST SOC AM, V129, P3610, DOI 10.1121/1.3583504; McGuire TL, 1998, BIOTROPICA, V30, P625, DOI 10.1111/j.1744-7429.1998.tb00102.x; Turvey ST, 2007, BIOLOGY LETT, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Mei ZG, 2012, BIOL CONSERV, V153, P192, DOI 10.1016/j.biocon.2012.04.029; Dong LJ, 2011, J ACOUST SOC AM, V130, P2285, DOI 10.1121/1.3625257; ELLIOTT M., 2002, FISHES ESTUARIES; Gao Anli, 1995, Acta Theriologica Sinica, V15, P81; Gomez Salazar C., 2012, MARINE MAMMAL SCI, V28, P124; IUCN, 2001, IUCN RED LIST CAT CR; Jefferson Thomas A., 2011, Journal of Marine Animals and their Ecology, V4, P3; Kimura S, 2010, J ACOUST SOC AM, V128, P1435, DOI 10.1121/1.3442574; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; [雷声 Lei Sheng], 2010, [水利水电技术, Water Resources and Hydropower Engineering], V41, P83; Li SH, 2010, J ACOUST SOC AM, V128, P1476, DOI 10.1121/1.3455829; Moore SE, 2010, DEEP-SEA RES PT II, V57, P153, DOI 10.1016/j.dsr2.2009.08.013; Simier M, 2006, ESTUAR COAST SHELF S, V69, P615, DOI 10.1016/j.ecss.2006.05.028; Vidal O, 1997, MAR MAMMAL SCI, V13, P427, DOI 10.1111/j.1748-7692.1997.tb00650.x; Wang D., 2000, BIOL CONSERVATION FR, P81; Wang KX, 2006, ENVIRON SCI POLLUT R, V13, P418, DOI 10.1065/espr2006.10.350; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; [魏卓 Wei Zhuo], 2002, [长江流域资源与环境, Resources and Environment in the Yangtze Valley], V11, P427; Xiao W., 2000, CHINESE BIODIVERSITY, V8, P106; Xiao Wen, 2002, Acta Theriologica Sinica, V22, P7; Zhang B., 1988, STUDIES POYANG LAKE; Zhang Xianfeng, 1993, Acta Theriologica Sinica, V13, P260; Zhao X., 2013, ANIMAL CONSERVATION, V16, P1; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-0469	1748-7692		MAR MAMMAL SCI	Mar. Mamm. Sci.	APR	2015	31	2					612	628		10.1111/mms.12181		17	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CG6CK	WOS:000353382900012		
J	Sakurai, Y; Okamatsu-Ogura, Y; Saito, M; Kimura, K; Nakao, R; Ohnuma, A; Kobayashi, M				Sakurai, Yuta; Okamatsu-Ogura, Yuko; Saito, Masayuki; Kimura, Kazuhiro; Nakao, Ryo; Ohnuma, Aiko; Kobayashi, Mari			Brown adipose tissue expresses uncoupling protein 1 in newborn harbor seals (Phoca vitulina)	MARINE MAMMAL SCIENCE			English	Article							PAGOPHILUS-GROENLANDICUS; HARP SEALS; PUPS; THERMOGENESIS; BLUBBER; BIRTH		[Sakurai, Yuta; Kobayashi, Mari] Tokyo Univ Agr, Dept Aquat Biosci & Ind, Grad Sch Bioind, Abashiri, Hokkaido 0992493, Japan; [Sakurai, Yuta; Okamatsu-Ogura, Yuko; Saito, Masayuki; Kimura, Kazuhiro] Hokkaido Univ, Dept Biomed Sci, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan; [Nakao, Ryo; Ohnuma, Aiko] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Kobayashi, Mari] NPO Marine Wildlife Ctr Japan, Abashiri, Hokkaido 0930042, Japan	Kimura, K (reprint author), Hokkaido Univ, Dept Biomed Sci, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan.	k-kimura@vetmed.hokudai.ac.jp					Addison RF, 2005, MAR ENVIRON RES, V59, P165, DOI 10.1016/j.marenvres.2004.04.005; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Liwanag HEM, 2012, BIOL J LINN SOC, V107, P774, DOI 10.1111/j.1095-8312.2012.01992.x; SCHOLANDER PF, 1950, BIOL BULL, V99, P225, DOI 10.2307/1538740; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; CASTEILLA L, 1989, BIOCHEM J, V257, P665; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Lowell BB, 2000, NATURE, V404, P652; Davydov A F, 1965, Fed Proc Transl Suppl, V24, P563; GRAV HJ, 1974, ACTA PHYSIOL SCAND, V92, P427; GRAV HJ, 1976, CAN J PHYSIOL PHARM, V54, P409; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Himms-Hagen J, 2001, Rev Endocr Metab Disord, V2, P395, DOI 10.1023/A:1011856617047; Naito Y., 1972, SCI REPORTS WHALES R, V24, P127; Oftedal OT, 1996, PHYSIOL ZOOL, V69, P635; Okamatsu-Ogura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084229; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Pearson L. E., 2014, COMP BIOCH PHYSL A, V78, P59; Pearson LE, 2014, J THERM BIOL, V44, P93, DOI 10.1016/j.jtherbio.2014.02.001; PITCHER KW, 1986, J WILDLIFE MANAGE, V50, P463, DOI 10.2307/3801106; STEWART REA, 1980, J MAMMAL, V61, P670, DOI 10.2307/1380312; STUTZ SS, 1966, J FISH RES BOARD CAN, V23, P607	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0824-0469	1748-7692		MAR MAMMAL SCI	Mar. Mamm. Sci.	APR	2015	31	2					818	827		10.1111/mms.12193		10	Marine & Freshwater Biology; Zoology	Marine & Freshwater Biology; Zoology	CG6CK	WOS:000353382900029		
J	Wang, JC; Ma, N; Murakawa, H				Wang, Jiangchao; Ma, Ninshu; Murakawa, Hidekazu			An efficient FE computation for predicting welding induced buckling in production of ship panel structure	MARINE STRUCTURES			English	Article						FE computation; Ship panel production; Welding induced buckling; Elastic FE analysis; Inherent deformation method	WELDED-JOINT; DISTORTION; MITIGATION	In a Thermal-Elastic-Plastic (TEP) FE analysis to investigate welding induced buckling of large thin plate welded structure such as ship panel, it will be extremely difficult to converge computation and obtain the results when the material and geometrical nonlinear behaviors are both considered. In this study, an efficient FE computation which is an elastic FE analysis based on inherent deformation method, is proposed to predict welding induced buckling with employing large deformation theory, and an application in ship panel production is carried out. The proposed FE computation is implemented with two steps: (1) The typical weld joint (fillet weld) existing in considered ship panel structure is conducted with sequential welding using actual welding condition, and welding angular distortion after completely cooling down is measured. A TEP FE analysis with solid elements model is carried out to predict the welding angular distortion, which is validated by comparing with experimental results. Then, inherent deformations in this examined fillet welded joint are evaluated as a loading for the subsequent elastic FE analysis. Also, the simultaneous welding to assemble this fillet welded joint is numerically considered and its inherent deformations are evaluated. (2) To predict the welding induced buckling in the production of ship panel structure, a shell element model of considered ship panel is then employed for elastic FE analysis, in which inherent deformation evaluated beforehand is applied and large deformation is considered. The computed results obviously show welding induced buckling in the considered ship panel structure after welding. With its instability and difficulty for straightening, welding induced buckling prefers to be avoided whenever it is possible. (C) 2014 Elsevier Ltd. All rights reserved.	[Wang, Jiangchao] Carleton Univ, Dept Aerosp & Mech Engn, Ottawa, ON K1S 5B6, Canada; [Wang, Jiangchao; Ma, Ninshu; Murakawa, Hidekazu] Osaka Univ, Joining & Welding Res Inst, Osaka, Japan	Wang, JC (reprint author), Carleton Univ, Dept Aerosp & Mech Engn, Ottawa, ON K1S 5B6, Canada.	WangJiangchaocn@gmail.com					Wang JC, 2013, J MATER PROCESS TECH, V213, P1447, DOI 10.1016/j.jmatprotec.2013.02.009; Michaleris P, 2006, SCI TECHNOL WELD JOI, V11, P707, DOI 10.1179/174329306X147724; Yang YP, 2012, J MATER ENG PERFORM, V21, P153, DOI 10.1007/s11665-011-9928-x; Wang JC, 2014, THIN WALL STRUCT, V80, P103, DOI 10.1016/j.tws.2014.03.003; Deng D, 2008, COMP MATER SCI, V43, P591, DOI 10.1016/j.commatsci.2008.01.003; Wang JC, 2013, MAR STRUCT, V34, P135, DOI 10.1016/j.marstruc.2013.09.003; Bhide SR, 2006, WELD J, V85, P189; Dean D, 2011, T JWRI, V40, P89; Deng D, 2008, COMP MATER SCI, V43, P353, DOI 10.1016/j.commatsci.2007.12.006; Deo MV, 2003, SCI TECHNOL WELD JOI, V8, P55, DOI 10.1179/13621710322500900; Frank MP., 1975, THESIS MIT; Goldak J, 2005, COMPUTATIONAL WELDIN; Huang TD, 2007, J SHIP PROD, V23, P89; Huang TD, 2004, J SHIP PROD, V20, P43; Liang W, 2005, WELD WORLD, V49, P30; Liang W, 2004, T JWRI, V33, P45; Lindgren LE, 2007, WOODHEAD PUBL MATER, P1; Masubuchi K., 1980, ANAL WELDED STRUCTUR; Masubuchi K., 1953, P 3 JAP NAT C APPL M, P107; Michaleris P, 2011, MINIMIZATION OF WELDING DISTORTION AND BUCKLING: MODELLING AND IMPLEMENTATION, P3; Michaleris P., 1996, J SHIP PRODUCTION, V12, P269; Mollicone P, 2008, THIN WALL STRUCT, V46, P1021, DOI 10.1016/j.tws.2008.01.044; Monfared AH., 2012, J ENG PHYS THERMOPH+, V85, P187; Murakawa H, 2009, T JWRI, V38, P63; Satoh K., 1957, J JPN WELD SOC, V26, P399; Satoh K, 1979, WELDING DISTORTION R; Tajiama Y, 2007, T JWRI, V36, P65; Terasaki T, 1998, T JPN SOC MECH ENG A, V64, P2239; Timoshenko S. P., 2009, THEORY ELASTIC STABI; Toshiharu N, 1997, T JPN SOC MECH ENG A, V63, P1063; Tsai C. L., 1999, WELD J, V78; Tsai C.L., 2006, WELD J, V85, P151; Ueda Y, 1999, COMPUTATIONAL WELDIN; Ueda Y, 2007, COMPUTATIONAL APPROA; Vanli OA, 2001, J SHIP PRODUCTION, V17, P226; Vega A., 2007, T JWRI, V36, P57; Wang JC, 2011, MATER DESIGN, V32, P4728, DOI 10.1016/j.matdes.2011.06.047; Wang JC, 2012, TRENDS WELD RES 2012, P165; Wang JC, 2012, J MATER PROCESS TECH, V212, P1705, DOI 10.1016/j.jmatprotec.2012.03.015; Wang JC, 2013, J SHIP PROD DES, V29, P1; Watanabe M, 1958, J JAPAN WELDING SOC, V27, P313; White JD, 1980, WELD METAL FABR, V1980, P587; Yang XQ., 2000, ACTA MET SIN ENGL LE, V13, P178; Zaeem MA, 2007, COMP MATER SCI, V38, P588, DOI 10.1016/j.commatsci.2006.03.016; Zhong XM, 1995, T JWRI, V24, P87	45	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0951-8339	1873-4170		MAR STRUCT	Mar. Struct.	APR	2015	41						20	52		10.1016/j.marstruc.2014.12.007		33	Engineering, Marine; Engineering, Civil	Engineering	CG2DT	WOS:000353085800002		
J	Matsuda, K; Gotoh, K				Matsuda, Kazuki; Gotoh, Koji			Numerical simulation of fatigue crack propagation under superimposed stress histories containing different frequency components with several mean stress conditions	MARINE STRUCTURES			English	Article						Fatigue; Superimposed stress history; Numerical simulation of fatigue crack propagation		Fatigue crack propagation behavior under superimposed stress histories containing different frequency components with several mean stress conditions was investigated. Numerical simulation of fatigue crack propagation based on an advanced fracture mechanics approach using the RPG (Re-tensile Plastic zone Generating) stress criterion for fatigue crack propagation was improved to extract the effective part from the applied stress history for fatigue crack propagation. The parameter, which is based on the plastic hysteresis energy consumed in the vicinity of a crack tip, was applied and implemented into the numerical simulation code of fatigue crack propagation. Fatigue crack propagation tests under various superimposed stress conditions with several mean stress conditions were performed and compared with the fatigue crack propagation histories obtained from the improved numerical simulations. These comparisons show the validity of the proposed procedure for extracting the effective stress history from the superimposed stress histories with different frequency components and mean stresses. Additionally, practical fatigue strength evaluations based on the linear cumulative fatigue damage parameter were conducted to investigate the tendency of the fatigue damage value under these stress conditions. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsuda, Kazuki] Kyushu Univ, Dept Civil & Struct Engn, Fukuoka 812, Japan; [Gotoh, Koji] Kyushu Univ, Dept Marine Syst Engn, Fukuoka 812, Japan	Gotoh, K (reprint author), 744 Motooka, Nishi Ku, Fukuoka 8190395, Japan.	gotoh@nams.kyushu-u.ac.jp			Japan Society for the Promotion of Science [26249136, 26004132]	This research was funded by JSPS Grant-in-Aid for Scientific Research (A) (26249136) and JSPS Fellows (26004132) from the Japan Society for the Promotion of Science.	Schutz W, 1996, ENG FRACT MECH, V54, P263, DOI 10.1016/0013-7944(95)00178-6; Toyosada M, 2004, INT J FATIGUE, V26, P983, DOI 10.1016/j.ijfatigue.2003.12.006; ASTM Standard, 2011, E104985 ASTM; Fricke W., 2013, P PRADS 2013 CHANGW, P465; Fricke W, 2012, P INT MAR DES C, V3, P3; Gotoh K, 2013, J JASNAOE, V17, P75; Gotoh K., 2012, P 6 INT C HYDR MAR T, P287; Haibach E, 1971, C FAT WELD STRUCT CA, V2, P328; Health and Safety Executive (UK-HSE), 2012, STAT TECHN GUID INF; Japanese Industrial Standard, 2008, G3106 JIS; Matsuda K., 2013, P OMAE 2013; Newman Jr JC, 1992, 104156 NASA; Newman Jr JC., 1981, 198181941 NASA, P81941; Osawa N, 2014, P OMAE 2014; Toyoda K, 2012, P HYDR MAR TECHN, P367; TOYOSADA M, 1994, INT J FRACTURE, V67, P217, DOI 10.1007/BF00016261	16	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0951-8339	1873-4170		MAR STRUCT	Mar. Struct.	APR	2015	41						77	95		10.1016/j.marstruc.2014.12.005		19	Engineering, Marine; Engineering, Civil	Engineering	CG2DT	WOS:000353085800004		
J	Inoue, D; Yoshida, K; Yoneda, N; Ozaki, K; Matsubara, T; Nagai, K; Okumura, K; Toshima, F; Toyama, J; Minami, T; Matsui, O; Gabata, T; Zen, Y				Inoue, Dai; Yoshida, Kotaro; Yoneda, Norihide; Ozaki, Kumi; Matsubara, Takashi; Nagai, Keiichi; Okumura, Kenichirou; Toshima, Fumihito; Toyama, Jun; Minami, Tetsuya; Matsui, Osamu; Gabata, Toshifumi; Zen, Yoh			IgG4-Related Disease: Dataset of 235 Consecutive Patients	MEDICINE			English	Article							AUTOIMMUNE PANCREATITIS; SERUM IGG4; SCLEROSING PANCREATITIS; CLOSE RELATIONSHIP; IMMUNOGLOBULIN G4; CT FINDINGS; CANCER; MANIFESTATIONS; PERIAORTITIS; CHOLANGITIS	Immunoglobulin G4-related disease (IgG4-RD) is a recently discovered systemic condition, in which various organ manifestations are linked by a similar histological appearance. Our knowledge of this condition is still fragmented, as most studies have examined only a few dozen patients or focused on a particular organ manifestation. This study was conducted to learn the demography and patient characteristics of IgG4-RD using a large cohort. A total of 235 consecutive patients with IgG4-RD, diagnosed in 8 general hospitals in the same medical district, were identified by searching the institutions' radiology database. Inclusion criteria were histology-proven IgG4-RD according to the Pathology Consensus Statement and/or definitive type 1 autoimmune pancreatitis meeting the International Consensus Diagnostic Criteria. Clinical notes and images of selected patients were retrospectively reviewed. All patients were adults (M/F = 4/1). The median age was 67 years (range 35-86). Nine tenths were diagnosed in their 50s to 70s. Among 486 manifestations identified in total, the most common was pancreatitis diagnosed in 142 patients (60%), followed by sialadenitis (34%), tubulointerstitial nephritis (23%), dacryoadenitis (23%), and periaortitis (20%). The majority of patients (95%) had at least 1 of the 5 most common manifestations. Male and female patients differed in their organ manifestations (periaortitis more common in males and sialodacryoadenitis more common in females). Serum IgG4 (normal <= 135 mg/dL) was elevated to >135 mg/dL in 208 patients (88%) and >270 mg/dL in 167 (71%). The IgG4 value was significantly higher in patients with multiorgan involvement than in those with a single manifestation (median 629 mg/dL vs 299 mg/dL, P<0.01). Of 218 patients, for whom both IgG4 and IgG values were available, the IgG4/IgG ratio was raised to >10% in 194 (89%). Corticosteroids were effective, but the relapse rate was estimated to be 24% in the study period (median 37 months). During the follow-up, 15 malignant diseases were diagnosed in 13 patients (6%). This figure is similar to the incidence (12.9 cancers) expected from the Japanese nationwide study for cancer epidemiology (standardized incidence ratio 1.16). In conclusion, this reliable dataset could improve the characterization of IgG4-RD, particularly its unique demography and the frequency of each organ manifestation.	[Inoue, Dai; Yoshida, Kotaro; Yoneda, Norihide; Ozaki, Kumi; Matsubara, Takashi; Nagai, Keiichi; Okumura, Kenichirou; Toshima, Fumihito; Toyama, Jun; Minami, Tetsuya; Matsui, Osamu; Gabata, Toshifumi] Kanazawa Univ, Grad Sch Med Sci, Dept Radiol, Kanazawa, Ishikawa, Japan; [Zen, Yoh] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Pathol Network Sect, Kobe, Hyogo 6500017, Japan	Zen, Y (reprint author), Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Pathol Network Sect, Kobe, Hyogo 6500017, Japan.	d-inoue@lake.ocn.ne.jp; yohzen@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26860986]	This work was supported in part by a Grant-in-Aid for Scientific Research (26860986) from the Ministry of Education, Culture, Sports, Science and Technology.	Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Fujita A, 2012, RADIOGRAPHICS, V32, P1945, DOI 10.1148/rg.327125032; Kamisawa T, 2003, GUT, V52, P683, DOI 10.1136/gut.52.5.683; Matsuda T, 2012, JPN J CLIN ONCOL, V42, P139, DOI 10.1093/jjco/hyr184; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Zen Y, 2009, AM J SURG PATHOL, V33, P1833; Yamamoto M, 2005, RHEUMATOLOGY, V44, P227, DOI 10.1093/rheumatology/keh447; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Inoue D, 2011, RADIOLOGY, V261, P625, DOI 10.1148/radiol.11102250; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Inoue D, 2009, RADIOLOGY, V251, P260, DOI 10.1148/radiol.2511080965; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Stone JH, 2012, ARTHRITIS RHEUM-US, V64, P3061, DOI 10.1002/art.34593; Sahani DV, 2004, RADIOLOGY, V233, P345, DOI 10.1148/radiol.2332031436; Sah RP, 2011, CURR OPIN RHEUMATOL, V23, P108, DOI 10.1097/BOR.0b013e3283413469; Zen Y, 2010, AM J SURG PATHOL, V34, P1812, DOI 10.1097/PAS.0b013e3181f7266b; Shiokawa M, 2013, AM J GASTROENTEROL, V108, P610, DOI 10.1038/ajg.2012.465; Oseini AM, 2011, HEPATOLOGY, V54, P940, DOI 10.1002/hep.24487; Yamamoto M, 2012, MOD RHEUMATOL, V22, P419, DOI 10.1007/s10165-011-0532-6; Kasashima S, 2008, AM J SURG PATHOL, V32, P197, DOI 10.1097/PAS.0b013e3181342f0d; Zen Y, 2004, AM J SURG PATHOL, V28, P1193, DOI 10.1097/01.pas.0000136449.37936.6c; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Takahashi N, 2007, RADIOLOGY, V242, P791, DOI 10.1148/radiol.2423060003; Geyer JT, 2010, AM J SURG PATHOL, V34, P202, DOI 10.1097/PAS.0b013e3181c811ad; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Fujinaga Y, 2009, EUR J RADIOL, V76, P228; Irie H, 1998, AM J ROENTGENOL, V170, P1323; Kamisawa T, 2015, LANCET, V385, P1460, DOI 10.1016/S0140-6736(14)60720-0; Kitagawa S, 2005, AM J SURG PATHOL, V29, P783, DOI 10.1097/01.pas.0000164031.59940.fc; Masaki Y, 2012, INT J RHEUMATOL, V2012, DOI [DOI 10.1155/2012/580814, 10.1155/2012/580814]	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	APR	2015	94	15								10.1097/MD.0000000000000680		8	Medicine, General & Internal	General & Internal Medicine	CG3AO	WOS:000353149000013		
J	Maehara, T; Moriyama, M; Kawano, S; Hayashida, JN; Furukawa, S; Ohta, M; Tanaka, A; Yamauchi, M; Ohyama, Y; Kiyoshima, T; Nakamura, S				Maehara, Takashi; Moriyama, Masafumi; Kawano, Shintaro; Hayashida, Jun-Nosuke; Furukawa, Sachiko; Ohta, Miho; Tanaka, Akihiko; Yamauchi, Masaki; Ohyama, Yukiko; Kiyoshima, Tamotsu; Nakamura, Seiji			Cytokine Profiles Contribute to Understanding the Pathogenic Difference Between Good Syndrome and Oral Lichen Planus Two Case Reports and Literature Review	MEDICINE			English	Review							PRIMARY SJOGRENS-SYNDROME; T-CELLS; THYMOMA; DISEASE; HYPOGAMMAGLOBULINEMIA; LYMPHOCYTES; PATIENT; LESIONS	We described and analyzed the pathogenic difference between Good syndrome (GS) and oral lichen planus (OLP) in oral mucosa. Good syndrome (GS) is a rare disease characterized by B and T cell immunodeficiency associated with hypogammaglobulinemia and thymoma. GS patients frequently develop oral lichenoid lesions with lymphocytic infiltration beneath the basal layer. Oral lichen planus (OLP) is a chronic inflammatory disease of the oral mucosa characterized by destruction of basal cells by Langerhans cells, macrophages, and T lymphocytes. Although the histological features of the lesions of both diseases are very similar, the pathogenesis of GS in the oral mucosa remains unknown. In this study, we thus investigated the expression of infiltrating lymphocyte subsets (CD3, CD20, CD4, and CD8) and T helper (Th) cytokines including interferon (IFN)-g (Th1 type), interleukin (IL) -4 (Th2 type), IL -17 (Th17 type), and IL -10 (regulatory T cell type) by immunohistochemistry in buccal mucosa specimens from 2 GS patients compared with 15 OLP patients. All patients showed a predominance of CD3(+) T cells over CD20(+) B cells, and CD4(+) Th cells over CD8(+) cytotoxic T cells. This polarization was especially prominent in GS. IFN-gamma and IL-10 were strongly detected in the infiltrating lymphocytes of all patients. However, IL -4 and IL -17 were detected in OLP patients only. These results suggest that the pathogenesis of GS is different from that of OLP. GS is a unique inflammatory disorder characterized by dysfunction of Th2 and Th17 immune reactions via abnormal T -B cell interaction.	Kyushu Univ, Fac Dent Sci, Div Maxillofacial Diagnost & Surg Sci, Lab Oral Pathol, Fukuoka 8128582, Japan	Moriyama, M (reprint author), Kyushu Univ, Sect Oral & Maxillofacial Oncol, Div Maxillofacial Diagnost & Surg Sci, Fac Dent Sci,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	moriyama@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26463013]	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://kaken.nii.ac.jp/d/p/26463013.ja.html), grant number: 26463013.	Kelesidis T, 2010, CLIN IMMUNOL, V135, P347, DOI 10.1016/j.clim.2010.01.006; Lodi G, 2005, ORAL SURG ORAL MED O, V100, P40, DOI 10.1016/j.tripleo.2004.06.077; Johnson SB, 2001, ONCOLOGIST, V6, P239, DOI 10.1634/theoncologist.6-3-239; MORGENTHALER TI, 1993, MAYO CLIN PROC, V68, P1110; Iijima W, 2003, AM J PATHOL, V163, P261, DOI 10.1016/S0002-9440(10)63649-8; HAYWARD AR, 1982, CLIN EXP IMMUNOL, V48, P437; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Maehara T, 2012, CLIN EXP IMMUNOL, V169, P89, DOI 10.1111/j.1365-2249.2012.04606.x; Seneschal J, 2008, J EUR ACAD DERMATOL, V22, P506, DOI 10.1111/j.1468-3083.2007.02370.x; Maehara T, 2012, ANN RHEUM DIS, V71, P2011, DOI 10.1136/annrheumdis-2012-201477; GOOD ROBERT A., 1955, JOUR LANCET, V75, P245; JAGER J, 1986, NETH J MED, V29, P118; Kawamura E, 2003, J ORAL PATHOL MED, V32, P282; KORNSTEIN MJ, 1985, ARCH PATHOL LAB MED, V109, P460; LEVINSON AI, 1985, J ALLERGY CLIN IMMUN, V76, P433, DOI 10.1016/0091-6749(85)90723-7; Miyakis S, 2006, SCAND J INFECT DIS, V38, P314, DOI 10.1080/00365540500372663; Moriyama M, 2012, CLIN EXP IMMUNOL, V169, P17, DOI 10.1111/j.1365-2249.2012.04587.x; SUGERMAN PB, 1994, BRIT J DERMATOL, V131, P319, DOI 10.1111/j.1365-2133.1994.tb08517.x; Tao XA, 2010, ORAL DIS, V16, P76, DOI 10.1111/j.1601-0825.2009.01608.x; YAMAZAKI K, 1994, INTERNAL MED, V33, P496, DOI 10.2169/internalmedicine.33.496	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	APR	2015	94	14							e704	10.1097/MD.0000000000000704		5	Medicine, General & Internal	General & Internal Medicine	CF8ET	WOS:000352789400014		
J	Nishina-Uchida, N; Fukuzawa, R; Hasegawa, Y; Morison, IM				Nishina-Uchida, Noriko; Fukuzawa, Ryuji; Hasegawa, Yukihiro; Morison, Ian M.			Identification of X Monosomy Cells From a Gonad of Mixed Gonadal Dysgenesis With a 46, XY Karyotype Case Report	MEDICINE			English	Article							DIFFERENTIATION	Mixed gonadal dysgenesis (MGD) is a disorder of sexual development that typically has a mosaic 45, X/46, XY karyotype. A 1-year-old infant with 46, XY identified by peripheral blood karyotype demonstrated clinical manifestations and gonadal pathologic features of MGD. Fluorescence in situ hybridization (FISH) for X and Y chromosomes and immunofluorescence for SRY along with testicular and ovarian lineage markers SOX9 and FOXL2, respectively, were performed on paraffin sections from the gonad to ascertain the somatic mosaic state for 45, Xmonosomy and 46, XYcells. The gonad consisted of cells withX and XY signals, which were further quantified in comparison with a normal control testis by a digital image analysis program. The average percentages of 45, X cells of this patient's gonad and a control testis were 39.0% and 5.7%, respectively (chi(2) test, P< 0.001). SRY expression was absent in approximately 10% of precursor granulosa cells (FOXL2 positive) and precursor Sertoli/granulosa cells (both SOX9 and FOXL2 positive) within gonadoblastomas, confirming the involvement of 45, X cells. A combination of analysis of FISH and immunofluorescence for SRY in the gonadal tissue could identify 45, X cells in MGD with 46, XY.	[Nishina-Uchida, Noriko; Fukuzawa, Ryuji] Tokyo Metropolitan Childrens Med Ctr, Mol & Dev Pathol Res Grp, Fuchu, Tokyo 1838561, Japan; [Nishina-Uchida, Noriko; Hasegawa, Yukihiro] Tokyo Metropolitan Childrens Med Ctr, Div Endocrinol & Metab, Fuchu, Tokyo 1838561, Japan; [Fukuzawa, Ryuji] Tokyo Metropolitan Childrens Med Ctr, Dept Pathol & Lab Med, Fuchu, Tokyo 1838561, Japan; [Morison, Ian M.] Univ Otago, Dept Pathol, Dunedin Sch Med, Dunedin, New Zealand	Fukuzawa, R (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Pathol & Lab Med, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	fukuzawa@1998.jukuin.keio.ac.jp	Morison, Ian/A-1236-2008	Morison, Ian/0000-0003-3616-0025	New Zealand and Japan Partnership Strategy; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [25460427]	New Zealand and Japan Partnership Strategy, Japan Society for the Promotion of Science, and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (25460427).	Anand A, 2010, INDIAN J PATHOL MICR, V53, P313, DOI 10.4103/0377-4929.64297; Hersmus R, 2008, J PATHOL, V215, P31, DOI 10.1002/path.2335; Modi D, 2005, REPRODUCTION, V130, P603, DOI 10.1530/rep.1.00413; Telvi L, 1999, PEDIATRICS, V104, P304, DOI 10.1542/peds.104.2.304; Cools M, 2007, CLIN ENDOCRINOL, V67, P184, DOI 10.1111/j.1365-2265.2007.02859.x; Bergeron MB, 2011, PEDIATR DEVEL PATHOL, V14, P445, DOI 10.2350/11-01-0960-OA.1; DAVIDOFF F, 1973, PEDIATRICS, V52, P725; Kent J, DEVELOPMENT; Ottolenghi C, HUM MOL GENET; Pena-Alonso R, 2005, MODERN PATHOL, V18, P439, DOI 10.1038/modpathol.3800293; SOHVAL AR, 1963, AM J HUM GENET, V15, P155; YAMAKITA N, 1989, JPN J MED, V28, P744	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	APR	2015	94	14							e720	10.1097/MD.0000000000000720		5	Medicine, General & Internal	General & Internal Medicine	CF8ET	WOS:000352789400017		
J	Ohashi-Fukuda, N; Inokuchi, R; Sato, H; Nakamura, K; Iwagami, M; Wada, T; Jona, M; Hisasue, T; Nakajima, S; Yahagi, N				Ohashi-Fukuda, Naoko; Inokuchi, Ryota; Sato, Hajime; Nakamura, Kensuke; Iwagami, Masao; Wada, Tomoki; Jona, Masahiro; Hisasue, Takashi; Nakajima, Susumu; Yahagi, Naoki			Poorer Prognosis With Ethylenediaminetetraacetic Acid-dependent Pseudothrombocytopenia A Single-center Case-control Study	MEDICINE			English	Article							ARTIFACT	In ethylenediaminetetraacetic acid (EDTA)-dependent pseudothrombocytopenia (PTCP), automated platelet counts are lower than actual counts because of EDTA-induced aggregation. Factors contributing to the incidence of EDTA-PTCP are unknown, and no study has assessed the prognosis of EDTA-PTCP patients. This retrospective study assessed characteristics in EDTA-PTCP patients and matched controls to determine differences in prognosis. A retrospective case-control study was designed. From the University of Tokyo Hospital database, we identified patients diagnosed with EDTA-PTCP between 2009 and 2012, and performed 1: 2 case:control matching for age and sex. A control group of sex-and age-matched patients was selected at random from the same database. We investigated differences in the frequency of complications, medication history, and blood transfusion history between the groups at the time of blood collection. Prognosis was evaluated using multivariate Cox regression analysis adjusting for age, sex, autoimmune disease, liver disease, and malignant tumor. We identified 104 EDTA-PTCP patients and 208 matched controls. The median age was 69.0 years (interquartile range: 54-76), with men comprising 51%. EDTA-PTCP patients had a higher frequency of malignant tumor and a lower frequency of hypertension and diabetes than controls. After adjustment for background factors, prognosis of EDTA-PTCP patients was significantly poorer than controls (hazard ratio, 11.8; 95% confidence intervals, 2.62-53.54). In conclusion, EDTA-PTCP patients had higher mortality, and EDTA-PTCP may need to be recognized as an indicator of worse prognosis.	[Ohashi-Fukuda, Naoko; Inokuchi, Ryota; Nakamura, Kensuke; Wada, Tomoki; Nakajima, Susumu; Yahagi, Naoki] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan; [Inokuchi, Ryota] JR Gen Hosp, Dept Emergency Med, Sibuya Ku, Tokyo, Japan; [Nakamura, Kensuke] Hitachi Gen Hosp, Dept Emergency & Crit Care Med, Hitachi, Ibaraki, Japan; [Sato, Hajime] Natl Inst Publ Hlth, Dept Hlth Policy & Technol Assessment, Wako, Saitama 3510197, Japan; [Iwagami, Masao] London Sch Hyg & Trop Med, London WC1, England; [Jona, Masahiro; Hisasue, Takashi] Tokyo Univ Hosp, Dept Clin Lab Med, Bunkyo Ku, Tokyo 1138655, Japan	Inokuchi, R (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	inokuchir-icu@h.u-tokyo.ac.jp					Akbayram S, 2011, CLIN APPL THROMB-HEM, V17, P494, DOI 10.1177/1076029610373367; Allerheiligen D, 1996, J Am Board Fam Pract, V9, P212; PAYNE BA, 1984, MAYO CLIN PROC, V59, P123; SUAREZ JG, 1992, AM J HEMATOL, V39, P146, DOI 10.1002/ajh.2830390215; BIZZARO N, 1995, AM J HEMATOL, V50, P103, DOI 10.1002/ajh.2830500206; Lippi G, 2012, CLIN CHEM LAB MED, V50, P1281, DOI 10.1515/cclm-2012-0081; BERKMAN N, 1991, AM J HEMATOL, V36, P195, DOI 10.1002/ajh.2830360307; CASONATO A, 1994, J CLIN PATHOL, V47, P625, DOI 10.1136/jcp.47.7.625; Bartels PCM, 1997, SCAND J CLIN LAB INV, V57, P629, DOI 10.3109/00365519709055287; CUNNINGHAM VL, 1992, AM J CLIN PATHOL, V97, P359; Kim HJ, 2012, ONCOL LETT, V4, P86, DOI 10.3892/ol.2012.675; Nagler Michael, 2014, BMC Clin Pathol, V14, P19, DOI 10.1186/1472-6890-14-19; Ohashi N, 2013, AM J EMERG MED, V31; Sakurai S, 1997, BRIT J HAEMATOL, V99, P817, DOI 10.1046/j.1365-2141.1997.4773280.x; SAVAGE RA, 1984, AM J CLIN PATHOL, V81, P317; VANVLIET HHDM, 1986, BRIT J HAEMATOL, V62, P501	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	APR	2015	94	15								10.1097/MD.0000000000000674		4	Medicine, General & Internal	General & Internal Medicine	CG3AO	WOS:000353149000012		
J	Yamada, Y; Yamada, M; Sugisawa, K; Akita, H; Shiomi, E; Abe, T; Okuda, S; Jinzaki, M				Yamada, Yoshitake; Yamada, Minoru; Sugisawa, Koichi; Akita, Hirotaka; Shiomi, Eisuke; Abe, Takayuki; Okuda, Shigeo; Jinzaki, Masahiro			Renal Cyst Pseudoenhancement: Intraindividual Comparison Between Virtual Monochromatic Spectral Images and Conventional Polychromatic 120-kVp Images Obtained During the Same CT Examination and Comparisons Among Images Reconstructed Using Filtered Back Projection, Adaptive Statistical Iterative Reconstruction, and Model-Based Iterative Reconstruction	MEDICINE			English	Article							CONTRAST-ENHANCED CT; COMPUTED-TOMOGRAPHY; MULTIDETECTOR CT; DOSE REDUCTION; MDCT; PHANTOM; ATTENUATION; ANGIOGRAPHY; DETECTORS; QUALITY	The purpose of this study was to compare renal cyst pseudoenhancement between virtual monochromatic spectral (VMS) and conventional polychromatic 120-kVp images obtained during the same abdominal computed tomography (CT) examination and among images reconstructed using filtered back projection (FBP), adaptive statistical iterative reconstruction (ASIR), and model-based iterative reconstruction (MBIR). Our institutional review board approved this prospective study; each participant provided written informed consent. Thirty-one patients (19 men, 12 women; age range, 59-85 years; mean age, 73.2 +/- 5.5 years) with renal cysts underwent unenhanced 120-kVp CT followed by sequential fast kVp-switching dual-energy (80/140 kVp) and 120-kVp abdominal enhanced CT in the nephrographic phase over a 10-cm scan length with a random acquisition order and 4.5-second intervals. Fifty-one renal cysts (maximal diameter, 18.0 +/- 14.7mm [range, 4-61 mm]) were identified. The CT attenuation values of the cysts as well as of the kidneys were measured on the unenhanced images, enhanced VMS images (at 70 keV) reconstructed using FBP and ASIR from dual-energy data, and enhanced 120-kVp images reconstructed using FBP, ASIR, and MBIR. The results were analyzed using the mixed-effects model and paired t test with Bonferroni correction. The attenuation increases (pseudoenhancement) of the renal cysts on the VMS images reconstructed using FBP/ASIR (least square mean, 5.0/6.0 Hounsfield units [HU]; 95% confidence interval, 2.6-7.4/3.6-8.4 HU) were significantly lower than those on the conventional 120-kVp images reconstructed using FBP/ASIR/MBIR (least square mean, 12.1/12.8/11.8 HU; 95% confidence interval, 9.8-14.5/10.4-15.1/9.4-14.2 HU) (all P<.001); on the other hand, the CT attenuation values of the kidneys on the VMS images were comparable to those on the 120-kVp images. Regardless of the reconstruction algorithm, 70-keV VMS images showed a lower degree of pseudoenhancement of renal cysts than 120-kVp images, while maintaining kidney contrast enhancement comparable to that on 120-kVp images.	[Yamada, Yoshitake; Sugisawa, Koichi; Akita, Hirotaka; Shiomi, Eisuke; Okuda, Shigeo; Jinzaki, Masahiro] Keio Univ, Sch Med, Dept Diagnost Radiol, Shinjuku Ku, Tokyo 1608582, Japan; [Yamada, Minoru] Keio Univ, Sch Med, Multidimens Biomed Imaging & Informat Lab Res Pk, Shinjuku Ku, Tokyo 1608582, Japan; [Abe, Takayuki] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth,Ctr Clin Res, Shinjuku Ku, Tokyo 1608582, Japan	Jinzaki, M (reprint author), Keio Univ, Sch Med, Dept Diagnost Radiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	jinzaki@rad.med.keio.ac.jp			JSPS KAKENHI [23591795, 26861016]; GE Healthcare Japan	This study was supported in part by JSPS KAKENHI Grant Number 23591795 and 26861016. Masahiro Jinzaki received a grant from GE Healthcare Japan. The remaining authors (YY, MY, KS, HA, ES, TA, and SO) have no financial disclosures to make and had complete unrestricted access to the study data at all stages of the study. None of the authors are employees of GE Healthcare or received individual industry funding for this project.	American Association of Physicists in Medicine, 2008, MEAS REP MAN RAD DOS; Leipsic J, 2010, AM J ROENTGENOL, V195, P649, DOI 10.2214/AJR.10.4285; Mitsumori LM, 2012, EUR RADIOL, V22, P138, DOI 10.1007/s00330-011-2186-3; Sai V, 2013, CLIN IMAG, V37, P520, DOI 10.1016/j.clinimag.2012.09.016; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Whiting BR, 2006, MED PHYS, V33, P3290, DOI 10.1118/1.2230762; Bae KT, 2000, RADIOLOGY, V216, P792; Yamada Y, 2012, INVEST RADIOL, V47, P292, DOI 10.1097/RLI.0b013e318240a874; Singh S, 2012, J COMPUT ASSIST TOMO, V36, P347, DOI 10.1097/RCT.0b013e31824e639e; BOSNIAK MA, 1986, RADIOLOGY, V158, P1; Sommer CM, 2010, INVEST RADIOL, V45, P406, DOI 10.1097/RLI.0b013e3181dfdabd; Coulam CH, 2000, AM J ROENTGENOL, V174, P493; Tappouni R, 2012, AM J ROENTGENOL, V198, P133, DOI 10.2214/AJR.10.6057; Maki DD, 1999, RADIOLOGY, V213, P468; Yamada Y, 2012, INVEST RADIOL, V47, P482, DOI 10.1097/RLI.0b013e3182562a89; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013; Yu Z, 2011, IEEE T IMAGE PROCESS, V20, P161, DOI 10.1109/TIP.2010.2058811; Birnbaum BA, 2002, RADIOLOGY, V225, P83, DOI 10.1148/radiol.2251010930; Sommer CM, 2012, EUR J RADIOL, V81, P692, DOI 10.1016/j.ejrad.2011.01.087; ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Birnbaum BA, 2007, RADIOLOGY, V244, P767, DOI 10.1148/radiol.2443061537; Bouman C, 1993, IEEE Trans Image Process, V2, P296, DOI 10.1109/83.236536; Chung EP, 2004, AM J ROENTGENOL, V182, P405; De Man B, 2004, PHYS MED BIOL, V49, P2463, DOI 10.1088/0031-9155/49/11/024; Dilmanian FA, 1992, AM J PHYSL IMAGING, V7, P175; Jinzaki M, 2004, AM J ROENTGENOL, V183, P223; Jung DC, 2012, AM J ROENTGENOL, V199, P1316, DOI 10.2214/AJR.12.8660; Lin XZ, 2011, J COMPUT ASSIST TOMO, V35, P294, DOI 10.1097/RCT.0b013e3182058d5c; Mileto A, 2014, RADIOLOGY; Silva AC, 2011, RADIOGRAPHICS, V31, P1031, DOI 10.1148/rg.314105159; Wang ZJ, 2008, RADIOLOGY, V248, P910, DOI 10.1148/radiol.2482071583; Wu X, 2009, P SOC PHOTO-OPT INS, V7258, DOI 10.1117/12.811698; Yamada Y, 2014, J CARDIOVASC COMPUT, V8, P391, DOI 10.1016/j.jcct.2014.08.005; Yamada Y, 2014, EUR J RADIOL, V83, P1715, DOI 10.1016/j.ejrad.2014.06.004	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	APR	2015	94	15								10.1097/MD.0000000000000754		8	Medicine, General & Internal	General & Internal Medicine	CG3AO	WOS:000353149000020		
J	Pal, P; Ashok, A; Haldar, S; Xing, Y; Sato, K				Pal, Prem; Ashok, Akarapu; Haldar, Subhomoy; Xing, Yan; Sato, Kazuo			Anisotropic etching in low-concentration KOH: effects of surfactant concentration	Micro & Nano Letters			English	Article							SINGLE-CRYSTAL SILICON; TMAH WATER SOLUTION; SOLAR-CELL; ORIENTATION; ETCHANTS; BEHAVIOR	Potassium hydroxide (KOH) provides high anisotropy between the Si{111} and Si{100} planes in comparison to tetramethylammonium hydroxide (TMAH). Moreover, the etch rate of Si{100} is higher in KOH than in TMAH, which is indispensable for high productivity to reduce the cost of end products. The etching study of pure and surfactant-added low-concentration KOH is presented. Triton X-100, with formula C14H22O(C2H4O)(n), where n = 9, 10, is used as the surfactant. This research focuses on the investigation of the effect of surfactant on the etching characteristics of low-concentration KOH. The value of the surfactant concentration ranges from 100 ppb to 1000 ppm and the etching temperature ranges from 60 to 76 degrees C. The low-concentration KOH is selected because of its low cost and because of its use as an oxide layer and as an etch mask. Furthermore, the etchant is explored for the fabrication of silicon dioxide micromechanical structures. The addition of a small amount of surfactant reduces the undercutting at the convex corners. This property is explored to perform almost conformal etching to fabricate microstructures with minimum undercutting at mask edges and corners.	[Pal, Prem; Ashok, Akarapu; Haldar, Subhomoy] Indian Inst Technol Hyderabad, Dept Phys, MEMS & Micro Nano Syst Lab, Hyderabad, Andhra Pradesh, India; [Xing, Yan] Southeast Univ, Dept Mech Engn, Lab Micronano Med Devices, Nanjing, Jiangsu, Peoples R China; [Sato, Kazuo] Aichi Inst Technol, Dept Mech Engn, Toyota, Aichi, Japan	Pal, P (reprint author), Indian Inst Technol Hyderabad, Dept Phys, MEMS & Micro Nano Syst Lab, Hyderabad, Andhra Pradesh, India.	prem@iith.ac.in			Department of Science and Technology, India [SR/S3/MERC/072/2011]; Japan Society for the Promotion of Science (JSPS); NSFC, China [51375093 NSFC]	The authors acknowledge support by a research grant from the Department of Science and Technology (project no. SR/S3/MERC/072/2011), India; the Japan Society for the Promotion of Science (JSPS); and a research grant from NSFC (no. 51375093 NSFC), China.	Iencinella D, 2005, SOL ENERG MAT SOL C, V87, P725, DOI 10.1016/j.solmat.2004.09.020; Pal P, 2009, J MICROELECTROMECH S, V18, P1345, DOI 10.1109/JMEMS.2009.2031688; Chen PH, 2001, SENSOR ACTUAT A-PHYS, V93, P132, DOI 10.1016/S0924-4247(01)00639-2; Dutta S, 2011, MICROSYST TECHNOL, V17, P1621, DOI 10.1007/s00542-011-1351-6; Biswas K, 2006, MICROELECTRON J, V37, P519, DOI 10.1016/j.mejo.2005.07.012; Rola KP, 2013, J MICROELECTROMECH S, V22, P1373, DOI 10.1109/JMEMS.2013.2262590; Tang B, 2009, SENSOR ACTUAT A-PHYS, V156, P334, DOI 10.1016/j.sna.2009.10.017; Paria S, 2004, ADV COLLOID INTERFAC, V110, P75, DOI 10.1016/j.cis.2004.03.001; Yang CR, 2005, SENSOR ACTUAT A-PHYS, V119, P263, DOI 10.1016/j.sna.2004.07.015; Zubel I, 2001, SENSOR ACTUAT A-PHYS, V93, P138, DOI 10.1016/S0924-4247(01)00648-3; Papet P, 2006, SOL ENERG MAT SOL C, V90, P2319, DOI 10.1016/j.solmat.2006.03.005; Cheng D, 2006, SENSOR ACTUAT A-PHYS, V125, P415, DOI 10.1016/j.sna.2005.08.022; Anoop Prakash A.B, 2013, IJCA P INT C INN INT, P26; Cho WJ, 2004, SENSOR ACTUAT A-PHYS, V116, P357, DOI 10.1016/j.sna.2004.04.033; Gad-el-Hak M., 2005, MEMS APPL MEMS HDB; Gosalvez MA, 2010, SENSOR ACTUAT A-PHYS, V157, P91, DOI 10.1016/j.sna.2009.10.023; JEON JS, 1995, J ELECTROCHEM SOC, V142, P621, DOI 10.1149/1.2044111; MATSUOKA M, 1992, J CHEM ENG JPN, V25, P735, DOI 10.1252/jcej.25.735; Pal P, 2007, J MICROMECH MICROENG, V17, pR1; Pal P, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/10/105008; Pal P, 2007, J MICROMECH MICROENG, V17, P2299, DOI 10.1088/0960-1317/17/11/017; Pal P, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.056702; Pal P, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/1/015008; Rosa M., 2001, SOL ENERG MAT SOL C, V95, P2987; Sato K, 1998, SENSOR ACTUAT A-PHYS, V64, P87, DOI 10.1016/S0924-4247(97)01658-0; Sato K, 1999, SENSOR ACTUAT A-PHYS, V73, P131, DOI 10.1016/S0924-4247(98)00271-4; SCHNAKENBERG U, 1990, SENSOR ACTUAT A-PHYS, V23, P1031, DOI 10.1016/0924-4247(90)87084-V; Seidel H., 1990, J ELECTROCHEM SOC, V137, P11; TABATA O, 1992, SENSOR ACTUAT A-PHYS, V34, P51, DOI 10.1016/0924-4247(92)80139-T; Tanaka H., 2013, TRANSD 2013 BARC SPA, P1978; Tanaka H, 2004, SENSOR ACTUAT A-PHYS, V114, P516, DOI 10.1016/j.sna.2003.11.036; Tang B, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.056501; Tellier CR, 2003, SENSOR ACTUAT A-PHYS, V105, P62, DOI 10.1016/S0924-4247(03)00064-5; Yang CR, 2005, J MICROMECH MICROENG, V15, P2028, DOI 10.1088/0960-1317/15/11/006; Yang CR, 2005, SENSOR ACTUAT A-PHYS, V119, P271, DOI 10.1016/j.sna.2004.09.017	35	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1750-0443			MICRO NANO LETT	Micro Nano Lett.	APR	2015	10	4					224	228		10.1049/mnl.2014.0685		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	CG8JM	WOS:000353553500010		
J	Ohsawa, H; Baba, T; Enami, J; Hiramatsu, K				Ohsawa, Hiroyoshi; Baba, Tadashi; Enami, Jumpei; Hiramatsu, Keiichi			Successful selection of an infection-protective anti-Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models	MICROBIOLOGY AND IMMUNOLOGY			English	Article						monoclonal antibody; peptidoglycan; Staphylococcus aureus; vaccine	CAPSULAR POLYSACCHARIDE; CELL-WALL; RECEIVING HEMODIALYSIS; UNITED-STATES; VACCINE; RESISTANT; VANCOMYCIN; PEPTIDOGLYCAN; PROTEIN; DETERMINANTS	Recent clinical trials to develop anti-methicillin-resistant Staphylococcus aureus (MRSA) therapeutic antibodies have met unsuccessful sequels. To develop more effective antibodies against MRSA infection, a panel of mAbs against S. aureus cell wall was generated and then screened for the most protective mAb in mouse infection models. Twenty-two anti-S. aureus IgG mAbs were obtained from mice that had been immunized with alkali-processed, deacetylated cell walls of S. aureus. One of these mAbs, ZBIA5H, exhibited life-saving effects in mouse models of sepsis caused by community-acquired MRSA strain MW2 and vancomycin-resistant S. aureus strain VRS1. It also had a curative effect in a MW2-caused pneumonia model. Curiously, the target of ZBIA5H was considered to be a conformational epitope of either the 1,4--linkage between N-acetylmuramic acid and N-acetyl-D-glucosamine or the peptidoglycan per se. Reactivity of ZBIA5H to S. aureus whole cells or purified peptidoglycan was weaker than that of most of the other mAbs generated in this study. However, the latter mAbs did not have the protective activities against S. aureus that ZBIA5H did. These data indicate that the epitopes that trigger production of high-yield and/or high-affinity antibodies may not be the most suitable epitopes for developing anti-infective antibodies. ZBIA5H or its humanized form may find a future clinical application, and its target epitope may be used for the production of vaccines against S. aureus infection.	[Ohsawa, Hiroyoshi; Enami, Jumpei] Cent Res Lab, Nerima Ku, Tokyo 1780062, Japan; [Ohsawa, Hiroyoshi; Baba, Tadashi; Hiramatsu, Keiichi] Juntendo Univ, Dept Bacteriol, Bunnkyo Ku, Tokyo 1138421, Japan	Ohsawa, H (reprint author), Cent Res Lab, Microbiol & Immunol, Dept Safety, Nerima Ku, 2-33-7 Ohizumi Machi, Tokyo 1780062, Japan.	Hiroyoshi_Ohsawa@mail.zenyaku.co.jp			Zenyaku Kogyo (Tokyo, Japan)	This study was supported by Zenyaku Kogyo (Tokyo, Japan).	Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; van Hal SJ, 2013, CLIN INFECT DIS, V56, P1779, DOI 10.1093/cid/cit178; Walsh S, 2004, PHARM RES, V21, P1770, DOI 10.1023/B:PHAM.0000045227.16829.37; Burnie JP, 2000, INFECT IMMUN, V68, P3200, DOI 10.1128/IAI.68.6.3200-3209.2000; Shinefield H, 2002, NEW ENGL J MED, V346, P491, DOI 10.1056/NEJMoa011297; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Schaffer AC, 2009, INFECT DIS CLIN N AM, V23, P153, DOI 10.1016/j.idc.2008.10.005; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005; Berry DS, 2002, INFECT IMMUN, V70, P3707, DOI 10.1128/IAI.70.7.3707-3713.2002; Daum RS, 2012, CLIN INFECT DIS, V54, P560, DOI 10.1093/cid/cir828; Weisman LE, 2011, PEDIATRICS, V128, P271, DOI 10.1542/peds.2010-3081; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Mera RM, 2011, MICROB DRUG RESIST, V17, P321, DOI 10.1089/mdr.2010.0193; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Jansen KU, 2013, VACCINE, V31, P2723, DOI 10.1016/j.vaccine.2013.04.002; Weems JJ, 2006, ANTIMICROB AGENTS CH, V50, P2751, DOI 10.1128/AAC.00096-06; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Capparelli R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028377; Centers for Disease Control and Prevention, 1999, MMWR-MORBID MORTAL W, V48, P707; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Chen YG, 2011, J MED MICROBIOL, V60, P995, DOI 10.1099/jmm.0.028647-0; Fattom AI, 1998, INFECT IMMUN, V66, P4588; Fattom AI, 1996, INFECT IMMUN, V64, P1659; Masuta K, 2012, CLIN INFECT DIS, V55, P161, DOI 10.1093/cid/cis331; Moustafa M, 2012, CLIN VACCINE IMMUNOL, V19, P1509, DOI 10.1128/CVI.00034-12; Senchenkova SN, 1997, EUR J BIOCHEM, V245, P637, DOI 10.1111/j.1432-1033.1997.00637.x; VERBRUGH HA, 1981, J INFECT DIS, V144, P1; WERGELAND HI, 1987, J CLIN MICROBIOL, V25, P540; YAMADA JK, 1983, J CLIN MICROBIOL, V17, P898	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	APR	2015	59	4					183	192		10.1111/1348-0421.12242		10	Immunology; Microbiology	Immunology; Microbiology	CG5AD	WOS:000353299800001		
J	Nukuzuma, S; Sugiura, S; Nakamichi, K; Kameoka, M; Nukuzuma, C; Tasaki, T; Takegami, T				Nukuzuma, Souichi; Sugiura, Shigeki; Nakamichi, Kazuo; Kameoka, Masanori; Nukuzuma, Chiyoko; Tasaki, Takafumi; Takegami, Tsutomu			Replication of IMR-32-adapted JC virus clones in human embryonic kidney cells	MICROBIOLOGY AND IMMUNOLOGY			English	Article						293 cells; DNA replication assay; IMR-32-adapted JCVs; large T antigen	PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; T-ANTIGEN; LINE; GROWTH; DNA; ESTABLISHMENT; POLYOMAVIRUS; BRAIN	It has been difficult to study JCV replication because of its restricted host range. In this study, JCV replication was examined using different clones in 293cells. RT-PCR assay revealed that large T antigen expression in cells transfected with IMR-32-adapted JCVs was significantly greater than in those transfected with Mad-1 or CY. DNA replication assay and viral load verified that the IMR-32-adapted JCVs were replication-competent in 293cells, but not Mad-1 or CY JCVs. These results suggest that a 293 culture system with IMR-32-adapted JCVs may be a useful tool for assessing replication of JCV in vitro.	[Nukuzuma, Souichi] Kobe Inst Hlth, Dept Infect Dis, Chuo Ku, Kobe, Hyogo 6500046, Japan; [Sugiura, Shigeki] Nara Med Sch, Med Genet Res Ctr, Kashihara, Nara 6348521, Japan; [Nakamichi, Kazuo] Natl Inst Infect Dis, Dept Virol 1, Shinjuku Ku, Tokyo 1628640, Japan; [Kameoka, Masanori] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Suma Ku, Kobe, Hyogo 6150124, Japan; [Nukuzuma, Chiyoko] Tokyo SOARA Clin, Shinagawa Ku, Tokyo 1410022, Japan; [Tasaki, Takafumi] Kanazawa Med Univ, Med Res Inst, Divison Prot Regulat Res, Uchinada, Ishikawa 9200293, Japan; [Takegami, Tsutomu] Kanazawa Med Univ, Med Res Inst, Div Mol Oncol & Virol, Uchinada, Ishikawa 9200293, Japan	Nukuzuma, S (reprint author), Kobe Inst Hlth, Dept Infect Dis, Chuo Ku, 4-6 Minatojima Nakamachi, Kobe, Hyogo 6500046, Japan.	s-nuku@gj8.so-net.ne.jp			Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labor and Welfare of Japan [H24-AIDS-Wakate-002]; Kanazawa Medical University [H2011-10]	We thank Dr Y. Yogo for kindly providing the JCV plasmids. This work was supported by Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus Infection and from the Research on HIV/AIDS (H24-AIDS-Wakate-002), the Ministry of Health, Labor and Welfare of Japan, and in part by a Grant for Project Research from the High-Tech Center (H2011-10) of Kanazawa Medical University.	AKATANI K, 1994, J MED VIROL, V43, P13, DOI 10.1002/jmv.1890430104; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; PADGETT BL, 1973, J INFECT DIS, V127, P467; STONER GL, 1988, J NEUROIMMUNOL, V17, P331, DOI 10.1016/0165-5728(88)90124-5; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Dang X, 2012, J GEN VIROL, V93, P175, DOI 10.1099/vir.0.037440-0; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hara K, 1998, J VIROL, V72, P5335; MIYAMURA T, 1980, J VIROL, V35, P498; Nukuzuma S, 2014, J MED VIROL, V86, P2026, DOI 10.1002/jmv.23886; Nukuzuma S, 2009, MICROBIOL IMMUNOL, V53, P621, DOI 10.1111/j.1348-0421.2009.00166.x; NUKUZUMA S, 1995, J MED VIROL, V47, P370, DOI 10.1002/jmv.1890470413; YOGO Y, 1993, VIROLOGY, V197, P793, DOI 10.1006/viro.1993.1659; YOSHIIKE K, 1982, J VIROL, V42, P395	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	APR	2015	59	4					238	242		10.1111/1348-0421.12243		5	Immunology; Microbiology	Immunology; Microbiology	CG5AD	WOS:000353299800007		
J	Kikuchi, H; Nakayama, M; Kawai, C; Kuribayashi, F; Mimuro, H; Imajoh-Ohmi, S; Nishitoh, H; Takami, Y; Nakayama, T				Kikuchi, Hidehiko; Nakayama, Masami; Kawai, Chikage; Kuribayashi, Futoshi; Mimuro, Hitomi; Imajoh-Ohmi, Shinobu; Nishitoh, Hideki; Takami, Yasunari; Nakayama, Tatsuo			Histone acetyltransferase p300/CBP-associated factor is an effective suppressor of secretory immunoglobulin synthesis in immature B cells	MICROBIOLOGY AND IMMUNOLOGY			English	Article						epigenetic regulation; histone acetyltransferase; immunoglobulin; p300; CBP-associated factor	PRE-MESSENGER-RNA; IGM H-CHAIN; GENE-EXPRESSION; TRANSCRIPTION; DIFFERENTIATION; HDAC2; DEFICIENCIES; LINE; GCN5; DT40	The histone acetyltransferase p300/CBP-associated factor (PCAF) catalyzes acetylation of core histones and plays important roles in epigenetics by altering the chromatin structure in vertebrates. In this study, PCAF-deficient DT40 mutants were analyzed and it was found that PCAF participates in regulation of secretory IgM heavy chain (H-chain) synthesis. Remarkably, PCAF-deficiency causes an increase in the amount of secretory IgM H-chain mRNA, but not in that of IgM light chain and membrane-bound IgM H-chain mRNAs, resulting in dramatic up-regulation of the amount of secretory IgM protein. These findings suggest that PCAF regulates soluble antibody production and is thus an effective suppressor of secretory IgM H-chain synthesis.	[Kikuchi, Hidehiko; Nakayama, Masami; Nishitoh, Hideki; Takami, Yasunari; Nakayama, Tatsuo] Miyazaki Univ, Fac Med, Dept Med Sci, Sect Biochem & Mol Biol, Miyazaki 8891692, Japan; [Kikuchi, Hidehiko; Kuribayashi, Futoshi; Mimuro, Hitomi] Univ Tokyo, Div Bacteriol, Dept Infect Dis Control, Int Res Ctr Infect Dis,Minato Ku, Tokyo 1088639, Japan; [Imajoh-Ohmi, Shinobu] Univ Tokyo, Lab Ctr Prote Res, Grad Sch Frontier Sci, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Kawai, Chikage; Kuribayashi, Futoshi] Kawasaki Med Univ, Dept Biochem, Kurashiki, Okayama 7010192, Japan	Kikuchi, H (reprint author), Miyazaki Univ, Fac Med, Dept Med Sci, Sect Biochem & Mol Biol, 5200 Kihara, Miyazaki 8891692, Japan.	masakari@med.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25430170]; Institute of Medical Science, University of Tokyo	We thank N. Nagamatsu-Yamamoto for technical support and H. Madhyastha and R. Madhyastha for editorial reading of the manuscript. This work was supported in part by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25430170, to H.K.). This work was also partly supported by a Grant for Joint Research Project from the Institute of Medical Science, University of Tokyo.	Kikuchi H, 2014, GENE, V544, P19, DOI 10.1016/j.gene.2014.04.030; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Lee SC, 2003, MOL IMMUNOL, V39, P923, DOI 10.1016/S0161-5890(03)00029-4; Kurosawa K, 2010, J BIOCHEM, V148, P201, DOI 10.1093/jb/mvq054; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Todo K, 2006, J BIOSCI BIOENG, V102, P478, DOI 10.1263/jbb.102.478; Biel M, 2005, ANGEW CHEM INT EDIT, V44, P3186, DOI 10.1002/anie.200461346; Liadaki K, 2013, CURR OPIN IMMUNOL, V25, P629, DOI 10.1016/j.coi.2013.06.003; Nakayama M, 2007, GENES CELLS, V12, P359, DOI 10.1111/j.1365-2443.2007.01059.x; Kikuchi H, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406389; LAMSON G, 1984, J EXP MED, V160, P877, DOI 10.1084/jem.160.3.877; Lin W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1122; Lu ZP, 2005, BIOCHEM BIOPH RES CO, V330, P204, DOI 10.1016/j.bbrc.2005.02.147; Selvi Ruthrotha B, 2009, Biotechnol J, V4, P375, DOI 10.1002/biot.200900032; Takami Y, 1999, J BIOL CHEM, V274, P23977, DOI 10.1074/jbc.274.34.23977; Takechi S, 2002, BIOCHEM BIOPH RES CO, V299, P263, DOI 10.1016/S0006-291X(02)02630-X; Vickery John D., 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P133	19	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	APR	2015	59	4					243	247		10.1111/1348-0421.12237		5	Immunology; Microbiology	Immunology; Microbiology	CG5AD	WOS:000353299800008		
J	Lin, B; Yin, TF; Wu, YI; Inoue, T; Levchenko, A				Lin, Benjamin; Yin, Taofei; Wu, Yi I.; Inoue, Takanari; Levchenko, Andre			Interplay between chemotaxis and contact inhibition of locomotion determines exploratory cell migration	Nature Communications			English	Article							CARCINOMA-CELLS; RAC ACTIVATION; EPH RECEPTORS; CANCER-CELLS; SPATIOTEMPORAL DYNAMICS; NEUTROPHIL CHEMOTAXIS; GENE-EXPRESSION; RHOA ACTIVITY; LIVING CELLS; POLARIZATION	Directed cell migration in native environments is influenced by multiple migratory cues. These cues may include simultaneously occurring attractive soluble growth factor gradients and repulsive effects arising from cell-cell contact, termed contact inhibition of locomotion (CIL). How single cells reconcile potentially conflicting cues remains poorly understood. Here we show that a dynamic crosstalk between epidermal growth factor (EGF)-mediated chemotaxis and CIL guides metastatic breast cancer cell motility, whereby cells become progressively insensitive to CIL in a chemotactic input-dependent manner. This balance is determined via integration of protrusion-enhancing signalling from EGF gradients and protrusion-suppressing signalling induced by CIL, mediated in part through EphB. Our results further suggest that EphB and EGF signalling inputs control protrusion formation by converging onto regulation of phosphatidylinositol 3-kinase (PI3K). We propose that this intricate interplay may enhance the spread of loose cell ensembles in pathophysiological conditions such as cancer, and possibly other physiological settings.	[Lin, Benjamin; Inoue, Takanari; Levchenko, Andre] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Lin, Benjamin; Inoue, Takanari] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Lin, Benjamin; Levchenko, Andre] Yale Univ, Syst Biol Inst, Dept Biomed Engn, West Haven, CT 06516 USA; [Yin, Taofei; Wu, Yi I.] Univ Connecticut, Dept Genet & Dev Biol, Ctr Cell Anal & Modeling, Ctr Hlth, Farmington, CT 06032 USA; [Inoue, Takanari] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Inoue, T (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	jctinoue@jhmi.edu; andre.levchenko@yale.edu			NIH [GM072024, GM084332, GM092930]; NCI [CA155758]; JST [10216]; UCHC start-up fund	We thank J. Segall and A. J. Ewald for critical reading of the manuscript. This work was supported by the NIH (GM072024, GM084332 (A.L. and B.L.), (GM092930 (T.I.)), NCI (CA155758 (A.L., B.L.)), JST (10216 (T.I.)) and the UCHC start-up fund (T.F., Y.W.).	Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Wang WG, 2002, CANCER RES, V62, P6278; Desai RA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0717; DeRose R, 2013, PFLUG ARCH EUR J PHY, V465, P409, DOI 10.1007/s00424-012-1208-6; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.3.CO;2-3; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-12; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; El-Sibai M, 2008, EXP CELL RES, V314, P1540, DOI 10.1016/j.yexcr.2008.01.016; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Wyckoff JB, 2000, CANCER RES, V60, P2504; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Park KC, 2004, EMBO J, V23, P4177, DOI 10.1038/sj.emboj.7600368; ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Lin B, 2012, P NATL ACAD SCI USA, V109, pE3668, DOI 10.1073/pnas.1210295109; Villar-Cervino V, 2013, NEURON, V77, P457, DOI 10.1016/j.neuron.2012.11.023; ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Davis JR, 2012, DEVELOPMENT, V139, P4555, DOI 10.1242/dev.082248; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Wyckoff JB, 2000, CANCER RES, V60, P5401; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hodgson L., 2001, CURRENT PROTOCOLS CE; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Oike Y, 2002, BLOOD, V100, P1326; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; PADDOCK SW, 1986, J CELL SCI, V81, P163; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Scarpa E, 2013, BIOL OPEN, V2, P901, DOI 10.1242/bio.20135504; Sharma VP, 2012, INTRAVITAL, V1, P77, DOI DOI 10.4161/INTV.22054; Yip SC, 2007, J CELL SCI, V120, P3138, DOI 10.1242/jcs.005298	56	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	APR	2015	6								6619	10.1038/ncomms7619		14	Multidisciplinary Sciences	Science & Technology - Other Topics	CH0FU	WOS:000353695700001		
J	Nakakido, M; Deng, ZZ; Suzuki, T; Dohmae, N; Nakamura, Y; Hamamoto, R				Nakakido, Makoto; Deng, Zhenzhong; Suzuki, Takehiro; Dohmae, Naoshi; Nakamura, Yusuke; Hamamoto, Ryuji			Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN	NEOPLASIA			English	Article							HISTONE METHYLTRANSFERASE EZH2; TUMOR-SUPPRESSOR GENE; CANCER-CELLS; PHOSPHATASE-ACTIVITY; HUMAN CARCINOGENESIS; PHOSPHORYLATION; PROLIFERATION; IDENTIFICATION; COMPLEX; SMYD2	Phosphatase and tensin homologue (PTEN), one of the well-characterized tumor suppressor proteins, counteracts the phosphatidylinositol 3-kinase-AKT pathway through its unique lipid phosphatase activity. The functions of PTEN are regulated by a variety of posttranslational modifications such as acetylation, oxidation, ubiquitylation, phosphorylation, and SUMOylation. However, methylation of PTEN has not been reported so far. In this study, we demonstrated that the oncogenic protein lysine methyltransferase SET and MYND domain containing 2 (SMYD2) methylates PTEN at lysine 313 in vitro and in vivo. Knockdown of SMYD2 suppressed the cell growth of breast cancer cells and attenuated phosphorylation levels of AKT, indicating that SMYD2-mediated methylation negatively regulates PTEN tumor suppressor activity and results in activation of the phosphatidylinositol 3-kinase-AKT pathway. Furthermore, PTEN protein with lysine 313 substitution diminished phosphorylation of PTEN at serine 380, which is known to inactivate tumor suppressor functions of PTEN. Taken together, our findings unveil a novel mechanism of PTEN dysregulation regulated by lysine methylation in human cancer.	[Nakakido, Makoto; Deng, Zhenzhong; Nakamura, Yusuke; Hamamoto, Ryuji] Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA; [Suzuki, Takehiro; Dohmae, Naoshi] RIKEN, Ctr Sustainable Resource Sci, Biomol Characterizat Unit, Saitama, Japan	Hamamoto, R (reprint author), Univ Chicago, Dept Med, Sect Hematol Oncol, 5835 S Cottage Grove Ave,MC2115, Chicago, IL 60637 USA.	rhamamoto@medicine.bsd.uchicago.edu	Dohmae, Naoshi/C-2040-2011		Oncotherapy Science	Disclosure of potential conflicts of interest: Y.N. is a stockholder and a scientific advisor of Oncotherapy Science and also has research grants from Oncotherapy Science. No potential conflicts of interest were disclosed by the other authors.	Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Zhang X, 2013, P NATL ACAD SCI USA, V110, P17284, DOI 10.1073/pnas.1307959110; Hamamoto R, 2014, CANCER LETT, V351, P126, DOI 10.1016/j.canlet.2014.05.014; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Di Cristofano A, 1998, NAT GENET, V19, P348; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1067/jbc.C100556200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Toyokawa G, 2011, NEOPLASIA, V13, P887, DOI 10.1593/neo.11048; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M60391200; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Silva A, 2008, J CLIN INVEST, V118, P3762, DOI 10.1172/JCI34616; Kogure M, 2013, NEOPLASIA, V15, P1251, DOI 10.1593/neo.131436; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Diao LR, 2007, CELL RES, V17, P291, DOI 10.1038/cr.2007.24; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Weng LP, 1999, CANCER RES, V59, P5808; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Cho H.S., 2011, CANCER RES, V71, P1; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Piao L, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.002; Sone K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6691; Wu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008570	48	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1476-5586			NEOPLASIA	Neoplasia	APR	2015	17	4					367	373		10.1016/j.neo.2015.03.002		7	Oncology	Oncology	CG9HV	WOS:000353626700005		
J	Sasaki, T; Izawa, M; Okada, Y				Sasaki, Toshiyuki; Izawa, Masahiro; Okada, Yoshikazu			Current Trends in Health Insurance Systems: OECD Countries vs. Japan	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						medical insurance; health-care system; universal health insurance; Organization for Economic Co-operation and Development countries	CARE	Over the past few decades, the longest extension in life expectancy in the world has been observed in Japan. However, the sophistication of medical care and the expansion of the aging society, leads to continuous increase in health-care costs. Medical expenses as a part of gross domestic product (GDP) in Japan are exceeding the current Organization for Economic Co-operation and Development (OECD) average, challenging the universally, equally provided low cost health care existing in the past. A universal health insurance system is becoming a common system currently in developed countries, currently a similar system is being introduced in the United States. Medical care in Japan is under a social insurance system, but the injection of public funds for medical costs becomes very expensive for the Japanese society. In spite of some urgently decided measures to cover the high cost of advanced medical treatment, declining birthrate and aging population and the tendency to reduce hospital and outpatients' visits numbers and shorten hospital stays, medical expenses of Japan continue to be increasing.	[Sasaki, Toshiyuki; Izawa, Masahiro; Okada, Yoshikazu] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo 1608666, Japan	Sasaki, T (reprint author), Tokyo Womens Med Univ, Dept Neurosurg, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1608666, Japan.	tsasaki@nij.twmu.ac.jp					Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Hashimoto H, 2011, LANCET, V378, P1174, DOI 10.1016/S0140-6736(11)60987-2; Hashimoto S, 2010, J EPIDEMIOL, V20, P308, DOI 10.2188/jea.JE20090190; Ikegami N, 2004, HEALTH AFFAIR, V23, P26, DOI 10.1377/hlthaff.23.3.26; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; [Anonymous], 2009, OECD IND 2009; Hisao WC, 2007, SOCIAL HLTH INSURANC, P21; Ito M, 2004, NEUROL MED-CHIR, V44, P617, DOI 10.2176/nmc.44.617; Matsuda S., 2008, Eurohealth, V14, P25; Ministry of Health Labor and Welfare, 2005, DAT 3 PROJ NAT MED E; Wagstaff A., 2005, 3790 WORLD BANK; WHO, 2005, WORLD HLTH ASS GEN; World Health Organization, WHO HLTH REP 2000 HL	13	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					267	275		10.2176/nmc.ra.2014-0317		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900001		
J	Matsushima, T; Kawashima, M; Matsushima, K; Wanibuchi, M				Matsushima, Toshio; Kawashima, Masatou; Matsushima, Ken; Wanibuchi, Masahiko			Japanese Neurosurgeons and Microsurgical Anatomy: A Historical Review	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						microsurgical anatomy; Japanese neurosurgeons; Rhoton's laboratory; microsurgical anatomy seminar; education of the surgical anatomy	BI-TRANSTENTORIAL/FALCINE APPROACH; POSTERIOR INCISURAL SPACE; INTERNAL CAROTID-ARTERY; FACIAL-NERVE; CEREBRAL REVASCULARIZATION; CHOROIDAL ARTERIES; ENDOSCOPIC ANATOMY; PETROSAL APPROACH; SURGICAL ANATOMY; CAVERNOUS SINUS	Research in microneurosurgical anatomy has contributed to great advances in neurosurgery in the last 40 years. Many Japanese neurosurgeons have traveled abroad to study microsurgical anatomy and played major roles in advancing and spreading the knowledge of anatomy, overcoming their disadvantage that the cadaver study has been strictly limited inside Japan. In Japan, they initiated an educational system for surgical anatomy that has contributed to the development and standardization of Japanese neurosurgery. For example, the Japanese Society for Microsurgical Anatomy started an annual educational meeting in the middle of 1980s and published its proceedings in Japanese every year for approximately 20 years. These are some of the achievements that bring worldwide credit to Japanese neurosurgeons. Not only should Japanese neurosurgeons improve their educational system but they should also contribute to the international education in this field, particularly in Asia.	[Matsushima, Toshio] Fukuoka Sanno Hosp, Neurosci Ctr, Fukuoka, Fukuoka 8140001, Japan; [Kawashima, Masatou] Saga Univ, Fac Med, Dept Neurosurg, Saga, Saga 840, Japan; [Matsushima, Ken] Univ Florida, Dept Neurol Surg, Gainesville, FL USA; [Wanibuchi, Masahiko] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido, Japan	Matsushima, T (reprint author), Fukuoka Sanno Hosp, Neurosci Ctr, Sawara Ku, 3-6-45 Momochihama, Fukuoka, Fukuoka 8140001, Japan.	matsuto@kouhoukai.or.jp					Kawashima M, 2006, SURG NEUROL, V65, P436, DOI 10.1016/j.surneu.2005.09.033; NATORI Y, 1995, NEUROSURGERY, V36, P762; Abe H, 2006, NEUROSURGERY, V58, P728, DOI 10.1227/01.NEU.0000204870.83778.A1; Tomii M, 2003, J NEUROSURG, V99, P121, DOI 10.3171/jns.2003.99.1.0121; FUJII K, 1979, J NEUROSURG, V50, P31, DOI 10.3171/jns.1979.50.1.0031; GIBO H, 1981, J NEUROSURG, V54, P151, DOI 10.3171/jns.1981.54.2.0151; Kawashima M, 2002, NEUROSURGERY, V51, P1208, DOI 10.1227/01.NEU.0000032542.40308.65; Noguchi A, 2005, J NEUROSURG, V102, P945, DOI 10.3171/jns.2005.102.5.0945; ONO M, 1984, NEUROSURGERY, V15, P621; Kawashima M, 2005, J NEUROSURG, V102, P132, DOI 10.3171/jns.2005.102.1.0132; Matsushima K, 2014, NEUROSURG REV, V37, P115, DOI 10.1007/s10143-013-0493-7; Inoue K, 2009, NEUROSURGERY, V65, P644, DOI 10.1227/01.NEU.0000351774.81674.32; SAEKI N, 1977, J NEUROSURG, V46, P563, DOI 10.3171/jns.1977.46.5.0563; MATSUSHIMA T, 1983, J NEUROSURG, V59, P63, DOI 10.3171/jns.1983.59.1.0063; OKA K, 1985, NEUROSURGERY, V17, P711; Matsushima K, 2014, J NEUROSURG, V121, P397, DOI 10.3171/2014.3.JNS132419; MATSUSHIMA T, 1982, NEUROSURGERY, V11, P631; Matsushima T, 1998, SKULL BASE SURG, V8, P119, DOI 10.1055/s-2008-1058570; Yoshioka N, 2005, NEUROSURGERY, V57, P11, DOI 10.1227/01.NEU.000163477.85087.B1; FUJII K, 1980, J NEUROSURG, V52, P165, DOI 10.3171/jns.1980.52.2.0165; Matsushima K, 2014, NEUROSURGERY, V10, P357, DOI 10.1227/NEU.0000000000000323; Osawa S, 2008, NEUROSURGERY, V63, P210, DOI 10.1227/01.NEU.0000327037.75571.10; Ueyama T, 1998, NEUROSURGERY, V43, P1137, DOI 10.1097/00006123-199811000-00068; NAGATA S, 1988, SURG NEUROL, V30, P3, DOI 10.1016/0090-3019(88)90180-2; FUJII K, 1980, J NEUROSURG, V52, P504, DOI 10.3171/jns.1980.52.4.0504; Osawa S, 2009, NEUROSURGERY, V64, P385, DOI 10.1227/01.NEU.0000338945.54863.D9; Kawashima M, 2005, J NEUROSURG, V102, P116, DOI 10.3171/jns.2005.102.1.0116; Funaki T, 2013, NEUROSURGERY, V73, P155, DOI 10.1227/01.neu.0000431469.82215.93; Sakata K, 2000, NEUROSURGERY, V47, P153, DOI 10.1097/00006123-200007000-00032; Arai H, 2003, SURG ANATOMY MICRONE; Arai H, 1996, NEUROSURGERY, V39, P1157, DOI 10.1097/00006123-199612000-00018; Asaoka K, 1999, J NEUROSURG, V91, P268, DOI 10.3171/jns.1999.91.2.0268; Fujii K, 1994, SERIES BRAIN ANATOMY, V1; Fujii K, 1990, SURG ANATOMY MICRONE; Fukushima T, 2010, FUKUSHIMA MANUAL SKU, V3; Funaki T, 2013, NEUROSURGERY S2, V73, DOI DOI 10.1227/01.NEU.0000431469.82215.93; GIBO H, 1981, J NEUROSURG, V55, P560, DOI 10.3171/jns.1981.55.4.0560; Gibo H, 1994, SERIES BRAIN ANATOMY, V4; Gibo H, 1993, SURG ANATOMY MICRONE; Gibo H, 2000, CLIN TOPOGRAPHIC NEU; Hongo K, 2006, SURG ANATOMY MICRONE; Inoue T, 2007, SURG ANATOMY MICRONE; INOUE T, 1990, NEUROSURGERY, V26, P903; Inoue T, 1993, SERIES BRAIN ANATOMY, V3; Ishii R, 1997, SURG ANATOMY MICROEN; Kakizawa Y, 2007, NEUROSURGERY S, V61, P23; Kakizawa Y, 2007, NEUROSURGERY, V60, P901, DOI 10.1227/01.NEU.0000255422.86054.51; Kakizawa Y, 2007, NEUROSURGERY, V61, P15, DOI 10.1227/01.NEU.0000279977.17932.EB; Kaneko N, 2012, NEUROSURGERY, V70, P298; Kaneko N, 2012, NEUROSURGERY, V70, P290, DOI 10.1227/NEU.0b013e3182315112; Katsuta T, 1997, NEUROSURGERY, V41, P149, DOI 10.1097/00006123-199707000-00030; Katsuta T, 1997, NEUROSURGERY, V41, P201; Katsuta T, 2000, NEUROL MED-CHIR, V40, P206, DOI 10.2176/nmc.40.206; Kawase T, 1996, NEUROSURGERY, V39, P527, DOI 10.1097/00006123-199609000-00019; Kawase T, 1998, SURG ANATOMY MICRONE; Kawashima M, 2003, NEUROSURGERY, V53, P662, DOI 10.1227/01.NEU.0000080070.16099.BB; Kawashima M, 2008, NEUROSURGERY, V62, P1136, DOI [10.1227/01.neu.0000333780.12058.44, 10.1227/01.NEU.0000032542.40308.65]; Kawashima M, 2003, J NEUROSURG, V98, P188, DOI 10.3171/spi.2003.98.2.0188; Kobayshi S, 1989, SURG ANATOMY MICRONE, VI; Komune N, 2014, NEUROSURGERY, V10, P334, DOI 10.1227/NEU.0000000000000324; Kusumi M, 2012, J NEUROSURG, V116, P566, DOI 10.3171/2011.11.JNS11985; MATSUNO H, 1988, NEUROSURGERY, V23, P58; Matsuno H, 1999, SURG ANATOMY MICRONE; Matsushima Ken, 2015, Neurosurgery, V11 Suppl 2, P135, DOI 10.1227/NEU.0000000000000570; Matsushima T, 2008, CLIN NEUROSCI, V26, P1406; Matsushima T, 1992, SERIES BRAIN ANATOMY, V8; Matsushima T, 2006, MICROSURGICAL ANATOM; Matsushima T, 1994, SURG ANATOMY MICRONE; Matsushima T, 1993, SERIES BRAIN ANATOMY, V9; MATSUSHIMA T, 1990, SURG NEUROL, V34, P87, DOI 10.1016/0090-3019(90)90102-U; MATSUSHIMA T, 1989, J NEUROSURG, V71, P923, DOI 10.3171/jns.1989.71.6.0923; Miyamoto S, 2011, JPN J NEUROSURG S2, V20, P5; Miyazaki Yoshihiro, 1994, Neurologia Medico-Chirurgica, V34, P150, DOI 10.2176/nmc.34.150; Mizuno J, 2004, SURG ANATOMY MICRONE; Morisako H, 2011, NEUROSURGERY S, V69, pons88; Muto J, 2010, NEUROSURGERY, V67; Muto J, 2010, NEUROSURGERY, V67, P291, DOI 10.1227/01.NEU.0000382967.84940.52; Nagata S, 2005, SURG ANATOMY MICRONE; Nagata S, 1993, SERIES BRAIN ANATOMY, V10; Nakagawa H, 1995, SURG ANATOMY MICROSU; NATORI Y, 1994, J NEUROSURG, V81, P78, DOI 10.3171/jns.1994.81.1.0078; Nonaka Y, 2013, NEUROSURG REV, V36, P579, DOI 10.1007/s10143-013-0482-x; Ohata K, 2001, SURG ANATOMY MICRONE; Ohue Shiro, 2010, Neurosurgery, V66, P306, DOI 10.1227/01.NEU.0000369703.67562.BB; Ohue S, 2012, NEUROSURG REV, V35, P583, DOI 10.1007/s10143-012-0389-y; Ohue S, 2010, NEUROSURGERY, V66, P312; Oka K, 2002, SURG ANATOMY MICRONE; ONO M, 1984, J NEUROSURG, V60, P365, DOI 10.3171/jns.1984.60.2.0365; RHOTON AL, 1968, J NEUROSURG, V29, P609, DOI 10.3171/jns.1968.29.6.0609; Rhoton Jr AL, 2003, NEUROSURGERY, P3; Rhoton Jr AL, 2003, CURRENTLY PRACTICAL, V13, P73; Shimizu S, 2005, NEUROSURGERY, V57, P152, DOI 10.1227/01.NEU.0000163600.31460.D8; Saeki M, 2000, SURG ANATOMY MICRONE; Saeki N, 1994, SERIES BRAIN ANATOMY, V7.; Sakata K, 2003, SURG ANATOMY MICRONE; Sameshima T, 2014, MICROANATOMY DISSECT; Sawamura Y, 1999, SKULL BASE SURG, V9, P119, DOI 10.1055/s-2008-1058158; Hitotsumatsu T, 2000, NEUROSURGERY, V46, P1416, DOI 10.1097/00006123-200006000-00025; Takemura Y, 2014, WORLD NEUROSURG, V82, P427, DOI 10.1016/j.wneu.2013.07.013; Terasaka S, 1999, SKULL BASE SURG, V9, P177, DOI 10.1055/s-2008-1058144; Tomio R, 2014, J NEUROSURG, V7, P1; Tsutsumi S, 2006, NEUROSURGERY, V59, P870, DOI 10.1227/01.NEU.0000232654.15306.4A; Wanibuchi M, 2011, NEUROSURGERY S, V69, pons95; Wanibuchi M, 2009, ATLAS MICROSURGICAL; Wanibuchi M, 2009, ACTA NEUROCHIR, V151, P1499, DOI 10.1007/s00701-009-0360-z; Wanibuchi M, 2009, PHOTO ATLAS SKULL BA; Yamamoto I, 1994, SERIES BRAIN ANATOMY, V5; YAMAMOTO I, 1980, J NEUROSURG, V53, P205, DOI 10.3171/jns.1980.53.2.0205; Yamamoto I, 1991, SURG ANATOMY MICRONE; Yamamoto I, 1993, SERIES BRAIN ANATOMY, V6; YAMAMOTO I, 1981, NEUROSURGERY, V8, P334; Yamaura A, 1992, SURG ANATOMY MICRONE; Yoshimoto S, 1996, SURG ANATOMY MICRONE; Yoshimoto T, 1994, SERIES BRAIN ANATOMY, V2; Yoshioka N, 2006, NEUROSURGERY, V58, P123, DOI 10.1227/01.NEU.0000193516.46104.27	115	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					276	285		10.2176/nmc.ra.2014-0408		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900002		
J	Narita, Y; Shibui, S				Narita, Yoshitaka; Shibui, Soichiro		Comm Brain Tumor Registry Japan	Trends and Outcomes in the Treatment of Gliomas Based on Data during 2001-2004 from the Brain Tumor Registry of Japan	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						brain tumor registry; glioma; glioblastoma; astrocytoma; oligodendroglioma	NERVOUS-SYSTEM TUMORS; LOW-GRADE GLIOMAS; UNITED-STATES; GLIOBLASTOMA; EPIDEMIOLOGY; RADIOTHERAPY; TEMOZOLOMIDE; CONCOMITANT; MANAGEMENT; RESECTION	The committee of Brain Tumor Registry of Japan (BTRJ) was founded in 1973 and conducts surveys and analyses of incidence, therapeutic methods, and treatment outcomes of primary and metastatic brain tumors with the cooperation of the Japan Neurosurgical Society members. Newly diagnosed 3,000-4,000 primary brain tumors and 600-1,000 brain metastases patients were enrolled in each year. This report describes the trends and treatment outcomes of gliomas from BTRJ volume 13, including 13,431 patients with primary brain tumors who newly started treatment from 2001 to 2004. Data from 382 diffuse astrocytomas (DAs), 121 oligodendrogliomas (OLs), 90 oligoastrocytomas (0As), 513 anaplastic astrocytomas (AM), 126 anaplastic oligodendrogliomas (AOs), 106 anaplastic oligoastrocytomas (AOAs), and 1,489 glioblastomas (GBMs) were analyzed for overall survival (OS) and progression free survival (PFS) depending on age, symptoms, Karnofsky performance status, location of the tumor, extent of resection (EOR), initial radiotherapy and chemotherapy. The 5-year PFS rates of the patients with DA, OL + OA, AA, AO + AOA, and GBM were 57.0%, 74.6%, 28.7%, 54.0%, and 9.2%, and the 5-year OS rates were 75.0%, 90.0%, 41.1%, 68.2%, and 10.1%, respectively. Higher EOR >= 75% in DA and OL + OA and that >= 50% in AA, AO + AOA, and GBM significantly prolonged OS. Complications and cause of death were also reported. BTRJ had been edited for all the patients, researchers, and especially for clinicians at bedside to give useful information about brain tumors and to contribute to the advances in brain tumor treatment. This report revealed various clinical problematic issues pertaining to the diagnosis and treatment of gliomas.	[Narita, Yoshitaka] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Tokyo 1040045, Japan; [Shibui, Soichiro] Teikyo Univ, Sch Med, Univ Hosp, Dept Neurosurg, Kawasaki, Kanagawa, Japan	Narita, Y (reprint author), Natl Canc Ctr, Dept Neurosurg & Neurooncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yonarita@ncc.go.jp					Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; [Anonymous], 1999, NEUROL MED CHIR TOKY, V39, P59; Potts MB, 2012, J NEUROSURG, V116, P365, DOI 10.3171/2011.9.JNS111068; Shibui S, 2013, CANCER CHEMOTH PHARM, V71, P511, DOI 10.1007/s00280-012-2041-5; Lee CH, 2010, J KOREAN NEUROSURG S, V48, P145, DOI 10.3340/jkns.2010.48.2.145; [Anonymous], 2000, NEUROL MED CHIR TO S, V40, P1; [Anonymous], 2009, NEUROL MED CHIR TO S, V49, pPS1; van den Bent MJ, 2005, LANCET, V366, P985, DOI 10.1016/S0140-6736(05)67070-5; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Bauchet L, 2007, J NEURO-ONCOL, V84, P189, DOI 10.1007/s11060-007-9356-9; Chang EF, 2008, J NEUROSURG, V108, P227, DOI 10.3171/JNS/2008/108/2/0227; NOMURA K, 1987, JPN J CLIN ONCOL, V17, P19; Nakamura H, 2011, INT J CLIN ONCOL, V16, P314, DOI 10.1007/s10147-010-0178-y; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; [Anonymous], 2003, NEUROL MED CHIR TO S, V43, pi; Thomas RP, 2013, J NEURO-ONCOL, V112, P91, DOI 10.1007/s11060-012-1030-1; Semrad TJ, 2007, J NEUROSURG, V106, P601, DOI 10.3171/jns.2007.106.4.601; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Brandes AA, 2009, J CLIN ONCOL, V27, P1275, DOI 10.1200/JCO.2008.19.4969; Babu R, 2013, J NEUROSURG, V119, P434, DOI 10.3171/2013.4.JNS122329; Brain Tumor Registry of Japan, 1992, NEUROL MED CHIR TOKY, V32, P381; Committee of Brain Tumor Registry of Japan, 1977, REPORT BRAIN TUMOR R, V1, P1; Gebhardt BJ, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-130; Jeswani S, 2013, NEUROSURGERY, V73, P240, DOI 10.1227/01.neu.0000430288.85680.37; Johnson DR, 2013, CANCER-AM CANCER SOC, V119, P3489, DOI 10.1002/cncr.28259; Jung Kyu-Won, 2013, Brain Tumor Res Treat, V1, P16, DOI 10.14791/btrt.2013.1.1.16; Kesari S, 2008, J NEURO-ONCOL, V88, P175, DOI 10.1007/s11060-008-9545-1; Louis DN, 2007, WHO CLASSIFICATION T; The Committee of Brain Tumor Registry of Japan, 2014, NEUROL MED CHIR TOKY, V54, P1; Velander AJ, 2012, CURR ATHEROSCLER REP, V14, P373, DOI 10.1007/s11883-012-0250-3	32	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					286	295		10.2176/nmc.ra.2014-0348		10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900003		
J	Nishimoto, H				Nishimoto, Hiroshi			Recent Progress and Future Issues in the Management of Abusive Head Trauma	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						abusive head trauma; shaken baby syndrome; child abuse; pediatric head injury; retinal hemorrhage	RETINAL HEMORRHAGES; BRAIN-INJURY; SUBDURAL-HEMATOMA; CHILD-ABUSE; EXTERNAL HYDROCEPHALUS; NONACCIDENTAL INJURY; BABY SYNDROME; INFANTS; AUTOPSY; MRI	Head trauma is the leading cause of death in child abuse cases and one of the important issues in the care of abused children. Since the Child Abuse Prevention Law was enforced in 2000 in Japan, various measures have been taken to prevent child abuse over the following decade. Accordingly, medical research on abusive head trauma (AHT)has advanced, leading to significant progress in the medical diagnosis of AHT. This progress has been brought about by (1) the widespread establishment of child protection teams (CPTs) at core hospitals, (2) the progress in neuroradiological imaging and ophthalmoscopic technologies, and (3) the introduction of postmortem imaging. However, the pathological condition of patients with AHT, particularly that of the diffuse brain swelling type, still remains poorly understood. As a result, no clear treatment strategies for AHT have been developed and no treatment outcomes have been improved to date. The development of new treatment strategies for AHT and the construction of a comprehensive database that supports clinical studies are required in the future.	[Nishimoto, Hiroshi] Saitama Childrens Med Ctr, Dept Neurosurg, Iwatsuki, Saitama, Japan; [Nishimoto, Hiroshi] Kasukabe Municipital Hosp, Dept Neurosurg, Kasukabe, Saitama 3448588, Japan	Nishimoto, H (reprint author), Kasukabe Municipital Hosp, Dept Neurosurg, 7-2-1 Chuo, Kasukabe, Saitama 3448588, Japan.	hiro_nishi1130@fd5.so-net.ne.jp					Adelson PD, 2009, J NEUROTRAUM, V26, P429, DOI 10.1089/neu.2008.0571; Anderson SE, 2011, RADIOLOGY, V262, P597; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Barnes PD, 2011, RADIOL CLIN N AM, V49, P205, DOI 10.1016/j.rcl.2010.08.001; Case ME, 2008, BRAIN PATHOL, V18, P571, DOI 10.1111/j.1750-3639.2008.00204.x; Oluigbo CO, 2012, J NEUROSURG-PEDIATR, V9, P125, DOI 10.3171/2011.11.PEDS09449; Green MA, 1996, BRIT J OPHTHALMOL, V80, P282, DOI 10.1136/bjo.80.4.282; Demaerel P, 2012, MAGN RESON IMAGING C, V20, P35, DOI 10.1016/j.mric.2011.08.007; Ashwal S, 2010, DEV NEUROSCI-BASEL, V32, P343, DOI 10.1159/000316801; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Vinchon M, 2005, J NEUROSURG, V102, P380; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Proisy M, 2013, EUR RADIOL, V23, P1711, DOI 10.1007/s00330-012-2738-1; [Anonymous], 2008, STAND RAD INV SUSP N; Chalian M, 2011, J NEURORADIOLOGY, V38, P187, DOI 10.1016/j.neurad.2010.12.006; Datta S, 2005, ARCH DIS CHILD, V90, P947, DOI 10.1136/adc.2002.021154; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Hart BL, 1996, AM J FOREN MED PATH, V17, P217, DOI 10.1097/00000433-199609000-00008; Kadom N, 2014, PEDIATR RADIOL, V44, P839, DOI 10.1007/s00247-014-2874-7; AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; Aoki N, 2011, NERVOUS SYSTEM CHILD, V36, P326; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Dias MS, 2002, NEUROSURG CLIN N AM, V13, P247, DOI 10.1016/S1042-3680(01)00009-2; Greenwald MJ, 1990, SEMIN OPHTHALMOL, V5, P202, DOI 10.3109/08820539009060172; Jaspan T, 2003, CLIN RADIOL, V58, P44, DOI 10.1053/crad.2002.1094; Kemp AM, 2010, ARCH DIS CHILD, V95, P355, DOI 10.1136/adc.2009.169110; KLEINMAN PK, 1989, NEW ENGL J MED, V320, P507, DOI 10.1056/NEJM198902233200807; Laurent-Vannier A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P533, DOI 10.1016/j.rehab.2011.10.003; Levin AV, 2009, PEDIATR CLIN N AM, V56, P333, DOI 10.1016/j.pcl.2009.02.003; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Miyazaki Y, 2012, P 12 INT C SHAK BAB; Morad Y, 2010, CLIN EXP OPHTHALMOL, V38, P514, DOI 10.1111/j.1442-9071.2010.02291.x; Nagashima T, 2007, NERVOUS SYSTEM CHILD, V32, P430; Nakagawa TA, 2001, ARCH PEDIAT ADOL MED, V155, P1149; Nishimoto H, 2006, NERVOUS SYSTEM CHILD, V31, P215; Noda Y, 2013, BIOMED RES INT, DOI 10.1155/2013/327903; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Rajaram S, 2010, POSTGRAD MED J, V87, P355; Ravid S, 2003, PEDIATR NEUROL, V28, P139, DOI 10.1016/S0887-8994(02)00500-3; Section on Radiology, 2009, PEDIATRICS, V123, P1430; Stoodley N, 2005, CLIN RADIOL, V60, P22, DOI 10.1016/j.crad.2004.06.023; [The Ministry of Health Labour and Welfare Ministry of Health Labour and Welfare], ANN HLTH LAB WELF RE; Vinchon M, 2010, CHILD NERV SYST, V26, P1195, DOI 10.1007/s00381-010-1105-2; Yilmaz U, 2014, CLIN NEURORADIOL; Zimmerman RA, 2007, J NEURORADIOLOGY, V34, P109, DOI 10.1016/j.neurad.2007.01.124; Zuccoli G, 2013, NEURORADIOLOGY, V55, P889, DOI 10.1007/s00234-013-1180-7	53	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					296	304		10.2176/nmc.ra.2014-0349		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900004		
J	Hasegawa, M; Nouri, M; Fujisawa, H; Hayashi, Y; Inamasu, J; Hirose, Y; Yamashita, J				Hasegawa, Mitsuhiro; Nouri, Mohsen; Fujisawa, Hironori; Hayashi, Yutaka; Inamasu, Joji; Hirose, Yuichi; Yamashita, Junkoh			Efficacy of Monitoring Patient's Position during Neurosurgical Procedures: Introduction of Real-time Display and Record	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						monitoring; operating table; position; real-time display	INTRACRANIAL-PRESSURE; SYSTEM	There are many reports on positionrelated complications in neurosurgical literature but so far, continuous quantification of the patient's position during the surgery has not been reported. This study aims to explore the utility of a new surgical table system and its software in displaying the patient's body positions during surgery on real-time basis. More than 200 neurosurgical cases were monitored for their positions intra-operatively. The position was digitally recorded and could be seen by all the members in the operating team. It also displayed the three-dimensional relationship between the head and the heart positions. No position-related complications were observed during the study. The system was able to serve as an excellent indicator for monitoring the patient's position. The recordings were analyzed and even used to reproduce or improve the position in the subsequent operations. The novel technique of monitoring the position of the head and the heart of the patients and the operating table planes are considered to be useful during delicate neurosurgical procedures thereby, preventing inadvertent procedural errors. This can be used to quantify various surgical positions in the future and define safety measures accordingly.	[Hasegawa, Mitsuhiro; Nouri, Mohsen; Inamasu, Joji; Hirose, Yuichi] Fujita Hlth Univ, Dept Neurosurg, Toyoake, Aichi, Japan; [Hasegawa, Mitsuhiro; Fujisawa, Hironori; Hayashi, Yutaka; Yamashita, Junkoh] Kanazawa Univ Hosp, Dept Neurosurg, Kanazawa, Ishikawa, Japan	Hasegawa, M (reprint author), Fujita Hlth Univ Hosp, Dept Neurosurg, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	mhasegawa-nsu@umin.ac.jp					Rogus RD, 1999, MED PHYS, V26, P721, DOI 10.1118/1.598578; Schwartz DM, 2000, J SPINAL DISORD, V13, P178, DOI 10.1097/00002517-200004000-00015; Rozet Irene, 2007, Anesthesiol Clin, V25, P631, DOI 10.1016/j.anclin.2007.05.009; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Johnson LS, 1999, INT J RADIAT ONCOL, V45, P205, DOI 10.1016/S0360-3016(99)00182-0; Larsen JKR, 2002, J NEUROSURG ANESTH, V14, P16; Porter JM, 1999, BRIT J ANAESTH, V82, P117; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; St-Arnaud D, 2009, CAN OPER ROOM NURS J, V27, P18; St-Arnaud Danielle, 2009, Can Oper Room Nurs J, V27, P7; St-Arnaud D, 2009, CAN OPER ROOM NURS J, V27, P16	11	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					305	310		10.2176/nmc.oa.2014-0256		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900005		
J	Hara, Y; Goto, T; Okamoto, J; Okuda, H; Iseki, H; Hongo, K				Hara, Yosuke; Goto, Tetsuya; Okamoto, Jun; Okuda, Hideki; Iseki, Hiroshi; Hongo, Kazuhiro			An Armrest Is Effective for Reducing Hand Tremble in Neurosurgeons	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						armrest; hand tremble; microsurgery; three-dimensional optical coordinate measuring machine; tremor	PHYSIOLOGICAL TREMOR; MICRONEUROSURGERY; COMPONENT; MOVEMENT	Experienced neurosurgeons reduce hand tremble by placing their hand beside the operative field when performing microneurosurgery conventionally. Another solution to reduce hand tremble is an armrest. However, the reduction of hand tremble by using an armrest or finger-placing technique has not been rigorously measured in microneurosurgery. This study was performed to provide a quantitative assessment of the efficacy of an armrest to reduce hand tremble in comparison with the finger-placing technique. Hand tremble was evaluated in 11 board-certified neurosurgeons in a simulated microneurosurgery. The loci of surgical forceps handled by neurosurgeons were measured by a three-dimensional optical coordinate measuring machine. A static task was performed under four conditions: with/without the finger-placing technique and/or an armrest. The radius of an imaginative sphere including 95% of each locus was calculated and reviewed according to the four conditions. Hand tremble was significantly larger when the finger-placing technique was not implemented compared to when the technique was used (P < 0.05). The armrest also reduced hand tremble (P < 0.05) similar to the finger-placing technique. Non-inferiority was retained between the finger-placing technique and the armrest. Concomitant use of the armrest and the finger-placing technique did not interfere with the efficacy of the technique to reduce neurosurgeon's hand tremble. The finger-placing technique was confirmed to reduce hand tremble. Resting the neurosurgeon's forearm on an armrest also reduced the hand tremble. An armrest is a device that reduces hand tremble in neurosurgeons like the finger-placing technique.	[Hara, Yosuke; Goto, Tetsuya; Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 3908621, Japan; [Okamoto, Jun; Iseki, Hiroshi] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Okuda, Hideki] DENSO Corp, Healthcare Business Dept, Kariya, Aichi, Japan	Goto, T (reprint author), Shinshu Univ, Sch Med, Dept Neurosurg, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tegotou@shinshu-u.ac.jp					Ohta T, 2000, NEUROSURGERY, V46, P1259, DOI 10.1097/00006123-200005000-00049; Elble RJ, 1996, J CLIN NEUROPHYSIOL, V13, P133, DOI 10.1097/00004691-199603000-00004; Deuschl G, 1998, MOVEMENT DISORD, V13, P2; BURNE JA, 1984, J PHYSIOL-LONDON, V348, P559; Coulson CJ, 2010, MICROSURG, V30, P565, DOI 10.1002/micr.20776; Csokay A, 2009, SURG NEUROL, V71, P469, DOI [10.1016/j.surneu.2008.05.003, 10.1016/j.surneu.2008.05.00]; DUFFY MM, 1968, PLAST RECONSTR SURG, V41, P87, DOI 10.1097/00006534-196801000-00021; ELBLE RJ, 1976, J NEUROPHYSIOL, V39, P370; Gathers I, 2006, EXP BRAIN RES, V171, P194; Jobbagy A, 2005, J NEUROSCI METH, V141, P29, DOI 10.1016/j.jneumeth.2004.05.009; LIPPOLD OCJ, 1970, J PHYSIOL-LONDON, V206, P359; SUGITA K, 1978, J NEUROSURG, V48, P656, DOI 10.3171/jns.1978.48.4.0656; Takanokura M, 2001, EUR J APPL PHYSIOL, V85, P214, DOI 10.1007/s004210100476; Goto Tetsuya, 2013, Neurosurgery, V72 Suppl 1, P39, DOI 10.1227/NEU.0b013e318271ee66; Yako T, 2009, INT J NEUROL NEUROSU, V1, P185; Yasargil MG, 1977, SURG NEUROL, V8, P331	16	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					311	316		10.2176/nmc.oa.2014-0384		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900006		
J	Takami, T; Naito, K; Yamagata, T; Ohata, K				Takami, Toshihiro; Naito, Kentaro; Yamagata, Toru; Ohata, Kenji			Surgical Management of Spinal Intramedullary Tumors: Radical and Safe Strategy for Benign Tumors	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						astrocytoma; cavernous malformation; ependymoma; hemangioblastoma; spinal intramedullary tumors	MOTOR EVOKED-POTENTIALS; ROOT ENTRY ZONE; CORD TUMORS; CLINICAL ARTICLE; EPENDYMOMAS; SURGERY; RESECTION; LAMINOPLASTY; REMOVAL; PAIN	Surgery for spinal intramedullary tumors remains one of the major challenges for neurosurgeons, due to their relative infrequency, unknown natural history, and surgical difficulty. We are sure that safe and precise resection of spinal intramedullary tumors, particularly encapsulated benign tumors, can result in acceptable or satisfactory postoperative outcomes. General surgical concepts and strategies, technical consideration, and functional outcomes after surgery are discussed with illustrative cases of spinal intramedullary benign tumors such as ependymoma, cavernous malformation, and hemangioblastoma. Selection of a posterior median sulcus, posterolateral sulcus, or direct transpial approach was determined based on the preoperative imaging diagnosis and careful inspection of the spinal cord surface. Tumor-cord interface was meticulously delineated in cases of benign encapsulated tumors. Our retrospective functional analysis of 24 consecutive cases of spinal intramedullary ependymoma followed for at least 6 months postoperatively demonstrated a mean grade on the modified McCormick functional schema of 1.8 before surgery, deteriorating significantly to 2.6 early after surgery (<1 month after surgery), and finally returning to 1.7 in the late postoperative period (>6 months after surgery). The risk of functional deterioration after surgery should be taken into serious consideration. Functional deterioration after surgery, including neuropathic pain even long after surgery, significantly affects patient quality of life. Better balance between tumor control and functional preservation can be achieved not only by the surgical technique or expertise, but also by intraoperative neurophysiological monitoring, vascular image guidance, and postoperative supportive care. Quality of life after surgery should inarguably be given top priority.	[Takami, Toshihiro; Naito, Kentaro; Ohata, Kenji] Osaka City Univ, Grad Sch Med, Dept Neurosurg, Osaka, Osaka 5458585, Japan; [Yamagata, Toru] Osaka City Gen Hosp, Dept Neurosurg, Osaka, Osaka, Japan	Takami, T (reprint author), Osaka City Univ, Grad Sch Med, Dept Neurosurg, Abeno Ku, 1-4-3 Asahi Machi, Osaka, Osaka 5458585, Japan.	ttakami@med.osaka-cu.ac.jp					Mitha AP, 2011, NEUROSURGERY, V68, P317, DOI 10.1227/NEU.0b013e3182138d6c; MCCORMICK PC, 1990, J NEUROSURG, V72, P523, DOI 10.3171/jns.1990.72.4.0523; Aghakhani N, 2008, NEUROSURGERY, V62, P1279, DOI 10.1227/01.neu.0000333299.26566.15; Hoshimaru M, 1999, NEUROSURGERY, V44, P264, DOI 10.1097/00006123-199902000-00012; Klekamp J, 2013, J NEUROSURG-SPINE, V19, P12, DOI 10.3171/2013.3.SPINE121063; Matsuyama Y, 2009, J NEUROSURG-SPINE, V10, P404, DOI 10.3171/2009.2.SPINE08698; Cheng JS, 2014, J NEUROSURG-PEDIATR, V13, P591, DOI 10.3171/2014.2.PEDS1392; Rajshekhar V, 2011, J NEUROSURG-SPINE, V14, P748, DOI 10.3171/2011.1.SPINE10310; Kothbauer KF, 2007, NEUROPHYSIOL CLIN, V37, P407, DOI 10.1016/j.neucli.2007.10.003; GARRIDO E, 1977, SURG NEUROL, V7, P215; Hyun SJ, 2009, BRIT J NEUROSURG, V23, P393, DOI 10.1080/02688690902964744; Brotchi J, 2002, NEUROSURGERY, V50, P1059; EPSTEIN FJ, 1993, J NEUROSURG, V79, P204, DOI 10.3171/jns.1993.79.2.0204; Goto T, 2002, J NEUROSURG, V97, P323, DOI 10.3171/spi.2002.97.3.0323; Goto T, 2003, J NEUROSURG, V99, P181, DOI 10.3171/spi.2003.99.2.0181; GREENWOOD J, 1954, J NEUROSURG, V11, P616, DOI 10.3171/jns.1954.11.6.0616; GUIDETTI B., 1967, ACTA NEUROCHIR, V17, P7, DOI 10.1007/BF01670413; Hida K, 2006, NEUROSURGERY, V58; Hwang SW, 2010, NEUROSURGERY S, V67; Iwasaki Y, 2000, BRIT J NEUROSURG, V14, P331; Kobayashi S, 2014, J NEUROSURG-SPINE, V20, P102, DOI 10.3171/2013.10.SPINE12944; Kothbauer K F, 1998, Neurosurg Focus, V4, pe1; Kucia EJ, 2011, NEUROSURGERY, V68, P57, DOI 10.1227/NEU.0b013e318208f181; Malis L I, 1978, Clin Neurosurg, V25, P512; Malls LI, 2002, J NEUROSURG S, V97, P1; McCormick PC, 1996, PRINCIPLES SPINAL SU, P1355; Mitha AP, 2011, NEUROSURGERY S, V68, P324; Morota N, 1997, NEUROSURGERY, V41, P1327; Nakamura M, 2008, SPINAL CORD, V46, P282, DOI 10.1038/sj.sc.3102130; Nakamura M, 2012, J ORTHOP SCI, V17, P352, DOI 10.1007/s00776-012-0236-6; NASHOLD BS, 1979, J NEUROSURG, V51, P59, DOI 10.3171/jns.1979.51.1.0059; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; Ohata K, 1999, ACTA NEUROCHIR, V141, P341, DOI 10.1007/s007010050309; Parent A, 1996, CARPENTERS HUMAN NEU, V9, P3; Quinones-Hinojosa A, 2005, NEUROSURGERY, V56, P982, DOI 10.1277/01.NEU.0000158203.29369.37; SINDOU M, 1986, NEUROSURGERY, V18, P587; Skinner Stanley A, 2005, Neurosurgery, V56, P299, DOI 10.1227/01.NEU.0000156545.33814.8D; Takami T, 2013, NEUROL MED-CHIR, V53, P920, DOI 10.2176/nmc.tn2012-0419; Takami Toshihiro, 2013, Surg Neurol Int, V4, P135, DOI 10.4103/2152-7806.119352; Takami T, 2004, NEUROL INDIA, V52, P59; Waxman SG, 1996, CORRELATIVE NEUROANA, V23, P45; Yasargil MG, 1976, SURG NEUROL, V6, P141	42	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					317	327		10.2176/nmc.ra.2014-0344		11	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900007		
J	Shin, M; Kondo, K; Kin, T; Suzukawa, K; Saito, N				Shin, Masahiro; Kondo, Kenji; Kin, Taichi; Suzukawa, Keigo; Saito, Nobuhito			Endoscopic Transnasal Interseptal Approach for Invasive Clival Tumors: Development of an Approach Method Regarding Maximal Preservation of the Nasal Anatomy	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						endoscopic transsphenoidal surgery; clival tumor; chordoma; chondrosarcoma; craniovertebral junction	SKULL BASE SURGERY; EXTENDED TRANSSPHENOIDAL APPROACH; EXPANDED ENDONASAL APPROACH; QUALITY-OF-LIFE; NASOSEPTAL FLAP; TECHNICAL NOTE; SEPTAL FLAP; RECONSTRUCTION; MANAGEMENT; MORBIDITY	Asian people frequently show small noses, narrow nasal apertures, and congestive mucosa on the turbinates and septum. To reduce the risk of nasal morbidity with increased radicality for skull base tumors in these patients, we developed endoscopic transnasal interseptal approach (ETISA) in transsphenoidal surgery for invasive diva! tumors (ICTs). Indication for ETISA is radical resection for tumors occupying deep ventral skull base regions, confined posterior to the level of the middle turbinates. After removing ethmoidal air cells, the middle turbinates are laterally deflected. A linear incision is made vertically on each side of the septal mucosa, which is separated from the bony septum as far as the sphenoid rostrum. The blades of an adjustable speculum are inserted submucosally, and the bony septum is temporarily displaced. The surgical pathway is widely maintained from the entrance to the deep surgical field without sacrificing the nasal mucosa and turbinates. Thirty-two consecutive patients with clival tumors (18 chordomas, 11 chondrosarcomas, 3 others) were treated. Bilateral middle turbinectomy was routinely performed in the initial 3 patients, but in only 4 of the remaining 29 (3 unilaterally, 1 bilaterally). Tumor was sufficiently resected in 29 patients (90.6%; gross total removal n = 25, subtotal resection n = 4). As complications, 6 patients showed mild and transient worsening of cranial nerve symptoms. Nasal complications arose in 3 patients, persisting > 3 months in 2 (5.7%). This approach allows fine bimanual handling and swift delivery of surgical equipment while reasonably preserving the nasal anatomy, which is useful in endoscopic transsphenoidal surgery for ICT.	[Shin, Masahiro; Kin, Taichi; Saito, Nobuhito] Tokyo Univ Hosp, Dept Neurosurg, Tokyo 1338655, Japan; [Kondo, Kenji; Suzukawa, Keigo] Tokyo Univ Hosp, Dept Otolaryngol, Tokyo 1338655, Japan	Shin, M (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1338655, Japan.	SHIN-NSU@h.u-tokyo.ac.jp					Abdelkader M, 2005, ARCH FACIAL PLAST S, V7, P111, DOI 10.1001/archfaci.7.2.111; Kassam AB, 2008, J NEUROSURG, V108, P715, DOI 10.3171/JNS/2008/108/4/0715; Gallagher MJ, 2014, BRIT J NEUROSURG, V28, P622, DOI 10.3109/02688697.2014.887656; Alobid I, 2013, NEUROSURGERY, V72, P540, DOI 10.1227/NEU.0b013e318282a535; Kitano M, 2008, J NEUROSURG, V108, P26, DOI 10.3171/JNS/2008/108/01/0026; Zanation AM, 2009, LARYNGOSCOPE, V119, P19, DOI 10.1002/lary.20027; Frank Giorgio, 2006, Neurosurgery, V59, pONS75; Chhabra N, 2009, OTOLARYNG CLIN N AM, V42, P311, DOI 10.1016/j.otc.2009.02.001; Georgalas C, 2012, RHINOLOGY, V50, P255, DOI 10.4193/Rhino12.050; Pant H, 2010, SKULL BASE-INTERD AP, V20, P35, DOI 10.1055/s-0029-1242983; Kimple AJ, 2012, LARYNGOSCOPE, V122, P1920, DOI 10.1002/lary.23325; Stippler M, 2009, NEUROSURGERY, V64, P268, DOI 10.1227/01.NEU.0000338071.01241.E2; de Almeida JR, 2011, HEAD NECK-J SCI SPEC, V33, P547, DOI 10.1002/hed.21483; Saeki N, 2010, NEUROL MED-CHIR, V50, P756; Jho HD, 1997, J NEUROSURG, V87, P44, DOI 10.3171/jns.1997.87.1.0044; Saito K, 2012, ACTA NEUROCHIR, V154, P879, DOI 10.1007/s00701-012-1317-1; Al-Mefty O, 2008, J NEUROSURG, V109, P783, DOI 10.3171/JNS/2008/109/11/0783; Shin JH, 2013, J CRANIOFAC SURG, V24, P1569, DOI 10.1097/SCS.0b013e31829a8105; Cappabianca P, 2004, NEUROSURGERY, V55, P933, DOI 10.1227/01.NEU.0000137330.02549.0D; Eloy JA, 2013, AM J OTOLARYNG, V34, P188, DOI 10.1016/j.amjoto.2012.10.005; El-Sayed IH, 2008, SKULL BASE-INTERD AP, V18, P385, DOI 10.1055/s-0028-1096202; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P146, DOI 10.1227/NEU.0b013e3182438915; Fernandez-Miranda JO, 2012, NEUROSURGERY, V71, P158; Fraser JF, 2010, NEUROSURGERY, V67, P150, DOI 10.1227/01.NEU.0000383130.80179.41; Gandhi CD, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.6.FOCUS09119; Kitano M, 2007, J NEUROSURG, V106, P932, DOI 10.3171/jns.2007.106.5.932; Morgan N. J., 1995, Rhinology (Utrecht), V33, P224; Pawankar R, 2012, WORLD ALLERGY ORGAN, V5, pS212; Shin M, 2012, NEUROL MED-CHIR, V52, P697; Stippler M, 2009, NEUROSURGERY, V64, P277; Takemura M, 2014, NEUROL MED-CHIR, V54, P622, DOI 10.2176/nmc.tn.2014-0004; Taniguchi M, 2012, ACTA NEUROCHIR, V154, P627, DOI 10.1007/s00701-011-1225-9; Tantilipikorn P, 2008, AM J RHINOL, V22, P617, DOI 10.2500/ajr.2008.22.3229; Zada G, 2010, WORLD NEUROSURG, V73, P334, DOI 10.1016/j.wneu.2010.02.069	34	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					336	344		10.2176/nmc.oa.2014-0280		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900009		
J	Fujimoto, Y; Ramos, HF; Mariani, PP; Romano, FR; Cukiert, A; Bor-Seng-Shu, E; Wakayama, A; Yoshimine, T				Fujimoto, Yasunori; Ramos, Henrique F.; Mariani, Pedro P.; Romano, Fabrizio R.; Cukiert, Arthur; Bor-Seng-Shu, Edson; Wakayama, Akatsuki; Yoshimine, Toshiki			Superior Turbinectomy: Role for a Two-surgeon Technique in Endoscopic Endonasal Transsphenoidal Surgery-Technical Note	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						endoscopic endonasal surgery; posterior ethmoidectomy; superior turbinectomy; transsphenoidal approach	SPHENOID SINUS; NATURAL OSTIUM; TURBINATE	We describe a practical technique of superior turbinectomy followed by posterior ethmoidectomy as a less invasive procedure for two-surgeon technique on endoscopic endonasal transsphenoidal surgery. After identification of the superior turbinate and the sphenoid ostium, the inferior third portion of the superior turbinate was coagulated and resected. This partial superior turbinectomy procedure exposed the posterior ethmoidal sinus. Resection of the bony walls between the sphenoid and posterior ethmoid sinuses provided more lateral and superior exposure of the sphenoid sinus. This technique was performed in 56 patients with midline skull base lesions, including 49 pituitary adenomas and 7 other lesions. Meticulous manipulation of instruments was performed in all cases without surgical complications such as permanent hyposmia/anosmia or nasal bleeding. Our findings suggested that the partial superior turbinectomy followed by retrograde posterior ethmoidectomy is a simple and safe technique providing a sufficient surgical corridor for two-surgeon technique to approaching midline skull base regions, mainly involving pituitary adenomas.	[Fujimoto, Yasunori; Wakayama, Akatsuki] Osaka Neurol Inst, Dept Neurosurg, Toyonaka, Osaka 5610836, Japan; [Ramos, Henrique F.] Univ Sao Paulo, Sch Med, Hosp Clin, Dept Otorhinolaryngol, Sao Paulo, Brazil; [Bor-Seng-Shu, Edson] Univ Sao Paulo, Sch Med, Hosp Clin, Div Neurol Surg, Sao Paulo, Brazil; [Mariani, Pedro P.; Romano, Fabrizio R.; Cukiert, Arthur] Hosp Transplantes Euryclides de Jesus Zerbini, Dept Neurosurg, Sao Paulo, Brazil; [Yoshimine, Toshiki] Osaka Univ, Dept Neurosurg, Grad Sch Med, Suita, Osaka, Japan	Fujimoto, Y (reprint author), Osaka Neurol Inst, Dept Neurosurg, 2-6-23 Shonai Takara Machi, Toyonaka, Osaka 5610836, Japan.	yasufujimoto@gmail.com					Say P, 2004, AM J RHINOL, V18, P157; Hart CK, 2010, OTOLARYNG HEAD NECK, V142, P95, DOI 10.1016/j.otohns.2009.09.032; Lane AP, 2002, LARYNGOSCOPE, V112, P1183, DOI 10.1097/00005537-200207000-00007; Orlandi RR, 1999, AM J RHINOL, V13, P251, DOI 10.2500/105065899782102908; Cankal F, 2004, CLIN RADIOL, V59, P1034, DOI 10.1016/j.crad.2004.04.016; Unal B, 2006, SURG RADIOL ANAT, V28, P195, DOI 10.1007/s00276-005-0073-9; Kim HU, 2001, LARYNGOSCOPE, V111, P1599, DOI 10.1097/00005537-200109000-00020; Bolger WE, 1999, OTOLARYNG HEAD NECK, V120, P308, DOI 10.1016/S0194-5998(99)70267-6; Carrau RL, 2001, OTOLARYNG CLIN N AM, V34, P1143, DOI 10.1016/S0030-6665(05)70371-6; Cavallo Luigi M, 2005, Neurosurg Focus, V19, pE2; Eweiss AZ, 2012, EUR ARCH OTO-RHINO-L, V269, P1451, DOI 10.1007/s00405-011-1832-3; Guthikonda B, 2010, LARYNGOSCOPE, V120, P2360, DOI 10.1002/lary.21153; Har-El G, 2001, AM J RHINOL, V15, P149, DOI 10.2500/105065801781543673; Kitano Masahiko, 2001, Journal of Neurosurgery, V94, P999, DOI 10.3171/jns.2001.94.6.0999; Lopes G, 2004, Rev Laryngol Otol Rhinol (Bord), V125, P189; Millar DA, 2006, AM J RHINOL, V20, P180; Yanagisawa E, 1993, Ear Nose Throat J, V72, P331	17	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					345	350		10.2176/nmc.tn.2014-0159		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900010		
J	Shibao, S; Toda, M; Tomita, T; Saito, K; Ogawa, K; Kawase, T; Yoshida, K				Shibao, Shunsuke; Toda, Masahiro; Tomita, Toshiki; Saito, Katsuya; Ogawa, Kaoru; Kawase, Takeshi; Yoshida, Kazunari			Petrous Apex Cholesterol Granuloma: Importance of Pedicled Nasoseptal Flap in Addition to Silicone T-tube for Prevention of Occlusion of Drainage Route in Transsphenoidal Approach-A Technical Note	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						cholesterol granuloma; pedicled nasoseptal flap; petrous apex; silicone tube; transsphenoidal approach	ENDOSCOPIC MANAGEMENT; DIAGNOSIS; CYST	Recently, petrous apex cholesterol granulomas (CGs) have been treated via the endoscopic endonasal transsphenoidal approach (EEA) using a silicone tube, to prevent drainage route occlusion. Occlusion of the drainage route has led to problems with recurrence. The aim of this report is to describe the use of a surgical technique to prevent drainage route occlusion. In surgical technique, the posterolateral wall of the sphenoid sinus was opened by EEA. After cyst debridement, a vascularized nasoseptal flap with a width of approximately 4 cm was inserted into the lumen with a silicone T-tube with a diameter of 7 mm. This technique was used in two patients: the first patient during the second operation after recurrence following occlusion of the drainage route, and the second patient during the first operation. Opening of the cyst wall was confirmed endoscopically in both patients 12-24 months after surgery, even after removal of the T-tube. In conclusion, the use of a pedicled nasoseptal flap with a silicone tube is useful to prevent CG recurrence, by paranasal cavitization of the cystic cavity.	[Shibao, Shunsuke; Toda, Masahiro; Saito, Katsuya; Kawase, Takeshi; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Tokyo 1608582, Japan; [Tomita, Toshiki; Ogawa, Kaoru] Keio Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tokyo 1608582, Japan	Shibao, S (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	pochisuke616@mac.com					SABIN HI, 1987, NEUROSURGERY, V21, P798; DiNardo LJ, 2003, OTOL NEUROTOL, V24, P939; Eisenberg MB, 1997, J NEUROSURG, V86, P822, DOI 10.3171/jns.1997.86.5.0822; FARRIOR B, 1981, LARYNGOSCOPE, V91, P1286; FUCCI MJ, 1994, SKULL BASE SURG, V4, P52, DOI 10.1055/s-2008-1058990; Georgalas C, 2008, CLIN OTOLARYNGOL, V33, P38, DOI 10.1111/j.1749-4486.2007.01589.x; GRAHAM MD, 1985, LARYNGOSCOPE, V95, P1401; Griffith AJ, 1996, OTOLARYNG HEAD NECK, V114, P91; Jaberoo MC, 2010, SKULL BASE-INTERD AP, V20, P375, DOI 10.1055/s-0030-1253574; Kusumi M, 2013, NEUROSURGERY, V72, P77, DOI 10.1227/NEU.0b013e3182724354; Kusumi M, 2013, NEUROSURGERY, V72, P86; Manasse P, 1894, VIRCHOWS ARCH, V136, P245, DOI 10.1007/BF01928875; Meyer C, 1983, ZIEGLERS BEITR, V13, P76; Michaelson PG, 2001, INT J PEDIATR OTORHI, V57, P165, DOI 10.1016/S0165-5876(00)00456-0; MONTGOMERY WW, 1977, ANN OTO RHINOL LARYN, V86, P429; Oyama K, 2007, ACTA NEUROCHIR, V149, P299, DOI 10.1007/s00701-006-1105-x; Paluzzi A, 2012, J NEUROSURG, V116, P792, DOI 10.3171/2011.11.JNS111077; Samadian M, 2009, TURK NEUROSURG, V19, P106; SHEEHY JL, 1969, LARYNGOSCOPE, V79, P1189, DOI 10.1288/00005537-196907000-00001; WALTNER JG, 1947, ARCH OTOLARYNGOL, V46, P398	20	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2015	55	4					351	355		10.2176/nmc.tn.2014-0254		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CF8RF	WOS:000352828900011		
J	Yamane, M; Ogawa, Y; Fukui, M; Kamoi, M; Saijo-Ban, Y; Yaguchi, S; Mukai, S; Kawakita, T; Simmura, S; Tsubota, K				Yamane, Mio; Ogawa, Yoko; Fukui, Masaki; Kamoi, Mizuka; Saijo-Ban, Yumiko; Yaguchi, Saori; Mukai, Shin; Kawakita, Tetsuya; Simmura, Shigeto; Tsubota, Kazuo			Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye	OPTOMETRY AND VISION SCIENCE			English	Article						dry eye; rebamipide; diquafosol; eye drops; mucin; chronic graft-versus-host disease; ocular cicatricial pemphigoid	VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; CORNEAL EPITHELIAL-CELLS; FUNCTIONAL VISUAL-ACUITY; CHRONIC GVHD; OPHTHALMIC SOLUTION; OCULAR SURFACE; SODIUM HYALURONATE; BARRIER FUNCTION; MULTICENTER	Purpose. Two new drugs with mucin-inducing and secretion-promotive effects, rebamipide and diquafosol, were recently approved as topical dry-eye treatments. We report two cases in which the long-term use of mucin-inducing eye drops improved chronic ocular graft-versus-host disease (cGVHD)-related dry eye and ocular cicatricial pemphigoid (OCP)-like disease. Case Reports. Case 1. A 61-year-old woman had cGVHD-related dry eye that resisted traditional medications. Next, we use topical diquafosol in addition to conventional treatments. The patient used diquafosol for 6 months without experiencing any side effects. The symptoms, including dry-eye sensation, ocular pain, foreign body sensation, and photophobia, as well as ocular surface findings including fluorescein and rose bengal scores and tear break-up time (TBUT), partly improved. To further improve the clinical signs and symptoms and decrease chronic inflammation, rebamipide was added to diquafosol. The symptoms, TBUT, and fluorescein and rose bengal scores markedly improved after long-term dual treatment without any side effects for 6 months. Case 2. A 77-year-old woman had OCP-like disease with dry eye. The patient did not improve using the currently available conventional treatments. Next, we use topical rebamipide in addition to conventional treatments. Symptoms including asthenopia, dry-eye sensation, ocular pain, and dull sensation, as well as fluorescein and rose bengal scores and TBUT, partly improved. Specifically, functional visual acuity was markedly improved after commencement of rebamipide. To further improve the clinical signs and symptoms and increase tear film stability and tear film volume, diquafosol was added to rebamipide. The combination of diquafosol and rebamipide worked for the patient. Improvements were seen in several symptoms, fluorescein and rose bengal scores, Schirmer test value, and TBUT without any side effects for 12 months. Conclusions. Long-term treatment with topical rebamipide and diquafosol can improve dry eye in patients with cGVHD or OCP-like disease.	[Yamane, Mio; Ogawa, Yoko; Fukui, Masaki; Kamoi, Mizuka; Saijo-Ban, Yumiko; Yaguchi, Saori; Mukai, Shin; Kawakita, Tetsuya; Simmura, Shigeto; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan	Ogawa, Y (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoko@z7.keio.jp			Japanese Ministry of Education, Science, Sports and Culture [23592590, 26462668]	This work was supported by the Japanese Ministry of Education, Science, Sports and Culture (no. 23592590 and no. 26462668).	Wang Y, 2010, BONE MARROW TRANSPL, V45, P1077, DOI 10.1038/bmt.2009.312; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Espana EM, 2013, GRAEF ARCH CLIN EXP, V251, P1257, DOI 10.1007/s00417-013-2301-z; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Ogawa Y, 2010, BONE MARROW TRANSPL, V45, P565, DOI 10.1038/bmt.2009.173; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Urashima H, 2004, CORNEA, V23, P613, DOI 10.1097/01.ico.0000126436.25751.fb; Riemens A, 2014, ACTA OPHTHALMOL, V92, P82, DOI 10.1111/aos.12047; Kinoshita S, 2013, OPHTHALMOLOGY, V120, P1158, DOI 10.1016/j.ophtha.2012.12.022; Rios JD, 2006, CORNEA, V25, P573; Kinoshita S, 2014, AM J OPHTHALMOL, V157, P576, DOI 10.1016/j.ajo.2013.11.010; Koh S, 2013, JPN J OPHTHALMOL, V57, P440, DOI 10.1007/s10384-013-0251-y; Shimazaki-Den S, 2013, CORNEA, V32, P1120, DOI 10.1097/ICO.0b013e3182930b1d; Kojima T, 2005, AM J OPHTHALMOL, V139, P242, DOI 10.1016/j.ajo.2004.08.040; Cowlen MS, 2003, EXP EYE RES, V77, P77, DOI 10.1016/S0014-4835(03)00068-X; Hessen M, 2012, CURR OPIN ALLERGY CL, V12, P540, DOI 10.1097/ACI.0b013e328357b4b9; Takamura E, 2012, BRIT J OPHTHALMOL, V96, P1310, DOI 10.1136/bjophthalmol-2011-301448; Tanaka H, 2013, BRIT J OPHTHALMOL, V97, P912, DOI 10.1136/bjophthalmol-2012-302868; Lemp MA, 2007, OCUL SURF, V5, P75; Nakamura M, 2012, ADV THER, V29, P579, DOI 10.1007/s12325-012-0033-9; Matsumoto Y, 2012, OPHTHALMOLOGY, V119, P1954, DOI 10.1016/j.ophtha.2012.04.010; Ban Y, 2011, MOL VIS, V17, P2533; Chang JH, 2005, CURR ALLERGY ASTHM R, V5, P333, DOI 10.1007/s11882-005-0078-9; Gipson Ilene K, 2004, Ocul Surf, V2, P131; Hida RY, 2008, CURR EYE RES, V33, P19, DOI 10.1080/02713680701817366; Ishida R, 2005, AM J OPHTHALMOL, V139, P253, DOI 10.1016/j.ajo.2004.08.075; Kashima Tomoyuki, 2012, Clin Ophthalmol, V6, P1403, DOI 10.2147/OPTH.S35122; Kimura K, 2013, INVEST OPHTH VIS SCI, V54, P2752, DOI 10.1167/iovs.12-11294; Lau OC, 2014, CLIN OPHTHALMOL, V30, P327; Ogawa Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03419; Ogawa Y, 2007, INVEST OPHTH VIS SCI, V48, P1079, DOI 10.1167/iovs.06-0601; Sugai S, 2009, MOD RHEUMATOL, V19, P114, DOI 10.1007/s10165-008-0141-1; Tatematsu Y, 2012, BONE MARROW TRANSPL, V47, P416, DOI 10.1038/bmt.2011.89; TSUBOTA K, 1994, CORNEA, V13, P202, DOI 10.1097/00003226-199405000-00002; Ueta M, 2013, J OCUL PHARMACOL TH, V29, P688, DOI 10.1089/jop.2012.0054; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Wang Y, 2008, BONE MARROW TRANSPL, V41, P293, DOI 10.1038/sj.bmt.1705900	38	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	APR	2015	92	4		1			S25	S32				8	Ophthalmology	Ophthalmology	CG6NX	WOS:000353420000006		
J	Ishihara, S; Boyles, RM; Matsubayashi, H; del Barrio, AN; Cebrian, MR; Ishida, A; Lapitan, RM; Atabay, EP; Cruz, LC; Kanai, Y				Ishihara, Shinya; Boyles, Rodel M.; Matsubayashi, Hisashi; del Barrio, Arnel N.; Cebrian, Merben R.; Ishida, Aiko; Lapitan, Rosalina M.; Atabay, Eufrocina P.; Cruz, Libertado C.; Kanai, Yukio			Long-term community-based monitoring of tamaraw Bubalus mindorensis on Mindoro Island, Philippines	ORYX			English	Article						Bubalus mindorensis; community-based monitoring; Critically Endangered species; Mindoro Island; population trend; tamaraw	TAPPU WILDLIFE RESERVE; SEXUAL SEGREGATION; CONSERVATION; POPULATION; PRIORITIES; BEHAVIOR; NEPAL	The Critically Endangered tamaraw Bubalus mindorensis is endemic to Mindoro Island, Philippines, and little is known of its ecology. During 2006-2011 we used community-based monitoring to examine the population status and ecology of tamaraw in the species' core habitat of Mount Iglit-Baco National Park. Each year, for 5 consecutive days at the end of the dry season, trained local volunteers and rangers or project staff were allocated to 18 vantage points in the study area (c. 160 km(2)). Tamaraw were categorized as adult (> 5 years), juvenile (2-5 years) or calf (< 2 years), and sexed when possible. During the study period the population was 239-314 (mean 271), with no significant fluctuations in age structure (percentage of adults, juveniles and calves: 57.8, 21.0 and 21.3%) or estimated adult female reproductive rates (29.1%). In adults, but not in juveniles, the sex ratio was biased towards females (1 : 1.86, P < 0.01). Bulls were often solitary (32.2% of sightings), whereas the majority of cows (94.7%) formed small groups of 2-12 individuals of different ages, with or without bulls (53.4 and 46.6%, respectively). These results demonstrate that the population remained relatively stable, maintaining a constant age structure and reproductive rate, and that long-term community-based monitoring was effective for quantitative characterization of the tamaraw's social behaviour, which is critical for conservation and management of the species.	[Ishihara, Shinya; Kanai, Yukio] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Boyles, Rodel M.] Dept Environm & Nat Resources, Tamaraw Conservat Programme, San Jose, Occidental Mind, Philippines; [Matsubayashi, Hisashi] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia; [del Barrio, Arnel N.; Lapitan, Rosalina M.] Univ Philippines, Philippine Carabao Ctr, Los Banos, Laguna, Philippines; [Cebrian, Merben R.] USDOI Bur Land Management, Fairbanks, AK USA; [Ishida, Aiko] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Atabay, Eufrocina P.; Cruz, Libertado C.] Philippine Carabao Ctr, Natl Headquarters, Munoz, Nueva Ecija, Philippines	Ishihara, S (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	montay@jcom.home.ne.jp			Japan Society for Promotion of Science [17405040, 09J00274]	Our study protocols and collection of field samples in Mount Iglit-Baco National Park were approved by the Memorandum of Agreement between the Department of Environment and Natural Resources and the Department of Agriculture-Philippine Carabao Centre in 2006. We thank the Regional Office of IV-B of the Department of Environment and Natural Resources for signing this Memorandum, Josefina L. de Leon from the Protected Areas and Wildlife Bureau for her advice on the planning of this study, Danilo Z. Rocca (Tamaraw Conservation Programme Field Operation Assistant), Tamaraw Conservation Programme rangers and all the volunteer observers for their perseverance in collecting data, Reynor A. Garcia, Jose C. Canaria and Noel A. Ceballos from the Philippine Carabao Center for grass and faecal sampling, and Professor Atsushi Tajima of the University of Tsukuba for his comments on this article. This study was supported in part by a Grant-in-Aid for Scientific Research (No. 17405040, 09J00274) from the Japan Society for Promotion of Science.	Ahrestani FS, 2011, MAMMAL REV, V41, P75, DOI 10.1111/j.1365-2907.2010.00166.x; HEINEN JT, 1993, BIOL CONSERV, V65, P29, DOI 10.1016/0006-3207(93)90193-5; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; SPINAGE CA, 1972, ECOLOGY, V53, P645, DOI 10.2307/1934778; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Caro T, 1999, TRENDS ECOL EVOL, V14, P366, DOI 10.1016/S0169-5347(99)01663-8; VANVUREN D, 1986, J MAMMAL, V67, P503, DOI 10.2307/1381282; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Collen B, 2008, TROP CONSERV SCI, V1, P75; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Burton AC, 2012, BIODIVERS CONSERV, V21, P3079, DOI 10.1007/s10531-012-0355-6; Anthony LL, 2000, BIOL CONSERV, V95, P303, DOI 10.1016/S0006-3207(00)00037-9; ANUNCIADO R. V. P., 1994, J VET MED, V31, P5; Berger J, 1999, J MAMMAL, V80, P1084, DOI 10.2307/1383162; Cebrian MR, 2014, ECOLOGY, EVOLUTION AND BEHAVIOUR OF WILD CATTLE: IMPLICATIONS FOR CONSERVATION, P310; Curie E, 1996, TRENDS ECOL EVOL, V11, P260, DOI 10.1016/0169-5347(96)20046-1; de Leon J., 1996, TAMARAW POPULATION H; DEPARTMENT OF ENVIRONMENT AND NATURAL RESOURCES REGION 4B (MIMAROPA), 2012, TAM POP COUNT; EVERETT A. H., 1878, P ZOOL SOC LOND, V5, P792; FRITSCHE T, 1993, VET PARASITOL, V49, P271, DOI 10.1016/0304-4017(93)90126-8; HARRISSON T, 1969, IUCN (International Union for Conservation of Nature and Natural Resources) Bulletin, V2, P85; HEDGES S., 2008, IUCN RED LIST THREAT; HENDRIX C. M., 1998, DIAGNOSTIC VET PARAS; Khatri Top Bahadur, 2012, Journal of Threatened Taxa, V4, P3294; Kuchai J. A., 2011, Online Journal of Animal and Feed Research (OJAFR), V1, P263; Kuehn D.W., 1976, National Pks Conserv Mag, V50, P18; KUEHN DW, 1986, BIOTROPICA, V18, P263, DOI 10.2307/2388495; MAALA C. P., 2001, J INT DEV COOPERATIO, V8, P1; MACE G. M., 2001, CONSERVATION EXPLOIT, P4; MANUEL G. C., 1957, P 8 PAC SCI C A, V3A, P1463; MATSUBAYASHI H., 2010, TROPICS, V18, P167; Momongan V. G., 1993, Asia Life Sciences, V2, P241; ONG P., 1996, TAMARAW POPULATION H, P51; OWENSMITH N, 1993, J ANIM ECOL, V62, P428, DOI 10.2307/5192; PHILIPPINE CLEARING HOUSE MECHANISM, 2012, TAM CONS PROGR; Primack R., 1993, ESSENTIALS CONSERVAT; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Sheil D, 2001, CONSERV BIOL, V15, P1179, DOI 10.1046/j.1523-1739.2001.0150041179.x; Sinclair A. R. E., 1977, AFRICAN BUFFALO STUD; STEERE J. B., 1888, P ZOOL SOC LOND, V29, P413; Suchomel Josef, 2005, Lynx (Prague), P103; Talbot L. M., 1966, Mammalia, V30, P1, DOI 10.1515/mamm.1966.30.1.1; Turner WC, 2005, J ZOOL, V267, P291, DOI 10.1016/S095283690500748X; WWF, 2004, MOZ WILDL MAN SER	45	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0030-6053	1365-3008		ORYX	Oryx	APR	2015	49	2					352	359		10.1017/S0030605314000313		8	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CF5WS	WOS:000352628600029		
J	Hayakawa, K; Matsuura, T				Hayakawa, Kazunobu; Matsuura, Toshiyuki			Trade liberalization in Asia and FDI strategies in heterogeneous firms: evidence from Japanese firm-level data	OXFORD ECONOMIC PAPERS-NEW SERIES			English	Article							FOREIGN DIRECT-INVESTMENT; INTEGRATION STRATEGIES; MULTINATIONALS; UNOBSERVABLES; PRODUCTIVITY; LOCATION; EXPORTS; CHOICE; IMPACT	This article clarifies the reasons for the recent rapid growth of foreign direct investment (FDI) in developing countries, particularly Asian countries. For this purpose, we theoretically and empirically examine the mechanics of both horizontal FDI and vertical FDI (VFDI) to shed light on the role of trade costs. Our empirical analysis using a logit or multinomial logit model of Japanese firms' FDI choices reveals that the tariff reduction in Asian countries has lowered the productivity cutoff for VFDI. This result indicates that since developing countries, particularly Asian countries, have experienced a relatively rapid decrease in tariff rates, the increase in VFDI through tariff reduction led to the recent surge of FDI in developing countries.	[Hayakawa, Kazunobu] Japan External Trade Org, Inst Developing Econ, Bangkok 10330, Thailand; [Matsuura, Toshiyuki] Keio Univ, Keio Econ Observ, Minato Ku, Tokyo 1088345, Japan	Hayakawa, K (reprint author), Japan External Trade Org, Inst Developing Econ, 16th Floor,Nantawan Bldg,161 Rajadamri Rd, Bangkok 10330, Thailand.	kazunobu_hayakawa@ide-jetro.org; matsuura@sanken.keio.ac.jp			Japan Society for the Promotion of Science [23730249, 22330087]	Japan Society for the Promotion of Science (Grant-in-aid for Young Researcher B 23730249 to T.M., Grant-in-aid for Scientific Research B 22330087 to K.H. and T.M.).	Ackerberg D. A., 2006, 38349 MPRA U LIB MUN; Ai C, 2003, ECON LETT, V80, P23; Helpman E, 2004, AM ECON REV, V94, P300, DOI 10.1257/000282804322970814; Yeaple SR, 2003, J INT ECON, V60, P293, DOI 10.1016/S0022-1996(02)00051-X; Grossman GM, 2006, J INT ECON, V70, P216, DOI 10.1016/j.jinteco.2005.07.011; Petrin A, 2012, RAND J ECON, V43, P705, DOI 10.1111/1756-2171.12005; Brainard SL, 1997, AM ECON REV, V87, P520; Levinsohn J, 2003, REV ECON STUD, V70, P317, DOI 10.1111/1467-937X.00246; Ekholm K, 2007, J EUR ECON ASSOC, V5, P776, DOI 10.1162/JEEA.2007.5.4.776; Wooldridge JM, 2009, ECON LETT, V104, P112, DOI 10.1016/j.econlet.2009.04.026; Chen MX, 2010, J INT ECON, V80, P188, DOI 10.1016/j.jinteco.2009.08.007; Aw BY, 2008, J INT ECON, V75, P167, DOI 10.1016/j.jinteco.2008.02.002; Fukao K, 2003, J JPN INT ECON, V17, P468, DOI 10.1016/j.jjie.2003.09.004; Bustos P, 2011, AM ECON REV, V101, P304, DOI 10.1257/aer.101.1.304; Baltagi BH, 2007, J ECONOMETRICS, V140, P260, DOI 10.1016/j.jeconom.2006.09.009; Barba Navaretti Giorgio, 2004, MULTINATIONAL FIRMS; Hayakawa K, 2013, JPN WORLD ECON, V27, P25, DOI 10.1016/j.japwor.2013.03.006; Hyun HJ, 2013, ASIAN-PAC ECON LIT, V27, P144, DOI 10.1111/apel.12029; Kimura F, 2006, REV WORLD ECON, V142, P695, DOI 10.1007/s10290-006-0089-1; Wakasugi R., 2012, MILLENNIAL ASIA, V3, P45; World Bank, 2006, GLOB EC PROSP 2007 M; Yeaple SR, 2009, J INT ECON, V78, P206, DOI 10.1016/j.jinteco.2009.03.002	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0030-7653	1464-3812		OXFORD ECON PAP	Oxf. Econ. Pap.-New Ser.	APR	2015	67	2					494	513		10.1093/oep/gpu033		20	Economics	Business & Economics	CG7SD	WOS:000353504300015		
J	Kanahara, M; Satoh, H; Higuchi, T; Takahara, A; Jinnai, H; Harano, K; Okada, S; Nakamura, E; Matsuo, Y; Yabu, H				Kanahara, Masaaki; Satoh, Hiroki; Higuchi, Takeshi; Takahara, Atsushi; Jinnai, Hiroshi; Harano, Koji; Okada, Satoshi; Nakamura, Eiichi; Matsuo, Yasutaka; Yabu, Hiroshi			Fabrication of NIR-Excitable SERS-Active Composite Particles Composed of Densely Packed Au Nanoparticles on Polymer Microparticles	PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION			English	Article							ENHANCED RAMAN-SCATTERING; PHASE-SEPARATION STRUCTURES; PLASMONIC NANOCLUSTERS; FRUSTRATED PHASES; OPTICAL-RESPONSE; GOLD NANOSHELLS; METAL; MORPHOLOGIES; POLYSTYRENE; RESONANCE	A simple fabrication method is demonstrated for surface-enhanced Raman scattering (SERS)-active plasmonic nanoballs, which consisted of Au nanoparticles (NPs) and core-shell polystyrene and amino-terminated poly(butadiene) particles, by heterocoagulation and Au NP diffusion. The amount of Au NPs introduced into the core-shell particles increases with the concentration of Au NPs added to the aqueous dispersion of the core-shell particles. When the amount of Au NPs increases, closely packed, three-dimensionally arranged and close-packed Au NPs arrays are formed in the shells. Strong SERS signals from para-mercaptophenol adsorbed onto composite particles with multilayered Au NPs arrays are obtained by near-infrared (NIR) light illumination.	[Kanahara, Masaaki; Satoh, Hiroki; Higuchi, Takeshi; Yabu, Hiroshi] Tohoku Univ, IMRAM, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Takahara, Atsushi; Jinnai, Hiroshi] Kyushu Univ, IMCE, Nishi Ku, Fukuoka 8190395, Japan; [Harano, Koji; Okada, Satoshi; Nakamura, Eiichi] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1138654, Japan; [Matsuo, Yasutaka] Hokkaido Univ, RIES, Sapporo, Hokkaido 0010021, Japan; [Yabu, Hiroshi] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Aoba Ku, Sendai, Miyagi, Japan	Kanahara, M (reprint author), Tohoku Univ, IMRAM, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	yabu@tagen.tohoku.ac.jp	Yabu, Hiroshi/A-4844-2010; Jinnai, Hiroshi/F-8456-2014; Harano, Koji/E-9443-2010; HIGUCHI, Takeshi/A-4845-2010		MEXT, Japan [26708025, 22000008]; MEXT of Japan [24310092]	H.Y. thank Nanotechnology Platform, the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, for supporting the SERS measurements. H.Y. also thanks Mrs. M. Suzuki for assisting with the TEM observation. This work was partially supported by a Grant-in-Aid for Young Researchers (A) (No. 26708025) and Specially Promoted Research (No. 22000008), MEXT, Japan. H.J. is grateful to the financial support received through a Grant-in-Aid (No. 24310092) from MEXT of Japan. M.K. conducted the composite particle preparation and colloidal analysis, and wrote a part of the manuscript. H.S., K.H., H.Y., S.O., and E.N. performed the FE-SEM observations and EDX analysis. M.K., T.H., A.T., and H.J. performed the TEMT observations. M.K., Y.M., and H.Y. carried out the SERS measurements. H.Y. planned and supervised the research and wrote the most of the manuscript.	Yabu H, 2010, MACROMOL RAPID COMM, V31, P1267, DOI 10.1002/marc.201000007; LEE HM, 1994, VIB SPECTROSC, V6, P205, DOI 10.1016/0924-2031(94)85007-0; Yabu H, 2013, POLYM J, V45, P261, DOI 10.1038/pj.2012.151; Zhang JH, 2004, ADV FUNCT MATER, V14, P1089, DOI 10.1002/adfm.200400119; Harano K, 2013, CHEM COMMUN, V49, P3525, DOI 10.1039/c3cc40752g; Zhu CH, 2011, CHEM COMMUN, V47, P2709, DOI 10.1039/c0cc04482b; Mulvihill MJ, 2010, J AM CHEM SOC, V132, P268, DOI 10.1021/ja906954f; Oldenburg SJ, 1999, APPL PHYS LETT, V75, P2897, DOI 10.1063/1.125183; Liu RY, 2012, CHEM COMMUN, V48, P9421, DOI 10.1039/c2cc34115h; Sun YG, 2003, ADV MATER, V15, P641, DOI 10.1002/adma.200301639; Ji W, 2011, CHEM COMMUN, V47, P2426, DOI 10.1039/c0cc03697h; Higuchi T, 2008, SOFT MATTER, V4, P1302, DOI 10.1039/b800904j; Wan LS, 2010, ACS APPL MATER INTER, V2, P3759, DOI 10.1021/am1009277; Li GL, 2008, COLLOID SURFACE A, V322, P192, DOI 10.1016/j.colsurfa.2008.03.006; Higuchi T, 2008, ANGEW CHEM INT EDIT, V47, P8044, DOI 10.1002/anie.200803003; Pekdemir ME, 2012, ANALYST, V137, P4834, DOI 10.1039/c2an35471c; Fan JA, 2011, NANO LETT, V11, P4859, DOI 10.1021/nl203194m; Yabu H, 2014, SOFT MATTER, V10, P2919, DOI 10.1039/c3sm52821a; Doering WE, 2007, ADV MATER, V19, P3100, DOI 10.1002/adma.200701984; Shi WL, 2005, LANGMUIR, V21, P1610, DOI 10.1021/la047628y; Esteban R, 2012, LANGMUIR, V28, P8881, DOI 10.1021/la300198r; Labhasetwar V, 1998, J PHARM SCI, V87, P1229, DOI 10.1021/js980021f; Yabu H, 2005, ADV MATER, V17, P2062, DOI 10.1002/adma.200500255; Nolan JP, 2012, METHODS, V57, P272, DOI 10.1016/j.ymeth.2012.03.024; Kanahara M, 2014, SOFT MATTER, V10, P275, DOI 10.1039/c3sm52077c; Tserkezis C, 2014, PART PART SYST CHAR, V31, P152, DOI 10.1002/ppsc.201300287; Motoyoshi K, 2010, SOFT MATTER, V6, P1253, DOI 10.1039/b918164d; Xie JP, 2008, ACS NANO, V2, P2473, DOI 10.1021/nn800442q; Harano K, 2014, J POLYM SCI POL PHYS, V52, P833, DOI 10.1002/polb.23493; Higuchi T, 2013, MACROMOLECULES, V46, P6991, DOI 10.1021/ma401193u; Cecchini MP, 2013, NAT MATER, V12, P165, DOI [10.1038/nmat3488, 10.1038/NMAT3488]; Wagner CS, 2011, J COLLOID INTERF SCI, V355, P115, DOI 10.1016/j.jcis.2010.12.017; Yabu H, 2013, ACS APPL MATER INTER, V5, P3262, DOI 10.1021/am4003149; Ye J, 2012, NANO LETT, V12, P1660, DOI 10.1021/nl3000453; Hirai Y, 2010, CHEM COMMUN, V46, P2298, DOI 10.1039/b923514k; Jackson JB, 2001, J PHYS CHEM B, V105, P2743, DOI 10.1021/jp003868k; Yan B, 2011, J PHYS CHEM C, V115, P24437, DOI 10.1021/jp207821t; Blakey I, 2013, LANGMUIR, V29, P8266, DOI 10.1021/la401361u; Higuchi T, 2009, ANGEW CHEM INT EDIT, V48, P5125, DOI 10.1002/anie.200900002; Huang P, 2010, CHEM COMMUN, V46, P4800, DOI 10.1039/c0cc00307g; Jinnai H., 2013, J ELECTRON MICROSC, V62, P243, DOI DOI 10.1093/jmicro/dfs070; Kanahara M., 2013, MACROMOL MATER ENG, V299, P478; Li Z., 2014, NAT COMMUN, V5, P1; Manikas AC, 2014, LANGMUIR, V30, P3869, DOI 10.1021/la4048616; Muhlig S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02328; Yabu H, 2011, J POLYM SCI POL PHYS, V49, P1717, DOI 10.1002/polb.22374; Yabu H, 2012, B CHEM SOC JPN, V85, P265, DOI 10.1246/bcsj.20110197; Yabu H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FT02; Zhu ZN, 2011, ANGEW CHEM INT EDIT, V50, P1593, DOI 10.1002/anie.201005493	49	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0934-0866	1521-4117		PART PART SYST CHAR	Part. Part. Syst. Charact.	APR	2015	32	4					441	447		10.1002/ppsc.201400191		7	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CG1RR	WOS:000353051900005		
J	Bai, DY; Nakao, R; Ito, A; Uematsu, H; Senpuku, H				Bai, Dongying; Nakao, Ryoma; Ito, Akihiro; Uematsu, Hiroshi; Senpuku, Hidenobu			Immunoreactive antigens recognized in serum samples from mice intranasally immunized with Porphyromonas gingivalis outer membrane vesicles	PATHOGENS AND DISEASE			English	Article						periodontitis; Porphyromonas gingivalis; intranasal immunization; vaccine; outer membrane vesicles	SECRETION SYSTEM; CYSTEINE PROTEINASES; PERIODONTAL PATHOGEN; PROTECTIVE IMMUNITY; BIOFILM FORMATION; CELL; ADHESINS; VIRULENCE; RESPONSES; DISEASE	Outer membrane vesicles (OMVs) of the periodontopathic bacterium Porphyromonas gingivalis contain a wide range of virulence factors including lipopolysaccharide (LPS), fimbriae and gingipains. We have recently reported strong immunogenicity of OMVs using an intranasal vaccine mouse model. In the present study, we performed sub-immunoproteome analysis of OMV-immunized mouse serum samples from six different mice in order to identify immunodominant antigens. The combination of two-dimensional (2D) gel electrophoresis and mass spectrometry analysis identified OMV proteins of 53 spots on a 2D map, and it was notable that OMV proteins were largely distributed within a low pH range, in marked contrast to the ubiquitous distribution of outer membrane proteins. Western blot using the six serum samples after 2D electrophoresis revealed that all showed immunoreactivity to some diffuse signals at extremely low pH, which was similar to the distribution of immunoreactive signals when the A-LPS antibody was used. Mass spectrometry analysis also demonstrated that the signals corresponded to a wide range of virulence factors including A-LPS-modified proteins such as gingipains. Absorption of serum with LPS resulted in a dramatic reduction of immmunoreactivity. We conclude that LPS and A-LPS-modified proteins in OMVs carry immunodominant determinants and eventually elicit P. gingivalis-specific antibodies in mice.	[Bai, Dongying; Nakao, Ryoma; Senpuku, Hidenobu] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo 1628640, Japan; [Bai, Dongying; Uematsu, Hiroshi] Tokyo Med & Dent Univ, Grad Sch, Dept Gerodontol, Bunkyo Ku, Tokyo 1138549, Japan; [Ito, Akihiro] RIKEN, Chem Genet Lab, Wako, Saitama 3510198, Japan	Nakao, R (reprint author), Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo 1628640, Japan.	ryoma73@nih.go.jp			JSPS KAKENHI [22791822, 24659821, 12840634, 26462866]; Ministry of Health, Labor and Welfare [H24-Iryo-Shitei-014]; Naito Foundation	We are grateful to Dr Minoru Yoshida for the generous support in our study. We thank Ms Michiyo Kataoka and Ms Yoshiko Obara for their technical assistance with electron microscopy analysis and in silico analysis, respectively. We also thank Dr Yoshio Nakano, Dr Nozomu Obana and Dr Shunsuke Minakuchi for the fruitful discussion. We also thank Dr Nobushiro Hamada and Dr Michael A. Curtis for kindly providing important materials. We also thank the Support Unit for Bio-Material Analysis, RIKEN BSI Research Resources Center, for technical help with the LCMS/MS analysis. This study was supported in part by JSPS KAKENHI (Grant nos. 22791822, 24659821, 12840634 and 26462866), a grant from the Ministry of Health, Labor and Welfare (H24-Iryo-Shitei-014) and The Naito Foundation.	McGraw WT, 1999, INFECT IMMUN, V67, P3248; Curtis MA, 1999, INFECT IMMUN, V67, P3816; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; GRENIER D, 1987, INFECT IMMUN, V55, P111; Umemoto T, 2003, J PERIODONTOL, V74, P119, DOI 10.1902/jop.2003.74.1.119; Mikuls TR, 2014, ARTHRITIS RHEUMATOL, V66, P1090, DOI 10.1002/art.38348; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Bishop AL, 2010, INFECT IMMUN, V78, P4402, DOI 10.1128/IAI.00398-10; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Ishihara K, 2004, J CLIN MICROBIOL, V42, P1313, DOI 10.1128/JCM.42.3.1313-1315.2004; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Veith PD, 2013, J PROTEOME RES, V12, P4449, DOI 10.1021/pr400487b; Dorn BR, 1999, INFECT IMMUN, V67, P5792; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Beveridge TJ, 1999, J BACTERIOL, V181, P4725; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Alaniz RC, 2007, J IMMUNOL, V179, P7692; Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028; Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223; Slakeski N, 1999, ORAL MICROBIOL IMMUN, V14, P92, DOI 10.1034/j.1399-302X.1999.140203.x; KESAVALU L, 1992, INFECT IMMUN, V60, P1455; Bhogal PS, 1997, MICROBIOL-UK, V143, P2485; Chen LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071953; Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200; DeCarlo AA, 1999, J BACTERIOL, V181, P3784; Elhenawy W, 2014, MBIO, V5, DOI 10.1128/mBio.00909-14; Nakao R, 2014, MICROBES INFECT, V16, P6, DOI 10.1016/j.micinf.2013.10.005; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nakao R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095137; Nakao R, 2008, BIOCHEM BIOPH RES CO, V365, P784, DOI 10.1016/j.bbrc.2007.11.035; Ogawa T, 1996, FEMS IMMUNOL MED MIC, V14, P1; Ojima M, 2005, DIABETES CARE, V28, P433, DOI 10.2337/diacare.28.2.433; LEPINE G, 1995, ORAL MICROBIOL IMMUN, V10, P1, DOI 10.1111/j.1399-302X.1995.tb00110.x; Sexton K, 2004, N Z MED J, V117, pU1015; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Slakeski N, 1998, MICROBIOL-UK, V144, P1583; TAKADA H, 1987, INFECT IMMUN, V55, P409; Tanamoto K, 1997, MICROBIOL-SGM, V143, P63; Veith PD, 2004, INFECT IMMUN, V72, P3655, DOI 10.1128/IAI.72.6.3655-3657.2004; WHITMIRE WM, 1993, INFECT IMMUN, V61, P1460	49	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2049-632X			PATHOG DIS	Pathog. Dis.	APR	2015	73	3							ftu006	10.1093/femspd/ftu006		16	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CG3CD	WOS:000353153600001		
J	Jia, R; Hashizume-Takizawa, T; Du, Y; Yamamoto, M; Kurita-Ochiai, T				Jia, Ru; Hashizume-Takizawa, Tomomi; Du, Yuan; Yamamoto, Masafumi; Kurita-Ochiai, Tomoko			Aggregatibacter actinomycetemcomitans induces Th17 cells in atherosclerotic lesions	PATHOGENS AND DISEASE			English	Article						Aggregatibacter actinomycetemcomitans; atherosclerosis; Th17 cells; inflammasome; microRNA	T-CELLS; PORPHYROMONAS-GINGIVALIS; NLRP3 INFLAMMASOME; DEFICIENT MICE; PLAQUE; CYTOKINES; DIFFERENTIATION; PATHOGENESIS; DISEASES; EXPRESSION	Th17 cells have been linked to the pathogenesis of several chronic inflammatory and autoimmune diseases. However, the role of Th17 cells and IL-17 in atherosclerosis remains poorly understood. We previously reported that Aggregatibacter actinomycetemcomitans (A alpha) bacteremia accelerated atherosclerosis accompanied by inflammation in apolipoprotein E-deficient spontaneously hyperlipidemic (Apoe(shl)) mice. In this study, we investigated whether A alpha promotes the Th17 inducing pathway in A alpha-challenged Apoe(shl) mice. Mice were intravenously injected with live A alpha HK1651 or vehicles. Time-course analysis of splenic IL-17(+) CD4(+) cell frequencies, the proximal aorta lesion area, serum IL-17, IL-6, TGF-beta and IL-1 beta levels, the mRNA expression of Th17-related molecules such as IL-1 beta, IL-6, IL17RA, STAT3, IL-21, IL-23, TGF-beta and ROR gamma t, Th17-related microRNA levels and the levels of AIM-2, Mincle and NLRP3 were examined. Challenge with A alpha time dependently induced tropism of Th17 cells in the spleen and increase in atheromatous lesions in the aortic sinus of Apoe(shl) mice. Serum IL-17, IL-6, TGF-beta and IL-1 beta levels were significantly enhanced by A alpha. The gene expression of IL-1 beta, IL-6, IL-17RA, IL-21, IL-23, TGF-beta, STAT3, ROR gamma t, AIM-2, Mincle and NLRP3 was also time dependently stimulated in the aorta of A alpha-challenged mice. Furthermore, A alpha challenge significantly increased the expression of miR-146b and miR-155 in the aorta. Based on the results, it seems that A alpha stimulates Th17 induction that affects the progression of A alpha-accelerated atherosclerosis.	[Jia, Ru; Hashizume-Takizawa, Tomomi; Du, Yuan; Yamamoto, Masafumi; Kurita-Ochiai, Tomoko] Nihon Univ, Sch Dent Matsudo, Dept Microbiol & Immunol, Matsudo, Chiba 2718587, Japan; [Jia, Ru] Tongji Univ, Stomatol Hosp, Shanghai 200092, Peoples R China; [Du, Yuan] Tianjin Med Univ, Coll, Dept Stomatol, Tianjin, Peoples R China	Kurita-Ochiai, T (reprint author), Nihon Univ, Sch Dent Matsudo, Dept Microbiol & Immunol, 2-870-1 Sakaecho Nishi, Matsudo, Chiba 2718587, Japan.	ochiai.tomoko@nihon-u.ac.jp			Japan Society for the Promotion of Science [26463145]; 'Strategic Research Base Development' Programme (Japan [MEXT]) for private universities from Ministry of Education, Culture, Sports Science and Technology, Japan [S1001024]	This study was supported by Grants-in-Aid for scientific research (26463145) from the Japan Society for the Promotion of Science, and by the 'Strategic Research Base Development' Programme (Japan [MEXT], 2010-14 [S1001024]) for private universities from the Ministry of Education, Culture, Sports Science and Technology, Japan.	Ather JL, 2011, J IMMUNOL, V187, P64, DOI 10.4049/jimmunol.1100500; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Viladomiu M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047525; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Zhang J, 2014, J NEUROIMMUNOL, V266, P56, DOI 10.1016/j.jneuroim.2013.09.019; Zhang T, 2010, FEMS IMMUNOL MED MIC, V59, P143, DOI 10.1111/j.1574-695X.2010.00674.x; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Chen C, 2010, MOL ORAL MICROBIOL, V25, P207, DOI 10.1111/j.2041-1014.2010.00567.x; Jia R, 2013, J DENT RES, V92, P247, DOI 10.1177/0022034513475625; Liu ZD, 2012, ATHEROSCLEROSIS, V221, P232, DOI 10.1016/j.atherosclerosis.2011.12.026; Adibrad M, 2012, J PERIODONTAL RES, V47, P525, DOI 10.1111/j.1600-0765.2011.01464.x; McGeachy MJ, 2012, J IMMUNOL, V189, P3285, DOI 10.4049/jimmunol.1201834; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Liu YL, 2013, ARCH VIROL, V158, P1953, DOI 10.1007/s00705-013-1695-6; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Diaz-Zuniga J, 2014, J CLIN PERIODONTOL, V41, P242, DOI 10.1111/jcpe.12205; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Cortelli JR, 2012, EUR J CLIN MICROBIOL, V31, P1311, DOI 10.1007/s10096-011-1444-2; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Zhou XH, 2000, CIRCULATION, V102, P2919; Bostanci N, 2009, CLIN EXP IMMUNOL, V157, P415, DOI 10.1111/j.1365-2249.2009.03972.x; Belibasakis Georgios N, 2012, Cytokine, V59, P124, DOI 10.1016/j.cyto.2012.03.016; Desel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053531; George J, 2012, ATHEROSCLEROSIS, V222, P519, DOI 10.1016/j.atherosclerosis.2012.03.016; Matsushima Y, 2001, J Atheroscler Thromb, V8, P71; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; Young JL, 2002, THROMB HAEMOSTASIS, V88, P554; Zhou XH, 2005, CIRC RES, V96, P427, DOI 10.1161/01.RES.0000156889.22364.f1	40	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2049-632X			PATHOG DIS	Pathog. Dis.	APR	2015	73	3							ftu027	10.1093/femspd/ftu027		8	Immunology; Infectious Diseases; Microbiology	Immunology; Infectious Diseases; Microbiology	CG3CD	WOS:000353153600006		
J	Tomita, H; Fuchimoto, Y; Ohkuma, K; Hoshino, K; Fujino, A; Kato, M; Fujimura, T; Ishihama, H; Takahashi, N; Tanami, Y; Nakatsuka, S; Ebinuma, H; Saito, H; Shinoda, M; Kitagawa, Y; Kuroda, T				Tomita, Hirofumi; Fuchimoto, Yasushi; Ohkuma, Kiyoshi; Hoshino, Ken; Fujino, Akihiro; Kato, Mototoshi; Fujimura, Takumi; Ishihama, Hideo; Takahashi, Nobuhiro; Tanami, Yutaka; Nakatsuka, Seishi; Ebinuma, Hirotoshi; Saito, Hidetsugu; Shinoda, Masahiro; Kitagawa, Yuko; Kuroda, Tatsuo			Spleen stiffness measurements by acoustic radiation force impulse imaging after living donor liver transplantation in children: a potential quantitative index for venous complications	PEDIATRIC RADIOLOGY			English	Article						Acoustic radiation force impulse imaging; Living donor liver transplantation; Child; Portal hypertension; Spleen stiffness measurement; Complications	TRANSIENT ELASTOGRAPHY; VASCULAR COMPLICATIONS; PORTAL-HYPERTENSION; ARFI ELASTOGRAPHY; HEALTHY-CHILDREN; NORMAL VALUES; SINGLE-CENTER; FIBROSIS; EXPERIENCE; CIRRHOSIS	Living donor liver transplantation in children often results in venous complications, leading to portal hypertension. Spleen stiffness measurements have been recently proposed as a new, noninvasive parameter for portal hypertension in cirrhotic patients. To evaluate the diagnostic value of spleen stiffness measurements by acoustic radiation force impulse (ARFI) imaging in diagnosing venous complications after pediatric living donor liver transplantation. We prospectively enrolled 69 patients after pediatric living donor liver transplantation using a left-side liver allograft. Around the time of the protocol liver biopsy examination, spleen stiffness measurements by ARFI imaging were performed via the left intercostal space at the center of the spleen parenchyma and repeated five times. Imaging examinations around the time of the spleen stiffness measurements were retrospectively reviewed. Regarding venous complications, significant portal and hepatic venous stenosis was defined as > 50% stenosis on multiphasic computed tomography. After post hoc exclusion, 62 patients were studied. Portal and hepatic venous stenosis was identified in three and two patients, respectively. The median spleen stiffness values were 2.70 and 4.00 m/s in patients without and with venous complications, respectively (P < 0.001). Spleen stiffness measurements showed good diagnostic power for venous complications, and the cutoff value was determined as 2.93 m/s, with 100% sensitivity and 78.9% specificity. Spleen stiffness measurements decreased with the relief of venous stenosis resulting from an interventional radiology procedure. Spleen stiffness measurements by ARFI imaging might provide a useful quantitative index for venous complications after pediatric living donor liver transplantation.	[Tomita, Hirofumi; Fuchimoto, Yasushi; Hoshino, Ken; Fujino, Akihiro; Kato, Mototoshi; Fujimura, Takumi; Ishihama, Hideo; Takahashi, Nobuhiro; Shinoda, Masahiro; Kitagawa, Yuko; Kuroda, Tatsuo] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Fuchimoto, Yasushi] Natl Ctr Child Hlth & Dev, Div Surg, Dept Surg Subspecialties, Setagaya Ku, Tokyo 1578535, Japan; [Ohkuma, Kiyoshi; Tanami, Yutaka; Nakatsuka, Seishi] Keio Univ, Sch Med, Dept Radiol, Shinjuku Ku, Tokyo 1608582, Japan; [Ebinuma, Hirotoshi; Saito, Hidetsugu] Keio Univ, Sch Med, Dept Med, Shinjuku Ku, Tokyo 1608582, Japan	Fuchimoto, Y (reprint author), Natl Ctr Child Hlth & Dev, Div Surg, Dept Surg Subspecialties, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	yfuchimoto@z5.keio.jp		Tomita, Hirofumi/0000-0002-0283-8240	Japan Society for the Promotion of Science (JSPS KAKENHI) [26870570]	The research presented in this manuscript was supported by the Japan Society for the Promotion of Science (JSPS KAKENHI, Grant-in-Aid for Young Scientists [B], Grant Number 26870570), and the authors have no conflicts of interest to disclose. The authors thank Mieko Tsuchida, Yuko Shirahata, Yoshiko Shiomi, Chigusa Mochizuki, Dr. Akihisa Ueno and Yuji Masuda for performing the measurements of spleen and liver stiffness by ARFI imaging.	Alvarez Fernando, 2012, Curr Gastroenterol Rep, V14, P270, DOI 10.1007/s11894-012-0257-5; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Noruegas MJ, 2012, PEDIATR RADIOL, V42, P201, DOI 10.1007/s00247-011-2257-2; Megremis SD, 2004, RADIOLOGY, V231, P129, DOI 10.1148/radiol.2311020963; Vermehren J, 2012, LIVER INT, V32, P852, DOI 10.1111/j.1478-3231.2011.02736.x; Mullan CP, 2010, AM J ROENTGENOL, V195, P1438, DOI 10.2214/AJR.10.4636; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Kaminuma C, 2011, J ULTRAS MED, V30, P745; Sakamoto S, 2010, LIVER TRANSPLANT, V16, P1207, DOI 10.1002/lt.22135; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Nierhoff J, 2013, EUR RADIOL, V23, P3040, DOI 10.1007/s00330-013-2927-6; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Takuma Y, 2013, GASTROENTEROLOGY, V144, P92, DOI 10.1053/j.gastro.2012.09.049; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Friedrich-Rust M, 2012, J VIRAL HEPATITIS, V19, pE212, DOI 10.1111/j.1365-2893.2011.01537.x; Ng VL, 2008, PEDIATRICS, V122, pE1128, DOI 10.1542/peds.2008-1363; Itri JN, 2013, ABDOM IMAGING, V38, P1300, DOI 10.1007/s00261-013-0002-z; Hanquinet S, 2013, PEDIATR RADIOL, V43, P545, DOI 10.1007/s00247-012-2595-8; Dani G, 2013, SEMIN ULTRASOUND CT, V34, P365, DOI 10.1053/j.sult.2013.04.002; Ueda M, 2008, AM J TRANSPLANT, V8, P2097, DOI 10.1111/j.1600-6143.2008.02360.x; Diamond IR, 2007, ANN SURG, V246, P301, DOI 10.1097/SLA.0b013e3180caa415; Buell JF, 2002, ANN SURG, V236, P658, DOI 10.1097/01.SLA.0000032944.15795.B8; Berzigotti A, 2013, EXPERT REV GASTROENT, V7, P141, DOI [10.1586/egh.12.83, 10.1586/EGH.12.83]; Bota S, 2010, MED ULTRASON, V12, P213; Behrens CB, 2012, PEDIATR RADIOL, V43, P552; Cheng YF, 2004, LIVER TRANSPLANT, V10, P248, DOI 10.1002/lt.20055; Eiler J, 2012, ULTRASCHALL MED, V33, P474, DOI 10.1055/s-0032-1313145; Hanquinet S, 2013, PEDIATR RADIOL, V43, P539, DOI 10.1007/s00247-012-2553-5; Heffron TG, 2010, PEDIATR TRANSPLANT, V14, P722, DOI 10.1111/j.1399-3046.2009.01259.x; Karlas T, 2014, ULTRASCHALL MED, V35, P38, DOI 10.1055/s-0033-1356230; Lee MJ, 2013, EUR J RADIOL, V82, pE290, DOI 10.1016/j.ejrad.2013.01.018; Loftus WK, 1997, J ULTRAS MED, V16, P345; OZAWA K, 1992, ANN SURG, V216, P547, DOI 10.1097/00000658-199211000-00004; Pinto J, 2014, J PEDIATR GASTR NUTR, V58, P382, DOI 10.1097/MPG.0000000000000226; Shima H, 2012, PEDIATR SURG INT, V28, P869, DOI 10.1007/s00383-012-3140-4; Tannuri U, 2011, J PEDIATR SURG, V46, P1379, DOI 10.1016/j.jpedsurg.2010.11.047; Tomita H, 2013, LIVER TRANSPLANT, V19, P1202, DOI 10.1002/lt.23708; Yilmaz A, 2007, PEDIATR TRANSPLANT, V11, P160, DOI 10.1111/j.1399-3046.2006.00601.x	39	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	APR	2015	45	5					658	666		10.1007/s00247-014-3215-6		9	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	CG4EA	WOS:000353234800007		
J	Owada, K; Miyazaki, O; Matsuoka, K; Sago, H; Nosaka, S				Owada, Keiho; Miyazaki, Osamu; Matsuoka, Kentaro; Sago, Haruhiko; Nosaka, Shunsuke			Unusual signal intensity of congenital pulmonary airway malformation on fetal magnetic resonance imaging	PEDIATRIC RADIOLOGY			English	Article						Magnetic resonance imaging; Congenital pulmonary airway malformation; Mucin; Fetus	CYSTIC ADENOMATOID MALFORMATION; THORACIC ABNORMALITIES; LUNG LESIONS	Congenital pulmonary airway malformation (CPAM) is classified into pathologically different types. These types are sometimes distinguishable by fetal lung MRI and are usually observed as higher-signal lesions on T2-weighted images than normal lung. We describe a case of unusual CPAM resembling neoplasms, with a lower signal than is found in normal lung. Histopathology showed a large number of mucogenic cells but found no evidence that could explain this feature on fetal MRI. An unusual low-signal mass associated with a pulmonary cyst in fetal lung on MRI may suggest an unusual type 1 CPAM.	[Owada, Keiho; Miyazaki, Osamu; Nosaka, Shunsuke] Natl Ctr Child Hlth & Dev, Dept Radiol, Setagaya Ku, Tokyo 1578535, Japan; [Matsuoka, Kentaro] Natl Ctr Child Hlth & Dev, Dept Pathol, Tokyo, Japan; [Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Dept Perinatal Med & Maternal Care, Tokyo, Japan	Owada, K (reprint author), Natl Ctr Child Hlth & Dev, Dept Radiol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	ohwada-k@ncchd.go.jp					STOCKER JT, 1977, HUM PATHOL, V8, P155, DOI 10.1016/S0046-8177(77)80078-6; Epelman M, 2010, SEMIN ULTRASOUND CT, V31, P141, DOI 10.1053/j.sult.2010.01.002; Levine D, 2003, RADIOLOGY, V228, P379, DOI 10.1148/radiol.2282020604; Hubbard AM, 1999, RADIOLOGY, V212, P43; Beydon N, 2013, PEDIATR RADIOL, V43, P685, DOI 10.1007/s00247-012-2596-7; Langston Claire, 2003, Semin Pediatr Surg, V12, P17, DOI 10.1053/spsu.2003.00001; Liu YP, 2010, PEDIATR PULM, V45, P592, DOI 10.1002/ppul.21226; Ota H, 1998, AM J CLIN PATHOL, V110, P450; Rodriguez MR, 2012, RADIOGRAPHICS, V32, pE305, DOI 10.1148/rg.327125053; ROSADODECHRISTENSON ML, 1991, RADIOGRAPHICS, V11, P865	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	APR	2015	45	5					763	766		10.1007/s00247-015-3288-x		4	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	CG4EA	WOS:000353234800021		
J	Hashimoto, I; Watanabe, K; Kaneda, H				Hashimoto, Ikuo; Watanabe, Kazuhiro; Kaneda, Hisashi			Z-values of tricuspid annular plane systolic excursion in Japanese children	PEDIATRICS INTERNATIONAL			English	Article						cardiac function; children; echocardiography; Japanese; pediatrics	RIGHT-VENTRICULAR VOLUME; ECHOCARDIOGRAPHY; QUANTIFICATION; MRI; TETRALOGY; PULMONARY; DISEASE; FALLOT; REPAIR	BackgroundThe aim of this study was to establish growth-related standard values and z-values for tricuspid annular plane systolic excursion (TAPSE) for Japanese children. MethodWe examined 953 consecutive healthy children and adolescents, ranging from newborn to 22.7 years of age (mean age, 4.4 4.0 years). TAPSE was measured as the longitudinal tricuspid valve annular motion from the apex on M-mode echocardiography. The right ventricular (RV) stroke volume (RVSV) divided by the body surface area (RVSV/BSA) was used as an independent indicator of body size. RVSV was determined from the recordings of the ejection blood flow velocity and the diameter at the level of the pulmonary orifice in the RV outflow tract. ResultsTAPSE had positive correlations with age and BSA, ranging from 6.0 to 31.4mm (mean, 19.1 +/- 4.4mm). The z-values ranged from -3.63 to 3.17. There was no significant difference in TAPSE between the genders (male, 19.0 +/- 4.6mm; female, 19.1 +/- 4.2mm). The z-values positively correlated with RVSV/BSA. ConclusionsGrowth-related normal TAPSE was studied in healthy Japanese children to obtain the TAPSE z-value. TAPSE z-value is one of the parameters that can be used to assess RV systolic function independent of body size.	[Hashimoto, Ikuo; Watanabe, Kazuhiro; Kaneda, Hisashi] Toyama City Hosp, Dept Pediat, Toyama, Japan	Hashimoto, I (reprint author), 2-1 Hokubu Mach, Toyama, Toyama 9398511, Japan.	i.hashimoto@icloud.com					Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Speiser U, 2012, BRIT J RADIOL, V85, pE716, DOI 10.1259/bjr/50238360; Zhang QB, 2013, INT J CARDIOL, V168, P3991, DOI 10.1016/j.ijcard.2013.06.088; Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026; KITABATAKE A, 1984, CIRCULATION, V69, P73; Kjaergaard J, 2006, EUR J ECHOCARDIOGR, V7, P430, DOI 10.1016/j.euje.2005.10.009; Harada K, 2004, J AM SOC ECHOCARDIOG, V17, P863, DOI 10.1016/j.echo.2004.04.037; Bonnemains L, 2012, MAGN RESON MED, V67, P1740, DOI 10.1002/mrm.23143; Harada M, 2012, HISTOPATHOLOGY, V61, P1156, DOI 10.1111/j.1365-2559.2012.04332.x; Kleinveld G, 2006, PEDIATR CARDIOL, V27, P329, DOI 10.1007/s00246-005-1137-7; Shiota T, 2009, CURR OPIN CARDIOL, V24, P410, DOI 10.1097/HCO.0b013e32832cf8f6; Tousignant C, 2012, CAN J ANESTH, V59, P376, DOI 10.1007/s12630-011-9659-3	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					199	204		10.1111/ped.12491		6	Pediatrics	Pediatrics	CG1MG	WOS:000353036100020		
J	Kawazu, Y; Inamura, N; Ishii, R; Terashima, Y; Hamamichi, Y; Kayatani, F; Iwai, S; Kawata, H; Kishimoto, H				Kawazu, Yukiko; Inamura, Noboru; Ishii, Ryo; Terashima, Yoshino; Hamamichi, Yuji; Kayatani, Futoshi; Iwai, Shigemitsu; Kawata, Hiroaki; Kishimoto, Hidefumi			Prognosis in tetralogy of Fallot with absent pulmonary valve	PEDIATRICS INTERNATIONAL			English	Article						absent pulmonary valve; configuration; prognosis; pulmonary artery; tetralogy of Fallot	INTACT VENTRICULAR SEPTUM; DUCTUS-ARTERIOSUS; ECHOCARDIOGRAPHIC FEATURES; PRENATAL-DIAGNOSIS; FETUS	BackgroundTetralogy of Fallot with absent pulmonary valve (TF/APV) is a rare and severe congenital heart disease with high mortality. The aim of this study was to assess whether TF/APV prognosis is related to fetal and postnatal clinical course and pulmonary artery (PA) configuration. MethodsThe fetal and postnatal echocardiograms and clinical outcomes of 13 patients with TF/APV (diagnosed antenatally in 9 patients and postnatally in 4) were reviewed, and divided into two groups: group A (n = 6), alive; and group D (n = 7), dead. ResultsFetal period: group A, polyhydramnios n = 0, hydrops fetalis (HF) n = 0, patent ductus arteriosus (PDA) n = 2; group D, polyhydramnios n = 3, HFn = 2, PDAn = 0. Postnatal period: group A, five patients underwent intracardiac repair, including one requiring artificial ventilation (AV). A further AV patient required three operations before extubation. Postoperative courses were all good. Group D, excluding the two intrauterine fetal deaths, four patients required AV (three of whom died neonatally or in early childhood) and one underwent intracardiac repair. PA configuration: all group A patients had bulbous expansion of left and right PA (clover type). Three patients in group D had bulbous expansion of main PA (balloon type). ConclusionsPDA was a factor associated with good prognosis. Hydramnion and HF were factors associated with poor prognosis. Given that there was a higher rate of postnatal AV and poorer prognosis in balloon type than in clover type PA (P < 0.05), PA configuration is also considered an important factor to predict postnatal outcome in TF/APV.	[Kawazu, Yukiko; Inamura, Noboru; Ishii, Ryo; Terashima, Yoshino; Hamamichi, Yuji; Kayatani, Futoshi] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, Izumi, Osaka 5941101, Japan; [Iwai, Shigemitsu; Kawata, Hiroaki; Kishimoto, Hidefumi] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Heart Surg, Izumi, Osaka 5941101, Japan	Kawazu, Y (reprint author), Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Pediat Cardiol, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	kadoy@mch.pref.osaka.jp					Volpe P, 2004, ULTRASOUND OBST GYN, V24, P623, DOI 10.1002/uog.1729; Inamura N, 2005, AM J PERINAT, V22, P199, DOI 10.1055/s-2005-866603; Becker R, 2001, ULTRASOUND OBST GYN, V17, P263, DOI 10.1046/j.1469-0705.2001.00242.x; EMMANOUILIDES GC, 1976, AM J CARDIOL, V37, P403, DOI 10.1016/0002-9149(76)90290-3; ETTEDGUI JA, 1990, AM J CARDIOL, V66, P233, DOI 10.1016/0002-9149(90)90598-U; Galindo A, 2006, ULTRASOUND OBST GYN, V28, P32, DOI 10.1002/uog.2807; Grotenhuis HB, 2003, ANN THORAC SURG, V75, P280, DOI 10.1016/S0003-4975(02)04297-2; JOHNSON P, 1992, AM J OBSTET GYNECOL, V167, P1309; Kawazu Y, 2011, PEDIAT CARDIOL CARDI, V27, P88; Moon-Grady AJ, 2002, AM J CARDIOL, V89, P1280, DOI 10.1016/S0002-9149(02)02326-3; Pachirat O, 1997, ECHOCARDIOGR-J CARD, V14, P129, DOI 10.1111/j.1540-8175.1997.tb00700.x; Podzimkova J, 1997, INT J CARDIOL, V61, P109, DOI 10.1016/S0167-5273(97)00140-X; RABINOVITCH M, 1982, AM J CARDIOL, V50, P804, DOI 10.1016/0002-9149(82)91238-3; Siwik ES, 2008, MOSS ADAMS HEART DIS, V7th, P905	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					210	216		10.1111/ped.12493		7	Pediatrics	Pediatrics	CG1MG	WOS:000353036100022		
J	Sakurai, Y; Tamura, M				Sakurai, Yoshio; Tamura, Masanori			Efficacy of the Airway Scope (Pentax-AWS) for training in pediatric intubation	PEDIATRICS INTERNATIONAL			English	Article						Airway Scope; laryngoscope; pediatrics; residency program; simulator	TRACHEAL INTUBATION; ENDOTRACHEAL INTUBATION; LARYNGOSCOPES; MACINTOSH; GLIDESCOPE(R); SKILLS; PARAMEDICS; AIRTRAQ; TRIAL	BackgroundThe aim of this study was to evaluate the efficacy of the Airway Scope (AWS) in the training of residents in pediatric intubation using high-performance simulators. MethodsA total of 51 residents were recruited. Baby SIM is a high-performance simulator with a built-in physiological program that reduces SpO(2) if it stops breathing and increases SpO(2) if assisted ventilation is provided using a bag mask. Therefore, real-life situations can be simulated with this program. Trial 1: after respiration of Baby SIM was stopped, intubation was initiated. If the intubation time was too long, a built-in physiological program led to desaturation. The intubation time and frequency of SpO(2) <90% were compared between the Miller laryngoscope and the AWS. Trial 2: an ALS Baby, which is more difficult to intubate than Baby SIM, was used in comparison of intubation time and frequency of failure to intubate within 60s between the two laryngoscopes. Mann-Whitney and chi-squared tests were used for statistical analysis. ResultsIntubation time was significantly shorter using the AWS than the Miller laryngoscope in both trials. Furthermore, desaturation occurred significantly less frequently with the AWS than the Miller laryngoscope in trial 1. The frequency of intubation failure within 60s was also significantly lower for the AWS than the Miller laryngoscope in trial 2. ConclusionThe inclusion of both direct laryngoscopy and the AWS in pediatric resident programs might give pediatricians the option of using a safer and more reliable intubation method for children.	[Sakurai, Yoshio; Tamura, Masanori] Saitama Med Univ, Saitama Med Ctr, Kawagoe, Saitama 3508550, Japan	Sakurai, Y (reprint author), Saitama Med Univ, Saitama Med Ctr, Dept Pediat, 1981 Kamoda, Kawagoe, Saitama 3508550, Japan.	sakura_y@saitama-med.ac.jp					Sun DA, 2005, BRIT J ANAESTH, V94, P381, DOI 10.1093/bja/aei041; Hirabayashi Y, 2009, J CLIN ANESTH, V21, P268, DOI 10.1016/j.jclinane.2008.08.024; Cooper RM, 2005, CAN J ANAESTH, V52, P191; Griesdale DEG, 2012, CAN J ANESTH, V59, P41, DOI 10.1007/s12630-011-9620-5; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Koyama JI, 2006, J NEUROSURG ANESTH, V18, P247, DOI 10.1097/00008506-200610000-00005; Teoh WHL, 2010, ANAESTHESIA, V65, P1126, DOI 10.1111/j.1365-2044.2010.06513.x; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Komasawa N, 2013, J ANESTH, V27, P778, DOI 10.1007/s00540-013-1607-7; Brett-Fleegler MB, 2008, PEDIATRICS, V121, pE597, DOI 10.1542/peds.2005-1259; Doherty JS, 2009, PEDIATR ANESTH, V19, P30, DOI 10.1111/j.1460-9592.2009.03001.x; Eich C, 2007, BRIT J ANAESTH, V98, P417, DOI 10.1093/bja/aem051; Enomoto T, 2008, BRIT J ANAESTH, V100, P544; Gaskin PRA, 2000, PEDIATRICS, V105, P1184, DOI 10.1542/peds.105.6.1184; Healy DW, 2012, BMC ANESTHESIOL, V12, DOI 10.1186/1471-2253-12-32; Maharaj CH, 2007, ANESTHESIOLOGY, V107, P53, DOI 10.1097/01.anes.0000267529.71756.f0; Nasim Sajid, 2009, BMC Emerg Med, V9, P9, DOI 10.1186/1471-227X-9-9; Schaefer JJ, 2004, PAEDIATR ANAESTH, V14, P28, DOI 10.1046/j.1460-9592.2003.01204.x; Surcouf Jeffrey W, 2013, Med Educ Online, V18, P1, DOI 10.3402/meo.v18i0.18726; Wahlen BM, 2004, EUR J ANAESTH, V21, P907, DOI 10.1017/S0265021504000274; Wang PK, 2013, AM J EMERG MED, V31, P330, DOI 10.1016/j.ajem.2012.08.026	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					217	221		10.1111/ped.12490		5	Pediatrics	Pediatrics	CG1MG	WOS:000353036100023		
J	Ito, Y; Shimizu, T; Nakamura, T; Takatama, C				Ito, Yasuo; Shimizu, Toshimitsu; Nakamura, Tomomi; Takatama, Chie			Effectiveness of tongue-tie division for speech disorder in children	PEDIATRICS INTERNATIONAL			English	Article						ankyloglossia; articulation test; frenuloplasty; frenulotomy; tongue-tie	ANKYLOGLOSSIA	BackgroundThe aim of this study was to determine the effectiveness of tongue-tie division (frenuloplasty/ frenulotomy) for speech articulation disorder in children with ankyloglossia (tongue-tie). MethodsArticulation test was done in five children (3-8years old) with speech problems who underwent tongue-tie division. The test consisted of 50 pictures of common Japanese words with 2-3 syllables. The patients were interviewed by a speech therapist and asked to pronounce what the picture card showed. Misarticulations of substitution, omission, and distortion were assessed. The preoperative results were compared with postoperative examinations at 1month, 3-4months, and 1-2years. ResultsNineteen substitutions that were observed in four patients preoperatively decreased to 10 in three patients at 1month, 7 in three patients at 3-4months, and 1 in one patient at 1-2years postoperatively. Five omissions that were observed in four patients preoperatively decreased to 3 in three patients at 1month, 2 in two patients at 3-4months, and 1 in one patient at 1-2years postoperatively. Thirteen distortions that were observed in five patients preoperatively decreased to 8 in four patients at 3-4months but increased to 11 in three patients at 1-2years postoperatively. ConclusionsSubstitution and omission improved relatively early after tongue-tie division and progressed to distortion, which is a less-impaired form of articulation disorder. Thus, distortion required more time for improvement and remained a defective speaking habit in some patients.	[Ito, Yasuo] Int Univ Hlth & Welf, Dept Pediat & Pediat Surg, Atami Hosp, Atami 4130012, Japan; [Shimizu, Toshimitsu; Nakamura, Tomomi; Takatama, Chie] Int Univ Hlth & Welf, Div Speech Therapy, Atami Hosp, Atami 4130012, Japan	Ito, Y (reprint author), Int Univ Hlth & Welf, Dept Pediat Surg, Atami Hosp, 13-1 Higashikaigancho, Atami 4130012, Japan.	yasuito@iuhw.ac.jp					Amir Lisa H, 2006, Int Breastfeed J, V1, P3, DOI 10.1186/1746-4358-1-3; Dollberg S, 2006, J PEDIATR SURG, V41, P1598, DOI 10.1016/j.jpedsurg.2006.05.024; Buryk M, 2011, PEDIATRICS, V128, P280, DOI 10.1542/peds.2011-0077; Berry J, 2012, BREASTFEED MED, V7, P189, DOI 10.1089/bfm.2011.0030; Block J R, 1968, N Y State Dent J, V34, P479; Dollberg S, 2011, ACTA PAEDIATR, V100, pE125, DOI 10.1111/j.1651-2227.2011.02265.x; Fletcher SG, 1968, J SPEECH HEAR RES, V2, P382; Heller J, 2005, ANN PLAS SURG, V54, P623, DOI 10.1097/01.sap.0000157917.91853.be; Ito S, 1988, KOKUBYO GAKKAI ZASSH, V55, P159; Klockars T, 2009, INT J PEDIATR OTORHI, V73, P1399, DOI 10.1016/j.ijporl.2009.07.004; Lalakea M, 2002, OTOLARYNGOL HEAD NEC, V13, P93; MacCarthy D, 1964, BMJ-BRIT MED J, V12, P1511; Messner AH, 2002, OTOLARYNG HEAD NECK, V127, P539, DOI 10.1067/mhn.2002.129823; Messner AH, 2000, INT J PEDIATR OTORHI, V54, P123, DOI 10.1016/S0165-5876(00)00359-1; National Institute for Health and Care Excellence, INT PROC GUID 149; PLUMMER R N, 1956, Ariz Med, V13, P139; WRIGHT JE, 1995, J PAEDIATR CHILD H, V31, P276, DOI 10.1111/j.1440-1754.1995.tb00810.x	17	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					222	226		10.1111/ped.12474		5	Pediatrics	Pediatrics	CG1MG	WOS:000353036100024		
J	Abe, N; Kodama, H				Abe, Noriko; Kodama, Hideya			Distal-proximal skin temperature gradient prior to sleep onset in infants for clinical use	PEDIATRICS INTERNATIONAL			English	Article						actigraphy; child care; circadian rhythm; sleep; skin temperature	CIRCADIAN-RHYTHMS; BODY-TEMPERATURE; FINGER TEMPERATURE; CORE TEMPERATURE; MELATONIN; LIFE; PROPENSITY; LATENCY; YOUNG; MEN	BackgroundThe objective of this study was to explore the possibility of using distal-proximal skin temperature gradient (DPG) to predict sleep-onset latency of night-time sleep for infants at home. MethodsFoot (for distal) and abdominal (for proximal) skin temperature during sleep onset in healthy infants, aged 4-9months, was continuously recorded using a temperature logger at home. Sleep-onset latency during each study night was defined as the interval from lights-off to sleep onset, determined on actigraphy. Association of DPG profile after lights-off with sleep-onset latency on the study nights was evaluated. ResultsData for 43 nights from 28 infants were available for analysis. With regard to low DPG (<-2.5 degrees C) at lights-off, >60% of infants fell asleep within 30min if DPG was increased to -2.5 degrees C within 15min after lights-off. If DPG remained at <-2.5 degrees C at 15min after lights-off, however, only 20% of infants fell asleep within 30min. In addition, if infants were still awake at 15min after lights-off and the DPG at that time was <-2.5 degrees C, they were not likely to quickly fall asleep (predictive value was 0.875). ConclusionsIncrease in DPG by 15min after lights-off is a key determinant for sleep-onset latency.	[Abe, Noriko] Japanese Red Cross Akita Coll Nursing, Akita, Japan; [Kodama, Hideya] Akita Grad Sch Med & Fac Med, Sch Hlth Sci, Dept Matern Child Nursing, Akita, Japan	Kodama, H (reprint author), 1-1-1 Hondo, Akita 0108543, Japan.	kodamah@hs.akita-u.ac.jp			Japan Society for the Promotion of Science [24593400]	The present study was supported by Grant-in-Aid for Scientific Research (No. 24593400) from the Japan Society for the Promotion of Science.	Fronczek R, 2006, SLEEP, V29, P1444; SADEH A, 1995, INFANT BEHAV DEV, V18, P329, DOI 10.1016/0163-6383(95)90021-7; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Murphy PJ, 1997, SLEEP, V20, P505; Gradisar M, 2004, J BIOL RHYTHM, V19, P157, DOI 10.1177/0748730403261560; Krauchi K, 2000, AM J PHYSIOL-REG I, V278, pR741; Zornoza-Moreno M, 2011, CHRONOBIOL INT, V28, P330, DOI 10.3109/07420528.2011.565895; RUBINSTEIN EH, 1990, ANESTHESIOLOGY, V73, P541, DOI 10.1097/00000542-199009000-00027; Mirmiran M, 2003, SLEEP MED REV, V7, P321, DOI 10.1053/smrv.2002.0243; Krauchi K, 1997, J APPL PHYSIOL, V83, P134; Braverman IM, 1997, MICROCIRCULATION-LON, V4, P329, DOI 10.3109/10739689709146797; GLOTZBACH SF, 1994, PEDIATRICS, V94, P482; Johnson John M, 2010, Front Biosci (Schol Ed), V2, P825; Kanda K, 1999, EUR J APPL PHYSIOL O, V80, P71, DOI 10.1007/s004210050560; KRAUCHI K, 1994, AM J PHYSIOL, V267, pR819; Lack L, 2002, J SLEEP RES, V11, P275, DOI 10.1046/j.1365-2869.2002.00312.x; Lack LC, 1996, J SLEEP RES, V5, P1, DOI 10.1046/j.1365-2869.1996.00005.x; MCMILLEN IC, 1991, PEDIATR RES, V29, P381, DOI 10.1203/00006450-199104000-00010; Nardin RA, 2010, J AM PODIAT MED ASSN, V100, P258; Sadeh A, 1997, SLEEP, V20, P185; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; Shinohara H, 2011, PEDIATR INT, V53, P29, DOI 10.1111/j.1442-200X.2010.03186.x; Tsai SY, 2012, J ADV NURS, V68, P1738, DOI 10.1111/j.1365-2648.2011.05857.x; Van den Heuvel CJ, 1998, J SLEEP RES, V7, P159, DOI 10.1046/j.1365-2869.1998.00112.x	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					227	233		10.1111/ped.12473		7	Pediatrics	Pediatrics	CG1MG	WOS:000353036100025		
J	Takei, Y; Ogata, A; Ozawa, M; Moritake, H; Hirai, K; Manabe, A; Suzuki, S				Takei, Yuko; Ogata, Akiko; Ozawa, Miwa; Moritake, Hiroshi; Hirai, Kei; Manabe, Atsushi; Suzuki, Shin-ichi			Psychosocial difficulties in adolescent and young adult survivors of childhood cancer	PEDIATRICS INTERNATIONAL			English	Article						adolescent; cancer; psychosocial difficulty; survivor; young adult	QUALITY-OF-LIFE; PEDIATRIC ONCOLOGY; CHILDREN; CARE	BackgroundWith a large number of children surviving cancer worldwide, numerous investigations have assessed psychological and social adjustment among childhood cancer survivors. According to these studies, it is unclear whether childhood cancer survivors successfully adjust to daily life after being discharged from hospital, especially for adolescent and young adult survivors who have unique needs and concerns. The primary aim of this study was to identify the factors underlying psychosocial difficulties faced by adolescent and young adult survivors in their day-to-day lives after being discharged from hospital. MethodsSemi-structured interviews were conducted. Twenty-five childhood cancer survivors were recruited from two regional cancer institutions in Japan. Content analysis was applied to the responses. ResultsNineteen attributes were extracted and classified into four categories as follows: physical difficulties, interpersonal difficulties, behavioral difficulties, and uncertainty about the future. The attributes indicated by >50% of the participants were I am worried about not feeling well, I have difficulty continuing treatment in daily life, I have difficulty moving my body, I have to be absent from school or work because of illness, and I am left behind academically. ConclusionsThis study identified important factors of psychosocial day-to-day difficulties. Clinically, these results suggest that it is important to watch for these signs and to provide early support to survivors so that their daily life and development are not hindered by the treatment and its side-effects, and to offer long-term support focusing on individual patient characteristics such as sex, age, and cancer history.	[Takei, Yuko] Univ Miyazaki Hosp, Fac Med, Kiyotake, Miyazaki 8891692, Japan; [Moritake, Hiroshi] Miyazaki Univ, Fac Med, Div Pediat, Dept Reprod & Dev Med, Miyazaki, Japan; [Ogata, Akiko] Hiroshima Univ, Fac Educ, Hiroshima, Japan; [Ozawa, Miwa; Manabe, Atsushi] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Hirai, Kei] Osaka Univ, Grad Sch Human Sci, Ctr Study Commun Design, Osaka, Japan; [Hirai, Kei] Osaka Univ, Grad Sch Med, Osaka, Japan; [Suzuki, Shin-ichi] Waseda Univ, Fac Human Sci, Saitama, Japan	Takei, Y (reprint author), Univ Miyazaki Hosp, Fac Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	yuko-t@fc.miyazaki-u.ac.jp			 [20220101]	We express our sincere gratitude to the patients who agreed to share their experiences with us. This study was supported by a Grant-in-aid for Health and Labor Science Research (20220101).	Meeske KA, 2007, PEDIATR BLOOD CANCER, V49, P298, DOI 10.1002/pbc.20923; Kazak AE, 2007, J PEDIATR PSYCHOL, V32, P1099, DOI 10.1093/jpepsy/jsm031; Ishida Y, 2011, INT J HEMATOL, V93, P633, DOI 10.1007/s12185-011-0843-6; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Varni JW, 2007, J PEDIATR PSYCHOL, V32, P1151, DOI 10.1093/jpepsy/jsm008; Hirai K, 2006, J PAIN SYMPTOM MANAG, V31, P140, DOI 10.1016/j.jpainsymman.2005.06.012; Evan EE, 2006, CANCER, V107, P1663, DOI 10.1002/cncr.22107; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Eiser C, 2000, J PEDIATR PSYCHOL, V25, P449, DOI 10.1093/jpepsy/25.6.449; Love C, 2011, PSYCHO-ONCOLOGY, V20, P278, DOI 10.1002/pon.1733; Dickerman JD, 2007, PEDIATRICS, V119, P554, DOI 10.1542/peds.2006-2826; Mulrooney DA, 2008, CANCER, V112, P2071, DOI 10.1002/cncr.23405; Stam H, 2001, SUPPORT CARE CANCER, V9, P489; Asami K, 2012, PEDIATR INT, V42, P513; Canadian Cancer Society, 2009, CAN CANC STAT 2009 S; Eiser C, 2007, CANC ADOLESCENTS YOU, P365, DOI 10.1007/978-3-540-68152-6_23; Hawkins MM, 1996, BRIT MED BULL, V52, P898; Hudson Melissa M., 2003, JAMA (Journal of the American Medical Association), V290, P1583, DOI 10.1001/jama.290.12.1583; Langeveld NE, 2002, SUPPORT CARE CANCER, V10, P579, DOI 10.1007/s00520-002-0388-6; Langeveld NE, 2003, PSYCHO-ONCOL, V12, P213, DOI 10.1002/pon.628; Meeske K A, 2001, Oncol Nurs Forum, V28, P481; Moody K, 2006, SUPPORT CARE CANCER, V14, P960, DOI 10.1007/s00520-006-0024-y; Sawyer LM, 1999, INT J CANCER, V12, P39; Schwartz CL, 2005, SURVIVORS CHILDHOOD, V2nd; Servitzoglou M, 2008, SUPPORT CARE CANCER, V16, P29, DOI 10.1007/s00520-007-0278-z; vonsEssen L, 2000, ACTA PAEDIATR, V89, P229; Weber R. P., 1990, BASIC CONTENT ANAL; Woodgate R, 2000, J Pediatr Oncol Nurs, V17, P192, DOI 10.1053/jpon.2000.16396; Yoshida S, 2009, SUPPORT CARE CANCER, V18, P439; Zebrack Brad J, 2007, J Cancer Surviv, V1, P137, DOI 10.1007/s11764-007-0015-0; Zebrack BJ, 2007, CANC ADOLESCENTS YOU, P375, DOI 10.1007/978-3-540-68152-6_24	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					239	246		10.1111/ped.12495		8	Pediatrics	Pediatrics	CG1MG	WOS:000353036100027		
J	Katsushima, Y; Katsushima, F; Suzuki, Y; Seto, J; Mizuta, K; Nishimura, H; Matsuzaki, Y				Katsushima, Yuriko; Katsushima, Fumio; Suzuki, Yu; Seto, Junji; Mizuta, Katsumi; Nishimura, Hidekazu; Matsuzaki, Yoko			Characteristics of Mycoplasma pneumoniae infection identified on culture in a pediatric clinic	PEDIATRICS INTERNATIONAL			English	Article						macrolide resistance; minocycline; Mycoplasma pneumoniae; tosufloxacin; viral infection	IN-VITRO; SEROLOGICAL TESTS; FLUOROQUINOLONES; MINOCYCLINE; RESISTANCE; MACROLIDES; DIAGNOSIS; CHILDREN; JAPAN	BackgroundThe appropriate choice of antibiotics against Mycoplasma pneumoniae infection has become difficult, as the prevalence of macrolide-resistant M.pneumoniae has increased. MethodsThroat swab specimens were collected from children with clinically suspected M.pneumoniae infection while visiting an outpatient clinic. Cultures for M.pneumoniae were done, and all isolates were sequenced for the presence of a mutation in 23S rRNA. ResultsOf the 80 specimens collected between February 2012 and March 2013, 27 (34%) were positive for M.pneumoniae on culture. Macrolide-resistant mutation was detected in 24 isolates (89%): 23 isolates had an A2063G transition, and one had a C2617G mutation. Both the median age and the prevalence of pneumonia were significantly higher in M.pneumoniae-positive than in M.pneumoniae-negative children (median, 7 years vs 4 years; 88.9% vs 60.4%, respectively). The percentage of serum samples with particle agglutination titer 1:160 was 69.6% in M.pneumoniae-positive cases and 17.6% in M.pneumoniae-negative cases when the serum was collected 4days after the onset of fever. Defervescence within 72h after the initiation of macrolides never occurred in M.pneumoniae-positive children and also did not occur in 54% of M.pneumoniae-negative children. Switching to either minocycline or tosufloxacin resulted in fever resolution within 48h in M.pneumoniae-positive children. ConclusionsThe described clinical and laboratory characteristics of M.pneumoniae infection may be useful in guiding appropriate treatment in an outpatient clinic.	[Katsushima, Yuriko; Katsushima, Fumio] Yamagata Prefectural Inst Publ Hlth, Katsushima Pediat Clin, Yamagata 9900031, Japan; [Suzuki, Yu; Seto, Junji; Mizuta, Katsumi] Yamagata Prefectural Inst Publ Hlth, Dept Microbiol, Yamagata 9900031, Japan; [Matsuzaki, Yoko] Yamagata Univ, Dept Infect Dis, Fac Med, Yamagata 9909585, Japan; [Nishimura, Hidekazu] Sendai Med Ctr, Virus Res Ctr, Div Clin Res, Sendai, Miyagi, Japan	Matsuzaki, Y (reprint author), Yamagata Univ, Dept Infect Dis, Fac Med, Iida Nishi 2-2-2, Yamagata 9909585, Japan.	matuzaki@med.id.yamagata-u.ac.jp					Gruson D, 2005, ANTIMICROB AGENTS CH, V49, P1190, DOI 10.1128/AAC.49.3.1190-1193.2005; Matsuoka M, 2004, ANTIMICROB AGENTS CH, V48, P4624, DOI 10.1128/AAC.48.12.4624-4630.2004; Okazaki N, 2001, MICROBIOL IMMUNOL, V45, P617; Tredwin CJ, 2005, J DENT RES, V84, P596; Suzuki S, 2006, ANTIMICROB AGENTS CH, V50, P709, DOI 10.1128/AAC.50.2.709-721.2006; Mizuta K, 2012, MICROBIOL IMMUNOL, V56, P855, DOI 10.1111/j.1348-0421.2012.00507.x; Morozumi M, 2010, J INFECT CHEMOTHER, V16, P78, DOI 10.1007/s10156-009-0021-4; Kim J, 2009, DRUG METAB PHARMACOK, V24, P167; Mizuta K, 2013, JPN J INFECT DIS, V66, P140; Okada T, 2012, CLIN INFECT DIS, V55, P1642, DOI 10.1093/cid/cis784; Pereyre S, 2004, ANTIMICROB AGENTS CH, V48, P460, DOI 10.1128/AAC.48.2.460-465.2004; Chiu CY, 2015, J MICROBIOL IMMUNOL, V48, P51, DOI 10.1016/j.jmii.2013.06.006; Ieven M, 1996, J INFECT DIS, V173, P1445; Kawai Y, 2013, ANTIMICROB AGENTS CH, V57, P2252, DOI 10.1128/AAC.00048-13; Kawai Yasuhiro, 2012, Respirology, V17, P354, DOI 10.1111/j.1440-1843.2011.02102.x; Liu FC, 2008, JPN J INFECT DIS, V61, P397; Suzuki Y, 2013, PEDIATR INFECT DIS J, V32, P237, DOI 10.1097/INF.0b013e31827aa7bd; The Committee for the Guidelines in Management of Respiratory Infectious Diseases in Children, 2013, J PEDIAT INFECT DIS, V25, P105; Ubukata K, 2011, INFECT AGENTS SURVEI, V32, P337; Yamazaki T, 2006, CLIN VACCINE IMMUNOL, V13, P708, DOI 10.1128/CDLI.00413-05	20	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					247	252		10.1111/ped.12513		6	Pediatrics	Pediatrics	CG1MG	WOS:000353036100028		
J	Hama, I; Takahashi, S; Nakamura, T; Ito, Y; Kawasaki, K; Sago, H				Hama, Ikuko; Takahashi, Shigehiro; Nakamura, Tomoo; Ito, Yushi; Kawasaki, Kazuteru; Sago, Haruhiko			Risk of respiratory syncytial virus infection in infants with congenital cystic lung disease	PEDIATRICS INTERNATIONAL			English	Article						bronchopulmonary sequestration; congenital cystic adenomatoid malformation; congenital lobar emphysema	ADENOMATOID MALFORMATION; YOUNG-CHILDREN; REDUCES HOSPITALIZATION; HEART-DISEASE; US CHILDREN; PALIVIZUMAB; MANAGEMENT; LESIONS	BackgroundCongenital cystic lung disease (CCLD), which includes congenital cystic adenomatoid malformation, bronchopulmonary sequestration, and congenital lobar emphysema, has been reported to increase the risk of recurrent respiratory infection. In particular, respiratory syncytial virus (RSV) causes severe lower respiratory tract disease in high-risk infants. The objective of this study was to investigate the risk of severe RSV infection in infants with CCLD. MethodsInfants antenatally diagnosed as having CCLD and admitted to a neonatal intensive care unit at the National Center for Child Health and Development in Tokyo between September 2002 and October 2011 were included in this study. We investigated retrospectively whether the infants were hospitalized with RSV infection by 24 months of age using their medical records. ResultsForty-eight infants were antenatally diagnosed as having CCLD. Of the 48 infants, four (8.3%) were hospitalized with RSV infection by 24 months of age. ConclusionsInfants with CCLD have increased risk of severe RSV infection.	[Hama, Ikuko; Takahashi, Shigehiro; Nakamura, Tomoo; Ito, Yushi] Natl Ctr Child Hlth & Dev, Div Neonatol, Tokyo 1578535, Japan; [Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo 1578535, Japan; [Kawasaki, Kazuteru] Natl Ctr Child Hlth & Dev, Dept Med Subspecial, Div Pulmonol, Tokyo 1578535, Japan	Hama, I (reprint author), Natl Ctr Child Hlth & Dev, Div Neonatol, Ctr Maternal Fetal & Neonatal Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	hama-i@ncchd.go.jp					Shay DK, 2001, J INFECT DIS, V183, P16, DOI 10.1086/317655; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Crombleholme TM, 2002, J PEDIATR SURG, V37, P331, DOI 10.1053/jpsu.2002.30832; MACDONALD NE, 1982, NEW ENGL J MED, V307, P397, DOI 10.1056/NEJM198208123070702; Masumoto K, 2008, PEDIATR INT, V50, P459, DOI 10.1111/j.1442-200X.2008.02580.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Davenport M, 2004, J PEDIATR SURG, V39, P549, DOI 10.1016/j.jpedsurg.2003.12.021; Langley GF, 2011, PEDIATR INFECT DIS J, V30, P510, DOI 10.1097/INF.0b013e3182184ae7; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Stanton M, 2009, J PEDIATR SURG, V44, P1027, DOI 10.1016/j.jpedsurg.2008.10.118; BAILEY PV, 1990, J THORAC CARDIOV SUR, V99, P597; Buckingham S C, 2001, Pediatr Crit Care Med, V2, P318, DOI 10.1097/00130478-200110000-00006; Calvert JK, 2006, ARCH DIS CHILD-FETAL, V91, pF26; HALLER JA, 1979, ANN THORAC SURG, V28, P33; Ierullo AM, 2005, ULTRASOUND OBST GYN, V26, P150, DOI 10.1002/uog.1920; Kamata S, 2006, J PEDIATR SURG, V41, P2023, DOI 10.1016/j.jpedsurg.2006.08.020; Kusuda S, 2006, PEDIATR INT, V48, P362, DOI 10.1111/j.1442-200X.2006.02222.x; MEERT K, 1989, PEDIATR PULM, V7, P167, DOI 10.1002/ppul.1950070309; Parikh D, 2005, PEDIATR PULM, V40, P533, DOI 10.1002/ppul.20300; Takeuchi Y, 2003, NIHON SHOUNIKA GAKKA, V107, P898; Null D, 1998, PEDIATRICS, V102, P531; WESLEY JR, 1986, J PEDIATR SURG, V21, P202, DOI 10.1016/S0022-3468(86)80833-8; Wong A, 2006, PEDIATR SURG INT, V25, P479, DOI 10.1007/s00383-009-2371-5	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					253	257		10.1111/ped.12544		5	Pediatrics	Pediatrics	CG1MG	WOS:000353036100029		
J	Hosono, S; Tamura, M; Kunikata, T; Wada, M; Kusakawa, I; Ibara, S				Hosono, Shigeharu; Tamura, Masanori; Kunikata, Tetsuya; Wada, Masaki; Kusakawa, Isao; Ibara, Satoshi			Survey of delivery room resuscitation practices at tertiary perinatal centers in Japan	PEDIATRICS INTERNATIONAL			English	Article						carbon dioxide detector; flow-inflating bag; neonatal resuscitation; oxygen blender; pulse oximeter	BIRTH-WEIGHT INFANTS; NEONATAL RESUSCITATION; NEWBORN-INFANTS; PRETERM INFANTS; NEW-ZEALAND; EQUIPMENT	BackgroundThe aim of this study was to determine the current neonatal resuscitation practices for term infants in Japan, immediately before the 2010 publication of the international neonatal resuscitation consensus. MethodsIn January 2010, a 26-question survey was mailed to neonatal department directors. ResultsA total of 287 neonatal departments were identified. Four surveys were returned as undeliverable. A total of 191 surveys were returned completed, but four departments had no labor and delivery rooms (66.6% response rate, 65.2% survey available response rate). Flow-inflating bags were most commonly used (63.2%), followed by self-inflating bags (35.8%), and T-piece resuscitators (1.0%). Among the participants, 42.1% used oxygen blenders, 56.2% used pure oxygen for initial resuscitation, and 79.5% used a pulse oximeter to change the fraction of inspired oxygen. Among the participants, 45.3% used carbon dioxide detectors to confirm intubation, 42.5% routinely used the detectors, and 55.2% used them when confirming a difficult intubation. In addition, 42.5% of the participants used continuous positive airway pressure to treat breathing problems, most commonly with flow-inflating bags (93.2%). ConclusionsThe equipment and techniques used in Japanese perinatal center delivery room resuscitation practices are highly varied. Further research is required to determine which devices and techniques are appropriate for this important and common intervention.	[Hosono, Shigeharu] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo 1738610, Japan; [Tamura, Masanori] Saitama Med Univ, Div Neonatal Med, Ctr Maternal Fetal & Neonatal Med, Kawagoe Med Ctr, Saitama, Japan; [Kunikata, Tetsuya] Saitama Med Univ Hosp, Div Neonatal Med, Dept Pediat, Saitama, Japan; [Wada, Masaki] Niigata Univ, Dept Pediat, Niigata, Japan; [Kusakawa, Isao] St Lukes Int Hosp, Dept Pediat, Tokyo, Japan; [Ibara, Satoshi] Kagoshima City Hosp, Div Neonatol, Perinatal Med Ctr, Kagoshima, Japan	Hosono, S (reprint author), Nihon Univ, Sch Med, Dept Pediat & Child Hlth, 30-1 Oyaguchi Itabashi, Tokyo 1738610, Japan.	hosono.shigeharu@nihon-u.ac.jp					Alanen S, 2009, WORLDV EVID-BASED NU, V6, P229, DOI 10.1111/j.1741-6787.2009.00167.x; American Heart Association, 2006, PEDIATRICS, V117, pe989, DOI DOI 10.1542/PEDS.2006-0219; Hosono S, 2009, J PERINAT MED, V37, P79, DOI 10.1515/JPM.2009.017; Bhola K, 2012, J PAEDIATR CHILD H, V48, P828, DOI 10.1111/j.1440-1754.2012.02545.x; Duran R, 2008, BRAIN DEV-JPN, V30, P43, DOI 10.1016/j.braindev.2007.05.009; El-Naggar W, 2012, J PERINATOL, V32, P491, DOI 10.1038/jp.2011.128; International Liaison Committee on Resuscitation, 2000, PEDIATRICS, V117, pe955; Iriondo M, 2009, ACTA PAEDIATR, V98, P786, DOI 10.1111/j.1651-2227.2009.01233.x; Kamlin COF, 2005, J PEDIATR-US, V147, P547, DOI 10.1016/j.jpeds.2005.05.014; Kattwinkel J., 2011, PREFERENCE TXB NEONA, V6th, pvii; Leone TA, 2006, PEDIATRICS, V117, pE164, DOI 10.1154/peds.2005.0936; Murthy V, 2012, ARCH DIS CHILD-FETAL, V97, pF154, DOI 10.1136/archdischild-2011-301251; O'Donnell CPF, 2005, ACTA PAEDIATR, V94, P1261, DOI 10.1080/08035250510036471; Repetto J E, 2001, J Perinatol, V21, P284, DOI 10.1038/sj.jp.7210534; Singh Y, 2013, RESUSCITATION, V84, P1558, DOI 10.1016/j.resuscitation.2013.06.026; Trevisanuto D, 2006, ARCH DIS CHILD-FETAL, V91, pF123, DOI 10.1136/adc.2005.0797772; Wyllie J, 2010, RESUSCITATION, V81, pE260, DOI 10.1016/j.resuscitation.2010.08.029	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					258	262		10.1111/ped.12496		5	Pediatrics	Pediatrics	CG1MG	WOS:000353036100030		
J	Ochi, F; Higaki, T; Ohta, M; Yamauchi, T; Tezuka, M; Chisaka, T; Moritani, T; Tauchi, H; Ishii, E				Ochi, Fumihiro; Higaki, Takashi; Ohta, Masaaki; Yamauchi, Toshifumi; Tezuka, Mari; Chisaka, Toshiyuki; Moritani, Tomozo; Tauchi, Hisamichi; Ishii, Eiichi			Procalcitonin as a marker of respiratory disorder in neonates	PEDIATRICS INTERNATIONAL			English	Article						C-reactive protein; neonate; procalcitonin electrochemiluminescence immunoassay; white blood cell count	C-REACTIVE PROTEIN; SERUM PROCALCITONIN; BACTERIAL-INFECTION; TRACT INFECTIONS; CONTROLLED-TRIAL; EARLY-DIAGNOSIS; ANTIBIOTIC USE; SEPSIS; INFANTS; INTERLEUKIN-6	BackgroundSerum procalcitonin (PCT) increases in various respiratory disorders such as acute respiratory distress syndrome. Elevated PCT is also observed in healthy neonates. In this study, we investigated whether PCT is a good marker of respiratory disorder in neonates. MethodsA total of 155 neonates with or without respiratory disorder, were eligible for the study. PCT was measured on electrochemiluminescence immunoassay. Each neonate was allocated to the non-respiratory disorder (control) group (n = 95), or a respiratory disorder group (n = 60). PCT was compared between the groups, and association with other markers, including C-reactive protein (CRP) and white blood cell (WBC) count, was analyzed. ResultsOf the 60 neonates in the respiratory disorder group, 39, 10, five, one, two, two, and one neonates had transient tachypnea of the newborn, respiratory distress syndrome, air leak syndrome, meconium aspiration syndrome, 18-trisomy, neonatal asphyxia, and congenital diaphragmatic hernia, respectively. Mean PCT, CRP and WBC count in the respiratory disorder group were 9.01ng/mL, 0.26mg/dL, and 16100 cells/L, respectively. The area under the curve obtained for PCT in distinguishing between the respiratory disorder and control groups was 0.85 (sensitivity, 66.7%; specificity, 93.0%; optimum cut-off, 3.73ng/mL), that for CRP was 0.72 (sensitivity, 75.0%; specificity, 64.6%; optimum cut-off, 0.14mg/dL), and for WBC it was 0.44 (sensitivity, 60.0%; specificity, 29.6%; optimum cut-off, 15000cells/L). ConclusionsPCT is more susceptible, as a diagnostic parameter of infection, to the effect of respiratory disturbance than CRP and WBC.	[Ochi, Fumihiro; Higaki, Takashi; Tezuka, Mari; Chisaka, Toshiyuki; Tauchi, Hisamichi; Ishii, Eiichi] Ehime Univ, Dept Pediat, Grad Sch Med, Toon, Ehime 7910295, Japan; [Ohta, Masaaki; Yamauchi, Toshifumi; Moritani, Tomozo] Ehime Univ Hosp, Perinatal Med Ctr, Toon, Ehime, Japan; [Ohta, Masaaki; Yamauchi, Toshifumi; Moritani, Tomozo] Ehime Univ Hosp, Childrens Gen Med Ctr, Toon, Ehime, Japan	Ochi, F (reprint author), Ehime Univ, Dept Pediat, Grad Sch Med, Toon, Ehime 7910295, Japan.	fmochi2000@yahoo.co.jp					Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Enguix A, 2001, INTENS CARE MED, V27, P211; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Maniaci V, 2008, PEDIATRICS, V122, P701, DOI 10.1542/peds.2007-3503; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Altunhan H, 2011, INT J INFECT DIS, V15, pE854, DOI 10.1016/j.ijid.2011.09.007; Chiesa C, 2003, CLIN CHEM, V49, P60, DOI 10.1373/49.1.60; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Chiesa C, 1998, CLIN INFECT DIS, V26, P664, DOI 10.1086/514576; Bonac B, 2000, PFLUG ARCH EUR J PHY, V440, pR72, DOI 10.1007/s004240000011; Benitz WE, 2010, CLIN PERINATOL, V37, P421, DOI 10.1016/j.clp.2009.12.001; Turner D, 2006, ARCH DIS CHILD-FETAL, V91, pF283, DOI 10.1136/adc.2005.085449; Briel M, 2008, ARCH INTERN MED, V168, P2000, DOI 10.1001/archinte.168.18.2000; Chiesa C, 2011, CLIN CHIM ACTA, V412, P1053, DOI 10.1016/j.cca.2011.02.020; Monneret G, 1997, ACTA PAEDIATR, V86, P209, DOI 10.1111/j.1651-2227.1997.tb08870.x; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Assumma M, 2000, CLIN CHEM, V46, P1583; Gendrel D, 1997, INFECTION, V25, P133, DOI 10.1007/BF02113598; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2, DOI 10.1097/01.PCC.0000149131.72248.E6; Lam HS, 2008, PATHOLOGY, V40, P141, DOI 10.1080/00313020701813735; Lapillonne A, 1998, LANCET, V351, P1211, DOI 10.1016/S0140-6736(05)79165-0; Llorente E, 2007, CLIN CHEM LAB MED, V45, P1531, DOI 10.1515/CCLM.2007.304; Lopez Sastre JB, 2007, BMC PEDIATR, V7, P9; Pavcnik-Arnol M, 2010, EUR J PEDIATR SURG, V20, P262, DOI 10.1055/s-0030-1253358; Sachse C, 1998, CLIN CHEM, V44, P1343; vansRossum AM, 2004, LANCET INFECT DIS, V4, P620	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					263	268		10.1111/ped.12505		6	Pediatrics	Pediatrics	CG1MG	WOS:000353036100031		
J	Konno, M; Takahashi, M; Toita, N; Fujiwara, S; Nojima, M				Konno, Mutsuko; Takahashi, Michiko; Toita, Nariaki; Fujiwara, Shin-ichi; Nojima, Masanori			Long-term therapeutic effectiveness of maintenance enteral nutrition for Crohn's disease	PEDIATRICS INTERNATIONAL			English	Article						children; Crohn's disease; elemental diet; enteral nutrition; maintenance therapy	INFLAMMATORY-BOWEL-DISEASE; CONTROLLED-TRIAL; ELEMENTAL DIET; CHILDREN; CORTICOSTEROIDS; GUIDELINES; REMISSION; GASTROENTEROLOGY; MANAGEMENT; EFFICACY	BackgroundLong-term effectiveness of enteral nutrition for maintaining remission in pediatric Crohn's disease (CD) is poorly documented. The aim of this study was therefore to examine the long-term effectiveness of enteral nutrition with aminosalicylates as maintenance therapy for those in whom remission was primarily induced by total parenteral nutrition or exclusive enteral nutrition with aminosalicylates. MethodsWe retrospectively analyzed data for 58 pediatric patients with newly diagnosed CD during a median follow-up period of 50 months (range, 12-216 months). Data for remission-induced patients in whom enteral nutrition with aminosalicylates was used as maintenance therapy were analyzed with particular reference to time to first relapse and time to first intestinal surgery. ResultsTwenty-five (43.1%) of the patients relapsed with a median duration of remission of 32.4 months (range, 6-73.2 months). The cumulative rates of continuous remission were 0.88 (95%CI: 0.79-0.96) at 1 year, 0.73 (95%CI: 0.61-0.85) at 2 years, and 0.52 (95%CI: 0.35-0.68) at 5 years. None of the patients received corticosteroids, immunomodulators or anti-tumor necrosis factor agents until relapse. Disease location had no impact on timing of relapse, but with regard to disease behavior there was a trend towards earlier relapse in patients with penetrating type. Only six of the 58 patients (10.3%) needed intestinal surgery. There was a trend towards need for surgery in patients with ileal disease and with stricturing type. ConclusionsEnteral nutrition therapy with aminosalicylates is effective for maintaining remission and decreasing the rate of intestinal surgery in pediatric CD.	[Konno, Mutsuko; Takahashi, Michiko; Toita, Nariaki; Fujiwara, Shin-ichi] Sapporo Kosei Gen Hosp, Dept Pediat, Sapporo, Hokkaido 0600033, Japan; [Nojima, Masanori] Univ Tokyo IMSUT, Inst Med Sci, Div Adv Med Promot, Adv Clin Res Ctr, Tokyo, Japan	Konno, M (reprint author), Sapporo Kosei Gen Hosp, Dept Pediat, Chuo Ku, N-3,E-8, Sapporo, Hokkaido 0600033, Japan.	mutsukon@ja-hokkaidoukouseiren.or.jp					Akobeng AK, 2009, COCHRANE DB SYST REV; Knight C, 2005, CLIN NUTR, V24, P775, DOI 10.1016/j.clnu.2005.03.005; Konno M, 2006, PEDIATR INT, V48, P349, DOI 10.1111/j.1442-200X.2006.02220.x; Lochs H, 2006, CLIN NUTR, V25, P260, DOI 10.1016/j.clnu.2006.01.007; Lucendo AJ, 2009, WORLD J GASTROENTERO, V15, P2081, DOI 10.3748/wjg.15.2081; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Heuschkel RB, 2000, J PEDIATR GASTR NUTR, V31, P8, DOI 10.1097/00005176-200007000-00005; Sandhu BK, 2010, J PEDIATR GASTR NUTR, V50, pS1, DOI 10.1097/MPG.0b013e3181c92c53; Critch J, 2012, J PEDIATR GASTR NUTR, V54, P298, DOI 10.1097/MPG.0b013e318235b397; Borrelli O, 2006, CLIN GASTROENTEROL H, V4, P744, DOI 10.1016/j.cgh.2006.03.010; Buchanan E, 2009, ALIMENT PHARM THER, V30, P501, DOI 10.1111/j.1365-2036.2009.04067.x; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Afzal NA, 2005, DIGEST DIS SCI, V50, P1471, DOI 10.1007/s10620-005-2864-6; Ardizzone D, 2007, DIGEST LIVER DIS, V39, P957; Bamba T, 2003, EUR J GASTROEN HEPAT, V15, P151, DOI 10.1097/01.meg.0000049987.68425.b3; Canani RB, 2006, DIGEST LIVER DIS, V38, P381, DOI 10.1016/j.dld.2005.10.005; Deperno M, 2004, GASTROINTEST ENDOSC, V60, P505; Esaki M, 2006, DIS COLON RECTUM, V49, P68; FERNANDEZBANARES F, 1994, GUT, V35, pS55, DOI 10.1136/gut.35.1_Suppl.S55; Hiwatashi N, 1997, DIS COLON RECTUM, V40, pS48, DOI 10.1007/BF02062020; Hyms JS, 1991, J PEDIAT GASTROENTER, V12, P439; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lambert B, 2012, DIGEST DIS SCI, V57, P2171, DOI 10.1007/s10620-012-2232-2; LEWIS JD, 1994, MED CLIN N AM, V78, P1443; MATSUEDA K, 1995, J GASTROENTEROL, V30, P91; Matsui T, 2005, J GASTROENTEROL, V40, P25, DOI 10.1007/BF02990575; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A; Takagi S, 2006, ALIMENT PHARM THERAP, V24, P1333, DOI 10.1111/j.1365-2036.2006.03120.x; Verma S, 2001, SCAND J GASTROENTERO, V36, P383, DOI 10.1080/003655201300051199; Verma S, 2000, DIGEST LIVER DIS, V32, P769, DOI 10.1016/S1590-8658(00)80353-9; Yamamoto T, 2007, INFLAMM BOWEL DIS, V13, P1493, DOI 10.1002/ibd.20238; Zachos M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000542.pub2	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					276	280		10.1111/ped.12494		5	Pediatrics	Pediatrics	CG1MG	WOS:000353036100033		
J	Arai, K; Funayama, R; Takahashi, M; Sakai, R; Shimizu, H; Obayashi, N; Matsui, A				Arai, Katsuhiro; Funayama, Rie; Takahashi, Mieko; Sakai, Rie; Shimizu, Hirotaka; Obayashi, Naho; Matsui, Akira			Validation of predictive equations for resting energy expenditure in Japanese pediatric Crohn's disease patients: Preliminary study	PEDIATRICS INTERNATIONAL			English	Article						Bland-Altman plot; Crohn's disease; Japanese Dietary Reference Intakes (2010); predictive equation; resting energy expenditure	INFLAMMATORY-BOWEL-DISEASE; BODY-COMPOSITION	BackgroundPredictive equations are often used to estimate resting energy expenditure (REE). Determining the appropriate equation for different patient types, however, remains inconclusive, as in the case of Japanese children with Crohn's disease (CD). The aim of this study was to identify an appropriate predictive equation for measuring REE in Japanese children with CD. MethodsTwelve Japanese children with CD managed at the National Center for Child Health and Development in Tokyo, Japan, were studied. REE (kcal/day) was measured using indirect calorimetry. The predictive equations used were the Japanese Dietary Reference Intakes (2010), the Schofield equation, the Food and Agriculture Organization/World Health Organization/United Nations University (FAO/WHO/UNU) equation and the Cunningham equation. Difference between predicted and measured REE was analyzed on Bland-Altman plot. ResultsJapanese Dietary Reference Intakes (2010) had the smallest difference between predicted and measured REE. Weight was the primary predictor of REE on multiple regression analysis. As well, Japanese Dietary Reference Intakes (2010) had the highest ratio of weight to predicted REE (98.5%). ConclusionsOf the four equations, Japanese Dietary Reference Intakes (2010) appeared to be the most practical and accurate predictive equation for REE in Japanese children with CD.	[Arai, Katsuhiro; Funayama, Rie; Shimizu, Hirotaka; Obayashi, Naho] Natl Ctr Child Hlth & Dev, Div Gastroenterol, Setagaya Ku, Tokyo 1578535, Japan; [Matsui, Akira] Natl Ctr Child Hlth & Dev, Div Hepatol, Setagaya Ku, Tokyo 1578535, Japan; [Takahashi, Mieko; Sakai, Rie] Natl Ctr Child Hlth & Dev, Dept Nutr Management, Setagaya Ku, Tokyo 1578535, Japan	Arai, K (reprint author), Natl Ctr Child Hlth & Dev, Div Gastroenterol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	arai-k@ncchd.go.jp			Japanese Ministry of Health, Labor, and Welfare [NCCHD22-2]	The authors would like to thank Dr Julian Tang from the Department of Education for Clinical Research, NCCHD, for reviewing this manuscript. The authors are also grateful to the American Journal Experts for article revision in English. This work was supported by a National Grant-in-Aid from the Japanese Ministry of Health, Labor, and Welfare (NCCHD22-2 to KA). The authors have no conflict of interest in connection with the publication of this article.	CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963; Heuschkel R, 2008, INFLAMM BOWEL DIS, V14, P839, DOI 10.1002/ibd.20378; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Wouters-Adriaens MPE, 2008, OBESITY, V16, P2212, DOI 10.1038/oby.2008.343; Baldassano RN, 1999, GASTROENTEROL CLIN N, V28, P445, DOI 10.1016/S0889-8553(05)70064-9; Sawczenko A, 2003, ARCH DIS CHILD, V88, P995, DOI 10.1136/adc.88.11.995; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439; BLAND JM, 1986, LANCET, V1, P307; FAO/WHO/UNU, 1985, FAO TECHN REP SER, V724; Hill RJ, 2011, INFLAMM BOWEL DIS, V17, P1587, DOI 10.1002/ibd.21518; Ishige T, 2010, J GASTROENTEROL, V45, P911, DOI 10.1007/s00535-010-0223-7; Kundhal P, 2002, CAN J GASTROENTE SSA, V16, pA118; Ministry of Health Labor and Welfare of Japan, 1999, REC DIET ALL JAP; Ministry of Health Labor and Welfare of Japan, 2005, DIET REF INT JAP 200; Ministry of Health. Labour and welfare, 2009, DIET REF INT JAP 201; Miyake R, 2012, J JPN SOC CLIN NUTR, V121, P224; Okada S, 1926, ARCH INTERN MED, V38, P590; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1; Wine E, 2004, PEDIATRICS, V114, P1281, DOI 10.1542/peds.2004-0417; Yamamoto S., 2001, Japanese Journal of Nutrition, V59, P51	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					290	294		10.1111/ped.12504		5	Pediatrics	Pediatrics	CG1MG	WOS:000353036100035		
J	Hori, H; Sato, Y; Shitara, T				Hori, Hideyuki; Sato, Yoshitake; Shitara, Tosiji			Congenital syphilis presenting as Jarisch-Herxheimer reaction at birth	PEDIATRICS INTERNATIONAL			English	Article						ampicillin; congenital syphilis; drug allergy; Jarisch-Herxheimer reaction; maculopapular		We report a rare case of congenital syphilis (CS) presenting as Jarisch-Herxheimer reaction (JHR) at birth. The mother (primigravida) presented in labor and had not received antenatal care. She was given prophylactic ampicillin 2g i.v. on admission and delivered shortly thereafter. The male infant (2899g) had normal vital signs, conjunctival congestion, splenohepatomegaly, and maculopapular rash with small blisters over the entire body. Serological tests on the infant and mother confirmed CS. The infant was given i.v. ampicillin for 14days (50mg/kg per day untilday 3, 100mg/kg per day thereafter). Onehour after the first injection, the infant developed fever (39 degrees C), tachycardia and tachypnea without worsening of rash. Vital signs improved gradually. The rash reduced markedly at postnatal day 1, and disappeared without pigmentation at day 3. This was considered a JHR following ampicillin injection given to the mother before delivery and to the infant after birth.	[Hori, Hideyuki; Sato, Yoshitake; Shitara, Tosiji] Ota Mem Hosp, Dept Pediat, Ota, Gumma 3730056, Japan	Hori, H (reprint author), Ota Mem Hosp, Fuji Heavy Ind Hlth Insurance Soc, 445-1 Ooshimacho, Ota, Gumma 3730056, Japan.	h.hori@ota-hosp.or.jp					Herremans T, 2010, EUR J CLIN MICROBIOL, V29, P495, DOI 10.1007/s10096-010-0900-8; Haruta T, 2001, ANTIBIOT CHEMOTHER, V17, P1238; Patterson MJ, 2011, NELSON TXB PEDIAT, V19th, P1016; Pound MW, 2005, J CLIN PHARM THER, V30, P291, DOI 10.1111/j.1365-2710.2005.00631.x; See S, 2005, ANN PHARMACOTHER, V39, P2128, DOI 10.1345/aph.1G308; Woods Charles R, 2005, Semin Pediatr Infect Dis, V16, P245, DOI 10.1053/j.spid.2005.06.005	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					299	301		10.1111/ped.12417		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100037		
J	Tozawa, Y; Fujita, S; Abe, S; Kitamura, K; Kobayashi, I				Tozawa, Yusuke; Fujita, Shouji; Abe, Shuji; Kitamura, Koichi; Kobayashi, Ichiro			Radiological improvement by tocilizumab in polyarticular juvenile idiopathic arthritis	PEDIATRICS INTERNATIONAL			English	Article						anti-citrullinated peptide antibody; bone repair; juvenile idiopathic arthritis; rheumatoid factor; tocilizumab	RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; THERAPY; PREDICT	Recent advances in biologic therapy have enabled reduction of the progression of destructive arthritis in rheumatoid arthritis. Once destroyed, however, the affected bones and cartilage are not fully repaired. We describe the case of an 8-year-old girl with anti-citrullinated peptide antibody (ACPA)-positive polyarticular juvenile idiopathic arthritis (p-JIA). Destructive arthritis progressed during combination therapy with infliximab, methotrexate, mizoribine and prednisolone. Clinical remission was achieved, however, after switching the biologic agent to tocilizumab, a humanized monoclonal antibody to interleukin-6 receptor. Both bone erosion and bone marrow edema on magnetic resonance imaging were repaired in association with restoration of joint spaces. Furthermore, there was no relapse of arthritis on weekly methotrexate alone for 2 years after discontinuation of the tocilizumab. Tocilizumab led to radiological repair of both bone and cartilage destruction and long-term biologics-free remission in a patient with ACPA-positive p-JIA, and should be considered for tumor necrosis factor inhibitor-resistant cases.	[Tozawa, Yusuke; Fujita, Shouji; Abe, Shuji] Goryokaku Hosp, Dept Pediat, Hakodate, Hokkaido, Japan; [Kitamura, Koichi] Goryokaku Hosp, Dept Orthoped, Hakodate, Hokkaido, Japan; [Kobayashi, Ichiro] Hokkaido Univ, Dept Pediat, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan	Kobayashi, I (reprint author), Hokkaido Univ, Dept Pediat, Grad Sch Med, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	ichikobaya@med.hokudai.ac.jp					Nishimoto N, 2014, MOD RHEUMATOL, V24, P17, DOI 10.3109/14397595.2013.854079; Omar A, 2013, JOINT BONE SPINE, V80, P38, DOI 10.1016/j.jbspin.2012.03.008; Finzel S, 2013, ANN RHEUM DIS, V72, P396, DOI 10.1136/annrheumdis-2011-201075; Hashimoto J, 2011, MOD RHEUMATOL, V21, P10, DOI 10.1007/s10165-010-0325-3; Dougados M, 2014, ANN RHEUM DIS, V73, P803, DOI 10.1136/annrheumdis-2013-204761; Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Imagawa T, 2012, MOD RHEUMATOL, V22, P109, DOI 10.1007/s10165-011-0481-0; Inaba Y, 2011, ANN RHEUM DIS, V70, P1693, DOI 10.1136/ard.2010.145359; Nishina N, 2014, ANN RHEUM DIS, V73, P945, DOI 10.1136/annrheumdis-2013-204137; Takeuchi T, 2011, ANN RHEUM DIS, V70, P1208, DOI 10.1136/ard.2011.153023; Tebo AE, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-29	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					307	310		10.1111/ped.12454		4	Pediatrics	Pediatrics	CG1MG	WOS:000353036100040		
J	Hisano, M; Ashida, A; Nakano, E; Suehiro, M; Yoshida, Y; Matsumoto, M; Miyata, T; Fujimura, Y; Hattori, M				Hisano, Masataka; Ashida, Akira; Nakano, Eiji; Suehiro, Mamiko; Yoshida, Yoko; Matsumoto, Masanori; Miyata, Toshiyuki; Fujimura, Yoshihiro; Hattori, Motoshi			Autoimmune-type atypical hemolytic uremic syndrome treated with eculizumab as first-line therapy	PEDIATRICS INTERNATIONAL			English	Article						atypical hemolytic uremic syndrome; eculizumab; plasma exchange	FACTOR-H	We report a case of atypical hemolytic uremic syndrome (aHUS) in a 4-year-old boy. Although the patient had the typical triad of aHUS (microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury), urgent dialysis was not indicated because he had neither oliguria nor severe electrolyte abnormality. He was given eculizumab as first-line therapy, which led to significant clinical improvement, thus avoiding any risk of complications associated with plasma exchange and central venous catheterization. Retrograde functional analysis of the patient's plasma using sheep erythrocytes indicated an increase in hemolysis, suggesting impairment of host cell protection by complement factor H. The use of eculizumab as first-line therapy in place of plasma exchange might be reasonable for pediatric patients with aHUS.	[Hisano, Masataka; Nakano, Eiji; Suehiro, Mamiko] Chiba Childrens Hosp, Dept Nephrol, Chiba, Japan; [Ashida, Akira] Dept Pediat, Osaka Med Coll, Takatsuki, Osaka, Japan; [Yoshida, Yoko; Matsumoto, Masanori; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara, Japan; [Miyata, Toshiyuki] Res Inst Natl Cerebral & Cardiovascular Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan; [Hattori, Motoshi] Tokyo Womens Med Univ, Dept Pediat Nephrol, Tokyo, Japan	Ashida, A (reprint author), Osaka Med Coll, Dept Pediat, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ped006@poh.osaka-med.ac.jp					Sanchez-Corral P, 2004, MOL IMMUNOL, V41, P81, DOI 10.1016/j.molimm.2004.01.003; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214; Zuber J, 2012, AM J TRANSPLANT, V12, P3337, DOI 10.1111/j.1600-6143.2012.04252.x; Noone D, 2014, PEDIATR NEPHROL, V29, P841, DOI 10.1007/s00467-013-2654-x; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Fan XP, 2013, MOL IMMUNOL, V54, P238, DOI 10.1016/j.molimm.2012.12.006; Dragon-Durey MA, 2010, J AM SOC NEPHROL, V21, P2180, DOI 10.1681/ASN.2010030315; Waters AM, 2011, PEDIATR NEPHROL, V26, P41, DOI 10.1007/s00467-010-1556-4; Ariceta G, 2009, PEDIATR NEPHROL, V24, P687, DOI 10.1007/s00467-008-0964-1; Taylor CM, 2009, BRIT J HAEMATOL, V148, P37	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					313	317		10.1111/ped.12469		5	Pediatrics	Pediatrics	CG1MG	WOS:000353036100042		
J	Kasahara, K; Uemura, O; Nagai, T; Yamakawa, S; Nakano, M; Iwata, N				Kasahara, Katsuaki; Uemura, Osamu; Nagai, Takuhito; Yamakawa, Satoshi; Nakano, Masaru; Iwata, Naoyuki			Stenosing ureteritis in Henoch-Schonlein purpura: Report of two cases	PEDIATRICS INTERNATIONAL			English	Article						gross hematuria; Henoch-Schonlein purpura; Henoch-Schonlein purpura nephritis; hydronephrosis; stenosing ureteritis; ultrasonography	OF-THE-LITERATURE; RENAL MANIFESTATIONS	Stenosing ureteritis (SU), a rare complication of Henoch-Schonlein purpura (HSP), typically presents with severe symptoms. We report the cases of two HSP patients presenting with gross hematuria, blood clotting, and colicky flank pain, followed by purpura on the lower extremities. Early-stage ultrasonography indicated hydronephrosis, thickened renal pelvic mucous membrane, and ureteral dilatation (UD), suggesting HSP complicated with SU. After early SU treatment with prednisolone, kidney function, thickened renal pelvic mucous membrane, and UD progressively normalized and the pain gradually disappeared. Regular ultrasonography of HSP patients from the onset of gross hematuria can be useful to detect early SU and facilitate conservative therapy with prednisolone. Diagnosis of SU can be easily missed by assuming HSP nephritis, particularly owing to the non-specific symptoms. Common characteristics as well as treatment methods and prognosis of SU are given in the literature review.	[Kasahara, Katsuaki; Uemura, Osamu; Nagai, Takuhito; Yamakawa, Satoshi; Nakano, Masaru; Iwata, Naoyuki] Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, Oobu, Aichi 4748710, Japan	Kasahara, K (reprint author), Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, 1-2 Osakata, Oobu, Aichi 4748710, Japan.	katsukasa@nifty.com					Chang WL, 2005, PEDIATR NEPHROL, V20, P1269, DOI 10.1007/s00467-005-1903-z; Jauhola O, 2010, ARCH DIS CHILD, V95, P877, DOI 10.1136/adc.2009.182394; Bruce RG, 1997, PEDIATR NEPHROL, V11, P347; Corbett ST, 2010, J PEDIATR UROL, V6, P538, DOI 10.1016/j.jpurol.2010.03.001; Jasic M, 2011, COLLEGIUM ANTROPOL, V35, P197; Maherzi A, 1997, ARCH PEDIATRIE, V4, P36, DOI 10.1016/S0929-693X(97)84305-9; Pfister C, 2000, EUR UROL, V38, P96, DOI 10.1159/000020259; Robson W L, 1994, J S C Med Assoc, V90, P592; Siegenthaler GM, 2014, PEDIATR NEPHROL, V29, P235, DOI 10.1007/s00467-013-2621-6; Siomou E, 2008, PEDIATR NEPHROL, V23, P821, DOI 10.1007/s00467-007-0698-5	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					317	320		10.1111/ped.12471		4	Pediatrics	Pediatrics	CG1MG	WOS:000353036100043		
J	Takeshita, S; Higuchi, M; Suyama, M; Koide, W; Maki, K; Ushijima, K; Ban, K; Saito, M; Kato, M; Saitoh, S				Takeshita, Satoru; Higuchi, Machiko; Suyama, Megumi; Koide, Wakato; Maki, Kanemasa; Ushijima, Katsumi; Ban, Kyoko; Saito, Mariko; Kato, Mitsuhiro; Saitoh, Shinji			Novel DCX mutation-caused lissencephaly in a boy and very mild heterotopia in his mother	PEDIATRICS INTERNATIONAL			English	Article						DCX; doublecortin; lissencephaly; subcortical band heterotopia; X chromosome inactivation	SUBCORTICAL BAND HETEROTOPIA; GENE; DOUBLECORTIN; EPILEPSY; MALES	We describe a novel mutation in DCX in a family in which a proband boy had classical lissencephaly and his mother had extremely mild subcortical band heterotopia. No factors that would make the mother's symptoms milder, such as somatic mosaicism or skewed X chromosome inactivation, were observed. From this family, we conclude that a DCX mutation causes a pleiotropic phenotype in the female even if X chromosome inactivation pattern is not skewed, and the novel missense mutation in DCX produced relatively mild dysfunction of the doublecortin protein.	[Takeshita, Satoru] Aichi Med Univ Hosp, Perinatal & Neonatal Ctr, Nagakute, Aichi 4801195, Japan; [Higuchi, Machiko; Suyama, Megumi; Koide, Wakato; Maki, Kanemasa; Ushijima, Katsumi; Ban, Kyoko; Saito, Mariko] Yokkaichi Municipal Hosp, Dept Pediat, Yokaichi, Mie, Japan; [Kato, Mitsuhiro] Yamagata Univ, Fac Med, Dept Pediat, Yamagata 990, Japan; [Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi, Japan	Takeshita, S (reprint author), Aichi Med Univ Hosp, Dept Pediat, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	satorut@aichi-med-u.ac.jp					ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Poolos NP, 2002, NEUROLOGY, V58, P1559; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Pilz DT, 1999, HUM MOL GENET, V8, P1757, DOI 10.1093/hmg/8.9.1757; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Demelas L, 2001, NEUROLOGY, V57, P327; Guerrini R, 2003, ANN NEUROL, V54, P30, DOI 10.1002/ana.10588; Leger PL, 2008, NEUROGENETICS, V9, P277, DOI 10.1007/s10048-008-0141-5; Leventer RJ, 2005, J CHILD NEUROL, V20, P307, DOI 10.1177/08830738050200040701; Matsumoto N, 2001, EUR J HUM GENET, V9, P5, DOI 10.1038/sj.ejhg.5200548	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					321	323		10.1111/ped.12502		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100044		
J	Wada, T; Takano, K; Tsurusaki, Y; Miyake, N; Nakashima, M; Saitsu, H; Matsumoto, N; Osaka, H				Wada, Takahito; Takano, Kyoko; Tsurusaki, Yoshinori; Miyake, Noriko; Nakashima, Mitsuko; Saitsu, Hirotomo; Matsumoto, Naomichi; Osaka, Hitoshi			Japanese familial case of myoclonus-dystonia syndrome with a splicing mutation in SGCE	PEDIATRICS INTERNATIONAL			English	Article						epsilon-sarcoglycan; myoclonus-dystonia syndrome; SGCE		Myoclonus-dystonia syndrome (MDS) is a rare autosomal-dominant movement disorder characterized by brief, frequently alcohol-responsive myoclonic jerks that begin in childhood or early adolescence, caused by mutations in the epsilon-sarcoglycan gene (SGCE). The patient was a 6-year-old boy. At 2 years 8 months, he had abnormal movement when he ran due to dystonia of his left leg. At 3 years 5 months, he exhibited dystonia and myoclonic movement of his arms when eating. Myoclonus was likely to develop when he felt anxiety or exhaustion. Genomic DNA showed a heterozygous mutation in SGCE (c.109 + 1 G > T). His father and uncle with the same mutation also experienced milder dystonia or myoclonic movements. SGCE mutation can cause a broad range of clinical symptoms between and within families. We should consider MDS as a differential diagnosis for patients with paroxysmal walking abnormalities and/or myoclonic movements.	[Wada, Takahito; Takano, Kyoko] Div Neurol, Kanagawa Childrens Med Ctr, Yokohama, Kanagawa, Japan; [Tsurusaki, Yoshinori; Miyake, Noriko; Nakashima, Mitsuko; Saitsu, Hirotomo; Matsumoto, Naomichi; Osaka, Hitoshi] Yokohama City Univ Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa, Japan; [Wada, Takahito] Kyoto Univ Grad Sch Med, Dept Med Ethics & Med Genet, Kyoto, Japan; Jichi Med Sch, Dept Pediat, Shimotsuke, Japan; [Wada, Takahito; Takano, Kyoko] Yokohama City Univ, Grad Sch Med, Kanagawa Childrens Med Ctr, Div Neurol, Yokohama, Kanagawa 232, Japan; [Tsurusaki, Yoshinori; Miyake, Noriko; Nakashima, Mitsuko; Saitsu, Hirotomo; Matsumoto, Naomichi; Osaka, Hitoshi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Wada, Takahito] Kyoto Univ, Dept Med Eth & Med Genet, Grad Sch Med, Kyoto, Japan	Wada, T (reprint author), Kyoto Grad Sch Med, Dept Med Eth & Med Genet, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	takahito.wada0001@me.com			Ministry of Health, Labour and Welfare; Kanagawa Pediatric Medical Fund	This work was supported by research grants from the Ministry of Health, Labour and Welfare (T.W and H.O.) and Kanagawa Pediatric Medical Fund (T.W.). The authors have no conflicts of interest to disclose.	Miyake N, 2012, J MED GENET, V49, P533, DOI 10.1136/jmedgenet-2012-101039; Lohmann K, 2013, MOVEMENT DISORD, V28, P899, DOI 10.1002/mds.25536; Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709; Peall KJ, 2013, BRAIN, V136, P294, DOI 10.1093/brain/aws308; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Chung EJ, 2007, MOVEMENT DISORD, V22, P1206, DOI 10.1002/mds.21093; Gasser T, 1998, Adv Neurol, V78, P325; Ghosh D, 2013, J CHILD NEUROL, V28, P1418, DOI 10.1177/0883073813488677; Kinugawa K, 2009, MOVEMENT DISORD, V24, P479, DOI 10.1002/mds.22425; Moghimi N, 2014, EUR J PAEDIATR NEURO, V18, P79, DOI 10.1016/j.ejpn.2013.05.015	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					324	326		10.1111/ped.12613		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100045		
J	Hori, I; Nakaseko, H; Kamei, M; Nomura, T; Iwata, N; Ito, Y; Saitoh, S				Hori, Ikumi; Nakaseko, Haruna; Kamei, Michi; Nomura, Takayasu; Iwata, Naomi; Ito, Yasuhiko; Saitoh, Shinji			Diffuse alveolar hemorrhage secondary to ANCA-associated vasculitis in a patient with Down syndrome	PEDIATRICS INTERNATIONAL			English	Article						anti-neutrophil cytoplasmic antibody; diffuse alveolar hemorrhage; glomerulonephritis; trisomy 21; vasculitis		Diffuse alveolar hemorrhage (DAH) is a rare disease characterized by dyspnea, cough, hemoptysis, and new alveolar infiltrates. Among the various underlying disorders, vasculitis is believed to play a significant role in the pathogenesis of DAH. Here we report the first case of a patient with Down syndrome who developed DAH secondary to anti-neutrophil cytoplasmic antibody-associated vasculitis. This case highlights the significance of vasculitis as well as pulmonary hypoplasia and vulnerability associated with Down syndrome in the development of DAH.	[Hori, Ikumi; Kamei, Michi; Nomura, Takayasu; Ito, Yasuhiko; Saitoh, Shinji] Nagoya City Univ, Dept Pediat & Neonatol, Grad Sch Med Sci, Nagoya, Aichi 4678601, Japan; [Nakaseko, Haruna; Iwata, Naomi] Aichi Childrens Hlth & Med Ctr, Dept Infect & Immunol, Obu, Japan	Hori, I (reprint author), Nagoya City Univ, Dept Pediat & Neonatol, Grad Sch Med Sci, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ikumi193@med.nagoya-cu.ac.jp	Kamei, Michi/Q-1460-2015; 	Kamei, Michi/0000-0002-3353-7045; Nomura, Takayasu/0000-0002-1915-2480			Aceti A, 2012, SARCOIDOSIS VASC DIF, V29, P58; Koldingsnes W, 2000, ARTHRITIS RHEUM, V43, P2481, DOI 10.1002/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6; McDowell KM, 2011, J PEDIATR-US, V158, P319, DOI 10.1016/j.jpeds.2010.07.023; COONEY TP, 1982, NEW ENGL J MED, V307, P1170, DOI 10.1056/NEJM198211043071902; Ioachimescu OC, 2008, CLEV CLIN J MED, V75, P258; Arulkumaran N, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-12; Cuadrado E, 1996, CLIN IMMUNOL IMMUNOP, V78, P209, DOI 10.1006/clin.1996.0031; DILLON MJ, 1991, PEDIATR NEPHROL, V5, P256; Ioachimescu OC, 2008, CLEV CLIN J MED, V75, P260; Ioachimescu OC, 2008, CLEV CLIN J MED, V75, P264; ROBSON WLM, 1995, PEDIATR NEPHROL, V9, P204; Schwab M, 1996, PEDIATR NEPHROL, V10, P249; Thickett DR, 2006, RHEUMATOLOGY, V45, P261, DOI 10.1093/rheumatology/kei217	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e45	e47		10.1111/ped.12612		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100008		
J	Inoue, M; Uchida, K; Otake, K; Okigami, M; Maji, T; Kusunoki, M				Inoue, Mikihiro; Uchida, Keiichi; Otake, Kohei; Okigami, Masato; Maji, Tomoaki; Kusunoki, Masato			Development of acute pancreatitis after Nissen fundoplication	PEDIATRICS INTERNATIONAL			English	Article						acute pancreatitis; fundoplication; gastroesophageal reflux disease	GASTROESOPHAGEAL-REFLUX DISEASE	Acute pancreatitis subsequent to Nissen fundoplication for gastroesophageal reflux disease (GERD) is an extremely rare adverse event. We describe a pediatric case of acute pancreatitis resulting from superior mesenteric artery syndrome (SMAS) and gas bloat after fundoplication. Gas bloat is one of the known postoperative complications after Nissen fundoplication. Poor nutrition status, which is often associated with severe pediatric GERD, is a risk factor for SMAS. In this case, development of gas bloat and SMAS led to the formation of a closed loop and increased intraluminal pressure of the duodenum and pancreatic duct. Many pediatric patients who need anti-reflux surgery face the risk of developing this entity. Preventive measures, such as treatment with prokinetics and frequent small-volume meals, should be considered until improvement of nutritional status after fundoplication.	[Inoue, Mikihiro; Uchida, Keiichi; Otake, Kohei; Okigami, Masato; Kusunoki, Masato] Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Tsu, Mie 5148507, Japan; [Maji, Tomoaki] Ise Red Cross Hosp, Dept Pediat, Ise, Japan	Inoue, M (reprint author), Mie Univ, Grad Sch Med, Dept Gastrointestinal & Pediat Surg, Edobashi 2-174, Tsu, Mie 5148507, Japan.	mikihiro@clin.medic.mie-u.ac.jp					Broeders JA, 2009, ANN SURG, V250, P698, DOI 10.1097/SLA.0b013e3181bcdaa7; Merrett ND, 2009, J GASTROINTEST SURG, V13, P287, DOI 10.1007/s11605-008-0695-4; Velanovich V, 1996, J AM COLL SURGEONS, V183, P217; Hassall E, 2005, J PEDIATR-US, V146, pS3, DOI 10.1016/j.jpeds.2004.11.034; Landreneau RJ, 1998, ANN THORAC SURG, V66, P1886, DOI 10.1016/S0003-4975(98)01260-0; Petrosyan M, 2009, CASE REP MED, V2009; Spechler SJ, 2004, AM J GASTROENTEROL, V99, P552, DOI 10.1111/j.1572-0241.2004.04081.x	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e48	e49		10.1111/ped.12610		2	Pediatrics	Pediatrics	CG1MG	WOS:000353036100009		
J	Ito, T; Watanabe, S; Tsuruga, K; Aizawa, T; Hirono, K; Ito, E; Joh, K; Tanaka, H				Ito, Tatsuya; Watanabe, Shojiro; Tsuruga, Kazushi; Aizawa, Tomomi; Hirono, Koji; Ito, Etsuro; Joh, Kensuke; Tanaka, Hiroshi			Severe intrinsic acute kidney injury associated with therapeutic doses of acetaminophen	PEDIATRICS INTERNATIONAL			English	Article						acetaminophen; acute kidney injury; acute tubular necrosis; tubulointerstitial nephritis	NEPHRITIS; FAILURE	Acetaminophen is a commonly used medication to manage fever and pain in children and the drug is generally considered to be safe when used at appropriate therapeutic dosages. Recently, we encountered the case of a 3-year-old Japanese girl who suffered from severe intrinsic acute kidney injury (AKI) after therapeutic doses of acetaminophen for a fever due to viral infection. Renal biopsy indicated severe acute tubular necrosis with a significant striped interstitial fibrosis and mild interstitial inflammation. Unfortunately, she developed chronic kidney disease thereafter. This is the youngest case of biopsy-proven severe intrinsic AKI associated with therapeutic doses of acetaminophen. Acetaminophen, even if administered at therapeutic dosages, may be dangerous in selected children, especially with possible pre-existing volume depletion.	[Ito, Tatsuya; Watanabe, Shojiro; Tsuruga, Kazushi; Aizawa, Tomomi; Hirono, Koji; Ito, Etsuro; Tanaka, Hiroshi] Hirosaki Univ Hosp, Dept Pediat, Hirosaki, Aomori 0368563, Japan; [Joh, Kensuke] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Tanaka, Hiroshi] Hirosaki Univ, Fac Educ, Dept Sch Hlth Sci, Hirosaki, Aomori, Japan	Tanaka, H (reprint author), Hirosaki Univ Hosp, Dept Pediat, Hirosaki, Aomori 0368563, Japan.	hirotana@hirosaki-u.ac.jp					Alkhuja S, 2001, NEPHROL DIAL TRANSPL, V16, P190, DOI 10.1093/ndt/16.1.190; Onay OS, 2009, PEDIATR EMERG CARE, V25, P263, DOI 10.1097/PEC.0b013e31819e38d4; Fruchter LL, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-17; Kanai T, 2011, PEDIATR INT, V52, pe23; Kato H, 2014, INTERNAL MED, V53, P1531, DOI 10.2169/internalmedicine.53.1502; Marzuillo P, 2014, EUR J PEDIATR, V173, P415, DOI 10.1007/s00431-013-2239-5; Mazer Maryann, 2008, J Med Toxicol, V4, P2; Tanaka H, 1997, ACTA PAEDIATR JAPON, V39, P698; Zaffanello M, 2009, ACTA PAEDIATR, V98, P903, DOI 10.1111/j.1651-2227.2008.01209.x	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e53	e55		10.1111/ped.12607		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100011		
J	Kuroda, J; Inoue, N; Satoh, H; Fukuzawa, R; Terakawa, T; Hasegawa, Y				Kuroda, Junpei; Inoue, Nobuaki; Satoh, Hiroyuki; Fukuzawa, Ryuji; Terakawa, Toshiro; Hasegawa, Yukihiro			Neonatal necrotizing fasciitis of the scrotum caused by Streptococcus agalactiae	PEDIATRICS INTERNATIONAL			English	Article						necrotizing fasciitis; neonate; Streptococcus agalactiae	INFANTS	We herein describe the case of a 27-day-old male infant who was brought to the emergency room for intermittent crying, and swelling of the left scrotum. Based on the clinical findings, necrotizing fasciitis was suspected, and surgical intervention was successfully completed within a few hours of admission. Streptococcus agalactiae type Ia was cultured from the drained abscess, and was considered the causative pathogen. To our knowledge, this is the first report of neonatal necrotizing fasciitis caused by S.agalactiae. Prompt diagnosis and immediate surgical debridement are crucial in the initial management of this disease.	[Kuroda, Junpei; Terakawa, Toshiro; Hasegawa, Yukihiro] Tokyo Metropolitan Childrens Med Ctr, Dept Gen Pediat, Fuchu, Tokyo 1838561, Japan; [Satoh, Hiroyuki] Tokyo Metropolitan Childrens Med Ctr, Dept Urol, Fuchu, Tokyo 1838561, Japan; [Fukuzawa, Ryuji] Tokyo Metropolitan Childrens Med Ctr, Dept Pathol & Lab Med, Fuchu, Tokyo 1838561, Japan; [Inoue, Nobuaki] Tokyo Metropolitan Childrens Med Ctr, Div Pediat Emergency Med, Dept Pediat Emergency & Crit Care Med, Fuchu, Tokyo 1838561, Japan	Kuroda, J (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Gen Pediat, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	junpeikuroda0308@yahoo.co.jp					ADEYOKUNNU AA, 1983, CLIN PEDIATR, V22, P101, DOI 10.1177/000992288302200203; Ameh EA, 2004, EUR J PEDIATR SURG, V14, P418, DOI 10.1055/s-2004-821138; Moss RLM, 1996, J PEDIATR SURG, V31, P1142, DOI 10.1016/S0022-3468(96)90104-9; Fustes-Morales A, 2002, ARCH DERMATOL, V138, P893, DOI 10.1001/archderm.138.7.893; Hsieh WS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e53; Lang ME, 2003, CLIN INFECT DIS, V37, pE132, DOI 10.1086/378892; Nazir Z, 2005, PEDIATR SURG INT, V21, P641, DOI 10.1007/s00383-005-1481-y	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e56	e58		10.1111/ped.12563		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100012		
J	Mizuochi, T; Suda, K; Seki, Y; Yanagi, T; Yoshimoto, H; Kudo, Y; Iemura, M; Tanikawa, K; Matsuishi, T				Mizuochi, Tatsuki; Suda, Kenji; Seki, Yoshitaka; Yanagi, Tadahiro; Yoshimoto, Hironaga; Kudo, Yoshiyuki; Iemura, Motofumi; Tanikawa, Ken; Matsuishi, Toyojiro			Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome	PEDIATRICS INTERNATIONAL			English	Article						diuretic; Noonan syndrome; protein-losing enteropathy; venous pressure	SPIRONOLACTONE; OPERATION	There are few reports on successful high-dose spironolactone treatment of refractory protein-losing enteropathy (PLE) caused by Fontan procedure. We report successful diuretics treatment with spironolactone and furosemide at standard dose, of refractory PLE in a patient with Noonan syndrome and repaired congenital heart disease. This is the first successful application of diuretics treatment in a patient with refractory PLE without Fontan procedure. This case illustrates that diuretics treatment can be the first-line treatment of PLE regardless of the causative physiology, and can be effective in refractory PLE with Noonan syndrome.	[Mizuochi, Tatsuki; Suda, Kenji; Seki, Yoshitaka; Yanagi, Tadahiro; Yoshimoto, Hironaga; Kudo, Yoshiyuki; Iemura, Motofumi; Matsuishi, Toyojiro] Kurume Univ, Dept Pediat & Child Hlth, Sch Med, Kurume, Fukuoka 8300011, Japan; [Tanikawa, Ken] Kurume Univ, Dept Diagnost Pathol, Sch Med, Kurume, Fukuoka 8300011, Japan	Mizuochi, T (reprint author), Kurume Univ, Dept Pediat & Child Hlth, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	mizuochi_tatsuki@kurume-u.ac.jp					Romano AA, 2010, PEDIATRICS, V126, P746, DOI 10.1542/peds.2009-3207; Hokari R, 2008, J GASTROEN HEPATOL, V23, pE88, DOI 10.1111/j.1440-1746.2007.05225.x; Umar SB, 2010, AM J GASTROENTEROL, V105, P43, DOI 10.1038/ajg.2009.561; Grattan MJ, 2010, CONGENIT HEART DIS, V5, P165, DOI 10.1111/j.1747-0803.2009.00320.x; John AS, 2011, CONGENIT HEART DIS, V6, P653, DOI 10.1111/j.1747-0803.2011.00518.x; Ringel RE, 2003, AM J CARDIOL, V91, P1031, DOI 10.1016/S0002-9149(03)00135-8; Suda K, 2004, ANN THORAC SURG, V78, P942, DOI 10.1016/j.athorascur.2004.03.039; Umeda M, 2014, INT J RHEUM DIS, DOI [10.1111/1756-185X.12417, DOI 10.1111/1756-185X.12417]	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e39	e41		10.1111/ped.12603		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100006		
J	Nishida, M; Morimoto, M; Ohno, K; Hamaoka, K				Nishida, Masashi; Morimoto, Masafumi; Ohno, Kunihiko; Hamaoka, Kenji			IgA nephropathy in a girl with mitochondrial disease	PEDIATRICS INTERNATIONAL			English	Article						IgA nephropathy; mesangial proliferative glomerulonephritis; mitochondrial cytopathy; mitochondrial renal disease; proteinuria		Mitochondrial renal disease is one of the important causes of end-stage renal disease in children and its incidence may be underestimated. We here describe the case of a 13-year-old girl who was diagnosed with mitochondrial disease (MD) accompanied by IgA nephropathy (IgAN). She presented with persistent proteinuria, short stature, and hearing defect, and her younger sister had the same symptoms. Renal biopsy indicated mild focal segmental mesangial proliferation with dominant mesangial IgA deposition on immunofluorescence. Electron microscopy showed marked proliferation of abnormal mitochondria in the proximal tubular cells. Enzyme activity of the mitochondrial respiratory chain complex I and IV in cultured skin fibroblasts was significantly decreased. This case indicated the possible co-occurrence of IgAN and MD. Underlying MD should be considered in patients with urine abnormalities, especially in those with multiple organ involvement.	[Nishida, Masashi; Hamaoka, Kenji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat Cardiol & Nephrol, Kyoto 6028566, Japan; [Morimoto, Masafumi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto 6028566, Japan; [Ohno, Kunihiko] Kyoto Second Red Cross Hosp, Dept Pediat, Kyoto, Japan	Nishida, M (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat Cardiol & Nephrol, Kamigyo Ku, Kyoto 6028566, Japan.	mnishida@koto.kpu-m.ac.jp					Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Suzuki K, 2003, KIDNEY INT, V63, P2286, DOI 10.1046/j.1523-1755.63.6s.2.x; Baskin E, 2011, PEDIATR NEPHROL, V26, P1157, DOI 10.1007/s00467-011-1814-0; Emma F, 2012, PEDIATR NEPHROL, V27, P539, DOI 10.1007/s00467-011-1926-6; Nishigaki Y, 2010, MITOCHONDRION, V10, P300, DOI 10.1016/j.mito.2010.01.003; Rahman S, 2013, PEDIATR NEPHROL, V28, P357, DOI 10.1007/s00467-012-2362-y; Utsunomiya Y, 2003, PEDIATR NEPHROL, V18, P511, DOI 10.1007/s00467-003-1127-z	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e50	e52		10.1111/ped.12540		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100010		
J	Okada, Y; Inoue, N; Fukushima, N; Yoshikawa, T; Takahashi, Y; Matsubara, S; Hasegawa, Y				Okada, Yuki; Inoue, Nobuaki; Fukushima, Naoya; Yoshikawa, Tadahiro; Takahashi, Yukihiro; Matsubara, Shigeki; Hasegawa, Yukihiro			Idiopathic mitral valve chordae rupture in an infant: Importance of rapid diagnosis and surgery	PEDIATRICS INTERNATIONAL			English	Article						age 4 months; emergency surgery; idiopathic; life-threatening disease; mitral valve chordae rupture	REGURGITATION; TENDINEAE	Mitral valve chordae rupture in infancy is a rare, but life-threatening disease. The progression of acute cardiac failure has been reported, with emergency surgery being required in most cases. Mitral valve chordae rupture typically occurs at the age of 4-6 months. Echocardiography is needed to diagnose this disease, and accurate diagnosis is difficult for general pediatricians. We herein describe the case of an acutely ill 4-month-old infant, who was saved and discharged without neurological sequelae due to the early diagnosis of mitral valve chordae rupture, life support, and surgery. We confirm the importance of acute pre-surgery treatment and immediate surgery for the survival and good outcome of infants.	[Okada, Yuki; Hasegawa, Yukihiro] Tokyo Metropolitan Children Med Ctr, Dept Gen Pediat, Fuchu, Tokyo 1838561, Japan; [Inoue, Nobuaki] Tokyo Metropolitan Children Med Ctr, Dept Pediat Emergency Med, Fuchu, Tokyo 1838561, Japan; [Fukushima, Naoya] Tokyo Metropolitan Children Med Ctr, Dept Cardiol, Fuchu, Tokyo 1838561, Japan; [Yoshikawa, Tadahiro] Sakakibara Heart Inst, Dept Pediat Cardiol, Fuchu, Tokyo, Japan; [Takahashi, Yukihiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Fuchu, Tokyo, Japan; [Matsubara, Shigeki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi, Japan; [Matsubara, Shigeki] Jichi Med Univ, Support Ctr Clin Invest, Shimotsuke, Tochigi, Japan	Okada, Y (reprint author), Tokyo Metropolitan Children Med Ctr, Dept Gen Pediat, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	y.okada0422@gmail.com					Anderson Y, 2008, J PAEDIATR CHILD H, V44, P134, DOI 10.1111/j.1440-1754.2007.01214.x; Cuneo BF, 2011, AM J CARDIOL, V107, P761, DOI 10.1016/j.amjcard.2010.10.059; Torigoe T, 2012, EUR J PEDIATR, V171, P259, DOI 10.1007/s00431-011-1528-0; Asakai H, 2011, PEDIATR CARDIOL, V32, P634, DOI 10.1007/s00246-011-9939-2; Grinberg AR, 1998, CLIN CARDIOL, V21, P300; Hamaoka A, 2009, EUR J PEDIATR, V168, P741, DOI 10.1007/s00431-008-0818-7; Mishima A, 1996, J THORAC CARDIOV SUR, V111, P895, DOI 10.1016/S0022-5223(96)70352-5; Ozawa Y, 2011, PEDIAT CARDIOL CARD, V27, P220; Sakaguchi H, 2012, J PEDIAT CARDIOL S1, V28, P5223; Shiraishi I, 2014, CIRCULATION, V130, P1053, DOI 10.1161/CIRCULATIONAHA.114.008592; Weidenbach M, 1999, PEDIATR CARDIOL, V20, P382, DOI 10.1007/s002469900493	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e65	e68		10.1111/ped.12568		4	Pediatrics	Pediatrics	CG1MG	WOS:000353036100015		
J	Okuno, T; Tokuriki, S; Yoshino, T; Tanaka, N; Ohshima, Y				Okuno, Takashi; Tokuriki, Shuko; Yoshino, Tomomi; Tanaka, Nanae; Ohshima, Yusei			Diffuse neonatal hemangiomatosis in a very low-birthweight infant treated with erythropoietin	PEDIATRICS INTERNATIONAL			English	Article						diffuse neonatal hemangiomatosis; erythropoietin; hemangioma; propranolol; very low-birthweight infant	ENDOTHELIAL GROWTH-FACTOR; ORAL PROPRANOLOL; PREMATURITY; RETINOPATHY	Diffuse neonatal hemangiomatosis (DNH) is a rare condition characterized by the concomitant development of multiple cutaneous infantile hemangiomas (IH) and visceral hemangiomas. Recently, an association between erythropoietin treatment and an increased incidence of infantile hemangioma was noted. A Japanese male infant was born via cesarean section at 27weeks of gestation. Following the commencement of erythropoietin treatment for anemia of prematurity, he developed multiple cutaneous hemangiomas, high cardiac output heart failure and hepatomegaly. Abdominal imaging indicated comorbidity of diffuse infantile hepatic hemanigomas, resulting in the final diagnosis of DNH. The discontinuation of erythropoietin treatment and long-term therapy with propranolol improved the hepatic lesions and cutaneous hemangiomas. The possibility of multiple organ involvement and the exacerbating effects of erythropoietin treatment should be considered in cases in which multiple cutaneous hemangiomas develop in preterm infants receiving erythropoietin treatment.	[Okuno, Takashi; Tokuriki, Shuko; Yoshino, Tomomi; Tanaka, Nanae; Ohshima, Yusei] Univ Fukui, Dept Pediat, Fac Med Sci, Eiheiji, Fukui 9101193, Japan	Okuno, T (reprint author), Univ Fukui, Dept Pediat, Fac Med Sci, 23-3 Shimoaizuki, Eiheiji, Fukui 9101193, Japan.	okuno@u-fukui.ac.jp					Sans V, 2009, PEDIATRICS, V124, pE423, DOI 10.1542/peds.2008-3458; Doege C, 2012, ARCH DIS CHILD-FETAL, V97, pF45, DOI 10.1136/adc.2010.187344; Suk KK, 2008, J AAPOS, V12, P233, DOI 10.1016/j.jaapos.2007.08.009; Kulungowski AM, 2012, J PEDIATR SURG, V47, P165, DOI 10.1016/j.jpedsurg.2011.10.037; Filippi L, 2013, J PEDIATR-US, V163, P1570, DOI 10.1016/j.jpeds.2013.07.049; Chang LC, 2008, PEDIATRICS, V122, P360, DOI 10.1542/peds.2007-2767; Chen XD, 2013, PEDIATR DERMATOL, V30, P549, DOI 10.1111/pde.12192; Dotan M, 2013, ACTA PAEDIATR, V102, DOI 10.1111/apa.12184; Eleftheriadis T, 2013, ADV MED SCI-POLAND, V58, P143, DOI 10.2478/v10039-012-0071-1; Mazereeuw-Hautier J, 2010, J PEDIATR-US, V157, P340, DOI 10.1016/j.jpeds.2010.04.003	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e34	e36		10.1111/ped.12517		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100004		
J	Oshiro, H; Goi, K; Akahane, K; Inukai, T; Sugita, K				Oshiro, Hiroko; Goi, Kumiko; Akahane, Koshi; Inukai, Takeshi; Sugita, Kanji			Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria	PEDIATRICS INTERNATIONAL			English	Article						bone marrow transplantation; eculizumab; paroxysmal nocturnal hemoglobinuria	HEMATOPOIETIC-CELL TRANSPLANTATION; PNH	A 9-year-old boy with paroxysmal nocturnal hemoglobinuria/aplastic anemia syndrome (PNH/AA) developed hemolytic crisis after receiving immunosuppressive therapy. Eculizumab dramatically relieved the signs and symptoms and then he safely underwent unrelated bone marrow transplantation, suggesting the feasibility and effectiveness of eculizumab before stem cell transplantation in children with PNH/AA in hemolytic crisis.	[Oshiro, Hiroko; Goi, Kumiko; Akahane, Koshi; Inukai, Takeshi; Sugita, Kanji] Univ Yamanashi, Dept Pediat, Sch Med, Kofu, Yamanashi 4093898, Japan	Goi, K (reprint author), Univ Yamanashi, Dept Pediat, Fac Med, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4093898, Japan.	kgoi@yamanashi.ac.jp					Curran KJ, 2012, PEDIATR BLOOD CANCER, V59, P525, DOI 10.1002/pbc.23410; Srinivasan R, 2006, BRIT J HAEMATOL, V133, P305, DOI 10.1111/j.1365-2141.2006.06019.x; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Takahashi Y, 2004, BLOOD, V103, P1383, DOI 10.1182/blood-2003-04-1281; Taniguchi K, 2011, INT J HEMATOL, V94, P403, DOI 10.1007/s12185-011-0931-7; Tiene BP, 2012, J PEDIAT HEMATOL ONC, V34, pe346; van den Heuvel-Eibrink MM, 2005, BRIT J HAEMATOL, V128, P571, DOI 10.1111/j.1365-2141.2004.05337.x; Yen TA, 2012, PEDIATR BLOOD CANCER, V59, P203, DOI 10.1002/pbc.24070	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e27	e29		10.1111/ped.12522		3	Pediatrics	Pediatrics	CG1MG	WOS:000353036100002		
J	Umeda, K; Fujino, H; Saida, S; Kato, I; Hiramatsu, H; Yamada, T; Hori, T; Adachi, S; Heike, T; Watanabe, KI				Umeda, Katsutsugu; Fujino, Hisanori; Saida, Satoshi; Kato, Itaru; Hiramatsu, Hidefumi; Yamada, Tomomi; Hori, Toshinori; Adachi, Souichi; Heike, Toshio; Watanabe, Ken-Ichiro			Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma	PEDIATRICS INTERNATIONAL			English	Article						Burkitt's lymphoma; chemotherapy; relapse; rituximab	NON-HODGKINS-LYMPHOMA; CELL; CHILDREN; THERAPY	A 14-year-old girl with multiple intra-abdominal tumors was diagnosed with stage III Burkitt's lymphoma. She achieved complete remission after multi-drug chemotherapy, but she relapsed after six courses. Autologous peripheral blood stem cells (PBSC) or allogeneic PBSC harvested from an HLA-identical sibling were insufficient, and her family did not agree to bone marrow collection from the sibling. Although the patient relapsed nine times (the relapses involved intra-abdominal organs or bone) during the following 4 years 7 months, treatment with rituximab monotherapy or in combination with ifosphamide, carboplastin, and etoposide, or local irradiation (33.8-40.0Gy) to treat the bone metastases, proved effective, resulting in complete or partial remission. At the time of writing, the patient was in a 10th cycle of remission lasting 1 year 6 months and had not required transplantation. Thus, a chemotherapy regimen including rituximab might be effective for Burkitt's lymphoma in patients experiencing multiple relapse.	[Umeda, Katsutsugu; Saida, Satoshi; Kato, Itaru; Hiramatsu, Hidefumi; Heike, Toshio; Watanabe, Ken-Ichiro] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto 6068507, Japan; [Adachi, Souichi] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto 6068507, Japan; [Fujino, Hisanori] Osaka Red Cross Hosp, Dept Pediat, Osaka, Japan; [Yamada, Tomomi; Hori, Toshinori] Aichi Med Univ, Sch Med, Adv Med Res Ctr, Nagakute, Aichi, Japan; [Hori, Toshinori] Aichi Med Univ, Sch Med, Dept Pediat, Nagakute, Aichi, Japan	Umeda, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	umeume@kuhp.kyoto-u.ac.jp					Akbayram S, 2010, TARGET ONCOL, V5, P291, DOI 10.1007/s11523-010-0161-6; Tsurusawa M, 2014, PEDIATR BLOOD CANCER, V61, P1215, DOI [10.1002/pbc.24975, 10.1002/pbc.24968]; Molyneux EM, 2012, LANCET, V379, P1234, DOI 10.1016/S0140-6736(11)61177-X; SUTCLIFFE SB, 1985, RADIOTHER ONCOL, V4, P211, DOI 10.1016/S0167-8140(85)80086-4; Griffin TC, 2009, PEDIATR BLOOD CANCER, V52, P177, DOI 10.1002/pbc.21753; Attias D, 2008, CURR OPIN PEDIATR, V20, P17, DOI 10.1097/MOP.0b013e3282f424b0; desVries MJ, 2004, BRIT J HAEMATOL, V125, P414; Hamabata Takayuki, 2013, Rinsho Ketsueki, V54, P653; Lister J, 1996, BLOOD, V88, P1407; PHILIP T, 1993, BLOOD, V81, P2003	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	APR	2015	57	2					e30	e33		10.1111/ped.12524		4	Pediatrics	Pediatrics	CG1MG	WOS:000353036100003		
J	Mine, I; Sekida, S; Okuda, K				Mine, Ichiro; Sekida, Satoko; Okuda, Kazuo			Cell wall and cell growth characteristics of giant-celled algae	PHYCOLOGICAL RESEARCH			English	Review						anisotropic growth; cell wall extensibility; cell wall matrix; cellulose microfibril; characean algae; diffuse growth; isotropic growth; tip growth; Valonia ventricosa; Vaucheria frigida	COENOCYTIC GREEN-ALGA; CHARA-CORALLINA; VAUCHERIA-TERRESTRIS; MECHANICAL-PROPERTIES; VALONIA-VENTRICOSA; PECTATE CHEMISTRY; CHAMAEDORIS-ORIENTALIS; INTERNODAL CELLS; TIP GROWTH; ELONGATION	Because of their large sizes and simple shapes, giant-celled algae have been used to study how the structural and mechanical properties of cell walls influence cell growth. Here we review known relationships between cell wall and cell growth properties that are characteristic of three representative taxa of giant-celled algae, namely, Valonia ventricosa, internodal cells of characean algae, and Vaucheria frigida. Tip-growing cells of the genus Vaucheria differ from cells undergoing diffuse growth in V.ventricosa and characean algae in terms of their basic architectures (non-lamellate vs. multilamellate) and their dependence upon pH and Ca2+ for cell wall extensibility. To further understand the mechanisms controlling cell growth by cell walls, comparative analyses of cell wall structures and/or associated growth modes will be useful. The giant-celled algae potentially serve as good models for such investigations because of their wide variety of developmental processes and cell shapes exhibited.	[Mine, Ichiro; Sekida, Satoko; Okuda, Kazuo] Kochi Univ, Grad Sch Kuroshio Sci, Kochi, Kochi 7808520, Japan	Mine, I (reprint author), Kochi Univ, Grad Sch Kuroshio Sci, 2-5-1 Akebono Cho, Kochi, Kochi 7808520, Japan.	mine@kochi-u.ac.jp					Proseus TE, 2007, J EXP BOT, V58, P4283, DOI 10.1093/jxb/erm318; COSGROVE DJ, 1993, NEW PHYTOL, V124, P1, DOI 10.1111/j.1469-8137.1993.tb03795.x; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; GREEN PB, 1971, PLANT PHYSIOL, V47, P423, DOI 10.1104/pp.47.3.423; Cosgrove DJ, 1996, BIOESSAYS, V18, P533, DOI 10.1002/bies.950180704; Nishitani K, 1997, INT REV CYTOL, V173, P157; Proseus TE, 2006, J EXP BOT, V57, P3989, DOI 10.1093/jxb/erl166; Proseus TE, 2005, ANN BOT-LONDON, V95, P967, DOI 10.1093/aob/mci113; Toole GA, 2001, PLANTA, V212, P606, DOI 10.1007/s004250000425; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; PRESTON RD, 1948, NATURE, V162, P665, DOI 10.1038/162665a0; Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Burgert I, 2009, INTEGR COMP BIOL, V49, P69, DOI 10.1093/icb/icp026; Elvira PR, 2013, PROTOPLASMA, V250, P407, DOI 10.1007/s00709-012-0381-y; GUIRY M. D., 2014, ALGAEBASE; HEJNOWICZ Z, 1977, Z PFLANZENPHYSIOL, V81, P409; KATAOKA H, 1982, BOT MAG TOKYO, V95, P317, DOI 10.1007/BF02488543; KATAOKA H, 1990, PLANT CELL PHYSIOL, V31, P933; MASUDA Y, 1990, BOT MAG TOKYO, V103, P345, DOI 10.1007/BF02488646; METRAUX JP, 1980, PLANT PHYSIOL, V65, P204, DOI 10.1104/pp.65.2.204; Mine I, 2007, PLANTA, V225, P1135, DOI 10.1007/s00425-006-0424-8; Mine I, 2008, INT REV CEL MOL BIO, V266, P37, DOI 10.1016/S1937-6448(07)66002-X; Mine I, 2007, PLANTA, V226, P971, DOI 10.1007/s00425-007-0543-x; Mine I, 2003, PLANTA, V217, P425, DOI 10.1007/s00425-003-0993-8; MIZUTA S, 1987, BOT GAZ, V148, P297, DOI 10.1086/337657; Nishitani K, 2007, PLANT CELL MONOGRAPH, V5, P89; Okuda Kazuo, 1997, Phycological Research, V45, P189, DOI 10.1111/j.1440-1835.1997.tb00075.x; OKUDA K, 1990, PLANT CELL PHYSIOL, V31, P357; OKUDA K, 1993, BOT MAR, V36, P53, DOI 10.1515/botm.1993.36.1.53; Okuda Kazuo, 1997, Memoirs of the Faculty of Science Kochi University Series D Biology, V18, P17; OLSEN JL, 1988, PHYCOLOGIA, V27, P103, DOI 10.2216/i0031-8884-27-1-103.1; PARKER BC, 1963, PROC R SOC SER B-BIO, V158, P435, DOI 10.1098/rspb.1963.0056; PRESTON RD, 1954, NATURE, V173, P203, DOI 10.1038/173203a0; PRESTON RD, 1951, J EXP BOT, V2, P247, DOI 10.1093/jxb/2.2.247; PROBINE M. C., 1963, TUATARA, V11, P115; PROBINE MC, 1961, J EXP BOT, V12, P261, DOI 10.1093/jxb/12.2.261; Proseus TE, 2008, PLANT CELL ENVIRON, V31, P1147, DOI 10.1111/j.1365-3040.2008.01829.x; Proseus TE, 2006, ANN BOT-LONDON, V98, P93, DOI 10.1093/aob/mcl098; RAYLE DL, 1992, PLANT PHYSIOL, V99, P1271, DOI 10.1104/pp.99.4.1271; Richmond P. A., 1983, J APPL POLYM SCI APP, V37, P107; RICHMOND PA, 1980, PLANT PHYSIOL, V65, P211, DOI 10.1104/pp.65.2.211; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Shibaoka H., 1991, CYTOSKELETAL BASIS P, P159; Shimmen T, 2002, PLANT CELL PHYSIOL, V43, P980, DOI 10.1093/pcp/pcf116; Takahashi F, 2001, PLANT CELL PHYSIOL, V42, P274, DOI 10.1093/pcp/pce033; TEPFER M, 1979, PLANT PHYSIOL, V63, P898, DOI 10.1104/pp.63.5.898; Toole GA, 2002, PLANTA, V214, P468, DOI 10.1007/s004250100641; WAALAND SD, 1972, J CELL BIOL, V54, P184, DOI 10.1083/jcb.54.1.184; ZHU GL, 1992, PLANT PHYSIOL, V100, P2071, DOI 10.1104/pp.100.4.2071	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	APR	2015	63	2					77	84		10.1111/pre.12088		8	Marine & Freshwater Biology	Marine & Freshwater Biology	CG5OA	WOS:000353340200001		
J	Mertens, KN; Takano, Y; Gu, HF; Yamaguchi, A; Pospelova, V; Ellegaard, M; Matsuoka, K				Mertens, Kenneth Neil; Takano, Yoshihito; Gu, Haifeng; Yamaguchi, Aika; Pospelova, Vera; Ellegaard, Marianne; Matsuoka, Kazumi			Cyst-theca relationship of a new dinoflagellate with a spiny round brown cyst, Protoperidinium lewisiae sp nov., and its comparison to the cyst of Oblea acanthocysta	PHYCOLOGICAL RESEARCH			English	Article						Bohai Sea; Changle Harbor; East China Sea; Jinzhou Harbor; Lake Saroma; large subunit rDNA; San Pedro Harbor; small subunit rDNA	MOTILE STAGE RELATIONSHIPS; LATE QUATERNARY; MONOVELA GROUP; SEQUENCE DATA; DINOPHYCEAE; PERIDINIALES; GENUS; SEA; PHYLOGENY; SEDIMENTS	Round spiny brown cysts with apiculocavate processes were isolated from sediments of Lake Saroma, Japan, Changle Harbor, East China Sea, China, Jinzhou Harbor, Bohai Sea, China, and San Pedro Harbor, California, USA. Superficially similar round spiny brown cysts of the species, Oblea acanthocysta were, for comparison, restudied through light microscopy and scanning electron microscopy (SEM) and by sequencing of small subunit (SSU) and large subunit (LSU) rDNA obtained through a single cyst from Lake Saroma. These morphological measurements and SEM observations showed that the new cysts can be discriminated from O.acanthocysta by the archeopyle, number of processes, shape of process bases and its apiculocavate processes. Based on LSU sequences, the most closely related species was Protoperidinium monovelum, for which no cyst stage has been described so far. However, the thecal morphology of the specimens found in this study differed from P.monovelum in details of the sulcal plates and shape of apical pore and 2a plate. We therefore describe Protoperidinium lewisiae sp. nov., which can be found in estuarine subtropical to temperate waters of the Pacific Ocean.	[Mertens, Kenneth Neil] Univ Ghent, Res Unit Palaeontol, B-9000 Ghent, Belgium; [Takano, Yoshihito; Matsuoka, Kazumi] Nagasaki Univ, Inst East China Sea Res ECSER, Nagasaki 852, Japan; [Yamaguchi, Aika] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 657, Japan; [Gu, Haifeng] SOA, Inst Oceanog 3, Xiamen, Peoples R China; [Pospelova, Vera] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Ellegaard, Marianne] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark	Mertens, KN (reprint author), Univ Ghent, Res Unit Palaeontol, B-9000 Ghent, Belgium.	kenneth.mertens@ugent.be	Mertens, Kenneth/C-3386-2015	Mertens, Kenneth/0000-0003-2005-9483	Kakenhi Grant [22-00805]; Natural Science and Engineering Research Council of Canada (NSERC) [224236]; National Natural Science Foundation of China [41376170]	KNM is a postdoctoral fellow of FWO Belgium, who conducted this research at the University of Victoria (British Columbia, Canada) and partly at Nagasaki University and was supported by a Kakenhi Grant 22-00805. The Natural Science and Engineering Research Council of Canada (NSERC) is acknowledged for partial funding of this project (VP Discovery Grant 224236). Haifeng Gu was supported by the National Natural Science Foundation of China (41376170). Hiromi Saitoh and Kimihiko Maekawa are thanked for assistance during sampling of Saroma Lake. Aya Morinaga is thanked for sampling Omura Bay. Carrie Wolfe, Adam Willingham, and Dennis Dunn from the Southern California Marine Institute, http://www.scmi.net/ are thanked for their help with sampling in San Pedro Harbor. Martin J. Head is acknowledged for sharing published measurements. Two anonymous reviewers and the editors, Mitsunobu Kamiya and Mona Hoppenrath, are thanked for helpful comments that significantly improved the manuscript.	Abe T. H., 1936, Science Reports of the Tohoku University (4), V10, P639; ABE TOHRU HIDEMITI, 1927, SCI REPT TOHOKU IMP UNIV 4TH SER BIOL, V2, P383; MATSUOKA K, 1988, REV PALAEOBOT PALYNO, V56, P95, DOI 10.1016/0034-6667(88)90077-2; Verleye TJ, 2011, MAR MICROPALEONTOL, V78, P65, DOI 10.1016/j.marmicro.2010.10.001; Zonneveld KAF, 1997, REV PALAEOBOT PALYNO, V97, P319, DOI 10.1016/S0034-6667(97)00002-X; Matsuoka K, 2013, MICROPALEAEONTOLOGIC, P275; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Potvin E, 2013, J PHYCOL, V49, P848, DOI 10.1111/jpy.12089; Head MJ, 2001, J QUATERNARY SCI, V16, P621, DOI 10.1002/jqs.657; Horiguchi T, 2012, PHYCOL RES, V60, P137, DOI 10.1111/j.1440-1835.2012.00645.x; Chomerat N, 2008, PHYCOLOGIA, V47, P392, DOI 10.2216/07-82.1; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Mertens KN, 2012, MAR MICROPALEONTOL, V96-97, P48, DOI 10.1016/j.marmicro.2012.08.002; Matsuoka K, 2013, MICROPALEAEONTOLOGIC, P325; Yamaguchi A, 2011, EUR J PHYCOL, V46, P98, DOI 10.1080/09670262.2011.564517; Kawami H, 2009, PHYCOL RES, V57, P259, DOI 10.1111/j.1440-1835.2009.00545.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Mertens KN, 2012, QUATERNARY SCI REV, V39, P45, DOI 10.1016/j.quascirev.2012.01.026; Mertens KN, 2012, REV PALAEOBOT PALYNO, V184, P74, DOI 10.1016/j.revpalbo.2012.06.012; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Mertens KN, 2014, GEOLOGY, V42, P531, DOI 10.1130/G35456.1; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; Radi T, 2013, MAR MICROPALEONTOL, V98, P41, DOI 10.1016/j.marmicro.2012.11.001; Balech E, 1988, PUBLICACIONES ESPECI, V1, P1; Bergh RS, 1881, MORPH JB, V7, P177; Bolch CJS, 1997, PHYCOLOGIA, V36, P472, DOI 10.2216/i0031-8884-36-6-472.1; Bolch CJS, 2001, PHYCOLOGIA, V40, P162, DOI 10.2216/i0031-8884-40-2-162.1; Butschli O., 1885, HG BRONNS KLASSEN OR, P906; DALE B, 1993, EUR J PHYCOL, V28, P129, DOI 10.1080/09670269300650211; desVernal A., 2013, QUATERNARY SCI REV, V79, P111; Fensome R.A., 1993, SPECIAL PUBLICATION, V7, P1; Gomez Fernando, 2005, Acta Botanica Croatica, V64, P129; Haeckel E., 1894, ENTWURF NATURLICHEN; Head MJ, 2002, J MICROPALAEONTOL, V21, P169; Head MJ, 2004, MAR PETROL GEOL, V21, P277, DOI 10.1016/j.marpetgeo.2003.12.002; Head M.J., 1996, PALYNOLOGY PRINCIPLE, P1197; Kawami Hisae, 2006, Plankton & Benthos Research, V1, P183; Liu TT, 2014, PHYCOL RES, V62, P109, DOI 10.1111/pre.12041; Maddison W. P., 2011, MESQUITE MODULAR SYS; Matsuoka K., 2006, FOSSILS, V80, P33; Matsuoka K., 1987, B FAC LIB ARTS NAGAS, V28, P35; Mertens KN, 2009, BOREAS, V38, P647, DOI 10.1111/j.1502-3885.2009.00095.x; Mertens KN, 2013, J EUKARYOT MICROBIOL, V60, P545, DOI 10.1111/jeu.12058; Pascher A., 1914, Berlin Ber D bot Ges, V32; Pospelova V, 2002, J PHYCOL, V38, P593, DOI 10.1046/j.1529-8817.2002.t01-1-01206.x; Price A., 2013, PALEOCEANOGRAPHY, V28, P1; Rochon A., 1999, CONTRIBUTION SERIES, V35, P152; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Siano R, 2005, EUR J PHYCOL, V40, P221, DOI 10.1080/09670260500128293; WALL D, 1968, Micropaleontology (New York), V14, P265, DOI 10.2307/1484690; Watanabe M. M., 2000, NIES COLLECTION LIST; ZINGONE A, 1988, CRYPTOGAMIE ALGOL, V9, P117; ZONNEVELD KA, 1994, PHYCOLOGIA, V33, P359, DOI 10.2216/i0031-8884-33-5-359.1; Zwickl DJ, 2006, THESIS U TEXAS AUSTI	55	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	APR	2015	63	2					110	124		10.1111/pre.12083		15	Marine & Freshwater Biology	Marine & Freshwater Biology	CG5OA	WOS:000353340200005		
J	Tawong, W; Nishimura, T; Sakanari, H; Sato, S; Yamaguchi, H; Adachi, M				Tawong, Wittaya; Nishimura, Tomohiro; Sakanari, Hiroshi; Sato, Shinya; Yamaguchi, Haruo; Adachi, Masao			Characterization of Gambierdiscus and Coolia (Dinophyceae) isolates from Thailand based on morphology and phylogeny	PHYCOLOGICAL RESEARCH			English	Article						Andaman Sea; benthic dinoflagellate; Gulf of Thailand; large subunit rDNA; scanning electron microscopy observation	SP-NOV DINOPHYCEAE; TOXIC DINOFLAGELLATE; BENTHIC DINOFLAGELLATE; ALEXANDRIUM-TAMARENSE; OSTREOPSIS-SIAMENSIS; SEQUENCE COMPARISONS; MONOTIS DINOPHYCEAE; MAXIMUM-LIKELIHOOD; CANARY-ISLANDS; RDNA SEQUENCES	The benthic dinoflagellates in the genus Gambierdiscus produce toxins that bioaccumulate in tropical and sub-tropical fish causing ciguatera fish poisoning (CFP). Other co-occurring genera such as Coolia have also been implicated in causing CFP. Little is known about the diversity of the two genera Gambierdiscus and Coolia along the Thai coasts. The results of morphological analyses based on observation under light microscopy and scanning electron microcopy showed that strains of Gambierdiscus from Thailand displayed the typical Gambierdiscus plate formula: Po, 4, 0a, 6, 6c,?s, 5, 0p and 2. Morphological examination of Thai Gambierdiscus enabled it to be identified as Gambierdiscuscaribaeus: round and anterior-posteriorly compressed cell shape, broad 2 plate, rectangular 2 plate, and symmetrical 3 plate. The phylogenetic analyses based on the large subunit (LSU) rDNA D8/D10 sequences of Gambierdiscus from Thailand confirmed the morphological identification. The thecal plate formula for all of the Coolia isolates from Thailand was Po, 4, 0a, 6,?c,?s, 5, 0p and 2. Most, but not all, of these isolates could be identified morphologically as Cooliamalayensis. An LSU rDNA D1/D2 phylogenetic analysis confirmed identity of C.malayensis isolates identified morphologically. The remaining unidentified isolates fell in the C.tropicalis clade.	[Tawong, Wittaya; Nishimura, Tomohiro; Sakanari, Hiroshi; Yamaguchi, Haruo; Adachi, Masao] Kochi Univ, Fac Agr, Nankoku, Kochi 783, Japan; [Tawong, Wittaya; Nishimura, Tomohiro] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime, Japan; [Sato, Shinya] Fukui Prefectural Univ, Obama, Fukui, Japan	Adachi, M (reprint author), Kochi Univ, Fac Agr, Nankoku, Kochi 783, Japan.	madachi@kochi-u.ac.jp			Naresuan University, Phisanulok, Thailand	This research was supported by Naresuan University, Phisanulok, Thailand. We thank K. Ohnishi, Kochi University, for allowing us to access his facilities and for his technical help; and K. Yagyu, T. Matsuzaki and M. Yamamoto, Kochi University, for SEM technical assistance. We are grateful to Thidarat Noiraksar, Aunchalee Chankong, Kobsak Kedmuean, Khoriat Koolkaew, Udom Meedach, Niphon Phongsuwan, Jantana Saengkaew, Pinit Inprom and Jitmanee Jitong for help in collecting samples. We thank D. Murphy of Ehime University for editing the English in our manuscript.	ADACHI R, 1979, B JPN SOC SCI FISH, V45, P67; Chinain M, 2010, TOXICON, V56, P674, DOI 10.1016/j.toxicon.2009.05.032; Litaker RW, 2010, TOXICON, V56, P711, DOI 10.1016/j.toxicon.2010.05.017; Rhodes L, 2000, NEW ZEAL J MAR FRESH, V34, P371; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; USAMI M, 1995, J AM CHEM SOC, V117, P5389, DOI 10.1021/ja00124a034; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Nishimura T, 2014, J PHYCOL, V50, P506, DOI 10.1111/jpy.12175; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Parsons ML, 2012, HARMFUL ALGAE, V14, P107, DOI 10.1016/j.hal.2011.10.017; Aligizaki K, 2006, HARMFUL ALGAE, V5, P717, DOI 10.1016/j.hal.2006.02.005; Penna A, 2005, J PHYCOL, V41, P212, DOI 10.1111/j.1529-8817.2005.04011.x; Chinain M, 1999, J PHYCOL, V35, P1282, DOI 10.1046/j.1529-8817.1999.3561282.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BESADA EG, 1982, B MAR SCI, V32, P723; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Dolapsakis NP, 2006, SCI MAR, V70, P67; Fleming L.E., 1998, HARMFUL ALGAE, p24S; Fraga S, 2008, J PHYCOL, V44, P1060, DOI 10.1111/j.1529-8817.2008.00555.x; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Higman WA, 2001, PHYCOLOGIA, V40, P256, DOI 10.2216/i0031-8884-40-3-256.1; Holmes MJ, 1998, J PHYCOL, V34, P661, DOI 10.1046/j.1529-8817.1998.340661.x; Jeong HJ, 2012, J EUKARYOT MICROBIOL, V59, P114, DOI 10.1111/j.1550-7408.2012.00610.x; Laza-Martinez A, 2011, EUR J PHYCOL, V46, P45, DOI 10.1080/09670262.2010.550387; Leaw CP, 2010, J PHYCOL, V46, P162, DOI 10.1111/j.1529-8817.2009.00778.x; Medlin LK, 1998, EUR J PROTISTOL, V34, P329; Meunier A, 1919, MEMOIRES MUSEE ROYAL, V8, P1; Mohammad-Noor N, 2013, J PHYCOL, V49, P536, DOI 10.1111/jpy.12062; Momigliano P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079278; Murray S., 2010, ALGAE AUSTR PHYTOPLA, P213; Nishimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060882; Nylander JAA, 2004, MRMODELTEST V2 PROGR; Piumsomboon A., 2001, BENTHIC MICROALGAE M, P1; Rasband WS., 1997, IMAGE J; Richlen ML, 2008, HARMFUL ALGAE, V7, P614, DOI 10.1016/j.hal.2007.12.020; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; Ten-Hage L, 2000, PHYCOLOGIA, V39, P377, DOI 10.2216/i0031-8884-39-5-377.1; Tindall Donald R., 1998, NATO ASI Series Series G Ecological Sciences, V41, P293	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	APR	2015	63	2					125	133		10.1111/pre.12074		9	Marine & Freshwater Biology	Marine & Freshwater Biology	CG5OA	WOS:000353340200006		
J	Liu, TT; Mertens, KN; Ribeiro, S; Ellegaard, M; Matsuoka, K; Gu, HF				Liu, Tingting; Mertens, Kenneth Neil; Ribeiro, Sofia; Ellegaard, Marianne; Matsuoka, Kazumi; Gu, Haifeng			Cyst-theca relationships and phylogenetic positions of Peridiniales (Dinophyceae) with two anterior intercalary plates, with description of Archaeperidinium bailongense sp nov and Protoperidinium fuzhouense sp nov.	PHYCOLOGICAL RESEARCH			English	Article						Archaeperidinium constrictum; Archaeperidinium minutum; cyst-theca relationship; dinoflagellate cysts; LSU rDNA; Protoperidinium abei; Protoperidinium avellana; Protoperidinium excentricum; Protoperidinium stellatum	RIBOSOMAL-RNA GENE; WALLED DINOFLAGELLATE CYSTS; MOTILE STAGE RELATIONSHIPS; HETEROTROPHIC DINOFLAGELLATE; MOLECULAR PHYLOGENY; MIXED MODELS; QUATERNARY; RDNA; JORGENSEN; SEQUENCES	Protoperidinium species with two anterior intercalary plates were originally classified by Jorgensen in the subgenus Archaeperidinium and assigned to the sections Excentrica, Avellana and Archaeperidinium by Taylor, on the basis of the relative size of anterior intercalary plates and the extent of cingulum displacement. Phylogenetic relationships among these three sections have not been fully explored. Recently, Archaeperidinium was reinstated as a genus, but several species fitting the emended description have not been transferred formally as molecular data were not available. In the present study we examined the cyst-theca relationship of seven species with two anterior intercalary plates: four species assigned to Protoperidinium and three to Archaeperidinium, from the China Sea. Partial large subunit ribosomal DNA sequences were obtained from these seven species by single-cell polymerase chain reaction, and for the cyst of Protoperidinium stellatum from France. Two new species, Archaeperidinium bailongense and Protoperidinium fuzhouense, were described based on both theca and cyst morphology, and the cyst-theca relationships of A.constrictum and P.abei var. rotunda were established for the first time. Maximum-likelihood and Bayesian inference analyses revealed that P.fuzhouense was nested within the Protoperidinium sensu stricto clade despite having only six postcingular plates, and sections Excentrica, Avellana and the genus Archaeperidinium were all monophyletic. Our results suggest that the presence/absence of a sulcal fin and antapical horns and the displacement of the cingulum are the most stable characteristics of the motile stages within the respective clades.	[Liu, Tingting; Gu, Haifeng] SOA, Inst Oceanog 3, Xiamen, Peoples R China; [Mertens, Kenneth Neil] Univ Ghent, Res Unit Palaeontol, B-9000 Ghent, Belgium; [Ribeiro, Sofia] Geol Survey Denmark & Greenland, Dept Marine Geol & Glaciol, Copenhagen, Denmark; [Ellegaard, Marianne] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Matsuoka, Kazumi] Nagasaki Univ, Nagasaki 852, Japan	Gu, HF (reprint author), SOA, Inst Oceanog 3, Xiamen, Peoples R China.	guhaifeng@tio.org.cn	Mertens, Kenneth/C-3386-2015; 	Mertens, Kenneth/0000-0003-2005-9483; Ribeiro, Sofia/0000-0003-0672-9161	National Science Foundation of China [41376170]	We thank the editor (Mitsunori Iwataki) and Karin Zonneveld for constructive suggestions that improved the manuscript. This project was supported by National Science Foundation of China (41376170). K.N.M. is a postdoctoral fellow of FWO Belgium. K.N.M. would like to thank J. P. Debenay for sampling Estuaire de la Vie.	Abe T., 1927, PERIDINIALES SCI REP, V4, P383; Abe T., 1981, PUB SETO MAR BIOL LA, V6, P1; Abe T., 1936, ARCHAEPERIDINIUM SCI, V10, P639; Zonneveld KAF, 1997, REV PALAEOBOT PALYNO, V97, P319, DOI 10.1016/S0034-6667(97)00002-X; Sarai C, 2013, REV PALAEOBOT PALYNO, V192, P103, DOI 10.1016/j.revpalbo.2012.12.007; Ribeiro S, 2010, PHYCOLOGIA, V49, P48, DOI 10.2216/09-11.1; Head MJ, 2001, J QUATERNARY SCI, V16, P621, DOI 10.1002/jqs.657; FRITZ L, 1985, J PHYCOL, V21, P662; Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Gomez F., 2012, CICIMAR Oceanides, V27, P65; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Mertens KN, 2012, MAR MICROPALEONTOL, V96-97, P48, DOI 10.1016/j.marmicro.2012.08.002; Matsuoka K, 2006, PHYCOLOGIA, V45, P632, DOI 10.2216/05-42.1; Matsuoka K, 2013, MICROPALEAEONTOLOGIC, P325; Yamaguchi A, 2011, EUR J PHYCOL, V46, P98, DOI 10.1080/09670262.2011.564517; Gribble KE, 2006, J PHYCOL, V42, P1081, DOI 10.1111/j.1529-8817.2006.00267.x; Yamaguchi A, 2007, PHYCOLOGIA, V46, P270, DOI 10.2216/06-82.1; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229; Radi T, 2013, MAR MICROPALEONTOL, V98, P41, DOI 10.1016/j.marmicro.2012.11.001; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; HARLAND R, 1982, PALAEONTOLOGY, V25, P369; BALECH E., 1980, ANALES CTR CIENCIAS, V7, P57; Balech E., 1978, Neotropica (La Plata), V24, P3; Balech E., 1974, Revista Mus argent Cienc nat Bernardino Rivadavia Inst nac Invest Cienc nac (Hydrobiol), V4, P1; BALECH E., 1964, BOL INST BIOL MAR MAR DEL PLATA, V4, P1; Boc Alix, 2012, Nucleic Acids Res, V40, pW573, DOI 10.1093/nar/gks485; Bolch CJS, 1997, PHYCOLOGIA, V36, P472, DOI 10.2216/i0031-8884-36-6-472.1; Debenay JP, 2003, ESTUAR COAST SHELF S, V58, P843, DOI 10.1016/S0272-7714(03)00189-6; DODGE JD, 1983, J PLANKTON RES, V5, P119, DOI 10.1093/plankt/5.2.119; Fensome R. A., 1998, Taxon, V47, P727, DOI 10.2307/1223594; Fensome R.A., 1993, SPECIAL PUBLICATION, V7, P1; Gribble KE, 2009, J EUKARYOT MICROBIOL, V56, P88, DOI 10.1111/j.1550-7408.2008.00378.x; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hoppenrath M, 2009, MARINE PHYTOPLANKTON; JOrgensen E, 1912, SVENSKA HYDROGRAFISK, V4, P1; Larsen N. H., 1994, SCANDINAVIAN CULTURE; Lebour M.V., 1925, DINOFLAGELLATES NO S; Lewis J., 1984, Journal of Micropalaeontology, V3, P25; Liu TT, 2014, PHYCOL RES, V62, P109, DOI 10.1111/pre.12041; Matsuoka K., 2013, BIOL GEOLOGICAL PERS, P267; Matsuoka K., 1984, B FAC LIB ARTS NAGAS, V25, P37; Mertens KN, 2013, J EUKARYOT MICROBIOL, V60, P545, DOI 10.1111/jeu.12058; Meunier A, 1919, MEMOIRES MUSEE ROYAL, V8, P1; PAULSEN OVE, 1949, K DANSKE VIDENSKAB SELSKAB BIOL SKRIFT, V6, P1; Paulsen O., 1907, SERIE PLANKTON, V1, P1; Reid P., 1977, NOVA HEDWIGIA, V29, P429; Rochon Andre, 1999, AASP Contributions Series, V35, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Steidinger Karen A., 1996, P387, DOI 10.1016/B978-012693015-3/50006-1; Taylor F. J. R, 1976, BIBLIOTHECA BOT, V132, P1; WALL D, 1968, Micropaleontology (New York), V14, P265, DOI 10.2307/1484690; Wall D., 1967, PALAEONTOLOGY, V10, P95; ZONNEVELD KA, 1994, PHYCOLOGIA, V33, P359, DOI 10.2216/i0031-8884-33-5-359.1	56	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	APR	2015	63	2					134	151		10.1111/pre.12081		18	Marine & Freshwater Biology	Marine & Freshwater Biology	CG5OA	WOS:000353340200007		
J	Kawai, H; Hanyuda, T; Mumford, T; Waaland, JR				Kawai, Hiroshi; Hanyuda, Takeaki; Mumford, Thomas; Waaland, J. Robert			An introduced population of Chorda asiatica (Chordaceae, Laminariales) in Puget Sound, Pacific coast of North America	PHYCOLOGICAL RESEARCH			English	Article						Hood Canal; introduction; non-indigenous species	MOLECULAR PHYLOGENY; PHAEOPHYCEAE; FILUM; HALOSIPHONACEAE; MODEL; SEA	Northeastern Pacific Ocean and northwestern Atlantic Ocean populations of Chorda species, which have not been examined in previous phylogenetic studies, were investigated. All specimens that were collected in Hood Canal, Puget Sound, WA, USA, Pacific coast of North America, showed identical ITS-5.8S rDNA sequences, and they were included in the clade of Japanese Chorda asiatica. With morphological data added to the molecular data, they were identified as C.asiatica and were concluded to be non-indigenous populations, most likely introduced with oyster spat together with Sargassum muticum. Specimens collected in New York, NY, USA, Atlantic coast of North America, were genetically closest to C.filum from Newfoundland and were identified as C.filum. The genetic divergence of the North Atlantic populations of C.filum was relatively small compared to that of Japanese C.asiatica considering their broader distributional ranges on both sides of the Atlantic.	[Kawai, Hiroshi; Hanyuda, Takeaki] Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 657, Japan; [Mumford, Thomas] Marine Agron LLC, Olympia, WA USA; [Waaland, J. Robert] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Kawai, H (reprint author), Kobe Univ, Res Ctr Inland Seas, Kobe, Hyogo 657, Japan.	kawai@kobe-u.ac.jp			JSPS [25291087]	We are grateful to Helen Berry (Washington State Department of Natural Resources) for her help in collecting the Puget Sound specimens, and Eric C. Henry for his help in collecting the New York specimens, Akira F. Peters for valuable comments and providing sequence data of Mediterranean Chorda species. A part of this work was supported by the JSPS Grants-in-Aid for Scientific Research (No. 25291087) to H. K.	Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Bonnot P., 1935, Nautilus Philadelphia, V49, P1; Cohen A., 1998, PUGET SOUND EXPEDITI; Cohen A. N., 2001, WASHINGTON STATE EXO; Kawai H, 2000, PHYCOLOGIA, V39, P416, DOI 10.2216/i0031-8884-39-5-416.1; Kawai H, 2001, J PHYCOL, V37, P130, DOI 10.1046/j.1529-8817.1999.014012130.x; Lis J T, 1980, Methods Enzymol, V65, P347; Peters AF, 1998, EUR J PHYCOL, V33, P65, DOI 10.1080/09670269810001736543; Rambaut A., 2013, TRACER V 1 6; RIOUALL R, 1985, BOT MAR, V28, P83; RUSSELL G, 1985, J MAR BIOL ASSOC UK, V65, P343; Sasaki H, 2001, PHYCOLOGIA, V40, P123, DOI 10.2216/i0031-8884-40-2-123.1; Sasaki H, 2007, PHYCOLOGIA, V46, P10, DOI 10.2216/06-06.1; SOUTH G. R., 1967, BRIT PHYCOL BULL, V3, P379; Steele E. N., 1964, IMMIGRANT OYSTER OST, P178; Yotsukura Norishige, 1999, Phycological Research, V47, P71, DOI 10.1111/j.1440-1835.1999.tb00286.x	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-0829	1440-1835		PHYCOL RES	Phycol. Res.	APR	2015	63	2					154	158		10.1111/pre.12089		5	Marine & Freshwater Biology	Marine & Freshwater Biology	CG5OA	WOS:000353340200009		
J	Mori, M; Shimotsuma, Y; Sei, T; Sakakura, M; Miura, K; Udono, H				Mori, Masahiro; Shimotsuma, Yasuhiko; Sei, Tomoaki; Sakakura, Masaaki; Miura, Kiyotaka; Udono, Haruhiko			Tailoring thermoelectric properties of nanostructured crystal silicon fabricated by infrared femtosecond laser direct writing	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						indirect band gap; infrared femtosecond laser; nanostructures; self-assembly; silicon; strain; thermoelectric effects	TRANSPARENT MATERIALS; PULSES; GLASS; SUPERLATTICES; NANOWIRES	The periodic nanostructuring of inner part of semiconductors can be successfully accomplished by the infrared ultrashort pulse laser with a double pulse configuration. Self-organized nanostructures inside semiconductor could be induced empirically only if it is indirect band gap semiconductor. The strained silicon regions with a width of about 100nm are self-aligned parallel to the polarization direction of the first arriving pulses, despite of the polarization direction of the secondly arriving pulses. AFM inspections reveal that such strained silicon nanostructures exhibit high electric conductivity and low thermal conductivity. The formation mechanisms would be interpreted in terms of the electrostrictive force through the interaction between electron-hole plasma and phonon. Apart from the basic understanding, such nanostructured silicon will open the door to the fabrication of the self-contained thermoelectric devices.	[Mori, Masahiro; Shimotsuma, Yasuhiko; Sei, Tomoaki; Sakakura, Masaaki; Miura, Kiyotaka] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Kyoto 6158510, Japan; [Udono, Haruhiko] Ibaraki Univ, Coll Engn, Hitachi, Ibaraki 3168511, Japan	Shimotsuma, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Kyoto 6158510, Japan.	yshimo@func.mc.kyoto-u.ac.jp			KAKENHI [26630129]	This work was partially supported by KAKENHI 26630129. The authors would like to thank S. Kakinuma and I. Hamagami of Horiba Ltd. for analyses of the infrared Raman mapping. We would also like to thank M. Iwasa of Hitachi High-Tech Science Corp. for AFM measurements.	SIPE JE, 1983, PHYS REV B, V27, P1141, DOI 10.1103/PhysRevB.27.1141; Chen G, 1998, PHYS REV B, V57, P14958, DOI 10.1103/PhysRevB.57.14958; Priolo F, 2014, NAT NANOTECHNOL, V9, P19, DOI [10.1038/nnano.2013.271, 10.1038/NNANO.2014.271]; Pronko PP, 1998, PHYS REV B, V58, P2387, DOI 10.1103/PhysRevB.58.2387; HICKS LD, 1993, PHYS REV B, V47, P16631, DOI 10.1103/PhysRevB.47.16631; DeWolf I, 1996, SEMICOND SCI TECH, V11, P139, DOI 10.1088/0268-1242/11/2/001; BIRNBAUM M, 1965, J APPL PHYS, V36, P3688, DOI 10.1063/1.1703071; Mouskeftaras A, 2013, APPL PHYS A-MATER, V110, P709, DOI 10.1007/s00339-012-7217-7; Sundaram SK, 2002, NAT MATER, V1, P217, DOI 10.1038/nmat767; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Barbagiovanni EG, 2012, J APPL PHYS, V111, DOI 10.1063/1.3680884; Kazansky PG, 1999, PHYS REV LETT, V82, P2199, DOI 10.1103/PhysRevLett.82.2199; Boukai AI, 2008, NATURE, V451, P168, DOI 10.1038/nature06458; Bonse J, 2012, J LASER APPL, V24, DOI 10.2351/1.4712658; Li XB, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245318; Shimotsuma Y, 2010, ADV MATER, V22, P4039, DOI 10.1002/adma.201000921; Shimotsuma Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247405; Beard MC, 2007, NANO LETT, V7, P2506, DOI 10.1021/nl071486l; Hase M, 2003, NATURE, V426, P51, DOI 10.1038/nature02044; DISMUKES JP, 1964, J APPL PHYS, V35, P2899, DOI 10.1063/1.1713126; Roberts MM, 2006, NAT MATER, V5, P388, DOI 10.1038/nmat1606; Her TH, 1998, APPL PHYS LETT, V73, P1673, DOI 10.1063/1.122241; Buividas R, 2013, OPT MATER EXPRESS, V3, P1674, DOI 10.1364/OME.3.001674; CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Bhardwaj VR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.057404; Boyd RW, 2008, NONLINEAR OPTICS, 3RD EDITION, P1; Chrastina D, 2013, THIN SOLID FILMS, V543, P153, DOI 10.1016/j.tsf.2013.01.002; Gibbs HM, 2011, NAT PHOTONICS, V5, P275, DOI [10.1038/nphoton.2011.15, 10.1038/NPHOTON.2011.15]; Hashida M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803940; Ishikawa Y, 2012, PROC SPIE, V8243, DOI 10.1117/12.908190; Kononenko VV, 2012, OPT LETT, V37, P3369, DOI 10.1364/OL.37.003369; Kumagai M, 2007, IEEE T SEMICONDUCT M, V20, P259, DOI 10.1109/TSM.2007.901849; Lancry M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245103; Okada T, 2009, J APPL PHYS, V106, DOI 10.1063/1.3211311; Richter S, 2013, OPT MATER EXPRESS, V3, P1161, DOI 10.1364/OME.3.001161; Shi XS, 2013, OPT LETT, V38, P3743, DOI 10.1364/OL.38.003743; Shimotsuma Y, 2006, J NON-CRYST SOLIDS, V352, P646, DOI [10.1016/j.jnoncrysol.2005.11.060, 10.1016/j.noncrysol.2005.11.060]; Shimotsuma Y, 2005, MOD PHYS LETT B, V19, P225, DOI 10.1142/S0217984905008281; Sugioka K, 2011, OPT LETT, V36, P2734, DOI 10.1364/OL.36.002734; Suzuki T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085207; Verburg PC, 2014, OPT EXPRESS, V22, P21958, DOI 10.1364/OE.22.021958; Wortmann D, 2007, OPT EXPRESS, V15, P10149, DOI 10.1364/OE.15.010149	43	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	APR	2015	212	4					715	721		10.1002/pssa.201431777		7	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CF8NZ	WOS:000352820100001		
J	Welna, M; Kudrawiec, R; Misiewicz, J; Yano, M; Koike, K; Sasa, S				Welna, M.; Kudrawiec, R.; Misiewicz, J.; Yano, M.; Koike, K.; Sasa, S.			Contactless electroreflectance spectroscopy of ZnO/ZnMgO quantum wells: Optical transitions and Fabry-Perot features	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						contactless electroreflectance; Fabry-Perot oscillations; quantum wells; ZnO		Contactless electroreflectance (CER) spectroscopy was applied to study optical transitions in ZnO/ZnMgO quantum wells (QWs) of various widths and barrier contents (Mg=10, 20, and 30%) grown on sapphire substrates with a Zn0.9Mg0.1O or ZnO buffer layer. Spectral features related to absorption in ZnO QW region and ZnMgO barrier were clearly observed in CER spectra. The spectral position of these features correlates very well with photoluminescence peaks related to emission from ZnO QW and ZnMgO barrier. Besides CER resonances, which are associated with optical transitions, some spectral features related to the Fabry-Perot (F-P) interference effect were clearly observed for these samples. They appear for these structures due to a strong contrast of refractive index between the sapphire and Zn(Mg)O layers and they are observed in the region of transparency for Zn(Mg)O epilayers. For some samples the F-P related signal is quite strong and interferes with CER resonances related to QW transitions. However the two contributions (i.e., CER signal related to optical transitions and the Fabry-Perot effect) can be recognized when the proper analysis of CER spectra is performed. This analysis is presented and discussed in this paper.	[Welna, M.; Kudrawiec, R.; Misiewicz, J.] Wroclaw Univ Technol, Inst Phys, PL-50370 Wroclaw, Poland; [Yano, M.; Koike, K.; Sasa, S.] Osaka Inst Technol, Nanomat Microdevices Res Ctr, Asahi Ku, Omiya, Osaka 5358585, Japan	Welna, M (reprint author), Wroclaw Univ Technol, Inst Phys, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.	monika.welna@pwr.edu.pl; robert.kudrawiec@pwr.edu.pl			MNiSzW [N N505 485540]	This work was supported within the grant no. N N505 485540 from the MNiSzW.	Chauveau JM, 2008, SEMICOND SCI TECH, V23, DOI 10.1088/0268-1242/23/3/035005; Hang DR, 2001, J APPL PHYS, V90, P1887, DOI 10.1063/1.1383259; Laumer B, 2012, J APPL PHYS, V111, DOI 10.1063/1.4723642; Munoz M, 2003, APPL PHYS LETT, V83, P1995, DOI 10.1063/1.1606875; Beaur L, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3565969; Hall CR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3428430; Kudrawiec R, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2840161; Kudrawiec R, 2010, PHYS STATUS SOLIDI B, V247, P1616, DOI 10.1002/pssb.200983688; Kudrawiec R, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533417; Kudrawiec R, 2006, J APPL PHYS, V100, DOI 10.1063/1.2206707; Kudrawiec R, 2009, J APPL PHYS, V106, DOI 10.1063/1.3266011; Kudrawiec R, 2008, J APPL PHYS, V104, DOI 10.1063/1.3009956; Li SM, 2010, J APPL PHYS, V107, DOI 10.1063/1.3284959	13	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	APR	2015	212	4					780	784		10.1002/pssa.201431564		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CF8NZ	WOS:000352820100011		
J	Zhang, H; Nakada, K; Miyajima, S; Konagai, M				Zhang, He; Nakada, Kazuyoshi; Miyajima, Shinsuke; Konagai, Makoto			High-performance a-Si1-xOx:H/c-Si heterojunction solar cells realized by the a-Si:H/a-Si1-xOx:H stack buffer layer	Physica Status Solidi-Rapid Research Letters			English	Article						solar cells; amorphous materials; silicon oxide; microcrystalline materials; buffer layers; surface passivation	SILICON-WAFER; EFFICIENCY; OPTIMIZATION	We used amorphous silicon oxide (a-Si1-xOx:H) and microcrystalline silicon oxide (mu c-Si1-xOx:H) as buffer layer and p-type emitter layer, respectively, in n-type silicon heterojunction (SHJ) solar cells. We proposed to insert a thin (2 nm) intrinsic amorphous silicon (a-Si: H) thin film between the thin (2.5 nm) a-Si1-xOx:H buffer layer and the p-layer to form a stack buffer layer of a-Si:H/a-Si1-xOx:H: H. As a result, a high open-circuit voltage (V-OC) and a high fill factor (FF) were obtained at the same time. Finally, a high efficiency of 19.0% (J(SC) = 33.46 mA/cm(2), V-OC = 738 mV, FF = 77.0%) was achieved on a 100 mu m thick polished wafer using the stack buffer layer. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Zhang, He; Konagai, Makoto] Japan Sci & Technol, MEXT FUTURE PV Innovat Res, Koriyama, Fukushima 9630215, Japan; [Nakada, Kazuyoshi; Miyajima, Shinsuke; Konagai, Makoto] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan	Zhang, H (reprint author), Japan Sci & Technol, MEXT FUTURE PV Innovat Res, 2-2-9 Machiike Dai, Koriyama, Fukushima 9630215, Japan.	he.zhang@pb.jst.jp		Nakada, Kazuyoshi/0000-0002-2219-6345	MEXT, FUTURE-PV Innovation (Fukushima Top-level United Center for Renewable Energy Research - Photovoltaics Innovation) Project	This work was supported by the MEXT, FUTURE-PV Innovation (Fukushima Top-level United Center for Renewable Energy Research - Photovoltaics Innovation) Project.	Taguchi M, 2000, PROG PHOTOVOLTAICS, V8, P503, DOI 10.1002/1099-159X(200009/10)8:5<503::AID-PIP347>3.0.CO;2-G; Holman ZC, 2012, IEEE J PHOTOVOLT, V2, P7, DOI 10.1109/JPHOTOV.2011.2174967; Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Jellison GE, 1996, APPL PHYS LETT, V69, P371, DOI 10.1063/1.118064; Taguchi M, 2008, JPN J APPL PHYS, V47, P814, DOI 10.1143/JJAP.47.814; Fujiwara H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2790815; Mueller T, 2012, ENRGY PROCED, V15, P97, DOI 10.1016/j.egypro.2012.02.012; Descoeudres A, 2013, IEEE J PHOTOVOLT, V3, P83, DOI 10.1109/JPHOTOV.2012.2209407; Ding KN, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798603; Sinton RA, 1996, APPL PHYS LETT, V69, P2510, DOI 10.1063/1.117723; Seif JP, 2014, J APPL PHYS, V115, DOI 10.1063/1.4861404; Taguchi M, 2014, IEEE J PHOTOVOLT, V4, P96, DOI 10.1109/JPHOTOV.2013.2282737; Nakamura J, 2014, IEEE J PHOTOVOLT, V4, P1491, DOI 10.1109/JPHOTOV.2014.2358377; Descoeudres A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3511737; Fujiwara H, 2009, SOL ENERG MAT SOL C, V93, P725, DOI 10.1016/j.solmat.2008.09.007; Demaurex B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4764529; Batzner DL, 2011, ENRGY PROCED, V8, P153, DOI 10.1016/j.egypro.2011.06.117; Choi J., 2011, P 26 EUR PHOT SOL EN, P3302; De Wolf Stefaan, 2012, Green, V2, DOI 10.1515/green-2011-0018; De Wolf S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2956668; Geissbuhler J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811253; Hermandez J. L., 2013, P 28 EUR PHOT SOL EN, P741; Liebhaber M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906195; MIMURA H, 1992, J APPL PHYS, V71, P2315, DOI 10.1063/1.351104; Mueller T., 2007, P 22 EUR PHOT SOL EN, P1552; Nakada K., 2012, P 27 EUR PHOT SOL EN, P1616; Pysch D., 2007, SOL ENERG MAT SOL C, V91, P1689; Schulze TF, 2010, J APPL PHYS, V107, DOI 10.1063/1.3267316; Sinton R.A., 2000, P 16 EUR PHOT SOL EN, P1152; Sritharathikhun J, 2008, JPN J APPL PHYS, V47, P8452, DOI 10.1143/JJAP.47.8452; Stegemann B, 2014, ENRGY PROCED, V55, P219, DOI 10.1016/j.egypro.2014.08.027; TANAKA M, 1992, JPN J APPL PHYS 1, V31, P3518, DOI 10.1143/JJAP.31.3518	32	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6254	1862-6270		PHYS STATUS SOLIDI-R	Phys. Status Solidi-Rapid Res. Lett.	APR	2015	9	4					225	229		10.1002/pssr.201409546		5	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CG6KQ	WOS:000353409700003		
J	Park, CB; Lee, CH				Park, Chang Bum; Lee, Choong Hyun			Investigation of light programmable non-volatile memory in an organic phototransistor	Physica Status Solidi-Rapid Research Letters			English	Article						non-volatile memories; organic electronics; charge trapping; photosensitivity; phototransistors	THIN-FILM TRANSISTORS; FIELD-EFFECT TRANSISTORS; DIELECTRICS	Excellent non-volatile memory characteristics have been demonstrated under the optoelectric conditions for organic phototransistors (OPTs). The high photosensitivity shown as reversible shifts in light-induced VTH exhibits a large memory window for programming caused by the excited immobile carriers (electron) trapped as a function of the electrical bias and the light intensity. The long life span of stored electrons also reveals promising behavior with respect to data retention as well as the electrical reliability to serve as a data storage medium with the non-volatile memory characteristic in OPTs. The VTH recovery accelerated by the reversible bias stress for the stored charges under irradiation shows that the erasing behavior is clearly brought by the discharge process of long-lived electrons occupied in deep states. Plausible mechanisms in the energy band are discussed for the programming and erasing process, which provides a fundamental understanding of the intrinsic charge storage behavior in OPTs. (C) 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Park, Chang Bum] LG Display R&D Ctr, Paju Si 413811, Gyeonggi Do, South Korea; [Park, Chang Bum; Lee, Choong Hyun] Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Lee, Choong Hyun] IBM Res, Albany, NY 12203 USA	Park, CB (reprint author), LG Display R&D Ctr, 1007 Deogeun Ri, Paju Si 413811, Gyeonggi Do, South Korea.	acen01.park@gmail.com					Noh YY, 2006, J APPL PHYS, V100, DOI 10.1063/1.2364449; Lucas B, 2012, POLYM INT, V61, P374, DOI 10.1002/pi.3213; Baeg KJ, 2006, ADV MATER, V18, P3179, DOI 10.1002/adma.200601434; Zan HW, 2009, IEEE ELECTR DEVICE L, V30, P721, DOI 10.1109/LED.2009.2021867; Mukherjee B, 2012, J MATER CHEM, V22, P3192, DOI 10.1039/c2jm14179e; Sessler GM, 2001, J ELECTROSTAT, V51, P137, DOI 10.1016/S0304-3886(01)00091-2; SATO N, 1987, CHEM PHYS, V115, P269, DOI 10.1016/0301-0104(87)80041-1; Hamilton MC, 2004, IEEE T ELECTRON DEV, V51, P877, DOI 10.1109/TED.2004.829619; Hormann U, 2011, PHYS STATUS SOLIDI-R, V5, P241, DOI 10.1002/pssr.201105238; Zan HW, 2010, IEEE ELECTR DEVICE L, V31, P135, DOI 10.1109/LED.2009.2037591; Knipp D, 2003, J APPL PHYS, V93, P347, DOI 10.1063/1.1525068; Salleo A, 2003, J APPL PHYS, V94, P471, DOI 10.1063/1.1581352; Capek V., 1994, ORGANIC MOL CRYSTALS; Gu G, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146059; Gu G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2841918; Park CB, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3680248; Park CB, 2012, IEEE ELECTR DEVICE L, V33, P1765, DOI 10.1109/LED.2012.2217472; Podzorov V, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.016602; Ren XC, 2013, PROC SPIE, V8831, DOI 10.1117/12.2022984; Zan HW, 2008, ELECTROCHEM SOLID ST, V11, pH222, DOI 10.1149/1.2936224	20	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6254	1862-6270		PHYS STATUS SOLIDI-R	Phys. Status Solidi-Rapid Res. Lett.	APR	2015	9	4					269	274		10.1002/pssr.201409563		6	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	CG6KQ	WOS:000353409700012		
J	Karkonen, A; Kuchitsu, K				Karkonen, Anna; Kuchitsu, Kazuyuki			Reactive oxygen species in cell wall metabolism and development in plants	PHYTOCHEMISTRY			English	Article						Amine oxidase; Apoplast; Class III peroxidase; Cell wall; Development; Hydrogen peroxide; Hydroxyl radical; NADPH oxidase; Oxalate oxidase; Quinone reductase; Rboh (respiratory burst oxidase homologue); Reactive oxygen species; Superoxide anion radical	APOPLASTIC OXIDATIVE BURST; CULTURED RICE CELLS; TOBACCO BY-2 CELLS; N-ACETYLCHITOOLIGOSACCHARIDE ELICITOR; POSITIVE FEEDBACK-REGULATION; ROS-PRODUCING ACTIVITY; PROTEIN-KINASE CIPK26; NADPH OXIDASE ATRBOHF; POLLEN-TUBE GROWTH; HYDROGEN-PEROXIDE	Although reactive oxygen species (ROS) are highly toxic substances that are produced during aerobic respiration and photosynthesis, many studies have demonstrated that ROS, such as superoxide anion radical (O-2(center dot-)) and hydrogen peroxide (H2O2), are produced in the plant cell wall in a highly regulated manner. These molecules are important signalling messengers playing key roles in controlling a broad range of physiological processes, such as cellular growth and development, as well as adaptation to environmental changes. Given the toxicity of ROS, especially of hydroxyl radical ((OH)-O-center dot), the enzymatic ROS production needs to be tightly regulated both spatially and temporally. Respiratory burst oxidase homologues (Rboh) have been identified as ROS-producing NADPH oxidases, which act as key signalling nodes integrating multiple signal transduction pathways in plants. Also other enzyme systems, such as class III peroxidases, amine oxidases, quinone reductases and oxalate oxidases contribute to apoplastic ROS production, some especially in certain plant taxa. Here we discuss the interrelationship among different enzymes producing ROS in the plant cell wall, as well as the physiological roles of the ROS produced. (C) 2014 Elsevier Ltd. All rights reserved.	[Karkonen, Anna] Univ Helsinki, Dept Agr Sci, FIN-00014 Helsinki, Finland; [Kuchitsu, Kazuyuki] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan	Kuchitsu, K (reprint author), Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan.	kuchitsu@rs.noda.tus.ac.jp			Academy of Finland [251390, 256174]; MEXT Japan [21117516, 23117718, 25114515]	This work was supported by Academy of Finland (grants 251390 and 256174 to A.K.) and Grant-in-Aid for Scientific Research in Priority Areas (grants 21117516, 23117718 and 25114515) to K.K. from MEXT Japan. We thank Teresa Laitinen for useful comments.	Angelini R, 2008, PLANT PHYSIOL, V146, P162, DOI 10.1104/pp.107.108902; ANGELINI R, 1989, J PLANT PHYSIOL, V135, P212; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Liszkay A, 2003, PLANTA, V217, P658, DOI 10.1007/s00425-003-1028-1; Fry SC, 1998, BIOCHEM J, V332, P507; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Schopfer P, 2008, PLANT PHYSIOL, V147, P864, DOI 10.1104/pp.108.118745; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Lehtonen MT, 2012, MOL PLANT MICROBE IN, V25, P363, DOI 10.1094/MPMI-10-11-0265; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Zhao Q, 2013, PLANT CELL, V25, P3976, DOI 10.1105/tpc.113.117770; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; Kaya H, 2014, PLANT CELL, V26, P1069, DOI 10.1105/tpc.113.120642; Green MA, 2005, NATURE, V433, P83, DOI 10.1038/nature03172; Berna A, 1999, PLANT MOL BIOL, V39, P539, DOI 10.1023/A:1006123432157; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Barcelo AR, 1998, PLANTA, V207, P207; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Swanson S, 2010, PHYSIOL PLANTARUM, V138, P384, DOI 10.1111/j.1399-3054.2009.01313.x; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; MADER M, 1980, PLANTA, V147, P467, DOI 10.1007/BF00380189; Kimura S, 2013, J BIOCHEM, V153, P191, DOI 10.1093/jb/mvs132; Wrzaczek M, 2013, CURR OPIN PLANT BIOL, V16, P575, DOI 10.1016/j.pbi.2013.07.002; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; O'Brien JA, 2012, PLANT PHYSIOL, V158, P2013, DOI 10.1104/pp.111.190140; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Wu JY, 2010, PLANT J, V63, P1042, DOI 10.1111/j.1365-313X.2010.04301.x; Angelini R, 2010, PLANT PHYSIOL BIOCH, V48, P560, DOI 10.1016/j.plaphy.2010.02.001; Fincato P, 2011, J EXP BOT, V62, P1155, DOI 10.1093/jxb/erq341; Rodriguez AA, 2009, J EXP BOT, V60, P4249, DOI 10.1093/jxb/erp256; Yoda H, 2006, PLANT PHYSIOL, V142, P193, DOI 10.1104/pp.106.080515; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Moller SG, 1998, PLANT J, V13, P781, DOI 10.1046/j.1365-313X.1998.00080.x; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Monshausen GB, 2009, PLANT CELL, V21, P2341, DOI 10.1105/tpc.109.068395; Pesquet E, 2013, PLANT CELL, V25, P1314, DOI 10.1105/tpc.113.110593; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Sirichandra C, 2009, FEBS LETT, V583, P2982, DOI 10.1016/j.febslet.2009.08.033; Yaeno T, 2004, PLANT J, V40, P931, DOI 10.1111/j.1365-313X.2004.02260.x; Lane BG, 2000, BIOCHEM J, V349, P309, DOI 10.1042/0264-6021:3490309; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Moschou PN, 2008, PLANT CELL, V20, P1708, DOI 10.1105/tpc.108.059733; Tisi A, 2011, PLANT PHYSIOL, V157, P200, DOI 10.1104/pp.111.173153; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Davidson RM, 2009, PLANT SCI, V177, P499, DOI 10.1016/j.plantsci.2009.08.012; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Wakabayashi K, 2011, J PLANT PHYSIOL, V168, P1997, DOI 10.1016/j.jplph.2011.05.010; Kurusu T, 2013, TRENDS PLANT SCI, V18, P227, DOI 10.1016/j.tplants.2012.12.002; Roach T, 2010, PLANT CELL ENVIRON, V33, P59, DOI 10.1111/j.1365-3040.2009.02053.x; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Karlsson M, 2005, J EXP BOT, V56, P2085, DOI 10.1093/jxb/eri207; Moschou PN, 2008, PLANT PHYSIOL, V147, P1845, DOI 10.1104/pp.108.123802; HALLIWELL B, 1978, PLANTA, V140, P81, DOI 10.1007/BF00389384; Takahashi S, 2012, J BIOCHEM, V152, P37, DOI 10.1093/jb/mvs044; Rodriguez AA, 2002, PLANT PHYSIOL, V129, P1627, DOI 10.1104/pp.001222; Muller K, 2009, NEW PHYTOL, V184, P885, DOI 10.1111/j.1469-8137.2009.03005.x; Harris PJ, 2010, PHYTOCHEM REV, V9, P19, DOI 10.1007/s11101-009-9146-4; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Lee Y, 2013, CELL, V153, P402, DOI 10.1016/j.cell.2013.02.045; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Drerup MM, 2013, MOL PLANT, V6, P559, DOI 10.1093/mp/sst009; LANE BG, 1994, FASEB J, V8, P294; Asai S, 2013, J BIOL CHEM, V288, P14332, DOI 10.1074/jbc.M112.448910; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kukavica BM, 2012, J EXP BOT, V63, P4631, DOI 10.1093/jxb/ers139; Bringezu K, 1999, J PLANT PHYSIOL, V154, P536; ELSTNER EF, 1976, PLANTA, V130, P175, DOI 10.1007/BF00384416; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Lassig R, 2014, PLANT J, V78, P94, DOI 10.1111/tpj.12452; Brownleader MD, 2000, PLANTA, V210, P668, DOI 10.1007/s004250050058; Ros LVG, 2006, PROTOPLASMA, V227, P175, DOI 10.1007/s00709-005-0128-0; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Bernards Mark A., 2004, Phytochemistry Reviews, V3, P113, DOI 10.1023/B:PHYT.0000047810.10706.46; Boisson-Dernier A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001719; Cervelli M, 2004, PLANT J, V40, P410, DOI 10.1111/j.1365-313X.2004.02221.x; Cona A, 2003, PLANT PHYSIOL, V131, P803, DOI 10.1104/pp.011379; Delis C, 2006, J EXP BOT, V57, P101, DOI 10.1093/jxb/erj009; FERRER MA, 1990, FEBS LETT, V276, P127, DOI 10.1016/0014-5793(90)80524-M; Frahry G, 1998, PHYTOCHEMISTRY, V48, P223, DOI 10.1016/S0031-9422(98)00004-1; Fry Stephen C., 2004, Phytochemistry Reviews, V3, P97, DOI 10.1023/B:PHYT.0000047808.74647.43; Hamada H, 2012, J BIOL CHEM, V287, P9931, DOI 10.1074/jbc.M111.337659; Kadota Y, 2006, PLANT CELL PHYSIOL, V47, P1337, DOI 10.1093/pcp/pcj098; Kadota Y, 2005, PLANT CELL PHYSIOL, V46, P156, DOI 10.1093/pcp/pci008; Kadota Y, 2004, PLANT CELL PHYSIOL, V45, P160, DOI 10.1093/pcp/pch020; Karkonen A., 2014, PHYSL PLANT; Karkonen A, 2010, J INTEGR PLANT BIOL, V52, P176, DOI 10.1111/j.1744-7909.2010.00913.x; Karkonen A, 2002, PHYSIOL PLANTARUM, V114, P343, DOI 10.1034/j.1399-3054.2002.1140303.x; Karkonen A, 2009, PLANTA, V230, P553, DOI 10.1007/s00425-009-0968-5; Karkonen A, 2006, J EXP BOT, V57, P1633, DOI 10.1093/jxb/erj197; Kawarazaki T, 2013, BBA-MOL CELL RES, V1833, P2775, DOI 10.1016/j.bbamcr.2013.06.024; Kaya H., 2014, PLANT SIGNA IN PRESS; Kimura S, 2012, BBA-MOL CELL RES, V1823, P398, DOI 10.1016/j.bbamcr.2011.09.011; Kuchitsu K, 1997, PLANT CELL PHYSIOL, V38, P1012; KUCHITSU K, 1995, PROTOPLASMA, V188, P138, DOI 10.1007/BF01276805; Kurusu T., 2013, HDB REACTIVE OXYGEN, P315; Kurusu T., 2012, BMC PLANT BIOL, V12, pe11; Kurusu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070623; Lehtonen MT, 2014, J PROTEOME RES, V13, P447, DOI 10.1021/pr400827a; Liithje S., 2008, PROGR BOT, V69, P169; Luthje S, 1998, PROTOPLASMA, V205, P43, DOI 10.1007/BF01279292; Martinez C, 1998, MOL PLANT MICROBE IN, V11, P1038, DOI 10.1094/MPMI.1998.11.11.1038; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Moschou Panagiotis N, 2008, Plant Signal Behav, V3, P1061; Novo-Uzal E, 2013, J EXP BOT, V64, P3499, DOI 10.1093/jxb/ert221; Otter T, 1997, PLANT CELL PHYSIOL, V38, P595; Passardi F, 2006, PLANTA, V223, P965, DOI 10.1007/s00425-005-0153-4; PEDRENO MA, 1987, PHYTOCHEMISTRY, V26, P3133, DOI 10.1016/S0031-9422(00)82456-5; PEDRENO MA, 1990, PLANT PHYSIOL BIOCH, V28, P37; Petrov VD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls014; PICHORNER H, 1992, PHYTOCHEMISTRY, V31, P3371, DOI 10.1016/0031-9422(92)83688-U; Planas-Portell J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-109; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; Ribeiro JM, 2006, J EXP BOT, V57, P2025, DOI 10.1093/jxb/erj153; SANTANEN A, 1994, PHYSIOL PLANTARUM, V90, P125; Sebela M, 2001, PLANT SCI, V160, P197, DOI 10.1016/S0168-9452(00)00380-0; SHINKLE JR, 1992, PLANT PHYSIOL, V98, P1336, DOI 10.1104/pp.98.4.1336; Simonovicova M, 2004, PROTOPLASMA, V224, P91, DOI 10.1007/s00709-004-0054-6; Tisi Alessandra, 2008, Plant Signal Behav, V3, P204; Van Gestelen P, 1998, PHYSIOL PLANTARUM, V104, P653, DOI 10.1034/j.1399-3054.1998.1040419.x; Wormit A, 2012, PLANT PHYSIOL, V159, P105, DOI 10.1104/pp.112.195198; Yoda H, 2003, PLANT PHYSIOL, V132, P1973, DOI 10.1104/pp.103.024737	143	4	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	APR	2015	112						22	32		10.1016/j.phytochem.2014.09.016		11	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CG2GU	WOS:000353093700004		
J	Hoson, T; Wakabayashi, K				Hoson, Takayuki; Wakabayashi, Kazuyuki			Role of the plant cell wall in gravity resistance	PHYTOCHEMISTRY			English	Review						Cell wall; Cellulose; Evolution; Gravity resistance; Hypergravity; Matrix polysaccharides; Microgravity; Phenolics; Rigidity; Space experiments	AZUKI-BEAN EPICOTYLS; CONTINUOUS HYPERGRAVITY CONDITIONS; GROWN RICE COLEOPTILES; ELONGATION GROWTH; MICROGRAVITY CONDITIONS; ARABIDOPSIS-HYPOCOTYLS; CORTICAL MICROTUBULES; XYLOGLUCAN BREAKDOWN; INFLORESCENCE STEMS; LIGNIN FORMATION	Gravity resistance, mechanical resistance to the gravitational force, is a principal graviresponse in plants, comparable to gravitropism. The cell wall is responsible for the final step of gravity resistance. The gravity signal increases the rigidity of the cell wall via the accumulation of its constituents, polymerization of certain matrix polysaccharides due to the suppression of breakdown, stimulation of cross-link formation, and modifications to the wall environment, in a wide range of situations from microgravity in space to hypergravity. Plants thus develop a tough body to resist the gravitational force via an increase in cell wall rigidity and the modification of growth anisotropy. The development of gravity resistance mechanisms has played an important role in the acquisition of responses to various mechanical stresses and the evolution of land plants. (C) 2014 Elsevier Ltd. All rights reserved.	[Hoson, Takayuki; Wakabayashi, Kazuyuki] Osaka City Univ, Grad Sch Sci, Dept Biol, Sumiyoshi Ku, Osaka 5588585, Japan	Hoson, T (reprint author), Osaka City Univ, Grad Sch Sci, Dept Biol, Sumiyoshi Ku, Osaka 5588585, Japan.	hoson@sci.osaka-cu.ac.jp			Japan Aerospace Exploration Agency, Japan Space Forum; Japan Society for the Promotion of Science	The ground-based studies and space experiments by the authors mentioned in the present article were supported by the Japan Aerospace Exploration Agency, Japan Space Forum, and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Slavov GT, 2014, NEW PHYTOL, V201, P1227, DOI 10.1111/nph.12621; KUTSCHERA U, 1988, PLANT PHYSIOL, V88, P361, DOI 10.1104/pp.88.2.361; Stutte GW, 2006, PLANTA, V224, P1038, DOI 10.1007/s00425-006-0290-4; Hoson T, 2003, INT REV CYTOL, V229, P209, DOI 10.1016/S0074-7696(03)29005-7; Masuda Y, 1994, Adv Space Biol Med, V4, P111; REVILLA G, 1987, J EXP BOT, V38, P1818, DOI 10.1093/jxb/38.11.1818; FRY SC, 1986, ANNU REV PLANT PHYS, V37, P165, DOI 10.1146/annurev.pp.37.060186.001121; Hoson T, 1998, J PLANT RES, V111, P167, DOI 10.1007/BF02507163; Wakabayashi K, 2009, J PLANT PHYSIOL, V166, P947, DOI 10.1016/j.jplph.2008.12.006; Soga K, 2002, PLANTA, V215, P1040, DOI 10.1007/s00425-002-0838-x; Soga K, 2004, PLANTA, V218, P1054, DOI 10.1007/s00425-003-1187-0; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Soga K, 2007, PHYSIOL PLANTARUM, V131, P332, DOI 10.1111/j.1399-3054.2007.00949.x; NAKAMURA T, 1994, PLANT CELL PHYSIOL, V35, P523; TAN KS, 1991, PHYSIOL PLANTARUM, V83, P397, DOI 10.1034/j.1399-3054.1991.830310.x; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Tasaka M, 2001, INT REV CYTOL, V206, P135; Hoson T, 2002, PLANT CELL PHYSIOL, V43, P1067, DOI 10.1093/pcp/pcf126; Hoson T, 2002, J PLANT RES, V115, P277, DOI 10.1007/s10265-002-0035-9; Tamaoki D, 2011, J EXP BOT, V62, P5463, DOI 10.1093/jxb/err224; Soga K, 2006, PLANTA, V224, P1485, DOI 10.1007/s00425-006-0319-8; Soga K, 2000, AUST J PLANT PHYSIOL, V27, P967, DOI 10.1071/PP00035; Soga K, 2005, FUNCT PLANT BIOL, V32, P175, DOI 10.1071/FP04145; Tamaoki D, 2009, ADV SPACE RES, V44, P245, DOI 10.1016/j.asr.2009.03.016; Yoshioka R, 2003, ADV SPACE RES, V31, P2187, DOI 10.1016/S0273-1177(03)00243-6; Verhertbruggen Y, 2013, PLANT CELL PHYSIOL, V54, P1278, DOI 10.1093/pcp/pct074; KUTSCHERA U, 1993, BOT ACTA, V106, P164; Chen L, 1999, J PLANT PHYSIOL, V155, P234; Martzivanou M, 2003, PHYSIOL PLANTARUM, V118, P221, DOI 10.1034/j.1399-3054.2003.00092.x; Wakabayashi K, 2005, ADV SPACE RES, V36, P1292, DOI [10.1016/j.asr.2005.02.066, 10.1016/j.asr.2005.02.006]; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Fasano JM, 2001, PLANT CELL, V13, P907, DOI 10.1105/tpc.13.4.907; Soga K, 2000, PLANT CELL PHYSIOL, V41, P509; Hodick D, 1998, PROTOPLASMA, V204, P145, DOI 10.1007/BF01280321; Hoson T, 2003, PLANT SOIL, V255, P19, DOI 10.1023/A:1026105431505; Volkmann D, 2006, PROTOPLASMA, V229, P143, DOI 10.1007/s00709-006-0200-4; Soga K, 2008, J PLANT RES, V121, P493, DOI 10.1007/s10265-008-0179-3; Tamaoki D, 2006, J PLANT RES, V119, P79, DOI 10.1007/s10265-005-0243-1; Hoson T, 2005, ADV SPACE RES, V36, P1196, DOI 10.1016/j.asr.2005.04.095; Blancaflor EB, 2013, AM J BOT, V100, P143, DOI 10.3732/ajb.1200283; Kawamura Y, 2000, J PLANT PHYSIOL, V156, P689; Allen J, 2009, AM J BOT, V96, P652, DOI 10.3732/ajb.0800261; Wakabayashi K, 2005, PHYSIOL PLANTARUM, V125, P127, DOI 10.1111/j.1399-3054.2005.00544.x; Hoson T, 2014, PLANT BIOLOGY, V16, P91, DOI 10.1111/plb.12099; Matia I, 2010, J PLANT PHYSIOL, V167, P184, DOI 10.1016/j.jplph.2009.08.012; Wakabayashi K, 2012, J PLANT PHYSIOL, V169, P262, DOI 10.1016/j.jplph.2011.10.002; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Tabuchi A, 2001, PLANT CELL PHYSIOL, V42, P154, DOI 10.1093/pcp/pce016; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Hoson T, 2010, BIOTECH AGR IND MED, P293; Matsumoto S, 2007, ADV SPACE RES, V39, P1176, DOI 10.1016/j.asr.2007.03.074; Hoson T, 1996, J EXP BOT, V47, P513, DOI 10.1093/jxb/47.4.513; Braam J, 2005, NEW PHYTOL, V165, P373, DOI 10.1111/j.1469-8137.2004.01263.x; Levine LH, 2001, PHYTOCHEMISTRY, V57, P835, DOI 10.1016/S0031-9422(01)00148-0; Baldwin KL, 2013, AM J BOT, V100, P126, DOI 10.3732/ajb.1200318; Archer RR, 1987, GROWTH STRESSES STRA; Bunzel M, 2010, PHYTOCHEM REV, V9, P47, DOI 10.1007/s11101-009-9139-3; Chebli Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058246; [Anonymous], 1989, ACS SYM SER; Du S, 2007, J INTEGR PLANT BIOL, V49, P131, DOI 10.1111/j.1744-7909.2007.00427.x; Fitzelle KJ, 2001, J EXP BOT, V52, P265, DOI 10.1093/jexbot/52.355.265; Grabber JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-114; Hoson T., 2006, J GRAV PHYSL, V13, P97; Hoson T., 2012, AEROSPACE TECHNOL JP, V10, P1; Hoson T., 2009, Biological Sciences in Space, V23, P131; JACKSON MB, 1985, ANNU REV PLANT PHYS, V36, P145, DOI 10.1146/annurev.pp.36.060185.001045; Matsumoto S, 2010, PLANT PHYSIOL, V152, P918, DOI 10.1104/pp.109.147330; Nakano S., 2007, Biological Sciences in Space, V21, P113, DOI 10.2187/bss.21.113; Soga K., 2009, BIOL SCI SPACE, V23, P3; Timell T.E., 1986, COMPRESSION WOOD GYM; Yoshida K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00383	71	2	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	APR	2015	112						84	90		10.1016/j.phytochem.2014.08.022		7	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CG2GU	WOS:000353093700010		
J	Tagle, AG; Chuma, I; Tosa, Y				Tagle, Analiza Grubanzo; Chuma, Izumi; Tosa, Yukio			Rmg7, a New Gene for Resistance to Triticum Isolates of Pyricularia oryzae Identified in Tetraploid Wheat	PHYTOPATHOLOGY			English	Article							MAGNAPORTHE-ORYZAE; GRISEA; BLAST; CULTIVARS; SPECIFICITY; PATHOTYPE; BRAZIL	A single gene for resistance, designated Rmg7 (Resistance to Magnaporthe grisea 7), was identified in a tetraploid wheat accession, St24 (Triticum dicoccum, KU120), against Br48, a Triticum isolate of Pyricularia oryzae. Two other wheat accessions, Stl7 (T. dicoccum, KU112) and St25 (T dicoccum, KU122), were also resistant against Br48 and showed a similar disease reaction pattern to St24. Crosses between these resistant accessions yielded no susceptible F2 seedlings, suggesting that St24, St17, and St25 carry the same resistance gene. Furthermore, a single avirulence gene corresponding to Rmg7 was detected in a segregation analysis of random Fl progenies between Br48 and MZ5-1-6, an Eleusine isolate virulent to St24 at a higher temperature. This avirulence gene was recognized not only by St24, but also by Stl7 and St25, thus supporting the preceding results indicating that all three accessions carry Rmg7. This resistance gene may have potential in future wheat breeding programs.	[Tagle, Analiza Grubanzo; Chuma, Izumi; Tosa, Yukio] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan	Tosa, Y (reprint author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	tosayuki@kobe-u.ac.jp					URASHIMA AS, 1993, PLANT DIS, V77, P1211; Inukai T, 2006, MOL PLANT MICROBE IN, V19, P1034, DOI 10.1094/MPMI-19-1034; Maciel JLN, 2014, PHYTOPATHOLOGY, V104, P95, DOI 10.1094/PHYTO-11-12-0294-R; Hirata K, 2007, MYCOL RES, V111, P799, DOI 10.1016/j.mycres.2007.05.014; Murakami J, 2000, PHYTOPATHOLOGY, V90, P1060, DOI 10.1094/PHYTO.2000.90.10.1060; Tosa Y, 2004, PHYTOPATHOLOGY, V94, P454, DOI 10.1094/PHYTO.2004.94.5.454; Murata N, 2014, J GEN PLANT PATHOL, V80, P66, DOI 10.1007/s10327-013-0477-z; Chuma I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002147; Cruz CD, 2012, PLANT DIS, V96, P1501, DOI 10.1094/PDIS-11-11-0944-RE; Cumagun CJR, 2014, PHYTOPATHOLOGY, V104, P634, DOI 10.1094/PHYTO-04-13-0106-R; Igarashi S, 1986, FITOPATOL BRAS, V11, P351; Inoue Y, 2013, PHYTOPATHOLOGY, V103, P575, DOI 10.1094/PHYTO-09-12-0216-R; Kato Hajime, 2000, Journal of General Plant Pathology, V66, P30, DOI 10.1007/PL00012919; Kohli MM, 2011, CZECH J GENET PLANT, V47, pS130; Nga NTT, 2009, GENOME, V52, P801, DOI [10.1139/g09-054, 10.1139/G09-054]; Oh HS, 2002, CAN J BOT, V80, P1088, DOI [10.1139/B02-101, 10.1139/b02-101]; Pratt K, 2012, UK COLL AGR NEWS; Takabayashi N, 2002, PHYTOPATHOLOGY, V92, P1182, DOI 10.1094/PHYTO.2002.92.11.1182; Tosa Y, 2014, J GEN PLANT PATHOL, V80, P202, DOI 10.1007/s10327-014-0513-7; Urashima A. S., 2004, Fitopatologia Brasileira, V29, P511, DOI 10.1590/S0100-41582004000500007; Vy TTP, 2014, J GEN PLANT PATHOL, V80, P59, DOI 10.1007/s10327-013-0478-y; Zhan SW, 2008, GENOME, V51, P216, DOI 10.1139/G07-094	22	0	0	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0031-949X	1943-7684		PHYTOPATHOLOGY	Phytopathology	APR	2015	105	4					495	499		10.1094/PHYTO-06-14-0182-R		5	Plant Sciences	Plant Sciences	CG0SS	WOS:000352979600012		
J	Sasaki, K; Nakahara, K; Tanaka, S; Shigyo, M; Ito, S				Sasaki, Kazunori; Nakahara, Katsuya; Tanaka, Shuhei; Shigyo, Masayoshi; Ito, Shin-ichi			Genetic and Pathogenic Variability of Fusarium oxysporum f. sp cepae Isolated from Onion and Welsh Onion in Japan	PHYTOPATHOLOGY			English	Article							VEGETATIVE COMPATIBILITY GROUPS; SP CUBENSE; VIRULENCE; EFFECTOR; TOMATO; DIVERSITY; STRAINS; WILT	Fusarium oxysporum f. sp. cepae causes Fusarium basal rot in onion (common onion) and Fusarium wilt in Welsh onion. Although these diseases have been detected in various areas in Japan, knowledge about the genetic and pathogenic variability of F oxysporum f. sp. cepae is very limited. In this study, F. oxysporum f. sp. cepae was isolated from onion and Welsh onion grown in 12 locations in Japan, and a total of 55 F. oxysporum f. sp. cepae isolates (27 from onion and 28 from Welsh onion) were characterized based on their rDNA intergenic spacer (IGS) and translation elongation factor-lo (EF-l1) nucleotide sequences, vegetative compatibility groups (VCGs), and the presence of the SIX (secreted in xylem) homologs. Phylogenetic analysis of IGS sequences showed that these isolates were grouped into eight clades (A to H), and 20 onion isolates belonging to clade H were monophyletic and assigned to the same VCG. All the IGS-clade H isolates possessed homologs of SIX3, SIX5, and SIX7. The SIX3 homolog was located on a 4 Mb-sized chromosome in the IGS-clade H isolates. Pathogenicity tests using onion seedlings showed that all the isolates with high virulence were in the IGSclade H. These results suggest that F oxysporum f. sp. cepae isolates belonging to the IGS-clade H are genetically and pathogenically different from those belonging to the other IGS clades.	[Sasaki, Kazunori] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Nakahara, Katsuya; Tanaka, Shuhei; Shigyo, Masayoshi; Ito, Shin-ichi] Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, Yamaguchi 7538515, Japan	Ito, S (reprint author), Yamaguchi Univ, Fac Agr, Dept Biol & Environm Sci, Yamaguchi 7538515, Japan.	shinsan@yamaguchi-u.ac.jp			Global COE Program "Advanced Utilization of Fungus/Mushroom Resources for Sustainable Society in Harmony with Nature" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japanese Society for Promotion of Sciences (JSPS) [23580063]	This work was supported in part by the Global COE Program "Advanced Utilization of Fungus/Mushroom Resources for Sustainable Society in Harmony with Nature" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, and a Grant-in-Aid for Scientific Research (C) (23580063) from the Japanese Society for Promotion of Sciences (JSPS). We thank A. Sue, T. Yoshida (Takii Seed), and M. Funahashi (Nissan Seed) for providing the diseased plants.	Alves-Santos FM, 1999, APPL ENVIRON MICROB, V65, P3335; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; Kashiwa T, 2013, J GEN PLANT PATHOL, V79, P412, DOI 10.1007/s10327-013-0471-5; Houterman PM, 2007, MOL PLANT PATHOL, V8, P215, DOI [10.1111/j.1364-3703.2007.00384.x, 10.1111/J.1364-3703.2007.00384.X]; Thatcher LF, 2012, MOL PLANT MICROBE IN, V25, P180, DOI 10.1094/MPMI-08-11-0212; Chakrabarti A, 2011, PLANT PATHOL, V60, P232, DOI 10.1111/j.1365-3059.2010.02363.x; Fourie G, 2009, APPL ENVIRON MICROB, V75, P4770, DOI 10.1128/AEM.00370-09; Webb KM, 2013, PLANT DIS, V97, P1200, DOI 10.1094/PDIS-11-12-1051-RE; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Dissanayake MLMC, 2009, J GEN PLANT PATHOL, V75, P37, DOI 10.1007/s10327-008-0135-z; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; van der Does HC, 2007, MOL PLANT MICROBE IN, V20, P1175, DOI 10.1094/MPMI-20-10-1175; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006; Akamatsu H, 1999, CURR GENET, V35, P647, DOI 10.1007/s002940050464; Bayraktar H, 2010, J PHYTOPATHOL, V158, P691, DOI 10.1111/j.1439-0434.2010.01685x; Dissanayake MLMC, 2009, J GEN PLANT PATHOL, V75, P125, DOI 10.1007/s10327-009-0152-6; EDEL V, 1995, PHYTOPATHOLOGY, V85, P579, DOI 10.1094/Phyto-85-579; FAO, 2012, FAOSTAT; Fraser-Smith S, 2014, PLANT PATHOL, V63, P1044, DOI 10.1111/ppa.12184; Inami K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044101; Inden H, 1990, ONIONS ALLIED CROPS, V3, P159; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kodama F., 1977, ANN PHYTOPATHOL SOC, V43, P340; Kodama F., 1983, REP HOKKAIDO AGR EXP, V39, P1; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Leslie JF, 2006, FUSARIUM LAB MANUAL; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schwartz H.F., 2008, COMPENDIUM ONION GAR; Southwood MJ, 2012, PHYTOPATHOLOGY, V102, P204, DOI 10.1094/PHYTO-04-11-0107; Southwood MJ, 2012, PLANT DIS, V96, P1250, DOI 10.1094/PDIS-10-11-0820-RE; Swift CE, 2002, PLANT DIS, V86, P606, DOI 10.1094/PDIS.2002.86.6.606; TAKAKUWA M, 1977, Annals of the Phytopathological Society of Japan, V43, P479; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; Widodo K. N., 2008, MICROBIOL INDONESIA, V2, P39; Yakuwa T., 2006, JAPANESE SOC HORTICU, P165	43	0	0	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0031-949X	1943-7684		PHYTOPATHOLOGY	Phytopathology	APR	2015	105	4					525	532		10.1094/PHYTO-06-14-0164-R		8	Plant Sciences	Plant Sciences	CG0SS	WOS:000352979600016		
J	Matsukura, K; Towata, T; Yoshida, K; Sakai, J; Okuda, M; Onuki, M; Matsumura, M				Matsukura, Keiichiro; Towata, Tomomi; Yoshida, Kazuhiro; Sakai, Junichi; Okuda, Mitsuru; Onuki, Masatoshi; Matsumura, Masaya			Quantitative Analysis of Southern rice black-streaked dwarf virus in Sogatella furcifera and Virus Threshold for Transmission	PHYTOPATHOLOGY			English	Article						overseas immigration; reovirus; stunted growth; viral disease	MOLECULAR CHARACTERIZATION; NILAPARVATA-LUGENS; PCR ASSAY; VECTOR; FIJIVIRUS; PLANTHOPPERS; ASSOCIATION; VIETNAM; PROTEIN	We investigated Southern rice black-streaked dwarf virus (SRBSDV) accumulation in a vector insect, the whitebacked planthopper (Sogatella furcifera), to elucidate the association of virus accumulation in the vector with virus transmission efficiency. Real-time quantitative reverse transcription polymerase chain reaction analysis confirmed that this virus is transmitted in a persistent-propagative manner. SRBSDV was successfully transmitted by S. furcifera males in which RNA accumulation of the capsid protein gene of SRBSDV was >10(3) in the whole body of S. furcifera, indicating that the threshold accumulation of the virus RNA for virus transmission is 10(3) in an S. furcifera male. The SRBSDV detection rate in the immigrant population of S. furcifera was high in 2011 (39.5%); however, most of the insects contained fewer than 10(3) RNAs of the capsid protein gene. This result indicates that the risk of SRBSDV epidemics could be estimated from the proportion of virus-transmissible S. furcifera (i.e., S. furcifera that contained more than 103 RNAs of the virus capsid protein gene) rather than the SRBSDV detection rate in S. furcifera.	[Matsukura, Keiichiro; Towata, Tomomi; Yoshida, Kazuhiro; Sakai, Junichi; Okuda, Mitsuru; Onuki, Masatoshi; Matsumura, Masaya] NARO Kyushu Okinawa Agr Res Ctr, Kumamoto 8611192, Japan; [Onuki, Masatoshi] NARO Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan	Matsukura, K (reprint author), NARO Kyushu Okinawa Agr Res Ctr, Suya 2421, Kumamoto 8611192, Japan.	mtkr@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [23034]	We thank Kayoko Abe and Reiko Yamada for preparation of insects for our experiments. We also thank Prof. Robert Cowie in University of Hawaii for grammatical editing our manuscript. This study was supported by research and development projects for application in promoting new policy of agriculture, forestry, and fisheries (23034) from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Ammar ED, 2009, ARCH VIROL, V154, P255, DOI 10.1007/s00705-008-0308-2; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Yin Xiao, 2011, Virologica Sinica, V26, P47, DOI 10.1007/s12250-011-3170-9; Quito-Avila DF, 2012, PHYTOPATHOLOGY, V102, P547, DOI 10.1094/PHYTO-12-11-0331; Boonham N, 2002, J VIROL METHODS, V101, P37, DOI 10.1016/S0166-0934(01)00418-9; Liu Y, 2011, ARCH VIROL, V156, P1729, DOI 10.1007/s00705-011-1041-9; Zhou GH, 2008, CHINESE SCI BULL, V53, P3677, DOI 10.1007/s11434-008-0467-2; Rubinstein G, 1997, J GEN VIROL, V78, P2683; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Jia DS, 2012, J VIROL, V86, P5800, DOI 10.1128/JVI.07121-11; Okuda S, 2013, EUR J PLANT PATHOL, V136, P355, DOI 10.1007/s10658-013-0169-8; Matsumura M, 2008, PEST MANAG SCI, V64, P1115, DOI 10.1002/ps.1641; Donaldson JR, 2007, ENVIRON ENTOMOL, V36, P918, DOI 10.1603/0046-225X(2007)36[918:AEOSVO]2.0.CO;2; Bachanek-Bankowska K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093758; Cuong H.V., 2009, B I TROP AGR KYUSHU, V32, P85; Hoang AT, 2011, PLANT DIS, V95, P1063, DOI 10.1094/PDIS-07-10-0535; Jia DS, 2012, VIRUS RES, V167, P404, DOI 10.1016/j.virusres.2012.05.023; King AMQ, 2012, VIRUS TAXONOMY, P1327; Li YZ, 2012, J INTEGR AGR, V11, P621, DOI 10.1016/S2095-3119(12)60049-5; Matsukura K, 2013, PHYTOPATHOLOGY, V103, P509, DOI 10.1094/PHYTO-10-12-0261-R; Matsumoto Y, 2013, B ENTOMOL RES, V103, P382, DOI 10.1017/S000748531200082X; Matsumura M., 2011, PLANT PROT, V65, P46; Mijatovic-Rustempasic S, 2013, J CLIN MICROBIOL, V51, P3047, DOI 10.1128/JCM.01192-13; Pu LL, 2012, CROP PROT, V41, P71, DOI 10.1016/j.cropro.2012.04.026; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue J, 2014, J PHYTOPATHOL, V162, P349, DOI 10.1111/jph.12196; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zhang X, 2010, J VIROL METHODS, V169, P416, DOI 10.1016/j.jviromet.2010.07.029; Zhou T, 2014, J PHYTOPATHOL, V162, P26, DOI 10.1111/jph.12152; Zhu JunZi, 2012, Journal of Hunan Agricultural University, V38, P58	31	0	0	AMER PHYTOPATHOLOGICAL SOC	ST PAUL	3340 PILOT KNOB ROAD, ST PAUL, MN 55121 USA	0031-949X	1943-7684		PHYTOPATHOLOGY	Phytopathology	APR	2015	105	4					550	554		10.1094/PHYTO-05-14-0142-R		5	Plant Sciences	Plant Sciences	CG0SS	WOS:000352979600019		
J	Makizako, H; Kabe, N; Takano, A; Isobe, K				Makizako, Hyuma; Kabe, Norihito; Takano, Asami; Isobe, Kanako			Use of the Berg Balance Scale to Predict Independent Gait After Stroke: A Study of an Inpatient Population in Japan	PM&R			English	Article							FUNCTIONAL STATUS; REHABILITATION; WALKING; PEOPLE; POSTSTROKE; MEANINGFUL; DISCHARGE; VARIABLES; THERAPY; TRIALS	Objective: To examine whether the Berg Balance Scale (BBS) score on admission and after 1 month can be used to predict the Functional Independence Measure (FIM) walking level 6 or 7 (modified independent and independent gait respectively) after 3 months and to determine the optimal BBS cut-off score for predicting independent gait among inpatients with first stroke in a rehabilitation facility. Design: Retrospective cohort study. Setting: Inpatient rehabilitation facility (Kaifukuki). Participants: Two hundred fifty-one consecutive patients with first stroke and nonindependent gait on admission. Outcome Measures: BBS on admission and after 1 month and FIM on admission and after 3 months. Results: Area under the receiver operating characteristic curves for predicting independent gait after 3 months were 0.81 (95% confidence interval [CI], 0.75-0.88) for BBS score on admission; the optimal cut-off score being >= 13 (63% sensitivity; 90% specificity). Achieving greater cut-off score on admission was significantly associated with subsequent independent gait (odds ratio, 9.7; 95% CI, 4.38-21.36; P < . 001). A subanalysis of patients with poor balance on admission (BBS score < 13; n = 191) showed area under the receiver operating characteristic curves for predicting independent gait after 3 months of 0.88 (95% CI, 0.80-0.95) for BBS scores 1 month after admission. In this subgroup, BBS scores at 1 month of >= 27 were significantly associated with subsequent independent gait (odds ratio, 21.6, 95% CI, 6.40-73.20; P < .001). Conclusions: Admission BBS scores predicted FIM walking level 6 or 7, which denotes modified independent or independent gait, after 3 months, the optimal cut-off for BBS scores being >= 13 among inpatients with first stroke in a rehabilitation facility. Patients with poor balance on admission whose BBS scores had improved to >= 27 at 1 month after admission were likely to achieve modified independent or independent gait within 3 months after admission.	[Makizako, Hyuma] Natl Ctr Geriatr & Gerontol, Dept Funct Activat, Ctr Gerontol & Social Sci, Obu, Aichi 4748511, Japan; [Kabe, Norihito] Natl Ctr Geriatr & Gerontol, Obu, Aichi 4748511, Japan; [Kabe, Norihito] Funabashi Municipal Rehabil Hosp, Dept Phys Therapy, Chiba, Japan; [Takano, Asami] Funabashi Municipal Rehabil Hosp, Dept Speech Therapy, Chiba, Japan; [Isobe, Kanako] Funabashi Municipal Rehabil Hosp, Dept Nursing & Care Work, Chiba, Japan	Makizako, H (reprint author), Natl Ctr Geriatr & Gerontol, Dept Funct Activat, Ctr Gerontol & Social Sci, 7-430 Morioka Machi, Obu, Aichi 4748511, Japan.	makizako@ncgg.go.jp					Alzahrani M, 2011, REV BRAS FISIOTER, V15, P45, DOI 10.1590/S1413-35552011005000002; Patel AT, 2000, ARCH PHYS MED REHAB, V81, P1357, DOI 10.1053/apmr.2000.9397; Vincent C, 2009, CEREBROVASC DIS, V27, P456, DOI 10.1159/000210092; White DK, 2011, ARTHRIT CARE RES, V63, pS297, DOI 10.1002/acr.20638; WADE DT, 1987, SCAND J REHABIL MED, V19, P25; Samsa GP, 2004, J REHABIL RES DEV, V41, P279, DOI 10.1682/JRRD.2003.08.0117; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Wandel A, 2000, ARCH PHYS MED REHAB, V81, P736, DOI 10.1053/apmr.2000.5609; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Miyai I, 2011, NEUROREHAB NEURAL RE, V25, P540, DOI 10.1177/1545968311402696; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Kwakkel G, 1996, AGE AGEING, V25, P479, DOI 10.1093/ageing/25.6.479; Reid JM, 2010, AGE AGEING, V39, P360, DOI 10.1093/ageing/afq027; Kollen B, 2005, STROKE, V36, P2676, DOI 10.1161/01.STR.0000190839.29234.50; Kollen B, 2006, CLIN REHABIL, V20, P262, DOI 10.1191/0269215506cr910oa; Kluding P, 2009, PHYS THER, V89, P73, DOI 10.2522/ptj.20070234; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Veerbeek JM, 2011, NEUROREHAB NEURAL RE, V25, P268, DOI 10.1177/1545968310384271; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Park SW, 2008, NEUROREHAB NEURAL RE, V22, P486, DOI 10.1177/1545968308316906; BARER DH, 1989, AGE AGEING, V18, P183, DOI 10.1093/ageing/18.3.183; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Bland MD, 2012, ARCH PHYS MED REHAB, V93, P1441, DOI 10.1016/j.apmr.2012.02.029; Bohannon R W, 1991, Int J Rehabil Res, V14, P246, DOI 10.1097/00004356-199109000-00010; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Ditunno JF, 2005, J REHABIL RES DEV, V42, P35, DOI 10.1682/JRRD.2004.08.0098; Dong YH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003105; Duarte E, 2010, NEUROREHABILITATION, V26, P317, DOI 10.3233/NRE-2010-0568; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldie PA, 1999, ARCH PHYS MED REHAB, V80, P415, DOI 10.1016/S0003-9993(99)90278-2; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kuys SS, 2009, AUST J PHYSIOTHER, V55, P265; Latham NK, 2005, ARCH PHYS MED REHAB, V86, pS41, DOI 10.1016/j.apmr.2005.08.128; Rabadi Meheroz H, 2005, Neurorehabil Neural Repair, V19, P20, DOI 10.1177/1545968304272762; Raven J. C., 1995, RAVENS COLORED PROGR; Salter KL, 2007, AM J PHYS MED REHAB, V86, P1007, DOI 10.1097/PHM.0b013e3181587b3d; Tsang YL, 2004, ARCH PHYS MED REHAB, V85, P94, DOI 10.1016/S0003-9993(03)00377-0; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Yavuzer G, 2001, AM J PHYS MED REHAB, V80, P250, DOI 10.1097/00002060-200104000-00003	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	APR	2015	7	4					392	399		10.1016/j.pmrj.2015.01.009		8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	CG2QZ	WOS:000353120900006		
J	Tsuchikawa, T; Hirano, S; Nakamura, T; Okamura, K; Tamoto, E; Shichinohe, T				Tsuchikawa, Takahiro; Hirano, Satoshi; Nakamura, Toru; Okamura, Keisuke; Tamoto, Eiji; Shichinohe, Toshiaki			Concomitant major vessel resection in pancreatic adenocarcinoma	POSTGRADUATE MEDICINE			English	Review						Pancreatic cancer; surgery; portal vein resection; arterial resection; DP-CAR; adjuvant surgery	CELIAC AXIS RESECTION; UNDERGO DISTAL PANCREATECTOMY; EN-BLOC RESECTION; DUCTAL ADENOCARCINOMA; PERINEURAL INVASION; BODY CANCER; EXTENDED LYMPHADENECTOMY; VASCULAR RECONSTRUCTION; NEOADJUVANT THERAPY; ARTERIAL RESECTION	Increasing evidence has contraindicated extended radical dissection of pancreatic adenocarcinoma (PC). With the recent improvement of perioperative management techniques and multimodal treatment strategy for PC, concomitant major vessel resection and reconstruction has thus been aggressively attempted in association with comparatively better pathologically negative surgical margins and postoperative survival. We have discussed the clinical relevance of concomitant major vessel resection mainly focusing on indications for such resection with borderline resectable tumor associated with chemoradiotherapy, distal pancreatectomy with en bloc celiac axis resection for pancreatic body and tail cancer, and adjuvant surgery for initially unresectable pancreatic cancer.	[Tsuchikawa, Takahiro; Hirano, Satoshi; Nakamura, Toru; Okamura, Keisuke; Tamoto, Eiji; Shichinohe, Toshiaki] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido 0608638, Japan	Tsuchikawa, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, N 15 W 7, Sapporo, Hokkaido 0608638, Japan.	tsuchi-t@med.hokudai.ac.jp					Mollberg N, 2011, ANN SURG, V254, P882, DOI 10.1097/SLA.0b013e31823ac299; Yu XZ, 2014, EJSO-EUR J SURG ONC, V40, P371, DOI 10.1016/j.ejso.2014.01.010; Okada K, 2013, SURGERY, V153, P365, DOI 10.1016/j.surg.2012.07.036; Nakao A, 2006, WORLD J SURG, V30, P976, DOI 10.1007/s00268-005-0438-6; Farnell MB, 2005, SURGERY, V138, P618, DOI 10.1016/j.surg.2005.06.044; Takahashi T, 1997, J SURG ONCOL, V65, P164, DOI 10.1002/(SICI)1096-9098(199707)65:3<164::AID-JSO4>3.0.CO;2-4; Takahashi Y, 2011, WORLD J SURG, V35, P2535, DOI 10.1007/s00268-011-1245-x; Miura T, 2014, SURGERY, V155, P457, DOI 10.1016/j.surg.2013.10.024; Hirano S, 2007, ANN SURG, V246, P46, DOI 10.1097/01.sla.0000258608.52615.5a; Yi SQ, 2003, PANCREAS, V27, P225, DOI 10.1097/00006676-200310000-00005; Yeo CJ, 1999, ANN SURG, V229, P613, DOI 10.1097/00000658-199905000-00003; Heinemann V, 2013, ANN ONCOL, V24, P2484, DOI 10.1093/annonc/mdt239; ISHIKAWA O, 1992, ANN SURG, V215, P231, DOI 10.1097/00000658-199203000-00006; He J, 2014, WORLD J GASTROENTERO, V20, P2255, DOI 10.3748/wjg.v20.i9.2255; Nimura Y, 2012, J HEPATO-BIL-PAN SCI, V19, P230, DOI 10.1007/s00534-011-0466-6; Tempero MA, 2012, J NATL COMPR CANC NE, V10, P703; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Rose JB, 2014, ANN SURG ONCOL, V21, P1530, DOI 10.1245/s10434-014-3486-z; Chatterjee D, 2012, CANCER-AM CANCER SOC, V118, P3182, DOI 10.1002/cncr.26651; Yamamoto Y, 2012, SURGERY, V151, P61, DOI 10.1016/j.surg.2011.06.030; Varadhachary GR, 2006, ANN SURG ONCOL, V13, P1035, DOI 10.1245/ASO.2006.08.011; Pedrazzoli S, 1998, ANN SURG, V228, P508, DOI 10.1097/00000658-199810000-00007; Yekebas EF, 2008, ANN SURG, V247, P300, DOI 10.1097/SLA.0b013e31815aab22; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Kato K, 2011, J HEPATO-BIL-PAN SCI, V18, P712, DOI 10.1007/s00534-011-0391-8; Marangoni G, 2012, SURG-J R COLL SURG E, V10, P102, DOI 10.1016/j.surge.2011.12.001; Ansari D, 2012, WORLD J GASTROENTERO, V18, P1417, DOI 10.3748/wjg.v18.i13.1417; Bockhorn M, 2011, BRIT J SURG, V98, P86, DOI 10.1002/bjs.7270; Cheung TT, 2014, WORLD J GASTROENTERO, V20, P17448, DOI 10.3748/wjg.v20.i46.17448; Christians KK, 2014, SURGERY, V155, P919, DOI 10.1016/j.surg.2014.01.003; Dudeja V, 2013, HPB, V15, P661, DOI 10.1111/hpb.12015; Farnell MB, 2005, SURGERY, V138, P28; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Hirono S, 2015, J HEPATO-BIL-PAN SCI, V22, pE4, DOI 10.1002/jhbp.184; Mellon EA, 2015, ACTA ONCOL; Nakao A, 2006, WORLD J SURG, V30, P83; Okada K, 2014, WORLD J SURG, V38, P2980, DOI 10.1007/s00268-014-2702-0; Ravikumar Reena, 2013, World J Gastrointest Surg, V5, P27, DOI 10.4240/wjgs.v5.i3.27; Satoi S, 2013, J HEPATO-BIL-PAN SCI, V20, P590, DOI 10.1007/s00534-013-0616-0; Sgroi MD, 2015, J VASC SURG, V61, P475, DOI 10.1016/j.jvs.2014.09.003; Sho M, 2013, J HEPATO-BIL-PAN SCI, V20, P197, DOI 10.1007/s00534-012-0532-8; Strobel O, 2012, SURGERY, V152, pS33, DOI 10.1016/j.surg.2012.05.029; Takahashi S, 2001, ANTICANCER RES, V21, P1407; Tucker ON, 2008, HPB SURG, V2008, DOI DOI 10.1155/2008/839503; Zhao Q, 2012, ANN DIAGN PATHOL, V16, P29, DOI 10.1016/j.anndiagpath.2011.08.005; Zhou Yan-Ming, 2014, Med Sci Monit, V20, P1, DOI 10.12659/MSM.889847	46	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0032-5481	1941-9260		POSTGRAD MED	Postgrad. Med.	APR	2015	127	3					273	276		10.1080/00325481.2015.1032180		4	Medicine, General & Internal	General & Internal Medicine	CG7AO	WOS:000353454500003		
J	Nakao, N; Kaneda, H; Tsushima, N; Ohta, Y; Tanaka, M				Nakao, N.; Kaneda, H.; Tsushima, N.; Ohta, Y.; Tanaka, M.			Characterization of primary structure and tissue expression profile of the chicken apical sodium-dependent bile acid transporter mRNA	POULTRY SCIENCE			English	Article						ASBT mRNA; bile acids; intestine; expression; chicken	MOLECULAR CHARACTERIZATION; SUBSTRATE-SPECIFICITY; MEMBRANE-VESICLES; LOWER INTESTINE; MOUSE ILEAL; RAT-LIVER; SLC10A2; CLONING; TAUROCHOLATE; CYSTEINES	The ileal apical sodium-dependent bile acid cotransporter (ASBT) plays an essential role in the absorption of bile acids from intestinal lumina. ASBT cDNA has been cloned from mammalian and fish species, and the primary structure of the protein and expression properties of the mRNA have been characterized. In this study, we identified chicken ASBT mRNA by cDNA cloning. Chicken ASBT cDNA consisted of 91 bp of the 5'-untranslated region, 1,083 bp of the coding region, and 1,896 bp of the 3'-untranslated region. The cDNA encoded a protein of 360 amino acids showing significant sequence identity with mammalian and fish ASBT. The amino acid residues known to participate in the functions of mammalian ASBT were conserved in chicken ASBT. Real-time polymerase chain reaction analysis revealed that chicken ASBT mRNA was expressed at markedly higher levels in the ileum and proximal colon/rectum, relatively lower levels in the kidney, and very low levels in the jejunum and cecum. Expression levels in the ileum markedly increased after hatching, reached the highest levels on day 7 posthatching, and then decreased to adult levels. A similar expression pattern was observed in the proximal colon/rectum except for the significant decrease from day 7 posthatching to day 21 posthatching. These results suggest that chicken ASBT functions as a bile acid transporter in the ileum and proximal colon/rectum, particularly during the early posthatching period.	[Nakao, N.; Kaneda, H.; Tsushima, N.; Tanaka, M.] Nippon Vet & Life Sci Univ, Fac Appl Life Sci, Dept Anim Sci, Physiol Anim Lab, Musashino, Tokyo 1808602, Japan; [Ohta, Y.] Nippon Vet & Life Sci Univ, Fac Appl Life Sci, Dept Anim Sci, Lab Appl Biochem, Musashino, Tokyo 1808602, Japan	Tanaka, M (reprint author), Nippon Vet & Life Sci Univ, Fac Appl Life Sci, Dept Anim Sci, Physiol Anim Lab, 1-7-1 Kyonancho, Musashino, Tokyo 1808602, Japan.	mitanaka@nvlu.ac.jp			 [24580434]	This work was supported by Grant-in-Aid for Scientific Research (C) 24580434 for Minoru Tanaka.	Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Laverty G, 2006, GEN COMP ENDOCR, V147, P70, DOI 10.1016/j.ygcen.2006.01.008; Alrefai WA, 2007, PHARM RES, V24, P1803, DOI 10.1007/s11095-007-9289-1; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; Zhang EY, 2004, BIOCHEMISTRY-US, V43, P11380, DOI 10.1021/bi049270a; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Craddock AL, 1998, AM J PHYSIOL-GASTR L, V274, pG157; Zahner D, 2003, EUR J BIOCHEM, V270, P1117, DOI 10.1046/j.1432-1033.2003.03463.x; WONG MH, 1995, J BIOL CHEM, V270, P27228; Meier Y, 2007, DRUG METAB DISPOS, V35, P590, DOI 10.1124/dmd.106.013342; Hruz P, 2006, GUT, V55, P395, DOI 10.1136/gut.2005.067389; SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722; Kramer W, 1999, J LIPID RES, V40, P1604; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; Coleto R, 1998, POULTRY SCI, V77, P594; Elbrond VS, 2004, COMP BIOCHEM PHYS A, V137, P683, DOI 10.1016/j.cbpb.2004.02.006; Lionarons DA, 2012, J LIPID RES, V53, P1535, DOI 10.1194/jlr.M025726; Murashita K., 2013, FISH PHYSL BIOCH; Saeki T, 1999, J BIOCHEM-TOKYO, V125, P846; Saeki T, 2009, BIOSCI BIOTECH BIOCH, V73, P1535, DOI 10.1271/bbb.90023; Saeki T., 2013, BMC PHYSL, V13, P1472; Saeki T, 2002, BIOSCI BIOTECH BIOCH, V66, P467; Shneider BL, 2001, J PEDIATR GASTR NUTR, V32, P407, DOI 10.1097/00005176-200104000-00002; Sun AQ, 1998, AM J PHYSIOL-GASTR L, V275, pG1045; Sun AQ, 2003, J BIOL CHEM, V278, P4000, DOI 10.1074/jbc.M207163200; Weihrauch D, 2006, AM J PHYSIOL-GASTR L, V290, pG439, DOI 10.1152/ajpgi.00163.2005; WONG MH, 1994, J BIOL CHEM, V269, P1340	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-5791	1525-3171		POULTRY SCI	Poult. Sci.	APR	2015	94	4					722	727		10.3382/ps/pev027		6	Agriculture, Dairy & Animal Science	Agriculture	CG5QB	WOS:000353347100020		
J	Yoshimura, Y				Yoshimura, Yukinori			Avian beta-defensins expression for the innate immune system in hen reproductive organs	POULTRY SCIENCE			English	Article						beta-defensin; cytokines; Toll-like receptors; ovary; oviduct	TOLL-LIKE RECEPTOR; LOWER OVIDUCTAL SEGMENTS; ANTIGEN-PRESENTING CELLS; SALMONELLA-ENTERITIDIS; FOLLICULAR-GROWTH; OVARIAN-FOLLICLES; LAYING HENS; PROINFLAMMATORY CYTOKINES; ANTIMICROBIAL PEPTIDE; EGGSHELL FORMATION	Avian beta-defensins (AvBDs) attack various microorganisms and may have efficacy to protect tissues from infection by unforeseen pathogenic microbes. This article describes the mechanism by which AvBDs are expressed in the innate immune system in hen reproductive organs. Both ovary and oviduct express Toll-like receptors (TLRs), which recognize microbe-associated molecular patterns, and express and produce AvBDs mRNA and peptides, which are antimicrobial peptides. The interaction of TLRs with their ligands upregulates the expression of AvBDs and proinflammatory cytokines, and proinflammatory cytokines also induce expression of AvBDs. The synthesized AvBDs are predicted to kill the microbes. However, strategies to enhance innate immune functions have not yet been established. Breeding of birds that have a higher ability to synthesize antimicrobial peptides in response to pathogens may be one such strategy. Because the ovary and oviduct are unique organs regulated by the endocrine system, consideration of the role of gonadotropic and gonadal hormones may also be important for the enhancement of local defense function. Physiological information about the mechanism of pathogen recognition and AvBD synthesis is essential to enhance immunodefense functions in the reproductive organs.	[Yoshimura, Yukinori] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Yoshimura, Yukinori] Hiroshima Univ, Res Ctr Anim Sci, Higashihiroshima 7398528, Japan	Yoshimura, Y (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan.	yyosimu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [25292161]	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (No. 25292161).	Mageed AMA, 2008, POULTRY SCI, V87, P979, DOI 10.3382/ps.2007-00283; Abdel-Mageed AM, 2014, VET IMMUNOL IMMUNOP, V162, P132, DOI 10.1016/j.vetimm.2014.10.013; Abdelsalam M, 2010, J POULT SCI, V47, P77, DOI 10.2141/jpsa.009083; Ahlborn G. J., 2006, PROTEIN J, V25, P171; van Dijk A, 2011, VET MICROBIOL, V153, P27, DOI 10.1016/j.vetmic.2011.03.028; Nii T, 2014, THERIOGENOLOGY, V81, P1129, DOI 10.1016/j.theriogenology.2014.02.002; Woods DC, 2009, REPRODUCTION, V137, P987, DOI 10.1530/REP-08-0320; Gautron J, 2007, J BIOL CHEM, V282, P5273, DOI 10.1074/jbc.M610294200; Ozoe A, 2009, VET IMMUNOL IMMUNOP, V127, P259, DOI 10.1016/j.vetimm.2008.10.325; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; Abdelsalam M, 2012, POULTRY SCI, V91, P2877, DOI 10.3382/ps.2012-02312; Murai A, 2013, J POULT SCI, V50, P185, DOI 10.2141/jpsa.0120194; St Paul M, 2013, VET IMMUNOL IMMUNOP, V152, P191, DOI 10.1016/j.vetimm.2012.10.013; Guard-Petter J, 2001, ENVIRON MICROBIOL, V3, P421, DOI 10.1046/j.1462-2920.2001.00213.x; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wellman-Labadie O, 2008, BRIT POULTRY SCI, V49, P133, DOI 10.1080/00071660802001722; Herve-Grepinet V, 2010, ANTIMICROB AGENTS CH, V54, P4401, DOI 10.1128/AAC.00204-10; Hong YH, 2012, POULTRY SCI, V91, P1081, DOI 10.3382/ps.2011-01948; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Nerren JR, 2010, VET IMMUNOL IMMUNOP, V136, P151, DOI 10.1016/j.vetimm.2010.02.017; Iqbal M, 2005, VET IMMUNOL IMMUNOP, V104, P117, DOI 10.1016/j.vetimm.2004.11.003; Keestra AM, 2007, J IMMUNOL, V178, P7110; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Mageed AMA, 2009, REPRODUCTION, V138, P971, DOI 10.1530/REP-09-0181; Ariyadi B, 2012, POULTRY SCI, V91, P1173, DOI 10.3382/ps.2011-02079; Ariyadi B, 2013, THERIOGENOLOGY, V79, P211, DOI 10.1016/j.theriogenology.2012.10.018; Ariyadi B, 2014, POULTRY SCI, V93, P673, DOI 10.3382/ps.2013-03667; Ariyadi B, 2013, POULTRY SCI, V92, P3205, DOI 10.3382/ps.2013-03414; Barua A, 1999, GEN COMP ENDOCR, V114, P28, DOI 10.1006/gcen.1998.7232; Chowdhury VS, 2002, GEN COMP ENDOCR, V125, P132, DOI 10.1006/gcen.2001.7739; Gong DQ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-12; Hasenstein JR, 2007, AVIAN DIS, V51, P561, DOI 10.1637/0005-2086(2007)51[561:CGGCAW]2.0.CO;2; Heryanto B, 1997, POULTRY SCI, V76, P1580; Holt PS, 2003, POULTRY SCI, V82, P1008; Johnson AL, 2007, REPRODUCTION, V133, P609, DOI 10.1530/REP-06-0287; Kogut MH, 2006, MICROBES INFECT, V8, P1866, DOI 10.1016/j.micinf.2006.02.026; Lian L, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-23; Lim W, 2013, MOL CELL ENDOCRINOL, V366, P1, DOI 10.1016/j.mce.2012.10.031; Mageed AMA, 2011, J POULT SCI, V48, P73, DOI 10.2141/jpsa.010058; Michailidis G, 2011, ANIM REPROD SCI, V123, P234, DOI 10.1016/j.anireprosci.2011.01.010; Michailidis G, 2010, ANIM REPROD SCI, V122, P294, DOI 10.1016/j.anireprosci.2010.09.004; Michailidis G, 2012, RES VET SCI, V92, P60, DOI 10.1016/j.rvsc.2010.10.010; Mine Y, 2003, J AGR FOOD CHEM, V51, P249, DOI 10.1021/jf020597x; Nii T, 2013, J POULT SCI, V50, P83, DOI 10.2141/jpsa.0120086; Poland AL, 2001, J FOOD PROTECT, V64, P486; Sonoda Y, 2013, REPRODUCTION, V145, P621, DOI 10.1530/REP-12-0518; Subedi K, 2007, J REPROD DEVELOP, V53, P1227, DOI 10.1262/jrd.19076; Subedi K, 2008, J POULT SCI, V45, P210, DOI 10.2141/jpsa.45.210; Takata T, 2003, POULTRY SCI, V82, P1170; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Wales AD, 2011, AVIAN PATHOL, V40, P429, DOI 10.1080/03079457.2011.606799; Xiao Y., 2004, BMC GENOMICS, V13, P56; Yoshimura Y, 2006, J REPROD DEVELOP, V52, P211, DOI 10.1262/jrd.17070; Yoshimura Yukinori, 1998, Japanese Poultry Science, V35, P314; Yoshimura Y, 1997, BRIT POULTRY SCI, V38, P590, DOI 10.1080/00071669708418041; Yoshimura Y, 2014, AVIAN BIOL RES, V7, P39, DOI 10.3184/175815514X13902927945697; Zheng WM, 1998, J REPROD FERTIL, V114, P45	60	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0032-5791	1525-3171		POULTRY SCI	Poult. Sci.	APR	2015	94	4					804	809		10.3382/ps/peu021		6	Agriculture, Dairy & Animal Science	Agriculture	CG5QB	WOS:000353347100031		
J	Urata, E				Urata, Eizo			The frequency response of rectangular ducts	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART C-JOURNAL OF MECHANICAL ENGINEERING SCIENCE			English	Article						Rectangular duct; oscillating flow; frequency transfer function; equal flow radius; fluid impedance; dimensionless frequency; first-order system approximation	FLOW; LINES	This article considers the oscillatory laminar flow of an incompressible fluid in a rectangular duct and expresses the flow rate due to an oscillatory pressure gradient using a frequency transfer function. For the description of the frequency characteristics, selection of a reference length suitable to the duct cross section is important. The selected reference length in this article is the radius of a circular tube whose flow rate is equal to that of the rectangular duct when the fluids are the same, and applied steady pressure gradients are the same. This reference length makes it easier to distinguish changes in the dynamic characteristics due to magnitude variation of duct cross sections from those due to shape variation of the duct cross sections. Numerical investigation of the exact transfer function reveals that a first-order system accurately approximates the transfer function. The aspect ratio of the rectangle determines the cut-off frequency of the first-order system.	Air & Water Soc, Machida, Tokyo 1940003, Japan	Urata, E (reprint author), Air & Water Soc, Ogawa 2-18-18, Machida, Tokyo 1940003, Japan.	jifujun65@yahoo.co.jp					Colin S, 1998, EUR J MECH B-FLUID, V17, P79, DOI 10.1016/S0997-7546(98)80053-8; IBERALL AS, 1950, J RES NAT BUR STAND, V45, P85, DOI 10.6028/jres.045.008; BROWN F.T., 1962, T ASME D, V84, P547; D'Souza A., 1964, T ASME             D, V86, P589; DRAKE DG, 1965, Q J MECH APPL MATH, V18, P1, DOI 10.1093/qjmam/18.1.1; FAN C, 1965, Z ANGEW MATH PHYS, V16, P351, DOI 10.1007/BF01591915; Franke ME, 1976, T ASME J BASIC ENG, V98, P421; Healey AJ, 1969, ASME WINT ANN M LOS, P1; Huchet F, 2011, EXP FLUIDS, V51, P597, DOI 10.1007/s00348-011-1079-1; Kirshner JM, 1975, DESIGN THEORY FLUIDI, P63; Nichols NB., 1962, ISA T, V1, P5; OBRIEN V, 1975, J FRANKLIN I, V300, P225, DOI 10.1016/0016-0032(75)90106-4; Ray S, 2004, PHYS FLUIDS, V16, P4371, DOI 10.1063/1.1786511; Schaedel HM, 1968, P 3 CRANF FLUID C TU; White FM., 2006, VISCOUS FLUID FLOW, V3rd, P127; Yakhot A, 1999, INT J NUMER METH FL, V29, P935, DOI 10.1002/(SICI)1097-0363(19990430)29:8<935::AID-FLD823>3.3.CO;2-3	16	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4062	2041-2983		P I MECH ENG C-J MEC	Proc. Inst. Mech. Eng. Part C-J. Eng. Mech. Eng. Sci.	APR	2015	229	6					1103	1111		10.1177/0954406214542037		9	Engineering, Mechanical	Engineering	CG7DY	WOS:000353463800009		
J	Endo, T; Kripke, DF; Ancoli-Israel, S				Endo, Takuro; Kripke, Daniel F.; Ancoli-Israel, Sonia			Wake Up Time, Light, and Mood in a Population Sample Age 40-64 Years	Psychiatry Investigation			English	Article						Light; Photometry; Sleep; Depression; Circadian rhythm	PHASE RESPONSE CURVE; BREAST-CANCER RISK; BRIGHT LIGHT; ACTIVITY PATTERNS; ILLUMINATION; SLEEP; MELATONIN; NIGHT; HAMSTERS; CYCLES	Objective Concern that disturbances of sleep and light exposures at night might increase cancer risks have been expressed, but little actual exposure data has been collected. Measurements from a representative population sample were examined to understand the magnitude of in-bed light exposure at night and possible correlates. Methods From 1990 to 1994, a home survey of sleep disorders among adults ages 40-64 was conducted in the City of San Diego California, using stratified representative sampling techniques. Along with questionnaires, sleep logs, and 3-night wrist activity and pulse oximetry measures, bedside illumination was measured with a computer recording system. Questionnaires included the CESD depression scale and a scale of symptoms typical of winter depression. Results Complete data were available from 286 men and women, whose mean in-bed intervals averaged 7 hours and 42 minutes. The mean room illumination during the first part of the night was mean 12.7 lux (median 3.2 lux) and during the last 2 hours in bed averaged 28.7 lux (median 18.9 lux). Nocturnal light exposure was positively correlated with age, male gender, summer season, time in bed, wake-up time, and depressive symptoms. Conclusion Complex bi-directional interactions may take place between sleep disturbances, depression, time in bed, wake-up-time, and in-bed illumination. The most crucial light exposures appear to occur in the last 2 hours in bed, largely after dawn, so daylight exposure may be an important factor.	[Endo, Takuro] Sleep Clin Chofu, Tokyo, Japan; [Kripke, Daniel F.; Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA	Kripke, DF (reprint author), Univ Calif San Diego, Dept Psychiat, 8437 Sugarman Dr, La Jolla, CA 92037 USA.	dkripke1@san.rr.com					Ando K, 2002, ISRAEL J PSYCHIAT, V39, P11; Chang AM, 2012, J PHYSIOL-LONDON, V590, P3103, DOI 10.1113/jphysiol.2011.226555; Gorman MR, 2004, J COMP PHYSIOL A, V190, P631, DOI 10.1007/s00359-004-0522-7; Kloog I, 2011, CHRONOBIOL INT, V28, P76, DOI 10.3109/07420528.2010.531490; Obayashi K, 2013, J AFFECT DISORDERS, V151, P331, DOI 10.1016/j.jad.2013.06.018; Avery DH, 2001, BIOL PSYCHIAT, V50, P205, DOI 10.1016/S0006-3223(01)01200-8; Kantermann T, 2009, CHRONOBIOL INT, V26, P1069, DOI [10.3109/07420520903223984, 10.1080/07420520903223984]; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; MINORS DS, 1991, NEUROSCI LETT, V133, P36, DOI 10.1016/0304-3940(91)90051-T; Evans JA, 2013, NEURON, V80, P973, DOI 10.1016/j.neuron.2013.08.022; Emens J, 2009, PSYCHIAT RES, V168, P259, DOI 10.1016/j.psychres.2009.04.009; Raiewski EE, 2012, CHRONOBIOL INT, V29, P1206, DOI 10.3109/07420528.2012.719965; Jean-Louis G, 2000, BIOL PSYCHIAT, V47, P921, DOI 10.1016/S0006-3223(99)00169-9; BEERSMA DGM, 1993, J BIOL RHYTHM, V8, P340, DOI 10.1177/074873049300800407; Comas M, 2007, J BIOL RHYTHM, V22, P432, DOI 10.1177/0748730407305728; CZEISLER CA, 1989, SCIENCE, V244, P1328, DOI 10.1126/science.2734611; EASTMAN CI, 1992, AM J PHYSIOL, V263, pR428; ESPIRITU RC, 1994, BIOL PSYCHIAT, V35, P403, DOI 10.1016/0006-3223(94)90007-8; Gorman MR, 2006, CHRONOBIOL INT, V23, P245, DOI 10.1080/07420520500521905; Gorman MR, 2005, J BIOL RHYTHM, V20, P38, DOI 10.1177/0748730404271573; Honma K, 1988, JAPAN J PSYCHIAT NEU, V42, P167; Jean-Louis G, 2000, PHYSIOL BEHAV, V68, P347, DOI 10.1016/S0031-9384(99)00186-9; Khalsa SBS, 1997, SLEEP RES, V26, P722; Kripke DF, 2014, PSYCHIAT INVEST, V11, P345, DOI 10.4306/pi.2014.11.4.345; Kripke DF, 1994, EVOLUTION CIRCADIAN, P349; Kripke Daniel F, 2007, J Circadian Rhythms, V5, P4, DOI 10.1186/1740-3391-5-4; Kripke DF, 1993, MELATONIN PINEAL GLA, P211; Kripke DF, 2005, CHRONOBIOL INT, V22, P695, DOI 10.1080/07420520500180439; Kripke DF, 1997, SLEEP, V20, P65; Muscat L, 2005, BRAIN RES, V1044, P59, DOI 10.1016/j.braines.2005.02.083; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schernhammer ES, 2005, J NATL CANCER I, V97, P1084, DOI 10.1093/jnci/dji190; Shanahan TL, 1997, J BIOL RHYTHM, V12, P556, DOI 10.1177/074873049701200610; Tuunainen A, 2002, J AFFECT DISORDERS, V69, P149, DOI 10.1016/S0165-0327(01)00303-2; Williams JBW, 1990, SLTBR 1988 1990 COMP, P207	36	0	0	KOREAN NEUROPSYCHIATRIC ASSOC	SEOUL	RN 522, G-FIVE CENTRAL PLAZA 1685-8 SEOCHO 4-DONG, SEOCHO-GU, SEOUL, 137-882, SOUTH KOREA	1738-3684	1976-3026		PSYCHIAT INVEST	Psychiatry Investig.	APR	2015	12	2					177	182		10.4306/pi.2015.12.2.177		6	Psychiatry	Psychiatry	CG5WW	WOS:000353367600004		
J	Yokoyama, K; Yamada, T; Mitani, H; Yamada, S; Pu, S; Yamanashi, T; Matsumura, H; Nakagome, K; Kaneko, K				Yokoyama, Katsutoshi; Yamada, Takeshi; Mitani, Hideaki; Yamada, Sayaka; Pu, Shenghong; Yamanashi, Takehiko; Matsumura, Hiroshi; Nakagome, Kazuyuki; Kaneko, Koichi			Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression	PSYCHIATRY RESEARCH			English	Article						Depression; Insulin resistance; Homeostasis model assessment of insulin resistance (HOMA-R); Hypothalamic-Pituitary-Adrenal (HPA) axis; Diabetes; Dexamethasone (DEX/CRH) test	FASTING PLASMA-GLUCOSE; LATER-LIFE; MAJOR DEPRESSION; CORTISOL-LEVELS; HPA AXIS; PREVALENCE; DEXAMETHASONE/CRH; HOMEOSTASIS; REACTIVITY; SYMPTOMS	Cortisol dysregulation has been proposed to be involved in depression. Hypothalamic-pituitary-adrenal (HPA) axis dysregulation associated with major depressive disorder (MDD) was previously reported to be higher in the elderly. Furthermore, insulin resistance and the prevalence of type 2 diabetes are known to increase with aging. The aim of the present study was to determine whether a relationship existed between plasma cortisol levels following the dexamethasone/corticotrophin-releasing hormone (DEX/CRH) test and insulin resistance evaluated by the homeostasis model assessment of insulin resistance (HOMA-R) in elderly MDD subjects. Fifteen unmedicated MDD inpatients and 17 age- and sex-matched healthy controls participated in this study. After overnight fasting, blood samples were collected to measure plasma glucose and insulin concentrations, estimate HOMA-R, and perform the DEX/CRH test to evaluate HPA axis function. The value of the area under the time curve of plasma cortisol concentrations (Cort(AUC)) and peak cortisol values (Cort(peak)) following the administration of DEX/CRH both correlated with HOMA-R in MDD group. In contrast, neither Cort(AUC) nor Cort(peak) correlated with HOMA-R in controls. This is the first study to directly demonstrate the relationship between HPA axis dysregulation assessed with the DEX/CRH test and the index of insulin resistance estimated as HOMA-R in elderly MOD patients. (C) 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Yokoyama, Katsutoshi; Mitani, Hideaki; Yamada, Sayaka; Pu, Shenghong; Yamanashi, Takehiko; Matsumura, Hiroshi; Kaneko, Koichi] Tottori Univ, Fac Med, Div Neuropsychiat, Dept Brain & Neurosci, Yonago, Tottori 683, Japan; [Yamada, Takeshi] Kurayoshi Hosp, Div Psychiat, Kurayoshi, Japan; [Nakagome, Kazuyuki] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo, Japan	Yokoyama, K (reprint author), Tottori Univ, Fac Med, Div Neuropsychiat, Dept Brain & Neurosci, 36-1 Nishi Cho, Yonago, Tottori 683, Japan.	kyinyonago@yahoo.co.jp		Nakagome, Kazuyuki/0000-0003-2919-8180	Tottori University Hospital	We received research funding from Tottori University Hospital.	MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; RIZZA RA, 1982, J CLIN ENDOCR METAB, V54, P131; GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Mezuk B, 2012, INT J GERIATR PSYCH, V27, P879, DOI 10.1002/gps.2807; Kunugi H, 2006, NEUROPSYCHOPHARMACOL, V31, P212, DOI 10.1038/sj.npp.1300868; Iwata M, 2013, BRAIN BEHAV IMMUN, V31, P105, DOI 10.1016/j.bbi.2012.12.008; Carpenter LL, 2009, PSYCHONEUROENDOCRINO, V34, P1208, DOI 10.1016/j.psyneuen.2009.03.009; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Mondelli V, 2010, SCHIZOPHR RES, V116, P234, DOI 10.1016/j.schres.2009.08.013; Kunzel HE, 2003, NEUROPSYCHOPHARMACOL, V28, P2169, DOI 10.1038/sj.npp.1300280; Travison TG, 2007, CLIN ENDOCRINOL, V67, P71, DOI 10.1111/j.1365-2265.2007.02837.x; Golden SH, 2004, DIABETES CARE, V27, P429, DOI 10.2337/diacare.27.2.429; Kunugi H, 2004, J PSYCHIAT RES, V38, P123, DOI 10.1016/S0022-3956(03)00103-1; ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914; Schillerstrom JE, 2008, J GERIATR PSYCH NEUR, V21, P183, DOI 10.1177/0891988708320971; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Owashi T, 2008, PSYCHONEUROENDOCRINO, V33, P152, DOI 10.1016/j.psyneuen.2007.10.011; Naismith SL, 2012, PROG NEUROBIOL, V98, P99, DOI 10.1016/j.pneurobio.2012.05.009; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Bergman RN, 2005, J CLIN PSYCHIAT, V66, P504; Bschor T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027613; Di Dalmazi G, 2012, J NUTR METAB, V2012, DOI [10.1155/2012/525093, DOI 10.1155/2012/525093]; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gevasoni N., 2004, J PSYCHIATR RES, V38, P553; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hatzinger M, 2011, J PSYCHIATR RES, V45, P1373, DOI 10.1016/j.jpsychires.2011.05.006; Kunugi Hiroshi, 2012, Japanese Journal of Neuropsychopharmacology, V32, P203; Manoudi F, 2012, ENCEPHALE, V38, P404, DOI 10.1016/j.encep.2012.01.010; Meigs James B, 2003, Curr Diab Rep, V3, P73, DOI 10.1007/s11892-003-0057-2; Mihic Marko, 2008, Curr Diabetes Rev, V4, P122, DOI 10.2174/157339908784220750; Prague JK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f945; Snowdon J, 2001, AUST NZ J PSYCHIAT, V35, P782, DOI 10.1046/j.1440-1614.2001.00968.x; Takeshita J, 2002, AM J PSYCHIAT, V159, P1127, DOI 10.1176/appi.ajp.159.7.1127; Tjokroprawiro Askandar, 2006, Acta Med Indones, V38, P160	38	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	APR	2015	226	2-3					494	498		10.1016/j.psychres.2015.01.026		5	Psychiatry	Psychiatry	CG2HM	WOS:000353095500013		
J	Stickley, A; Koyanagi, A; Leinsalu, M; Ferlander, S; Sabawoon, W; Mckee, M				Stickley, A.; Koyanagi, A.; Leinsalu, M.; Ferlander, S.; Sabawoon, W.; Mckee, M.			Loneliness and health in Eastern Europe: findings from Moscow, Russia	PUBLIC HEALTH			English	Article						Loneliness; Russia; Self-rated health; Mental ill health; Moscow Health Survey	MORTALITY CRISIS; OLDER-ADULTS; TRUST	Objectives: To examine which factors are associated with feeling lonely in Moscow, Russia, and to determine whether loneliness is associated with worse health. Study design: Cross-sectional study. Methods: Data from 1190 participants were drawn from the Moscow Health Survey. Logistic regression analysis was used to examine which factors were associated with feeling lonely and whether loneliness was linked to poor health. Results: Almost 10% of the participants reported that they often felt lonely. Divorced and widowed individuals were significantly more likely to feel lonely, while not living alone and having greater social support reduced the risk of loneliness. Participants who felt lonely were more likely to have poor self-rated health (odds ratio [OR]: 2.28; 95% confidence interval [CI]: 1.38-3.76), and have suffered from insomnia (OR: 2.43; CI: 1.56-3.77) and mental ill health (OR: 2.93; CI: 1.88-4.56). Conclusions: Feeling lonely is linked to poorer health in Moscow. More research is now needed on loneliness and the way it affects health in Eastern Europe, so that appropriate interventions can be designed and implemented to reduce loneliness and its harmful impact on population well-being in this setting. (C) 2015 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.	[Stickley, A.; Koyanagi, A.; Leinsalu, M.; Ferlander, S.] Sodertorn Univ, Stockholm Ctr Hlth Soc Transit SCOHOST, S-14189 Huddinge, Sweden; [Stickley, A.] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo, Japan; [Leinsalu, M.] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Tallinn, Estonia; [Sabawoon, W.] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Mckee, M.] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	Stickley, A (reprint author), Sodertorn Univ, Stockholm Ctr Hlth Soc Transit SCOHOST, S-14189 Huddinge, Sweden.	andrew.stickley@sh.se			Estonian Research Council [IUT5-1]	ML's work was funded in part by the Estonian Research Council (IUT5-1).	Abbott P, 2007, J COMMUNIST STUDIES, V23, P181, DOI 10.1080/13523270701317455; AKERLIND I, 1992, SOC SCI MED, V34, P405, DOI 10.1016/0277-9536(92)90300-F; Hawkley LC, 2007, CURR DIR PSYCHOL SCI, V16, P187, DOI 10.1111/j.1467-8721.2007.00501.x; Andersson L, 1998, AGING MENT HEALTH, V2, P264, DOI 10.1080/13607869856506; Stickley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067978; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Vagero D, 2008, INT J PUBLIC HEALTH, V53, P171, DOI 10.1007/s00038-008-7052-y; Cacioppo JT, 2009, J PERS SOC PSYCHOL, V97, P977, DOI 10.1037/a0016076; Fokkema T, 2012, J PSYCHOL, V146, P201, DOI 10.1080/00223980.2011.631612; Pinquart M, 2003, J SOC PERS RELAT, V20, P31, DOI 10.1177/02654075030201002; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Stickley A, 2009, EUROPE-ASIA STUD, V61, P779, DOI 10.1080/09668130902904951; Kennedy BP, 1998, WORLD DEV, V26, P2029, DOI 10.1016/S0305-750X(98)00094-1; Cacioppo JT, 2003, CURR DIR PSYCHOL SCI, V12, P71, DOI 10.1111/1467-8721.01232; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Ferlander S, 2009, SOC SCI MED, V69, P1323, DOI 10.1016/j.socscimed.2009.08.009; Yang KM, 2011, AGEING SOC, V31, P1368, DOI 10.1017/S0144686X1000139X; Leon DA, 1998, JAMA-J AM MED ASSOC, V279, P790, DOI 10.1001/jama.279.10.790; Bessudnov A, 2012, EUR J PUBLIC HEALTH, V22, P332, DOI 10.1093/eurpub/ckr130; Centre for the Study of Public Policy University of Strathclyde, NEW RUSS BAR 11 QUES; de Jong Gierveld J., 1998, REV CLIN GERONTOLOGY, V8, P73, DOI DOI 10.1017/S0959259898008090; Field M. G., 2000, RUSSIAS TORN SAFETY; Gierveld JDJ, 2010, EUR J AGEING, V7, P121, DOI 10.1007/s10433-010-0144-6; Lauder William, 2006, Psychol Health Med, V11, P233, DOI 10.1080/13548500500266607; Nations United, 2013, DEM SOC STAT MARR DI; Peplau L. A., 1982, LONELINESS SOURCEBOO, P1; Richard Rose, 2009, UNDERSTANDING POSTCO; Rose R, 2010, J COMMUNIST STUD TRA, V26, P80; Rose R, 2000, SOC SCI MED, V51, P1421, DOI 10.1016/S0277-9536(00)00106-4; Rosstat, 2013, REG ROSS SOTS EK POK; Round J, 2006, OXFORD DEV STUDIES, V34, P441, DOI DOI 10.1080/13600810601045791; Secor AJ, 2005, T I BRIT GEOGR, V30, P66, DOI 10.1111/j.1475-5661.2005.00152.x; Shevchenko O., 2009, CRISIS EVERYDAY POST; Stack S, 1998, SOCIOL PERSPECT, V41, P415; Victor Christina R, 2012, J Cross Cult Gerontol, V27, P65, DOI 10.1007/s10823-012-9161-6; Weiss RS, 1982, LONELINESS SOURCEBOO, P71; World Health Organization, 2014, HLTH ALL DAT HFA DB	37	0	0	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0033-3506	1476-5616		PUBLIC HEALTH	Public Health	APR	2015	129	4					403	410		10.1016/j.puhe.2014.12.021		8	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CG3NJ	WOS:000353186600016		
J	Doi, A				Doi, Akihiro			An obscured narrow-line Seyfert 1 galaxy candidate, Mrk 1388 with nonthermal jets	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						galaxies: active; galaxies: bulges; galaxies: individual (Mrk 1388); galaxies: jets; galaxies: Seyfert; quasars: supermassive black holes; radio continuum: galaxies	SUPERMASSIVE BLACK-HOLES; ACTIVE GALACTIC NUCLEI; FUNDAMENTAL PLANE; X-RAY; INFRARED-SPECTROSCOPY; STARBURST GALAXIES; SERSIC INDEX; MASS; PSEUDOBULGES; SAMPLE	Mrk 1388 has an unusual Seyfert nucleus that shows narrow emission-line components without broad emission-line ones, but shows a strong featureless continuum and strong iron-forbidden, high-ionization emission lines. The apparent coexistence of type-1/2 characteristics is potentially attributed to a heavily obscured broad-line region or to an intermediate-mass black hole with a broad-line component that is intrinsically narrower than those of typical narrow-line Seyfert 1 (NLS1) galaxies. Our observation carried out by using very-long-baseline interferometry (VLBI) reveals high-brightness radio emission in nonthermal jets emerging from an active galactic nucleus (AGN) with a significant radio luminosity. Furthermore, we investigate the radial profile of the host galaxy using a Hubble Space Telescope (HST) image, which shows a Se ' rsic index suggestive of a pseudobulge. Using the VLBI and HST results which essentially are not affected by dust extinction, we apply the three individual methods to an estimate of the black hole mass and obtain three similar ones: (0.76-5.4) x 10(6) M-circle dot, 1.5 x 10(6) M-circle dot, and 4.1 x 10(6) M-circle dot. These masses are within a range that is fitted with typical NLS1 galaxies rather than with intermediate-mass black holes. Based on the estimated masses, a full width at half maximum FWHM(H beta) of approximately 1200-1700 km s(-1) should have been seen. The scenario in a heavily absorbed NLS1 nucleus can explain the peculiarities previously observed.	[Doi, Akihiro] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuou Ku, Sagamihara, Kanagawa 2298510, Japan; [Doi, Akihiro] Grad Univ Adv Studies, Dept Space & Astronaut Sci, Chuou Ku, Sagamihara, Kanagawa 2298510, Japan	Doi, A (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuou Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.	akihiro.doi@vsop.isas.jaxa.jp			NASA [NAS 5-26555]; Japan Society for the Promotion of Science (JSPS) [24340042]	We used the US National Aeronautics and Space Administration's (NASA) Astrophysics Data System (ADS) abstract service and NASA/IPAC Extragalactic Database (NED), which is operated by the Jet Propulsion Laboratory (JPL). The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. This work is based on an observation made with the NASA/ESA Hubble Space Telescope, obtained from the Data Archive at the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555. This observation is associated with program #5479. This study was partially supported by a Grants-in-Aid for Scientific Research (B; 24340042, AD) from Japan Society for the Promotion of Science (JSPS).	OSTERBROCK DE, 1985, ASTROPHYS J, V297, P166, DOI 10.1086/163513; Maiolino R, 1998, ASTRON ASTROPHYS, V338, P781; Kaspi S, 2005, ASTROPHYS J, V629, P61, DOI 10.1086/431275; Cote P, 2006, ASTROPHYS J SUPPL S, V165, P57, DOI 10.1086/504042; Kormendy J, 2011, NATURE, V469, P374, DOI 10.1038/nature09694; Greene JE, 2007, ASTROPHYS J, V670, P92, DOI 10.1086/522082; PREDEHL P, 1995, ASTRON ASTROPHYS, V293, P889; Heinz S, 2003, MON NOT R ASTRON SOC, V343, pL59, DOI 10.1046/j.1365-8711.2003.06918.x; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; DAHARI O, 1988, ASTROPHYS J SUPPL S, V67, P249, DOI 10.1086/191273; Filippenko AV, 2003, ASTROPHYS J, V588, pL13, DOI 10.1086/375361; Yuan F, 2009, ASTROPHYS J, V703, P1034, DOI 10.1088/0004-637X/703/1/1034; Bassani L, 1999, ASTROPHYS J SUPPL S, V121, P473, DOI 10.1086/313202; Graham AW, 2007, ASTROPHYS J, V655, P77, DOI 10.1086/509758; Pogge RW, 2000, NEW ASTRON REV, V44, P381, DOI 10.1016/S1387-6473(00)00065-8; Plotkin RM, 2012, MON NOT R ASTRON SOC, V419, P267, DOI 10.1111/j.1365-2966.2011.19689.x; Kording E, 2006, ASTRON ASTROPHYS, V456, P439, DOI 10.1051/0004-6361:20054144; Fisher DB, 2008, ASTRON J, V136, P773, DOI 10.1088/0004-6256/136/2/773; BEASLEY AJ, 1995, ASTR SOC P, V82, P327; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Boker T, 2002, ASTRON J, V123, P1389, DOI 10.1086/339025; Wrobel JM, 2006, ASTROPHYS J, V646, pL95, DOI 10.1086/507102; Zhou HY, 2006, ASTROPHYS J SUPPL S, V166, P128, DOI 10.1086/504869; Heckman TM, 2005, ASTROPHYS J, V634, P161, DOI 10.1086/491665; de Gasperin F, 2011, MON NOT R ASTRON SOC, V415, P2910, DOI 10.1111/j.1365-2966.2011.18904.x; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; CONDON JJ, 1995, ASTRON J, V109, P2318, DOI 10.1086/117454; Dennefeld M, 2003, ASTRON ASTROPHYS, V406, P527, DOI 10.1051/0004-6361:20030702; Doi A, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/41; Fey A., 2009, 35 IERS; GOODRICH RW, 1994, ASTROPHYS J, V422, P521, DOI 10.1086/173746; Graham AW, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/151; Greisen E. W., 2003, INFORM HANDLING ASTR, P109; Gultekin K, 2014, ASTROPHYS J LETT, V788, DOI 10.1088/2041-8205/788/2/L22; Markaryan B. E., 1979, Astrophysics, V15, DOI 10.1007/BF01005372; Mathur S, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/146; Middelberg E, 2004, ASTRON ASTROPHYS, V417, P925, DOI 10.1051/0004-6361:20040019; Nagar NM, 2002, ASTRON ASTROPHYS, V391, pL21, DOI 10.1051/0004-6361:20021039; Netzer H., 1990, ACTIVE GALACTIC NUCL, V20, P57; OSTERBROCK DE, 1985, PUBL ASTRON SOC PAC, V97, P25, DOI 10.1086/131487; Osterbrock D. E., 1984, BAAS, V16, P987; Shepherd M. C., 1994, B AM ASTRON SOC, V26, P987; Smith DA, 1998, ASTROPHYS J, V494, P150, DOI 10.1086/305175; ULVESTAD JS, 1995, ASTRON J, V109, P81, DOI 10.1086/117258; Veilleux S, 1997, ASTROPHYS J, V477, P631, DOI 10.1086/303735; Veron-Cetty MP, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014188; Voges W., 2000, IAU CIRC, P7432; XANTHOPOULOS E, 1991, ASTRON J, V102, P1980, DOI 10.1086/116020; Zwicky F., 1963, CATALOGUE GALAXIES C, V2	51	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							15	10.1093/pasj/psu147		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200003		
J	Fukue, J				Fukue, Jun			Relativistic radiative transfer and relativistic plane-parallel flows	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; radiative transfer; relativistic processes; stars: winds, outflows	VARIABLE EDDINGTON FACTOR; LUMINOUS DISK II	Relativistic radiative transfer and relativistic plane-parallel flows accelerated from their base like accretion disk winds are numerically examined under the special relativistic treatment. We first solve the relativistic transfer equation iteratively, using a given velocity field, and obtain specific intensities as well as moment quantities. Using the obtained flux, we then solve the hydrodynamical equation, and obtain the new velocity field and the mass-loss rate as an eigen value. We repeat these double-iteration processes until both the intensity and velocity profiles converge. Under this double iteration, we solve the relativistic radiative transfer equation and relativistic flows in the vertical direction, simultaneously. The flows are gradually accelerated, as the optical depth decreases towards the surface. The mass-loss rate (.)J is roughly expressed in terms of the optical depth tau(b) and terminal speed beta(s) of the flow as (.)J similar to 10 tau(b)beta(-3/4)(s).	Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan	Fukue, J (reprint author), Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan.	fukue@cc.osaka-kyoiku.ac.jp					LEVERMORE CD, 1981, ASTROPHYS J, V248, P321, DOI 10.1086/159157; Ohsuga K, 2005, ASTROPHYS J, V628, P368, DOI 10.1086/430728; Castor J., 2004, RAD HYDRODYNAMICS; Chandrasekhar S., 1934, Monthly Notices of the Royal Astronomical Society, V94; Chandrasekhar S., 1960, RAD TRANSFER; Eddington A. S., 1926, INTERNAL CONSITITUTI; Fukue J, 2006, PUBL ASTRON SOC JPN, V58, P461; Fukue J, 2005, PUBL ASTRON SOC JPN, V57, P1023; Fukue J, 2008, PUBL ASTRON SOC JPN, V60, P377; Fukue J, 2012, PUBL ASTRON SOC JPN, V64; Fukue J, 2006, PUBL ASTRON SOC JPN, V58, P187; Fukue J, 2008, PUBL ASTRON SOC JPN, V60, P627; Fukue J, 2005, PUBL ASTRON SOC JPN, V57, P841; Fukue J, 2008, PUBL ASTRON SOC JPN, V60, P1209; Fukue J, 2006, PUBL ASTRON SOC JPN, V58, P1073; Fukue J, 2009, PUBL ASTRON SOC JPN, V61, P367; Fukue J, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu048; Kato S., 2008, BLACK HOLE ACCRETION; Kato S., 1998, BLACK HOLE ACCRETION; Koerner A., 1992, ASTRON ASTROPHYS, V265, P345; Kosirev N.A., 1934, Monthly Notices of the Royal Astronomical Society, V94; LEVERMORE CD, 1984, J QUANT SPECTROSC RA, V31, P149, DOI 10.1016/0022-4073(84)90112-2; Mihalas D., 1970, STELLAR ATMOSPHERES; Mihalas D., 1984, FDN RAD HYDRODYNAMIC; Mihalas D, 2001, J QUANT SPECTROSC RA, V71, P61, DOI 10.1016/S0022-4073(01)00013-9; Milne E. A., 1921, MNRAS, V81, P382; Peraiah A., 2002, INTRO RAD TRANSFER M; Rybicki G. B., 1979, RAD PROCESSES ASTROP	28	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							14	10.1093/pasj/psu146		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200002		
J	Haze, K; Enya, K; Abe, L; Takahashi, A; Kotani, T; Yamamuro, T				Haze, Kanae; Enya, Keigo; Abe, Lyu; Takahashi, Aoi; Kotani, Takayuki; Yamamuro, Tomoyasu			Experimental demonstration of binary shaped pupil mask coronagraphs for telescopes with obscured pupils	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						instrumentation: high angular resolution; planetary systems; telescopes		We present the fabrication and experimental demonstration of three free-standing binary shaped pupil mask coronagraphs, which are applicable for telescopes with partially obscured pupils. Three masks, designed to be complementary (labeled Mask-A, Mask-B, and Mask-C), were formed in 5 mu m thick nickel. The design of Mask-A is based on a one-dimensional barcode mask. The design principle of Mask-B is similar, but has a smaller inner working angle and a lower contrast than Mask-A. Mask-C is based on a concentric ring mask and provides the widest dark region and a symmetric point spread function. Mask-A and Mask-C were both designed to produce a flexibly tailored dark region (i.e., non-uniform contrast). The contrast was evaluated using a light source comprising a broadband super-luminescent light-emitting diode with a center wavelength of 650 nm, and the measurements were carried out in a large vacuum chamber. Active wavefront control was not applied in this work. The coronagraphic images obtained by experiment were mostly consistent with the designs. The contrast of Mask-A within the ranges 3.3-8 lambda/D and 8-12 lambda/D was similar to 10(-4)-10(-7) and similar to 10(-7), respectively, where. is the wavelength and D is the pupil diameter. The contrast of Mask-B was similar to 10(-4) and that of Mask-C over an extended field of view (5-25 lambda/D) was similar to 10(-5)-10(-6). The effect of tilting the masks was investigated, and found to be irrelevant at the similar to 10(-7) contrast level. Therefore the masks can be tilted to avoid ghosting. These high-contrast free-standing masks	[Haze, Kanae; Enya, Keigo; Takahashi, Aoi] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Abe, Lyu] Univ Nice Sophia Antipolis, UMR 6525, Lab Hippolyte Fizeau, F-06108 Nice, France; [Takahashi, Aoi] Grad Univ Adv Studies, Dept Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Kotani, Takayuki] Natl Inst Nat Sci, Natl Astron Observ Japan, Interuniv Res Inst Corp, Mitaka, Tokyo 1818588, Japan; [Yamamuro, Tomoyasu] Optcraft, Sagamihara, Kanagawa 2291101, Japan	Haze, K (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	haze@ir.isas.jaxa.jp			Japan Science and Technology Agency from Japan Society for the Promotion of Science [24840049, 22244016]	First of all we are grateful to R. J. Vanderbei and the LOQO solver presented by him (Vanderbei 1999). This work was financially supported by the Japan Science and Technology Agency and Grants-in-Aid for Scientific Research (Nos. 24840049 and 22244016) from the Japan Society for the Promotion of Science. We thank T. Ishii from Photo Precision Co., Ltd., A. Suenaga from HOWA Sangyo Co., Ltd, and their colleagues in each of these companies.	Vanderbei RJ, 1999, OPTIM METHOD SOFTW, V11-2, P485, DOI 10.1080/10556789908805760; Vanderbei RJ, 2003, ASTROPHYS J, V599, P686, DOI 10.1086/379238; Vanderbei RJ, 2004, ASTROPHYS J, V615, P555, DOI 10.1086/423947; Haze K, 2011, PUBL ASTRON SOC JPN, V63, P873; Kasdin NJ, 2005, APPL OPTICS, V44, P1117, DOI 10.1364/AO.44.001117; Haze K, 2009, ADV SPACE RES, V43, P181, DOI 10.1016/j.asr.2008.10.007; Enya K, 2007, ASTRON ASTROPHYS, V461, P783, DOI 10.1051/0004-6361:20066351; Enya K, 2011, ADV SPACE RES, V48, P323, DOI 10.1016/j.asr.2011.03.010; Enya K, 2008, ASTRON ASTROPHYS, V480, P899, DOI 10.1051/0004-6361:20078627; Belikov R., 2007, P SOC PHOTO-OPT INS, V6693; Carlotti A., 2011, ARXIV11084050; Enya K, 2010, PUBL ASTRON SOC JPN, V62, P1407; Enya K, 2011, PROC SPIE, V8146, DOI 10.1117/12.893508; Enya K, 2012, PUBL ASTRON SOC JPN, V64; Fukagawa M., 2009, P SPICA JOINT EUR JA; Guyon O., 2009, P SOC PHOTO-OPT INS, V7440; Haze K., 2012, THESIS GRADUATE U AD; Matsuo T, 2011, ADV SPACE RES, V47, P1455, DOI 10.1016/j.asr.2011.01.012; Schneider J., 2006, P ANN M FRENCH SOC A, P429; Spergel D. N., 2001, ASTROPH0101142; Tanaka S, 2006, PUBL ASTRON SOC JPN, V58, P627; Traub WA, 2006, P SOC PHOTO-OPT INS, V6268, pT2680, DOI 10.1117/12.673608; Traub W. A., 2002, ASTROPH0205369; Vanderbei RJ, 2003, ASTROPHYS J, V590, P593, DOI 10.1086/374971	24	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							28	10.1093/pasj/psu161		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200016		
J	Kamitsukasa, F; Koyama, K; Uchida, H; Nakajima, H; Hayashida, K; Mori, K; Katsuda, S; Tsunemi, H				Kamitsukasa, Fumiyoshi; Koyama, Katsuji; Uchida, Hiroyuki; Nakajima, Hiroshi; Hayashida, Kiyoshi; Mori, Koji; Katsuda, Satoru; Tsunemi, Hiroshi			Global distribution of ionizing and recombining plasmas in the supernova remnant G290.1-0.8	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						ISM: abundances; ISM: individual objects (G290.1-0.8); ISM: supernova remnants; X-rays: ISM	FORMED DENSE SHELL; X-RAY-EMISSION; FE-RICH EJECTA; IGR J11014-6103; IC 443; SPECTROMETER ABOARD; THERMAL CONDUCTION; MODELING W44; HOT INTERIOR; SUZAKU	We report on the Suzaku results of the mixed-morphology supernova remnant (SNR) G290.1-0.8 (MSH 11-61A). The SNR has an asymmetric structure extended to the southeast and the north-west. In the X-ray spectra of the center and the north-west regions, we discover recombining plasma features with a strong Si Ly alpha and radiative recombination continuum at similar to 2.7 keV. These features are the most significant in the north-west region, and the spectra are well reproduced with a recombining plasma of kT(e) = 0.5 keV, whereas the spectra of other regions are expressed by an ionizing plasma of kT(e) = 0.6 keV. The recombining plasma has over-solar abundances, while the ionizing plasma has roughly solar abundances. Hence they are likely ejecta and of interstellar medium (ISM) origin, respectively. The recombining plasma in the north-west of G290.1-0.8 would be generated by a break-out of the supernova ejecta from a high density circumstellar medium to a low density ISM.	[Kamitsukasa, Fumiyoshi; Koyama, Katsuji; Nakajima, Hiroshi; Hayashida, Kiyoshi; Tsunemi, Hiroshi] Osaka Univ, Dept Earth & Space Sci, Toyonaka, Osaka 5600043, Japan; [Koyama, Katsuji; Uchida, Hiroyuki] Kyoto Univ, Grad Sch Sci, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan; [Mori, Koji] Miyazaki Univ, Fac Engn, Dept Appl Phys & Elect Engn, Miyazaki 8892192, Japan; [Katsuda, Satoru] Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2298510, Japan	Kamitsukasa, F (reprint author), Osaka Univ, Dept Earth & Space Sci, 1-1 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	kamitsukasa@ess.sci.osaka-u.ac.jp	XRAY, SUZAKU/A-1808-2009		Japan Society for the Promotion of Science (JSPS) [23000004, 23340071, 24540229, 24684010, 24740167, 25800119, 26800102]	We thank all members of the Suzaku operation and calibration teams. This work is supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 23000004, 23340071, 24540229, 24684010, 24740167, 25800119, and 26800102.	Jones TW, 1998, PUBL ASTRON SOC PAC, V110, P125, DOI 10.1086/316122; Ohnishi T, 2011, PUBL ASTRON SOC JPN, V63, P527; LYNE AG, 1994, NATURE, V369, P127, DOI 10.1038/369127a0; Slane P, 2002, ASTROPHYS J, V564, P284, DOI 10.1086/324155; Ozawa M, 2009, ASTROPHYS J LETT, V706, pL71, DOI 10.1088/0004-637X/706/1/L71; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Pavan L, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322588; Abdo AA, 2010, ASTROPHYS J, V712, P459, DOI 10.1088/0004-637X/712/1/459; Rho J, 1998, ASTROPHYS J, V503, pL167, DOI 10.1086/311538; Reynoso EM, 2006, MON NOT R ASTRON SOC, V369, P416, DOI 10.1111/j.1365-2966.2006.10325.x; Kaneda H, 1997, ASTROPHYS J, V491, P638, DOI 10.1086/304965; ITOH H, 1989, MON NOT R ASTRON SOC, V236, P885; KESTEVEN MJ, 1987, ASTRON ASTROPHYS, V183, P118; MILNE DK, 1989, P ASTRON SOC AUST, V8, P187; Kushino A, 2002, PUBL ASTRON SOC JPN, V54, P327; Yamaguchi H, 2009, ASTROPHYS J LETT, V705, pL6, DOI 10.1088/0004-637X/705/1/L6; Pavan L, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117379; Brinkman AC, 2000, ASTROPHYS J, V530, pL111, DOI 10.1086/312504; Borkowski KJ, 2006, ASTROPHYS J, V652, P1259, DOI 10.1086/508335; Cox DP, 1999, ASTROPHYS J, V524, P179, DOI 10.1086/307781; Ergin T, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/65; Filipovic M. D., 2005, SERB ASTRON J, V170, P47; Garcia F, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201218959; Halpern JP, 2014, ASTROPHYS J LETT, V795, DOI 10.1088/2041-8205/795/2/L27; Ishisaki Y, 2007, PUBL ASTRON SOC JPN, V59, pS113; KESTEVEN MJ, 1968, AUST J PHYS, V21, P739; Koyama K, 2007, PUBL ASTRON SOC JPN, V59, pS23; Miceli M, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913713; Mitsuda K, 2007, PUBL ASTRON SOC JPN, V59, pS1; Nakajima H, 2008, PUBL ASTRON SOC JPN, V60, pS1; Ohnishi T, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/74; Sawada M, 2012, PUBL ASTRON SOC JPN, V64; Serlemitsos PJ, 2007, PUBL ASTRON SOC JPN, V59, pS9; SEWARD FD, 1990, ASTROPHYS J SUPPL S, V73, P781, DOI 10.1086/191489; Henley DB, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/92; Shelton RL, 1999, ASTROPHYS J, V524, P192, DOI 10.1086/307799; Shimizu T, 2012, PUBL ASTRON SOC JPN, V64, DOI 10.1093/pasj/64.2.24; Tawa N, 2008, PUBL ASTRON SOC JPN, V60, pS11; Uchida H, 2012, PUBL ASTRON SOC JPN, V64; Uchiyama H, 2013, PUBL ASTRON SOC JPN, V65; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; Yamaguchi H, 2011, PUBL ASTRON SOC JPN, V63, pS837; Yamauchi S, 2013, PUBL ASTRON SOC JPN, V65; Yusef-Zadeh F, 2003, ASTROPHYS J, V585, P319	44	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							16	10.1093/pasj/psu149		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200004		
J	Kato, T; Hambsch, FJ; Monard, B				Kato, Taichi; Hambsch, Franz-Josef; Monard, Berto			ASASSN-14cc: A likely helium analog of RZ Leonis Minoris	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; novae, cataclysmic variables; stars: dwarf novaestars: individual (ASASSN-14cc)	TIME TRANSIENT SURVEY; ER-URSAE-MAJORIS; AM CVN STARS; SU UMA STAR; DWARF-NOVA; PERIOD VARIATIONS; CATACLYSMIC VARIABLES; SUPERHUMPS; MODEL; SUPEROUTBURST	We identified that ASASSN-14cc is a very active dwarf nova spending approximately 60% of the time in outburst. Our long-term photometry revealed that the object shows long outbursts recurring with a period of 21-33 d and very brief short outbursts lasting less than 1 d. The maximum fading rate exceeds 2.8 mag d(-1). The duration of the long outbursts is 9-18 d, comprising 50%-60% of the recurrence time of long outbursts. We detected 0.01560-0.01562 d (22.5min) modulations during long outbursts, which we identified as superhumps. These features indicate that ASASSN-14cc has outburst parameters very similar to the extremely unusual dwarf nova RZ LMi but with a much shorter superhump period. All the observations can be naturally understood, considering that this object is a helium analog (AMCVn-type object) of RZ LMi. The highest outburst activity among AMCVn-type objects can be understood as the high-mass transfer rate expected for the orbital period giving a condition close to the stability limit of the accretion disk. In contrast to RZ LMi, this object shows little evidence for premature quenching of the superoutburst, which has been proposed to explain the unusual outburst parameters in RZ LMi.	[Kato, Taichi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Hambsch, Franz-Josef] GEOS, F-28300 Bailleau Leveque, France; [Hambsch, Franz-Josef] Bundesdeutsch Arbeitsgemeinschaft Veranderliche S, D-12169 Berlin, Germany; [Hambsch, Franz-Josef] VVS, B-2400 Mol, Belgium; [Monard, Berto] Ctr Backyard Astrophys Kleinkaroo, Kleinkaroo Observ, ZA-6660 Calitzdorp, South Africa	Kato, T (reprint author), Kyoto Univ, Dept Astron, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	tkato@kusastro.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported by a Grant-in-Aid "Initiative for High-Dimensional Data-Driven Science through Deepening of Sparse Modeling" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We are grateful to the ASAS-SN team for making their detections of CV outbursts available to the public. We are grateful to the Catalina Real-time Transient Survey team for making their database available to the public. We thank K. Isogai for helping in the compilation of the observation.	Woudt PA, 2012, MON NOT R ASTRON SOC, V421, P2414, DOI 10.1111/j.1365-2966.2012.20476.x; Thorstensen JR, 2002, ASTROPHYS J, V567, pL49, DOI 10.1086/339905; Drake AJ, 2009, ASTROPHYS J, V696, P870, DOI 10.1088/0004-637X/696/1/870; Nogami D, 1995, PUBL ASTRON SOC JPN, V47, P897; Nelemans G, 2005, ASTR SOC P, V330, P27; Levitan D, 2015, MON NOT R ASTRON SOC, V446, P391, DOI 10.1093/mnras/stu2105; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; FERNIE JD, 1989, PUBL ASTRON SOC PAC, V101, P225, DOI 10.1086/132426; Hambsch Franz-Josef, 2012, Journal of the American Association of Variable Star Observers, V40; Hellier C., 2001, CATACLYSMIC VARIABLE; Hellier C, 2001, PUBL ASTRON SOC PAC, V113, P469, DOI 10.1086/319540; Kato T, 2009, PUBL ASTRON SOC JPN, V61, pS395; Kato T, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu077; KATO T, 1995, PUBL ASTRON SOC JPN, V47, P163; Kato T, 2013, PUBL ASTRON SOC JPN, V65; Kato T, 2010, PUBL ASTRON SOC JPN, V62, P1525; Kato T, 2000, MON NOT R ASTRON SOC, V315, P140, DOI 10.1046/j.1365-8711.2000.03440.x; Kato T, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu014; Levitan D, 2013, MON NOT R ASTRON SOC, V430, P996, DOI 10.1093/mnras/sts672; Levitan D, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/114; Olech A, 2008, ACTA ASTRONOM, V58, P131; OSAKI Y, 1995, PUBL ASTRON SOC JPN, V47, pL11; OSAKI Y, 1995, PUBL ASTRON SOC JPN, V47, pL25; OSAKI Y, 1989, PUBL ASTRON SOC JPN, V41, P1005; Osaki Y, 1996, PUBL ASTRON SOC PAC, V108, P39, DOI 10.1086/133689; ROBERTSON JW, 1995, PUBL ASTRON SOC PAC, V107, P443, DOI 10.1086/133572; Shappee BJ, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/48; Solheim JE, 2010, PUBL ASTRON SOC PAC, V122, P1133; STELLINGWERF RF, 1978, ASTROPHYS J, V224, P953, DOI 10.1086/156444; Tsugawa M, 1997, PUBL ASTRON SOC JPN, V49, P75; Uemura M, 2002, PUBL ASTRON SOC JPN, V54, pL15; Warner B, 1995, CATACLYSMIC VARIABLE; Woudt P. A., 2013, ASTRON TELEGRAM, P4726	33	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							L2	10.1093/pasj/psv010		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200001		
J	Kawakita, H; Fujii, M; Nagashima, M; Kajikawa, T; Kubo, N; Arai, A				Kawakita, Hideyo; Fujii, Mitsugu; Nagashima, Masayoshi; Kajikawa, Tomoyo; Kubo, Natsuki; Arai, Akira			Formation of C-2 and CN in nova V2676 Oph around its visual brightness maximum	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						molecular processes; novae, cataclysmic variables; nuclear reactions, nucleosynthesis, abundances	NOVA-HERCULIS-1934; EVOLUTION	The slow nova V2676 Oph was unique in that both C2 and CN molecules were observed during its early phase around the visual brightness maximum. The absorption bands of these molecules were detected using spectroscopic techniques and disappeared within several days. The formation of CO was followed by dust formation, which was confirmed via observations in the latter phase of the nova. The formation of molecules is critically important in understanding the origin of dust grains in novae; however, the formation mechanism of C2 and CN molecules in the early phase of novae remain unclear. Here we report optical spectroscopic observations of the dust-forming nova V2676 Oph in the early phase, and we use these data in addition to spectroscopic observations reported previously to discuss the origin of diatomic molecules in the nova. We conclude that C2 and CN molecules formed in the nova outflow when the outer gas envelope cooled sufficiently and that they survived for more than 2 days but less than 7 days in the nova outflow.	[Kawakita, Hideyo] Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto 6038555, Japan; [Fujii, Mitsugu] Fujii Kurosaki Observ, Kurashiki, Okayama 7138126, Japan; [Nagashima, Masayoshi; Kajikawa, Tomoyo; Kubo, Natsuki] Kyoto Sangyo Univ, Kita Ku, Kyoto 6038555, Japan; [Arai, Akira] Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan	Kawakita, H (reprint author), Kyoto Sangyo Univ, Koyama Astron Observ, Kita Ku, Kyoto 6038555, Japan.	kawakthd@cc.kyoto-su.ac.jp			MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan) [2014-2018, S1411028]	This work was financially supported by MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan)-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018, S1411028 (H. Kawakita). We acknowledge with thanks the variable star observations from the AAVSO International Database contributed by observers worldwide and used in this research. Furthermore, we acknowledge with thanks the spectroscopic observations with the 1.5 m telescope operated by the SMARTS Consortium at Cerro Tololo Interamerican Observatory.	Adande GR, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/194; WILLIAMS RE, 1992, ASTRON J, V104, P725, DOI 10.1086/116268; Walter FM, 2012, PUBL ASTRON SOC PAC, V124, P1057, DOI 10.1086/668404; ANTIPOVA LI, 1969, SOV ASTRON, V13, P288; Evans A, 2008, CAM ASTROPH, P308; HAUSCHILDT PH, 1994, ASTR SOC P, V64, P705; Nagashima M, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/2/L26; Nagashima M., 2015, ACTA POLYTE IN PRESS; Nishiyama H., 2012, CBET, P3072; Nittler L. R., 2008, P 10 S NUCL COSM POS; Pontefract M, 2004, MON NOT R ASTRON SOC, V347, P1294, DOI 10.1111/j.1365-2966.2004.07330.x; Rudy R. J., 2012, CBET, P3103; Sanford R. F., 1935, PASP, V47, P209; Shore SN, 2008, CAM ASTROPH, P194; SNEDEN C, 1975, MON NOT R ASTRON SOC, V170, P533; Starrfield S., 2008, CLASSICAL NOVAE, V2nd, P308; Stoy R. H., 1935, PASP, V47, P50, DOI 10.1086/124536; Sytov A. Yu., 2007, ASTRON ZH, V84, P926; Wilson O. C., 1935, PASP, V47, P53, DOI 10.1086/124538	19	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							17	10.1093/pasj/psu150		8	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200005		
J	Sai, S; Itoh, Y; Fukagawa, M; Shibai, H; Sumi, T				Sai, Shoko; Itoh, Yoichi; Fukagawa, Misato; Shibai, Hiroshi; Sumi, Takahiro			Near-infrared image of the debris disk around HD 15115	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						circumstellar matter; planet-disk interactions; stars: individual (HD 15115); techniques: high angular resolution	SCATTERED-LIGHT IMAGES; CIRCUMSTELLAR DISK; GIANT PLANETS; HR 8799; SIGNATURES; MASS; PLANETESIMALS; ASYMMETRIES; TELESCOPE; EVOLUTION	We present a Subaru/Infrared Camera and Spectrograph H-band image of the edge-on debris disk around the F2V star HD15115. We detected the debris disk, which has a bow shape and an asymmetric surface brightness, at a projected separation of 1 ''-3 '' (similar to 50-150 au). The disk surface brightness is similar to 0.5-1.5 mag brighter on the western side than on the eastern side. We use an inclined annulus disk model to probe the disk geometry. The model fitting suggests that the disk has an inner hole with a radius of 86 au and an eccentricity of 0.06. The disk model also indicates that the amount of dust on the western side is 2.2 times larger than that on the eastern side. A several Jupiter-mass planet may exist at greater than or similar to 45 au and capture grains at the Lagrangian points to open the eccentric gap. This scenario can explain both the eccentric gap and the difference in the amount of dust. In case of the stellar age of several 100 Myr, a dramatic planetesimal collision possibly causes the dust to increase in the western side. Interstellar medium interaction is also considered as a possible explanation of the asymmetric surface brightness, however, it hardly affects large grains in the vicinity of the inner hole.	[Sai, Shoko; Itoh, Yoichi] Univ Hyogo, Grad Sch Mat Sci, Kamigori, Hyogo 6781297, Japan; [Sai, Shoko; Itoh, Yoichi] Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan; [Fukagawa, Misato; Shibai, Hiroshi; Sumi, Takahiro] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Sai, S (reprint author), Univ Hyogo, Grad Sch Mat Sci, 3-2-1 Kouto, Kamigori, Hyogo 6781297, Japan.	sai@nhao.jp					Kuchner MJ, 2003, ASTROPHYS J, V588, P1110, DOI 10.1086/374213; Marois C, 2006, ASTROPHYS J, V641, P556, DOI 10.1086/500401; Chiang E, 2009, ASTROPHYS J, V693, P734, DOI 10.1088/0004-637X/693/1/734; Williams JP, 2006, ASTROPHYS J, V653, P1480, DOI 10.1086/508919; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Zuckerman B, 2004, ASTROPHYS J, V603, P738, DOI 10.1086/381700; Strubbe LE, 2006, ASTROPHYS J, V648, P652, DOI 10.1086/505736; Marois C, 2008, SCIENCE, V322, P1348, DOI 10.1126/science.1166585; Debes JH, 2009, ASTROPHYS J, V702, P318, DOI 10.1088/0004-637X/702/1/318; Kalas P, 2005, NATURE, V435, P1067, DOI 10.1038/nature03601; Marois C, 2010, NATURE, V468, P1080, DOI 10.1038/nature09684; Debes JH, 2008, ASTROPHYS J LETT, V684, pL41, DOI 10.1086/592018; DOHNANYI JS, 1969, J GEOPHYS RES, V74, P2531, DOI 10.1029/JB074i010p02531; Liou JC, 1999, ASTRON J, V118, P580, DOI 10.1086/300938; Rhee JH, 2007, ASTROPHYS J, V660, P1556, DOI 10.1086/509912; Pearce TD, 2014, MON NOT R ASTRON SOC, V443, P2541, DOI 10.1093/mnras/stu1302; Wyatt MC, 1999, ASTROPHYS J, V527, P918, DOI 10.1086/308093; Bailey V, 2014, ASTROPHYS J LETT, V780, DOI 10.1088/2041-8205/780/1/L4; Currie T, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/28; Dvorak R., 2007, IAU S, V249, P461; Ertel S, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219236; Esposito TM, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/25; Hahn JM, 2010, ASTROPHYS J, V719, P1699, DOI 10.1088/0004-637X/719/2/1699; Kalas P, 2007, ASTROPHYS J, V661, pL85, DOI 10.1086/518652; Currie T, 2009, ASTRON J, V138, P703, DOI 10.1088/0004-6256/138/3/703; Lagrange AM, 2009, ASTRON ASTROPHYS, V506, P927, DOI 10.1051/0004-6361/200912098; Marchal C., 1990, 3 BODY PROBLEM; Mazoyer J, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424479; Milli J, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219687; Moor A, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/1/4; Moor A, 2006, ASTROPHYS J, V644, P525, DOI 10.1086/503381; Nesvold ER, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/2/144; Quillen AC, 2007, MON NOT R ASTRON SOC, V380, P1642, DOI 10.1111/j.1365-2966.2007.12217.x; Rameau J, 2013, ASTROPHYS J LETT, V772, DOI 10.1088/2041-8205/772/2/L15; Rodigas TJ, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/1/21; Rodigas TJ, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/65; Rodigas TJ, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/57; Soummer R, 2005, ASTROPHYS J, V618, pL161, DOI 10.1086/427923; Stark CC, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/58; Thalmann C, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/1/L6; Thebault P, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219962; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357	42	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							20	10.1093/pasj/psu152		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200008		
J	Serino, M; Shidatsu, M; Ueda, Y; Matsuoka, M; Negoro, H; Yamaoka, K; Kennea, JA; Fukushima, K; Nagayama, T				Serino, Motoko; Shidatsu, Megumi; Ueda, Yoshihiro; Matsuoka, Masaru; Negoro, Hitoshi; Yamaoka, Kazutaka; Kennea, Jamie A.; Fukushima, Kosuke; Nagayama, Takahiro			Low-mass X-ray binary MAXI J1421-613 observed by MAXI GSC and Swift XRT	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						methods: data analysis; X-rays: bursts; X-rays: individual (MAXI J1421-613)	AQUILA X-1; TRANSIENT MONITOR; GALACTIC BULGE; 4U 1608-52; SKY; BURSTS; LUMINOSITIES; GEOMETRY; SPECTRA; ISS	Monitor of All sky X-ray Image (MAXI) discovered a new outburst of an X-ray transient source named MAXI J1421-613. Because of the detection of three X-ray bursts from the source, it was identified as a neutron star low-mass X-ray binary. The results of data analyses of the MAXI GSC (Gas Slit Camera) and the Swift XRT (X-Ray Telescope) follow-up observations suggest that the spectral hardness remained unchanged during the first two weeks of the outburst. All the XRT spectra in the 0.5-10 keV band can be well explained by thermal Comptonization of multi-color disk blackbody emission. The photon index of the Comptonized component is approximate to 2, which is typical of low-mass X-ray binaries in the low/hard state. Since X-ray bursts have a maximum peak luminosity, it is possible to estimate the (maximum) distance from its observed peak flux. The peak flux of the second X-ray burst, which was observed by the GSC, is about 5 photons cm(-2) s(-1). By assuming a blackbody spectrum of 2.5 keV, the maximum distance to the source is estimated as 7 kpc. The position of this source is contained by the large error regions of two bright X-ray sources detected with Orbiting Solar Observatory-7 (OSO-7) in the 1970s. Besides this, no past activities at the XRT position are reported in the literature. If MAXI J1421-613 is the same source as ( one of) these, the outburst observed with MAXI may have occurred after a quiescence of 30-40 years.	[Serino, Motoko; Matsuoka, Masaru] RIKEN, Inst Phys & Chem Res, MAXI Team, Wako, Saitama 3510198, Japan; [Shidatsu, Megumi; Ueda, Yoshihiro] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Matsuoka, Masaru] Japan Aerosp Explorat Agcy JAXA, ISAS, ISS Sci Project Off, Tsukuba, Ibaraki 3058505, Japan; [Negoro, Hitoshi; Fukushima, Kosuke] Nihon Univ, Dept Phys, Chiyoda Ku, Tokyo 1018308, Japan; [Yamaoka, Kazutaka] Nagoya Univ, Dept Particle Phys & Astron, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Yamaoka, Kazutaka] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kennea, Jamie A.] Penn State Univ, Dept Astron & Astrophys, Davey Lab 0525, University Pk, PA 16802 USA; [Nagayama, Takahiro] Kagoshima Univ, Dept Phys & Astron, Kagoshima 8900065, Japan	Serino, M (reprint author), RIKEN, Inst Phys & Chem Res, MAXI Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	motoko@crab.riken.jp			National Aeronautics and Space Administration; National Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [24740186]	This research has made use of the MAXI data provided by RIKEN, JAXA, and the MAXI team, and Swift XRT data obtained from The High Energy Astrophysics Science Archive Research Center of NASA. We thank the Suzaku operation team for arranging and carrying out the TOO observations. We thank Robert J. Czanik for the IRSF observations. This publication made use of data products from the Two Micron All-Sky Survey, which is a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center/California Institute of Technology, funded by the National Aeronautics and Space Administration and the National Science Foundation. This research was partially supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Grant-in-Aid No. 24740186.	Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Wenger M, 2000, ASTRON ASTROPHYS SUP, V143, P9, DOI 10.1051/aas:2000332; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Kuulkers E, 2003, ASTRON ASTROPHYS, V399, P663, DOI 10.1051/0004-6361:20021781; MITSUDA K, 1984, PUBL ASTRON SOC JPN, V36, P741; WAINSCOAT RJ, 1992, ASTROPHYS J SUPPL S, V83, P111, DOI 10.1086/191733; Raichur H, 2011, MON NOT R ASTRON SOC, V416, P637, DOI 10.1111/j.1365-2966.2011.19075.x; Galloway DK, 2008, ASTROPHYS J SUPPL S, V179, P360, DOI 10.1086/592044; Maccarone TJ, 2003, ASTRON ASTROPHYS, V409, P697, DOI 10.1051/0004-6361:20031146; Matsuoka M, 2009, PUBL ASTRON SOC JPN, V61, P999; LEWIN WHG, 1981, SPACE SCI REV, V28, P3, DOI 10.1007/BF00353555; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; MORRISON R, 1983, ASTROPHYS J, V270, P119, DOI 10.1086/161102; Evans PA, 2009, MON NOT R ASTRON SOC, V397, P1177, DOI 10.1111/j.1365-2966.2009.14913.x; Voges W, 1999, ASTRON ASTROPHYS, V349, P389; Asai K, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/117; Asai K, 2012, PUBL ASTRON SOC JPN, V64; Baumgartner W. H., 2014, GCN CIRC, P15749; Bohlin R. C., 1978, ASTROPHYS J, V224, P32; Bozzo E., 2014, ASTRONOMERS TELEGRAM, P5765; Campana S, 1998, ASTROPHYS J, V499, pL65, DOI 10.1086/311357; Chakrabarty D., 2014, ASTRONOMERS TELEGRAM, P5894; Coriat M., 2014, ASTRONOMERS TELEGRAM, P5759; Coriat M., 2014, ASTRONOMERS TELEGRAM, P5802; EBISUZAKI T, 1984, PUBL ASTRON SOC JPN, V36, P551; Kennea J. A., 2014, ASTRONOMERS TELEGRAM, P5751; Krimm HA, 2013, ASTROPHYS J SUPPL S, V209, DOI 10.1088/0067-0049/209/1/14; Lewin W. H., 1993, SPACE SCI REV, V62, P223, DOI DOI 10.1007/BF00196124; Markert T. H., 1975, IAU CIRC, V2765, P1; MARKERT TH, 1977, ASTROPHYS J, V218, P801, DOI 10.1086/155737; Mori H, 2012, PUBL ASTRON SOC JPN, V64; Morooka Y., 2014, ASTRONOMERS TELEGRAM, P5750; Nagayama T., 2003, SPIE, V4841, P459; Negoro H, 2010, ASTR SOC P, V434, P127; Sakurai S, 2012, PUBL ASTRON SOC JPN, V64; Sugizaki M, 2013, PUBL ASTRON SOC JPN, V65; Tody D, 1986, SPIE C SER, V627, P733; Voges W., 2000, IAU CIRC, V7432, P1; Wheaton W. A., 1975, IAU CIRC, V2761, P1; Zdziarski AA, 1996, MON NOT R ASTRON SOC, V283, P193	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							30	10.1093/pasj/psv003		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200018		
J	Shaltout, AMK; Ichimoto, K				Shaltout, Abdelrazek M. K.; Ichimoto, Kiyoshi			Coupling of the magnetic field and gas flows inferred from the net circular polarization in a sunspot penumbra	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						line: profiles; Sun: magnetic fields; Sun: photosphere; sunspots	SOLAR OPTICAL TELESCOPE; HIGH-SPATIAL-RESOLUTION; FINE-STRUCTURE; 2-DIMENSIONAL SPECTROSCOPY; SPECTRAL SIGNATURE; SIMULATED SUNSPOTS; FLUX TUBES; FREE GAPS; FILAMENTS; HINODE	We analyze penumbral fine structure using high-resolution spectropolarimetric data obtained by the Solar Optical Telescope on board the Hinode satellite. The spatial correlation between the net circular polarization (NCP) and Evershed flow is investigated in detail. Here we obtain that negative NCP structures are correlated with the Evershed flow channels in the limb-side penumbra, and that negative NCP or depressions of positive NCP are associated with the Evershed flow channels in the disk center-side of the penumbra for a negative-polarity sunspot in NOAA 10923. The positive NCP dominant in the disk center-side penumbra is essentially attributed to interflow channels instead of Evershed flow channels. The stratification of magnetic field and velocity are investigated by using SIR-JUMP inversion with a one-component atmosphere, and the NCP of spectral lines in the limb-side and disk center-side of the penumbra is successfully reproduced. The inversion results show that an increased Evershed flow is associated with a strong magnetic field located in the deep photosphere. Our result does not match with the simple two-component penumbral models in which the penumbra consists of Evershed flow and interflow channels and the global NCP is attributed only to the Evershed flow channels.	[Shaltout, Abdelrazek M. K.; Ichimoto, Kiyoshi] Kyoto Univ, Kwasan Observ, Takayama, Gifu 5061314, Japan; [Shaltout, Abdelrazek M. K.; Ichimoto, Kiyoshi] Kyoto Univ, Hida Observ, Takayama, Gifu 5061314, Japan; [Shaltout, Abdelrazek M. K.] Al Azhar Univ, Fac Sci, Dept Astron & Meteorol, Cairo 11884, Egypt	Shaltout, AMK (reprint author), Kyoto Univ, Kwasan Observ, Kurabashira Kamitakara Cho, Takayama, Gifu 5061314, Japan.	ahaltout@azhar.edu.eg; ichimoto@kwasan.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22244013]	The authors are grateful to Dr. Bellot Rubio for valuable comments on SIR study, and Tetsu Anan and Dr. Hiroko Watanabe for their help in data analysis. We also thank Dr. Andrew Hillier for correcting the English and valuable comments to the manuscript. The author wants to express great thanks to the Egyptian government for supporting his study in Japan. This work was partly supported by a Grant-in-Aid for Scientific Research (No. 22244013, PI: KI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Hinode is a Japanese mission developed and launched by ISAS/JAXA, with NAOJ as domestic partner and NASA and STFC (UK) as international partners. It is operated by these agencies in cooperation with ESA and NSC (Norway). The authors wish to thank the referee for a thorough and constructive report that improved our manuscript.	Lites BW, 2013, SOL PHYS, V283, P601, DOI 10.1007/s11207-012-0205-4; Tritschler A, 2004, ASTRON ASTROPHYS, V415, P717, DOI 10.1051/0004-6361:20034599; Langhans K, 2005, ASTRON ASTROPHYS, V436, P1087, DOI 10.1051/0004-6361:20052678; Rimmele T, 2006, ASTROPHYS J, V646, P593, DOI 10.1086/504794; Spruit HC, 2006, ASTRON ASTROPHYS, V447, P343, DOI 10.1051/0004-6361:20054000; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Scharmer GB, 2006, ASTRON ASTROPHYS, V460, P605, DOI 10.1051/0004-6361:20066019; SHINE RA, 1994, ASTROPHYS J, V430, P413, DOI 10.1086/174416; Ichimoto K, 2007, SCIENCE, V318, P1597, DOI 10.1126/science.1146046; Borrero JM, 2008, ASTRON ASTROPHYS, V481, pL13, DOI 10.1051/0004-6361:20079002; Rempel M, 2009, SCIENCE, V325, P171, DOI 10.1126/science.1173798; AUER LH, 1978, ASTRON ASTROPHYS, V64, P67; Kosugi T, 2007, SOL PHYS, V243, P3, DOI 10.1007/s11207-007-9014-6; Solanki SK, 2003, ASTRON ASTROPHYS REV, V11, P153, DOI 10.1007/s00159-003-0018-4; SOLANKI SK, 1993, ASTRON ASTROPHYS, V275, P283; Scharmer GB, 2008, ASTROPHYS J LETT, V677, pL149, DOI 10.1086/587982; Beck C, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015484; Gonzalez NB, 2005, ASTRON ASTROPHYS, V434, P317, DOI 10.1051/0004-6361:20042001; Rubio LRB, 2004, ASTRON ASTROPHYS, V427, P319, DOI 10.1051/0004-6361:20041277; Rubio LRB, 2006, ASTRON ASTROPHYS, V453, P1117, DOI 10.1051/0004-6361:20054768; Borrero JM, 2011, LIVING REV SOL PHYS, V8; Borrero JA, 2004, ASTRON ASTROPHYS, V422, P1093, DOI 10.1051/0004-6361:20041001; Borrero JM, 2006, ASTRON ASTROPHYS, V450, P383, DOI 10.1051/0004-6361:20054378; Borrero JM, 2007, ASTROPHYS J, V666, pL133, DOI 10.1086/521923; Borrero JM, 2008, ASTROPHYS J, V687, P668, DOI 10.1086/591220; Borrero JM, 2010, ASTROPHYS J, V709, P349, DOI 10.1088/0004-637X/709/1/349; INIESTA JCD, 1994, ASTROPHYS J, V436, P400; HENSON GD, 1984, SOL PHYS, V93, P289, DOI 10.1007/BF02270840; Ichimoto K., 2010, MAGNETIC COUPLING IN, P186, DOI 10.1007/978-3-642-02859-5_14; Ichimoto K, 2007, PUBL ASTRON SOC JPN, V59, pS593; Ichimoto K, 2008, ASTRON ASTROPHYS, V481, pL9, DOI 10.1051/0004-6361:20079055; ILLING RME, 1974, ASTRON ASTROPHYS, V35, P327; Jurcak J, 2007, PUBL ASTRON SOC JPN, V59, pS601; Pillet VM, 2000, ASTRON ASTROPHYS, V361, P734; Muller DAN, 2002, ASTRON ASTROPHYS, V393, P305, DOI 10.1051/0004-6361:20020990; Muller DAN, 2006, ASTRON ASTROPHYS, V460, P925, DOI 10.1051/0004-6361:20066062; Press W. H., 1986, NUMERICAL RECIPES; Rempel M, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/5; COBO BR, 1992, ASTROPHYS J, V398, P375; ALMEIDA JS, 1992, ASTROPHYS J, V398, P359; Almeida JS, 2005, ASTROPHYS J, V622, P1292, DOI 10.1086/427930; Schlichenmaier R, 2002, ASTRON ASTROPHYS, V381, pL77, DOI 10.1051/0004-6361:20011706; SKUMANICH A, 1987, ASTROPHYS J, V322, P483, DOI 10.1086/165744; Spruit HC, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/200912519; TITLE AM, 1992, NATO ADV SCI I C-MAT, V375, P195; Tritschler A, 2007, ASTROPHYS J LETT, V671, pL85, DOI 10.1086/524872; Suematsu Y, 2008, SOL PHYS, V249, P197, DOI 10.1007/s11207-008-9129-4; Tiwari SK, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321391	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							27	10.1093/pasj/psu159		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200015		
J	Takeda, Y; Honda, S				Takeda, Yoichi; Honda, Satoshi			On the oxygen abundances of M 67 stars from the turn-off point through the red giant branch	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						open clusters and associations: individual (M 67); stars: abundances; stars: atmospheres; stars: evolution; stars: late-type	LAMBDA 7771-5 TRIPLET; OPEN CLUSTERS; ELEMENTAL ABUNDANCES; MAIN-SEQUENCE; NGC 2682; M67; CARBON; SCALE	With an aim to examine whether the surface oxygen composition suffers any appreciable change due to evolution-induced mixing of nuclear-processed material in the envelope of red giants, abundance determinations for O/Fe/Ni based on the synthetic spectrum-fitting method were performed by using the moderate-dispersion spectra in the 7770-7792 angstrom region (comprising O vertical bar 7771-5, Fe vertical bar 7780, and Ni vertical bar 7788 lines) for 16 stars of the old open cluster M 67 in various evolutionary stages from the turn-off point through the red giant branch. We could not find any meaningful difference in the oxygen abundances between the non-giant group (T-eff > 5000 K) and the red-giant group (T-eff < 5000 K), which are almost consistent with each other on average (despite that both have rather large dispersions of a few tenths dex caused by insufficient data quality), though only one giant star (S 1054) appears to show an exceptionally low O abundance and thus needs a more detailed study. This result may suggest that oxygen content in the stellar envelope is hardly affected (or any changes are insignificant) by the mixing of H-burning products in the red giant phase, as far as M 67 stars of low mass (similar to 1.3M(circle dot)) are concerned, which is consistent with the prediction from the conventional stellar evolution theory of first dredge-up.	[Takeda, Yoichi] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Takeda, Yoichi] Grad Univ Adv Studies, Mitaka, Tokyo 1818588, Japan; [Honda, Satoshi] Univ Hyogo, Ctr Astron, Nishi Harima Astron Observ, Sayo, Hyogo 6795313, Japan	Takeda, Y (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	takeda.yoichi@nao.ac.jp					Randich S, 2006, ASTRON ASTROPHYS, V450, P557, DOI 10.1051/0004-6361:20054291; Lagarde N, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118331; Takeda Y, 2008, PUBL ASTRON SOC JPN, V60, P781; Alonso A, 1999, ASTRON ASTROPHYS SUP, V140, P261, DOI 10.1051/aas:1999521; Yong D, 2005, ASTRON J, V130, P597, DOI 10.1086/430934; Shetrone MD, 2000, ASTRON J, V120, P1913, DOI 10.1086/301569; Pace G, 2008, ASTRON ASTROPHYS, V489, P403, DOI 10.1051/0004-6361:200809969; Alonso A, 1996, ASTRON ASTROPHYS, V313, P873; MATHIEU RD, 1986, ASTRON J, V92, P1100, DOI 10.1086/114240; Demarque P, 2004, ASTROPHYS J SUPPL S, V155, P667, DOI 10.1086/424966; Mishenina TV, 2006, ASTRON ASTROPHYS, V456, P1109, DOI 10.1051/0004-6361:20065141; ALONSO A, 1995, ASTRON ASTROPHYS, V297, P197; BROWN JA, 1985, ASTROPHYS J, V297, P233, DOI 10.1086/163519; Cayrel R., 1988, IAU S, V132, P345; ERIKSSON K, 1979, ASTRON ASTROPHYS, V71, P178; Kurucz R. L., 1995, KURUCZ CD ROM 23 ATO; Kurucz R. L., 1975, 362 SMITHS ASTR OBS; KURUCZ RL, 1993, KURUCZ CD ROM 13 ATL; Mermilliod J. C., 1995, INFORMATION ON LINE, P127; Ozaki S., 2005, ANN REP NISHI HARIMA, V15, P15; Pancino E, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200912965; Sandquist EL, 2004, MON NOT R ASTRON SOC, V347, P101, DOI 10.1111/j.1365-2966.2004.07174.x; Takeda Y, 2005, PUBL ASTRON SOC JPN, V57, P415; Takeda Y, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psu158; Takeda Y, 1997, PUBL ASTRON SOC JPN, V49, P367; Takeda Y, 1998, PUBL ASTRON SOC JPN, V50, P97; Takeda Y, 2013, PUBL ASTRON SOC JPN, V65; TAKEDA Y, 1995, PUBL ASTRON SOC JPN, V47, P287; Takeda Y, 2003, ASTRON ASTROPHYS, V402, P343, DOI 10.1051/0004-6361:20030217; Tautvaisiene G, 2000, ASTRON ASTROPHYS, V360, P499; Tautvaisiene G, 2010, MON NOT R ASTRON SOC, V409, P1213, DOI 10.1111/j.1365-2966.2010.17381.x	31	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							25	10.1093/pasj/psu157		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200013		
J	Takeda, Y; Sato, B; Omiya, M; Harakawa, H				Takeda, Yoichi; Sato, Bun'ei; Omiya, Masashi; Harakawa, Hiroki			Can surface oxygen abundances of red giants be explained by the canonical mixing theory?	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						stars: abundances; stars: atmospheres; stars: evolution; stars: late-type	SOLAR-TYPE STARS; NON-LTE ANALYSIS; ELEMENTAL ABUNDANCES; K STARS; TRIPLET; PARAMETERS; DATABASE; SPECTRA; LINE	Extensive oxygen abundance determinations were carried out for 239 late-G/early-K giant stars of 1.5-5 M-circle dot by applying the spectrum-fitting technique to OI 7771-5 and [O I] 6300/6363 lines based on the high-dispersion spectra in the red region newly obtained at the Okayama Astrophysical Observatory. Our main purpose was to clarify whether any significantly large (less than or similar to 0.4-0.5 dex) O-deficit really exists in these evolved stars, which was once suspected by Takeda et al. (2008, PASJ, 60, 781) from the analysis of the [O I] 5577 line, since it (if real) cannot be explained by the current theory and may require the necessity of special non-canonical deep mixing in the envelope. We found, however, that the previous [O/H](5577) results (differential abundances relative to the Sun) were systematically underestimated compared to the more reliable [O/H](7773) (from OI 7771-5 triplet lines) or [O/H](6300) (from [O I] 6300 line) obtained in this study. Comparing the updated [O/Fe] ratios with the theoretically predicted surface abundance changes caused by mixing of nuclear-processed products dredged-up from the interior, we concluded that the oxygen deficiency in these red giants is insignificantly marginal (only by less than or similar to 0.1 dex), which does not contradict the expectation from the recent theoretical simulation. This consequence of reasonable consistency between theory and observation also applies to the extent of peculiarity in [C/Fe] and [Na/Fe], which were also examined by re-analyzing the previous equivalent-width data of CI 5052/5380 and Na I 6160 lines.	[Takeda, Yoichi; Omiya, Masashi; Harakawa, Hiroki] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Takeda, Yoichi] Grad Univ Adv Studies, Mitaka, Tokyo 1818588, Japan; [Sato, Bun'ei] Tokyo Inst Technol, Meguro Ku, Tokyo 1528550, Japan	Takeda, Y (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	takeda.yoichi@nao.ac.jp					Lagarde N, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118331; Takeda Y, 2008, PUBL ASTRON SOC JPN, V60, P781; Takeda Y, 2005, PUBL ASTRON SOC JPN, V57, P65; Melendez J, 2008, ASTRON ASTROPHYS, V490, P817, DOI 10.1051/0004-6361:200810347; Galavis ME, 1997, ASTRON ASTROPHYS SUP, V123, P159, DOI 10.1051/aas:1997344; Lejeune T, 2001, ASTRON ASTROPHYS, V366, P538; Mishenina TV, 2006, ASTRON ASTROPHYS, V456, P1109, DOI 10.1051/0004-6361:20065141; ERIKSSON K, 1979, ASTRON ASTROPHYS, V71, P178; Kurucz R., 1993, ATLAS9 STELLAR ATMOS; Kurucz R. L., 1993, SYNTHE SPECTRUM SYNT; Kurucz R L, 1995, ATOMIC LINE DATA; Takeda Y, 2005, PUBL ASTRON SOC JPN, V57, P13; Takeda Y, 1998, PUBL ASTRON SOC JPN, V50, P97; Takeda Y, 2003, CHINESE J ASTRON AST, V3, P316; Takeda Y, 2007, PUBL ASTRON SOC JPN, V59, P335; Takeda Y, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu066; TAKEDA Y, 1995, PUBL ASTRON SOC JPN, V47, P287; TAKEDA Y, 1994, PUBL ASTRON SOC JPN, V46, P53; Takeda Y, 2003, ASTRON ASTROPHYS, V402, P343, DOI 10.1051/0004-6361:20030217; Tautvaisiene G, 2010, MON NOT R ASTRON SOC, V409, P1213, DOI 10.1111/j.1365-2966.2010.17381.x	20	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							24	10.1093/pasj/psu158		17	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200012		
J	Tamura, T; Iizuka, R; Maeda, Y; Mitsuda, K; Yamasaki, NY				Tamura, Takayuki; Iizuka, Ryo; Maeda, Yoshitomo; Mitsuda, Kazuhisa; Yamasaki, Noriko Y.			An X-ray spectroscopic search for dark matter in the Perseus cluster with Suzaku	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						dark matter; galaxies: clusters: individual (Abell 426, Perseus); X-rays: galaxies: clusters	GAS BULK MOTION; XMM-NEWTON; IMAGING SPECTROMETER; CROSS-CALIBRATION; CHARGE-INJECTION; STERILE NEUTRINO; LINE DIAGNOSTICS; EMISSION-LINE; WILLMAN 1; CHANDRA	We present the results from deep Suzaku observations of the central region of the Perseus cluster. Bulbul et al. (2014, ApJ, 789, 13) reported the detection by XMM-Newton instruments of an unidentified X-ray emission line at an energy around 3.5 keV in spectra for the Perseus and other clusters. They argued for a possibility of the decay of sterile neutrino, a dark matter candidate. We examine Suzaku X-ray Imaging Spectrometer (XIS) spectra of the Perseus cluster for evidence in the 3.5 keV line and other possible dark matter features in the 2-6 keV energy band. In order to search for and constrain a weak line feature with the XIS, observations of the Crab Nebula are used to evaluate the system's effective area. We found no line feature at the claimed position with a systematic line flux upper limit at a half (1.5 eV in line equivalent width) of the claimed best-fitting value by Bulbul et al. (2014). We discuss this inconsistency in terms of instrumental calibration errors and modeling of continuum emission. Future prospects for high-energy resolution spectroscopy with ASTRO-H are presented.	[Tamura, Takayuki; Iizuka, Ryo; Maeda, Yoshitomo; Mitsuda, Kazuhisa; Yamasaki, Noriko Y.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2298510, Japan	Tamura, T (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.	tamura.takayuki@jaxa.jp	Yamasaki, Noriko/C-2252-2008; XRAY, SUZAKU/A-1808-2009		MEXT [24540243, 25105516]	We thank the referee for useful suggestions and the following scientists for helpful discussion: N. Yoshida, A. Kamada, T. Kitayama, K. Matsushita, E. Bulbul, R. Smith, A. Foster, M. Loewenstein, A. Boyarsky, O. Ruchayskiy, and N. Sekiya. We thank all the Suzaku team members for their support. We acknowledge the support by a Grants-in-Aid for Scientific Research from the MEXT, No. 24540243 (TT) and 25105516 (YM).	Abazajian K. N, 2012, ARXIV12045379; Feng JL, 2010, ANNU REV ASTRON ASTR, V48, P495, DOI 10.1146/annurev-astro-082708-101659; Nakayama K, 2014, PHYS LETT B, V737, P311, DOI 10.1016/j.physletb.2014.08.061; Kusenko A, 2009, PHYS REP, V481, P1, DOI 10.1016/j.physrep.2009.07.004; Loewenstein M, 2010, ASTROPHYS J, V714, P652, DOI 10.1088/0004-637X/714/1/652; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Abazajian K, 2001, ASTROPHYS J, V562, P593, DOI 10.1086/323867; Boyarsky A, 2012, PHYS DARK UNIVERSE, V1, P136, DOI 10.1016/j.dark.2012.11.001; Smith RK, 2001, ASTROPHYS J, V556, pL91, DOI 10.1086/322992; Tamura T, 2009, ASTROPHYS J LETT, V705, pL62, DOI 10.1088/0004-637X/705/1/L62; Tamura T, 2011, PUBL ASTRON SOC JPN, V63, pS1009; Horiuchi S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.025017; Loewenstein M, 2009, ASTROPHYS J, V700, P426, DOI 10.1088/0004-637X/700/1/426; Arnaud KA, 1996, ASTR SOC P, V101, P17; Boyarsky A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.251301; Boyarsky A., 2014, ARXIC14082503; Mitsuda K, 2010, PROC SPIE, V7732, DOI 10.1117/12.856778; Bulbul E, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/13; Ishida M, 2011, PUBL ASTRON SOC JPN, V63, pS657; Ishisaki Y, 2007, PUBL ASTRON SOC JPN, V59, pS113; Kitayama T., 2014, ARXIV14121176; Koyama K, 2007, PUBL ASTRON SOC JPN, V59, pS245; Loewenstein M, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/82; Mitsuda K, 2007, PUBL ASTRON SOC JPN, V59, pS1; Ozawa M, 2009, PUBL ASTRON SOC JPN, V61, pS1; Read AM, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201423422; Serlemitsos PJ, 2007, PUBL ASTRON SOC JPN, V59, pS9; Sofue Y, 2001, ANNU REV ASTRON ASTR, V39, P137, DOI 10.1146/annurev.astro.39.1.137; Takahashi T, 2012, PROC SPIE, V8443, DOI 10.1117/12.926190; Tamura T, 2008, PUBL ASTRON SOC JPN, V60, P695; Tamura T, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/1/38; Tawa N, 2008, PUBL ASTRON SOC JPN, V60, pS11; Tsujimoto M, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015597; Uchiyama H, 2009, PUBL ASTRON SOC JPN, V61, pS9	34	5	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							23	10.1093/pasj/psu156		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200011		
J	Tsuji, T; Nakajima, T; Takeda, Y				Tsuji, Takashi; Nakajima, Tadashi; Takeda, Yoichi			Near-infrared spectroscopy of M dwarfs. II. H2O molecule as an abundance indicator of oxygen	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						molecular data; stars: abundances; stars: atmospheres; stars: fundamental parameters; stars: low-mass	RED SUPERGIANT BETELGEUSE; WATER-VAPOR; HOT-WATER; PHOTOSPHERIC ENVIRONMENT; LABORATORY SPECTROSCOPY; PLANET-METALLICITY; SOLAR ABUNDANCE; GALACTIC DISK; BAND SPECTRUM; GIANT STARS	Based on the near-infrared spectra (R approximate to 20000) of M dwarfs, oxygen abundances are determined from the rovibrational lines of H2O. Although H2O lines in M dwarfs are badly blended with each other and the continuum levels are depressed appreciably by the collective effect of the numerous H2O lines themselves, quantitative analysis of H2O lines has been carried out by referring to the pseudo-continua, consistently defined on the observed and theoretical spectra. For this purpose, the pseudo-continuum on the theoretical spectrum has been evaluated accurately by the use of the recent high-precision H2O line-list. Then, we propose a simple and flexible method of analyzing the equivalent widths (EWs) of blended features (i.e., not necessarily limited to single lines) by the use of a mini-curve-of-growth (CG), which is a small portion of the usual CG around the observed EW. The mini-CG is generated by using the theoretical EWs evaluated from the synthetic spectrum in exactly the same way as the EWs are measured from the observed spectrum. The observed EW is converted to the abundance by the use of the mini-CG, and the process is repeated for all the observed EWs line-by-line or blend-by-blend. In cool M dwarfs, almost all the oxygen atoms left after CO formation are in stable H2O molecules, which suffer little change for the uncertainties due to imperfect modelling of the photospheres. Thus the numerous H2O lines are excellent abundance indicators of oxygen. The oxygen abundances are determined to be log A(O) (A(O) = N-O/N-H) between -3.5 and -3.0 in 38 M dwarfs, but cannot be determined in four early M dwarfs in which H2O lines are detected only marginally. The resulting log A(O)/A(C) values plotted against log A(C) appear to be systematically smaller in the carbon-rich M dwarfs, showing the different formation histories of oxygen and carbon in the chemical evolution of the Galactic disk. Also, A(O)/A(Fe) ratios in most M dwarfs are closer to the solar A(O)/A(F)e ratio, based on the classical high oxygen abundance rather than on the recently downward-revised low value.	[Tsuji, Takashi] Univ Tokyo, Inst Astron, Sch Sci, Mitaka, Tokyo 1810015, Japan; [Nakajima, Tadashi; Takeda, Yoichi] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan	Tsuji, T (reprint author), Univ Tokyo, Inst Astron, Sch Sci, 2-21-1 Osawa, Mitaka, Tokyo 1810015, Japan.	ttsuji@ioa.s.u-tokyo.ac.jp			NASA	This research makes use of data products from the Wide-field Infrared Survey Explorer which is a joint project of the University of California, Los Angeles, and the Jet Propulsion Laboratory/California Institute of Technology, funded by NASA.	Allende Prieto C., 2002, APJ, V573, pL137; Grevesse N, 1999, ASTRON ASTROPHYS, V347, P348; Rothman LS, 2010, J QUANT SPECTROSC RA, V111, P2139, DOI 10.1016/j.jqsrt.2010.05.001; Ryde N, 2002, ASTROPHYS J, V580, P447, DOI 10.1086/343040; WOOLF NJ, 1964, ASTROPHYS J, V140, P833, DOI 10.1086/147989; Gustafsson B, 1999, ASTRON ASTROPHYS, V342, P426; JOY AH, 1974, ASTROPHYS J SUPPL S, V28, P1, DOI 10.1086/190307; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Steyert DW, 2004, J QUANT SPECTROSC RA, V83, P183, DOI 10.1016/S0022-4073(02)00300-X; Johnson JA, 2009, ASTROPHYS J, V699, P933, DOI 10.1088/0004-637X/699/2/933; WALLACE L, 1995, SCIENCE, V268, P1155, DOI 10.1126/science.7761830; Barber RJ, 2006, MON NOT R ASTRON SOC, V368, P1087, DOI [10.1111/j.1365-2966.2006.10184.x, 10.1111/j.1365-2966.10184.x]; Nomoto K, 2013, ANNU REV ASTRON ASTR, V51, P457, DOI 10.1146/annurev-astro-082812-140956; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; EDVARDSSON B, 1993, ASTRON ASTROPHYS, V275, P101; Tsuji T, 1996, ASTRON ASTROPHYS, V305, pL1; Decin L, 2003, ASTRON ASTROPHYS, V400, P709, DOI 10.1051/0004-6361:20021786; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Zobov NF, 2008, MON NOT R ASTRON SOC, V387, P1093, DOI 10.1111/j.1365-2966.2008.13234.x; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Bernath PF, 2002, PHYS CHEM CHEM PHYS, V4, P1501, DOI 10.1039/b200372d; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; TINNEY CG, 1993, ASTRON J, V105, P1045, DOI 10.1086/116492; Gamache RR, 1996, J QUANT SPECTROSC RA, V56, P471, DOI 10.1016/0022-4073(96)00098-2; BIEMONT E, 1991, ASTRON ASTROPHYS, V249, P539; AUMAN J, 1967, ASTROPHYS J, VS 14, P171, DOI 10.1086/190153; Auman J. R., 1969, LOW LUMINOSITY STARS, P483; Bean JL, 2006, ASTROPHYS J, V652, P1604, DOI 10.1086/508321; BERRIMAN G, 1987, MON NOT R ASTRON SOC, V227, P315; Boyajian TS, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/112; CONNES P, 1970, ANNU REV ASTRON ASTR, V8, P209, DOI 10.1146/annurev.aa.08.090170.001233; Cox A. N., 1999, ALLENS ASTROPHYSICAL, V4th, P145; Faure A, 2013, J QUANT SPECTROSC RA, V116, P79, DOI 10.1016/j.jqsrt.2012.09.015; Gliese W., 1991, PRELIMINARY VERSION; Hattori K, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/153; Herzberg G., 1945, MOL SPECTRA MOL STRU, P207; HINKLE KH, 1979, ASTROPHYS J, V227, P923, DOI 10.1086/156801; HOLWEGER H, 1990, ASTRON ASTROPHYS, V232, P510; JONES HRA, 1994, MON NOT R ASTRON SOC, V267, P413; Kessler MF, 1996, ASTRON ASTROPHYS, V315, pL27; King GW, 1943, J CHEM PHYS, V11, P27, DOI 10.1063/1.1723778; Kuiper G. P, 1962, COMM LUNAR PLANET LA, V23, P179; Lebzelter T, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219142; Mohler O. C, 1955, TABLE SOLAR SPECTRUM; Montarges M, 2014, ASTRON ASTROPHYS, V572, DOI 10.1051/0004-6361/201423538; MOULD JR, 1978, ASTROPHYS J, V226, P923, DOI 10.1086/156673; Neves V, 2013, ASTRON ASTROPHYS, V551, DOI 10.1051/0004-6361/201220574; Ohnaka K, 2011, ASTRON ASTROPHYS, V529, DOI 10.1051/0004-6361/201016279; Ohnaka K, 2004, ASTRON ASTROPHYS, V421, P1149, DOI 10.1051/0004-6361.20035668; Onehag A, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118101; Polyansky OL, 1997, ASTROPHYS J, V489, pL205, DOI 10.1086/316794; Ridgway S. T., 1984, ARA A, V22, P29; Russell HN, 1934, ASTROPHYS J, V79, P317, DOI 10.1086/143539; Struve O, 1934, ASTROPHYS J, V79, P409, DOI 10.1086/143551; Tereszchuk K, 2002, ASTROPHYS J, V577, P496, DOI 10.1086/342167; Tsuji T, 2005, ASTROPHYS J, V621, P1033, DOI 10.1086/427747; Tsuji T, 2002, ASTROPHYS J, V575, P264, DOI 10.1086/341262; Tsuji T, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu078; Tsuji T, 2000, ASTROPHYS J, V538, P801, DOI 10.1086/309185; Tsuji T, 1969, LOW LUMINOSITY STARS, P457; Tsuji T, 2008, ASTRON ASTROPHYS, V489, P1271, DOI 10.1051/0004-6361:200809869; TSUJI T, 1966, PUBL ASTRON SOC JPN, V18, P127; Tsuji T, 2001, ASTRON ASTROPHYS, V376, pL1, DOI 10.1051/0004-6361:20011012; Unsold A., 1955, PHYS STERNATMOSPHARE; van Leeuwen F., 2007, ASTRON ASTROPHYS, V474, P653; von Braun K., 2014, MNRAS, V438, P2413; Wallace L., 1992, 92001 NSO NOAO; YOSHII Y, 1981, ASTRON ASTROPHYS, V97, P280; Zobov NF, 2000, ASTROPHYS J, V530, P994, DOI 10.1086/308419	69	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							26	10.1093/pasj/psu160		30	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200014		
J	Uemura, M; Kato, T; Nogami, D; Mennickent, R				Uemura, Makoto; Kato, Taichi; Nogami, Daisaku; Mennickent, Ronald			Doppler tomography by total variation minimization	PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF JAPAN			English	Article						accretion, accretion disks; methods: data analysis; novae, cataclysmic variables	ACCRETION; STAR	We have developed a new model of Doppler tomography using total variation minimization (DTTVM). This method can reconstruct localized and nonaxisymmetric profiles with sharp edges in the Doppler map. This characteristic is emphasized in the case where input data are small in number. We apply this model to natural data for the dwarf nova WZ Sge in superoutburst and TU Men in quiescence. We confirm that DTTVM can reproduce the observed spectra with high precision. Compared with the models based on the maximum entropy method, our new model can provide Doppler maps that little depend on the hyperparameter and on the presence of the absorption core. We also introduce a cross-validation method of estimating reasonable values of a hyperparameter in the model from the data themselves.	[Uemura, Makoto] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Kato, Taichi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Nogami, Daisaku] Kyoto Univ, Kwasan Observ, Yamashina Ku, Kyoto 6078471, Japan; [Nogami, Daisaku] Kyoto Univ, Hida Observ, Yamashina Ku, Kyoto 6078471, Japan; [Mennickent, Ronald] Univ Concepcion, Dept Astron, Concepcion, Chile	Uemura, M (reprint author), Hiroshima Univ, Hiroshima Astrophys Sci Ctr, 1-3-1 Kagamiyama, Hiroshima 7398526, Japan.	uemuram@hiroshima-u.ac.jp			JSPS [22540252, 25120007]; Fondecyt [1110347]; BASAL Centro de Astrofisica y Tecnologias Afines (CATA) [PFB-06/2007]	This work was supported by JSPS KAKENHI Grant Numbers 22540252 and 25120007. We appreciate the comments and suggestions from Dr. Shiro Ikeda and an anonymous referee. REM acknowledges the support of the Fondecyt grant 1110347 and the BASAL Centro de Astrofisica y Tecnologias Afines (CATA) PFB-06/2007.	MARSH TR, 1988, MON NOT R ASTRON SOC, V235, P269; YOUNG P, 1981, ASTROPHYS J, V245, P1035, DOI 10.1086/158880; Schwope AD, 1997, ASTRON ASTROPHYS, V319, P894; Nogami D, 2004, PUBL ASTRON SOC JPN, V56, pS163; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Bioucas-Dias J. M., 2007, IEEE INT C IM PROC, VI, P105; Harlaftis ET, 1996, ASTRON ASTROPHYS, V308, P97; Marsh T. R., 2001, ASTROTOMOGRAPHY INDI, P1; MARSH TR, 1990, ASTROPHYS J, V364, P637, DOI 10.1086/169446; MENNICKENT RE, 1995, ASTRON ASTROPHYS, V294, P126; Smak J., 1981, Acta Astronomica, V31; Spruit H. C., 1998, ARXIVASTROPH9806141; Steeghs D., 1997, MNRAS, V290, P28; Steeghs D, 2004, ASTRON NACHR, V325, P185, DOI 10.1002/asna.200310221; Tappert C, 2003, ASTRON ASTROPHYS, V408, P651, DOI 10.1051/0004-6361:20030933	16	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0004-6264	2053-051X		PUBL ASTRON SOC JPN	Publ. Astron. Soc. Jpn.	APR	2015	67	2							22	10.1093/pasj/psu154		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CG7WE	WOS:000353516200010		
J	Kobashigawa, S; Kashino, G; Suzuki, K; Yamashita, S; Mori, H				Kobashigawa, Shinko; Kashino, Genro; Suzuki, Keiji; Yamashita, Shunichi; Mori, Hiromu			Ionizing Radiation-Induced Cell Death Is Partly Caused by Increase of Mitochondrial Reactive Oxygen Species in Normal Human Fibroblast Cells	RADIATION RESEARCH			English	Article							SUPEROXIDE-DISMUTASE; ASCORBIC-ACID; OXIDATIVE STRESS; IRRADIATION; RADIORESISTANCE; OVEREXPRESSION; TRANSFORMATION; AMPLIFICATION; DYSFUNCTION; CHECKPOINT	Radiation-induced cell death is thought to be caused by nuclear DNA damage that cannot be repaired. However, in this study we found that a delayed increase of mitochondrial reactive oxygen species (ROS) is responsible for some of the radiation-induced cell death in normal human fibroblast cells. We have previously reported that there is a delayed increase of mitochondrial O-center dot(2)-, measured using MitoSOX (TM) Red reagent, due to gamma irradiation. This is dependent on Drp1 localization to mitochondria. Here, we show that knockdown of Drp1 expression reduces the level of DNA double-strand breaks (DSBs) remaining 3 days after 6 Gy irradiation. Furthermore, cells with knockdown of Drp1 expression are more resistant to gamma radiation. We then tested whether the delayed increase of ROS causes DNA damage. The antioxidant, 2-glucopyranoside ascorbic acid (AA-2G), was applied before or after irradiation to inhibit ROS production during irradiation or to inhibit delayed ROS production from mitochondria. Interestingly, 1 h after exposure, the AA-2G treatment reduced the level of DSBs remaining 3 days after 6 Gy irradiation. In addition, irradiated AA-2G-treated cells were more resistant to radiation than the untreated cells. These results indicate that delayed mitochondrial ROS production may cause some of the cell death after irradiation. (C) 2015 by Radiation Research Society	[Kobashigawa, Shinko; Mori, Hiromu] Oita Univ, Sch Med, Dept Radiol, Yufu City, Oita 8795593, Japan; [Kashino, Genro] Oita Univ, Adv Mol Imaging Ctr, Sch Med, Oita 87011, Japan; [Suzuki, Keiji; Yamashita, Shunichi] Nagasaki Univ, Dept Radiat Med Sci, Atom Bomb Dis Inst, Nagasaki 852, Japan	Kobashigawa, S (reprint author), Oita Univ, Sch Med, Dept Radiol, 1-1 Idaigaoka, Yufu City, Oita 8795593, Japan.	kobashin@oita-u.ac.jp			Global Center of Excellence (GCOE) Program	This study was supported by the Global Center of Excellence (GCOE) Program and Grants-in-Aid for Scientific Research, Japan.	Fisher CJ, 2008, CANCER BIOL THER, V7, P1271; Ogura A, 2009, CANCER LETT, V277, P64, DOI 10.1016/j.canlet.2008.11.021; Yamauchi M, 2008, DNA REPAIR, V7, P405, DOI 10.1016/j.dnarep.2007.11.011; Zhang B, 2013, CANCER RES, V73, P6700, DOI 10.1158/0008-5472.CAN-13-1411; Kobashigawa S, 2011, BIOCHEM BIOPH RES CO, V414, P795, DOI 10.1016/j.bbrc.2011.10.006; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Koyama S, 1998, MUTAT RES-FUND MOL M, V421, P45, DOI 10.1016/S0027-5107(98)00153-5; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Atkinson J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1499; Epperly MW, 2013, RADIAT RES, V180, P189, DOI 10.1667/RR3177.1; Epperly MW, 2007, RADIAT RES, V168, P560, DOI 10.1667/RR1071R.1; HIROSE K, 1993, FASEB J, V7, P361; Hu H, 2007, CHINESE MED J-PEKING, V120, P2092; Huang WY, 2013, BIOORG MED CHEM LETT, V23, P1583, DOI 10.1016/j.bmcl.2013.01.111; Kinashi Y, 2004, APPL RADIAT ISOTOPES, V61, P929, DOI 10.1016/j.apradiso.2004.05.011; MUNRO TR, 1961, ANN NY ACAD SCI, V95, P920, DOI 10.1111/j.1749-6632.1961.tb50087.x; Oka Y, 2011, J RADIAT RES, V52, P766, DOI 10.1269/jrr.10164; Saenko Y, 2013, RADIAT RES, V180, P360, DOI 10.1667/RR3247.1; Tamari Y, 2013, FREE RADICAL RES, V47, P1, DOI 10.3109/10715762.2012.734916; WATANABE M, 1992, INT J RADIAT BIOL, V62, P711, DOI 10.1080/09553009214552661; Yamauchi M, 2005, BIOCHEM BIOPH RES CO, V330, P483, DOI 10.1016/j.bbrc.2004.11.174; Yoshida T, 2012, FREE RADICAL RES, V46, P147, DOI 10.3109/10715762.2011.645207; Zhang XC, 2008, HUM GENE THER, V19, P820, DOI 10.1089/hum.2007.141; Zhou HN, 2001, P NATL ACAD SCI USA, V98, P14410, DOI 10.1073/pnas.251524798	26	2	2	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	APR	2015	183	4					455	464		10.1667/RR13772.1		10	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	CG6MW	WOS:000353416500010		
J	Crowley, KD; Cullings, HM; Landes, RD; Shore, RE; Ullrich, RL				Crowley, Kevin D.; Cullings, Harry M.; Landes, Reid D.; Shore, Roy E.; Ullrich, Robert L.			Comments on Estimating Risks of Low Radiation Doses-A Critical Review of the BEIR VII Report and Its Use of the Linear No-Threshold (LNT) Hypothesis by Edward J. Calabrese and Michael K. O'Connor	RADIATION RESEARCH			English	Letter							ATOMIC-BOMB SURVIVORS; TECHA RIVER COHORT; BREAST-CANCER RISK; LUNG-CANCER; RESIDENTIAL RADON; EXPOSURE; MORTALITY		[Crowley, Kevin D.] Natl Acad Sci, Natl Res Council, Washington, DC 20001 USA; [Cullings, Harry M.; Landes, Reid D.; Shore, Roy E.; Ullrich, Robert L.] Radiat Effects Res Fdn, Minami Ku, Hiroshima, Japan	Crowley, KD (reprint author), CNR, Nucl & Radiat Studies Board, 500 Fifth St NW, Washington, DC 20001 USA.	kcrowley@nas.edu					Krestinina LY, 2005, RADIAT RES, V164, P602, DOI 10.1667/RR3452.1; Lubin JH, 2004, INT J CANCER, V109, P132, DOI 10.1002/ijc.11683; ULLRICH RL, 1987, RADIAT RES, V111, P179, DOI 10.2307/3577031; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Darby S, 2005, BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Doss M, 2013, DOSE-RESPONSE, V11, P480, DOI 10.2203/dose-response.13-005.Doss; Krewski D, 2006, J TOXICOL ENV HEAL A, V69, P533, DOI 10.1080/15287390500260945; Krestinina LY, 2013, BRIT J CANCER, V109, P2886, DOI 10.1038/bjc.2013.614; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Cornforth MN, 2002, RADIAT RES, V158, P43, DOI 10.1667/0033-7587(2002)158[0043:DRFCAP]2.0.CO;2; Thompson RE, 2008, HEALTH PHYS, V94, P228, DOI 10.1097/01.HP.0000288561.53790.5f; ULLRICH RL, 1979, RADIAT RES, V80, P325, DOI 10.2307/3575061; Calabrese EJ, 2014, RADIAT RES, V182, P463, DOI 10.1667/RR13829.1; Cicerone RJ, 2014, ARCH TOXICOL, V88, P171, DOI 10.1007/s00204-013-1176-4; Eidemuller M, 2009, MUTAT RES-FUND MOL M, V669, P48, DOI 10.1016/j.mrfmmm.2009.04.009; Hwang SL, 2006, INT J RADIAT BIOL, V82, P849, DOI 10.1080/09553000601085980; Lundell M, 1999, RADIAT RES, V151, P626, DOI 10.2307/3580039; NAS, 2006, HLTH RISKS EXP LOW L; NAS/National Research Council, 1980, EFF POP EXP LOW LEV; NAS/National Research Council, 1956, BIOL EFFF AT RAD; NAS/National Research Council, 1990, HLTH EFF EXP LOW LEV; National Academy of Sciences (NAS)/National Research Council (NRC), 1972, EFF POP EXP LOW LEV	22	0	0	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	APR	2015	183	4					476	481		10.1667/RR4029.1		6	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	CG6MW	WOS:000353416500012		
J	Canonica, GW; Ansotegui, IJ; Pawankar, R; Schmid-Grendelmeier, P; van Hage, M; Baena-Cagnani, CE; Melioli, G; Nunes, C; Passalacqua, G; Rosenwasser, L; Sampson, H; Sastre, J; Bousquet, J; Zuberbier, T				Canonica, G. W.; Ansotegui, I. J.; Pawankar, R.; Schmid-Grendelmeier, P.; van Hage, M.; Baena-Cagnani, C. E.; Melioli, G.; Nunes, C.; Passalacqua, G.; Rosenwasser, L.; Sampson, H.; Sastre, J.; Bousquet, J.; Zuberbier, T.		WAO-ARIA-GA LEN Task Force	A WAO-ARIA-GA(2) LEN consensus document on molecular-based allergy diagnostics	Revue Francaise d Allergologie			French	Review						Molecular-based allergy diagnosis; Component-resolved diagnosis; Molecular allergen; Recombinant allergen; Natural allergen; Polysensitization; Specific immunoglobulin E; Consensus; Allergen chip; Allergen microarray	COMPONENT-RESOLVED DIAGNOSIS; EXERCISE-INDUCED ANAPHYLAXIS; LIPID TRANSFER PROTEINS; GRASS-POLLEN ALLERGENS; RED MEAT ALLERGY; ARA H 2; IGE ANTIBODIES; SENSITIZATION PROFILES; RECOMBINANT ALLERGENS; PHLEUM-PRATENSE	Molecular-based allergy (MA) diagnostics is an approach used to map the allergen sensitization of a patient at a molectilar level, using purified natural or recombinant allergenic molecules (allergen components) instead of allergen extracts. Since its introduction, MA diagnostics has increasingly entered routine care, with currently more than 130 allergenic molecules commercially available for in vitro specific IgE (sIgE) testing. MA diagnostics allows for an increased accuracy in allergy diagnosis and prognosis and plays an important role in three key aspects of allergy diagnosis: (1) resolving genuine versus cross-reactive sensitization in poly-sensitized patients, thereby improving the understanding of triggering allergens; (2) assessing, in selected cases, the risk of severe, systemic versus mild, local reactions in food allergy, thereby reducing unnecessary anxiety for the patient and the need for food challenge testing; and (3) identifying patients and triggering allergens for specific immunotherapy (SIT). Singleplex and multiplex measurement platforms' are available for MA diagnostics. The Immuno-Solid phase Allergen Chip (ISAC) is the most comprehensive platform currently available, which involves a biochip technology to measure sIgE antibodies against more than one hundred allergenic molecules in a single assay. As the field of MA diagnostics advances, future work needs to focus on large-scale, population-based studies involving practical applications, elucidation and expansion of additional allergenic molecules, and support for appropriate test interpretation. With the rapidly expanding evidence-base for MA diagnosis, there is a need for allergists to keep abreast of the latest information. The aim of this consensus document is to provide a practical guide for the indications, determination, and interpretation of MA diagnostics for clinicians trained in allergology. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Canonica, G. W.] Univ Genoa, Dept Internal Med, DIMI, Allergy & Resp, I-16126 Genoa, Italy; [Ansotegui, I. J.] Hosp Quiron Bizkaia, Dept Allergy & Immunol, Erandio, Bilbao, Spain; [Pawankar, R.] Nippon Med Sch, Div Allergy, Dept Pediat, Tokyo 113, Japan; [Schmid-Grendelmeier, P.] Univ Zurich Hosp, Allergy Unit, Dept Dermatol, CH-8091 Zurich, Switzerland; [van Hage, M.] Karolinska Inst, Dept Med Solna, Clin Immunol & Allergy Unit, Stockholm, Sweden; [van Hage, M.] Univ Hosp, Stockholm, Sweden; [Baena-Cagnani, C. E.] Catholic Univ, Res Ctr Resp Med, Cordoba, Argentina; [Melioli, G.] Ist Giannina Gaslini, Dipartimento Med Sperimentale, I-16148 Genoa, Italy; [Nunes, C.] Ctr Allergy Algarve, Algarve, Portugal; [Passalacqua, G.] Univ Genoa, Genoa, Italy; [Rosenwasser, L.] Univ Missouri, City Sch Med, Childrens Mercy Hosp & Clin, Kansas City, KS USA; [Sampson, H.] Icahn Sch Med Mt Sinai, Dept Pediat, Div Allergy Immunol, New York, NY 10029 USA; [Sastre, J.] Univ Autonoma Madrid, Dept Med, Fdn Jimenez Diaz, Madrid, Spain; [Bousquet, J.] Hop Arnaud Villeneuve, Serv Malad Resp, Montpellier, France; [Zuberbier, T.] Charite, Clin Dermatol & Allergy, D-10117 Berlin, Germany	Canonica, GW (reprint author), Univ Genoa, Dept Internal Med, DIMI, Allergy & Resp, Largo Rosanna Benzi, I-16126 Genoa, Italy.	canonica@unige.it					Cox L, 2009, ANN ALLERG ASTHMA IM, V103, P451, DOI 10.1016/S1081-1206(10)60259-1; Resch Y, 2011, CLIN EXP ALLERGY, V41, P1468, DOI 10.1111/j.1365-2222.2011.03798.x; Ruiz-Garcia M, 2011, J ALLERGY CLIN IMMUN, V128, P416, DOI 10.1016/j.jaci.2011.03.008; Holzhauser T, 2009, J ALLERGY CLIN IMMUN, V123, P452, DOI 10.1016/j.jaci.2008.09.034; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Constantin C, 2009, ALLERGY, V64, P1030, DOI 10.1111/j.1398-9995.2009.01955.x; Ebo DG, 2010, CLIN EXP ALLERGY, V40, P348, DOI 10.1111/j.1365-2222.2009.03370.x; Bronnert M, 2012, CLIN EXP ALLERGY, V42, P1406, DOI 10.1111/j.1365-2222.2012.04035.x; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Lopata AL, 2009, CURR OPIN ALLERGY CL, V9, P270, DOI 10.1097/ACI.0b013e32832b3e6f; Ebisawa M, 2012, INT ARCH ALLERGY IMM, V158, P71, DOI 10.1159/000330661; Flinterman AE, 2008, CURR OPIN ALLERGY CL, V8, P261, DOI 10.1097/ACI.0b013e3282ffb145; Palacin A, 2010, CLIN EXP ALLERGY, V40, P1422, DOI 10.1111/j.1365-2222.2010.03578.x; Seiki K, 2007, J AGR FOOD CHEM, V55, P9345, DOI 10.1021/jf0715471; Matsuo H, 2008, ALLERGY, V63, P233, DOI 10.1111/j.1398-9995.2007.01504.x; Cabrera-Freitag P, 2011, CLIN EXP ALLERGY, V41, P1440, DOI 10.1111/j.1365-2222.2011.03818.x; Tripodi S, 2012, J ALLERGY CLIN IMMUN, V129, P834, DOI 10.1016/j.jaci.2011.10.045; Focke M, 2009, EUR J CLIN INVEST, V39, P429, DOI 10.1111/j.1365-2362.2009.02109.x; Pascal M, 2012, CLIN EXP ALLERGY, V42, P1529, DOI 10.1111/j.1365-2222.2012.04071.x; Mullins RJ, 2012, J ALLERGY CLIN IMMUN, V129, P1334, DOI 10.1016/j.jaci.2012.02.038; Nelson HS, 2009, CURR OPIN ALLERGY CL, V9, P549, DOI 10.1097/ACI.0b013e328330ee69; Ayuso R, 2010, J ALLERGY CLIN IMMUN, V125, P1286, DOI 10.1016/j.jaci.2010.03.010; Asarnoj A, 2012, J ALLERGY CLIN IMMUN, V130, P468, DOI 10.1016/j.jaci.2012.05.019; Focke M, 2008, CLIN EXP ALLERGY, V38, P1400, DOI 10.1111/j.1365-2222.2008.03031.x; Casaulta C, 2005, PEDIATR ALLERGY IMMU, V16, P217, DOI 10.1111/j.1399-3038.2005.00262.x; Lizaso MT, 2011, ANN ALLERG ASTHMA IM, V107, P35, DOI 10.1016/j.anai.2011.03.017; Glaumann S, 2012, ALLERGY, V67, P242, DOI 10.1111/j.1398-9995.2011.02754.x; Treudler R, 2013, CURR ALLERGY ASTHM R, V13, P110, DOI 10.1007/s11882-012-0318-8; Kurup VP, 2000, CLIN EXP ALLERGY, V30, P988, DOI 10.1046/j.1365-2222.2000.00837.x; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Pali-Scholl I, 2011, ALLERGY, V66, P469, DOI 10.1111/j.1398-9995.2010.02511.x; Commins SP, 2009, J ALLERGY CLIN IMMUN, V123, P426, DOI 10.1016/j.jaci.2008.10.052; Mattsson L, 2009, J ALLERGY CLIN IMMUN, V123, P362, DOI 10.1016/j.jaci.2008.11.021; Fernandez-Rivas M, 2006, J ALLERGY CLIN IMMUN, V118, P481, DOI 10.1016/j.jaci.2006.05.012; Canonica GW, 2009, ALLERGY, V64, P1, DOI 10.1111/j.1398-9995.2009.02309.x; Chung CH, 2008, NEW ENGL J MED, V358, P1109, DOI 10.1056/NEJMoa074943; Nicolaou N, 2011, CURR OPIN ALLERGY CL, V11, P222, DOI 10.1097/ACI.0b013e32834656c2; Egger M, 2010, CURR ALLERGY ASTHM R, V10, P326, DOI 10.1007/s11882-010-0128-9; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Barber D, 2008, ALLERGY, V63, P1550, DOI 10.1111/j.1398-9995.2008.01807.x; Lee MF, 2012, ANN ALLERG ASTHMA IM, V108, P243, DOI 10.1016/j.anai.2012.01.014; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Dang TD, 2012, J ALLERGY CLIN IMMUN, V129, P1056, DOI 10.1016/j.jaci.2012.01.056; Balboni I, 2008, PROTEOMICS, V8, P3443, DOI 10.1002/pmic.200800146; Hamsten C, 2013, J ALLERGY CLIN IMMUN, V132, P1431, DOI 10.1016/j.jaci.2013.07.050; Santos A, 2011, INT ARCH ALLERGY IMM, V155, P191, DOI 10.1159/000321178; Klemans RJB, 2013, J ALLERGY CLIN IMMUN, V131, P157, DOI 10.1016/j.jaci.2012.08.010; Gronlund H, 2009, J ALLERGY CLIN IMMUN, V123, P1189, DOI 10.1016/j.jaci.2009.03.011; Vicente-Serrano J, 2007, PEDIATR ALLERGY IMMU, V18, P503, DOI 10.1111/j.1399-3038.2007.00548.x; Hatzler L, 2012, J ALLERGY CLIN IMMUN, V130, P894, DOI 10.1016/j.jaci.2012.05.053; Wohrl S, 2006, ALLERGY, V61, P633, DOI 10.1111/j.1398-9995.2006.01078.x; Nordlund B, 2012, ALLERGY, V67, P661, DOI 10.1111/j.1398-9995.2012.02797.x; Bousquet J, 1998, ANN ALLERG ASTHMA IM, V81, P401, DOI 10.1016/S1081-1206(10)63136-5; Melioli G, 2012, PEDIAT ALLERG IMM-UK, V23, P433, DOI 10.1111/j.1399-3038.2011.01228.x; Valenta R, 2007, J INVEST ALLERG CLIN, V17, P36; Wang J, 2010, J ALLERGY CLIN IMMUN, V125, P695, DOI 10.1016/j.jaci.2009.12.017; Roux KH, 2003, INT ARCH ALLERGY IMM, V131, P234, DOI 10.1159/000072135; Vereda A, 2011, J ALLERGY CLIN IMMUN, V127, P603, DOI 10.1016/j.jaci.2010.09.010; Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x; Melioli G, 2011, CLIN BIOCHEM, V44, P1005, DOI 10.1016/j.clinbiochem.2011.05.007; Sastre J, 2012, ALLERGY, V67, P709, DOI 10.1111/j.1398-9995.2012.02808.x; Ebo DG, 2010, CLIN EXP ALLERGY, V40, P339, DOI 10.1111/j.1365-2222.2009.03345.x; Palosuo K, 2001, J ALLERGY CLIN IMMUN, V108, P634, DOI 10.1067/mai.2001.118602; Ott H, 2010, J INVEST ALLERG CLIN, V20, P129; Shreffler WG, 2011, J ALLERGY CLIN IMMUN, V127, P843, DOI 10.1016/j.jaci.2011.02.011; Sastre J, 2010, CLIN EXP ALLERGY, V40, P1442, DOI 10.1111/j.1365-2222.2010.03585.x; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; Romano A, 2012, CLIN EXP ALLERGY, V42, P1643, DOI 10.1111/cea.12011; Kosma P, 2011, ACTA PAEDIATR, V100, P305, DOI 10.1111/j.1651-2227.2010.02049.x; Arkestal K, 2011, J ALLERGY CLIN IMMUN, V127, P1024, DOI 10.1016/j.jaci.2011.01.033; Bones MP, 2011, PEDIAT ALLERGY IMMUN, V6, P454; Bugajska-Schretter A, 1998, J ALLERGY CLIN IMMUN, V101, P67, DOI 10.1016/S0091-6749(98)70195-2; Cabrera-Freitag P, 2011, J INVEST ALLERG CLIN, V21, P414; Caubet I-C, 2011, CURR OPIN ALLERGY CL, V6, P210; Caubet JC, 2013, J ALLERGY CLIN IMMUN, V131, P222, DOI 10.1016/j.jaci.2012.06.049; Ciprandi G, 2008, Eur Ann Allergy Clin Immunol, V40, P77; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Cromwell O, 2011, J ALLERGY CLIN IMMUN, V6, P865; Gadisseur R, 2011, CLIN CHEM LAB MED, V6, P277; Gassner M, 2013, NEW ENGL J MED, V368, P393, DOI 10.1056/NEJMc1214426; Gronlund H, 2008, CLIN EXP ALLERGY, V38, P1275, DOI 10.1111/j.1365-2222.2008.03003.x; Hamsten C, 2013, ALLERGY; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Leung NY, 2012, CLIN REV ALLERGY IMM; Marogna M, 2006, ALLERGY, V61, P1209, DOI 10.1111/j.1398-9995.2006.01164.x; Masthoff LJ, 2013, J ALLERGY CLIN IMMUN; Melioli G, 2012, CURR OPIN ALLERGY CL, V12, P434, DOI 10.1097/ACI.0b013e32835535b8; Mertens M, 2011, INT ARCH ALLERGY IMM, V156, P43, DOI 10.1159/000322279; Muller U, 2012, ALLERGY, V6, P1069; Onell A, 2012, CLIN TRANSL ALLERGY, V6, P24; Perez-Gordo M, 2011, CLIN EXP ALLERGY, V41, P750, DOI 10.1111/j.1365-2222.2011.03721.x; Sanchez-Monge R, 2006, J ALLERGY CLIN IMMUN, V118, P705, DOI 10.1016/j.jaci.2006.04.058; Schmid-Grendelmeier P, 2010, HAUTARZT, V61, P946, DOI 10.1007/s00105-010-1967-y; THOMAS WR, 1988, INT ARCH ALLER A IMM, V85, P127; Torres Borrego J, 2003, ALLERGOL IMMUNOPATHO, V6, P146; Twaroch TE, 2012, CLIN EXP ALLERGY, V42, P966, DOI 10.1111/j.1365-2222.2012.03996.x; VALENTA R, 1992, INT ARCH ALLERGY IMM, V97, P287; Valenta R, 2001, IMMUNOL REV, V179, P119, DOI 10.1034/j.1600-065X.2001.790112.x; VALENTA R, 1991, J ALLERGY CLIN IMMUN, V88, P889, DOI 10.1016/0091-6749(91)90245-J; Van Do T, 2005, MOL IMMUNOL, V42, P345, DOI 10.1016/j.molimm.2004.09.001; Verweij MM, 2011, PEDIAT ALLERG IMM-UK, V22, P196, DOI 10.1111/j.1399-3038.2010.01088.x; Walsh J, 2011, BRIT J GEN PRACT, V61, P473, DOI 10.3399/bjgp11X583498; Weber RW, 2007, ANN ALLERG ASTHMA IM, V99, P203; Zijlstra WT, 2010, PEDIAT ALLERG IMM-UK, V21, pE439, DOI 10.1111/j.1399-3038.2009.00929.x	109	1	1	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	1877-0320			REV FR ALLERGOL	Rev. Fr. Allergol.	APR	2015	55	2					83	99		10.1016/j.reval.2014.10.001		17	Allergy	Allergy	CG5XY	WOS:000353370400009		
J	Hayakawa, M; Gando, S; Ono, Y; Mizugaki, A; Katabami, K; Maekawa, K; Miyamoto, D; Wada, T; Yanagida, Y; Sawamura, A				Hayakawa, Mineji; Gando, Satoshi; Ono, Yuichi; Mizugaki, Asumi; Katabami, Kenichi; Maekawa, Kunihiko; Miyamoto, Daisuke; Wada, Takeshi; Yanagida, Yuichiro; Sawamura, Atsushi			Rapid Evaluation of Fibrinogen Levels Using the CG02N Whole Blood Coagulation Analyzer	SEMINARS IN THROMBOSIS AND HEMOSTASIS			English	Article						fibrinogen; point-of-care; coagulopathy; massive transfusion	MASSIVE TRANSFUSION; ROTATION THROMBOELASTOMETRY; CARDIAC-SURGERY; EUROPEAN GUIDELINE; TRAUMA PATIENTS; MAJOR TRAUMA; HEAD-INJURY; MANAGEMENT; HEMATOCRIT; PLASMA	Rapid evaluation of fibrinogen (Fbg) levels is essential for maintaining homeostasis in patients with massive bleeding during severe trauma and major surgery. This study evaluated the accuracy of fibrinogen levels measured by the CG02N whole blood coagulation analyzer (A&T Corporation, Kanagawa, Japan) using heparinized blood drawn for blood gas analysis (whole blood-Fbg). A total of 100 matched pairs of heparinized blood samples and citrated blood samples were simultaneously collected from patients in the intensive care unit. Whole blood-Fbg results were compared with those of citrated plasma (standard-Fbg). The whole blood coagulation analyzer measured fibrinogen levels within 2 minutes. Strong correlations between standard-Fbg and whole blood-Fbg were observed (=0.91, p<0.001). Error grid analysis showed that 88% of the values were clinically acceptable, and 12% were in a range with possible effects on clinical decision-making; none were in a clinically dangerous range without appropriate treatment. Using a fibrinogen cutoff value of 1.5 g/L for standard-Fbg, the area under the receiver operating characteristic curve of whole blood-Fbg was 0.980 (95% confidence interval 0.951-1.000, p<0.001). The whole blood coagulation analyzer can rapidly measure fibrinogen levels in heparinized blood and could be useful in critical care settings where excessive bleeding is a concern.	[Hayakawa, Mineji; Gando, Satoshi; Ono, Yuichi; Mizugaki, Asumi; Katabami, Kenichi; Maekawa, Kunihiko; Miyamoto, Daisuke; Wada, Takeshi; Yanagida, Yuichiro; Sawamura, Atsushi] Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Kita Ku, Sapporo, Hokkaido 0608648, Japan	Hayakawa, M (reprint author), Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Kita Ku, N14W5, Sapporo, Hokkaido 0608648, Japan.	mineji@dream.com			A&T Corporation, Kanagawa, Japan	S. G. obtained research funds from A&T Corporation, Kanagawa, Japan. All other authors declare no conflicts of interest.	Jensen AS, 2013, INT J CARDIOL, V167, P1317, DOI 10.1016/j.ijcard.2012.03.181; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Nagler M, 2013, THROMB RES, V131, P249, DOI 10.1016/j.thromres.2013.01.009; [Anonymous], 2006, ANESTHESIOLOGY, V105, P198; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; O'Shaughnessy DF, 2004, BRIT J HAEMATOL, V126, P11, DOI 10.1111/j.1365-2141.2004.04972.x; Miesbach W, 2010, THROMB RES, V126, pE428, DOI 10.1016/j.thromres.2010.09.004; Solomon C, 2011, TRANSFUSION, V51, P1695, DOI 10.1111/j.1537-2995.2011.03066.x; Ogawa S, 2012, TRANSFUSION, V52, P14, DOI 10.1111/j.1537-2995.2011.03241.x; Stainsby D, 2006, BRIT J HAEMATOL, V135, P634; Ogawa S, 2012, ANESTH ANALG, V115, P16, DOI 10.1213/ANE.0b013e31824d523b; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Rahe-Meyer N, 2013, ANESTHESIOLOGY, V118, P40, DOI 10.1097/ALN.0b013e3182715d4d; Spiezia L, 2008, THROMB HAEMOSTASIS, V100, P1106, DOI 10.1160/TH08-04-0243; Karkouti K, 2013, ANESTH ANALG, V117, P14, DOI 10.1213/ANE.0b013e318292efa4; White NJ, 2010, RESUSCITATION, V81, P111, DOI 10.1016/j.resuscitation.2009.09.017; Inaba K, 2013, J AM COLL SURGEONS, V216, P290, DOI 10.1016/j.jamcollsurg.2012.10.017; Smith SA, 2012, AM J VET RES, V73, P789, DOI 10.2460/ajvr.73.6.789; Levy JH, 2012, ANESTH ANALG, V114, P261, DOI 10.1213/ANE.0b013e31822e1853; Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644; Chambers LA, 2011, AM J CLIN PATHOL, V136, P364, DOI 10.1309/AJCPH16YXJEFSHEO; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Gaarder C, 2008, SCAND J SURG, V97, P15; GOODNIGH.SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Hayakawa M, 2015, SEMIN THROMB HEMOST, V41, P35, DOI 10.1055/s-0034-1398379; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Lippi G, 2013, SEMIN THROMB HEMOST, V39, P83, DOI 10.1055/s-0032-1328936; McLoughlin TM, 1996, ANESTH ANALG, V83, P459, DOI 10.1097/00000539-199609000-00003; OBERHARDT BJ, 1991, CLIN CHEM, V37, P520; Ogawa S, 2014, ANESTH ANALG; Roullet S, 2010, BRIT J ANAESTH, V104, P422, DOI 10.1093/bja/aeq022; Schlimp CJ, 2014, HAMOSTASEOLOGIE, V34, P29, DOI 10.5482/HAMO-13-07-0038; Schochl H, 2011, CRIT CARE, V15, DOI 10.1186/cc10539; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686	36	1	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0094-6176	1098-9064		SEMIN THROMB HEMOST	Semin. Thromb. Hemost.	APR	2015	41	3					267	271		10.1055/s-0035-1547372		5	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CG8SL	WOS:000353582300002		
J	Ohe, T; Moriyoshi, K; Ohmoto, T; Yoshimura, Y; Shimada, Y				Ohe, Takeru; Moriyoshi, Kunihiko; Ohmoto, Takashi; Yoshimura, Yurika; Shimada, Yuji			Anti-Bacterial Activity of Polyamide Fibers Colored by Maillard Reaction	SEN-I GAKKAISHI			Japanese	Article							COLORATION	In our previous studies, the polyamide materials, such as wool, silk, nylon 6, and tanned leather, were colored in a water solution containing reducing sugars, similar to the brownish coloration of various foods containing both protein and reducing sugars, and these coloration reactions are called Maillard reaction. Interestingly, the obtained color materials or their related materials give foods not only color but also distinctive flavor, anti-oxidative capacity, and anti-bacterial activity. In this paper, anti-bacterial properties of the polyamide fibers colored by the Maillard reaction were investigated using conventional methods of JIS L 1902. As a result, polyamide fibers reacted with xylose, one of reducing sugars, showed very strong anti-bacterial activity against both Gram-positive and Gram-negative bacteria, such as S. aureus, E. coli, and so on. However, a clear relationship between the color concentration of these fibers and their anti-bacterial properties was not observed.	[Ohe, Takeru; Moriyoshi, Kunihiko; Ohmoto, Takashi; Yoshimura, Yurika] Osaka Municipal Tech Res Inst, Joto Ku, Osaka 5368553, Japan; [Shimada, Yuji] Okamura Oil Mill Co Ltd, Kashiwara, Osaka 5820004, Japan	Ohe, T (reprint author), Osaka Municipal Tech Res Inst, Joto Ku, 1-6-50 Morinomiya, Osaka 5368553, Japan.						Honma K., 2005, J JPN SOC NUTR FOOD, V58, P85; Inazu Y., 2007, J JPN SOC FOOD SCI, V54, P425; Kato H., 1991, DENPUN KAGAKU, V38, P109; KAWANA K, 1980, Eisei Kagaku, V26, P259; Munk P. K-F., 1931, Z TECH PHYS, V12, P593; Nakajima T., 2006, J JPN RES ASS TEXT E, V47, P586; Ohe T, 2014, TEXT RES J, V84, P539, DOI 10.1177/0040517513503731; Ohe T, 2014, SEN-I GAKKAISHI, V70, P187; Ohe T., 2014, KAGAKU KOGYO, V88, P89; Okabe T., 2014, FIBER PREPRINTS JAPA, V69, p2G; Onishi T., 1992, EISEI KAGAKU, V36, P179; Tomoda Y., 1955, U TOKYO SEISAN KENKY, V7, P37; WATANABE S, 1980, Japanese Journal of Anesthesiology, V29, P536; Yamaguchi N., 1969, Journal of the Japanese Oil Chemists Society, V18, P111; Yamamoto N., 1999, J INORG MAT JPN, V6, P468	15	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	APR	2015	71	4					151	156				6	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CG6RB	WOS:000353428800011		
J	Jung, JS; Komaki, M				Jung, Jong-sun; Komaki, Motoko			Coloration of Cotton Fabric with Clay Particles	SEN-I GAKKAISHI			Japanese	Article								The cotton fibers, threads and fabrics which were repeatedly colored with clay minerals by the process of immersing, drying, and rinsing were observed with an optical microscope and a SEM. The particle size distribution of the clay suspension, absorption spectra of the filtration of the suspension and K/S values of the colored fabrics were measured by laser diffraction scattering method, uv-vis spectrophotometry and diffuse-reflectivity at 400 nm, respectively. As a result, it was revealed that the smaller the diameters of the clay particles were, and the more repeating the process of immersing, drying, and rinsing was, the more deeper coloration were obtained. The clay particles of 0.3 similar to 3 mu m were observed on fiber surface after coloring, though the average diameters of the clay used for coloration were approximately 10-14 mu m.	[Jung, Jong-sun] Paichai Univ, Dept Clothing & Text, Taejon 320735, South Korea; [Komaki, Motoko] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan	Jung, JS (reprint author), Paichai Univ, Dept Clothing & Text, 155-40 Baejae Ro Doma Dong, Taejon 320735, South Korea.						Araki H., 2014, 145 M 120 COMM PROC; Ishibashi H., 1990, B KAGOSHIMA PREF JR, V41, P71; Jung J, 2011, SEN-I GAKKAISHI, V67, P66; Jung M. S., 2004, J KOR SOC CLOTH IND, V6, P234; Kaneko S., 1983, ARCHEOLOGY NATURAL S, V16, P115; Kim S. J., 2001, J KOREAN SOC CLOTHIN, V25, P1770; Kim S. Y., 2000, J KOREAN SOC CLOTH I, V2, P118; Kwon M. S., 2006, J KOREAN SOC DYERS F, V18, P1; Matsuoka A., 2000, P ENV MUTAGEN SOC JA, V29, P109; Ryu D. O., 1995, THE SECRET OF LOESS, P24; Shiozawa T., 1999, P ENV MUTAGEN SOC JA, V28, P103; The Clay Science Society of Japan, 1994, CLAY SCI SOC JAP CLA, P910; Vickerstaff T., 1954, PHYS CHEM DYEING, P6; Waldmoto R., 2004, EARTH SCI, V58, P199	14	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	APR	2015	71	4					157	160				4	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CG6RB	WOS:000353428800012		
J	Koganeya, K				Koganeya, Keizou			A Measuring Method of the Bending Rigidity of Thread	SEN-I GAKKAISHI			Japanese	Article								As for measurement of the bending rigidity of thread, generally, the KES method has been used. A test sample based on the relation among the bending rigidity of a ring-formed beam, compression load and displacement is adopted. Results from the test samples are comparatively in agreement with those of KES method.	Wakayama Coll, Natl Inst Technol, Wakayama 6440023, Japan	Koganeya, K (reprint author), Wakayama Coll, Natl Inst Technol, 77 Nadachou Nojima, Wakayama 6440023, Japan.						Niwa M., 1974, J TEXT MECH SOC JAPA, V27, P192; Terasawa K., 1975, ZAIRYOURIKIGAKU JOUK, V4th, P188; Yasuda A., 2010, AICHIKEN SANGYOUGIJU, P96	3	0	0	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	APR	2015	71	4					161	163				3	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CG6RB	WOS:000353428800013		
J	Sasaki, N; Ozono, R; Edahiro, Y; Okita, T; Teramen, K; Kisaka, T; Fujiwara, S; Kihara, Y				Sasaki, Nobuo; Ozono, Ryoji; Edahiro, Yoshinobu; Okita, Tomomi; Teramen, Kazushi; Kisaka, Tomohiko; Fujiwara, Saeko; Kihara, Yasuki			Short-term blood pressure variability in hypertensive patients with obstructive sleep apnea syndrome	Sleep and Biological Rhythms			English	Article						blood pressure variability; continuous positive airway pressure; hypertension; hypoxemia; sleep apnea	POSITIVE AIRWAY PRESSURE; SYMPATHETIC-NERVOUS-SYSTEM; VISIT-TO-VISIT; PROGNOSTIC-SIGNIFICANCE; CARDIOVASCULAR MORTALITY; RISK-FACTOR; POPULATION; PREDICTOR; EVENTS; IMPACT	Short-term blood pressure (BP) variability is an important cardiovascular risk factor. Whether patients with obstructive sleep apnea syndrome (OSAS) indeed display increased short-term BP variability and, if so, what is its underlying mechanism remain unclear. We compared the short-term BP variability between hypertensive patients with OSAS (OSAS group; n=212) and those without OSAS (control group; n=82) by examining data of 24-h ambulatory BP monitoring (ABPM) and investigated the effects of continuous positive airway pressure (CPAP) therapy on short-term BP variability in 37 hypertensive patients with OSAS. Short-term BP variability was calculated with the average real variability (ARV) of awake and sleep BP. ARVs of sleep systolic BP (SBP) and diastolic BP (DBP) were significantly higher in the OSAS group than in the control group. There was no significant difference in ARVs of awake SBP and DBP between the two groups. In the OSAS group, multiple regression analyses revealed that the body mass index (BMI) was an independent determinant for ARV of sleep DBP and that the lowest SpO(2) was an independent determinant for ARVs of sleep SBP and sleep DBP. CPAP therapy decreased ARVs of sleep SBP and DBP. These results suggested that higher short-term BP variability during sleep is a characteristic feature of hypertensive patients with OSAS and that obesity and hypoxemia play essential roles in increasing short-term BP variability during sleep. CPAP therapy may improve exaggerated short-term BP variability during sleep in patients with OSAS.	[Sasaki, Nobuo; Fujiwara, Saeko] Hiroshima Atom Bomb Casualty Council, Hlth Management & Promot Ctr, Naka Ku, Hiroshima 7300052, Japan; [Ozono, Ryoji] Hiroshima Univ, Dept Gen Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Kisaka, Tomohiko; Kihara, Yasuki] Hiroshima Univ, Dept Cardiovasc Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Edahiro, Yoshinobu; Okita, Tomomi] Mitsubishi Mihara Hosp, Dept Clin Labs, Mihara, Japan; [Teramen, Kazushi] Mitsubishi Mihara Hosp, Dept Internal Med, Mihara, Japan	Sasaki, N (reprint author), Hiroshima Atom Bomb Casualty Council, Hlth Management & Promot Ctr, Naka Ku, 3-8-6 Senda Machi, Hiroshima 7300052, Japan.	nb7ssk7@sd6.so-net.ne.jp					American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, P292; Flemons WW, 1999, SLEEP, V22, P667; Ozawa M, 2009, CLIN EXP HYPERTENS, V31, P259, DOI 10.1080/10641960902822518; Becker HF, 2003, CIRCULATION, V107, P68, DOI 10.1161/01.CIR.0000042706.47107.7A; Eguchi K, 2009, AM J HYPERTENS, V22, P46, DOI 10.1038/ajh.2008.294; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; Verdecchia P, 2007, AM J HYPERTENS, V20, P154, DOI 10.1016/j.amjhyper.2006.07.017; Bjorklund K, 2004, J HYPERTENS, V22, P1691; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; Sasaki N, 2012, CLIN EXP HYPERTENS, V34, P270, DOI 10.3109/10641963.2012.681083; Barbe F, 2001, ANN INTERN MED, V134, P1015; Kikuya M, 2005, HYPERTENSION, V45, P240, DOI 10.1161/01.HYP.0000152079.04553.2c; Martinez-Garcia MA, 2012, AM J RESP CRIT CARE, V186, P909, DOI 10.1164/rccm.201203-0448OC; Stolarz-Skrzypek K, 2010, HYPERTENS RES, V33, P757, DOI 10.1038/hr.2010.110; Narkiewicz K, 1998, CIRCULATION, V98, P1071; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Kario K, 2009, HYPERTENS RES, V32, P428, DOI 10.1038/hr.2009.56; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/01.hjh.0000098144.70956.0f; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Mancia G, 2001, J HYPERTENS, V19, P1981, DOI 10.1097/00004872-200111000-00008; Narkiewicz K, 1997, J HYPERTENS, V15, P1613, DOI 10.1097/00004872-199715120-00062; Diaz KM, 2012, HYPERTENS RES, V35, P55, DOI 10.1038/hr.2011.135; Pennestri MH, 2007, NEUROLOGY, V68, P1213, DOI 10.1212/01.wnl.0000259036.89411.52; SOMERS VK, 1993, NEW ENGL J MED, V328, P303, DOI 10.1056/NEJM199302043280502; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Schillaci G, 2012, HYPERTENSION, V60, P369, DOI 10.1161/HYPERTENSIONAHA.112.197491; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; ASDA E., 1992, SLEEP, V15, P173; Bao XP, 2002, BLOOD PRESS MONIT, V7, P301, DOI 10.1097/.01.mbp.0000047144.34024.5a; Eto M, 2005, HYPERTENS RES, V28, P1, DOI 10.1291/hypres.28.1; Kasiakogias A, 2013, J HYPERTENS, V31, P352, DOI 10.1097/HJH.0b013e32835bdcda; Nakamura K, 2010, CLIN EXP HYPERTENS, V32, P523, DOI 10.3109/10641963.2010.496513; Rechtschaffen A., 1968, PUBLICATION NATL I H, V204; Sasaki N, 2013, CLIN EXP HYPERTENS, V35, P250, DOI 10.3109/10641963.2013.780069; Steinhorst AP, 2014, SLEEP BREATH, V18, P397, DOI 10.1007/s11325-013-0899-z	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1446-9235	1479-8425		SLEEP BIOL RHYTHMS	Sleep Biol. Rhythms	APR	2015	13	2					117	126		10.1111/sbr.12094		10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG4ER	WOS:000353236800003		
J	Matsui, K; Sasai-Sakuma, T; Takahashi, M; Ishigooka, J; Inoue, Y				Matsui, Kentaro; Sasai-Sakuma, Taeko; Takahashi, Masayoshi; Ishigooka, Jun; Inoue, Yuichi			Restless legs syndrome in hemodialysis patients: Prevalence and association to daytime functioning	Sleep and Biological Rhythms			English	Article						depression; dialysis; prevalence; quality of life; restless legs syndrome	QUALITY-OF-LIFE; REGULAR DIALYSIS TREATMENT; ATHENS INSOMNIA SCALE; RISK-FACTORS; JAPANESE VERSION; HEALTH; POPULATION; DISEASE; VALIDATION; COMMUNITY	The prevalence of restless legs syndrome and its impact on daytime function were explored in a hemodialysis population, particularly addressing the response consistency of restless legs syndrome symptoms. A two-point internet-based questionnaire survey with a one week interval was administered to 645 subjects of a hemodialysis population. Five hundred and four candidates (332 men and 172 women with mean [SD] age of 59.1 [12.8] years) with hemodialysis who completed the two surveys were selected for analysis. Questionnaire items included personal data, four criteria items for diagnosis of restless legs syndrome, Athens Insomnia Scale, Center for Epidemiologic Studies Depression Scale, Short Form 8-items for health survey, and items of the International Restless Legs Syndrome Severity Scale. Factors associated with deteriorated mental component summary and physical component summary on Short Form 8-items for health survey and depression were assessed. Prevalence of restless legs syndrome was the rate of those meeting the four diagnostic criteria items for this disorder in both surveys: 12.9%. Restless legs syndrome category defined by response consistency to the restless legs syndrome criteria items was significantly associated with the physical component summary score deterioration. This two-point survey indicated reliable prevalence of restless legs syndrome in a hemodialysis population, and revealed that stability of restless legs syndrome symptoms might contribute to the presence of certain daytime dysfunctions in this population.	[Matsui, Kentaro; Ishigooka, Jun] Tokyo Womens Med Univ, Dept Psychiat, Tokyo, Japan; [Sasai-Sakuma, Taeko; Takahashi, Masayoshi; Inoue, Yuichi] Tokyo Med Univ, Dept Somnol, Tokyo 1510053, Japan; [Matsui, Kentaro; Sasai-Sakuma, Taeko; Inoue, Yuichi] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan; [Sasai-Sakuma, Taeko] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Div Biomed Lab Sci, Dept Life Sci & Bioinformat, Tokyo, Japan; [Takahashi, Masayoshi] Otsuka Pharmaceut Co Ltd, Dept Clin Res & Dev, Tokyo, Japan	Inoue, Y (reprint author), Tokyo Med Univ, Dept Somnol, Shibuya Ku, 1-24-6 Yoyogi, Tokyo 1510053, Japan.	inoue@somnology.com			Otsuka Pharmaceutical Co, Ltd; Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare, Japan [H25-"Seishin-Ippan-"010]; MEXT/JSPS KAKENHI [24791435]; Charitable Trust Laboratory Medicine Research Foundation of Japan; Yoshitomiyakuhin Corporation; Pfizer, Inc.; Astellas Pharma Inc.; GlaxoSmithKline K.K.; Novartis Pharma K.K.; Eisai Co., Ltd; Eli Lilly and Company; Janssen Pharmaceutical K.K.; Otsuka Pharmaceutical Co., Ltd; Dainippon Sumitomo Pharma Co., Ltd; Chugai Pharmaceutical Co., Ltd; Meiji Seika Pharma Co., Ltd; Takeda Pharmaceutical Company Limited; Mochida Pharmaceutical Co., Ltd; Shionogi Co., Ltd.; HISAMITSU PHARMACEUTICAL CO., INC.; Philips Respironics GK; sanofi-aventis K.K.; Eisai Co., Ltd.	This study was financially supported by (i) Otsuka Pharmaceutical Co, Ltd, (ii) Health and Labour Sciences Research Grants for Comprehensive Research on Disability Health and Welfare (H25-"Seishin-Ippan-"010), Japan to Yuichi Inoue, (iii) MEXT/JSPS KAKENHI (Grant-in-Aid for Young Scientists, no. 24791435) to Taeko Sasai and (iv) Charitable Trust Laboratory Medicine Research Foundation of Japan to Taeko Sasai.; This was not an industry supported study. Dr Ishigooka has received support for consultancy from Otsuka Pharmaceutical Co., Ltd, and Dainippon Sumitomo Pharma Co., Ltd, grants from Yoshitomiyakuhin Corporation, Pfizer, Inc., Astellas Pharma Inc., GlaxoSmithKline K.K., and Novartis Pharma K.K., Eisai Co., Ltd, and payment for lectures from Eli Lilly and Company, Janssen Pharmaceutical K.K., Otsuka Pharmaceutical Co., Ltd, Eisai Co., Ltd, Dainippon Sumitomo Pharma Co., Ltd, Novartis Pharma K.K., GlaxoSmithKline K.K., Yoshitomiyakuhin Corporation, Chugai Pharmaceutical Co., Ltd, Meiji Seika Pharma Co., Ltd, Takeda Pharmaceutical Company Limited, Mochida Pharmaceutical Co., Ltd, and Shionogi & Co., Ltd. Dr Inoue has received consultancy fee from HISAMITSU PHARMACEUTICAL CO., INC., expert testimony from Nippon Boehringer Ingelheim Co., Ltd, Philips Respironics GK, Alfresa Pharma Corporation, Takeda Pharmaceutical Company Limited, MSD K.K., Pacific Medico Co., Ltd, Otsuka Pharmaceutical Co., Ltd, Eisai Co., Ltd, and Mitsubishi Tanabe Pharma Corporation, and payment for lectures from Philips Respironics GK, Takeda Pharmaceutical Company Limited, GlaxoSmithKline K.K., Astellas Pharma Inc., sanofi-aventis K.K., Yoshitomiyakuhin Corporation, Otsuka Pharmaceutical Co., Ltd, and Eisai Co., Ltd. Mr Takahashi, who is in charge of the department of clinical research and development in Otsuka Pharmaceutical Co., Ltd, substantively contributed to data collection related to this study but were engaged in neither data analysis nor interpretation of the results. The other authors have indicated no financial conflicts of interest.	AASM, 2005, INT CLASS SLEEP DIS; Allen RP, 2010, SLEEP MED, V11, P31, DOI 10.1016/j.sleep.2009.03.007; Lin CH, 2013, EUR J NEUROL, V20, P1025, DOI 10.1111/ene.12095; Walters AS, 2003, SLEEP MED, V4, P121, DOI 10.1016/S1389-9457(02)00258-7; Sasai T, 2010, SLEEP MED, V11, P452, DOI 10.1016/j.sleep.2009.09.011; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Rothdach AJ, 2000, NEUROLOGY, V54, P1064; Hogl B, 2005, NEUROLOGY, V64, P1920, DOI 10.1212/01.WNL.0000163996.64461.A3; Lefante JJ, 2005, QUAL LIFE RES, V14, P665, DOI 10.1007/s11136-004-0784-0; Li LH, 2012, SLEEP MED, V13, P342, DOI 10.1016/j.sleep.2011.09.008; Tison F, 2005, NEUROLOGY, V65, P239, DOI 10.1212/01.wnl.0000168910.48309.4a; Bjorvatn B, 2005, SLEEP MED, V6, P307, DOI 10.1016/j.sleep.2005.03.008; Tuncel D, 2011, SLEEP BREATH, V15, P311, DOI 10.1007/s11325-010-0382-z; Okajima I, 2013, PSYCHIAT CLIN NEUROS, V67, P420, DOI 10.1111/pcn.12073; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; La Manna G, 2011, NEPHROL DIAL TRANSPL, V26, P1976, DOI 10.1093/ndt/gfq681; Anand S, 2013, HEMODIAL INT, V17, P50, DOI 10.1111/j.1542-4758.2012.00726.x; Nomura T, 2008, MOVEMENT DISORD, V23, P2363, DOI 10.1002/mds.22274; Ekbom KA, 1960, NEUROLOGY, V10, P868; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Araujo SMHA, 2010, SLEEP MED, V11, P785, DOI 10.1016/j.sleep.2010.02.011; Nomura T, 2006, J NEUROL SCI, V250, P39, DOI 10.1016/j.jns.2006.06.023; Allen RP, 2011, MOVEMENT DISORD, V26, P114, DOI 10.1002/mds.23430; Ulfberg J, 2001, MOVEMENT DISORD, V16, P1159, DOI 10.1002/mds.1209; Kawauchi A, 2006, CLIN NEPHROL, V66, P440; Kim JM, 2008, J CLIN NEUROL, V4, P153, DOI 10.3988/jcn.2008.4.4.153; Kinoshita E, 2001, NATL FAM RES JPN, V2, P141; Nakai S, 2007, THER APHER DIAL, V11, P411, DOI 10.1111/j.1744-9987.2007.00523.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Tokuda Y, 2009, VALUE HEALTH, V12, P568, DOI 10.1111/j.1524-4733.2008.00449.x; Tsuboi Y, 2009, PARKINSONISM RELAT D, V15, P598, DOI 10.1016/j.parkreldis.2009.02.014	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1446-9235	1479-8425		SLEEP BIOL RHYTHMS	Sleep Biol. Rhythms	APR	2015	13	2					127	135		10.1111/sbr.12095		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG4ER	WOS:000353236800004		
J	Furihata, R; Uchiyama, M; Suzuki, M; Konno, C; Konno, M; Takahashi, S; Kaneita, Y; Ohida, T; Akahoshi, T; Hashimoto, S; Akashiba, T				Furihata, Ryuji; Uchiyama, Makoto; Suzuki, Masahiro; Konno, Chisato; Konno, Michiko; Takahashi, Sakae; Kaneita, Yoshitaka; Ohida, Takashi; Akahoshi, Toshiki; Hashimoto, Shu; Akashiba, Tsuneto			Association of short sleep duration and short time in bed with depression: A Japanese general population survey	Sleep and Biological Rhythms			English	Article						depression; epidemiology; insomnia; Japan; sleep duration; time in bed	COGNITIVE-BEHAVIORAL THERAPY; KOREAN ADULTS; RISK-FACTOR; PSYCHIATRIC-DISORDERS; DAYTIME SLEEPINESS; QUALITY INDEX; INSOMNIA; PREVALENCE; SYMPTOMS; SAMPLE	Recent epidemiological studies have documented that depression is associated with short sleep duration, which may be interpreted as a consequence of comorbid insomnia and/or that of curtailment of time in bed (TIB). However, none of the studies examined association between depression and TIB. Here, we study TIB, short sleep duration and depression in the Japanese general adult population. Cross-sectional surveys with a face-to-face interview were conducted in 2009 as part of the Nihon University Sleep and Mental Health Epidemiology Project (NUSMEP). Data from 2532 individuals were analyzed. The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess the prevalence of depression with a cut-off point of 16. Sleep habits and sleep problems during the previous month, including bed time, getting up time, sleep duration, insomnia symptoms, and hypnotic medication use were evaluated. TIB was calculated from bed time and getting up time. The prevalence of depression identified with CES-D was 6.0% in total samples, 5.1% in men and 6.7% in women. Multiple logistic regression analysis revealed that both short sleep duration (<6h) and short TIB (<6h) were significantly associated with CES-D depression after adjusting for the confounding effects of sociodemographic variables, insomnia symptoms, and hypnotic medication use. We postulate that TIB, a modifiable sleep habit, may be an important target for improvement of sleep hygiene as a means of preventing depression.	[Furihata, Ryuji; Uchiyama, Makoto; Suzuki, Masahiro; Konno, Chisato; Konno, Michiko; Takahashi, Sakae] Nihon Univ, Dept Psychiat, Sch Med, Tokyo 1738610, Japan; [Ohida, Takashi] Nihon Univ, Dept Social Med, Sch Med, Div Publ Hlth, Tokyo 1738610, Japan; [Akahoshi, Toshiki; Hashimoto, Shu; Akashiba, Tsuneto] Nihon Univ, Dept Internal Med, Sch Med, Div Resp Med, Tokyo 1738610, Japan; [Akashiba, Tsuneto] Nihon Univ, Dept Internal Med, Sch Med, Div Sleep Med, Tokyo 1738610, Japan; [Kaneita, Yoshitaka] Oita Univ, Fac Med, Dept Publ Hlth & Epidemiol, Oita 87011, Japan	Uchiyama, M (reprint author), Nihon Univ, Dept Psychiat, Sch Med, 30-1 Itabashi Ku, Tokyo 1738610, Japan.	uchiyama.makoto@nihon-u.ac.jp			Ministry of Health, Labor and Welfare of the Japanese Government [H18-JUNKANKITOU -005, H20-JUNKANKITOU-IPPAN-002, H25-JUNKANKITOU-IPPAN-007]; Japan Society for Promoting Science and Technology Agency [18603012, 22591301, 23390181, 25861032]	This study was partly supported by Health Science Research Grants from the Ministry of Health, Labor and Welfare of the Japanese Government (H18-JUNKANKITOU -005, H20-JUNKANKITOU-IPPAN-002 and H25-JUNKANKITOU-IPPAN-007), and by a Research Grant from the Japan Society for Promoting Science and Technology Agency (18603012, 2006-2007, 22591301, 2010-2013, 23390181, 2011-2013, 25861032, 2013). The authors report no other financial affiliation or relationship relevant to the subject of the article. We would like to thank Paul Langman, PhD. for discussion and English editing.	Kaneita Y, 2006, J CLIN PSYCHIAT, V67, P196; Natale V, 2009, SLEEP, V32, P767; FRANKEL BL, 1976, ARCH GEN PSYCHIAT, V33, P615; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P593, DOI 10.1016/S0022-3999(02)00449-X; Park S, 2010, J SLEEP RES, V19, P567, DOI 10.1111/j.1365-2869.2010.00841.x; Oh DH, 2013, J KOREAN MED SCI, V28, P128, DOI 10.3346/jkms.2013.28.1.128; Kaneita Y, 2005, J EPIDEMIOL, V15, P1, DOI 10.2188/jea.15.1; Meng L, 2013, HYPERTENS RES, V36, P985, DOI 10.1038/hr.2013.70; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; van Mill JG, 2010, J CLIN PSYCHIAT, V71, P239, DOI 10.4088/JCP.09m05218gry; Gangwisch JE, 2007, SLEEP, V30, P1667; Drake CL, 2004, SLEEP, V27, P1453; Ritchie K, 2009, J CLIN PSYCHIAT, V70, P1281, DOI 10.4088/JCP.08m04510; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Taylor DJ, 2007, BEHAV THER, V38, P49, DOI 10.1016/j.beth.2006.04.002; Manber R, 2008, SLEEP, V31, P489; Ohayon MM, 2004, SLEEP, V27, P1255; Giedke H, 2002, SLEEP MED REV, V6, P361, DOI 10.1053/smrv.2002.0235; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Grandner MA, 2010, SLEEP MED REV, V14, P239, DOI 10.1016/j.smrv.2009.08.001; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254; HOCH CC, 1987, PSYCHOPHYSIOLOGY, V24, P293, DOI 10.1111/j.1469-8986.1987.tb00298.x; Amagai Y, 2010, J EPIDEMIOL, V20, P106, DOI 10.2188/jea.JE20090053; McNeil J, 2013, CAN J DIABETES, V37, P103, DOI 10.1016/j.jcjd.2013.02.060; Liu XC, 2000, PSYCHIAT RES, V93, P1, DOI 10.1016/S0165-1781(99)00119-5; Itani O, 2011, SLEEP MED, V12, P341, DOI 10.1016/j.sleep.2010.09.007; Cho MJ, 1998, PSYCHIAT RES, V81, P341, DOI 10.1016/S0165-1781(98)00122-X; BOYD JH, 1981, ARCH GEN PSYCHIAT, V38, P1039; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Franzen PL, 2008, J SLEEP RES, V17, P34, DOI 10.1111/j.1365-2869.2008.00635.x; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; John U, 2005, J PSYCHIAT RES, V39, P577, DOI 10.1016/j.jpsychires.2005.01.066; Szklo-Coxe M, 2010, AM J EPIDEMIOL, V171, P709, DOI 10.1093/aje/kwp454; Soldatos CR, 2005, SLEEP MED, V6, P5, DOI 10.1016/j.sleep.2004.10.006; Lusardi P, 1999, AM J HYPERTENS, V12, P63, DOI 10.1016/S0895-7061(98)00200-3; BIXLER EO, 1979, AM J PSYCHIAT, V136, P1257; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; OHARA MW, 1985, J NERV MENT DIS, V173, P582, DOI 10.1097/00005053-198510000-00002; BARNES GE, 1988, CAN J PSYCHIAT, V33, P386; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Doi Y, 2000, J Epidemiol, V10, P79; FEINBERG M, 1984, ARCH GEN PSYCHIAT, V41, P1080; Furihata R, 2012, SLEEP MED, V13, P831, DOI 10.1016/j.sleep.2012.03.011; Furihata R, 2011, J AFFECT DISORDERS, V130, P75, DOI 10.1016/j.jad.2010.09.019; Morin CM, 2014, SLEEP, V37, P319, DOI 10.5665/sleep.3406; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Scott AJ, 1997, INT J OCCUP ENV HEAL, V3, pS2; Shima S, 1985, CLIN PSYCHIATR, V27, P717; Son BK, 1997, AM J EPIDEMIOL, V145, P110; van den Berg JF, 2009, J CLIN PSYCHIAT, V70, P1105, DOI 10.4088/JCP.08m04448; WALLACE J, 1992, J ABNORM PSYCHOL, V101, P398, DOI 10.1037//0021-843X.101.3.398	55	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1446-9235	1479-8425		SLEEP BIOL RHYTHMS	Sleep Biol. Rhythms	APR	2015	13	2					136	145		10.1111/sbr.12096		10	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG4ER	WOS:000353236800005		
J	Aritake, S; Kaneita, Y; Ohtsu, T; Uchiyama, M; Mishima, K; Akashiba, T; Uchimura, N; Nakaji, S; Munezawa, T; Ohida, T				Aritake, Sayaka; Kaneita, Yoshitaka; Ohtsu, Tadahiro; Uchiyama, Makoto; Mishima, Kazuo; Akashiba, Tsuneto; Uchimura, Naohisa; Nakaji, Shigeyuki; Munezawa, Takeshi; Ohida, Takashi			Prevalence of fatigue symptoms and correlations in the general adult population	Sleep and Biological Rhythms			English	Article						depression; epidemiology; fatigue; Japan; quality of life; sleep; stress	PSYCHOSOCIAL WORK CHARACTERISTICS; PSYCHOLOGICAL DISTRESS; DEPRESSIVE DISORDER; PHYSICAL SYMPTOMS; NORMATIVE DATA; QUESTIONNAIRE; SLEEP; EPIDEMIOLOGY; FATIGABILITY; COMPLAINTS	This study sought to clarify the prevalence and associated factors of subjective fatigue symptoms, by analyzing epidemiological data for a sample of the Japanese population. Data from 1224 individuals (539 men and 685 women) aged 20 years were subsequently analyzed. Prevalence of fatigability was 17.2% (n = 211) and that of residual fatigue was 13.6% (n = 167), with women showing significantly higher prevalence of both symptoms than men (fatigability: men 12.6% vs women 20.9%, (2) = 14.43, P = 0.001; residual fatigue: men 10.0% vs women 16.5%, P = 0.001). Multivariate logistic regression analyses revealed that being female, nonrestorative sleep, decreased quality of life, and stress showed significant positive associations with fatigability and residual fatigue. However, a significant positive association was found between depressed mood and fatigability, and short sleep duration and long working hours (9h) were specifically significantly positively associated with residual fatigue. Sleep hygiene instruction and a psychiatric approach are needed to reduce fatigue in the Japanese population.	[Aritake, Sayaka; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Tokyo, Japan; [Aritake, Sayaka] Waseda Univ, Fac Sport Sci, Div Sports Psychiat & Neurosci, Tokyo, Japan; [Kaneita, Yoshitaka; Munezawa, Takeshi; Ohida, Takashi] Nihon Univ, Sch Med, Dept Publ Hlth, Tokyo, Japan; [Uchiyama, Makoto] Nihon Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Akashiba, Tsuneto] Nihon Univ, Sch Med, Dept Sleep & Resp Med, Tokyo, Japan; [Kaneita, Yoshitaka] Oita Univ, Fac Med, Dept Publ Hlth & Epidemiol, Oita 87011, Japan; [Ohtsu, Tadahiro] Showa Univ, Sch Med, Dept Publ Hlth, Tokyo 142, Japan; [Uchimura, Naohisa] Kurume Univ, Sch Med, Dept Neuropsychiat, Kurume, Fukuoka 830, Japan; [Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori, Japan	Kaneita, Y (reprint author), Oita Univ, Dept Publ Hlth & Epidemiol, Fac Med, Oita 8795593, Japan.	kaneita.yoshitaka@gmail.com			Ministry of Health, Labor and Welfare of the Japanese Government	This study was supported by a Health Science Research Grant from the Ministry of Health, Labor and Welfare of the Japanese Government.	Andrea H, 2004, J PSYCHOSOM RES, V57, P399, DOI 10.1016/j.jpsychores.2003.09.013; Neu D, 2009, J CLIN NEUROPHYSIOL, V26, P207, DOI 10.1097/WNP.0b013e3181a1841b; Franssen PML, 2003, J PSYCHOSOM RES, V54, P339, DOI 10.1016/S0022-3999(02)00395-1; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Fortier-Brochu E, 2010, J PSYCHOSOM RES, V69, P475, DOI 10.1016/j.jpsychores.2010.05.005; Watt T, 2000, J EPIDEMIOL COMMUN H, V54, P827, DOI 10.1136/jech.54.11.827; Fava M, 2009, PSYCHOTHER PSYCHOSOM, V78, P91, DOI 10.1159/000201934; Watanabe N, 2008, J PSYCHOSOM RES, V64, P357, DOI 10.1016/j.jpsychores.2007.12.003; Dinos S, 2009, INT J EPIDEMIOL, V38, P1554, DOI 10.1093/ije/dyp147; Matza LS, 2013, QUAL LIFE RES, V22, P351, DOI 10.1007/s11136-012-0142-6; Bultmann U, 2002, J PSYCHOSOM RES, V52, P445, DOI 10.1016/S0022-3999(01)00228-8; CHEN MK, 1986, PREV MED, V15, P74, DOI 10.1016/0091-7435(86)90037-X; Eldadah BA, 2010, PM&R, V2, P406, DOI 10.1016/j.pmrj.2010.03.022; Bultmann U, 2002, PSYCHOL MED, V32, P333, DOI 10.1017/S0033291701005098; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Nyman E, 2011, J AFFECT DISORDERS, V131, P393, DOI 10.1016/j.jad.2010.12.008; Fossey M, 2004, J BEHAV MED, V27, P581, DOI 10.1007/s10865-004-0004-y; Greco T, 2004, J GEN INTERN MED, V19, P813, DOI 10.1111/j.1525-1497.2004.30531.x; Wessely S, 1996, AM J PSYCHIAT, V153, P1050; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Mucsi I, 2004, NEPHROL DIAL TRANSPL, V19, P1815, DOI 10.1093/ndt/gfh130; Lawrie SM, 1997, PSYCHOL MED, V27, P343, DOI 10.1017/S0033291796004357; Bultmann U, 2002, INT ARCH OCC ENV HEA, V75, P259, DOI 10.1007/s00420-001-0294-0; Cohen J., 1988, STAT POWER ANAL BEHA; Cullen W, 2002, IRISH J MED SCI, V171, P10; DAVID A, 1990, BRIT MED J, V301, P1199; Fava M, 2006, J CLIN PSYCHIAT, V67, P1754; Fava M, 2014, DEPRESS ANXIETY, V31, P250, DOI 10.1002/da.22199; Ferentinos P, 2010, PSYCHIAT RES, V177, P114, DOI 10.1016/j.psychres.2009.01.029; Garssen MPJ, 2007, MUSCLE NERVE, V36, P93, DOI 10.1002/mus.20739; Kim K, 2001, PSYCHOSOM MED, V63, P441; Lee IS, 2010, J CLIN SLEEP MED, V6, P163; Ministry of Health Labour and Welfare, 2011, ANN REP NAT HLTH NUT; Ministry of International Affairs and Communications, 2006, 2006 SURV TIM US LEI; Minowa M, 2005, ANN REPORT RES PROJE, P173; Minowa M, 1999, ANN REPORT RES PROJE, P19; Mizumoto A, 2008, ENG ED RES, V31, P57; Scheidegger O, 2010, SCHWEIZ ARCH NEUROL, V161, P150; Straus SE, 2005, HARRISONS TXB INTERN, P2545; Ustinov Y, 2010, SLEEP MED, V11, P65, DOI 10.1016/j.sleep.2009.07.009; Yun YH, 2008, J PAIN SYMPTOM MANAG, V36, P259, DOI 10.1016/j.jpainsymman.2007.10.016	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1446-9235	1479-8425		SLEEP BIOL RHYTHMS	Sleep Biol. Rhythms	APR	2015	13	2					146	154		10.1111/sbr.12099		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CG4ER	WOS:000353236800006		
J	Shinoda, M				Shinoda, Masahiro			Seismic stability and displacement analyses of earth slopes using non-circular slip surface	SOILS AND FOUNDATIONS			English	Article						Slope; Stability analysis; Displacement analysis; Permanent seismic displacement	PARTICLE SWARM OPTIMIZATION; REINFORCED SOIL SLOPES; FAILURE SURFACE; INDUCED DEFORMATIONS; EMBANKMENTS; EARTHQUAKES; ALGORITHM; LOCATION	The seismic stability and deformability of earth slopes are conventionally evaluated by simple, practical methods. Because a multimodal function optimization problem makes it mathematically difficult to search large critical slip surface of earth slopes with complex strata, stability analysis is one of the classical problems of geotechnical engineering. One option is to evaluate the seismic deformability of earth slopes using permanent seismic displacements via Newmark's sliding block analysis in the current seismic design. The advantage of this method is that it is useful in practice and is less time consuming in terms of calculations. However, the calculations require that the critical slip is assumed either linear or circular. This paper proposes two methods for computing safety factors and permanent seismic displacements of earth slopes using an efficient non-circular slip surface search algorithm based on the force equilibrium given by the Spencer method. The validity of these proposed methods is verified by applying them to models with a known safety factor or theoretically calculated permanent seismic displacement and the results obtained compared. Comparative analyses are also conducted in order to demonstrate their efficacy in terms of computation precision and convergence performance. Further, they are utilized to calculate the pertnanent seismic displacement of a practical earth slope model subjected to seismic motions in both the horizontal and vertical directions. The results obtained indicate that they can calculate the safety factor of earth slopes using a smaller number of simulations than conventional methods and that they can also be applied to calculate the pertnanent seismic displacement of earth slopes. The results also indicate that the permanent seismic displacement calculated is an important index that can be used to quantitatively evaluate the seismic performance of earth slopes. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	Railway Tech Res Inst, Kokubunji Shi, Tokyo 1858540, Japan	Shinoda, M (reprint author), Railway Tech Res Inst, 2-8-38 Hikari Cho, Kokubunji Shi, Tokyo 1858540, Japan.	shinoda.masahiro.97@rtri.or.jp					MAKDISI FI, 1978, J GEOTECH ENG-ASCE, V104, P849; Khajehzadeh M, 2012, CIV ENG ENVIRON SYST, V29, P41, DOI 10.1080/10286608.2012.663356; SPENCER E, 1967, GEOTECHNIQUE, V17, P11; SPENCER E, 1973, GEOTECHNIQUE, V23, P85; Cheng YM, 2007, COMPUT GEOTECH, V34, P462, DOI 10.1016/j.compgeo.2007.01.004; Greco VR, 1996, J GEOTECH ENG-ASCE, V122, P517, DOI 10.1061/(ASCE)0733-9410(1996)122:7(517); Zolfaghari AR, 2005, COMPUT GEOTECH, V32, P139, DOI 10.1016/j.compgeo.2005.02.001; Jibson RW, 2011, ENG GEOL, V122, P43, DOI 10.1016/j.enggeo.2010.09.017; NEWMARK NM, 1965, GEOTECHNIQUE, V15, P139; Cheng YM, 2007, COMPUT GEOTECH, V34, P92, DOI 10.1016/j.compgeo.2006.10.012; Arias A., 1970, SEISMIC DESIGN NUCL, P438; BISHOP A. W., 1954, GEOTECHNIQUE, V5, P7; Bray JD, 2007, J GEOTECH GEOENVIRON, V133, P381, DOI 10.1061/(ASCE)1090-0241(2007)133:4(381); Fellenius W., 1936, P 2 C LARG DAMS WASH, V4, P445; Francais, 1820, RECHERCHES POUSSEE T; Furuya T., 1997, J JPN LANDSLIDE SOC, V34, P35; Goh A.T., 1999, CAN GEOTECH J, V36, P359; Hyodo M, 2012, SOILS FOUND, V52, P975, DOI 10.1016/j.sandf.2012.11.015; Janbu N., 1954, P EUR C STAB EARTH S, P43; Japan Road Association (JRA), 2010, GUID ROAD EARTH WORK; Kennedy J., 1995, P IEEE INT C NEUR NE, P1942, DOI DOI 10.1109/ICNN.1995.488968; Kondo K., 1997, J JPN LANDSLIDE SOC, V34, P15; Koseki J., 1998, SOILS FOUND, P209; Koseki J, 2012, SOILS FOUND, V52, P872, DOI 10.1016/j.sandf.2012.11.009; Kramer S. L., 1996, GEOTECHNICAL EARTHQU; Matasovic N, 1997, P GEOSYNTHETICS 97, V2, P989; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, DOI 10.1145/272991.272995; Ministry of Land Infrastructure and Transport (MLIT), 2005, GUID SEISM IN PRESS; MORGENST.NR, 1965, GEOTECHNIQUE, V15, P79; Pradel D, 2005, J GEOTECH GEOENVIRON, V131, P1360, DOI 10.1061/(ASCE)1090-0241(2005)131:11(1360); Railway Technical Research Institute (RTRI), 2000, DES STAND RAILW EART; SARMA SK, 1979, J GEOTECH ENG-ASCE, V105, P1511; Seed HB, 1966, J SOIL MECH FDN DIV, V90, P125; Shinoda M, 2007, J GEOTECH GEOENVIRON, V133, P393, DOI 10.1061/(ASCE)1090-0241(2007)133:4(393); Shinoda M, 2006, SOILS FOUND, V46, P477, DOI 10.3208/sandf.46.477; Shinoda M., 2013, J JPN SOC CIVIL ENG, V69, P432; Shinoda M., 2013, J JPN SOC CIVIL ENG, V69, P491; Tamura T., 1999, JAFEE J, P95; Tezuka S., 1995, UNIFORM RANDOM NUMBE; Wakasa Yuji, 2010, Transactions of the Institute of Systems, Control and Information Engineers, V23; Wartman J, 2003, J GEOTECH GEOENVIRON, V129, P673, DOI 10.1061/(ASCE)1090-0241(2003)129:8(673); Wartman J, 2005, J GEOTECH GEOENVIRON, V131, P610, DOI 10.1061/(ASCE)1090-0241(2005)131:4(610); Wasowski J, 2011, ENG GEOL, V122, P1, DOI 10.1016/j.enggeo.2011.06.001; WILSON RC, 1983, B SEISMOL SOC AM, V73, P863; Yamagami T., 1988, P 6 INT C NUM METH G, P1219; YAN LP, 1996, P 11 ASCE ENG MECH C, P1110	46	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					227	241		10.1016/j.sandf.2015.02.001		15	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800001		
J	Ishikawa, T; Miura, S				Ishikawa, Tatsuya; Miura, Seiichi			Influence of moving wheel loads on mechanical behavior of submerged granular roadbed	SOILS AND FOUNDATIONS			English	Article						Base course; Cyclic load; Gravel; Moving wheel load; Special shear test; Water content (IGC: D6/E11/H6)	OF-THE-ART; DEFORMATION CHARACTERISTICS; SUBSTRUCTURE; ROTATION; SOIL	This paper presents an experimental study to evaluate the synergistic effects of principal stress axis rotation and change in water content on the mechanical behavior of granular roadbed subjected to cyclic moving wheel loads. Two types of small scale model tests and laboratory element tests, in which a single-point loading method and a moving-wheel loading method were adopted, were mainly performed with a base course material under air-dried condition and saturated condition. Based on the test results, the applicability of a multi-ring shear test, which is a torsional simple shear test, to an element test of granular base course materials subjected to moving wheel loads, and the influence of water content and moving-wheel loads on the deformation strength characteristics of granular roadbed were examined. The results indicate that the multi-ring shear test has excellent applicability to the estimation of deformation behavior of granular base course materials subjected to repeated moving-wheel loads. Besides, it was revealed that residual settlement of submerged granular roadbed is more likely to increase with the repetition of moving-wheel loads than that of air-dried one and under single-point loading, showing that the difference in the loading method and water content has a considerable influence on the cyclic plastic deformation of granular roadbed. These lead to the conclusion that for the precise prediction of the long-term performance of granular roadbed under cyclic moving-wheel loads, it is important to take into account the synergistic effects of principal stress axis rotation and change in water content on the cyclic plastic deformation characteristics of granular base course materials. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Ishikawa, Tatsuya; Miura, Seiichi] Hokkaido Univ, Fac Engn, Lab Analyt Geomech, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Ishikawa, T (reprint author), Hokkaido Univ, Fac Engn, Lab Analyt Geomech, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	t-ishika@eng.hokudai.ac.jp; s-miura@eng.hokudai.ac..jp			Japan Society for the Promotion of Science (JSPS) [18560479, 20360206]	The authors would like to thank Mr. Mitsuru Hosoda, Mr. Hirosato Segawa, and Dr. Aasim Inam (formerly at Hokkaido University.), who performed laboratory shear tests and arranged the experimental results. This research was supported in part by Grant-in-Aid for Scientific Research (C) (18560479) and (B) (20360206) from Japan Society for the Promotion of Science (JSPS).	Grabe PJ, 2009, J GEOTECH GEOENVIRON, V135, P555, DOI 10.1061/(ASCE)1090-0241(2009)135:4(555); Lekarp F, 2000, J TRANSP ENG-ASCE, V126, P76, DOI 10.1061/(ASCE)0733-947X(2000)126:1(76); Maheshwari P, 2012, SOILS FOUND, V52, P114, DOI 10.1016/j.sandf.2012.01.004; Ishikawa T, 2011, CAN GEOTECH J, V48, P691, DOI 10.1139/T10-099; Brown SF, 1996, GEOTECHNIQUE, V46, P383; Bertsekas D., 1995, NONLINEAR PROGRAMMIN; Burrow M.P.N., 2005, P RAILW INT C DERB U; CHAN FWK, 1994, P 13 INT C SOIL MECH, V4, P1823; Coronado O., 2005, P 7 INT C BEAR CAP R, P27; Duong TV, 2013, SOILS FOUND, V53, P868, DOI 10.1016/j.sandf.2013.10.006; EKBLAD J, 2008, P INT C ADV TRANSP G, P117; Hachiya Y., 1999, J JSCE, V613, P19; Inam A, 2012, SOILS FOUND, V52, P465, DOI 10.1016/j.sandf.2012.05.006; Ishikawa T., 2007, P INT WORKSH GEOT AS, P53; ISHIKAWA T, 2012, P 2 INT C ADV TRANSP, P534; Japan Road Association, 2006, PAV DES MAN; Japanese Geotechnical Society, 2003, 15212003 JGS, P162; Japanese Geotechnical Society, 2009, 01512009 JGS, P162; Japanese Standards Association, 2009, A12112009 JIS; Japanese Standards Association, 2009, A12102009 JIS; Japanese Standards Association, 2009, A12242009 JIS; Kim I.T., 2005, TRANSPORT RES REC, V1913, P41, DOI 10.3141/1913-05; Lekarp F, 2000, J TRANSP ENG-ASCE, V126, P66, DOI 10.1061/(ASCE)0733-947X(2000)126:1(66); Maina J.W., 2004, TRANSPORT RES REC, V1896, P107, DOI 10.3141/1896-11; Momoya Y., 2007, P INT WORKSH DES CON, P77; Momoya Y, 2005, SOILS FOUND, V45, P99; Powric W., 2008, P 1 INT C ADV TRANSP, P37; Society Japanese Geotechnical, 2009, 01622009 JGS, P198; Tatsuoka F., 1988, ASTM STP, V977, P7; Trinh VN, 2012, SOILS FOUND, V52, P511, DOI 10.1016/j.sandf.2012.05.009; Zapata C.E., 2000, ADV UNSATURATED GEOT, P84	31	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					242	257		10.1016/j.sandf.2015.02.002		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800002		
J	Watabe, Y; Saitoh, K				Watabe, Yoichi; Saitoh, Kunio			Importance of sedimentation process for formation of microfabric in clay deposit	SOILS AND FOUNDATIONS			English	Article						Microfabric; Clay deposit; Sedimentation; Flocculation; Void ratio; Consolidation	SHEAR-STRENGTH; CONSOLIDATION; BEHAVIOR; COMPRESSIBILITY	When a clay sample is reconstituted from a slurry state to a normally consolidated state, a higher initial water content generally derives a higher void ratio in e-logp relationship. However, in undisturbed Holocene clay samples collected from a soil layer under the seabed, Void ratio is much higher than that for the reconstituted, even though the reconstituted sample was consolidated from a sample slurry state with a very high initial water content. Therefore, the higher void ratio for undisturbed Holocene clay cannot be explained by the initial water content. There must be another key factor to explain the higher void ratio for undisturbed Holocene clay. In this study, the difference between the microfabric of deposited clay from suspension state and reconstituted clay from a slurry state is investigated to clarify the key factors contributing to the higher void ratio. The clay in this study is Osaka Bay Holocene clay sampled from 15 to 19 in below the seabed. Sedimentation tests from the suspension state were carried out in various conditions of initial water content, salt concentration, and pH. A series of sedimentation tests was carried out with two types of hollow cylinders: an observation glass cylinder with an inner diameter of 60 mm and a height of 400 mm (specimen height of 350 mm), and a cylindrical acrylic container with an inner diameter of 100 mm and a height of 1800 into (specimen height of 1500 mm). In the 100-mm diameter cylinder, the deposited sample was consolidated by a pressure of 19.6 kPa, then mounted in an oedometer ring with an inner diameter of 60 mm and a height of 20 mm. An incremental loading oedometer test was then carried out up to 39.2 kPa. The microfabric of the consolidated specimen was observed by scanning electron microscope (SEM) and quantitatively investigated by mercury intrusion porosimeter (MIP). It was shown that the high void ratio of natural clay deposit is not only due to the high initial water content but also to the sedimentation process with flocculation. This plays an important role in the formation of the microfabric of natural clay deposits characterized by a significantly higher Void ratio than reconstituted samples. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Watabe, Yoichi] Port & Airport Res Inst, Geotech Engn Field, Yokosuka, Kanagawa 2390826, Japan; [Saitoh, Kunio] Chuo Univ, Dept Civil & Environm Engn, Bunkyo Ku, Tokyo 1128551, Japan	Watabe, Y (reprint author), Port & Airport Res Inst, Geotech Engn Field, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan.	watabe@ipc.pari.go.jp					Watabe Y, 2003, SOILS FOUND, V43, P1; Ma KS, 1999, CLAY CLAY MINER, V47, P522; Bjerrum L., 1973, P 8 INT C SOIL MECH, V3, P111; BURLAND JB, 1990, GEOTECHNIQUE, V40, P329; Egashira K, 2003, SOFT GROUND ENGINEERING IN COASTAL AREAS, P119, DOI 10.1201/9781439833919.ch12; Imai G., 1979, SOILS FOUND, P45; Imai G., 1981, SOILS FOUND, V21, P7; Imai G., 1980, SOILS FOUND, V20, P61; Sridharan A, 1999, GEOTECH TEST J, V22, P235; Sridharan A, 2003, MAR GEORESOUR GEOTEC, V21, P73, DOI 10.1080/03608860290051903; Sridharan A, 2001, GEOTECH TEST J, V24, P109; Tong F, 2012, MAR GEORESOUR GEOTEC, V30, P291, DOI 10.1080/1064119X.2011.626508; Watabe Y, 2002, J GEOTECH GEOENVIRON, V128, P216, DOI 10.1061/(ASCE)1090-0241(2002)128:3(216); Xu GZ, 2012, MAR GEORESOUR GEOTEC, V30, P143, DOI 10.1080/1064119X.2011.602382; [张楠 Zhang Nan], 2013, [岩土力学, Rock and Soil Mechanics], V34, P1681	15	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					276	283		10.1016/j.sandf.2015.02.004		8	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800004		
J	Ogino, T; Kawaguchi, T; Yamashita, S; Kawajiri, S				Ogino, Toshihiro; Kawaguchi, Takayuki; Yamashita, Satoshi; Kawajiri, Shunzo			Measurement deviations for shear wave velocity of bender element test using time domain, cross-correlation, and frequency domain approaches	SOILS AND FOUNDATIONS			English	Article						Bender element test; Shear wave velocity; Time domain; Frequency domain; Cross-correlation	PERFORMANCE	Discrepancies in shear wave velocity measurements, attributed to the use of different methods to estimate travel time, for the bender element test were examined for various types of samples in this paper. A series of bender element tests using three different techniques, the time domain (TD), cross-correlation (CC), and frequency domain (FD) techniques, were performed to estimate travel times on identical specimens in triaxial or unconfined compression apparatuses, Experimental results revealed that the CC technique can provide reasonable values of the travel time by the maximum peak point for soft soils, while it is difficult to apply to sandy or artificially treated soils because of the unclear arrival point. From both, experimental investigation and numerical analysis of CC, the frequency dependence of the travel time is demonstrated. As a result of travel time estimation using frequency sweep signals, strong dispersion and scattering of phase and group velocities due to the non-linearity of the test system are indicated in the FD technique. The FD technique broadly underestimates the shear wave velocity compared with the TD technique, a trend shown in most soil samples. Shear wave velocities obtained from the CC and FD techniques are also compared with those obtained from the TD technique. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Ogino, Toshihiro] Akita Univ, Grad Sch Engn & Resource Sci, Akita 010, Japan; [Kawaguchi, Takayuki; Yamashita, Satoshi; Kawajiri, Shunzo] Kitami Inst Technol, Dept Civil & Environm Engn, Kitami, Hokkaido 090, Japan	Ogino, T (reprint author), Akita Univ, Grad Sch Engn & Resource Sci, 1-1 Tegata Gakuen Machi, Akita 010, Japan.	ogino@gipc.akita-u.ac.jp			JSPS KAKENHI [23760438]	This research was partially supported by JSPS KAKENHI Grant no. 23760438.	Airey D, 2013, GEOTECH TEST J, V36, P506, DOI 10.1520/GTJ20120125; Alvarado G, 2012, GEOTECHNIQUE, V62, P1, DOI 10.1680/geot.7.00086; Wang YH, 2007, J GEOTECH GEOENVIRON, V133, P564, DOI 10.1061/(ASCE)1090-0241(2007)133:5(564); Brignoli EGM, 1996, GEOTECH TEST J, V19, P384; Yamashita S, 2009, SOILS FOUND, V49, P631, DOI 10.3208/sandf.49.631; Greening PD, 2004, GEOTECH TEST J, V27, P288; Viggiani G, 1995, GEOTECHNIQUE, V45, P149; Arulnathan R, 1998, GEOTECH TEST J, V21, P120; Lee JS, 2005, J GEOTECH GEOENVIRON, V131, P1063, DOI 10.1061/(ASCE)1090-0241(2005)131:9(1071); Gu XQ, 2013, SOILS FOUND, V53, P735, DOI 10.1016/j.sandf.2013.08.011; SHIRLEY DJ, 1978, J ACOUST SOC AM, V63, P607, DOI 10.1121/1.381760; AOSHIMA N, 1981, J ACOUST SOC AM, V69, P1484, DOI 10.1121/1.385782; Arroyo M, 2003, GEOTECHNIQUE, V53, P337, DOI 10.1680/geot.53.3.337.37277; Dyvik R., 1985, ADV ART TESTING SOIL, P186; Fonseca A.V., 2009, ASTM GEOTECH TEST J, V32, P1; Gajo A, 1997, GEOTECHNIQUE, V47, P993; Hardin B. O., 1963, J SOIL MECH FOUND EN, V89, P33; Iwasaki T., 1977, SOILS FOUND, V17, P19, DOI DOI 10.3208/SANDF1972. 17. 3_19; Japanese Geotechnical Society, 2011, METH LAB MEAS SHEAR; Kataoka S., 2013, P 18 ICSMGE; Ogino T, 2010, SOILS FOUND, V50, P737, DOI 10.3208/sandf.50.737; Sanchez-Salinero I., 1986, 8615 GR; Santamarina J. C., 1997, GEOTECHNIQUE, V47, P873, DOI DOI 10.1680/GEOT.1997.47.4.873; Seng S, 2012, SOILS FOUND, V52, P335, DOI 10.1016/j.sandf.2012.02.010; Styler MA, 2013, GEOTECH TEST J, V36, P649, DOI 10.1520/GTJ20120081; Viggiani G, 1997, GEOTECHNIQUE, V47, P873	26	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					329	342		10.1016/j.sandf.2015.02.009		14	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800009		
J	Tashiro, M; Nguyen, SH; Inagaki, M; Yamada, S; Noda, T				Tashiro, Mutsumi; Nguyen, Son Hong; Inagaki, Motohiro; Yamada, Shotaro; Noda, Toshihiro			Simulation of large-scale deformation of ultra-soft peaty ground under test embankment loading and investigation of effective countermeasures against residual settlement and failure	SOILS AND FOUNDATIONS			English	Article						Peat; Residual settlement; Test embankment; Soil-water coupled analysis; SYS Cam-clay model	SOIL	The construction of a test embankment on ultra-soft ground containing an approximately 50-m-deep soft peat layer with N-values of 0 to 1 did not result in catastrophic slip failure during construction but did cause substantial deformation of the adjacent ground. In addition, large-scale settlement in excess of 11 m occurred in the approximately 3 years following embankment construction. Based on field observations, it became evident that this large settlement was attributable to delayed compression of the deep peat layer, which was assumed at the design stage not to be subject to settlement. Based on laboratory tests and site investigations, it was deduced that due to depositions under continuous artesian conditions, this peat layer had an extremely low consolidation yield stress and was in a state such that even a slight increase in stress would result in large-scale compression. After confirming the ability of the analysis code based on soil water coupled finite deformation theory, which included an elasto-plastic constitutive equation describing the behavior of the soil skeleton, to reproduce the observed ground behavior, the code was used to predict future settlement. These simulations were then used to evaluate the effectiveness of countermeasures aimed not only at itnproving stability during construction, but also at reducing residual settletnent. The results of these analyses were applied in the planning of large-scale repair work performed on the test embankment. Also, when an embankment was subsequently constructed near the test embankment on similar ultra-soft ground, ground improvements were conducted prior to embankment construction as a countermeasure against residual settlement. In this paper, valuable field data related to these latter construction efforts is also presented. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Tashiro, Mutsumi; Yamada, Shotaro] Nagoya Univ, Dept Civil Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nguyen, Son Hong; Noda, Toshihiro] Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan; [Inagaki, Motohiro] Cent Nippon Expressway Co Ltd, Tsuruga Construct Off, Nagoya, Aichi, Japan	Tashiro, M (reprint author), Nagoya Univ, Dept Civil Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	mutsumi@civil.nagoya-u.ac.jp; hongsonde3005@gmail.com; m.inagaki.aa@c-nexeo.co.jp; s-yamada@civil.nagoya-u.ac.jp; noda@nagoya-u.jp					Asaoka A, 2002, SOILS FOUND, V42, P47; Takaine T, 2010, SOILS FOUND, V50, P245, DOI 10.3208/sandf.50.245; Tashiro M, 2011, SOILS FOUND, V51, P133, DOI 10.3208/sandf.51.133; Noda T, 2008, SOILS FOUND, V48, P771, DOI 10.3208/sandf.48.771; Noda T, 2005, SOILS FOUND, V45, P39; Asaoka A., 1995, SOILS FOUND, V35, P43; Asaoka A., 2007, P INT WORKSH CONST M, P11; Asaoka A., 2003, P 12 AS REG C SOIL M, V2, P1157; Hayashi H, 2012, SOILS FOUND, V52, P299, DOI 10.1016/j.sandf.2012.02.007; Hirata M., 2010, J JPN SOC CIV ENG, V66, P356; Inagaki M, 2010, SOILS FOUND, V50, P109, DOI 10.3208/sandf.50.109; Japan Highway Public Corporation, 1998, DES GUID; Kosaka T., 2011, P INT C GEOT SUST DE, P65; Lea N.D., 1963, HIGHWAY RES REC, P1; Mochinaga R., 1984, J JPN SOC CIVIL ENG, V6, P74; Nakano M., 2010, GEOTECHNICAL SPECIAL, V201, P139; Noda T., 2008, THEOR APPL MECH JPN, V57, P41; Noto S., 1991, GEOTECHNICAL ENG PEA; Root A.W., 1958, HIGHWAY RES BOARD B, V173; Sekiguchi H., 1977, P 9 ICSMFE SPEC SESS, P229; The Japanese Geotechnical Society, 2004, 14 JAP GEOT SOC	21	1	1	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					343	358		10.1016/j.sandf.2015.02.010		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800010		
J	Tsuchida, T; Tang, YX				Tsuchida, Takashi; Tang, Yi Xin			Estimation of compressive strength of cement-treated marine clays with different initial water contents	SOILS AND FOUNDATIONS			English	Article						Cement-treated soil; Marine clay Unconfined compressive strength; Dredged soil; Port and harbor	SOIL; BEHAVIOR	A formula to estimate unconfined compressive strength of cement-treated marine clays is proposed. The formula has a form similar to the gel space ratio theory. In the proposed formula, the strength of cement-treated soil is given by volumetric solid content, strength increase coefficient due to cement, exponential parameter N representing the effect of the void structure of soil and cement content in respect to the solid material of soil. The formula was adapted to the results of laboratory strength tests of cement-treated soils made of six dredged marine clays with different levels of initial water content. The strengths estimated by the proposed formula agreed with the measured strengths fairly well, using the parameter N=3.5 4.6. The formula was applied to the strength estimate of lbarn- and bead-treated soils made from dredged marine clay, using the parameter N=2.1 2.5. The applicability of the proposed formula was examined with the results of strength tests carried out for the design of cement-treated soil for the construction of 17 runway at Tokyo's Ilaneda Airport. Seven samples collected in the construction sites were mixed with different amounts of cement and the different levels of initial water content. On fitting the proposed formula to the results of all the data, the proposed formula estimates the measured strength well. On comparing the estitnates with those using a conventional formula based on the water cement ratio, the proposed fortnula generated better-fit estimates. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier By. All rights reserved	[Tsuchida, Takashi] Hiroshima Univ, Inst Engn, Higashihiroshima, Hiroshima 724, Japan; [Tang, Yi Xin] Kanmon Kowan Construct Co Ltd, Shimonoseki, Yamaguchi, Japan	Tsuchida, T (reprint author), Hiroshima Univ, Inst Engn, 1-4-1 Kagamiyama, Higashihiroshima, Hiroshima 724, Japan.	ttuchida@hiroshima-u.ac.jp; yxtang@kanmon-const.co.jp					Tremblay H, 2002, CAN GEOTECH J, V39, P535, DOI 10.1139/T02-002; Horpibulsuk S, 2003, GEOTECHNIQUE, V53, P439, DOI 10.1680/geot.53.4.439.37319; Tang YX, 2001, SOILS FOUND, V41, P129; Horpibulsuk S, 2004, J GEOTECH GEOENVIRON, V130, P1096, DOI 10.1061/(ASCE)1090-0241(2004)130:10(1096); Horpibulsk S, 2011, SOILS FOUND, V51, P239; Horpibulsuk S., 2001, THESIS SAGA U SAGA; Iba H., 2009, RESULTS MIX PROPORTI, P551; Japan Cement Association, 2012, MAN GROUND IMPR CEM; Kasama K, 2007, SOILS FOUND, V47, P171, DOI 10.3208/sandf.47.171; Kasama K, 2006, SOILS FOUND, V46, P221, DOI 10.3208/sandf.46.221; Kida T., 1977, P 12 ANN M JAP GEOT, P1309; Lee FH, 2005, J GEOTECH GEOENVIRON, V131, P178, DOI 10.1061/(ASCE)1090-0241(2005)131:2(178); Miyazaki Y., 2003, THESIS KYUSHU U; Miyazaki Y., 2003, J JPN SOC CIVIL ENG, V750, P193; Port Harbour Bureau Ministry of Land Infrastructures, 2006, JAP DEV TECHN GUID O; POWERS TC, 1958, J AM CERAM SOC, V41, P1, DOI 10.1111/j.1151-2916.1958.tb13494.x; Sakai E., 1998, JCI P, V20, P101; Sakai E., 2004, P JCI, V26, P135; Sasanian S, 2014, SOILS FOUND, V54, P209, DOI 10.1016/j.sandf.2014.02.011; Satoh T, 2001, SOILS FOUND, V41, P145; Satoh T, 2003, P JPN SOC CIVIL ENG, V749, P33; Tsuchida T., 2014, JGS J, V9, P71; Tsuchida T, 2007, SOILS FOUND, V47, P731, DOI 10.3208/sandf.47.731; Tsuchida T, 1996, TECH NOTE PORT AIRPO, V834, P1; Tsuchida T., 2001, TECH NOTE PORT AIRPO, V1007, P1; Udaka K., 2013, JGS J, V8, P425; Watabe Y., 2001, P JPN SOC CIVIL ENG, V694, P331; Watabe Y, 2011, SOILS FOUND, V51, P1003, DOI 10.3208/sandf.51.1003; Watabe Y., 2000, COAST GEOTECH ENG PR, V1, P739; Watanabe M., 2009, RESULTS MIX PROPOR 2, P553	30	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					359	374		10.1016/j.sandf.2015.02.011		16	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800011		
J	Kang, G; Tsuchida, T; Athapaththu, AMRG				Kang, Gyeongo; Tsuchida, Takashi; Athapaththu, A. M. R. G.			Strength mobilization of cement-treated dredged clay during the early stages of curing	SOILS AND FOUNDATIONS			English	Article						Cement-treated clay; Un-drained shear strength; Unconfined compressive strength; Normalized specific volume ratio Normalized initial water content	HIGH WATER-CONTENT; ADMIXED CLAY; MARINE CLAY; SOIL; PARAMETERS; BEHAVIOR	Cement-treated marine clays have been widely used as a construction filling material in coastal engineering projects in recent years. The strength mobilization of cement-treated clay in terms of early stages of curing is important because the strength increases during the transportation and the placement to the construction site. In this study, to examine the characteristics of strength for cement treated clays during the early stages of curing, a series of vane shear and unconfined compression tests were carried out with varying water and cement contents for four marine dredged clays. On the basis of the results obtained from the laboratory tests, it kvas found that the strength mobilization process can he divided into two stages; first stage within 3 days after curing (the early stage of cwing) and the second stage 3 days after the curing. Two equations to evaluate strength during early stages of curing were proposed based on the initial water content and specific volume ratio normalized by liquid limit. The equations consisted of coefficient al, strength at 1 h curing, and coefficient b(1), strength increment ratio. It was found that the equation based on the specific volume ratio is slightly better in predicting the strength during the early stages of curing than the equation based on nonnalized water content. It is concluded that the proposed equations are very simple and useful to determine the strength of cement-treated clay during the early stages of curing. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Kang, Gyeongo] Hiroshima Univ, Grad Sch Engn, Dept Civil & Environm Engn, Higashihiroshima, Hiroshima 7398527, Japan; [Tsuchida, Takashi; Athapaththu, A. M. R. G.] Hiroshima Univ, Inst Engn, Higashihiroshima, Hiroshima 7398527, Japan	Tsuchida, T (reprint author), Hiroshima Univ, Inst Engn, 1-4-1 Kagamiyama, Higashihiroshima, Hiroshima 7398527, Japan.	ttuchida@hiroshima-u.ac.jp					Abrams D.A., 1918, BULLETIN, V1; Seng S, 2011, SOILS FOUND, V51, P775, DOI 10.3208/sandf.51.775; Tan TS, 2002, GEOTECH TEST J, V25, P422; Horpibulsuk S, 2003, GEOTECHNIQUE, V53, P439, DOI 10.1680/geot.53.4.439.37319; Tang YX, 2001, SOILS FOUND, V41, P129; [Anonymous], 2008, A1216 JIS; Consoli NC, 2011, ENG GEOL, V122, P328, DOI 10.1016/j.enggeo.2011.05.017; Consoli NC, 2000, GEOTECHNIQUE, V50, P99; Horpibulsuk S, 2004, J GEOTECH GEOENVIRON, V130, P1096, DOI 10.1061/(ASCE)1090-0241(2004)130:10(1096); Consoli NC, 2010, J GEOTECH GEOENVIRON, V136, P759, DOI 10.1061/(ASCE)GT.1943-5606.0000278; Lorenzo GA, 2004, J GEOTECH GEOENVIRON, V130, P1042, DOI 10.1061/(ASCE)1090-0241(2004)130:10(1042); Chiu C.F., 2008, ENG GEOL, V103, P1; CLOUGH GW, 1981, J GEOTECH ENG-ASCE, V107, P799; Horpibulsk S, 2011, SOILS FOUND, V51, P239; Kamon M., 1999, SOILS FOUND, V39, P31; Kasama K, 2007, SOILS FOUND, V47, P171, DOI 10.3208/sandf.47.171; Kasama K, 2006, SOILS FOUND, V46, P221, DOI 10.3208/sandf.46.221; KOGURE K, 1988, J TERRAMECHANICS, V25, P201, DOI 10.1016/0022-4898(88)90003-1; Larsson S, 2001, GROUND IMPROVEMENT, V5, P111, DOI 10.1680/grim.5.3.111.40328; Liu SY, 2008, MAR GEORESOUR GEOTEC, V26, P19, DOI 10.1080/10641190801937916; Mitchell J.K., 1974, BEHAV STABILIZED SOI; Miura N, 2001, SOILS FOUND, V41, P33; Nader G., 1993, J MATER CIVIL ENG, V5, P249; Nagaraj T.S., 1996, P INT S LOWL TECHN S, P85; Omine K., 1998, SOILS FOUND, V38, P17; Sasanian S, 2014, SOILS FOUND, V54, P209, DOI 10.1016/j.sandf.2014.02.011; Suzuki K, 1990, P 25 JPN NAT C JSSMF, P1945; Suzuki M, 2014, SOILS FOUND, V54, P687, DOI 10.1016/j.sandf.2014.06.023; Terashi M, 1981, 10 INT C SOIL MECH F, V3, P777; Terashi M., 1979, P 6 AS REG C SMFE, V1, P191; Tsuchida T., 2014, JGS J, V9, P71; Tsuchida T., 2012, JGS J, V7, P435; Tsuchida T., 1999, REPORT PORT HARBOUR, V38, P131; Tsuchida T., 2002, PORT AIRPORT RES I R, V41, P45; TSUCHIDA T, 1996, P ENV GEOT BALK, P415; Uddin K., 1997, GEOTECHNICAL ENG J, V28, P89; Watabe Y, 2011, SOILS FOUND, V51, P1003, DOI 10.3208/sandf.51.1003; Yajima J., 1996, JSCE, V544, P251; Yamadera A., 1997, SHORT COURSE IMPROVE, P141; Zhang RJ, 2013, J GEOTECH GEOENVIRON, V139, P2170, DOI 10.1061/(ASCE)GT.1943-5606.0000951; Zhu W, 2007, J GEOTECH GEOENVIRON, V133, P588, DOI 10.1061/(ASCE)1090-0241(2007)133:5(588)	41	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					375	392		10.1016/j.sandf.2015.02.012		18	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800012		
J	Miyata, Y; Bathurst, RJ				Miyata, Yoshihisa; Bathurst, Richard J.			Reliability analysis of geogrid installation damage test data in Japan	SOILS AND FOUNDATIONS			English	Article						Geogrid; Installation damage; Reliability; Bias; Load and resistance factor design; LRFD	REDUCTION FACTORS; REINFORCEMENT; STRAIN; DEFORMATION; SIMULATION; STIFFNESS; BEHAVIOR; HDPE; LOAD	The paper reports the results of the analysis of field installation damage tests carried out on geogrid soil reinforcement products used in Japan. The data are taken from Public Works Research Center (PWRC) product certification reports. The database comprises a total of 130 tensile tests performed on undamaged (reference) tests and 390 tensile tests performed on exhumed damaged geogrid specimens. A total of 78 installation damage factors were computed by the writers representing 26 different geogrid products from 12 different product lines in combination with three different aggregate types. The field tests were carried out using a standard PWRC protocol and the calculation of installation damage factors and spread in data was carried out in a consistent manner by the writers. The data are shown to be in good agreement with the results of tests carried out on similar products reported in other countries. The installation damage factors summarized in this study provide a useful benchmark for future field installation damage test results in Japan and worldwide. The statistical analysis of variability in installation damage test results is a prerequisite for future probabilistic analysis and design for the ultimate tensile rupture limit state in geogrid reinforced soil structures and for load and resistance l'actor design (ERR)) calibration of this limit state. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier By. All rights reserved.	[Miyata, Yoshihisa] Natl Def Acad, Dept Civil & Environm Engn, Yokosuka, Kanagawa 2398686, Japan; [Bathurst, Richard J.] Royal Mil Coll Canada, Dept Civil Engn, GeoEngn Ctr Queens RMC, Kingston, ON K7K 7B4, Canada	Miyata, Y (reprint author), Natl Def Acad, Dept Civil & Environm Engn, 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.	miyamiya@nda.ac.jp; bathurst-r@rmc.ca			Japan Ministry of Education, Culture, Sports, Science and Technology [24360195]; Japan Ministry of Defense	The authors are grateful to the Public Works Research Center, Japan, for permission to use their data for preparation of this paper including additional data not available in the product certification reports. The first author is grateful for funding awarded by the Japan Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research (B) No. 24360195) and the Japan Ministry of Defense to collaborate with the second author in Canada where the preparation of this paper was carried out.	Akagi T., 2004, P 3 AS REG C GEOS, P363; Allen T. M., 1994, GEOSYNTH INT, V1, P181; [Anonymous], 2009, WSDOT T925, P62; Hufenus R, 2005, GEOTEXT GEOMEMBRANES, V23, P401, DOI 10.1016/j.geotexmem.2005.02.003; Kongkitkul W, 2007, SOILS FOUND, V47, P265, DOI 10.3208/sandf.47.265; [Anonymous], 2001, D6637 ASTM; Bathurst RJ, 2011, GEOTEXT GEOMEMBRANES, V29, P323, DOI 10.1016/j.geotexmem.2010.10.003; Lim SY, 2013, GEOSYNTH INT, V20, P62, DOI 10.1680/gein.13.00002; Hirakawa D, 2003, GEOSYNTH INT, V10, P176, DOI 10.1680/gein.10.6.176.37246; Kongkitkul W, 2004, GEOSYNTH INT, V11, P73, DOI 10.1680/gein.11.2.73.46850; Shinoda M, 2004, GEOTEXT GEOMEMBRANES, V22, P205, DOI 10.1016/j.geotexmem.2004.03.003; Walters DL, 2002, GEOSYNTH INT, V9, P483; Rowe RK, 2009, GEOTEXT GEOMEMBRANES, V27, P137, DOI 10.1016/j.geotexmem.2008.09.007; Bathurst RJ, 2015, SOILS FOUND, V55, P437, DOI 10.1016/j.sandf.2015.02.017; Bathurst R.J., 1994, GEOSYNTH INT, V1, P3; Bathurst R.J., 2014, RELIABILITY BASED DE, P339; Elias V., 2000, FHWANHI00044; Elias V., 2001, FHWANHI00043; Ezzein F., 2014, POLYM ENG SCI; Greenwood J.H., 2012, 243 STICHT CURNET; Jeon H.Y., 2010, GROUND IMPROV, V163, P197; KONDO H, 1992, PURE APPL CHEM, V64, P1945, DOI 10.1351/pac199264121945; Miyata Y, 2007, SOILS FOUND, V47, P319, DOI 10.3208/sandf.47.319; Miyata Y, 2014, SOILS FOUND, V54, P608, DOI 10.1016/j.sandf.2014.06.004; NTPEP, 2007, US APPL NTPEP GEOS R; Pinho-Lopes M., 2013, ENV GEOTECHNICS ICE, V1, P161; PWRC, 2013, DES CONSTR MAN GEOS, P305; PWRC, 2000, TECHN REP PWRC CERT, P135; PWRC, 2004, TECHN REP PWRC CERT, P169; PWRC, 2002, TECHN REP PWRC CERT, P171; PWRC, 2007, TECHN REP PWRC CERT, P118; PWRC, 2008, TECHN REP PWRC CERT, P115; PWRC, 2000, DES CONSTR MAN GEOS, P305; PWRC, 2006, TECHN REP PWRC CERT, P156; Shinoda M, 2004, GEOTECH TEST J, V27, P456; Shinoda M., 2002, J GEOSYNTH, V17, P137; Tanaka T., 1979, T JAPAN SOC MECH E A, VA45, P211	37	2	2	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					393	403		10.1016/j.sandf.2015.02.013		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800013		
J	Bathurst, RJ; Miyata, Y				Bathurst, Richard J.; Miyata, Yoshihisa			Reliability-based analysis of combined installation damage and creep for the tensile rupture limit state of geogrid reinforcement in Japan	SOILS AND FOUNDATIONS			English	Article						Geogrid; Installation damage; Creep; Reliability; Load and resistance factor design; ERFD; Factor ol safety; Tensile rupture; Limit state	FACTOR DESIGN LRFD; GEOSYNTHETIC REINFORCEMENT; PULLOUT MODELS; SOIL WALLS; CALIBRATION; LOAD; DEFORMATION; STRAIN; SIMULATION; STIFFNESS	The paper uses statistical data for the prediction of installation damage and creep-reduced strength collected by the writers in earlier investigations to estitnate the probability of failure of tensile rupture of geogrid reinforcement products. The original data were compiled frotn Public Works Research Center (PWRC) geogrid product certification reports issued in Japan. The paper develops the formulation for the ultimate tensile rupture litnit state equation and links it to allowable stress design (ASD) practice currently used in Japan and reliability theory-based load and resistance factor design (LRFD) used in North America. The paper shows that variability in the prediction of creep-reduced strength is largely captmed by the inherent variability in strength of the materials at the time of manufacture. Combined variability due to creep and installation damage is typically dominated by variability in the prediction of strength after installation damage. Where this is not the case the combined variability is very low (less than 5%). The variability in the estimate of strength reduction due to combined installation damage and creep is detnonstrated to be less than the variability in the estitnates of reinforcetnent load even for the case of a load model judged to give relatively accurate load predictions. For poorer load tnodels the under-prediction of reinforcetnent loads provides an additional margin of safety. The paper provides a framework for future rigorous reliability theory-based LRFD calibration for the ultitnate tensile rupture of geogrid reinforcetnent in reinforced soil applications in Japan and elsewhere, and provides the necessary bias statistics for the resistance side in the ultimate tensile rupture limit state equation. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Bathurst, Richard J.] Royal Mil Coll Canada, Geoengn Ctr Queens RMC, Dept Civil Engn, Kingston, ON K7K 7B4, Canada; [Miyata, Yoshihisa] Natl Def Acad, Dept Civil & Environm Engn, Yokosuka, Kanagawa 2398686, Japan	Miyata, Y (reprint author), Natl Def Acad, Dept Civil & Environm Engn, 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.	bathurst-r@rmc.ca; miyamiya@nda.ac.jp			Japan Ministry of Education, Culture, Sports, Science and Technology [24360195]; Japan Ministry of Defense	The authors are grateful to the Public Works Research Center, Japan, for permission to use their data for preparation of this paper, including additional data not available in the product certification reports. The second author is grateful for funding awarded by the Japan Ministry of Education, Culture, Sports, Science and Technology (Grant-in-Aid for Scientific Research (B) no. 24360195) and the Japan Ministry of Defense to collaborate with the first author in Canada where the preparation of this paper was carried out.	AASHTO, 2012, AASHTO LRFD BRIDG DE; Akagi T., 2004, P 3 AS REG C GEOS, P363; Allen T. M., 2005, EC079 TRANSP RES BOA; Allen T.M., 1996, GEOSYNTH INT, V3, P407; Ang AHS, 1975, PROBABILITY CONCEPTS, V1; Miyata Y, 2012, SOILS FOUND, V52, P620, DOI 10.1016/j.sandf.2012.07.004; Bathurst RJ, 2011, SOILS FOUND, V51, P1051, DOI 10.3208/sandf.51.1051; Kongkitkul W, 2007, SOILS FOUND, V47, P265, DOI 10.3208/sandf.47.265; Greenwood JH, 2002, GEOSYNTH INT, V9, P247; Bathurst RJ, 2012, GEOSYNTH INT, V19, P39, DOI 10.1680/gein.2012.19.1.39; Miyata Y, 2015, SOILS FOUND, V55, P393, DOI 10.1016/j.sandf.2015.02.013; [Anonymous], 2001, D6637 ASTM; Bathurst RJ, 2011, GEOTEXT GEOMEMBRANES, V29, P323, DOI 10.1016/j.geotexmem.2010.10.003; Hirakawa D, 2003, GEOSYNTH INT, V10, P176, DOI 10.1680/gein.10.6.176.37246; Kongkitkul W, 2004, GEOSYNTH INT, V11, P73, DOI 10.1680/gein.11.2.73.46850; Shinoda M, 2004, GEOTEXT GEOMEMBRANES, V22, P205, DOI 10.1016/j.geotexmem.2004.03.003; Bathurst RJ, 2012, INT J GEOMECH, V12, P399, DOI 10.1061/(ASCE)GM.1943-5622.0000219; Walters DL, 2002, GEOSYNTH INT, V9, P483; Bathurst R.J., 2011, GEORISK, V5, P218; Bathurst RJ, 2008, CAN GEOTECH J, V45, P1377, DOI 10.1139/T08-063; Bathurst R.J., 1994, GEOSYNTH INT, V1, P3; Bathurst R.J., 2014, RELIABILITY BASED DE, P339; Canadian Standards Association (CSA), 2006, S606 CSA; Huang BQ, 2009, GEOTECH TEST J, V32, P489; Jeon H.Y., 2010, GROUND IMPROV, V163, P197; Kongkitkul W, 2007, GEOSYNTH INT, V14, P189, DOI 10.1680/gein.2007.14.4.189; Miyata Y, 2007, SOILS FOUND, V47, P319, DOI 10.3208/sandf.47.319; Miyata Y, 2014, SOILS FOUND, V54, P608, DOI 10.1016/j.sandf.2014.06.004; PWRC, 2013, DES CONSTR MAN GEOS; PWRC, 2000, TECHN REP PWRC CERT; PWRC, 2002, TECHN REP PWRC CERT, V2nd; PWRC, 2007, TECHN REP PWRC CERT, V2nd; PWRC, 2006, TECHN REP PWRC CERT, V2nd; PWRC, 2000, DES CONSTR MAN GEOS; PWRC, 2008, TECHN REP PWRC CERT; PWRC, 2004, TECHN REP PWRC CERT; Shinoda M, 2004, GEOTECH TEST J, V27, P456; Shinoda M., 2002, J GEOSYNTH, V17, P137; Tanaka T., 1979, T JAPAN SOC MECH E A, VA45, P211	39	1	1	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					437	446		10.1016/j.sandf.2015.02.017		10	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800017		
J	Neupane, D; Yasuhara, H; Kinoshita, N; Ando, Y				Neupane, Debendra; Yasuhara, Hideaki; Kinoshita, Naoki; Ando, Yuji			Dis ibution of mineralized carbonate and its quantification method in enzyme mediated calcite precipitation technique	SOILS AND FOUNDATIONS			English	Article						Urease; Precipitation; CaCO3; Quantification; Grouting	SOIL; SAND; MICROORGANISMS; CEMENTATION; IMPROVEMENT	This study discusses the possible application of enzyme mediated calcite precipitation, EMCP, as a soil-improvement technique. It explains the experimental works on this EMCP technique. The first part of this paper addresses the different methods for quantifying the amount of calcite precipitated within sand. Two methods, namely, the thermal decomposition method and the CO2 volume evaluation method, are examined. These methods serve to evaluate the calcite distribution within the treated sand. The second part of this paper explains the experimental procedures and the results of drum-can experiments. Homogenous sand specimens, with a diameter of 57 cm and a height of 60 cm, are prepared inside a steel drum-can. A grout solution, comprising urea, urease, and CaCl2, is injected into the centre of the sand specimens. Subsequently, the improved samples within the specimens are collected and their compressive strength is evaluated. The maximum measured unconfined compressive strength is 380 kPa. An attempt is made to relate the improved mechanical properties of EMCP-treated sand to the amount of mineralized carbonate. The obtained calcite-strength relation is found to be in close agreement with the relation obtained in previous literature. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Neupane, Debendra; Yasuhara, Hideaki; Kinoshita, Naoki] Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime 7908577, Japan; [Ando, Yuji] Penta Ocean Construct Co Ltd, Inst Technol, Nasushiobara 3292746, Japan	Neupane, D (reprint author), Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime 7908577, Japan.	debendra.neupane.10@cee.ehime-u.ac.jp			Maeda Engineering Foundation, Tokyo, Japan; Shikoku Create Association, Kagawa, Japan	This work has been partly supported by research grants from the Maeda Engineering Foundation, Tokyo, Japan and the Shikoku Create Association, Kagawa, Japan. Their support is gratefully acknowledged.	Al-Thawadi S M, 2011, J ADV SCI ENG RES, V1, P98; Neupane D, 2013, J GEOTECH GEOENVIRON, V139, P2201, DOI 10.1061/(ASCE)GT.1943-5606.0000959; Burbank MB, 2011, GEOMICROBIOL J, V28, P301, DOI 10.1080/01490451.2010.499929; Ivanov Volodymyr, 2008, Reviews in Environmental Science and Bio/Technology, V7, P139, DOI 10.1007/s11157-007-9126-3; Whiffin VS, 2007, GEOMICROBIOL J, V24, P417, DOI 10.1080/01490450701436505; Cheng L, 2013, CAN GEOTECH J, V50, P81, DOI 10.1139/cgj-2012-0023; van Paassen LA, 2010, J GEOTECH GEOENVIRON, V136, P1721, DOI 10.1061/(ASCE)GT.1943-5606.0000382; Dejong JT, 2013, GEOTECHNIQUE, V63, P287, DOI 10.1680/geot.SIP13.P.017; Yasuhara H, 2012, SOILS FOUND, V52, P539, DOI 10.1016/j.sandf.2012.05.011; Harkes MP, 2010, ECOL ENG, V36, P112, DOI 10.1016/j.ecoleng.2009.01.004; Fukue M, 2011, SOILS FOUND, V51, P83; De Belie N., 2009, CONCRETE REPAIR REHA; Follmer C, 2001, BIOCHEM J, V360, P217, DOI 10.1042/0264-6021:3600217; Halikia I., 2001, EUROPEAN J MINERAL P, V1, P89; Lade P.V., 1973, SOIL MECH FOUND ENG, V99, P793; Mortensen B.M., 2011, GEOFRONTIERS, V2011, P4012; Navarro C. R., 2009, AM MINERAL, V94, P578; Nemati M, 2005, PROCESS BIOCHEM, V40, P925, DOI 10.1016/j.procbio.2004.02.019; Qabany A., 2011, GEOFRONTIERS, V2011, P3993; van der Star W.R.L., 2011, P 15 EUR C SOIL MECH; Yasuhara H., 2014, J JAPAN SOC CIVIL C, V70, P290	21	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					447	457		10.1016/j.sandf.2015.02.018		11	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800018		
J	Nonoyama, H; Moriguchi, S; Sawada, K; Yashima, A				Nonoyama, Hideto; Moriguchi, Shuji; Sawada, Kazuhide; Yashima, Atsushi			Slope stability analysis using smoothed particle hydrodynamics (SPH) method	SOILS AND FOUNDATIONS			English	Article						Slope stability analysis; Mesh-free mehtod; Safety factor; Elasto-plastic constitutive model (IGC: E6)	TENSION INSTABILITY; SIMULATION; FAILURE; MODEL; FLOW; DYNAMICS	In conventional deformation analysis of geomaterials, the infinitesimal and the finite deformation theories have been widely used These theories have been successfully implemented in several numerical methods, such as finite element method (FEM). As a result, it is now possible to predict a wide variety of deformation behaviors of geotnaterials. However, when dealing with large deformation problems using the framework of the FEM, excess distortion of the FEM mesh may lead to instability of the calculation. In this study, in order to solve large deformation problem of geomaterials, the smoothed particle hydrodynamics (SPII) method is used. The method is a kind of particle method based on the mesh-free Lagrangian scheme, and is one of the promising numerical methods in the field of geotechnical engineering. The method can solve large deformation problems without mesh distortion. Moreover, it can handle the governing equations and existing constitutive models for geomaterials based on a continuum mechanics. Therefore, this method can represent the entire deformation process of a geotnaterial frotn the small strain region to the large defortnation region. In this paper, first, basic theory and formulation of the SPII method based on solid mechanics are summarized. Then, the result of a simple calculation is shown to verify the accuracy of the spatial derivatives based on the theory of the SPH method. Also, simulations of simple shear tests of both an elastic and elasto-plastic material are carried out and the obtained results are compared with theoretical solutions. Based on the obtained results, calculation accuracy of the method is discussed. Finally, a series of slope stability analyses are carried out The numerical results obtained from the SPH method and the safety factors obtained from the Fellenius method are compared. The results indicated that the SPH method is able to express the same tendencies of safety factor obtained from the conventional circular slippage calculations. Moreover, the SPH method can evaluate both the deformation and stability simultaneously. Based on the series of validations and simulations, the effectiveness of the SPII method is discussed from the point of view of geotechnical engineering. (C) 2015 The Japanese Geotechnical Society. Production and hosting by Elsevier B.V. All rights reserved.	[Nonoyama, Hideto] Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan; [Moriguchi, Shuji] Tohoku Univ, Int Res Inst Disaster Sci Lab Reg Safety Engn, Tohoku, Japan; [Sawada, Kazuhide; Yashima, Atsushi] Gifu Univ, Dept Civil Engn, Gifu, Japan	Nonoyama, H (reprint author), Nagoya Univ, Dept Civil Engn, Nagoya, Aichi 4648601, Japan.	nonoyama@civil.nagoya-u.ac.jp					Dyka CT, 1997, INT J NUMER METH ENG, V40, P2325, DOI 10.1002/(SICI)1097-0207(19970715)40:13<2325::AID-NME161>3.0.CO;2-8; SWEGLE JW, 1995, J COMPUT PHYS, V116, P123, DOI 10.1006/jcph.1995.1010; MONAGHAN JJ, 1983, J COMPUT PHYS, V52, P374, DOI 10.1016/0021-9991(83)90036-0; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47; Pastor M, 2009, INT J NUMER ANAL MET, V33, P143, DOI 10.1002/nag.705; Zabala F, 2011, GEOTECHNIQUE, V61, P795, DOI 10.1680/geot.9.P.134; Manenti S, 2012, J HYDRAUL ENG-ASCE, V138, P272, DOI 10.1061/(ASCE)HY.1943-7900.0000516; Gray JP, 2001, COMPUT METHOD APPL M, V190, P6641, DOI 10.1016/S0045-7825(01)00254-7; Monaghan JJ, 2000, J COMPUT PHYS, V159, P290, DOI 10.1006/jcph.2000.6439; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375; DYKA CT, 1995, COMPUT STRUCT, V57, P573, DOI 10.1016/0045-7949(95)00059-P; SULSKY D, 1995, COMPUT PHYS COMMUN, V87, P236, DOI 10.1016/0010-4655(94)00170-7; Cuomo S, 2013, ACTA GEOTECH, V8, P125, DOI 10.1007/s11440-012-0179-2; DRUCKER DC, 1952, Q APPL MATH, V10, P157; BALSARA DS, 1995, J COMPUT PHYS, V121, P357, DOI 10.1016/S0021-9991(95)90221-X; Bui H.H., 2007, THESIS RITSUMEIKAN U, P170; Bui HH, 2011, GEOTECHNIQUE, V61, P565, DOI 10.1680/geot.9.P.046; Chen W. F., 1990, DEV GEOTECHNICAL ENG, V53; Gotou M., 1986, J JPN SOC MECH ENG A, V52-A, P1134; Haddad B, 2010, ENG GEOL, V114, P312, DOI 10.1016/j.enggeo.2010.05.009; Higo Y, 2010, SOILS FOUND, V50, P515, DOI 10.3208/sandf.50.515; Kuroda M., 1991, J STRUCT ENG A, V37-A, P401; Liu G.R., 2003, SMOOTHED PARTICLE HY; Lucy L.B., 1977, AJ, V82, P1023; Maeda K., 2004, J APPL MECH JSCE, V7, P775; Moriguchi S., 2005, THESIS GIFU U JAPAN, P123; Moriguchi S, 2005, SOILS FOUND, V45, P155; Roscoe K H, 1968, GEN STRESS STRAIN BE, P535; Roscoe K. H., 1963, GEOTECHNIQUE, V13, P211, DOI DOI 10.1680/GE0T.1963.13.3.211; Sakai H., 2009, THESIS NAGOYA I TECH, P217; Swegle J.W., 1994, SAND932513	31	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					458	470		10.1016/j.sandf.2015.02.019		13	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800019		
J	Tsuchida, T; Athapaththu, AMRG				Tsuchida, Takashi; Athapaththu, A. M. R. G.			Practical slip circle method of slices for calculation of bearing capacity factors (vol 54, pg 1127, 2014)	SOILS AND FOUNDATIONS			English	Correction									[Tsuchida, Takashi; Athapaththu, A. M. R. G.] Hiroshima Univ, Civil & Environm Engn, Inst Engn, Higashihiroshima, Hiroshima 724, Japan	Tsuchida, T (reprint author), Hiroshima Univ, Civil & Environm Engn, Inst Engn, 1-4-1 Kagamiyama, Higashihiroshima, Hiroshima 724, Japan.	ttuchida@hiroshima-u.ac.jp					Tsuchida T, 2014, SOILS FOUND, V54, P1127, DOI 10.1016/j.sandf.2014.11.008	1	0	0	JAPANESE GEOTECHNICAL SOC	TOKYO	SUGAYAMA BLDG 4F, KANDA AWAJI-CHO 2-23, CHIYODA-KU, TOKYO, 101-0063, JAPAN	0038-0806			SOILS FOUND	Soils Found.	APR	2015	55	2					484	484		10.1016/j.sandf.2015.03.001		1	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CG2YJ	WOS:000353141800021		
J	Louarn, P; Andre, N; Jackman, CM; Kasahara, S; Kronberg, EA; Vogt, MF				Louarn, Philippe; Andre, Nicolas; Jackman, Caitriona M.; Kasahara, Satoshi; Kronberg, Elena A.; Vogt, Marissa F.			Magnetic Reconnection and Associated Transient Phenomena Within the Magnetospheres of Jupiter and Saturn	SPACE SCIENCE REVIEWS			English	Review						Magnetosphere; Giant planet	SHEET BOUNDARY-LAYER; IONOSPHERE COUPLING CURRENTS; SUBSTORM-LIKE PROCESSES; SOLAR-WIND CONTROL; JOVIAN MAGNETOSPHERE; PLASMA SHEET; RADIO EMISSIONS; NIGHTSIDE MAGNETOSPHERE; KILOMETRIC RADIATION; ENERGETIC PARTICLES	We review in situ observations made in Jupiter and Saturn's magnetosphere that illustrate the possible roles of magnetic reconnection in rapidly-rotating magnetospheres. In the Earth's solar wind-driven magnetosphere, the magnetospheric convection is classically described as a cycle of dayside opening and tail closing reconnection (the Dungey cycle). For the rapidly-rotating Jovian and Kronian magnetospheres, heavily populated by internal plasma sources, the classical concept (the Vasyliunas cycle) is that the magnetic reconnection plays a key role in the final stage of the radial plasma transport across the disk. By cutting and closing flux tubes that have been elongated by the rotational stress, the reconnection process would lead to the formation of plasmoids that propagate down the tail, contributing to the final evacuation of the internally produced plasma and allowing the return of the magnetic flux toward the planet. This process has been studied by inspecting possible 'local' signatures of the reconnection, as magnetic field reversals, plasma flow anisotropies, energetic particle bursts, and more global consequences on the magnetospheric activity. The investigations made at Jupiter support the concept of an 'average' X-line, extended in the dawn/dusk direction and located at 90-120 Jovian radius (R-J) on the night side. The existence of a similar average X-line has not yet been established at Saturn, perhaps by lack of statistics. Both at Jupiter and Saturn, the reconfiguration signatures are consistent with magnetospheric dipolarizations and formation of plasmoids and flux ropes. In several cases, the reconfigurations also appear to be closely associated with large scale activations of the magnetosphere, seen from the radio and auroral emissions. Nevertheless, the statistical study also suggests that the reconnection events and the associated plasmoids are not frequent enough to explain a plasma evacuation that matches the mass input rate from the satellites and the rings. Different forms of transport should thus act together to evacuate the plasma, which still needs to be established. Investigations of reconnection signatures at the magnetopause and other processes as the Kelvin-Helmholtz instability are also reviewed. A provisional conclusion would be that the dayside reconnection is unlikely a crucial process in the overall dynamics. On the small scales, the detailed analysis of one reconnection event at Jupiter shows that the local plasma signatures (field-aligned flows, energetic particle bursts...) are very similar to those observed at Earth, with likely a similar scaling with respect to characteristic kinetic lengths (Larmor radius and inertial scales).	[Louarn, Philippe; Andre, Nicolas] UPS, CNRS, Inst Astrophys & Planetol IRAP, Toulouse, France; [Jackman, Caitriona M.] Univ Southampton, Southampton, Hants, England; [Kasahara, Satoshi] Inst Space & Astronaut Sci JAXA, Sagamihara, Kanagawa, Japan; [Kronberg, Elena A.] Max Planck Inst Solar Syst Res, Gottingen, Germany; [Vogt, Marissa F.] Univ Leicester, Leicester, Leics, England	Louarn, P (reprint author), UPS, CNRS, Inst Astrophys & Planetol IRAP, Toulouse, France.	philippe.louarn@irap.omp.eu	Vogt, Marissa/C-6237-2014	Vogt, Marissa/0000-0003-4885-8615	EUROPLANET RI project - EU [228319]; International Space Science Institute (Bern)	The authors acknowledge the support of EUROPLANET RI project (Grant agreement no.: 228319) funded by EU; and also the support of the International Space Science Institute (Bern). The Editor thanks the work of two anonymous referees.	Gustin J, 2009, ICARUS, V200, P176, DOI 10.1016/j.icarus.2008.11.013; Badman SV, 2013, GEOPHYS RES LETT, V40, P1027, DOI 10.1002/grl.50199; Louarn P, 1998, GEOPHYS RES LETT, V25, P2905, DOI 10.1029/98GL01774; Vogt MF, 2014, J GEOPHYS RES-SPACE, V119, P821, DOI 10.1002/2013JA019393; Lai HR, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2011JA017263; Mitchell DG, 2009, PLANET SPACE SCI, V57, P1732, DOI 10.1016/j.pss.2009.04.002; Hill TW, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012626; Zong QG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019128; Masters A, 2014, GEOPHYS RES LETT, V41, P1862, DOI 10.1002/2014GL059288; KHURANA KK, 1993, J GEOPHYS RES, V98, P67, DOI 10.1029/92JA01890; Grodent D, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016818; Hill TW, 2001, J GEOPHYS RES-SPACE, V106, P8101, DOI 10.1029/2000JA000302; Phan TD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.255002; Bunce EJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022888; McComas DJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031078; Arridge CS, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011574; Cowley SWH, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010375; Fukazawa K, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015228; Vaivads A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.105001; Jackman CM, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA015973; Cowley SWH, 2001, PLANET SPACE SCI, V49, P1067, DOI 10.1016/S0032-0633(00)00167-7; Hill ME, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014374; Fukazawa K, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011874; LUI ATY, 1991, J GEOPHYS RES, V96, P11389, DOI 10.1029/91JA00892; Radioti A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032460; Cowley SWH, 2003, ANN GEOPHYS-GERMANY, V21, P1691; Russell CT, 2000, ADV SPACE RES, V26, P1499, DOI 10.1016/S0273-1177(00)00084-3; Radioti A, 2013, GEOPHYS RES LETT, V40, P4498, DOI 10.1002/grl.50889; Desroche M, 2013, J GEOPHYS RES-SPACE, V118, P3087, DOI 10.1002/jgra.50294; BAGENAL F, 1981, J GEOPHYS RES-SPACE, V86, P8447, DOI 10.1029/JA086iA10p08447; Jackman CM, 2013, PLANET SPACE SCI, V82-83, P34, DOI 10.1016/j.pss.2013.03.010; Cowley SWH, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011237; Jackman CM, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016682; Southwood DJ, 2001, J GEOPHYS RES-SPACE, V106, P6123, DOI 10.1029/2000JA000236; Prange R, 2004, NATURE, V432, P78, DOI 10.1038/nature02986; McAndrews HJ, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012581; Bunce EJ, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013257; SCURRY L, 1991, J GEOPHYS RES, V96, P9541, DOI 10.1029/91JA00569; Delamere PA, 2013, J GEOPHYS RES-SPACE, V118, P393, DOI 10.1029/2012JA018197; Kronberg EA, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010777; Ge YS, 2010, PLANET SPACE SCI, V58, P1455, DOI 10.1016/j.pss.2010.06.013; Mitchell DA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023014; Runov A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038980; Jackman CM, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013997; Phan TD, 2010, ASTROPHYS J LETT, V719, pL199, DOI 10.1088/2041-8205/719/2/L199; Zieger B, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014951; Waite JH, 2001, NATURE, V410, P787, DOI 10.1038/35071018; Kivelson MG, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011176; Jia XZ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017575; Badman SV, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011240; Huddleston DE, 1997, J GEOPHYS RES-SPACE, V102, P24289, DOI 10.1029/97JA02416; Kronberg EA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013332; Kasahara S, 2013, J GEOPHYS RES-SPACE, V118, P375, DOI 10.1029/2012JA018130; Swisdak M, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009726; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Badman SV, 2007, ANN GEOPHYS-GERMANY, V25, P941; Radioti A, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014844; Grocott A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014330; Russell CT, 1998, SCIENCE, V280, P1061, DOI 10.1126/science.280.5366.1061; GURNETT DA, 1992, SPACE SCI REV, V60, P341; Jackman CM, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013592; Thomsen MF, 2013, J GEOPHYS RES-SPACE, V118, P5767, DOI 10.1002/jgra.50552; NISHIDA A, 1983, GEOPHYS RES LETT, V10, P451, DOI 10.1029/GL010i006p00451; Galopeau PHM, 1995, J GEOPHYS RES-PLANET, V100, P26397, DOI 10.1029/95JE02132; Daughton W, 2011, NAT PHYS, V7, P539, DOI [10.1038/nphys1965, 10.1038/NPHYS1965]; Karimabadi H, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010749; Ogino T, 1998, J GEOPHYS RES-SPACE, V103, P225, DOI 10.1029/97JA02247; Bonfond B, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045981; Borg AL, 2012, ANN GEOPHYS-GERMANY, V30, P761, DOI 10.5194/angeo-30-761-2012; Pritchett PL, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3206947; Kasahara S, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016892; Clarke JT, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013694; Pallier L, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018041; Kronberg EA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012880; Olshevsky V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.045002; Kronberg EA, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA011994; Bagenal F, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016294; McNutt RL, 2007, SCIENCE, V318, P220, DOI 10.1126/science.1148025; Angelopoulos V, 2008, SPACE SCI REV, V141, P5, DOI 10.1007/s11214-008-9336-1; McComas DJ, 2007, SCIENCE, V318, P217, DOI 10.1126/science.1147393; Gurnett DA, 2002, NATURE, V415, P985, DOI 10.1038/415985a; Vogt MF, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016148; Jackman CM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039149; Vasyliunas VM, 2008, ANN GEOPHYS-GERMANY, V26, P1341; Desroche M, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017621; BARROW CH, 1986, ASTRON ASTROPHYS, V165, P244; Belcher J.W., 1983, PHYSICS JOVIAN MAGNE, P68, DOI 10.1017/CBO9780511564574.005; Birn J., 2007, MHD COLLISIONLESS TH; Biskamp D., 2005, CAMBRIDGE MONOGRAPHS; Boozer AH, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4796051; Cowley SWH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032645; Cowley SWH, 2007, ANN GEOPHYS-GERMANY, V25, P1433; Cowley SWH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2001GL016030; Delamere P.A., 2013, J GEOPHYS RES, V118, P1; Delamere P.A., 2011, J GEOPHYS RES, V116, P10222; Delamere PA, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015347; Dessler A.J., 1983, PHYS JOVIAN MAGNETOS, V395, DOI [http://dx.doi.org/10.1017/CBO9780511564574.013, DOI 10.1017/CBO9780511564574.013]; Drake J. F., 2007, RECONNECTION MAGNETI, P87; Freeman M.P., 2004, GEOPHYS RES LETT, V31, P807; Fu HS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051784; Fuselier SA, 2014, J GEOPHYS RES-SPACE, V119, P2563, DOI 10.1002/2013JA019684; Ge YS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031987; Gerard JC, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011094; Gombosi T.I., 2009, SATURN CASSINI HUYGH, P257; Grigorenko EE, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013811; Grodent D, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010341; Grodent D, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA010017; HILL TW, 1979, J GEOPHYS RES-SPACE, V84, P6554, DOI 10.1029/JA084iA11p06554; Jackman C.M., 2014, J GEOPHYS RES UNPUB; Jackman CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029764; KAISER ML, 1993, J GEOPHYS RES-PLANET, V98, P18757, DOI 10.1029/93JE01279; Kennel C.F., 1995, CONVECTION SUBSTORMS; Khurana K.K., 2004, CAMBRIDGE PLANET SCI, V1, P593; Kivelson MG, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000249; KIVELSON MG, 1992, SPACE SCI REV, V60, P357; Krimigis S.M., 1983, PHYSICS JOVIAN MAGNE, P106, DOI [10.1029/CBO9780511564574.005, DOI 10.1017/CBO9780511564574.006]; Kronberg EA, 2009, ANN GEOPHYS-GERMANY, V27, P2565, DOI 10.5194/angeo-27-2565-2009; Kronberg EA, 2012, ICARUS, V217, P55, DOI 10.1016/j.icarus.2011.10.011; Krupp N, 1998, GEOPHYS RES LETT, V25, P1249, DOI 10.1029/98GL00863; Krupp N, 2001, J GEOPHYS RES-SPACE, V106, P26017, DOI 10.1029/2000JA900138; LADREITER HP, 1989, ASTRON ASTROPHYS, V226, P297; Liu WW, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA018161; Louarn P, 2000, J GEOPHYS RES-SPACE, V105, P13073, DOI 10.1029/1999JA900478; Louarn P, 2001, J GEOPHYS RES-SPACE, V106, P29883, DOI 10.1029/2001JA900067; Louarn P., 2013, MAGN OUT PLAN UNPUB; Markidis S, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA016429; Masters A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051372; Milan SE, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039997; Miyoshi T, 2001, J GEOPHYS RES-SPACE, V106, P10723, DOI 10.1029/2000JA900153; Mozer FS, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2011JA017109; Nichols J.D., 2007, J GEOPHYS RES SPACE, V112, P2203; ONSAGER TG, 1991, J GEOPHYS RES, V96, P20999, DOI 10.1029/91JA01983; Pallier L, 2001, PLANET SPACE SCI, V49, P1159, DOI 10.1016/S0032-0633(01)00023-X; PRANGE R, 1993, J GEOPHYS RES-PLANET, V98, P18779, DOI 10.1029/93JE01802; PRIEST E., 2007, MAGNETIC RECONNECTIO; Pryor WR, 2005, ICARUS, V178, P312, DOI 10.1016/j.icarus.2005.05.021; QUEST KB, 1981, J GEOPHYS RES-SPACE, V86, P3299, DOI 10.1029/JA086iA05p03299; Radioti A., 2011, J GEOPHYS RES, V116; RICHARDSON IG, 1987, J GEOPHYS RES, V92, P9997, DOI 10.1029/JA092iA09p09997; ROUX A, 1991, J GEOPHYS RES, V96, P17697, DOI 10.1029/91JA01106; Rucker HO, 2008, ADV SPACE RES, V42, P40, DOI 10.1016/j.asr.2008.02.008; Runov A, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016316; Rymer AM, 2013, GEOPHYS RES LETT, V40, P2479, DOI 10.1002/grl.50530; Sarafopoulos DV, 1997, ANN GEOPHYS-ATM HYDR, V15, P1246, DOI 10.1007/s00585-997-1246-0; SCHOLER M, 1986, J GEOPHYS RES, V91, P4277, DOI 10.1029/JA091iA04p04277; Sergeev V, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040658; Shay MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.175001; Smith E.J., 1974, J GEOPHYS RES, V79, P25; Tao C, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010959; Vaivads A, 2006, SPACE SCI REV, V122, P19, DOI 10.1007/s11214-006-7019-3; Vasyliunas VM, 1997, GEOPHYS RES LETT, V24, P869, DOI 10.1029/97GL00757; Vogt MF, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA015098; WALKER RJ, 1985, J GEOPHYS RES-SPACE, V90, P7397, DOI 10.1029/JA090iA08p07397; Walker RJ, 2001, PLANET SPACE SCI, V49, P237; WILLIAMS DJ, 1992, SPACE SCI REV, V60, P385; Woch J., 2002, Geophysical Research Letters, V29, DOI 10.1029/2001GL014080; Woch J, 1998, GEOPHYS RES LETT, V25, P1253, DOI 10.1029/98GL00861; Woch J, 1999, GEOPHYS RES LETT, V26, P2137, DOI 10.1029/1999GL900493; Yin L, 2000, J GEOPHYS RES-SPACE, V105, P25345, DOI 10.1029/2000JA000016; Zarka P, 1998, J GEOPHYS RES-PLANET, V103, P20159, DOI 10.1029/98JE01323; ZIMBARDO G, 1993, PLANET SPACE SCI, V41, P357, DOI 10.1016/0032-0633(93)90069-E	161	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0038-6308	1572-9672		SPACE SCI REV	Space Sci. Rev.	APR	2015	187	1-4					181	227		10.1007/s11214-014-0047-5		47	Astronomy & Astrophysics	Astronomy & Astrophysics	CG4FW	WOS:000353241300006		
J	Ishikawa, D; Motomura, A; Igarashi, Y; Ozaki, Y				Ishikawa, Daitaro; Motomura, Asako; Igarashi, Yoko; Ozaki, Yukihiro			Near-Infrared Imaging Using a High-Speed Monitoring Near Infrared Hyperspectral Camera (Compovision)	SPECTROSCOPY AND SPECTRAL ANALYSIS			English	Article						Near infrared spectroscopy; Imaging; Hyperspectral camera	BLENDS; SPECTROSCOPY; TABLETS; POLY(3-HYDROXYBUTYRATE)	This review paper reports near-infrared (NIR) imaging studies using a newly-developed NIR camera, Compovision. Compovision can measure a significantly wide area of 150 mm x 250 mm at high speed of between 2 and 5 s. It enables a wide spectral region measurement in the 1 000 similar to 2 350 nm range at 6 nm intervals. We investigated the potential of Compovision in the applications to industrial problems such as the evaluation of pharmaceutical tablets and polymers. Our studies have demonstrated that NIR imaging based on Compovision can solve several issues such as long acquisition times and relatively low sensitivity of detection. NIR imaging with Compovision is strongly expected to be applied not only to pharmaceutical tablet monitoring and polymer characterization but also to various applications such as those to food products, biomedical substances and organic and inorganic materials.	[Ishikawa, Daitaro] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Motomura, Asako; Igarashi, Yoko] Sumitomo Elect Ind Ltd, Yokohama, Kanagawa 2448588, Japan; [Ozaki, Yukihiro] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda, Hyogo 6691337, Japan	Ozaki, Y (reprint author), Kwansei Gakuin Univ, Sch Sci & Technol, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	daitaroishikawa@m.tohoku.ac.jp; ozaki@kwansei.ac.jp					Ishikawa D, 2013, ANAL BIOANAL CHEM, V405, P9401, DOI 10.1007/s00216-013-7355-6; Awa K, 2008, ANAL CHIM ACTA, V619, P81, DOI 10.1016/j.aca.2008.02.033; Furukawa T, 2007, ANAL SCI, V23, P871, DOI 10.2116/analsci.23.871; Ishikawa D, 2013, APPL SPECTROSC, V67, P1441, DOI 10.1366/13-07103; Tsuji H, 1998, J APPL POLYM SCI, V67, P405; Tsuji H, 1996, MACROMOL CHEM PHYSIC, V197, P3483, DOI 10.1002/macp.1996.021971033; Erickson SJ, 2009, MED ENG PHYS, V31, P495, DOI 10.1016/j.medengphy.2008.10.004; Shinzawa H, 2012, APPL SPECTROSC, V66, P470, DOI 10.1366/11-06540; Ozaki Y, 2012, ANAL SCI, V28, P545; Ciurczak E.W., 2002, PHARM MED APPL NEAR; Ishikawa D, 2013, ANAL SCI, V30, P143; Ishikawa D, 2012, NIR NEWS, V23, P19; Ishikawa D, 2013, NIR NEWS, V24, P6; Lewis E. N., 2001, NIR NEWS, V12, P16; Ozaki Y., 2006, NEAR INFRARED SPECTR; Sasic S, 2010, RAMAN, INFRARED, AND NEAR-INFRARED CHEMICAL IMAGING, P1, DOI 10.1002/9780470768150; Shinzawa H, 2011, J NEAR INFRARED SPEC, V19, P15, DOI 10.1255/jnirs.918; Siesler H. W., 2002, NEAR INFRARED SPECTR; Siesler H.W., 2009, INFRARED RAMAN SPECT; Suttiwijitpukdee N, 2012, MACROMOLECULES, V45, P2738, DOI 10.1021/ma201598s; Unger M, 2013, APPL SPECTROSC, V67, P141, DOI 10.1366/12-06712; Workman Jr J., 2012, PRACTICAL GUIDE SPEC	22	0	0	OFFICE SPECTROSCOPY & SPECTRAL ANALYSIS	BEIJING	NO 76 COLLAGE SOUTH RD BEIJING, BEIJING 100081, PEOPLES R CHINA	1000-0593			SPECTROSC SPECT ANAL	Spectrosc. Spectr. Anal.	APR	2015	35	4					865	869		10.3964/j.issn.1000-0593(2015)04-0865-05		5	Spectroscopy	Spectroscopy	CF9ZR	WOS:000352926900001		
J	Yokouchi, Y; Imaoka, M; Niino, N; Kiyosawa, N; Sayama, A; Jindo, T				Yokouchi, Yusuke; Imaoka, Masako; Niino, Noriyo; Kiyosawa, Naoki; Sayama, Ayako; Jindo, Toshimasa			(+)-Usnic Acid-induced Myocardial Toxicity in Rats	TOXICOLOGIC PATHOLOGY			English	Article						usnic acid; F344 rat; heart; mitochondria; immunohistochemistry; ultrastructure; microarray; real-time RT-PCR; oxidative stress; endoplasmic reticulum stress; amino acid limitation; uncoupler	ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; USNIC-ACID; MESSENGER-RNA; CELL-DEATH; APOPTOSIS; MITOCHONDRIA; EXPRESSION; PROHIBITIN; INHIBITION	(+)-Usnic acid (UA) has been known to be a strong uncoupler, and mitochondrial and endoplasmic reticulum (ER)-related stresses are suggested to be involved in the mechanism of hepatotoxicity. However, it has not been clarified whether UA causes toxicity in other mitochondria-rich organs such as the heart. We elucidated whether UA induces cardiotoxicity and its mechanism. UA was orally administered to rats for 14 days, and laboratory and histopathological examinations were performed in conjunction with toxicogenomic analysis. As a result, there was no alteration in blood chemistry, whereas cytoplasmic rarefaction of myocardium was observed microscopically. This finding corresponded to the swollen mitochondria observed ultrastructurally. Immunohistochemically, expression of prohibitin, indicating mitochondrial imbalance, increased in the sarcoplasmic area. Toxicogenomic analysis highlighted the upregulation of gene groups consisting of oxidative stress, ER stress, and amino acid limitation. Interestingly, the number of upregulated genes was larger in the amino acid limitation-related gene group than that in other groups, implying that amino acid limitation might be one of the sources of oxidative stress, not only mitochondria and ER-originated stresses. In conclusion, the heart was manifested to be one of the target organs of UA. Mitochondrial imbalance with complex stresses may be involved in the toxic mechanism.	[Yokouchi, Yusuke; Imaoka, Masako; Niino, Noriyo; Kiyosawa, Naoki; Sayama, Ayako; Jindo, Toshimasa] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Tokyo 1348630, Japan	Yokouchi, Y (reprint author), Daiichi Sankyo Co Ltd, Kasai R&D Ctr, Med Safety Res Labs, Edogawa Ku, 1-16-13 Kita Kasai, Tokyo 1348630, Japan.	yokouchi.yusuke.uw@daiichisankyo.co.jp					Guo L, 2008, J ENVIRON SCI HEAL C, V26, P317, DOI 10.1080/10590500802533392; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Cocchietto M, 2002, NATURWISSENSCHAFTEN, V89, P137, DOI 10.1007/s00114-002-0305-3; Cook WE, 2007, J WILDLIFE DIS, V43, P498; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Lee JH, 2010, FEBS J, V277, P488, DOI 10.1111/j.1742-4658.2009.07505.x; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; NICHOLAS RA, 1978, BIOCHEM J, V176, P639; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445; Lu XY, 2011, INT J TOXICOL, V30, P478, DOI 10.1177/1091581811414436; Shibanuma M, 2011, FREE RADICAL RES, V45, P672, DOI 10.3109/10715762.2011.564169; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012; Dailey RN, 2008, VET PATHOL, V45, P19, DOI 10.1354/vp.45-1-19; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Eisler H, 2004, EXP CELL RES, V300, P345, DOI 10.1016/j.yexcr.2004.07.025; Lee H, 2010, INT J BIOL MACROMOL, V47, P685, DOI 10.1016/j.ijbiomac.2010.08.018; Ariyama Y, 2008, METABOLISM, V57, P1625, DOI 10.1016/j.metabol.2008.06.019; Bock KW, 2012, BIOCHEM PHARMACOL, V83, P833, DOI 10.1016/j.bcp.2011.12.006; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Das SK, 2011, J CLIN ENDOCR METAB, V96, pE1308, DOI 10.1210/jc.2011-0101; Han D, 2004, BIOCHEM PHARMACOL, V67, P439, DOI 10.1016/j.bcp.2003.09.032; Hiller N, 2013, ANESTH ANALG, V116, P83, DOI 10.1213/ANE.0b013e31826c8095; Hsu LM, 2005, J GASTROEN HEPATOL, V20, P1138; HUTSON RG, 1994, BIOCHEM J, V304, P745; JOHNSON RB, 1950, ARCH BIOCHEM, V28, P317; Krishna D. R., 1995, Drug Metabolism and Drug Interactions, V12, P53; Li L, 2013, J NEUROSCI RES, V91, P786, DOI 10.1002/jnr.23216; Liang L., 2013, J AGR FOOD CHEM; Liu Q, 2012, J AGR FOOD CHEM, V60, P7312, DOI 10.1021/jf2046834; Pramyothin P, 2004, J ETHNOPHARMACOL, V90, P381, DOI 10.1016/j.jep.2003.10.019; Watatani Y, 2007, LIFE SCI, V80, P879, DOI 10.1016/j.lfs.2006.11.013; Zhang Z, 1999, AM J PHYSIOL-RENAL, V276, pF786	41	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0192-6233	1533-1601		TOXICOL PATHOL	Toxicol. Pathol.	APR	2015	43	3					424	434		10.1177/0192623313504308		11	Pathology; Toxicology	Pathology; Toxicology	CG3AN	WOS:000353148900010		
J	Yokoyama, N; Ishimura, T				Yokoyama, N.; Ishimura, T.			Usefulness of Three-Dimensional Computerized Tomographic Volumetry for Determining Split Renal Function in Donors for Living-Related Kidney Transplantation	TRANSPLANTATION PROCEEDINGS			English	Article								Background. In living-related kidney transplantation, it is important to spare the superior kidney for the donor if there is a significant difference in split renal function. We have been using renal scintigraphy to decide which kidney to be donated. Recently, we used data regarding kidney volume and maximum area in the frontal plane of the 3-dimensional computerized tomography (3DCT) image of the kidney. We evaluated the validity of these parameters for estimating split renal function. Methods. We calculated the ratio of right kidney volume (VOL-ratio) and maximum area in the frontal plane of the kidney (AREA-ratio) with the use of 3DCT and examined the correlation between these 2 parameters and the ratio of right kidney estimated renal plasma flow (ERPF-ratio) calculated with the use of technetium-99m mercaptoacetyltriglycine ((99m)Tc44AG3) renal scintigraphy. Forty-six donors for living-related kidney transplantation were evaluated. Their mean age was 53 years; there were 14 male and 32 female donors. Results. Correlation coefficients between VOL-ratio and ERPF-ratio and between AREA-ratio and ERPF-ratio were 0.441 and 0.471, respectively (P = .002; P = .001). Bland-Altman analysis confirmed that the majority of difference scores between VOL-ratio-ERPF-ratio and AREA-ratio-ERPF-ratio were within the 95% confidence interval of the differences. The differences between VOL-ratio-ERPF-ratio and AREA-ratio-ERPF-ratio were (mean 1.96SD) 1.17 +/- 6.04% and -0.82 +/- 6.09%, respectively. It seemed that the distribution of AREA-ratio-ERPF-ratio was less biased than that of VOL-ratio-ERPF-ratio. Conclusions. The discrepancy between the ratio of kidney volume and the maximum area in the frontal plane of the kidney may have been due to the rotation of the kidney. The ratio of ERPF obtained with the use of renal scintigraphy approximates not only the ratio of kidney volume but also the ratio of maximum area in the frontal plane of the kidney. Thus, our findings suggest that the use of Tc-99m-MAG3 renal scintigraphy alone may underestimate the function of a rotated kidney.	[Yokoyama, N.; Ishimura, T.] Kobe Univ, Dept Urol, Kobe, Hyogo 6500017, Japan	Ishimura, T (reprint author), Kobe Univ, Dept Urol, Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	stonevil@med.kobe-u.ac.jp					Hackstein N, 2007, EUR J RADIOL, V61, P303, DOI 10.1016/j.ejrad.2006.09.001; BLAND JM, 1986, LANCET, V1, P307; Kato F, 2009, EUR J RADIOL, V79, P15; Miyazaki C, 2010, ANN NUCL MED, V24, P189, DOI 10.1007/s12149-010-0349-y; Nilsson H, 2004, ACTA RADIOL, V45, P474, DOI 10.1080/02841850410005282; Testa HJ, 1996, CLIN GUIDE NUCL MED	6	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					588	590		10.1016/j.transproceed.2014.11.044		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900005		
J	Kusaka, M; Sugimoto, M; Fukami, N; Sasaki, H; Takenaka, M; Anraku, T; Ito, T; Kenmochi, T; Shiroki, R; Hoshinaga, K				Kusaka, M.; Sugimoto, M.; Fukami, N.; Sasaki, H.; Takenaka, M.; Anraku, T.; Ito, T.; Kenmochi, T.; Shiroki, R.; Hoshinaga, K.			Initial Experience With a Tailor-made Simulation and Navigation Program Using a 3-D Printer Model of Kidney Transplantation Surgery	TRANSPLANTATION PROCEEDINGS			English	Article								Introduction. Three-dimensional (3-D) printing systems allow for the creation of surgical models mimicking real tissue. We developed a kidney graft and pelvic cavity replica as a patient-specific 3-D model using a 3-D printing system with simultaneous jetting of different materials and subsequently evaluated the usefulness of surgical simulation and navigation of living kidney transplantation. Methods. After generating a stereolithographic file of the organ surface based on multidetector computed tomographic data, we created a 3-D organ model using an inkjet 3-D printer and manufactured a pelvic cavity replica using patient-specific data. Results. The patients' individual 3-D printed models were used to plan and guide the surgical procedures for laparoscopic donor nephrectomy and recipient transplantation surgery. The 3-D organ replicas obtained using transparent materials allowed for the creation of models that showed the visceral organs, blood vessels, and other details, thereby overcoming the limitations of conventional image-guided navigation. Our pelvic replicas can be made according to each patient's specific anatomical data, thus representing personalized surgical procedures. This level of detail of the anatomy enables the surgeons and trainees to virtually treat various pelvic conditions before they perform the surgical procedure. The use of these replicas may also reduce the length of the operation and provide better anatomical reference tools for tailor-made simulation and navigation of kidney transplantation surgery, consequently helping to improve training for the operating room staff, students, and trainees. Conclusions. We believe that our sophisticated personalized donor graft and pelvic replications obtained using a 3-D printing system are advantageous for kidney transplantation surgery.	[Kusaka, M.; Fukami, N.; Sasaki, H.; Takenaka, M.; Shiroki, R.; Hoshinaga, K.] Fujita Hlth Univ, Dept Urol, Sch Med, Toyoake, Aichi 4701192, Japan; [Sugimoto, M.] Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 657, Japan; [Anraku, T.] Fasotec Co Ltd, Chiba, Japan; [Ito, T.; Kenmochi, T.] Fujita Hlth Univ, Dept Organ Transplantat Surg, Toyoake, Aichi 4701192, Japan	Kusaka, M (reprint author), Fujita Hlth Univ, Dept Urol, Sch Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	mkusaka@fujita-hu.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities of Japan [S1001035]	Supported by MEXT-Supported Program for the Strategic Research Foundation at Private Universities (S1001035) of Japan.	Silberstein JL, 2014, UROLOGY, V84, P268, DOI 10.1016/j.urology.2014.03.042; Friedman AL, 2006, ANN SURG, V243, P126, DOI 10.1097/01.sla.0000193841.43474.ec; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Niikura Takahiro, 2014, Orthopedics, V37, P237, DOI 10.3928/01477447-20140401-05	4	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					596	599		10.1016/j.transproceed.2014.12.045		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900007		
J	Noguchi, H; Kitada, H; Kaku, K; Kurihara, K; Kawanami, S; Tsuchimoto, A; Masutani, K; Nakamura, U; Tanaka, M				Noguchi, H.; Kitada, H.; Kaku, K.; Kurihara, K.; Kawanami, S.; Tsuchimoto, A.; Masutani, K.; Nakamura, U.; Tanaka, M.			Outcome of Renal Transplantation in Patients With Type 2 Diabetic Nephropathy: A Single-Center Experience	TRANSPLANTATION PROCEEDINGS			English	Article							KIDNEY-TRANSPLANTATION; RECIPIENTS; DISEASE; RISK; EPIDEMIOLOGY; MORTALITY; MORBIDITY; SURVIVAL	Background. Renal transplantation has been established as a treatment for end-stage renal disease (ESRD) due to diabetic nephropathy. However, few studies have focused on the outcome after renal transplantation in patients with ESRD and type 2 diabetic nephropathy. To investigate the effect of renal transplantation on ESRD with type 2 diabetic nephropathy, we retrospectively analyzed patients who received renal transplantation at our facility. This study aimed to compare the outcome of renal transplantation for type 2 diabetic nephropathy with that for noncliabetic nephropathy. Methods. We studied 290 adult patients, including 65 with type 2 diabetic nephropathy (DM group) and 225 with nondiabetic nephropathy (NDM group), who underwent living-donor renal transplantation at our facility from February 2008 to March 2013. We compared the 2 groups retrospectively. Results. In the DM and NDM groups, the 5-year patient survival rates were 96.6% and 98.7%, and the 5-year graft survival rates were 96.8% and 98.0%, respectively, with no significant differences between the groups. There were no significant differences in the rates of surgical complications, rejection, and infection. The cumulative incidence of postoperative cardiovascular events was higher in the DM group than in the NDM group (8.5% vs 0.49% at 5 years; P = .002). Conclusions. Patient and graft survival rates after renal transplantation for type 2 diabetic nephropathy are not inferior to those for recipients without diabetic nephropathy. Considering the poor prognosis of patients with diabetic nephropathy on dialysis, renal transplantation can provide significant benefits for these patients.	[Noguchi, H.; Kitada, H.; Kaku, K.; Kurihara, K.; Kawanami, S.; Tanaka, M.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Tsuchimoto, A.; Masutani, K.; Nakamura, U.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan	Noguchi, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	noguchih@surg1.med.kyushu-u.ac.jp					Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Cosio FG, 2008, AM J TRANSPLANT, V8, P593, DOI 10.1111/j.1600-6143.2007.02101.x; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Molnar MZ, 2011, AM J KIDNEY DIS, V58, P101, DOI 10.1053/j.ajkd.2010.11.027; Gill JS, 2003, TRANSPLANTATION, V75, P113, DOI 10.1097/01.TP.0000038317.37386.1F; KHAULI RB, 1986, UROLOGY, V27, P521, DOI 10.1016/0090-4295(86)90331-6; LEMMERS MJ, 1991, DIABETES CARE, V14, P295, DOI 10.2337/diacare.14.4.295; Nakai S, 2014, NIHON TOSEKI IGAKKAI, V47, P1; Ramezani M, 2007, TRANSPL P, V39, P966, DOI 10.1016/j.transproceed.2007.03.074; RISCHENVOS J, 1992, NEPHROL DIAL TRANSPL, V7, P433; Tobin GS, 2014, RENAL TRANSPLANTATIO; Valera B, 2006, TRANSPLANT P, V38, P2414, DOI 10.1016/j.transproceed.2006.08.018	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					608	611		10.1016/j.transproceed.2014.12.047		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900009		
J	Ushigome, H; Harada, S; Nakao, M; Nakamura, T; Koshino, K; Suzuki, T; Ito, T; Nobori, S; Yoshimura, N				Ushigome, H.; Harada, S.; Nakao, M.; Nakamura, T.; Koshino, K.; Suzuki, T.; Ito, T.; Nobori, S.; Yoshimura, N.			Living-donor Kidney Transplantation With Existing Anti-donor Specific Antibodies at a Japanese Single Center	TRANSPLANTATION PROCEEDINGS			English	Article							ALLOGRAFT REJECTION; MEDIATED REJECTION	Improving the short-term outcome of kidney transplantation, the rejection induced by anti-donor specific antibody (DSA) has been the large complication. We analyzed 324 living-donor kidney transplant recipients (procedures performed between April 2003 and August 2014) to investigate the outcome of kidney transplant recipients with DSA. We divided them into four groups (anti-blood type antibody alone, group A [n = 73]; antihuman lymphocyte antigen [HLA] antibody alone, group B [n = 11]; both antibodies, group C [n = 8]; and no DSA, group D [n = 232]) and investigated the incidence of rejection and those histologic findings. Each case with DSA underwent some desensitization therapy before transplantation. There was no significant difference in graft survival (all cases: 100% at 1 year, group A: 97.6%, B: 95.9%, C: 100%, and at 5 years, group D: 96.1%). There were some significant differences in incidence of acute antibody-mediated rejection (AAMR) and chronic active antibody-mediated rejection (CAAMR) among four groups (group A: 4.1% and 2.7%, B: 18.2% and 9.1%, C: 12.5% and 12.5%, D: 0% and 0.9%, respectively). Each AAMR case was improved by ordinary desensitization therapy, but half of the CAAMR cases, diagnosed early after transplantation, had no effect of any therapy to result in graft failure. Our results suggested that even the case with DSA could be transplanted safely by some desensitization therapy. However, we should be cautious regarding recipients with DSA for the long term even if there is no histologic change early after transplantation because graft loss may occur due to CAAMR.	[Ushigome, H.; Harada, S.; Nakao, M.; Nakamura, T.; Koshino, K.; Ito, T.; Nobori, S.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Transplantat & Regenerat Surg, Kyoto 6028566, Japan; [Suzuki, T.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Interact Res Med, Kyoto 6028566, Japan	Ushigome, H (reprint author), Kyoto Prefectural Univ Med, Dept Transplantat & Regenerat Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	ushi@koto.kpu-m.ac.jp					Lee PC, 2009, TRANSPLANTATION, V88, P568, DOI 10.1097/TP.0b013e3181b11b72; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Haas M, 2009, J AM SOC NEPHROL, V20, P197, DOI 10.1681/ASN.2008030279; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Sis B, 2010, CURR OPIN ORGAN TRAN, V15, P42, DOI 10.1097/MOT.0b013e3283352a50; Ashton-Chess J, 2010, KIDNEY INT, V77, P880, DOI 10.1038/ki.2010.15; Everly Matthew J, 2010, Clin Transpl, P353; Okamoto M, 2004, CLIN TRANSPLANT, V18, P44, DOI 10.1111/j.1399-0012.2004.00247.x; Racusen Lorraine C, 2004, Am J Transplant, V4, P1562, DOI 10.1111/j.1600-6143.2004.00585.x; Sberro-Soussan R, 2010, AM J TRANSPLANT, V10, P681, DOI 10.1111/j.1600-6143.2009.02968.x; Seemayer CA, 2007, NEPHROL DIAL TRANSPL, V22, P568, DOI 10.1093/ndt/gfl594; Yoshimura N, 2005, TRANSPLANT P, V37, P687, DOI 10.1016/j.transproceed.2005.01.008	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					612	616		10.1016/j.transproceed.2014.12.039		5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900010		
J	Nakamura, T; Ushigome, H; Nakao, T; Harada, S; Koshino, K; Suzuki, T; Ito, T; Nobori, S; Yoshimura, N				Nakamura, T.; Ushigome, H.; Nakao, T.; Harada, S.; Koshino, K.; Suzuki, T.; Ito, T.; Nobori, S.; Yoshimura, N.			Advantages and Disadvantages of Pre-emptive Kidney Transplantation: Results From a Single Transplantation Center	TRANSPLANTATION PROCEEDINGS			English	Article							SURVIVAL; BARRIERS	Background. There is a growing tendency to perform pre-emptive kidney transplantation (PKT). However, less research has been performed on outcomes of PKT and kidney transplantation (KT) after long-term dialysis (LD). Methods. To elucidate advantages of PKT to KTLD, 96 patients who underwent livingdonor KT at our university from 2000 to 2011 were enrolled for this study: 64 patients in the PKT0 (0 months dialysis) group; 14 patients in the PKT-3 group (less than 3 months dialysis); 18 patients in the LD (dialysis > 120 months) group. All recipients were assessed for patients' survival, graft survival, urinary tract infection, laboratory data, episodes of acute rejection, cytomegalovirus-related diseases, and other significant infectious diseases which required hospitalization. Results. Although there were no significant differences in 5-year graft survival (93.8% in PKT0, 85.7% in PKT-3, and 83.7% in control), 5-year patient survival is better in the PKT0 group (96.9%) and the PKT-3 group (92.9%) compared to 88.9% in the control group. Urinary tract infection is clearly correlated with the LD group (44.4% in the LD group vs 19.2% in the PKT group) primarily due to atrophic bladder and subsequent vesicoureteral reflux. Slightly higher rates of acute rejection were found in the PKT groups (30.8% vs 26.3%). Conclusion. This study revealed that there are both advantages and disadvantages of PKT. It is clear, therefore, that PKT can be recommended for end-stage renal disease patients provided enough attention is paid to the onset of acute rejection.	[Nakamura, T.; Ushigome, H.; Nakao, T.; Harada, S.; Koshino, K.; Ito, T.; Nobori, S.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kyoto, Kyoto 6028566, Japan; [Suzuki, T.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Interact Res Med, Kyoto, Kyoto 6028566, Japan	Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kamigyo Ku, Kajii Cho 465, Kyoto, Kyoto 6028566, Japan.	tsukasa@koto.kpu-m.ac.jp					Meije Y, 2014, TRANSPL INFECT DIS, V16, P387, DOI 10.1111/tid.12226; Goldsmith DJA, 1997, NEPHRON, V77, P37; Kallab S, 2010, TRANSPL P, V42, P782, DOI 10.1016/j.transproceed.2010.02.031; Meier-Kriesche HU, 2000, KIDNEY INT, V58, P1311, DOI 10.1046/j.1523-1755.2000.00287.x; Mange KC, 2001, NEW ENGL J MED, V344, P726, DOI 10.1056/NEJM200103083441004; Girndt M, 2001, KIDNEY INT, V59, pS206; Kaihara S, 2005, TRANSPLANT P, V37, P1804, DOI 10.1016/j.transproceed.2005.02.107; Knight RJ, 2015, TRANSPLANTATION, V99, P576, DOI 10.1097/TP.0000000000000357; Whang M, 2011, TRANSPL P, V43, P1619, DOI 10.1016/j.transproceed.2011.02.014; Yamagata K, 2015, CLIN EXP NEPHROL, V19, P54, DOI 10.1007/s10157-014-0978-x; Yoshimura N, 2010, SURG TODAY, V40, P514, DOI 10.1007/s00595-009-4214-3	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					626	629		10.1016/j.transproceed.2014.09.179		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900013		
J	Nakamura, T; Ushigome, H; Takata, T; Nakao, T; Harada, S; Koshino, K; Suzuki, T; Ito, T; Nobori, S; Yoshimura, N				Nakamura, T.; Ushigome, H.; Takata, T.; Nakao, T.; Harada, S.; Koshino, K.; Suzuki, T.; Ito, T.; Nobori, S.; Yoshimura, N.			Histopathologic Impacts of Everolimus Introduction on Kidney Transplant Recipients	TRANSPLANTATION PROCEEDINGS			English	Article							NEPHROTOXICITY; CYCLOSPORINE; INHIBITORS; CONVERSION; SIROLIMUS; BIOPSIES	Background. Introduction of everolimus (RAID) has been established as a new immunosuppressive medication for kidney transplant (KT) recipients. Administration of RAID is capable of reducing the dosage of coadministrated calcineurin inhibitors (CNI). However, histological investigations have rarely been performed. Methods. To clarify histopathologic effects of RAID, a total of 9 adult KT recipients were enrolled (RAID group, n = 5; Mycophenolate mofetil (MMF) group, n = 4). Renal graft biopsies had been performed at 3 weeks and 1 year following KT. Results. There were no differences in 1-, 3-, and 5-year graft survival rates (RAID group: 100%, 100%, and 80%, respectively; MMF group: 100%, 100%, and 75%, respectively), and patient survival between the 2 groups (no deaths during the 5 years post-transplantation). Interestingly, although 2 patients in the RAID group had developed CNI nephrotoxicity clinically, renal biopsies had proven no CNI-related lesions 1 year later, which might be due to the reduction in CNI. On the other hand, 1 patient, in the MMF group, had been diagnosed histologically with new-onset CNI nephrotoxicity 1 year following KT. Importantly, the frequency and mean arteriolar hyalinosis (ah) scores, which reflect CNI nephrotoxicity, were significantly higher in the MMF group at 1-year biopsy (P < .05, P < .0001). Two patients in the RAID group improved their ah scores between 3 weeks and 1 year. Conclusions. Pathological findings revealed that reversible CNI nephrotoxicity can be improved by RAID with reduced CNI maintenance therapy. It is reasonable to believe, therefore, that introduction of RAID is useful for patients who have been diagnosed with CNI nephrotoxicity.	[Nakamura, T.; Ushigome, H.; Takata, T.; Nakao, T.; Harada, S.; Koshino, K.; Ito, T.; Nobori, S.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kamigyo Ku, Kyoto, Kyoto 6028566, Japan; [Suzuki, T.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Interact Res Med, Kamigyo Ku, Kyoto, Kyoto 6028566, Japan	Nakamura, T (reprint author), Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kamigyo Ku, Kajii Cho 465, Kyoto, Kyoto 6028566, Japan.	tsukasa@koto.kpu-m.ac.jp					Alpay N, 2014, CLIN EXP NEPHROL, V18, P961, DOI 10.1007/s10157-014-0939-4; Fioretto P, 2006, KIDNEY INT, V69, P907, DOI 10.1038/sj.ki.5000153; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Nashan B, 2012, TRANSPLANTATION, V94, P547, DOI 10.1097/TP.0b013e3182551021; Jacobson PA, 2012, TRANSPLANTATION, V93, P624, DOI 10.1097/TP.0b013e3182461288; Snanoudj R, 2011, AM J TRANSPLANT, V11, P2635, DOI 10.1111/j.1600-6143.2011.03718.x; Hiemann NE, 2011, TRANSPLANTATION, V92, P1165, DOI 10.1097/TP.0b013e3182332886; Chiurchiu C, 2010, TRANSPL P, V42, P277, DOI 10.1016/j.transproceed.2009.11.017; Cibrik D, 2011, TRANSPL P, V43, P2562, DOI 10.1016/j.transproceed.2011.05.052; Fernández-Yunquera Ainhoa, 2014, World J Transplant, V4, P133, DOI 10.5500/wjt.v4.i2.133; Koshino K, 2014, TRANSPL P, V46, P385, DOI 10.1016/j.transproceed.2013.11.073; Larson TS, 2006, AM J TRANSPLANT, V6, P514, DOI 10.1111/j.1600-6143.2005.01177.x; Oh CK, 2015, TRANSPLANTATION, V99, P180, DOI 10.1097/TP.0000000000000225; Sennesael JJ, 2005, TRANSPLANTATION, V80, P1578, DOI 10.1097/01.tp.0000184623.35773.6a; Tanabe T, 2014, NEPHROLOGY, V19, P2, DOI 10.1111/nep.12253	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					630	634		10.1016/j.transproceed.2014.09.180		5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900014		
J	Nakao, T; Ushigome, H; Nakamura, T; Harada, S; Koshino, K; Suzuki, T; Ito, T; Nobori, S; Yoshimura, N				Nakao, T.; Ushigome, H.; Nakamura, T.; Harada, S.; Koshino, K.; Suzuki, T.; Ito, T.; Nobori, S.; Yoshimura, N.			Evaluation of Renal Allograft Fibrosis by Transient Elastography (Fibro Scan)	TRANSPLANTATION PROCEEDINGS			English	Article							LIVER STIFFNESS; NEPHROPATHY	Background. Chronic allograft injury (CAI) is one of the most important factors for graft failure after renal transplantation. Protocol biopsy is the most valuable tool for revealing subclinical renal allograft failure. Transient elastography (TE) is a noninvasive technique that has shown utility for the assessment of hepatic and renal fibrosis. This study sought to evaluate whether TE was a viable and effective method for the assessment of renal allograft failure. Patients and Methods. Thirty-five patients underwent TE by Fibro Scan (Echosense, Paris, France). Biopsies were performed in 27 patients, allowing classification according to Banff chronic changes in the interstitium grade 0, grade 1 or grade 2. Results. Measurement of parenchymal stiffness was successful in 31 of 35 patients (91%). Stiffness was significantly correlated with interstitial fibrosis (P < .05) and inversely related with estimated glomerular filtration rate (eGFR; P < .05). Stiffness values of patients with eGFR > 50 mL/min were lower than those of patients with eGFR < 50 mL/min (P < .05). Patients classed as CAI Banff grade 0 had significantly less parenchymal stiffness than patients with Banff grade 1 or grade 2 CAI (P < .05). Parenchymal stiffness measured by TE reflected interstitial fibrosis in renal allograft. Conclusion. Assessment of parenchymal renal allograft stiffness by was effective for identifying patients with CAI who may subsequently benefit from biopsy and modification of the immunosuppressive regimen. Assessment of parenchymal renal allograft stiffness can be effective for identifying patients with CAI. TE has the potential to reduce the number of renal allograft biopsies required for accurate assessment of CAI.	[Nakao, T.; Ushigome, H.; Nakamura, T.; Harada, S.; Koshino, K.; Ito, T.; Nobori, S.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kamigyo Ku, Kyoto, Kyoto 028566, Japan; [Suzuki, T.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Interact Res Med, Kamigyo Ku, Kyoto, Kyoto 028566, Japan	Nakao, T (reprint author), Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kamigyo Ku, Kajii Cho 465, Kyoto, Kyoto 028566, Japan.	toshi876@koto.kpu-m.ac.jp					Schwarz A, 2005, AM J TRANSPLANT, V5, P1992, DOI 10.1111/j.1600-6143.2005.00988.x; Liu CH, 2011, CLIN J AM SOC NEPHRO, V6, P1057, DOI 10.2215/CJN.04320510; Arndt R, 2010, TRANSPL INT, V23, P871, DOI 10.1111/j.1432-2277.2010.01057.x; Sommerer C, 2013, TRANSPL INT, V26, P545, DOI 10.1111/tri.12073; Lukenda V, 2014, INT UROL NEPHROL, V46, P1435, DOI 10.1007/s11255-014-0697-y; Foucher J, 2006, EUR J GASTROEN HEPAT, V18, P411, DOI 10.1097/00042737-200604000-00015; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Deffieux T, 2015, J HEPATOL, V62, P317, DOI 10.1016/j.jhep.2014.09.020; Zadrazil Josef, 2004, Ann Transplant, V9, P8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					640	643		10.1016/j.transproceed.2014.12.034		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900016		
J	Nakao, T; Ushigome, H; Kawai, K; Nakamura, T; Harada, S; Koshino, K; Suzuki, T; Ito, T; Nobori, S; Yoshimura, N				Nakao, T.; Ushigome, H.; Kawai, K.; Nakamura, T.; Harada, S.; Koshino, K.; Suzuki, T.; Ito, T.; Nobori, S.; Yoshimura, N.			Evaluation of Rituximab Dosage for ABO-Incompatible Living-donor Kidney Transplantation	TRANSPLANTATION PROCEEDINGS			English	Article							SINGLE-CENTER; ANTI-CD20; DESENSITIZATION; PLASMAPHERESIS; SPLENECTOMY; EXPERIENCE	Background. The introduction of ritwdmab has led to a growing tendency to perform ABO-incompatible living-donor kidney transplantation (LDKT) without splenectomy. However, the optimal dosage of rituximab is undefined. Method. Fifty-five LDKT recipients who had neither a history of hepatitis B infection nor positive crossmatch were enrolled between October 2005 and June 2014. Recipients were divided into three groups by year of transplantation: 2005 to 2008; 2009 to 2011; and 2012 to 2014. Percentages of CD20-positive B lymphocytes and blood-group antibody titers were monitored before renal transplantation. An initial rituximab dosage of 100 mg/body (for titers below 64) or 200 mg/body (for titers above 128) was administered 2 weeks before transplantation. If the percentage of peripheral B lymphocytes remained greater than 0.5%, additional rituximab (100 mg or 200 mg) was administered. Patient demographics, patient survival, graft survival, and complication rates were compared. Results. Nine patients received rituximab 100 mg/body (low-dose rituximab [LDR] group). Overall survival and graft survival rates did not differ significantly between the LDR group and other cases. The incidences of myelosuppression and viral infection were lower in the LDR group than the other cases. Conclusion. A low dose of rituximab (100 mg/body) is adequate in ABO-incompatible LDKT, especially in cases with low blood-type antibody titer against ABO-antigens. Ritwdmab dosage reduction has been successful in our hospital without serious complications. Moreover, as over-dosage of rituxirnab may cause myelosuppression, it is reasonable to believe that LDR is a suitable option to safely perform ABO-incompatible LDKT without splenectomy.	[Nakao, T.; Ushigome, H.; Kawai, K.; Nakamura, T.; Harada, S.; Koshino, K.; Ito, T.; Nobori, S.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kyoto, Japan; [Suzuki, T.; Yoshimura, N.] Kyoto Prefectural Univ Med, Dept Organ Interact Res Med, Kyoto, Japan	Nakao, T (reprint author), Kyoto Prefectural Univ Med, Dept Organ Transplantat & Gen Surg, Kamigyo Ku, Kajii Cho 465, Kyoto, Kyoto 6028566, Japan.	toshi876@koto.kpu-m.ac.jp					Sawada T, 2002, TRANSPLANTATION, V74, P1207, DOI 10.1097/01.TP.0000040990.15896.76; Hatakeyama S, 2014, TRANSPL P, V46, P445, DOI 10.1016/j.transproceed.2013.09.036; Ashimine S, 2014, KIDNEY INT, V85, P425, DOI 10.1038/ki.2013.291; Chung BH, 2012, RENAL FAILURE, V34, P974, DOI 10.3109/0886022X.2012.700892; Egawa H, 2014, AM J TRANSPLANT, V14, P102, DOI 10.1111/ajt.12520; Kaihara S, 2005, TRANSPLANT P, V37, P1804, DOI 10.1016/j.transproceed.2005.02.107; Silvestre C, 2014, TRANSPL P, V46, P2209, DOI 10.1016/j.transproceed.2014.07.063; Tsai DE, 1999, BONE MARROW TRANSPL, V24, P521, DOI 10.1038/sj.bmt.1701944; Won D, 2014, J CLIN APHERESIS, V29, P243, DOI 10.1002/jca.21312	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					644	648		10.1016/j.transproceed.2014.12.033		5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900017		
J	Ichimaru, N; Yamanaka, K; Kato, T; Kakuta, Y; Abe, T; Imamura, R; Nonomura, N; Kaimori, JY; Takahara, S				Ichimaru, N.; Yamanaka, K.; Kato, T.; Kakuta, Y.; Abe, T.; Imamura, R.; Nonomura, N.; Kaimori, J. -Y.; Takahara, S.			Risk Factors and Incidence for Lipid Abnormalities in Kidney Transplant Patients	TRANSPLANTATION PROCEEDINGS			English	Article							CYCLOSPORINE; RECIPIENTS	Background. Lipid abnormalities (LA) are related to an increased risk for cardiovascular diseases in kidney transplantation patients. Patients and Methods. Multivariable logistic regression models were used to estimate the risk of LA associated with potential risk factors, including immunosuppressant use, patient background characteristics, and laboratory data. Results. In total, 386 patients who were undergoing kidney transplantation were included in the study. Statins were prescribed to 43% of patients. The LA composite outcome was defined as statin use and/or low density lipoprotein cholesterol level >= 120 mg/dL, and 229 patients (59.3%) developed LA as a result. LA was significantly related to everolimus, corticosteroid, age, and estimated glomerular filtration ratio in the multiple logistic regression analysis. The odds ratios were 2.264, 3.119, 1.186, and 0.870, respectively. Mycophenolate mofetil, mizoribine, azathioprine, cyclosporine (CYA), tacrolimus, proteinuria, body mass index, and male sex were not related to LA. Discussion. CYA influenced lipid metabolism but was not related to LA in our study. The mean post transplantation period was 8.4 years, and the CYA dose decreased over time. The CYA blood concentration was 70.0 ng/mL, which is relatively low, but it decreased the susceptibility to LA. Serum lipid levels were well controlled by statins, and the estimated glomerular filtration rate was maintained stably. Conclusions. Everolimus and corticosteroid use, as well as a lower estimated glomerular filtration rate and higher age, were significant risk factors for LA. CYA is known for its adverse LA effects, but it was not a significant risk factor for LA in patients undergoing maintenance phase kidney transplantation.	[Ichimaru, N.; Kaimori, J. -Y.; Takahara, S.] Osaka Univ, Grad Sch Med, Dept Adv Technol Transplantat, Suita, Osaka 5650871, Japan; [Yamanaka, K.; Kato, T.; Kakuta, Y.; Abe, T.; Imamura, R.; Nonomura, N.] Osaka Univ, Grad Sch Med, Dept Specif Organ Regulat, Suita, Osaka 5650871, Japan	Ichimaru, N (reprint author), Osaka Univ, Grad Sch Med, 2-2,J8, Suita, Osaka 5650871, Japan.	ichimaru@att.med.osaka-u.ac.jp			Novartis Pharma; Astellas Pharma; Chugai Pharmaceutical	This work was supported by Novartis Pharma, Astellas Pharma, and Chugai Pharmaceutical (N.I., J.-Y.K., and S.T.).	Ichimaru N, 2001, ATHEROSCLEROSIS, V158, P417, DOI 10.1016/S0021-9150(01)00438-5; [Anonymous], 2009, AM J TRANSPLANT S3, V9, pS1; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; KUSTER GM, 1994, TRANSPLANTATION, V57, P1479, DOI 10.1097/00007890-199405270-00014; Kaplan B, 2014, TRANSPLANT REV-ORLAN, V28, P126, DOI 10.1016/j.trre.2014.03.002; Vanrenterghem Y, 2000, TRANSPLANTATION, V70, P1352, DOI 10.1097/00007890-200011150-00015; Yoichi Ito RK, 2011, LIPID ABNORMALITY KI, P30	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					672	674		10.1016/j.transproceed.2014.12.029		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900022		
J	Soyama, A; Takatsuki, M; Hidaka, M; Adachi, T; Kitasato, A; Kinoshita, A; Natsuda, K; Baimakhanov, Z; Kuroki, T; Eguchi, S				Soyama, A.; Takatsuki, M.; Hidaka, M.; Adachi, T.; Kitasato, A.; Kinoshita, A.; Natsuda, K.; Baimakhanov, Z.; Kuroki, T.; Eguchi, S.			Hybrid Procedure in Living Donor Liver Transplantation	TRANSPLANTATION PROCEEDINGS			English	Article							UPPER MIDLINE LAPAROTOMY; HEPATECTOMY; INCISION	Background. We have previously reported a hybrid procedure that uses a combination of laparoscopic mobilization of the liver and subsequent hepatectomy under direct vision in living donor liver transplantation (LDLT). We present the details of this hybrid procedure and the outcomes of the procedure. Methods. Between January 1997 and August 2014, 204 LDLTs were performed at Nagasaki University Hospital. Among them, 67 recent donors underwent hybrid donor hepatectomy. Forty-one donors underwent left hemihepatectomy, 25 underwent right hemihepatectomy, and 1 underwent posterior sectionectomy. First, an 8-cm subxiphoid midline incision was made; laparoscopic mobilization of the liver was then achieved with a hand-assist through the midline incision under the pneumoperitoneum. Thereafter, the incision was extended up to 12 cm for the right lobe and posterior sector graft and 10 cm left lobe graft procurement. Under direct vision, parenchymal transection was performed by means of the liver-hanging maneuver. The hybrid procedure for LDLT recipients was indicated only for selected cases with atrophic liver cirrhosis without a history of upper abdominal surgery, significant retroperitoneal collateral vessels, or hypertrophic change of the liver (n = 29). For total hepatectomy and splenectomy, the midline incision was sufficiently extended. Results. All of the hybrid donor hepatectomies were completed without an extra subcostal incision. No significant differences were observed in the blood loss or length of the operation compared with conventional open procedures. All of the donors have returned to their preoperative activity level, with fewer wound-related complaints compared with those treated with the use of the conventional open procedure. In recipients treated with the hybrid procedure, no clinically relevant drawbacks were observed compared with the recipients treated with a regular Mercedes-Benz-type incision. Conclusions. Our hybrid procedure was safely conducted with the same quality as the conventional open procedure in both LDLT donors and recipients.	[Soyama, A.; Takatsuki, M.; Hidaka, M.; Adachi, T.; Kitasato, A.; Kinoshita, A.; Natsuda, K.; Baimakhanov, Z.; Kuroki, T.; Eguchi, S.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan	Eguchi, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueguchi@nagasaki-u.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Troisi RI, 2013, AM J TRANSPLANT, V13, P2472, DOI 10.1111/ajt.12362; Nagai S, 2012, LIVER TRANSPLANT, V18, P1188, DOI 10.1002/lt.23488; Lee KW, 2011, LIVER TRANSPLANT, V17, P969, DOI 10.1002/lt.22337; Soyama A, 2012, TRANSPL P, V44, P353, DOI 10.1016/j.transproceed.2012.01.050; Eguchi S, 2011, SURGERY, V150, P1002, DOI 10.1016/j.surg.2011.06.021; Koffron AJ, 2006, AM J TRANSPLANT, V6, P2522, DOI 10.1111/j.1600-6143.2006.01498.x; Imamura H, 2013, CLIN TRANSPLANT, V27, pE605, DOI 10.1111/ctr.12226; Soyama A, 2014, SURG ENDOSC, V28, P203, DOI 10.1007/s00464-013-3159-1; Suh SW, 2015, LIVER TRANSPLANT, V21, P72, DOI 10.1002/lt.24033; Takatsuki M, 2011, J HEPATO-BIL-PAN SCI, V18, P170, DOI 10.1007/s00534-010-0322-0	12	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					679	682		10.1016/j.transproceed.2015.02.016		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900024		
J	Yoshizumi, T; Itoh, S; Imai, D; Ikegami, T; Ninomiya, M; Iguchi, T; Harimoto, N; Takeishi, K; Kimura, Y; Uchiyama, H; Soejima, Y; Ikeda, T; Kawanaka, H; Shirabe, K; Maehara, Y				Yoshizumi, T.; Itoh, S.; Imai, D.; Ikegami, T.; Ninomiya, M.; Iguchi, T.; Harimoto, N.; Takeishi, K.; Kimura, Y.; Uchiyama, H.; Soejima, Y.; Ikeda, T.; Kawanaka, H.; Shirabe, K.; Maehara, Y.			Impact of Platelets and Serotonin on Liver Regeneration After Living Donor Hepatectomy	TRANSPLANTATION PROCEEDINGS			English	Article								Background. Several animal models have revealed that platelet-derived serotonin initiates liver regeneration after hepatectomy. However, there are few reports regarding the effects of serotonin in the clinical setting. The aim of this study was to explore the impact of serotonin and platelets in the early phase after healthy living donor hepatectomy. Study Design. Stored samples from 34 living donors who received left lobectomy with caudate lobectomy (LL+C) or right lobectomy (RL) were available in the study. Serum serotonin levels and platelet counts associated with liver regeneration such as whole liver volume and hepatic graft weight (GW) were retrospectively collected from the database and analyzed. Results. The remnant liver volume rate of RL grafts was smaller than that of LL+C grafts (45.4% vs 64.7%; P < .001). The regeneration rate at 7 days after surgery did not differ between the 2 groups (123% vs 122%). The serotonin levels and platelet counts decreased after surgery until postoperative day 3, then increased thereafter. The platelet counts and serotonin levels of LL+C donors were significantly higher than those of RL donors. Conclusions. Our findings suggest that platelets and serotonin play a pivotal role in initiating liver regeneration in the remnant liver.	[Yoshizumi, T.; Itoh, S.; Imai, D.; Ikegami, T.; Ninomiya, M.; Iguchi, T.; Harimoto, N.; Takeishi, K.; Kimura, Y.; Uchiyama, H.; Soejima, Y.; Ikeda, T.; Kawanaka, H.; Shirabe, K.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Yoshizumi, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yosizumi@surg2.med.kyushu-u.ac.jp			Ministry of Education, Science, and Culture [26506013]; Ministry of Health, Labor and Welfare of Japan [26380201]	This study was partly funded by Grant-in-Aid (No 26506013) from the Ministry of Education, Science, and Culture and by Grant-in-Aid for Scientific Research (26380201) from the Ministry of Health, Labor and Welfare of Japan.	George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Starlinger P, 2014, HEPATOLOGY, V60, P257, DOI 10.1002/hep.26950; Gruttadauria S, 2012, LIVER TRANSPLANT, V18, P907, DOI 10.1002/lt.23450; Kayashima H, 2013, TRANSPLANTATION, V95, P353, DOI 10.1097/TP.0b013e31827147d8; Nagasako Y, 2006, LIVER TRANSPLANT, V12, P435, DOI 10.1002/lt.20608; Yoshizumi T, 2014, LIVER TRANSPLANT, V20, P323, DOI 10.1002/lt.23804	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					683	685		10.1016/j.transproceed.2014.11.050		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900025		
J	Kugiyama, T; Hidaka, M; Soyama, A; Takatsuki, M; Natsuda, K; Kinoshita, A; Carpenter, I; Adachi, T; Kitasato, A; Kuroki, T; Eguchi, S				Kugiyama, T.; Hidaka, M.; Soyama, A.; Takatsuki, M.; Natsuda, K.; Kinoshita, A.; Carpenter, I.; Adachi, T.; Kitasato, A.; Kuroki, T.; Eguchi, S.			E-Cadherin Expression in Hepatocellular Carcinoma Treated With Previous Local Treatment in Patients Undergoing Living Donor Liver Transplantation	TRANSPLANTATION PROCEEDINGS			English	Article								Background. The aim of this study was to evaluate the influence of previous local treatment on the E-cadherin (E-cad) expression in cases of hepatocellular carcinoma (HCC) after living donor liver transplantation (LDLT) within the Milan criteria. Methods. Seventy-four of 204 patients with HCC underwent LDLT between 1997 and 2014. Previous local treatment for HCC was performed for 121 lesions in 47 patients (47/74, 63.5%). Histological and immunohistochemical E-cad expression analyses were conducted on the basis of the whole-liver histological examination technique. Results. The interval to LDLT after the initial and last treatments was 24 months (2-206) and 10.5 months (1-58), respectively. Preoperative imaging showed necrosis in 92 (92/121, 76.0%) lesions caused by the effects of local treatment, whereas the histological examinations revealed viable HCC cells in 22 (22/92, 23.9%) lesions, demonstrating well or moderate differentiation without vascular invasion. Immunohistochemically, the expression of E-cad was maintained in 17 viable (17/22, 77.3%) lesions. There were no signs of malignant transformation or sarcomatous changes in the HCCs treated with previous therapy. The recipients who maintained an E-cad expression in the lesion with local treatment showed no recurrence or distant metastasis after LDLT. Conclusions. HCC cells remained in approximately 20% of the evaluated lesions, even those exhibiting necrosis on imaging of the explanted cirrhotic liver. However, the expression of E-cad was maintained in most of these lesions. Furthermore, there were no significant differences in the rate of recurrence after LDLT between the patients who did and those did not receive previous local treatment for HCC.	[Kugiyama, T.; Hidaka, M.; Soyama, A.; Takatsuki, M.; Natsuda, K.; Kinoshita, A.; Carpenter, I.; Adachi, T.; Kitasato, A.; Kuroki, T.; Eguchi, S.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, Nagasaki 8528501, Japan	Eguchi, S (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	sueguchi@nagasaki-u.ac.jp					Soyama A, 2008, HEPATO-GASTROENTEROL, V55, P1390; Eguchi S, 2009, J GASTROENTEROL, V44, P624, DOI 10.1007/s00535-009-0043-9; Hidaka M, 2009, HEPATOL RES, V39, P143, DOI 10.1111/j.1872-034X.2008.00443.x; Matsumura T, 2001, CLIN CANCER RES, V7, P594; Tajima H, 2010, ONCOL LETT, V1, P91, DOI 10.3892/ol_00000016	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					700	702		10.1016/j.transproceed.2015.02.017		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900028		
J	Harimoto, N; Yoshida, Y; Kurihara, T; Takeishi, K; Itoh, S; Harada, N; Tsujita, E; Yamashita, YI; Uchiyama, H; Soejima, Y; Ikegami, T; Yoshizumi, T; Kawanaka, H; Ikeda, T; Shirab'e, K; Saeki, H; Oki, E; Kimura, Y; Maehara, Y				Harimoto, N.; Yoshida, Y.; Kurihara, T.; Takeishi, K.; Itoh, S.; Harada, N.; Tsujita, E.; Yamashita, Y. -I.; Uchiyama, H.; Soejima, Y.; Ikegami, T.; Yoshizumi, T.; Kawanaka, H.; Ikeda, T.; Shirab'e, K.; Saeki, H.; Oki, E.; Kimura, Y.; Maehara, Y.			Prognostic Impact of Des-gamma-carboxyl Prothrombin in Living-Donor Liver Transplantation for Recurrent Hepatocellular Carcinoma	TRANSPLANTATION PROCEEDINGS			English	Article							TUMOR SIZE	Background. Although the Milan criteria are widely accepted for liver transplantation (LT) in patients for hepatocellular carcinoma (HCC), they have not been fully evaluated for salvage LT in patients with recurrent HCC. We have previously reported outcomes of living-donor LT (LDLT) for HCC and identified 2 risk factors affecting recurrence-free survival (RF'S): tumor size >5 cm and des-gamma-carboxyl prothrombin (DCP) concentration >300 mAU/mL (Kyushu University criteria). This study was designed to clarify risk factors for tumor recurrence after LDLT in patients with recurrent HCC. Methods. Outcomes in 114 patients who underwent LDLT for recurrent HCC were analyzed retrospectively. RFS rates after LDLT were calculated, and risk factors for tumor recurrence were identified. Results. The 1-, 3-, and 5-year RFS rates after LDLT were 90.6%, 80.4%, and 78.8%, respectively. Univariate analysis showed that tumor recurrence was associated with alpha-fetoprotein concentration >= 300 ng/mL, DCP concentration >300 mAU/mL, tumor number >= 4, tumor size >= 5 cm, transarterial chemotherapy before LDLT, duration of last treatment of HCC to LDLT <3 months, bilobar distribution, exceeding Milan criteria, exceeding Kyushu University criteria, poor differentiation, and histologic vascular invasion. Multivariate analysis showed that DCP >= 300 mAU/mL (P = .03) and duration from last treatment to LDLT <3 months (P = .01) were independent predictors of RFS. Conclusions. DCP concentration and time between last treatment and LDLT are prognostic of RFS in patients undergoing LDLT for HCC.	[Harimoto, N.; Yoshida, Y.; Kurihara, T.; Takeishi, K.; Itoh, S.; Harada, N.; Tsujita, E.; Yamashita, Y. -I.; Uchiyama, H.; Soejima, Y.; Ikegami, T.; Yoshizumi, T.; Kawanaka, H.; Ikeda, T.; Shirab'e, K.; Saeki, H.; Oki, E.; Kimura, Y.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Harimoto, N (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	harimoto@surg2.med.kyushu-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan [26380201]	Grant-in-Aid for Scientific Research (26380201) from the Ministry of Health, Labor, and Welfare of Japan.	Kaido T, 2013, SURGERY, V154, P1053, DOI 10.1016/j.surg.2013.04.056; Shirabe K, 2007, J SURG ONCOL, V95, P235, DOI 10.1002/jso.20655; Taketomi A, 2009, TRANSPLANTATION, V87, P531, DOI 10.1097/TP.0b013e3181943bee; Yoshizumi T, 2013, HEPATOL RES, V43, P709, DOI 10.1111/hepr.12016; Yonemura Y, 2005, LIVER TRANSPLANT, V11, P1556, DOI 10.1002/lt.20537; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Yoshizumi T, 2011, TRANSPLANTATION, V91, pE61, DOI 10.1097/TP.0b013e318210de92	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					703	704		10.1016/j.transproceed.2014.09.178		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900029		
J	Ikegami, T; Yoshizumi, T; Soejima, Y; Harimoto, N; Itoh, S; Takeishi, K; Uchiyama, H; Kawanaka, H; Yamashita, YI; Tsujita, E; Harada, N; Oki, E; Saeki, H; Kimura, Y; Shirabe, K; Maehara, Y				Ikegami, T.; Yoshizumi, T.; Soejima, Y.; Harimoto, N.; Itoh, S.; Takeishi, K.; Uchiyama, H.; Kawanaka, H.; Yamashita, Y. -I.; Tsujita, E.; Harada, N.; Oki, E.; Saeki, H.; Kimura, Y.; Shirabe, K.; Maehara, Y.			Triple Therapy Using Direct-Acting Agents for Recurrent Hepatitis C After Liver Transplantation: A Single-Center Experience	TRANSPLANTATION PROCEEDINGS			English	Article							HCV; PEGINTERFERON; INTERFERON; RIBAVIRIN; JAPAN	Background. Hepatitis C viral graft reinfection is almost a universal event after liver transplantation with consequent disease progression. Methods. We applied triple therapy (n = 21) with the use of telaprevir (TVR; n = 12) or simeprevir (SVR; n = 9). Results. TVR was given at the dose 1,500 mg daily (n = 11) with reduced dose of cyclosporine at 25% to 50%, and SVR was given at the dose 100 mg daily with unadjusted cyclosporine, followed by 12 weeks of dual therapy. The early viral response was achieved in 91.7% (n = 11), end of treatment response rate was 91.7% (n = 11), and sustained viral response rate was 83.3% (n = 10) in the TVR group, and respective rates were 88.9% (n = 8), 77.8% (n = 7), and 77.8% (n = 7) in the SVR group. Although granulocyte colony-stimulating factor was not given in the patients with triple therapy, blood transfusion was performed in 7 cases (58.3%) in the TVR group and 1 case (11.1%) in the SVR group. Interferon-mediated graft dysfunction was observed in 4 cases (33.3%) in the TVR group and 3 cases (33.3%) in the SVR group, respectively. The cumulative viral clearance rates in triple (n = 21) and dual (n = 105) therapy were 95.0% and 18.1% at 12 weeks, and 95.0% and 40.0%, respectively, at 24 weeks (P < .01). Conclusions. Although careful monitoring for possible adverse events is required during treatment, triple therapy with the use of direct-acting agents are very effective in treating hepatitis C after liver transplantation.	[Ikegami, T.; Yoshizumi, T.; Soejima, Y.; Harimoto, N.; Itoh, S.; Takeishi, K.; Uchiyama, H.; Kawanaka, H.; Yamashita, Y. -I.; Tsujita, E.; Harada, N.; Oki, E.; Saeki, H.; Kimura, Y.; Shirabe, K.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan	Ikegami, T (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan.	tikesurg@surg2.med.kyushu-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan [26380201]	Grant-in-Aid for Scientific Research (26380201) from the Ministry of Health, Labor, and Welfare of Japan.	Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Levitsky J, 2012, GASTROENTEROLOGY, V142, P1132, DOI 10.1053/j.gastro.2012.01.030; Coilly A, 2014, J HEPATOL, V60, P78, DOI 10.1016/j.jhep.2013.08.018; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Ikegami T, 2009, TRANSPL P, V41, P4246, DOI 10.1016/j.transproceed.2009.08.070	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					730	732		10.1016/j.transproceed.2014.10.058		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900035		
J	Kaku, K; Kitada, H; Noguchi, H; Kurihara, K; Kawanami, S; Nakamura, U; Tanaka, M				Kaku, K.; Kitada, H.; Noguchi, H.; Kurihara, K.; Kawanami, S.; Nakamura, U.; Tanaka, M.			Living Donor Kidney Transplantation Preceding Pancreas Transplantation Reduces Mortality in Type 1 Diabetics With End-stage Renal Disease	TRANSPLANTATION PROCEEDINGS			English	Article							SURVIVAL; MELLITUS; IMPACT	Background. Simultaneous pancreas-kidney transplantation (SPK) is a definitive treatment for type 1 diabetics with end-stage renal disease (ESRD). Because of the shortage of deceased donors in Japan, the mortality rate during the waiting period is high. We evaluated mortality risk in patients with type 1 diabetes waiting for SPK, and the benefit of living-donor kidney transplantation (LDK) preceding pancreas transplantation, which may reduce mortality in patients awaiting SPK. Methods. This retrospective study included 71 patients with type 1 diabetes. Twenty-six patients underwent SPK, 15 underwent LDK, and 30 were waiting for SPK. Their cumulative patient and graft survival rates were retrospectively evaluated. Risk factors contributing to mortality in patients with type 1 diabetes awaiting SPK were evaluated with the use of a Cox proportional hazards model. Results. The 5-year cumulative patient survival rates in the SPK and LDK groups were 100% and 93.3%, respectively (P = .19), and 5-year kidney graft survival rates were 95.7% and 100% (P = .46), respectively. The cumulative survival rate in patients awaiting SPK was 77.7% at 5 years after registration. Duration of dialysis was the only factor significantly associated with patient and graft survivals according to both univariate and multivariate analyses. Conclusions. Patient and graft survival rates were similar in the SPK and LDK groups, but the survival rate of patients awaiting SPK decreased over time. Duration of dialysis was an independent risk factor for patient and graft survival. LDK preceding pancreas transplantation may be an effective therapeutic option for patients with type 1 diabetes and ESRD.	[Kaku, K.; Kitada, H.; Noguchi, H.; Kurihara, K.; Kawanami, S.; Tanaka, M.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka 8128582, Japan; [Nakamura, U.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan	Kaku, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	k-kaku@surg1.med.kyushu-u.ac.jp					Stratta RJ, 2014, TRANSPL P, V46, P1924, DOI 10.1016/j.transproceed.2014.05.079; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Ojo AO, 2001, TRANSPLANTATION, V71, P82, DOI 10.1097/00007890-200101150-00014; Larsen JL, 2004, DIABETES CARE, V27, P1706, DOI 10.2337/diacare.27.7.1706; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Sureshkumar KK, 2006, CLIN TRANSPLANT, V20, P19, DOI 10.1111/j.1399-0012.2005.00433.x; Reddy KS, 2003, AM J KIDNEY DIS, V41, P464, DOI 10.1053/ajkd.2003.50057; Meier-Kriesche HU, 2000, KIDNEY INT, V58, P1311, DOI 10.1046/j.1523-1755.2000.00287.x; Kleinclauss F, 2009, CLIN TRANSPLANT, V23, P437, DOI 10.1111/j.1399-0012.2009.00998.x; Gruessner RWG, 2004, AM J TRANSPLANT, V4, P2018, DOI 10.1111/j.1600-6143.2004.00667.x; Navarro X, 1997, ANN NEUROL, V42, P727, DOI 10.1002/ana.410420509; Young BY, 2009, CLIN J AM SOC NEPHRO, V4, P845, DOI 10.2215/CJN.02250508; Becker BN, 2000, KIDNEY INT, V57, P2129, DOI 10.1046/j.1523-1755.2000.00064.x; Chau K, 2014, NEPHROLOGY, V19, P275, DOI 10.1111/nep.12212; Dinckan A, 2012, ANN TRANSPL, V17, P14; Foley R N, 1998, J Am Soc Nephrol, V9, pS16; Gruessner Angelika C, 2011, Rev Diabet Stud, V8, P6, DOI 10.1900/RDS.2011.8.6; HELD PJ, 1994, DEV NEPHROL, V35, P13; Huang E, 2011, TRANSPLANTATION, V92, P1115, DOI 10.1097/TP.0b013e31823328a6; Ishida-Oku M, 2010, DIABETOLOGIA, V59, P210; Kaufman DB, 2009, CLIN TRANSPLANT, V23, P435, DOI 10.1111/j.1399-0012.2009.01032.x; Kobayashi T, 2014, TRANSPL P, V46, P948, DOI 10.1016/j.transproceed.2013.11.058; Larson TS, 2004, TRANSPLANTATION, V77, P838, DOI 10.1097/01.TP.0000114611.73689.3B; Raqqi P, 2002, J AM COLL CARDIOL, V39, P695; Sampaio MS, 2010, CLIN TRANSPLANT, V24, P812, DOI 10.1111/j.1399-0012.2009.01195.x	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					733	737		10.1016/j.transproceed.2014.12.048		5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900036		
J	Lee, S; Takahashi, Y; Lee, KM; Mizuno, M; Nemeno, JG; Takebe, T; Lee, JI				Lee, S.; Takahashi, Y.; Lee, K. M.; Mizuno, M.; Nemeno, J. G.; Takebe, T.; Lee, J. I.			Viability and Functional Assessment of Murine Pancreatic Islets After Transportation Between Korea and Japan	TRANSPLANTATION PROCEEDINGS			English	Article							FREE IMMUNOSUPPRESSIVE REGIMEN; TRANSPLANTATION; MAINTENANCE; SHIPMENT; GRAGIL	Background. Organ donor scarcity remains a restricting factor for pancreatic islet transplantation. To date, limited information is available on the impact of long-distance transportation on transplantable pancreatic islets. The objective of this study was to assess the effects of transportation on the viability and function of murine pancreatic islet cells. Methods. The isolated murine pancreatic islets were transported from Japan to Korea with the use of commercial modes of transportation: subway and commercial airplane. After transportation, the islets were assessed by performing a viability assay and by evaluating the islets' insulin secretion in response to glucose stimulation. A comparative study was performed for evaluating the insulin secretory responses of transported and control islets (not transported). Results. There was no evidence of contamination in the transported pancreatic islets. No significant differences were observed in the viability and functionality of the transported and control islet cells. Conclusions. These findings show the feasibility of pancreatic islet transportation from Japan to Korea. Our data could be used not only for the inter-Asian but also for global advancement of animal and human islet transportation methods and transplantation research.	[Lee, S.; Lee, K. M.; Nemeno, J. G.; Lee, J. I.] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Regenerat Med Lab,Ctr Stem Cell Res, Seoul 143701, South Korea; [Lee, J. I.] Konkuk Univ, Coll Vet Med, Dept Vet Med, Seoul 143701, South Korea; [Takahashi, Y.; Mizuno, M.; Takebe, T.] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan; [Takebe, T.] Yokohama City Univ, Project Leader Adv Med Res Ctr, Yokohama, Kanagawa 232, Japan; [Takebe, T.] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Lee, JI (reprint author), Konkuk Univ, 120 Neungdong Ro, Seoul 143701, South Korea.	jeongik@konkuk.ac.kr			Konkuk University	This paper was supported by Konkuk University in 2014.	Ichii H, 2009, J HEPATO-BILIARY-PAN, V16, P101, DOI 10.1007/s00534-008-0021-2; Guignard AP, 2004, DIABETES CARE, V27, P895, DOI 10.2337/diacare.27.4.895; Ichii H, 2007, AM J TRANSPLANT, V7, P1010, DOI 10.1111/j.1600-6143.2006.01687.x; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Arata T, 2004, ARTIF ORGANS, V28, P529, DOI 10.1111/j.1525-1594.2004.07296.x; Corominola H, 1998, CRYOBIOLOGY, V37, P110, DOI 10.1006/cryo.1998.2107; D'Aleo V, 2010, TRANSPL P, V42, P2250, DOI 10.1016/j.transproceed.2010.05.132; Ikemoto T, 2010, CELL TRANSPLANT, V19, P731, DOI 10.3727/096368910X508834; Kaddis JS, 2013, CELL TRANSPLANT, V22, P1101, DOI 10.3727/096368912X653219; Kessler L, 2004, TRANSPLANTATION, V77, P1301, DOI 10.1097/01.TP.0000122223.79315.5D; Kim TS, 2013, TRANSPL P, V45, P3097, DOI 10.1016/j.transproceed.2013.08.083; Kim YS, 2011, PANCREAS, V40, P855, DOI 10.1097/MPA.0b013e318214832d; Li N, 2014, BIOTECHNOL APPL BIOC, DOI [10.1002/bab.1295, DOI 10.1002/BAB.1295[EPUBAHEADOFPRINT]]; Matsumoto S, 2002, CELL TRANSPLANT, V11, P769; Oh BJ, 2013, AM J TRANSPLANT, V13, P1429, DOI 10.1111/ajt.12222; Ricordi C, 2003, TRANSPLANTATION, V75, P1524, DOI 10.1097/01.TP.0000058813.95063.7A; Rozak PR, 2008, TRANSPL P, V40, P407, DOI 10.1016/j.transproceed.2008.01.060; Tan JM, 2008, DIABETES, V57, P2666, DOI 10.2337/db08-0358; Yang Z, 2004, TRANSPLANT P, V36, P1532, DOI 10.1016/j.transproceed.2004.04.075	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					738	741		10.1016/j.transproceed.2014.12.031		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900037		
J	Tomimaru, Y; Ito, T; Marubashi, S; Kawamoto, K; Tomokuni, A; Asaoka, T; Wada, H; Eguchi, H; Mori, M; Doki, Y; Nagano, H				Tomimaru, Y.; Ito, T.; Marubashi, S.; Kawamoto, K.; Tomokuni, A.; Asaoka, T.; Wada, H.; Eguchi, H.; Mori, M.; Doki, Y.; Nagano, H.			De Novo Malignancy After Pancreas Transplantation in Japan	TRANSPLANTATION PROCEEDINGS			English	Article							KIDNEY-TRANSPLANTATION; CANCER; RISK	Background. Long-term immunosuppression is associated with an increased risk of cancer. Especially, the immunosuppression in pancreas transplantation is more intensive than that in other organ transplantation because of its strong immunogenicity. Therefore, it suggests that the risk of post-transplant de novo malignancy might increase in pancreas transplantation. However, there have been few studies of de novo malignancy after pancreas transplantation. The aim of this study was to analyze the incidence of de novo malignancy after pancreas transplantation in Japan. Methods. Post-transplant patients with de novo malignancy were surveyed and characterized in Japan. Results. Among 107 cases receiving pancreas transplantation in Japan between 2001 and 2010, de novo malignancy developed in 9 cases (8.4%): post-transplant lymphoproliferative disorders in 6 cases, colon cancer in 1 case, renal cancer in 1 case, and brain tumor in 1 case. Conclusions. We clarified the incidence of de novo malignancy after pancreas transplantation in Japan.	[Tomimaru, Y.; Ito, T.; Marubashi, S.; Kawamoto, K.; Tomokuni, A.; Asaoka, T.; Wada, H.; Eguchi, H.; Mori, M.; Doki, Y.; Nagano, H.] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan; [Ito, T.] Osaka Univ, Grad Sch Med, Dept Complementary & Alternat Med, Suita, Osaka 5650871, Japan; [Ito, T.; Marubashi, S.] Japan Soc Pancreas & Islet Transplantat, Japan Registry Pancreas Transplantat, Osaka, Japan	Nagano, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	hnagano@gesurg.med.osaka-u.ac.jp					Benlloch S, 2004, AM J TRANSPLANT, V4, P596, DOI 10.1111/j.1600-6143.2004.00380.x; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Catena F, 2001, TRANSPLANT P, V33, P1858, DOI 10.1016/S0041-1345(00)02724-X; Drognitz O, 2004, TRANSPLANTATION, V78, P1802, DOI 10.1097/01.TP.0000147789.06043.A6; Girman P, 2011, TRANSPL P, V43, P3288, DOI 10.1016/j.transproceed.2011.09.011; Hoshida Y, 1997, INT J CANCER, V71, P517, DOI 10.1002/(SICI)1097-0215(19970516)71:4<517::AID-IJC3>3.0.CO;2-X; Martinenghi S, 1997, DIABETES CARE, V20, P272, DOI 10.2337/diacare.20.3.272; Muir CS, 1976, IARC SCI PUBL, V13, P279; Paraskevas S, 2004, POSTTRANSPLANT MALIG; Parkin DM, 1992, IARC SCI PUBL, V120, P45	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					742	745		10.1016/j.transproceed.2014.11.052		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900038		
J	Hoshikawa, Y; Okada, Y; Ashikari, J; Matsuda, Y; Niikawa, H; Noda, M; Sado, T; Watanabe, T; Notsuda, H; Chen, F; Inoue, M; Miyoshi, K; Shiraishi, T; Miyazaki, T; Chida, M; Fukushima, N; Kondo, T				Hoshikawa, Y.; Okada, Y.; Ashikari, J.; Matsuda, Y.; Niikawa, H.; Noda, M.; Sado, T.; Watanabe, T.; Notsuda, H.; Chen, F.; Inoue, M.; Miyoshi, K.; Shiraishi, T.; Miyazaki, T.; Chida, M.; Fukushima, N.; Kondo, T.			Medical Consultant System for Improving Lung Transplantation Opportunities and Outcomes in Japan	TRANSPLANTATION PROCEEDINGS			English	Article							DONOR-MANAGEMENT	Because the shortage of donor organs is especially serious in Japan, since 2002 a unique partnership between transplant consultant physicians and local physicians has been developed to maximize the organ utilization rate. Since 2011, more than 25 lung consultant physicians have been registered to specifically assess donor lungs and provide advice on intensive respiratory care to donors. In this study, we retrospectively reviewed the efficacy of this system for lung transplantation opportunities and outcomes. One hundred eighty-seven brain-dead lung donor candidates were chronologically divided into 3 phases: I (May 1998-November 2006) and II (December 2006-January 2011), before and after medical consultants requested that local physicians administer aggressive bronchial suctioning using bronchoscopy, respectively; and phase III (February 2011-January 2013), after the emergence of lung consultants. The lung utilization rate, Pao(2)/FIo(2) ratio at the first and second brain death examinations and at the tertiary assessment before recovery, and graft survival were analyzed. The lung utilization rate was significantly higher in phases II and III than in phase I. In phases I and II, the Pao(2)/FIo(2) ratio at the tertiary assessment was significantly lower than that at the first or the second brain death examination, whereas it did not worsen with time in phase III. Graft survival was significantly better in phases II and III than in phase I. Graft death due to primary graft dysfunction was significantly more frequent in phase I than in phases II and III. In conclusion, this system is effective in improving lung transplantation opportunities and outcomes.	[Hoshikawa, Y.; Okada, Y.; Matsuda, Y.; Niikawa, H.; Noda, M.; Watanabe, T.; Notsuda, H.; Kondo, T.] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Sendai, Miyagi 9808575, Japan; [Ashikari, J.] Japan Organ Transplant Network, Tokyo, Japan; [Sado, T.; Chida, M.] Dokkyo Med Univ, Dept Thorac Surg, Mibu, Tochigi, Japan; [Chen, F.] Kyoto Univ, Dept Thorac Surg, Kyoto, Japan; [Inoue, M.] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan; [Miyoshi, K.] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Thorac Surg, Okayama, Japan; [Shiraishi, T.] Fukuoka Univ, Sch Med, Dept Thorac Surg, Fukuoka 81401, Japan; [Miyazaki, T.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Translat Med Sci, Div Surg Oncol, Nagasaki 852, Japan; [Fukushima, N.] Grad Sch Med, Dept Therapeut End Stage Organ Dysfunct, Suita, Osaka, Japan	Hoshikawa, Y (reprint author), Tohoku Univ, Aoba Ku, 4-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	hoshikawa@idac.tohoku.ac.jp					[Anonymous], 2012 ANN DAT REP ADR; [Anonymous], REG REP; Angel LF, 2006, AM J RESP CRIT CARE, V174, P710, DOI 10.1164/rccm.200603-432OC; [Anonymous], DON TRANSPL DAT; Orens JB, 2003, J HEART LUNG TRANSPL, V22, P1183, DOI 10.1016/S1053-2498(03)00096-2; Cummings J, 1995, J TRANSPLANT COORDIN, V5, P103; Egawa H, 2012, AM J TRANSPLANT, V12, P523, DOI 10.1111/j.1600-6143.2011.03822.x; European Commission, 2013, EUROTRANSPLANT DONAT, P41; Fukushima N, 2009, TRANSPL P, V41, P273, DOI 10.1016/j.transproceed.2008.10.081; Fukushima N., 2011, JAPANESE J TRANSPLAN, V46, P251; Hoshikawa Y, 2014, AM J RESP CRIT CARE, V189, pA5160; Lloyd-Jones H, 1996, AORN J, V63, P416, DOI 10.1016/S0001-2092(06)63229-8; Parry A, 1999, J HEART LUNG TRANSPL, V18, P121, DOI 10.1016/S1053-2498(98)00026-6; WHEELDON DR, 1995, J HEART LUNG TRANSPL, V14, P734	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					746	750		10.1016/j.transproceed.2014.12.041		5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900039		
J	Takeishi, K; Ikegami, T; Yoshizumi, T; Itoh, S; Harimoto, N; Harada, N; Tsujita, E; Kimura, Y; Yamashita, Y; Saeki, K; Oki, E; Shirabe, K; Maehara, Y				Takeishi, K.; Ikegami, T.; Yoshizumi, T.; Itoh, S.; Harimoto, N.; Harada, N.; Tsujita, E.; Kimura, Y.; Yamashita, Y.; Saeki, K.; Oki, E.; Shirabe, K.; Maehara, Y.			Thymoglobulin for Steroid-Resistant Immune-Mediated Graft Dysfunction During Simeprevir-Based Antiviral Treatment for Post-Transplantation Hepatitis C: Case Report	TRANSPLANTATION PROCEEDINGS			English	Article							LIVER-TRANSPLANTATION; PEGYLATED INTERFERON; THERAPY	Introduction. Immune-mediated graft dysfunction (IGD), a recently established disease entity with unfavourable outcome, is an antigraft immune reaction during interferon-based antiviral treatment for hepatitis C virus (HCV) infection after liver transplantation (LT). We report a case having steroid-resistant acute cellular rejection (ACR) type IGD, which was successfully treated using thymoglobulin. Case Report. A 56-year-old woman with recurrent HCV after LT was commenced on antiviral treatment including simeprevir, pegylated-interferon (IFN) 2a, and ribavirin. A negative serum HCV-RNA was confirmed after 4 weeks. After 12 weeks of therapy, severe liver dysfunction developed, despite a constantly negative HCV-RNA. Liver biopsy revealed portal and periportal inflammatory infiltrates including numerous eosinophils, lymphocytes, and bile duct damages, indicating ACR. IFN therapy was ceased, and she was treated with steroid pulse treatment, followed by high-level immunosuppression maintenance. However, ACR was irremediable. Thereafter she was treated with thymoglobulin (75 mg/d for 5 days). Her serum alanine aminotransaminase and total bilirubin levels decreased immediately, and her liver biopsy specimen showed no activity. During these periods of the treatment, the HCV-RNA became positive and the liver enzyme elevated, but other liver function tests still remained within normal range. Conclusion. Thymoglobulin could be the best choice in steroid-resistant IGD during antiviral treatment for post-transplantation recurrent hepatitis C.	[Takeishi, K.; Ikegami, T.; Yoshizumi, T.; Itoh, S.; Harimoto, N.; Harada, N.; Tsujita, E.; Kimura, Y.; Yamashita, Y.; Saeki, K.; Oki, E.; Shirabe, K.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan	Takeishi, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ktake@surg2.med.kyushu-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [26380201]	This work was supported by a Grant-in-Aid for Scientific Research (26380201) from the Ministry of Health, Labor and Welfare of Japan.	Levitsky J, 2012, GASTROENTEROLOGY, V142, P1132, DOI 10.1053/j.gastro.2012.01.030; Ghanekar A, 2012, TRANSPL P, V44, P1351, DOI 10.1016/j.transproceed.2012.01.117; Ikegami T, 2014, J HEPATOL, V60, P894, DOI 10.1016/j.jhep.2013.10.037; Takeishi K, 2011, SURG TODAY, V41, P1016, DOI 10.1007/s00595-010-4392-z	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					794	795		10.1016/j.transproceed.2014.11.056		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900049		
J	Takano, K; Shimazu, M; Chiba, N; Iwamoto, H; Nakamura, Y; Konno, O; Sano, T; Fuji, T; Serizawa, H; Kawachi, S				Takano, K.; Shimazu, M.; Chiba, N.; Iwamoto, H.; Nakamura, Y.; Konno, O.; Sano, T.; Fuji, T.; Serizawa, H.; Kawachi, S.			Adult Living-Donor Liver Transplantation for a Recipient With a High Preoperative 1,3-Beta-D-Glucan Level and Positive Test Result for Aspergillus Antigen	TRANSPLANTATION PROCEEDINGS			English	Article							INVASIVE ASPERGILLOSIS; GALACTOMANNAN; REACTIVITY; DIAGNOSIS	The patient was a 45-year-old man with underlying alcoholic liver cirrhosis. Two years prior, he was repeatedly hospitalized for liver failure symptoms and requested a living-donor liver transplantation (LDLT) because of end-stage cirrhosis. A pretransplantation blood test revealed a high 1,3-beta-D-glucan (BDG) value of 102.0 pg/mL (reference value <20.0 pg/mL) and a high blood Aspergillus antigen (AsAg) value of 1.6 cutoff index (COI; reference value <0.5 COI). Contrast-enhanced thoracoabdominalpelvic computed tomography (CT) and cranial magnetic resonance imaging revealed no fungal infection. However, latent fungal infection could not be ruled out, hence preoperative antifungal agent treatment was administered. BDG and AsAg levels showed a decreasing trend after treatment initiation. However, normalization did not occur; the BDG and AsAg levels were 25.8 pg/mL and 1.0 COI, respectively. Although the possibility of latent fungal infection was judged low, we prophylactically administered antifungal agents after LDLT. The BDG level consistently increased at 35-39 pg/mL until postoperative day 5 but subsequently normalized. The AsAg level was higher than the limit of detection at 5.0 COI on postoperative day 3 but normalized to 0.2 COI on postoperative day 5 and did not subsequently increase. The postoperative course was uneventful despite bacterial pneumonia and the patient was discharged on postoperative day 35. A histopathologic examination (Grocott methenamine silver staining) and a fungal polymerase chain reaction assay were performed for the resected liver, but the results of both were negative. At 9 postoperative months, the patient was making ambulatory follow-up visits. Currently, the BDG and AsAg values remain normal and clinical progress is favorable. We found no reports of LDLT for a recipient with a high preoperative BDG level and positive test result for AsAg. Thus, we report on such a case with a discussion of the literature on the causes of high preoperative BDG and AsAg values.	[Takano, K.; Shimazu, M.; Chiba, N.; Iwamoto, H.; Nakamura, Y.; Konno, O.; Sano, T.; Kawachi, S.] Tokyo Med Univ, Dept Digest & Transplant Surg, Hachioji Med Ctr, Tokyo 1930998, Japan; [Fuji, T.] Tokyo Med Univ, Dept Infect Dis, Hachioji Med Ctr, Tokyo 1930998, Japan; [Serizawa, H.] Tokyo Med Univ, Dept Diagnost Pathol, Hachioji Med Ctr, Tokyo 1930998, Japan	Takano, K (reprint author), Tokyo Med Univ, Dept Digest & Transplant Surg, Hachioji Med Ctr, 1163 Tatemachi, Tokyo 1930998, Japan.	kiminoriman526@yahoo.co.jp					OBAYASHI T, 1995, LANCET, V345, P17, DOI 10.1016/S0140-6736(95)91152-9; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Fortun J, 2009, TRANSPLANTATION, V87, P256, DOI 10.1097/TP.0b013e31819288d5; Nakao A, 1997, HEPATO-GASTROENTEROL, V44, P1413; Pagano L, 2001, HAEMATOLOGICA, V86, P862; Usami M, 2002, TRANSFUSION, V42, P1189, DOI 10.1046/j.1537-2995.2002.00162.x; Hori A, 2002, J HOSP INFECT, V50, P175, DOI 10.1053/jhin.2001.1170; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Gangneux JP, 2002, LANCET, V359, P1251, DOI 10.1016/S0140-6736(02)08238-7; Mennink-Kersten MAS, 2005, J CLIN MICROBIOL, V43, P3925, DOI 10.1128/JCM.43.8.3925-3931.2005; Mennink-Kersten MASH, 2004, LANCET, V363, P325, DOI 10.1016/S0140-6736(03)15393-7; Presterl E, 2009, INT J INFECT DIS, V13, P707, DOI 10.1016/j.ijid.2008.10.013; Singh N, 2000, CLIN INFECT DIS, V31, P545, DOI 10.1086/313943; Spriet I, 2011, MYCOSES, V54, pE352, DOI 10.1111/j.1439-0507.2010.01922.x; Sulahian A, 2003, NEW ENGL J MED, V349, P2366, DOI 10.1056/NEJM200312113492424	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					799	803		10.1016/j.transproceed.2015.01.014		5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900050		
J	Kitajima, T; Fujimoto, Y; Hatano, E; Nishida, H; Ogawa, K; Mori, A; Okajima, H; Kaido, T; Nakamura, A; Nagamatsu, H; Uemoto, S				Kitajima, T.; Fujimoto, Y.; Hatano, E.; Nishida, H.; Ogawa, K.; Mori, A.; Okajima, H.; Kaido, T.; Nakamura, A.; Nagamatsu, H.; Uemoto, S.			Salvage Living-Donor Liver Transplantation for Liver Failure Following Definitive Radiation Therapy for Recurrent Hepatocellular Carcinoma: A Case Report	TRANSPLANTATION PROCEEDINGS			English	Article							LONG-TERM OUTCOMES; RESECTION; RADIOTHERAPY; BRIDGE; DISEASE; CANCER	A 57-year-old man with a history of hepatitis B virus infection was referred to our hospital for living-donor liver transplantation (LDLT). Five years earlier, right lobectomy had been performed for solitary hepatocellular carcinoma (HCC) with bile duct tumor thrombus in segments 5 and 6 in the liver. Two years later, transarterial chemoembolization and radiofrequency ablation were performed for recurrent HCC. Two years after those local therapies, another recurrent HCC was treated with transhepatic arterial infusion chemotherapy with cisplatin and conventional radiation therapy (RT) with 60 Gy in 20 fractions, because the tumor was contiguous to the trunk of the portal vein. After the completion of RT, symptoms due to liver failure and severe infection caused by multiple liver abscesses developed despite the administration of antibiotics and percutaneous transhepatic cholangiodrainage. Therefore, LDLT was performed with the use of a right lobe graft donated by his wife. Vascular anastomosis was successfully performed with the use of normal procedures. The patient recovered uneventfully, and has since been doing well for 34 months, with no evidence of vascular complications. However, the degree of injury to the anastomotic vessels caused by definitive RT before LDLT remains unclear, whereas the safety and efficacy of some forms of RT as a bridge to deceased-donor LT have been reported. Salvage LDLT is effective for patients with liver failure after multidisciplinary treatment including radiation, while carefully taking radiation-induced vessel injury as a potential late complication into consideration, especially in LDLT cases.	[Kitajima, T.; Fujimoto, Y.; Hatano, E.; Nishida, H.; Ogawa, K.; Mori, A.; Okajima, H.; Kaido, T.; Uemoto, S.] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068507, Japan; [Nakamura, A.] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto 6068507, Japan; [Nagamatsu, H.] Yame Gen Hosp, Dept Med, Yame, Japan	Kitajima, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	t.kitajima0407@gmail.com					FAJARDO LF, 1988, PATHOL ANNU, V23, P297; Guerrini GP, 2014, LIVER INT, V34, pE96, DOI 10.1111/liv.12497; Adam R, 2003, ANN SURG, V238, P508, DOI 10.1097/01.sla.0000090449.87109.44; Andolino DL, 2011, INT J RADIAT ONCOL, V81, pE447, DOI 10.1016/j.ijrobp.2011.04.011; Majno PE, 2000, HEPATOLOGY, V31, P899, DOI 10.1053/he.2000.5763; O'Connor JK, 2012, LIVER TRANSPLANT, V18, P949, DOI 10.1002/lt.23439; Mantel HTJ, 2007, LIVER TRANSPLANT, V13, P1372, DOI 10.1002/lt.21107; Bush DA, 2011, CANCER-AM CANCER SOC, V117, P3053, DOI 10.1002/cncr.25809; Belghiti Jacques, 2003, Ann Surg, V238, P885, DOI 10.1097/01.sla.0000098621.74851.65; Friedlander Arthur H, 2009, Spec Care Dentist, V29, P75, DOI 10.1111/j.1754-4505.2008.00066.x; Hwang S, 2005, LIVER TRANSPLANT, V11, P1265, DOI 10.1002/lt.20549; Kaido T, 2012, SURGERY, V151, P55, DOI 10.1016/j.surg.2011.06.032; Melliere D, 1997, J CARDIOVASC SURG, V38, P261; Patel DA, 2006, CANCER, V106, P718, DOI 10.1002/cncr.21636; Popovtzer A, 2008, EXPERT REV ANTICANC, V8, P633, DOI 10.1586/14737140.8.4.633; Qu W, 2015, CLIN RES HEPATOL GAS, V39, P93, DOI 10.1016/j.clinre.2014.07.006; Sandroussi C, 2010, TRANSPL INT, V23, P299, DOI 10.1111/j.1432-2277.2009.00980.x; Wigg A, 2013, LIVER TRANSPLANT, V19, P1119, DOI 10.1002/lt.23714; Zhu Y, 2013, TRANSPL P, V45, P3329, DOI 10.1016/j.transproceed.2013.06.004	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					804	808		10.1016/j.transproceed.2015.02.011		5	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900051		
J	Kawaoka, T; Imamura, M; Kan, H; Fujino, H; Fukuhara, T; Kobayashi, T; Honda, Y; Naeshiro, N; Hiramatsu, A; Tsuge, M; Hayes, CN; Kawakami, Y; Aikata, H; Ochi, H; Ishiyama, K; Tashiro, H; Ohdan, H; Chayama, K				Kawaoka, T.; Imamura, M.; Kan, H.; Fujino, H.; Fukuhara, T.; Kobayashi, T.; Honda, Y.; Naeshiro, N.; Hiramatsu, A.; Tsuge, M.; Hayes, C. N.; Kawakami, Y.; Aikata, H.; Ochi, H.; Ishiyama, K.; Tashiro, H.; Ohdan, H.; Chayama, K.			Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report	TRANSPLANTATION PROCEEDINGS			English	Article							SUSTAINED VIROLOGICAL RESPONSE; VIRUS-INFECTION; GENOTYPE 1; ANTIVIRAL TREATMENT; PROTEASE INHIBITOR; DUAL THERAPY; TELAPREVIR; PEGINTERFERON; DACLATASVIR; RECIPIENTS	We previously reported our data on telaprevir (TVR) used in combination with pegylated-interferon and ribavirin (PEG-IFN/RBV) for the treatment of recurrent hepatitis C virus (HCV) genotype 1 infection after liver transplantation (LT). TVR substantially increases the blood levels of immunosuppressive agents such as cyclosporine and tacrolimus for drug-drug interactions. On the other hand, the effect of simeprevir (SMV) on the blood levels of these immunosuppressive agents is unclear. We report 2 patients who achieved viral responses with little effect on the blood levels of cyclosporine and tacrolimus using SMV plus PEG-IFN/RBV treatment. The first was a 71-year-old woman with HCV-related liver cirrhosis and hepatocellular carcinoma who failed to respond to PEG-IFN/RBV after living donor LT. She was treated with 40 mg/d of cyclosporine, and received SMV plus PEG-IFN/RBV treatment. The second was a 65-year-old man with HCV-related liver cirrhosis who failed to respond to PEG-IFN/RBV after living donor LT. He was treated with 3 mg/d of tacrolimus, and received SMV plus PEG-IFN/RBV treatment. Serum HCV RNA became undetectable using TaqMan polymerase chain reaction (PCR) test after 4 weeks of treatment in both patients, and no remarkable fluctuation in blood concentration was observed either in cyclosporine or tacrolimus during the 12 weeks of SMV treatment. Completion of 12-week SMV triple therapy was followed by PEG-IFN alpha 2b plus RBV, and both patients achieved sustained virological response 12 weeks after the end of treatment. SMV plus PEG-IFNRBV treatment showed a remarkable viral response with little effect on blood levels of immunosuppressive agents for recurrent HCV genotype 1 infection after LT.	[Kawaoka, T.; Imamura, M.; Kan, H.; Fujino, H.; Fukuhara, T.; Kobayashi, T.; Honda, Y.; Naeshiro, N.; Hiramatsu, A.; Tsuge, M.; Hayes, C. N.; Kawakami, Y.; Aikata, H.; Ochi, H.; Chayama, K.] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan; [Ishiyama, K.; Tashiro, H.; Ohdan, H.] Hiroshima Univ, Grad Sch Biomed Sci, Programs Biomed Res, Div Frontier Med Sci,Dept Surg, Hiroshima 7348551, Japan	Chayama, K (reprint author), Hiroshima Univ, Appl Life Sci Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	chayama@hiroshima-u.ac.jp					Berenguer M, 2008, AM J TRANSPLANT, V8, P679, DOI 10.1111/j.1600-6143.2007.02126.x; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Saab S, 2007, LIVER TRANSPLANT, V13, P1032, DOI 10.1002/lt.21184; You DM, 2013, EXPERT OPIN PHARMACO, V14, P2581, DOI 10.1517/14656566.2013.850074; Karino Y, 2013, J HEPATOL, V58, P646, DOI 10.1016/j.jhep.2012.11.012; Roche B, 2008, LIVER TRANSPLANT, V14, P1766, DOI 10.1002/lt.21635; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Berenguer M, 2000, J HEPATOL, V32, P673, DOI 10.1016/S0168-8278(00)80231-7; Reesink HW, 2010, GASTROENTEROLOGY, V138, P913, DOI 10.1053/j.gastro.2009.10.033; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Irish WD, 2011, AM J TRANSPLANT, V11, P1676, DOI 10.1111/j.1600-6143.2011.03508.x; Kawaoka T, 2010, SCAND J GASTROENTERO, V45, P1488, DOI 10.3109/00365521.2010.505657; Kawaoka T, 2014, HEPATOL RES, V44, P1259, DOI 10.1111/hepr.12296; Le Pogam S, 2012, ANTIMICROB AGENTS CH, V56, P5494, DOI 10.1128/AAC.01035-12; Lodato F, 2008, ALIMENT PHARM THER, V28, P450, DOI 10.1111/j.1365-2036.2008.03761.x; Motoda Hirotoshi, 2011, Plant Signal Behav, V6, P98; Pungpapong S, 2013, LIVER TRANSPLANT, V19, P690, DOI 10.1002/lt.23669; Schmidt SC, 2010, DIGEST DIS SCI, V55, P2063, DOI 10.1007/s10620-009-0982-2; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Werner CR, 2012, LIVER TRANSPLANT, V18, P1464, DOI 10.1002/lt.23542; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	APR	2015	47	3					809	814		10.1016/j.transproceed.2014.10.052		6	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	CG6PT	WOS:000353424900052		
J	Fleming, RW; Gegenfurtner, KR; Nishida, S				Fleming, Roland W.; Gegenfurtner, Karl R.; Nishida, Shin'ya			Visual perception of materials: The science of stuff	VISION RESEARCH			English	Editorial Material							COLOR TRANSPARENCY; LIGHTNESS		[Fleming, Roland W.; Gegenfurtner, Karl R.] Univ Giessen, Abt Allgemeine Psychol, D-35625 Giessen, Germany; [Nishida, Shin'ya] NTT Corp, Commun Sci Labs, Atsugi, Kanagawa 2430198, Japan	Fleming, RW (reprint author), Univ Giessen, Abt Allgemeine Psychol, Otto Behaghel Str 10F, D-35625 Giessen, Germany.	roland.w.fleming@psychol.uni-giessen.de; gegenfurtner@uni-giessen.de; shinyanishida@mac.com		Fleming, Roland/0000-0001-5033-5069			Anderson BL, 2005, NATURE, V434, P79, DOI 10.1038/nature03271; DZmura M, 1997, PERCEPTION, V26, P471, DOI 10.1068/p260471; GERBINO W, 1990, J EXP PSYCHOL HUMAN, V16, P3; Nishida S, 1998, J OPT SOC AM A, V15, P2951, DOI 10.1364/JOSAA.15.002951; Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; Anderson BL, 1997, PERCEPTION, V26, P419, DOI 10.1068/p260419; BLAKE A, 1990, NATURE, V343, P165, DOI 10.1038/343165a0; BECK J, 1988, PERCEPT PSYCHOPHYS, V44, P585, DOI 10.3758/BF03207492; Beck J., 1972, SURFACE COLOR PERCEP; BECK J, 1978, PERCEPT PSYCHOPHYS, V23, P265, DOI 10.3758/BF03204137; BECK J, 1981, PERCEPT PSYCHOPHYS, V30, P407, DOI 10.3758/BF03206160; D'Zmura M, 2000, PERCEPTION, V29, P911, DOI 10.1068/p2988; Helmholtz Hermann von, 1962, HELMHOLTZS TREATISE; Hering E, 1964, OUTLINES THEORY LIGH; Hunter R. S., 1975, MEASUREMENT APPEARAN; Kanizsa G., 1955, RIV PSICOL, V49, P3; Katz D., 1935, THE WORLD OF COLOUR; Masin SC, 1997, PERCEPTION, V26, P39, DOI 10.1068/p260039; Metelli F, 1974, Sci Am, V230, P90; Singh M, 2002, PSYCHOL REV, V109, P492, DOI 10.1037//0033-295X.109.3.492	20	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	APR	2015	109		B		SI		123	124		10.1016/j.visres.2015.01.014		2	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CG5WV	WOS:000353367500001		
J	Kawabe, T; Maruya, K; Fleming, RW; Nishida, S				Kawabe, Takahiro; Maruya, Kazushi; Fleming, Roland W.; Nishida, Shin'ya			Seeing liquids from visual motion	VISION RESEARCH			English	Article						Material perception; Viscosity; Liquid impression; Visual motion	BIOLOGICAL MOTION; PERCEPTION; SENSITIVITY; FLOW; RECOGNITION; SELECTIVITY; STATISTICS; MECHANISMS; HUMANS; GLOSS	Most research on human visual recognition focuses on solid objects, whose identity is defined primarily by shape. In daily life, however, we often encounter materials that have no specific form, including liquids whose shape changes dynamically over time. Here we show that human observers can recognize liquids and their viscosities solely from image motion information. Using a two-dimensional array of noise patches, we presented observers with motion vector fields derived from diverse computer rendered scenes of liquid flow. Our observers perceived liquid-like materials in the noise-based motion fields, and could judge the simulated viscosity with surprising accuracy, given total absence of non-motion information including form. We find that the critical feature for apparent liquid viscosity is local motion speed, whereas for the impression of liquidness, image statistics related to spatial smoothness including the mean discrete Laplacian of motion vectors is important. Our results show the brain exploits a wide range of motion statistics to identify non-solid materials. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.	[Kawabe, Takahiro; Maruya, Kazushi; Nishida, Shin'ya] NTT Corp, Commun Sci Labs, Atsugi, Kanagawa 2430198, Japan; [Fleming, Roland W.] Univ Giessen, Dept Expt Psychol, D-53594 Giessen, Germany	Kawabe, T (reprint author), NTT Corp, Commun Sci Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	kawabe.takahiro@lab.ntt.co.jp		Fleming, Roland/0000-0001-5033-5069	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22135004]	This study was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Shitsukan" (No. 22135004) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Aggarwal JK, 1998, COMPUT VIS IMAGE UND, V70, P142, DOI 10.1006/cviu.1997.0620; Emrith K, 2010, J OPT SOC AM A, V27, P1232, DOI 10.1364/JOSAA.27.001232; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Fleming RW, 2014, VISION RES, V94, P62, DOI 10.1016/j.visres.2013.11.004; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346; Fleming RW, 2011, PSYCHOL SCI, V22, P812, DOI 10.1177/0956797611408734; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Nishida S, 1998, J OPT SOC AM A, V15, P2951, DOI 10.1364/JOSAA.15.002951; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Newell FN, 2004, J VISION, V4, P118, DOI 10.1167/4.2.5; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198; SACHTLER WL, 1995, VISION RES, V35, P807, DOI 10.1016/0042-6989(94)00160-N; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Adelson EH, 2001, PROC SPIE, V4299, P1, DOI 10.1117/12.429489; Kim J, 2012, NAT NEUROSCI, V15, P1590, DOI 10.1038/nn.3221; Nishida S, 2011, J VISION, V11, DOI 10.1167/11.5.11; Maloney LT, 2003, J VISION, V3, P573, DOI 10.1167/3.8.5; Alvarez GA, 2011, TRENDS COGN SCI, V15, P122, DOI 10.1016/j.tics.2011.01.003; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Doerschner K, 2011, CURR BIOL, V21, P2010, DOI 10.1016/j.cub.2011.10.036; Bar-Meier G., 2011, BASIC FLUID MECH; Bouguet J.-Y., 1999, PYRAMIDAL IMPLEMENTA; Charrier C, 2007, J OPT SOC AM A, V24, P3418, DOI 10.1364/JOSAA.24.003418; Chuang L. L., 2012, FRONT COMPUT NEUROSC, V6, P1; CIA, WORLD FACT BOOK; Development Core Team R, 2008, R LANG ENV STAT COMP; Devinck F, 2014, J OPT SOC AM A, V31, pA1, DOI 10.1364/JOSAA.31.0000A1; Fleming R., 2012, J VISION, V12, P949, DOI DOI 10.1167/12.9.949.[; Heuer HW, 2004, J NEUROPHYSIOL, V91, P1314, DOI 10.1152/jn.00637.2003; Jain A, 2011, P NATL ACAD SCI USA, V108, P1663, DOI 10.1073/pnas.1016211108; JOHANSSO.G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kersten D., 2011, WORKSH MAT PERC RAUI; Kingdom F. F. A, 2009, PALAMEDES MATLAB ROU; KOENDERINK JJ, 1976, J OPT SOC AM, V66, P717, DOI 10.1364/JOSA.66.000717; Lu HJ, 2010, J VISION, V10, DOI 10.1167/10.12.13; Lucas B. D., 1981, P IM UND WORKSH, V130, P121; Mart D., 1975, AL MEMOS; Maruya K., 2013, J VISION, V4, P1; Moutsiana C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022902; NAKAYAMA K, 1981, VISION RES, V21, P427, DOI 10.1016/0042-6989(81)90089-4; NAKAYAMA K, 1985, PERCEPTION, V14, P225, DOI 10.1068/p140225; Norman JF, 2007, PERCEPTION, V36, P980, DOI 10.1068/p5641; Obein G, 2004, J VISION, V4, P711, DOI 10.1167/4.9.4; Paulun V. C., SEEING LIQUIDS UNPUB; Stone JV, 1998, VISION RES, V38, P947, DOI 10.1016/S0042-6989(97)00301-5; Troje N.F., 2008, SENSES COMPREHENSIVE, V2, P231; Vuong QC, 2006, PERCEPTION, V35, P497, DOI 10.1068/p5491; Zaidi Q., 2011, VISUAL INFERENCES MA	51	5	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	APR	2015	109		B		SI		125	138		10.1016/j.visres.2014.07.003		14	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CG5WV	WOS:000353367500002		
J	Sun, HC; Ban, H; Di Luca, M; Welchman, AE				Sun, Hua-Chun; Ban, Hiroshi; Di Luca, Massimiliano; Welchman, Andrew E.			fMRI evidence for areas that process surface gloss in the human visual cortex	VISION RESEARCH			English	Article						Surface gloss; Material perception; Posterior fusiform sulcus; V3B/KO; fMRI	INFERIOR TEMPORAL CORTEX; HUMAN BRAIN; SPECULAR REFLECTIONS; VENTRAL STREAM; DISPARITY CUES; PERCEPTION; TEXTURE; MOTION; SHAPE; REGIONS	Surface gloss is an important cue to the material properties of objects. Recent progress in the study of macaque's brain has increased our understating of the areas involved in processing information about gloss, however the homologies with the human brain are not yet fully understood. Here we used human functional magnetic resonance imaging (fMRI) measurements to localize brain areas preferentially responding to glossy objects. We measured cortical activity for thirty-two rendered three-dimensional objects that had either Lambertian or specular surface properties. To control for differences in image structure, we overlaid a grid on the images and scrambled its cells. We found activations related to gloss in the posterior fusiform sulcus (pFs) and in area V3B/KO. Subsequent analysis with Granger causality mapping indicated that V3B/KO processes gloss information differently than pFs. Our results identify a small network of mid-level visual areas whose activity may be important in supporting the perception of surface gloss. (C) 2014 Published by Elsevier Ltd. This is an open access article under the CC BY license.	[Sun, Hua-Chun; Di Luca, Massimiliano] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Ban, Hiroshi] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Osaka, Japan; [Ban, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Ban, Hiroshi] Japan Soc Promot Sci, Tokyo, Japan; [Welchman, Andrew E.] Univ Cambridge, Dept Psychol, Cambridge CB2 1TN, England	Sun, HC (reprint author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	hxs195@bham.ac.uk	Welchman, Andrew/B-7542-2013; Di Luca, Massimiliano/A-7850-2012	Welchman, Andrew/0000-0002-7559-3299; Di Luca, Massimiliano/0000-0003-3085-7251	Wellcome Trust [095183/Z/10/Z]; Japan Society for the Promotion of Science [H22.290]; KAKENHI [26870911]	We thank Alan Meeson for providing the script of PSC analysis and Yang Zhang for providing the script of global signal variance analysis. This project was supported by fellowships to A.E.W. from the Wellcome Trust (095183/Z/10/Z) and to H.B. from the Japan Society for the Promotion of Science (H22.290), KAKENHI 26870911.	Anderson B. L, 2012, J VISION, V12, P947; Anderson B. L, 2011, J VISION, V11, P396; Ban H, 2012, NAT NEUROSCI, V15, P636, DOI 10.1038/nn.3046; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cavina-Pratesi C, 2010, CEREB CORTEX, V20, P433, DOI 10.1093/cercor/bhp111; Kourtzi Z, 2000, J NEUROSCI, V20, P3310; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Muryy AA, 2013, P NATL ACAD SCI USA, V110, P2413, DOI 10.1073/pnas.1212417110; Olkkonen M, 2010, J VISION, V10, DOI 10.1167/10.9.5; Tyler CW, 2006, NEUROIMAGE, V30, P228, DOI 10.1016/j.neuroimage.2005.09.067; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; Kim J, 2010, J VISION, V10, DOI 10.1167/10.9.3; Wada A, 2014, NEUROIMAGE, V98, P243, DOI 10.1016/j.neuroimage.2014.05.001; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Nishio A, 2014, J NEUROSCI, V34, P11143, DOI 10.1523/JNEUROSCI.1451-14.2014; Anderson BL, 2009, J VISION, V9, DOI 10.1167/9.11.10; Dror R, 2004, J VISION, V4, P821, DOI 10.1167/4.9.11; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Orban GA, 2011, ANNU REV NEUROSCI, V34, P361, DOI 10.1146/annurev-neuro-061010-113819; Fleming RW, 2004, J VISION, V4, P798, DOI 10.1167/4.9.10; Nishio A, 2012, J NEUROSCI, V32, P10780, DOI 10.1523/JNEUROSCI.1095-12.2012; Marlow PJ, 2012, CURR BIOL, V22, P1909, DOI 10.1016/j.cub.2012.08.009; Wijntjes MWA, 2010, J VISION, V10, DOI 10.1167/10.9.13; Marlow P, 2011, J VISION, V11, DOI 10.1167/11.9.16; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Vanduffel W, 2002, SCIENCE, V298, P413, DOI 10.1126/science.1073574; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Murphy AP, 2013, J NEUROPHYSIOL, V110, P190, DOI 10.1152/jn.01055.2012; Cant JS, 2009, EXP BRAIN RES, V192, P391, DOI 10.1007/s00221-008-1573-8; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Doerschner K, 2010, J VISION, V10, DOI 10.1167/10.4.8; Norman JF, 2004, PSYCHOL SCI, V15, P565, DOI 10.1111/j.0956-7976.2004.00720.x; Wendt G, 2010, J VISION, V10, DOI 10.1167/10.9.7; Cant JS, 2007, CEREB CORTEX, V17, P713, DOI 10.1093/cercor/bhk022; Kim J, 2011, J VISION, V11, DOI 10.1167/11.9.4; Cavina-Pratesi C, 2010, CEREB CORTEX, V20, P2319, DOI 10.1093/cercor/bhp298; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Dovencioglu D, 2013, J COGNITIVE NEUROSCI, V25, P1527, DOI 10.1162/jocn_a_00417; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Junghofer M, 2005, NEUROIMAGE, V25, P520, DOI 10.1016/j.neuroimage.2004.12.011; Doerschner K, 2011, CURR BIOL, V21, P2010, DOI 10.1016/j.cub.2011.10.036; Fleming RW, 2012, CURR BIOL, V22, pR865, DOI 10.1016/j.cub.2012.08.030; BLAKE A, 1990, NATURE, V343, P165, DOI 10.1038/343165a0; Okazawa G, 2012, NEUROIMAGE, V63, P1321, DOI 10.1016/j.neuroimage.2012.07.052; Beck J., 1972, SURFACE COLOR PERCEP; Gegenfurtner K., 2013, J VISION, V13, P200; Kentridge RW, 2012, CORTEX, V48, P1244, DOI 10.1016/j.cortex.2012.01.011; Kerrigan I. S., 2013, J VISION, V13, P1, DOI [10.1167/13.1.9, DOI 10.1167/13.1.9]; Kerrigan IS, 2010, J VISION, V10, P868, DOI DOI 10.1167/10.7.868; Marlow PJ, 2013, J VISION, V13, DOI 10.1167/13.14.2; Muryy A. A., 2012, J VISION, V12, P869, DOI DOI 10.1167/12.9.869.; Nishida S., 2011, J VIS, V11, P397; Okazawa G., 2011, J VISION, V11; Sakano Y, 2010, J VISION, V10, DOI 10.1167/10.9.15; Sawabe M., 2010, J VISION, V10, P60, DOI 10.1167/10.15.60; Scheller Lichtenauer M., 2013, J VISION, V13; Te Pas S. F., 2010, J VIS, V10, p[450, 450]; Uehara T., 2013, J VISION, V13, P204; Wendt G., 2008, J VISION, V8, P1, DOI DOI 10.1167/8.1.14	60	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	APR	2015	109		B		SI		149	157		10.1016/j.visres.2014.11.012		9	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CG5WV	WOS:000353367500004		
J	Fujisaki, W; Tokita, M; Kariya, K				Fujisaki, Waka; Tokita, Midori; Kariya, Kenji			Perception of the material properties of wood based on vision, audition, and touch	VISION RESEARCH			English	Article						Vision; Audition; Touch; Material properties; Wood	SURFACE-REFLECTANCE PROPERTIES; VISUAL-PERCEPTION; TEXTURE; SOUNDS; INTEGRATION; ROUGHNESS; SYSTEMS; WORLD; CUES	Most research on the multimodal perception of material properties has investigated the perception of material properties of two modalities such as vision-touch, vision-audition, audition-touch, and vision-action. Here, we investigated whether the same affective classifications of materials can be found in three different modalities of vision, audition, and touch, using wood as the target object. Fifty participants took part in an experiment involving the three modalities of vision, audition, and touch, in isolation. Twenty-two different wood types including genuine, processed, and fake were perceptually evaluated using a questionnaire consisting of twenty-three items (12 perceptual and 11 affective). The results demonstrated that evaluations of the affective properties of wood were similar in all three modalities. The elements of "expensiveness, sturdiness, rareness, interestingness, and sophisticatedness" and "pleasantness, relaxed feelings, and liked-disliked" were separately grouped for all three senses. Our results suggest that the affective material properties of wood are at least partly represented in a supramodal fashion. Our results also suggest an association between perceptual and affective properties, which will be a useful tool not only in science, but also in applied fields. 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.	[Fujisaki, Waka] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Tokita, Midori] Ochanomizu Univ, Fac Letters & Educ, Bunkyo, Japan; [Kariya, Kenji] Sumitomo Forestry Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki, Japan	Fujisaki, W (reprint author), Tsukuba Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	w-fujisaki@aist.go.jp			Sumitomo Forestry Co., Ltd; Ministry of Education, Science, Culture, Sports and Science, Japan [22135004]	This work was supported by research funds from Sumitomo Forestry Co., Ltd. WF is partially supported by Grant-in-Aid for Scientific Research on Innovative Areas (22135004) from the Ministry of Education, Science, Culture, Sports and Science, Japan. We thank Yohei Yamada and Kumiko Akiyama for their support throughout this study, and the Geological Museum, Geological Survey of Japan, AIST, for letting us utilize the photos of stones for the subsidiary experiment.	Aramaki M, 2011, IEEE T AUDIO SPEECH, V19, P301, DOI 10.1109/TASL.2010.2047755; Giordano BL, 2006, J ACOUST SOC AM, V119, P1171, DOI 10.1121/1.2149839; Tiest WMB, 2006, ACTA PSYCHOL, V121, P1, DOI 10.1016/j.actpsy.2005.04.005; Fleming RW, 2011, PSYCHOL SCI, V22, P812, DOI 10.1177/0956797611408734; GABRIELSSON A, 1979, J ACOUST SOC AM, V65, P1019, DOI 10.1121/1.382579; Nishida S, 1998, J OPT SOC AM A, V15, P2951, DOI 10.1364/JOSAA.15.002951; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Lemaitre G, 2012, J ACOUST SOC AM, V131, P1337, DOI 10.1121/1.3675946; Overvliet KE, 2011, ACTA PSYCHOL, V136, P95, DOI 10.1016/j.actpsy.2010.10.007; Klatzky RL, 2000, PRESENCE-TELEOP VIRT, V9, P399, DOI 10.1162/105474600566907; Rozin P, 2005, PSYCHOL SCI, V16, P652, DOI 10.1111/j.1467-9280.2005.01589.x; Hiramatsu C, 2011, NEUROIMAGE, V57, P482, DOI 10.1016/j.neuroimage.2011.04.056; Baumgartner E, 2013, MULTISENS RES, V26, P429, DOI 10.1163/22134808-00002429; Zampini M, 2004, J SENS STUD, V19, P347, DOI 10.1111/j.1745-459x.2004.080403.x; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Whitaker TA, 2008, BRAIN RES, V1242, P59, DOI 10.1016/j.brainres.2008.05.037; Okamoto S, 2013, IEEE T HAPTICS, V6, P81, DOI [10.1109/TOH.2012.32, 10.1109/ToH.2012.32]; Fleming RW, 2013, J VISION, V13, DOI 10.1167/13.8.9; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Tiest WMB, 2007, ACTA PSYCHOL, V124, P177, DOI 10.1016/j.actpsy.2006.03.002; Klatzky RL, 2010, MULTISENSORY OBJECT PERCEPTION IN THE PRIMATE BRAIN, P211, DOI 10.1007/978-1-4419-5615-6_12; Cunningham D., 2007, PERCEPTUAL REPARAMET; Fujisaki W, 2014, J VISION, V14, DOI 10.1167/14.4.12; Fujisawa Nozomu, 2004, J Physiol Anthropol Appl Human Sci, V23, P351, DOI 10.2114/jpa.23.351; Gibson J. J., 1966, SENSES CONSIDERED PE; Guest S, 2003, INT J PSYCHOPHYSIOL, V50, P63, DOI 10.1016/S0167-8760(03)00125-9; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; LEDERMAN SJ, 1986, J EXP PSYCHOL HUMAN, V12, P169, DOI 10.1037//0096-1523.12.2.169; Lutfi RA, 1997, J ACOUST SOC AM, V102, P3647, DOI 10.1121/1.420151; Motoyoshi I, 2010, J VISION, V10, DOI 10.1167/10.9.6; OSGOOD CE, 1957, AM J PSYCHOL, V70, P411, DOI 10.2307/1419577; Overvliet K. E., 2008, MEASURING PERCEPTION; Seashore C. E., 1899, U IOWA STUDIES PSYCH, V2, P36; Sharan L., 2009, J VISION, V9, P784, DOI [10.1167/9.8.784, DOI 10.1167/9.8.784]; SOLOMON LN, 1958, J ACOUST SOC AM, V30, P421, DOI 10.1121/1.1909632; Tani Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086400; von Bismarck G., 1974, Acustica, V30; von Bismarck G., 1974, Acustica, V30; Wildes R. P., 1988, NATURAL COMPUTATION, P356	40	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	APR	2015	109		B		SI		185	200		10.1016/j.visres.2014.11.020		16	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CG5WV	WOS:000353367500008		
J	Masuda, T; Matsubara, K; Utsumi, K; Wada, Y				Masuda, Tomohiro; Matsubara, Kazuya; Utsumi, Ken; Wada, Yuji			Material perception of a kinetic illusory object with amplitude and frequency changes in oscillated inducer motion	VISION RESEARCH			English	Article						Material perception; Motion perception; Illusory contour	VISUAL-PERCEPTION; FORM	The magnitude of the phase difference between inducers' oscillation of a kinetic illusory surface influences visual material impressions (Masuda et al., 2013). For example, impressions of bending or waving motions on a surface tend to occur at a 30- or 90-deg. phase difference, respectively. Here, we elucidate whether amplitude and frequency changes in an inducer's oscillation influence the visual impressions of an illusory surface's hardness, elasticity, and viscosity. Nine participants were asked to use an analog scale to judge their visual impressions relative to a standard pattern with no damping and no frequency change for each phase difference. Results revealed that hardness ratings were greater when amplitude decayed with time only in the 30-deg. phase difference. Elasticity ratings were greater when the frequency of oscillation had a large increase in the 90-deg. phase difference. In the 30-deg. phase difference, similar tendencies were only observed with no damping and ample damping. Viscosity ratings were greater when the frequency of oscillation decreased in both phase differences and when the amplitude decayed with time in the 30-deg. phase difference. These findings suggest that amplitude and frequency changes in an inducer's oscillation are significant factors for material perception derived from motion. (C) 2014 Elsevier Ltd. All rights reserved.	[Masuda, Tomohiro; Matsubara, Kazuya; Utsumi, Ken; Wada, Yuji] Natl Agr & Food Res Org, Natl Food Res Inst, Food Funct Div, Ibaraki, Japan	Wada, Y (reprint author), 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	yujiwd@affrc.go.jp			Japan Society for Promotion of Science [25780452, 25135735]	This work was supported in part by the Grant-in-Aid for Young Scientists (B) from the Japan Society for Promotion of Science (25780452 awarded to T.M.) and the Grant-in-Aid for Scientific Research on Innovative Areas (25135735 awarded to Y.W.).	Abe S., 1935, TOHOKU PSYCHOL FOLIA, V3, P53; SZCZESNIAK AS, 1963, J FOOD SCI, V28, P385, DOI 10.1111/j.1365-2621.1963.tb00215.x; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; COHEN J, 1953, NATURE, V172, P901, DOI 10.1038/172901a0; JANSSON G, 1977, SCAND J PSYCHOL, V18, P209, DOI 10.1111/j.1467-9450.1977.tb00279.x; JANSSON G, 1973, PERCEPTION, V2, P321, DOI 10.1068/p020321; JANSSON G, 1977, PERCEPTION, V6, P595, DOI 10.1068/p060595; JOHANSSON G, 1964, SCAND J PSYCHOL, V5, P181, DOI 10.1111/j.1467-9450.1964.tb01425.x; Masuda T, 2011, VISION RES, V51, P1728, DOI 10.1016/j.visres.2011.05.016; Masuda T, 2011, JPN PSYCHOL RES, V53, P440, DOI 10.1111/j.1468-5884.2011.00487.x; Masuda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078621; Norman JF, 2007, PERCEPTION, V36, P980, DOI 10.1068/p5641; TODD JT, 1982, PERCEPTION, V11, P325, DOI 10.1068/p110325; WARREN WH, 1987, PERCEPTION, V16, P309	14	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	APR	2015	109		B		SI		201	208		10.1016/j.visres.2014.11.019		8	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CG5WV	WOS:000353367500009		
J	Sawayama, M; Kimura, E				Sawayama, Masataka; Kimura, Eiji			Stain on texture: Perception of a dark spot having a blurred edge on textured backgrounds	VISION RESEARCH			English	Article						Edge classification; Illumination; Reflectance; Texture; Edge blurriness; Surface material	PERCEIVED SPATIAL ARRANGEMENT; LIGHTNESS; CONTRAST; VISION; DEPTH; EXPLANATION; SURFACES; SHADOWS; IMAGES; CUE	When distinguishing illumination from reflectance edges, both edge blurriness and textural continuity across an edge are generally used as cues to promote the illumination-edge interpretation. However, when these cues were combined, i.e., when a dark spot having a blurred edge was placed on textured backgrounds, we unexpectedly found that the spot appears stained or painted rather than differently illuminated ("stain on texture" phenomenon). This phenomenon suggests a disruptive interaction between the visual processing of blurred edges and background texture. Our experiments showed that middle spatial-frequency components of background texture play a critical role in producing this interaction. Specifically, when a textured background had relatively stronger energy in middle spatial-frequency bands, the dark spot having a blurred edge on the textured background was perceived as differing in reflectance. The findings are discussed in view of multiple levels of visual processes: one mainly concerns low-level features such as spatial-frequency components and another is a higher-level process that takes into account the likelihood of spatial configurations in natural scenes, such as "spot shadow" in which the shadow is isolated and the shadow caster is out of sight. (C) 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.	[Sawayama, Masataka] NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan; [Kimura, Eiji] Chiba Univ, Fac Letters, Dept Psychol, Inage Ku, Chiba, Chiba 2638522, Japan	Sawayama, M (reprint author), NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan.	masa.sawayama@gmail.com; kimura@L.chi-ba-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [10J02311]; Japan Society for the Promotion of Science [26285162]; MEXT, Japan [22135004]	The authors would like to thank the two anonymous reviewers for their helpful comments and suggestions. This work was partly supported by a Grant-in-Aid for JSPS Fellows from the Ministry of Education, Culture, Sports, Science, and Technology (No. 10J02311), by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 26285162), and by a Grant-in-Aid for Scientific Research on Innovative Areas "Shitsukan" (No. 22135004) from MEXT, Japan.	Adelson E. H., 1995, CHECKERSHADOW ILLUSI; Anderson BL, 2006, VISION RES, V46, P1982, DOI 10.1016/j.visres.2005.11.024; Mather G, 1996, P ROY SOC B-BIOL SCI, V263, P169, DOI 10.1098/rspb.1996.0027; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Marshall JA, 1996, J OPT SOC AM A, V13, P681, DOI 10.1364/JOSAA.13.000681; Mather G, 2002, PERCEPTION, V31, P1211, DOI 10.1068/p3254; Olmos A, 2004, PERCEPTION, V33, P1463, DOI 10.1068/p5321; Agostini T, 2002, PSYCHON B REV, V9, P264, DOI 10.3758/BF03196281; Kingdom FAA, 2008, VISION RES, V48, P2090, DOI 10.1016/j.visres.2008.03.020; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Purves D, 2011, P NATL ACAD SCI USA, V108, P15588, DOI 10.1073/pnas.1012178108; Sakai K, 2006, J OPT SOC AM A, V23, P1805, DOI 10.1364/JOSAA.23.001805; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; Arend L. E., 1994, LIGHTNESS BRIGHTNESS, P159; Elder JH, 2004, PERCEPTION, V33, P1319, DOI 10.1068/p5323; Giesel M., 2013, J VISION, V13, p[7, 1], DOI [10.1167/13.14.7, DOI 10.1167/13.14.7]; Gilchrist A., 2006, SEEING BLACK WHITE; GILCHRIST AL, 1980, PERCEPT PSYCHOPHYS, V28, P527, DOI 10.3758/BF03198821; GILCHRIST AL, 1988, PERCEPT PSYCHOPHYS, V43, P415, DOI 10.3758/BF03207877; Hering E., 1874, OUTLINES THEORY LIGH; Hillis JM, 2007, CURR BIOL, V17, P1714, DOI 10.1016/j.cub.2007.09.012; Kingdom FAA, 2003, NAT NEUROSCI, V6, P641, DOI 10.1038/nn1060; Knill D. C., 1996, PERCEPTION BAYESIAN, P239; Kovacs I, 1997, VISION RES, V37, P1167, DOI 10.1016/S0042-6989(96)00206-4; Lotto RB, 2001, J COGNITIVE NEUROSCI, V13, P547, DOI 10.1162/089892901750363154; Metelli F, 1974, Sci Am, V230, P90; Sawayama M., 2012, J VISION, V12, P1206; Schofield AJ, 2010, J VISION, V10, DOI 10.1167/10.9.2; Schofield AJ, 2006, VISION RES, V46, P3462, DOI 10.1016/j.visres.2006.03.014; Weiss Y., 2001, P IEEE INT C COMP VI, P68, DOI 10.1109/ICCV.2001.937606	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.	APR	2015	109		B		SI		209	220		10.1016/j.visres.2014.11.017		12	Neurosciences; Ophthalmology	Neurosciences & Neurology; Ophthalmology	CG5WV	WOS:000353367500010		
J	Huff, G; Majima, S				Huff, Gregg; Majima, Shinobu			The Challenge of Finance in South East Asia during the Second World War	WAR IN HISTORY			English	Article						War finance; military scrip; occupation costs; bilateral clearing arrangements; seigniorage; hyperinflation; monetary overhang; Japan; South East Asia		This article analyses finance in South East Asia during the Second World War in terms of three challenges. Beginning in December 1941, Japan swiftly occupied South East Asia and immediately faced the challenge of how to finance occupation. Finance largely through printing money gave rise to a further challenge in the need to avoid hyperinflationary pressures. After the war the reoccupying powers faced their own, and a third, challenge of wartime finance in deciding how to deal with a large stock of money created during the conflict. Comparison with war finance elsewhere shows that the three challenges were met in sometimes unusual but rather effective ways.	[Huff, Gregg] Univ Oxford Pembroke Coll, Oxford OX1 1DW, England; [Majima, Shinobu] Gakushuin Univ, Gen Econ Hist, Tokyo 171, Japan	Huff, G (reprint author), Univ Oxford Pembroke Coll, Oxford OX1 1DW, England.	gregg.huff@pmb.ox.ac.uk			ESRC [RES-062-23-1392]	Huff gratefully acknowledges support and funding from ESRC grant RES-062-23-1392 which made this article possible.		0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0968-3445	1477-0385		WAR HIST	War Hist.	APR	2015	22	2					191	210		10.1177/0968344514522998		20	History; International Relations	History; International Relations	CG1HR	WOS:000353024200004		
J	Tanaka, Y				Tanaka, Yuki			Evil Men	WAR IN HISTORY			English	Book Review									[Tanaka, Yuki] Hiroshima City Univ, Hiroshima Peace Inst, Hiroshima, Japan	Tanaka, Y (reprint author), Hiroshima City Univ, Hiroshima Peace Inst, Hiroshima, Japan.						Dawes J., 2013, EVIL MEN	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0968-3445	1477-0385		WAR HIST	War Hist.	APR	2015	22	2					265	267		10.1177/0968344515575852j		3	History; International Relations	History; International Relations	CG1HR	WOS:000353024200028		
J	Amheka, A; Higano, Y				Amheka, A.; Higano, Y.			Current household waste management in Indonesia by introducing 3R in regional area: Lesson learned from Yogyakarta city and Surabaya City	WASTE MANAGEMENT			English	Editorial Material									[Amheka, A.; Higano, Y.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan	Amheka, A (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan.						Amheka A., 2014, PROCEDIA ENV SCI, P79; Damanhuri E., 2009, CURRENT SITUATION WA, P23	2	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	APR	2015	38						I	I		10.1016/S0956-053X(15)00195-6		1	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CG3JN	WOS:000353176600056		
J	Yano, J; Aoki, T; Nakamura, K; Yamada, K; Sakai, S				Yano, Junya; Aoki, Tatsuki; Nakamura, Kazuo; Yamada, Kazuo; Sakai, Shin-ichi			Life cycle assessment of hydrogenated biodiesel production from waste cooking oil using the catalytic cracking and hydrogenation method	WASTE MANAGEMENT			English	Article						Waste-to-fuel; Biodiesel fuel (BDF); Hydrogenated biodiesel (HBD); Waste cooking oil; Catalytic cracking method; Life cycle assessment (LCA)	RENEWABLE DIESEL; VEGETABLE-OIL	There is a worldwide trend towards stricter control of diesel exhaust emissions, however presently, there are technical impediments to the use of FAME (fatty acid methyl esters)-type biodiesel fuel (BDF). Although hydrogenated biodiesel (HBD) is anticipated as a new diesel fuel, the environmental performance of HBD and its utilization system have not been adequately clarified. Especially when waste cooking oil is used as feedstock, not only biofuel production but also the treatment of waste cooking oil is an important function for society. A life cycle assessment (LCA), including uncertainty analysis, was conducted to determine the environmental benefits (global warming, fossil fuel consumption, urban air pollution, and acidification) of HBD produced from waste cooking oil via catalytic cracking and hydrogenation, compared with fossil-derived diesel fuel or FAME-type BDF. Combined functional unit including "treatment of waste cooking oil" and "running diesel vehicle for household waste collection" was established in the context of Kyoto city, Japan. The calculation utilized characterization, damage, and integration factors identified by LIME2, which was based on an endpoint modeling method. The results show that if diesel vehicles that comply with the new Japanese long-term emissions gas standard are commonly used in the future, the benefit of FAME-type BDF will be relatively limited. Furthermore, the scenario that introduced HBD was most effective in reducing total environmental impact, meaning that a shift from FAME-type BDF to HBD would be more beneficial. (C) 2015 Elsevier Ltd. All rights reserved.	[Yano, Junya; Aoki, Tatsuki; Sakai, Shin-ichi] Kyoto Univ, Environm Preservat Res Ctr, Sakyo Ku, Kyoto 6068501, Japan; [Nakamura, Kazuo] Adv Sci Technol & Management, Shimogyo Ku, Kyoto 6068813, Japan; [Yamada, Kazuo] Kyoto City Environm Policy Bur, Nakagyo Ku, Kyoto 6040924, Japan	Yano, J (reprint author), Kyoto Univ, Environm Preservat Res Ctr, Sakyo Ku, Kyoto 6068501, Japan.	yano@eprc.kyoto-u.ac.jp			Low-Carbon Technology Research and Development program of the Ministry of the Environment, Japan	This research was supported by the Low-Carbon Technology Research and Development program of the Ministry of the Environment, Japan. The demonstration project entitled "R&D towards the utilization of 2nd generation biodiesel suitable for vehicles" between FY2012-FY2014 was managed by ASTEM (Advanced Scientific Technology & Management Research, Institute of KYOTO); City of Kyoto; and research partners: Toyota Motor Corporation; Japan Organics Recycling Association. The author would like to express gratitude for their cooperation.	Meher LC, 2006, RENEW SUST ENERG REV, V10, P248, DOI 10.1016/j.rser.2004.09.002; Gentil EC, 2010, WASTE MANAGE, V30, P2636, DOI 10.1016/j.wasman.2010.06.004; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Bezergianni S, 2013, RENEW SUST ENERG REV, V21, P110, DOI 10.1016/j.rser.2012.12.042; Salvi BL, 2012, RENEW SUST ENERG REV, V16, P3680, DOI 10.1016/j.rser.2012.03.050; Arvidsson R, 2011, J CLEAN PROD, V19, P129, DOI 10.1016/j.jclepro.2010.02.008; Tani H, 2011, CATAL TODAY, V164, P410, DOI 10.1016/j.cattod.2010.10.059; [Anonymous], 2014, HYDR VEG OIL HVO PRE; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Naik SN, 2010, RENEW SUST ENERG REV, V14, P578, DOI 10.1016/j.rser.2009.10.003; Moller J, 2011, WASTE MANAGE, V31, P1184, DOI 10.1016/j.wasman.2010.12.019; Morais S, 2010, J CLEAN PROD, V18, P1251, DOI 10.1016/j.jclepro.2010.04.014; Clavreul J, 2012, WASTE MANAGE, V32, P2482, DOI 10.1016/j.wasman.2012.07.008; Dufour J, 2012, RENEW ENERG, V38, P155, DOI 10.1016/j.renene.2011.07.016; Varanda MG, 2011, FUEL PROCESS TECHNOL, V92, P1087, DOI 10.1016/j.fuproc.2011.01.003; ASTEM, 2013, REP R D UT 2 GEN BIO; DELPHI, 2014, WORLDW EM STAND HEAV; European Commission Joint Research Centre Institute for Environment and Sustainability, 2010, ILCD HDB AN EX ENV I; Fukuda K., 2008, 2008012494 SAE; Garrain D, 2014, BIOMASS BIOENERG, V63, P239, DOI 10.1016/j.biombioe.2014.01.035; Hirai Y., 2001, WASTE MANAGE RES, V12, P219; Huijbregts M., 1998, INT J LCA, V3, P273, DOI DOI 10.1007/BF02979835; IEA, 2013, WORLD EN OUTL; Ishikawa M., 1996, J PACKAGING SCI TECH, V5, P119; JLCA, 2012, JLCA NEWS ENGLISH ED, V2012; JLCA, 2013, JLCA DAT BAS VER 3; JPEC (Japan Petroleum Energy Center), 2005, 4 JCAP C TOK JAP; Kakuta Y., 2014, P 3R INT SCI C MAT C; Koyano S., 2009, ANN REPORT TOKYO MET, P101; Liang S, 2013, BIORESOURCE TECHNOL, V129, P72, DOI 10.1016/j.biortech.2012.11.037; MOE Japan, 2013, MAINT PLAN WAST TREA; MOE Japan, 2013, ANN REP ENV SOUND MA; MOE Japan, 2009, GUID EST ITS REP GRE; MOE Japan greenhouse gas inventory office of Japan (GIO) CGER NIES, 2012, NAT GREENH INV REP J; Motoshita M., 2008, J LIFE CYCLE ASSESS, V4, P260; Neste Oil, 2013, NEST OILS ANN REP 20; NIES, 2008, TECHN DEV REP HYDR P; Nylund NO, 2011, VTT RES NOTES, V2604, P1; Shiota K., 2011, J JAPAN SOC ATMOS EN, V46, P224; Takamizawa K, 2013, J MATER CYCLES WASTE, V15, P16, DOI 10.1007/s10163-012-0078-5; Takasuga T., 2014, P 3R INT SCI C MAT C; Tani Haruki, 2011, Journal of the Japan Institute of Energy, V90, DOI 10.3775/jie.90.466; Worldwide Fuel Charter Committee, 2013, WORLDW FUEL CAHRT, Vfifth; Yasuda K., 1997, J JPN SOC WASTE MANA, V8, P432	45	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	APR	2015	38						409	423		10.1016/j.wasman.2015.01.014		15	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CG3JN	WOS:000353176600046		
J	Hijikata, N; Yamauchi, N; Ishiguro, M; Ushijima, K; Funamizu, N				Hijikata, Nowaki; Yamauchi, Natsuru; Ishiguro, Masaki; Ushijima, Ken; Funamizu, Naoyuki			Suitability of biochar as a matrix for improving the performance of composting toilets	WASTE MANAGEMENT & RESEARCH			English	Article						Wastewater reuse; composting toilet; faecal decomposition; oxizen utilisation ratio; nitrogen loss; soil conditioning; nutrient recycling	CHEMICAL-PROPERTIES; NITROGEN LOSS; SOIL; CHARCOAL; CARBON; MANURE; BIODEGRADATION; TEMPERATURE; BACTERIA; SAWDUST	To evaluate the suitability of biochar (rice husk charcoal) as a matrix in composting toilets that can decompose human faeces and recover fertiliser components, the composting process during toilet operation and the agricultural value of the resulting compost were characterised by performing a comparison with sawdust, rice husks, and corn stalks. The faecal decomposition ratio in biochar was 42%, similar to the values for rice husks (46%) and corn stalks (41%), but higher than the value for sawdust (25%). Heterotroph micro-organism acidity is qualitatively higher in biochar than in sawdust. However, nitrogen loss in biochar was 19%, lower than that in rice husks (36%) and corn stalks (25%), but similar to that in sawdust (16%). Although the biochar compost had no significant impact on the cation exchange capacity and water retention of sandy soil, the ratio of nitrogen transportation into plants was 12.8%, higher than that for the other materials. These results suggest that biochar is effective for achieving high faecal decomposition, low nitrogen loss, and high nutrient supply.	[Hijikata, Nowaki; Yamauchi, Natsuru; Ishiguro, Masaki; Ushijima, Ken; Funamizu, Naoyuki] Hokkaido Univ, Sapporo, Hokkaido 0608628, Japan	Hijikata, N (reprint author), Hokkaido Univ, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	nowaki@eng.hokudai.ac.jp			Science and Technology Research Partnership for Sustainable Development (SATREPS) grant from the Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Core Research for Evolutional Science and Technology (CREST) from JST	This study was supported by a Science and Technology Research Partnership for Sustainable Development (SATREPS) grant from the Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA) and a grant from the Core Research for Evolutional Science and Technology (CREST) from JST.	Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Yamato M, 2006, SOIL SCI PLANT NUTR, V52, P489, DOI 10.1111/j.1747-0765.2006.00065.x; Hotta S, 2007, BIORESOURCE TECHNOL, V98, P3412, DOI 10.1016/j.biortech.2006.10.045; Steiner C, 2010, J ENVIRON QUAL, V39, P1236, DOI 10.2134/jeq2009.0337; Zhao L, 2011, WATER RES, V45, P2322, DOI 10.1016/j.watres.2011.01.014; Dias BO, 2010, BIORESOURCE TECHNOL, V101, P1239, DOI 10.1016/j.biortech.2009.09.024; Berglund LM, 2004, SOIL BIOL BIOCHEM, V36, P2067, DOI 10.1016/j.soilbio.2004.06.005; Liang C, 2003, BIORESOURCE TECHNOL, V86, P131, DOI 10.1016/S0960-8524(02)00153-0; Kakimoto T, 2007, BIORESOURCE TECHNOL, V98, P3555, DOI 10.1016/j.biortech.2006.11.029; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Silva ME, 2009, WASTE MANAGE RES, V27, P119, DOI 10.1177/0734242X08096693; Redlinger T, 2001, APPL ENVIRON MICROB, V67, P4036, DOI 10.1128/AEM.67.9.4036-4040.2001; Sanchez-Monedero MA, 2001, BIORESOURCE TECHNOL, V78, P301, DOI 10.1016/S0960-8524(01)00031-1; Hua L, 2009, ENVIRON SCI POLLUT R, V16, P1, DOI 10.1007/s11356-008-0041-0; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Horisawa S, 1999, J WOOD SCI, V45, P492, DOI 10.1007/BF00538959; Iqbal MK, 2010, BIORESOURCE TECHNOL, V101, P1913, DOI 10.1016/j.biortech.2009.10.030; Gundale MJ, 2007, BIOL FERT SOILS, V43, P303, DOI 10.1007/s00374-006-0106-5; Blackwell P, 2009, BIOCHAR ENV MANAGEME; FAO, 2008, CLIM REL TRANSB PEST, P1; Hijikata N., 2012, P DRY TOIL C 2012 TA; Horisawa S, 2000, J WOOD SCI, V46, P317, DOI 10.1007/BF00766223; Hotta S, 2009, BIORESOURCE TECHNOL, V100, P1310, DOI 10.1016/j.biortech.2008.07.044; Kazama S., 2011, Journal of Water and Environment Technology, V9, P53, DOI 10.2965/jwet.2011.53; Lopez ZMA, 2005, COMPOST SCI UTIL, V13, P208; Lopez ZMA, 2002, J JSCE, V720, P99; Lopez ZMA, 2004, WATER RES, V38, P1327; Lopez ZMA, 2002, WATER SCI TECHNOL, V46, P317; LYNCH JM, 1993, SCIENCE AND ENGINEERING OF COMPOSTING : DESIGN, ENVIRONMENTAL, MICROBIOLOGICAL AND UTILIZATION ASPECTS, P24; Mnkeni PNS, 2008, WASTE MANAGE RES, V26, P132, DOI 10.1177/0734242X07079179; Muramoto J., 1992, Japanese Journal of Soil Science and Plant Nutrition, V63, P210; Sossou SK, 2014, ENVIRON TECHNOL, V35, P674, DOI 10.1080/09593330.2013.841268; Tiquia SM, 2000, ENVIRON TECHNOL, V21, P1037, DOI 10.1080/09593332108618048; [UNICEF WHO], 2010, PROGR SAN DRINK WAT; WHO, 2006, GUID SAF US WAST EXC, V2; Winblad U, 2004, ECOLOGICAL SANITATIO, P53	37	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0734-242X	1096-3669		WASTE MANAGE RES	Waste Manage. Res.	APR	2015	33	4					313	321		10.1177/0734242X15572179		9	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CG3CR	WOS:000353155300003		
J	He, XG; Kim, H; Kirstetter, PE; Yoshimura, K; Chang, EC; Ferguson, CR; Erlingis, JM; Hong, Y; Oki, T				He, Xiaogang; Kim, Hyungjun; Kirstetter, Pierre-Emmanuel; Yoshimura, Kei; Chang, Eun-Chul; Ferguson, Craig R.; Erlingis, Jessica M.; Hong, Yang; Oki, Taikan			The Diurnal Cycle of Precipitation in Regional Spectral Model Simulations over West Africa: Sensitivities to Resolution and Cumulus Schemes	WEATHER AND FORECASTING			English	Article						Precipitation; Hydrometeorology; Climate models; Convective parameterization; Diurnal effects	GENERAL-CIRCULATION MODEL; UNITED-STATES; CONVECTIVE PARAMETERIZATION; WARM-SEASON; SOIL-MOISTURE; VERTICAL DIFFUSION; HYDROLOGIC-CYCLE; SUMMER MONSOON; RAINFALL; VARIABILITY	As a basic form of climate patterns, the diurnal cycle of precipitation (DCP) can provide a key test bed for model reliability and development. In this study, the DCP over West Africa was simulated by the National Centers for Environmental Prediction (NCEP) Regional Spectral Model (RSM) during the monsoon season (April-September) of 2005. Three convective parameterization schemes (CPSs), single-layer simplified Arakawa-Schubert (SAS), multilayer relaxed Arakawa-Schubert (RAS), and new Kain-Fritsch (KF2), were evaluated at two horizontal resolutions (20 and 10 km). The Benin mesoscale site was singled out for additional investigation of resolution effects. Harmonic analysis was used to characterize the phase and amplitude of the DCP. Compared to satellite observations, the overall spatial distributions of amplitude were well captured at regional scales. The RSM properly reproduced the observed late afternoon peak over land and the early morning peak over ocean. Nevertheless, the peak time was early. Sensitivity experiments of CPSs showed similar spatial patterns of rainfall totals among the schemes; CPSs mainly affected the amplitude of the diurnal cycle, while the phase was not significantly shifted. There is no clear optimal pairing of resolution and CPS. However, it is found that the sensitivity of DCP to CPSs and resolution varies with the partitioning between convective and stratiform, which implies that appropriate partitioning needs to be considered for future development of CPSs in global or regional climate models.	[He, Xiaogang; Kim, Hyungjun; Oki, Taikan] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Kirstetter, Pierre-Emmanuel; Hong, Yang] Univ Oklahoma, Adv Radar Res Ctr, Norman, OK 73019 USA; [Kirstetter, Pierre-Emmanuel] NOAA, Natl Severe Storms Lab, Norman, OK 73069 USA; [Kirstetter, Pierre-Emmanuel; Hong, Yang] Natl Weather Ctr, Norman, OK USA; [Yoshimura, Kei] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Chang, Eun-Chul] Kongju Natl Univ, Dept Atmospher Sci, Gongju, South Korea; [Ferguson, Craig R.] SUNY Albany, Atmospher Sci Res Ctr, Albany, NY 12222 USA; [Erlingis, Jessica M.] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Hong, Yang] Univ Oklahoma, Sch Civil Engn & Environm Sci, Norman, OK 73019 USA	Hong, Y (reprint author), ARRC, Natl Weather Ctr, Ste 4610,120 David L Boren Blvd, Norman, OK 73072 USA.	yanghong@ou.edu	Yoshimura, Kei/F-2041-2010; Hong, Yang/D-5132-2009; Oki, Taikan/E-5778-2010; KIM, HYUNGJUN/I-5099-2014; Kirstetter, Pierre/E-2305-2013	Oki, Taikan/0000-0003-4067-4678; KIM, HYUNGJUN/0000-0003-1083-8416; Kirstetter, Pierre/0000-0002-7381-0229	Japan Society for the Promotion of Science "KAKENHI" [23226012]; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Environment [S-10]; seventh research announcement for Precipitation Measuring Mission (PMM)	This study was supported by the Japan Society for the Promotion of Science "KAKENHI" (23226012); the Japanese Ministry of Education, Culture, Sports, Science, and Technology "SOUSEI" Program; the Japanese Ministry of Environment Environmental Research and Technology Development Fund (S-10: comprehensive study to develop a global climate change risks management strategy); and the seventh research announcement for Precipitation Measuring Mission (PMM) managed by Japan Aerospace Exploration Agency. We would like to acknowledge the AMMA Land Surface Model Intercomparison Project (ALMIP) and the AMMA-CATCH network for use of the mesoscale precipitation fields. The authors are also grateful to the editor and three anonymous reviewers for their reviews and valuable suggestions during the review process.	Alpert J., 1988, 8 C NUM WEATH PRED B, P726; Alpert J. C., 1996, 11 C NUM WEATH PRED, P322; WALLACE JM, 1975, MON WEATHER REV, V103, P406, DOI 10.1175/1520-0493(1975)103<0406:DVIPAT>2.0.CO;2; Davis CA, 2003, MON WEATHER REV, V131, P2667, DOI 10.1175/1520-0493(2003)131<2667:COWCRI>2.0.CO;2; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Lin X, 2000, J CLIMATE, V13, P4159, DOI 10.1175/1520-0442(2000)013<4159:DVOTHC>2.0.CO;2; ARAKAWA A, 1974, J ATMOS SCI, V31, P674, DOI 10.1175/1520-0469(1974)031<0674:IOACCE>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Roca R, 2010, J APPL METEOROL CLIM, V49, P715, DOI 10.1175/2009JAMC2318.1; Hong SY, 1996, MON WEATHER REV, V124, P2322, DOI 10.1175/1520-0493(1996)124<2322:NBLVDI>2.0.CO;2; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Couvreux F, 2012, Q J ROY METEOR SOC, V138, P56, DOI 10.1002/qj.903; Rio C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036779; Juang HMH, 1997, B AM METEOROL SOC, V78, P2125, DOI 10.1175/1520-0477(1997)078<2125:TNRSMA>2.0.CO;2; Kang HS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009692; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Dai A, 2001, J CLIMATE, V14, P1112, DOI 10.1175/1520-0442(2001)014<1112:GPATFP>2.0.CO;2; Nikulin G, 2012, J CLIMATE, V25, P6057, DOI 10.1175/JCLI-D-11-00375.1; Huang WR, 2011, Q J ROY METEOR SOC, V137, P959, DOI 10.1002/qj.815; MOORTHI S, 1992, MON WEATHER REV, V120, P978, DOI 10.1175/1520-0493(1992)120<0978:RASAPO>2.0.CO;2; Lee MI, 2007, J CLIMATE, V20, P1862, DOI 10.1175/JCL14090.1; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Randall D, 2003, B AM METEOROL SOC, V84, P1547, DOI 10.1175/BAMS-84-11-1547; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Basu BK, 2007, MON WEATHER REV, V135, P2155, DOI 10.1175/MWR3355.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Boyle J, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014262; Lebel T, 2009, J HYDROL, V375, P3, DOI 10.1016/j.jhydrol.2009.03.020; Giorgi F, 1999, J GEOPHYS RES-ATMOS, V104, P6353, DOI 10.1029/98JD01164; Chen TC, 1999, B AM METEOROL SOC, V80, P2299, DOI 10.1175/1520-0477(1999)080<2299:DASVOT>2.0.CO;2; Ridout JA, 2005, MON WEATHER REV, V133, P3315, DOI 10.1175/MWR3034.1; Parker DJ, 2005, Q J ROY METEOR SOC, V131, P2839, DOI 10.1256/qj.04.52; Taylor CM, 2001, Q J ROY METEOR SOC, V127, P845, DOI 10.1256/smsqj.57307; Dai A, 1999, J GEOPHYS RES-ATMOS, V104, P6377, DOI 10.1029/98JD02720; Yoshimura K, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014032; Fritsch JM, 2004, B AM METEOROL SOC, V85, P955, DOI 10.1175/BAMS-85-7-955; Kain JS, 2004, J APPL METEOROL, V43, P170, DOI 10.1175/1520-0450(2004)043<0170:TKCPAU>2.0.CO;2; JUANG HMH, 1994, MON WEATHER REV, V122, P3, DOI 10.1175/1520-0493(1994)122<0003:TNNRSM>2.0.CO;2; Cappelaere B, 2009, J HYDROL, V375, P34, DOI 10.1016/j.jhydrol.2009.06.021; Laing AG, 2008, Q J ROY METEOR SOC, V134, P93, DOI 10.1002/qj.194; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; Taylor CM, 2011, NAT GEOSCI, V4, P430, DOI 10.1038/ngeo1173; Taylor CM, 2013, GEOPHYS RES LETT, V40, P6213, DOI 10.1002/2013GL058511; GRAY WM, 1977, MON WEATHER REV, V105, P1171, DOI 10.1175/1520-0493(1977)105<1171:DVODCC>2.0.CO;2; Yang GY, 2001, MON WEATHER REV, V129, P784, DOI 10.1175/1520-0493(2001)129<0784:TDCITT>2.0.CO;2; Clark AJ, 2007, MON WEATHER REV, V135, P3456, DOI 10.1175/MWR3467.1; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Hong SY, 2006, MON WEATHER REV, V134, P2318, DOI 10.1175/MWR3199.1; RANDALL DA, 1991, J ATMOS SCI, V48, P40, DOI 10.1175/1520-0469(1991)048<0040:DVOTHC>2.0.CO;2; Yu RC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028129; Dai A, 2004, J CLIMATE, V17, P930, DOI 10.1175/1520-0442(2004)017<0930:TDCAID>2.0.CO;2; BALLING RC, 1985, J CLIM APPL METEOROL, V24, P1383, DOI 10.1175/1520-0450(1985)024<1383:WSNPIT>2.0.CO;2; Betts AK, 1996, J GEOPHYS RES-ATMOS, V101, P7209, DOI 10.1029/95JD02135; Boone A., 2009, GEWEX NEWS, V9, P9; Boyd E, 2013, NAT CLIM CHANGE, V3, P631, DOI 10.1038/NCLIMATE1856; Brier G. W., 1965, MON WEA REV, V93, P93, DOI [10.1175/1520-0493(1965)093<lessthan>0093:DASATI<greaterthan>2.3.CO;2., DOI 10.1175/1520-0493(1965)093<LESSTHAN>0093:DASATI<GREATERTHAN>2.3.CO;2]; Chen HM, 2010, J CLIMATE, V23, P905, DOI 10.1175/2009JCLI3187.1; Chou M. -D., 1994, SERIES GLOBAL MODELI, V3; Gallus WA, 1999, WEATHER FORECAST, V14, P405, DOI 10.1175/1520-0434(1999)014<0405:ESOTEP>2.0.CO;2; GARRATT JR, 1993, J CLIMATE, V6, P1090, DOI 10.1175/1520-0442(1993)006<1090:TSEBAL>2.0.CO;2; Gounou A., 2011, THESIS U P SABATIER; Hannay C., 2012, CESM ATM MOD WORK GR; HAURWITZ B, 1973, PURE APPL GEOPHYS, V102, P193, DOI 10.1007/BF00876607; Hodges KI, 1997, MON WEATHER REV, V125, P2821, DOI 10.1175/1520-0493(1997)125<2821:DASOAM>2.0.CO;2; Hong SY, 1999, J CLIMATE, V12, P592, DOI 10.1175/1520-0442(1999)012<0592:AEOTNR>2.0.CO;2; KIM JW, 1992, J ATMOS SCI, V49, P735, DOI 10.1175/1520-0469(1992)049<0735:MTBGW>2.0.CO;2; Koo MS, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012574; Li Z, 2014, J APPL METEOROL CLIM, V53, P873, DOI 10.1175/JAMC-D-13-0277.1; Lin YL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017018; MCGARRY MM, 1978, MON WEATHER REV, V106, P101, DOI 10.1175/1520-0493(1978)106<0101:DVICAA>2.0.CO;2; Mohr KI, 2004, J CLIMATE, V17, P2441, DOI 10.1175/1520-0442(2004)017<2441:IMARVI>2.0.CO;2; Pan H-L, 1995, NMC OFFICE NOTE, V409, P40; Pu B, 2010, J CLIMATE, V23, P6263, DOI 10.1175/2010JCLI3648.1; Ramage C. S., 1971, MONSOON METEOROLOGY; RAMAGE CS, 1952, J METEOROL, V9, P83, DOI 10.1175/1520-0469(1952)009<0083:DVOSRO>2.0.CO;2; SCHWARTZ BE, 1979, MON WEATHER REV, V107, P1535, DOI 10.1175/1520-0493(1979)107<1535:TDVOFR>2.0.CO;2; Shin DW, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008333; SLINGO A, 1987, MON WEATHER REV, V115, P1451, DOI 10.1175/1520-0493(1987)115<1451:SOTDCO>2.0.CO;2; Sperber KR, 2006, B AM METEOROL SOC, V87, P1399, DOI 10.1175/BAMS-87-10-1399; Vischel T, 2011, J HYDROMETEOROL, V12, P1465, DOI 10.1175/JHM-D-10-05015.1; Wai MMK, 1996, BOUND-LAY METEOROL, V81, P123, DOI 10.1007/BF00119062; Wang W, 1997, MON WEATHER REV, V125, P252, DOI 10.1175/1520-0493(1997)125<0252:ACSOCP>2.0.CO;2; Wilks DS, 2005, STAT METHODS ATMOSPH; Yoshimura K, 2008, MON WEATHER REV, V136, P2983, DOI 10.1175/2008MWR2281.1; Yuan WH, 2013, J CLIMATE, V26, P3159, DOI 10.1175/JCLI-D-12-00119.1	85	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0882-8156	1520-0434		WEATHER FORECAST	Weather Forecast.	APR	2015	30	2					424	445		10.1175/WAF-D-14-00013.1		22	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CG2KN	WOS:000353103600011		
J	Inoue, M; Fraser, AD; Adams, N; Carpentier, S; Phillips, HE				Inoue, Mana; Fraser, Alexander D.; Adams, Neil; Carpentier, Scott; Phillips, Helen E.			An Assessment of Numerical Weather Prediction-Derived Low-Cloud-Base Height Forecasts	WEATHER AND FORECASTING			English	Article						Antarctica; Forecast verification; skill; Forecasting techniques; Numerical weather prediction; forecasting	SUBVISUAL CIRRUS CLOUDS; MODEL PERFORMANCE; HUMIDITY	As demand for flight operations in Antarctica grows, accurate weather forecasting of cloud properties such as extent, cloud base, and cloud-top altitude becomes essential. The primary aims of this work are to ascertain relationships between numerical weather prediction (NWP) model output variables and surface-observed cloud properties and to develop low-cloud-base (<2000 m) height prediction algorithms for use across Antarctica to assist in low-cloud forecasting for aircraft operations. NWP output and radiosonde data are assessed against surface observations, and the relationship between the relative humidity RH profile and the height of the observed low-cloud base is investigated. The ability of NWP-derived RH and ice-water cloud optical depth profiles to represent the observed low-cloud conditions around each of the three Australian stations in East Antarctica is assessed. NWP-derived RH is drier than that reported by radiosonde from ground level up to similar to 2000 m. This trend reverses in the higher troposphere, and the largest positive difference is observed at similar to 10 000 m. A consequence is very low RH thresholds are needed for low-cloud-base height prediction using NWP RH profiles. RH and optical depth-based threshold techniques all show skill in reproducing the observed cloud-base height at all Australian Antarctic stations, but the radiosonde-derived RH technique is superior in all cases. This comparison of three low-cloud-base height retrieval techniques provides the first documented assessment of the relative efficacy of each technique in Antarctica.	[Inoue, Mana; Phillips, Helen E.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7001, Australia; [Inoue, Mana; Fraser, Alexander D.] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia; [Fraser, Alexander D.] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Adams, Neil; Carpentier, Scott] Australian Bur Meteorol, Hobart, Tas, Australia	Inoue, M (reprint author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Inst Marine & Antarctic Studies, Private Bag 129, Hobart, Tas 7001, Australia.	mana.inoue@utas.edu.au			Australian Government Cooperative Research Centres Programme through the Australian Bureau of Meteorology; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); Japan Society for the Promotion of Science (JSPS) KAKENHI [25.03748]	This work was carried out with the support of the Australian Government Cooperative Research Centres Programme through the Australian Bureau of Meteorology and the Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC), and was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 25.03748.	Adams N., 1999, AUST METEOROL MAG, V50, P12; Adams N, 2002, METEOROL APPL, V9, P335, DOI 10.1017/S1350482702003079; Adams N, 2004, WEATHER FORECAST, V19, P653, DOI 10.1175/1520-0434(2004)019<0653:ANMSOT>2.0.CO;2; Adams N., 2007, P 2 ANT MET OBS MOD; Lachlan-Cope T, 2010, POLAR RES, V29, P150, DOI 10.1111/j.1751-8369.2010.00148.x; Miloshevich LM, 2004, J ATMOS OCEAN TECH, V21, P1305, DOI 10.1175/1520-0426(2004)021<1305:DAVOAT>2.0.CO;2; McFarquhar GM, 2000, J ATMOS SCI, V57, P1841, DOI 10.1175/1520-0469(2000)057<1841:TASTTC>2.0.CO;2; Miloshevich LM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011565; Walden VP, 2003, J APPL METEOROL, V42, P1391, DOI 10.1175/1520-0450(2003)042<1391:AICOTA>2.0.CO;2; Tomasi C, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015803; Korolev A, 2006, J ATMOS SCI, V63, P2865, DOI 10.1175/JAS3784.1; Australian Bureau of Meteorology, 2014, AER SERV HDB 2014, V2014, P57; BOHREN CF, 1995, J ATMOS SCI, V52, P1257, DOI 10.1175/1520-0469(1995)052<1257:AWOTDA>2.0.CO;2; Bourassa AE, 2005, ADV SPACE RES, V36, P807, DOI 10.1016/j.asr.2005.05.045; Bromwich DH, 2013, J GEOPHYS RES-ATMOS, V118, P274, DOI 10.1029/2012JD018139; Giannakaki E, 2007, ATMOS CHEM PHYS, V7, P5519; Heymsfield AJ, 2003, J APPL METEOROL, V42, P1369, DOI 10.1175/1520-0450(2003)042<1369:IWPDRF>2.0.CO;2; Holton J., 1992, INT GEOPHYS SERIES, V48; Landulfo E., 2008, SPIE P, V7107, DOI [10.1117/12.799872, DOI 10.1117/12.799872]; Lo C., 2006, DOESCARMTR077 PNNL; Luo Y., 2004, P 14 ARM SCI TEAM M; National Weather Service Environmental Modeling Center, GLOB FOR SYST GFS GL; Pendlebury SF, 2003, MON WEATHER REV, V131, P335, DOI 10.1175/1520-0493(2003)131<0335:NWPMPO>2.0.CO;2; Puri K, 1998, AUST METEOROL MAG, V47, P203; SASSEN K, 1989, J APPL METEOROL, V28, P91, DOI 10.1175/1520-0450(1989)028<0091:OSAMPO>2.0.CO;2; SCHAEFER JT, 1990, WEATHER FORECAST, V5, P570, DOI 10.1175/1520-0434(1990)005<0570:TCSIAA>2.0.CO;2; SCHMIDT EO, 1993, P SOC PHOTO-OPT INS, V1934, P230, DOI 10.1117/12.154907; Turner J., 2000, B AM METEOROL SOC, V81, P75, DOI 10.1175/1520-0477(2000)081<lessthan>0075:ROTFIS<greaterthan>2.3.CO;2; Wood R., RELATIONSHIPS BETWEE	29	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0882-8156	1520-0434		WEATHER FORECAST	Weather Forecast.	APR	2015	30	2					486	497		10.1175/WAF-D-14-00052.1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CG2KN	WOS:000353103600015		
J	Kim, YC; Tamura, Y; Yoon, SW				Kim, Yong Chul; Tamura, Yukio; Yoon, Sung-won			Effect of taper on fundamental aeroelastic behaviors of super-tall buildings	WIND AND STRUCTURES			English	Article						wind tunnel experiment; aeroelastic behavior; taper; low-turbulence flow; grid-generated flow; boundary-layer flow	WIND PRESSURES; SET-BACK; TURBULENCE; TOWER; LOADS	Aeroelastic wind tunnel experiments were conducted for conventional and tapered super-tall building models to investigate the effect of taper on fundamental aeroelastic behaviors in various incident flows. Three incident flows were simulated: a turbulent boundary-layer flow representing urban area; a low-turbulent flow; and a grid-generated flow. Results were summarized focusing on the effect of taper and the effect of incident flows. The suppression of responses by introducing taper was profound in the low-turbulence flow and boundary-layer flow, but in the grid-generated flow, the response becomes larger than that of the square model when the wind is applied normal to the surface. The effects of taper and incident flows were clearly shown on the normalized responses, power spectra, stability diagrams and probability functions.	[Kim, Yong Chul] Tokyo Polytech Univ, Wind Engn Res Ctr, Atsugi, Kanagawa 2420297, Japan; [Tamura, Yukio] Beijing Jiaotong Univ, Sch Civil Engn, Beijing 100044, Peoples R China; [Yoon, Sung-won] Seoul Natl Univ Sci & Technol, Sch Architecture, Seoul 139743, South Korea	Kim, YC (reprint author), Tokyo Polytech Univ, Wind Engn Res Ctr, 1583 Liyama, Atsugi, Kanagawa 2420297, Japan.	gentle95@gmail.com; yukio@arch.t-kougei.ac.jp; swyoon@seoultech.ac.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A6A3A01064632]; Ministry of Education, Science, and Technology [NRF-2013R1A1A2006737]; Ministry of Education, Culture, Sports, Science and Technology, Japan, through Global Center of Excellence Program	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A6A3A01064632) and by the Ministry of Education, Science, and Technology (NRF-2013R1A1A2006737). This study was partly funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan, through the Global Center of Excellence Program, 2008-2012. The authors gratefully acknowledge their support.	Carassale L, 2013, J WIND ENG IND AEROD, V123, P274, DOI 10.1016/j.jweia.2013.09.002; Kim YC, 2013, J FLUID STRUCT, V39, P306, DOI 10.1016/j.jfluidstructs.2013.02.008; Kim YM, 2008, J WIND ENG IND AEROD, V96, P1307, DOI 10.1016/j.jweia.2008.02.038; Tanaka H, 2012, J WIND ENG IND AEROD, V107, P179, DOI 10.1016/j.jweia.2012.04.014; Kawai H, 1998, J WIND ENG IND AEROD, V74-6, P719, DOI 10.1016/S0167-6105(98)00065-8; PARKINSON GV, 1964, Q J MECH APPL MATH, V17, P225, DOI 10.1093/qjmam/17.2.225; Architectural Institution of Japan, 2004, REC LOADS BUILD 2004; Belloli M, 2011, J WIND ENG IND AEROD, V99, P729, DOI 10.1016/j.jweia.2011.03.013; Belloli M, 2014, J WIND ENG IND AEROD, V126, P75, DOI 10.1016/j.jweia.2014.01.004; Huang P., 2013, MATH PROBL ENG, V2013, P1; John AD, 2011, PROCEDIA ENGINEER, V14, P1252, DOI 10.1016/j.proeng.2011.07.157; KAWAI H, 1995, J WIND ENG IND AEROD, V54, P125, DOI 10.1016/0167-6105(94)00035-C; Kim Y, 2010, WIND STRUCT, V13, P499; KWOK KCS, 1980, J ENG MECH DIV-ASCE, V106, P273; Naudascher E., 2005, FLUID INDUCED VIBRAT; Novak M., 1970, J ENGINEERING MECHAN, V96, P17; Pozzuoli C, 2013, J WIND ENG IND AEROD, V123, P325, DOI 10.1016/j.jweia.2013.09.014; Tamura Y., 2012, INT J HIGH RISE BUIL, V1, P1; Tanaka H., 2013, INT J HIGH RISE BUIL, V2, P213; Ukeguchi N., 1970, P 1 NAT S WIND ENG, P153	20	1	1	TECHNO-PRESS	DAEJEON	PO BOX 33, YUSEONG, DAEJEON 305-600, SOUTH KOREA	1226-6116	1598-6225		WIND STRUCT	Wind Struct.	APR	2015	20	4					527	548		10.12989/was.2015.20.4.527		22	Construction & Building Technology; Engineering, Civil; Mechanics	Construction & Building Technology; Engineering; Mechanics	CG3ZM	WOS:000353219100003		
J	Wanibuchi, M; Akiyama, Y; Mikami, T; Iihoshi, S; Miyata, K; Horita, Y; Sugino, T; Komatsu, K; Suzuki, K; Yamashita, K; Mikuni, N				Wanibuchi, Masahiko; Akiyama, Yukinori; Mikami, Takeshi; Iihoshi, Satoshi; Miyata, Kei; Horita, Yoshifumi; Sugino, Toshiya; Komatsu, Katsuya; Suzuki, Kengo; Yamashita, Ken; Mikuni, Nobuhiro			Radical Removal of Recurrent Malignant Meningeal Tumors of the Cavernous Sinus in Combination with High-Flow Bypass	WORLD NEUROSURGERY			English	Editorial Material						Cavernous sinus; High-flow bypass; Meningioma; Radical removal; Skull base	SKULL BASE MENINGIOMAS; ANAPLASTIC MENINGIOMAS; CAROTID-ARTERY; SURGERY; RECONSTRUCTION; INFILTRATION; ANEURYSMS; EVOLUTION	BACKGROUND: Meningiomas or solitary fibrous tumors arising from the cavernous sinus (CS) are usually treated with radiosurgery to control growth. Surgical removal of cavernous tumors is indicated only for tumors extending outside the CS. However, even after adequate treatment, the tumor may exhibit recurrence or malignant transformation. We report a treatment option for recurrent meningeal tumors of the CS. METHODS: In 4 patients with CS tumors that exhibited regrowth after multiple operations and radiosurgery, radical removal in combination with high-flow bypass was performed, and a vascularized muscle flap was used for reconstruction. One patient had a radiation-induced atypical meningioma, 2 patients had transformed atypical meningiomas, and 1 patient had a frequently recurring solitary fibrous tumor. RESULTS: No local recurrence was observed in any patients during a follow-up period of 13-41 months. In all patients, a Karnofsky performance scale score of >80 on admission was maintained at >70 at the final follow-up evaluation. CONCLUSIONS: Radical removal in combination with high-flow bypass provides favorable results and maintains quality of life in patients with recurrent CS meningeal tumors.	[Wanibuchi, Masahiko; Akiyama, Yukinori; Mikami, Takeshi; Iihoshi, Satoshi; Miyata, Kei; Horita, Yoshifumi; Sugino, Toshiya; Komatsu, Katsuya; Suzuki, Kengo; Mikuni, Nobuhiro] Sapporo Med Univ Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Yamashita, Ken] Sapporo Med Univ Sch Med, Dept Plast & Reconstruct Surg, Sapporo, Hokkaido, Japan	Wanibuchi, M (reprint author), Sapporo Med Univ Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan.	wanibuti@sapmed.ac.jp					ALMEFTY O, 1988, SURG NEUROL, V30, P370, DOI 10.1016/0090-3019(88)90200-5; Skeie BS, 2010, NEUROSURGERY, V66, P661, DOI 10.1227/01.NEU.0000366112.04015.E2; LARSON JJ, 1995, J NEUROSURG, V83, P596, DOI 10.3171/jns.1995.83.4.0596; JAASKELAINEN J, 1986, SURG NEUROL, V25, P233, DOI 10.1016/0090-3019(86)90233-8; Sekhar LN, 2008, NEUROSURGERY, V62, P1373, DOI [10.1227/01.neu.0000333803.97703.c6, 10.1227/01.NEU.0000315873.41953.74]; Krayenbuhl N, 2007, NEUROSURGERY, V61, P495, DOI 10.1227/01.NEU.0000280009.79813.DE; Al-Mefty O, 2004, J NEUROSURG, V101, P210, DOI 10.3171/jns.2004.101.2.0210; Pasquier D, 2008, INT J RADIAT ONCOL, V71, P1388, DOI 10.1016/j.ijrobp.2007.12.020; Di Maio S, 2012, WORLD NEUROSURG, V78, P260, DOI 10.1016/j.wneu.2011.09.004; Gil Z, 2010, SKULL BASE-INTERD AP, V20, P1, DOI 10.1055/s-0029-1242976; Johnson MD, 2008, J NEURO-ONCOL, V86, P109, DOI 10.1007/s11060-007-9434-z; KOTAPKA MJ, 1994, J NEUROSURG, V81, P252, DOI 10.3171/jns.1994.81.2.0252; Litre CF, 2009, INT J RADIAT ONCOL, V74, P1012, DOI 10.1016/j.ijrobp.2008.09.012; PARKINSO.D, 1965, J NEUROSURG, V23, P474, DOI 10.3171/jns.1965.23.5.0474; Sekhar LN, 1999, NEUROSURGERY, V44, P1207, DOI 10.1097/00006123-199906000-00028; West CA, 2006, J PLAST RECONSTR AES, V59, P631, DOI 10.1016/j.bjps.2005.06.001; YAMADA A, 1992, BRIT J PLAST SURG, V45, P302, DOI 10.1016/0007-1226(92)90057-5	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2015	83	4					424	430		10.1016/j.wneu.2015.01.019		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG1NJ	WOS:000353039500006		
J	Nitta, N; Nozaki, K				Nitta, Naoki; Nozaki, Kazuhiko			Treatment for Large Cerebral Infarction: Past, Present, and Future	WORLD NEUROSURGERY			English	Editorial Material						Decompressive hemicraniectomy; Elderly patients; Functional outcomes; Malignant middle cerebral artery infarction; Mortality; Nationwide survey	ARTERY INFARCTION; DECOMPRESSIVE SURGERY; CEREBELLAR INFARCTION; BRAIN; HEMICRANIECTOMY; TRIAL; HYPOTHERMIA; STROKE; MULTICENTER; OCCLUSION		[Nitta, Naoki; Nozaki, Kazuhiko] Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 52021, Japan	Nozaki, K (reprint author), Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 52021, Japan.	noz@belle.shiga-med.ac.jp					Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Walz B, 2002, J NEUROL, V249, P1183, DOI 10.1007/s00415-002-0798-x; De Georgia MA, 2004, NEUROLOGY, V63, P312; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; SHAW CM, 1959, ARCH NEUROL-CHICAGO, V1, P161; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Schwab S, 1998, STROKE, V29, P1888; Brient B W, 1965, Surg Forum, V16, P407; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621; Cushing H, 1905, SURG GYNECOL OBSTET, V1, P297; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; GREENWOO.J, 1968, JOHNS HOPKINS MED J, V122, P254; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236; LEHRICH JR, 1970, ARCH NEUROL-CHICAGO, V22, P490; RIEKE K, 1995, CRIT CARE MED, V23, P1576, DOI 10.1097/00003246-199509000-00019; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19; TAYLOR CB, 1949, ARCH PATHOL, V48, P195	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2015	83	4					483	485		10.1016/j.wneu.2014.08.054		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG1NJ	WOS:000353039500022		
J	Ohya, J; Chikuda, H; Kato, S; Horiguchi, H; Takeshita, K; Tanaka, S; Yasunaga, H				Ohya, Junichi; Chikuda, Hirotaka; Kato, So; Horiguchi, Hiromasa; Takeshita, Katsushi; Tanaka, Sakae; Yasunaga, Hideo			Risks of In-Hospital Death and Complications After Fusion Surgery in Patients with Atlantoaxial Subluxation: Analysis of 1090 Patients Using the Japanese Diagnosis Procedure Combination Database	WORLD NEUROSURGERY			English	Article						Atlantoaxial subluxation; Complications; Database; Rheumatoid arthritis; Mortality	TRANSARTICULAR SCREW FIXATION; VERTEBRAL ARTERY INJURY; RHEUMATOID-ARTHRITIS; ADMINISTRATIVE DATABASE; LIVER-TRANSPLANTATION; SPINE SURGERY; MORTALITY; REDUCTION; TRANSFUSION; ASSOCIATION	OBJECTIVE: To examine in-hospital mortality and postoperative major complications in patients undergoing fusion surgery for atlantoaxial subluxation (AAS) and to examine whether the risk of perioperative complications varies between patients with and without rheumatoid arthritis (RA). METHODS: A retrospective analysis of data from the Diagnosis Procedure Combination database, a nationwide administrative impatient database in Japan, identified 1090 patients who underwent spinal fusion surgery for AAS during 2007-2012. Patients' clinical characteristics were extracted, including age, sex, use of homologous blood transfusion, length of stay, and type of hospital. Clinical outcomes included in-hospital death and major complications, including surgical-site infection, sepsis, cardiac events, respiratory disorders, acute renal failure, pulmonary embolism, perioperative stroke, and vertebral injury. Massive blood transfusion was defined as at least 6 units of red blood cells. RESULTS: Four hundred sixty-five patients (42.7%) were classified as the RA group. In-hospital mortality after fusion surgery for AAS was 0.5% (5/1090), and major complications occurred in 5% (55/1090). Multivariate analyses showed that patients with RA were more likely to have major complications after surgery than patients without RA (odds ratio: 1.69; 95% confidence interval: 0.96-2.97; P = 0.07), and the rate of massive blood transfusion was significantly greater in patients with RA than in patients without RA (odds ratio: 2.29; 95% confidence interval: 1.12-4.68; P = 0.02). CONCLUSIONS: The in-hospital mortality after fusion surgery for AAS was relatively low. However, patients with RA had an increased risk of postoperative complications and massive blood transfusion compared with patients without RA.	[Ohya, Junichi; Chikuda, Hirotaka; Kato, So; Takeshita, Katsushi; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Horiguchi, Hiromasa; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan	Ohya, J (reprint author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan.	oyaj-ort@h.u-tokyo.ac.jp			Ministry of Health, Labour and Welfare, Japan [H22-Policy-031, H23-Nanchi-032]	This study was funded by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H22-Policy-031; Research on Intractable Diseases grant number: H23-Nanchi-032). The funders played no role in the design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Madawi AA, 1997, J NEUROSURG, V86, P961, DOI 10.3171/jns.1997.86.6.0961; Gluf WM, 2005, J NEUROSURG-SPINE, V2, P155, DOI 10.3171/spi.2005.2.2.0155; Dekutoski MB, 2010, SPINE, V35, pS9, DOI 10.1097/BRS.0b013e3181d830de; Jamsen E, 2009, J BONE JOINT SURG AM, V91A, P38, DOI 10.2106/JBJS.G.01686; Nagaria J, 2009, SPINE, V34, P2880, DOI 10.1097/BRS.0b013e3181b4e218; Kawakami K, 2010, RHEUMATOLOGY, V49, P341, DOI 10.1093/rheumatology/kep376; Karkouti K, 2004, TRANSFUSION, V44, P1453, DOI 10.1111/j.1537-2995.2004.04144.x; Bongartz T, 2008, ARTHRIT RHEUM-ARTHR, V59, P1713, DOI 10.1002/art.24060; Neo M, 2008, SPINE, V33, P779, DOI 10.1097/BRS.0b013e31816957a7; Ramos E, 2003, LIVER TRANSPLANT, V9, P1320, DOI 10.1016/j.lts.2003.50204; Chikuda H, 2012, J BONE JOINT SURG AM, V94A, P433, DOI 10.2106/JBJS.K.00183; Chikuda H, 2014, EMERG MED J, V31, P201, DOI 10.1136/emermed-2012-202058; Klimo P, 2008, J NEUROSURG-SPINE, V9, P332, DOI 10.3171/SPI.2008.9.10.332; Wright NM, 1998, J NEUROSURG, V88, P634, DOI 10.3171/jns.1998.88.4.0634; Chang PY, 2014, J NEUROSURG-SPINE, V20, P121, DOI 10.3171/2013.7.SPINE13676; Chikuda H, 2014, SPINE J, V14, P2275, DOI 10.1016/j.spinee.2014.01.024; Chikuda H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-173; Dahdaleh NS, 2013, WORLD NEUROSURG, V80, pE391, DOI 10.1016/j.wneu.2012.11.040; Dimitroulas T, 2013, CLIN RHEUMATOL, V32, P1357, DOI 10.1007/s10067-013-2283-6; Elliott RE, 2013, WORLD NEUROSURG, V80, P627, DOI 10.1016/j.wneu.2012.03.012; Finn Michael A, 2010, Neurosurgery, V66, P184, DOI 10.1227/01.NEU.0000365798.53288.A3; Izeki M, 2013, SPINE, V38, pE513, DOI 10.1097/BRS.0b013e31828b26df; Lunardini DJ, 2013, SPINE J, V14, P1520; McCluskey SA, 2006, LIVER TRANSPLANT, V12, P1584, DOI 10.1002/lt.20868; Miyata M, 2008, J NEUROSURG-SPINE, V9, P17, DOI 10.3171/SPI/2008/9/7/017; Miyata M, 2008, SPINE, V33, P2007, DOI 10.1097/BRS.0b013e31817c6bf7; Suh BG, 2013, J NEUROSURG-SPINE, V19, P160, DOI 10.3171/2013.5.SPINE12859	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2015	83	4					603	607		10.1016/j.wneu.2014.12.019		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG1NJ	WOS:000353039500040		
J	Ota, N; Tanikawa, R; Miyazaki, T; Miyata, S; Oda, J; Noda, K; Tsuboi, T; Takeda, R; Kamiyama, H; Tokuda, S				Ota, Nakao; Tanikawa, Rokuya; Miyazaki, Takanori; Miyata, Shiro; Oda, Jumpei; Noda, Kosumo; Tsuboi, Toshiyuki; Takeda, Rihei; Kamiyama, Hiroyasu; Tokuda, Sadahisa			Surgical Microanatomy of the Anterior Clinoid Process for Paraclinoid Aneurysm Surgery and Efficient Modification of Extradural Anterior Clinoidectomy	WORLD NEUROSURGERY			English	Article						Anatomic variation of the anterior clinoid process; Caroticoclinoid foramen; Extradural anterior clinoidectomy; Interclinoid osseous bridge; Paraclinoid aneurysms; Pneumatization of the anterior clinoid process	ANATOMICAL VARIATIONS; CLINICAL IMPORTANCE; REGION; SINUS; FORAMEN	BACKGROUND: Anatomic variations of the anterior clinoid process (ACP) should be recognized before clinoidectomy to ensure a safe approach. This study describes the incidence of caroticoclinoid foramen (CCF), interclinoid osseous bridge, and pneumatization of the ACP during extradural anterior clinoidectomy. The problems and technical issues encountered in such cases are described. METHODS: Using multidetector-row computed tomography, 144 sides in 72 cases of paraclinoid aneurysm treated by extradural anterior clinoidectomy were analyzed preoperatively. RESULTS: CCF, interclinoid osseous bridge, and pneumatization of the ACP were observed in 16.6%, 2.77%, and 27.7% of cases. Pneumatized patterns were divided into 3 groups according to route: pneumatization via the optic strut (in 74.1%), pneumatization via the anterior root (in 14.8%), and pneumatization via optic strut and anterior root (in 11.1%). CCF and interclinoid osseous bridge represent obstacles to complete extradural removal of the ACP. The ACP should not be moved even after drilling the lateral wall of the ACP, orbital roof, and optic strut, so an intradural approach is sometimes needed. A CCF warrants careful removal to open the distal dural ring. Awareness of the routes of pneumatization for the ACP should reduce the risk of tears in the paranasal mucosa. If tears arise in the mucosa, suturing and closure are needed to prevent liquorrhea. CONCLUSIONS: Preoperative computed tomography is useful to detect variations in the anatomy around the ACP. When performing extradural anterior clinoidectomy in such anomalous cases, appropriate modifications are needed to ensure a safe approach.	[Ota, Nakao; Tanikawa, Rokuya; Miyazaki, Takanori; Miyata, Shiro; Oda, Jumpei; Noda, Kosumo; Tsuboi, Toshiyuki; Takeda, Rihei; Kamiyama, Hiroyasu; Tokuda, Sadahisa] Teishinkai Hosp, Dept Neurosurg, Stroke Ctr, Sapporo, Hokkaido, Japan	Ota, N (reprint author), Teishinkai Hosp, Dept Neurosurg, Stroke Ctr, Sapporo, Hokkaido, Japan.	nakao1980@gmail.com					Erturk M, 2004, NEUROSURG REV, V27, P22, DOI 10.1007/s10143-003-0265-x; Citardi MJ, 2004, AM J RHINOL, V18, P173; Mikami T, 2007, J NEUROSURG, V106, P170, DOI 10.3171/jns.2007.106.1.170; Yonekawa Y, 1997, J NEUROSURG, V87, P636, DOI 10.3171/jns.1997.87.4.0636; Kantarci M, 2004, EUR J RADIOL, V50, P296, DOI 10.1016/j.ejrad.2003.08.012; Avci E, 2005, MINIM INVAS NEUROSUR, V48, P268, DOI 10.1055/s-2005-915595; Das S, 2007, SAO PAULO MED J, V125, P351, DOI 10.1590/S1516-31802007000600009; DOLENC V, 1983, J NEUROSURG, V58, P824, DOI 10.3171/jns.1983.58.6.0824; Henle J, 1855, HDB SYSTEMATISCHEN A, P99; Huynh-Le Phuong, 2004, J Clin Neurosci, V11, P283, DOI 10.1016/j.jocn.2003.08.005; INOUE T, 1990, NEUROSURGERY, V26, P903; Kapur E, 2012, BOSNIAN J BASIC MED, V12, P88; Keyes JEL, 1935, ARCH OPHTHALMOL-CHIC, V13, P538; LANG J, 1977, ACTA ANAT, V99, P121; Ozdogmus O, 2003, SURG RADIOL ANAT, V25, P241, DOI 10.1007/s00276-003-0111-4; Williams PL, 1995, GRAYS ANATOMY, P569	16	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2015	83	4					635	643		10.1016/j.wneu.2014.12.014		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CG1NJ	WOS:000353039500045		
J	Sasahara, K; Kumasaki, M; Date, S; Koshi, M				Sasahara, Kohei; Kumasaki, Mieko; Date, Shingo; Koshi, Mitsuo			Electrostatic Interaction and Reaction Behavior of a 1, 2,4-Triazole Mixture with Dinitrobenzene	ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE			English	Article						Electrostatic interactions; 1,2,4-Triazole; Dinitrohenzene; Density functional calculations; Thermal behavior	ELECTRONIC POPULATION ANALYSIS; MOLECULAR WAVE FUNCTIONS; CRYSTAL-STRUCTURE; NITROBENZENES; PYROTECHNICS; COMBUSTION	The electrostatic interactions between gas generating agent and organic electron withdrawing additives were studied to understand how the interaction affects the reactions of their thermal behavior. To explore the electronic interaction and its effect, the thermal behavior of a mixture of dinitrobenzene isomers [p-dinitrobenzene (pDNB) and m-dinitrobenzene (mDNB)] and 1,2,4-tri.azole (TA) was analyzed. Density functional calculations and electron density analysis proved that both pDNB and mDNB in a 1:1 ratio withdraw electrons from 4A. The analysis of pyrolysis behavior showed that TA and dinitrobenzene, mixtures (TA/pDMB or TA/mDNB) react at lower temperatures than each precursor. Gas chromatography mass analysis and UV/Ms spectroscopy showed reasonable results that suggested that pDNB and TA make condensed products in the initial stage of the reaction according to the differential scanning calorimetry measurement. When the mixtures were ignited under pressurized conditions, TA/pDNB burned easily while TA/mDNB burned only partially. Those results suggested that the interaction between tbazole and &nitrobenzene affects the pyrolysis and combustion behavior of a TA/dinitrobenzene, mixture.	[Sasahara, Kohei; Kumasaki, Mieko; Koshi, Mitsuo] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa 240, Japan; [Date, Shingo] Natl Def Acad, Yokosuka, Kanagawa 239, Japan	Kumasaki, M (reprint author), Yokohama Natl Univ, Grad Sch Environm & Informat Sci, 79-5 Tokiwadai, Yokohama, Kanagawa 240, Japan.	kumasaki@ynu.ac.jp			Cooperative Research and Development Project of Graduate School of Environment and Information Sciences in Yokohama National University	This project was funded by the Cooperative Research and Development Project of Graduate School of Environment and Information Sciences in Yokohama National University. The authors would like to thank to Mr Kaneko and Mr. Ishihara at Instrument Analysis Centre of Yokohama National University for using GC-MS, <SUP>1</SUP>H NMR, and their technical advice.	MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588; Fayet G, 2008, J PHYS CHEM A, V112, P4054, DOI 10.1021/jp800043x; MULLIKEN RS, 1955, J CHEM PHYS, V23, P1841, DOI 10.1063/1.1740589; FUKUDA EK, 1985, J AM CHEM SOC, V107, P2291, DOI 10.1021/ja00294a014; Danali SM, 2010, DEFENCE SCI J, V60, P152; Bennett GM, 1936, J CHEM SOC, P1108, DOI 10.1039/jr9360001108; Berneman C. M., 1990, J COMPUT CHEM, V11, P361; FIELDS EK, 1972, J ORG CHEM, V37, P3861, DOI 10.1021/jo00797a021; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hertel E, 1933, Z PHYS CHEM B-CHEM E, V22, P280; Hertel E., 1930, Z PHYS CH B, V11, P59; Hertel E, 1931, Z PHYS CHEM B-CHEM E, V13, P387; Itoh M., 1990, KOGYO KAYAKU, V51, P76; Klapotke TM, 2008, Z ANORG ALLG CHEM, V634, P2777, DOI 10.1002/zaac.200800171; KONDRIKOV BN, 1973, COMBUST EXPLO SHOCK+, V9, P68, DOI 10.1007/BF00740362; Kumasaki M., 2001, KAYAKU GAKKAISHI SCI, V62, P109; Ohno Y., 1999, KAYAKU GAKKAISHI SCI, V60, P212; PARINI VP, 1962, RUSS CHEM REV+, V31, P408, DOI 10.1070/RC1962v031n07ABEH001302; Sanhey R. C., 1949, J INDIAN CHEM SOC, V26, P329; Sinditskii VP, 2005, PROPELL EXPLOS PYROT, V30, P269, DOI 10.1002/prep.200500017; Steinhauser G, 2008, ANGEW CHEM INT EDIT, V47, P3330, DOI 10.1002/anie.200704510; THOMAS J, 1988, FRESEN Z ANAL CHEM, V331, P825, DOI 10.1007/BF00469458	22	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0044-2313	1521-3749		Z ANORG ALLG CHEM	Z. Anorg. Allg. Chem.	APR	2015	641	5					786	791		10.1002/zaac.201400411		6	Chemistry, Inorganic & Nuclear	Chemistry	CG1LR	WOS:000353034600007		
J	Ito, A				Ito, Akiko			Notes on the divisibility of the class numbers of imaginary quadratic fields Q(root 3(2e)-4k(n))	ABHANDLUNGEN AUS DEM MATHEMATISCHEN SEMINAR DER UNIVERSITAT HAMBURG			English	Article						Class number; Imaginary quadratic field; Divisibility	EQUATION	Let be a positive integer, an integer greater than , and a positive integer with . We study the divisibility of the class numbers of the imaginary quadratic fields . First, we treat the case where . This case is studied by Le (Kexue Tongbao 32:724-727, 1987) and Louboutin (Proc Am Math Soc 137:4025-4028, 2009). Combining their methods and results on positive integer solutions of certain Diophantine equations, we refine their results. Next, we treat the case where is a prime number and is a power of three. Let be a prime number except for and let and be positive integers. Using Kishi's method in (Glasgow Math J 51:187-191, 2009), we show that the class numbers of the imaginary quadratic fields are divisible by if or with some conditions.	Kanagawa Univ, Kanagawa Ku, Yokohama, Kanagawa 2218686, Japan	Ito, A (reprint author), Kanagawa Univ, Kanagawa Ku, 3-27-1 Rokkakubashi, Yokohama, Kanagawa 2218686, Japan.	aito@kanagawa-u.ac.jp			JSPS [18005]	The author is supported by JSPS Core-to-Core 18005.	Ankeny N., 1955, PAC J MATH, V5, P321; Louboutin SR, 2009, P AM MATH SOC, V137, P4025; Soundararajan K, 2000, J LOND MATH SOC, V61, P681, DOI 10.1112/S0024610700008887; Bugeaud Y, 2001, J REINE ANGEW MATH, V539, P55; Cohn J. H. E., 1965, P GLASGOW MATH ASSOC, V7, P24; Cohn J.H.E., 2001, P AM MATH SOC, V130, P1275; GROSS BH, 1978, INVENT MATH, V44, P201, DOI 10.1007/BF01403161; Ishii K, 2011, P JPN ACAD A-MATH, V87, P142, DOI 10.3792/pjaa.87.142; Ito A, 2011, GLASGOW MATH J, V53, P379, DOI 10.1017/S0017089511000012; Kishi Y, 2010, GLASGOW MATH J, V52, P207, DOI 10.1017/S0017089509990371; Le M., 1987, KEXUE TONGBAO, V32, P724; Leu MG, 2003, P AM MATH SOC, V131, P3643, DOI 10.1090/S0002-9939-03-07212-5; Mollin RA, 1996, GLASGOW MATH J, V38, P195; Nagell T., 1922, ABH MATH SEM HAMBURG, V1, P140, DOI 10.1007/BF02940586; Ribenboim P., 1994, CATALANS CONJECTURE; Yuan P.Z., 2005, HEILONGJIANG DAXUE Z, V22, P195	16	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5858	1865-8784		ABH MATH SEM HAMBURG	Abh. Math. Semin. Univ. Hamburg	APR	2015	85	1					1	21		10.1007/s12188-015-0106-1		21	Mathematics	Mathematics	CF6XW	WOS:000352701200001		
J	Deitmar, A; Koyama, S; Kurokawa, N				Deitmar, Anton; Koyama, Shin-ya; Kurokawa, Nobushige			Counting and zeta functions over F-1	ABHANDLUNGEN AUS DEM MATHEMATISCHEN SEMINAR DER UNIVERSITAT HAMBURG			English	Article						F-1-geometry; Hasse-Weil zeta functions; Soule condition; Determinants of Laplacians	DETERMINANTS; LAPLACIANS		[Deitmar, Anton] Univ Tubingen, Math Inst, D-72076 Tubingen, Germany; [Koyama, Shin-ya] Toyo Univ, Dept Biomed Engn, Kawagoe, Saitama 3508585, Japan; [Kurokawa, Nobushige] Tokyo Inst Technol, Dept Math, Meguro Ku, Tokyo 1528551, Japan	Deitmar, A (reprint author), Univ Tubingen, Math Inst, Morgenstelle 10, D-72076 Tubingen, Germany.	anton.deitmar@uni-tuebingen.de					RAY DB, 1971, ADV MATH, V7, P145, DOI 10.1016/0001-8708(71)90045-4; CONNES A, 2011, NONCOMMUTATIVE GEOME, P75; Deitmar A, 2008, CONTRIB ALGEBRA GEOM, V49, P517; Deitmar A, 2005, PROG MATH, V239, P87; Deitmar A, 2006, P JPN ACAD A-MATH, V82, P141; Deitmar A, 2008, P JPN ACAD A-MATH, V84, P138; Deligne P., 1974, I HAUTES ETUDES SCI, V43, P273, DOI 10.1007/BF02684373; DHOKER E, 1986, COMMUN MATH PHYS, V104, P537, DOI 10.1007/BF01211063; Lorscheid O, 2010, CR MATH, V348, P1143, DOI 10.1016/j.crma.2010.10.010; SARNAK P, 1987, COMMUN MATH PHYS, V110, P113, DOI 10.1007/BF01209019; Soule C, 2004, MOSC MATH J, V4, P217	11	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5858	1865-8784		ABH MATH SEM HAMBURG	Abh. Math. Semin. Univ. Hamburg	APR	2015	85	1					59	71		10.1007/s12188-015-0104-3		13	Mathematics	Mathematics	CF6XW	WOS:000352701200005		
J	Chen, YZ; Zhou, YX; Wang, HW; Lu, JL; Uchida, T; Xu, Q; Yu, SH; Jiang, HL				Chen, Yu-Zhen; Zhou, Yu-Xiao; Wang, Hengwei; Lu, Junling; Uchida, Takeyuki; Xu, Qiang; Yu, Shu-Hong; Jiang, Hai-Long			Multifunctional PdAg@MIL-101 for One-Pot Cascade Reactions: Combination of Host-Guest Cooperation and Bimetallic Synergy in Catalysis	ACS CATALYSIS			English	Article						metal-organic framework; heterogeneous catalysis; bimetallic nanoparticles; multifunctional catalyst; cascade reaction	METAL-ORGANIC FRAMEWORKS; EFFICIENT HETEROGENEOUS CATALYSTS; ALLOY NANOPARTICLES; AEROBIC OXIDATION; BENZYL ALCOHOL; AT-MOF; AU-AG; PD; TRANSFORMATIONS; NANOSTRUCTURES	Metal nanoparticles (NPs) stabilized by metal-organic frameworks (MOFs) are very promising for catalysis, while reports on their cooperative catalysis for a cascade reaction have been very rare. In this work, Pd NPs incorporated into a MOF, MIL-101, have jointly completed a tandem reaction on the basis of MOF Lewis acidity and Pd NPs. Subsequently, ultrafine PdAg alloy NPs (similar to 1.5 nm) have been encapsulated into MIL-101. The obtained multifunctional PdAg@MIL-101 exhibits good catalytic activity and selectivity in cascade reactions under mild conditions, on the basis of the combination of host-guest cooperation and bimetallic synergy, where MIL-101 affords Lewis acidity and Pd offers hydrogenation activity while Ag greatly improves selectivity to the target product. As far as we know, this is the first work on bimetallic NP@MOFs as multifunctional catalysts with multiple active sites (MOF acidity and bimetallic species) that exert respective functions and cooperatively catalyze a one-pot cascade reaction.	[Chen, Yu-Zhen; Zhou, Yu-Xiao; Wang, Hengwei; Lu, Junling; Yu, Shu-Hong; Jiang, Hai-Long] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Key Lab Soft Matter Chem,Sch Chem & Mat Sci, Chinese Acad Sci,Collaborat Innovat Ctr Suzhou Na, Hefei 230026, Anhui, Peoples R China; [Uchida, Takeyuki; Xu, Qiang] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Xu, Q (reprint author), Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan.	q.xu@aist.go.jp; jianglab@ustc.edu.cn	Yu, Shu-Hong/A-1903-2010; Lu, Junling/F-3791-2010; Xu, Qiang/H-4997-2011; Jiang, Hai-Long/B-2995-2011	Yu, Shu-Hong/0000-0003-3732-1011; Lu, Junling/0000-0002-7371-8414; Jiang, Hai-Long/0000-0002-2975-7977	NSFC [21371162, 51301159]; 973 program [2014CB931803]; NSF of Anhui Province [1408085MB23]; Research Fund for the Doctoral Program of Higher Education of China [20133402120020]; Recruitment Program of Global Youth Experts; Fundamental Research Funds for the Central Universities [WK2060190026]	We gratefully thank the reviewers for their valuable suggestions. This work was supported by the NSFC (21371162 and 51301159), the 973 program (2014CB931803), the NSF of Anhui Province (1408085MB23), the Research Fund for the Doctoral Program of Higher Education of China (20133402120020), the Recruitment Program of Global Youth Experts, and the Fundamental Research Funds for the Central Universities (WK2060190026).	He YB, 2014, CHEM SOC REV, V43, P5657, DOI 10.1039/c4cs00032c; Jiang HL, 2011, J AM CHEM SOC, V133, P1304, DOI 10.1021/ja1099006; Wang ZQ, 2009, CHEM SOC REV, V38, P1315, DOI 10.1039/b802258p; Li XL, 2014, ACS CATAL, V4, P3490, DOI 10.1021/cs5006635; Jiang HL, 2009, J AM CHEM SOC, V131, P11302, DOI 10.1021/ja9047653; Huang YB, 2011, CHEM-EUR J, V17, P12706, DOI 10.1002/chem.201101705; He LC, 2013, ANGEW CHEM INT EDIT, V52, P3741, DOI 10.1002/anie.201209903; Zhang T, 2014, CHEM SOC REV, V43, P5982, DOI 10.1039/c4cs00103f; Liu HL, 2012, CHEMSUSCHEM, V5, P1892, DOI 10.1002/cssc.201200611; Hu YL, 2014, CHEMSUSCHEM, V7, P734, DOI 10.1002/cssc.201301163; Horike S, 2008, J AM CHEM SOC, V130, P5854, DOI 10.1021/ja800669j; Liu JW, 2014, CHEM SOC REV, V43, P6011, DOI 10.1039/c4cs00094c; Houk RJT, 2009, NANO LETT, V9, P3413, DOI 10.1021/nl901397k; Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x; Vilhelmsen LB, 2012, J AM CHEM SOC, V134, P12807, DOI 10.1021/ja305004a; Climent MJ, 2014, ACS CATAL, V4, P870, DOI 10.1021/cs401052k; Sreedhar B, 2009, J ORG CHEM, V74, P8806, DOI 10.1021/jo901787t; Zhu QL, 2013, J AM CHEM SOC, V135, P10210, DOI 10.1021/ja403330m; Zhou HC, 2014, CHEM SOC REV, V43, P5415, DOI 10.1039/c4cs90059f; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Sumida K, 2012, CHEM REV, V112, P724, DOI 10.1021/cr2003272; Chen YZ, 2015, SMALL, V11, P71, DOI 10.1002/smll.201401875; Kitagawa H, 2009, NAT CHEM, V1, P689, DOI 10.1038/nchem.454; Hermes S, 2005, ANGEW CHEM INT EDIT, V44, P6237, DOI 10.1002/anie.200462515; Gascon J, 2014, ACS CATAL, V4, P361, DOI 10.1021/cs400959k; Li JR, 2012, CHEM REV, V112, P869, DOI 10.1021/cr200190s; Corma A, 2010, CHEM REV, V110, P4606, DOI 10.1021/cr9003924; Ma SQ, 2010, CHEM COMMUN, V46, P44, DOI 10.1039/b916295j; Horcajada P, 2012, CHEM REV, V112, P1232, DOI 10.1021/cr200256v; Seo JS, 2000, NATURE, V404, P982; Mallick A, 2013, ANGEW CHEM INT EDIT, V52, P13755, DOI 10.1002/anie.201307486; Pan YY, 2010, CHEM COMMUN, V46, P2280, DOI 10.1039/b922061e; Zhang ZC, 2014, ANGEW CHEM INT EDIT, V53, P429, DOI 10.1002/anie.201308589; Blaser HU, 2003, ADV SYNTH CATAL, V345, P103, DOI 10.1002/adsc.200390000; Vermoortele F, 2013, J AM CHEM SOC, V135, P11465, DOI 10.1021/ja405078u; Hwang YK, 2008, ANGEW CHEM INT EDIT, V47, P4144, DOI 10.1002/anie.200705998; Jiang HL, 2011, CHEM COMMUN, V47, P3351, DOI 10.1039/c0cc05419d; Na K, 2014, NANO LETT, V14, P5979, DOI 10.1021/nl503007h; Lu G, 2012, NAT CHEM, V4, P310, DOI 10.1038/nchem.1272; Moon HR, 2005, ANGEW CHEM INT EDIT, V44, P1261, DOI 10.1002/anie.200461408; Hu ZC, 2014, CHEM SOC REV, V43, P5815, DOI 10.1039/c4cs00010b; An JY, 2009, J AM CHEM SOC, V131, P8376, DOI 10.1021/ja902972w; Huang XM, 2013, J CATAL, V301, P217, DOI 10.1016/j.jcat.2013.02.011; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Cook TR, 2013, CHEM REV, V113, P734, DOI 10.1021/cr3002824; Yuan BZ, 2010, ANGEW CHEM INT EDIT, V49, P4054, DOI 10.1002/anie.201000576; Fu YH, 2012, ANGEW CHEM INT EDIT, V51, P3364, DOI 10.1002/anie.201108357; Chen BL, 2010, ACCOUNTS CHEM RES, V43, P1115, DOI 10.1021/ar100023y; Chen YT, 2012, J CATAL, V289, P105, DOI 10.1016/j.jcat.2012.01.020; Bellina F, 2007, TETRAHEDRON, V63, P1970, DOI 10.1016/j.tet.2006.12.068; Arnanz A, 2012, ADV SYNTH CATAL, V354, P1347, DOI 10.1002/adsc.201100503; Zhao MT, 2014, J AM CHEM SOC, V136, P1738, DOI 10.1021/ja411468e; Liu YL, 2013, ADV MATER, V25, P5819, DOI 10.1002/adma.201302781; Kim MJ, 2003, J MATER CHEM, V13, P1789, DOI 10.1039/b304006m; [Anonymous], 2009, CHEM SOC REV, V38, P1213; Lin RB, 2013, ANGEW CHEM INT EDIT, V52, P13429, DOI 10.1002/anie.201307217; Suh MP, 2012, CHEM REV, V112, P782, DOI 10.1021/cr200274s; Long JL, 2013, ACS CATAL, V3, P647, DOI 10.1021/cs300754k; Lee JM, 2004, CHEM SOC REV, V33, P302, DOI 10.1039/b309033g; Ajamian A, 2004, ANGEW CHEM INT EDIT, V43, P3754, DOI 10.1002/anie.200301727; Farrusseng D, 2009, ANGEW CHEM INT EDIT, V48, P7502, DOI 10.1002/anie.200806063; Ramaswamy P, 2014, CHEM SOC REV, V43, P5913, DOI 10.1039/c4cs00093e; Kreno LE, 2012, CHEM REV, V112, P1105, DOI 10.1021/cr200324t; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Fang XL, 2012, ACS NANO, V6, P4434, DOI 10.1021/nn3011703; Schlichte K, 2004, MICROPOR MESOPOR MAT, V73, P81, DOI 10.1016/j.micromeso.2003.12.027; Khajavi H, 2013, ACS CATAL, V3, P2617, DOI 10.1021/cs400681s; Zhang M, 2014, J AM CHEM SOC, V136, P7241, DOI 10.1021/ja502643p; Cirujano FG, 2013, CHEMCATCHEM, V5, P538, DOI 10.1002/cctc.201200878; Hermannsdorfer J, 2012, ANGEW CHEM INT EDIT, V51, P11473, DOI 10.1002/anie.201205078; Ayhan-Kilcigil Gülgün, 2003, Farmaco, V58, P1345; Barluenga J, 2008, ANGEW CHEM INT EDIT, V47, P7044, DOI 10.1002/anie.200802582; Dhakshinamoorthy A, 2010, CHEM-EUR J, V16, P8530, DOI 10.1002/chem.201000588; Kuo CH, 2012, J AM CHEM SOC, V134, P14345, DOI 10.1021/ja306869j; Pan WT, 2006, BIOORG MED CHEM LETT, V16, P409, DOI 10.1016/j.bmcl.2005.09.069; Sengar S. K., 2014, J APPL PHYS, V115; Takashima Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1170	77	15	15	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	APR	2015	5	4					2062	2069		10.1021/cs501953d		8	Chemistry, Physical	Chemistry	CF3QU	WOS:000352464400006		
J	Todoroki, N; Kato, T; Hayashi, T; Takahashi, S; Wadayama, T				Todoroki, Naoto; Kato, Takashi; Hayashi, Takehiro; Takahashi, Shuntaro; Wadayama, Toshimasa			Pt-Ni Nanoparticle-Stacking Thin Film: Highly Active Electrocatalysts for Oxygen Reduction Reaction	ACS CATALYSIS			English	Article						thin film catalysts; oxygen reduction reaction; Pt-based alloys; arc plasma deposition; proton exchange membrane fuel cell	ALLOY NANOPARTICLES; FUEL-CELLS; CATALYSTS; PLATINUM; SURFACES; SEGREGATION; STABILITY	A novel nanoparticle-stacking thin film (NPSTF) of Pt-Ni alloy for highly active oxygen reduction reaction (ORR) electrocatalyst was synthesized. The Pt mass activity of the synthesized Pt-Ni NPSTF were 10-fold higher than commercial carbon-supported Pt catalysts. The remarkable ORR activity enhancement of the Pt-Ni NPSTF was attributed to the modified electronic properties of the surface Pt-enriched layers induced by underlying Ni atoms and to the increased active surface area achieved by stacking of Pt-Ni nanoparticles.	[Todoroki, Naoto; Kato, Takashi; Hayashi, Takehiro; Takahashi, Shuntaro; Wadayama, Toshimasa] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan	Todoroki, N (reprint author), Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 9808579, Japan.	n-todoroki@material.tohoku.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) of Japan	This study was supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Gan L, 2012, NANO LETT, V12, P5423, DOI 10.1021/nl302995z; Sasaki K, 2010, ELECTROCHIM ACTA, V55, P2645, DOI 10.1016/j.electacta.2009.11.106; Paulus UA, 2002, ELECTROCHIM ACTA, V47, P3787, DOI 10.1016/S0013-4686(02)00349-3; van der Vliet D, 2011, ELECTROCHIM ACTA, V56, P8695, DOI 10.1016/j.electacta.2011.07.063; Stephens IEL, 2012, ENERG ENVIRON SCI, V5, P6744, DOI 10.1039/c2ee03590a; Lee SW, 2010, J PHYS CHEM LETT, V1, P1316, DOI 10.1021/jz100241j; Debe MK, 2006, J POWER SOURCES, V161, P1002, DOI 10.1016/j.jpowsour.2006.05.033; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Cui CH, 2014, J AM CHEM SOC, V136, P4813, DOI 10.1021/ja4124658; Lee KS, 2013, J PHYS CHEM C, V117, P9164, DOI 10.1021/jp403135k; Stamenkovic VR, 2006, J AM CHEM SOC, V128, P8813, DOI 10.1021/ja0600476; Yang RZ, 2010, CHEM MATER, V22, P4712, DOI 10.1021/cm101090p; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/nmat3668, 10.1038/NMAT3668]; Chen C, 2014, SCIENCE, V343, P1339, DOI 10.1126/science.1249061; Kibsgaard J, 2012, J AM CHEM SOC, V134, P7758, DOI 10.1021/ja2120162; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Yamada Y, 2013, SURF SCI, V607, P54, DOI 10.1016/j.susc.2012.08.016; Toda T, 1999, J ELECTROCHEM SOC, V146, P3750, DOI 10.1149/1.1392544; van der Vliet DF, 2012, NAT MATER, V11, P1051, DOI [10.1038/nmat3457, 10.1038/NMAT3457]; Wang HJ, 2012, J AM CHEM SOC, V134, P10819, DOI 10.1021/ja303773z; Bonakdarpour A, 2008, J ELECTROCHEM SOC, V155, pB108, DOI 10.1149/1.2806166; Henry JB, 2012, ACS CATAL, V2, P1457, DOI 10.1021/cs300165t; Hwang SM, 2010, ELECTROCHIM ACTA, V55, P8938, DOI 10.1016/j.electacta.2010.08.013; Liu YH, 2012, J PHYS CHEM C, V116, P7848, DOI 10.1021/jp300672h; Rudi S, 2012, ELECTROCATALYSIS-US, V3, P265, DOI 10.1007/s12678-012-0098-x; Todoroki N, 2013, PHYS CHEM CHEM PHYS, V15, P17771, DOI 10.1039/c3cp53340a; Wang C., 2012, ANGEW CHEM, V124, P3193	28	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	APR	2015	5	4					2209	2212		10.1021/acscatal.5b00065		4	Chemistry, Physical	Chemistry	CF3QU	WOS:000352464400023		
J	Majumdar, N; Paul, ND; Mandal, S; de Bruin, B; Wulff, WD				Majumdar, Nilanjana; Paul, Nanda D.; Mandal, Sutanuva; de Bruin, Bas; Wulff, William D.			Catalytic Synthesis of 2H-Chromenes	ACS CATALYSIS			English	Review						21-1-chromenes; heterocycles; catalysis; metal-mediated; organo-catalysis; enantioselective; ring-closure; ortho-quinone methide	CLAISEN REARRANGEMENT REACTIONS; TANDEM INTRAMOLECULAR WITTIG; ARYL PROPARGYL ETHERS; ANTI-BREAST CANCER; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; CHIRAL CHROMENES; FUNCTIONALIZED 2H-CHROMENES; ELECTROPHILIC CYCLIZATION; ANTICANCER ACTIVITY	2H-Chromenes (2H-1-benzopyran derivatives) display a broad spectrum of biological activities. The 2H-chromene substructure is an important structural motif present in a variety of medicines, natural products, and materials showing unique photophysical properties. Hence, the structural importance of the benzopyran moiety has elicited a great deal of interest in the field of organic synthesis and chemical biology to develop new and improved synthesis of these molecular skeletons. This review gives an up-to-date overview of different catalytic methodologies developed for the synthesis of 2H-chromenes and is structured around the three main approaches applied in catalytic 2H-chromene synthesis: (I) catalysis with (transition) metals, (II) metal-free Bronsted and Lewis acid/base catalysis, which includes examples of nonenantioselective organocatalysis, and (III) enantioselective organo-catalysis. The section in which the metal-catalyzed reactions are discussed describes different ring-closing strategies based on (transition) metal catalysis, including a few enantioselective approaches. For most of these reactions, plausible mechanisms are delineated. Moreover, synthesis of some natural products and medicinally important drugs are included. Specific advantages and disadvantages of the several synthetic methodologies are discussed. The review focuses on catalytic 2H-chromene synthesis. However, for a complete overview, synthetic routes involving some stoichiometric steps and reactions producing ring-scaffolds that are closely related to 2H-chromenes are also included.	[Majumdar, Nilanjana; Wulff, William D.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Majumdar, Nilanjana] Inst Microbial Chem, Shinagawa Ku, Tokyo 1410021, Japan; [Paul, Nanda D.; Mandal, Sutanuva; de Bruin, Bas] Univ Amsterdam, Homogeneous & Supramol Catalysis Grp, Vant Hoff Inst Mol Sci HIMS, NL-1098 XH Amsterdam, Netherlands	de Bruin, B (reprint author), Univ Amsterdam, Homogeneous & Supramol Catalysis Grp, Vant Hoff Inst Mol Sci HIMS, NL-1098 XH Amsterdam, Netherlands.	b.debruin@uva.nl; wulff@chemistry.msu.edu	de Bruin, Bas/K-7761-2012	de Bruin, Bas/0000-0002-3482-7669	Netherlands Organization for Scientific Research (NWO-VICI) [016.122.613]; University of Amsterdam; National Institute of General Medical Sciences [GM094478]; Michigan State University	Financial support was provided by The Netherlands Organization for Scientific Research (to B.d.-B.; NWO-VICI grant no. 016.122.613), the University of Amsterdam (to B.d.-B.), the National Institute of General Medical Sciences (to W.D.W.; grant no. GM094478), and the Michigan State University (to W.D.W.).	An H, 2008, J ORG CHEM, V73, P1752, DOI 10.1021/jo702196f; Korotaev VY, 2008, TETRAHEDRON, V64, P5055, DOI 10.1016/j.tet.2008.03.065; Menon RS, 2009, J ORG CHEM, V74, P8901, DOI 10.1021/jo902032p; Wang ZQ, 2011, ORG LETT, V13, P14, DOI 10.1021/ol102761m; Godoi B, 2009, J ORG CHEM, V74, P3469, DOI 10.1021/jo900307k; Luo SP, 2009, ORG BIOMOL CHEM, V7, P4539, DOI 10.1039/b910835a; Coi A, 2009, BIOORGAN MED CHEM, V17, P5565, DOI 10.1016/j.bmc.2009.06.028; Azizmohammadi M, 2013, EUR J MED CHEM, V59, P15, DOI 10.1016/j.ejmech.2012.10.044; Balabani A, 2011, EUR J MED CHEM, V46, P5894, DOI 10.1016/j.ejmech.2011.09.053; Zeni G, 2004, CHEM REV, V104, P2285, DOI 10.1021/cr020085h; Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381; Aponick A, 2010, CHEM COMMUN, V46, P6849, DOI 10.1039/c0cc01961e; Zeng BS, 2014, CHEM SCI, V5, P2277, DOI 10.1039/c4sc00423j; Kashiwada Y, 2001, TETRAHEDRON, V57, P1559, DOI 10.1016/S0040-4020(00)01144-3; Siyang HX, 2014, CHEM COMMUN, V50, P8514, DOI 10.1039/c4cc02862g; Alcaide B, 2015, CHEM-EUR J, V21, P1533, DOI 10.1002/chem.201404516; Yoshioka E, 2011, ANGEW CHEM INT EDIT, V50, P6638, DOI 10.1002/anie.201102088; Karthikeyan T, 2008, TETRAHEDRON-ASYMMETR, V19, P2741, DOI 10.1016/j.tetasy.2008.12.007; Hussain MK, 2014, RSC ADV, V4, P8828, DOI 10.1039/c3ra45749d; Kogan NM, 2004, J MED CHEM, V47, P3800, DOI 10.1021/jm040042o; Xie JW, 2010, ORG BIOMOL CHEM, V8, P2117, DOI 10.1039/b922668k; Moorthy JN, 2013, J AM CHEM SOC, V135, P6872, DOI 10.1021/ja312027c; Engler TA, 1996, BIOORGAN MED CHEM, V4, P1755, DOI 10.1016/0968-0896(96)00192-7; Raju BC, 2011, HELV CHIM ACTA, V94, P248, DOI 10.1002/hlca.201000181; Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s; Trenor SR, 2004, CHEM REV, V104, P3059, DOI 10.1021/cr030037c; Adler MJ, 2009, TETRAHEDRON LETT, V50, P5075, DOI 10.1016/j.tetlet.2009.06.090; Tahtaoui C, 2010, J ORG CHEM, V75, P3781, DOI 10.1021/jo100566c; Xu CL, 2013, MOLECULES, V18, P11964, DOI 10.3390/molecules181011964; Xia YM, 2014, ORG BIOMOL CHEM, V12, P9333, DOI 10.1039/c4ob01979b; Sun JF, 2012, CHEM COMMUN, V48, P4169, DOI 10.1039/c2cc16690a; Majumdar N, 2012, J AM CHEM SOC, V134, P1357, DOI 10.1021/ja210655g; Roy R, 2014, J ORG CHEM, V79, P6603, DOI 10.1021/jo5011125; Hornillos V, 2012, CHEM COMMUN, V48, P3712, DOI 10.1039/c2cc30395g; Ranjith C, 2010, SPECTROCHIM ACTA A, V75, P1610, DOI 10.1016/j.saa.2010.02.027; Yi XY, 2013, DYES PIGMENTS, V96, P104, DOI 10.1016/j.dyepig.2012.07.020; Ishikawa T, 1997, HETEROCYCLES, V45, P2261; Nevado C, 2005, CHEM-EUR J, V11, P3155, DOI 10.1002/chem.200401069; Mun J, 2012, J MED CHEM, V55, P6738, DOI 10.1021/jm300752n; Worlikar SA, 2007, J ORG CHEM, V72, P1347, DOI 10.1021/jo062234s; Keskin S, 2015, ORG LETT, V17, P964, DOI 10.1021/acs.orglett.5b00067; Sunden H, 2007, CHEM-EUR J, V13, P574, DOI 10.1002/chem.200600572; Dai LZ, 2007, CHEM-EUR J, V13, P3701, DOI 10.1002/chem.200601033; Bera K, 2011, J ORG CHEM, V76, P3539, DOI 10.1021/jo2000012; Petasis NA, 2009, J ORGANOMET CHEM, V694, P1747, DOI 10.1016/j.jorganchem.2008.11.050; Govender T, 2006, TETRAHEDRON-ASYMMETR, V17, P1763, DOI 10.1016/j.tetasy.2006.06.028; Paul ND, 2014, J AM CHEM SOC, V136, P1090, DOI 10.1021/ja4111336; Rueping M, 2011, J AM CHEM SOC, V133, P3732, DOI 10.1021/ja110213t; Xu XB, 2009, ADV SYNTH CATAL, V351, P2599, DOI 10.1002/adsc.200900483; Xu DQ, 2008, ADV SYNTH CATAL, V350, P2610, DOI 10.1002/adsc.200800535; Arcadi A, 2006, SYNLETT, P909, DOI 10.1055/s-2006-939048; Bamfield P., 2010, CHROMIC PHENOMENA TE, P15; Bohmdorfer S, 2011, TETRAHEDRON, V67, P6181, DOI 10.1016/j.tet.2011.06.070; Bougdid L, 2007, TETRAHEDRON, V63, P8242, DOI 10.1016/j.tet.2007.05.113; Brimble M. A., 2008, COMPREHENSIVE HETERO, V7, P419; Bruder M, 2008, SYNLETT, P575, DOI 10.1055/s-2008-1032090; Bruder M, 2009, ORG BIOMOL CHEM, V7, P2127, DOI 10.1039/b901358j; Casanova N, 2015, ANGEW CHEM INT EDIT, V54, P2374, DOI 10.1002/anie.201410350; Clirnent M. J., 2014, APPL CATAL A-GEN, V481, P27; Das BC, 2010, TETRAHEDRON LETT, V51, P2567, DOI 10.1016/j.tetlet.2010.02.143; da Silva FDC, 2007, SYNLETT, P3123, DOI 10.1055/s-2007-990925; Dong YZ, 2012, J NAT PROD, V75, P370, DOI 10.1021/np2007878; Doodeman R, 2000, TETRAHEDRON LETT, V41, P5979, DOI 10.1016/S0040-4039(00)00955-2; Ellis G. P., 2009, CHEM HETEROCYCLIC CO, V31, P1; Escande V., ENV SCI POL IN PRESS; Fravel W. B., 2008, COMPREHENSIVE HETERO, V7, P701; Gembus V, 2009, B CHEM SOC JPN, V82, P843, DOI 10.1246/bcsj.82.843; Graham TJA, 2012, ORG LETT, V14, P1616, DOI 10.1021/ol300364s; HARFENIS.M, 1972, J ORG CHEM, V37, P841, DOI 10.1021/jo00971a006; Hepworth J., 1984, COMPREHENSIVE HETERO, V3, P737, DOI DOI 10.1016/B978-008096519-2.00046-1; Hershberger JC, 2006, J ORG CHEM, V71, P231, DOI 10.1021/jo052105w; Katritzky A. R., 2010, HDB HETEROCYCLIC CHE, P815; Kharrat SE, 2006, J ORG CHEM, V71, P8637; Khodabakhshi S., 2014, TETRAHEDRON LETT, V55, P3755; Kobayashi A, 2012, PHOTOCH PHOTOBIO SCI, V11, P1368, DOI 10.1039/c2pp25055a; Koussini R, 2008, JORDAN J CHEM, V3, P103; Kumar JA, 2013, EUR J MED CHEM, V65, P389, DOI 10.1016/j.ejmech.2013.03.042; Kureshy RI, 2009, CATAL COMMUN, V10, P572, DOI 10.1016/j.catcom.2008.10.035; Li H, 2007, CHEM COMMUN, P507, DOI 10.1039/b611502k; Liu F, 2008, TETRAHEDRON LETT, V49, P1578, DOI 10.1016/j.tetlet.2008.01.008; Lykakis IN, 2011, EUR J ORG CHEM, P2334, DOI 10.1002/ejoc.201001674; Machado AHL, 2009, TETRAHEDRON LETT, V50, P1222, DOI 10.1016/j.tetlet.2009.01.017; Moquist PN, 2010, ANGEW CHEM INT EDIT, V49, P7096, DOI 10.1002/anie.201003469; Murthy YLN, 2013, EUR J MED CHEM, V62, P545, DOI 10.1016/j.ejmech.2013.01.027; Pan XL, 2014, CHEM COMMUN, V50, P5891, DOI 10.1039/c4cc00374h; Prado S, 2006, J HETEROCYCLIC CHEM, V43, P1605; Ramachary DB, 2008, EUR J ORG CHEM, P3907, DOI 10.1002/ejoc.200800472; Rao VVVNSR, 2007, SYNTHETIC COMMUN, V37, P535, DOI 10.1080/00397910601055024; Ravichandran S., 2009, INT J CHEM TECHNOL R, V1, P329; Raymundo C. A., 1995, HETEROCYCL CHEM, V32, P219; Reddy CS, 2011, J HETEROCYCLIC CHEM, V48, P176, DOI 10.1002/jhet.505; REHMAN H, 1987, TETRAHEDRON, V43, P5335, DOI 10.1016/S0040-4020(01)87711-5; Relunan H., 1987, SYNTHETIC COMMUN, V17, P1119; Reynolds TE, 2007, ANGEW CHEM INT EDIT, V46, P7806, DOI 10.1002/anie.200702818; Samet AV, 2011, TETRAHEDRON LETT, V52, P3026, DOI 10.1016/j.tetlet.2011.04.004; Savitha G, 2009, SYNLETT, P2079, DOI 10.1055/s-0029-1217563; Schweizer E E, 1977, CHEM HETEROCYCLIC CO, V31, P11, DOI 10.1002/9780470187012.ch2; Shen H, 2011, EUR J ORG CHEM, P5031, DOI 10.1002/ejoc.201100613; Shi J. B., 2014, RSC ADV, V4, P5607; Shi M, 2006, ADV SYNTH CATAL, V348, P967, DOI 10.1002/adsc.200505496; Sosnovskikh VY, 2006, J ORG CHEM, V71, P4538, DOI 10.1021/jo060459x; Sousa CM, 2012, EUR J ORG CHEM, P1768, DOI 10.1002/ejoc.201101702; Takenaka K, 2010, TETRAHEDRON-ASYMMETR, V21, P767, DOI 10.1016/j.tetasy.2010.04.060; Usha R., 1983, TETRAHEDRON LETT, V24, P5023; Usha R., 1984, HETEROCYCLES, V22, P1351; Wu YC, 2011, ORG BIOMOL CHEM, V9, P2868, DOI 10.1039/c0ob01143f; Yadav J., 2009, TETRAHEDRON LETT, V50, P5798; YADLA R, 1987, HETEROCYCLES, V26, P329; Ye LW, 2006, ORG LETT, V8, P3853, DOI 10.1021/ol0615174; Zeng HX, 2011, TETRAHEDRON LETT, V52, P3926, DOI 10.1016/j.tetlet.2011.05.093; Zhang ZG, 2011, SYNLETT, P1262, DOI 10.1055/s-0030-1259956; Zhao LZ, 2008, TETRAHEDRON LETT, V49, P7364, DOI 10.1016/j.tetlet.2008.10.025; Zhou L, 2011, BEILSTEIN J ORG CHEM, V7, P631, DOI 10.3762/bjoc.7.74	113	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	APR	2015	5	4					2329	2366		10.1021/acscatal.5b00026		38	Chemistry, Physical	Chemistry	CF3QU	WOS:000352464400039		
J	Furuya, Y; Mashio, T; Ohma, A; Tian, M; Kaveh, F; Beauchemin, D; Jerkiewicz, G				Furuya, Yoshihisa; Mashio, Tetsuya; Ohma, Atsushi; Tian, Min; Kaveh, Farhad; Beauchemin, Diane; Jerkiewicz, Gregory			Influence of Electrolyte Composition and pH on Platinum Electrochemical and/or Chemical Dissolution in Aqueous Acidic Media	ACS CATALYSIS			English	Article						fuel cells; platinum electro-dissolution; platinum oxide; potential cycling; inductively coupled plasma mass spectrometry	FUEL-CELLS; 111 SURFACE; ADSORPTION; CATALYST; IONOMER; ANIONS; GROWTH; MODEL; TEMPERATURE; REDUCTION	Comprehension of the impact of electrolyte nature and concentration on Pt degradation is essential for the improvement of durability of catalyst layers (CLs), which are the heart of polymer electrolyte membrane fuel cells (PEMFCs). Electrochemical and chemical dissolution of polycrystalline Pt in aqueous CF3SO3H, H2SO4, and HClO4 solutions of different concentrations (c = 0.1 and 0.5 M) upon potential switching and holding in the 0.60-1.20 V versus RHE range is analyzed using inductively coupled plasma mass spectroscopy. This potential range mimics the conditions encountered in operating PEMFCs. Trifluoromethanesulfonic acid (CF3SO3H) is employed because it is the smallest fluorinated sulfonic acid and can serve as a model molecule. Degradation of Pt in H2SO4 and HClO4 solutions is examined for comparative analysis. The results reveal that the electrolyte concentration has a significant impact on Pt electrochemical and chemical dissolution. The amount of dissolved Pt in 0.1 M solutions of CF3SO3H, H2SO4, and HClO4 is practically the same and lower than that in analogous 0.5 M solutions. However, the amount of dissolved Pt in 0.5 M H2SO4 solution is greater than that in 0.5 M solutions of CF3SO3H or HClO4. The influence of anion nature and pH on Pt dissolution is examined in 0.1 and 0.5 M HClO4 solutions without and with 1.0 x 10(-2) M H2SO4 addition. The results show that under these conditions the anion nature has no or negligible impact on Pt dissolution, but pH significantly affects the process. An analysis of potential versus pH diagrams (Pourbaix diagrams) for acid solutions of different pH values suggests that Pt degradation (with the formation of Pt2+(aq) and Pt4+(aq)) might proceed through both electrochemical and chemical pathways.	[Furuya, Yoshihisa; Mashio, Tetsuya; Ohma, Atsushi] Nissan Motor Co Ltd, Nissan Res Ctr, Yokosuka, Kanagawa 2378523, Japan; [Furuya, Yoshihisa; Tian, Min; Kaveh, Farhad; Beauchemin, Diane; Jerkiewicz, Gregory] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada	Jerkiewicz, G (reprint author), Queens Univ, Dept Chem, 90 Bader Lane, Kingston, ON K7L 3N6, Canada.	gregory.jerkiewicz@chem.queensu.ca					Chen D, 2011, ELECTROCATALYSIS, V2, P207, DOI 10.1007/s12678-011-0054-1; Darling RM, 2005, J ELECTROCHEM SOC, V152, pA242, DOI 10.1149/1.1836156; Wang XP, 2006, ELECTROCHEM SOLID ST, V9, pA225, DOI 10.1149/1.2180536; Topalov AA, 2014, ELECTROCHEM COMMUN, V40, P49, DOI 10.1016/j.elecom.2013.12.021; Zolfaghari A, 1997, J ELECTROCHEM SOC, V144, P3034, DOI 10.1149/1.1837955; Matsumoto M, 2011, J PHYS CHEM C, V115, P11163, DOI 10.1021/jp201959h; Ohma A, 2010, ELECTROCHIM ACTA, V55, P8829, DOI 10.1016/j.electacta.2010.08.005; Kongkanand A, 2012, J PHYS CHEM C, V116, P3684, DOI 10.1021/jp211490a; Rinaldo SG, 2010, J PHYS CHEM C, V114, P5773, DOI 10.1021/jp9101509; Mitsushima S, 2008, ELECTROCHIM ACTA, V54, P455, DOI 10.1016/j.electacta.2008.07.052; Tang L, 2010, J AM CHEM SOC, V132, P596, DOI 10.1021/ja9071496; Cherevko S, 2014, ELECTROCATALYSIS-US, V5, P235, DOI 10.1007/s12678-014-0187-0; Cherevko S, 2014, J ELECTROCHEM SOC, V161, pH822, DOI 10.1149/2.0881412jes; CONWAY BE, 1973, ANAL CHEM, V45, P1331, DOI 10.1021/ac60330a025; CONWAY BE, 1990, J CHEM PHYS, V93, P8361, DOI 10.1063/1.459319; Alsabet M, 2006, J ELECTROANAL CHEM, V589, P120, DOI 10.1016/j.jelechem.2006.01.022; Mitsushima S, 2007, J ELECTROCHEM SOC, V154, pB153, DOI 10.1149/1.2400596; Ohma A, 2011, ECS TRANSACTIONS, V41, P775, DOI 10.1149/1.3635611; Yadav AP, 2012, J ELECTROCHEM SOC, V159, pC190, DOI 10.1149/2.065204jes; Ohma A, 2011, ELECTROCHIM ACTA, V56, P10832, DOI 10.1016/j.electacta.2011.04.058; Darling RM, 2003, J ELECTROCHEM SOC, V150, pA1523, DOI 10.1149/1.1613669; Fayette M, 2013, ACS CATAL, V3, P1709, DOI 10.1021/cs400347u; Topalov AA, 2012, ANGEW CHEM INT EDIT, V51, P12613, DOI 10.1002/anie.201207256; Subbaraman R, 2010, J PHYS CHEM C, V114, P8414, DOI 10.1021/jp100814x; Xing LY, 2014, ELECTROCATALYSIS-US, V5, P96, DOI 10.1007/s12678-013-0167-9; Jerkiewicz G, 2004, ELECTROCHIM ACTA, V49, P1451, DOI 10.1016/j.electacta.2003.11.008; Kodama K, 2014, J ELECTROCHEM SOC, V161, pF649, DOI 10.1149/2.051405jes; Ahluwalia RK, 2013, J ELECTROCHEM SOC, V160, pF447, DOI 10.1149/2.018306jes; Teliska M, 2007, J PHYS CHEM C, V111, P9267, DOI 10.1021/jp071106k; Masuda T, 2013, J PHYS CHEM C, V117, P15704, DOI 10.1021/jp404376t; Attard GA, 2014, PHYS CHEM CHEM PHYS, V16, P13689, DOI 10.1039/c4cp00564c; Aoyama T., 2009, SAE INT J ENGINES, V1, P314; Bard A.J., 1985, STANDARD POTENTIALS; Bema A., 2008, ELECTROCHEM COMMUN, V10, P1695; Hanawa H, 2012, J PHYS CHEM C, V116, P21401, DOI 10.1021/jp306955q; Hiraoka F., 2012, ELECTROCATALYSIS, V4, P10; HSUEH KL, 1985, ELECTROCHIM ACTA, V30, P1137, DOI 10.1016/0013-4686(95)80004-2; Kodama K, 2013, ELECTROCHEM COMMUN, V36, P26, DOI 10.1016/j.elecom.2013.09.005; Komanicky V, 2006, J ELECTROCHEM SOC, V153, pB446, DOI 10.1149/1.2229284; Liu Y., 2010, J ELECTROCHEM SOLID, V13, pB1; Ohma A, 2010, SURF SCI, V604, P965, DOI 10.1016/j.susc.2010.02.031; Papageorgopoulos D., 2014, US DEP EN DOE 2014 F; Pourbaix M. J. N., 1959, PLATIN MET REV, V3, P47; Rinaldo SG, 2011, ELECTROCHEM SOLID ST, V14, pB47, DOI 10.1149/1.3548504; Sugawara Y, 2012, J ELECTROCHEM SOC, V159, pF779, DOI 10.1149/2.017212jes; TOPALOV AA, 2014, J CHEM SCI, V5, P631; Uchimura M., 2007, ECS T, V11, P1215, DOI DOI 10.1149/1.2781035	47	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2155-5435			ACS CATAL	ACS Catal.	APR	2015	5	4					2605	2614		10.1021/cs5016035		10	Chemistry, Physical	Chemistry	CF3QU	WOS:000352464400067		
J	Numata, K; Morisaki, K				Numata, Keiji; Morisaki, Kumiko			Screening of Marine Bacteria To Synthesize Polyhydroxyalkanoate from Lignin: Contribution of Lignin Derivatives to Biosynthesis by Oceanimonas doudoroffii	ACS SUSTAINABLE CHEMISTRY & ENGINEERING			English	Article						Polyhydroxyalkanoate; marine bacteria; lignin; lignin derivatives; Oceanimonas doudoroffii	DEEP-SEA BACTERIA; CATABOLIC PATHWAYS; AROMATIC-COMPOUNDS; ENVIRONMENT; OCEAN	To convert lignin and lignin derivatives to biopolyesters, six types of marine bacterial strains were investigated with mineral salt media containing lignin and lignin derivatives. Our results showed that Oceanimonas doudoroffii, which was isolated from an area of the sea polluted with allantoin, directly synthesized polyhydroxyalkanoate (PHA) using lignin or several lignin derivatives as sole carbon sources. Based on the PHA accumulation data, the conversion from lignin to PHA can be carried out mainly via sinapinic acid and syringic acid rather than other lignin derivatives. This is the first study to show the direct microbial conversion from lignin to biopolyester, which will open the door for lignin-based biorefinery applications.	[Numata, Keiji; Morisaki, Kumiko] RIKEN, Enzyme Res Team, Ctr Sustainable Resource Sci, Wako, Saitama 3510198, Japan	Numata, K (reprint author), RIKEN, Enzyme Res Team, Ctr Sustainable Resource Sci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	keiji.numata@riken.jp	Numata, Keiji/H-9751-2012		RIKEN Biomass Engineering Program	This work was supported by RIKEN Biomass Engineering Program (K.N.).	Iwata T, 2004, MACROMOL RAPID COMM, V25, P1100, DOI 10.1002/marc.200400110; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; Gonzalez JM, 1997, INT J SYST BACTERIOL, V47, P773; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Curson ARJ, 2012, BIOGEOCHEMISTRY, V110, P109, DOI 10.1007/s10533-011-9663-2; Pailleret M, 2007, MAR ECOL-EVOL PERSP, V28, P233, DOI 10.1111/j.1439-0485.2006.00149.x; Umani SF, 2007, AQUAT MICROB ECOL, V46, P163; Numata K, 2012, MAR BIOTECHNOL, V14, P323, DOI 10.1007/s10126-011-9416-1; Tomizawa S, 2014, ACS SUSTAIN CHEM ENG, V2, P1106, DOI 10.1021/sc500066f; Gonzalez-Garcia Y, 2008, J IND MICROBIOL BIOT, V35, P629, DOI 10.1007/s10295-007-0299-0; VICUNA R, 1987, APPL ENVIRON MICROB, V53, P2605; WU GX, 1994, IND ENG CHEM RES, V33, P718, DOI 10.1021/ie00027a034; Tuomela M, 2000, BIORESOURCE TECHNOL, V72, P169, DOI 10.1016/S0960-8524(99)00104-2; Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c; Doi Y., 2001, BIOPOLYMERS, V3; Doi Y, 1990, MICROBIAL POLYESTERS; KUNIOKA M, 1989, APPL MICROBIOL BIOT, V30, P569; Numata K, 2013, POLYM J, V45, P1094, DOI 10.1038/pj.2013.25; Ohta Y., 2012, OPEN J MAR SCI, V2, P177, DOI DOI 10.4236/ojms.2012.24021; SAWADA T, 1995, BIOTECHNOL BIOENG, V48, P719, DOI 10.1002/bit.260480621; Wang Q, 2010, WORLD J MICROB BIOT, V26, P1149, DOI 10.1007/s11274-009-0282-1	27	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2168-0485			ACS SUSTAIN CHEM ENG	ACS Sustain. Chem. Eng.	APR	2015	3	4					569	573		10.1021/acssuschemeng.5b00031		5	Chemistry, Multidisciplinary; Engineering, Chemical	Chemistry; Engineering	CF4MA	WOS:000352522000003		
J	Yang, W; Shimanouchi, T; Kimura, Y				Yang, Wei; Shimanouchi, Toshinori; Kimura, Yukitaka			Characterization of the Residue and Liquid Products Produced from Husks of Nuts from Carya cathayensis Sarg by Hydrothermal Carbonization	ACS SUSTAINABLE CHEMISTRY & ENGINEERING			English	Article						Hydrothermal carbonization; husks of nuts from Carya cathayensis Sarg; pH; residue; fuel property	WET TORREFACTION; BIOMASS; FUEL; WATER; CELLULOSE; VALUES; LIGNIN; WASTE; WOOD; OILS	Hydrothermal carbonization is considered to be an environment-friendly method to pretreat biomass. Therefore, hydrothermal carbonization of the husks of nuts from Carya cathayensis Sarg,, at various temperatures and pHs were performed and the fuel properties of the obtained residue, water-soluble products (WSP) and acetone-soluble products (ASP) were characterized. It was found that the residue yield decreased with increasing hydrothermal carbonization temperature while the yield of total soluble products (WSP and ASP) was nearly the same. The residue and total soluble products yields had no large changes in the pH range of 4.0-10.0, but fewer residues and more total soluble products were obtained at pH 13.0. It was confirmed that hemicellulose was more reactive than cellulose and lignin during hydrothermal carbonization and that lignin could be effectively hydrolyzed/decomposed at pH 13.0. The higher heating values (HHVs) of residues were in the ranges of 22.0 to 28.2 MJ kg(-1) at temperatures from 180 to 260 inverted perpendicular C and pH from 4.0 to 10.0. The HHVs of these residues could be comparable with those of some commercial coals, such as lignite. However, the HI-IVs of residues decreased when the pH reached to 13.0. The WSP and ASP showed lower HHVs compared with heavy fuel oils, which meant the HHVs of WSP and ASP should be increased before being applied as bio-fuels.	[Yang, Wei; Shimanouchi, Toshinori; Kimura, Yukitaka] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan	Kimura, Y (reprint author), Okayama Univ, Grad Sch Environm & Life Sci, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	yktkkimu@cc.okayama-u.ac.jp			Special Project from MEXT for the Environmental and Life Scientific Researches on the Integration of Low-carbon Society and Ensuring Food Safety and Security	The authors are grateful to the Special Project from MEXT for the Environmental and Life Scientific Researches on the Integration of Low-carbon Society and Ensuring Food Safety and Security for Financial Support.	Acharjee TC, 2011, BIORESOURCE TECHNOL, V102, P4849, DOI 10.1016/j.biortech.2011.01.018; Liu ZG, 2013, FUEL, V103, P943, DOI 10.1016/j.fuel.2012.07.069; Prins MJ, 2006, J ANAL APPL PYROL, V77, P35, DOI 10.1016/j.jaap.2006.01.001; Yan W, 2010, ENERG FUEL, V24, P4738, DOI 10.1021/ef901273n; Hanaoka T, 2013, FUEL PROCESS TECHNOL, V116, P9, DOI 10.1016/j.fuproc.2013.03.049; Chen WH, 2012, BIORESOURCE TECHNOL, V118, P195, DOI 10.1016/j.biortech.2012.04.101; Lynam JG, 2011, BIORESOURCE TECHNOL, V102, P6192, DOI 10.1016/j.biortech.2011.02.035; Kang SM, 2013, RENEW SUST ENERG REV, V27, P546, DOI 10.1016/j.rser.2013.07.013; Xu CB, 2008, ENERG FUEL, V22, P635, DOI 10.1021/ef700424k; Yokoyama T, 2002, J AGR FOOD CHEM, V50, P1040, DOI 10.1021/jf011173q; Kang SM, 2012, IND ENG CHEM RES, V51, P9023, DOI 10.1021/ie300565d; Pinkowska H, 2011, BIOMASS BIOENERG, V35, P3902, DOI 10.1016/j.biombioe.2011.06.015; Peterson AA, 2008, ENERG ENVIRON SCI, V1, P32, DOI 10.1039/b810100k; Friedl A, 2005, ANAL CHIM ACTA, V544, P191, DOI 10.1016/j.aca.2005.01.041; Fogassy G, 2010, APPL CATAL B-ENVIRON, V96, P476, DOI 10.1016/j.apcatb.2010.03.008; Lu XW, 2013, BIORESOURCE TECHNOL, V138, P180, DOI 10.1016/j.biortech.2013.03.163; Yan W, 2014, ENVIRON PROG SUSTAIN, V33, P676, DOI 10.1002/ep.11974; Funke A, 2010, BIOFUEL BIOPROD BIOR, V4, P160, DOI 10.1002/bbb.198; Channiwala SA, 2002, FUEL, V81, P1051, DOI 10.1016/S0016-2361(01)00131-4; Venderbosch RH, 2010, J CHEM TECHNOL BIOT, V85, P674, DOI 10.1002/jctb.2354; Ben B. X., 2012, GREEN CHEM, V14, P72; Krushna PS, 2014, FUEL, V115, P434; Libra J. A., 2011, BIOFUELS, V2, P89, DOI DOI 10.4155/BFS:10.81; Marion C, 2012, BIOMASS BIOENERG, V35, P298; Reza M. T., 2014, BIOMASS CONVERS BIOR, V4, P311, DOI DOI 10.1007/S13399-014-0115-9; Jiang XX, 2011, KOREAN J CHEM ENG, V28, P133, DOI 10.1007/s11814-010-0328-y; Yu Y., 2007, ENERG FUEL, V20, P46	27	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2168-0485			ACS SUSTAIN CHEM ENG	ACS Sustain. Chem. Eng.	APR	2015	3	4					591	598		10.1021/acssuschemeng.5b00103		8	Chemistry, Multidisciplinary; Engineering, Chemical	Chemistry; Engineering	CF4MA	WOS:000352522000006		
J	Sawama, Y; Niikawa, M; Yabe, Y; Goto, R; Kawajiri, T; Marumoto, T; Takahashi, T; Itoh, M; Kimura, Y; Sasai, Y; Yamauchi, Y; Kondo, S; Kuzuya, M; Monguchi, Y; Sajiki, H				Sawama, Yoshinari; Niikawa, Miki; Yabe, Yuki; Goto, Ryota; Kawajiri, Takahiro; Marumoto, Takahisa; Takahashi, Tohru; Itoh, Miki; Kimura, Yuuichi; Sasai, Yasushi; Yamauchi, Yukinori; Kondo, Shin-ichi; Kuzuya, Masayuki; Monguchi, Yasunari; Sajiki, Hironao			Stainless-Steel-Mediated Quantitative Hydrogen Generation from Water under Ball Milling Conditions	ACS SUSTAINABLE CHEMISTRY & ENGINEERING			English	Article						Hydrogen generation; oxygen free; mechanochemistry; stainless steel; chromium	VISIBLE-LIGHT; AMINO ESTERS; PHOTOCATALYSTS; CATALYSIS; MECHANOCHEMISTRY; CONFIGURATION; IRRADIATION; ACTIVATION; POWDERS; OXYGEN	A robust and quantitative gaseous hydrogen generation method has been developed in an effort to achieve efficient H-2 generation derived from H2O. The present reaction could be achieved by a simple ball friction (milling) reaction of H2O using a planetary ball mill machine with a stainless-steel vessel and balls. It was mediated by metals as an element of stainless steel of the ball mill and also promoted by mechanochemical processing.	[Sawama, Yoshinari; Niikawa, Miki; Yabe, Yuki; Goto, Ryota; Kawajiri, Takahiro; Marumoto, Takahisa; Takahashi, Tohru; Monguchi, Yasunari; Sajiki, Hironao] Gifu Pharmaceut Univ, Lab Organ Chem, Gifu 5011196, Japan; [Itoh, Miki; Kimura, Yuuichi] Canon Inc, Frontier Res Ctr, Ohta Ku, Tokyo 1468501, Japan; [Sasai, Yasushi; Kondo, Shin-ichi] Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, Gifu 5011196, Japan; [Yamauchi, Yukinori] Matsuyama Univ, Coll Pharmaceut Sci, Dept Pharmaceut Phys Chem, Matsuyama, Ehime 7908578, Japan; [Kuzuya, Masayuki] Chubu Gakuin Univ, Fac Human Welf, Dept Hlth & Human Welf, Seki 5013993, Japan	Sawama, Y (reprint author), Gifu Pharmaceut Univ, Lab Organ Chem, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	sawama@gifu-pu.ac.jp; sajiki@gifu-pu.ac.jp			Canon Foundation; Koshiyama Research Grant; Shiono Chemical Co., Ltd.;  [26670005]	This work was partially supported by The Canon Foundation. YS expresses his deep and sincere gratitude for the Grant-in-Aid for Challenging Exploratory Research (26670005) and the Koshiyama Research Grant. We sincerely thank Shiono Chemical Co., Ltd., for the partial financial support and Mr. Masatoshi Yamada, Mr. Yoshiyuki Mori, and Dr. Eiji Imai of Shiono Chemical Co., Ltd., for the intellectual discussions. We are grateful for the kind assistance provided by Fritsch Japan Co, Ltd., relevant to the Fritsch Pulverisette Premium Line 7 Ball Mill (PLP-7).	Wang GW, 2013, CHEM SOC REV, V42, P7668, DOI 10.1039/c3cs35526h; Blakemore JD, 2013, ACS CATAL, V3, P2497, DOI 10.1021/cs400639b; Abe R, 2011, B CHEM SOC JPN, V84, P1000, DOI 10.1246/bcsj.20110132; Joya KS, 2013, ANGEW CHEM INT EDIT, V52, P10426, DOI 10.1002/anie.201300136; Maeda K, 2007, J PHYS CHEM C, V111, P7851, DOI 10.1021/jp070911w; Maeda K, 2013, ACS CATAL, V3, P1486, DOI 10.1021/cs4002089; Kumar V, 2014, J ORG CHEM, V79, P3427, DOI 10.1021/jo5001753; Takacs L, 2013, CHEM SOC REV, V42, P7649, DOI 10.1039/c2cs35442j; Stolle A, 2011, CHEM SOC REV, V40, P2317, DOI 10.1039/c0cs00195c; Hetterscheid DGH, 2012, ANGEW CHEM INT EDIT, V51, P9740, DOI 10.1002/anie.201202948; Zhang KL, 2013, ENVIRON SCI TECHNOL, V47, P6471, DOI 10.1021/es400346n; Stephens IEL, 2011, ANGEW CHEM INT EDIT, V50, P1476, DOI 10.1002/anie.201005921; Bruckmann A, 2008, GREEN CHEM, V10, P1131, DOI 10.1039/b812536h; Osterloh FE, 2013, CHEM SOC REV, V42, P2294, DOI 10.1039/c2cs35266d; Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645; Hetterscheid DGH, 2009, ANGEW CHEM INT EDIT, V48, P8178, DOI 10.1002/anie.200902455; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h; Konnert L, 2014, J ORG CHEM, V79, P10132, DOI 10.1021/jo5017629; Sepelak V, 2013, CHEM SOC REV, V42, P7507, DOI 10.1039/c2cs35462d; Artero V, 2011, ANGEW CHEM INT EDIT, V50, P7238, DOI 10.1002/anie.201007987; MULLER P, 1994, PURE APPL CHEM, V66, P1077, DOI 10.1351/pac199466051077; Konnert L, 2014, J ORG CHEM, V79, P4008, DOI 10.1021/jo500463y; Hara M, 2000, J PHYS CHEM B, V104, P780, DOI 10.1021/jp993441h; Maeda K, 2013, PHYS CHEM CHEM PHYS, V15, P10537, DOI 10.1039/c2cp43914j; Maeda K, 2013, CHEM-EUR J, V19, P4986, DOI 10.1002/chem.201300158; Janot R, 2002, J ALLOY COMPD, V333, P302, DOI 10.1016/S0925-8388(01)01737-6; Chen D, 2007, CHINA PART, V5, P357, DOI 10.1016/j.cpart.2007.05.005; Delogu F, 2011, INT J HYDROGEN ENERG, V36, P15145, DOI 10.1016/j.ijhydene.2011.08.120; Domen K, 2000, B CHEM SOC JPN, V73, P1307, DOI 10.1246/bcsj.73.1307; Ikeda S, 1998, CHEM COMMUN, P2185, DOI 10.1039/a804549f; Ikeda S, 1999, PHYS CHEM CHEM PHYS, V1, P4485, DOI 10.1039/a903543e; Rodiguez B., 2007, ADV SYNTH CATAL, V349, P2213; Sugioka M., 2006, MEM MURORAN I TECHNO, V56, P35; Yaegashi R., 2005, Academic Reports, Faculty of Engineering, Tokyo Institute of Polytechnics, V28; Youngblood WJ, 2009, ACCOUNTS CHEM RES, V42, P1966, DOI 10.1021/ar9002398	36	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2168-0485			ACS SUSTAIN CHEM ENG	ACS Sustain. Chem. Eng.	APR	2015	3	4					683	689		10.1021/sc5008434		7	Chemistry, Multidisciplinary; Engineering, Chemical	Chemistry; Engineering	CF4MA	WOS:000352522000017		
J	Yamada, H; Nagae, T; Watanabe, N				Yamada, Hiroyuki; Nagae, Takayuki; Watanabe, Nobuhisa			High-pressure protein crystallography of hen egg-white lysozyme	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						hen egg-white lysozyme; high pressure	PH MOLECULAR-DYNAMICS; X-RAY-DIFFRACTION; MACROMOLECULAR CRYSTALLOGRAPHY; STRUCTURAL TRANSITION; WATER PENETRATION; CRYSTAL-STRUCTURE; EXPLICIT SOLVENT; NMR; SIMULATION; REFINEMENT	Crystal structures of hen egg-white lysozyme (HEWL) determined under pressures ranging from ambient pressure to 950 MPa are presented. From 0.1 to 710 MPa, the molecular and internal cavity volumes are monotonically compressed. However, from 710 to 890 MPa the internal cavity volume remains almost constant. Moreover, as the pressure increases to 950 MPa, the tetragonal crystal of HEWL undergoes a phase transition from P4(3)2(1)2 to P4(3). Under high pressure, the crystal structure of the enzyme undergoes several local and global changes accompanied by changes in hydration structure. For example, water molecules penetrate into an internal cavity neighbouring the active site and induce an alternate conformation of one of the catalytic residues, Glu35. These phenomena have not been detected by conventional X-ray crystal structure analysis and might play an important role in the catalytic activity of HEWL.	[Yamada, Hiroyuki; Watanabe, Nobuhisa] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Nagae, Takayuki; Watanabe, Nobuhisa] Nagoya Univ, Synchrotron Radiat Res Ctr, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Watanabe, N (reprint author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	nobuhisa@nagoya-u.jp			JSPS KAKENHI [21657027, 24657071]	We thank the beamline staff at the Photon Factory for their assistance in the synchrotron experiments. This study was partly supported by JSPS KAKENHI Grants No. 21657027 and No. 24657071.	Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Refaee M, 2003, J MOL BIOL, V327, P857, DOI 10.1016/S0022-2836(03)00209-2; Wallace JA, 2011, J CHEM THEORY COMPUT, V7, P2617, DOI 10.1021/ct200146j; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Egli M, 2007, ACCOUNTS CHEM RES, V40, P197, DOI 10.1021/ar068174u; DIAMOND R, 1974, J MOL BIOL, V82, P371, DOI 10.1016/0022-2836(74)90598-1; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Vehlow C, 2011, BIOINFORMATICS, V27, P1573, DOI 10.1093/bioinformatics/btr163; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Imai T, 2007, PROTEIN SCI, V16, P1927, DOI 10.1110/ps.072909007; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Bon C, 1999, ACTA CRYSTALLOGR D, V55, P978, DOI 10.1107/S0907444998018514; Jain A, 2009, PROTEIN SCI, V18, P595, DOI 10.1002/pro.67; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Goh GB, 2014, PROTEINS, V82, P1319, DOI 10.1002/prot.24499; Ascone I, 2010, J APPL CRYSTALLOGR, V43, P407, DOI [10.1107/S002110003055, 10.1107/S0021889810003055]; Ascone I, 2010, ACTA CRYSTALLOGR D, V66, P654, DOI 10.1107/S0907444910012321; Balny C, 2006, BBA-PROTEINS PROTEOM, V1764, P632, DOI 10.1016/j.bbapap.2005.10.004; BRUNNE RM, 1993, FEBS LETT, V323, P215, DOI 10.1016/0014-5793(93)81342-W; Chavas LMG, 2013, J SYNCHROTRON RADIAT, V20, P838, DOI 10.1107/S0909049513020797; Cioni P, 2011, BBA-PROTEINS PROTEOM, V1814, P934, DOI 10.1016/j.bbapap.2010.09.017; Collins MD, 2011, ANNU REV BIOPHYS, V40, P81, DOI 10.1146/annurev-biophys-042910-155304; Collins MD, 2005, P NATL ACAD SCI USA, V102, P16668, DOI 10.1073/pnas.0508224102; DeLano W. L., 2002, PYMOL; Fourme R, 2002, STRUCTURE, V10, P1409, DOI 10.1016/S0969-2126(02)00850-X; Fourme R, 2001, J SYNCHROTRON RADIAT, V8, P1149, DOI 10.1107/S0909049501011037; Fourme R, 2012, CURR OPIN STRUC BIOL, V22, P636, DOI 10.1016/j.sbi.2012.07.007; Fourme R., 2003, ADV HIGH PRESSURE BI, VII, P161; Girard E, 2005, BIOPHYS J, V88, P3562, DOI 10.1529/biophysj.104.058636; Girard E, 2007, J APPL CRYSTALLOGR, V40, P912, DOI 10.1107/S0021889807033833; HEREMANS K, 1985, CHEM PHYS LETT, V118, P101, DOI 10.1016/0009-2614(85)85275-1; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Imai T, 2010, J PHYS CHEM B, V114, P2281, DOI 10.1021/jp909701j; INOUE M, 1992, BIOCHEMISTRY-US, V31, P5545, DOI 10.1021/bi00139a017; JONAS J, 1990, BER BUNSEN PHYS CHEM, V94, P307; Katrusiak A, 1996, ACTA CRYSTALLOGR D, V52, P607, DOI 10.1107/S0907444996000431; KUNDROT CE, 1987, J MOL BIOL, V193, P157, DOI 10.1016/0022-2836(87)90634-6; KURAMITSU S, 1977, J BIOCHEM-TOKYO, V82, P585; KURAMITSU S, 1980, J BIOCHEM-TOKYO, V87, P1215; MAENAKA K, 1995, J MOL BIOL, V247, P281, DOI 10.1006/jmbi.1994.0139; Marchi M, 2001, J PHYS CHEM B, V105, P711, DOI 10.1021/jp002539p; Nagae T, 2012, ACTA CRYSTALLOGR D, V68, P300, DOI 10.1107/S0907444912001862; Niimura N, 1997, NAT STRUCT BIOL, V4, P909, DOI 10.1038/nsb1197-909; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips DC, 1967, P NATL ACAD SCI USA, V57, P483, DOI 10.1073/pnas.57.3.483; Schwalbe H, 2001, PROTEIN SCI, V10, P677, DOI 10.1110/ps.43301; Suzuki Y, 2002, BBA-PROTEIN STRUCT M, V1595, P345, DOI 10.1016/S0167-4838(01)00355-7; Webb H, 2011, PROTEINS, V79, P685, DOI 10.1002/prot.22886	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	APR	2015	71		4				742	753		10.1107/S1399004715000292		12	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CF4GQ	WOS:000352507200001		
J	Shimada, T; Suzuki, M; Katakura, S				Shimada, Takashi; Suzuki, Makoto; Katakura, Shin-ichi			Structure of N-myristoyltransferase from Aspergillus fumigatus	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						N-myristoyltransferase; Aspergillus fumigatus	CANDIDA-ALBICANS; CRYSTAL-STRUCTURES; INVASIVE ASPERGILLOSIS; PLASMODIUM-FALCIPARUM; BOUND MYRISTOYLCOA; AZOLE RESISTANCE; INHIBITORS; DISCOVERY; DESIGN; BENZOFURANS	N-Myristoyltransferase (NMT) is an enzyme which translocates the 14-carbon saturated fatty acid myristate from myristoyl-CoA to the N-terminal glycine of substrate peptides. This myristoylation process is involved in protein modification in various eukaryotes, including animals and fungi. Furthermore, this enzyme has been shown to be essential to the growth of various species, such as Saccharomyces cerevisiae, which indicates that NMT is an attractive target for the development of a novel antifungal drug. In this study, the crystal structure of a ternary complex of NMT from Aspergillus fumigatus with S-(2-oxo) pentadecyl-CoA, a myristoyl-CoA analogue cofactor, and a synthetic inhibitor is reported at a resolution of 2.1 angstrom. The results advance the understanding of the specificity of NMT inhibitors and provide valuable information for structurebased drug design.	[Shimada, Takashi; Suzuki, Makoto; Katakura, Shin-ichi] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Edogawa Ku, Tokyo 1348630, Japan	Shimada, T (reprint author), Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Edogawa Ku, 1-16-13 Kita Kasai, Tokyo 1348630, Japan.	shimada.takashi.zj@rdn.daiichisankyo.co.jp					Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/nchem.1830, 10.1038/NCHEM.1830]; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Masubuchi M, 2001, BIOORG MED CHEM LETT, V11, P1833, DOI 10.1016/S0960-894X(01)00319-5; Howard SJ, 2010, CLIN MICROBIOL INFEC, V16, P683, DOI 10.1111/j.1469-0691.2009.02911.x; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Snelders E, 2011, FUTURE MICROBIOL, V6, P335, DOI [10.2217/fmb.11.4, 10.2217/FMB.11.4]; Zhou P, 2009, J CHEM INF MODEL, V49, P2344, DOI 10.1021/ci9002393; Brannigan JA, 2014, IUCRJ, V1, P250, DOI 10.1107/S2052252514013001; Ebiike H, 2002, BIOORG MED CHEM LETT, V12, P607, DOI 10.1016/S0960-894X(01)00808-3; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Yu ZY, 2012, J MED CHEM, V55, P8879, DOI 10.1021/jm301160h; Brannigan JA, 2010, J MOL BIOL, V396, P985, DOI 10.1016/j.jmb.2009.12.032; Farazi TA, 2001, BIOCHEMISTRY-US, V40, P6335, DOI 10.1021/bi0101401; Weston SA, 1998, NAT STRUCT BIOL, V5, P213, DOI 10.1038/nsb0398-213; Masubuchi M, 2003, BIOORGAN MED CHEM, V11, P4463, DOI 10.1016/S0968-0896(03)00429-2; Goncalves V, 2012, J MED CHEM, V55, P3578, DOI 10.1021/jm300040p; Brand S, 2012, J MED CHEM, V55, P140, DOI 10.1021/jm201091t; Kawasaki K, 2003, BIOORG MED CHEM LETT, V13, P87, DOI 10.1016/S0960-894X(02)00844-2; MURRAYRUST P, 1983, J AM CHEM SOC, V105, P3206, DOI 10.1021/ja00348a041; Dunitz JD, 1997, CHEM-EUR J, V3, P89, DOI 10.1002/chem.19970030115; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310; Rackham MD, 2013, J MED CHEM, V56, P371, DOI 10.1021/jm301474t; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Bhatnagar RS, 1998, NAT STRUCT BIOL, V5, P1091, DOI 10.1038/4202; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen SH, 2003, DRUG FUTURE, V28, P441, DOI 10.1358/dof.2003.028.05.737309; DEVADAS B, 1995, J MED CHEM, V38, P1837, DOI 10.1021/jm00011a001; Ebara S, 2005, BIOL PHARM BULL, V28, P591, DOI 10.1248/bpb.28.591; KNOLL LJ, 1995, METHOD ENZYMOL, V250, P405; Laczkowski KZ, 2013, LETT DRUG DES DISCOV, V10, P798; Pfaller A. P., 2006, CLIN INFECT DIS, V43, pS3; RUDNICK DA, 1993, ADV ENZYMOL RAMB, V67, P375; Siwek A, 2012, J MOL MODEL, V18, P4159, DOI 10.1007/s00894-012-1420-5; Sogabe S, 2002, CHEM BIOL, V9, P1119, DOI 10.1016/S1074-5521(02)00240-5; Wu J, 2007, J BIOL CHEM, V282, P22185, DOI 10.1074/jbc.M702696200; Zhao C, 2014, CHEMMEDCHEM, V9, P2425, DOI 10.1002/cmdc.201402174	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	APR	2015	71		4				754	761		10.1107/S1399004715000401		8	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CF4GQ	WOS:000352507200002		
J	Liebschner, D; Rosenbaum, G; Dauter, M; Dauter, Z				Liebschner, Dorothee; Rosenbaum, Gerold; Dauter, Miroslawa; Dauter, Zbigniew			Radiation decay of thaumatin crystals at three X-ray energies	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						radiation damage; dose limit; energy dependence	PROTEIN CRYSTALS; MACROMOLECULAR CRYSTALLOGRAPHY; SYNCHROTRON-RADIATION; DAMAGE; CRYOCRYSTALLOGRAPHY; DEPENDENCE; DIFFRACTION	Radiation damage is an unavoidable obstacle in X-ray crystallographic data collection for macromolecular structure determination, so it is important to know how much radiation a sample can endure before being degraded beyond an acceptable limit. In the literature, the threshold at which the average intensity of all recorded reflections decreases to a certain fraction of the initial value is called the 'dose limit'. The first estimated D-50 dose-limit value, at which the average diffracted intensity was reduced to 50%, was 20 MGy and was derived from observing sample decay in electron-diffraction experiments. A later X-ray study carried out at 100 Kon ferritin protein crystals arrived at a D-50 of 43 MGy, and recommended an intensity reduction of protein reflections to 70%, D-70, corresponding to an absorbed dose of 30 MGy, as a more appropriate limit for macromolecular crystallography. In the macromolecular crystallography community, the rate of intensity decay with dose was then assumed to be similar for all protein crystals. A series of diffraction images of cryocooled (100 K) thaumatin crystals at identical small, 2 degrees rotation intervals were recorded at X-ray energies of 6.33, 12.66 and 19.00 keV. Five crystals were used for each wavelength. The decay in the average diffraction intensity to 70% of the initial value, for data extending to 2.45 angstrom resolution, was determined to be about 7.5 MGy at 6.33 keV and about 11 MGy at the two higher energies.	[Liebschner, Dorothee] High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Struct Biol Res Ctr, Tsukuba, Ibaraki, Japan; [Rosenbaum, Gerold] Univ Georgia, Dept Biochem, Argonne, IL 60439 USA; [Rosenbaum, Gerold] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Dauter, Miroslawa] Argonne Natl Lab, Basic Sci Program, Leidos Biomed Res Inc, Argonne, IL 60439 USA; [Dauter, Zbigniew] Argonne Natl Lab, Synchrotron Radiat Res Sect, MCL, Natl Canc Inst, Argonne, IL 60439 USA	Dauter, Z (reprint author), Argonne Natl Lab, Synchrotron Radiat Res Sect, MCL, Natl Canc Inst, 9700 S Cass Ave, Argonne, IL 60439 USA.	dauter@anl.gov			Intramural Research Program of the National Cancer Institute, Center for Cancer Research; Federal funds from the National Cancer Institute, National Institutes of Health [HHSN261200800E]; Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	This project was supported in part by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research and with Federal funds from the National Cancer Institute, National Institutes of Health (Contract No. HHSN261200800E). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products or organizations imply endorsement by the US Government. Diffraction data were collected on beamline 19-ID of the Structural Biology Center at the Advanced Photon Source, Argonne National Laboratory operated under contract DE-AC02-06CH11357 of the Department of Energy, Office of Biological and Environmental Research. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. W-31-109-Eng-38.	Alkire RW, 2000, J SYNCHROTRON RADIAT, V7, P61, DOI 10.1107/S090904959901568X; Weiss MS, 2005, J SYNCHROTRON RADIAT, V12, P304, DOI 10.1107/S0909049505003328; Ravelli RBG, 2000, STRUCT FOLD DES, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Fourme R, 2012, J APPL CRYSTALLOGR, V45, P652, DOI 10.1107/S0021889812019164; Holton JM, 2009, J SYNCHROTRON RADIAT, V16, P133, DOI 10.1107/S0909049509004361; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Ravelli RBG, 2006, CURR OPIN STRUC BIOL, V16, P624, DOI 10.1016/j.sbi.2006.08.001; Blake C. C. F., 1962, BIOL EFFECTS IONIZIN, P2; Garman E, 2002, J SYNCHROTRON RADIAT, V9, P327, DOI 10.1107/S0909049502014565; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; HENDRICKSON WA, 1976, J MOL BIOL, V106, P889, DOI 10.1016/0022-2836(76)90271-0; Homer C, 2011, J SYNCHROTRON RADIAT, V18, P338, DOI 10.1107/S0909049511005504; HOPE H, 1988, ACTA CRYSTALLOGR B, V44, P22, DOI 10.1107/S0108768187008632; Kmetko J, 2006, ACTA CRYSTALLOGR D, V62, P1030, DOI 10.1107/S0907444906023869; Liebschner D, 2012, ACTA CRYSTALLOGR D, V68, P1430, DOI 10.1107/S0907444912034658; McMaster W. H., 1969, PERIODIC TABLE XRAY; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; RODGERS DW, 1994, STRUCTURE, V2, P1135, DOI 10.1016/S0969-2126(94)00116-2; Shimizu N, 2007, J SYNCHROTRON RADIAT, V14, P4, DOI 10.1107/S0909049506049296; Sliz P, 2003, STRUCTURE, V11, P13, DOI 10.1016/S0969-2126(02)00910-3; Warkentin M, 2013, J SYNCHROTRON RADIAT, V20, P7, DOI 10.1107/S0909049512048303; Warkentin Matthew, 2010, Journal of Structural and Functional Genomics, V11, P85, DOI 10.1007/s10969-009-9074-y; Zeldin OB, 2013, P NATL ACAD SCI USA, V110, P20551, DOI 10.1073/pnas.1315879110	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	APR	2015	71		4				772	778		10.1107/S1399004715001030		7	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CF4GQ	WOS:000352507200004		
J	Amano, Y; Yamaguchi, T; Niimi, T; Sakashita, H				Amano, Yasushi; Yamaguchi, Tomohiko; Niimi, Tatsuya; Sakashita, Hitoshi			Structures of complexes of type 5 17 beta-hydroxysteroid dehydrogenase with structurally diverse inhibitors: insights into the conformational changes upon inhibitor binding	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						type 5 17 beta-hydroxysteroid dehydrogenase; prostate cancer	RESISTANT PROSTATE-CANCER; PROSTAGLANDIN-F-SYNTHASE; CRYSTAL-STRUCTURES; SELECTIVE INHIBITORS; AKR1C3; POTENT; INDOMETHACIN; ASP9521; TARGET; ENZYME	Type 5 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD5) is an aldo-keto reductase expressed in the human prostate which catalyzes the conversion of androstenedione to testosterone. Testosterone is converted to 5 alpha-dihydrotestosterone, which is present at high concentrations in patients with castration-resistant prostate cancer (CRPC). Inhibition of 17 beta-HSD5 is therefore considered to be a promising therapy for treating CRPC. In the present study, crystal structures of complexes of 17 beta-HSD5 with structurally diverse inhibitors derived from high-throughput screening were determined. In the structures of the complexes, various functional groups, including amide, nitro, pyrazole and hydroxyl groups, form hydrogen bonds to the catalytic residues His117 and Tyr55. In addition, major conformational changes of 17 beta-HSD5 were observed following the binding of the structurally diverse inhibitors. These results demonstrate interactions between 17 beta-HSD5 and inhibitors at the atomic level and enable structure-based drug design for anti-CRPC therapy.	[Amano, Yasushi; Yamaguchi, Tomohiko; Niimi, Tatsuya; Sakashita, Hitoshi] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Amano, Y (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	yasushi-amano@astellas.com					Chen M, 2012, BIOORG MED CHEM LETT, V22, P3492, DOI 10.1016/j.bmcl.2012.03.085; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; Komoto J, 2006, BIOCHEMISTRY-US, V45, P1987, DOI 10.1021/bi051861t; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Byrns MC, 2011, J STEROID BIOCHEM, V125, P95, DOI 10.1016/j.jsbmb.2010.11.004; Labrie F, 2011, NAT REV UROL, V8, P73, DOI 10.1038/nrurol.2010.231; Adeniji AO, 2013, J STEROID BIOCHEM, V137, P136, DOI 10.1016/j.jsbmb.2013.05.012; Komoto J, 2004, BIOCHEMISTRY-US, V43, P2188, DOI 10.1021/bi036046x; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Liedtke AJ, 2013, J MED CHEM, V56, P2429, DOI 10.1021/jm3017656; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jamieson SMF, 2012, J MED CHEM, V55, P7746, DOI 10.1021/jm3007867; Byrns MC, 2008, BIOCHEM PHARMACOL, V75, P484, DOI 10.1016/j.bcp.2007.09.008; Lovering AL, 2004, CANCER RES, V64, P1802, DOI 10.1158/0008-5472.CAN-03-2847; Chavas LMG, 2012, J SYNCHROTRON RADIAT, V19, P450, DOI 10.1107/S0909049512009727; Flanagan JU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043965; Flanagan JU, 2014, BIOORGAN MED CHEM, V22, P967, DOI 10.1016/j.bmc.2013.12.050; Heinrich DM, 2013, EUR J MED CHEM, V62, P738, DOI 10.1016/j.ejmech.2013.01.047; Jackson VJ, 2012, ACTA CRYSTALLOGR F, V68, P409, DOI 10.1107/S1744309112009049; Kikuchi A, 2014, INVEST NEW DRUG, V32, P860, DOI 10.1007/s10637-014-0130-5; Loriot Y, 2014, INVEST NEW DRUG, V32, P995, DOI 10.1007/s10637-014-0101-x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiu W, 2007, J BIOL CHEM, V282, P8368, DOI 10.1074/jbc.M606784200; Watanabe K, 2013, BIOORGAN MED CHEM, V21, P5261, DOI 10.1016/j.bmc.2013.06.025	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	APR	2015	71		4				918	927		10.1107/S1399004715002175		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CF4GQ	WOS:000352507200018		
J	Lin, CC; Chuankhayan, P; Chang, WN; Kao, TT; Guan, HH; Fun, HK; Nakagawa, A; Fu, TF; Chen, CJ				Lin, Chien-Chih; Chuankhayan, Phimonphan; Chang, Wen-Ni; Kao, Tseng-Ting; Guan, Hong-Hsiang; Fun, Hoong-Kun; Nakagawa, Atsushi; Fu, Tzu-Fun; Chen, Chun-Jung			Structures of the hydrolase domain of zebrafish 10-formyltetrahydrofolate dehydrogenase and its complexes reveal a complete set of key residues for hydrolysis and product inhibition	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article						10-formyltetrahydrofolate dehydrogenase; zebrafish	INDUCED OXIDATIVE STRESS; CRYSTAL-STRUCTURE; CATALYTIC MECHANISM; TERMINAL DOMAIN; BINDING SITE; FOLATE; RAT; IDENTIFICATION; METABOLISM; PROTEIN	10-Formyltetrahydrofolate dehydrogenase (FDH), which is composed of a small N-terminal domain (Nt-FDH) and a large C-terminal domain, is an abundant folate enzyme in the liver and converts 10-formyltetrahydrofolate (10-FTHF) to tetrahydrofolate (THF) and CO2. Nt-FDH alone possesses a hydrolase activity, which converts 10-FTHF to THF and formate in the presence of beta-mercaptoethanol. To elucidate the catalytic mechanism of Nt-FDH, crystal structures of apo-form zNt-FDH from zebrafish and its complexes with the substrate analogue 10-formyl-5,8-dideazafolate (10-FDDF) and with the products THF and formate have been determined. The structures reveal that the conformations of three loops (residues 86-90, 135-143 and 200-203) are altered upon ligand (10-FDDF or THF) binding in the active site. The orientations and geometries of key residues, including Phe89, His106, Arg114, Asp142 and Tyr200, are adjusted for substrate binding and product release during catalysis. Among them, Tyr200 is especially crucial for product release. An additional potential THF binding site is identified in the cavity between two zNt-FDH molecules, which might contribute to the properties of product inhibition and THF storage reported for FDH. Together with mutagenesis studies and activity assays, the structures of zNt-FDH and its complexes provide a coherent picture of the active site and a potential THF binding site of zNt-FDH along with the substrate and product specificity, lending new insights into the molecular mechanism underlying the enzymatic properties of Nt-FDH.	[Lin, Chien-Chih; Chuankhayan, Phimonphan; Guan, Hong-Hsiang; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan; [Chang, Wen-Ni; Kao, Tseng-Ting; Fu, Tzu-Fun] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan; [Fun, Hoong-Kun; Chen, Chun-Jung] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia; [Fun, Hoong-Kun] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, Usm Penang 11800, Malaysia; [Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 701, Taiwan; [Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu 30043, Taiwan	Fu, TF (reprint author), Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan.	tffu@mail.ncku.edu.tw; cjchen@nsrrc.org.tw	Chen, Chun-Jung/A-6880-2011; Fun, Hoong-Kun/A-3561-2009; Fu, Tzu-Fun/G-7820-2011	Chen, Chun-Jung/0000-0002-5157-4288; 	Masato Yoshimura at the Taiwan [2012A4009, 2012A6760, 2012A6600, 2012B4002, 2012B4012, 2012B6600, 2013A4011, 2013A6600, 2013B4000, 2013B6600, 2014A4000, 2014A6600, 2014A6965, 2014A4004]; National Science Council (NSC) [98-2313-B-009-001-MY3, 101-2628-B-213-001-MY4, 102-2627-M-213-001-MY3]; NSRRC [1013RSB02, 1023RSB02]; NSC [99-2320-B-006-013-MY3]; Deanship of Scientific Research at King Saud University [RGP-VPP-207]	We are indebted to the support staff at beamlines BL13B1, BL13C1 and BL15A1 at the National Synchrotron Radiation Research Center (NSRRC) and Masato Yoshimura at the Taiwan-contracted beamline BL12B2 and beamline BL44XU at SPring-8 for technical assistance under proposal Nos. 2012A4009, 2012A6760, 2012A6600, 2012B4002, 2012B4012, 2012B6600, 2013A4011, 2013A6600, 2013B4000, 2013B6600, 2014A4000, 2014A6600, 2014A6965 and 2014A4004. We thank Sunney I. Chan for discussion and manuscript editing. Portions of this research were carried out at the NSRRC-NCKU Protein Crystallography Laboratory at the University Center for Bioscience and Biotechnology of National Cheng Kung University (NCKU). This work was supported in part by National Science Council (NSC) grants 98-2313-B-009-001-MY3, 101-2628-B-213-001-MY4, 102-2627-M-213-001-MY3 and NSRRC grants 1013RSB02 and 1023RSB02 to C-JC and NSC grant 99-2320-B-006-013-MY3 to T-FF. The authors extend their appreciation to The Deanship of Scientific Research at King Saud University for funding this work through research group project No. RGP-VPP-207. C-JC thanks King Saud University for a Visiting Professorship.	Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Gatzeva-Topalova PZ, 2005, BIOCHEMISTRY-US, V44, P5328, DOI 10.1021/bi047384g; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Rezk BM, 2003, FEBS LETT, V555, P601, DOI 10.1016/S0014-5793(03)01358-9; Schmitt E, 1996, EMBO J, V15, P4749; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338; Chang WN, 2014, BBA-GEN SUBJECTS, V1840, P2340, DOI 10.1016/j.bbagen.2014.04.009; Chang WN, 2010, PROTEIN EXPRES PURIF, V72, P217, DOI 10.1016/j.pep.2010.04.003; Chumanevich AA, 2004, J BIOL CHEM, V279, P14355, DOI 10.1074/jbc.M313934200; COOK RJ, 1991, J BIOL CHEM, V266, P4965; Donato H, 2007, J BIOL CHEM, V282, P34159, DOI 10.1074/jbc.M707627200; Fu TF, 2003, J BIOL CHEM, V278, P2645, DOI 10.1074/jbc.M210649200; Fu TF, 1999, ARCH BIOCHEM BIOPHYS, V367, P161, DOI 10.1006/abbi.1999.1262; Hsiao TH, 2014, MOL CELL BIOL, V34, P498, DOI 10.1128/MCB.01427-13; Kao TT, 2014, NEUROBIOL DIS, V71, P234, DOI 10.1016/j.nbd.2014.08.004; Kim DW, 1996, BIOCHEMISTRY-US, V35, P15772, DOI 10.1021/bi9619684; Krupenko SA, 2001, J BIOL CHEM, V276, P24030, DOI 10.1074/jbc.M009257200; Krupenko SA, 1997, J BIOL CHEM, V272, P10273; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; KRUPENKO SA, 1995, BIOCHEM J, V306, P651; Krupenko SA, 1999, J BIOL CHEM, V274, P35777, DOI 10.1074/jbc.274.50.35777; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; Kursula P, 2006, ACTA CRYSTALLOGR D, V62, P1294, DOI 10.1107/S0907444906026849; MCMARTIN KE, 1977, J PHARMACOL EXP THER, V201, P564; MIN H, 1988, BIOCHIM BIOPHYS ACTA, V967, P348, DOI 10.1016/0304-4165(88)90097-9; Newton DT, 1999, BIOCHEM J, V339, P63, DOI 10.1042/0264-6021:3390063; Neymeyer V, 1997, BRAIN RES, V766, P195, DOI 10.1016/S0006-8993(97)00528-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reuland SN, 2006, PROTEIN SCI, V15, P1076, DOI 10.1110/ps.052062806; SCHIRCH D, 1994, J BIOL CHEM, V269, P24728; Shim JH, 1999, BIOCHEMISTRY-US, V38, P10024, DOI 10.1021/bi9904609; Strickland KC, 2010, J BIOL CHEM, V285, P1627, DOI 10.1074/jbc.M109.080556; Yoshizawa T, 2011, FEBS J, V278, P1944, DOI 10.1111/j.1742-4658.2011.08111.x	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1399-0047			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	APR	2015	71		4				1006	1021		10.1107/S1399004715002928		16	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	CF4GQ	WOS:000352507200025		
J	Nakamura, K; Iga, J; Matsumoto, N; Ohmori, T				Nakamura, Kimiya; Iga, Junichi; Matsumoto, Naoki; Ohmori, Tetsuro			Risk of bipolar disorder and psychotic features in patients initially hospitalised with severe depression	ACTA NEUROPSYCHIATRICA			English	Article						bipolar disorder; co-morbidity; depression; psychosis	UNIPOLAR DEPRESSION; ELECTROCONVULSIVE-THERAPY; HEPATITIS-C; ASSOCIATION; COMORBIDITY; PREDICTORS; CONVERSION; VETERANS; SUBTYPES; COHORT	Objective: Severe depression may be a risk factor for diagnostic conversion into bipolar disorder (BD), and psychotic depression (PD) has been consistently associated with BD. The aims of the present study were to investigate the stability of the diagnosis of severe depression and the differences between PD and non-psychotic severe depression (non-PD), as well as to assess the effectiveness of electroconvulsive therapy (ECT). Methods: Patients who were hospitalised for severe depression (diagnosed according to ICD-10) both with and without psychotic symptoms (n = 89; mean age = 55.6 years, SD = 13.9) from 2001 to 2010 were retrospectively assessed. Results: By the 75th month of follow-up assessments, 11(12.4%) patients had developed BD. Among these 11 converters, nine had developed BD within 1 year after admission. Only sub-threshold hypomanic symptoms were significantly related to developing BD. The number of depressive episodes and history of physical diseases were significantly increased in non-PD compared with PD patients, whereas ECT was significantly increased in PD compared with non-PD patients. There was a significant association between length of stay at the hospital and the number of days between admission and ECT. Conclusion: Sub-threshold hypomanic symptoms may represent a prodrome of BD or an indicator of an already manifest phenotype, especially in older patients, which suggests cautious use of antidepressants. In severe depression, non-PD may often occur secondary to physical diseases and patients may experience increased recurrences compared with PD patients, which may be a more 'primary' disorder and often requires ECT treatments. ECT is effective for severe depression regardless of the presence of any psychotic feature; the earlier ECT is introduced, the better the expected treatment outcome.	[Nakamura, Kimiya; Iga, Junichi; Matsumoto, Naoki; Ohmori, Tetsuro] Univ Tokushima, Dept Psychiat, Course Integrated Brain Sci, Sch Med, Tokushima 7708503, Japan	Iga, J (reprint author), Univ Tokushima, Dept Psychiat, Course Integrated Brain Sci, Sch Med, Tokushima 7708503, Japan.	igajunichi@hotmail.com					Angst J, 2005, J AFFECT DISORDERS, V84, P149, DOI 10.1016/S0165-0327(03)00195-2; Fiedorowicz JG, 2011, AM J PSYCHIAT, V168, P40, DOI 10.1176/appi.ajp.2010.10030328; Kingston T, 2013, PSYCHOL MED, V43, P2523, DOI 10.1017/S003329171300041X; Wu Q, 2010, OSTEOPOROSIS INT, V21, P1627, DOI 10.1007/s00198-010-1181-x; CORYELL W, 1984, J NERV MENT DIS, V172, P521, DOI 10.1097/00005053-198409000-00002; Ostergaard SD, 2013, PSYCHOTHER PSYCHOSOM, V82, P45, DOI 10.1159/000337746; Wu Q, 2012, OSTEOPOROSIS INT, V23, P365, DOI 10.1007/s00198-011-1778-8; Goldberg JF, 2009, AM J PSYCHIAT, V166, P173, DOI 10.1176/appi.ajp.2008.08050746; Hardeveld F, 2013, PSYCHOL MED, V43, P39, DOI 10.1017/S0033291712002395; Lichtenberg P, 2010, PSYCHOTHER PSYCHOSOM, V79, P131, DOI 10.1159/000286957; Nelligan JA, 2008, J CLIN PSYCHIAT, V69, P810; Rowan PJ, 2005, J CLIN GASTROENTEROL, V39, P731, DOI 10.1097/01.mcg.0000173860.08478.a6; Goldberg JF, 2001, AM J PSYCHIAT, V158, P1265, DOI 10.1176/appi.ajp.158.8.1265; CORYELL W, 1995, AM J PSYCHIAT, V152, P385; SOLAN WJ, 1988, J CLIN PSYCHIAT, V49, P97; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Domschke K, 2013, SCHIZOPHRENIA BULL, V39, P766, DOI 10.1093/schbul/sbt040; Dudek D, 2013, J AFFECT DISORDERS, V144, P112, DOI 10.1016/j.jad.2012.06.014; Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011; Nemeroff CB, 2012, NAT REV CARDIOL, V9, P526, DOI 10.1038/nrcardio.2012.91; Basso MR, 1999, NEUROPSYCHOLOGY, V13, P69, DOI 10.1037/0894-4105.13.1.69; Bock Camilla, 2009, Clin Pract Epidemiol Ment Health, V5, P4, DOI 10.1186/1745-0179-5-4; Etain Bruno, 2012, J Clin Psychiatry, V73, pe561, DOI 10.4088/JCP.10m06504; Gournellis R, 2001, INT J GERIATR PSYCH, V16, P1085, DOI 10.1002/gps.483; Holma KM, 2008, J CLIN PSYCHIAT, V69, P196; Lam RW, 1999, CAN J PSYCHIAT, V44, P158; LECKMAN JF, 1984, ARCH GEN PSYCHIAT, V41, P833; Ostergaard SD, 2014, BIPOLAR DISORD, V16, P180, DOI 10.1111/bdi.12152; Ostergaard SD, 2013, ACTA NEUROPSYCHIATR, P25; Perlis RH, 2005, AM J MANAG CARE, V11, pS271; Sobin C, 1996, BRIT J PSYCHIAT, V169, P322, DOI 10.1192/bjp.169.3.322; Souery D, 2011, J AFFECT DISORDERS, V135, P241, DOI 10.1016/j.jad.2011.07.027; Thakur M, 1999, PSYCHIAT RES, V86, P99, DOI 10.1016/S0165-1781(99)00030-X; Vythilingam M, 2003, AM J PSYCHIAT, V160, P574, DOI 10.1176/appi.ajp.160.3.574	34	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1601-5215			ACTA NEUROPSYCHIATR	Acta Neuropsychiatr.	APR	2015	27	2					113	118		10.1017/neu.2014.42		6	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	CF7CZ	WOS:000352715100007		
J	Gu, L; Xiao, DD; Hu, YS; Li, H; Ikuhara, Y				Gu, Lin; Xiao, Dongdong; Hu, Yong-Sheng; Li, Hong; Ikuhara, Yuichi			Atomic-Scale Structure Evolution in a Quasi-Equilibrated Electrochemical Process of Electrode Materials for Rechargeable Batteries	ADVANCED MATERIALS			English	Article							LITHIUM-ION BATTERIES; X-RAY-DIFFRACTION; SITU NEUTRON-DIFFRACTION; EQUAL-TO 0.5; IN-SITU; CATHODE MATERIAL; LI-ION; PHASE-TRANSITION; HIGH-VOLTAGE; STORAGE MECHANISM	Lithium-ion batteries have proven to be extremely attractive candidates for applications in portable electronics, electric vehicles, and smart grid in terms of energy density, power density, and service life. Further performance optimization to satisfy ever-increasing demands on energy storage of such applications is highly desired. In most of cases, the kinetics and stability of electrode materials are strongly correlated to the transport and storage behaviors of lithium ions in the lattice of the host. Therefore, information about structural evolution of electrode materials at an atomic scale is always helpful to explain the electrochemical performances of batteries at a macroscale. The annular-bright-field (ABF) imaging in aberration-corrected scanning transmission electron microscopy (STEM) allows simultaneous imaging of light and heavy elements, providing an unprecedented opportunity to probe the nearly equilibrated local structure of electrode materials after electrochemical cycling at atomic resolution. Recent progress toward unraveling the atomic-scale structure of selected electrode materials with different charge and/or discharge state to extend the current understanding of electrochemical reaction mechanism with the ABF and high angle annular dark field STEM imaging is presented here. Future research on the relationship between atomic-level structure evolution and microscopic reaction mechanisms of electrode materials for rechargeable batteries is envisaged.	[Gu, Lin; Xiao, Dongdong; Hu, Yong-Sheng; Li, Hong] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China; [Gu, Lin] Collaborat Innovat Ctr Quantum Matter, Beijing 100190, Peoples R China; [Ikuhara, Yuichi] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Ikuhara, Yuichi] Japan Fine Ceram Ctr, Nanostruct Res Lab, Nagoya, Aichi 4568587, Japan; [Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Tokyo 1138654, Japan	Gu, L (reprint author), Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing 100190, Peoples R China.	l.gu@iphy.ac.cn	Gu, Lin/D-9631-2011; Li, Hong/C-4643-2008; Ikuhara, Yuichi/N-1001-2015; Hu, Yong-Sheng/H-1177-2011; Ikuhara, Yuichi/F-3066-2010	Gu, Lin/0000-0002-7504-031X; Li, Hong/0000-0002-8659-086X; Ikuhara, Yuichi/0000-0003-3886-005X; Hu, Yong-Sheng/0000-0002-8430-6474; 	NSFC [11174334, 51325206]; Chinese Academy of Sciences	This work was supported by funding from the NSFC (11174334, 51325206) and the Chinese Academy of Sciences.	Janssen Y, 2013, CHEM MATER, V25, P4574, DOI 10.1021/cm4027682; Mukerjee S, 1998, J ELECTROCHEM SOC, V145, P466, DOI 10.1149/1.1838286; Lu X, 2012, ADV MATER, V24, P3233, DOI 10.1002/adma.201200450; Lu ZH, 2002, J ELECTROCHEM SOC, V149, pA815, DOI 10.1149/1.1480014; Gu M, 2013, ACS NANO, V7, P760, DOI 10.1021/nn305065u; Borghols WJH, 2009, J AM CHEM SOC, V131, P17786, DOI 10.1021/ja902423e; Mohanty D, 2013, J POWER SOURCES, V229, P239, DOI 10.1016/j.jpowsour.2012.11.144; Manthiram A, 2011, J PHYS CHEM LETT, V2, P176, DOI 10.1021/jz1015422; DAHN JR, 1991, PHYS REV B, V44, P9170, DOI 10.1103/PhysRevB.44.9170; Zhu CB, 2014, ADV FUNCT MATER, V24, P312, DOI 10.1002/adfm.201301792; Yu DYW, 2011, J ELECTROCHEM SOC, V158, pA1015, DOI 10.1149/1.3609849; Orikasa Y, 2013, J AM CHEM SOC, V135, P5497, DOI 10.1021/ja312527x; Scharner S, 1999, J ELECTROCHEM SOC, V146, P857, DOI 10.1149/1.1391692; Thackeray MM, 1998, ELECTROCHEM SOLID ST, V1, P7; Yang ZG, 2011, CHEM REV, V111, P3577, DOI 10.1021/cr100290v; Rana J, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201300998; Laffont L, 2006, CHEM MATER, V18, P5520, DOI 10.1021/cm0617182; Zhao L, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/2/028201; Chen JS, 2006, J POWER SOURCES, V157, P515, DOI 10.1016/j.jpowsour.2005.08.019; Balasubramanian M, 2002, J ELECTROCHEM SOC, V149, pA176, DOI 10.1149/1.1431962; Liu H, 2014, SCIENCE, V344, DOI 10.1126/science.1252817; Wang YG, 2008, ANGEW CHEM INT EDIT, V47, P7461, DOI 10.1002/anie.200802539; Yamada A, 2001, J ELECTROCHEM SOC, V148, pA224, DOI 10.1149/1.1348257; Niu JJ, 2014, NANO LETT, V14, P4005, DOI 10.1021/nl501415b; DEPICCIOTTO LA, 1984, MATER RES BULL, V19, P1497, DOI 10.1016/0025-5408(84)90264-2; Xu B, 2011, ENERG ENVIRON SCI, V4, P2223, DOI 10.1039/c1ee01131f; Findlay SD, 2010, ULTRAMICROSCOPY, V110, P903, DOI 10.1016/j.ultramic.2010.04.004; Croy JR, 2012, J ELECTROCHEM SOC, V159, pA781, DOI 10.1149/2.080206jes; Kang E, 2011, ADV FUNCT MATER, V21, P4349, DOI 10.1002/adfm.201101123; Thackeray MM, 2005, J MATER CHEM, V15, P2257, DOI 10.1039/b417616m; Wang YG, 2011, ENERG ENVIRON SCI, V4, P805, DOI 10.1039/c0ee00176g; Nishimura S, 2008, NAT MATER, V7, P707, DOI 10.1038/nmat2251; Abe T, 2004, J ELECTROCHEM SOC, V151, pA1120, DOI 10.1149/1.1763141; Kim C, 2013, ADV FUNCT MATER, V23, P1214, DOI 10.1002/adfm.201201684; Pang WK, 2014, J POWER SOURCES, V246, P464, DOI 10.1016/j.jpowsour.2013.07.114; Belharouak I, 2012, J ELECTROCHEM SOC, V159, pA1165, DOI 10.1149/2.013208jes; Batson PE, 2011, NAT MATER, V10, P270, DOI 10.1038/nmat2993; Verma P, 2010, ELECTROCHIM ACTA, V55, P6332, DOI 10.1016/j.electacta.2010.05.072; Wang YG, 2009, J MATER CHEM, V19, P6789, DOI 10.1039/b908025b; Park OK, 2011, ENERG ENVIRON SCI, V4, P1621, DOI 10.1039/c0ee00559b; Croy JR, 2014, CHEM MATER, V26, P7091, DOI 10.1021/cm5039792; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Johnson CS, 2004, ELECTROCHEM COMMUN, V6, P1085, DOI 10.1016/j.elecom.2004.08.002; Park KY, 2014, CHEM MATER, V26, P5345, DOI 10.1021/cm502432q; Croy JR, 2014, J ELECTROCHEM SOC, V161, pA318, DOI 10.1149/2.049403jes; Zheng SJ, 2011, J ELECTROCHEM SOC, V158, pA357, DOI 10.1149/1.3544843; Delmas C, 2008, NAT MATER, V7, P665, DOI 10.1038/nmat2230; Kim SW, 2012, ADV ENERGY MATER, V2, P710, DOI 10.1002/aenm.201200026; Srinivasan V, 2004, J ELECTROCHEM SOC, V151, pA1517, DOI 10.1149/1.1785012; Croy JR, 2013, J PHYS CHEM C, V117, P6525, DOI 10.1021/jp312658q; Pistoia G, 1996, ELECTROCHIM ACTA, V41, P2683, DOI 10.1016/0013-4686(96)00122-3; Tang DC, 2014, CHEM MATER, V26, P3535, DOI 10.1021/cm501125e; Bruce PG, 1999, J MATER CHEM, V9, P193, DOI 10.1039/a803938k; Aldon L, 2004, CHEM MATER, V16, P5721, DOI 10.1021/cm0488837; Lyu YC, 2015, J POWER SOURCES, V273, P1218, DOI 10.1016/j.jpowsour.2014.09.082; Ishikawa R, 2011, NAT MATER, V10, P278, DOI [10.1038/nmat2957, 10.1038/NMAT2957]; Lee JW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.085507; Morcrette M, 2003, NAT MATER, V2, P755, DOI 10.1038/nmat1002; Hwang S, 2014, CHEM MATER, V26, P1084, DOI 10.1021/cm403332s; Xu K, 2007, J ELECTROCHEM SOC, V154, pA162, DOI 10.1146/1.2409866; Dogan F, 2015, J ELECTROCHEM SOC, V162, pA235, DOI 10.1149/2.1041501jes; Thackeray MM, 2007, J MATER CHEM, V17, P3112, DOI 10.1039/b702425h; Abraham DP, 2002, ELECTROCHEM COMMUN, V4, P620, DOI 10.1016/S1388-2481(02)00388-0; Lin MX, 2015, CHEM MATER, V27, P292, DOI 10.1021/cm503972a; Yu XQ, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201300950; Yu DYW, 2009, J ELECTROCHEM SOC, V156, pA417, DOI 10.1149/1.3110803; Zaghib K, 2011, J POWER SOURCES, V196, P3949, DOI 10.1016/j.jpowsour.2010.11.093; Zhu GN, 2012, ENERG ENVIRON SCI, V5, P6652, DOI 10.1039/c2ee03410g; Ramana CV, 2009, J POWER SOURCES, V187, P555, DOI 10.1016/j.jpowsour.2008.11.042; Palomares V, 2012, ENERG ENVIRON SCI, V5, P5884, DOI 10.1039/c2ee02781j; Bettge M, 2013, J ELECTROCHEM SOC, V160, pA2046, DOI 10.1149/2.034311jes; BROWNING ND, 1993, NATURE, V366, P143, DOI 10.1038/366143a0; Reed J, 2004, CHEM REV, V104, P4513, DOI 10.1021/cr020733x; Huang H, 2001, ELECTROCHEM SOLID ST, V4, pA170, DOI 10.1149/1.1396695; Yuan LX, 2011, ENERG ENVIRON SCI, V4, P269, DOI 10.1039/c0ee00029a; Zhang XY, 2014, NANO LETT, V14, P2279, DOI 10.1021/nl404285y; Yu HJ, 2013, J PHYS CHEM LETT, V4, P1268, DOI 10.1021/jz400032v; Pan HL, 2013, ENERG ENVIRON SCI, V6, P2338, DOI 10.1039/c3ee40847g; Nellist PD, 2004, SCIENCE, V305, P1741, DOI 10.1126/science.1100965; Chung SY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.195501; Zheng JM, 2014, NANO LETT, V14, P2628, DOI 10.1021/nl500486y; Yan PF, 2015, NANO LETT, V15, P514, DOI 10.1021/nl5038598; Okunishi E, 2012, MICRON, V43, P538, DOI 10.1016/j.micron.2011.10.007; HILLYARD S, 1995, ULTRAMICROSCOPY, V58, P6, DOI 10.1016/0304-3991(94)00173-K; Takami N, 2011, J ELECTROCHEM SOC, V158, pA725, DOI 10.1149/1.3574037; Malik R, 2011, NAT MATER, V10, P587, DOI [10.1038/nmat3065, 10.1038/NMAT3065]; Abraham DP, 2003, J POWER SOURCES, V119, P511, DOI 10.1016/S0378-7753(03)00275-1; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; REIMERS JN, 1992, J ELECTROCHEM SOC, V139, P2091, DOI 10.1149/1.2221184; Aoshima T, 2001, J POWER SOURCES, V97-8, P377, DOI 10.1016/S0378-7753(01)00551-1; Yabuuchi N, 2011, J AM CHEM SOC, V133, P4404, DOI 10.1021/ja108588y; Oshima Y, 2010, J ELECTRON MICROSC, V59, P457, DOI 10.1093/jmicro/dfq017; Findlay SD, 2011, ULTRAMICROSCOPY, V111, P285, DOI 10.1016/j.ultramic.2010.12.022; Slater MD, 2013, ADV FUNCT MATER, V23, P947, DOI 10.1002/adfm.201200691; Boulineau A, 2012, CHEM MATER, V24, P3558, DOI 10.1021/cm301140g; Robertson AD, 2003, CHEM MATER, V15, P1984, DOI 10.1021/cm030047u; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Yu XQ, 2013, NANO LETT, V13, P4721, DOI 10.1021/nl402263g; Gu L, 2011, J AM CHEM SOC, V133, P4661, DOI 10.1021/ja109412x; Tang DC, 2014, J MATER CHEM A, V2, P14519, DOI 10.1039/c4ta02109f; Kim JS, 2004, CHEM MATER, V16, P1996, DOI 10.1021/cm0306461; Wen JG, 2011, SOLID STATE IONICS, V182, P98, DOI 10.1016/j.ssi.2010.11.030; Delacourt C, 2006, ELECTROCHEM SOLID ST, V9, pA352, DOI 10.1149/1.2201987; Chen ZH, 2002, J ELECTROCHEM SOC, V149, pA1184, DOI 10.1149/1.1498255; Ellis BL, 2010, CHEM MATER, V22, P691, DOI 10.1021/cm902696j; Andersson AS, 2001, J POWER SOURCES, V97-8, P498, DOI 10.1016/S0378-7753(01)00633-4; FERG E, 1994, J ELECTROCHEM SOC, V141, pL147, DOI 10.1149/1.2059324; Huang R, 2011, ANGEW CHEM INT EDIT, V50, P3053, DOI 10.1002/anie.201004638; Poizot P, 2000, NATURE, V407, P496; Choi NS, 2012, ANGEW CHEM INT EDIT, V51, P9994, DOI 10.1002/anie.201201429; Yoon WS, 2005, J AM CHEM SOC, V127, P17479, DOI 10.1021/ja0530568; Jang DH, 1996, J ELECTROCHEM SOC, V143, P2204, DOI 10.1149/1.1836981; Ariyoshi K, 2004, J ELECTROCHEM SOC, V151, pA296, DOI 10.1149/1.1639162; Sharma N, 2010, J POWER SOURCES, V195, P8258, DOI 10.1016/j.jpowsour.2010.06.114; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Wolverton C, 1998, PHYS REV LETT, V81, P606, DOI 10.1103/PhysRevLett.81.606; Gao X, 2013, CHEM MATER, V25, P1607, DOI 10.1021/cm3041357; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; Boulineau A, 2013, NANO LETT, V13, P3857, DOI 10.1021/nl4019275; Shao-Horn Y, 2003, NAT MATER, V2, P464, DOI 10.1038/nmat922; Findlay SD, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3265946; Mohanty D, 2014, CHEM MATER, V26, P6272, DOI 10.1021/cm5031415; Yu HJ, 2013, ANGEW CHEM INT EDIT, V52, P5969, DOI 10.1002/anie.201301236; Haider M, 1998, ULTRAMICROSCOPY, V75, P53, DOI 10.1016/S0304-3991(98)00048-5; Chung SY, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.125502; Islam MS, 2005, CHEM MATER, V17, P5085, DOI 10.1021/cm050999v; Breger J, 2006, CHEM MATER, V18, P4768, DOI 10.1021/cm060886r; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; LI W, 1993, SOLID STATE IONICS, V67, P123, DOI 10.1016/0167-2738(93)90317-V; Amalraj SF, 2014, ELECTROCHIM ACTA, V123, P395, DOI 10.1016/j.electacta.2014.01.051; Armstrong AR, 2006, J AM CHEM SOC, V128, P8694, DOI 10.1021/ja062027+; Gu M, 2012, NANO LETT, V12, P5186, DOI 10.1021/nl302249v; SCHERZER O, 1949, J APPL PHYS, V20, P20, DOI 10.1063/1.1698233; Gallagher KG, 2013, ELECTROCHEM COMMUN, V33, P96, DOI 10.1016/j.elecom.2013.04.022; Whittingham MS, 2014, CHEM REV, V114, P11414, DOI 10.1021/cr5003003; Wang R, 2013, ADV ENERGY MATER, V3, P1358, DOI 10.1002/aenm.201200842; Carroll KJ, 2013, PHYS CHEM CHEM PHYS, V15, P11128, DOI 10.1039/c3cp51927a; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Grey CP, 2004, CHEM REV, V104, P4493, DOI 10.1021/cr020734p; Xiao RJ, 2012, CHEM MATER, V24, P4242, DOI 10.1021/cm3027219; Genevois C, 2015, J PHYS CHEM C, V119, P75, DOI 10.1021/jp509388j; Goodenough JB, 2013, J AM CHEM SOC, V135, P1167, DOI 10.1021/ja3091438; Kang K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094105; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Lu X, 2011, ENERG ENVIRON SCI, V4, P2638, DOI 10.1039/c0ee00808g; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Chen GY, 2006, ELECTROCHEM SOLID ST, V9, pA295, DOI 10.1149/1.2192695; Chu MW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.196101; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; Findlay SD, 2011, ULTRAMICROSCOPY, V111, P1144, DOI 10.1016/j.ultramic.2011.03.005; Findlay SD, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.116603; He YB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00913; Huang HT, 1999, J ELECTROCHEM SOC, V146, P481, DOI 10.1149/1.1391632; Huang R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3551538; HUNTER JC, 1981, J SOLID STATE CHEM, V39, P142, DOI 10.1016/0022-4596(81)90323-6; Hy S, 2014, CHEM MATER, V26, P6919, DOI 10.1021/cm501664y; Iwaya K, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.126104; Jung SK, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201300787; Kim D, 2013, ELECTROCHEM COMMUN, V36, P103, DOI 10.1016/j.elecom.2013.08.022; Lee E, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201400498; Lin F, 2014, ENERG ENVIRON SCI, V7, P3077, DOI 10.1039/c4ee01400f; Lin F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05694; Lin F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4529; Liu XS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3568; Lu X, 2012, NANO LETT, V12, P6192, DOI 10.1021/nl303036e; Malik R, 2013, J ELECTROCHEM SOC, V160, pA3179, DOI 10.1149/2.029305jes; Nakamura A, 2014, CHEM MATER, V26, P6178, DOI 10.1021/cm5024986; OHZUKU T, 1995, J ELECTROCHEM SOC, V142, P1431, DOI 10.1149/1.2048592; O'Keefe MA, 2001, ULTRAMICROSCOPY, V89, P215, DOI 10.1016/S0304-3991(01)00094-8; Okunishi E, 2009, MICROSC MICROANAL, V15, P164, DOI 10.1017/S1431927609093891; Rana J, 2014, J POWER SOURCES, V255, P439, DOI 10.1016/j.jpowsour.2014.01.037; Reed J, 2001, ELECTROCHEM SOLID ST, V4, pA78, DOI 10.1149/1.1368896; Sathiya M, 2015, NAT MATER, V14, P230, DOI [10.1038/nmat4137, 10.1038/NMAT4137]; Scherzer O, 1936, Z PHYS, V101, P593, DOI 10.1007/BF01349606; Shao-Horn Y, 2003, J ELECTROCHEM SOC, V150, pA366, DOI 10.1149/1.1553787; Shin YJ, 2002, ELECTROCHEM SOLID ST, V5, pA55, DOI 10.1149/1.1450063; Sun Y, 2012, CHEM MATER, V24, P4693, DOI 10.1021/cm3028324; Sun Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2878; Suo LM, 2012, PHYS CHEM CHEM PHYS, V14, P5363, DOI 10.1039/c2cp40610a; Tian H., 2011, PHYS REV LETT, V107; Tiemeijer PC, 2012, ULTRAMICROSCOPY, V114, P72, DOI 10.1016/j.ultramic.2012.01.008; Varela M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095502; Wang LF, 2003, J ELECTROCHEM SOC, V150, pA905, DOI 10.1149/1.1577543; Wang XL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00747; Wang ZC, 2013, ADV MATER, V25, P218, DOI 10.1002/adma.201203134; YAMADA A, 1995, MATER RES BULL, V30, P715, DOI 10.1016/0025-5408(95)00048-8	187	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0935-9648	1521-4095		ADV MATER	Adv. Mater.	APR 1	2015	27	13					2134	2149		10.1002/adma.201404620		16	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF4UX	WOS:000352548900002		
J	Toshima, N; Oshima, K; Anno, H; Nishinaka, T; Ichikawa, S; Iwata, A; Shiraishi, Y				Toshima, Naoki; Oshima, Keisuke; Anno, Hiroaki; Nishinaka, Takahiko; Ichikawa, Shoko; Iwata, Arihiro; Shiraishi, Yukihide			Novel Hybrid Organic Thermoelectric Materials: Three-Component Hybrid Films Consisting of a Nanoparticle Polymer Complex, Carbon Nanotubes, and Vinyl Polymer	ADVANCED MATERIALS			English	Article							POLYANILINE FILMS; CONVERSION; TRANSPORT; PEDOTPSS; DEVICES; FIGURE; MERIT	A novel class of hybrid organic thermoelectric materials is demonstrated for the first time for constructing flexible thermoelectric devices on polyimide substrates with high output power by using nanotechnology instead of conducting polymers such as poly(3,4-ethylenedioxythiophene). The hybrid organic thermoelectric materials are composed of nanoparticles of a polymer complex, carbon nanotubes, and poly(vinyl chloride), and show high performance (dimensionless thermoelectric figure-of-merit, ZT approximate to 0.3, based on the thermal conductivity through the film).	[Toshima, Naoki; Shiraishi, Yukihide] Tokyo Univ Sci Yamaguchi, Dept Appl Chem, Sanyoonoda, Yamaguchi 7560884, Japan; [Toshima, Naoki; Anno, Hiroaki; Ichikawa, Shoko; Shiraishi, Yukihide] Tokyo Univ Sci Yamaguchi, Adv Mat Inst, Sanyoonoda, Yamaguchi 7560884, Japan; [Oshima, Keisuke; Nishinaka, Takahiko] Tokyo Univ Sci Yamaguchi, Grad Sch Engn, Sanyoonoda, Yamaguchi 7560884, Japan; [Anno, Hiroaki] Tokyo Univ Sci Yamaguchi, Dept Elect Engn, Sanyoonoda, Yamaguchi 7560884, Japan; [Iwata, Arihiro] Yamaguchi Prefecture Ind Technol Inst, Ube, Yamaguchi 7550195, Japan	Toshima, N (reprint author), Tokyo Univ Sci Yamaguchi, Dept Appl Chem, Sanyoonoda, Yamaguchi 7560884, Japan.	toshima@rs.tus.ac.jp			Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan	This work was financially supported by "Yamaguchi Green Materials Cluster" project registered as Regional Innovation Strategy Support Program (Global Type) by the Ministry of Education, Culture, Sports, Science & Technology (MEXT), Japan. Polyimide films were provided by UBE Industries, Ltd.	Anno H, 2015, J ELECTRON MATER, V44, P2105, DOI 10.1007/s11664-015-3668-x; Yan H, 2001, MACROMOL MATER ENG, V286, P139, DOI 10.1002/1439-2054(20010301)286:3<139::AID-MAME139>3.3.CO;2-6; Bubnova O, 2011, NAT MATER, V10, P429, DOI [10.1038/nmat3012, 10.1038/NMAT3012]; Wei QS, 2013, ADV MATER, V25, P2831, DOI 10.1002/adma.201205158; Yan H, 2002, J THERM ANAL CALORIM, V69, P881, DOI 10.1023/A:1020612123826; Kim GH, 2013, NAT MATER, V12, P719, DOI [10.1038/nmat3635, 10.1038/NMAT3635]; Bubnova O, 2014, NAT MATER, V13, P190, DOI [10.1038/nmat3824, 10.1038/NMAT3824]; Nakai Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.025103; Sun YM, 2012, ADV MATER, V24, P932, DOI 10.1002/adma.201104305; Wang D, 2012, PHYS CHEM CHEM PHYS, V14, P16505, DOI 10.1039/c2cp42710a; Toshima N, 2012, J ELECTRON MATER, V41, P1735, DOI 10.1007/s11664-012-2041-6; Moriarty GP, 2013, ENERGY TECHNOL-GER, V1, P265, DOI 10.1002/ente.201300018; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; [Anonymous], 2006, NANO LETT, DOI DOI 10.1021/NL052145F; Hiroshige Y, 2007, SYNTHETIC MET, V157, P467, DOI 10.1016/j.synthmet.2007.05.003; Hokazono M, 2014, J ELECTRON MATER, V43, P2196, DOI 10.1007/s11664-014-3003-y; Jiao F., 2013, PHIL T R SOC A, V372, DOI DOI 10.1098/RSTA.2013.0008); Nonoguchi Y, 2013, SCI REP-UK, V3, DOI [10.1038/srep03344, 10.1038/srep03344(2013)]; Toshima N, 2002, MACROMOL SYMP, V186, P81, DOI 10.1002/1521-3900(200208)186:1<81::AID-MASY81>3.0.CO;2-S; Wei Q, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.031601; Yevtushenko OM, 1997, PHYS REV LETT, V79, P1102, DOI 10.1103/PhysRevLett.79.1102	21	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0935-9648	1521-4095		ADV MATER	Adv. Mater.	APR 1	2015	27	13					2246	+		10.1002/adma.201405463		7	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	CF4UX	WOS:000352548900015		
J	Esterov, A; Takeuchi, K				Esterov, Alexander; Takeuchi, Kiyoshi			CONFLUENT A-HYPERGEOMETRIC FUNCTIONS AND RAPID DECAY HOMOLOGY CYCLES	AMERICAN JOURNAL OF MATHEMATICS			English	Article							TORIC VARIETIES; ZETA-FUNCTION; GAUSS-MANIN; SYSTEMS; MONODROMY; INTEGRALS	We study confluent A-hypergeometric functions introduced by Adolphson. In particular, we give their integral representations by using rapid decay homology cycles of Hien. The method of toric compactifications introduced in our previous works will be used to prove our main theorem. Moreover we apply it to obtain a formula for the asymptotic expansions at infinity of confluent A-hypergeometric functions.	[Esterov, Alexander] Natl Res Univ Higher Sch Econ, Fac Math NRU HSE, Moscow 117312, Russia; [Takeuchi, Kiyoshi] Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 3058571, Japan	Esterov, A (reprint author), Natl Res Univ Higher Sch Econ, Fac Math NRU HSE, 7 Vavilova, Moscow 117312, Russia.	aesterov@hse.ru; takemicro@nifty.com	Esterov, Alexander/H-6964-2015	Esterov, Alexander/0000-0001-9526-900X	National Research University Higher School of Economics Academic Fund Program [14-01-0152]; RFBR [13-01-00755, 12-01-31233]; MESRF [MK-6223.2012.1]; Dynasty Foundation fellowship	Research (research grant No 14-01-0152) supported by The National Research University Higher School of Economics Academic Fund Program in 2014/2015, and supported in part by RFBR grants 13-01-00755 and 12-01-31233, MESRF grant MK-6223.2012.1, and the Dynasty Foundation fellowship.	Ando K, 2015, ADV MATH, V272, P1, DOI 10.1016/j.aim.2014.10.024; GELFAND IM, 1990, ADV MATH, V84, P255, DOI 10.1016/0001-8708(90)90048-R; Saito M, 2011, COMPOS MATH, V147, P613, DOI 10.1112/S0010437X10004987; Schulze M, 2008, DUKE MATH J, V142, P465, DOI 10.1215/00127094-2008-011; Matsui Y, 2011, TOHOKU MATH J, V63, P113; Takeuchi K, 2010, MATH ANN, V348, P815, DOI 10.1007/s00208-010-0501-y; VARCHENKO AN, 1976, INVENT MATH, V37, P253, DOI 10.1007/BF01390323; KOUCHNIRENKO AG, 1976, INVENT MATH, V32, P1, DOI 10.1007/BF01389769; Daia L, 2000, ANN I FOURIER, V50, P1891; LIBGOBER A, 1995, COMPOS MATH, V95, P287; Esterov A, 2012, INT MATH RES NOTICES, P3567, DOI 10.1093/imrn/rnr154; Matusevich LF, 2005, J AM MATH SOC, V18, P919, DOI 10.1090/S0894-0347-05-00488-1; KIMURA H, 1992, P JPN ACAD A-MATH, V68, P290; Hien M, 2008, B SOC MATH FR, V136, P505; Matsui Y, 2011, MATH Z, V268, P409, DOI 10.1007/s00209-010-0678-5; Borisov LA, 2006, ADV MATH, V207, P876, DOI 10.1016/j.aim.2006.01.011; Schulze M, 2009, J ALGEBRA, V322, P3392, DOI 10.1016/j.jalgebra.2008.09.010; ADOLPHSON A, 1994, DUKE MATH J, V73, P269, DOI 10.1215/S0012-7094-94-07313-4; Aomoto K, 2011, SPRINGER MONOGR MATH, P1, DOI 10.1007/978-4-431-53938-4_1; Askold G., 1977, FUNCT ANAL APPL, V11, P289; Beukers F., 2013, PREPRINT; Beukers F, 2011, INDAGAT MATH NEW SER, V21, P30, DOI 10.1016/j.indag.2010.12.002; Dubrovin B., 1998, P ICM, V11, P315; Esterov A., 2013, PREPRINT; Esterov A., 2003, VESTN MOSK U MAT M+, V58, P7; Fulton W., 1993, ANN MATH STUD, V131; Gel'fand I.M., 1994, DISCRIMINANTS RESULT; GELFAND IM, 1987, DOKL AKAD NAUK SSSR+, V295, P14; Hien M, 2007, MATH ANN, V337, P631, DOI 10.1007/s00208-006-0050-6; Hien M, 2009, INVENT MATH, V178, P1, DOI 10.1007/s00222-009-0185-7; Horja R. P., 2000, PREPRINT; Hotta R., 1998, PREPRINT; Hotta R, 2008, PROG MATH, V236, P1; GELFAND IM, 1989, FUNCT ANAL APPL+, V23, P94, DOI 10.1007/BF01078777; Katz N., 1985, I HAUTES ETUDES SCI, V62, P361; Malgrange B., 1987, SEMINAIRE BOURBAKI, V1987, P133; Matsui Y, 2011, ADV MATH, V226, P2040, DOI 10.1016/j.aim.2010.08.020; Matsui Y, 2013, INT MATH RES NOTICES, P1691, DOI 10.1093/imrn/rns092; Mochizuki T., 2011, ASTERISQUE; Oda T., 1988, CONVEX BODIES ALGEBR, V15; Oka M., 1997, NONDEGENERAE COMPLET; Pajitnov A, 2006, DEGRUYTER STUD MATH, V32, P1, DOI 10.1515/9783110197976; PHAM F, 1985, ASTERISQUE, P11; Saito M., 2000, ALGORITHMS COMPUT MA, V6; Schulze M, 2012, ALGEBR NUMBER THEORY, V6, P527; Tanabe S, 2013, COMMUN NUMBER THEORY, V7, P327	46	0	0	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4363 USA	0002-9327	1080-6377		AM J MATH	Am. J. Math.	APR	2015	137	2					365	409				45	Mathematics	Mathematics	CG1ZR	WOS:000353075200003		
J	Yamada, S; Tsuchiya, K; Bradley, WG; Law, M; Winkler, ML; Borzage, MT; Miyazaki, M; Kelly, EJ; McComb, JG				Yamada, S.; Tsuchiya, K.; Bradley, W. G.; Law, M.; Winkler, M. L.; Borzage, M. T.; Miyazaki, M.; Kelly, E. J.; McComb, J. G.			Current and Emerging MR Imaging Techniques for the Diagnosis and Management of CSF Flow Disorders: A Review of Phase-Contrast and Time-Spatial Labeling Inversion Pulse	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Review							NORMAL-PRESSURE HYDROCEPHALUS; CEREBROSPINAL-FLUID FLOW; CHIARI-I MALFORMATION; MAGNETIC-RESONANCE; COMMUNICATING HYDROCEPHALUS; FORAMEN MAGNUM; PATHOPHYSIOLOGIC CONDITIONS; STROKE VOLUME; HUMAN-BRAIN; BLOOD-FLOW	This article provides an overview of phase-contrast and time-spatial labeling inversion pulse MR imaging techniques to assess CSF movement in the CNS under normal and pathophysiologic situations. Phase-contrast can quantitatively measure stroke volume in selected regions, notably the aqueduct of Sylvius, synchronized to the heartbeat. Judicious fine-tuning of the technique is needed to achieve maximal temporal resolution, and it has limited visualization of CSF motion in many CNS regions. Phase-contrast is frequently used to evaluate those patients with suspected normal pressure hydrocephalus and a Chiari I malformation. Correlation with successful treatment outcome has been problematic. Time-spatial labeling inversion pulse, with a high signal-to-noise ratio, assesses linear and turbulent motion of CSF anywhere in the CNS. Time-spatial labeling inversion pulse can qualitatively visualize whether CSF flows between 2 compartments and determine whether there is flow through the aqueduct of Sylvius or a new surgically created stoma. Cine images reveal CSF linear and turbulent flow patterns.	[Yamada, S.] Toshiba Rinkan Hosp, Dept Neurosurg, Sagamihara, Kanagawa, Japan; [Tsuchiya, K.] Kyorin Univ, Dept Radiol, Mitaka, Tokyo, Japan; [Bradley, W. G.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Law, M.] Univ So Calif, Dept Neuroradiol, Los Angeles, CA USA; [Winkler, M. L.] Steinberg Diagnost Imaging Ctr, Las Vegas, NV USA; [Borzage, M. T.] Childrens Hosp Los Angeles, Dept Radiol, Div Neuroradiol, Inst Maternal Fetal Hlth, Los Angeles, CA 90027 USA; [Borzage, M. T.] Univ So Calif, Dept Biomed Engn, USC Viterbi Sch Engn, Los Angeles, CA 90089 USA; [Miyazaki, M.] Toshiba Med Res Inst, Vernon Hills, IL USA; [Kelly, E. J.] Toshiba Amer Med Syst Inc, Tustin, CA 92780 USA; [McComb, J. G.] Childrens Hosp Los Angeles, Div Neurosurg, Los Angeles, CA 90027 USA; [McComb, J. G.] Univ So Calif, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA 90033 USA	Kelly, EJ (reprint author), Toshiba Amer Med Syst Inc, 2441 Michelle Dr, Tustin, CA 92780 USA.	ekelly@tams.com					Miyazaki M, 2008, RADIOLOGY, V248, P20, DOI 10.1148/radiol.2481071497; Hori M, 2011, ACTA RADIOL, V52, P808, DOI 10.1258/ar.2011.110128; BRADLEY WG, 1986, RADIOLOGY, V159, P611; Haughton VM, 2003, AM J NEURORADIOL, V24, P169; Egnor M, 2002, PEDIATR NEUROSURG, V36, P281, DOI 10.1159/000063533; Luetmer PH, 2002, NEUROSURGERY, V50, P534, DOI 10.1097/00006123-200203000-00020; Bateman GA, 2000, AM J NEURORADIOL, V21, P1574; Baledent O, 2001, INVEST RADIOL, V36, P368; SHAW CM, 1969, BRAIN, V92, P213, DOI 10.1093/brain/92.1.213; Quigley MF, 2004, RADIOLOGY, V232, P229, DOI 10.1148/radiol.2321030666; Satogami N, 2009, J MAGN RESON IMAGING, V30, P678, DOI 10.1002/jmri.21883; Yamada S, 2008, RADIOLOGY, V249, P644, DOI 10.1148/radiol.2492071985; Baledent O, 2004, INVEST RADIOL, V39, P45, DOI 10.1097/01.rli.0000100892.87214.49; GREITZ D, 1994, ACTA RADIOL, V35, P204; SINGER JR, 1983, SCIENCE, V221, P654; FEINBERG DA, 1987, RADIOLOGY, V163, P793; Poca MA, 2002, ACT NEUR S, V81, P7; TSURUDA JS, 1991, AM J NEURORADIOL, V12, P481; Bateman GA, 2007, ACTA NEUROCHIR, V149, P455, DOI 10.1007/s00701-007-1142-0; Bateman GA, 2005, NEURORADIOLOGY, V47, P741, DOI 10.1007/s00234-005-1418-0; BRADLEY WG, 1991, RADIOLOGY, V178, P459; Bradley WG, 1996, RADIOLOGY, V198, P523; Bradley WG, 2002, MAYO CLIN PROC, V77, P507; BRANCO G, 1993, NEURORADIOLOGY, V35, P447; Chen Xian, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P881; Connor SEJ, 2001, CLIN RADIOL, V56, P763, DOI 10.1053/crad.2001.0761; Dixon GR, 2002, MAYO CLIN PROC, V77, P509; DUMOULIN CL, 1990, J COMPUT ASSIST TOMO, V14, P779, DOI 10.1097/00004728-199009000-00020; Egeler-Peerdeman SM, 1998, ACT NEUR S, V71, P340; GIDEON P, 1994, NEURORADIOLOGY, V36, P210; Greitz D, 1993, Acta Radiol Suppl, V386, P1; Henry-Feugeas MC, 2001, INVEST RADIOL, V36, P146, DOI 10.1097/00004424-200103000-00003; Ishimori Yoshiyuki, 2011, Radiol Phys Technol, V4, P78, DOI 10.1007/s12194-010-0108-8; Iskandar BJ, 2004, J NEUROSURG, V101, P169; Kogure T, 2010, J MAGN RESON IMAGING, V32, P429, DOI 10.1002/jmri.22273; Luetmer PH, 2002, NEUROSURGERY, V50, P543; Mark A S, 1986, Acta Radiol Suppl, V369, P296; Naidich T P, 1993, Neurosurg Clin N Am, V4, P677; SALONER D, 1995, RADIOGRAPHICS, V15, P453; Scollato A, 2008, AM J NEURORADIOL, V29, P192, DOI 10.3174/ajnr.A0785; Singer JR, 1986, CARDIOVASC INTERVENT, V8, P251; Stoquart-ElSankari S, 2007, J CEREBR BLOOD F MET, V27, P1563, DOI 10.1038/sj.jcbfm.9600462; Sugita R, 2012, J MAGN RESON IMAGING, V35, P1119, DOI 10.1002/jmri.23533; Wagshul ME, 2006, J NEUROSURG, V104, P810, DOI 10.3171/jns.2006.104.5.810; Yamada Shinya, 2005, Tokai J Exp Clin Med, V30, P21; Yamada Shinya, 2010, Rinsho Shinkeigaku, V50, P966; Yamada Shinya, 2013, Fluids Barriers CNS, V10, P36, DOI 10.1186/2045-8118-10-36; Yamada S, 2013, WORLD NEUROSURG, V80	48	1	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2015	36	4					623	630		10.3174/ajnr.A4030		8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CF4IO	WOS:000352512400009		
J	Ohta, T; Nakahara, I; Ishibashi, R; Matsumoto, S; Gomi, M; Miyata, H; Nishi, H; Watanabe, S; Nagata, I				Ohta, T.; Nakahara, I.; Ishibashi, R.; Matsumoto, S.; Gomi, M.; Miyata, H.; Nishi, H.; Watanabe, S.; Nagata, I.			The Maze-Making and Solving Technique for Coil Embolization of Large and Giant Aneurysms	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							NECKED INTRACRANIAL ANEURYSMS; CAROTID-ARTERY OCCLUSION; ENDOVASCULAR TREATMENT; CEREBRAL ANEURYSMS; INITIAL-EXPERIENCE; FOLLOW-UP; TRIAL; MULTICENTER; STENT; OUTCOMES	These authors describe the use of 2 intra-aneurysmal catheters to deploy first large coils and then smaller, more traditional coils that ultimately fill the interstices left by the larger coils until aneurysms are tightly packed. When this technique was used to occlude large/giant aneurysms, follow-up angiography revealed no recurrences compared with nearly 40% in a group of similar lesions treated in conventional fashion. BACKGROUND AND PURPOSE: Despite major progress in treating aneurysms by coil embolization, the complete occlusion of aneurysms of >10 mm in diameter (large/giant aneurysms) remains challenging. We present a novel endovascular treatment method for large and giant cerebral aneurysms called the maze-making and solving technique and compare the short-term follow-up results of this technique with those of conventional coil embolization. MATERIALS AND METHODS: Eight patients (65 11.5 years of age, 7 women) with large/giant unruptured nonthrombosed cerebral aneurysm (mean largest aneurysm dimension, 19 4.4 mm) were treated by the maze-making and solving technique, a combination of the double-catheter technique and various assisted techniques. The coil-packing attenuation, postoperative courses, and recurrence rate of this maze group were compared with 30 previous cases (conventional group, 65.4 +/- 13.0 years of age; 22 women; mean largest aneurysm dimension, 13.4 +/- 3.8 mm). RESULTS: Four maze group cases were Raymond class 1; and 4 were class 2 as indicated by immediate postsurgical angiography. No perioperative deaths or major strokes occurred. Mean packing attenuation of the maze group was significantly higher than that of the conventional group (37.4 +/- 5.9% versus 26.2 +/- 5.6%). Follow-up angiography performed at 11.3 +/- 5.4 months revealed no recurrence in the maze group compared with 39.2% in the conventional group. CONCLUSIONS: The maze-making and solving technique achieves high coil-packing attenuation for efficient embolization of large and giant cerebral aneurysms with a low risk of recurrence.	[Ohta, T.; Nakahara, I.; Ishibashi, R.; Matsumoto, S.; Gomi, M.; Miyata, H.; Nishi, H.; Watanabe, S.; Nagata, I.] Kokura Mem Hosp, Dept Neurosurg, Kitakyushu, Fukuoka, Japan	Ohta, T (reprint author), Kokura Mem Hosp, Dept Neurosurg, Kokurakita Ku, 3-2-1 Asano, Kitakyushu, Fukuoka, Japan.	tsuyoshi@ya2.so-net.ne.jp		Nakahara, Ichiro/0000-0001-8909-2949	Stryker; Kaneka; Cordis; Mochida; Otsuka; Japanese Society for Neuroendovascular Therapy; Boehringer Ingelheim; Japanese Society of Neurosurgery	Tsuyoshi Ohta-UNRELATED: Consultancy: Terumo, Kaneka, Comments: None exceeds the criteria for self-reported conflict of interest disclosure according to the Ethical Guidelines for Clinical Research (Ministry of Labor, Health, and Welfare of Japan); Payment for Lectures (including service on Speakers Bureaus): Stryker, Kaneka, Cordis, Mochida, Otsuka, Comments: None exceeds the criteria for self-reported conflict of interest disclosure according to the Ethical Guidelines for Clinical Research (Ministry of Labor, Health, and Welfare of Japan). Ichiro Nakahara-UNRELATED: Consultancy: Terumo, Covidien, Johnson & Johnson, Kaneka, Comments: Consultant fee was paid to me by each neurointerventional device company. Each fee was less than $10,000 per year and did not meet the criteria for declaration of conflict of interest by the Japanese Society of Neurosurgery and Japanese Society for Neuroendovascular Therapy. Hidehisa Nishi-UNRELATED: Payment for Lectures (including service on Speakers Bureaus): Boehringer Ingelheim, Comments: None exceeds the criteria for self-reported conflict of interest disclosure according to the Ethical Guidelines for Clinical Research (Ministry of Labor, Health, and Welfare of Japan).	Arambepola PK, 2010, SKULL BASE-INTERD AP, V20, P405, DOI 10.1055/s-0030-1253578; Becske T, 2013, RADIOLOGY, V267, P858, DOI 10.1148/radiol.13120099; McDougall CG, 2014, AM J NEURORADIOL, V35, P935, DOI 10.3174/ajnr.A3857; van Rooij WJ, 2008, AM J NEURORADIOL, V29, P997, DOI 10.3174/ajnr.A1023; Weber W, 2005, AM J NEURORADIOL, V26, P1909; Roy D, 2001, STROKE, V32, P1998, DOI 10.1161/hs0901.095600; Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151; Berge J, 2012, AM J NEURORADIOL, V33, P1150, DOI 10.3174/ajnr.A2907; Geyik S, 2013, AM J NEURORADIOL, V34, P2157, DOI 10.3174/ajnr.A3574; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Choi IS, 2003, EUR J RADIOL, V46, P178, DOI 10.1016/S0720-048X(03)00090-1; Sluzewski M, 2004, RADIOLOGY, V231, P653, DOI 10.1148/radiol.2313030460; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Baxter BW, 1998, AM J NEURORADIOL, V19, P1176; Brilstra EH, 2002, J NEUROSURG, V97, P1029, DOI 10.3171/jns.2002.97.5.1029; Fukuda H, 2014, J STROKE CEREBROVASC, V23, P1730, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.037; Harada K, 2013, J NEUROINTERV SURG, V5, P577, DOI 10.1136/neurintsurg-2012-010498; Mascitelli JR, 2013, J NEUROINTERV SURG, V5, P573, DOI 10.1136/neurintsurg-2012-010483; Milburn J, 2014, J NEUROINTERV SURG, V6, P121, DOI 10.1136/neurintsurg-2012-010587; Miyachi S, 2014, J NEUROINTERV SURG, V6, P357, DOI 10.1136/neurintsurg-2013-010688; Molyneux AJ, 2004, AM J NEURORADIOL, V25, P39; Morita A, 2012, NEW ENGL J MED, V366, P2474; Nussbaum Eric S, 2010, Neurosurgery, V67, P333, DOI 10.1227/NEU.0b013e3181f7451b; Raymond J, 2014, AM J NEURORADIOL, V35, P1667, DOI 10.3174/ajnr.A4035; Speirs JW, 2013, J NEUROINTERV SUR S3, V5, piii72; van Rooij WJ, 2009, AM J NEURORADIOL, V30, P12, DOI 10.3174/ajnr.A1267	26	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2015	36	4					744	750		10.3174/ajnr.A4198		7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CF4IO	WOS:000352512400027		
J	Narumi, S; Sasaki, M; Natori, T; Oura, MY; Ogasawara, K; Kobayashi, M; Sato, Y; Ogasawara, Y; Hitomi, J; Terayama, Y				Narumi, S.; Sasaki, M.; Natori, T.; Oura, M. Yamaguchi; Ogasawara, K.; Kobayashi, M.; Sato, Y.; Ogasawara, Y.; Hitomi, J.; Terayama, Y.			Carotid Plaque Characterization Using 3D T1-Weighted MR Imaging with Histopathologic Validation: A Comparison with 2D Technique	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							ENDARTERECTOMY SPECIMENS; HEMORRHAGE; ASSOCIATION; ULTRASONOGRAPHY; EMBOLIZATION; STENOSIS; DOPPLER; EVENTS; SIGNAL	BACKGROUND AND PURPOSE: 3D FSE T1WI has recently been used for carotid plaque imaging, given the potential advantages in contrast and spatial resolutions. However, its diagnostic performance remains unclear. Hence, we compared the ability of this technique to readily assess plaque characteristics with that of conventional images and validated the results with histologic classification. MATERIALS AND METHODS: We prospectively examined 34 patients with carotid stenosis who underwent carotid endarterectomy by using 1.5T scanners and obtained 3D-FSE T1WI and 2D spin-echo T1WI scans. After generating reformatted images obtained from the 3D-FSE T1-weighted images, we calculated the contrast ratios for the plaques and the adjacent muscles and compared these findings with the pathologic classifications. RESULTS: Carotid plaques were histologically classified as types VII, VIII, IV-V, or VI. With 3D-FSE T1WI, the range of contrast ratios for each classification was the following: 0.94-0.97 (median, 0.95), 0.95-1.29 (median, 1.10), 1.33-1.54 (median, 1.42), and 1.53-2.12 (median, 1.80), respectively. With 2D imaging, the range of contrast ratios for each classification was the following: 0.79-1.02 (median, 0.90), 0.88-1.19 (median, 1.01), 1.17-1.46 (median, 1.23), and 1.55-2.51 (median, 2.07), respectively. Results were significantly different among the 4 groups (P < .001). Sensitivity and specificity for discriminating vulnerable plaques (IV-VI) from stable plaques (VII, VIII) were both 100% for the 3D technique and 100% and 91%, respectively, for the 2D technique. CONCLUSIONS: 3D-FSE T1WI accurately characterizes intraplaque components of the carotid artery, with excellent sensitivity and specificity compared with those of 2D-T1WI.	[Narumi, S.; Natori, T.; Oura, M. Yamaguchi; Terayama, Y.] Iwate Med Univ, Dept Neurol & Gerontol, Morioka, Iwate 0208505, Japan; [Ogasawara, K.; Kobayashi, M.; Sato, Y.; Ogasawara, Y.] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 0208505, Japan; [Hitomi, J.] Iwate Med Univ, Dept Anat, Morioka, Iwate 0208505, Japan; [Sasaki, M.] Iwate Med Univ, Inst Biomed Sci, Morioka, Iwate 0208505, Japan	Narumi, S (reprint author), Iwate Med Univ, Dept Neurol, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	snarumi@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [S1491001, 25861122]	This work was partly supported by Grants-in-Aid for Strategic Medical Science Research (S1491001, 2014-2018) and for Scientific Research (25861122) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Altaf N, 2007, STROKE, V38, P1633, DOI 10.1161/STROKEAHA.106.473066; Waki H, 2003, CIRC J, V67, P1013, DOI 10.1253/circj.67.1013; Chu BC, 2004, STROKE, V35, P1079, DOI 10.1161/01.STR.0000125856.25309.86; Altaf N, 2007, J VASC SURG, V46, P31, DOI 10.1016/j.jvs.2007.02.072; Watanabe Y, 2008, J MAGN RESON IMAGING, V28, P478, DOI 10.1002/jmri.21250; Pipe JG, 1999, MAGNET RESON MED, V42, P963, DOI 10.1002/(SICI)1522-2594(199911)42:5<963::AID-MRM17>3.0.CO;2-L; Yoshimura S, 2011, STROKE, V42, P3132, DOI 10.1161/STROKEAHA.111.615708; Saito A, 2012, NEURORADIOLOGY, V54, P1187, DOI 10.1007/s00234-012-1025-9; Yamada N, 2007, AM J NEURORADIOL, V28, P287; Sztajzel R, 2005, STROKE, V36, P741, DOI 10.1161/01.STR.0000157599.10026.ad; Moody AR, 2003, CIRCULATION, V107, P3047, DOI 10.1161/01.CIR.0000074222.61572.44; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Cappendijk VC, 2005, RADIOLOGY, V234, P487, DOI 10.1148/radiol.2342032101; Qiao Y, 2011, AM J NEURORADIOL, V32, P454, DOI 10.3174/ajnr.A2320; Ota H, 2010, RADIOLOGY, V254, P551, DOI 10.1148/radiol.09090535; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Gaunt ME, 1996, EUR J VASC ENDOVASC, V11, P78, DOI 10.1016/S1078-5884(96)80139-0; Narumi S, 2014, AM J NEURORADIOL, V35, P766, DOI 10.3174/ajnr.A3741; Narumi S, 2013, AM J NEURORADIOL, V34, P191, DOI 10.3174/ajnr.A3249; Narumi S, 2010, NEURORADIOLOGY, V52, P285, DOI 10.1007/s00234-009-0642-4; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Yamaguchi M, 2012, NEURORADIOLOGY, V54, P939, DOI 10.1007/s00234-012-1011-2; Yoshida K, 2008, AM J NEURORADIOL, V29, P868, DOI 10.3174/ajnr.A1015	23	1	1	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2015	36	4					751	756		10.3174/ajnr.A4197		6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CF4IO	WOS:000352512400028		
J	Branton, R; Martinez-Ebers, V; Carey, TE; Matsubayashi, T				Branton, Regina; Martinez-Ebers, Valerie; Carey, Tony E., Jr.; Matsubayashi, Tetsuya			Social Protest and Policy Attitudes: The Case of the 2006 Immigrant Rallies	AMERICAN JOURNAL OF POLITICAL SCIENCE			English	Article							PUBLIC-OPINION; VIETNAM-WAR; LATINOS; THREAT; ACCULTURATION; CONSEQUENCES; MOBILIZATION; MOVEMENTS; AMERICAN; TRIGGERS	Do protests sway public opinion? If so, why and how? To address these questions, we examine the impact of the 2006 immigration protests on immigration policy preferences. We use the 2006 Latino National Survey coupled with protest data to examine whether temporal and spatial exposure to the protests are associated with policy preferences. Our findings lend evidence that protest activity influences Latinos' immigration policy preferences. However, the findings suggest the effect of protest on immigration policy preferences is not uniform across the population, but rather contingent on generational status and the intensity of protest activity at the local level.	[Branton, Regina; Martinez-Ebers, Valerie; Carey, Tony E., Jr.] Univ N Texas, Polit Sci, Denton, TX 76203 USA; [Matsubayashi, Tetsuya] Osaka Univ, Osaka Sch Int Publ Policy, Toyonaka, Osaka 5600043, Japan	Branton, R (reprint author), Univ N Texas, Polit Sci, 1155 Union Circle 305340, Denton, TX 76203 USA.	branton@unt.edu; valmartinez@unt.edu; tony.carey@unt.edu; matsubayashi@osipp.osaka-u.ac.jp					Achen CH, 1986, STAT ANAL QUASIEXPER; Amenta Edwin, 1999, SOCIAL MOVEMENTS MAT, P22; Andersen Kurt, 2011, TIME MAGAZINE; [Anonymous], 2013, LD NCLR AV SEIU LATI; Amenta E, 2010, ANNU REV SOCIOL, V36, P287, DOI 10.1146/annurev-soc-070308-120029; Barreto MA, 2009, URBAN AFF REV, V44, P736, DOI 10.1177/1078087409332925; Felix A, 2008, AM BEHAV SCI, V52, P618, DOI 10.1177/0002764208324611; Hood MV, 1997, POLIT RES QUART, V50, P627, DOI 10.1177/106591299705000307; Rocha RR, 2011, SOC SCI QUART, V92, P1, DOI 10.1111/j.1540-6237.2011.00754.x; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Giugni MG, 1998, ANNU REV SOCIOL, V24, P371, DOI 10.1146/annurev.soc.24.1.371; GRANT PR, 1995, SOC PSYCHOL QUART, V58, P195, DOI 10.2307/2787042; LOHMANN S, 1994, WORLD POLIT, V47, P42, DOI 10.2307/2950679; Miller JM, 2004, POLIT PSYCHOL, V25, P507, DOI 10.1111/j.1467-9221.2004.00384.x; Brader T, 2008, AM J POLIT SCI, V52, P959, DOI 10.1111/j.1540-5907.2008.00353.x; Flippen AR, 1996, PERS SOC PSYCHOL B, V22, P882, DOI 10.1177/0146167296229003; Gartner SS, 1997, J CONFLICT RESOLUT, V41, P669, DOI 10.1177/0022002797041005004; [Anonymous], 2014, CTR AM PROGR ACT FUN; Bada Xochitl, 2006, IMMIGRANT MARCHES SP; Banaszak Lee Ann, 2009, ANN M AM POL SCI ASS; Benjamin-Alvarado J, 2009, URBAN AFF REV, V44, P718, DOI 10.1177/1078087408323380; Binder NE, 1997, SOC SCI QUART, V78, P324; Branton R, 2011, J POLIT, V73, P664, DOI 10.1017/S0022381611000375; Branton R, 2007, POLIT RES QUART, V60, P293, DOI 10.1177/1065912907301983; Burstein P, 1999, SOCIAL MOVEMENTS MAT, P3; Carey Jr Tony E., 2013, POLITICS GROUPS IDEN, V1, P311; Carey TE, 2014, POLIT RES QUART, V67, P615, DOI 10.1177/1065912914534074; Citrin J, 1997, J POLIT, V59, P858, DOI 10.2307/2998640; Dunning Thad, 2008, QUALITATIVE METHODS, V6, P17; Bedolla LG, 2005, FLUID BORDERS: LATINO POWER, IDENTITY, AND POLITICS IN LOS ANGELES, P1; Gartner SS, 2000, J POLIT, V62, P115; Giugni M., 2004, SOCIAL PROTEST POLIC; Koopman Douglas L., 2008, PEWS PRAYERS PARTICI; Marcus G. E., 2000, AFFECTIVE INTELLIGEN; Mohamed HS, 2013, AM POLIT RES, V41, P298, DOI 10.1177/1532673X12456237; Pantoja AD, 2003, POLIT BEHAV, V25, P265, DOI 10.1023/A:1025119724207; Remler D. K., 2011, RES METHODS PRACTICE; Sanchez GR, 2006, POLIT RES QUART, V59, P435, DOI 10.1177/106591290605900311; Wallace SJ, 2014, AM J POLIT SCI, V58, P433, DOI 10.1111/ajps.12060; Wilson Steven J., 2012, PATTERNS METROPOLITA; Zepeda-Millan C., 2013, POLITICS GROUPS IDEN, V1, P1, DOI [10.1080/21565503.2013.842492, DOI 10.1080/21565503.2013.842492]	41	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0092-5853	1540-5907		AM J POLIT SCI	Am. J. Polit. Sci.	APR	2015	59	2					390	402		10.1111/ajps.12159		13	Political Science	Government & Law	CF4QI	WOS:000352535000008		
J	Yamamoto, S; Wunna; Rafique, T; Arizaga, MV; Fukui, K; Gutierrez, EJC; Martinez, CRC; Watanabe, K; Niino, T				Yamamoto, Shin-ichi; Wunna; Rafique, Tariq; Valle Arizaga, Miriam; Fukui, Kuniaki; Cruz Gutierrez, Esmeralda J.; Castillo Martinez, Carlos R.; Watanabe, Kazuo; Niino, Takao			The Aluminum Cryo-plate Increases Efficiency of Cryopreservation Protocols for Potato Shoot Tips	AMERICAN JOURNAL OF POTATO RESEARCH			English	Article						Air dehydration; Aluminum plate; D cryo-plate method; PVS2; V cryo-plate method; Vitrification	DROPLET VITRIFICATION; GENEBANKS; L.	The possibility of streamlining general cryoprotection procedures is investigated using aluminium cryoplates with wells, facilitating fluid handling and drying treatment. Precultured shoot tips of potato cultivar 'Sayaka' were embedded in calcium alginate gel in wells of the aluminium cryo-plates. In the V cryo-plate protocol, dehydration was performed for 30 min at 25 A degrees C in plant vitrification solution after osmoprotection. In the D cryo-plate protocol, dehydration was performed by placing the cryo-plates for 2.0 h under an air current in a laminar flow cabinet after osmoprotection. In both protocols, cooling was performed by placing the cryo-plates in uncapped cryotubes, which were immersed in liquid nitrogen. For rewarming, the cryo-plates were immersed in liquid MS medium supplemented with 1.0 M sucrose and diluted for 15 min at room temperature. Under these conditions, regrowth rates of cryopreserved shoot tips in V cryo-plate and D cryo-plate were 96.7 and 93.3 %, respectively. Both protocols will facilitate efficient strategies for preservation, storage, and maintenance of genetic stability of important potato germplasm.	[Yamamoto, Shin-ichi; Rafique, Tariq; Fukui, Kuniaki] Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki 3058602, Japan; [Wunna; Valle Arizaga, Miriam; Watanabe, Kazuo; Niino, Takao] Univ Tsukuba, Ctr Gene Res, Tsukuba, Ibaraki 3058572, Japan; [Valle Arizaga, Miriam; Cruz Gutierrez, Esmeralda J.; Castillo Martinez, Carlos R.] Natl Forestry Crops & Livestock Res Inst, Natl Genet Resources Ctr, Tepatitlan De Morelos 47600, Mexico; [Rafique, Tariq] Natl Agr Res Ctr, Plant Genet Resources Programme, Islamabad 45500, Pakistan	Yamamoto, S (reprint author), Natl Inst Agrobiol Sci, Genet Resources Ctr, Tsukuba, Ibaraki 3058602, Japan.	shiyam@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [CRS-1001, CRS-1002]; JST/JICA, SATREPS: Diversity Assessment and Development of Sustainable Use of Mexican Genetic Resources	We are grateful to Dr. B. A. Antonio for critical reading the manuscript and to Ms. N. Nohara, Ms. A. Nishiuchi, Ms. N. Ishikura and Ms. Y. Sato for their excellent technical assistance. This work was mainly supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, CRS-1001, CRS-1002) and was partially supported by JST/JICA, SATREPS: Diversity Assessment and Development of Sustainable Use of Mexican Genetic Resources.	Reed BM, 2004, CRYOLETTERS, V25, P341; Yamamoto S, 2011, CRYOLETTERS, V32, P256; Kaczmarczyk A, 2008, PLANT CELL REP, V27, P1551, DOI 10.1007/s00299-008-0574-1; Sekizawa K, 2011, PLANT BIOTECHNOL-NAR, V28, P401, DOI 10.5511/plantbiotechnology.11.0531a; Hirai D, 1999, POTATO RES, V42, P153, DOI 10.1007/BF02358405; NISHIZAWA S, 1992, CRYO-LETT, V13, P379; Yamamoto S, 2012, CRYOLETTERS, V33, P12; Niino T, 2013, CRYOLETTERS, V34, P549; Engelmann Florent, 2008, P59, DOI 10.1007/978-0-387-72276-4_4; Folgado R, 2014, J PROTEOMICS, V98, P99, DOI 10.1016/j.jprot.2013.11.027; Golmirzaie A. M., 2000, Cryopreservation of tropical plant germplasm: current research progress and application. Proceedings of an international workshop, Tsukuba, Japan, October, 1998, P250; Hirai D, 2011, CRYOLETTERS, V32, P287; Keller ERJ, 2008, CRYOLETTERS, V29, P53; Kim HH, 2006, CRYOLETTERS, V27, P223; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Panta A, 2014, CRYOLETTERS, V35, P255; Sakai A., 1990, PLANT CRYOPRESERVATI, P33; Schafer-Menuhr A, 1997, ACTA HORTIC, P477; Tanaka D, 2011, ACTA HORTIC, V908, P325; Yamamoto S, 2011, PLANT GENET RESOUR-C, V10, P14; Yamamoto S., 2012, Sanshi Konchu Biotec (Journal of Insect Biotechnology and Sericology), V81, P57	21	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1099-209X	1874-9380		AM J POTATO RES	Am. J. Potato Res.	APR	2015	92	2					250	257		10.1007/s12230-014-9425-5		8	Agronomy	Agriculture	CF9VN	WOS:000352915400008		
J	Takamizawa, Y; Kobayashi, Y				Takamizawa, Yasuyuki; Kobayashi, Yoshifumi			Adhesive Intestinal Obstruction Caused by Extragastrointestinal Anisakiasis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Editorial Material									[Takamizawa, Yasuyuki; Kobayashi, Yoshifumi] Suwa Cent Hosp, Dept Surg, Chino, Nagano 3918503, Japan	Takamizawa, Y (reprint author), Suwa Cent Hosp, Dept Surg, 4300 Tamagawa, Chino, Nagano 3918503, Japan.	yasu.mizawa@gmail.com					ISHIKURA H, 1988, Hokkaido Journal of Medical Science, V63, P376; Pravettoni V., 2012, EUR ANN ALLERGY CLIN, V4, P150	2	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	APR	2015	92	4					675	676		10.4269/ajtmh.14-0673		2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	CF8QY	WOS:000352828200001		
J	Wu, LQ; Takatsu, A; Park, SR; Yang, B; Yang, HX; Kinumi, T; Wang, J; Bi, JM; Wang, Y				Wu, Liqing; Takatsu, Akiko; Park, Sang-Ryoul; Yang, Bin; Yang, Huaxin; Kinumi, Tomoya; Wang, Jing; Bi, Jiaming; Wang, Yang			Development and co-validation of porcine insulin certified reference material by high-performance liquid chromatography-isotope dilution mass spectrometry	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Porcine insulin; Certified reference material; Liquid chromatography-isotope dilution mass spectrometry; Co-validation	AMINO-ACID ENANTIOMERS; CAPILLARY-ELECTROPHORESIS; PROTEIN QUANTIFICATION; GAS-CHROMATOGRAPHY; QUANTITATION; PEPTIDE; ASSAY; SERUM	This article concerns the development and co-validation of a porcine insulin (pINS) certified reference material (CRM) produced by the National Institute of Metrology, People's Republic of China. Each CRM unit contained about 15 mg of purified solid pINS. The moisture content, amount of ignition residue, molecular mass, and purity of the pINS were measured. Both high-performance liquid chromatography-isotope dilution mass spectrometry and a purity deduction method were used to determine the mass fraction of the pINS. Fifteen units were selected to study the between-bottle homogeneity, and no inhomogeneity was observed. A stability study concluded that the CRM was stable for at least 12 months at -20 A degrees C. The certified value of the CRM was (0.892 A +/- 0.036) g/g. A co-validation of the CRM was performed among Chinese, Japanese, and Korean laboratories under the framework of the Asian Collaboration on Reference Materials. The co-validation results agreed well with the certified value of the CRM. Consequently, the pINS CRM may be used as a calibration material or as a validation standard for pharmaceutical purposes to improve the quality of pharmaceutical products.	[Wu, Liqing; Yang, Bin; Wang, Jing] Natl Inst Metrol, Div Med & Biol Measurements, Beijing 100013, Peoples R China; [Takatsu, Akiko; Kinumi, Tomoya] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Park, Sang-Ryoul] Korea Res Inst Stand & Sci, Ctr Bioanal, Taejon 305340, South Korea; [Yang, Huaxin] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China; [Bi, Jiaming; Wang, Yang] Beijing Univ Chem Technol, Coll Sci, Beijing 100029, Peoples R China	Wu, LQ (reprint author), Natl Inst Metrol, Div Med & Biol Measurements, 18 Bei San Huan Dong Lu, Beijing 100013, Peoples R China.	wulq@nim.ac.cn			National Science & Technology Pillar Program of the Eleventh Five-Year Plan Period [2006DFB41610, 2006BAK04A02]	This work was supported by the National Science & Technology Pillar Program of the Eleventh Five-Year Plan Period (2006DFB41610 and 2006BAK04A02).	[Anonymous], 2006, ISO GUID 35 2006 REF; Kato M, 2009, J CHROMATOGR B, V877, P3059, DOI 10.1016/j.jchromb.2009.07.027; Iguchi K, 2004, J CHROMATOGR B, V806, P25, DOI 10.1016/j.jchromb.2004.01.038; Staub A, 2010, J CHROMATOGR A, V1217, P8041, DOI 10.1016/j.chroma.2010.08.076; Arsene CG, 2010, ANAL BIOCHEM, V401, P228, DOI 10.1016/j.ab.2010.03.005; Brun V, 2009, J PROTEOMICS, V72, P740, DOI 10.1016/j.jprot.2009.03.007; Darby SM, 2001, J ANAL TOXICOL, V25, P8; Kito K, 2008, CURR GENOMICS, V9, P263, DOI 10.2174/138920208784533647; Zampolli MG, 2007, J CHROMATOGR A, V1150, P162, DOI 10.1016/j.chroma.2006.12.033; Kippen AD, 1997, J BIOL CHEM, V272, P12513, DOI 10.1074/jbc.272.19.12513; Arsene CG, 2008, ANAL CHEM, V80, P4154, DOI 10.1021/ac7024738; Ben MB, 2013, FOOD CHEM, V141, P2163; Bertrand M, 2008, J CHROMATOGR A, V1180, P131, DOI 10.1016/j.chroma.2007.12.004; Burkitt WI, 2008, ANAL BIOCHEM, V376, P242, DOI 10.1016/j.ab.2008.02.010; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 2012, JJF 11171 2012 MEASU; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 1994, JJF 1006 1994 TECHNI; ISO Guide 34:2009, 2009, ISO GUID 34 2009 GEN; Jung-Hyuk Y, 2014, ANAL BIOANAL CHEM, V406, P4401; Kilpatrick EL, 2009, CLIN CHEM, V55, pA205; Kunkel A, 1997, J CHROMATOGR A, V781, P445, DOI 10.1016/S0021-9673(97)00530-X; Kunkel A, 1998, AM LAB, V30, p76C; Ministry of Health of the People's Republic of China, 2005, PHARMACOPOEIA PEOPLE; Pantelis GR, 2012, INSTRUM SCI TECHNOL, V40, P161; Rodriguez-Cabaleiro D, 2007, CLIN CHEM, V53, P1462, DOI 10.1373/clinchem.2007.088393; Smith JT, 1997, ELECTROPHORESIS, V18, P2377, DOI 10.1002/elps.1150181228	25	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	APR	2015	407	11					3125	3135		10.1007/s00216-014-8385-4		11	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CF1GJ	WOS:000352292000018		
J	Kato, M; Kinumi, T; Yoshioka, M; Goto, M; Fujii, S; Takatsu, A				Kato, Megumi; Kinumi, Tomoya; Yoshioka, Mariko; Goto, Mari; Fujii, Shin-ichiro; Takatsu, Akiko			Development of C-reactive protein certified reference material NMIJ CRM 6201-b: optimization of a hydrolysis process to improve the accuracy of amino acid analysis	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						C-reactive protein; Certified reference material; Amino acid analysis; Isotope dilution mass spectrometry; Hydrolysis optimization	DILUTION MASS-SPECTROMETRY; CORONARY-HEART-DISEASE; QUANTIFICATION; INFLAMMATION; BINDING	To standardize C-reactive protein (CRP) assays, the National Metrology Institute of Japan (NMIJ) has developed a C-reactive protein solution certified reference material, CRM 6201-b, which is intended for use as a primary reference material to enable the SI-traceable measurement of CRP. This study describes the development process of CRM 6201-b. As a candidate material of the CRM, recombinant human CRP solution was selected because of its higher purity and homogeneity than the purified material from human serum. Gel filtration chromatography was used to examine the homogeneity and stability of the present CRM. The total protein concentration of CRP in the present CRM was determined by amino acid analysis coupled to isotope-dilution mass spectrometry (IDMS-AAA). To improve the accuracy of IDMS-AAA, we optimized the hydrolysis process by examining the effect of parameters such as the volume of protein samples taken for hydrolysis, the procedure of sample preparation prior to the hydrolysis, hydrolysis temperature, and hydrolysis time. Under optimized conditions, we conducted two independent approaches in which the following independent hydrolysis and liquid chromatography-isotope dilution mass spectrometry (LC-IDMS) were combined: one was vapor-phase acid hydrolysis (130 A degrees C, 24 h) and hydrophilic interaction liquid chromatography-mass spectrometry (HILIC-MS) method, and the other was microwave-assisted liquid-phase acid hydrolysis (150 A degrees C, 3 h) and pre-column derivatization liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. The quantitative values of the two different amino acid analyses were in agreement within their uncertainties. The certified value was the weighted mean of the results of the two methods. Uncertainties from the value-assignment method, between-method variance, homogeneity, long-term stability, and short-term stability were taken into account in evaluating the uncertainty for a certified value. The certified value and the expanded uncertainty (k = 2) of CRM 6201-b are (40.0 A +/- 1.6) mu mol kg(-1).	[Kato, Megumi; Kinumi, Tomoya; Yoshioka, Mariko; Goto, Mari; Fujii, Shin-ichiro; Takatsu, Akiko] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Biomed Stand Sect, Organ Analyt Chem Div, Tsukuba, Ibaraki 3058563, Japan	Kato, M (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Biomed Stand Sect, Organ Analyt Chem Div, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.	katou-megu@aist.go.jp	Kato, Megumi/D-6092-2014	Kato, Megumi/0000-0002-4930-4852			Danesh J, 2000, BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Kimberly MM, 2003, CLIN CHEM, V49, P611, DOI 10.1373/49.4.611; Rifai N, 2001, CLIN CHEM, V47, P403; Jeong JS, 2011, J CHROMATOGR A, V1218, P6596, DOI 10.1016/j.chroma.2011.07.053; Rzychon M, 2010, CLIN CHEM, V56, P1475, DOI 10.1373/clinchem.2010.147124; Retterstol L, 2002, ATHEROSCLEROSIS, V160, P433, DOI 10.1016/S0021-9150(01)00595-0; Munoz A, 2011, ANAL BIOCHEM, V408, P124, DOI 10.1016/j.ab.2010.08.037; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Burkitt WI, 2008, ANAL BIOCHEM, V376, P242, DOI 10.1016/j.ab.2008.02.010; Eurachem guide, 2012, QUANT UNC AN MEAS; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; International Organization for Standardization, 2006, REF MAT GEN STAT PRI; Kinumi T, 2010, ANAL SCI, V26, P1007; Kinumi T, 2012, ANAL BIOANAL CHEM, V404, P13, DOI 10.1007/s00216-012-6097-1; Kushner I, 2002, SCIENCE, V297, P520, DOI 10.1126/science.297.5581.520; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Pritchard C, 2011, ANAL BIOCHEM, V412, P40, DOI 10.1016/j.ab.2010.12.015; ROUX KH, 1983, J IMMUNOL, V131, P2411; Tanaka T, 2002, BIOCHEM BIOPH RES CO, V295, P163, DOI 10.1016/S0006-291X(02)00622-8; Wu LQ, 2011, ANAL BIOANAL CHEM, V400, P3443, DOI 10.1007/s00216-011-4994-3	21	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	APR	2015	407	11					3137	3146		10.1007/s00216-014-8190-0		10	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CF1GJ	WOS:000352292000019		
J	Hanari, N; Ishikawa, K; Shimizu, Y; Otsuka, S; Iwasawa, R; Fujiki, N; Numata, M; Yarita, T; Kato, K				Hanari, Nobuyasu; Ishikawa, Keiichiro; Shimizu, Yoshitaka; Otsuka, Satoko; Iwasawa, Ryoko; Fujiki, Naomi; Numata, Masahiko; Yarita, Takashi; Kato, Kenji			Certification of reference materials for the determination of alkylphenols	ANALYTICAL AND BIOANALYTICAL CHEMISTRY			English	Article						Certified reference material; Endocrine disrupter; Alkylphenol; Japan Calibration Service System; Traceability	DIFFERENTIAL SCANNING CALORIMETRY; POINT DEPRESSION METHOD; VALUES	Certified reference materials (CRMs) are playing an increasingly important role in national and international standardizing activities. In Japan, primary standard solutions for analyses of endocrine disrupters are supplied under the national standards dissemination system named the Japan Calibration Service System (JCSS). For the traceability on reference materials used for preparation of the primary standard solutions based on the JCSS, the National Metrology Institute of Japan, National Institute of Advanced Industrial Science and Technology (NMIJ/AIST) has developed and certified high-purity reference materials of alkylphenols as NMIJ CRMs, such as 4-n-nonylphenol, 4-tert-octylphenol, 4-n-heptylphenol, 4-tert-butylphenol, and 2,4-dichlorophenol. Thereafter, it is essential to determine the alkylphenols by using these solutions based on the JCSS for environmental monitoring and risk assessments because analytical values obtained by using the solutions can ensure the reliability and traceability of the chemical analyses.	[Hanari, Nobuyasu; Ishikawa, Keiichiro; Shimizu, Yoshitaka; Otsuka, Satoko; Iwasawa, Ryoko; Fujiki, Naomi; Numata, Masahiko; Yarita, Takashi; Kato, Kenji] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan	Hanari, N (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.	hanari-n@aist.go.jp					JOBLING S, 1993, AQUAT TOXICOL, V27, P361, DOI 10.1016/0166-445X(93)90064-8; Milton MJT, 2001, METROLOGIA, V38, P289, DOI 10.1088/0026-1394/38/4/1; Mohr PJ, 1999, J PHYS CHEM REF DATA, V28, P1713, DOI 10.1063/1.556049; Coplen TB, 1998, PURE APPL CHEM, V70, P237, DOI 10.1351/pac199870010237; Environment Canada Health Canada, 2000, NON ITS ETH PRIOR SU; Hanari N, 2011, BUNSEKI KAGAKU, V60, P877; Hanari N, 2008, POLYCYCL AROMAT COMP, V28, P302, DOI 10.1080/10406630802373863; Hanari N, 2010, ACCREDIT QUAL ASSUR, V15, P673, DOI 10.1007/s00769-010-0714-5; Hanari N, 2009, ORGANOHALOGEN COMPD, V71, P1605; Ihara T, 2008, BUNSEKI KAGAKU, V57, P493, DOI 10.2116/bunsekikagaku.57.493; International Organization for Standardization, 2006, ISO GUID 35 REF MAT; International Organization for Standardization, 2005, 17025 ISOIEC; International Organization for Standardization, 2000, ISO GUID 34 GEN REQ; INTERNATIONAL ORGANIZATION FOR STANDARDIZATION (Geneva Switzerland), 1993, GUID EXPR UNC MEAS; International Organization for Standardization (ISO), 2001, 6142 ISO; Ishikawa K, 2011, ACCREDIT QUAL ASSUR, V16, P311, DOI 10.1007/s00769-011-0767-0; Japanese Industrial Standards Committee, 2006, K04501010 JIS; Japanese Industrial Standards Committee, 2006, K04502010 JIS; Khim JS, 1999, ENVIRON TOXICOL CHEM, V18, P2424, DOI 10.1897/1551-5028(1999)018<2424:APAHAO>2.3.CO;2; Miyata Y, 2003, CHEM TIMES, V4, P2; MRAW SC, 1982, REV SCI INSTRUM, V53, P228, DOI 10.1063/1.1136933; NESTEROVA TN, 1990, J CHEM THERMODYN, V22, P365, DOI 10.1016/0021-9614(90)90122-7; NIST, 2012, 1584 NIST SRM; SAITO Y, 1986, THERMOCHIM ACTA, V99, P299, DOI 10.1016/0040-6031(86)85292-3; Shimizu Y, 2008, ACCREDIT QUAL ASSUR, V13, P389, DOI 10.1007/s00769-008-0389-3; VANDOOREN AA, 1984, INT J PHARM, V20, P217, DOI 10.1016/0378-5173(84)90170-4; Verevkin SP, 1999, J CHEM THERMODYN, V31, P559, DOI 10.1006/jcht.1998.0459	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1618-2642	1618-2650		ANAL BIOANAL CHEM	Anal. Bioanal. Chem.	APR	2015	407	11					3239	3247		10.1007/s00216-014-8319-1		9	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CF1GJ	WOS:000352292000030		
J	Taniguchi, M; Arakawa, A; Motoyama, M; Nakajima, I; Nii, M; Mikawa, S				Taniguchi, Masaaki; Arakawa, Aisaku; Motoyama, Michiyo; Nakajima, Ikuyo; Nii, Masahiro; Mikawa, Satoshi			Genomic structural analysis of porcine fatty acid desaturase cluster on chromosome 2	ANIMAL SCIENCE JOURNAL			English	Article						adipocyte; alternative transcription; fatty acid desaturase; genomic structure; porcine	MEAT QUALITY; GENE; EXPRESSION; TRAITS; GROWTH; LIPIDS; FADS3; PIGS	Fatty acid composition is an economically important trait in meat-producing livestock. To gain insight into the molecular genetics of fatty acid desaturase (FADS) genes in pigs, we investigated the genomic structure of the porcine FADS gene family on chromosome 2. We also examined the tissue distribution of FADS gene expression. The genomic structure of FADS family in mammals consists of three isoforms FADS1, FADS2 and FADS3. However, porcine FADS cluster in the latest pig genome assembly (Sscrofa 10.2) containing some gaps is distinct from that in other mammals. We therefore sought to determine the genomic structure, including the FADS cluster in a 200-kbp range by sequencing gap regions. The structure we obtained was similar to that in other mammals. We then investigated the porcine FADS1 transcription start site and identified a novel isoform named FADS1b. Phylogenetic analysis revealed that the three members of the FADS cluster were orthologous among mammals, whereas the various FADS1 isoforms identified in pigs, mice and cattle might be attributable to species-specific transcriptional regulation with alternative promoters. Porcine FADS1b and FADS3 isoforms were predominantly expressed in the inner layer of the subcutaneous adipose tissue. Additional analyses will reveal the effects of these functionally unknown isoforms on fatty acid composition in pig fat tissues.	[Taniguchi, Masaaki; Arakawa, Aisaku; Mikawa, Satoshi] Natl Inst Agrobiol Sci, Anim Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Motoyama, Michiyo; Nakajima, Ikuyo] Natl Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan; [Nii, Masahiro] Tokushima Agr Forestry & Fisheries Technol Suppor, Livestock Res Div, Tokushima, Japan	Mikawa, S (reprint author), Natl Inst Agrobiol Sci, Anim Genome Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	mikawa@affrc.go.jp					Ros-Freixedes R, 2012, J ANIM SCI, V90, P4230, DOI 10.2527/jas.2011-5063; Sprecher H, 1995, J LIPID RES, V36, P2471; CARLSON SE, 1993, P NATL ACAD SCI USA, V90, P1073, DOI 10.1073/pnas.90.3.1073; WALDMAN RC, 1968, J ANIM SCI, V27, P632; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Saeki K, 2004, P NATL ACAD SCI USA, V101, P6361, DOI 10.1073/pnas.0308111101; Joseph J, 2009, J NEUROSCI, V29, P12795, DOI 10.1523/JNEUROSCI.3520-09.2009; WESTERLING DB, 1979, J ANIM SCI, V48, P1343; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Hargrove RL, 2001, J NUTR, V131, P1758; Pedrono F, 2010, J LIPID RES, V51, P472, DOI 10.1194/jlr.M000588; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; WOOD JD, 1989, LIVEST PROD SCI, V22, P351, DOI 10.1016/0301-6226(89)90066-3; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; BERNERT JT, 1975, BIOCHIM BIOPHYS ACTA, V398, P354, DOI 10.1016/0005-2760(75)90186-1; Blanchard H, 2011, BIOCHIMIE, V93, P87, DOI 10.1016/j.biochi.2010.03.002; Carpentier Y.A., 2006, AM J CLIN NUTR, V83, P1499; Hancock JM, 2005, TRENDS GENET, V21, P591, DOI 10.1016/j.tig.2005.08.008; Hu ZL, 2010, 9 WORLD C GEN APPL L; National Agriculture and Food Research Organization (NARO), 2013, JAP FEED STAND SWIN; Nii M, 2006, ANIM GENET, V37, P342, DOI 10.1111/j.1365-2052.2006.01485.x; Park WJ, 2012, J LIPID RES, V53, P1502, DOI 10.1194/jlr.M025312; PE Applied Biosystems, 1997, USER B, V2, P16; R Development Core Team, 2013, R LANG ENV STAT COMP; Sneath P. H. A., 1973, NUMERICAL TAXONOMY; SPRECHER H, 1981, Progress in Lipid Research, V20, P13, DOI 10.1016/0163-7827(81)90009-6	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	APR	2015	86	4					369	377		10.1111/asj.12308		9	Agriculture, Dairy & Animal Science	Agriculture	CG1XF	WOS:000353068100001		
J	Asanuma, N; Yokoyama, S; Hino, T				Asanuma, Narito; Yokoyama, Shota; Hino, Tsuneo			Effects of nitrate addition to a diet on fermentation and microbial populations in the rumen of goats, with special reference to Selenomonas ruminantium having the ability to reduce nitrate and nitrite	ANIMAL SCIENCE JOURNAL			English	Article						nitrate reduction; nitrite reduction; rumen microbes; ruminant; Selenomonas ruminantium	REAL-TIME PCR; METHANE PRODUCTION; MEGASPHAERA-ELSDENII; L-CYSTEINE; IN-VITRO; SHEEP; BACTERIUM; CATTLE; ASSAY; SUCCINOGENES	This study investigated the effects of dietary nitrate addition on ruminal fermentation characteristics and microbial populations in goats. The involvement of Selenomonas ruminantium in nitrate and nitrite reduction in the rumen was also examined. As the result of nitrate feeding, the total concentration of ruminal volatile fatty acids decreased, whereas the acetate:propionate ratio and the concentrations of ammonia and lactate increased. Populations of methanogens, protozoa and fungi, as estimated by real-time PCR, were greatly decreased as a result of nitrate inclusion in the diet. There was modest or little impact of nitrate on the populations of prevailing species or genus of bacteria in the rumen, whereas Streptococcus bovis and S.ruminantium significantly increased. Both the activities of nitrate reductase (NaR) and nitrite reductase (NiR) per total mass of ruminal bacteria were increased by nitrate feeding. Quantification of the genes encoding NaR and NiR by real-time PCR with primers specific for S.ruminantium showed that these genes were increased by feeding nitrate, suggesting that the growth of nitrate- and nitrite-reducing S.ruminantium is stimulated by nitrate addition. Thus, S.ruminantium is likely to play a major role in nitrate and nitrite reduction in the rumen.	[Asanuma, Narito; Yokoyama, Shota; Hino, Tsuneo] Meiji Univ, Dept Life Sci, Kawasaki, Kanagawa 2148571, Japan	Asanuma, N (reprint author), Meiji Univ, Dept Life Sci, Tama Ku, Kawasaki, Kanagawa 2148571, Japan.	asanuma@isc.meiji.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [23580377]	This study was supported in part by a Grant-in-Aid for Scientific Research (No. 23580377) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Welkie DG, 2010, ANAEROBE, V16, P94, DOI 10.1016/j.anaerobe.2009.07.002; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; TAKAHASHI J, 1991, ANIM FEED SCI TECH, V35, P105, DOI 10.1016/0377-8401(91)90103-Y; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1016/S0378-1097(01)00428-1; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; HILLMAN K, 1988, LETT APPL MICROBIOL, V7, P49, DOI 10.1111/j.1472-765X.1988.tb01250.x; Petri RM, 2012, J APPL MICROBIOL, V112, P1152, DOI 10.1111/j.1365-2672.2012.05295.x; van Zijderveld SM, 2010, J DAIRY SCI, V93, P5856, DOI 10.3168/jds.2010-3281; CHANEY AL, 1962, CLIN CHEM, V8, P130; Ushida K, 1996, LETT APPL MICROBIOL, V23, P129, DOI 10.1111/j.1472-765X.1996.tb00047.x; Asanuma N, 2008, ANAEROBE, V14, P237, DOI 10.1016/j.anaerobe.2008.05.004; Sar C, 2005, BRIT J NUTR, V94, P691, DOI 10.1079/BJN20051517; Sylvester JT, 2004, J NUTR, V134, P3378; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Iwamoto M, 2002, ANAEROBE, V8, P209, DOI 10.1006/anae.2002.0428; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Asanuma N, 1999, J DAIRY SCI, V82, P780; Hulshof RBA, 2012, J ANIM SCI, V90, P2317, DOI 10.2527/jas.2011-4209; Zhou YW, 2012, ANIMAL, V6, P815, DOI 10.1017/S1751731111002102; FARRA PA, 1971, J DAIRY SCI, V54, P1018; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; HINO T, 1994, APPL ENVIRON MICROB, V60, P1827; Asanuma N, 2004, J GEN APPL MICROBIOL, V50, P55, DOI 10.2323/jgam.50.55; Asanuma N., 2002, Animal Science Journal, V73, P199, DOI 10.1046/j.1344-3941.2002.00028.x; Dawson K. A., 1988, The rumen microbial ecosystem., P445; HINO T, 1993, J DAIRY SCI, V76, P2213, DOI 10.3168/jds.S0022-0302(93)77558-X; HINO T, 1983, Japanese Journal of Zootechnical Science, V54, P320; Iwamoto M, 2001, KANTO J ANIM SCI, V51, P9; Iwamoto Miwa, 1999, Animal Science Journal, V70, P471; Iwamoto Miwa, 2001, Animal Science Journal, V72, P117; Khalil MAK, 2000, ATMOSPHERIC METHANE, P1; Ouwerkerk D, 2002, J APPL MICROBIOL, V92, P753, DOI 10.1046/j.1365-2672.2002.01580.x; STEWART C.S.FLINTHI, 1997, RUMEN MICROBIAL ECOS, P10, DOI 10.1007/978-94-009-1453-72; Takahashi J, 1998, ANIM FEED SCI TECH, V74, P273, DOI 10.1016/S0377-8401(98)00176-X; Wolin MJ, 1975, DIGESTION METABOLISM, P135; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P117; Yoshii Takahiro, 2003, Animal Science Journal, V74, P483, DOI 10.1046/j.1344-3941.2003.00142.x	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	APR	2015	86	4					378	384		10.1111/asj.12307		7	Agriculture, Dairy & Animal Science	Agriculture	CG1XF	WOS:000353068100002		
J	El-Sabagh, M; Taniguchi, D; Sugino, T; Obitsu, T; Taniguchi, K				El-Sabagh, Mabrouk; Taniguchi, Dai; Sugino, Toshihisa; Obitsu, Taketo; Taniguchi, Kohzo			Insulin-independent actions of glucagon-like peptide-1 in wethers	ANIMAL SCIENCE JOURNAL			English	Article						extrapancreatic effects; insulin; glucagon-like peptide-1 (7-36) amide; wethers	PLASMA-CONCENTRATIONS; GROWING WETHERS; GUT PEPTIDES; DAIRY-COWS; EXPRESSION; INFUSION; HEPATOCYTES; METABOLISM; SECRETION; BIOLOGY	Insulin-independent actions of glucagon-like peptide-1 (GLP-1) are not yet clear in ruminants. Four Suffolk mature wethers (60.0 +/- 6.7kg body weight (BW)) were intravenously infused with insulin (0.5mU/kg BW/min; from 0 to 90min) and GLP-1 (0.5g/kg BW/min; from 60 to 150min) with both hormones co-administered from 60 to 90min, in a repeated-measure design under euglycemic clamp for 150min, to investigate whether GLP-1 has insulin-independent actions. Jugular blood samples were taken at 15-min intervals for plasma hormones and metabolites analysis. Compared to baseline concentrations (at 0min), insulin infusion decreased (P<0.05) plasma concentrations of glucagon, non-esterified fatty acids (NEFA), lactate, nonessential amino acids (NEAA), branched-chain amino acids (BCAA), total amino acids (TAA) and urea nitrogen (UN). Insulin plus GLP-1 infusion induced a greater increase (P<0.05) in plasma concentrations of insulin and triglyceride (TG), but decreased (P<0.05) glucagon, total cholesterol (T-Cho), NEAA and UN plasma concentrations. GLP-1 infusion increased (P<0.05) NEFA, -hydroxybutyrate and TG, but decreased (P<0.05) glucagon, T-Cho, NEAA, BCAA and UN plasma concentrations. In conclusion, GLP-1 exerts extrapancreatic roles in ruminants not only insulin-independent but probably, in contrast to non-ruminants, antagonistic to insulin effects.	[El-Sabagh, Mabrouk; Taniguchi, Dai; Sugino, Toshihisa; Obitsu, Taketo; Taniguchi, Kohzo] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan; [El-Sabagh, Mabrouk] Kafrelsheikh Univ, Fac Vet Med, Kafrelsheikh, Egypt	Sugino, T (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima 7398528, Japan.	sugino@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23688033]; Ministry of Higher Education, Egypt	This work was supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research no. 23688033), and the Ministry of Higher Education, Egypt.	Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Alam T, 2012, PHYSIOL GENOMICS, V44, P198, DOI 10.1152/physiolgenomics.00102.2011; Relling AE, 2008, DOMEST ANIM ENDOCRIN, V35, P35, DOI 10.1016/j.domaniend.2008.01.005; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Larsen M, 2010, J DAIRY SCI, V93, P5729, DOI 10.3168/jds.2010-3258; Pezeshki A, 2012, J DAIRY SCI, V95, P5089, DOI 10.3168/jds.2011-5311; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Gutzwiller JP, 1999, GUT, V44, P81; Borgono CA, 2012, ENDOCRIN METAB CLIN, V41, P1, DOI 10.1016/j.ecl.2012.03.002; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Chehade JM, 2013, METABOLISM, V62, P265, DOI 10.1016/j.metabol.2012.07.005; Cho YM, 2013, ANNU REV PHYSIOL, V13, P14; Faulkner A, 1997, COMP BIOCHEM PHYS B, V118, P563, DOI 10.1016/S0305-0491(97)00227-7; Fukumori R, 2012, DOMEST ANIM ENDOCRIN, V43, P299, DOI 10.1016/j.domaniend.2012.05.003; Gathercole LL, 2013, VITAM HORM, V91, P1, DOI 10.1016/B978-0-12-407766-9.00001-8; HAMILTON PB, 1963, ANAL CHEM, V35, P2055, DOI 10.1021/ac60206a024; Ikezawa Y, 2003, REGUL PEPTIDES, V111, P207, DOI 10.1016/S0167-0014(02)00287-2; Martin Pamela A., 1993, Biochemical Society Transactions, V21, p443S; NRC, 2007, NUTR REQ SMALL RUM S; Peyot ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006221; Relling AE, 2010, J ANIM SCI, V88, P737, DOI 10.2527/jas.2009-2316; Relling AE, 2011, J ANIM SCI, V89, P168, DOI 10.2527/jas.2010-2976; Shalev A, 1997, EUR J CLIN INVEST, V27, P10, DOI 10.1046/j.1365-2362.1997.540613.x; Takahashi H, 2006, J ENDOCRINOL, V189, P67, DOI 10.1677/joe.1.06310; ThanThan S, 2012, DOMEST ANIM ENDOCRIN, V42, P155, DOI 10.1016/j.domaniend.2011.11.004; Timothy JK, 1999, ENDOCR REV, V20, P876	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	APR	2015	86	4					385	391		10.1111/asj.12306		7	Agriculture, Dairy & Animal Science	Agriculture	CG1XF	WOS:000353068100003		
J	Watanabe, G; Kobayashi, H; Shibata, M; Kubota, M; Kadowaki, M; Fujimura, S				Watanabe, Genya; Kobayashi, Hiroyuki; Shibata, Masahiro; Kubota, Masatoshi; Kadowaki, Motoni; Fujimura, Shinobu			Regulation of free glutamate content in meat by dietary lysine in broilers	ANIMAL SCIENCE JOURNAL			English	Article						amino acid; dietary lysine; glutamic acid; metabolism; muscle	PIPECOLIC ACID; KETOGLUTARATE REDUCTASE; DELTA-SEMIALDEHYDE; METABOLISM; CHICKEN; QUALITY; MUSCLE; BRAIN; PIGS; PIPERIDINE	Regulation of taste is important for improving meat quality and glutamate (Glu) is one of the important taste-active components in meat. Here, the effects of dietary lysine (Lys) content on taste-active components in meat, especially free Glu, were investigated. Fourteen-day-old broiler chicks (Gallus gallus) were fed on diets containing 100% or 150% of the recommended Lys content for 10 days. Concentrations of free amino acids in plasma, muscle and liver were measured. The levels of messenger RNAs (mRNAs) for enzymes related to Glu metabolism were determined in muscle and liver. The concentration of muscle metabolites was also determined. The free Glu content in muscle of chicks fed the Lys150% diet was increased by 44.0% compared with that in chicks fed the Lys100% diet (P<0.01). The mRNA level of lysine -ketoglutarate reductase, which is involved in Lys degradation and Glu production, was significantly increased (P<0.05) in the Lys150% group. Metabolome analysis showed that the Lys degradation products, muscular saccharopine, pipecolic acid and -aminoadipic acid, were increased in the Lys150% group. Our results suggest that free Glu content in muscle is regulated by Lys degradation. These results suggest that a short-term feeding of high-Lys diet could improve the taste of meat.	[Watanabe, Genya; Kobayashi, Hiroyuki; Kadowaki, Motoni; Fujimura, Shinobu] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Kubota, Masatoshi; Kadowaki, Motoni; Fujimura, Shinobu] Niigata Univ, Ctr Transdisciplinary Res, Niigata 9502181, Japan; [Shibata, Masahiro] Natl Agr Res Ctr Western Reg, Ohda, Shimane, Japan	Fujimura, S (reprint author), Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan.	fujimura@agr.niigata-u.ac.jp			JSPS KAKENHI, from Japan Society for the Promotion of Science (JSPS) [23580366]	Part of this research was financially supported by a Grant-in-Aid for Scientific Research (C), JSPS KAKENHI Grant Number 23580366, from Japan Society for the Promotion of Science (JSPS) to S. Fujimura.	BROQUIST HP, 1991, ANNU REV NUTR, V11, P435; Kristensen L, 2002, J ANIM SCI, V80, P2862; Manangi MK, 2005, J NUTR, V135, P81; Shibata M, 2006, J ANIM SCI, V84, P2983, DOI 10.2527/jas.2006-118; Hasty JL, 2002, J ANIM SCI, V80, P3230; Reeds PJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE413; BASSO LV, 1962, J BIOL CHEM, V237, P2239; Bou R, 2001, POULTRY SCI, V80, P800; CALVERT AF, 1966, J BIOL CHEM, V241, P409; Farmer L.J., 1999, POULTRY SCI S SERIES, V25, P127; Fujimura S, 2001, J ANIM SCI, V72, P223; Fujimura S, 1996, J ANIMAL SCI TECHNOL, V67, P423; GIACOBINI E, 1980, CELL MOL BIOL, V26, P135; GROVE JA, 1971, ARCH BIOCHEM BIOPHYS, V144, P230, DOI 10.1016/0003-9861(71)90473-5; HIGASHIN.K, 1967, BIOCHEM BIOPH RES CO, V29, P95, DOI 10.1016/0006-291X(67)90547-5; HUTZLER J, 1968, BIOCHIM BIOPHYS ACTA, V158, P62, DOI 10.1016/0304-4165(68)90072-X; Imanari M, 2007, BRIT POULTRY SCI, V48, P167, DOI 10.1080/00071660701244738; Kato H., 1987, Umami: a basic taste. Physiology, biochemistry, nutrition, food science, P289; Kobayashi H, 2011, ANIM SCI J, V82, P86, DOI 10.1111/j.1740-0929.2010.00811.x; MURAMATSU K, 1984, AGR BIOL CHEM TOKYO, V48, P703; National Research Council (NRC), 1994, NUTR REQ POULTR; NOMURA Y, 1978, DEV NEUROSCI-BASEL, V1, P239, DOI 10.1159/000112578; Ross, 2009, BROILER MANAGEMENT M; SAS Institute, 1985, SAS US GUID VERSION5; SCHMIDTGLENEWINKEL T, 1977, NEUROCHEM RES, V2, P619, DOI 10.1007/BF00963776; Smith DP, 2002, POULTRY SCI, V81, P1584; WANG SH, 1972, J NUTR, V102, P583; Young JF, 2004, POULTRY SCI, V83, P400	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	APR	2015	86	4					435	442		10.1111/asj.12321		8	Agriculture, Dairy & Animal Science	Agriculture	CG1XF	WOS:000353068100010		
J	Nakamura, R; Nakamura, F; Fukunaga, S				Nakamura, Ryosuke; Nakamura, Fumio; Fukunaga, Shigeharu			Disruption of endogenous perlecan function improves differentiation of rat articular chondrocytes in vitro	ANIMAL SCIENCE JOURNAL			English	Article						culture; extracellular matrix; HS; HSPG; perlecan	HEPARAN-SULFATE; CHONDROGENIC DIFFERENTIATION; CARTILAGE; OSTEOARTHRITIS; PATHWAYS; DISEASE; PROTEIN; MATRIX; CELLS; PROLIFERATION	Heparan sulfate (HS) and heparan sulfate proteoglycans (HSPG) are necessary for normal cartilage development and chondrocyte differentiation. However, recent studies demonstrated that HSPG accelerate dedifferentiation and catabolism in chondrocytes from degenerative cartilage. In this study, we investigated the inhibitory effect of HSPG on chondrocyte differentiation in vitro. Rat articular chondrocytes were cultured at low (0.3x10(4) cells/cm(2)) and high (1.5x10(5) cells/cm(2)) density in the presence or absence of heparitinase I, an HS degrading enzyme. Cells cultured at low density dedifferentiated and exhibited an elongated morphology, and treatment with heparitinase I precluded cell elongation. Conversely, populations of chondrocytes cultured at high density exhibited either a dedifferentiated or differentiated phenotype. Glycosaminoglycan accumulation increased in heparitinase I-treated cells. To determine the function of perlecan, an important HSPG for cartilage development, in chondrocyte differentiation, rat chondrocyte cultures were exposed to an anti-perlecan antiserum to inhibit perlecan function. Western blotting analysis indicated that preventing perlecan activity increased type II collagen synthesis. Our results suggest that HSPG are negative regulators of chondrocyte differentiation in vitro and that perlecan contributes to chondrocyte dedifferentiation in vitro.	[Nakamura, Ryosuke; Nakamura, Fumio; Fukunaga, Shigeharu] Hokkaido Univ, Res Fac Agr, Lab Anim By Prod Sci, Sapporo, Hokkaido 0608589, Japan	Fukunaga, S (reprint author), Hokkaido Univ, Res Fac Agr, Lab Anim By Prod Sci, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido 0608589, Japan.	kamui@anim.agr.hokudai.ac.jp					Bertrand J, 2013, ARTHRITIS RHEUM-US, V65, P743, DOI 10.1002/art.37817; Melrose J, 2008, BIOESSAYS, V30, P457, DOI 10.1002/bies.20748; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Cheng T, 2012, J ORTHOP RES, V30, P234, DOI 10.1002/jor.21503; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Santiago B, 2012, ARTHRITIS RHEUM-US, V64, P409, DOI 10.1002/art.33345; Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354; Shimo T, 2004, DEV DYNAM, V229, P607, DOI 10.1002/dvdy.20009; Tesche F, 2005, HISTOL HISTOPATHOL, V20, P329; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Pap T, 2013, NAT REV RHEUMATOL, V9, P43, DOI 10.1038/nrrheum.2012.178; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Ellman MB, 2008, GENE, V420, P82, DOI 10.1016/j.gene.2008.04.019; Bansal PN, 2011, OSTEOARTHR CARTILAGE, V19, P970, DOI 10.1016/j.joca.2011.04.004; Gouttenoire J, 2010, EUR J CELL BIOL, V89, P307, DOI 10.1016/j.ejcb.2009.10.018; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Echtermeyer F, 2009, NAT MED, V15, P1072, DOI 10.1038/nm.1998; Otsuki S, 2010, P NATL ACAD SCI USA, V107, P10202, DOI 10.1073/pnas.0913897107; Spierings ELH, 2013, PAIN, V154, P1603, DOI 10.1016/j.pain.2013.04.035; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Minina E, 2001, DEVELOPMENT, V128, P4523; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Aubert-Foucher E, 2014, MATRIX BIOL, V34, P80, DOI 10.1016/j.matbio.2013.09.001; Batty L, 2011, ANZ J SURG, V81, P18, DOI 10.1111/j.1445-2197.2010.05495.x; BCC Research, 2012, ANT DRUGS TECHN GLOB; Gomes RR, 2003, CONNECT TISSUE RES, V44, P196, DOI 10.1080/03008200390181645; Gomes RR, 2006, DIFFERENTIATION, V74, P53, DOI 10.1111/j.1432-0436.2005.00055.x; Gouttenoire Jerome, 2004, Biorheology, V41, P535; Kino-oka M, 2009, J BIOSCI BIOENG, V107, P544, DOI 10.1016/j.jbiosc.2008.12.018; Matsumoto Y, 2010, J BIOL CHEM, V285, P19227, DOI 10.1074/jbc.M110.105338; Melrose J, 2006, J BIOL CHEM, V281, P36905, DOI 10.1074/jbc.M608462200; Nakamura R, 2014, ANIM SCI J, V85, P262, DOI 10.1111/asj.12116; Tesche F, 2004, OSTEOARTHR CARTILAGE, V12, P852, DOI 10.1016/j.joca.2004.07.004; Whitelock JM, 2008, J BIOCH, V144, P7; Yang WD, 2006, TISSUE ENG, V12, P2009, DOI 10.1089/ten.2006.12.2009	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	APR	2015	86	4					449	458		10.1111/asj.12309		10	Agriculture, Dairy & Animal Science	Agriculture	CG1XF	WOS:000353068100012		
J	Ojima, K; Oe, M; Nakajima, I; Shibata, M; Muroya, S; Chikuni, K; Hattori, A; Nishimura, T				Ojima, Koichi; Oe, Mika; Nakajima, Ikuyo; Shibata, Masahiro; Muroya, Susumu; Chikuni, Koichi; Hattori, Akihito; Nishimura, Takanori			The importance of subfragment 2 and C-terminus of myosin heavy chain for thick filament assembly in skeletal muscle cells	ANIMAL SCIENCE JOURNAL			English	Article						myofibril; myofibrillogenesis; sarcomere; skeletal muscle; thick filament	S2 HINGE REGIONS; Z-I BODIES; ELECTRON-MICROSCOPE; SARCOMERIC MYOSIN; NONMUSCLE MYOSIN; ROD; LOCALIZATION; DETERMINES; MYOFIBRILS; DOMAIN	In skeletal muscle cells, myofibrillar proteins are highly organized into sarcomeres in which thick filaments interdigitate with thin filaments to generate contractile force. The size of thick filaments, which consist mainly of myosin molecules, is strictly controlled. However, little is known about the mechanisms by which myosin molecules assemble into thick filaments. Here, we assessed the ability of each domain of myosin heavy chain (Myh) to form thick filaments. We showed that exogenously expressed subfragment 2 (S2)+light meromyosin (LMM) of Myh was efficiently incorporated into thick filaments in muscle cells, although neither solely expressed S2 nor LMM targeted to thick filaments properly. In nonmuscle COS7 cells, S2+LMM formed more enlarged filaments/speckles than LMM. These results suggest that Myh filament formation is induced by S2 accompanying LMM. We further examined the effects of Myh C-terminus on thick filament assembly. C-terminal deletion mutants were incorporated not into entire thick filaments but rather into restricted regions of thick filaments. Our findings suggest that the elongation of myosin filaments to form thick filaments is regulated by S2 as well as C-terminus of LMM.	[Ojima, Koichi; Oe, Mika; Nakajima, Ikuyo; Muroya, Susumu; Chikuni, Koichi] Inst Livestock & Grassland Sci, NARO, Anim Prod Res Div, Tsukuba, Ibaraki 3050901, Japan; [Shibata, Masahiro] NARO, Western Region Agr Res Ctr, Oda, Japan; [Hattori, Akihito; Nishimura, Takanori] Hokkaido Univ, Grad Sch Agr, Res Fac Agr, Sapporo, Hokkaido, Japan; [Hattori, Akihito] Japan Meat Sci & Technol Inst, Tokyo, Japan	Ojima, K (reprint author), Inst Livestock & Grassland Sci, NARO, Anim Prod Res Div, Ikenodai 2, Tsukuba, Ibaraki 3050901, Japan.	koojima@affrc.go.jp		Muroya, Susumu/0000-0002-2376-9352	JSPS. KAKENHI [22580301]	We appreciate the help of Professor Siegfried Labeit (Department of Integrative Pathophysiology, University Medical Centre Mannheim, University of Heidelberg), who gave us an excellent anti-connectin/titin Z1Z2 antibody. We are deeply grateful for the fruitful discussion with Professor Howard Holtzer (University of Pennsylvania). This work was supported in part by a JSPS. KAKENHI grant (no. 22580301) to A. H and K.O.	Holtzer H, 1997, CELL STRUCT FUNCT, V22, P83; LUTHER PK, 1981, J MOL BIOL, V151, P703, DOI 10.1016/0022-2836(81)90430-7; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Cripps RM, 1999, EMBO J, V18, P1793, DOI 10.1093/emboj/18.7.1793; PINSETHARSTROM I, 1979, J MOL BIOL, V134, P173, DOI 10.1016/0022-2836(79)90419-4; Miller MS, 2009, BIOPHYS J, V96, P4132, DOI 10.1016/j.bpj.2009.02.034; HUXLEY HE, 1963, J MOL BIOL, V7, P281, DOI 10.1016/S0022-2836(63)80008-X; Thompson RC, 2012, FEBS LETT, V586, P3008, DOI 10.1016/j.febslet.2012.06.019; Nakasawa T, 2005, BIOCHEMISTRY-US, V44, P174, DOI 10.1021/bi048807h; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; CRAIG R, 1976, J MOL BIOL, V102, P325, DOI 10.1016/S0022-2836(76)80057-5; SCHULTHEISS T, 1990, J CELL BIOL, V110, P1159, DOI 10.1083/jcb.110.4.1159; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Suggs JA, 2007, J MOL BIOL, V367, P1312, DOI 10.1016/j.jmb.2007.01.045; Ojima K, 1999, J CELL SCI, V112, P4101; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Craig RW, 2003, MYOLOGY, V1, P129; Engelhardt WA, 1939, NATURE, V144, P688; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; HARRINGT.WF, 1972, BIOCHEMISTRY-US, V11, P2945, DOI 10.1021/bi00766a004; Ikebe M, 2001, J BIOL CHEM, V276, P30293, DOI 10.1074/jbc.M101969200; ISHIJIMA A, 1991, NATURE, V352, P301, DOI 10.1038/352301a0; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; MONCMAN CL, 1993, MOL BIOL CELL, V4, P1051; Ojima K, 2004, BIOCHEM BIOPH RES CO, V321, P1050, DOI 10.1016/j.bbrc.2004.07.069; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; STRZELECKAGOLASZEWSKA H, 1985, J MUSCLE RES CELL M, V6, P641, DOI 10.1007/BF00711918; Vikstrom KL, 1997, CELL STRUCT FUNCT, V22, P123; WEEDS AG, 1971, J MOL BIOL, V61, P701, DOI 10.1016/0022-2836(71)90074-X; Welikson RE, 2002, J CELL SCI, V115, P3517	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	APR	2015	86	4					459	467		10.1111/asj.12310		9	Agriculture, Dairy & Animal Science	Agriculture	CG1XF	WOS:000353068100013		
J	Yano, C; Saeki, H; Komine, M; Kagami, S; Tsunemi, Y; Ohtsuki, M; Nakagawa, H				Yano, Chizuko; Saeki, Hidehisa; Komine, Mayumi; Kagami, Shinji; Tsunemi, Yuichiro; Ohtsuki, Mamitaro; Nakagawa, Hidemi			Mechanism of Macrophage-Derived Chemokine/CCL22 Production by HaCaT Keratinocytes	ANNALS OF DERMATOLOGY			English	Article						Chemokine CCL22; Chemokine CCL17; Epidermal growth factor receptor; HaCaT keratinocytes	GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; IFN-GAMMA; EPIDERMAL-KERATINOCYTES; SUPPRESSES TARC/CCL17; MDC/CCL22 PRODUCTION; TNF-ALPHA; ACTIVATION; EXPRESSION; CELLS	CC chemokine ligand 17 (CCL17) and CCL22 are the functional ligands for CCR4. We previously reported that inhibitors of nuclear factor-kappa B and p38 mitogen-activated protein kinase (p38 MAPK), but not of extracellular signal-related kinase (ERK), inhibited tumor necrosis factor (TNF)- alpha - and interferon (IFN)- gamma -induced production of CCL17 by the human keratinocyte cell line, HaCaT. Further, an inhibitor of epidermal growth factor receptor (EGFR) enhanced the CCL17 production by these keratinocytes. Objective: To identify the mechanism underlying CCL22 production by HaCaT cells. Methods: We investigated the signal transduction pathways by which TNF- alpha and IFN- gamma stimulate HaCaT cells to produce CCL22 by adding various inhibitors. Results: TNF- alpha - and IN-gamma - induced CCL22 production was inhibited by PD98059, PD153035, Bay 11-7085, SB202190, c-Jun N-terminal kinase (INK) inhibitor II, and Janus kinase OAK) inhibitor 1. Conclusion: Our results indicate that CCL22 production in HaCaT cells is dependent on ERK, EGFR, p38 MAPK, JNK, and JAK and is mediated by different signal pathways from those regulating CCL17 production. Altogether, our previous and present results suggest that EGFR activation represses CCL17 but enhances CCL22 production by these cells.	[Yano, Chizuko; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 1138603, Japan; [Komine, Mayumi; Ohtsuki, Mamitaro] Jichi Med Univ, Dept Dermatol, Shimotsuke, Japan; [Kagami, Shinji] Kanto Cent Hosp, Dept Dermatol, Tokyo, Japan; [Tsunemi, Yuichiro] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan	Saeki, H (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	h-saeki@nms.ac.jp			Ministry of Health, Welfare and Labor of Japan	This work was partly supported by Health Science Research Grants from the Ministry of Health, Welfare and Labor of Japan.	Mascia F, 2003, AM J PATHOL, V163, P303, DOI 10.1016/S0002-9440(10)63654-1; Nguyen VAT, 2000, BIOCHEM J, V349, P427, DOI 10.1042/0264-6021:3490427; Paul T, 2014, EUR J CANCER, V50, P1855, DOI 10.1016/j.ejca.2014.04.026; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; Kwon DJ, 2012, BIOCHEM BIOPH RES CO, V417, P1254, DOI 10.1016/j.bbrc.2011.12.119; Qi XF, 2009, MOL IMMUNOL, V46, P1925, DOI 10.1016/j.molimm.2009.03.018; Tsuda T, 2003, J DERMATOL SCI, V31, P37, DOI 10.1016/S0923-1811(02)00138-X; Horikawa T, 2002, INT IMMUNOL, V14, P767, DOI 10.1093/intimm/dxf044; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Iordanov MS, 2002, MOL CELL BIOL, V22, P5380, DOI 10.1128/MCB.22.15.5380-5394.2002; Xiao T, 2003, J DERMATOL SCI, V31, P111, DOI 10.1016/S0923-1811(02)00149-4; Holvoet S, 2003, EXP CELL RES, V290, P108, DOI 10.1016/S0014-4827(03)00293-3; Kobayashi M, 2004, CELL IMMUNOL, V228, P27, DOI 10.1016/j.cellimm.2004.03.011; Komine M, 2005, J INVEST DERMATOL, V125, P491, DOI 10.1111/j.0022-202X.2005.23840.x; Matsui K, 2011, J INVEST ALLERG CLIN, V21, P354	16	0	0	KOREAN DERMATOLOGICAL ASSOC	SEOUL	305 SEOCHO NASAN, SUITE OFFICE 1330-16, SEOCHO-2-DONG, SEOCHO-GU, SEOUL, 137-858, SOUTH KOREA	1013-9087			ANN DERMATOL	Ann. Dermatol.	APR	2015	27	2					152	156		10.5021/ad.2015.27.2.152		5	Dermatology	Dermatology	CF6IC	WOS:000352659400005		
J	Baron, B; Wang, YF; Maehara, SI; Maehara, Y; Kuramitsu, Y; Nakamura, K				Baron, Byron; Wang, Yufeng; Maehara, Shin-Ichiro; Maehara, Yoshihiko; Kuramitsu, Yasuhiro; Nakamura, Kazuyuki			Resistance to Gemcitabine in the Pancreatic Cancer Cell Line KLM1-R Reversed by Metformin Action	ANTICANCER RESEARCH			English	Article						HSP27; metformin; pancreatic cancer	ACTIVATED PROTEIN-KINASE; BREAST-CANCER; IN-VITRO; RESPIRATORY-CHAIN; DIABETIC-PATIENTS; LEUKEMIA THERAPY; CYCLE ARREST; COMPLEX 1; APOPTOSIS; GROWTH	Background/Aim. The pancreatic cancer cell line KLM1 can gain chemoresistance following gemcitabine (GEM) treatment. Metformin was found to be a useful sensitising agent towards GEM treatment following gain of chemoresistance. Materials and Methods: The proliferation of GEM-sensitive and -resistant cells was investigated over a range of metformin concentrations from 03005 to 5 mM. The intra- and extra-cellular energetic profiles of these two cell types under metformin exposure were investigated through adenosine triphosphate (ATP) and L-lactate assays. Results: There was an unexpected decrease in intracellular L-lactate following gain of chemoresistance, despite observable medium acidification. At the biochemical level, a marked effect on phosphorylated proteins upstream of Akt, along the mTOR pathway, was observed at 6 h. These changes followed a time-dependent pattern linked closely to the changes in the energetic profile. Conclusion: Together, these results indicate that metformin indirectly blocks protein phosphorylation, including that of heat shock protein 27 (HSP27).	[Baron, Byron; Wang, Yufeng; Kuramitsu, Yasuhiro; Nakamura, Kazuyuki] Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Proteom, Ube, Yamaguchi 755, Japan; [Baron, Byron] Univ Malta, Fac Med & Surg, Dept Anat & Cell Biol, Msida, Malta; [Nakamura, Kazuyuki] Tokuyama Med Assoc Hosp, Ctr Clin Labs, Shunan, Japan; [Maehara, Shin-Ichiro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Baron, B (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Biochem & Funct Proteom, Ube, Yamaguchi 755, Japan.	angenlabs@gmail.com					Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Mearow KM, 2002, J NEUROCHEM, V83, P452, DOI 10.1046/j.1471-4159.2002.01151.x; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Tomimoto A, 2008, CANCER SCI, V99, P2136, DOI 10.1111/j.1349-7006.2008.00933.x; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499; Evans JMM, 2005, BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Henshall DC, 2002, J NEUROSCI, V22, P8458; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Nawata J, 2014, ANTICANCER RES, V34, P4807; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Wang LW, 2008, WORLD J GASTROENTERO, V14, P7192, DOI 10.3748/wjg.14.7192; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Markman B, 2010, ANN ONCOL, V21, P683, DOI 10.1093/annonc/mdp347; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; Vazquez-Martin A, 2009, CLIN TRANSL ONCOL, V11, P455, DOI 10.1007/s12094-009-0384-0; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Maehara S, 2004, INT J CANCER, V112, P184, DOI 10.1002/ijc.20304; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Mori-Iwamoto S, 2007, INT J ONCOL, V31, P1345; Guigas B, 2004, BIOCHEM J, V382, P877; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Thoreen CC, 2005, CELL METAB, V1, P287, DOI 10.1016/j.cmet.2005.04.009; Kohn AD, 1996, J BIOL CHEM, V271, P31372; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Oliveras-Ferraros C, 2009, CELL CYCLE, V8, P1633; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Wieman Heather L, 2007, Mol Biol Cell, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Zhuang Yongxian, 2008, J Mol Signal, V3, P18, DOI 10.1186/1750-2187-3-18	62	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					1941	1949				9	Oncology	Oncology	CF7JF	WOS:000352731600011		
J	Yamaguchi, A; Usami, K; Shimabe, M; Hasegawa, K; Asada, M; Motoki, K; Tahara, T; Masuda, K				Yamaguchi, Ayami; Usami, Katsuaki; Shimabe, Munetake; Hasegawa, Kazumasa; Asada, Masao; Motoki, Kazuhiro; Tahara, Tomoyuki; Masuda, Kazuhiro			The Novel CA IX Inhibition Antibody chKM4927 Shows Anti-tumor Efficacy In Vivo	ANTICANCER RESEARCH			English	Article						CAIX; carbonic anhydrase; antibody; antibody-dependent cellular cytotoxicity; kidney cancer	CARBONIC-ANHYDRASE-IX; TUMOR-CELL GROWTH; MONOCLONAL-ANTIBODY; CANCER-CELLS; INTRACELLULAR PH; HYPOXIA; EXPRESSION; RESISTANCE; ACIDOSIS; MICROENVIRONMENT	Carbonic anhydrase IX (CA IX) is an attractive target for cancer therapy. Many anti-CA IX antibodies have been reported but few have been shown to possess inhibition activity. Furthermore, effective use of CA IX-inhibition antibodies for cancer immunotherapy has not been well-validated since data are mainly limited to in vitro assays. In this study, we established that chKM4927, an anti-CA IX chimeric antibody, recognizes CA IX and has CA IX-specific inhibition activity. ChKM4927 also retains antibody-dependent cellular cytotoxicity (ADCC) activity against CA IX-expressing cancer cells. Compared to controls, chKM4927 treatment (10 mg/kg) showed anti-tumor activity in the VMRC-RCW xenograft model in vivo. ChKM4927-attenuated ADCC activity showed equally effective anti-tumor activity. These results suggest that the CA IX-inhibition antibody chKM4927 has an anti-tumor effect in the VMRC-RCW xenograft model via an ADCC-independent mechanism.	[Yamaguchi, Ayami] Kyowa Hakko Kirin Co Ltd, Nephrol R&D Unit, Nephrol Res Labs, Machida, Tokyo, Japan; [Usami, Katsuaki; Masuda, Kazuhiro] Kyowa Hakko Kirin Co Ltd, Innovat Technol Labs, Res Funct Unit, Machida, Tokyo, Japan; [Shimabe, Munetake] Kyowa Hakko Kirin Co Ltd, Immunol & Allergy R&D Unit, Immunol & Allergy Res Labs, Machida, Tokyo, Japan; [Hasegawa, Kazumasa; Asada, Masao] Kyowa Hakko Kirin Co Ltd, Res Funct Unit, Res Core Funct Labs, Machida, Tokyo, Japan; [Motoki, Kazuhiro] Kyowa Hakko Kirin Co Ltd, Oncol R&D Unit, Oncol Res Labs, Machida, Tokyo, Japan; [Tahara, Tomoyuki] Kyowa Hakko Kirin Co Ltd, R&D Div, Open Innovat Dept, Machida, Tokyo, Japan	Masuda, K (reprint author), Kyowa Hakko Kirin Co Ltd, Innovat Technol Labs, Res Funct Unit, R&D Div, 3-6-6 Asahi Machi, Machida, Tokyo, Japan.	kazuhiro.masuda@kyowa-kirin.co.jp					Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; VAUPEL P, 1989, CANCER RES, V49, P6449; Macor P, 2006, CANCER RES, V66, P3876, DOI 10.1158/0008-5472.CAN-05-3434; Brennan DJ, 2006, CLIN CANCER RES, V12, P6421, DOI 10.1158/1078-0432.CCR-06-0480; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; McIntyre A, 2012, CLIN CANCER RES, V18, P3100, DOI 10.1158/1078-0432.CCR-11-1877; Shin HJ, 2011, J CELL SCI, V124, P1077, DOI 10.1242/jcs.072207; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Cianchi F, 2010, J PHARMACOL EXP THER, V334, P710, DOI 10.1124/jpet.110.167270; Siebels M, 2011, WORLD J UROL, V29, P121, DOI 10.1007/s00345-010-0570-2; Dubois L, 2011, RADIOTHER ONCOL, V99, P424, DOI 10.1016/j.radonc.2011.05.045; Juhl H, 1997, J SURG ONCOL, V64, P222, DOI 10.1002/(SICI)1096-9098(199703)64:3<222::AID-JSO9>3.0.CO;2-C; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Marushima H, 2011, INT J ONCOL, V39, P1327, DOI 10.3892/ijo.2011.1142; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; Aggarwal M, 2013, EXPERT OPIN THER PAT, V23, P717, DOI 10.1517/13543776.2013.782394; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Ebbesen P, 2009, J ENZYM INHIB MED CH, V24, P1, DOI 10.1080/14756360902784425; Ahlskog JKJ, 2009, BIOORG MED CHEM LETT, V19, P4851, DOI 10.1016/j.bmcl.2009.06.022; Thiry A, 2006, TRENDS PHARMACOL SCI, V27, P566, DOI 10.1016/j.tips.2006.09.002; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Zheng GP, 2010, FEBS J, V277, P4506, DOI 10.1111/j.1742-4658.2010.07836.x; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Divgi CR, 2013, J CLIN ONCOL, V31, P187, DOI 10.1200/JCO.2011.41.2445; Ditte Z, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-358; Feinstein Y, 2014, HORM RES PAEDIAT, V81, P336, DOI 10.1159/000358327; Kivela A, 2000, AM J PATHOL, V156, P577, DOI 10.1016/S0002-9440(10)64762-1; Kon-No H, 2006, LUNG CANCER, V54, P409, DOI 10.1016/j.lungcan.2006.08.017; Murri-Plesko MT, 2011, EUR J PHARMACOL, V657, P173, DOI 10.1016/j.ejphar.2011.01.063; Nakamura K, 2000, MOL IMMUNOL, V37, P1035, DOI 10.1016/S0161-5890(01)00021-9; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Sasaki Y, 2010, BIOCHEM BIOPH RES CO, V394, P498, DOI 10.1016/j.bbrc.2010.02.166; Xu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009625	39	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					1997	2004				8	Oncology	Oncology	CF7JF	WOS:000352731600017		
J	Banno, E; Togashi, Y; Kobayashi, Y; Hayashi, H; Mitsudomi, T; Nishio, K				Banno, Eri; Togashi, Yosuke; Kobayashi, Yoshihisa; Hayashi, Hidetoshi; Mitsudomi, Tetsuya; Nishio, Kazuto			Afatinib is Especially Effective Against Non-small Cell Lung Cancer Carrying an EGFR Exon 19 Deletion	ANTICANCER RESEARCH			English	Article						Non-small cell lung cancer; epidermal growth factor receptor gene mutation; exon 19 deletion; exon 21 L858R; afatinib	GROWTH-FACTOR RECEPTOR; RANDOMIZED PHASE-3 TRIAL; 1ST-LINE TREATMENT; OPEN-LABEL; MUTATIONS; CHEMOTHERAPY; GEFITINIB; SENSITIVITY; ERLOTINIB; ADENOCARCINOMA	Background: A recent pooled analysis of the LUX-LUNG3 and LUX-LUNG6 trials suggested that afatinib (an irreversible epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)) is especially effective against non-small cell lung cancer (NSCLC) carrying an EGFR exon 19 deletion. Materials and Methods: Stable viral transfectant HEK293 cell lines carrying an exon 19 deletion (HEK293/19 del) or exon 21 L858R mutation (HEK293/L858R)) were created and their drug sensitivities to AG1478 (a reversible EGFR-TKI) and afatinib were examined using an MTT assay. Western blot analyses were performed to estimate the phosphorylation of EGFR. Results: In the HEK293/19 del, the 50% inhibitory concentration (IC50) of afatinib was significantly lower than that in the HEK293/L858R. In addition, afatinib inhibited the phosphorylation of EGFR to a greater degree in the HEK293/19 del than in the HEK293/L858R. Conclusion: Our experimental findings suggest that afatinib is especially effective against NSCLC carrying an EGFR exon 19 deletion.	[Banno, Eri; Togashi, Yosuke; Hayashi, Hidetoshi; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka 5898511, Japan; [Kobayashi, Yoshihisa; Mitsudomi, Tetsuya] Kinki Univ, Fac Med, Dept Surg, Osaka 5898511, Japan; [Hayashi, Hidetoshi] Kinki Univ, Fac Med, Dept Med Oncol, Osaka 5898511, Japan; [Hayashi, Hidetoshi] Kishiwada Municipal Hosp, Dept Med Oncol, Osaka, Japan	Nishio, K (reprint author), Kinki Univ, Fac Med, Dept Genome Biol, 377-2 Ohno Higashi, Osaka 5898511, Japan.	knishio@med.kindai.ac.jp					Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Cho J, 2013, CANCER RES, V73, P6770, DOI 10.1158/0008-5472.CAN-13-1145; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Arao T, 2004, CANCER RES, V64, P9101, DOI 10.1158/0008-5472.CAN-04-2360; Maegawa M, 2009, CANCER SCI, V100, P552, DOI 10.1111/j.1349-7006.2008.01071.x; Sebastian Martin, 2014, Eur Respir Rev, V23, P92, DOI 10.1183/09059180.00008413; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1	15	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2005	2008				4	Oncology	Oncology	CF7JF	WOS:000352731600018		
J	Itakura, Y; Taga, S; Iwata, C; Teramachi, H; Miyamoto, KI; Tsuchiya, H; Nada, T; Matsushita, R				Itakura, Yukari; Taga, Shino; Iwata, Chieko; Teramachi, Hitomi; Miyamoto, Ken-ichi; Tsuchiya, Hiroyuki; Nada, Takashi; Matsushita, Ryo			Structural Changes in Albumin Are a Possible Mechanism for Fluctuation of Cefazorin and Ibuprofen Plasma Protein Binding in Rats with Carcinogen-induced Osteosarcoma	ANTICANCER RESEARCH			English	Article						Plasma protein binding; albumin; oxidation; cancer; osteosarcoma; rat	HUMAN-SERUM-ALBUMIN; OXIDATIVE STRESS	Background/Aim: It is known that the protein-unbound fraction (fp) of warfarin fluctuates in the plasma of cancer patients and the fluctuation of fp is correlated with albumin concentration. However, this mechanism remains unclear. The present study was performed with the objective of elucidating variations in the protein-binding rate of specific drugs in the presence of cancer, as well as the mechanisms involved. Materials and Methods: Experiments were performed using Fisher 344 model rats, that we have used in previous studies. A single i.v. injection of cefazolin (CEZ) 20 mg/kg or ibuprofen (IB) 10 mg/kg was administered to both tumor-bearing and control groups. We compared relevant pharmacokinetics. Purified albumin was checked for purity with SDS-PAGE and was used in experiments on protein binding of CEZ and IB. Results: The fp of CEZ in plasma from the tumor-bearing group increased approximately 2.9-fold and the fp of IB also increased about 2.7-fold. For that reason, we purified albumin from plasma and examined its spectroscopic signature. We showed that conformational changes (i.e., decreases in the hydrophobic region, increases in endogenous tryptophan fluorescence intensity and decrease in a-helical content) had occurred in albumin in the tumor-bearing group. Conclusion: In the present study, we confirmed that, in a state of cancer morbidity, fp was elevated for site I high-affinity CEZ and site II high-affinity IB. Moreover, our findings indicated that, as a cause of those elevations, a decrease in the albumin concentration and conformational changes due to an oxidation are involved.	[Itakura, Yukari; Taga, Shino; Iwata, Chieko; Matsushita, Ryo] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan; [Teramachi, Hitomi] Gifu Pharmaceut Univ, Lab Clin Pharm, Gifu, Japan; [Miyamoto, Ken-ichi] Kanazawa Univ Hosp, Dept Pharm, Kanazawa, Ishikawa, Japan; [Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan; [Nada, Takashi] Kanazawa Univ, Coll Med Pharmaceut & Hlth Sci, Sch Med, Dept Lab Med, Kanazawa, Ishikawa, Japan	Matsushita, R (reprint author), Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	matusita@p.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	The Authors wish to acknowledge the skillful technical assistance of Mr. Y. Kondo. This study was supported partially by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	SUDLOW G, 1975, MOL PHARMACOL, V11, P824; BENET LZ, 1979, J PHARM SCI, V68, P1071, DOI 10.1002/jps.2600680845; [Anonymous], 1995, ALL ALBUMIN BIOCH GE; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Mera K, 2005, BIOCHEM BIOPH RES CO, V334, P1322, DOI 10.1016/j.bbrc.2005.07.035; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; DEGUCHI Y, 1988, J PHARM SCI, V77, P559, DOI 10.1002/jps.2600770702; Liliemark E, 1996, CANCER LETT, V106, P97, DOI 10.1016/0304-3835(96)04308-X; Longworth J W, 1981, Ann N Y Acad Sci, V366, P237, DOI 10.1111/j.1749-6632.1981.tb20757.x; SATTERWHITE JH, 1989, J CHROMATOGR-BIOMED, V497, P330, DOI 10.1016/0378-4347(89)80038-6; Shimada I, 2012, ANTICANCER RES, V32, P823; Takamura N, 2007, YAKUGAKU ZASSHI, V127, P231, DOI 10.1248/yakushi.127.231; URIEN S, 1986, CLIN PHARMACOL THER, V39, P683	14	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2063	2069				7	Oncology	Oncology	CF7JF	WOS:000352731600026		
J	Eto, S; Yoshikawa, K; Shimada, M; Higashijima, J; Tokunaga, T; Nakao, T; Nishi, M; Takasu, C; Sato, H; Kurita, N				Eto, Shohei; Yoshikawa, Kozo; Shimada, Mitsuo; Higashijima, Jun; Tokunaga, Takuya; Nakao, Toshihiro; Nishi, Masaaki; Takasu, Chie; Sato, Hirohiko; Kurita, Nobuhiro			The Relationship of CD133, Histone Deacetylase 1 and Thrombospondin-1 in Gastric Cancer	ANTICANCER RESEARCH			English	Article						Gastric cancer; histone deacetylase; HDAC; CD133; thrombospondin-1; THBS1	STEM-CELLS; PANCREATIC-CANCER; INDUCED APOPTOSIS; HDAC INHIBITORS; EXPRESSION; PROGNOSIS; ASSOCIATION; HIF-1-ALPHA; METASTASIS	Background/Aim. Gastric cancer is one of the most common types of cancer. Cancer stem cells (CSCs) have been reported to play important roles in multiple cancer types. This study investigated the correlation between cluster of differentiation 133 (CD133), histone deacetylase 1 (HDAC1) and thrombospondin-1 (THBS1) expression in advanced gastric cancer. Materials and Methods: The study included 65 patients with gastric cancer with recurrence after surgery. Expression of CD133, HDAC1 and THBS1 was examined by immunohistochemistry. Prognostic factors were investigated by multivariate analysis using Cox's proportional hazard model. Results: Clinicopathological variables, including survival, of patients positive for CD133 expression (n=6, 23%), were compared with those without CD133 expression (n=20, 77%). Positive HDAC1 expression and THBS1 expression were observed in 34 (52%) and 17 (26%) patients, respectively. Using univariate analysis, positive expression of CD133 and negative expression of THBS1 predicted significantly worse prognosis. Multivariate analysis revealed CD133-positive and THBS1-negative expression were independent prognostic indicators. Conclusion: CD133 expression and THBS1 expression were prognostic factors, and a negative relationship between HDAC and THBS1 was observed in advanced gastric cancer. These biomarkers may help determine postoperative treatment in patients with gastric cancer.	[Eto, Shohei; Yoshikawa, Kozo; Shimada, Mitsuo; Higashijima, Jun; Tokunaga, Takuya; Nakao, Toshihiro; Nishi, Masaaki; Takasu, Chie; Sato, Hirohiko; Kurita, Nobuhiro] Univ Tokushima, Dept Digest Surg, Tokushima 7708503, Japan	Yoshikawa, K (reprint author), Univ Tokushima, Grad Sch Med Sci, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	yoshikawa.kozo@tokushima-u.ac.jp					Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Marks PA, 2001, CURR OPIN ONCOL, V13, P477, DOI 10.1097/00001622-200111000-00010; Mayer B, 2001, GASTROENTEROLOGY, V121, P839, DOI 10.1053/gast.2001.27989; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Nakao T, 2011, INT J CLIN ONCOL, V16, P145, DOI 10.1007/s10147-010-0147-5; Singh SK, 2003, CANCER RES, V63, P5821; Iwahashi S, 2013, SURG TODAY, V43, P654, DOI 10.1007/s00595-012-0437-9; Maeda S, 2008, BRIT J CANCER, V98, P1389, DOI 10.1038/sj.bjc.6604307; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Morine Y, 2012, SURGERY, V151, P412, DOI 10.1016/j.surg.2011.07.038; Kim SH, 2007, ONCOL REP, V17, P647; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Maeda K, 2001, ONCOL REP, V8, P763; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Ishigami S, 2010, ANTICANCER RES, V30, P2453; Kurdistani SK, 2007, BRIT J CANCER, V97, P1, DOI 10.1038/sj.bjc.6603844; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Somech R, 2004, CANCER TREAT REV, V30, P461, DOI 10.1016/j.ctrv.2004.04.006; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Horst D, 2008, BRIT J CANCER, V99, P1285, DOI 10.1038/sj.bjc.6604664; Bertrand J, 2009, INT J ONCOL, V34, P717, DOI 10.3892/ijo_00000198; Grossfeld GD, 1997, J NATL CANCER I, V89, P219, DOI 10.1093/jnci/89.3.219; Iordache F, 2012, INT J MOL SCI, V13, P15074, DOI 10.3390/ijms131115074; Morales JC, 2010, CANCER LETT, V297, P91, DOI 10.1016/j.canlet.2010.04.029; Morelli D, 1998, CLIN CANCER RES, V4, P1221; Osada-Oka M, 2008, J CELL BIOCHEM, V104, P1918, DOI 10.1002/jcb.21759; Roukos DH, 2000, CANCER TREAT REV, V26, P243, DOI 10.1053/ctrv.2000.0164; Shimada M, 2010, J GASTROENTEROL, V45, P896, DOI 10.1007/s00535-010-0235-3; Yamaguchi M, 2002, LUNG CANCER-J IASLC, V36, P143, DOI 10.1016/S0169-5002(01)00470-6	31	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2071	2076				6	Oncology	Oncology	CF7JF	WOS:000352731600027		
J	Nakagawa, S; Hayashi, H; Nitta, H; Okabe, H; Sakamoto, K; Higashi, T; Kuroki, H; Imai, K; Hashimoto, D; Sakamoto, Y; Chikamoto, A; Beppu, T; Baba, H				Nakagawa, Shigeki; Hayashi, Hiromitsu; Nitta, Hidetoshi; Okabe, Hirohisa; Sakamoto, Keita; Higashi, Takaaki; Kuroki, Hideyuki; Imai, Katsunori; Hashimoto, Daisuke; Sakamoto, Yasuo; Chikamoto, Akira; Beppu, Toru; Baba, Hideo			Scoring System Based on Tumor Markers and Child-Pugh Classification for HCC Patients who Underwent Liver Resection	ANTICANCER RESEARCH			English	Article						Hepatocellular carcinoma (HCC); alpha-fetoprotein (AFP); Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3); des-gamma-carboxyprothrombin (DCP); tumor marker	GAMMA-CARBOXY PROTHROMBIN; REACTIVE ALPHA-FETOPROTEIN; PROGNOSTIC STAGING SYSTEM; VITAMIN-K ABSENCE; HEPATOCELLULAR-CARCINOMA; HEPATIC RESECTION; MILAN CRITERIA; ANTAGONIST-II; CLIP SCORE; JIS SCORE	Background: The long-term prognosis of hepatocellular carcinoma (HCC) patients after hepatic resection (HR) remains poor because of limited liver function and frequent recurrences. We created a prognostic system of HCC based on tumor markers and Child-Pugh classification. Patients and Methods: This study investigated 427 HCC patients and three tumor markers (alpha-fetoprotein (AFP), Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3), des-gamma-carboxyprothrombin (DCP)) in relation to Child-Pugh classification by the stepwise Cox regression model for establishing a tumor marker staging (TMS). Results: The TMS shows four levels (0/1/2/3) with 5-year recurrence rate of each stage of 76.7, 72.3, 80.9 and 100%, respectively, and 5-year overall survival of 77.0, 68.7, 52.1 and 28.9%, respectively. This TMS appears to be a better model to predict the recurrence and survival of HCC patients after hepatectomy than only the number of positive tumor markers. Conclusion: TMS is a useful staging system to evaluate biological status and background liver function.	[Nakagawa, Shigeki; Hayashi, Hiromitsu; Nitta, Hidetoshi; Okabe, Hirohisa; Sakamoto, Keita; Higashi, Takaaki; Kuroki, Hideyuki; Imai, Katsunori; Hashimoto, Daisuke; Sakamoto, Yasuo; Chikamoto, Akira; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Sakamoto, Yasuo; Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Adachi E, 2002, SURGERY, V131, pS148, DOI 10.1067/msy.2002.119496; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Kudo M, 2010, ONCOLOGY-BASEL, V78, P180, DOI 10.1159/000315740; Shirabe K, 2007, J SURG ONCOL, V95, P235, DOI 10.1002/jso.20655; Toyoda H, 2006, CLIN GASTROENTEROL H, V4, P111, DOI 10.1053/S1542-3565(05)00855-4; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Utsunomiya T, 2014, ANN SURG, V259, P336, DOI 10.1097/SLA.0b013e31829291e9; Koike Y, 2001, CANCER, V91, P561, DOI 10.1002/1097-0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Kiriyama S, 2011, ANN SURG, V254, P984, DOI 10.1097/SLA.0b013e3182215016; Kumada T, 1999, J HEPATOL, V30, P125, DOI 10.1016/S0168-8278(99)80016-6; Kamiyama T, 2009, ANN SURG ONCOL, V16, P1560, DOI 10.1245/s10434-009-0407-7; Hanazaki K, 2001, AM J GASTROENTEROL, V96, P1243; Takada Y, 2007, DIGEST DIS, V25, P299, DOI 10.1159/000106908; Yamashita F, 1996, GASTROENTEROLOGY, V111, P996, DOI 10.1016/S0016-5085(96)70067-7; Shaw JJ, 2011, EXPERT REV GASTROENT, V5, P365, DOI [10.1586/egh.11.20, 10.1586/EGH.11.20]; Marrero JA, 2010, ONCOLOGIST, V15, P23, DOI 10.1634/theoncologist.2010-S4-23; Fujiki M, 2009, AM J TRANSPLANT, V9, P2362, DOI 10.1111/j.1600-6143.2009.02783.x; Yamakado K, 2014, JPN J RADIOL, V32, P260, DOI 10.1007/s11604-014-0298-9; Toyoda H, 2012, J HEPATOL, V57, P1251, DOI 10.1016/j.jhep.2012.07.018; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Manghisi G, 1998, HEPATOLOGY, V28, P751; Fujioka M, 2001, HEPATOLOGY, V34, P1128, DOI 10.1053/jhep.2001.29202; Imai K, 2013, HEPATOL RES, V43, P853, DOI 10.1111/hepr.12035; Kobayashi M, 2011, HEPATOL RES, V41, P1036, DOI 10.1111/j.1872-034X.2011.00858.x; Masuda T, 2010, J SURG ONCOL, V102, P490, DOI 10.1002/jso.21451; Nakagawa S, 2013, HEPATOL RES; Sakaguchi T, 2010, SURG TODAY, V40, P638, DOI 10.1007/s00595-009-4109-3; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Soejima Y, 2007, TRANSPLANTATION, V83, P893, DOI 10.1097/01.tp.0000259015.46798.ec; Takanishi Danny M Jr, 2007, Hawaii Med J, V66, P209; Tanaka S, 2007, J AM COLL SURGEONS, V204, P1, DOI 10.1016/j.jamcollsurg.2006.10.004; Yamanaka J, 2000, J GASTROEN HEPATOL, V15, P1192, DOI 10.1046/j.1440-1746.2000.02323.x; Yano Y, 2006, LIVER INT, V26, P789, DOI 10.1111/j.1478-3231.2006.01310.x; Zhang JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088182	38	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2157	2163				7	Oncology	Oncology	CF7JF	WOS:000352731600037		
J	Kosuga, T; Ichikawa, D; Okamoto, K; Komatsu, S; Konishi, H; Takeshita, H; Shiozaki, A; Fujiwara, H; Mokimura, R; Ikoma, H; Murayama, Y; Kuriu, Y; Nakanishi, M; Sakakura, C; Otsuji, E				Kosuga, Toshiyuki; Ichikawa, Daisuke; Okamoto, Kazuma; Komatsu, Shuhei; Konishi, Hikotaka; Takeshita, Hiroki; Shiozaki, Atsushi; Fujiwara, Hitoshi; Mokimura, Ryo; Ikoma, Hisashi; Murayama, Yasutoshi; Kuriu, Yoshiaki; Nakanishi, Masayoshi; Sakakura, Chouhei; Otsuji, Eigo			Impact of Age on Early Surgical Outcomes of Laparoscopy-assisted Gastrectomy with Suprapancreatic Nodal Dissection for Clinical Stage I Gastric Cancer	ANTICANCER RESEARCH			English	Article						Gastric cancer; laparoscopic surgery; gastrectomy; elderly patients; laparoscopy-assisted gastrectomy	DISTAL GASTRECTOMY; ELDERLY-PATIENTS; SUBTOTAL GASTRECTOMY; OLDER PERSONS; COMPLICATIONS; MORTALITY; SURGERY; SAFETY; TRIAL; CLASSIFICATION	Background/Aim: Although laparoscopy-assisted gastrectomy (LAG) is widely used for the treatment of gastric cancer, its safety and feasibility for elderly patients remains controversial. We herein examined the impact of age on the early surgical outcomes of LAG with suprapancreatic nodal dissection for elderly patients with clinical stage I gastric cancer. Patients and Methods: This retrospective study included 292 patients undergoing LAG with suprapancreatic nodal dissection for clinical stage I gastric cancer. We divided patients into an elderly group (age >= 75 years; n=55) and non-elderly group (age <75 years; n=237). Preoperative conditions, operative findings and postoperative outcomes, including complications, were compared between these two groups. Results: The elderly group had a higher incidence of co-morbidities (61.8%) and lower forced expiratory volume in 1 second/forced vital capacity (74.8%). Preoperative levels of hemoglobin (Hb) and serum albumin (Alb), as well as the total lymphocyte count (TLC) were lower in the elderly group (p<0.001, <0.001 and =0.018, respectively). No significant differences were observed in intraoperative findings between the two groups. The incidence of overall and surgical complications in the elderly group (21.8% and 14.5%, respectively) did not significantly differ from those in the non-elderly group. The frequency of non-surgical complications in the elderly group (9.1%) was significantly higher (p =0.018), whereas no critical complications or mortality were observed. No significant differences were noted in the severity of complications or hospital courses between the groups. Conclusion: LAG with suprapancreatic nodal dissection appears to be safe and feasible for elderly patients with clinical stage I gastric cancer.	[Kosuga, Toshiyuki; Ichikawa, Daisuke; Okamoto, Kazuma; Komatsu, Shuhei; Konishi, Hikotaka; Takeshita, Hiroki; Shiozaki, Atsushi; Fujiwara, Hitoshi; Mokimura, Ryo; Ikoma, Hisashi; Murayama, Yasutoshi; Kuriu, Yoshiaki; Nakanishi, Masayoshi; Sakakura, Chouhei; Otsuji, Eigo] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 6028566, Japan	Ichikawa, D (reprint author), Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	ichikawa@koto.kpu-m.ac.jp					Nunobe S, 2011, J GASTROINTEST SURG, V15, P1520, DOI 10.1007/s11605-011-1489-7; Mochiki E, 2005, WORLD J SURG, V29, P1585, DOI 10.1007/s00268-005-0208-5; Hwang SH, 2009, J AM COLL SURGEONS, V208, P186, DOI 10.1016/j.jamcollsurg.2008.10.023; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Persiani R, 2008, J AM COLL SURGEONS, V207, P13, DOI 10.1016/j.jamcollsurg.2007.12.050; Katai H, 1998, JPN J CLIN ONCOL, V28, P112, DOI 10.1093/jjco/28.2.112; Watanabe M, 2012, WORLD J SURG, V36, P1632, DOI 10.1007/s00268-012-1526-z; Katai H, 2004, SURG ONCOL, V13, P235, DOI 10.1016/j.suronc.2004.09.007; Adachi Y, 2000, ARCH SURG-CHICAGO, V135, P806, DOI 10.1001/archsurg.135.7.806; Hayashi T, 2012, WORLD J SURG, V36, P2139, DOI 10.1007/s00268-012-1653-6; Saif MW, 2010, EJSO-EUR J SURG ONC, V36, P709, DOI 10.1016/j.ejso.2010.05.023; Takeshita H, 2013, WORLD J SURG, V37, P2891, DOI 10.1007/s00268-013-2210-7; Stocchi L, 2000, DIS COLON RECTUM, V43, P326, DOI 10.1007/BF02258297; Park DJ, 2005, BRIT J SURG, V92, P1099, DOI 10.1002/bjs.4952; Jeong O, 2010, ANN SURG ONCOL, V17, P1589, DOI 10.1245/s10434-010-0916-4; Matsuda A, 2014, JPN J CLIN ONCOL, V44, P388, DOI 10.1093/jjco/hyu003; Tokunaga M, 2008, J GASTROINTEST SURG, V12, P1502, DOI 10.1007/s11605-008-0567-y; [Anonymous], 2011, GASTRIC CANC, V14, P101; Kunisaki C, 2009, SURG ENDOSC, V23, P377, DOI 10.1007/s00464-008-9949-1; Yasuda K, 2004, BRIT J SURG, V91, P1061, DOI 10.1002/bjs.4615; Cho GS, 2009, BRIT J SURG, V96, P1437, DOI 10.1002/bjs.6777; Katai H, 2010, GASTRIC CANCER, V13, P238, DOI 10.1007/s10120-010-0565-0; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Huscher CGS, 2005, ANN SURG, V241, P232, DOI 10.1097/01.sla.0000151892.35922.f2; Garth AK, 2010, J HUM NUTR DIET, V23, P393, DOI 10.1111/j.1365-277X.2010.01058.x; Lujan JA, 1998, SURG LAPAROSC ENDOSC, V8, P208, DOI 10.1097/00019509-199806000-00009; Omran ML, 2000, NUTRITION, V16, P131, DOI 10.1016/S0899-9007(99)00251-8; Kunisaki C, 2006, AM J SURG, V191, P216, DOI 10.1016/j.amjsurg.2005.09.001; Hayashi H, 2005, SURG ENDOSC, V19, P1172, DOI 10.1007/s00464-04-8207-4; Orsenigo E, 2007, GASTRIC CANCER, V10, P39, DOI 10.1007/s10120-006-0409-0; Kim YW, 2008, ANN SURG, V248, P721, DOI 10.1097/SLA.0b013e318185e62e; Senagore AJ, 2003, ARCH SURG-CHICAGO, V138, P252, DOI 10.1001/archsurg.138.3.252; Bardram L, 2000, BRIT J SURG, V87, P1540, DOI 10.1046/j.1365-2168.2000.01559.x; Ichikawa D, 2010, HEPATO-GASTROENTEROL, V57, P975; Ichikawa Daisuke, 2009, Surg Laparosc Endosc Percutan Tech, V19, pe163, DOI 10.1097/SLE.0b013e3181b6c867; Ichikawa D, 2012, LANGENBECK ARCH SURG, V397, P57, DOI 10.1007/s00423-011-0840-5; Izaks GJ, 2003, J AM GERIATR SOC, V51, P1461, DOI 10.1046/j.1532-5415.2003.51467.x; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Kumagai K, 2014, GASTRIC CANCER, V17, P548, DOI 10.1007/s10120-013-0292-4; LESOURD B, 1995, NUTR REV, V53, pS86; Seiler WO, 2001, NUTRITION, V17, P496, DOI 10.1016/S0899-9007(01)00558-5; Stewart BT, 1999, BRIT J SURG, V86, P938, DOI 10.1046/j.1365-2168.1999.01160.x; Tekkis PP, 2003, BMJ-BRIT MED J, V326, P786, DOI 10.1136/bmj.326.7393.786; Yamada H, 2010, J SURG RES, V161, P259, DOI 10.1016/j.jss.2009.01.032; Yano H, 2001, Gastric Cancer, V4, P93, DOI 10.1007/PL00011730	45	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2191	2198				8	Oncology	Oncology	CF7JF	WOS:000352731600042		
J	Yamamoto, Y; Watanabe, K; Tsukiyama, I; Matsushita, H; Yabushita, H; Matsuura, K; Wakatsuki, A				Yamamoto, Yoshihiro; Watanabe, Kazushi; Tsukiyama, Ikuto; Matsushita, Hiroshi; Yabushita, Hiromitsu; Matsuura, Katsuhiko; Wakatsuki, Akihiko			Nephroprotective Effects of Hydration with Magnesium in Patients with Cervical Cancer Receiving Cisplatin	ANTICANCER RESEARCH			English	Article						cervical cancer; cisplatin; hydration; magnesium; nephrotoxicity	COMBINATION CHEMOTHERAPY; HYPOMAGNESEMIA; NEPHROTOXICITY; TOXICITY; THERAPY	Aim: The present study aimed to assess the efficacy of 15 mEq magnesium supplied as part of a prehydration regimen in preventing cisplatin-induced nephrotoxicity in patients undergoing therapy with cisplatin-alone (40 mg/m(2)/week) for cervical cancer. Patients and Methods: We studied 28 patients with cervical cancer. This prospective cohort study compared nephrotoxicity in patients who received hydration with and without magnesium sulfate (Mg-hydration group, n=14; non- Mg-hydration group, n=14). Results: Baseline characteristics, stage of cervical cancer, cisplatin dose and renal function did not differ significantly between the two groups. The serum creatinine level significantly increased from 0.58 to 0.75 mg/dl, and the estimated glomerular filtration rate significantly decreased from 85.1 to 66.5 ml/min by chemotherapy in the non-Mg-hydration group. In contrast, these levels did not change significantly in the Mg-hydration group. Conclusion: A magnesium dose of 15 mEq was found to provide nephroprotective effects among patients with cervical cancer undergoing chemotherapy with cisplatin alone.	[Yamamoto, Yoshihiro; Tsukiyama, Ikuto; Matsuura, Katsuhiko] Aichi Med Univ, Sch Med, Dept Pharm, Nagakute, Aichi 4801195, Japan; [Watanabe, Kazushi; Matsushita, Hiroshi; Yabushita, Hiromitsu; Wakatsuki, Akihiko] Aichi Med Univ, Sch Med, Dept Obstet & Gynecol, Nagakute, Aichi 4801195, Japan	Yamamoto, Y (reprint author), Aichi Med Univ, Sch Med, Dept Pharm, Nagakute, Aichi 4801195, Japan.	yamamo_0308@yahoo.co.jp					de Jongh FE, 2003, BRIT J CANCER, V88, P1199, DOI 10.1038/sj.bjc.6600884; Yokoo K, 2009, CLIN EXP NEPHROL, V13, P578, DOI 10.1007/s10157-009-0215-1; SAFIRSTEIN R, 1986, AM J KIDNEY DIS, V8, P356; Yonezawa A, 2005, BIOCHEM PHARMACOL, V70, P1823, DOI 10.1016/j.bcp.2005.09.020; Hodgkinson E, 2006, CLIN ONCOL-UK, V18, P710, DOI 10.1016/j.clon.2006.06.011; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; CVITKOVIC E, 1977, CANCER, V39, P1357, DOI 10.1002/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C; Gaffney DK, 2011, INT J RADIAT ONCOL, V81, P609, DOI 10.1016/j.ijrobp.2010.11.005; Monk BJ, 2007, J CLIN ONCOL, V25, P2952, DOI 10.1200/JCO.2007.10.8324; WACKER WEC, 1968, NEW ENGL J MED, V278, P658, DOI 10.1056/NEJM196803212781205; Bellomo R, 2004, CRIT CARE, V8, P204; Bodnar L, 2008, EUR J CANCER, V44, P2608, DOI 10.1016/j.ejca.2008.08.005; BUCKLEY JE, 1984, ARCH INTERN MED, V144, P2347, DOI 10.1001/archinte.144.12.2347; LAM M, 1986, AM J KIDNEY DIS, V8, P164; Ryu SY, 2011, INT J RADIAT ONCOL, V81, P577; SCHILSKY RL, 1979, ANN INTERN MED, V90, P929; WILLOX JC, 1986, BRIT J CANCER, V54, P19, DOI 10.1038/bjc.1986.147; WITTES RE, 1975, ONCOLOGY, V32, P202; Yoshida T, 2014, JPN J CLIN ONCOL, V44, P346, DOI 10.1093/jjco/hyu004	19	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2199	2204				6	Oncology	Oncology	CF7JF	WOS:000352731600043		
J	Matsui, D; Nagai, H; Mukozu, T; Ogino, Y; Sumino, Y				Matsui, Daigo; Nagai, Hidenari; Mukozu, Takanori; Ogino, Yu; Sumino, Yasukiyo			VEGF in Patients with Advanced Hepatocellular Carcinoma Receiving Intra-arterial Chemotherapy	ANTICANCER RESEARCH			English	Article						VEGF; advanced HCC; intra-arterial chemotherapy; liver cirrhosis	ENDOTHELIAL-GROWTH-FACTOR; ARTERIAL INFUSION CHEMOTHERAPY; LIVER-CIRRHOSIS; PROGNOSTIC-SIGNIFICANCE; CLINICAL-SIGNIFICANCE; TUMOR-MARKER; SERUM VEGF; EXPRESSION; 5-FLUOROURACIL; SORAFENIB	Aim: Vascular endothelial growth factor (VEGF) is a primary driving force for both physiological and pathological angiogenesis and over-expression of VEGF has been detected in hepatocellular carcinoma (HCC). The aim of the present study was to clarify the usefulness of VEGF for monitoring the response to intra-arterial chemotherapy in patients with HCC. Patients and Methods: Seventy-three patients with liver cirrhosis (LC) and advanced HCC (aHCC) received hepatic arterial infusion chemotherapy (HAIC: leucovorin (LV) at 12 mg/h, cisplatin (CDDP) at 10 mg/h and 5-fluorouracil (5-FU) at 250 mg/22 h) via the proper hepatic artery every 5 days for 4 weeks using a catheter connected to a subcutaneous drug delivery system. Results: i) Serum VEGF levels were higher in patients with progressive disease than those in patients with a partial response or stable disease. ii) VEGF levels were higher in patients with alcoholic LC than those in patients with hepatitis C-related or hepatitis B-related LC. iii) VEGF levels were higher in stage IVB patients than those in patients with stage III or IVA disease. iv) VEGF levels were significantly higher in patients with giant or confluent multinodular tumors than those in patients with multiple discrete nodules. v) Serum VEGF levels were higher in patients with vascular invasion than in patients without vascular invasion. Conclusion: Monitoring the serum VEGF level is useful for predicting the response of aHCC to HAIC, as well as for predicting metastasis, tumor type and vascular invasion.	[Matsui, Daigo; Nagai, Hidenari; Mukozu, Takanori; Ogino, Yu; Sumino, Yasukiyo] Toho Univ, Dept Internal Med Omori, Sch Med, Div Gastroenterol & Hepatol,Fac Med, Tokyo, Japan	Nagai, H (reprint author), Toho Univ, Dept Internal Med Omori, Sch Med, Div Gastroenterol & Hepatol,Fac Med,Ota Ku, 6-11-1 Omorinishi, Tokyo, Japan.	hidenari@aol.com					Mise M, 1996, HEPATOLOGY, V23, P455; UEDA K, 1992, HUM PATHOL, V23, P619, DOI 10.1016/0046-8177(92)90316-U; Pinter M, 2009, ONCOLOGIST, V14, P70, DOI 10.1634/theoncologist.2008-0191; El-Assal ON, 1998, HEPATOLOGY, V27, P1554, DOI 10.1002/hep.510270613; Shim JH, 2008, CANCER SCI, V99, P2037, DOI 10.1111/j.1349-7006.2008.00909.x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Moreno-Aspitia A, 2009, J CLIN ONCOL, V27, P11, DOI 10.1200/JCO.2007.15.5242; Yamaguchi R, 1998, HEPATOLOGY, V28, P68, DOI 10.1002/hep.510280111; Stroescu C, 2008, J GASTROINTEST LIVER, V17, P411; Poon RTP, 2004, ONCOL REP, V11, P1077; Miura H, 1997, J HEPATOL, V27, P854, DOI 10.1016/S0168-8278(97)80323-6; Poon RTP, 2001, ANN SURG, V233, P227, DOI 10.1097/00000658-200102000-00012; Chao Y, 2003, ANN SURG ONCOL, V10, P355, DOI 10.1245/ASO.2003.10.002; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; BROWN LF, 1992, KIDNEY INT, V42, P1457, DOI 10.1038/ki.1992.441; IWAMIYA T, 1994, CANCER CHEMOTH PHARM, V33, pS134, DOI 10.1007/BF00686685; Jin-no K, 1998, J GASTROENTEROL, V33, P376, DOI 10.1007/s005350050099; Kong SY, 2007, HEPATOLOGY, V46, P446, DOI 10.1002/hep.21720; Kudo Masatoshi, 2014, Liver Cancer, V3, P458, DOI 10.1159/000343875; Mukozu T, 2013, ANTICANCER RES, V33, P1013; Murata K, 2003, ANTICANCER RES, V23, P1719; Nagai H, 2010, CANCER CHEMOTH PHARM, V66, P1123, DOI 10.1007/s00280-010-1270-8; Nagai H, 2008, RECENT PAT ANTI-CANC, V3, P220, DOI 10.2174/157489208786242296; Nagai H, 2007, WORLD J GASTROENTERO, V13, P280; Okuda K, 1999, ONCOL REP, V6, P587; Semela D, 2005, SIGNALING PATHWAYS IN LIVER DISEASES, P91, DOI 10.1007/3-540-27194-5_8; TAKAYASU K, 1986, AM J ROENTGENOL, V147, P525; Terashima T, 2014, HEPATOL RES, V44, P1179, DOI 10.1111/hepr.12266; TOYODA H, 1995, ONCOLOGY, V52, P295; Yamane A, 1994, ONCOGENE, V9, P683	32	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2205	2210				6	Oncology	Oncology	CF7JF	WOS:000352731600044		
J	Kurokawa, Y; Hamakawa, T; Miyazaki, Y; Takahashi, T; Yamasaki, M; Miyata, H; Nakajima, K; Takiguchi, S; Mori, M; Doki, Y				Kurokawa, Yukinori; Hamakawa, Takuya; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Yamasaki, Makoto; Miyata, Hiroshi; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro			Preoperative Systemic and Intraperitoneal Chemotherapy Consisting of S-1, Cisplatin and Docetaxel in Patients with Marginally Resectable Gastric Cancer	ANTICANCER RESEARCH			English	Article						Gastric cancer; intraperitoneal chemotherapy; S-1; cisplatin; docetaxel; DCS	PHASE-II; NEOADJUVANT CHEMOTHERAPY; GASTRECTOMY; METASTASIS; DISSECTION; SURGERY; TRIAL	Background/Aim: S-1, cisplatin, and docetaxel (DCS) constitute an effective regimen for gastric cancer. We conducted a retrospective cohort study of systemic DCS and a prospective phase I trial of intraperitoneal DCS in the preoperative setting for marginally resectable gastric cancer. Patients and Methods: Under the systemic regimen, patients received cisplatin (60 mg/m(2)) plus docetaxel (40 mg/m(2)) intravenously on day 1 and S-1 (80 mg/m(2)) on days 1-14, of a 28-day cycle. With the intraperitoneal regimen, the schedule for S-1 and cisplatin was the same. Dose escalation for docetaxel started at 30 mg/m(2) (level 1). Results: Between August 2010 and July 2013, 26 consecutive patients were treated with the systemic regimen. Grade 3-4 neutropenia occurred in 81% but the toxicity profile was very tolerable. The response rate based on the Response Evaluation Criteria in Solid Tumors (RECIST) was 89%. Between April 2012 and April 2014, 5 patients with linitis plastica, large ulcero-invasive type tumors, positive washing cytology or peritoneal metastasis were enrolled in the phase I trial of the intraperitoneal regimen. Grade 3-4 elevations in aspartate/alanine aminotransferase (AST/ALT) occurred in the first 2 patients. The next 3 patients, who received docetaxel (20 mg/m(2)) on days 1 and 15 (level 0), had no dose-limiting toxicity. Four patients, including 3 with peritoneal metastasis and/or positive cytology before treatment, underwent R0 resection after intraperitoneal chemotherapy. Conclusion: Our studies revealed the efficacy of the systemic regimen and the safety of the intraperitoneal regimen. Further investigation of these two types of preoperative DCS chemotherapy is warranted.	[Kurokawa, Yukinori; Hamakawa, Takuya; Miyazaki, Yasuhiro; Takahashi, Tsuyoshi; Yamasaki, Makoto; Miyata, Hiroshi; Nakajima, Kiyokazu; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka 5650871, Japan	Kurokawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, 2-2-E2 Yamadaoka, Suita, Osaka 5650871, Japan.	ykurokawa@gesurg.med.osaka-u.ac.jp			Japanese Foundation for Multidisciplinary Treatment of Cancer	The study was funded in part by the Japanese Foundation for Multidisciplinary Treatment of Cancer.	Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Kinoshita T, 2009, GASTRIC CANCER, V12, P37, DOI 10.1007/s10120-008-0496-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Kikuchi S, 1998, HEPATO-GASTROENTEROL, V45, P1183; Tsuburaya A, 2014, BRIT J SURG, V101, P653, DOI 10.1002/bjs.9484; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Koizumi W, 2012, CANCER CHEMOTH PHARM, V69, P407, DOI 10.1007/s00280-011-1701-1; Iwasaki Y, 2013, J SURG ONCOL, V107, P741, DOI 10.1002/jso.23301; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Yoshikawa T, 2009, BRIT J SURG, V96, P1015, DOI 10.1002/bjs.6665; Sato Y, 2010, CANCER CHEMOTH PHARM, V66, P721, DOI 10.1007/s00280-009-1215-2; Fujiwara Y, 2011, ANN SURG ONCOL, V18, P3726, DOI 10.1245/s10434-011-1770-8; Fujiwara Y, 2012, J SURG ONCOL, V105, P38, DOI 10.1002/jso.22057; Fushida S, 2013, CANCER CHEMOTH PHARM, V71, P1265, DOI 10.1007/s00280-013-2122-0; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Cancer Association, 2001, GASTRIC CANCER, V4, P1, DOI DOI 10.1007/S101200100009]; KOGA S, 1980, AM J SURG, V140, P356, DOI 10.1016/0002-9610(80)90167-1; Kurokawa Y, BR J SURG IN PRESS; Sobin LH, 2009, TNM CLASSIFICATION M; Soma D, 2009, J SURG RES, V155, P142, DOI 10.1016/j.jss.2008.06.049	25	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2223	2228				6	Oncology	Oncology	CF7JF	WOS:000352731600047		
J	Nogami, Y; Banno, K; Irie, H; Iida, M; Masugi, Y; Murakami, K; Aoki, D				Nogami, Yuya; Banno, Kouji; Irie, Haruko; Iida, Miho; Masugi, Yohei; Murakami, Koji; Aoki, Daisuke			Efficacy of 18-FDG PET-CT Dual-phase Scanning for Detection of Lymph Node Metastasis in Gynecological Cancer	ANTICANCER RESEARCH			English	Article						Positron emission tomography; diagnostic imaging; lymphatic metastasis; gynecology; clinical oncology	ENDOMETRIAL CANCER; CERVICAL-CANCER; FDG-PET	Aim: This study investigated whether dual-phase scanning (DPS) with 18-fludeoxyglucose positron emission tomography -computed tomography (FDG PET-CT) improves diagnosis of lymph node metastasis (LNM) in gynecologic malignancies, compared to mono-phase scan ning (MPS). Patients and Methods: The study included 139 patients who underwent PET-CT followed by systemic lymph node dissection. PET-CT scans were obtained twice. The maximum standardized uptake value (SUVmax) was measured and the retention index (RI) was calculated as the % change from the early to the delayed scan. The optimal threshold of RI was determined using a receiver operating characteristic (ROC) curve. Diagnostic efficacies were calculated for MPS and DPS using pathological results. Results: In total, 1,879 regions were dissected. The optimal RI was 9%. The sensitivity, specificity and accuracy were 35.8%, 99.0% and 96.8% for MPS and 26.9%, 99.6% and 97.0% for DPS, respectively. Specificity was significantly improved by DPS and accuracy was also improved, but not significantly. Conclusion: DPS had an unsatisfactory impact on the diagnostic efficacy for LNM.	[Nogami, Yuya; Banno, Kouji; Irie, Haruko; Iida, Miho; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1608582, Japan; [Masugi, Yohei] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan; [Murakami, Koji] Keio Univ, Sch Med, Dept Radiol, Tokyo 1608582, Japan	Banno, K (reprint author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	kbanno@z7.keio.jp					Signorelli M, 2009, GYNECOL ONCOL, V115, P231, DOI 10.1016/j.ygyno.2009.07.020; Zhuang HM, 2001, J NUCL MED, V42, P1412; Kitajima K, 2008, AM J ROENTGENOL, V190, P1652, DOI 10.2214/AJR.07.3372; Lawrence WD, 2001, VIRCHOWS ARCH, V439, P601; Chung HH, 2008, GYNECOL OBSTET INVES, V67, P61, DOI 10.1159/000162101; Goyal BK, 2010, INT J GYNECOL CANCER, V20, P1041, DOI 10.1111/IGC.0b013e3181dcadeb; Hu M, 2011, CLIN NUCL MED, V36, P429, DOI 10.1097/RLU.0b013e3182173810; Ma SY, 2003, J NUCL MED, V44, P1775; Mochizuki Y, 2012, OR SURG OR MED OR PA, V113, P274, DOI 10.1016/j.tripleo.2011.08.022; Nogami Y, 2014, ANTICANCER RES, V34, P585; Nogami Y, 2015, JPN J CLIN ONCOL, V45, P26, DOI 10.1093/jjco/hyu161; Shen GH, 2015, ACTA RADIOL, V56, P681, DOI 10.1177/0284185114535210	12	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2247	2253				7	Oncology	Oncology	CF7JF	WOS:000352731600051		
J	Utsumi, H; Honma, Y; Nagashima, K; Iwasa, S; Takashima, A; Kato, K; Hamaguchi, T; Yamada, Y; Shimada, Y; Kishi, Y; Nara, S; Esaki, M; Shimada, K				Utsumi, Hirofumi; Honma, Yoshitaka; Nagashima, Kengo; Iwasa, Satoru; Takashima, Atsuo; Kato, Ken; Hamaguchi, Tetsuya; Yamada, Yasuhide; Shimada, Yasuhiro; Kishi, Yoji; Nara, Satoshi; Esaki, Minoru; Shimada, Kazuaki			Bevacizumab and Postoperative Wound Complications in Patients with Liver Metastases of Colorectal Cancer	ANTICANCER RESEARCH			English	Article						Bevacizumab; postoperative wound complications; liver metastases of colorectal cancer	OXALIPLATIN; RESECTION; IRINOTECAN; SURGERY; TRIAL; FLUOROURACIL; ANGIOGENESIS; LEUCOVORIN; MORBIDITY	Aim: The present study investigated whether bevacizumab (BV) is associated with postoperative wound complications (PWCs). Patients and Methods: We retrospectively analyzed patients undergoing surgery for liver metastases of colorectal cancer at our Institution. Patients were divided into 3 groups according to the preoperative treatment: chemotherapy with BV (group A), chemotherapy without BV (group B) and no chemotherapy (group C). Results: Between February 2003 and September 2012, 297 patients underwent 373 surgeries. Groups A, B and C consisted of 23, 62 and 288 patients, respectively. PWCs occurred in 29 patients (7.8%). In multivariate analysis, there were no differences in PWCs among the groups (C vs. B: P=0.739; C vs. A: P=0.110). Conversely, lower serum albumin levels (<3.5g/dl vs. >= 3.5g/dl: p=0.030) and synchronous colorectal resection (no vs. yes; p<0.001) remained significant risk factors of developing PWCs. Conclusion: Chemotherapy with or without BV did not influence the risk of PWCs.	[Utsumi, Hirofumi; Honma, Yoshitaka; Iwasa, Satoru; Takashima, Atsuo; Kato, Ken; Hamaguchi, Tetsuya; Yamada, Yasuhide; Shimada, Yasuhiro] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo 1040045, Japan; [Nagashima, Kengo] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; [Kishi, Yoji; Nara, Satoshi; Esaki, Minoru; Shimada, Kazuaki] Natl Canc Ctr, Hepatobiliary Pancreat Surg Div, Tokyo 1040045, Japan	Honma, Y (reprint author), Natl Canc Ctr, Gastrointestinal Med Oncol Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yohonma@ncc.go.jp	Nagashima, Kengo/I-1726-2013	Nagashima, Kengo/0000-0003-4529-9045			Gordon MS, 2001, J CLIN ONCOL, V19, P843; Kesmodel SB, 2008, J CLIN ONCOL, V26, P5254, DOI 10.1200/JCO.2008.17.7857; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Thornton AD, 2006, BRIT J SURG, V93, P1456, DOI 10.1002/bjs.5624; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Kozloff M, 2009, ONCOLOGIST, V14, P862, DOI 10.1634/theoncologist.2009-0071; Scappaticci FA, 2005, J SURG ONCOL, V91, P173, DOI 10.1002/jso.20301; Okines A, 2009, BRIT J CANCER, V101, P1033, DOI 10.1038/sj.bjc.6605259; Fuchs CS, 2007, J CLIN ONCOL, V25, P4779, DOI 10.1200/JCO.2007.11.3357; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; D'Angelica M, 2007, ANN SURG ONCOL, V14, P759, DOI 10.1245/s10434-006-9074-0; Gruenberger B, 2008, J CLIN ONCOL, V26, P1830, DOI 10.1200/JCO.2007.13.7679; Tamandl D, 2010, ANN SURG, V252, P124, DOI 10.1097/SLA.0b013e3181deb67f; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Reddy SK, 2008, J AM COLL SURGEONS, V206, P96, DOI 10.1016/j.jamcollsurg.2007.06.290; Ellis LM, 2005, J CLIN ONCOL, V23, P4853, DOI 10.1200/JCO.2005.23.754; van der Bilt JDW, 2004, BBA-REV CANCER, V1654, P95, DOI 10.1016/j.bbcan.2004.01.003; Van der Pool AEM, 2012, J SURG ONCOL, V106, P892, DOI 10.1002/jso.23142; Wicherts DA, 2011, BRIT J SURG, V98, P399, DOI 10.1002/bjs.7368	20	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2255	2261				7	Oncology	Oncology	CF7JF	WOS:000352731600052		
J	Nagai, H; Mukozu, T; Ogino, Y; Matsui, D; Matsui, T; Wakui, N; Momiyama, K; Igarashi, Y; Sumino, Y; Higai, K				Nagai, Hidenari; Mukozu, Takanori; Ogino, Yu; Matsui, Daigo; Matsui, Teppei; Wakui, Noritaka; Momiyama, Koichi; Igarashi, Yoshinori; Sumino, Yasukiyo; Higai, Koji			Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus	ANTICANCER RESEARCH			English	Article						HCC; sorafenib; hepatic arterial infusion chemotherapy; liver cirrhosis	APOPTOSIS-INDUCING LIGAND; INTRAARTERIAL CHEMOTHERAPY; NATURAL-HISTORY; LIVER-CIRRHOSIS; INTERFERON-ALPHA; CLINICAL-TRIALS; DRUG-DELIVERY; 5-FLUOROURACIL; CISPLATIN; EFFICACY	Background: Patients with advanced hepatocellular carcinoma (aHCC) and portal vein tumor thrombus (PVTT) still have a very poor prognosis, even though the oral multikinase inhibitor sorafenib has revolutionized treatment of aHCC in patients with liver cirrhosis (LC). Standardization of multimodal therapy for aHCC with PVTT has not yet been achieved. Aim: This retrospective study was performed to clarify the usefulness of combined treatment with sorafenib and hepatic arterial infusion chemotherapy (HAIC) for patients with LC, aHCC and PVTT. Patients and Methods: Twenty adult Japanese patients with LC underwent HAIC (HAIC group) between 2002 and 2009, while 18 patients received HAIC after treatment with sorafenib between 2009 and 2014 (SF-HAIC group). Results: Among patients with Child-Pugh class A disease, the median survival time of the SF-HAIC group (315 days) was significantly longer than that of the HAIC group (197 days), while there was no significant difference between the two groups (234 and 228 days) among patients with Child-Pugh class B disease. HAIC led to a partial response (PR) in 16.7% of patients with class A disease and 21.4% of patients with class B disease. With SF-HAIC, PR was obtained in 63.8% and 42.9% of patients respectively, although the PR rate was only 9.1% and 0.0%, respectively, after treatment with sorafenib alone for four weeks. Conclusion: When multimodal therapy is employed for patients with LC in Child-Pugh class A disease with aHCC and PVTT, performing HAIC after four weeks of sorafenib treatment might improve both the tumor response and patient survival.	[Nagai, Hidenari; Mukozu, Takanori; Ogino, Yu; Matsui, Daigo; Matsui, Teppei; Wakui, Noritaka; Momiyama, Koichi; Igarashi, Yoshinori; Sumino, Yasukiyo] Toho Univ, Dept Internal Med Omori, Div Gastroenterol & Hepatol, Sch Med,Fac Med,Ota Ku, Tokyo 1438541, Japan; [Higai, Koji] Toho Univ, Fac Pharmaceut Sci, Dept Med Biochem, Funabashi, Chiba 274, Japan	Nagai, H (reprint author), Toho Univ, Dept Internal Med Omori, Div Gastroenterol & Hepatol, Sch Med,Fac Med,Ota Ku, 6-11-1 Omorinishi, Tokyo 1438541, Japan.	hidenari@aol.com					Cabibbo G, 2010, HEPATOLOGY, V51, P1274, DOI 10.1002/hep.23485; Baish JW, 2000, CANCER RES, V60, P3683; Minagawa M, 2006, WORLD J GASTROENTERO, V12, P7561; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Moreno-Aspitia A, 2009, J CLIN ONCOL, V27, P11, DOI 10.1200/JCO.2007.15.5242; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Lee CG, 2000, CANCER RES, V60, P5565; Nagane M, 2000, CANCER RES, V60, P847; JAIN RK, 1994, SCI AM, V271, P58; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Shiraki K, 2005, INT J ONCOL, V26, P1273; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765; Obi S, 2006, CANCER, V106, P1990, DOI 10.1002/cncr.21832; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Tsuzuki Y, 2000, CANCER RES, V60, P6248; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Hansen-Algenstaedt N, 2000, CANCER RES, V60, P4556; Hayashi N, 1997, J GASTROEN HEPATOL, V12, pS223, DOI 10.1111/j.1440-1746.1997.tb00504.x; IWAMIYA T, 1994, CANCER CHEMOTH PHARM, V33, pS134, DOI 10.1007/BF00686685; Jodo S, 1998, CLIN EXP IMMUNOL, V112, P166; Kadambi A, 2001, CANCER RES, V61, P2404; Kudo M, 2010, DIG DIS, V29, P339; Matsui T, 2008, CANCER CHEMOTH PHARM, V62, P401, DOI 10.1007/s00280-007-0618-1; Momiyama K, 2009, CANCER CHEMOTH PHARM, V64, P271, DOI 10.1007/s00280-008-0866-8; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murata K, 2003, ANTICANCER RES, V23, P1719; Nagai H, 2008, CANCER CHEMOTH PHARM, V62, P271, DOI 10.1007/s00280-007-0602-9; Nagai H, 2008, RECENT PAT ANTI-CANC, V3, P220, DOI 10.2174/157489208786242296; Nagai H, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/607851; Nagai H, 2014, CANCER CHEMOTH PHARM, V73, P223, DOI 10.1007/s00280-013-2344-1; Nagai H, 2007, WORLD J GASTROENTERO, V13, P280; Nagai H, 2008, CANCER CHEMOTH PHARM, V62, P959, DOI 10.1007/s00280-008-0685-y; Nagano H, 2011, ONCOLOGY-BASEL, V80, P63, DOI 10.1159/000328281; NAGASUE N, 1984, CANCER, V54, P1461, DOI 10.1002/1097-0142(19841001)54:7<1461::AID-CNCR2820540740>3.0.CO;2-7; Okuda K, 1999, ONCOL REP, V6, P587; Schoniger-Hekele M, 2001, GUT, V48, P103, DOI 10.1136/gut.48.1.103; Seishima M, 1997, J HEPATOL, V27, P424, DOI 10.1016/S0168-8278(97)80191-2; TOYODA H, 1995, ONCOLOGY, V52, P295; Wenn J, 2000, BLOOD, V96, P3900; Yamasaki T, 2002, HEPATOL RES, V23, P7, DOI 10.1016/S1386-6346(01)00163-2	47	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2269	2277				9	Oncology	Oncology	CF7JF	WOS:000352731600054		
J	Ishigami, S; Arigami, T; Okumura, H; Uchikado, Y; Kita, Y; Kurahara, H; Maemura, K; Kijima, Y; Ishihara, Y; Sasaki, K; Uenosono, Y; Natsugoe, S				Ishigami, Sumiya; Arigami, Takaaki; Okumura, Hiroshi; Uchikado, Yasuto; Kita, Yoshiaki; Kurahara, Hiroshi; Maemura, Kosei; Kijima, Yuko; Ishihara, Yuka; Sasaki, Ken; Uenosono, Yoshikazu; Natsugoe, Shoji			Human Leukocyte Antigen (HLA)-E and HLA-F Expression in Gastric Cancer	ANTICANCER RESEARCH			English	Article						Gastric cancer; HLA-E; HLA-F; immuno suppression; postoperative outcome	TUMOR-CELLS; PROGNOSTIC-SIGNIFICANCE; E CONTRIBUTES; CARCINOMA; RECOGNITION; LYMPHOCYTES; INCREASES; MOLECULES; SURVIVAL; PROTEIN	Human leukocyte antigen (HLA)-E and HLA-F are classified as non-classical HLA class Ib antigens. Ectopic HLA-E and HLA-F expression was recently detected in cancer cells; however, the clinical implication of their expression remains unknown. A total of 209 patients with gastric cancer were enrolled in this study. Immunohistochemistry was used to evaluate the expression of HLA-E and HLA-F in gastric cancer specimens. HLA-E and HLA-F expression were seen in the cell membrane. HLA-E and HLA-F expression significantly correlated with depth of invasion, nodal involvement, lymphatic invasion, and venous invasion. No significant correlation between HLA-E and HLA-F expression was found (p<0.05, r=0.24). The five-year survival rate of the HLA-E-positive group and HLA-F-positive group were significantly poorer than that of their respective negative groups. Combination of HLA-E and HLA-F made the p-value smaller than single analysis (p<0.009). This is the first report detailing a clinical implication of HLA-E and HLA-F expression simultaneously in gastric cancer. We identified that the HLA-E and HLA-F in gastric cancer independently affected clinical factors, including postoperative outcome. For HLA-E- or HLA-F-positive gastric cancer, we should settle on a treatment strategy that reinforces the host immune response.	[Ishigami, Sumiya; Arigami, Takaaki; Okumura, Hiroshi; Uchikado, Yasuto; Kita, Yoshiaki; Kurahara, Hiroshi; Maemura, Kosei; Kijima, Yuko; Ishihara, Yuka; Sasaki, Ken; Uenosono, Yoshikazu; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg & Breast & Thyroid Surg, Kagoshima 8908520, Japan	Ishigami, S (reprint author), Kagoshima Univ, Sch Med, Dept Digest Surg & Breast & Thyroid Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	ishiga@m.kufm.kagoshima-u.ac.jp					Allard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021118; Lin AF, 2011, LUNG CANCER, V74, P504, DOI 10.1016/j.lungcan.2011.04.006; Lo Monaco E, 2011, NEOPLASIA, V13, P822, DOI 10.1593/neo.101684; Pietra G, 2009, CURR PHARM DESIGN, V15, P3336; de Kruijf EM, 2010, J IMMUNOL, V185, P7452, DOI 10.4049/jimmunol.1002629; Sano T, 2011, GASTRIC CANCER, V14, P97, DOI 10.1007/s10120-011-0040-6; Gooden M, 2011, P NATL ACAD SCI USA, V108, P10656, DOI 10.1073/pnas.1100354108; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; Arigami T, 2011, CANCER SCI, V102, P1019, DOI 10.1111/j.1349-7006.2011.01877.x; Sasako M, 2007, DIGEST SURG, V24, P101, DOI 10.1159/000101896; Wolpert F, 2012, J NEUROIMMUNOL, V250, P27, DOI 10.1016/j.jneuroim.2012.05.010; Kren L, 2011, NEUROPATHOLOGY, V31, P129, DOI 10.1111/j.1440-1789.2010.01149.x; Kang JS, 2009, CARCINOGENESIS, V30, P1987, DOI 10.1093/carcin/bgp158; Ishitani A, 2003, J IMMUNOL, V171, P1376; Kamikihara T, 2012, PATHOL INT, V62, P161, DOI 10.1111/j.1440-1827.2011.02774.x; Ishigami S, 2013, J SURG RES, V184, P802, DOI 10.1016/j.jss.2013.04.003; Jang BG, 2011, PATHOBIOLOGY, V78, P302, DOI 10.1159/000321703; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Benevolo M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-184; Bhalla A, 2006, REPRODUCTION, V131, P583, DOI 10.1530/rep.1.00892; Enqvist M, 2011, J IMMUNOL, V187, P3546, DOI 10.4049/jimmunol.1100610; Ishigami S, 2006, ANTICANCER RES, V26, P2467; Ishigami S, 2008, J SURG ONCOL, V97, P605, DOI 10.1002/jso.21029; Ishigami S, 2002, CANCER, V94, P1437, DOI 10.1002/cncr.10346; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kishimoto I, 2008, J SURG ONCOL, V98, P60, DOI 10.1002/jso.21087; Kren L, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-58; Marin R, 2003, IMMUNOGENETICS, V54, P767, DOI 10.1007/s00251-002-0526-9; Menier C, 2003, HUM IMMUNOL, V64, P315, DOI 10.1016/S0198-8859(02)00821-2; Shobu T, 2006, J REPROD IMMUNOL, V72, P18, DOI 10.1016/j.jri.2006.02.001; Spaans VM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-184; Szekeres-Bartho Julia, 2002, Int Rev Immunol, V21, P471, DOI 10.1080/08830180215017; Tahara E., 2004, IARC SCI PUBL, V157, P327; WEI XH, 1990, HUM IMMUNOL, V29, P131, DOI 10.1016/0198-8859(90)90076-2; Xiangming Che, 2000, Cancer, V89, P1214; Zhang J, 2012, IMMUNOGENETICS, V64, P251, DOI 10.1007/s00251-011-0580-2; Zhen ZJ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0482-2	37	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2279	2285				7	Oncology	Oncology	CF7JF	WOS:000352731600055		
J	Nishiwada, S; Sho, M; Yasuda, S; Shimada, K; Yamato, I; Akahori, T; Kinoshita, S; Nagai, M; Konishi, N; Nakajima, Y				Nishiwada, Satoshi; Sho, Masayuki; Yasuda, Satoshi; Shimada, Keiji; Yamato, Ichiro; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Konishi, Noboru; Nakajima, Yoshiyuki			Clinical Significance of CD155 Expression in Human Pancreatic Cancer	ANTICANCER RESEARCH			English	Article						CD155; prognostic factor; pancreatic cancer; tumor immunity; angiogenesis	SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; LUNG ADENOCARCINOMA; TUMOR-CELLS; PHASE-III; T-CELLS; RECEPTOR; ANGIOGENESIS; PROLIFERATION; GEMCITABINE	Background/Aim: CD155 is expressed in many types of human cells and has diverse functions. We herein evaluated the clinical importance of CD155 in pancreatic cancer. Materials and Methods: We investigated CD155 expression in 134 patients with pancreatic cancer, and evaluated the correlations of CD155 with prognosis, tumor immunity and angio genesis. Furthermore, CD155 functions were examined. Results: CD155 expression was abundant in pancreatic cancer tissues. Patients with high CD155 expression had poorer postoperative prognosis than those with low expression. Multivariate analysis indicated that CD155 expression had a significant independent prognostic value. Tumor CD155 expression inversely correlated with the presence of tumor-infiltrating lymphocytes. Furthermore, it significantly positively correlated with vascular endothelial growth factor expression and intra tumoral microvessel density. In addition, silencing of CD155 inhibited proliferation, and induced cell-cycle arrest at G2/M phase in pancreatic cancer cells. Conclusion: CD155 may play a critical role through both immunological and non-immuno logical mechanisms in pancreatic cancer and may be a therapeutic target for this intractable malignancy.	[Nishiwada, Satoshi; Sho, Masayuki; Yasuda, Satoshi; Yamato, Ichiro; Akahori, Takahiro; Kinoshita, Shoichi; Nagai, Minako; Nakajima, Yoshiyuki] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan; [Shimada, Keiji; Konishi, Noboru] Nara Med Univ, Dept Pathol, Kashihara, Nara 6348522, Japan	Sho, M (reprint author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	m-sho@naramed-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Daiwa Securities Health Foundation; Japanese Society of Gastroenterology; Takeda Science Foundation; Nakayama Cancer Research Institute	This work was supported by the following grants: Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Research Grant from Daiwa Securities Health Foundation; Research Grant from The Japanese Society of Gastroenterology; a research grant from Takeda Science Foundation; and Research Grant from Nakayama Cancer Research Institute (M. Sho).	Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Cho Y, 2003, CANCER RES, V63, P1555; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Yasuda S, 2013, CLIN EXP IMMUNOL, V172, P500, DOI 10.1111/cei.12069; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Ikeda N, 1999, BRIT J CANCER, V79, P1553, DOI 10.1038/sj.bjc.6690248; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Lee HE, 2008, BRIT J CANCER, V99, P1704, DOI 10.1038/sj.bjc.6604738; Carlsten M, 2009, J IMMUNOL, V183, P4921, DOI 10.4049/jimmunol.0901226; Enomoto K, 2012, CLIN EXP IMMUNOL, V168, P186, DOI 10.1111/j.1365-2249.2012.04565.x; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lozano E, 2012, J IMMUNOL, V188, P3869, DOI 10.4049/jimmunol.1103627; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Levin SD, 2011, EUR J IMMUNOL, V41, P902, DOI 10.1002/eji.201041136; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Sloan KE, 2005, CANCER RES, V65, P10930, DOI 10.1158/0008-5472.CAN-05-1890; Morimoto K, 2008, ONCOGENE, V27, P264, DOI 10.1038/sj.onc.1210645; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Atsumi S, 2013, ONCOL LETT, V5, P1771, DOI 10.3892/ol.2013.1280; Bevelacqua Valentina, 2012, Oncotarget, V3, P882; Escalante NK, 2011, ARTERIOSCL THROM VAS, V31, P1177, DOI 10.1161/ATVBAHA.111.224162; Ferrone CR, 2005, J CLIN ONCOL, V23, P7529, DOI 10.1200/JCO.2005.01.8101; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Kakunaga S, 2004, J BIOL CHEM, V279, P36419, DOI 10.1074/jbc.M406340200; Kinugasa M, 2012, CIRC RES, V110, P716, DOI 10.1161/CIRCRESAHA.111.256834; Kono T, 2008, INT J CANCER, V122, P317, DOI 10.1002/ijc.23080; Nakai R, 2010, CANCER SCI, V101, P1326, DOI 10.1111/j.1349-7006.2010.01530.x; Shimada K, 2006, HISTOL HISTOPATHOL, V21, P415; Sobin LH, 2010, INT UNION CANC UICC; Tane S, 2013, EXP MOL PATHOL, V94, P330, DOI 10.1016/j.yexmp.2012.12.003; Yamato I, 2012, CANCER RES, V72, P4829, DOI 10.1158/0008-5472.CAN-12-0328	53	1	1	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2287	2297				11	Oncology	Oncology	CF7JF	WOS:000352731600056		
J	Nishimura, S; Saeki, H; Nakanoko, T; Kasagi, Y; Tsuda, Y; Zaitsu, Y; Ando, K; Nakashima, Y; Imamura, Y; Ohgaki, K; Oki, E; Ohga, S; Nakamura, K; Morita, M; Maehara, Y				Nishimura, Sho; Saeki, Hiroshi; Nakanoko, Tomonori; Kasagi, Yuta; Tsuda, Yasuo; Zaitsu, Yoko; Ando, Koji; Nakashima, Yuichiro; Imamura, Yu; Ohgaki, Kippei; Oki, Eiji; Ohga, Saiji; Nakamura, Katsumasa; Morita, Masaru; Maehara, Yoshihiko			Hyperthermia Combined with Chemotherapy for Patients with Residual or Recurrent Oesophageal Cancer After Definitive Chemoradiotherapy	ANTICANCER RESEARCH			English	Article						Esophageal cancer; hyperthermia; definitive chemoradiotherapy; long-term survival	SQUAMOUS-CELL CARCINOMA; SURGICAL RESECTION; LOCAL FAILURE; RADIOTHERAPY; THERAPY; COMBINATION; DOCETAXEL; CISPLATIN; RADIATION; SURGERY	Background/Aim: Definitive chemoradiotherapy (dCRT) is frequently administered in oesophageal cancer. We carried out hyperthermochemotherapy (HCT) for residual or recurrent cases after dCRT for oesophageal cancer. The aim of this study was to elucidate the usefulness of salvage HCT for these patients. Patients and Methods: Salvage HCT after dCRT was performed in 11 patients with residual or recurrent oesophageal cancer. We used an 8-MHz radiofrequency capacitive heating system for hyperthermia. The combined chemotherapy comprised of cisplatin/5-fluorouracil, an oral fluoropyrimidine and irinotecan. Results: There were no severe adverse events caused by hyperthermia. Complete response and stable disease was achieved in three and five patients, respectively; symptoms were improved in the remaining three patients. The median survival time after HCT was 12 (range=3-88) months. Conclusion: HCT is a feasible and potent salvage therapy for patients with residual or recurrent oesophageal cancer after dCRT, unless salvage surgery is indicated.	[Nishimura, Sho; Saeki, Hiroshi; Nakanoko, Tomonori; Kasagi, Yuta; Tsuda, Yasuo; Zaitsu, Yoko; Ando, Koji; Nakashima, Yuichiro; Imamura, Yu; Ohgaki, Kippei; Oki, Eiji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan; [Ohga, Saiji; Nakamura, Katsumasa] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, Higashi Ku, Fukuoka 8128582, Japan; [Morita, Masaru] Kyushu Natl Canc Ctr, Dept Surg Gastroenterol, Higashi Ku, Fukuoka, Japan	Maehara, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	maehara@surg2.med.kyushu-u.ac.jp					Morita M, 2008, SURGERY, V143, P499, DOI 10.1016/j.surg.2007.12.007; Liu JY, 2012, ONCOL REP, V27, P791, DOI 10.3892/or.2011.1603; Kato H, 2009, JPN J CLIN ONCOL, V39, P638, DOI 10.1093/jjco/hyp069; Gwynne S, 2011, CLIN ONCOL-UK, V23, P182, DOI 10.1016/j.clon.2010.12.001; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Gardner-Thorpe J, 2007, BRIT J SURG, V94, P1059, DOI 10.1002/bjs.5865; Yano T, 2008, ENDOSCOPY, V40, P717, DOI 10.1055/s-2008-1077480; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; ABE M, 1986, CANCER, V58, P1589, DOI 10.1002/1097-0142(19861015)58:8<1589::AID-CNCR2820580802>3.0.CO;2-B; Wu PC, 2003, LANCET ONCOL, V4, P481, DOI 10.1016/S1470-2045(03)01167-7; Bergs JWJ, 2007, ONCOL REP, V18, P219; Chan A, 1999, INT J RADIAT ONCOL, V45, P265, DOI 10.1016/S0360-3016(99)00199-6; Eguchi R, 1999, Jpn J Thorac Cardiovasc Surg, V47, P552; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Hildebrandt B, 2007, Cancer Treat Res, V134, P185; Kitamura M, 1997, HEPATO-GASTROENTEROL, V44, P175; Kuwahara Akiko, 2010, Int J Med Sci, V7, P48; Kuwahara A, 2009, INT J MED SCI, V6, P305; LEE CK, 1995, INT J RADIAT ONCOL, V32, P733, DOI 10.1016/0360-3016(94)00608-N; Morita M, 2012, ANTICANCER RES, V32, P3275; Morita M, 2001, INT J RADIAT ONCOL, V49, P1259, DOI 10.1016/S0360-3016(00)01465-6; MULLER JM, 1990, BRIT J SURG, V77, P845, DOI 10.1002/bjs.1800770804; Ohga S, 2012, THERMAL MED, V28, P17; Saeki H, 1998, J SURG ONCOL, V69, P224; Sagowski C, 2002, EUR ARCH OTO-RHINO-L, V259, P27, DOI 10.1007/PL00007524; Shirakawa T, 2014, CANCER CHEMOTH PHARM, V74, P1207, DOI 10.1007/s00280-014-2597-3; Song ZB, 2014, ONCOTARGETS THER, V7, P1875, DOI 10.2147/OTT.S66525; Triantopoulou S, 2013, CLIN TRANSL ONCOL, V15, P95, DOI 10.1007/s12094-012-0947-3; Van Haaren PMA, 2008, INT J HYPERTHER, V24, P663, DOI 10.1080/02656730802210448	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2299	2303				5	Oncology	Oncology	CF7JF	WOS:000352731600057		
J	Koga, T; Hirayama, Y; Yoshiya, S; Taketani, K; Nakanoko, T; Yoshida, R; Minagawa, R; Kai, M; Kajiyama, K; Akahoshi, K; Maehara, Y				Koga, Tadashi; Hirayama, Yoshie; Yoshiya, Syohei; Taketani, Kenji; Nakanoko, Tomonori; Yoshida, Rintaro; Minagawa, Ryosuke; Kai, Masanori; Kajiyama, Kiyoshi; Akahoshi, Kazuya; Maehara, Yoshihiko			Necessity for Resection of Gastric Gastrointestinal Stromal Tumors <= 20 mm	ANTICANCER RESEARCH			English	Article						Gastric gastrointestinal stromal tumor; tumor size; post-operative sequelae	GASTRECTOMY; TRIAL	Background/Aim: To evaluate whether surgical intervention was useful in patients undergoing surgery for gastric gastrointestinal stromal tumors (GISTs), for tumors <= 20 mm in size. Patients and Methods: Between August 2002 and July 2014, 138 patients with GIST underwent surgery at our Hospital, including 112 patients with gastric GISTs. The medical records of these patients were retrospectively reviewed. Results: Postoperative recurrence was observed in three patients, each having tumors with high mitotic rates and >= 21 mm in size. In 89 patients undergoing gastric wedge resection, the incidence of postoperative complications was 10.1%; 5.6% of the patients developed late sequelae, all of which were mild. The group classified as having tumors >= 21 mm in size had a higher proportion of elderly patients (p=0.0010), more complications (p=0.0152), and longer hospital stay (p=0.0589). Conclusion: To prevent recurrence, definitive diagnosis and aggressive resection while the tumor size is 20 mm or less is recommended. However, because some patients also carry surgical risks, sufficient consideration must be given to the needs of individual patients.	[Koga, Tadashi; Hirayama, Yoshie; Yoshiya, Syohei; Taketani, Kenji; Nakanoko, Tomonori; Yoshida, Rintaro; Minagawa, Ryosuke; Kai, Masanori; Kajiyama, Kiyoshi] Iizuka Hosp, Dept Surg, Iizuka, Fukuoka 8208505, Japan; [Akahoshi, Kazuya] Iizuka Hosp, Dept Gastroenterol, Iizuka, Fukuoka 8208505, Japan; [Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Koga, T (reprint author), Iizuka Hosp, Dept Surg, 3-83 Yoshio Town, Iizuka, Fukuoka 8208505, Japan.	tkogah1@aih-net.com					Akahoshi Kazuya, 2010, World J Gastrointest Endosc, V2, P271, DOI 10.4253/wjge.v2.i8.271; Sakamoto Y, 2012, SURG TODAY, V42, P708, DOI 10.1007/s00595-012-0121-0; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Akahoshi K, 2007, WORLD J GASTROENTERO, V13, P2077; Corless CL, 2014, J CLIN ONCOL, V32, P1563, DOI 10.1200/JCO.2013.51.2046; [Anonymous], 2014, JAP CLIN PRACT GUID; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Loffeld RJLF, 2000, CAN J GASTROENTEROL, V14, P681; Miyazaki Y, 2013, EUR J CANCER, V49, P2681, DOI 10.1016/j.ejca.2013.04.006; Terashima M, 2014, ANN SURG ONCOL, V21, P370, DOI 10.1245/s10434-014-3583-z	12	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2341	2344				4	Oncology	Oncology	CF7JF	WOS:000352731600063		
J	Sakamoto, Y; Miyamoto, Y; Beppu, T; Nitta, H; Imai, K; Hayashi, H; Baba, Y; Yoshida, N; Chikamoto, A; Baba, H				Sakamoto, Yasuo; Miyamoto, Yuji; Beppu, Toru; Nitta, Hidetoshi; Imai, Katsunori; Hayashi, Hiromitsu; Baba, Yoshifumi; Yoshida, Naoya; Chikamoto, Akira; Baba, Hideo			Post-chemotherapeutic CEA and CA19-9 Are Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Hepatic Resection After Oxaliplatin-based Chemotherapy	ANTICANCER RESEARCH			English	Article						Colorectal cancer; colorectal liver metastasis; hepatectomy; chemotherapy	CARBOHYDRATE ANTIGEN 19-9; CANCER PATIENTS; CARCINOEMBRYONIC ANTIGEN; SURGICAL RESECTION; SERUM; RECURRENCE; SURVIVAL; TRIAL; VALIDATION; SURGERY	Background/Aim: The prognostic value of tumor markers remains unclear in patients with colorectal liver metastases (CRLM) who undergo hepatectomy following chemotherapy. The aim of the present study was to identify prognostic factors associated with recurrence and survival in such patients. Patients and Methods: Between 2005 and 2012, 62 patients with initially unresectable or marginally unresectable CRLM who underwent hepatectomy following chemotherapy were enrolled. A Cox proportional hazards model was used to identify the prognostic factors. Results: Multivariate analysis indicated that a high level of carbohydrate antigen 19-9 (CA19-9) in serum post-chemo therapy was significant factor, predictive of poor overall survival [Hazard Ratio (HR)=4.46, 95% Confidence Interval (CI)=1.68-11.8; p=0.003] and marginally significant regarding poorer relapse-free survival (HR=2.11, 95% CI=0.99-4.47; p=0.050). Non-response to preoperative chemotherapy was a significant prognostic factor regarding shorter relapse-free (HR=2.18, 95% CI=1.10-4.33; p=0.026) and overall survival (HR=3.14, 95% CI=1.22-8.08; p=0.018). High levels of carcinoembryonic antigen CEA in serum post-chemotherapy (HR=3.08, 95% CI=1.13-8.39; p=0.028) and the absence of adjuvant chemotherapy (HR=2.27, 95% CI=1.17-4.41; p=0.016) were independent risk factors for recurrence. Conclusion: Measurement of both CEA and CA19-9 level is strongly recommended for patients with CRLM treated with preoperative chemotherapy followed by hepatectomy because normalization of serum CEA and CA19-9 levels after chemotherapy will demonstrate a good prognosis after curative hepatectomy.	[Sakamoto, Yasuo; Miyamoto, Yuji; Beppu, Toru; Nitta, Hidetoshi; Imai, Katsunori; Hayashi, Hiromitsu; Baba, Yoshifumi; Yoshida, Naoya; Chikamoto, Akira; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Sakamoto, Yasuo; Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Mitry E, 2008, J CLIN ONCOL, V26, P4906, DOI 10.1200/JCO.2008.17.3781; Adam R, 2007, J CLIN ONCOL, V25, P4593, DOI 10.1200/JCO.2007.10.8126; Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Ohtsuka M, 2002, BRIT J SURG, V89, P1525, DOI 10.1046/j.1365-2168.2002.02268.x; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Kanemitsu Y, 2009, JPN J CLIN ONCOL, V39, P406, DOI 10.1093/jjco/hyp035; Inoue Y, 2012, J GASTROINTEST SURG, V16, P1171, DOI 10.1007/s11605-012-1840-7; Humphris JL, 2012, ANN ONCOL, V23, P1713, DOI 10.1093/annonc/mdr561; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Schindl M, 2005, ARCH SURG-CHICAGO, V140, P183, DOI 10.1001/archsurg.140.2.183; Sorbye H, 2012, ANN SURG, V255, P534, DOI 10.1097/SLA.0b013e3182456aa2; Minagawa M, 2007, ARCH SURG-CHICAGO, V142, P269, DOI 10.1001/archsurg.142.3.269; Mitsuyama Y, 2012, ONCOL LETT, V3, P767, DOI 10.3892/ol.2012.574; Nakagoe T, 2002, J CLIN GASTROENTEROL, V34, P408, DOI 10.1097/00004836-200204000-00005; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R; Park IJ, 2009, ANTICANCER RES, V29, P4303; Bogaerts J, 2009, EUR J CANCER, V45, P248, DOI 10.1016/j.ejca.2008.10.027; Beppu T, 2010, ANTICANCER RES, V30, P1015; Beppu Toru, 2014, Ann Surg Oncol, V21 Suppl 3, pS405, DOI 10.1245/s10434-014-3577-x; Beppu T, 2012, J HEPATO-BIL-PAN SCI, V19, P72, DOI 10.1007/s00534-011-0460-z; Ishiguro Shingo, 2011, Nihon Rinsho, V69 Suppl 3, P325; Ishizuka D, 2001, INT J COLORECTAL DIS, V16, P32, DOI 10.1007/s003840000268; Katoh H, 2008, WORLD J SURG, V32, P1130, DOI 10.1007/s00268-008-9535-7; Mima K, 2013, INT J CLIN ONCOL, V18, P847, DOI 10.1007/s10147-012-0471-z; Nakayama T, 1997, J SURG ONCOL, V66, P238; Sakamoto Y, 2013, J HEPATO-BIL-PAN SCI, V20, P307, DOI 10.1007/s00534-012-0523-9; Zhang S, 2010, COLORECTAL DIS, V12, P754, DOI 10.1111/j.1463-1318.2009.01911.x	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2359	2368				10	Oncology	Oncology	CF7JF	WOS:000352731600066		
J	Aoyagi, T; Morii, T; Tajima, T; Yoshiyama, A; Ichimura, S				Aoyagi, Takayuki; Morii, Takeshi; Tajima, Takashi; Yoshiyama, Akira; Ichimura, Shoichi			Analysis of the Risk Factors for Febrile Neutropenia in Patients with Bone and Soft Tissue Sarcoma	ANTICANCER RESEARCH			English	Article						Febrile neutropenia; bone and soft tissue sarcoma; chemotherapy	CLINICAL-PRACTICE GUIDELINE; NON-HODGKINS-LYMPHOMA; CANCER-PATIENTS; ONCOLOGY GROUP; ANTIMICROBIAL AGENTS; SOLID TUMORS; 2010 UPDATE; PHASE-II; CHEMOTHERAPY; IFOSFAMIDE	Background: Although systemic chemotherapy is inevitably selected as the modality of treatment for high-grade bone and soft tissue sarcoma (BSTS), limited information is available regarding febrile neutropenia (FN). Patients and Methods: FN incidence, blood culture results and risk factors were analyzed in 35 patients with high-grade BSTS. Results: FN occurred in 51% of the patients and 24% of the courses of systemic chemotherapy. Culture results indicated pathogen in only 33.3% of patients who had FN. Methicillin-resistant Staphylococcus epidermidis and methicillin-resistant Staphylococcus aureus were frequently observed. Body weight of less than 61.0 kg and a tumor originating from the bone in a patient-based analysis, and serum albumin <4.2 g/dl and having a source of infection in a course-based analysis were independent risk factors for FN. Conclusion: Considerably high risks for FN during chemotherapy for BSTS were confirmed. The risk factors presented here appeared to differ from those in previously reported guidelines.	[Aoyagi, Takayuki; Morii, Takeshi; Tajima, Takashi; Yoshiyama, Akira; Ichimura, Shoichi] Kyorin Univ, Fac Med, Dept Orthoped Surg, Mitaka, Tokyo 1818611, Japan	Morii, T (reprint author), Kyorin Univ, Fac Med, Dept Orthopaed Surg, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	t-morii@gb3.so-net.ne.jp			Ministry of Health, Labour and Welfare [H26-084]	This investigation was supported by the Health and Labour Sciences Research Expenses for Commission, Applied Research for Innovative Treatment of Cancer from the Ministry of Health, Labour and Welfare (H26-084).	Kuderer NM, 2006, CANCER, V106, P2258, DOI 10.1002/cncr.21847; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; von Minckwitz G, 2009, EUR J CANCER, V45, P608, DOI 10.1016/j.ejca.2008.11.021; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Hosmer W, 2011, SUPPORT CARE CANCER, V19, P333, DOI 10.1007/s00520-010-0821-1; Klastersky J, 2000, J CLIN ONCOL, V18, P3038; Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Altaf S, 2013, PEDIATR BLOOD CANCER, V60, P2042, DOI 10.1002/pbc.24580; Lyman GH, 2004, J CLIN ONCOL, V22, P4302, DOI 10.1200/JCO.2004.03.213; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Iwamoto Y, 2009, J ORTHOP SCI, V14, P397, DOI 10.1007/s00776-009-1347-6; Crawford J, 2004, CANCER, V100, P228, DOI 10.1002/cncr.11882; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Iwamoto Y, 2012, JPN J CLIN ONCOL, V42, P467, DOI 10.1093/jjco/hys059; Ray-Coquard I, 2003, BRIT J CANCER, V88, P181, DOI 10.1038/sj.bjc.6600724; Bacci G, 2002, J CHEMOTHERAPY, V14, P198; Badalamenti G, 2013, ANTICANCER RES, V33, P679; Borinstein SC, 2009, PEDIATR BLOOD CANCER, V53, P375, DOI 10.1002/pbc.22086; Chrischilles Elizabeth, 2002, Cancer Control, V9, P203; Cooper KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-404; Intragumtornchai T, 2000, LEUKEMIA LYMPHOMA, V37, P351; Kalofonos Haralabos P., 2004, Sarcoma, V8, P129, DOI 10.1080/13577140400016705; Lewin Jeremy, 2013, Clin Sarcoma Res, V3, P15, DOI 10.1186/2045-3329-3-15; Lopez Pousa A, 2006, SARCOMA, V2006, P26986; Schmitt T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-510; Takamatsu Y, 2013, JPN J CANC CHEMOTHER, V406, P697; Tanaka K, 2009, JPN J CLIN ONCOL, V39, P271, DOI 10.1093/jjco/hyn153; Voog E, 2000, J CLIN ONCOL, V18, P325	29	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2375	2383				9	Oncology	Oncology	CF7JF	WOS:000352731600068		
J	Kimura, K; Itoh, Y; Okada, T; Nakahara, R; Kawamura, M; Kubota, S; Itoh, J; Hiramatsu, M; Fujimoto, Y; Shibata, T; Naganawa, S				Kimura, Kana; Itoh, Yoshiyuki; Okada, Tohru; Nakahara, Rie; Kawamura, Mariko; Kubota, Seiji; Itoh, Junji; Hiramatsu, Mariko; Fujimoto, Yasushi; Shibata, Takashi; Naganawa, Shinji			Critical Evaluation of a Prospective Study of Concurrent Chemoradiotherapy with S-1 for Early Glottic Carcinoma	ANTICANCER RESEARCH			English	Article						Head and neck cancer; S-1; early glottic cancer; concurrent chemoradiotherapy; phase I/II study; prospective study; recommend-dose; radiosentitizer	SQUAMOUS-CELL CARCINOMA; FLUOROPYRIMIDINE ANTICANCER AGENT; RADIATION-THERAPY; PHASE-I; RETROSPECTIVE ANALYSIS; LARYNGEAL-CANCER; LOCAL-CONTROL; RADIOTHERAPY; TRIAL; 5-FLUOROURACIL	Aim: To improve the outcomes of radiotherapy alone for T2 glottic carcinoma (GC), we initiated a prospective study of concurrent chemoradiotherapy with S-1 for patients with early GC, primarily T2 cases. We report the efficacy and safety of this protocol. Patients and Methods: Eligible patients had T1b or T2 glottic squamous cell carcinomas. Patients received S-1 (55.3 mg/m(2)/day, once daily) and radiotherapy (2 Gy/day, five days/week, to a total of 30 fractions). Results: Thirteen patients were eligible. Complete responses were observed in all 13 patients (100%). At a median follow-up duration of 53 months (range=23-68 months), the 3-year local control and overall survival rates were both 100%. Grade 3 dermatitis occurred in only one patient. Conclusion: This chemoradiotherapy protocol is well -tolerated and effective in patients with early glottic carcinoma. Furthermore, due to its once-daily administration, this protocol is considered to be easier than usual chemoradiotherapy, and makes outpatient-treatment possible.	[Kimura, Kana; Itoh, Yoshiyuki; Okada, Tohru; Nakahara, Rie; Kawamura, Mariko; Kubota, Seiji; Itoh, Junji; Naganawa, Shinji] Nagoya Univ, Grad Sch Med, Dept Radiol, Nagoya, Aichi 4668550, Japan; [Hiramatsu, Mariko; Fujimoto, Yasushi] Nagoya Univ, Grad Sch Med, Dept Otorhinolaryngol, Nagoya, Aichi 4668550, Japan; [Shibata, Takashi] Nagoya Univ, Grad Sch Med, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi 4668550, Japan	Kimura, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Radiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nishicherry@med.nagoya-u.ac.jp	Naganawa, Shinji/I-1572-2012	Naganawa, Shinji/0000-0002-0214-613X			Akimoto T, 2006, INT J RADIAT ONCOL, V64, P995, DOI 10.1016/j.ijrobp.2005.10.003; Garden AS, 2003, INT J RADIAT ONCOL, V55, P322, DOI 10.1016/S0360-3016(02)03938-X; Sakata KI, 2011, CANCER SCI, V102, P1712, DOI 10.1111/j.1349-7006.2011.02004.x; Sakata Y, 1998, EUR J CANCER, V34, P1715, DOI 10.1016/S0959-8049(98)00211-1; Pfister DG, 2006, J CLIN ONCOL, V24, P3693, DOI 10.1200/JCD.2006.07.4559; Lawrence TS, 2003, SEMIN RADIAT ONCOL, V13, P13, DOI 10.1053/srao.2003.50002; Mendenhall WM, 2004, CANCER, V100, P1786, DOI 10.1002/cncr.20181; Frata P, 2005, INT J RADIAT ONCOL, V63, P1387, DOI 10.1016/j.ijrobp.2005.05.013; Ohnishi K, 2011, J RADIAT RES, V52, P47, DOI 10.1269/jrr.10081; Trotti A, 2014, INT J RADIAT ONCOL, V89, P958, DOI 10.1016/j.ijrobp.2014.04.041; BYFIELD JE, 1982, INT J RADIAT ONCOL, V8, P1923; Fujimoto Y, 2014, ANTICANCER RES, V34, P209; Fukushima M, 2010, OPTIM METHOD SOFTW, V25, P1, DOI 10.1080/10556780903312936; Groeningen CJ, 2000, J CLIN ONCOL, V18, P2772; Harada K, 2005, CANCER LETT, V226, P161, DOI 10.1016/j.canlet.2004.12.048; Harada K, 2004, ORAL ONCOL, V40, P713, DOI 10.1016/j.oraloncology.2004.01.013; Hino S, 2011, ONCOL LETT, V2, P839, DOI 10.3892/ol.2011.347; Hirasawa N, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-20; Ikeda M, 2007, BRIT J CANCER, V96, P1650, DOI 10.1038/sj.bjc.6603788; Ikeda Y, 2008, JPN J CANC CHEMOTHER, V35, P789; International Union against Cancer, 2002, TNM CLASSIFICATION M; Itoh Yoshiyuki, 2006, Radiat Med, V24, P277, DOI 10.1007/s11604-005-1517-1; Mendenhall WM, 2013, PEREZ BRADYS PRINCIP, P850; Nakayama M, 2010, JPN J CLIN ONCOL, V40, P921, DOI 10.1093/jjco/hyq077; National Cancer Institute at the National Institutes of Health, 2014, LAR CANC TREATM PDQ; Niibe Y, 2007, ANTICANCER RES, V27, P3497; Nishimura G, 2009, ANTICANCER RES, V29, P661; Nonoshita T, 2010, J RADIAT RES, V51, P481, DOI 10.1269/jrr.09134; Reddy SP, 2007, INT J RADIAT ONCOL, V69, P1389, DOI 10.1016/j.ijrobp.2007.05.077; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Taguchi T, 1997, JPN J CANC CHEMOTHER, V24, P2253; Tsuji H, 2006, ONCOLOGY-BASEL, V71, P369, DOI 10.1159/000108385; Ueno H, 2004, BRIT J CANCER, V91, P1769, DOI 10.1038/sj.bjc.6602208; Zeng LH, 2008, CANCER SCI, V99, P2327, DOI 10.1111/j.1349-7006.2008.00943.x	34	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2385	2390				6	Oncology	Oncology	CF7JF	WOS:000352731600069		
J	Aoyama, T; Murakawa, M; Katayama, Y; Yamaoku, K; Kanazawa, A; Higuchi, A; Shiozawa, M; Morimoto, M; Yoshikawa, T; Yamamoto, N; Rino, Y; Masuda, M; Morinaga, S				Aoyama, Toru; Murakawa, Masaaki; Katayama, Yusuke; Yamaoku, Koichiro; Kanazawa, Amane; Higuchi, Akio; Shiozawa, Manabu; Morimoto, Manabu; Yoshikawa, Takaki; Yamamoto, Naoto; Rino, Yasushi; Masuda, Munetaka; Morinaga, Soichiro			Impact of Postoperative Complications on Survival and Recurrence in Pancreatic Cancer	ANTICANCER RESEARCH			English	Article						Pancreatic cancer; surgical complication; survival; recurrence	RANDOMIZED CONTROLLED-TRIAL; LONG-TERM SURVIVAL; COLORECTAL-CANCER; INFECTIOUS COMPLICATIONS; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; HEAD RESECTION; PANCREATICODUODENECTOMY; ADENOCARCINOMA; GEMCITABINE	Background: We investigated the impact of postoperative complications on survival and recurrence after curative surgery for pancreatic cancer. Patients and Methods: This study included 164 patients who underwent curative surgery for pancreatic cancer between 2005 and 2014. The patients were classified into those with post operative complications (C group) and those without postoperative complications (NC group). The risk factors for overall survival (OS) and recurrence-free survival (RFS) were identified. Results: Postoperative complications were found in 61 out of the 164 patients (37.2%). The RFS rate at five years after surgery was 10.6% in the C group and 21.0% in the NC group. The RFS tended to be worse in the C group than in the NC group (p=0.1756). The OS rate at five years after surgery was 7.4% in the C group and 22.8% in the NC group, which was significantly different (p=0.0189). The multivariate analysis demonstrated that the occurrence of postoperative complications was a significant independent risk factor for OS and a marginally significant risk factor for RFS. Conclusion: The development of postoperative complications was a risk factor for a decreased overall survival in the patients who underwent curative surgery for pancreatic cancer. The surgical procedure, perioperative care and the surgical strategy should be carefully planned to avoid complications.	[Aoyama, Toru; Murakawa, Masaaki; Katayama, Yusuke; Yamaoku, Koichiro; Kanazawa, Amane; Higuchi, Akio; Shiozawa, Manabu; Yoshikawa, Takaki; Morinaga, Soichiro] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2418515, Japan; [Morimoto, Manabu] Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2418515, Japan; [Yamamoto, Naoto; Rino, Yasushi; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan	Aoyama, T (reprint author), Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	aoyamat@kcch.jp			Kanagawa Prefectural Hospitals Cancer Fund; Yokohama Foundation for Advancement of Medical Science	The Authors are grateful to Professor Yamanaka and Dr Oba of the Department of Biostatistics and Epidemiology, Yokohama City University, for their kind support for the statistical consideration and advice. This work was supported, in part, by the Kanagawa Prefectural Hospitals Cancer Fund and Yokohama Foundation for Advancement of Medical Science.	Merkow RP, 2014, ANN SURG, V260, P372, DOI 10.1097/SLA.0000000000000378; Kamphues C, 2012, ANN SURG ONCOL, V19, P856, DOI 10.1245/s10434-011-2041-4; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Seiler CA, 2000, J GASTROINTEST SURG, V4, P443, DOI 10.1016/S1091-255X(00)80084-0; Petermann D, 2013, WORLD J SURG, V37, P1901, DOI 10.1007/s00268-013-2023-8; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Tsujimoto H, 2009, ANN SURG ONCOL, V16, P311, DOI 10.1245/s10434-008-0249-8; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/01.SLA.0000027272.08464.0B; Kawai M, 2006, ANN SURG, V244, P1, DOI 10.1097/01.sla.0000218077.14035.a6; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; McArdle CS, 2005, BRIT J SURG, V92, P1150, DOI 10.1002/bjs.5054; Buchler MW, 2000, BRIT J SURG, V87, P883, DOI 10.1046/j.1365-2168.2000.01465.x; Lagarde SM, 2008, ANN SURG, V247, P71, DOI 10.1097/SLA.0b013e31815b695e; Andren-Sandberg A, 1999, DIGEST SURG, V16, P305, DOI 10.1159/000018740; Goldfarb Y, 2011, ANN SURG, V253, P798, DOI 10.1097/SLA.0b013e318211d7b5; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701; Povoski SP, 1999, ANN SURG, V230, P131, DOI 10.1097/00000658-199908000-00001; Bonadonna G, 1981, NEW ENGL J MED, V304, P101; Burris HA, 1997, J CLIN ONCOL, V15, P2403; Hayashi T, 2014, GASTRIC CANCER, V18, P368; INOUE D, 2014, JPN J CLIN ONCOL, V45, P61; Miki C, 2008, SURG TODAY, V38, P579, DOI 10.1007/s00595-007-3674-6; Munoz-Bongrand N, 2004, J AM COLL SURGEONS, V199, P198, DOI 10.1016/j.jamcollsurg.2004.03.015; Mynster T, 2000, BRIT J SURG, V87, P1553, DOI 10.1046/j.1365-2168.2000.01570.x; Nakao A, 2006, WORLD J GASTROENTERO, V12, P4466; Sobin LH, 2009, TNM CLASSIFICATION M; Tokunaga M, 2013, ANN SURG ONCOL, V20, P1575, DOI 10.1245/s10434-012-2720-9; Uesaka K, 2013, J CLIN ONCOL S4, V31; Wagner M, 2001, DIGEST SURG, V18, P188, DOI 10.1159/000050128	30	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2401	2409				9	Oncology	Oncology	CF7JF	WOS:000352731600071		
J	Kuranami, S; Yokobori, T; Mogi, A; Altan, B; Yajima, T; Onozato, R; Azuma, Y; Iijima, M; Kosaka, T; Kuwano, H				Kuranami, Satoshi; Yokobori, Takehiko; Mogi, Akira; Altan, Bolag; Yajima, Toshiki; Onozato, Ryoichi; Azuma, Yoko; Iijima, Misaki; Kosaka, Takayuki; Kuwano, Hiroyuki			Src Kinase-associated Phosphoprotein2 Expression Is Associated with Poor Prognosis in Non-small Cell Lung Cancer	ANTICANCER RESEARCH			English	Article						SKAP2; lung cancer; actin assembly; Src	IN-VIVO; CHROMOSOMAL-ABERRATIONS; SKAP-HOM; ACTIN; ADENOCARCINOMA; ADAPTER	Background/Aim: Non-small cell lung cancer (NSCLC) is among the leading causes of cancer-related deaths world wide. In certain human cancer types, Src is associated with cancer progression and refractory cancer. To improve the prognoses of NSCLC patients, we evaluated Src kinase-associated phosphoprotein 2 (SKAP2), a factor associated with integrin-stimulated cytoskeletal rearrangement, as a new therapeutic target. Materials and Methods: We performed immunohistochemistry for SKAP2 in 99 NSCLC samples and evaluated the relationship between SKAP2 expression, clinicopathological factors and prognosis. Results: Higher SKAP2 expression was detected in cancerous tissues and was predominantly expressed in the cytoplasm. Elevated SKAP2 expression levels were associated with poor prognosis (p=0.007) and shorter survival time after recurrence (p=0.035). High SKAP2 expression was an independent prognostic factor in NSCLC patients (p=0.027). Conclusion: High SKAP2 expression levels in NSCLC tissues could be a powerful biomarker of poor prognosis. Therefore, SKAP2 is a promising candidate molecular target for NSCLC treatment.	[Kuranami, Satoshi; Yokobori, Takehiko; Mogi, Akira; Altan, Bolag; Yajima, Toshiki; Onozato, Ryoichi; Azuma, Yoko; Iijima, Misaki; Kosaka, Takayuki; Kuwano, Hiroyuki] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gumma 3718511, Japan	Yokobori, T (reprint author), Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	bori45@gunmau.ac.jp			Japan Society for the Promotion of Science (JSPS) [21591690, 22591450, 23591857]	We thank Ms. Yukie Saito, Ms. Tomoko Yano, Ms. Yuka Matsui, Ms. Ayaka Ishida and Ms. Ayaka Ishikubo for their assistance. This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), grant numbers 21591690, 22591450 and 23591857.	Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Alas S, 2001, CLIN CANCER RES, V7, P709; Sung WW, 2013, CLIN CANCER RES, V19, P4092, DOI 10.1158/1078-0432.CCR-12-3439; Rolan HG, 2013, CELL HOST MICROBE, V14, P306, DOI 10.1016/j.chom.2013.08.013; Berger W, 1999, INT J CANCER, V83, P415, DOI 10.1002/(SICI)1097-0215(19991029)83:3<415::AID-IJC19>3.0.CO;2-Y; Ferlay J, 2010, Eur J Cancer, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ayoub E, 2013, J BIOL CHEM, V288, P25739, DOI 10.1074/jbc.M113.501007; Bourette RP, 2005, CELL SIGNAL, V17, P941, DOI 10.1016/j.cellsig.2004.11.009; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Reinhold A, 2009, J LEUKOCYTE BIOL, V86, P61, DOI [10.1189/jlb.0608344, 10.1189/JLB.0608344]; Robinson KW, 2013, ONCOLOGIST, V18, P115, DOI 10.1634/theoncologist.2012-0262; Shimamura S, 2013, J BIOL CHEM, V288, P1171, DOI 10.1074/jbc.M112.386722; Stern HM, 2012, SCI TRANSL MED, V4; Togni M, 2005, MOL CELL BIOL, V25, P8052, DOI 10.1128/MCB.25.18.8052-8063.2005; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Yen CC, 2007, LUNG CANCER, V57, P292, DOI 10.1016/j.lungcan.2007.04.007; Yokobori T, 2014, MOL CANCER RES, V12, P32, DOI 10.1158/1541-7786.MCR-13-0341; Zhou L, 2011, J CELL MOL MED, V15, P783, DOI 10.1111/j.1582-4934.2010.01048.x; Zutter MM, 2007, ADV EXP MED BIOL, V608, P87	21	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2410	2415				5	Oncology	Oncology	CF7JF	WOS:000352731600072		
J	Otsu, H; Oki, E; Ikawa-Yoshida, A; Kawano, H; Ando, K; Ida, S; Kimura, Y; Aishima, S; Saeki, H; Morita, M; Kohnoe, S; Oda, Y; Maehara, Y				Otsu, Hajime; Oki, Eiji; Ikawa-Yoshida, Ayae; Kawano, Hiroyuki; Ando, Koji; Ida, Satoshi; Kimura, Yasue; Aishima, Shinichi; Saeki, Hiroshi; Morita, Masaru; Kohnoe, Shunji; Oda, Yoshinao; Maehara, Yoshiniko			Correlation of HER2 Expression with Clinicopathological Characteristics and Prognosis in Resectable Gastric Cancer	ANTICANCER RESEARCH			English	Article						HER2; gastric cancer; prognosis; tumor grade	GROWTH-FACTOR RECEPTORS; IN-SITU HYBRIDIZATION; MONOCLONAL-ANTIBODY; GENE AMPLIFICATION; P53 EXPRESSION; BREAST-CANCER; CARCINOMA; IMMUNOHISTOCHEMISTRY; ASSOCIATION; ONCOPROTEIN	Results from the Trastuzumab for Gastric Cancer (ToGA) trial highlighted the clinical significance of trastuzumab in the treatment of HER2 (Human Epidermal Growth Factor Receptor type 2)-positive gastric cancer. However, whether expression of HER2 is related to prognosis of gastric cancer is still controversial. A total of 360 consecutive patients with gastric cancer who underwent surgical resection in our Department from 1994 to 2007 were analyzed. We performed immunohistochemical analysis of HER2 expression. HER2 expression level was classified into four scores (0, 1+, 2+ and 3+). There were 37 (10%) patients with a score of 3+. A score of 3+ was defined as being HER2-positive. Recurrence-free survival was worse in HER2-positive cases (p=0.045). When the analysis was conducted with intestinal types of cancer, RFS was considerably worse in the HER2-positive group (p=0.011). HER2 expression may have potential as a prognostic factor for intestinal cancer types. Further research is warranted.	[Otsu, Hajime; Oki, Eiji; Ikawa-Yoshida, Ayae; Kawano, Hiroyuki; Ando, Koji; Ida, Satoshi; Kimura, Yasue; Saeki, Hiroshi; Morita, Masaru; Kohnoe, Shunji; Maehara, Yoshiniko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Aishima, Shinichi; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Pathol Sci, Fukuoka 8128582, Japan; [Ikawa-Yoshida, Ayae] Chugai Res Inst Med Sci Inc, Shizuoka, Japan	Maehara, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	maehara@surg2.med.kyushu-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [25460390]	The Authors are grateful to Y. Kubota, T. Shishino and N. Makikusa for their technical assistance. This study was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (25460390).	Park DI, 2006, DIGEST DIS SCI, V51, P1371, DOI 10.1007/s10620-005-9057-1; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Baselga J, 1996, J CLIN ONCOL, V14, P737; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Yano T, 2006, ONCOL REP, V15, P65; Nakajima M, 1999, CANCER, V85, P1894; Barros-Silva JD, 2009, BRIT J CANCER, V100, P487, DOI 10.1038/sj.bjc.6604885; Dang HZ, 2012, WORLD J GASTROENTERO, V18, P2402, DOI 10.3748/wjg.v18.i19.2402; TETU B, 1994, CANCER, V73, P2359, DOI 10.1002/1097-0142(19940501)73:9<2359::AID-CNCR2820730919>3.0.CO;2-9; Hsu JT, 2011, ONCOLOGIST, V16, P1706, DOI 10.1634/theoncologist.2011-0199; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Kim MA, 2007, HUM PATHOL, V38, P1386, DOI 10.1016/j.humpath.2007.02.005; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955; Gomez-Martin C, 2012, J CLIN PATHOL, V65, P751, DOI 10.1136/jclinpath-2012-200774; Lorenzen S, 2011, CURR OPIN ONCOL, V23, P396, DOI 10.1097/CCO.0b013e3283469567; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; JASS JR, 1990, CANCER, V66, P2162, DOI 10.1002/1097-0142(19901115)66:10<2162::AID-CNCR2820661020>3.0.CO;2-N; Kaur A, 2011, EXPERT OPIN PHARMACO, V12, P2493, DOI 10.1517/14656566.2011.605354; McCulloch P, 1997, EUR J SURG ONCOL, V23, P304, DOI 10.1016/S0748-7983(97)90669-7; MCCULLOCH PG, 1995, CANCER, V75, P920, DOI 10.1002/1097-0142(19950215)75:4<920::AID-CNCR2820750405>3.0.CO;2-E; SAKAI K, 1986, J NATL CANCER I, V77, P1047; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tamura G, 2012, PATHOL INT, V62, P513, DOI 10.1111/j.1440-1827.2012.02843.x; YONEMURA Y, 1991, CANCER, V67, P2914, DOI 10.1002/1097-0142(19910601)67:11<2914::AID-CNCR2820671134>3.0.CO;2-G	25	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2441	2446				6	Oncology	Oncology	CF7JF	WOS:000352731600077		
J	Itoh, S; Ikegami, T; Yoshizumi, T; Wang, HL; Takeishi, K; Harimoto, N; Yamashita, YI; Kawanaka, H; Aishima, S; Shirabe, K; Maehara, Y				Itoh, Shinji; Ikegami, Toru; Yoshizumi, Tomoharu; Wang, Huanlin; Takeishi, Kazuki; Harimoto, Norifumi; Yamashita, Yo-Ichi; Kawanaka, Hirofumi; Aishima, Shinichi; Shirabe, Ken; Maehara, Yoshihiko			Long-term Outcome of Living-donor Liver Transplantation for Combined Hepatocellular-cholangiocarcinoma	ANTICANCER RESEARCH			English	Article						Combined hepatocellular-cholangiocarcinoma; hepatocellular carcinoma; living-donor liver transplantation		Background/Aim: Combined hepatocellular-cholangiocarcinoma (cHC-CC) is found unexpectedly in explanted or resected liver specimens. The current study evaluated the longterm outcomes of living-donor liver transplantation (LDLT) between patients with cHC-CC and hepatocellular carcinoma (HCC). Patients and Methods: We performed 178 LDLT including 8 patients of pathologically and immunohistochemically diagnosed cHC-CC who all under went LDLT with a preoperative diagnosis of HCC by imaging study. Results: Out of the 8 patients, 6 were within the Milan criteria and all were within the Kyushu University criteria. The 1-, 5- and 10-year overall survival (OS) and disease-free survival (DFS) rates after LDLT for patients with cHC-CC were 87.5, 72.9 and 48.6% and 85.7, 85.7 and 85.7%, respectively. The OS and DFS between patients with cHC-CC and HCC were not statistically different. Conclusion: LDLT for patients with cHC-CC using the Milan criteria or the Kyushu University criteria, as well as HCC, could have an acceptable long-term outcome.	[Itoh, Shinji; Ikegami, Toru; Yoshizumi, Tomoharu; Wang, Huanlin; Takeishi, Kazuki; Harimoto, Norifumi; Yamashita, Yo-Ichi; Kawanaka, Hirofumi; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Aishima, Shinichi] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga 840, Japan	Maehara, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan.	maehara@surg2.med.kyushu-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [26380201]	This work was supported by a grant Grant-in-Aid for Scientific Research (26380201) from the Ministry of Health, Labor and Welfare of Japan. No financial or other conflict of interest exists with the authors.	Jarnagin WR, 2002, CANCER, V94, P2040, DOI 10.1002/cncr.10392; Yoshizumi T, 2008, LIVER TRANSPLANT, V14, P1007, DOI 10.1002/lt.21462; Ikegami T, 2013, J AM COLL SURGEONS, V216, P353, DOI 10.1016/j.jamcollsurg.2012.11.011; Yano Y, 2003, JPN J CLIN ONCOL, V33, P283, DOI 10.1093/jjco/hyg056; Ijichi H, 2013, HEPATOL RES, V45, P481; Shirabe K, 2011, CLIN TRANSPLANT, V25, pE491, DOI 10.1111/j.1399-0012.2011.01463.x	6	0	0	INT INST ANTICANCER RESEARCH	ATHENS	EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22, ATHENS 19014, GREECE	0250-7005	1791-7530		ANTICANCER RES	Anticancer Res.	APR	2015	35	4					2475	2476				2	Oncology	Oncology	CF7JF	WOS:000352731600081		
J	Zhang, AC; Lai, XZ; Wu, M; She, JH				Zhang, Ancai; Lai, Xuzhi; Wu, Min; She, Jinhua			Global stabilization of underactuated spring-coupled three-link horizontal manipulator using position measurements only	APPLIED MATHEMATICAL MODELLING			English	Article						Underactuated mechanical system; Nonlinear dynamics; Horizontal manipulator; Equivalent input disturbance	SWING-UP CONTROL; VIRTUAL-HOLONOMIC-CONSTRAINTS; MECHANICAL SYSTEMS; ACROBOT; PENDUBOT; PENDULUM; DESIGN; ROBOT	This paper concerns the global stabilization of an underactuated spring-coupled three-link horizontal manipulator (STHM), which is an underactuated mechanical system (UMS) with two actuators and three degrees of freedom (DOF). A new control method is developed that asymptotically stabilizes the STHM at the origin using the position measurements of the manipulator only. First, we introduce a homeomorphic coordinate transformation for the STHM system. This changes the stabilization of the STHM into that of the transformed system. Next, we analyze the characteristics of the transformed system. After that, we construct an equivalent-input-disturbance- (EID-) based control system to globally stabilize the transformed system at the origin. Finally, a numerical example demonstrates the validity of the presented method. Our method only uses the position measurements of the STHM to design stabilizing controller. It reduces the cost of the whole control system and avoids the influence on the system's control performance imposed by velocity noises. In addition, the analysis and control method of this paper is easy to extend to the global stabilization of other n-DOF (n >= 3) UMSs. (C) 2014 Elsevier Inc. All rights reserved.	[Zhang, Ancai] Linyi Univ, Sch Automobile Engn, Linyi 276005, Shandong, Peoples R China; [Lai, Xuzhi; Wu, Min] China Univ Geosci, Sch Automat, Wuhan 430074, Hubei, Peoples R China; [She, Jinhua] Tokyo Univ Technol, Sch Comp Sci, Hachioji, Tokyo 1920982, Japan	Lai, XZ (reprint author), China Univ Geosci, Sch Automat, Wuhan 430074, Hubei, Peoples R China.	zhangancai123@hotmail.com; laixz@cug.edu.cn; wumin@cug.edu.cn; she@stf.teu.ac.jp			National Natural Science Foundation of China [61304023, 61374106]; Applied Mathematics Enhancement Program of Linyi University	This work was supported in part by the National Natural Science Foundation of China (Nos. 61304023 and 61374106), and by Applied Mathematics Enhancement Program of Linyi University.	Lee D, 2009, INT J CONTROL AUTOM, V7, P419, DOI 10.1007/s12555-009-0311-8; Siuka A, 2009, ROBOT AUTON SYST, V57, P1012, DOI 10.1016/j.robot.2009.07.016; Xin X, 2007, INT J ROBUST NONLIN, V17, P1503, DOI 10.1002/rnc.1184; Sarras I, 2013, AUTOMATICA, V49, P1442, DOI 10.1016/j.automatica.2013.01.059; Shiriaev AS, 2007, IEEE T ROBOT, V23, P827, DOI 10.1109/TRO.2007.900597; Xin X, 2007, IEEE T ROBOT, V23, P1277, DOI 10.1109/TRO.2007.909805; Brown SC, 1997, J INTELL ROBOT SYST, V18, P209, DOI 10.1023/A:1007953809856; Grizzle JW, 2005, IEEE T AUTOMAT CONTR, V50, P559, DOI 10.1109/TAC.2005.847057; Xie J, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS, INTELLIGENT SYSTEMS AND SIGNAL PROCESSING, VOLS 1 AND 2, PROCEEDINGS, P83; She JH, 2012, NONLINEAR DYNAM, V69, P495, DOI 10.1007/s11071-011-0280-3; Lai XZ, 2009, IEEE T SYST MAN CY B, V39, P389, DOI 10.1109/TSMCB.2008.2005910; Blajer W, 2011, COMMUN NONLINEAR SCI, V16, P2265, DOI 10.1016/j.cnsns.2010.04.047; Constantin J, 2005, ROBOTICA, V23, P781, DOI 10.1017/S0263574705001992; Freidovich L, 2008, AUTOMATICA, V44, P785, DOI 10.1016/j.automatica.2007.07.011; Henmi T, 2006, IEEE INT C NETW SENS, P60; Kimura H., 1981, IEEE Transactions on Automatic Control, VAC-26, DOI 10.1109/TAC.1981.1102573; Mahindrakar AD, 2006, INT J ROBUST NONLIN, V16, P671, DOI 10.1002/rnc.1088; Mullhaupt P, 2002, AUTOMATICA, V38, P1565, DOI 10.1016/S0005-1098(02)00048-1; Oriolo G, 1991, P 30 IEEE C DEC CONT, V3, P2398; Popescu C., 2003, P FLOR C REC ADV ROB, P1; Qaiser N, 2007, J CIRCUIT SYST COMP, V16, P81, DOI 10.1142/S0218126607003514; She JH, 2008, IEEE T IND ELECTRON, V55, P380, DOI 10.1109/TIE.2007.905976; Spong M., 1995, IEEE CONTR SYST MAG, V15, P44; Sun Ning, 2010, Acta Automatica Sinica, V36, DOI 10.3724/SP.J.1004.2010.01287; Zhang A., 2011, P 18 IFAC WORLD C MI, P14596; Zhou K., 1996, ROBUST OPTICAL CONTR	26	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0307-904X	1872-8480		APPL MATH MODEL	Appl. Math. Model.	APR 1	2015	39	7					1917	1928		10.1016/j.apm.2014.10.010		12	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications; Mechanics	Engineering; Mathematics; Mechanics	CG2BM	WOS:000353079900013		
J	Saito, K; Tanabe, T; Oyama, Y				Saito, Kyosuke; Tanabe, Tadao; Oyama, Yutaka			Concept of annular vector beam generation at terahertz wavelengths via a nonlinear parametric process	APPLIED OPTICS			English	Article							ORBITAL ANGULAR-MOMENTUM; OPTICAL TWEEZERS; LIGHT-BEAMS; LASER-BEAMS; DISLOCATIONS; MICROSCOPY	In this paper, we describe our theoretical investigation and calculations for a terahertz (THz)-wave profile generated by difference frequency mixing (DFM) of focused, cylindrically symmetric, and polarized optical vector beams. Using vector diffraction theory, the second-order nonlinear polarization was estimated from the electric field components of the optical pump beams penetrating uniaxial, birefringent nonlinear optics (NLO) crystals, GaSe and CdSe. The approximate beam patterns of the THz waves were simulated using DFM formulation. The intensity patterns of the THz waves for GaSe and CdSe showed sixfold symmetry and cylindrical symmetry, respectively, based on the nonlinear susceptibility tensor of the crystals. As the phase-matching angle theta(PM) was constant with respect to the c axis of the NLO crystals, an annular vector beam with a narrow width was expected. (C) 2015 Optical Society of America	[Saito, Kyosuke; Oyama, Yutaka] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Sendai, Miyagi 9808579, Japan; [Tanabe, Tadao] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan	Saito, K (reprint author), Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Aoba Yama 6-6-11-1021, Sendai, Miyagi 9808579, Japan.	k-saito@material.tohoku.ac.jp					Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Vaziri A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.240401; Biss DP, 2001, OPT EXPRESS, V9, P490; TAMM C, 1990, J OPT SOC AM B, V7, P1034, DOI 10.1364/JOSAB.7.001034; ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Liu MK, 2012, NATURE, V487, P345, DOI 10.1038/nature11231; Zhang CH, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/055017; Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; BEIJERSBERGEN MW, 1993, OPT COMMUN, V96, P123, DOI 10.1016/0030-4018(93)90535-D; Fleischer S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.163603; HECKENBERG NR, 1992, OPT LETT, V17, P221, DOI 10.1364/OL.17.000221; Youngworth KS, 2000, OPT EXPRESS, V7, P77; Simpson NB, 1997, OPT LETT, V22, P52, DOI 10.1364/OL.22.000052; BARNETT SM, 1994, OPT COMMUN, V110, P670, DOI 10.1016/0030-4018(94)90269-0; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549; Gibson G, 2004, OPT EXPRESS, V12, P5448, DOI 10.1364/OPEX.12.005448; Danielson JR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.237401; VODOPYANOV KL, 1995, OPT COMMUN, V118, P375, DOI 10.1016/0030-4018(95)00228-Z; STEUBING RW, 1991, CYTOMETRY, V12, P505, DOI 10.1002/cyto.990120607; Sheppard CJR, 2004, APPL OPTICS, V43, P4322, DOI 10.1364/AO.43.004322; Dorn R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.233901; Quabis S, 2000, OPT COMMUN, V179, P1, DOI 10.1016/S0030-4018(99)00729-4; Chen HT, 2008, NAT PHOTONICS, V2, P295, DOI 10.1038/nphoton.2008.52; Otomo K, 2014, OPT EXPRESS, V22, P28215, DOI 10.1364/OE.22.028215; He JW, 2013, OPT EXPRESS, V21, P20230, DOI 10.1364/OE.21.020230; Imai R, 2012, OPT EXPRESS, V20, P21896, DOI 10.1364/OE.20.021896; BAZHENOV VY, 1990, JETP LETT+, V52, P429; Miyamoto K, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4886407; Beijersbergen M. W., OPT COMMUN, V112, P321; Boyd R. W., 2008, NONLINEAR OPTICS, P48; Dmitriev V. G., 1999, HDB NONLINEAR OPTICA, P166; Grosjean T, 2007, APPL OPTICS, V46, P1994, DOI 10.1364/AO.46.001994; Guo R, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2953452; Markelz AG, 2000, CHEM PHYS LETT, V320, P42, DOI 10.1016/S0009-2614(00)00227-X; Molina-Terriza G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.013601; NYE JF, 1974, P ROY SOC LOND A MAT, V336, P165, DOI 10.1098/rspa.1974.0012; Ohno S, 2009, J EUR OPT SOC-RAPID, V4, DOI 10.2971/jeos.2009.09012; Palik E. D., 1991, HDB OPTICAL CONSTANT, P559; Sanchez A. R., 2008, IEEE J SEL TOP QUANT, V14, P260; Sato S, 2009, OPT LETT, V34, P3166, DOI 10.1364/OL.34.003166; SEEGER S, 1991, CYTOMETRY, V12, P497, DOI 10.1002/cyto.990120606; Zhan O., 2009, ADV OPT PHOTONICS, V1, P1	44	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	APR 1	2015	54	10					2769	2775		10.1364/AO.54.002769		7	Optics	Optics	CE9GP	WOS:000352152400031		
J	Dai, FZ; Wang, XZ; Sasaki, O				Dai, Fengzhao; Wang, Xiangzhao; Sasaki, Osami			Orthonormal polynomials for annular pupil including a cross-shaped obstruction	APPLIED OPTICS			English	Article							WAVE-FRONT ANALYSIS; ZERNIKE POLYNOMIALS; ALIGNMENT; APERTURE; SYSTEMS	By nonrecursive matrix method using the Zernike circle polynomials as the basis functions, we derived a set of polynomials up to fourth order which is approximately orthonormal for optical systems with an annular pupil having a cross-shaped obstruction. The performance of the polynomials is compared with the strictly orthonormal polynomials with some numerical examples. (C) 2015 Optical Society of America	[Dai, Fengzhao; Wang, Xiangzhao] Chinese Acad Sci, Lab Informat Opt & Optoelect Technol, Shanghai Inst Opt & Fine Mech, Shanghai 201800, Peoples R China; [Sasaki, Osami] Niigata Univ, Fac Engn, Niigata 9502181, Japan	Wang, XZ (reprint author), Chinese Acad Sci, Lab Informat Opt & Optoelect Technol, Shanghai Inst Opt & Fine Mech, Shanghai 201800, Peoples R China.	wxz26267@siom.ac.cn			National Natural Sciences Foundation of China (NSFC) [61405210, 61205102, 61275207, 61474129]; Shanghai Natural Science Fund [14ZR1444900]	This work was supported by a grant from the National Natural Sciences Foundation of China (NSFC) under Nos. 61405210, 61205102, 61275207, and 61474129, and by Shanghai Natural Science Fund under No. 14ZR1444900.	Dai GM, 2007, OPT LETT, V32, P74, DOI 10.1364/OL.32.000074; Dai GM, 2008, APPL OPTICS, V47, P3433, DOI 10.1364/AO.47.003433; Liao KL, 2014, APPL OPTICS, V53, P6362, DOI 10.1364/AO.53.006362; Mahajan VN, 2007, J OPT SOC AM A, V24, P2994, DOI 10.1364/JOSAA.24.002994; Dai G. M., 2008, WAVEFRONT OPTICS VIS; Diaz JA, 2014, APPL OPTICS, V53, P2051, DOI 10.1364/AO.53.002051; Diaz JA, 2013, APPL OPTICS, V52, P1136, DOI 10.1364/AO.52.001136; Upton R, 2004, OPT LETT, V29, P2840, DOI 10.1364/OL.29.002840; Goldberg KA, 2004, J VAC SCI TECHNOL B, V22, P2956, DOI 10.1116/1.1815303; Goldberg KA, 2004, P SOC PHOTO-OPT INS, V5374, P64, DOI 10.1117/12.546199; Mahajan V. N., 2007, OPTICAL SHOP TESTING, P498, DOI 10.1002/9780470135976.ch13; Mahajan V. N., 2013, OPTICAL IMAGING AB 3; Mahajan VN, 2006, OPT LETT, V31, P2462, DOI 10.1364/OL.31.002462; MAHAJAN VN, 1981, J OPT SOC AM, V71, P75, DOI 10.1364/JOSA.71.000075; Navarro R., 2014, ARXIV14053434; Niu SS, 2013, CHIN OPT LETT, V11, DOI 10.3788/COL201311.022201; Shakibaei BH, 2013, OPT LETT, V38, P2487, DOI 10.1364/OL.38.002487; Shakibaei BH, 2013, CHIN OPT LETT, V11, DOI 10.3788/COL201311.080101; SWANTHNER W, 1994, APPL OPTICS, V33, P1832, DOI 10.1364/AO.33.001832; Ye JF, 2014, J OPT SOC AM A, V31, P2304, DOI 10.1364/JOSAA.31.002304	20	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	APR 1	2015	54	10					2922	2928		10.1364/AO.54.002922		7	Optics	Optics	CE9GP	WOS:000352152400051		
J	Jin, LH; Kasuga, S; Kondoh, E; Gelloz, B				Jin, Lianhua; Kasuga, Syouki; Kondoh, Eiichi; Gelloz, Bernard			Correction of large retardation window effect for ellipsometry measurements using quasi-Newton method	APPLIED OPTICS			English	Article							MUELLER MATRIX; ERRORS	Optical windows attached to the sample chamber for ellipsometry measurements often manifest stress-induced retardation. In reality, the retardation is not always small enough to be simplified with the small angle approximation, varies within the optical beam, and furthermore may change with the evolution of the environmental conditions of the chamber. Large retardations and retardation distributions result in complicated Mueller matrices of the input window-sample-output window system. Consequently, extensive computation is required to obtain the true ellipsometric parameters (Delta, Psi) of the sample. In this paper, we show that the quasi-Newton method can be used to simultaneously obtain 14 unknown parameters (including ellipsometric parameters) from the Mueller matrix, with a single measurement under conditions of large and inhomogeneous window retardation. A limitation of the method is that it is valid only for isotropic samples. The validity of the method has been tested using a set of samples: a silicon substrate, a TiN-coated silicon wafer, and a thermally grown silicon dioxide film. Measurements were done under the window effect and corrected using the proposed method. The corrected results showed excellent agreement with ellipsometric parameters obtained without window effect. (C) 2015 Optical Society of America	[Jin, Lianhua; Kasuga, Syouki; Kondoh, Eiichi] Univ Yamanashi, Grad Sch Med & Engn, Yamanashi 4008511, Japan; [Gelloz, Bernard] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648601, Japan	Jin, LH (reprint author), Univ Yamanashi, Grad Sch Med & Engn, Yamanashi 4008511, Japan.	lianhua@yamanashi.ac.jp					GOLDFARB D, 1970, MATH COMPUT, V24, P23, DOI 10.2307/2004873; FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317; AZZAM RMA, 1978, OPT LETT, V2, P148, DOI 10.1364/OL.2.000148; BROYDEN CG, 1969, NOT AM MATH SOC, V16, P670; ASPNES DE, 1971, J OPT SOC AM, V61, P1077, DOI 10.1364/JOSA.61.001077; Broch L, 2008, OPT EXPRESS, V16, P8814, DOI 10.1364/OE.16.008814; DENIJS JMM, 1988, J OPT SOC AM A, V5, P773, DOI 10.1364/JOSAA.5.000773; Jellison GE, 1999, APPL OPTICS, V38, P4784, DOI 10.1364/AO.38.004784; Jin LH, 2014, THIN SOLID FILMS, V571, P532, DOI 10.1016/j.tsf.2014.05.017; Jin LH, 2014, OPT EXPRESS, V22, P27811, DOI 10.1364/OE.22.027811; Jin LH, 2014, OPT LETT, V39, P1549, DOI 10.1364/OL.39.001549; MCCRACKI.FL, 1970, J OPT SOC AM, V60, P57, DOI 10.1364/JOSA.60.000057; Nissim N, 2009, OPT COMMUN, V282, P3414, DOI 10.1016/j.optcom.2009.05.051; Sasaki T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.05EA02; SHANNO DF, 1970, MATH COMPUT, V24, P657, DOI 10.2307/2004841; Stagg G. J., 1993, J PHYS D, V26, P2028; Tompkins H G, 2005, HDB ELLIPSOMETRY	17	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	APR 1	2015	54	10					2991	2998		10.1364/AO.54.002991		8	Optics	Optics	CE9GP	WOS:000352152400057		
J	Sato, A; Okubo, S; Asai, K; Ishii, S; Mizutani, K; Sugimoto, N				Sato, Atsushi; Okubo, Shimpei; Asai, Kazuhiro; Ishii, Shoken; Mizutani, Kohei; Sugimoto, Nobuo			Stable dual-wavelength Q-switched Nd:YAG laser using a two-step energy extraction technique	APPLIED OPTICS			English	Article							EMISSION CROSS-SECTION; ND-YAG LASER; INTERMITTENT OSCILLATION; COMPUTATIONAL MODEL; ND-GDVO4 LASERS; ND-YALO3 LASER; DIODE; LEVEL; CONFIGURATION; EFFICIENCY	The generation of stable dual-wavelength pulses from an actively Q-switched Nd:YAG laser operating at 1064 and 1319 nm was demonstrated. Pulse energies of the dual-wavelength laser were extracted by two temporally separated stimulated-emission processes for a single pumping process, thereby avoiding line competition between the two laser transitions. Total energy of the order of 20 mJ was achieved for the two pulses, and the ratio of the pulse energies of the two lasers could be selected by adjusting the output couplings. The pulse-to-pulse fluctuations for the lasers operating at 1319 and 1064 nm were 4.7%-4.8% and 1.5%-2.6%, respectively, which were almost equivalent to those for a single emission line in our system. The experimentally observed laser performance agreed reasonably well with theoretical predictions. (C) 2015 Optical Society of America	[Sato, Atsushi; Okubo, Shimpei; Asai, Kazuhiro] Tohoku Inst Technol, Taihaku Ku, Sendai, Miyagi 9828577, Japan; [Ishii, Shoken; Mizutani, Kohei] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan; [Sugimoto, Nobuo] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Sato, A (reprint author), Tohoku Inst Technol, Taihaku Ku, 35-1 Yagiyama Kasumi Cho, Sendai, Miyagi 9828577, Japan.	atsushi@tohtech.ac.jp					SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335; SHEN HY, 1993, APPL OPTICS, V32, P5952, DOI 10.1364/AO.32.005952; Schutz BE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024009; Chen YF, 2002, OPT LETT, V27, P397, DOI 10.1364/OL.27.000397; SINGH S, 1974, PHYS REV B, V10, P2566, DOI 10.1103/PhysRevB.10.2566; Zhang L, 2006, OPT COMMUN, V264, P51, DOI 10.1016/j.optcom.2006.02.020; Asai K, 2010, P SOC PHOTO-OPT INS, V7860, DOI 10.1117/12.871982; Degnan JJ, 1998, IEEE J QUANTUM ELECT, V34, P887, DOI 10.1109/3.668777; FAN TY, 1988, IEEE J QUANTUM ELECT, V24, P2345, DOI 10.1109/3.14358; Fan XW, 2007, IEEE J QUANTUM ELECT, V43, P884, DOI 10.1109/JQE.2007.904310; He JL, 2004, APPL PHYS B-LASERS O, V79, P301, DOI 10.1007/s00340-004-1558-7; HENDERSON GA, 1990, J APPL PHYS, V68, P5451, DOI 10.1063/1.347001; HOVIS FE, 1992, IEEE J QUANTUM ELECT, V28, P39, DOI 10.1109/3.119492; HUA DH, 1988, J CHEM PHYS, V89, P5398, DOI 10.1063/1.455590; Huang HT, 2009, APPL PHYS B-LASERS O, V96, P815, DOI 10.1007/s00340-009-3586-9; Kisov H, 2013, PROC SPIE, V8770, DOI 10.1117/12.2013695; Koechner W., 1999, SOLID STATE LASER EN; Lin WX, 2003, J OPT SOC AM B, V20, P479, DOI 10.1364/JOSAB.20.000479; Lin WX, 1999, J APPL PHYS, V86, P2979, DOI 10.1063/1.371157; National Oceanic and Atmospheric Administration, 2007, NOAA KLM US GUID; Ng SP, 2006, IEEE J QUANTUM ELECT, V42, P625, DOI 10.1109/JQE.2006.875866; Sato A, 2012, PROC SPIE, V8526, DOI 10.1117/12.977317; Sato A, 2014, APPL PHYS B-LASERS O, V117, P621, DOI 10.1007/s00340-014-5875-1; Su H, 1998, J APPL PHYS, V84, P6519, DOI 10.1063/1.369022; Walsh B. M., 2005, ADV SOLID STATE PHOT	25	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	APR 1	2015	54	10					3032	3042		10.1364/AO.54.003032		11	Optics	Optics	CE9GP	WOS:000352152400062		
J	Suzuki, M; Matsushima-Nishiwaki, R; Kuroyanagi, G; Suzuki, N; Takamatsu, R; Furui, T; Yoshimi, N; Kozawa, O; Morishige, K				Suzuki, Mariko; Matsushima-Nishiwaki, Rie; Kuroyanagi, Gen; Suzuki, Noriko; Takamatsu, Reika; Furui, Tatsuro; Yoshimi, Naoki; Kozawa, Osamu; Morishige, Ken-ichirou			Regulation by heat shock protein 22 (HSPB8) of transforming growth factor-alpha-induced ovary cancer cell migration	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						HSP22; Ovary cancer; TGF-alpha; Migration	SURFACE EPITHELIUM; KINASE PATHWAY; EXPRESSION; METASTASIS; INHIBITOR; RECEPTOR; PROLIFERATION; CARCINOMA	Accumulating evidence suggests that heat shock proteins (HSPs) are implicated in progression of cancer. HSP22 (HSPB8), a small HSP, is recognized to be ubiquitously expressed in various tissues. However, the expression and the role of HSP22 in ovarian cancer remain to be clarified. In the present study, we investigated the involvement of HSP22 in transforming growth factor (TGF)-alpha-induced migration of ovarian cancer cells. The expression of HSP22 was detected in a serous ovarian cancer cell line, SKOV3.ip1. The migration was reduced by down-regulation of HSP22 expression. The TGF-alpha-induced migration was reduced by SB203580 (a p38 MAP kinase inhibitor), SP600125 (a SAPK/JNK inhibitor) and Y27632 (a Rho-kinase inhibitor). However, down-regulation of HSP22 had little effect on the TGF-alpha-induced phosphorylation of p38 MAP kinase, SAPK/JNK and MYPT, a target protein of Rho-kinase. The HSP22 expression was further analyzed in 20 resected specimens of human ovarian serous carcinoma. The expression of HSP22 was detected in-all the twenty tissues (8.24-109.22 pg/mg protein), and the cases with highly expression of HSP22 showed a tendency to acquire the progressive ability. Our results strongly suggest that HSP22 acts as a positive regulator in TGF-alpha-induced migration of ovarian cancer cells, subsequently directing ovarian cancer toward progression. (C) 2015 Elsevier Inc. All rights reserved.	[Suzuki, Mariko; Suzuki, Noriko; Furui, Tatsuro; Morishige, Ken-ichirou] Gifu Univ, Grad Sch Med, Dept Obstet & Gynecol, Gifu 5011194, Japan; [Suzuki, Mariko; Matsushima-Nishiwaki, Rie; Kuroyanagi, Gen; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Takamatsu, Reika; Yoshimi, Naoki] Univ Ryukyus, Grad Sch Med, Dept Pathol & Oncol, Okinawa 9030215, Japan	Kozawa, O (reprint author), Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan.	okozawa@gifu-u.ac.jp					Amadori D., 1997, FRONT BIOSCI, V2, P8; Kyriakis JM, 2001, PHYSIOL REV, V81, P807; Sewell JM, 2005, EXP CELL RES, V304, P305, DOI 10.1016/j.yexcr.2004.11.007; DERYNCK R, 1990, MOL REPROD DEV, V27, P3, DOI 10.1002/mrd.1080270104; Modem S, 2011, J CELL PHYSIOL, V226, P2747, DOI 10.1002/jcp.22868; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Hudson LG, 2009, FUTURE ONCOL, V5, P323, DOI [10.2217/fon.09.10, 10.2217/FON.09.10]; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Sawada K, 2002, GYNECOL ONCOL, V87, P252, DOI 10.1006/gyno.2002.6831; Balcan E, 2012, INT J GYNECOL CANCER, V22, P1138, DOI 10.1097/IGC.0b013e31825b7dcc; Doraiswamy V, 2000, BIOL REPROD, V63, P789, DOI 10.1095/biolreprod63.3.789; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; ALESSI DR, 1995, J BIOL CHEM, V270, P27489; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Gui T, 2012, CANCER EPIDEMIOL, V36, P490, DOI 10.1016/j.canep.2012.06.005; Tan DSP, 2006, LANCET ONCOL, V7, P925, DOI 10.1016/S1470-2045(06)70939-1; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; English DP, 2013, MOL DIAGN THER, V17, P85, DOI 10.1007/s40291-013-0024-9; YU DH, 1993, CANCER RES, V53, P891; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Charpentier AH, 2000, CANCER RES, V60, P5977; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Kurman R.J., 2014, WHO CLASSIFICATION T, P21; Matsushima-Nishiwaki R, 2008, J BIOL CHEM, V283, P18852, DOI 10.1074/jbc.M801301200; Pavan S, 2014, INT J CANCER, V134, P1289, DOI 10.1002/ijc.28464; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Smith CC, 2000, J BIOL CHEM, V275, P25690, DOI 10.1074/jbc.M002140200; Wang YY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0379-8; Zhao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113478; Zhao M, 2012, REPROD SCI, V19, P748, DOI 10.1177/1933719111432875	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	APR 1	2015	571						40	49		10.1016/j.abb.2015.02.030		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CF9ZQ	WOS:000352926800005		
J	Furukawa, K; Ohmi, Y; Kondo, Y; Ohkawa, Y; Tajima, O; Furukawa, K				Furukawa, Koichi; Ohmi, Yuhsuke; Kondo, Yuji; Ohkawa, Yuki; Tajima, Orie; Furukawa, Keiko			Regulatory function of glycosphingolipids in the inflammation and degeneration	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Review						Inflammation; Glycosphingolipid; Neurodegeneration	AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; GLOBO-SERIES GLYCOSPHINGOLIPIDS; LYMPHOMA-ASSOCIATED ANTIGEN; ALZHEIMERS-DISEASE BRAIN; TUMOR-NECROSIS-FACTOR; GD3 SYNTHASE GENE; COMPLEX GANGLIOSIDES; MUTANT MICE; SPINAL-CORD	Recent progress in the biological sciences has revealed that a number of extrinsic and intrinsic environmental factors may cause chronic inflammation. When these insults are persistent or intermittently repeated, regardless of extrinsic or intrinsic origins, homeostasis of our bodies would be disturbed and undergo long-term impact. These situations might give rise to chronic inflammation, leading to various diseases as results of accumulative effects of various inflammatory reactions. Complex carbohydrates expressed mainly on the cell surface have been demonstrated to play roles in fine-tuning of various biological processes to maintain homeostasis of cells, organs and our bodies. When abnormal physicochemical insults and harmful pathogens invade, the fine-tuning including modification of the glycosylation patterns is continuously exerted. Therefore, defects in the proper response with proper glycosylation lead to chronic inflammation and subsequent deterioration of individual tissues and organs. Genetic depletion of sialic acid-containing glycolipids, gangliosides resulted in the inflammation of CNS and neurodegeneration. Lactosylceramide was also reported to mediate neuroinflammation, leading to chronic inflammatory diseases. Defects of globoseries glycolipids resulted in the increased sensitivity to LPS toxicity. Thus, possibilities that manipulation of synthesis and expression of glycosphingolipids may be applicable for the disease control are now proposed. (C) 2015 Elsevier Inc. All rights reserved.	[Furukawa, Koichi; Ohmi, Yuhsuke; Kondo, Yuji; Ohkawa, Yuki; Tajima, Orie; Furukawa, Keiko] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4648601, Japan; [Tajima, Orie; Furukawa, Keiko] Chubu Univ, Fac Life & Hlth Sci, Dept Life & Med Sci, Kasugai, Aichi 487, Japan	Furukawa, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4648601, Japan.	koichi@med.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [21390076, 23590371, 23110008, 24111519]	We would like to thank Ms. Yoshiko Shibagaki for editorial assistance. These studies were supported by a Grant-in-Aid for Scientific Research (#21390076) and partly by a Grant-in-Aid for Scientific Research (#23590371) and by Grants-in-Aid for Scientific Research on Innovative Areas (#23110008) (#24111519, "Brain Environment") from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Way EE, 2013, EUR J IMMUNOL, V43, P3116, DOI 10.1002/eji.201343713; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; SCHNEIDER JS, 1992, SCIENCE, V256, P843, DOI 10.1126/science.1350379; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Miyata M, 2014, BIOCHEM BIOPH RES CO, V445, P504, DOI 10.1016/j.bbrc.2014.02.038; Strohmeyer R, 2000, MOL BRAIN RES, V81, P7, DOI 10.1016/S0169-328X(00)00149-2; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; Van Beek J, 2003, ANN NY ACAD SCI, V992, P56; Benard M, 2004, J BIOL CHEM, V279, P43487, DOI 10.1074/jbc.M404124200; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; KARLSSON KA, 1995, CURR OPIN STRUC BIOL, V5, P622, DOI 10.1016/0959-440X(95)80054-9; Takamiya K, 1996, P NATL ACAD SCI USA, V93, P10662, DOI 10.1073/pnas.93.20.10662; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Wu GS, 2012, J NEUROSCI RES, V90, P1997, DOI 10.1002/jnr.23090; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Rogers J, 2000, ANN NY ACAD SCI, V924, P132; Terai K, 1997, BRAIN RES, V769, P385, DOI 10.1016/S0006-8993(97)00849-4; Shen Y, 2001, NEUROSCI LETT, V305, P165, DOI 10.1016/S0304-3940(01)01842-0; Furukawa K, 2012, J BIOCHEM, V151, P573, DOI 10.1093/jb/mvs043; Woodruff TM, 2008, ADV EXP MED BIOL, V632, P143, DOI 10.1007/978-0-387-78952-1_11; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; Tokuda N, 2013, GLYCOBIOLOGY, V23, P1175, DOI 10.1093/glycob/cwt054; Dong Y, 2010, CANCER SCI, V101, P2039, DOI 10.1111/j.1349-7006.2010.01613.x; Yasojima K, 1999, AM J PATHOL, V154, P927, DOI 10.1016/S0002-9440(10)65340-0; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Boukhris A, 2013, AM J HUM GENET, V93, P118, DOI 10.1016/j.ajhg.2013.05.006; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Chapman-Kiddell CA, 2010, INFLAMM BOWEL DIS, V16, P137, DOI 10.1002/ibd.20968; Barnum SR, 2002, IMMUNOL RES, V26, P7, DOI 10.1385/IR:26:1-3:007; Cazet A, 2012, GLYCOBIOLOGY, V22, P806, DOI 10.1093/glycob/cws049; Christen U, 2014, INT REV IMMUNOL, V33, P296, DOI 10.3109/08830185.2014.921162; DAWSON G, 1984, J NEUROSCI RES, V12, P213, DOI 10.1002/jnr.490120209; Farkas I, 2003, J IMMUNOL, V170, P5764; Fujii Y, 2005, GLYCOBIOLOGY, V15, P1257, DOI 10.1093/glycob/cwj015; Furukawa K., 1990, HUMAN MELANOMA BASIC, P15; FURUKAWA K, 1993, P NATL ACAD SCI USA, V90, P1972, DOI 10.1073/pnas.90.5.1972; Furukawa Koichi, 2014, Adv Neurobiol, V9, P307, DOI 10.1007/978-1-4939-1154-7_14; GEISLER FH, 1990, ACTA NEUROBIOL EXP, V50, P515; Hamamura K, 2005, P NATL ACAD SCI USA, V102, P11041, DOI 10.1073/pnas.0503658102; Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; Kane BA, 2014, J INNATE IMMUN, V6, P727, DOI 10.1159/000363449; Karasawa F, 2012, J CLIN INVEST, V122, P923, DOI 10.1172/JCI59087; KIJIMOTOOCHIAI S, 1977, P NATL ACAD SCI USA, V74, P5407, DOI 10.1073/pnas.74.12.5407; Kumagai T, 2009, BIOCHEM BIOPH RES CO, V379, P456, DOI 10.1016/j.bbrc.2008.12.078; Kumagai T, 2010, GLYCOCONJUGATE J, V27, P685, DOI 10.1007/s10719-010-9313-2; Mason JC, 1999, BLOOD, V94, P1673; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; MERRITT WD, 1987, CANCER RES, V47, P1724; Miyamoto K, 2008, GLYCOBIOLOGY, V18, P408, DOI 10.1093/glycob/cwn017; MURRAY LJ, 1985, INT J CANCER, V36, P561, DOI 10.1002/ijc.2910360508; NAIKI M, 1975, BIOCHEMISTRY-US, V14, P4837, DOI 10.1021/bi00693a010; Nishie T, 2010, GLYCOBIOLOGY, V20, P1311, DOI 10.1093/glycob/cwq098; Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791; Ohmi Y, 2009, P NATL ACAD SCI USA, V106, P22405, DOI 10.1073/pnas.0912336106; Ohmi Y, 2012, NEUROCHEM RES, V37, P1185, DOI 10.1007/s11064-012-0764-7; Ohmi Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-61; Okuda T, 2010, GLYCOCONJUGATE J, V27, P287, DOI 10.1007/s10719-009-9277-2; RAPPORT MM, 1990, ACTA NEUROBIOL EXP, V50, P505; Rasch Sebastian, 2014, Clin Exp Gastroenterol, V7, P261, DOI 10.2147/CEG.S43457; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; SIDDIQUI B, 1984, CANCER RES, V44, P5262; Smith DC, 2002, TRAFFIC, V3, P697, DOI 10.1034/j.1600-0854.2002.31001.x; Sugiura Y, 2005, NEUROSCIENCE, V135, P1167, DOI 10.1016/j.neuroscience.2005.07.035; Tajima O, 2009, BEHAV BRAIN RES, V198, P74, DOI 10.1016/j.bbr.2008.10.024; Tajima O, 2010, BEHAV BRAIN RES, V206, P101, DOI 10.1016/j.bbr.2009.09.005; Tenner AJ, 2001, NEUROBIOL AGING, V22, P849, DOI 10.1016/S0197-4580(01)00301-3; Van de Kar N.C., 1993, BEHRING I MITT, V92, P202; VANDEKAR NCAJ, 1992, BLOOD, V80, P2755; Wang JQ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00367; Watanabe Y, 2012, DIABETES, V61, P1199, DOI 10.2337/db11-1182; WIELS J, 1981, P NATL ACAD SCI-BIOL, V78, P6485, DOI 10.1073/pnas.78.10.6485; Won JS, 2007, J NEUROCHEM, V103, P180, DOI 10.1111/j.1471-4159.2007.04822.x; Woodruff TM, 2008, J IMMUNOL, V181, P8727; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; YAMASHIRO S, 1995, GLYCOCONJUGATE J, V12, P894, DOI 10.1007/BF00731251; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yang LB, 2000, J NEUROSCI, V20, P7505; Yao DG, 2014, J NEUROSCI, V34, P880, DOI 10.1523/JNEUROSCI.3996-13.2014	94	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	APR 1	2015	571						58	65		10.1016/j.abb.2015.02.007		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CF9ZQ	WOS:000352926800007		
J	Konishi, S; Fukunaga, A; Yamashita, H; Miyata, M; Usami, M				Konishi, Shuji; Fukunaga, Atsushi; Yamashita, Hayato; Miyata, Masahiro; Usami, Makoto			Eluted Substances From Hemodialysis Membranes Elicit Positive Skin Prick Tests in Bioincompatible Patients	ARTIFICIAL ORGANS			English	Article						Polyvinylpyrrolidone; Skin prick test; Hemodialysis; Priming fluid; Polysulfone; Hemodialysis membrane; Polymethyl methacrylate	POVIDONE-IODINE; BISPHENOL-A; JAPANESE SOCIETY; POLYVINYLPYRROLIDONE; ANAPHYLAXIS; DERMATITIS; MANAGEMENT; HISTAMINE	Recently, hypotension and malaise during hemodialysis using polysulfone (PS) membranes have been reported. This study aimed to evaluate the bioin-compatibility of eluted substances from PS hemodialysis membranes that can induce hypotension, malaise, and anaphylactic shock. Polyvinylpyrrolidone (PVP) elution from five hemodialysis membranes was measured in an in vitro experimental circulation. Skin prick tests (SPTs) with PVP or the priming fluid of hemodialysis membranes were carried out for seven PS membrane-incompatible patients and seven healthy volunteers. Skin reactivity for histamine was compared in patients and healthy volunteers. The symptoms of PS membrane-incompatible cases were hypotension, dyspnea, nausea, or vomiting. One patient had gone into shock. PVP was eluted from hemodialysis membranes, but the SPT for PVP was negative in all patients. SPTs with priming fluid (or priming fluid effluxed during priming) were positive in four out of six patients. However, the SPT with bisphenol A was positive in one patient. The area of the flare reaction against histamine in patients was smaller than that of healthy subjects. In conclusion, eluted substances apart from PVP from hemodialysis membranes could cause bioincompatibility with PS membranes.	[Konishi, Shuji; Yamashita, Hayato; Usami, Makoto] Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Div Nutr & Metab, Kobe, Hyogo 6540142, Japan; [Fukunaga, Atsushi] Kobe Univ, Grad Sch Med, Dept Internal Related, Div Dermatol, Kobe, Hyogo 6540142, Japan; [Konishi, Shuji; Miyata, Masahiro] Hattori Hosp, Dept Clin Engn, Miki, Kagawa, Japan; [Miyata, Masahiro] Osaka Electrocommun Univ, Dept Biomed Engn, Osaka, Japan	Usami, M (reprint author), Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Div Nutr & Metab,Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	musa@kobe-u.ac.jp					Adachi A, 2003, CONTACT DERMATITIS, V48, P133, DOI 10.1034/j.1600-0536.2003.00050.x; Lachapelle JM, 2005, CONTACT DERMATITIS, V52, P9, DOI 10.1111/j.0105-1873.2005.00479.x; Ronnau AC, 2000, BRIT J DERMATOL, V143, P1055, DOI 10.1046/j.1365-2133.2000.03843.x; Hayama M, 2004, BIOMATERIALS, V25, P1019, DOI 10.1016/S0142-9612(03)00629-X; Yoshida K, 2008, INT ARCH ALLERGY IMM, V146, P169, DOI 10.1159/000113522; Hirakata H, 2012, THER APHER DIAL, V16, P387, DOI 10.1111/j.1744-9987.2012.01088.x; Kanerva L, 2002, ALLERGY, V57, P1205, DOI 10.1034/j.1398-9995.2002.13118.x; Marques IDB, 2011, HEMODIAL INT, V15, P399, DOI 10.1111/j.1542-4758.2011.00553.x; BOUSQUET J, 1988, Journal of Allergy and Clinical Immunology, V81, P605, DOI 10.1016/0091-6749(88)90201-1; Daugirdas JT, 1988, KIDNEY INT S, V24, P37; GOLDBERG A, 1991, ANN ALLERGY, V67, P525; Hashima Y, 2001, J BIOMED MATER RES, V58, P209; Heegard KD, 2013, INT J ARTIF ORGANS, V36, P363, DOI 10.5301/ijao.5000136; Kawanishi H, 2011, CONTRIB NEPHROL, V168, P107, DOI 10.1159/000321749; Kawanishi H, 2009, THER APHER DIAL, V13, P161, DOI 10.1111/j.1744-9987.2009.00674.x; Krieter DH, 2013, ARTIF ORGANS, V37, P283, DOI 10.1111/j.1525-1594.2012.01556.x; MULLER K, 1968, PHARM ACTA HELV, V43, P107; Namekawa K, 2012, J ARTIF ORGANS, V15, P185, DOI 10.1007/s10047-012-0629-5; Namekawa K, 2011, J ARTIF ORGANS, V14, P52, DOI 10.1007/s10047-011-0552-1; Ohashi N, 2003, CLIN NEPHROL, V60, P214; STAHLEBACKDAHL M, 1988, ACTA DERM-VENEREOL, V68, P230; Volker B, 1998, KOLLIDON POLYVINYLPY; Yamasaki H, 2001, NEPHRON, V88, P376, DOI 10.1159/000046023	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	APR	2015	39	4					343	351		10.1111/aor.12392		9	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CF5EV	WOS:000352580300007		
J	Li, CZ				Li, Changzheng			FUNCTORIAL RELATIONSHIPS BETWEEN QH*(G/B) AND QH*(C/P), (II)	ASIAN JOURNAL OF MATHEMATICS			English	Article						Quantum cohomology; flag varieties; filtered algebras; Gromov-Witten invariants	GROMOV-WITTEN INVARIANTS; QUANTUM COHOMOLOGY; HOMOGENEOUS SPACES; PRODUCT; G/B	We show a canonical injective morphism from the quantum cohomology ring QH*(G/P) to the associated graded algebra of QH*(G/B), which is with respect to a nice filtration on QH*(G/B) introduced by Leung and the author. This tells us the vanishing of a lot of genus zero, three-pointed Gromov-Witten invariants of flag varieties G/P.	Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan	Li, CZ (reprint author), Univ Tokyo, Todai Inst Adv Study, Kavli Inst Phys & Math Universe WPI, 5-1-5 Kashiwa No Ha, Kashiwa, Chiba 2778583, Japan.	changzheng.li@ipmu.jp			JSPS [25870175]	The author is grateful to Naichung Conan Leung for valuable suggestions and constant encouragement. He also thanks Ivan Chi-Ho Ip and Leonardo Constantin Mihalcea for useful discussions and advice. Especially, he thanks the referee for his/her careful reading and very helpful comments. The author is partially supported by JSPS Grant-in-Aid for Young Scientists (B) No. 25870175.	Kim B, 1999, ANN MATH, V149, P129, DOI 10.2307/121021; Buch AS, 2009, INVENT MATH, V178, P345, DOI 10.1007/s00222-009-0201-y; ASTASHKEVICH A, 1995, COMMUN MATH PHYS, V170, P503, DOI 10.1007/BF02099147; Bernstein IN, 1973, RUSS MATH SURV, V28, P1, DOI 10.1070/RM1973v028n03ABEH001557; BOURBAKI N., 2002, LIE GROUPS LIE ALGEB; Buch AS, 2003, J AM MATH SOC, V16, P901, DOI 10.1090/S0894-0347-03-00429-6; Chaput PE, 2009, MATH RES LETT, V16, P7; Chaput PE, 2008, TRANSFORM GROUPS, V13, P47, DOI 10.1007/s00031-008-9001-5; Fulton W, 2004, J ALGEBRAIC GEOM, V13, P641; FULTON W., 1997, P S PURE MATH 2, V62; FULTON W., 2004, QUANTUM COHOMOLOGY H, P729; HUMPHREYS J. E., 1980, GRADUATE TEXTS MATH, V9; Humphreys James, 1975, GRADUATE TEXTS MATH, V21; Humphreys J.E., 1990, REFLECTION GROUPS CO; Lam T, 2010, ACTA MATH-DJURSHOLM, V204, P49, DOI 10.1007/s11511-010-0045-8; Leung NC, 2013, ADV MATH, V248, P279, DOI 10.1016/j.aim.2013.07.017; Leung NC, 2010, J DIFFER GEOM, V86, P303; Leung NC, 2012, T AM MATH SOC, V364, P2567; Leung NC, 2012, INT MATH RES NOTICES, P3706, DOI 10.1093/imrn/rnr157; Peterson D., 1997, LECT NOTES MIT; Woodward CT, 2005, P AM MATH SOC, V133, P1601, DOI 10.1090/S0002-9939-05-07709-9	21	0	0	INT PRESS BOSTON, INC	SOMERVILLE	PO BOX 43502, SOMERVILLE, MA 02143 USA	1093-6106	1945-0036		ASIAN J MATH	Asian J. Math.	APR	2015	19	2					203	234				32	Mathematics, Applied; Mathematics	Mathematics	CG1KK	WOS:000353031300001		
J	Ito, T; Scardua, B; Yamagishi, Y				Ito, Toshikazu; Scardua, Bruno; Yamagishi, Yoshikazu			TRANSVERSALITY OF COMPLEX LINEAR DISTRIBUTIONS WITH SPHERES, CONTACT FORMS AND MORSE TYPE FOLIATIONS - II	ASIAN JOURNAL OF MATHEMATICS			English	Article						Takagi's factorization theorem; holomorphic distribution; holonomy group; linear Morse foliation	HOLOMORPHIC FOLIATIONS; ISOLATED SINGULARITY; CANONICAL FORM; MATRICES; CONSIMILARITY; TOPOLOGY; THEOREM	The study of holomorphic foliations transverse to real submanifolds has its own interest, as for instance its connections with the construction or existence of complex structures. The comprehension of the transverse dynamics of such foliations is also granted by that study. As for the non-integrable case, the study of contact forms in the holomorphic framework is related to the study of (non-integrable) codimension one distributions which are transverse to spheres in the affine space. The starting point for our work is the following question: Is there any codimension one holomorphic foliation F in a neighborhood of the closed unit disk <(D-2n(1))over bar> Iota C-n such that F is transverse to the boundary sphere S2n-1(1) for n >= 3? In this paper we study transversality of (integrable or not) holomorphic perturbations of codimension one linear distributions, with spheres in the complex affine space. So far, the examples of such distributions are related to contact forms and are as a kind of counterpart of the integrable case. Based on an extension of Takagi's factorization theorem for nonsingular matrices in terms of Jordan canonical forms of its generalized coneigenvectors, we prove that given a generic nonsingular nxn complex matrix A and any holomorphic one-form omega having its linear part at the origin given by A, the corresponding distribution K(omega):{omega=0} is not transverse to the spheres S2n-1(r) for small r>0. Here, by generic we mean that (A) over barA has a simple positive eigenvalue lambda>0, and any other eigenvalue has absolute value different from lambda. Using this, we are able to conclude that, in C-n, a distribution which is a perturbation of a linear Morse foliation, is not transverse to small spheres and its variety of contacts has at least n branches in a neighborhood of the origin.	[Ito, Toshikazu; Yamagishi, Yoshikazu] Ryukoku Univ, Dept Nat Sci, Fushimi Ku, Kyoto 6120021, Japan; [Scardua, Bruno] Univ Fed Rio de Janeiro, Inst Math, BR-21945970 Rio De Janeiro, RJ, Brazil	Scardua, B (reprint author), Univ Fed Rio de Janeiro, Inst Math, CP 68530, BR-21945970 Rio De Janeiro, RJ, Brazil.	scardua@im.ufrj.br; yg@rins.ryukoku.ac.jp					Fassbender H, 2008, LINEAR ALGEBRA APPL, V429, P1425, DOI 10.1016/j.laa.2008.03.009; Huang LP, 2001, LINEAR ALGEBRA APPL, V331, P21; HONG YP, 1988, LINEAR ALGEBRA APPL, V102, P143, DOI 10.1016/0024-3795(88)90324-2; HONG YP, 1990, LINEAR ALGEBRA APPL, V133, P1, DOI 10.1016/0024-3795(90)90237-7; Chern S. S., 1967, J DIFFER GEOM, V1, P21; Cohn P. M., 1971, FREE RINGS THEIR REL; GOMEZMONT X, 1993, FUNCT ANAL APPL+, V27, P97, DOI 10.1007/BF01085980; Ito T, 2005, TOPOLOGY, V44, P73, DOI 10.1016/j.top.2004.03.005; Ito T, 2010, J GEOM PHYS, V60, P1370, DOI 10.1016/j.geomphys.2010.05.003; Ito T., 1994, RIMS KOKYUROKU, V878, P1; Ito T, 2010, INT J MATH, V21, P435, DOI 10.1142/S0129167X1000615X; Ito T, 2014, J MATH SOC JPN, V66, P123, DOI 10.2969/jmsj/06610123; Ito T, 2005, MOSC MATH J, V5, P379; Jacobson N., 1943, THEORY RINGS; Johnson C. R., 1985, MATRIX ANAL; Limon B, 2011, J TOPOL, V4, P667, DOI 10.1112/jtopol/jtr018; Shub M., 1987, GLOBAL STABILITY DYN; Takagi T., 1924, JAPAN J MATH, V1, P83; Thom R., 1964, ANN I FOURIER, V14, P173	19	0	0	INT PRESS BOSTON, INC	SOMERVILLE	PO BOX 43502, SOMERVILLE, MA 02143 USA	1093-6106	1945-0036		ASIAN J MATH	Asian J. Math.	APR	2015	19	2					343	355				13	Mathematics, Applied; Mathematics	Mathematics	CG1KK	WOS:000353031300008		
J	Kitamura, K; Iino, Y; Kamide, Y; Kudo, F; Nakayama, T; Suzuki, K; Taiji, H; Takahashi, H; Yamanaka, N; Uno, Y				Kitamura, Ken; Iino, Yukiko; Kamide, Yosuke; Kudo, Fumiyo; Nakayama, Takeo; Suzuki, Kenji; Taiji, Hidenobu; Takahashi, Haruo; Yamanaka, Noboru; Uno, Yoshifumi			Clinical Practice Guidelines for the diagnosis and management of acute otitis media (AOM) in children in Japan-2013 update	AURIS NASUS LARYNX			English	Article						Acute otitis media (AOM); Antimicrobial agent; Treatment algorithm; Multidrug-resistant bacteria; Recurrent otitis media (ROM); Vaccination	RANDOMIZED CONTROLLED-TRIAL; PNEUMOCOCCAL CONJUGATE VACCINE; CHRONIC TUBOTYMPANAL DISORDERS; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; HAEMOPHILUS-INFLUENZAE; DOUBLE-BLIND; GASTROESOPHAGEAL-REFLUX; ANTIBIOTIC-TREATMENT; MIDDLE-EAR	Objective: To (1) indicate methods of diagnosis and testing for childhood (<15 years) acute otitis media (AOM) and (2) recommend methods of treatment in accordance with the evidence-based consensus reached by the Subcommittee of Clinical Practice Guideline for Diagnosis and Management of AOM in Children (Subcommittee of Clinical Practice Guideline), in light of the causative bacteria and their drug sensitivity of AOM in Japan. Methods: We investigated the most recently detected bacteria causing childhood AOM in Japan as well as antibacterial sensitivity and the worldwide distinct progress of vaccination, produced Clinical Questions concerning the diagnosis, testing methods, and treatment of AOM, searched literature published during 2000-2004, and issued the 2006 Guidelines [1-4]. In the 2009 and 2013 Guidelines, we performed the same investigation with the addition of literature, which were not included in the 2006 Guidelines and published during 2005-2008 and during 2009-2012, respectively. Results: We categorized AOM as mild, moderate, or severe on the basis of tympanic membrane findings and clinical symptoms, and presented recommended treatment for each degree of severity. Conclusion: Accurate assessment of tympanic membrane findings is important for judging the degree of severity and selecting a method of treatment. Some of new antimicrobial agents and pneumococcal vaccination are recommended as new treatment options. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kitamura, Ken] Chigasaki Cent Hosp, Dept Otolaryngol, Chigasaki, Kanagawa, Japan; [Iino, Yukiko] Jichi Med Univ, Saitama Med Ctr, Dept Otolaryngol, Shimotsuke, Japan; [Kamide, Yosuke] Kamide ENT Clin, Shizuoka, Japan; [Kudo, Fumiyo] Chiba Prefectural Univ Hlth Sci, Fac Hlth Care Sci, Dept Nutr, Chiba, Japan; [Nakayama, Takeo] Kyoto Univ, Grad Sch Med, Dept Hlth Informat, Kyoto 6068501, Japan; [Suzuki, Kenji] Fujita Hlth Univ, Sch Med, Banbuntane Houtokukai Hosp, Dept Otolaryngol, Toyoake, Aichi, Japan; [Taiji, Hidenobu] Saiseikai Cent Hosp, Dept Otorhinolaryngol, Tokyo, Japan; [Takahashi, Haruo] Nagasaki Univ, Grad Sch Biomed Sci, Dept Otolaryngol Head & Neck Surg, Nagasaki 8528501, Japan; [Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Uno, Yoshifumi] UNO ENT Clin, Okayama, Japan	Takahashi, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Otolaryngol Head & Neck Surg, Sakamoto 1-7-1, Nagasaki 8528501, Japan.	htak0831@nagasaki-u.ac.jp			JOS operating expenses	Production of these Guidelines was funded by JOS operating expenses. The JOS does not receive support from any specific organizations or companies. A list of organizations and companies that posed non-personal financial conflicts of interest to members of the Subcommittee of Clinical Practice Guideline during the production of these Guidelines is provided as follows:; Astellas Pharma Inc.; Bayer Yakuhin, Ltd.; Dahchi Sankyo Company,; Limited GlaxoSmithKline K.K.; Kyorin 'Pharmaceutical Co., Ltd.; Kowa Shinyaku Co., Ltd.; Lumenis Japan Co., Ltd.; Meiji Seika Pharma Co. Ltd.; Nippon Boehringer Ingelheim Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Pfizer Japan Inc.; Sanofi K.K.; Sumitomo Dainippon Pharma Co., Ltd.; Taisho Toyama Pharmaceutical Co., Ltd.; AstraZeneca K.K.; Chugai Pharmaceutical Co., Ltd.; Eisai Co., Ltd.; Kissei Pharmaceutical Co., Ltd.; Kowa Pharmaceutical Co. Ltd.; Kyowa Hakko Kirin., Co. Ltd.; MSD K.K.; Mitsubishi Tanabe Pharma Corporation; Nippon Shinyaku Co., Ltd.; Otsuka Pharmaceutical Co. Ltd.; Shionogi & Co., Ltd.; Senju Pharmaceutical Co., Ltd.; Taiho Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Company Limited	Ables AZ, 2004, J FAM PRACTICE, V53, P186; Littlejohns P, 2000, INT J TECHNOL ASSESS, V16, P1039; TEELE DW, 1989, J INFECT DIS, V160, P83; Atkins D, 2004, BRIT MED J, V328, P1490; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Rosenfeld RM, 2001, OTOLARYNG HEAD NECK, V125, P440, DOI 10.1067/mhn.2001.119326; Marchisio P, 2010, INT J PEDIATR OTORHI, V74, P1209, DOI 10.1016/j.ijporl.2010.08.016; Shiffman RN, 2003, ANN INTERN MED, V139, P493; [Anonymous], 2006, OTOL JPN S1, V16; [Anonymous], 2010, MINERVA PEDIATR; Hammaren-Malmi S, 2005, PEDIATRICS, V116, P185, DOI 10.1542/peds.2004-2253; Brouwer CNM, 2005, PEDIATRICS, V115, P273, DOI 10.1542/peds.2004-0778; Ghaffar F, 2002, CLIN INFECT DIS, V34, P1301, DOI 10.1086/340054; Little P, 2006, BRIT J GEN PRACT, V56, P176; Miura MS, 2012, OTOLARYNG HEAD NECK, V146, P345, DOI 10.1177/0194599811430809; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Friedman NR, 2006, PEDIATR INFECT DIS J, V25, P101, DOI 10.1097/01.inf.0000199290.73333.89; [Anonymous], 2006, PEDIAT OTORHINOLARYN, V27, P71; Rosenfeld RM, 2003, LARYNGOSCOPE, V113, P1645, DOI 10.1097/00005537-200310000-00004; Spiro DM, 2006, JAMA-J AM MED ASSOC, V296, P1235, DOI 10.1001/jama.296.10.1235; Tasker A, 2002, LARYNGOSCOPE, V112, P1930, DOI 10.1097/00005537-200211000-00004; Arrieta A, 2004, PEDIATR INFECT DIS J, V23, pS115, DOI 10.1097/01.inf.0000112525.88779.8b; Benninger MS, 2008, OTOLARYNG HEAD NECK, V138, P274, DOI 10.1016/j.otohns.2007.11.011; Biner B, 2007, TURKISH J PEDIATR, V49, P390; Boonacker CWB, 2011, PHARMACOECONOMICS, V29, P199, DOI 10.2165/11584930-000000000-00000; Chan LS, 2001, PEDIATRICS, V108, P248, DOI 10.1542/peds.108.2.248; Dagan R, 2000, VACCINE, V19, pS9, DOI 10.1016/S0264-410X(00)00272-3; Dagan R, 2001, J INFECT DIS, V183, P880, DOI 10.1086/319250; Damoiseaux RAMJ, 2000, BRIT MED J, V320, P350, DOI 10.1136/bmj.320.7231.350; Dinleyici Ener Cagri, 2010, Expert Rev Vaccines, V9, P1017, DOI 10.1586/erv.10.86; Faden H, 1998, PEDIATR INFECT DIS J, V17, P1105, DOI 10.1097/00006454-199812000-00002; Forgie S, 2009, PAEDIATR CHILD HEALT, V14, P457; Fukui T, 2003, EBM J, V4, P284; Ghaffar F, 2000, CLIN INFECT DIS, V31, P875, DOI 10.1086/318160; Gisselsson-Solen M, 2011, ACTA PAEDIATR, V100, P1354, DOI 10.1111/j.1651-2227.2011.02332.x; Glasziou PP, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858BCD000219.PUB2; Glasziou PP, 2000, COCHRANE DB SYST REV; Haiman T, 2002, PEDIATR INFECT DIS J, V21, P642, DOI 10.1097/01.inf.0000019886.24862.20; Hayashi T, 2007, OTOL JPN, V17, P118; Hotomi M, 2012, PLOS ONE, V7; Hotomi M, 2004, ANN OTO RHINOL LARYN, V113, P846; Hotomi M, 2005, EUR J PEDIATR, V164, P3, DOI 10.1007/s00431-004-1564-0; Ito M, 2008, PEDIAT OTORHINOLARYN, V29, P20; Jacobs J, 2001, PEDIATR INFECT DIS J, V20, P177, DOI 10.1097/00006454-200102000-00012; Japan Otological Society Japan Society for Pediatric Otorhinolar-yngology Japan Society for Infectious Diseases in Otolaryngology, 2006, CLIN PRACT GUID DIAG; Japan Otological Society Japan Society for Pediatric Otorhinolaryngology Japan Society for Infectious Diseases in Otolaryngology, 2009, CLIN PRACT GUID DIAG; Kamide Y, 2003, OTORHINOLARYNGOL TOK, V46, P17; Kay D, 2003, EVIDENCE BASED OTITI, P180; Koivunen P, 2004, BRIT MED J, V328, P487, DOI 10.1136/bmj.37972.678345.0D; Le Saux N, 2005, CAN MED ASSOC J, V172, P335, DOI 10.1503/cmaj.1040771; Lubianca Neto José Faibes, 2006, J. Pediatr. (Rio J.), V82, P87, DOI 10.1590/S0021-75572006000200003; Maruyama Y, 2009, ACTA OTO-LARYNGOL, V129, P14, DOI 10.1080/00016480801998838; McCormick DP, 2005, PEDIATRICS, V115, P1455, DOI 10.1542/peds.2004-1665; Montanari G, 2010, MINERVA PEDIATR, V62, P9; Nakayama T, 2004, CLIN PRACTICE GUIDEL; Nishimura T, 2004, J JPN SOC INFECT DIS, V22, P12; Nomura Y, 2005, INT J PEDIATR OTORHI, V69, P61, DOI 10.1016/j.ijporl.2004.08.002; Oomen KPC, 2005, LARYNGOSCOPE, V115, P731, DOI 10.1097/01.mlg.0000161328.37482.a2; Ovetchkine Philippe, 2003, Paediatr Drugs, V5, P133, DOI 10.2165/00128072-200305020-00006; Piglansky L, 2003, PEDIATR INFECT DIS J, V22, P405, DOI 10.1097/00006454-200305000-00003; Rosenfeld RM, 2003, EVIDENCE BASED OTITI, P199; Rozmanic V, 2002, J PEDIATR GASTR NUTR, V34, P278; Saeed K, 2004, PEDIATR INFECT DIS J, V23, P1030, DOI 10.1097/01.inf.0000143653.69275.4d; Sher L, 2005, PEDIATR INFECT DIS J, V24, P301, DOI 10.1097/01.inf.0000157084.35865.ba; Straetemans M, 2004, COCHRANE DB SYST REV, V1; Sugahara K, 2007, PEDIAT OTORHINOLARYN, V28, P206; Suzuki K, 2000, PEDIAT OTORHINOLARYN, V21, P26; SUZUKI K, 2009, JPN J CHEMOTHER S1, V57, P167; Toltzis P, 2005, PEDIATR INFECT DIS J, V24, P24, DOI 10.1097/01.inf.0000148880.61449.82; Uno Y, 2007, OTOL JPN, V17, P194; Uno Y, 2007, OTOL JPN, V17, P16; VANBUCHEM FL, 1985, BRIT MED J, V290, P1033; van Gils EJM, 2011, VACCINE, V29, P7595, DOI 10.1016/j.vaccine.2011.08.049; van Kempen MJP, 2004, EUR J PEDIATR, V163, P524, DOI 10.1007/s00431-004-1475-0; Velepic M, 2000, INT J PEDIATR OTORHI, V55, P187, DOI 10.1016/S0165-5876(00)00396-7; Wiertsema SP, 2006, J ALLERGY CLIN IMMUN, V117, P1344, DOI 10.1016/j.jaci.2006.01.031; Yamanaka N, 2014, PRACT OTORHINOLARYNG, V107, P7; Yamanaka Noboru, 2008, Journal of Infection and Chemotherapy, V14, P180, DOI 10.1007/s10156-007-0599-3; Yoshizaki T, 2012, MULTICENTER RANDOMIZ	79	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					99	106		10.1016/j.anl.2014.09.006		8	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500001		
J	Shiono, O; Sakuma, Y; Komatsu, M; Hirama, M; Yamashita, Y; Ishitoya, J; Oridate, N				Shiono, Osamu; Sakuma, Yasunori; Komatsu, Masanori; Hirama, Mariko; Yamashita, Yukiko; Ishitoya, Junichi; Oridate, Nobuhiko			Differential expression of periostin in the nasal polyp may represent distinct histological features of chronic rhinosinusitis	AURIS NASUS LARYNX			English	Article						Periostin; Chronic rhinosinusitis; Nasal polyp; Remodeling	EOSINOPHILIC CHRONIC RHINOSINUSITIS; PERIODONTAL-LIGAMENT; CHRONIC SINUSITIS; BRONCHIAL-ASTHMA; CELLS; COLLAGEN; DISEASE; BETA	Objective: Chronic rhinosinusitis (CRS) is thought to be a multifactorial disease, and it is classified into a number of subtypes according to clinicohistological features. Periostin, a 90-kDa secreted protein, was reported to exist in nasal polyps (NPs) associated with CRS. We compared the expression of periostin with the degree of eosinophilic infiltration as well as tissue remodeling. Materials and methods: Tissue samples were collected from 28 patients of CRS with NPs, and clinicohistological features were evaluated. The pattern of periostin expression was assessed immunohistochemically. Result: Two patterns of periostin expression was observed in nasal polyps: "diffuse type", in which periostin was expressed throughout the lamina propria starting just below the basement membrane, and "superficial type", in which the protein was detected only in the subepithelial layers between the basement membrane and the nasal gland. The average infiltrated eosinophil count in the diffuse type was significantly higher than that in the superficial type (diffuse type 360.5 +/- 393.0 vs. superficial type 8.46 +/- 13.81, p = 0.001). Tissue remodeling was observed in 17 (85.0%) of the 20 diffuse-type nasal polyps, but only in one (12.5%) of the eight superficial-type nasal polyps (p < 0.001). Conclusion: At least two distinct patterns of periostin expression were observed in the nasal polyps associated with CRS in accordance with the heterogeneous mechanisms underlying the pathogenesis of CRS with NPs. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Shiono, Osamu; Komatsu, Masanori; Oridate, Nobuhiko] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Yokohama, Kanagawa 2360004, Japan; [Shiono, Osamu; Sakuma, Yasunori; Hirama, Mariko; Yamashita, Yukiko; Ishitoya, Junichi] Yokohama City Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Yokohama, Kanagawa 2360004, Japan	Shiono, O (reprint author), Yokohama City Univ, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	oshiono@yokohama-cu.ac.jp					Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Takeno Sachio, 2010, Allergol Int, V59, P247, DOI 10.2332/allergolint.10-RAI-0202; Cao Ping-Ping, 2009, J Allergy Clin Immunol, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Stankovic KM, 2008, LARYNGOSCOPE, V118, P881, DOI 10.1097/MLG.0b013e31816b4b6f; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Kim SW, 2013, LARYNGOSCOPE, V123, P1075, DOI 10.1002/lary.23786; Wilde J, 2003, CELL TISSUE RES, V312, P345, DOI 10.1007/s00441-002-0664-2; Sakuma Y, 2011, AURIS NASUS LARYNX, V38, P583, DOI 10.1016/j.anl.2011.01.007; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Ishida A, 2012, ALLERGOL INT, V61, P589, DOI 10.2332/allergolint.11-OA-0370; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Ichimura Keiichi, 1996, Auris Nasus Larynx, V23, P48; Ishitoya Junichi, 2010, Allergol Int, V59, P239, DOI 10.2332/allergolint.10-RAI-0231; Li P, 2004, J APPL PHYSIOL, V97, P1550, DOI 10.1152/japplphysiol.01311.2003; Meltzer EO, 2006, J ALLERGY CLIN IMMUN, V118, pS17, DOI 10.1016/j.jaci.2006.09.005; Moriyama Hiroshi, 1995, Rhinology (Utrecht), V33, P166; Suzuki H, 1997, TOHOKU J EXP MED, V182, P115, DOI 10.1620/tjem.182.115; Watanabe T, 2014, ARCH ORAL BIOL, V59, P595, DOI 10.1016/j.archoralbio.2014.03.003; Yang LL, 2014, J INVEST DERMATOL, V134, P2105, DOI 10.1038/jid.2014.120; Yuyama N, 2002, CYTOKINE, V19, P287, DOI 10.1006/cyto.2002.1972	24	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	APR	2015	42	2					123	127		10.1016/j.anl.2014.09.003		5	Otorhinolaryngology	Otorhinolaryngology	CF9YT	WOS:000352924500005		
